Psyllid ID: psy14431
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1219 | 2.2.26 [Sep-21-2011] | |||||||
| Q8TD08 | 544 | Mitogen-activated protein | yes | N/A | 0.185 | 0.415 | 0.544 | 5e-77 | |
| Q9Z2A6 | 547 | Mitogen-activated protein | yes | N/A | 0.182 | 0.407 | 0.554 | 7e-76 | |
| Q80Y86 | 549 | Mitogen-activated protein | yes | N/A | 0.182 | 0.406 | 0.554 | 9e-76 | |
| Q11179 | 470 | Putative serine/threonine | yes | N/A | 0.189 | 0.491 | 0.532 | 1e-74 | |
| Q54QB1 | 369 | Extracellular signal-regu | yes | N/A | 0.185 | 0.612 | 0.532 | 2e-71 | |
| P70336 | 1388 | Rho-associated protein ki | no | N/A | 0.232 | 0.204 | 0.396 | 6e-57 | |
| Q62868 | 1388 | Rho-associated protein ki | no | N/A | 0.232 | 0.204 | 0.393 | 1e-56 | |
| Q39025 | 376 | Mitogen-activated protein | yes | N/A | 0.169 | 0.550 | 0.478 | 2e-55 | |
| A5PKJ4 | 781 | Mitogen-activated protein | no | N/A | 0.173 | 0.271 | 0.475 | 1e-54 | |
| Q9WVS8 | 806 | Mitogen-activated protein | no | N/A | 0.173 | 0.263 | 0.475 | 1e-54 |
| >sp|Q8TD08|MK15_HUMAN Mitogen-activated protein kinase 15 OS=Homo sapiens GN=MAPK15 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 290 bits (742), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 129/237 (54%), Positives = 177/237 (74%), Gaps = 11/237 (4%)
Query: 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 608
+D + R L++Q+ G+GAYGIV+KA D+ + VAIKKIF+AFR+KTDAQRT+R
Sbjct: 5 VDPRIVRRYLLRRQL-----GQGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFR 59
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMF 667
EI L+ F HPNII++LD+ +A N++D+Y+VFE+M+ DLN VIR +L+DVH+R I +
Sbjct: 60 EITLLQEFGDHPNIISLLDVIRAENDRDIYLVFEFMDTDLNAVIRKGGLLQDVHVRSIFY 119
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIA 722
QL ++H+ V+HRD KPSN+L+D +C++K+ D GLARSL D E +TEY+A
Sbjct: 120 QLLRATRFLHSGHVVHRDQKPSNVLLDANCTVKLCDFGLARSLGDLPEGPEDQAVTEYVA 179
Query: 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779
TRWYRAPE+L+S+ RYT VD+WSLGCIL EML+ +PLFPG ST HQL+LI+ + P
Sbjct: 180 TRWYRAPEVLLSSHRYTLGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETIPP 236
|
In vitro, phosphorylates MBP. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9Z2A6|MK15_RAT Mitogen-activated protein kinase 15 OS=Rattus norvegicus GN=Mapk15 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 7e-76, Method: Compositional matrix adjust.
Identities = 127/229 (55%), Positives = 172/229 (75%), Gaps = 6/229 (2%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
DR Q+ + + GKGAYGIV+KA D+ + VAIKKIF+AFR++TDAQRT+REI+ L+
Sbjct: 7 DRHVSQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQTDAQRTFREIMLLR 66
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNGL 673
F HPNII +LD+ A N++D+Y+VFE M+ DLN VI + ++L+D+H R I +QL
Sbjct: 67 EFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLEDIHKRCIFYQLLRAT 126
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYRA 728
+IH+ +V+HRD KP+N+L+D +C +K+ D GLARSLSD E LTEY+ATRWYRA
Sbjct: 127 KFIHSGRVIHRDQKPANVLLDAACRVKLCDFGLARSLSDFPEGPGGQALTEYVATRWYRA 186
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
PE+L+S+R YT VD+WSLGCIL EML+ +PLFPG ST HQL+LI+ +
Sbjct: 187 PEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILETI 235
|
Constitutively active kinase which may function as a negative regulator of cell growth. In vitro, phosphorylates FOS. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q80Y86|MK15_MOUSE Mitogen-activated protein kinase 15 OS=Mus musculus GN=Mapk15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 127/229 (55%), Positives = 170/229 (74%), Gaps = 6/229 (2%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
DR Q+ + + GKGAYGIV+KA D+ + VAIKKIF+AFR++ DAQRT+REI+ LK
Sbjct: 7 DRHVAQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQIDAQRTFREIMLLK 66
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNGL 673
F HPNII +LD+ A N++D+Y+VFE M+ DLN VI + ++LKD+H R I +QL
Sbjct: 67 EFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLKDIHKRCIFYQLLRAT 126
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYRA 728
+IH+ +V+HRD KP+N+L+D +C +K+ D GLARSL D E LTEY+ATRWYRA
Sbjct: 127 KFIHSGRVIHRDQKPANVLLDSACRVKLCDFGLARSLGDLPEGPGGQALTEYVATRWYRA 186
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
PE+L+S+R YT VD+WSLGCIL EML+ +PLFPG ST HQL+LI+ +
Sbjct: 187 PEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILKTI 235
|
Constitutively active kinase which may function as a negative regulator of cell growth. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q11179|YPC2_CAEEL Putative serine/threonine-protein kinase C05D10.2 OS=Caenorhabditis elegans GN=C05D10.2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 131/246 (53%), Positives = 185/246 (75%), Gaps = 15/246 (6%)
Query: 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 608
+D + ++ DLQ+++ GKGAYGIV+KAYDK +++ VA+KKIF+AFRN TD+QRT+R
Sbjct: 5 VDTHIHEKFDLQKRL-----GKGAYGIVWKAYDKRSRETVALKKIFDAFRNPTDSQRTFR 59
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMF 667
E++FL+ F +HPN+I + +I++A N++D+Y+ FE+ME DL+ VI + ILKDVH +YIM
Sbjct: 60 EVMFLQEFGKHPNVIKLYNIFRADNDRDIYLAFEFMEADLHNVIKKGSILKDVHKQYIMC 119
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKEC-----LTE 719
QL + ++H+ V+HRDLKPSN+L+D C +K+ D GLARSLS D E LTE
Sbjct: 120 QLFRAIRFLHSGNVLHRDLKPSNVLLDADCRVKLADFGLARSLSSLEDYPEGQKMPDLTE 179
Query: 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779
Y+ATRWYR+PEIL++ +RYT VD+WSLGCILAEML + LFPG+ST +Q++ I+N +
Sbjct: 180 YVATRWYRSPEILLAAKRYTKGVDMWSLGCILAEMLIGRALFPGSSTINQIERIMNTIA- 238
Query: 780 NPPHAD 785
P AD
Sbjct: 239 KPSRAD 244
|
Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q54QB1|ERK2_DICDI Extracellular signal-regulated kinase 2 OS=Dictyostelium discoideum GN=erkB PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 124/233 (53%), Positives = 174/233 (74%), Gaps = 7/233 (3%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
D+ L++ L K GKGAYGIV+KA DK KQ VA+KKIF+AF+N TDAQRT+REI+FL+
Sbjct: 7 DKHVLRKYEVLQKIGKGAYGIVWKAIDKKTKQTVALKKIFDAFQNATDAQRTFREIMFLQ 66
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLS 674
H NII +L++ KA N++D+Y+VFE+ME DL+ VIR KIL+++H +Y ++QL L
Sbjct: 67 ELHGHENIIKLLNVIKADNDRDIYLVFEHMETDLHAVIRAKILEEIHKQYTIYQLLKALK 126
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS------DSKECLTEYIATRWYRA 728
Y+H+ V+HRD+KPSN+L++ C +K+ D GLARS++ ++ LTEY+ATRWYRA
Sbjct: 127 YMHSANVLHRDIKPSNLLLNSECLVKVADFGLARSITSLESIAEANPVLTEYVATRWYRA 186
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPN 780
PEIL+ + +YT VD+WS+GCIL E+L K +FPG ST +QL LI+ + RP+
Sbjct: 187 PEILLGSTKYTKGVDMWSIGCILGELLGEKAMFPGNSTMNQLDLIIEVTGRPS 239
|
Implicated in the relay of the cAMP chemotactic signal and cell differentiation. Important for receptor-mediated activation of adenylyl cyclase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|P70336|ROCK2_MOUSE Rho-associated protein kinase 2 OS=Mus musculus GN=Rock2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 143/361 (39%), Positives = 199/361 (55%), Gaps = 77/361 (21%)
Query: 917 ELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKS 976
ELE+K++MA+H+ +L+ K++ +++ +E + L ++E+L ++ +E+L K
Sbjct: 947 ELEIKEMMARHKQELTEKDTTIASLEETNRTLTSDVANLANEKEELNNKLKDSQEQLSKL 1006
Query: 977 SNSSEEME------KLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRK 1030
+ EEM + KQL E+ LK QAVNKLAEIMNRK+ + S DVR+
Sbjct: 1007 KD--EEMSAAAIKAQFEKQLLNERTLKTQAVNKLAEIMNRKE------PVKRGSDTDVRR 1058
Query: 1031 KEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 1090
KEKE RKL EL EREK Q ++K QKEL E+Q+Q+ EE+ +++LQM LDSKDS+IEQ
Sbjct: 1059 KEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQ 1118
Query: 1091 LQGKLAAL--GSETASLSS--ADVENDESYV----------------------------- 1117
L+ +L AL G +++S+ S D E D+ +
Sbjct: 1119 LRSQLQALHIGMDSSSIGSGPGDAEPDDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVS 1178
Query: 1118 ----------QDEVRS--------------RSVTQGDVIRADAKDIPRIFQLLYAGEGEA 1153
QD+ +S R VTQ DV RADAK+IPRIFQ+LYA EGE+
Sbjct: 1179 SKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGES 1238
Query: 1154 RRPEDGGAELPAVLRGGDEKPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALE 1213
++ E P G EK I KGHEF+ YH PT CE C KP+WH+ +PPPALE
Sbjct: 1239 KK----EPEFPVEPVG--EKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALE 1292
Query: 1214 C 1214
C
Sbjct: 1293 C 1293
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q62868|ROCK2_RAT Rho-associated protein kinase 2 OS=Rattus norvegicus GN=Rock2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 222 bits (566), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 143/363 (39%), Positives = 199/363 (54%), Gaps = 79/363 (21%)
Query: 917 ELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDRE-------DLQQQINLL 969
ELE+K++MA+H+ +L+ K++ +++ +E + L ++E D Q+Q++ L
Sbjct: 947 ELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDTQEQLSKL 1006
Query: 970 KEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVR 1029
K+E ++ + EK QL E+ LK QAVNKLAEIMNRK+ + S DVR
Sbjct: 1007 KDEEISAAAIKAQFEK---QLLTERTLKTQAVNKLAEIMNRKE------PVKRGSDTDVR 1057
Query: 1030 KKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 1089
+KEKE RKL EL EREK Q ++K QKEL E+Q+Q+ EE+ +++LQM LDSKDS+IE
Sbjct: 1058 RKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIE 1117
Query: 1090 QLQGKLAAL--GSETASLSS--ADVENDESYV---------------------------- 1117
QL+ +L AL G +++S+ S D E D+ +
Sbjct: 1118 QLRSQLQALHIGMDSSSIGSGPGDAEPDDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIV 1177
Query: 1118 -----------QDEVRS--------------RSVTQGDVIRADAKDIPRIFQLLYAGEGE 1152
QD+ +S R VTQ DV RADAK+IPRIFQ+LYA EGE
Sbjct: 1178 SSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGE 1237
Query: 1153 ARRPEDGGAELPAVLRGGDEKPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPAL 1212
+++ E P G EK I KGHEF+ YH PT CE C KP+WH+ +PPPAL
Sbjct: 1238 SKK----EPEFPVEPVG--EKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPAL 1291
Query: 1213 ECG 1215
EC
Sbjct: 1292 ECS 1294
|
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 102/213 (47%), Positives = 149/213 (69%), Gaps = 6/213 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG V A D + +AIKKI +AF NK DA+RT REI L+ + H N++ + DI
Sbjct: 50 GRGAYGFVCAAVDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLE-HENVVVIKDI 108
Query: 629 YKAVNNKDL---YVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ +D Y+VFE M+ DL+++IR ++ L D H +Y ++Q+ GL YIH+ V+HR
Sbjct: 109 IRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHR 168
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSN+L++ +C +KI D GLAR+ S++ E +TEY+ TRWYRAPE+L+++ YT +D+
Sbjct: 169 DLKPSNLLLNSNCDLKITDFGLARTTSET-EYMTEYVVTRWYRAPELLLNSSEYTSAIDV 227
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
WS+GCI AE++ +PLFPG HQL+LI L+
Sbjct: 228 WSVGCIFAEIMTREPLFPGKDYVHQLKLITELI 260
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|A5PKJ4|MK07_BOVIN Mitogen-activated protein kinase 7 OS=Bos taurus GN=MAPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 106/223 (47%), Positives = 149/223 (66%), Gaps = 11/223 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG+V A + Q VAIKKI AF T+A+RT RE+ LK F +H NII + DI
Sbjct: 62 GNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDI 120
Query: 629 YKAVNN----KDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ K +YVV + ME+DL+++I + L H+RY ++QL GL Y+H+ +V+H
Sbjct: 121 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIH 180
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILISNRRYT 739
RDLKPSN+L++++C +KIGD G+AR L S +TEY+ATRWYRAPE+++S YT
Sbjct: 181 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 240
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 781
+D+WS+GCI EML + LFPG + HQLQLI+ ++ P+P
Sbjct: 241 QAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMTVLGTPSP 283
|
Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9WVS8|MK07_MOUSE Mitogen-activated protein kinase 7 OS=Mus musculus GN=Mapk7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 106/223 (47%), Positives = 149/223 (66%), Gaps = 11/223 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG+V A + Q VAIKKI AF T+A+RT RE+ LK F +H NII + DI
Sbjct: 62 GNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDI 120
Query: 629 YKAVNN----KDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMH 683
K + +YVV + ME+DL+++I + L H+RY ++QL GL Y+H+ +V+H
Sbjct: 121 LKPTVPYGEFRSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIH 180
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILISNRRYT 739
RDLKPSN+L++++C +KIGD G+AR L S +TEY+ATRWYRAPE+++S YT
Sbjct: 181 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 240
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 781
+D+WS+GCI EML + LFPG + HQLQLI+ ++ P+P
Sbjct: 241 QAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 283
|
Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1219 | ||||||
| 307183656 | 1370 | Rho-associated protein kinase 2 [Campono | 0.415 | 0.370 | 0.481 | 1e-123 | |
| 307212717 | 1370 | Rho-associated protein kinase 2 [Harpegn | 0.422 | 0.375 | 0.476 | 1e-122 | |
| 383861819 | 1370 | PREDICTED: rho-associated protein kinase | 0.420 | 0.373 | 0.475 | 1e-121 | |
| 332025901 | 1371 | Rho-associated protein kinase 2 [Acromyr | 0.422 | 0.375 | 0.479 | 1e-121 | |
| 328792632 | 1370 | PREDICTED: rho-associated protein kinase | 0.420 | 0.373 | 0.470 | 1e-119 | |
| 340708620 | 1342 | PREDICTED: rho-associated protein kinase | 0.420 | 0.381 | 0.470 | 1e-119 | |
| 380023438 | 1370 | PREDICTED: rho-associated protein kinase | 0.420 | 0.373 | 0.470 | 1e-119 | |
| 350413242 | 1370 | PREDICTED: rho-associated protein kinase | 0.420 | 0.373 | 0.470 | 1e-119 | |
| 189237841 | 2513 | PREDICTED: similar to rho-associated pro | 0.410 | 0.199 | 0.461 | 1e-115 | |
| 270007958 | 1336 | hypothetical protein TcasGA2_TC014705 [T | 0.410 | 0.375 | 0.461 | 1e-115 |
| >gi|307183656|gb|EFN70359.1| Rho-associated protein kinase 2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1155), Expect = e-123, Method: Compositional matrix adjust.
Identities = 283/588 (48%), Positives = 384/588 (65%), Gaps = 81/588 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N + NG + +L++LL+RERR++ +E RQ+ L+ Q EA++ RE LR+E+G+
Sbjct: 418 LENHVNNGTTDDVKISQLENLLDRERRQIETMESRQKALNIQLEAMTCREAELREEVGRA 477
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAEVNL---------------------------- 99
+K LT+LRH+ KE+QRR ++E+E ++KAE L
Sbjct: 478 DKELTLLRHNYKEAQRRVEHETEIRRKAESLLVEVKKKFDEEQTRRARDVSTSQQTSERV 537
Query: 100 ----QVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
+ I +M KL+ E ET TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 538 TTLEKQIKEMQCKLERETETVTRLRKQATEITVARQAAEQMASELQVARAQLQAQRDNLQ 597
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVATLQ ++S+ERSS++QA L ELE
Sbjct: 598 QEVATLQGQLSKERSSRSQASLLTAELE-------------------------------- 625
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
RL AL+ ELER++ +E + DNR L E++S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 626 -----TRLSALHLELERSREKEEKATLDNRQLNERISALEKEAASLTLELKAAQARYNQE 680
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 681 VMAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 733
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL QTSEA L+
Sbjct: 734 LSVDYRQIQQRLQKLE--GEHRQEVEKVKVLQGQVEQEQQKRNVLQTDLGQQTSEAGRLR 791
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 792 AREQQLIGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 851
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE++R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 852 ELREELDEKARLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 911
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI 563
E KD +AKH +LS+KE +++ KE E ++KKS+DQ +K++EDL +++
Sbjct: 912 EYKDGVAKHHQELSAKEQIINRLKENESEFKKSVDQTLKEKEDLSKRL 959
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307212717|gb|EFN88393.1| Rho-associated protein kinase 2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-122, Method: Compositional matrix adjust.
Identities = 284/596 (47%), Positives = 388/596 (65%), Gaps = 81/596 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N + NG + +L++LL+RERR++ +E RQ+ L+ Q +A++ RE LR+E+G+
Sbjct: 419 LENHVNNGTTDDVKISQLENLLDRERRQVETMESRQKVLNTQLDAMTRREAELREEIGRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAEVNL---------------------------- 99
+K LT+LRH+ KE+QRR ++E+ET++KAE L
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETETRRKAESLLVELKKKFDEEQTRRVRDASNSQQTSERV 538
Query: 100 ----QVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
+ + +M KL+ E ETATRLRKQ+ E+TVA+ A EQM ELQ + A L+ +RD LQ
Sbjct: 539 TTLEKQLKEMQCKLERETETATRLRKQTTEVTVARQAAEQMASELQVVRAQLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVA LQ ++S+ERSS++QA +L ELE
Sbjct: 599 QEVAALQGQLSKERSSRSQASSLTAELE-------------------------------- 626
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
RL AL+ ELER+ +E + DNR L E+VS+LEKE ASL+LELKAAQA+Y QE
Sbjct: 627 -----TRLSALHLELERSHEKEEKATLDNRQLNERVSALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQVKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ++L QTSEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEMEKVKVLQGQVEQEQQKRNVLQTELGQQTSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLVGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R E EEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKVRLQQEFEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKG 571
E KD +AKH +L++KE L++ KE E ++KKS++Q +KD+EDL +++ L+E G
Sbjct: 913 EYKDGVAKHHQELNAKEQLINRLKENESEFKKSVEQTLKDKEDLSKRLKELQEQLG 968
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383861819|ref|XP_003706382.1| PREDICTED: rho-associated protein kinase 2 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1140), Expect = e-121, Method: Compositional matrix adjust.
Identities = 282/593 (47%), Positives = 388/593 (65%), Gaps = 81/593 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N I NG + +L++LL++ERR++ LE RQ+ L+ Q EA++ RET LR+E+G++
Sbjct: 419 LENHINNGTSDDVKISQLENLLDKERRQVESLESRQKALTTQLEAMTRRETELREEIGRV 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAE---VNLQV----------------------- 101
+K LT+LRH+ KE+QRR ++E+ET++KAE V L+
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETETRRKAESLFVELKKKFDEEQTKRARDASNSQQTSERV 538
Query: 102 ------ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
I +M KL+ E ET TRLRKQ+ E+TV + A EQM ELQ A L+ +RD LQ
Sbjct: 539 TTLEKQIKEMQSKLERETETVTRLRKQATEITVVRQAAEQMASELQVARAQLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVATLQ ++S+ERSS++QA +L ELE
Sbjct: 599 QEVATLQGQLSKERSSRSQASSLTAELE-------------------------------- 626
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
RL AL+ ELE ++ +E + DNR L E++S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 627 -----TRLSALHLELEHSREKEEKALLDNRQLTERISALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL+ Q+SEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEVEKVKVLQGQVEQEQQKRNVLQTDLAQQSSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLVGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERASLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
E KD +AKH +L+SKE +++ K+ E + KKS+DQ +K+++D +++ L++
Sbjct: 913 EYKDGVAKHHQELNSKEQIINRLKDNESELKKSVDQYLKEKDDFSKRLKELQD 965
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332025901|gb|EGI66057.1| Rho-associated protein kinase 2 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1136), Expect = e-121, Method: Compositional matrix adjust.
Identities = 286/596 (47%), Positives = 384/596 (64%), Gaps = 81/596 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N + NG + +L++LLERERR++ +E RQ+ L+ Q E ++ RE LR+E+ +
Sbjct: 419 LENHVNNGTSDDIKISQLENLLERERRQVETMESRQKALNTQLETMACREVELREEVSRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAEVNL---------------------------- 99
+K LT+LRH+ KE+QRR ++E+ET++KAE L
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETETRRKAESLLVEVKKKFDEEQTRRARDASNSQQTSERV 538
Query: 100 ----QVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
+ I +M KL+ E ET TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 539 TTLEKQIKEMQCKLERETETVTRLRKQATEITVARQAAEQMANELQVARAQLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVATLQ ++S+ERSS++QA L ELE RL L HL
Sbjct: 599 QEVATLQGQLSKERSSRSQASLLTAELETRLSTL-------------------HL----- 634
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
ELER+ +E + DNR L E+VS+LEKE ASL+LELKAAQA+Y QE
Sbjct: 635 -------------ELERSHEKEEKATLDNRQLTERVSALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQVKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK+K LQ QVEQEQ K+ LQ++L QTSEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEMEKAKVLQGQVEQEQQKRNVLQTELGQQTSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLVGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKG 571
E KD + KH +LS+KE +++ KE E ++KKS+DQ +K++EDL ++ L+E G
Sbjct: 913 EYKDGVTKHHQELSTKEQIINRLKENESEFKKSVDQTLKEKEDLSKRYKELQEQLG 968
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792632|ref|XP_003251752.1| PREDICTED: rho-associated protein kinase 2-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-119, Method: Compositional matrix adjust.
Identities = 279/593 (47%), Positives = 385/593 (64%), Gaps = 81/593 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N I NG + +L++LL++E+R++ LE RQ+ L+ Q E ++ RET LR+E+G+
Sbjct: 419 LENHINNGTSDDIKISQLENLLDKEKRQVESLESRQKALTTQLEVMTRRETELREEIGRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAE---VNLQV----------------------- 101
+K LT+LRH+ KE+QRR ++E+E+++KAE V L+
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETESRRKAESLFVELKKKFDEEQTKRARDASNSQQTSERV 538
Query: 102 ------ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
I +M KL+ E ET TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 539 TSLEKQIKEMQSKLERETETVTRLRKQATEITVARQAAEQMANELQVARAQLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEV TLQ ++S+ERSS++QA +L ELE RL
Sbjct: 599 QEVVTLQGQLSKERSSRSQASSLTAELESRLS---------------------------- 630
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
AL+ ELE ++ +E + DNR L EK+S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 631 ---------ALHLELEHSREKEEKAIMDNRQLTEKISALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL+ Q+SEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEMEKVKVLQGQVEQEQQKRNVLQTDLAQQSSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLVGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
E KD + KH +L++KE +++ K+ E + KK++DQ +K++EDL ++ L++
Sbjct: 913 EYKDGVTKHHQELNAKEQIINRLKDSESELKKNVDQYLKEKEDLNKRFKELQD 965
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340708620|ref|XP_003392920.1| PREDICTED: rho-associated protein kinase 2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-119, Method: Compositional matrix adjust.
Identities = 279/593 (47%), Positives = 388/593 (65%), Gaps = 81/593 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N I NG + +L++LL++E+R++ LE RQ+ L+ + EA++ RET LR+E+G+
Sbjct: 419 LENHINNGTSDDIKISQLENLLDKEKRQVESLESRQKALTTRLEAMTRRETELREEIGRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAE---VNLQV----------------------- 101
+K LT+LRH+ KE+QRR ++E+E+++KAE V L+
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETESRRKAESLIVELKKKYDEEQTKRARDASNSQQTSERV 538
Query: 102 ------ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
I +M KL+ E E TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 539 TSLEKQIKEMQSKLERETEMVTRLRKQATEITVARQAAEQMANELQVERAKLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVATLQ ++S+ERSS++QA +L ELE RL
Sbjct: 599 QEVATLQGQLSKERSSRSQASSLTAELESRLS---------------------------- 630
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
AL+ ELE ++ +E + DNR L EK+S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 631 ---------ALHVELEHSREKEEKAIMDNRQLTEKISALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL+ Q+SEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEVEKVKVLQGQVEQEQQKRNILQTDLAQQSSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL+ EVA LREAKR IE+E H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLAGEVAQLREAKRQIEDELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
E KD +AKH +L++KE +++ K+ E + KK++DQ +K++EDL ++ L++
Sbjct: 913 EFKDGVAKHHQELNAKEQIINRLKDSEGELKKNVDQYLKEKEDLNKRFKELQD 965
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380023438|ref|XP_003695530.1| PREDICTED: rho-associated protein kinase 2 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1118), Expect = e-119, Method: Compositional matrix adjust.
Identities = 279/593 (47%), Positives = 384/593 (64%), Gaps = 81/593 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N I NG + +L++LL++E+R++ LE RQ+ L+ Q E ++ RET LR+E+G+
Sbjct: 419 LENHINNGTSDDIKISQLENLLDKEKRQVESLESRQKALTTQLEVMTRRETELREEIGRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAE---VNLQV----------------------- 101
+K LT+LRH+ KE+QRR ++E E+++KAE V L+
Sbjct: 479 DKELTLLRHNYKEAQRRVEHEIESRRKAESLFVELKKKFDEEQTKRARDASNSQQTSERV 538
Query: 102 ------ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
I +M KL+ E ET TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 539 TSLEKQIKEMQSKLERETETVTRLRKQATEITVARQAAEQMANELQVARAQLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEV TLQ ++S+ERSS++QA +L ELE RL
Sbjct: 599 QEVVTLQGQLSKERSSRSQASSLTAELESRLS---------------------------- 630
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
AL+ ELE ++ +E + DNR L EK+S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 631 ---------ALHLELEHSREKEEKAIMDNRQLTEKISALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL+ Q+SEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEMEKVKVLQGQVEQEQQKRNVLQTDLAQQSSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL EVA LREAKR IEEE H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLVGEVAQLREAKRQIEEELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
E KD + KH +L++KE +++ K+ E + KK++DQ +K++EDL ++ L++
Sbjct: 913 EYKDGVTKHHQELNAKEQIINRLKDSESELKKNVDQYLKEKEDLNKRFKELQD 965
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350413242|ref|XP_003489930.1| PREDICTED: rho-associated protein kinase 2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1118), Expect = e-119, Method: Compositional matrix adjust.
Identities = 279/593 (47%), Positives = 387/593 (65%), Gaps = 81/593 (13%)
Query: 11 VDNAIPNGGQAN---GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQL 67
++N I NG + +L++LL++E+R++ LE RQ+ L+ + EA++ RET LR+E+G+
Sbjct: 419 LENHINNGTSDDIKISQLENLLDKEKRQVESLESRQKALTTRLEAMTRRETELREEIGRA 478
Query: 68 EKNLTILRHDLKESQRRADNESETKKKAE---VNLQV----------------------- 101
+K LT+LRH+ KE+QRR ++E+E ++KAE V L+
Sbjct: 479 DKELTLLRHNYKEAQRRVEHETELRRKAESLIVELKKKYDEEQTKRARDASNSQQTSERV 538
Query: 102 ------ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQ 155
I +M KL+ E E TRLRKQ+ E+TVA+ A EQM ELQ A L+ +RD LQ
Sbjct: 539 TSLEKQIKEMQSKLERETEMVTRLRKQATEITVARQAAEQMANELQVERAKLQAQRDNLQ 598
Query: 156 QEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVS 215
QEVATLQ ++S+ERSS++QA +L ELE RL
Sbjct: 599 QEVATLQGQLSKERSSRSQASSLTAELESRLS---------------------------- 630
Query: 216 SLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQE 275
AL+ ELE ++ +E + DNR L EK+S+LEKE ASL+LELKAAQA+Y QE
Sbjct: 631 ---------ALHVELEHSREKEEKAIMDNRQLTEKISALEKEAASLTLELKAAQARYNQE 681
Query: 276 VRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 335
V AH+ET++SR+++KEEA++E+VK L+ + + +S E LL+ KER+
Sbjct: 682 VVAHQETERSRILSKEEANLEVVKALQAKLNEEKSGRQRAE-LLAQEKERQTSM------ 734
Query: 336 LMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
L D +QQ++ L+ E RQE+EK K LQ QVEQEQ K+ LQ+DL+ Q+SEA L+
Sbjct: 735 LSVDYRQIQQRLQKLE--GEHRQEVEKVKVLQGQVEQEQQKRNILQTDLAQQSSEAGRLR 792
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAH 455
ARE+QL+ EVA LREAKR IE+E H LKT+R+V+ LQ KELQ+QLE E YFSTLYKTQ
Sbjct: 793 AREQQLAGEVAQLREAKRQIEDELHHLKTQRNVDQLQTKELQEQLEAEAYFSTLYKTQTQ 852
Query: 456 ELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL 515
EL+EELDE+ R ELEEER L H+LQL++AR DSEALARSIAEETV +LEKE+TMKEL
Sbjct: 853 ELREELDEKIRLQQELEEERSSLVHQLQLSLARGDSEALARSIAEETVADLEKERTMKEL 912
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
E KD +AKH +L++KE +++ K+ E + KK++DQ +K++EDL ++ L++
Sbjct: 913 EYKDGIAKHHQELNAKEQIINRLKDSEGELKKNVDQYLKEKEDLNKRFKELQD 965
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189237841|ref|XP_974666.2| PREDICTED: similar to rho-associated protein kinase 1 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-115, Method: Compositional matrix adjust.
Identities = 273/592 (46%), Positives = 382/592 (64%), Gaps = 91/592 (15%)
Query: 17 NGGQANGE---LKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTI 73
N AN + L+ LL++ER + +L+E+QR+L Q +++ E+A+R+E + EK LTI
Sbjct: 1572 NDKDANAQVTKLQQLLDQERNTVEELKEKQRKLIAQISSLAQNESAIREESSKYEKELTI 1631
Query: 74 LRHDLKESQRRADNESETKKKAE------------------------------VNL--QV 101
L+H+ KE QR+A+NE+E +KK E +N+ +
Sbjct: 1632 LKHNYKELQRKAENENELRKKTEKYLADIKRTLEEEQNKRTREMNNNQQHNDKINILEKQ 1691
Query: 102 ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATL 161
++DM EKLK E E RLRKQ+ ELT+AK+A EQ V E Q +L L+ +RD+LQ EVATL
Sbjct: 1692 VNDMQEKLKVETENCQRLRKQTTELTMAKAAFEQKVAEYQAVLQNLQAQRDSLQAEVATL 1751
Query: 162 QAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 221
Q +++QE +++TQ ++ +E R Q +
Sbjct: 1752 QGQLTQEIAARTQTSEEYRVMENRFQNV-------------------------------- 1779
Query: 222 RLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEE 281
N+ELER+ RE ++ DN L EKVS+LEKECASL LELKAAQ +YQQEVRAHEE
Sbjct: 1780 -----NSELERSVQRERKILTDNTQLTEKVSTLEKECASLCLELKAAQNRYQQEVRAHEE 1834
Query: 282 TQKSRMVNKEEASVEIVKELKDLM-----AKHRSDLSSKESLLSNGKEREVDYKKSIDQL 336
T++SR++NKEEA++E+VK L+ + A+ ++DL+++E KER+ I L
Sbjct: 1835 TERSRLLNKEEANLEVVKALQAKLNEEKSARQKADLNTQE------KERQ------ISML 1882
Query: 337 MKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKA 396
D +QQ++ L EG E RQE+EK K L SQ+EQEQ KK LQS++S SE A LKA
Sbjct: 1883 SVDYRQIQQRLQKL-EG-EHRQEVEKVKALHSQLEQEQQKKTILQSEMSQHISEVAKLKA 1940
Query: 397 REEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHE 456
RE QL+ E+ ++EAK+ +EE+ KLK +E LQMKELQD ETEQYFSTLYKTQ +E
Sbjct: 1941 RESQLAIELNQVQEAKKKLEEDLFKLKRDWQMEQLQMKELQDSFETEQYFSTLYKTQTNE 2000
Query: 457 LKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELE 516
L+EEL+E+++ E EEE L H+ Q+A+ARADSEALARSIAEET+ +LEKEKTMKELE
Sbjct: 2001 LREELEEKNKINKEFEEECASLKHQCQIALARADSEALARSIAEETIADLEKEKTMKELE 2060
Query: 517 LKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
LKDL+AKHRS+++SKE ++++ K+RE++ KK + L K+RED+ +Q+ L+E
Sbjct: 2061 LKDLLAKHRSEVNSKEVVINSLKDREMELKKMNEHLSKEREDINRQLKQLQE 2112
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270007958|gb|EFA04406.1| hypothetical protein TcasGA2_TC014705 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1083), Expect = e-115, Method: Compositional matrix adjust.
Identities = 273/592 (46%), Positives = 382/592 (64%), Gaps = 91/592 (15%)
Query: 17 NGGQANGE---LKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTI 73
N AN + L+ LL++ER + +L+E+QR+L Q +++ E+A+R+E + EK LTI
Sbjct: 424 NDKDANAQVTKLQQLLDQERNTVEELKEKQRKLIAQISSLAQNESAIREESSKYEKELTI 483
Query: 74 LRHDLKESQRRADNESETKKKAE------------------------------VNL--QV 101
L+H+ KE QR+A+NE+E +KK E +N+ +
Sbjct: 484 LKHNYKELQRKAENENELRKKTEKYLADIKRTLEEEQNKRTREMNNNQQHNDKINILEKQ 543
Query: 102 ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATL 161
++DM EKLK E E RLRKQ+ ELT+AK+A EQ V E Q +L L+ +RD+LQ EVATL
Sbjct: 544 VNDMQEKLKVETENCQRLRKQTTELTMAKAAFEQKVAEYQAVLQNLQAQRDSLQAEVATL 603
Query: 162 QAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 221
Q +++QE +++TQ ++ +E R Q +
Sbjct: 604 QGQLTQEIAARTQTSEEYRVMENRFQNV-------------------------------- 631
Query: 222 RLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEE 281
N+ELER+ RE ++ DN L EKVS+LEKECASL LELKAAQ +YQQEVRAHEE
Sbjct: 632 -----NSELERSVQRERKILTDNTQLTEKVSTLEKECASLCLELKAAQNRYQQEVRAHEE 686
Query: 282 TQKSRMVNKEEASVEIVKELKDLM-----AKHRSDLSSKESLLSNGKEREVDYKKSIDQL 336
T++SR++NKEEA++E+VK L+ + A+ ++DL+++E KER+ I L
Sbjct: 687 TERSRLLNKEEANLEVVKALQAKLNEEKSARQKADLNTQE------KERQ------ISML 734
Query: 337 MKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKA 396
D +QQ++ L EG E RQE+EK K L SQ+EQEQ KK LQS++S SE A LKA
Sbjct: 735 SVDYRQIQQRLQKL-EG-EHRQEVEKVKALHSQLEQEQQKKTILQSEMSQHISEVAKLKA 792
Query: 397 REEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHE 456
RE QL+ E+ ++EAK+ +EE+ KLK +E LQMKELQD ETEQYFSTLYKTQ +E
Sbjct: 793 RESQLAIELNQVQEAKKKLEEDLFKLKRDWQMEQLQMKELQDSFETEQYFSTLYKTQTNE 852
Query: 457 LKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELE 516
L+EEL+E+++ E EEE L H+ Q+A+ARADSEALARSIAEET+ +LEKEKTMKELE
Sbjct: 853 LREELEEKNKINKEFEEECASLKHQCQIALARADSEALARSIAEETIADLEKEKTMKELE 912
Query: 517 LKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
LKDL+AKHRS+++SKE ++++ K+RE++ KK + L K+RED+ +Q+ L+E
Sbjct: 913 LKDLLAKHRSEVNSKEVVINSLKDREMELKKMNEHLSKEREDINRQLKQLQE 964
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1219 | ||||||
| FB|FBgn0026181 | 1390 | rok "Rho-kinase" [Drosophila m | 0.438 | 0.384 | 0.360 | 2e-121 | |
| UNIPROTKB|F1NRH6 | 1329 | ROCK1 "Uncharacterized protein | 0.481 | 0.441 | 0.290 | 6.3e-99 | |
| UNIPROTKB|F1NRH5 | 1331 | ROCK1 "Uncharacterized protein | 0.481 | 0.441 | 0.290 | 6.3e-99 | |
| UNIPROTKB|F1NMU3 | 1331 | ROCK1 "Uncharacterized protein | 0.481 | 0.441 | 0.290 | 6.3e-99 | |
| MGI|MGI:107927 | 1354 | Rock1 "Rho-associated coiled-c | 0.469 | 0.422 | 0.288 | 2.7e-98 | |
| UNIPROTKB|D4A5S0 | 1354 | Rock1 "Rho-associated protein | 0.469 | 0.422 | 0.297 | 7.3e-98 | |
| UNIPROTKB|F1MF50 | 1367 | ROCK1 "Rho-associated protein | 0.458 | 0.408 | 0.295 | 8.1e-98 | |
| UNIPROTKB|F1NM42 | 1288 | Gga.17943 "Uncharacterized pro | 0.460 | 0.435 | 0.280 | 9.6e-98 | |
| UNIPROTKB|F1NK88 | 1289 | Gga.17943 "Uncharacterized pro | 0.416 | 0.394 | 0.294 | 1.6e-97 | |
| UNIPROTKB|F1PU60 | 1372 | ROCK1 "Uncharacterized protein | 0.469 | 0.416 | 0.294 | 2.4e-97 |
| FB|FBgn0026181 rok "Rho-kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 2.0e-121, Sum P(3) = 2.0e-121
Identities = 206/572 (36%), Positives = 314/572 (54%)
Query: 56 RETALRDEMGQLEKNLTILRHDLKESQRRADN-ESETKKKA---EVNLQVISDMHE-KLK 110
R AL + L + + ++ E QR A E + + +V +Q + E + K
Sbjct: 470 RSEALEQQDAGLRQQIELITKREAELQRIASEYEKDLALRQHNYKVAMQKVEQEIELRKK 529
Query: 111 TEAETA-TRLRKQSAELTVAKSAG-EQMVVELQNILATLEMERDTLQQEVATLQ---AKI 165
TEA T+ ++ + T A+ VV L+ L +E T + L+ A++
Sbjct: 530 TEALLVETQRNLENEQKTRARDLNINDKVVSLEKQLLEMEQSYKTETENTQKLKKHNAEL 589
Query: 166 SQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQ-LAEDNRHLGEKVSSLEKEC--R 222
S+ + V ++ LQ EL + ++ ELQ L ++L ++ + KE +
Sbjct: 590 DFTVKSQEEKVRDMVDMIDTLQKHKEELGQ-ENAELQALVVQEKNLRPQLKEMHKEAENK 648
Query: 223 LQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEET 282
+Q L ++ER RE + EDNR L EK+S LEK A L ELKAAQ +YQQEV+AH+ET
Sbjct: 649 MQTLINDIERTMCREQKAQEDNRALLEKISDLEKAHAGLDFELKAAQGRYQQEVKAHQET 708
Query: 283 QKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDRED 342
+KSR+V++EEA+++ E+K L +K + S++ + +E+E + + L D
Sbjct: 709 EKSRLVSREEANLQ---EVKALQSKLNEEKSARIKADQHSQEKE----RQLSMLSVDYRQ 761
Query: 343 LQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLS 402
+Q ++ L EG E RQE EK LQSQ++QE +K+ +L S+LS+ +SE AHL++RE QL
Sbjct: 762 IQLRLQKL-EG-ECRQESEKVAALQSQLDQEHSKRNALLSELSLHSSEVAHLRSRENQLQ 819
Query: 403 HEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELD 462
E++ REAKR EE+ +LK+ +ELQ QLE EQ FS LYKTQA+E +EE
Sbjct: 820 KELSTQREAKRRFEEDLTQLKSTHHEALANNRELQAQLEAEQCFSRLYKTQANENREESA 879
Query: 463 ERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMA 522
ER I +LEEER L H++Q+AVARADSEALARSIAEETV +
Sbjct: 880 ERLSKIEDLEEERVSLKHQVQVAVARADSEALARSIAEETVADLEKEKTIKELELKDFVM 939
Query: 523 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDL-------QQQINLLKEGKGAYGI 575
KHR+++++KE+ L+ KE E + K + Q + EDL Q+++ L++ K
Sbjct: 940 KHRNEINAKEAALATLKEAENELHKKLGQKAAEYEDLVQQHKKQQEELALMRSSKDEE-- 997
Query: 576 VYKAYDK-NNK---QYVAIKKIFEAFRNKTDA 603
+ K DK N+ + VA+ K+ E N+ D+
Sbjct: 998 ITKLLDKCKNEVLLKQVAVNKLAEVM-NRRDS 1028
|
|
| UNIPROTKB|F1NRH6 ROCK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 6.3e-99, Sum P(3) = 6.3e-99
Identities = 188/648 (29%), Positives = 320/648 (49%)
Query: 64 MGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQS 123
+ Q+EK L+H + + QR+ + ESE ++ E + + D E LK + Q
Sbjct: 454 VSQIEKEKMALQHKINDYQRKIEQESEKRRNVENEVSTLKDQMEDLKKIS--------QH 505
Query: 124 AELTVAKSAGEQMVVELQNILATLEMERDTL--QQEVATLQAKISQERS-SKTQAVNLHK 180
+++T K + +LQ LE D L + E A K + E S S +Q +L++
Sbjct: 506 SQITNEK------ITQLQK---QLEEANDLLRTESETAVRLRKGNTEMSKSLSQVESLNR 556
Query: 181 ELEGRLQALNT-ELERNK-HRELQLA-----EDNRHLGEKVSSLEKECRLQALNTELERN 233
EL+ R + L + +L+ K + +LQ A D H E + L+ R+ L EL+
Sbjct: 557 ELQERCRVLESAKLQVEKDYYQLQAALESERRDRSHGSEMIGELQ--VRITTLQEELKNL 614
Query: 234 KHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMVN 289
K+ ++ + + ++++ EKE +L ++L K+ Q + +QEV H+ T K+R+ +
Sbjct: 615 KNNLERVEAERKQAQDRLNHSEKEKNNLEIDLNYKLKSLQDRLEQEVNEHKVT-KARLTD 673
Query: 290 KEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-N 348
K + S+E K + M + + + + + R V +K L D + QQ++ +
Sbjct: 674 KHQ-SIEEAKSVA--MCEMEKKVKEERAAREKAENRIVQAEKQCSMLDFDLKQSQQKVEH 730
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
LL++ L E+ K L Q+EQE K+ Q++L Q EA +LK E+QL E+ L
Sbjct: 731 LLQQKERLEDEV---KNLSLQLEQETNKRIMAQNELKAQAFEADNLKGSEKQLKQEINTL 787
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERS--- 465
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE+DE++
Sbjct: 788 LEAKRLLEVELAQLAKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIDEKNKET 847
Query: 466 -RNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
R + EL+ E+ LT +L LA +A+SE LAR++ EE ++H
Sbjct: 848 QRKMQELQNEKETLTTQLDLAETKAESEQLARALLEEQY-------FELSQESKKAASRH 900
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+S++ +E K +D + K+ ++ ++ +K+ + Y + K + NN
Sbjct: 901 RQEMTDKDSIIRRLEETNSTLTKDVDLVTKENSEMSEK---MKKQEEEYKLK-KEEEINN 956
Query: 585 KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFEY 643
+ K I KT A EI+ K F+ +M D+ K N+ L +
Sbjct: 957 IRMQYEKSINNERTLKTQAVNKLAEIMNRKDFKIDRKKASMQDLRKKEKENRKLQLELNQ 1016
Query: 644 MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI 691
+ N+++ K K+++ + QL +Y + + M D K S+I
Sbjct: 1017 EKEKFNQMVV-KYQKELN--EMQAQLAEESTYRNELQ-MQLDSKESDI 1060
|
|
| UNIPROTKB|F1NRH5 ROCK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 6.3e-99, Sum P(3) = 6.3e-99
Identities = 188/648 (29%), Positives = 320/648 (49%)
Query: 64 MGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQS 123
+ Q+EK L+H + + QR+ + ESE ++ E + + D E LK + Q
Sbjct: 456 VSQIEKEKMALQHKINDYQRKIEQESEKRRNVENEVSTLKDQMEDLKKIS--------QH 507
Query: 124 AELTVAKSAGEQMVVELQNILATLEMERDTL--QQEVATLQAKISQERS-SKTQAVNLHK 180
+++T K + +LQ LE D L + E A K + E S S +Q +L++
Sbjct: 508 SQITNEK------ITQLQK---QLEEANDLLRTESETAVRLRKGNTEMSKSLSQVESLNR 558
Query: 181 ELEGRLQALNT-ELERNK-HRELQLA-----EDNRHLGEKVSSLEKECRLQALNTELERN 233
EL+ R + L + +L+ K + +LQ A D H E + L+ R+ L EL+
Sbjct: 559 ELQERCRVLESAKLQVEKDYYQLQAALESERRDRSHGSEMIGELQ--VRITTLQEELKNL 616
Query: 234 KHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMVN 289
K+ ++ + + ++++ EKE +L ++L K+ Q + +QEV H+ T K+R+ +
Sbjct: 617 KNNLERVEAERKQAQDRLNHSEKEKNNLEIDLNYKLKSLQDRLEQEVNEHKVT-KARLTD 675
Query: 290 KEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-N 348
K + S+E K + M + + + + + R V +K L D + QQ++ +
Sbjct: 676 KHQ-SIEEAKSVA--MCEMEKKVKEERAAREKAENRIVQAEKQCSMLDFDLKQSQQKVEH 732
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
LL++ L E+ K L Q+EQE K+ Q++L Q EA +LK E+QL E+ L
Sbjct: 733 LLQQKERLEDEV---KNLSLQLEQETNKRIMAQNELKAQAFEADNLKGSEKQLKQEINTL 789
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERS--- 465
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE+DE++
Sbjct: 790 LEAKRLLEVELAQLAKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIDEKNKET 849
Query: 466 -RNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
R + EL+ E+ LT +L LA +A+SE LAR++ EE ++H
Sbjct: 850 QRKMQELQNEKETLTTQLDLAETKAESEQLARALLEEQY-------FELSQESKKAASRH 902
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+S++ +E K +D + K+ ++ ++ +K+ + Y + K + NN
Sbjct: 903 RQEMTDKDSIIRRLEETNSTLTKDVDLVTKENSEMSEK---MKKQEEEYKLK-KEEEINN 958
Query: 585 KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFEY 643
+ K I KT A EI+ K F+ +M D+ K N+ L +
Sbjct: 959 IRMQYEKSINNERTLKTQAVNKLAEIMNRKDFKIDRKKASMQDLRKKEKENRKLQLELNQ 1018
Query: 644 MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI 691
+ N+++ K K+++ + QL +Y + + M D K S+I
Sbjct: 1019 EKEKFNQMVV-KYQKELN--EMQAQLAEESTYRNELQ-MQLDSKESDI 1062
|
|
| UNIPROTKB|F1NMU3 ROCK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 6.3e-99, Sum P(3) = 6.3e-99
Identities = 188/648 (29%), Positives = 320/648 (49%)
Query: 64 MGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQS 123
+ Q+EK L+H + + QR+ + ESE ++ E + + D E LK + Q
Sbjct: 456 VSQIEKEKMALQHKINDYQRKIEQESEKRRNVENEVSTLKDQMEDLKKIS--------QH 507
Query: 124 AELTVAKSAGEQMVVELQNILATLEMERDTL--QQEVATLQAKISQERS-SKTQAVNLHK 180
+++T K + +LQ LE D L + E A K + E S S +Q +L++
Sbjct: 508 SQITNEK------ITQLQK---QLEEANDLLRTESETAVRLRKGNTEMSKSLSQVESLNR 558
Query: 181 ELEGRLQALNT-ELERNK-HRELQLA-----EDNRHLGEKVSSLEKECRLQALNTELERN 233
EL+ R + L + +L+ K + +LQ A D H E + L+ R+ L EL+
Sbjct: 559 ELQERCRVLESAKLQVEKDYYQLQAALESERRDRSHGSEMIGELQ--VRITTLQEELKNL 616
Query: 234 KHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMVN 289
K+ ++ + + ++++ EKE +L ++L K+ Q + +QEV H+ T K+R+ +
Sbjct: 617 KNNLERVEAERKQAQDRLNHSEKEKNNLEIDLNYKLKSLQDRLEQEVNEHKVT-KARLTD 675
Query: 290 KEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-N 348
K + S+E K + M + + + + + R V +K L D + QQ++ +
Sbjct: 676 KHQ-SIEEAKSVA--MCEMEKKVKEERAAREKAENRIVQAEKQCSMLDFDLKQSQQKVEH 732
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
LL++ L E+ K L Q+EQE K+ Q++L Q EA +LK E+QL E+ L
Sbjct: 733 LLQQKERLEDEV---KNLSLQLEQETNKRIMAQNELKAQAFEADNLKGSEKQLKQEINTL 789
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERS--- 465
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE+DE++
Sbjct: 790 LEAKRLLEVELAQLAKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIDEKNKET 849
Query: 466 -RNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
R + EL+ E+ LT +L LA +A+SE LAR++ EE ++H
Sbjct: 850 QRKMQELQNEKETLTTQLDLAETKAESEQLARALLEEQY-------FELSQESKKAASRH 902
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+S++ +E K +D + K+ ++ ++ +K+ + Y + K + NN
Sbjct: 903 RQEMTDKDSIIRRLEETNSTLTKDVDLVTKENSEMSEK---MKKQEEEYKLK-KEEEINN 958
Query: 585 KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFEY 643
+ K I KT A EI+ K F+ +M D+ K N+ L +
Sbjct: 959 IRMQYEKSINNERTLKTQAVNKLAEIMNRKDFKIDRKKASMQDLRKKEKENRKLQLELNQ 1018
Query: 644 MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI 691
+ N+++ K K+++ + QL +Y + + M D K S+I
Sbjct: 1019 EKEKFNQMVV-KYQKELN--EMQAQLAEESTYRNELQ-MQLDSKESDI 1062
|
|
| MGI|MGI:107927 Rock1 "Rho-associated coiled-coil containing protein kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 2.7e-98, Sum P(3) = 2.7e-98
Identities = 180/625 (28%), Positives = 309/625 (49%)
Query: 60 LRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRL 119
L + Q+EK +L+H + E QR+ + E+E ++ E + + D E L+ ++T+
Sbjct: 477 LESAVSQIEKEKMLLQHRINEYQRKVEQENEKRRNIENEVSTLKDQLEDLRKASQTSQLA 536
Query: 120 RKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLH 179
++ +L ++ + E ++L T E DT L+ ++ S +Q +L+
Sbjct: 537 NEKLTQL-------QKQLEEANDLLRT---ESDT----AVRLRKSHTEMSKSISQLESLN 582
Query: 180 KELEGRLQAL-NTELERNK-HRELQL---AE--DNRHLGEKVSSLEKECRLQALNTELER 232
+EL+ R + L N++ + +K + +LQ AE D H E + L+ R+ +L E++
Sbjct: 583 RELQERNRILENSKSQADKDYYQLQAVLEAERRDRGHDSEMIGDLQ--ARITSLQEEVKH 640
Query: 233 NKHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMV 288
KH ++ + + + ++ EKE +L ++L K+ Q + +QEV H+ T K+R+
Sbjct: 641 LKHNLERVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSIQQRLEQEVNEHKVT-KARLT 699
Query: 289 NKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 348
+K + S+E K + M + L + + R V+ +K L D + QQ++
Sbjct: 700 DKHQ-SIEEAKSVA--MCEMEKKLKEEREAREKAENRVVETEKQCSMLDVDLKQSQQKLE 756
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
L E E R E ++ K L Q+EQE K+ LQ++L Q EA +LK E+Q+ E+ L
Sbjct: 757 HLTENKE-RME-DEVKNLALQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTL 814
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN- 467
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE++E++R
Sbjct: 815 LEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNREN 874
Query: 468 ---ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
I EL+ E+ L+ +L LA +A+SE LAR I EE +++
Sbjct: 875 LRKIQELQSEKETLSTQLDLAETKAESEQLARGILEEQY-------FELTQESKKAASRN 927
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+ +S +E K I+ L K+ E+L +++ +E Y + K ++ N
Sbjct: 928 RQEITDKDHTVSRLEETNSVLTKDIEMLRKENEELNERMRTAEE---EYKL--KKEEEIN 982
Query: 585 KQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFE 642
A +K R KT A EI+ K F+ D+ K N+ L +
Sbjct: 983 NLKAAFEKNISTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELN 1042
Query: 643 YMENDLNKVI--RDKILKDVHIRYI 665
N+++ K L D+ + +
Sbjct: 1043 QEREKFNQMVVKHQKELNDMQAQLV 1067
|
|
| UNIPROTKB|D4A5S0 Rock1 "Rho-associated protein kinase 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 7.3e-98, Sum P(3) = 7.3e-98
Identities = 186/625 (29%), Positives = 304/625 (48%)
Query: 60 LRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRL 119
L + Q+EK +L+H + E QR+ + E+E ++ E + + D E L R
Sbjct: 477 LESAVSQIEKEKMLLQHRINEYQRKVEQENEKRRNVENEVSTLKDQLEDL--------RK 528
Query: 120 RKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLH 179
QS++L K Q +E N L L E DT L+ ++ S +Q +L+
Sbjct: 529 ASQSSQLANEKLTQLQKQLEEANDL--LRTESDT----AVRLRKSHTEMSKSVSQLESLN 582
Query: 180 KELEGRLQAL-NTELERNK-HRELQL---AE--DNRHLGEKVSSLEKECRLQALNTELER 232
+EL+ R + L N++ + +K + +LQ AE D H E + L+ R+ +L E++
Sbjct: 583 RELQERNRMLENSKSQADKDYYQLQAVLEAERRDRGHDSEMIGDLQ--ARITSLQEEVKH 640
Query: 233 NKHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMV 288
KH ++ + + + ++ EKE +L ++L K+ Q + +QEV H+ T K+R+
Sbjct: 641 LKHNLERVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSIQQRLEQEVNEHKVT-KARLT 699
Query: 289 NKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 348
+K + S+E K + M + L + + R V+ +K L D + QQ++
Sbjct: 700 DKHQ-SIEEAKSVA--MCEMEKKLKEEREAREKAENRVVETEKQCSMLDVDLKQSQQKLE 756
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
L E E ++ KS TLQ +EQE K+ LQS+L Q EA +LK E+Q+ E+ L
Sbjct: 757 HLTENKERLEDAVKSLTLQ--LEQESNKRILLQSELKTQAFEADNLKGLEKQMKQEINTL 814
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN- 467
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE++E++R
Sbjct: 815 LEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNREN 874
Query: 468 ---ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
I EL+ E+ L+ +L LA +A+SE LAR I EE +++
Sbjct: 875 LRKIQELQSEKETLSTQLDLAETKAESEQLARGILEEQY-------FELTQESKKAASRN 927
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+ +S +E K I+ L K+ E+L +++ +E Y + + N
Sbjct: 928 RQEITDKDHTVSRLEEANNALTKDIELLRKENEELNERMRTAEE---EYKLKKEEEISNL 984
Query: 585 KQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFE 642
K A +K R KT A EI+ K F+ D+ K N+ L +
Sbjct: 985 K--AAFEKNISTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELN 1042
Query: 643 YMENDLNKVI--RDKILKDVHIRYI 665
N+++ K L D+ + +
Sbjct: 1043 QEREKFNQMVVKHQKELNDMQAQLV 1067
|
|
| UNIPROTKB|F1MF50 ROCK1 "Rho-associated protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 8.1e-98, Sum P(3) = 8.1e-98
Identities = 180/610 (29%), Positives = 302/610 (49%)
Query: 60 LRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRL 119
L + Q+EK +L+H + E QR+A+ E+E ++ E + + D E LK ++ +
Sbjct: 490 LESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLA 549
Query: 120 RKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLH 179
++ A+L ++ + E ++L T E DT L+ ++ S TQ +L+
Sbjct: 550 NEKLAQL-------QKQLEEANDLLRT---ESDT----AVRLRKSHTEMSKSITQLESLN 595
Query: 180 KELEGRLQAL-NTELERNK-HRELQL---AE--DNRHLGEKVSSLEKECRLQALNTELER 232
+EL+ R + L N++ + +K + +LQ AE D H EK+ L+ R+ +L E++
Sbjct: 596 RELQERNRILENSKSQMDKDYYQLQAVLEAERRDRGHDSEKIGDLQ--ARITSLQEEVKH 653
Query: 233 NKHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMV 288
KH ++ + + + ++ EKE +L ++L K+ Q + +QEV H+ T K+R+
Sbjct: 654 LKHNLERVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVT-KARLT 712
Query: 289 NKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 348
+K + S+E K + M + L + + R V +K L D + QQ++
Sbjct: 713 DKHQ-SIEEAKSVA--MCEMEKKLKEERDAREKAENRVVQIEKQCSMLDVDLKQSQQKLE 769
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
L E + R E ++ K L Q+EQE K+ LQ++L Q EA +LK E+Q+ E+ L
Sbjct: 770 HLIENKD-RME-DEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTL 827
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN- 467
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE++E++R
Sbjct: 828 LEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNREN 887
Query: 468 ---ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
I EL+ E+ L +L LA +A+SE LAR + EE +++
Sbjct: 888 LKKIQELQSEKETLATQLDLAETKAESEQLARGLLEEQY-------FELTQESKKAASRN 940
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+ LS +E K I+ L K+ E+L ++ +E Y + K ++ N
Sbjct: 941 RQEITDKDHTLSRLEETNSMLTKDIELLRKENEELTDKMRKAEE---EYKL--KKEEEIN 995
Query: 585 KQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFE 642
A +K R KT A EI+ K F+ D+ K N+ L +
Sbjct: 996 ILKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELN 1055
Query: 643 YMENDLNKVI 652
N+++
Sbjct: 1056 QEREKFNQMV 1065
|
|
| UNIPROTKB|F1NM42 Gga.17943 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 9.6e-98, Sum P(3) = 9.6e-98
Identities = 169/602 (28%), Positives = 292/602 (48%)
Query: 1 MCFLHLHGFQVDNAIPNGGQANGELKDLLXXXXXXMXXXXXXXXXXXXXXXAVSARETAL 60
+CF +++ + N QA EL+ + V E+A+
Sbjct: 398 LCFFSKKVSKLEEQLSNELQAKDELEQKYRSANTRLEKIVKELDEEITSRKNV---ESAV 454
Query: 61 RDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLR 120
R QLE+ +L+H E QR+A++E++ K+ E + + D E LK + +
Sbjct: 455 R----QLEREKALLQHKNTEYQRKAEHEADKKRNLENEVNSLKDQLEDLKKRNQNSQISN 510
Query: 121 KQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHK 180
++ +L ++ A L + +++ L+A + + N
Sbjct: 511 EKINQLQRQLDEANSLLRSESETAARLRKNQTESTKQIQQLEANNRELQDKNCLLENAKL 570
Query: 181 ELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQL 240
+LE L + LE + D H E +S L+ R+ +L E++ K +L
Sbjct: 571 KLEKDFLNLQSALESERR-------DRSHGSEIISDLQG--RISSLEEEVKNGKSALAKL 621
Query: 241 AEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMVNKEEASVE 296
+ R L EK++ LEKE +++ +++ K Q +QE H+ T K+R+ +K + E
Sbjct: 622 EMEKRQLQEKLTDLEKEKSNMEIDMTYKFKVMQQNLEQEEAEHKAT-KARLADKNKI-YE 679
Query: 297 IVKELK-DLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN-LLKEGA 354
++E K + M + L + +L + R ++ +K L D + QQ+IN LL++
Sbjct: 680 SIEEAKSEAMKEMEKKLLEERALKQKVENRLLEAEKQRSMLDCDLKQSQQKINELLRQKD 739
Query: 355 ELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRN 414
+L +++ K L ++EQE K+ Q+DL +QT + LK E+QL E L+E K +
Sbjct: 740 KLNEDV---KNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLQEIKLS 796
Query: 415 IEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSR-------N 467
+E++ ++L+ +R D QMKELQDQLE EQYFSTLYKTQ ELKEE +E+++
Sbjct: 797 LEKQNNELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLCKEMQQK 856
Query: 468 ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKHRSD 527
I EL++ER L +L++ + +ADSE LARSIAEE MA+H+ +
Sbjct: 857 IQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQE 916
Query: 528 LSSKESLLSNGKEREVDYKKSIDQLMKDREDL-------QQQINLLKEGKGAYGIVYKAY 580
L+ K++ +++ +E + L ++E+L Q+QI LKE + G + +
Sbjct: 917 LAEKDATIASLEEANRTLTSDVANLANEKEELNNKLKEEQEQITKLKEEEANIGNIKAQF 976
Query: 581 DK 582
+K
Sbjct: 977 EK 978
|
|
| UNIPROTKB|F1NK88 Gga.17943 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 1.6e-97, Sum P(3) = 1.6e-97
Identities = 161/546 (29%), Positives = 277/546 (50%)
Query: 57 ETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETA 116
E+A+R QLE+ +L+H E QR+A++E++ K+ E + + D E LK + +
Sbjct: 452 ESAVR----QLEREKALLQHKNTEYQRKAEHEADKKRNLENEVNSLKDQLEDLKKRNQNS 507
Query: 117 TRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAV 176
++ +L ++ A L + +++ L+A + +
Sbjct: 508 QISNEKINQLQRQLDEANSLLRSESETAARLRKNQTESTKQIQQLEANNRELQDKNCLLE 567
Query: 177 NLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHR 236
N +LE L + LE + D H E +S L+ R+ +L E++ K
Sbjct: 568 NAKLKLEKDFLNLQSALESERR-------DRSHGSEIISDLQG--RISSLEEEVKNGKSA 618
Query: 237 ELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMVNKEE 292
+L + R L EK++ LEKE +++ +++ K Q +QE H+ T K+R+ +K +
Sbjct: 619 LAKLEMEKRQLQEKLTDLEKEKSNMEIDMTYKFKVMQQNLEQEEAEHKAT-KARLADKNK 677
Query: 293 ASVEIVKELK-DLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN-LL 350
E ++E K + M + L + +L + R ++ +K L D + QQ+IN LL
Sbjct: 678 I-YESIEEAKSEAMKEMEKKLLEERALKQKVENRLLEAEKQRSMLDCDLKQSQQKINELL 736
Query: 351 KEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLRE 410
++ +L +++ K L ++EQE K+ Q+DL +QT + LK E+QL E L+E
Sbjct: 737 RQKDKLNEDV---KNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLQE 793
Query: 411 AKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSR---- 466
K ++E++ ++L+ +R D QMKELQDQLE EQYFSTLYKTQ ELKEE +E+++
Sbjct: 794 IKLSLEKQNNELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLCKE 853
Query: 467 ---NILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAK 523
I EL++ER L +L++ + +ADSE LARSIAEE MA+
Sbjct: 854 MQQKIQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMAR 913
Query: 524 HRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDL-------QQQINLLKEGKGAYGIV 576
H+ +L+ K++ +++ +E + L ++E+L Q+QI LKE + G +
Sbjct: 914 HKQELAEKDATIASLEEANRTLTSDVANLANEKEELNNKLKEEQEQITKLKEEEANIGNI 973
Query: 577 YKAYDK 582
++K
Sbjct: 974 KAQFEK 979
|
|
| UNIPROTKB|F1PU60 ROCK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 2.4e-97, Sum P(3) = 2.4e-97
Identities = 184/625 (29%), Positives = 303/625 (48%)
Query: 60 LRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRL 119
L + Q+EK +L+H + E QR+A+ E+E ++ E + + D E LK
Sbjct: 477 LESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVEHEVSTLKDQLEDLKKV------- 529
Query: 120 RKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLH 179
Q+++L K A Q +E N L L E DT L+ ++ S +Q +L+
Sbjct: 530 -NQNSQLANEKLAQLQKQLEEANDL--LRTESDT----AVRLRKSHTEMSKSVSQLESLN 582
Query: 180 KELEGRLQAL-NTELERNK-HRELQL---AE--DNRHLGEKVSSLEKECRLQALNTELER 232
+EL+ R + L N++ + +K + +LQ AE D H E + L+ R+ +L E++
Sbjct: 583 RELQERNRILENSKTQMDKDYYQLQAVLEAERRDRGHDSEMIGDLQ--ARITSLQEEVKH 640
Query: 233 NKHRELQLAEDNRHLGEKVSSLEKECASLSLEL----KAAQAQYQQEVRAHEETQKSRMV 288
KH ++ + + + ++ EKE +L ++L K+ Q + +QEV H+ T K+R+
Sbjct: 641 LKHNLERVEGERKEAQDLLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVT-KARLT 699
Query: 289 NKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 348
+K + S+E K + M + L + + R V +K L D + QQ++
Sbjct: 700 DKHQ-SIEEAKSVA--MCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLE 756
Query: 349 LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
L E E R E ++ K L Q+EQE K+ LQ++L Q EA +LK E+Q+ E+ L
Sbjct: 757 HLTENKE-RME-DEVKNLSLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTL 814
Query: 409 REAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN- 467
EAKR +E E +L + + QM+ELQDQLE EQYFSTLYKTQ ELKEE++E++R
Sbjct: 815 LEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNREN 874
Query: 468 ---ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGXXXXXXXXXXXXXXXXMAKH 524
I EL+ E+ L +L LA +A+SE LAR + EE +++
Sbjct: 875 LKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQY-------FELTQESKKAASRN 927
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
R +++ K+ +S +E K + L K+ E+L + +K + Y + K ++ N
Sbjct: 928 RQEITDKDHTVSRLEESNSMLTKDNELLRKENEELTDK---MKRAEEEYKL--KKEEEIN 982
Query: 585 KQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-NKDLYVVFE 642
A +K R KT A EI+ K F+ D+ K N+ L +
Sbjct: 983 NLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELN 1042
Query: 643 YMENDLNKVI--RDKILKDVHIRYI 665
N+++ K L D+ + +
Sbjct: 1043 QEREKFNQMVVKHQKELNDMQAQLV 1067
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8TD08 | MK15_HUMAN | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5443 | 0.1853 | 0.4154 | yes | N/A |
| Q11179 | YPC2_CAEEL | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5325 | 0.1894 | 0.4914 | yes | N/A |
| Q80Y86 | MK15_MOUSE | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5545 | 0.1829 | 0.4061 | yes | N/A |
| Q54QB1 | ERK2_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5321 | 0.1853 | 0.6124 | yes | N/A |
| Q9Z2A6 | MK15_RAT | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5545 | 0.1829 | 0.4076 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1219 | |||
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-119 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-96 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-81 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-80 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-79 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-76 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-74 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-73 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-71 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-68 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-67 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-66 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-65 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-63 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-63 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-62 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-58 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-57 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-56 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-55 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-55 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-55 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-54 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-53 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-53 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-53 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-52 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-52 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-52 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-51 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-51 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-50 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-50 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-50 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-50 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-49 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-49 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-48 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-48 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-48 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-46 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-45 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-43 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-43 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-42 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-41 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-41 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-41 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-40 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-40 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-40 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-39 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-37 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-33 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-32 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd01242 | 126 | cd01242, PH_ROCK, Rho-associated coiled-coil conta | 2e-24 | |
| cd01242 | 126 | cd01242, PH_ROCK, Rho-associated coiled-coil conta | 2e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-15 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-12 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-12 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 8e-12 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-11 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-11 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 8e-11 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 8e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-09 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-09 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-08 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-08 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 8e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-07 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-07 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-07 | |
| pfam08912 | 68 | pfam08912, Rho_Binding, Rho Binding | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-06 | |
| pfam13514 | 1118 | pfam13514, AAA_27, AAA domain | 4e-06 | |
| PRK02224 | 880 | PRK02224, PRK02224, chromosome segregation protein | 4e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-06 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| pfam05622 | 713 | pfam05622, HOOK, HOOK protein | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| pfam05557 | 722 | pfam05557, MAD, Mitotic checkpoint protein | 8e-06 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| PRK02224 | 880 | PRK02224, PRK02224, chromosome segregation protein | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-05 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 3e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-05 | |
| TIGR04211 | 198 | TIGR04211, SH3_and_anchor, SH3 domain protein | 4e-05 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 5e-05 | |
| TIGR00606 | 1311 | TIGR00606, rad50, rad50 | 5e-05 | |
| PRK04863 | 1486 | PRK04863, mukB, cell division protein MukB; Provis | 5e-05 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 9e-05 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| pfam09726 | 680 | pfam09726, Macoilin, Transmembrane protein | 1e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 2e-04 | |
| pfam05557 | 722 | pfam05557, MAD, Mitotic checkpoint protein | 2e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 3e-04 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 3e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-04 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 3e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 4e-04 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 4e-04 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 4e-04 | |
| COG3096 | 1480 | COG3096, MukB, Uncharacterized protein involved in | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 5e-04 | |
| TIGR01843 | 423 | TIGR01843, type_I_hlyD, type I secretion membrane | 7e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-04 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 9e-04 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 9e-04 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 0.001 | |
| TIGR00606 | 1311 | TIGR00606, rad50, rad50 | 0.001 | |
| COG4717 | 984 | COG4717, COG4717, Uncharacterized conserved protei | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| COG3206 | 458 | COG3206, GumC, Uncharacterized protein involved in | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| PHA02562 | 562 | PHA02562, 46, endonuclease subunit; Provisional | 0.001 | |
| COG2433 | 652 | COG2433, COG2433, Uncharacterized conserved protei | 0.001 | |
| pfam07888 | 546 | pfam07888, CALCOCO1, Calcium binding and coiled-co | 0.001 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.002 | |
| pfam13514 | 1118 | pfam13514, AAA_27, AAA domain | 0.002 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 0.002 | |
| cd01243 | 136 | cd01243, PH_MRCK, MRCK (myotonic dystrophy-related | 0.002 | |
| TIGR00618 | 1042 | TIGR00618, sbcc, exonuclease SbcC | 0.002 | |
| PHA02562 | 562 | PHA02562, 46, endonuclease subunit; Provisional | 0.003 | |
| PRK05771 | 646 | PRK05771, PRK05771, V-type ATP synthase subunit I; | 0.003 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.004 | |
| pfam05557 | 722 | pfam05557, MAD, Mitotic checkpoint protein | 0.004 | |
| TIGR01843 | 423 | TIGR01843, type_I_hlyD, type I secretion membrane | 0.004 | |
| smart00109 | 50 | smart00109, C1, Protein kinase C conserved region | 0.004 | |
| TIGR03185 | 650 | TIGR03185, DNA_S_dndD, DNA sulfur modification pro | 0.004 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.004 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 373 bits (959), Expect = e-119
Identities = 136/242 (56%), Positives = 180/242 (74%), Gaps = 11/242 (4%)
Query: 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 608
ID+ + + ++ Q++ GKGAYGIV+KA D+ K+ VA+KKIF+AFRN TDAQRT+R
Sbjct: 1 IDKHILRKYEILQKL-----GKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR 55
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ 668
EI+FL+ HPNI+ +L++ KA N+KD+Y+VFEYME DL+ VIR IL+DVH RYIM+Q
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQ 115
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-----LTEYIAT 723
L L YIH+ V+HRDLKPSNIL++ C +K+ D GLARSLS+ +E LT+Y+AT
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
RWYRAPEIL+ + RYT VD+WS+GCIL EML KPLFPG ST +QL+ I+ ++ P
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI-GPPSA 234
Query: 784 AD 785
D
Sbjct: 235 ED 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = 2e-96
Identities = 111/216 (51%), Positives = 144/216 (66%), Gaps = 8/216 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG+V A DK + VAIKKI F + DA+R REI L+ RH NII +LDI
Sbjct: 9 GSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDI 67
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + D+Y+V E ME DL+KVI+ L D HI+Y ++Q+ GL Y+H+ V+HR
Sbjct: 68 LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHR 127
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSL---SDSKECLTEYIATRWYRAPEILISNRRYTHH 741
DLKPSNIL++ +C +KI D GLAR + D K LTEY+ TRWYRAPE+L+S+ RYT
Sbjct: 128 DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA 187
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+DIWS+GCI AE+L KPLFPG QL LIV ++
Sbjct: 188 IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 4e-81
Identities = 109/216 (50%), Positives = 150/216 (69%), Gaps = 8/216 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG+V A D + + VAIKKI AF T A+RT RE+ L+ F +H NII + DI
Sbjct: 14 GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDI 72
Query: 629 YKAVNN--KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ KD+YVV + ME+DL+ +I D+ L + HIRY ++QL GL YIH+ V+HRD
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRD 132
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDS----KECLTEYIATRWYRAPEILISNRRYTHH 741
LKPSN+L+++ C ++IGD G+AR LS S K +TEY+ATRWYRAPE+L+S YT
Sbjct: 133 LKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA 192
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+D+WS+GCI AEML + LFPG + HQL+LI++++
Sbjct: 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 1e-80
Identities = 103/228 (45%), Positives = 142/228 (62%), Gaps = 6/228 (2%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
L K G+G YG+VYKA DK + VAIKKI F ++ + REI LK HPNII
Sbjct: 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNII 61
Query: 624 TMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKV 681
+LD+++ DLY+VFE+M+ DL K+I+D + L + I+ ++QL GL++ H+ +
Sbjct: 62 KLLDVFRH--KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
+HRDLKP N+LI+ +K+ D GLARS T Y+ TRWYRAPE+L+ ++ Y+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKFY 788
VDIWS+GCI AE+L +PLFPG S QL I L P+P KF
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 9e-79
Identities = 111/236 (47%), Positives = 151/236 (63%), Gaps = 11/236 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V A K VAIKKI F ++T QRT REI L+ F +H NII +LDI
Sbjct: 14 GEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRF-KHENIIGILDI 71
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ + D+Y+V E ME DL K+I+ + L + HI+Y ++Q+ GL YIH+ V+HRD
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRD 131
Query: 686 LKPSNILIDKSCSIKIGDLGLARS---LSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
LKPSN+L++ +C +KI D GLAR D LTEY+ATRWYRAPEI+++++ YT +
Sbjct: 132 LKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798
DIWS+GCILAEML ++PLFPG HQL LI+ ++ P + S R
Sbjct: 192 DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL--GTPSQEDLN-CIISLRARN 244
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 9e-76
Identities = 104/213 (48%), Positives = 145/213 (68%), Gaps = 5/213 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYGIV A + + VAIKKI AF N+ DA+RT REI L+ H N+I + DI
Sbjct: 14 GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDI 72
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ D+Y+V+E M+ DL+++IR + L D H +Y ++QL GL YIH+ V+HR
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHR 132
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSN+L++ +C +KI D GLAR+ S+ + +TEY+ TRWYRAPE+L++ YT +D+
Sbjct: 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
WS+GCI AE+L KPLFPG HQL+LI L+
Sbjct: 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 1e-74
Identities = 95/213 (44%), Positives = 128/213 (60%), Gaps = 17/213 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHPNI 622
G+G YG+VYKA DK + VA+KKI + D + REI LK + HPNI
Sbjct: 8 GEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKELK-HPNI 60
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ +LD+ + LY+VFEY + DL K + R L I+ IM+QL GL+Y H+ +
Sbjct: 61 VKLLDVI--HTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
++HRDLKP NILI++ +K+ D GLAR+ T + T WYRAPEIL+ ++ Y+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
VDIWS+GCI AEM+ KPLFPG S QL I
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 1e-73
Identities = 85/225 (37%), Positives = 123/225 (54%), Gaps = 11/225 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G VY A DK + VAIK I + K D +R REI LK +HPNI+ + D+
Sbjct: 8 GEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKL-KHPNIVRLYDV 65
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ + LY+V EY E DL +++ + L + R+ + Q+ + L Y+H+ ++HRDL
Sbjct: 66 F--EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDL 123
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP NIL+D+ +K+ D GLAR L E LT ++ T Y APE+ + + Y VDIWS
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEV-LLGKGYGKAVDIWS 181
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791
LG IL E+L KP FPG QL + + P
Sbjct: 182 LGVILYELLTGKPPFPG---DDQLLELFKKIGKPKPPFPPPEWDI 223
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 1e-72
Identities = 106/272 (38%), Positives = 162/272 (59%), Gaps = 13/272 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG V A+D + VAIKK+ F++ A+RTYRE+ LK H N+I +LD+
Sbjct: 24 GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDV 82
Query: 629 Y---KAVNN-KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ ++ + +D+Y+V M DLN +++ + L D HI+++++Q+ GL YIH+ ++HR
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHR 142
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSNI +++ C +KI D GLAR D +T Y+ATRWYRAPEI+++ Y VDI
Sbjct: 143 DLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDI 199
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQV 803
WS+GCI+AE+L K LFPG+ QL+ I+NLV P+ ++ S+ R +
Sbjct: 200 WSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD----EELLQKISSESARNYIQSL 255
Query: 804 VVKCQKELQELQSQVVEENTSKLKLQMELDSK 835
+K+ +E+ S L+ + LD
Sbjct: 256 PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 8e-71
Identities = 84/216 (38%), Positives = 119/216 (55%), Gaps = 5/216 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++G VYKA K + VA+K + + Q REI L+ HPNI+ ++D
Sbjct: 8 GSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNIVRLIDA 66
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ + LY+V EY E DL + L + + I Q+ GL Y+H+ ++HRDL
Sbjct: 67 F--EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP NIL+D++ +KI D GLA+ L S LT ++ T WY APE+L+ Y VD+WS
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
LG IL E+L KP F G + QLQLI ++ P
Sbjct: 185 LGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220
|
Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 5e-68
Identities = 92/210 (43%), Positives = 122/210 (58%), Gaps = 8/210 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQRHPNIITM 625
G+G Y +VYKA DK + VAIKKI R + REI L+ +HPNII +
Sbjct: 9 GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGL 67
Query: 626 LDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMH 683
LD++ +N + +VFE+ME DL KVI+DK +L I+ M GL Y+H+ ++H
Sbjct: 68 LDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILH 125
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RDLKP+N+LI +K+ D GLARS +T + TRWYRAPE+L R Y VD
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVD 185
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
+WS+GCI AE+L P PG S QL I
Sbjct: 186 MWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (585), Expect = 1e-67
Identities = 88/209 (42%), Positives = 131/209 (62%), Gaps = 7/209 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G VY A +K + VAIKK+ + F + + RE+ L+ HPNI+ + ++
Sbjct: 8 GDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLKEV 66
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ N +LY VFEYME +L ++++D K + IR I++Q+ GL++IH HRD
Sbjct: 67 FR--ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRD 124
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP N+L+ +KI D GLAR + S+ T+Y++TRWYRAPEIL+ + Y+ VDIW
Sbjct: 125 LKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIV 774
+LGCI+AE+ +PLFPG+S QL I
Sbjct: 184 ALGCIMAELYTLRPLFPGSSEIDQLYKIC 212
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 7e-66
Identities = 86/212 (40%), Positives = 123/212 (58%), Gaps = 6/212 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITMLD 627
G+G YG VYKA +K + VA+KKI K T REI L+ RHPNI+ + +
Sbjct: 8 GEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKL-RHPNIVRLKE 65
Query: 628 IYKAVNNKDLYVVFEYMENDLNKVIRDKILK--DVHIRYIMFQLCNGLSYIHACKVMHRD 685
I + +Y+VFEYM++DL ++ +K + I+ M QL GL Y+H+ ++HRD
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRD 125
Query: 686 LKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
+K SNILI+ +K+ D GLAR + T + T WYR PE+L+ RY VD+
Sbjct: 126 IKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDM 185
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
WS+GCILAE+ KP+F G++ QL+ I L
Sbjct: 186 WSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 2e-65
Identities = 100/222 (45%), Positives = 142/222 (63%), Gaps = 10/222 (4%)
Query: 565 LLKE-GKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 621
L+KE G+GAYGIV A + + ++ VAIKKI F K A+R RE+ L+ F+ H N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 622 IITM--LDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA 678
I + +DI N +LY+ E ME DL+++IR + L D H + ++Q+ GL YIH+
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILIS 734
V+HRDLKP N+L++ C +KI D GLAR S++ +TEY+ATRWYRAPEI++S
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+ YT +D+WS+GCILAE+L KP+F G QL I+ +
Sbjct: 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 4e-63
Identities = 104/224 (46%), Positives = 142/224 (63%), Gaps = 9/224 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG+YG+V A D + + VAIKKI + F + +DA R REI L+ RHP+I+ + I
Sbjct: 9 GKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHI 67
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ KD+YVVFE ME+DL++VI+ + L H ++ ++QL L YIH V HR
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127
Query: 685 DLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECL--TEYIATRWYRAPEILIS-NRRYTH 740
DLKP NIL + C +KI D GLAR + +D+ + T+Y+ATRWYRAPE+ S +YT
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784
+DIWS+GCI AE+L KPLFPG + HQL LI +L+ P
Sbjct: 188 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 5e-63
Identities = 97/272 (35%), Positives = 150/272 (55%), Gaps = 23/272 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD--AQRTYREILFLKSFQRHPNIITML 626
G+GA+GIV+KA D+ + VA+KK+ A R + REI L++ Q HP ++ +L
Sbjct: 9 GEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQ-HPYVVKLL 65
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
D++ +V EYM +DL++V+RD + L + ++ M L G++Y+HA +MHR
Sbjct: 66 DVFPH--GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR 123
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIATRWYRAPEILISNRRYTHHVD 743
DLKP+N+LI +KI D GLAR S+ + L + +ATRWYRAPE+L R+Y VD
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNP---------PHADKFYAGFKS 793
+W++GCI AE+L PLFPG + QL ++ L PN P +K F
Sbjct: 184 LWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT--FP- 240
Query: 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSK 825
+ + ++ E +L ++ + SK
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 4e-62
Identities = 99/214 (46%), Positives = 145/214 (67%), Gaps = 6/214 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA+G+V A D+ Q VAIKKI + F A+RTYRE+ LK RH NII++ DI
Sbjct: 19 GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDI 77
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKP 688
+ + +D+Y V E + DL++++ + L+ I+Y ++Q+ GL Y+H+ V+HRDLKP
Sbjct: 78 FIS-PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP 136
Query: 689 SNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLG 748
SNILI+++C +KI D GLAR + D + +T Y++TR+YRAPEI+++ ++Y VDIWS G
Sbjct: 137 SNILINENCDLKICDFGLAR-IQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193
Query: 749 CILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
CI AEML+ KPLFPG +Q +I +L+ PP
Sbjct: 194 CIFAEMLEGKPLFPGKDHVNQFSIITDLL-GTPP 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 3e-58
Identities = 88/233 (37%), Positives = 137/233 (58%), Gaps = 12/233 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V K +K + VAIKK E+ ++ + RE+ L+ RH NI+ + +
Sbjct: 10 GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEA 68
Query: 629 YKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
++ LY+VFEY+E L +++ L +R ++QL ++Y H+ ++HRD+
Sbjct: 69 FR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAPEILISNRRYTHHVDIW 745
KP NIL+ +S +K+ D G AR+L LT+Y+ATRWYRAPE+L+ + Y VD+W
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVW 186
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP------HADKFYAGFK 792
++GCI+AE+L +PLFPG S QL LI + P PP ++ +AG
Sbjct: 187 AIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 5e-58
Identities = 73/217 (33%), Positives = 112/217 (51%), Gaps = 20/217 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G VY A DK + VAIK I + + + REI LK HPNI+ + +
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN-HPNIVKLYGV 59
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + LY+V EY E L ++++ L + I I+ Q+ GL Y+H+ ++HRD
Sbjct: 60 FE--DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 686 LKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
LKP NIL+D +K+ D GL++ L+ K L + T Y APE+L+ Y+ DI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781
WSLG IL E+ LI +++ +P
Sbjct: 178 WSLGVILYEL------------PELKDLIRKMLQKDP 202
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 5e-57
Identities = 93/212 (43%), Positives = 131/212 (61%), Gaps = 16/212 (7%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ----RTYREILFLKSFQRHPNI 622
K G+G YG+VYKA DK + VA+KKI R +T+ + REI LK HPNI
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKEL-NHPNI 60
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH----IRYIMFQLCNGLSYIHA 678
+ +LD+ + N LY+VFE+++ DL K + D I+ ++QL G++Y H+
Sbjct: 61 VRLLDVVHSENK--LYLVFEFLDLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+V+HRDLKP N+LID+ ++K+ D GLAR+ T + T WYRAPEIL+ +R+Y
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770
+ VDIWS+GCI AEM+ +PLFPG S QL
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 3e-56
Identities = 85/224 (37%), Positives = 125/224 (55%), Gaps = 18/224 (8%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQR 618
+++ + G+GAYG VYKA D N ++VA+KK+ + T REI LK +
Sbjct: 2 EELAEI--GEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLES 57
Query: 619 --HPNIITMLDIYKAVNNK---DLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLC 670
HPNI+ +LD+ L +VFE+++ DL + L I+ +M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLTEYIATRWYRAP 729
G+ ++H+ +++HRDLKP NIL+ +KI D GLAR S + LT + T WYRAP
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAP 175
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
E+L+ Y VD+WS+GCI AE+ + +PLF G S + QL I
Sbjct: 176 EVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-55
Identities = 103/260 (39%), Positives = 161/260 (61%), Gaps = 13/260 (5%)
Query: 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
++ NL G GAYG V AYD +Q VA+KK+ F++ A+RTYRE+ LK +H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KH 73
Query: 620 PNIITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 675
N+I +LD++ N ++Y+V M DLN +++ + L D H++++++QL GL Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
IH+ ++HRDLKPSN+ +++ C ++I D GLAR D +T Y+ATRWYRAPEI+++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNW 190
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSK 794
Y VDIWS+GCI+AE+L+ K LFPG QL+ I+ +V P+P + S+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP----EVLKKISSE 246
Query: 795 HEREKFNQVVVKCQKELQEL 814
H R+ + Q++L+++
Sbjct: 247 HARKYIQSLPHMPQQDLKKI 266
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-55
Identities = 88/228 (38%), Positives = 141/228 (61%), Gaps = 9/228 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA+G+V+ D + + VA+KK+ F+N +R +RE+ L F +H N+++ LDI
Sbjct: 9 GYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDI 67
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + +++YVV E M++DL+K+I + L H++ ++Q+ GL Y+H+ ++HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 685 DLKPSNILIDKSCSIKIGDLGLAR--SLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
D+KP N+L++ +C +KI D GLAR +SK +T+ + T++YRAPEIL+ +R YT V
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAV 186
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790
DIWS+GCI AE+L + LF S QL LI +L+ P A
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG-TPSLEAMRSAC 233
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 3e-55
Identities = 97/242 (40%), Positives = 150/242 (61%), Gaps = 10/242 (4%)
Query: 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
Y++ +++ + + + Q NL G GAYG V A+D VA+KK+ F++ A+
Sbjct: 4 YRQELNKTIWEVPERYQ--NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 61
Query: 605 RTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDV 660
RTYRE+ LK +H N+I +LD++ + D+Y+V M DLN +++ + L D
Sbjct: 62 RTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 661 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720
H++++++Q+ GL YIH+ ++HRDLKPSN+ +++ C +KI D GLAR D +T Y
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGY 177
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
+ATRWYRAPEI+++ Y VDIWS+GCI+AE+L + LFPG QL+LI+ LV
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 781 PP 782
Sbjct: 238 GA 239
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 88/242 (36%), Positives = 139/242 (57%), Gaps = 22/242 (9%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TY-REILFLK 614
+++N ++EG YG+VY+A DK + VA+KK+ K + ++ T REI L
Sbjct: 8 EKLNRIEEG--TYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLREINILL 59
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNG 672
Q HPNI+T+ ++ N +Y+V EY+E+DL ++ ++ +M QL +G
Sbjct: 60 KLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 732
++++H ++HRDLK SN+L++ +KI D GLAR + T+ + T WYRAPE+L
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGF 791
+ + Y+ +D+WS+GCI AE+L KPLFPG S QL I L+ P +K + GF
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT----EKIWPGF 234
Query: 792 KS 793
Sbjct: 235 SE 236
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 3e-53
Identities = 83/235 (35%), Positives = 117/235 (49%), Gaps = 26/235 (11%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G +G VYKA + VA+KKI REI LK +HPN++ ++
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLI 73
Query: 627 DIY------KAVNNKDLYVVFEYMENDL-----NKVIRDKILKDVHIRYIMFQLCNGLSY 675
D+ +Y+V YM++DL N ++ L + I+ M QL G++Y
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYMLQLLEGINY 130
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--------ECLTEY---IATR 724
+H ++HRD+K +NILID +KI D GLAR +Y + TR
Sbjct: 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779
WYR PE+L+ RRYT VDIW +GC+ AEM +P+ G S QL LI L
Sbjct: 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 7e-53
Identities = 78/229 (34%), Positives = 125/229 (54%), Gaps = 6/229 (2%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G + V KA + +Y AIK + + F++ REI L+ HPNI+ ++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLI 64
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ L +VFE M+ +L ++I+ + L + ++ M+QL L ++H + HR
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+KP NILI +K+ D G R + SK TEYI+TRWYRAPE L+++ Y +DI
Sbjct: 125 DIKPENILIKDDI-LKLADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDI 182
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFK 792
W++GC+ E+L PLFPG + Q+ I +++ P+ KF
Sbjct: 183 WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 8e-53
Identities = 104/276 (37%), Positives = 154/276 (55%), Gaps = 28/276 (10%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ----RTYREILFLKSFQRHPNI 622
K G+G YG+VYKA +K + VA+KKI R T+ + REI LK HPNI
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELN-HPNI 61
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHAC 679
+ +LD+ LY+VFE++ DL K + L + I+ +FQL GL++ H+
Sbjct: 62 VKLLDVIH--TENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
+V+HRDLKP N+LI+ +IK+ D GLAR+ T + T WYRAPEIL+ + Y+
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAG------FK 792
VDIWSLGCI AEM+ + LFPG S QL ++ L P+ + + G +K
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSLPDYK 235
Query: 793 S---KHEREKFNQVVVKCQKELQELQSQVVEENTSK 825
K R+ F++VV ++ ++L SQ++ + +K
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNK 271
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 80/212 (37%), Positives = 129/212 (60%), Gaps = 19/212 (8%)
Query: 569 GKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTD--AQRTYREILFLKSFQRHPNIIT 624
G+G YG VYKA KN K + AIKK F+ + + +Q REI L+ + H N+++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK-HENVVS 66
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVH---IRYIMFQLCNGLSYIHA 678
+++++ +K +Y++F+Y E+DL ++I R + ++ +++Q+ NG+ Y+H+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 679 CKVMHRDLKPSNILI----DKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWYRAPEI 731
V+HRDLKP+NIL+ + +KIGDLGLAR + K + T WYRAPE+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPEL 186
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763
L+ R YT +DIW++GCI AE+L +P+F G
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 1e-52
Identities = 87/215 (40%), Positives = 134/215 (62%), Gaps = 9/215 (4%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
NL G+G+YG+V K K Q VAIKK E+ +K + REI LK RH N++
Sbjct: 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLV 63
Query: 624 TMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
++++++ K LY+VFE+++ +DL K L + +R +FQ+ G+ + H+
Sbjct: 64 NLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH 119
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRD+KP NIL+ +S +K+ D G AR+L+ E T+Y+ATRWYRAPE+L+ + +Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
VDIW++GC++ EML +PLFPG S QL I+
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-52
Identities = 92/217 (42%), Positives = 140/217 (64%), Gaps = 8/217 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
+L + G GAYG V A D+ VAIKK++ F+++ A+R YRE+ LK +H N+I
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVI 77
Query: 624 TMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
+LD++ + D Y+V +M DL K+++ + L + I+++++Q+ GL YIHA
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRDLKP N+ +++ C +KI D GLAR +DS+ +T Y+ TRWYRAPE++++ YT
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSE--MTGYVVTRWYRAPEVILNWMHYT 194
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
VDIWS+GCI+AEML KPLF G QL I+ +
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-51
Identities = 86/235 (36%), Positives = 120/235 (51%), Gaps = 30/235 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTY-----------REILFLKSF 616
G+G YG V KAYD + VAIKK+ N R RE+ +
Sbjct: 18 GEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77
Query: 617 QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSY 675
+ H NI+ ++D+Y V + +V + M +DL KV+ KI L + ++ I+ Q+ NGL+
Sbjct: 78 K-HENIMGLVDVY--VEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--------------SDSKECLTEYI 721
+H MHRDL P+NI I+ KI D GLAR +E +T +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
T WYRAPE+L+ +Y VD+WS+GCI AE+L KPLFPG + QL I L
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 6e-51
Identities = 82/213 (38%), Positives = 132/213 (61%), Gaps = 9/213 (4%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
L K G+G+YG+V+K ++ Q VAIKK E+ + + REI LK +HPN++
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVN 64
Query: 625 MLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
++++++ + L++VFEY + N+L K + + + I+ I++Q +++ H
Sbjct: 65 LIEVFR--RKRKLHLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
+HRD+KP NILI K IK+ D G AR L+ + T+Y+ATRWYRAPE+L+ + +Y
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
VD+W++GC+ AE+L +PL+PG S QL LI
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 91/223 (40%), Positives = 122/223 (54%), Gaps = 10/223 (4%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
L K G+G YG VYKA DKN + VA+KK + REI L+ I+
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 625 MLDIYKAVNNK---DLYVVFEYMENDLNKVIRDKILKDVH------IRYIMFQLCNGLSY 675
+LD+ LY+VFEY+++DL K + I+ M+QL G+++
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 676 IHACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
H VMHRDLKP N+L+DK +KI DLGL R+ S + T I T WYRAPE+L+
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+ Y+ VDIWS+GCI AEM + +PLFPG S QL I L+
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 2e-50
Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG++G VY K++ + +K+I + ++ + + E+ LK HPNII +
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK-LNHPNIIKYYES 67
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIR-----YIMFQLCNGLSYIHACKVM 682
+ L +V EY + DL++ I+ + + QLC L Y+H+ K++
Sbjct: 68 F--EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+KP NI + + +K+GD G+++ LS + + + T +Y +PE+ N+ Y +
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL-CQNKPYNYKS 184
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
DIWSLGC+L E+ K F G + L+L + +++ P
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYP 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-50
Identities = 91/239 (38%), Positives = 135/239 (56%), Gaps = 27/239 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHPNI 622
G+G YGIVY+A D + + VA+KK+ + D +R + REI L + RHPNI
Sbjct: 16 GEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNL-RHPNI 68
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACK 680
+ + ++ + +++V EY E DL ++ + + ++ +M QL GL Y+H
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 681 VMHRDLKPSNILI-DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRDLK SN+L+ DK C +KI D GLAR+ + +T + T WYRAPE+L+ YT
Sbjct: 129 IIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP---------PHADKFY 788
+D+W++GCILAE+L KPL PG S QL LI+ L+ PN P KF
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 3e-50
Identities = 90/210 (42%), Positives = 134/210 (63%), Gaps = 9/210 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG V A DK + VAIKK+ F+++ A+R YRE+ LK Q H N+I +LD+
Sbjct: 24 GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDV 82
Query: 629 YKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + +D Y+V YM+ DL K++ L + ++Y+++Q+ GL YIH+ ++HR
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP-LSEDKVQYLVYQMLCGLKYIHSAGIIHR 141
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKP N+ +++ C +KI D GLAR +D++ +T Y+ TRWYRAPE++++ Y VDI
Sbjct: 142 DLKPGNLAVNEDCELKILDFGLARH-ADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDI 198
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
WS+GCI+AEML K LF G QL I+
Sbjct: 199 WSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-50
Identities = 88/209 (42%), Positives = 133/209 (63%), Gaps = 8/209 (3%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618
L++ NL G GA GIV AYD Q VAIKK+ F+N T A+R YRE++ +K
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-N 73
Query: 619 HPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLS 674
H NII +L+++ + +D+Y+V E M+ +L +VI+ L + Y+++Q+ G+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQMLCGIK 132
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
++H+ ++HRDLKPSNI++ C++KI D GLAR+ S +T Y+ TR+YRAPE+ I
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEV-IL 190
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPG 763
Y +VDIWS+GCI+ EM++ LFPG
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 82/222 (36%), Positives = 125/222 (56%), Gaps = 18/222 (8%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TYREILFLKSFQRH 619
L K G+G Y VYK ++ + VA+K+I DA+ REI +K +H
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKEL-KH 57
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHIRYIMFQLCNGLSY 675
NI+ + D+ NK L +VFEYM+ DL K + L ++ +QL G+++
Sbjct: 58 ENIVRLHDVIH-TENK-LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
H +V+HRDLKP N+LI+K +K+ D GLAR+ + + T WYRAP++L+ +
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
R Y+ +DIWS+GCI+AEM+ +PLFPG + QL I ++
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 86/232 (37%), Positives = 127/232 (54%), Gaps = 13/232 (5%)
Query: 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 616
+++ + L K G+G +G V+KA K KQ VA+KK+ + REI L+
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL 68
Query: 617 QRHPNIITMLDI----YKAVNNK--DLYVVFEYMENDLNKVIRDKILK--DVHIRYIMFQ 668
+H N++ +++I N Y+VFE+ E+DL ++ +K +K I+ +M
Sbjct: 69 -KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATR 724
L NGL YIH K++HRD+K +NILI K +K+ D GLAR+ S SK T + T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
WYR PE+L+ R Y +D+W GCI+AEM P+ G + HQL LI L
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 89/215 (41%), Positives = 130/215 (60%), Gaps = 7/215 (3%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G YG+VYKA D+ + +A+KKI ++ REI LK Q H NI+ +
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQ 67
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVH-IRYIMFQLCNGLSYIHACKVMH 683
D+ + K LY+VFEY++ DL K + K+ I+ ++Q+ G++Y H+ +V+H
Sbjct: 68 DVVH--SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125
Query: 684 RDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
RDLKP N+LID+ ++K+ D GLAR+ T + T WYRAPEIL+ +R Y+ V
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPV 185
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
DIWS+GCI AEM+ KPLFPG S +L I ++
Sbjct: 186 DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-48
Identities = 86/225 (38%), Positives = 125/225 (55%), Gaps = 19/225 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G+ G+V+ A D + + VA+KKI + + REI ++ H NI+ + ++
Sbjct: 14 GCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLD-HDNIVKVYEV 70
Query: 629 YKAVNNKD------------LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676
+ +Y+V EYME DL V+ L + H R M+QL GL YI
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 677 HACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEIL 732
H+ V+HRDLKP+N+ I+ + +KIGD GLAR + K L+E + T+WYR+P +L
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+S YT +D+W+ GCI AEML KPLF GA Q+QLI+ V
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-48
Identities = 83/208 (39%), Positives = 119/208 (57%), Gaps = 7/208 (3%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G YG+VYK +K Q VA+KKI + REI LK Q HPNI+ +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQ 65
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
D+ + LY++FE++ DL K + + + + ++ ++Q+ G+ + H+ +V+
Sbjct: 66 DVLMQESR--LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRDLKP N+LID IK+ D GLAR+ T + T WYRAPE+L+ + RY+ V
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQL 770
DIWS+G I AEM KPLF G S QL
Sbjct: 184 DIWSIGTIFAEMATKKPLFHGDSEIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 79/213 (37%), Positives = 123/213 (57%), Gaps = 8/213 (3%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
L K G+G YG V+KA ++ + VA+K++ ++ REI LK +H NI+
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVR 63
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
+ D+ + +K L +VFEY + DL K I ++ ++ MFQL GL++ H+ V
Sbjct: 64 LYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-VKSFMFQLLKGLAFCHSHNV 120
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
+HRDLKP N+LI+K+ +K+ D GLAR+ C + + T WYR P++L + Y+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 742 VDIWSLGCILAEMLQS-KPLFPGASTSHQLQLI 773
+D+WS GCI AE+ + +PLFPG QL+ I
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 6/198 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G VY A DK+ + +A+K + + ++ + + REI L S Q HPNI+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGS 67
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ L + EY+ L+ +++ L + IR Q+ GL+Y+H+ ++HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISNRRYTHHVDI 744
K +NIL+D +K+ D G A+ L D E T ++ APE +I Y DI
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADI 186
Query: 745 WSLGCILAEMLQSKPLFP 762
WSLGC + EM KP +
Sbjct: 187 WSLGCTVIEMATGKPPWS 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 83/223 (37%), Positives = 120/223 (53%), Gaps = 25/223 (11%)
Query: 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQRTYREILFL 613
L K G+G+Y VYK K Q VA+K+I F A R E L
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----------EASLL 57
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCN 671
K +H NI+T+ DI K L +VFEY++ DL + + D L ++R +FQL
Sbjct: 58 KDL-KHANIVTLHDIIHT--KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 731
GL+Y H +V+HRDLKP N+LI + +K+ D GLAR+ S + + + T WYR P++
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLI 773
L+ + Y+ +D+W +GCI EM +PLFPG++ QL I
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
L K GKG +G VYKA K + VAIK I +K ++ EI LK +HPNI+
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILK-KCKHPNIV 60
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
Y + +L++V E+ DL K ++ L + I Y+ +L GL Y+H+
Sbjct: 61 KYYGSY--LKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRD+K +NIL+ +K+ D GL+ LSD+K T + T ++ APE+ I+ + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPYWMAPEV-INGKPYD 175
Query: 740 HHVDIWSLGCILAEMLQSKP 759
+ DIWSLG E+ + KP
Sbjct: 176 YKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 86/234 (36%), Positives = 123/234 (52%), Gaps = 31/234 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHPNI 622
G+G YG VYKA DK+ + VA+KK+ + D ++ REI L+ H NI
Sbjct: 16 GEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKILRQLN-HRNI 68
Query: 623 ITMLDIYKAVNNKD-----------LYVVFEYMENDLNKVIRDKIL--KDVHIRYIMFQL 669
+ + +I V +K Y+VFEYM++DL ++ ++ + HI+ M QL
Sbjct: 69 VNLKEI---VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIATRWYRA 728
GL+Y H +HRD+K SNIL++ IK+ D GLAR S+ T + T WYR
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 781
PE+L+ RY +D+WS GCIL E+ KP+F QL+LI L P P
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 3e-43
Identities = 93/234 (39%), Positives = 146/234 (62%), Gaps = 9/234 (3%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618
L++ NL G GA GIV AYD + VAIKK+ F+N+T A+R YRE++ +K
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 74
Query: 619 HPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLS 674
H NII++L+++ + +D+Y+V E M+ +L +VI+ + L + Y+++Q+ G+
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIK 133
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
++H+ ++HRDLKPSNI++ C++KI D GLAR+ S +T Y+ TR+YRAPE+++
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 192
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF 787
Y +VDIWS+GCI+ EM++ K LFPG Q ++I L P P K
Sbjct: 193 -MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 92/234 (39%), Positives = 145/234 (61%), Gaps = 9/234 (3%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618
L++ NL G GA GIV AYD ++ VAIKK+ F+N+T A+R YRE++ +K
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 81
Query: 619 HPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLS 674
H NII +L+++ + +D+Y+V E M+ +L +VI+ + L + Y+++Q+ G+
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIK 140
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
++H+ ++HRDLKPSNI++ C++KI D GLAR+ S +T Y+ TR+YRAPE+++
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 199
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF 787
Y +VDIWS+GCI+ EM++ LFPG Q ++I L P P K
Sbjct: 200 -MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 74/199 (37%), Positives = 108/199 (54%), Gaps = 10/199 (5%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
NL K G+GA G VYKA D+ + VAIKK+ R + + EIL +K +HPNI+
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNK-ELIINEILIMKDC-KHPNIV 78
Query: 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACK 680
D Y +L+VV EYM+ L +I + + I Y+ ++ GL Y+H+
Sbjct: 79 DYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
V+HRD+K NIL+ K S+K+ D G A L+ K + T ++ APE +I + Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE-VIKRKDYGP 195
Query: 741 HVDIWSLGCILAEMLQSKP 759
VDIWSLG + EM + +P
Sbjct: 196 KVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 81/222 (36%), Positives = 133/222 (59%), Gaps = 8/222 (3%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 617
L+ + L K G+G Y V+K K + VA+K+I ++ A T RE+ LK+
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNL- 60
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 675
+H NI+T+ DI + L +VFEY+++DL + + + ++ +++ MFQL GLSY
Sbjct: 61 KHANIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
H K++HRDLKP N+LI++ +K+ D GLAR+ S + + + T WYR P++L+ +
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
Y+ +D+W +GCIL EM +P+FPG++ +L LI L+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 4e-41
Identities = 85/218 (38%), Positives = 123/218 (56%), Gaps = 12/218 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR--HPNIITML 626
G GAYG VYKA D ++ +VA+K + T RE+ LK + HPNI+ ++
Sbjct: 9 GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLM 68
Query: 627 DIYKAVNNK---DLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHAC 679
D+ + +VFE+++ DL + DK+ L I+ +M Q GL ++HA
Sbjct: 69 DVCATSRTDRETKVTLVFEHVDQDL-RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRDLKP NIL+ +K+ D GLAR S + LT + T WYRAPE+L+ + Y
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVLLQS-TYA 185
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
VD+WS+GCI AEM + KPLF G S + QL I +L+
Sbjct: 186 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 9e-41
Identities = 86/217 (39%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQRH 619
+NL K G+G+Y VYK + N Q VA+K I KT+ + RE LK +H
Sbjct: 8 LNLEKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGL-KH 62
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIH 677
NI+ + DI + L VFEYM DL + + L ++R MFQL GL+YIH
Sbjct: 63 ANIVLLHDIIHT--KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
++HRDLKP N+LI +K+ D GLAR+ S + + + T WYR P++L+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLI 773
Y+ +DIW GCI EMLQ +P FPG S QL+ I
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 86/246 (34%), Positives = 141/246 (57%), Gaps = 11/246 (4%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 617
++ I L K G+G Y V+K K + VA+K+I ++ A T RE+ LK
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDL- 61
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 675
+H NI+T+ DI +K L +VFEY++ DL + + D I+ +++ ++Q+ GL+Y
Sbjct: 62 KHANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
H KV+HRDLKP N+LI++ +K+ D GLAR+ S + + + T WYR P++L+ +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795
Y+ +D+W +GCI EM +PLFPG++ +L LI L+ P ++ + G S
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL--GTP-TEETWPGISSND 236
Query: 796 EREKFN 801
E + +N
Sbjct: 237 EFKNYN 242
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 84/222 (37%), Positives = 127/222 (57%), Gaps = 8/222 (3%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 617
L+ I L K G+G Y VYK K VA+K+I ++ A T RE+ LK
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDL- 61
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 675
+H NI+T+ DI K L +VFEY++ DL + + D + +++ +FQL GL+Y
Sbjct: 62 KHANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
H KV+HRDLKP N+LI++ +K+ D GLAR+ S + + + T WYR P+IL+ +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
Y+ +D+W +GCI EM +PLFPG++ QL I ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 9e-40
Identities = 79/210 (37%), Positives = 132/210 (62%), Gaps = 8/210 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA GIV A+D VA+KK+ F+N+T A+R YRE++ LK H NII++L++
Sbjct: 30 GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNV 88
Query: 629 YKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + +D+Y+V E M+ +L +VI + L + Y+++Q+ G+ ++H+ ++HR
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHSAGIIHR 147
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSNI++ C++KI D GLAR+ + +T Y+ TR+YRAPE+++ Y +VDI
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRYYRAPEVILG-MGYKENVDI 205
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
WS+GCI+ E+++ +F G Q ++
Sbjct: 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 6e-39
Identities = 88/227 (38%), Positives = 134/227 (59%), Gaps = 12/227 (5%)
Query: 561 QQINLLKE-GKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ- 617
QQ + E G+GAYG V+KA D KN ++VA+K++ + T RE+ L+ +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 618 -RHPNIITMLDI---YKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLC 670
HPN++ + D+ + L +VFE+++ DL + + + I+ +MFQL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
GL ++H+ +V+HRDLKP NIL+ S IK+ D GLAR S + LT + T WYRAPE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAPE 179
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+L+ + Y VD+WS+GCI AEM + KPLF G+S QL I++++
Sbjct: 180 VLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 9e-39
Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 24/243 (9%)
Query: 563 INLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 615
+ L K+ G+GA+G VYK + VA+K + E + ++ Q RE ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRK 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIR---YIMFQLCN 671
HPNI+ +L + + L +V EYM DL +R K++ + Q+
Sbjct: 58 LD-HPNIVKLLGV--CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAP 729
G+ Y+ + +HRDL N L+ ++ +KI D GL+R L D + RW AP
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-AP 173
Query: 730 EILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVN-LVRPNPPHA-DK 786
E + ++T D+WS G +L E+ + +PG S + L+ + P PP+ +
Sbjct: 174 ES-LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 787 FYA 789
Y
Sbjct: 233 LYK 235
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 81/224 (36%), Positives = 133/224 (59%), Gaps = 9/224 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V K K K+ VAIKK ++ N+ + T RE+ L++ ++ NI+ + +
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE-NIVELKEA 68
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ LY+VFEY+E ++ +++ + + + +R ++QL + + H ++HRD
Sbjct: 69 FR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAPEILISNRRYTHHVDI 744
+KP N+LI + +K+ D G AR+LS+ TEY+ATRWYR+PE+L+ Y VD+
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDM 184
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788
WS+GCIL E+ +PLFPG S QL I ++ P P K +
Sbjct: 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 71/247 (28%), Positives = 113/247 (45%), Gaps = 33/247 (13%)
Query: 563 INLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 615
+ L K+ G+GA+G VYK K VA+K + E + ++ Q RE ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE---DASEQQIEEFLREARIMRK 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNG 672
HPN++ +L + + LY+V EYME DL +R L + Q+ G
Sbjct: 58 LD-HPNVVKLLGV--CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RW 725
+ Y+ + +HRDL N L+ ++ +KI D GL+R L D +Y RW
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-----DDYYRKRGGKLPIRW 169
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVN-LVRPNPPH 783
APE + ++T D+WS G +L E+ + +PG S L+ + N P PP+
Sbjct: 170 M-APES-LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN 227
Query: 784 A-DKFYA 789
+ Y
Sbjct: 228 CPPELYD 234
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 147 bits (370), Expect = 5e-38
Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 20/234 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLKSFQRHPNIITMLD 627
G+G++G VY A D+ + VA+K + + +K+ +R REI L S PNI+ + D
Sbjct: 9 GEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVM 682
+ + LY+V EY++ L +++ L + +I+ Q+ + L Y+H+ ++
Sbjct: 66 FF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123
Query: 683 HRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKE------CLTEYIATRWYRAPEIL--I 733
HRD+KP NIL+D+ +K+ D GLA+ L D + + T Y APE+L +
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787
S + DIWSLG L E+L P F G S + ++ P +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 71/218 (32%), Positives = 116/218 (53%), Gaps = 10/218 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR-EILFLKSFQRHPNIITMLD 627
G+GA+G+VYK + +VAIK+I + K +A ++ EI LK+ + HPNI+ +
Sbjct: 9 GRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIG 66
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + LY++ EY EN L ++I+ + + Y+ +Q+ GL+Y+H V+HR
Sbjct: 67 SIE--TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-YQVLQGLAYLHEQGVIHR 123
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+K +NIL K +K+ D G+A L+D + + T ++ APE+ I + DI
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV-IEMSGASTASDI 182
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
WSLGC + E+L P + + L IV P P
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP 220
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 88/253 (34%), Positives = 141/253 (55%), Gaps = 29/253 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++G+VY+A + + VAIKK+ + D Q RE+L +K+ H NII + D
Sbjct: 75 GNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLN-HINIIFLKDY 127
Query: 629 Y------KAVNNKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIH 677
Y K N L VV E++ ++K ++ + L ++ +QLC L+YIH
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 678 ACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 736
+ + HRDLKP N+LID + ++K+ D G A++L + ++ YI +R+YRAPE+++
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRFYRAPELMLGAT 246
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP---------NPPHADKF 787
YT H+D+WSLGCI+AEM+ P+F G S+ QL I+ ++ NP +AD
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306
Query: 788 YAGFKSKHEREKF 800
+ K K ++ F
Sbjct: 307 FPDVKPKDLKKVF 319
|
Length = 440 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 76/237 (32%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQRHPNI 622
L GKG++G V K K++ + + K+I + N T+ ++ E+ L+ +HPNI
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILREL-KHPNI 61
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI------RDKILKDVHIRYIMFQLCNGLSY 675
+ D +N+ LY+V EY E DL ++I R I ++ R I+ QL L
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR-ILTQLLLALYE 120
Query: 676 IH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
H V+HRDLKP+NI +D + ++K+GD GLA+ L Y+ T +Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL----VRPNPPH 783
+++ Y DIWSLGC++ E+ P F + QLQL + R P
Sbjct: 181 Q-LNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKFRRIPYR 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 73/243 (30%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G++ V A +K + AIK K K + +E+L + HP II +
Sbjct: 10 GEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGIIKL 67
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVMH 683
Y + ++LY V EY N +L + IR D R+ ++ L Y+H+ ++H
Sbjct: 68 --YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIH 125
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDS------KECLTE--------------YIAT 723
RDLKP NIL+DK IKI D G A+ L + K T ++ T
Sbjct: 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
Y +PE L++ + D+W+LGCI+ +ML KP F G++ Q I+ L PP+
Sbjct: 186 AEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPN 244
Query: 784 ADK 786
Sbjct: 245 FPP 247
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 74/201 (36%), Positives = 110/201 (54%), Gaps = 15/201 (7%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
K GKG + +VYKA + + VA+KK IFE K Q +EI LK HPN+I
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA-RQDCLKEIDLLKQLD-HPNVIK 66
Query: 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA 678
L + + N +L +V E + DL+++I+ +++ + I QLC+ L ++H+
Sbjct: 67 YLASF--IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
++MHRD+KP+N+ I + +K+GDLGL R S + T +Y +PE I Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGY 183
Query: 739 THHVDIWSLGCILAEM--LQS 757
DIWSLGC+L EM LQS
Sbjct: 184 NFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 81/246 (32%), Positives = 116/246 (47%), Gaps = 24/246 (9%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G+YG VYKA K Q VAIK + + D Q +EI LK P I+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQ-CDSPYIVKYY 64
Query: 627 DIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
Y N DL++V EY +D+ K I +K L + I I++Q GL Y+H+ K +
Sbjct: 65 GSY--FKNTDLWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K NIL+++ K+ D G++ L+D+ I T ++ APE+ I Y +
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYNNKA 180
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK-FN 801
DIWSLG EM + KP + + +I N PP + FN
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPP------PTLSDPEKWSPEFN 230
Query: 802 QVVVKC 807
V KC
Sbjct: 231 DFVKKC 236
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYRE--ILFLKSFQRHPNIIT 624
GKG++G V K+ + A+K + + + K + + T E IL S HP I+
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNIL---SRINHPFIVK 57
Query: 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ Y + LY+V EY +L + + R+ ++ L Y+H+ ++
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
+RDLKP NIL+D IK+ D GLA+ LS + T Y APE+ + + Y V
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV-LLGKGYGKAV 174
Query: 743 DIWSLGCILAEMLQSKPLFPGAST 766
D WSLG +L EML KP F
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 563 INLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 615
+ L K+ G+GA+G VYK + + VA+K + E ++ +R E +K
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE---GASEEEREEFLEEASIMKK 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNG 672
HPNI+ +L + + LY+V EYM DL +R L + + Q+ G
Sbjct: 58 LS-HPNIVRLLGV--CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RW 725
+ Y+ + +HRDL N L+ ++ +KI D GL+R + + Y +W
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED----DYYRKRGGGKLPIKW 170
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
APE + + ++T D+WS G +L E+ L +P +PG S L+L+ + R P
Sbjct: 171 M-APE-SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLEDGYRLPRPE 227
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 40/247 (16%)
Query: 569 GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNII 623
G+GA+G VYK VA+K + E + ++ +R +E +K HPN++
Sbjct: 4 GEGAFGEVYKGKLKGKDGKTTEVAVKTLKE---DASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR----------DKILKDVHIRYIMFQLCNG 672
+L + + LY+V EYME DL +R L + Q+ G
Sbjct: 60 RLLGV--CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RW 725
+ Y+ + K +HRDL N L+ + +KI D GL+R + D Y RW
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKKTGGKLPIRW 173
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR-PNPP 782
APE + + +T D+WS G +L E+ L + P +PG S L+ + R P P
Sbjct: 174 M-APE-SLKDGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRKGYRLPKPE 230
Query: 783 HA-DKFY 788
+ D+ Y
Sbjct: 231 YCPDELY 237
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 87/254 (34%), Positives = 131/254 (51%), Gaps = 20/254 (7%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
L K G+G+Y VYK K N + VA+K I T RE LK +H NI+
Sbjct: 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT-AIREASLLKGL-KHANIVL 67
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHACKV 681
+ DI + L +VFEY+ DL + + DK +H ++ +FQL GLSYIH +
Sbjct: 68 LHDIIHT--KETLTLVFEYVHTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
+HRDLKP N+LI + +K+ D GLAR+ S + + T WYR P++L+ + Y+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 742 VDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLI-VNLVRPN----------PPHADKFYA 789
+D+W +GCI EM+Q FPG QL+ I + L PN P + +
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT 244
Query: 790 GFKSKHEREKFNQV 803
+ K+ R+ +N++
Sbjct: 245 LYSPKNLRQAWNKL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 74/214 (34%), Positives = 125/214 (58%), Gaps = 24/214 (11%)
Query: 567 KEGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
K G+G YG VYKA K+ K + A+K+I + REI L+ +HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLREL-KHPNVIA 62
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVIR----------DKILKDVHIRYIMFQLCNGLS 674
+ ++ + +++ ++++F+Y E+DL +I+ L ++ +++Q+ +G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 675 YIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYR 727
Y+HA V+HRDLKP+NIL+ + +KI D+G AR + + L + + T WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+L+ R YT +DIW++GCI AE+L S+P+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 73/214 (34%), Positives = 125/214 (58%), Gaps = 24/214 (11%)
Query: 567 KEGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
K G+G YG VYKA K+ K + A+K+I + REI L+ +HPN+I+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLREL-KHPNVIS 62
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH----------IRYIMFQLCNGLS 674
+ ++ + ++ ++++F+Y E+DL +I+ + ++ +++Q+ +G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 675 YIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYR 727
Y+HA V+HRDLKP+NIL+ + +KI D+G AR + + L + + T WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+L+ R YT +DIW++GCI AE+L S+P+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +G VY A + + + +A+K+I + KT + E+ L+ +HPN++
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNLVKYYG 66
Query: 628 IYKAVNNKDLYVVFEY-MENDLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVMHRD 685
+ V+ + +Y+ EY L +++ + D H IR QL GL+Y+H+ ++HRD
Sbjct: 67 V--EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSK----ECLTEYIATRWYRAPEILISNRRYTHH 741
+KP+NI +D + IK+GD G A L ++ E + T Y APE+ I+ + H
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV-ITGGKGKGH 183
Query: 742 ---VDIWSLGCILAEMLQSKPLFPGASTSHQL 770
DIWSLGC++ EM K + Q+
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
KGAYG V+ A K+ AIK I +A +N+ D T R+IL S + P ++ +
Sbjct: 2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL---SQAQSPYVVKL 58
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMH 683
++ N LY+V EY+ DL ++ + L + R + ++ L Y+H+ ++H
Sbjct: 59 YYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 684 RDLKPSNILIDKSCSIKIGDLGLAR---------SLSDSKECLTEYIATRWYRAPEILIS 734
RDLKP NILID + +K+ D GL++ D KE + T Y APE+++
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDYIAPEVIL- 174
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLF 761
+ ++ VD WSLGCIL E L P F
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 17/224 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G+ G+VYK K + A+KKI ++ ++ RE+ L+S P ++
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRS-CESPYVVKC--- 64
Query: 629 YKAV-NNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC-KVM 682
Y A ++ +V EYM+ DL K + + + + YI Q+ GL Y+H ++
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+KPSN+LI+ +KI D G+++ L ++ + ++ T Y +PE I Y++
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAA 181
Query: 743 DIWSLGCILAEMLQSK-PLFPGASTS--HQLQLIVNLVRPNPPH 783
DIWSLG L E K P P S +Q I + P+ P
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA 225
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 77/254 (30%), Positives = 118/254 (46%), Gaps = 28/254 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G YG VYKA K Q VAIK + + + + E L+ + HPNI T
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYGA 71
Query: 629 YKA----VNNKDLYVVFEYMEN----DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA 678
+ N+ L++V E DL K +R K LK+ I YI+ + GL+Y+H
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN--- 735
KV+HRD+K NIL+ K+ +K+ D G++ L + +I T ++ APE++ +
Sbjct: 132 NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP 191
Query: 736 -RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794
Y D+WSLG E+ KP H ++ + + R PP KS
Sbjct: 192 DASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNPPP-------TLKSP 241
Query: 795 HE-REKFNQVVVKC 807
+KFN + +C
Sbjct: 242 ENWSKKFNDFISEC 255
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 76/205 (37%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQRHPNIITML 626
GKG+YG VYK ++ Q+ A+K++ + + +R EI L S HPNII+
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVN-HPNIISYK 65
Query: 627 DIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACK 680
+ + N L +V EY DL+K I K++ + I I QL GL +H K
Sbjct: 66 EAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
++HRDLK +NIL+ + +KIGDLG+++ L K I T Y APE+ R Y++
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVW-KGRPYSY 180
Query: 741 HVDIWSLGCILAEMLQSKPLFPGAS 765
DIWSLGC+L EM P F S
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 74/232 (31%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
GKG++G VYKA DK Q VAIK I EA D Q+ EI FL S R P I
Sbjct: 10 GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFL-SQCRSPYITKYY 65
Query: 627 DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ + L+++ EY DL ++ L + +I +I+ ++ GL Y+H +
Sbjct: 66 GSF--LKGSKLWIIMEYCGGGSCLDL---LKPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K +NIL+ + +K+ D G++ L+ + ++ T ++ APE+ I Y
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV-IKQSGYDEKA 179
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKFYAGFK 792
DIWSLG E+ + +P S H ++++ + + NPP +KF FK
Sbjct: 180 DIWSLGITAIELAKGEPPL---SDLHPMRVLFLIPKNNPPSLEGNKFSKPFK 228
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 25/216 (11%)
Query: 554 KDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----RE 609
++ +L Q+I G G YG VYKA D + VAIK I K + + +E
Sbjct: 2 QEDYELIQRI-----GSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQE 50
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYI 665
I LK RHPNI+ Y + L++V EY D+ +V R L ++ I Y+
Sbjct: 51 ISMLKEC-RHPNIVAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYV 106
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW 725
+ GL+Y+H +HRD+K +NIL+ + +K+ D G++ L+ + +I T +
Sbjct: 107 CRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY 166
Query: 726 YRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKP 759
+ APE+ R+ Y DIW+LG E+ + +P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 31/277 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G GA+G VYKA K + A K I E+ D EI L +HPNI+ + +
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSEC-KHPNIVGLYE 69
Query: 628 IYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
Y L+++ E+ + D + ++ L + IRY+ Q+ L+++H+ KV+HR
Sbjct: 70 AY--FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI----SNRRYTH 740
DLK NIL+ +K+ D G++ + + +I T ++ APE++ + Y +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800
DIWSLG L E+ Q +P P + +++++ +++ PP D + F
Sbjct: 188 KADIWSLGITLIELAQMEP--PHHEL-NPMRVLLKILKSEPPTLD------QPSKWSSSF 238
Query: 801 NQVVVKC-QKELQE-------LQSQVVEENTSKLKLQ 829
N + C K+ + L+ V + + ++
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIK 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 67/220 (30%), Positives = 116/220 (52%), Gaps = 11/220 (5%)
Query: 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622
L K GKG++G+V+K K +K+ A+K+I + N+ + + E L I
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYI 61
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 678
I + + ++ L +V EY EN L K+ R + L + + Q+ GL+++H+
Sbjct: 62 IRYYESF--LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
K++HRD+K N+ +D ++KIGDLG+A+ LSD+ + T +Y +PE L ++ Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPY 178
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 778
D+W+LG +L E K F ++Q LI+ ++R
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF---DANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 76/222 (34%), Positives = 120/222 (54%), Gaps = 12/222 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G +Y A K++ ++ IK+I + + + +E++ L +HPNI+T
Sbjct: 9 GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFAS 67
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ N L++V EY + DL K I R + + I Q+ GL +IH K++HR
Sbjct: 68 FQ--ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR 125
Query: 685 DLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
D+K NI + K+ + K+GD G+AR L+DS E + T +Y +PEI NR Y + D
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPYNNKTD 184
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPH 783
IWSLGC+L E+ K F G + HQL L + P P+
Sbjct: 185 IWSLGCVLYELCTLKHPFEGNNL-HQLVLKICQGYFAPISPN 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618
L + I G GA +VY A N + VAIK+I + + +T +E+ +
Sbjct: 5 LIEVI-----GVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCN- 57
Query: 619 HPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNK-VIRDKILKDVHIRYIMFQLCNGL 673
HPN++ + V +L++V Y+ D+ K L + I ++ ++ GL
Sbjct: 58 HPNVVKYYTSF--VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWYRAP 729
Y+H+ +HRD+K NIL+ + S+KI D G++ SL+D + ++ T + AP
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKF 787
E++ Y DIWS G E+ + S +++++ ++ +PP
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 788 YAGFKSKHEREKFNQVVVKC-QKE 810
Y + SK F +++ C QK+
Sbjct: 233 YKKY-SK----SFRKMISLCLQKD 251
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 76/227 (33%), Positives = 121/227 (53%), Gaps = 11/227 (4%)
Query: 563 INLLKEGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 621
+ + K G+G++G K + KQYV IK+I + + + + + +E+ L S +HPN
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVL-SNMKHPN 60
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLCNGLSYIH 677
I+ + ++ N +LY+V +Y E DL K I R + + I Q+C L ++H
Sbjct: 61 IVQYQESFE--ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
K++HRD+K NI + K +IK+GD G+AR L+ + E I T +Y +PEI NR
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CENRP 177
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPH 783
Y + DIW+LGC+L EM K F + + L++I P H
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF--- 612
R L N +K G+G+ GIV A DK+ + VA+KK+ + QR RE+LF
Sbjct: 18 RSYLD---NFVKIGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQR--RELLFNEV 67
Query: 613 --LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQL 669
++ +Q HPNI+ M Y + +L+VV E++E L ++ + + I + +
Sbjct: 68 VIMRDYQ-HPNIVEMYSSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729
LS++HA V+HRD+K +IL+ +K+ D G +S + T ++ AP
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
E +IS Y VDIWSLG ++ EM+ +P +
Sbjct: 185 E-VISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 33/237 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG YGIVY A D + + +AIK+I E R+ Q + EI L S+ +H NI+ L
Sbjct: 17 GKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIA-LHSYLKHRNIVQYLG- 72
Query: 629 YKAVNNKDLYVVFEYMEN----DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACK 680
+ + + +F ME L+ ++R K + I + Q+ GL Y+H +
Sbjct: 73 --SDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 681 VMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-Y 738
++HRD+K N+L++ S +KI D G ++ L+ C + T Y APE++ R Y
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795
DIWSLGC + EM KP F +L P A F G H
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPF------IELG---------EPQAAMFKVGMFKIH 230
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ---RTYREILFLKSFQRHPNIITM 625
G G++G VY+ + ++ + A+K++ A +T + + +EI L Q HPNI+
Sbjct: 9 GSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQY 67
Query: 626 LDIYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMH 683
L + +N LY+ E + L K+++ + IR Q+ GL Y+H +H
Sbjct: 68 LGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RD+K +NIL+D + +K+ D G+A+ + + + + + ++ APE++ Y D
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 744 IWSLGCILAEMLQSKP 759
IWSLGC + EM KP
Sbjct: 185 IWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G N+ Q A+K+I ++ + + + +E + L + +HPNI+ +
Sbjct: 9 GEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLL-AKMKHPNIVAFKES 66
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++A + LY+V EY + DL + I+ K+ + I Q+C G+ +IH +V+HR
Sbjct: 67 FEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+K NI + ++ +K+GD G AR L+ Y+ T +Y PEI N Y + DI
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-ENMPYNNKSDI 183
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPH 783
WSLGCIL E+ K F S + L++ +P P H
Sbjct: 184 WSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/249 (31%), Positives = 125/249 (50%), Gaps = 21/249 (8%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
K G+G + VY+A +++ VA+KK IFE K Q +EI LK HPN+I
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA-RQDCVKEIDLLKQLN-HPNVIK 66
Query: 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVI-----RDKILKDVHIRYIMFQLCNGLSYIHA 678
LD + + + +L +V E + DL+++I + +++ + + QLC+ + ++H+
Sbjct: 67 YLDSF--IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+VMHRD+KP+N+ I + +K+GDLGL R S + T +Y +PE + N Y
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GY 183
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798
DIWSLGC+L EM + F G +NL Y ++H E
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDK--------MNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 799 KFNQVVVKC 807
K ++V C
Sbjct: 236 KLRELVSMC 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 21/226 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------AQRTYREILFLKSFQRHPNI 622
GKGA+G V ++ K+ A+K + NK + E L+ HP +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYM-----NKQKCVEKGSVRNVLNERRILQEL-NHPFL 62
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ + Y + +++Y+V + + DL + + + +++ + ++ L Y+H+
Sbjct: 63 VNLW--YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
++HRD+KP NIL+D+ + I D +A ++ T T Y APE+L + Y+
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPEVLCR-QGYSV 178
Query: 741 HVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRPNPPH 783
VD WSLG E L+ K + G S P
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHPNIITMLD 627
G G +G V K+ + A+K + + +T Q + E L+ HP I+ +
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYR 60
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+K + K +Y++ EY +L ++RD+ + + R+ + + Y+H +++RD
Sbjct: 61 TFK--DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP N+L+D + +K+ D G A+ L ++ T + T Y APEI I N+ Y VD W
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEI-ILNKGYDFSVDYW 176
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-----PPHADK 786
SLG +L E+L +P F G +++ ++++ N P + DK
Sbjct: 177 SLGILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQ 617
+K G G++G V K + +Y A+K + + K + E L+S
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK-QVEHVLNEKRILQSI- 58
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNG 672
RHP ++ + ++ ++ +LY+V EY + + L K R + R+ Q+
Sbjct: 59 RHPFLVNLYGSFQ--DDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLA 113
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAP 729
L Y+H+ +++RDLKP N+L+D IKI D G A+ + C T EY+ AP
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYL------AP 167
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
EI I ++ Y VD W+LG ++ EML P F
Sbjct: 168 EI-ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 77/239 (32%), Positives = 109/239 (45%), Gaps = 27/239 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G G+V K + + +A+K I N+ ++ RE+ L P I+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCN-SPYIVGF--- 64
Query: 629 YKA-VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY-------IMFQLCNGLSYIHAC- 679
Y A NN D+ + EYM + DKILK+V R I + GL+Y+H
Sbjct: 65 YGAFYNNGDISICMEYM----DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
K++HRD+KPSNIL++ IK+ D G++ L +S ++ T Y APE I Y+
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPE-RIQGNDYS 177
Query: 740 HHVDIWSLGCILAEM-LQSKPLFPGASTS----HQLQLIVNLVRPNPPHADKFYAGFKS 793
DIWSLG L E+ P P LQ IVN P P + KF F+
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-SGKFSPDFQD 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 7/227 (3%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+GA G VY A D Q VAIK++ + + + EIL ++ +HPNI+ L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRE-NKHPNIVNYL 82
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D Y + +L+VV EY+ L V+ + + + I + + L ++H+ +V+HRD
Sbjct: 83 DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K NIL+ S+K+ D G ++ + + + T ++ APE+ ++ + Y VDIW
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDIW 199
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792
SLG + EM++ +P + + L LI P + +K A F+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR----EILFLKSFQRHPNIIT 624
G+GA+G VY YD + + +A+K+ + + ++ EI LK+ Q H I+
Sbjct: 11 GQGAFGRVYLCYDVDTGRELAVKQ-VPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQ 68
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIHAC 679
+ +++ L + EYM ++D++ L + R Q+ G+ Y+H+
Sbjct: 69 YYGCLR--DDETLSIFMEYMPGG---SVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILISNR 736
++HRD+K +NIL D + ++K+GD G ++ L S + T ++ +PE+ IS
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV-ISGE 182
Query: 737 RYTHHVDIWSLGCILAEMLQSKP 759
Y D+WS+GC + EML KP
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKGA+G + V K++ ++ + + EI+ L Q HPNII +
Sbjct: 9 GKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNH 67
Query: 629 YKAVNNKDLYVVFEYME--NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ +++ L + EY +K++R ++ ++ + + +FQ+ + +SYIH ++HR
Sbjct: 68 F--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+K NI + K+ IK+GD G+++ L + T +Y +PE L +Y DI
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDI 184
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
W+LGC+L E+L K F ++ L L+V +V+ N
Sbjct: 185 WALGCVLYELLTLKRTFDA---TNPLNLVVKIVQGN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITMLD 627
G+GA G V K KN A+K I D Q+ RE+ KS + P I+
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITT--DPNPDLQKQILRELEINKSCK-SPYIVKYYG 66
Query: 628 IYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIR----------YIMFQLCNGLSYI 676
+ ++ + + EY E L D I K V R I + GLSY+
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 736
H+ K++HRD+KPSNIL+ + +K+ D G++ L +S + T +Y APE I +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPE-RIQGK 178
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFP 762
Y+ D+WSLG L E+ Q++ FP
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|241275 cd01242, PH_ROCK, Rho-associated coiled-coil containing protein kinase pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-24
Identities = 42/50 (84%), Positives = 47/50 (94%)
Query: 871 SRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELEL 920
SRLEGW+SIPNKQNIKRHGWKKQ+VVVSSKKI+FYNSE DKQN+DP L +
Sbjct: 1 SRLEGWLSIPNKQNIKRHGWKKQFVVVSSKKILFYNSEQDKQNSDPFLII 50
|
ROCK is a serine/threonine kinase that binds GTP-Rho. It consists of a kinase domain, a coiled coil region and a PH domain. The ROCK PH domain is interrupted by a C1 domain. ROCK plays a role in cellular functions, such as contraction, adhesion, migration, and proliferation and in the regulation of apoptosis. There are two ROCK isoforms, ROCK1 and ROCK2. In ROCK2 the Rho Binding Domain (RBD) and the PH domain work together in membrane localization with RBD receiving the RhoA signal and the PH domain receiving the phospholipid signal. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 126 |
| >gnl|CDD|241275 cd01242, PH_ROCK, Rho-associated coiled-coil containing protein kinase pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-24
Identities = 44/71 (61%), Positives = 54/71 (76%), Gaps = 3/71 (4%)
Query: 1124 RSVTQGDVIRADAKDIPRIFQLLYAGEGEARRPEDGGAELPAVLRGGDEKPGIIALKGHE 1183
RSVTQGDVIRADAK+IPRIFQ+LYA EGE+R P + + DEK G+I+ KGH+
Sbjct: 59 RSVTQGDVIRADAKEIPRIFQILYANEGESRNPSELSSSDQLE---QDEKAGVISHKGHD 115
Query: 1184 FLNISYHMPTT 1194
F+ ISYHMPT+
Sbjct: 116 FVPISYHMPTS 126
|
ROCK is a serine/threonine kinase that binds GTP-Rho. It consists of a kinase domain, a coiled coil region and a PH domain. The ROCK PH domain is interrupted by a C1 domain. ROCK plays a role in cellular functions, such as contraction, adhesion, migration, and proliferation and in the regulation of apoptosis. There are two ROCK isoforms, ROCK1 and ROCK2. In ROCK2 the Rho Binding Domain (RBD) and the PH domain work together in membrane localization with RBD receiving the RhoA signal and the PH domain receiving the phospholipid signal. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 126 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQRHPNIIT 624
G GA+ Y+A D +A+K++ ++ + +EI + HP+II
Sbjct: 9 GTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIR 67
Query: 625 MLDIYKAVNNKDLYVVF-EYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACK 680
M A + +F E+M + K + V I Y QL GLSY+H +
Sbjct: 68 M---LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-QLLRGLSYLHENQ 123
Query: 681 VMHRDLKPSNILIDKSCS-IKIGDLG----LARSLSDSKECLTEYIATRWYRAPEILISN 735
++HRD+K +N+LID + ++I D G LA + + E + + T + APE+L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-RG 182
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+Y D+WS+GC++ EM +KP + S+ L LI +
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 9/217 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITML 626
G+GAYG VY+ + VA+K I D RE+ L ++ PNI
Sbjct: 10 GRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y + L+++ EY E + +++ + + +I I+ ++ L YIH V+HRD
Sbjct: 69 GSY--LKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K +NIL+ + ++K+ D G+A L+ + + ++ T ++ APE++ + Y DIW
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIW 186
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
SLG + EM P + + LI + PP
Sbjct: 187 SLGITIYEMATGNPPYSDVDAFRAMMLI---PKSKPP 220
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQ-YVAIKKIF---EAFR-NKTDAQRTYR----EILFLKSFQRH 619
G GA+G VYK KNN Q +A+K+I AF +K + ++ E+ +K RH
Sbjct: 9 GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRY-------IMFQLC 670
PNI+ + + N LY+V + +E + + LK+ R+ I Q+
Sbjct: 69 PNIVRYYKTF--LENDRLYIVMDLIEG---APLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 671 NGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729
L Y+H K ++HRDL P+NI++ + + I D GLA+ + LT + T Y P
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSCP 182
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
EI + N Y D+W+ GCIL +M +P F
Sbjct: 183 EI-VKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GA+GIV+ K +++ V IK+I K + E LK HPNII +
Sbjct: 9 GRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYEN 67
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + +K L +V EY L + I+ + +L + I + Q+ L ++H ++HR
Sbjct: 68 F--LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 685 DLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
DLK NIL+DK + KIGD G+++ LS SK + T Y +PE L + Y D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPE-LCEGKPYNQKSD 183
Query: 744 IWSLGCILAEMLQSKPLFPGAS 765
IW+LGC+L E+ K F A+
Sbjct: 184 IWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 566 LKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPN 621
LK KGA+G VY A ++ Y AIK + ++ +N+ + R I+ ++ P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES--PY 58
Query: 622 IITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 678
+ + Y + +KD LY+V EY+ D +I+ L + + + ++ G+ +H
Sbjct: 59 VAKL---YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
++HRD+KP N+LID++ +K+ D GL+R+ ++K +++ T Y APE ++
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGVGD- 170
Query: 739 THHVDIWSLGCILAEMLQSKPLF 761
D WSLGC++ E L P F
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 71/219 (32%), Positives = 120/219 (54%), Gaps = 24/219 (10%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILF 612
++D ++ L+E G G++G VY A D + VAIKK+ + + + Q +E+ F
Sbjct: 9 SKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 613 LKSFQRHPNIITMLDIYKAVNNKD--LYVVFEYM---ENDLNKVIRDKILKDVHIRYIMF 667
L+ RHPN I YK ++ ++V EY +D+ +V + K L++V I I
Sbjct: 69 LQQL-RHPNTIE----YKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICH 122
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
GL+Y+H+ + +HRD+K NIL+ + ++K+ D G A +S + ++ T ++
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPYWM 178
Query: 728 APEILIS--NRRYTHHVDIWSLG--CI-LAEMLQSKPLF 761
APE++++ +Y VD+WSLG CI LAE + PLF
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 41/235 (17%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V+ DK+ Q A+K + ++ RN+ R R+IL + P I+ +
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL---ADADSPWIVKL 66
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + + LY+V EYM DL N +IR + + R+ + +L L +H +H
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH 124
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------------CLTEYIATRW----- 725
RD+KP NILID IK+ D GL + ++ +K+ + R
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 726 -----------YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769
Y APE+L Y D WSLG IL EML P F + T +
Sbjct: 185 VRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF-YSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFLKSFQRHPN 621
L + G+G YG V+ A K+ + VA+K++ ++ K + R T R+IL + +
Sbjct: 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL---TTTKSEW 62
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHAC 679
++ +L Y +++ LY+ EY+ D ++ + +L + H R+ M ++ + +H
Sbjct: 63 LVKLL--YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEILISNR 736
+HRDLKP N LID S IK+ D GL SK +T + + Y APE+L +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPEVL-RGK 173
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGAST 766
Y VD WSLGC+L E L P F G++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 76/246 (30%), Positives = 121/246 (49%), Gaps = 36/246 (14%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
K G+G + VY+A + VA+KK IF+ K +EI LK HPN+I
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQLN-HPNVIK 66
Query: 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHA 678
+ + + +L +V E + DL+++I+ +++ + + QLC+ L ++H+
Sbjct: 67 YYASF--IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+VMHRD+KP+N+ I + +K+GDLGL R S + T +Y +PE + N Y
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GY 183
Query: 739 THHVDIWSLGCILAEM--LQSK--------------------PLFPGASTSHQLQLIVNL 776
DIWSLGC+L EM LQS P P S +L+ +VN+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 777 -VRPNP 781
+ P+P
Sbjct: 244 CINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 569 GKGAYGIVYKA-YDKNNKQ---YVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNI 622
G+G +G V YD VA+K + + + R+ REI L++ H NI
Sbjct: 13 GEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLD-HENI 68
Query: 623 ITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 678
+ + + + L ++ EY+ D + RD+I + + Q+C G+ Y+ +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQICKGMDYLGS 127
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT----EYIATRWYRAPEILIS 734
+ +HRDL NIL++ +KI D GLA+ L + K+ WY APE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL-R 185
Query: 735 NRRYTHHVDIWSLGCILAEML 755
+++ D+WS G L E+
Sbjct: 186 TSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 9e-23
Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 7/227 (3%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+GA G VY A D Q VAI+++ + + + EIL ++ ++PNI+ L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE-NKNPNIVNYL 83
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D Y + +L+VV EY+ L V+ + + + I + + L ++H+ +V+HRD
Sbjct: 84 DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K NIL+ S+K+ D G ++ + + + T ++ APE+ ++ + Y VDIW
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDIW 200
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792
SLG + EM++ +P + + L LI P + +K A F+
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-22
Identities = 81/307 (26%), Positives = 141/307 (45%), Gaps = 36/307 (11%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+GA G VY A D Q VAIK++ + + + EIL ++ ++PNI+ L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRE-NKNPNIVNYL 82
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D Y + +L+VV EY+ L V+ + + + I + + L ++H+ +V+HRD
Sbjct: 83 DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K NIL+ S+K+ D G ++ + + + T ++ APE+ ++ + Y VDIW
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDIW 199
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVV 805
SLG + EM++ +P + + L LI P + ++ A F R+ N+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF-----RDFLNRC-- 252
Query: 806 KCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASLSSADVENDE 865
L+M++D + S E LQ L +SL+ + E
Sbjct: 253 ----------------------LEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKE 290
Query: 866 SYVQDSR 872
+ SR
Sbjct: 291 AIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 7/227 (3%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+GA G V+ A D Q VAIK+I + + + EIL +K ++PNI+ L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKEL-KNPNIVNFL 82
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D + + +L+VV EY+ L V+ + + + I + + L ++HA +V+HRD
Sbjct: 83 DSF--LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K N+L+ S+K+ D G ++ + + + T ++ APE+ ++ + Y VDIW
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDIW 199
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792
SLG + EM++ +P + + L LI P + +K F+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 25/232 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTY------REILFLKSFQRHPN 621
G G++G VY + ++ + +A+K++ + + ++ REI LK Q H N
Sbjct: 9 GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HEN 67
Query: 622 IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHAC 679
I+ L +++ L + EY+ + + ++ +R + Q+ GL+Y+H
Sbjct: 68 IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT------EYIATRWYRAPEILI 733
++HRD+K +NIL+D IKI D G+++ L + + ++ APE+ +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV-V 184
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV---NLVRPNPP 782
YT DIWSLGC++ EML K FP + QLQ I P P
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIP 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 616
+DL+ L G+GAYG+V K +A+K+I R ++Q R ++ L
Sbjct: 1 DDLEVIEEL---GRGAYGVVDKMRHVPTGTIMAVKRI----RATVNSQEQKRLLMDLDIS 53
Query: 617 QRHPNIITMLDIYKAV-NNKDLYVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLC 670
R + + Y A+ D+++ E M+ L+K + K + I I +
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 671 NGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729
L Y+H+ V+HRD+KPSN+LI+++ +K+ D G++ L DS T + Y AP
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAP 172
Query: 730 EIL---ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH--A 784
E + ++ + Y D+WSLG + E+ + FP S Q + +V P A
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSPQLPA 230
Query: 785 DKFYAGF---------KSKHEREKFNQV 803
+KF F K+ ER + ++
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI----------FEAFRNKTDAQRTYREILFLKSFQR 618
GKG YG VY A + + +A+K++ ++ A R+ EI LK
Sbjct: 10 GKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS--EIETLKDLD- 66
Query: 619 HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSY 675
H NI+ L + L + EY+ + +R + + + +R+ Q+ GL+Y
Sbjct: 67 HLNIVQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-VRFFTEQVLEGLAY 123
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILI 733
+H+ ++HRDLK N+L+D KI D G+++ D + + ++ APE++
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 734 SNRR-YTHHVDIWSLGCILAEMLQSK 758
S + Y+ VDIWSLGC++ EM +
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 8/211 (3%)
Query: 551 QLMKDREDLQQQI-NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE 609
QL+ D ++ + + +K G+G+ GIV A +K+ + VA+KK+ R + + + E
Sbjct: 12 QLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNE 69
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQ 668
++ ++ + H N++ M + Y + +L+VV E++E L ++ + + I +
Sbjct: 70 VVIMRDYH-HENVVDMYNSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS 126
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+ LSY+H V+HRD+K +IL+ IK+ D G +S + T ++ A
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKP 759
PE+ IS Y VDIWSLG ++ EM+ +P
Sbjct: 187 PEV-ISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 569 GKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFLKSFQRHPNIITML 626
GKG+YG V + + KQYV IKK+ RN + +R E L S +HPNI+
Sbjct: 9 GKGSYGEVSLVRHRTDGKQYV-IKKL--NLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ ++ + LY+V + E DL +++ K+L + + Q+ L Y+H ++
Sbjct: 66 ESWEGEDGL-LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRDLK N+ + ++ IK+GDLG+AR L + + + I T +Y +PE L SN+ Y +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYNYKS 183
Query: 743 DIWSLGCILAEMLQSKPLF 761
D+W+LGC + EM K F
Sbjct: 184 DVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G G +G V++ KN + VAIK + + Q +E+ LK RH ++I++
Sbjct: 13 KLGSGYFGEVWEGLWKNRVR-VAIKILKSD--DLLKQQDFQKEVQALKRL-RHKHLISLF 68
Query: 627 DIYKAVNNKD--LYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACK 680
AV + +Y++ E ME L +R ++L + + Q+ G++Y+
Sbjct: 69 ----AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLAR-------SLSDSKECLTEYIATRWYRAPEILI 733
+HRDL NIL+ + K+ D GLAR SD K I +W APE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK------IPYKW-TAPEA-A 176
Query: 734 SNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVR-PNPP 782
S+ ++ D+WS G +L EM + +PG + I R P P
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 25/251 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G YG VYK Q AIK + + ++ + + EI LK + H NI T
Sbjct: 25 GNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKL--EINMLKKYSHHRNIATYYGA 81
Query: 629 Y----KAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ ++ L++V E+ DL K + LK+ I YI ++ GL+++HA K
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--- 737
V+HRD+K N+L+ ++ +K+ D G++ L + +I T ++ APE++ +
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201
Query: 738 -YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796
Y + DIWSLG EM + P H ++ + + R PP KSK
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPPK-------LKSKKW 251
Query: 797 REKFNQVVVKC 807
+KF + C
Sbjct: 252 SKKFIDFIEGC 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G G +G V+ D+ ++ Y A+K I E R K + Q + E LK HP II +
Sbjct: 10 GTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEV-SHPFIIRLF 67
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
LY++ EY+ +L +R+ + + ++ L Y+H+ ++++R
Sbjct: 68 WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKP NIL+DK IK+ D G A+ L D L T Y APE+ I ++ + VD
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---GTPEYLAPEV-IQSKGHNKAVDW 181
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
W+LG ++ EML P F + + I+
Sbjct: 182 WALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 59/194 (30%), Positives = 104/194 (53%), Gaps = 20/194 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQRHPNIITML 626
G GA G VYK + + A+K I+ N D R REI L+ HPN++
Sbjct: 83 GSGAGGTVYKVIHRPTGRLYALKVIYG---NHEDTVRRQICREIEILRDVN-HPNVVKCH 138
Query: 627 DIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
D++ +N ++ V+ E+M+ + + ++ L DV Q+ +G++Y+H ++H
Sbjct: 139 DMFD--HNGEIQVLLEFMDGGSLEGTHIADEQFLADV-----ARQILSGIAYLHRRHIVH 191
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNRRYTH 740
RD+KPSN+LI+ + ++KI D G++R L+ + + + T Y +PE + +++ Y
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
Query: 741 HV-DIWSLGCILAE 753
+ DIWSLG + E
Sbjct: 252 YAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 68/224 (30%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA+G VYKA +K A K I +++ + + EI L S HPNI+ +LD
Sbjct: 14 GDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCD-HPNIVKLLDA 70
Query: 629 YKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ NN L+++ E+ D + ++ L + IR + Q L+Y+H K++HRD
Sbjct: 71 FYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI----SNRRYTHH 741
LK NIL IK+ D G++ + + + +I T ++ APE+++ +R Y +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP 782
D+WSLG L EM Q +P H+L ++++ + + PP
Sbjct: 189 ADVWSLGITLIEMAQIEP------PHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 65/235 (27%), Positives = 118/235 (50%), Gaps = 7/235 (2%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
N +K G+G+ GIV A K++ + VA+KK+ R + + + E++ ++ +Q H N++
Sbjct: 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVV 80
Query: 624 TMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
M + Y + +L+VV E++E L ++ + + I + + LS +HA V+
Sbjct: 81 EMYNSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K +IL+ +K+ D G +S + T ++ APE LIS Y V
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEV 197
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797
DIWSLG ++ EM+ +P + +++I + + P + K K +R
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 72/267 (26%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG YG V+K +K N A+K + + + Y LK+ HPN++ +
Sbjct: 27 GKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN---ILKALSDHPNVVKFYGM 83
Query: 629 Y--KAVNNKD-LYVVFEYME----NDLNK--VIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
Y K V N D L++V E DL K + R + +++ I YI+ + GL ++H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-- 737
K +HRD+K +NIL+ +K+ D G++ L+ ++ + T ++ APE++ ++
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD 203
Query: 738 --YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKFYAGFKS 793
Y D+WSLG E+ P P A H ++ + + R PP H + ++
Sbjct: 204 STYDARCDVWSLGITAIELGDGDP--PLADL-HPMRALFKIPRNPPPTLHQPELWSN--- 257
Query: 794 KHEREKFNQVVVKCQKELQELQSQVVE 820
+FN + KC + E + V +
Sbjct: 258 -----EFNDFIRKCLTKDYEKRPTVSD 279
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFL 613
+ED ++ L+E G G++G VY A D + VAIKK+ + + + Q +E+ FL
Sbjct: 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKV--IRDKILKDVHIRYIMFQLCN 671
+ + HPN I Y + ++V EY + + + K L++V I I
Sbjct: 80 QRIK-HPNSIEYKGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 731
GL+Y+H+ ++HRD+K NIL+ + +K+ D G A S + ++ T ++ APE+
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEV 192
Query: 732 LIS--NRRYTHHVDIWSLGCILAEMLQSKP 759
+++ +Y VD+WSLG E+ + KP
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREI------LFLKSFQRHPN 621
G+GA+G VY YD + + +A+K++ F+ D+Q T +E+ + L RH
Sbjct: 11 GRGAFGEVYLCYDADTGRELAVKQVPFDP-----DSQETSKEVNALECEIQLLKNLRHDR 65
Query: 622 IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYI 676
I+ + K L + EYM I+D++ L + R Q+ G+SY+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGG---SIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILI 733
H+ ++HRD+K +NIL D + ++K+GD G ++ + S + T ++ +PE+ I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV-I 181
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKP 759
S Y D+WS+ C + EML KP
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/232 (29%), Positives = 115/232 (49%), Gaps = 21/232 (9%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
EDL+ +L + G+GA+G V K K + +A+K+I + ++ + +R ++ +
Sbjct: 3 AEDLK---DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMR 58
Query: 616 FQRHPNIITMLDIYKAV-NNKDLYVVFEYMENDLNK-------VIRDKILKDVHIRYIMF 667
P I+ Y A+ D ++ E M+ L+K V++ I +++ + I
Sbjct: 59 SSDCPYIVKF---YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEI-LGKIAV 114
Query: 668 QLCNGLSYI-HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
L+Y+ K++HRD+KPSNIL+D++ +IK+ D G++ L DS T R Y
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPY 173
Query: 727 RAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLIVN 775
APE + + R Y D+WSLG L E+ K +P S QL +V
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 66/211 (31%), Positives = 115/211 (54%), Gaps = 15/211 (7%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFL 613
++D ++ + L+E G G++G VY A D N + VAIKK+ + ++ Q +E+ FL
Sbjct: 10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLC 670
+ RHPN I Y + ++V EY +DL +V K L++V I +
Sbjct: 70 QKL-RHPNTIQYRGCY--LREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGAL 125
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
GL+Y+H+ ++HRD+K NIL+ + +K+GD G A ++ + ++ T ++ APE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPE 181
Query: 731 ILIS--NRRYTHHVDIWSLGCILAEMLQSKP 759
++++ +Y VD+WSLG E+ + KP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 574 GIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633
IV+ A K VA+KKI +K D + +EI+ + Q HPNI+ + + +
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSF--IV 70
Query: 634 NKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689
+ +LYVV M DL K + L ++ I +I+ + N L YIH+ +HR +K S
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKAS 130
Query: 690 NILIDKSCSIKIGDLGLARSLSDSKE------CLTEYIAT--RWYRAPEILISNRR-YTH 740
+IL+ + + L + S+ + + W +PE+L N + Y
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQGYNE 189
Query: 741 HVDIWSLGCILAEM 754
DI+S+G E+
Sbjct: 190 KSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 13/231 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR----EILFLKSFQRHPNIIT 624
GKGAYG VY N Q +A+K++ N A++ Y E+ LKS +H NI+
Sbjct: 9 GKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQ 66
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
L N +++ F + + + R L + Q+ +G++Y+H V+HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 685 DLKPSNILIDKSCSIKIGDLGLAR-----SLSDSK-ECLTEYIATRWYRAPEILISNRRY 738
D+K +N+++ + IK+ D G AR L + L T ++ APE+ I+ Y
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV-INESGY 185
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789
DIWS+GC + EM KP + I P D F A
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYRE--ILFLKSFQRHPNIITM 625
G+GA+G VY YD + + +A K++ F+ +T + + E I LK+ +H I+
Sbjct: 11 GQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQY 69
Query: 626 LDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIHACK 680
+ K L + EYM ++D++ L + R Q+ G+SY+H+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGG---SVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILISNRR 737
++HRD+K +NIL D + ++K+GD G ++ L S + T ++ +PE+ IS
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV-ISGEG 185
Query: 738 YTHHVDIWSLGCILAEMLQSKP 759
Y D+WSLGC + EML KP
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 60/215 (27%), Positives = 112/215 (52%), Gaps = 9/215 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG++G VYK D K+ VAIK I + + + + +EI L P I
Sbjct: 13 GKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGS 70
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687
Y + L+++ EY+ +++ L++ +I I+ ++ GL Y+H+ + +HRD+K
Sbjct: 71 Y--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 688 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 747
+N+L+ + +K+ D G+A L+D++ ++ T ++ APE+ I Y DIWSL
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDFKADIWSL 187
Query: 748 GCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
G E+ + +P S H ++++ + + +PP
Sbjct: 188 GITAIELAKGEPPN---SDLHPMRVLFLIPKNSPP 219
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 30/255 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF---EAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G VY YD + + +A+K++ E+ + EI LK+ H I+
Sbjct: 11 GQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQY 69
Query: 626 LDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIHACK 680
+ + L + E+M I+D++ L + R Q+ G+SY+H+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGG---SIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILISNRR 737
++HRD+K +NIL D ++K+GD G ++ L S + T ++ +PE+ IS
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV-ISGEG 185
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN----PPHADKFYAGFKS 793
Y DIWS+GC + EML KP P A + +P PPH S
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTNPVLPPHV--------S 235
Query: 794 KHEREKFNQVVVKCQ 808
H R+ ++ V+ +
Sbjct: 236 DHCRDFLKRIFVEAK 250
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 71/238 (29%), Positives = 117/238 (49%), Gaps = 32/238 (13%)
Query: 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFL 613
+D+Q Q L G G G VYKAY ++ +A+K I + Q+ + EIL+
Sbjct: 1 QDIQYQEIL---GHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYK 55
Query: 614 KSFQRHPNIITMLDIYKA--VNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQ 668
P II Y A V N+ + + E+M+ D+ + I + +L + + +
Sbjct: 56 CD---SPYIIGF---YGAFFVENR-ISICTEFMDGGSLDVYRKIPEHVLGRIAVAVV--- 105
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
GL+Y+ + K++HRD+KPSN+L++ +K+ D G++ L +S Y+ T Y A
Sbjct: 106 --KGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMA 161
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNPP 782
PE IS +Y H D+WSLG E+ + +P + LQL+ +V +PP
Sbjct: 162 PE-RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 25/251 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G YG VYK Q AIK + + + + +EI LK + H NI T
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIK-VMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 629 YKAVN----NKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ N + L++V E+ DL K + LK+ I YI ++ GLS++H K
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--- 737
V+HRD+K N+L+ ++ +K+ D G++ L + +I T ++ APE++ +
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191
Query: 738 -YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796
Y D+WSLG EM + P H ++ + + R P KSK
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPAPR-------LKSKKW 241
Query: 797 REKFNQVVVKC 807
+KF + C
Sbjct: 242 SKKFQSFIESC 252
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 56/197 (28%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
N +K G+G+ GIV A +K++ + VA+K + R + + + E++ ++ +Q H N++
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQ-HQNVV 81
Query: 624 TMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
M Y + ++L+V+ E+++ L ++ L + I + + L Y+H+ V+
Sbjct: 82 EMYKSY--LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K +IL+ +K+ D G +S + T ++ APE+ IS Y V
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-ISRTPYGTEV 198
Query: 743 DIWSLGCILAEMLQSKP 759
DIWSLG ++ EM+ +P
Sbjct: 199 DIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-19
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 7/211 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G +G V A K + AIK + + R++ ++ + I + +RHP ++ +
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ + V EY DL I + + + + GL Y+H K+++R
Sbjct: 68 FACFQT--EDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLK N+L+D +KI D GL + + + + T + APE+L + YT VD
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL-TETSYTRAVDW 184
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
W LG ++ EML + FPG IVN
Sbjct: 185 WGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL--FL 613
R LQQ++ GKG++G VY DK +K + E + + T + L
Sbjct: 1 RYILQQRL-----GKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL 55
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMF 667
S HP I+ + + ++ EY E DL+ + + K L + +
Sbjct: 56 LSKLDHPAIVKFHASF--LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
QL G+ Y+H +++HRDLK NI + + +KIGD G++R L S + T + T +Y
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 728 APEILISNRRYTHHVDIWSLGCILAEM 754
+PE L ++ Y DIWSLGCIL EM
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 43/225 (19%)
Query: 561 QQINLLKE-GKGAYGIVYKA-----YDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFL 613
I L +E G+GA+G V+ +N+K+ VA+K + E N DA++ + RE L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELL 62
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR---------------DKIL 657
+FQ H NI+ + +VFEYME+ DLNK +R L
Sbjct: 63 TNFQ-HENIVKFYGV--CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 658 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717
+ I Q+ +G+ Y+ + +HRDL N L+ +KIGD G++R +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----- 174
Query: 718 TEY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
T+Y + RW PE ++ R++T D+WS G +L E+
Sbjct: 175 TDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 6/210 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + ++ A+K + +A K + + E L +HP ++ +
Sbjct: 4 GKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH- 62
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y LY V +Y+ + R++ + R+ ++ + L Y+H+ +++RD
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP NIL+D + + D GL + + + + + T Y APE+L + Y VD W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL-RKQPYDRTVDWW 180
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
LG +L EML P F T+ I+N
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 21/224 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA+G VYKA +K A K I +++ + + EI L + HP I+ +L
Sbjct: 21 GDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVEIEILATCN-HPYIVKLLGA 77
Query: 629 YKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ + L+++ E+ D + D+ L + I+ I Q+ L Y+H+ K++HRD
Sbjct: 78 F--YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL----ISNRRYTHH 741
LK N+L+ IK+ D G++ + + +I T ++ APE++ + + Y +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP 782
DIWSLG L EM Q +P H+L ++++ + + PP
Sbjct: 196 ADIWSLGITLIEMAQIEP------PHHELNPMRVLLKIAKSEPP 233
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQRHPNIITM 625
GKG++G V A K + A+K + + + D T + +L L +HP + +
Sbjct: 4 GKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFLTQL 61
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
++ + L+ V EY+ DL I R + R+ ++ GL ++H +++
Sbjct: 62 HSCFQTKDR--LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISNRR 737
RDLK N+L+D IKI D G+ KE + + T Y APEIL S +
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGM------CKEGILGGVTTSTFCGTPDYIAPEIL-SYQP 172
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
Y VD W+LG +L EML + F G Q I+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPN 621
+ L + G G++G VY A + + + VA+KK+ + + Q +E+ FL+ +HPN
Sbjct: 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPN 82
Query: 622 IITMLDIYKAVNNKDLYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 678
I Y + ++V EY +DL +V K L++V I I GL+Y+H+
Sbjct: 83 TIEYKGCY--LKEHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--NR 736
++HRD+K NIL+ + +K+ D G A S + ++ T ++ APE++++
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEG 195
Query: 737 RYTHHVDIWSLGCILAEMLQSKP 759
+Y VD+WSLG E+ + KP
Sbjct: 196 QYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G G++G V A K +Y AIK K E + K Q +E L HP I+ M+
Sbjct: 27 GTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK-QVQHVAQEKSILMELS-HPFIVNMM 84
Query: 627 DIYKAVNNKDLYVVFEY-MENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMH 683
++ + +Y + E+ + +L +R + DV ++ +L Y+H+ +++
Sbjct: 85 CSFQ--DENRVYFLLEFVVGGELFTHLRKAGRFPNDVA-KFYHAELVLAFEYLHSKDIIY 141
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RDLKP N+L+D +K+ D G A+ + D L T Y APE+ I ++ + VD
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---GTPEYLAPEV-IQSKGHGKAVD 197
Query: 744 IWSLGCILAEMLQSKPLF 761
W++G +L E + P F
Sbjct: 198 WWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 62/226 (27%), Positives = 115/226 (50%), Gaps = 9/226 (3%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
L K GKG++G V+K D ++ VAIK I + + + + +EI L P +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PYVTK 66
Query: 625 MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + + L+++ EY+ ++ L + I I+ ++ GL Y+H+ K +H
Sbjct: 67 YYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RD+K +N+L+ + +K+ D G+A L+D++ ++ T ++ APE+ I Y D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDSKAD 183
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789
IWSLG E+ + + P S H ++++ + + NPP + Y+
Sbjct: 184 IWSLGITAIELAKGE---PPHSELHPMKVLFLIPKNNPPTLEGNYS 226
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 24/240 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG YG VYK +K + A+K I + + + IL +S HPN++ +
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNIL--QSLPNHPNVVKFYGM 87
Query: 629 -YKA--VNNKDLYVVFEYME----NDLNK--VIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
YKA + L++V E +L K +I + L + I YI++ GL ++H
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
+++HRD+K +NIL+ +K+ D G++ L+ ++ + T ++ APE++ ++Y
Sbjct: 148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD 207
Query: 740 H----HVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPP---HADKFYAGF 791
+ D+WSLG E+ PLF H ++ + + R PP H +K+ F
Sbjct: 208 YSYDARCDVWSLGITAIELGDGDPPLF----DMHPVKTLFKIPRNPPPTLLHPEKWCRSF 263
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRT-YREILFLKSFQRHPNIITM 625
GKG +G VY+ K+ ++ A+K + E K A R IL P I+ +
Sbjct: 2 GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGL 61
Query: 626 LDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
++ + DLY+V +YM + ++ + ++ + +L L ++H +++
Sbjct: 62 KFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
RDLKP NIL+D + I + D GL+++ L+D+K T + T Y APE+L+ + YT HV
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKHV 178
Query: 743 DIWSLGCILAEM 754
D WSLG ++ EM
Sbjct: 179 DFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFL 613
D DL+ NL + G G G VYK K +A+K++ NK + +R ++ + L
Sbjct: 13 DLNDLE---NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVVL 68
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME---NDLNKVIRDKILKDVHIRYIMFQLC 670
KS P I+ + + + D+++ E M + L K I+ I +D+ + + +
Sbjct: 69 KSHD-CPYIVKCYGYF--ITDSDVFICMELMSTCLDKLLKRIQGPIPEDI-LGKMTVAIV 124
Query: 671 NGLSYI---HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
L Y+ H V+HRD+KPSNIL+D S ++K+ D G++ L DSK T Y
Sbjct: 125 KALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYM 181
Query: 728 APEIL---ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPH 783
APE + N +Y D+WSLG L E+ + + T + L I+ P+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241
Query: 784 ADKFYAGF---------KSKHEREKFNQ 802
+ F F K +R K+ +
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRE 269
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 9/215 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG++G V+K D +Q VAIK I + + + + +EI L P +
Sbjct: 13 GKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGS 70
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687
Y + L+++ EY+ ++R + I ++ ++ GL Y+H+ K +HRD+K
Sbjct: 71 Y--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 688 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 747
+N+L+ + +K+ D G+A L+D++ ++ T ++ APE+ I Y DIWSL
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IQQSAYDSKADIWSL 187
Query: 748 GCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
G E+ + + P S H ++++ + + NPP
Sbjct: 188 GITAIELAKGE---PPNSDMHPMRVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
R + Q+ L++ G G YG VYKA + N + AIK I D +EI+ +K
Sbjct: 4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMK 61
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLC 670
+H NI+ Y + L++ E+ D+ V L + I Y+ +
Sbjct: 62 DC-KHSNIVAYFGSY--LRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETL 116
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
GL Y+H+ MHRD+K +NIL+ + +K+ D G++ ++ + +I T ++ APE
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
Query: 731 ILISNRR--YTHHVDIWSLGCILAEMLQSKP 759
+ R+ Y DIW++G E+ + +P
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-17
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 9/218 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K +++ A+K + +A K + + E L +HP ++ +
Sbjct: 4 GKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF 63
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + LY V +Y+ + R++ + R+ ++ + L Y+H+ +++RD
Sbjct: 64 SFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP NIL+D I + D GL + + + + T Y APE+L + Y VD W
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTVDWW 180
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVN---LVRPN 780
LG +L EML P F +T+ I+N ++PN
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 41/225 (18%)
Query: 561 QQINLLKE-GKGAYGIVYKA--YDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLK 614
+ L+E G+GA+G VYK N + VAIK + E + Q+ +R+ L
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE--NAEPKVQQEFRQEAELM 62
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK-VIRDKILKDVHIR--------- 663
S +HPNI+ +L + + ++FEY+ + DL++ ++R+ DV
Sbjct: 63 SDLQHPNIVCLLGV--CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 664 -------YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SD-- 712
+I Q+ G+ Y+ + +HRDL N L+ + ++KI D GL+R + +D
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 713 ---SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
SK L RW PE ++ ++T DIWS G +L E+
Sbjct: 181 RVQSKSLL----PVRWM-PPEAILYG-KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 44/247 (17%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRT--YR 608
E +++I L++E G+G++G+VY+ K + VAIK + E N + +R
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLN 58
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRYIM- 666
E +K F H +++ +L + + VV E M + DL +R + + + +
Sbjct: 59 EASVMKEFNCH-HVVRLLGV--VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 667 ----------FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716
++ +G++Y+ A K +HRDL N ++ + ++KIGD G+ R + +
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE---- 171
Query: 717 LTEY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAST 766
T+Y + RW APE L + +T D+WS G +L EM L +P + G S
Sbjct: 172 -TDYYRKGGKGLLPVRWM-APESL-KDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSN 227
Query: 767 SHQLQLI 773
L+ +
Sbjct: 228 EEVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
R + Q L++ G G YG VYKA + + + A+K I D +EI +K
Sbjct: 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVK 61
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLC 670
+H NI+ Y ++ + L++ EY D+ V L ++ I Y+ +
Sbjct: 62 EC-KHCNIVAYFGSY--LSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL 116
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
GL+Y+H+ MHRD+K +NIL+ + +K+ D G+A ++ + +I T ++ APE
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
Query: 731 I--LISNRRYTHHVDIWSLGCILAEMLQSKP 759
+ + N Y DIW++G E+ + +P
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 71/243 (29%), Positives = 114/243 (46%), Gaps = 18/243 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V+ A K Q+ AIK + + D + T E L HP + +
Sbjct: 4 GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYC 63
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV-HIRYIMFQLCNGLSYIHACKVMHRD 685
++ N L+ V EY+ DL I+ D+ + ++ GL ++H+ +++RD
Sbjct: 64 TFQTKEN--LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARS--LSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
LK NIL+D IKI D G+ + L D+K C + T Y APEIL+ ++Y VD
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TFCGTPDYIAPEILLG-QKYNTSVD 178
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQV 803
WS G +L EML + F G Q I R + P Y + ++ ++ ++
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSI----RMDNP----CYPRWLTREAKDILVKL 230
Query: 804 VVK 806
V+
Sbjct: 231 FVR 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFLKSFQRHPNIITM 625
GKG++G V A K++ + A+K + + K Q R +L LK+ +HP ++ +
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LKNL-KHPFLVGL 61
Query: 626 LDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + LY V +Y+ + R++ + R+ ++ + + Y+H+ +++
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RDLKP NIL+D + + D GL + + +E + + T Y APE+L Y VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-RKEPYDRTVD 178
Query: 744 IWSLGCILAEMLQSKPLF 761
W LG +L EML P F
Sbjct: 179 WWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K ++ AIK + + D + T E L HP + +
Sbjct: 4 GKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFC 63
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVMHRD 685
++ + L+ V EY+ DL I+ D R+ ++ GL ++H +++RD
Sbjct: 64 TFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+L+DK IKI D G+ + + + + + T Y APEI + ++Y VD W
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQKYNESVDWW 180
Query: 746 SLGCILAEMLQSKPLFPG 763
S G +L EML + F G
Sbjct: 181 SFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 37/252 (14%)
Query: 562 QINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++ L K G+GA+G V KA + N VA+K + + + D E+ +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKM 71
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEY-----------------MEN--DLNKVIRDKI 656
+H NII +L + LYVV EY D + +
Sbjct: 72 IGKHKNIINLLGV--CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET- 128
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--- 713
L + +Q+ G+ ++ + K +HRDL N+L+ + +KI D GLAR +
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 771
++ + +W APE L +R YTH D+WS G +L E+ L P +PG +
Sbjct: 189 RKTTNGRLPVKWM-APEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSP-YPGIPVEELFK 245
Query: 772 LIVNLVRPNPPH 783
L+ R P
Sbjct: 246 LLKEGYRMEKPQ 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 6/196 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + + A+K + + N+ + + E L +HP ++ +
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH- 62
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y + LY V +++ + R++ + R+ ++ + L Y+H+ +++RD
Sbjct: 63 -YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP NIL+D + + D GL + + T + T Y APE+ I + Y + VD W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPYDNTVDWW 180
Query: 746 SLGCILAEMLQSKPLF 761
LG +L EML P F
Sbjct: 181 CLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 32/205 (15%)
Query: 569 GKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNII 623
GKG +G V Y N + VA+KK+ + + R + REI LKS Q H NI+
Sbjct: 13 GKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIV 68
Query: 624 TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV----HIRYIMF--QLCNGLSYIH 677
+ + ++L +V EY+ +RD + K H + +++ Q+C G+ Y+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYG---SLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------WYRAP 729
+ + +HRDL NIL++ +KIGD GL + L K EY R WY AP
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESPIFWY-AP 180
Query: 730 EILISNRRYTHHVDIWSLGCILAEM 754
E L + +++ D+WS G +L E+
Sbjct: 181 ESLTES-KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G G +G V+ Y + + VAIK + + + E +K Q HP ++ +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTK-VAIKSLKQG---SMSPEAFLAEANLMKQLQ-HPRLVRL- 66
Query: 627 DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
Y V + +Y++ EYMEN D K L + + Q+ G+++I +
Sbjct: 67 --YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAPEILISN 735
HRDL+ +NIL+ ++ KI D GLAR + D+ EY A +W APE I+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDN-----EYTAREGAKFPIKW-TAPEA-INY 177
Query: 736 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778
+T D+WS G +L E++ + +PG + ++I NL R
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 2/94 (2%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
Q+ GL ++H ++++RDLKP N+L+D +++I DLGLA L K+ + T Y
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRAGTPGYM 161
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+L Y VD ++LGC L EM+ + F
Sbjct: 162 APEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
+ L ++ G G +G V+ N VA+K + + +E +K RH
Sbjct: 7 SLKLERKLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKL-RHD 61
Query: 621 NIITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIR---YIMFQLCNGLSY 675
++ + Y + ++ +Y+V EYM L ++ K + + + Q+ G++Y
Sbjct: 62 KLVQL---YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRA 728
+ + +HRDL NIL+ ++ KI D GLAR + D EY A +W A
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-----EYTAREGAKFPIKW-TA 172
Query: 729 PEILISNRRYTHHVDIWSLGCILAEM 754
PE R+T D+WS G +L E+
Sbjct: 173 PEAANYG-RFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 569 GKGAYGIVY---KAYDKNNKQYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRHPNII 623
GKG YG V+ K + + A+K + +A RN+ D T E L++ + HP I+
Sbjct: 5 GKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIV 63
Query: 624 TMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 681
+ IY LY++ EY+ + R+ I + + + ++ L ++H +
Sbjct: 64 DL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
++RDLKP NIL+D +K+ D GL + + T Y APEIL+ R H
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM---RSGHG 178
Query: 742 --VDIWSLGCILAEMLQSKPLFPG 763
VD WSLG ++ +ML P F
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 569 GKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G++G V+ K + Q A+K + +A D RT E L HP I+ +
Sbjct: 5 GQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKL 63
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y LY++ +++ DL ++ ++ + + +++ + +L L ++H+ +++
Sbjct: 64 H--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-YTHHV 742
RDLKP NIL+D+ IK+ D GL++ D ++ + T Y APE++ NRR +T
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--NRRGHTQSA 179
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
D WS G ++ EML F G + +I+
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 42/127 (33%), Positives = 70/127 (55%), Gaps = 3/127 (2%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
++ GL +H ++++RDLKP NIL+D I+I DLGLA + + E + + T Y
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYM 168
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADK 786
APE+ + N RYT D W LGC++ EM++ K F + + + V+ + +++K
Sbjct: 169 APEV-VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
Query: 787 FYAGFKS 793
F +S
Sbjct: 228 FSEAARS 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
++ LKE G G +G+V+ + VAIK I E ++ D E + HP
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDD---FIEEAKVMMKLS-HP 59
Query: 621 NIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLSYIH 677
N++ + + + +++V EYM N L +R+ L + + +C + Y+
Sbjct: 60 NLVQLYGV--CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 730
+ +HRDL N L+ + +K+ D GLAR + D +Y ++ +W PE
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-----QYTSSQGTKFPVKW-APPE 171
Query: 731 ILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPH 783
+ + R++ D+WS G ++ E+ + K + S S ++ + R P
Sbjct: 172 VFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 617
L I GKG +G V + K VA+K + + T AQ E + +
Sbjct: 9 KLGATI-----GKGEFGDVMLGDYRGQK--VAVKCLK---DDSTAAQAFLAEASVMTTL- 57
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNG 672
RHPN++ +L + + LY+V EYM L R I + + + +C G
Sbjct: 58 RHPNLVQLLGV--VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL-DVCEG 114
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 732
+ Y+ +HRDL N+L+ + K+ D GLA+ S ++ + + +W APE L
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKW-TAPEAL 171
Query: 733 ISNRRYTHHVDIWSLGCILAEM 754
++++ D+WS G +L E+
Sbjct: 172 -REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 38/209 (18%)
Query: 569 GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNK-TDAQRT---YREILFLKSFQRHPN 621
GKG +G VY K + A+K + N+ TD + +E + +K F HPN
Sbjct: 4 GKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFS-HPN 57
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMF--QLCNGLS 674
++++L I L VV YM++ DL IR + +KD+ I F Q+ G+
Sbjct: 58 VLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDL----IGFGLQVAKGME 112
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI- 733
Y+ + K +HRDL N ++D+S ++K+ D GLAR + D EY + + ++ +
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK-----EYYSVHNHTGAKLPVK 167
Query: 734 -------SNRRYTHHVDIWSLGCILAEML 755
+++T D+WS G +L E++
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 7/209 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG +G V +K + +Y A+K + E K + T E LK+ RHP + ++
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK- 61
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y L V EY+ + R+++ + R+ ++ + L Y+H+ K+++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+++DK IKI D GL + + + T Y APE+L N Y VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWW 179
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIV 774
LG ++ EM+ + F +LI+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-15
Identities = 53/165 (32%), Positives = 88/165 (53%), Gaps = 11/165 (6%)
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-----LKDVHIRYIMFQLCN 671
H I+ D +K+ + L ++ EY DLNK I+ ++ ++ + + +Q+
Sbjct: 123 DHFGIVKHFDDFKS--DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL 180
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAP 729
L +H+ K+MHRDLK +NI + + IK+GD G ++ SDS + + + T +Y AP
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
E L +RY+ D+WSLG IL E+L F G S +Q ++
Sbjct: 241 E-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-15
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL-KSFQRHP-NIITML 626
G+G +G V +A+D+ K+Y A+K + + DA+ EI F+ K Q P + ++
Sbjct: 138 GEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKI---EIQFMEKVRQADPADRFPLM 194
Query: 627 DIYKAVNNKDLY---VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVM 682
I + N+ + V+ +Y L+ +++ H+ I+FQ L Y H +M
Sbjct: 195 KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLM 254
Query: 683 HRDLKPSNILIDKS----------------CSIKIGDLGLARSLSDSKECLTEYIATRWY 726
H DLKP NIL++ S C ++I DLG D + T ++TR Y
Sbjct: 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG---GCCDERHSRTAIVSTRHY 311
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
R+PE+++ + + D+WS+GCI+ E+ K L+ L L+
Sbjct: 312 RSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
|
Length = 467 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 569 GKGAYGIVYKAYDKNNKQY-----VAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 622
G+GA+G V++A Y VA+K + E D Q + RE + F HPNI
Sbjct: 14 GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-HPNI 70
Query: 623 ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-----------------------LK 658
+ +L + K + ++FEYM DLN+ +R + L
Sbjct: 71 VKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 659 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL- 717
I Q+ G++Y+ K +HRDL N L+ ++ +KI D GL+R++ +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 718 --TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769
+ I RW PE + N RYT D+W+ G +L E+ S + P +H+
Sbjct: 189 SENDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIF-SYGMQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 11/239 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG +G V +K +Y A+K + E K + T E L++ RHP + +
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK- 61
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y + L V EY + R+++ + R+ ++ + L Y+H+ V++RD
Sbjct: 62 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K N+++DK IKI D GL + + + T Y APE+L N Y VD W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWW 179
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKSKHEREKF 800
LG ++ EM+ + F +LI + R P A AG K +++
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 569 GKGAYGIVYKA-YDKNNKQY--VAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNII 623
G G +G V + K+ VAIK + +D QR E + F HPNII
Sbjct: 13 GGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD-HPNII 68
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACK 680
+ + + + ++ EYMEN L+K +R D + ++ + +G+ Y+
Sbjct: 69 RLEGVVTKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYRAPEILISNRR 737
+HRDL NIL++ + K+ D GL+R L DS+ T I RW APE I+ R+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA-IAYRK 184
Query: 738 YTHHVDIWSLGCILAEML 755
+T D+WS G ++ E++
Sbjct: 185 FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 571 GAYGIVYKAYDKNNKQYVAIKKIFE---AFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GAYG VY K +Q A+KKI + RN+ R+IL +F +P +++M
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL---TFAENPFVVSMFC 68
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMF-QLCNGLSYIHACKVMHRD 685
++ + L +V EY+E D ++++ V + + F + L Y+H ++HRD
Sbjct: 69 SFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 686 LKPSNILIDKSCSIKIGDLGL--------------------ARSLSDSKECLT-EYIATR 724
LKP N+LI IK+ D GL R D + C T EYI
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI--- 183
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763
APE+ I + Y VD W++G IL E L F G
Sbjct: 184 ---APEV-ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-15
Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 42/264 (15%)
Query: 569 GKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---RHPNI 622
G G +G V + K + +VAIK + + T+ QR R+ L S HPNI
Sbjct: 13 GAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQR--RDFLSEASIMGQFDHPNI 67
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHAC 679
I + + ++ + ++ E+MEN L+ +R D + + ++ + G+ Y+
Sbjct: 68 IHLEGV--VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE------CLTEYIATRWYRAPEILI 733
+HRDL NIL++ + K+ D GL+R L D L I RW APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEA-I 183
Query: 734 SNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-----PNPP---- 782
+ R++T D+WS G ++ E++ +P + ++ Q ++N + P P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIEQDYRLPPPMDCPT 238
Query: 783 --HADKFYAGFKSKHEREKFNQVV 804
H K ++ R KF Q+V
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 28/180 (15%)
Query: 632 VNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYIH-ACKVMH 683
++ ++ + E+M+ L++V++ + IL + I + GL+Y+ K+MH
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVL-----RGLTYLREKHKIMH 123
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RD+KPSNIL++ IK+ D G++ L DS ++ TR Y +PE L YT D
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGT-HYTVQSD 180
Query: 744 IWSLGCILAEML------------QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791
IWSLG L EM + + +F + + + V +PP + + A F
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 49/192 (25%), Positives = 96/192 (50%), Gaps = 16/192 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G+V+ Y K+ VAIK I E ++ D + ++ L HP ++ + +
Sbjct: 13 GSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS----HPKLVQLYGV 67
Query: 629 YKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ +VFE+ME+ L+ +R + + + +C G++Y+ + V+HRD
Sbjct: 68 --CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRYTHHV 742
L N L+ ++ +K+ D G+ R + D + T T++ + +PE+ S +Y+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEV-FSFSKYSSKS 182
Query: 743 DIWSLGCILAEM 754
D+WS G ++ E+
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG +G V +K +Y A+K + E K + T E L++ RHP + +
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK- 61
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y + L V EY + R+++ + R+ ++ + L Y+H+C V++RD
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 686 LKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
LK N+++DK IKI D GL + +SD T + T Y APE+L N Y VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN-DYGRAVDW 178
Query: 745 WSLGCILAEML 755
W LG ++ EM+
Sbjct: 179 WGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K GKG +G VYK K N + VA+K ++ +E LK + HPNI+ ++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTL-PPDLKRKFLQEAEILKQY-DHPNIVKLI 58
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ V + +Y+V E + L +R K L + + G+ Y+ + +H
Sbjct: 59 GV--CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 684 RDLKPSNILIDKSCSIKIGDLGLAR-------SLSDSKECLTEYIATRWYRAPEILISNR 736
RDL N L+ ++ +KI D G++R ++SD + I +W APE L +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG----LKQIPIKW-TAPEAL-NYG 170
Query: 737 RYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPP 782
RYT D+WS G +L E L P +PG S + I + R P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTP-YPGMSNQQTRERIESGYRMPAP 217
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 569 GKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNII 623
G G +G V++ K + VAIK + + T+ QR E + F H NII
Sbjct: 14 GAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFS-HHNII 69
Query: 624 TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCN-------GLSYI 676
+ + K ++ EYMEN DK L+D + +QL G+ Y+
Sbjct: 70 RLEGVVTKF--KPAMIITEYMENG----ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----IATRWYRAPEIL 732
+HRDL NIL++ + K+ D GL+R L D E I RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEA- 181
Query: 733 ISNRRYTHHVDIWSLGCILAEML 755
I+ R++T D+WS G ++ E++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 11/219 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G V +K A+K + ++ + + E + S P I +
Sbjct: 10 GRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-- 67
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
Y + +LY+V EY DL ++ + + ++ + +L + +H +HRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEILI-----SNRRYT 739
+KP N+LID++ IK+ D G A L+ +K ++ + T Y APE+L Y
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 778
D WSLG I EM+ + F +++ I+N R
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR 226
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 569 GKGAYGIVYKAY--DKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G G +G V K K+ K+ VA+K + + RE + HP I+ +
Sbjct: 4 GHGNFGSVVKGVYLMKSGKEVEVAVK-TLKQEHIAAGKKEFLREASVMAQLD-HPCIVRL 61
Query: 626 LDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ + K + L +V E L K ++ + + ++ + Q+ G++Y+ + +H
Sbjct: 62 IGVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIAT-------RWYRAPEILISN 735
RDL N+L+ KI D G++R+L + S Y AT +WY APE I+
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWY-APEC-INY 172
Query: 736 RRYTHHVDIWSLGCILAEML 755
+++ D+WS G L E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 12/219 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K +Y A+K + + D + T E L +P +
Sbjct: 4 GKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP---FLTH 60
Query: 628 IYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVMHR 684
+Y K+ L+ V E++ DL I+DK D++ + ++ GL ++H+ +++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLK N+++D+ IKI D G+ + + + T Y APEIL +YT VD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL-QGLKYTFSVDW 179
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
WS G +L EML + F G + I R + PH
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESI----RVDTPH 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 76/282 (26%), Positives = 116/282 (41%), Gaps = 53/282 (18%)
Query: 569 GKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----- 617
G GA+G VY+ + VA+K + + TD ++ FLK
Sbjct: 4 GSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEK----KEFLKEAHLMSNF 56
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQ 668
HPNI+ +L + + N+ Y++ E ME DL +RD +L + I
Sbjct: 57 NHPNIVKLLGV--CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 669 LCNGLSYIHACKVMHRDLKPSNILI---DKSCS--IKIGDLGLARSLSDSKECLTE---Y 720
+ G Y+ +HRDL N L+ +KIGD GLAR + S E
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR 778
+ RW APE L+ ++T D+WS G ++ E+L +P +P + LQ + R
Sbjct: 175 LPVRWM-APESLLDG-KFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTAGGR 231
Query: 779 PNPPH--ADKFYAGF-----KSKHEREKFNQVVVKCQKELQE 813
P DK Y + ER F+ + Q+ LQ
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFD----RIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQRHPNII 623
K G G YG VY+ K VA+K + K D +E +K +HPN++
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI-KHPNLV 65
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHAC 679
+L + Y++ E+M +L +R+ + + V + Y+ Q+ + + Y+
Sbjct: 66 QLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNR 736
+HRDL N L+ ++ +K+ D GL+R ++ + T + ++ + APE L N
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN- 180
Query: 737 RYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPP 782
+++ D+W+ G +L E+ P +PG S +L+ R P
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKGYRMERP 227
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 2/94 (2%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
++C GL +H ++++RDLKP NIL+D I+I DLGLA + + + + + T Y
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYM 168
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+ + N RYT D W+LGC+L EM+ + F
Sbjct: 169 APEV-VKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-14
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 586 QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR---------HPNIITMLDIYKAVNNKD 636
VAIK + +TDA + F+R HPNI+ +LD +A
Sbjct: 4 HEVAIKLL------RTDAPEEEHQR---ARFRRETALCARLYHPNIVALLDSGEAPPGL- 53
Query: 637 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI- 693
L+ VFEY+ L +V+ D L +M Q+ + L+ H ++HRDLKP NI++
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 694 ---DKSCSIKIGDLGLARSLSDSKECL-------TEYIATRWYRAPEILISNRRYTHHVD 743
+ + K+ D G+ L ++ TE + T Y APE L T + D
Sbjct: 114 QTGVRPHA-KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSD 171
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQ 771
+++ G I E L + + GAS + L
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 39/94 (41%), Positives = 58/94 (61%), Gaps = 2/94 (2%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
+LC GL + ++++RDLKP NIL+D I+I DLGLA + + E + + T Y
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYM 168
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+ I+N +YT D W LGC++ EM+Q + F
Sbjct: 169 APEV-INNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 68/236 (28%), Positives = 108/236 (45%), Gaps = 27/236 (11%)
Query: 587 YVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644
VAIK + + T+ QR E + F HPNII + + +K + +V EYM
Sbjct: 34 PVAIKTLKAGY---TEKQRRDFLSEASIMGQFD-HPNIIHLEGV--VTKSKPVMIVTEYM 87
Query: 645 EN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701
EN L+ +R D + + ++ + +G+ Y+ +HRDL NIL++ + K+
Sbjct: 88 ENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKV 147
Query: 702 GDLGLARSLSDSKECLTEY----IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ- 756
D GL+R L D E I RW APE I+ R++T D+WS G ++ E++
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEA-IAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 757 -SKPLFPGASTSHQLQLIVNLVRPNPP-------HADKFYAGFKSKHEREKFNQVV 804
+P + S ++ I R P H K ++ER KF Q+V
Sbjct: 206 GERPYWE-MSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 42/217 (19%)
Query: 569 GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
G+GA+G V+ A N +K VA+K + EA +++ Q RE L Q H +I+
Sbjct: 14 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQ-HQHIV 70
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KIL---KDV--------HIRYIM 666
+ + L +VFEYM + DLN+ +R KIL +DV + I
Sbjct: 71 RFYGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY------ 720
Q+ +G+ Y+ + +HRDL N L+ + +KIGD G++R + T+Y
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVGGR 183
Query: 721 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ RW IL R++T DIWS G +L E+
Sbjct: 184 TMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 67/240 (27%), Positives = 107/240 (44%), Gaps = 12/240 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG +G V +K +Y A+K + E K + T E L++ RHP +T L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP-FLTALK 61
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK-VMHR 684
Y + L V EY + R+++ + R+ ++ + L Y+H+ K V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLK N+++DK IKI D GL + + + T Y APE+L N Y VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDW 179
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKSKHEREKF 800
W LG ++ EM+ + F +LI + R P A +G K +++
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 31/195 (15%)
Query: 606 TYREILFLKSFQRHPNIITMLD--IYKAVN-------NKDLYVVFEYMENDLNKVIRDKI 656
T E + L++ HP++I M D + A+ + DLY Y+ + D+
Sbjct: 104 TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYSSDLYT---YLTKRSRPLPIDQA 159
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716
L I Q+ GL Y+HA +++HRD+K NI I+ + IGDLG A+ +
Sbjct: 160 L------IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML----------QSKPLFPGAST 766
L T APE+L + +Y DIWS G +L EML S P S
Sbjct: 214 LG-LAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSC 271
Query: 767 SHQLQLIVNLVRPNP 781
L I++ ++ +P
Sbjct: 272 HSHLLKIISTLKVHP 286
|
Length = 357 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 38/96 (39%), Positives = 58/96 (60%), Gaps = 2/96 (2%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
++ GL +H ++RDLKP NIL+D I+I DLGLA + + E + + T Y
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYM 168
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763
APE+ ++N+RYT D W LGC++ EM++ + F G
Sbjct: 169 APEV-LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 555 DREDLQQQINLLKE--GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYRE 609
RED+ L G+G +G VY+ +N K VA+K + + + ++ +E
Sbjct: 4 QREDIT-----LGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQE 57
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDLNKVIRDKILKDVHIRYIMF- 667
++ F HP+I+ ++ + + +++V E +L ++ I++
Sbjct: 58 AYIMRQF-DHPHIVKLIGV---ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 668 -QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR-- 724
QL L+Y+ + + +HRD+ N+L+ +K+GD GL+R L D + Y A++
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE----SYYKASKGK 169
Query: 725 ----WYRAPEILISNRRYTHHVDIWSLGCILAE--MLQSKPLF 761
W APE I+ RR+T D+W G + E ML KP
Sbjct: 170 LPIKWM-APES-INFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 1/94 (1%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
Q+ +GL ++H ++++RDLKP N+L+D +++I DLGLA L D + Y T +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761
APE+L Y VD ++LG L EM+ ++ F
Sbjct: 165 APELL-QGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 32/242 (13%)
Query: 569 GKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622
G+G +G V A DK NK K+ + D E+ +K +H NI
Sbjct: 21 GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNI 80
Query: 623 ITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILKDVHIRY 664
I +L + LYV+ EY + +L + +R ++ L +
Sbjct: 81 INLLG--ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYI 721
+Q+ G+ Y+ + K +HRDL N+L+ + +KI D GLAR + + K+ +
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPN 780
+W APE L +R YTH D+WS G +L E+ +PG +L+ R +
Sbjct: 199 PVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 256
Query: 781 PP 782
P
Sbjct: 257 KP 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 41/272 (15%)
Query: 569 GKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622
G+G +G V A +K N+ K+ ++ + D E+ +K +H NI
Sbjct: 27 GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 86
Query: 623 ITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILKDVHIRY 664
I +L + LYV+ EY + +L + +R ++ L +
Sbjct: 87 INLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYI 721
+Q+ G+ Y+ + K +HRDL N+L+ + +KI D GLAR + K+ +
Sbjct: 145 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 779
+W APE L +R YTH D+WS G +L E+ L P +PG +L+ R
Sbjct: 205 PVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLKEGHRM 261
Query: 780 NPPH--ADKFYAGFKS-----KHEREKFNQVV 804
+ P ++ Y + +R F Q+V
Sbjct: 262 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQRHPNIIT 624
G+G +G VY + + A+K + R K T R +L L S P I+
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 625 MLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
M Y L + + M DL+ + + + + +R+ ++ GL ++H V+
Sbjct: 62 M--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
+RDLKP+NIL+D+ ++I DLGLA S K + + T Y APE+L Y
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSA 177
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQL 772
D +SLGC+L ++L+ F T + ++
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 31/204 (15%)
Query: 569 GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FLKSFQRHPN 621
G GA+G VYK + K VAIK + R +T + +EIL ++ + HP+
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVL----REETSPK-ANKEILDEAYVMASVDHPH 70
Query: 622 IITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
++ +L I + + ++ + M D + +D I ++ Q+ G+SY+
Sbjct: 71 VVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNI-GSQYLLNWCVQIAKGMSYLE 126
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RWYRAPEI 731
+++HRDL N+L+ +KI D GLA+ L D E EY A +W A E
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDE--KEYHAEGGKVPIKWM-ALES 182
Query: 732 LISNRRYTHHVDIWSLGCILAEML 755
I +R YTH D+WS G + E++
Sbjct: 183 -ILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 547 KSIDQLMKDREDLQQQINLLKE-----------GKGAYGIVYKAYDKNNKQYVAIKKI-- 593
K+ID + E ++I L+ G+GA+G V K++KQ A+K +
Sbjct: 19 KNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK 78
Query: 594 FEAFRNKTDAQRTY--REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK 650
FE + ++D+ + R+I+ + I+ + Y ++K LY+V EYM DL
Sbjct: 79 FEMIK-RSDSAFFWEERDIM---AHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVN 132
Query: 651 VIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710
++ + + + R+ ++ L IH+ +HRD+KP N+L+DKS +K+ D G +
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 711 SDSK--ECLTEYIATRWYRAPEILISNR---RYTHHVDIWSLGCILAEMLQSKPLF 761
+ C T + T Y +PE+L S Y D WS+G L EML F
Sbjct: 193 DANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
GKG++G V A K + AIK K + + + +L L P +T
Sbjct: 9 GKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG---KPPFLTQ 65
Query: 626 LDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVM 682
L + D LY V EY+ DL I+ K+ H + ++ GL ++H+ ++
Sbjct: 66 L--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
+RDLK N+++D IKI D G+ + + + T Y APEI I+ + Y V
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI-IAYQPYGKSV 182
Query: 743 DIWSLGCILAEMLQSKPLFPG 763
D W+ G +L EML +P F G
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 49/250 (19%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V K+ A+KK+ ++ + + R R+IL + +P ++ +
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL---AEADNPWVVKL 66
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + LY++ EY+ D+ +++ + R+ + + + IH +H
Sbjct: 67 Y--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLS---------------------------DSKEC 716
RD+KP N+L+D IK+ D GL L SK
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 717 LTEY-----------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 765
+ + T Y APE+ + Y D WSLG I+ EML P F +
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCSDN 243
Query: 766 TSHQLQLIVN 775
+ I+N
Sbjct: 244 PQETYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 49/228 (21%)
Query: 569 GKGAYGIVYKA--YD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
G+GA+G V+ A Y+ +K VA+K A ++ T A R K FQR ++
Sbjct: 14 GEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAAR--------KDFQREAELL 61
Query: 624 TMLD------IYKAVNNKD-LYVVFEYMEN-DLNKVIRDK-----ILKDVHIR------- 663
T L Y + D L +VFEYM++ DLNK +R IL D R
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 664 -----YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718
+I Q+ +G+ Y+ + +HRDL N L+ + +KIGD G++R + +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 719 ---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLF 761
+ RW P I R++T D+WS G IL E+ +P F
Sbjct: 182 GGHTMLPIRW--MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-13
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V + ++ ++ A+K I +A ++++ T E L P I+ +
Sbjct: 2 GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKF 60
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+++ + LY+V ++ + + R+ R+ +L L +H V++RD
Sbjct: 61 SFQS--PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 686 LKPSNILIDKSCSIKIGDLGLAR-SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
LKP NIL+D I + D GL + ++ D + T + T Y APE L+ YT VD
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPE-LLLGHGYTKAVDW 176
Query: 745 WSLGCILAEMLQSKPLF 761
W+LG +L EML P F
Sbjct: 177 WTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 42/242 (17%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--- 617
I LL++ G G +G V++ NN VA+K + + D FL Q
Sbjct: 7 SIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKD---------FLAEAQIMK 56
Query: 618 --RHPNIITMLDIYKAVNNKD--LYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQL 669
RHP +I + AV + +Y+V E M+ + + + LK + + Q+
Sbjct: 57 KLRHPKLIQLY----AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 723
+G++Y+ A +HRDL N+L+ ++ K+ D GLAR + + Y A
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-----IYEAREGAKFP 167
Query: 724 -RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PN 780
+W APE + N R++ D+WS G +L E++ + +PG + + LQ + R P
Sbjct: 168 IKW-TAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225
Query: 781 PP 782
PP
Sbjct: 226 PP 227
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
++ +KE G G +G+V+ K Q VAIK I E ++ D + ++ L H
Sbjct: 5 ELTFMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLS----H 58
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEND--LN--KVIRDKILKDVHIRYIMFQLCNGLSY 675
P ++ + + K LY+V E+MEN LN + + K+ KD+ + + +C G+ Y
Sbjct: 59 PKLVQLYGV--CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEGMEY 115
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRA 728
+ +HRDL N L+ + +K+ D G+ R + D EY ++ +W
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKW-SP 169
Query: 729 PEILISNRRYTHHVDIWSLGCILAEM 754
PE+ + +Y+ D+WS G ++ E+
Sbjct: 170 PEVFNFS-KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 6/196 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G+Y V K N Q A+K + E + D E + +P ++ +
Sbjct: 4 GRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHS 63
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + L++V EY+ + + R + L + H R+ ++C L+++H +++RD
Sbjct: 64 CFQTTSR--LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+L+D IK+ D G+ + + + + T Y APEIL Y VD W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWW 180
Query: 746 SLGCILAEMLQSKPLF 761
+LG ++ EM+ + F
Sbjct: 181 ALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-13
Identities = 61/228 (26%), Positives = 115/228 (50%), Gaps = 24/228 (10%)
Query: 547 KSIDQLMKDREDLQQQINLLKE-----------GKGAYGIVYKAYDKNNKQYVAIKKI-- 593
K+ID + E + ++I L+ G+GA+G V K++++ A+K +
Sbjct: 19 KNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK 78
Query: 594 FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI 652
FE + ++D+ + E + +F P ++ + ++ ++K LY+V EYM DL ++
Sbjct: 79 FEMIK-RSDSAFFWEERDIM-AFANSPWVVQLFCAFQ--DDKYLYMVMEYMPGGDLVNLM 134
Query: 653 RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712
+ + + ++ ++ L IH+ ++HRD+KP N+L+DK +K+ D G + +
Sbjct: 135 SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 713 SK--ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEML 755
+ C T + T Y +PE+L S + Y D WS+G L EML
Sbjct: 195 TGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 569 GKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622
G+G +G V A DK + K+ + + D E+ +K +H NI
Sbjct: 24 GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 83
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI-LKDVHI 662
I +L + LYV+ EY D+ +V +++ KD +
Sbjct: 84 INLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD--L 139
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTE 719
+Q+ G+ Y+ + K +HRDL N+L+ ++ +KI D GLAR +++ K+
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLV 777
+ +W APE L +R YTH D+WS G ++ E+ L P +PG +L+
Sbjct: 200 RLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGH 256
Query: 778 RPNPP 782
R + P
Sbjct: 257 RMDKP 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 33/190 (17%)
Query: 588 VAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFE 642
VA+K + + D +T R FLK + ++PNII +L + V++ L ++ E
Sbjct: 47 VAVKML------RADVTKTARND-FLKEIKIMSRLKNPNIIRLLGV--CVSDDPLCMITE 97
Query: 643 YMEN-DLNKV-----IRDKILKDVHIR--------YIMFQLCNGLSYIHACKVMHRDLKP 688
YMEN DLN+ I +I Y+ Q+ +G+ Y+ + +HRDL
Sbjct: 98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157
Query: 689 SNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILISNRRYTHHVDIW 745
N L+ +IKI D G++R+L + + RW IL+ ++T D+W
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVW 215
Query: 746 SLGCILAEML 755
+ G L EM
Sbjct: 216 AFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-13
Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTD 602
YK +I+++ R + + G+GA+G V K+ ++ A+K + FE + ++D
Sbjct: 28 YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSD 86
Query: 603 AQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH 661
+ + E + +F P ++ + Y +++ LY+V EYM DL ++ + + +
Sbjct: 87 SAFFWEERDIM-AFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 143
Query: 662 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTE 719
R+ ++ L IH+ +HRD+KP N+L+DKS +K+ D G ++ C T
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 720 YIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEML 755
+ T Y +PE+L S + Y D WS+G L EML
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREIL 611
++D ++I+ L G G G+V+K K + +A K +I A RN+ RE+
Sbjct: 3 KDDDFEKISELGAGNG--GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQ 55
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRY 664
L P I+ + ++ ++ + E+M+ L++V++ ++IL V I
Sbjct: 56 VLHECNS-PYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 665 IMFQLCNGLSYI-HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723
I GL+Y+ K+MHRD+KPSNIL++ IK+ D G++ L DS ++ T
Sbjct: 113 I-----KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGT 165
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
R Y +PE L Y+ DIWS+G L EM
Sbjct: 166 RSYMSPERL-QGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQRHPNIITM 625
GKG +G V KN + A KK+ + K ++ +EIL + P I+ +
Sbjct: 2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN---SPFIVNL 58
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMF---QLCNGLSYIHACKV 681
Y + L +V M DL I + + + + ++ Q+ G+ ++H+ +
Sbjct: 59 --AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
++RD+KP N+L+D + ++ DLGLA L D K +T+ T Y APEIL Y++
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRAGTNGYMAPEIL-KEEPYSYP 174
Query: 742 VDIWSLGCILAEMLQSKPLF 761
VD +++GC + EM+ + F
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 45/280 (16%)
Query: 523 KHRSDLSSKESLLS---NGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVY- 577
H +D + E LS + + + S D R Q N+L G+ G V+
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVR----MQYNILSSLTPGSEGEVFV 110
Query: 578 -KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--- 633
+ ++ V +K + T + REI LK+ H II ++ Y+ +
Sbjct: 111 CTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTIS-HRAIINLIHAYRWKSTVC 162
Query: 634 ------NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
DL+ + L + I I +L L+Y+H ++HRD+
Sbjct: 163 MVMPKYKCDLFTYVDRSGPLPLEQAI-----------TIQRRLLEALAYLHGRGIIHRDV 211
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWYRAPEILISNRRYTHHVDI 744
K NI +D+ + +GD G A L + Y T +PE+L + Y DI
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDI 270
Query: 745 WSLGCILAEML-QSKPLF--PGASTSHQLQLIVNLVRPNP 781
WS G +L EM ++ LF S+S QL+ I+ ++ +P
Sbjct: 271 WSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310
|
Length = 392 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 31/241 (12%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
+I +L E GKG YG VYK + +A+K+I R + D + + +I+
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI----RLELD-ESKFNQIIMELDILHKA 56
Query: 621 NIITMLDIYKAVNNKD-LYVVFEYME-NDLNKV----IRDKILKDVHIRYIMFQLCNGLS 674
++D Y A + +Y+ EYM+ L+K+ + + + + +R I + + GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 675 YI-HACKVMHRDLKPSNILIDKSCSIKIGDLG----LARSLSDSKECLTEYIATRWYRAP 729
++ ++HRD+KP+N+L++ + +K+ D G L SL+ + I + Y AP
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAP 170
Query: 730 EILIS-----NRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTS--HQLQLIVNLVRPNP 781
E + S N YT D+WSLG + EM L P P + QL IV+ P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230
Query: 782 P 782
P
Sbjct: 231 P 231
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 19/217 (8%)
Query: 560 QQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618
++ I L+K+ G G +G V+ Y NN VA+K + Q E +K+ Q
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQ- 59
Query: 619 HPNIITMLDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNGL 673
H ++ + Y V ++ +Y++ EYM L+ + D+ K + + I F Q+ G+
Sbjct: 60 HDKLVRL---YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEI 731
+YI +HRDL+ +N+L+ +S KI D GLAR + D++ E +W APE
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEA 175
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTS 767
I+ +T D+WS G +L E++ K +PG S S
Sbjct: 176 -INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 11/231 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQRHPNIIT 624
G+G +G VY + + A+K + R K T R +L L S P I+
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 625 MLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
M Y L + + M DL+ + + + + +R+ ++ GL ++H V+
Sbjct: 62 M--TYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
+RDLKP+NIL+D+ ++I DLGLA S K + + T Y APE+L Y
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSA 177
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793
D +SLGC+L ++L+ F T + ++ + N D F KS
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 40/215 (18%)
Query: 569 GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
G+GA+G V+ A N +K VA+K + +A N + +RE L + Q H +I+
Sbjct: 14 GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQ-HEHIV 70
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR----DKIL----------KDVHIRYIMFQ 668
+ V L +VFEYM++ DLNK +R D +L + +I Q
Sbjct: 71 KFYGV--CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-------- 720
+ G+ Y+ + +HRDL N L+ ++ +KIGD G++R + T+Y
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-----TDYYRVGGHTM 183
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ RW P I R++T D+WSLG +L E+
Sbjct: 184 LPIRW--MPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 43/229 (18%)
Query: 564 NLLKE-GKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRH 619
+K GKG G V+ K + A+K K RNK T +EIL + H
Sbjct: 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL---ATLDH 60
Query: 620 PNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIR---DKILKDVHIRYIMFQLCNGLSY 675
P + T+ ++ L +V +Y +L ++++ K L + R+ ++ L Y
Sbjct: 61 PFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-----------------KECLT 718
+H +++RDLKP NIL+ +S I + D L++ +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 719 EYIA------------TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
E + T Y APE+ IS + VD W+LG +L EML
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-12
Identities = 85/370 (22%), Positives = 175/370 (47%), Gaps = 11/370 (2%)
Query: 166 SQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECR--- 222
S+ + S KELE L L +LE+ + L + R L + + L ++
Sbjct: 656 SRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELE 715
Query: 223 --LQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQ--YQQEVRA 278
L+ L EL + QL L E++ LE+E L L+ + + +E A
Sbjct: 716 RQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALA 775
Query: 279 HEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMK 338
+ + + K +A E ++EL++ + + L + E L + ++R ++ I++L +
Sbjct: 776 KLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEE 835
Query: 339 DREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKARE 398
+ E+L+++++ L+E EL + ++ + L+ ++E+ +A+K L+ +L E L+
Sbjct: 836 EIEELEEKLDELEE--ELEELEKELEELKEELEELEAEKEELEDELKELEEEKEELEEEL 893
Query: 399 EQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETE--QYFSTLYKTQAHE 456
+L E+A L+E + E +L+ K ++++ EL+++LE E T + +
Sbjct: 894 RELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTLETELEREIER 953
Query: 457 LKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELE 516
L+EE++ L EE ++ R + ++ + A+ E + EL+KEK + E
Sbjct: 954 LEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDLEEAKEKLLEVIEELDKEKRERFKE 1013
Query: 517 LKDLMAKHRS 526
D + ++ S
Sbjct: 1014 TFDKINENFS 1023
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-12
Identities = 74/366 (20%), Positives = 157/366 (42%), Gaps = 30/366 (8%)
Query: 210 LGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQ 269
L +K E E L L +LE+ + L + R L + + L ++ L +L+ +
Sbjct: 663 LAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELK 722
Query: 270 AQYQQEVRAHEETQKSRMVNKEEAS--VEIVKELKDLMAKHRSDLSSKESLLSNGKEREV 327
+ E+ Q +EE E ++EL++ + + +L S E L+ KE
Sbjct: 723 RELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIE 782
Query: 328 DYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQ 387
+ ++ L ++ E+L++++ + + L+ ++E + ++ L+ ++
Sbjct: 783 ELEEKRQALQEELEELEEELEEAERRLD---------ALERELESLEQRRERLEQEIEEL 833
Query: 388 TSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFS 447
E L+ + ++L E+ L + ++EE +L+ ++ + ++KEL+++ E
Sbjct: 834 EEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELEEEKE------ 887
Query: 448 TLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELE 507
EL+EEL E + EL+EE L RL+ A+ + + EE + E
Sbjct: 888 --------ELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEY 939
Query: 508 KEKTMKELELK-DLMAKHRSDLS----SKESLLSNGKEREVDYKKSIDQLMKDREDLQQQ 562
++ ELE + + + + L +ER + K + L + +E L +
Sbjct: 940 EDTLETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDLEEAKEKLLEV 999
Query: 563 INLLKE 568
I L +
Sbjct: 1000 IEELDK 1005
|
Length = 1163 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 6/209 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + AIK + + D + T E L + P + +
Sbjct: 9 GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS 68
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ V+ LY V EY+ DL I+ K+ + ++ GL ++H +++RD
Sbjct: 69 CFQTVDR--LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+++D IKI D G+ + + T Y APEI I+ + Y VD W
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI-IAYQPYGKSVDWW 185
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIV 774
+ G +L EML +P F G Q I+
Sbjct: 186 AYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 36/235 (15%)
Query: 569 GKGAYGIVYKA----YDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 621
G+G +G V +A DK+ VA+K + + +K D E+ +K +H N
Sbjct: 21 GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKLIGKHKN 79
Query: 622 IITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILKDVHIR 663
II +L + LYV+ EY + +L + +R ++ L +
Sbjct: 80 IINLLGV--CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEY 720
+Q+ G+ Y+ + + +HRDL N+L+ + +KI D GLAR + D K+
Sbjct: 138 SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 773
+ +W APE L +R YTH D+WS G ++ E+ L P +PG +L+
Sbjct: 198 LPVKWM-APEALF-DRVYTHQSDVWSFGILMWEIFTLGGSP-YPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 22/184 (11%)
Query: 588 VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN- 646
VA+K + + + +E+ L PNI +L + + L ++ EYMEN
Sbjct: 49 VAVKVLRPD-ASDNAREDFLKEVKILSRLS-DPNIARLLGV--CTVDPPLCMIMEYMENG 104
Query: 647 DLNKVIRDKILKDVHIR------------YIMFQLCNGLSYIHACKVMHRDLKPSNILID 694
DLN+ ++ + + + Y+ Q+ +G+ Y+ + +HRDL N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 695 KSCSIKIGDLGLARSLSDSKECLTEYIAT---RWYRAPEILISNRRYTHHVDIWSLGCIL 751
K+ +IKI D G++R+L S + A RW +L+ ++T D+W+ G L
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTL 222
Query: 752 AEML 755
E+L
Sbjct: 223 WEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 30/230 (13%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
RE L+ + L G+G +G V+ N VAIK + + T + + +
Sbjct: 5 RESLRLDVKL---GQGCFGEVWMG-TWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMK 56
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCN 671
RH ++ + Y V+ + +Y+V E+M D K K LK + + Q+ +
Sbjct: 57 KLRHDKLVPL---YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TR 724
G++YI +HRDL+ +NIL+ + KI D GLAR + D+ EY A +
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-----EYTARQGAKFPIK 168
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI 773
W APE + R+T D+WS G +L E++ + + +PG L+ +
Sbjct: 169 W-TAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 6/196 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + AIK + + D T E L +HP + +
Sbjct: 4 GKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHC 63
Query: 628 IYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + L+ V EY+ DL ++ R + + R+ ++ L ++H V++RD
Sbjct: 64 CFQTKDR--LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK NIL+D K+ D G+ + + T + T Y APEIL Y VD W
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL-QELEYGPSVDWW 180
Query: 746 SLGCILAEMLQSKPLF 761
+LG ++ EM+ +P F
Sbjct: 181 ALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 31/240 (12%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
RE L+ ++ L G+G +G V+ N VAIK + + +E +K
Sbjct: 5 RESLRLEVKL---GQGCFGEVWMG-TWNGTTRVAIKTLKPG---TMSPEAFLQEAQVMKK 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCN 671
RH ++ + Y V+ + +Y+V EYM D K K L+ + + Q+ +
Sbjct: 58 L-RHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TR 724
G++Y+ +HRDL+ +NIL+ ++ K+ D GLAR + D+ EY A +
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIK 168
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPP 782
W APE + R+T D+WS G +L E+ + + +PG L + R P PP
Sbjct: 169 W-TAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNG 672
H N+I + Y V L +V E + L K L Y + Q+ NG
Sbjct: 54 DHENLIRL---YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV-QIANG 109
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR----- 727
+ Y+ + + +HRDL NIL+ +KIGD GL R+L +++ Y+ +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---YVMEEHLKVPFAW 166
Query: 728 -APEILISNRRYTHHVDIWSLGCILAEM 754
APE L R ++H D+W G L EM
Sbjct: 167 CAPESL-RTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-12
Identities = 72/340 (21%), Positives = 142/340 (41%), Gaps = 37/340 (10%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
EL++ LE + E+ + EE +L+ + + + + LR E+ +LE+ + L+ +L
Sbjct: 236 ELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALAN 295
Query: 84 RADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNI 143
+ K+ L L +Q EL E + EL
Sbjct: 296 EISRLEQQKQILRERLA-----------------NLERQLEELEAQLEELESKLDELAEE 338
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQL 203
LA LE + + L++E+ +L+A++ + +ELE RL+ L +LE L
Sbjct: 339 LAELEEKLEELKEELESLEAELEELE-------AELEELESRLEELEEQLE-------TL 384
Query: 204 AEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSL 263
L +++SL E ++ L LER + R +L ++ L +K+ E + L
Sbjct: 385 RSKVAQLELQIASLNNE--IERLEARLERLEDRRERLQQEIEELLKKLEEAELKELQAEL 442
Query: 264 ELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGK 323
E + + QE E + + E + + + + +A+ ++ L S E L N +
Sbjct: 443 EELEEELEELQEELERLEEALEELREELEEAEQALDAAERELAQLQARLDSLERLQENLE 502
Query: 324 EREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKS 363
+ + + L+K++ L + +L E + + E +
Sbjct: 503 ----GFSEGVKALLKNQSGLSGILGVLSELISVDEGYEAA 538
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 6/196 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G+Y V K ++ A+K I E + D E ++ HP ++ +
Sbjct: 4 GRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS 63
Query: 628 IYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + L+ V E++ DL + R + L + H R+ ++ L+++H +++RD
Sbjct: 64 CFQTESR--LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+L+D IK+ D G+ + + + + T Y APEIL Y VD W
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWW 180
Query: 746 SLGCILAEMLQSKPLF 761
+LG ++ EM+ + F
Sbjct: 181 ALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 6/209 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + AIK + + D + T E L + P + +
Sbjct: 9 GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHS 68
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ ++ LY V EY+ DL I+ K+ H + ++ GL ++H+ +++RD
Sbjct: 69 CFQTMDR--LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+++D IKI D G+ + + T Y APEI I+ + Y VD W
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDWW 185
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIV 774
+ G +L EML + F G Q I+
Sbjct: 186 AFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 32/231 (13%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
RE LQ + K G G +G V+ ++ N K VA+K + + T + ++ E +
Sbjct: 5 RESLQL---IKKLGNGQFGEVWMGTWNGNTK--VAVKTL----KPGTMSPESFLEEAQIM 55
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRD---KILKDVHIRYIMFQLC 670
RH ++ + Y V+ + +Y+V EYM + L ++D + LK ++ + Q+
Sbjct: 56 KKLRHDKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------T 723
G++YI +HRDL+ +NIL+ KI D GLAR + D+ EY A
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN-----EYTARQGAKFPI 167
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI 773
+W APE + R+T D+WS G +L E++ + + +PG + L+ +
Sbjct: 168 KW-TAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-12
Identities = 110/572 (19%), Positives = 217/572 (37%), Gaps = 48/572 (8%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
L+ LE E+ +LE R +L EQ E + ++ L ++ L + L L+ +
Sbjct: 355 SLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLED 414
Query: 84 RADNESETKKKAEVNLQ-------------VISDMHEKLKTEAETATRLRKQSAELTVAK 130
R + + ++ L+ + ++ E + L + EL A+
Sbjct: 415 RRERLQQEIEELLKKLEEAELKELQAELEELEEELEELQEELERLEEALEELREELEEAE 474
Query: 131 SAGEQMVVELQNILATLEMERDTLQQEVATLQ---AKISQERSSKTQAVNLHKEL----E 183
A + EL + A L+ LQ+ + + + +S + + + EL E
Sbjct: 475 QALDAAERELAQLQARLDSLER-LQENLEGFSEGVKALLKNQSGLSGILGVLSELISVDE 533
Query: 184 GRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAED 243
G A+ L + + E+ + ++ L++ + L+ K E+Q +
Sbjct: 534 GYEAAIEAALG--GRLQAVVVENLNAAKKAIAFLKQNELGRVTFLPLDSIKGTEIQGNDR 591
Query: 244 NRHLGEK-VSSLEKECASLSLELKAA-QAQYQQEVRAHEETQKSRMVNKEEASVEIVKEL 301
+ + K+ +L+ A + + + K IV
Sbjct: 592 EILKNIEGFLGVAKDLVKFDPKLRKALSYLLGGVLVVDDLDNALELAKKLRPGYRIVTLD 651
Query: 302 KDLMAKH----RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL-KEGAEL 356
DL+ + S+L +E I++L + E+L+++I L K AEL
Sbjct: 652 GDLVRPGGVITGGSAKTNSSILERRRE--------IEELEEKIEELEEKIAELEKALAEL 703
Query: 357 RQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIE 416
R+ELE L+ ++EQ + + L +S + A L+A EQL +A L + +E
Sbjct: 704 RKELE---ELEEELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTELE 760
Query: 417 EEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERG 476
E +L+ + + ++ E + ++E + Q +LKEEL + EL E
Sbjct: 761 AEIEELEERLEEAEEELAEAEAEIEELE-------AQIEQLKEELKALREALDELRAELT 813
Query: 477 DLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLS 536
L R +S + E + +LE++ +++ L A+ E L S
Sbjct: 814 LLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELES 873
Query: 537 NGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
+ + + L R +L++ L+E
Sbjct: 874 ELEALLNERASLEEALALLRSELEELSEELRE 905
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-11
Identities = 115/583 (19%), Positives = 233/583 (39%), Gaps = 54/583 (9%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLK 79
EL++ LE R +++QLE + L+ + E + AR L D +L++ + L L+
Sbjct: 372 SRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQEIEELLKKLE 431
Query: 80 ESQRRA-DNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVV 138
E++ + E E ++ LQ + E+L+ E +++ + A +
Sbjct: 432 EAELKELQAELEELEEELEELQ---EELERLEEALEELREELEEAEQALDAAERELAQLQ 488
Query: 139 ELQNILATLEMERDTLQQEVATL---QAKISQERSSKTQAVNLHKELEGRLQALNTELER 195
+ L L+ + + V L Q+ +S ++ +++ + E A+ L
Sbjct: 489 ARLDSLERLQENLEGFSEGVKALLKNQSGLSGILGVLSELISVDEGYE---AAIEAALG- 544
Query: 196 NKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEK-VSSL 254
+ + E+ + ++ L++ + L+ K E+Q + + +
Sbjct: 545 -GRLQAVVVENLNAAKKAIAFLKQNELGRVTFLPLDSIKGTEIQGNDREILKNIEGFLGV 603
Query: 255 EKECASLSLELKAA-QAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKH----R 309
K+ +L+ A + + + K IV DL+
Sbjct: 604 AKDLVKFDPKLRKALSYLLGGVLVVDDLDNALELAKKLRPGYRIVTLDGDLVRPGGVITG 663
Query: 310 SDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL-KEGAELRQELEKSKTLQS 368
+ S+L +E I++L + E+L+++I L K AELR+ELE L+
Sbjct: 664 GSAKTNSSILERRRE--------IEELEEKIEELEEKIAELEKALAELRKELE---ELEE 712
Query: 369 QVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSV 428
++EQ + + L +S + A L+A EQL +A L + +E E +L+ +
Sbjct: 713 ELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEE 772
Query: 429 EDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRL------ 482
+ ++ E + ++E + K + L+E LDE + L EE +L RL
Sbjct: 773 AEEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERR 832
Query: 483 -------------QLAVARADSEALARSIAEETVGELEKEKTMKEL-----ELKDLMAKH 524
Q+ D E+LA I E E E ++ L L++ +A
Sbjct: 833 IAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALALL 892
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLK 567
RS+L L + + + ++ +++L + L+ ++ L+
Sbjct: 893 RSELEELSEELRELESKRSELRRELEELREKLAQLELRLEGLE 935
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-11
Identities = 75/365 (20%), Positives = 148/365 (40%), Gaps = 48/365 (13%)
Query: 79 KESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVV 138
KE++R+ + E + E L + + L+ +AE A R ++ AEL
Sbjct: 175 KETERKLERTRENLDRLEDILNELERQLKSLERQAEKAERYKELKAELR----------- 223
Query: 139 ELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKH 198
EL+ L L +E L+ ++ + + +A +EL LQ L +LE +
Sbjct: 224 ELELALLVLRLEE---------LREELEELQEELKEAEEELEELTAELQELEEKLEELRL 274
Query: 199 RELQLAEDNRH-------LGEKVSSLEKECR------------LQALNTELERNKHRELQ 239
+L E+ L ++S LE++ + L+ L +LE + + +
Sbjct: 275 EVSELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDE 334
Query: 240 LAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVK 299
LAE+ L EK+ L++E SL EL+ +A+ +E+ + E + ++ ++
Sbjct: 335 LAEELAELEEKLEELKEELESLEAELEELEAE-LEELESRLEELEEQLETLRSKVAQLEL 393
Query: 300 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQE 359
++ L + + E L E + + + + + + + L E EL +E
Sbjct: 394 QIASLNNEIERLEARLERL-----EDRRERLQQEIEELLKKLEEAELKELQAELEELEEE 448
Query: 360 LEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEY 419
LE+ LQ ++E+ + L+ +L + QL + L + N+E
Sbjct: 449 LEE---LQEELERLEEALEELREELEEAEQALDAAERELAQLQARLDSLERLQENLEGFS 505
Query: 420 HKLKT 424
+K
Sbjct: 506 EGVKA 510
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-11
Identities = 61/192 (31%), Positives = 89/192 (46%), Gaps = 24/192 (12%)
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKIL--KDV----HI 662
EIL L H NI+ + +I ++ N Y++ + + DL + D+ KD
Sbjct: 213 EILALG-RLNHENILKIEEILRSEANT--YMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-- 720
R IM QL + YIH K++HRD+K NI ++ I +GD G A +E +Y
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGW 328
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP----GASTSHQLQLIVNL 776
+ T +PEIL + Y DIWS G IL +ML S P G QL I++
Sbjct: 329 VGTVATNSPEILAGD-GYCEITDIWSCGLILLDML-SHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 777 VR------PNPP 782
+ P+PP
Sbjct: 387 LSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRT---YREILFLK 614
++I +L EG +Y YD N + VA+K + + Q T +EI LK
Sbjct: 7 KKIRVLGEGHFGKVSLYC-YDPANDGTGEMVAVK----TLKRECGQQNTSGWKKEINILK 61
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGL 673
+ H NI+ K L ++ EY+ L + L + Q+C G+
Sbjct: 62 TLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------W 725
+Y+H+ +HRDL N+L+D +KIGD GLA+++ + EY R W
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFW 176
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEML 755
Y A E L N ++++ D+WS G L E+L
Sbjct: 177 Y-AVECLKEN-KFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 568 EGKGAYGIVY---KAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPN 621
G GAYG V+ K + + A+K K + KT A+ T E L++ +R P
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKT-AEHTRTERQVLEAVRRCPF 66
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
++T+ Y + L+++ +Y+ + + + + +R + ++ L ++H
Sbjct: 67 LVTLH--YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRR- 737
+++RD+K NIL+D + + D GL++ L++ +E + T Y APE++
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184
Query: 738 YTHHVDIWSLGCILAEML 755
+ VD WSLG + E+L
Sbjct: 185 HDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 553 MKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
MK+ + L Q I GKG +G V + NK VA+K I +N AQ E
Sbjct: 5 MKELK-LLQTI-----GKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASV 52
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDK---ILKDVHIRYIMFQ 668
+ RH N++ +L + LY+V EYM + L +R + +L +
Sbjct: 53 MTQL-RHSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+C + Y+ A +HRDL N+L+ + K+ D GL + S +++ T + +W A
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TA 167
Query: 729 PEILISNRRYTHHVDIWSLGCILAEM 754
PE L ++++ D+WS G +L E+
Sbjct: 168 PEAL-REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-11
Identities = 121/574 (21%), Positives = 239/574 (41%), Gaps = 61/574 (10%)
Query: 23 GELKDLLERERREMSQLEERQRQLSEQYEAVSARE----------TALRDEMGQLEKNLT 72
E + LE RE++++ +L E+ E + L E+ LE +
Sbjct: 196 KEKEKELEEVLREINEISSELPELREELEKLEKEVKELEELKEEIEELEKELESLEGSKR 255
Query: 73 ILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSA 132
L ++E + R + E KK+ E + + ++ ++LK +AE +L + E
Sbjct: 256 KLEEKIRELEERIE---ELKKEIEELEEKVKEL-KELKEKAEEYIKLSEFYEEYLDELR- 310
Query: 133 GEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTE 192
+E L++E+ ++ +I E K + + +EL+ +L+ L
Sbjct: 311 -------------EIEKRLSRLEEEINGIEERIK-ELEEKEERL---EELKKKLKELEKR 353
Query: 193 LER--NKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEK 250
LE +H + A+ + E++ + L ELE + + ++ E+ + +
Sbjct: 354 LEELEERHELYEEAKAKKEELERLKKRLTGLTPEKLEKELEELEKAKEEIEEEISKITAR 413
Query: 251 VSSLEKECASLSL---ELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIV----KELKD 303
+ L+KE L ELK A+ + R E + ++ + A ++ + KE+++
Sbjct: 414 IGELKKEIKELKKAIEELKKAKGKCPVCGRELTEEHRKELLEEYTAELKRIEKELKEIEE 473
Query: 304 LMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKS 363
K R +L E +L KE E+ K + + +K+ E+ ++ NL +ELEK
Sbjct: 474 KERKLRKELRELEKVLK--KESELIKLKELAEQLKELEEKLKKYNL--------EELEKK 523
Query: 364 KTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLK 423
+++++ K L + + LK + +L ++ L E + +E +L
Sbjct: 524 AEEYEKLKEKLIKLKGEIKSLKKELEKLEELKKKLAELEKKLDELEEELAELLKELEELG 583
Query: 424 TKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRL- 482
+ SVE+L+ + L++ + L K EL+ E E + EL++ +L
Sbjct: 584 FE-SVEELE-ERLKELEPFYNEYLEL-KDAEKELEREEKELKKLEEELDKAFEELAETEK 640
Query: 483 QLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESL------LS 536
+L R + E L + +EE EL +E EL L A+ +E + L
Sbjct: 641 RLEELRKELEELEKKYSEEEYEELREEYLELSRELAGLRAELEELEKRREEIKKTLEKLK 700
Query: 537 NGKEREVDYKKSIDQLMKDREDLQQQINLLKEGK 570
E KK +++L K E +++ +K+ K
Sbjct: 701 EELEEREKAKKELEKLEKALERVEELREKVKKYK 734
|
Length = 880 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 6/196 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLD 627
G+G+Y V K ++ A+K + + N D E + HP ++ +
Sbjct: 4 GRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 63
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ L+ V EY+ + + R + L + H R+ ++ L+Y+H +++RD
Sbjct: 64 CFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+L+D IK+ D G+ + + + + T Y APEIL Y VD W
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWW 180
Query: 746 SLGCILAEMLQSKPLF 761
+LG ++ EM+ + F
Sbjct: 181 ALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 41/271 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILF 612
D +DL LKE G G +G+V Y K QY VAIK I E ++ + + ++
Sbjct: 2 DPKDL----TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMK 55
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQL 669
L H ++ + + + +Y+V EYM N L +R+ K + + + +
Sbjct: 56 LS----HEKLVQLYGV--CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV 109
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 723
C G++Y+ + + +HRDL N L+D +K+ D GL+R + D EY ++
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFP 164
Query: 724 -RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKP--LFPGASTSHQLQLIVNLVR 778
RW PE+L+ + +++ D+W+ G ++ E+ L P F + T ++ + L R
Sbjct: 165 VRW-SPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR 222
Query: 779 PNPPHADKFYAGFKS-----KHEREKFNQVV 804
P+ ++K YA S ER F Q++
Sbjct: 223 PHLA-SEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 569 GKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
G+G +G V Y N + VA+K + A +EI L++ H NI+
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLY-HENIVK 70
Query: 625 MLDIYKAVNNKD------LYVVF-------EYMENDLNKVIRDKILKDVHIRYIMFQLCN 671
YK + +D L + F EY+ + NK+ LK +Y + Q+C
Sbjct: 71 ----YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN----LKQQL-KYAV-QICK 120
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRA 728
G+ Y+ + + +HRDL N+L++ +KIGD GL +++ KE T + + ++ A
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 729 PEILISNRRYTHHVDIWSLGCILAEML 755
PE LI ++ Y D+WS G L E+L
Sbjct: 181 PECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 52/189 (27%), Positives = 90/189 (47%), Gaps = 32/189 (16%)
Query: 588 VAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFE 642
VA+K + + DA + R FLK + + PNII +L + + + L ++ E
Sbjct: 49 VAVKML------REDANKNARND-FLKEIKIMSRLKDPNIIRLLAV--CITSDPLCMITE 99
Query: 643 YMEN-DLNKVIRDKILKD------------VHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689
YMEN DLN+ + ++ + ++ Q+ +G+ Y+ + +HRDL
Sbjct: 100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159
Query: 690 NILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT---RWYRAPEILISNRRYTHHVDIWS 746
N L+ K+ +IKI D G++R+L + A RW IL+ ++T D+W+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWA 217
Query: 747 LGCILAEML 755
G L E+L
Sbjct: 218 FGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-11
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG G VY AYD + VA+KKI E N +R RE + + HP I+ +
Sbjct: 11 GKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAK-IAADLIHPGIVPVYS 69
Query: 628 IYKAVNNKDL-YVVFEYMENDLNKVI------RDKILKDVHIRY-------IMFQLCNGL 673
I ++ D Y Y+E K + ++ + K++ + I ++C +
Sbjct: 70 IC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT--------------- 718
Y+H+ V+HRDLKP NIL+ + I D G A +E L
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 719 ---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ + T Y APE L+ + DI++LG IL +ML
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
G G G+V K K + +A K +I A RN+ RE+ L P I+
Sbjct: 14 GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIVG 67
Query: 625 MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYI-HACKV 681
+ ++ ++ + E+M+ L++V+++ K + + + + + GL+Y+ ++
Sbjct: 68 FYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
MHRD+KPSNIL++ IK+ D G++ L DS ++ TR Y +PE L Y+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QGTHYSVQ 182
Query: 742 VDIWSLGCILAEM 754
DIWS+G L E+
Sbjct: 183 SDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 31/215 (14%)
Query: 567 KEGKGAYGIVYKA-YDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSFQRH 619
K G G +G V+ A Y+K+ K VA+K + EAF + + +K+ Q
Sbjct: 13 KLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEAN---------VMKTLQHD 61
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNGLSY 675
++ ++ V + +Y++ E+M L+ + D+ K + I F Q+ G+++
Sbjct: 62 ----KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILI 733
I +HRDL+ +NIL+ S KI D GLAR + D++ E +W APE I
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEA-I 175
Query: 734 SNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTS 767
+ +T D+WS G +L E++ + +PG S
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLS 674
R P I++ + +N ++ + E+M+ L+++ + I ++ + I + GL+
Sbjct: 61 RSPYIVSFYGAF--LNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLT 117
Query: 675 YIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 733
Y++ ++MHRD+KPSNIL++ IK+ D G++ L +S ++ T Y +PE I
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPE-RI 174
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFP----------GASTSHQLQLIVNLVRPNPPH 783
+YT D+WSLG + E+ K FP L L+ +V+ PP
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232
Query: 784 --ADKF 787
+ F
Sbjct: 233 LPSSDF 238
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-11
Identities = 103/558 (18%), Positives = 228/558 (40%), Gaps = 16/558 (2%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLK 79
Q EL+ +E +++LEE + +L E + E+ + + E+ L L L+
Sbjct: 225 QEEEELEQEIEALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLE 284
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVE 139
E + + + E +++ E + + + L+ E +L+ L + E++ E
Sbjct: 285 ELEEKIERLEELEREIEELEEELEGLRALLEELEELLEKLKSLEERLEKLEEKLEKLESE 344
Query: 140 LQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHR 199
L+ + L++ + L+ ++ + +A+ K+LE +Q L EL
Sbjct: 345 LEELAEEKNELAKLLEERLKELEERLEELEKELEKALERLKQLEEAIQELKEELAELSAA 404
Query: 200 ELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECA 259
++ E L E LE+ R E + ++ E + +++ ++C
Sbjct: 405 LEEIQE---ELEELEKELEELERELEELEEEIKKLEEQINQLESKELMIAELAGAGEKCP 461
Query: 260 SLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLL 319
EL +++E+ E + + +E + + EL++ + + +L E L
Sbjct: 462 VCGQELPEE---HEKELLELYELELEE-LEEELSREKEEAELREEIEELEKELRELEEEL 517
Query: 320 SNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQV------EQE 373
E E K+ +++ ++ E+L +++ LKE +L+Q E+ + L+ ++ +E
Sbjct: 518 IELLELEEALKEELEEKLEKLENLLEELEELKEKLQLQQLKEELRQLEDRLQELKELLEE 577
Query: 374 QAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQ- 432
+ + +L LK + ++L ++ L E +++E + + + + E+L+
Sbjct: 578 LRLLRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEAENELEEAEEELES 637
Query: 433 -MKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADS 491
+++L Q E E+ + +++E E R + +E E +L +
Sbjct: 638 ELEKLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLEEKLEELEQLEEEL 697
Query: 492 EALARSIAEETVGELEKEKTMKELE-LKDLMAKHRSDLSSKESLLSNGKEREVDYKKSID 550
E L + E E E+ ++ELE K + + + +L E L +E K+
Sbjct: 698 EQLREELEELLKKLGEIEQLIEELESRKAELEELKKELEKLEKALELLEELREKLGKAGL 757
Query: 551 QLMKDREDLQQQINLLKE 568
+ R L Q E
Sbjct: 758 RADILRNLLAQIEAEANE 775
|
Length = 908 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-10
Identities = 51/246 (20%), Positives = 100/246 (40%), Gaps = 14/246 (5%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
EL L R++ ++E+ QL ++ E + R L +++ LE+ + ++ +LKE +
Sbjct: 706 ELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELEEDLSSLEQEIENVKSELKELEA 765
Query: 84 RADNESETKKKAEVNLQVISDM--HEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQ 141
R + E K E L + H ++ ++L ++ + + EQ + L
Sbjct: 766 RIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQKLNRLT 825
Query: 142 NILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHREL 201
LE E LQ++ L+ +I + L G+ + L ELE +
Sbjct: 826 LEKEYLEKEIQELQEQRIDLKEQIKSIEKEI-------ENLNGKKEELEEELEELEAALR 878
Query: 202 QLAEDNRHLGEKVSSLEKECR-----LQALNTELERNKHRELQLAEDNRHLGEKVSSLEK 256
L L ++ LE + R ++ L ++E+ + R +L L E++S +E
Sbjct: 879 DLESRLGDLKKERDELEAQLRELERKIEELEAQIEKKRKRLSELKAKLEALEEELSEIED 938
Query: 257 ECASLS 262
Sbjct: 939 PKGEDE 944
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 569 GKGAYG-IVYKAYDKNNKQYVAIKKIFEAFR----NKTDAQRTYREILFLKSFQRHPNII 623
G G++G ++ Y + VAIK+ FE + + D + R+IL ++ HP +
Sbjct: 39 GTGSFGRVILATYKNEDFPPVAIKR-FEKSKIIKQKQVDHVFSERKIL---NYINHPFCV 94
Query: 624 TMLDIYKAVNNKDLYVVFEY-MENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACK 680
+ +K + LY+V E+ + + +R + DV Y Q+ Y+ +
Sbjct: 95 NLYGSFK--DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA-QIVLIFEYLQSLN 151
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
+++RDLKP N+L+DK IK+ D G A+ + L T Y APEIL+ N +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---GTPEYIAPEILL-NVGHGK 207
Query: 741 HVDIWSLGCILAEMLQSKPLF 761
D W+LG + E+L P F
Sbjct: 208 AADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-10
Identities = 65/239 (27%), Positives = 111/239 (46%), Gaps = 41/239 (17%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
K G G +G V+ K +++ K I + + + +Q E+ ++ +H NI+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMREL-KHKNIVRY 77
Query: 626 LDIYKAVNNKDLYVVFEYME-NDLNKVIRD--KILKDVH---IRYIMFQLCNGLSYIHAC 679
+D + N+ LY++ E+ + DL++ I+ K+ + I I QL + L+Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 680 K-------VMHRDLKPSNILIDKSCS-----------------IKIGDLGLARSL---SD 712
K V+HRDLKP NI + KIGD GL++++ S
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197
Query: 713 SKECLTEYIATRWYRAPEILI-SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770
+ C + T +Y +PE+L+ + Y D+W+LGCI+ E+ K F A+ QL
Sbjct: 198 AHSC----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 617
+LQ+ G+G +G V + + Q VA+K I + AQ E +
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLH 57
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-IRYIMFQL--CNGL 673
H N++ +L + + + LY+V E M + +L +R + V I+ + F L G+
Sbjct: 58 -HKNLVRLLGV---ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 733
Y+ + K++HRDL NIL+ + K+ D GLAR S + +W APE L
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKW-TAPEAL- 169
Query: 734 SNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 782
+++++ D+WS G +L E+ + +P S + + R PP
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 66/256 (25%), Positives = 107/256 (41%), Gaps = 56/256 (21%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
G GA+G V + A+K + +A RN+ + R+IL + + ++ +
Sbjct: 10 GIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL---AEADNEWVVKL 66
Query: 626 LDIYKAVNNKD-LYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
Y + +KD LY V +Y+ D+ + +IR I ++ R+ + +L + +H +
Sbjct: 67 ---YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSL----------------SDSKECLTEY------ 720
HRD+KP NILID+ IK+ D GL DS E E+
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 721 ---------------------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 759
+ T Y APE+L+ YT D WS+G IL EML +P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 760 LFPGASTSHQLQLIVN 775
F + + ++N
Sbjct: 243 PFLADTPAETQLKVIN 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 569 GKGAYGIVY---KAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNI 622
G GAYG V+ K + + A+K + +A + KT + T E L+ ++ P +
Sbjct: 9 GTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKT-VEHTRTERNVLEHVRQSPFL 67
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+T+ Y L+++ +Y+ + + + +R+ ++ L ++H
Sbjct: 68 VTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRRYT 739
+++RD+K NIL+D + + D GL++ LS+ KE + T Y APEI+ +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 740 HHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 782
VD WSLG ++ E+L + P + Q ++ +++ +PP
Sbjct: 186 KAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-10
Identities = 90/402 (22%), Positives = 164/402 (40%), Gaps = 66/402 (16%)
Query: 32 ERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESET 91
++RE+ +LEE +L Q E + +L++E+ LE L LR L+E +R+
Sbjct: 665 QKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQ------- 717
Query: 92 KKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMER 151
E+LK E +Q + EL+ L LE E
Sbjct: 718 --------------LEELKRELAALEEELEQLQSR----------LEELEEELEELEEEL 753
Query: 152 DTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLG 211
+ LQ+ + L+ ++ + + +ELE + QAL ELE EL+ AE
Sbjct: 754 EELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELE-ELEEELEEAER----- 807
Query: 212 EKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQ 271
RL AL ELE + R +L ++ L E++ LE++ L EL+ + +
Sbjct: 808 ----------RLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKE 857
Query: 272 YQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKK 331
++ EE + + EL+D + + + E L + + K+
Sbjct: 858 LEELKEELEELEAEKE------------ELEDELKELEEEKEELEEELRELESELAELKE 905
Query: 332 SIDQLMKDREDLQQQINLLKEGAELRQELEKS---KTLQSQVEQEQAKKFSLQSDLSVQT 388
I++L + E+L+ ++ L+ +E + TL++++E+E + L
Sbjct: 906 EIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTLETELEREIERLEEEIEALGPVN 965
Query: 389 SEA----AHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKR 426
A ++ R E+L + L EAK + E +L ++
Sbjct: 966 LRAIEEYEEVEERYEELKSQREDLEEAKEKLLEVIEELDKEK 1007
|
Length = 1163 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-10
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 52/200 (26%)
Query: 625 MLDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 681
++ +Y + +KD LY V +Y+ ++ +IR ++ +V R+ + +L + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLA---------------------------------- 707
+HRD+KP NILID IK+ D GL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 708 ------------RSLSDSKECLTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
R+ + CL + T Y APE+L+ + YT D WS+G IL EM
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEM 241
Query: 755 LQSKPLFPGAS-TSHQLQLI 773
L +P F + T QL++I
Sbjct: 242 LVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 569 GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FLKSFQRHPN 621
G GA+G VYK + K VAIK++ EA K + +EIL ++ + +P+
Sbjct: 16 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYVMASVDNPH 70
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
+ +L I + ++ + M D + +D I ++ Q+ G++Y+
Sbjct: 71 VCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-YLLNWCVQIAKGMNYLE 126
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWYRAPEILIS 734
+++HRDL N+L+ +KI D GLA+ L +D KE E + +W IL
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL-- 184
Query: 735 NRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 782
+R YTH D+WS G + E++ SKP + G S ++ R P PP
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 23/200 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FLKSFQRHPNIITM 625
G GA+G VYK + + V I + R T + + +EIL ++ + P + +
Sbjct: 16 GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 626 LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 681
L I + +V + M D + +D+I + + + Q+ G+SY+ ++
Sbjct: 75 LGI---CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV-QIAKGMSYLEEVRL 130
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY------IATRWYRAPEILISN 735
+HRDL N+L+ +KI D GLAR L D E TEY + +W IL +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDE--TEYHADGGKVPIKWMALESIL--H 185
Query: 736 RRYTHHVDIWSLGCILAEML 755
RR+TH D+WS G + E++
Sbjct: 186 RRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 15/222 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G V+ + + VA+K E A + +E LK + HPNI+ ++ +
Sbjct: 4 GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYS-HPNIVRLIGV 61
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ +Y+V E ++ D +R + LK + ++ G+ Y+ + +HRD
Sbjct: 62 --CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEILISNRRYTHHV 742
L N L+ + +KI D G++R D T + I +W APE L + RY+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL-NYGRYSSES 177
Query: 743 DIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPP 782
D+WS G +L E L + P + S + I VR P
Sbjct: 178 DVWSFGILLWEAFSLGAVP-YANLSNQQTREAIEQGVRLPCP 218
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 33/289 (11%)
Query: 569 GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
G GA+G VYK + K VAIK + E K + + E L + S HP+++
Sbjct: 16 GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPHLVR 73
Query: 625 MLDIYKAVNNKDLY------VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 678
+L + + + + + +Y+ +D I + + + + Q+ G+ Y+
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEH-----KDNIGSQLLLNWCV-QIAKGMMYLEE 127
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLTE--YIATRWYRAPEILISN 735
+++HRDL N+L+ +KI D GLAR L D KE + + +W I
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHY 185
Query: 736 RRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP--HADKFYAG 790
R++TH D+WS G + E++ KP + G T L+ R P PP D +
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 244
Query: 791 FK----SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSK 835
K R KF ++ + + ++ Q +V + ++KL DSK
Sbjct: 245 VKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSK 293
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 67/246 (27%), Positives = 101/246 (41%), Gaps = 60/246 (24%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
G GA+G V A + K A+K + + RN+ + R+IL + +
Sbjct: 10 GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE------WV 63
Query: 626 LDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ +Y + +KD LY V +Y+ ++ +IR I + R+ + +L + +H +
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLA---RSLSDSK------------------------- 714
HRD+KP NILID+ IK+ D GL R DSK
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 715 ------------------ECLTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
CL + T Y APE+L+ YT D WS+G IL EML
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEML 242
Query: 756 QSKPLF 761
+P F
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 34/185 (18%)
Query: 600 KTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR 653
+ DA + R FLK + + PNII +L + V+ L ++ EYMEN DLN+ +
Sbjct: 55 RPDANKNARND-FLKEVKILSRLKDPNIIRLLGV--CVDEDPLCMITEYMENGDLNQFLS 111
Query: 654 DKILKD---------------VHIRYIMF-----QLCNGLSYIHACKVMHRDLKPSNILI 693
L D I Y Q+ +G+ Y+ + +HRDL N L+
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171
Query: 694 DKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILISNRRYTHHVDIWSLGCI 750
++ +IKI D G++R+L + + RW IL+ ++T D+W+ G
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVT 229
Query: 751 LAEML 755
L E+L
Sbjct: 230 LWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V KN + A+K + +E R +T R R++L IT
Sbjct: 10 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV----NGDNQWITT 65
Query: 626 LDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
L Y + +LY+V +Y + DL ++ D++ +D+ R+ + ++ + +H
Sbjct: 66 LH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVIAIDSVHQLHY 123
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEILISNR---- 736
+HRD+KP NIL+D + I++ D G L + + + T Y +PEIL +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+Y D WSLG + EML + F S I+N
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 51/219 (23%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 569 GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
GKG +G V +A + + Q VA+K + + +D + RE +K F HPN+I +
Sbjct: 8 GKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKL 66
Query: 626 LDIYKAVNNKDL----YVVFEYMEN-DLNKVIRDKILKD--------VHIRYIMFQLCNG 672
+ + K V+ +M++ DL+ + + + +R+ M + +G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIASG 125
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIATRWYRAP 729
+ Y+ + +HRDL N +++++ ++ + D GL++ + ++ + +W A
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL-AL 184
Query: 730 EILISNRRYTHHVDIWSLGCILAE-MLQSKPLFPGASTS 767
E L N YT H D+W+ G + E M + + + G S
Sbjct: 185 ESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-10
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 11/177 (6%)
Query: 619 HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYI 676
HP ++ +LD+ + V V+ +Y +DL + R + L + + QL + + YI
Sbjct: 219 HPAVLALLDV-RVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI 276
Query: 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IA-TRWYRAPEILIS 734
H ++HRD+K N+L++ I +GD G A S Y IA T APE+L
Sbjct: 277 HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336
Query: 735 NRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQL---IVNLVRPNPPHADKF 787
+ YT VDIWS G ++ E + + LF + + I+ ++R H D+F
Sbjct: 337 D-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392
|
Length = 461 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 569 GKGAYGIVYK--AYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILF-----LKSFQR 618
G GA+G V + AY + VA+K + K A + RE L +
Sbjct: 44 GAGAFGKVVEATAYGLSKSDAVMKVAVKML------KPTAHSSEREALMSELKIMSHLGN 97
Query: 619 HPNIITMLDIYKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGL 673
H NI+ +L + V+ EY + N L + R+ L + +Q+ G+
Sbjct: 98 HENIVNLLG--ACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGM 154
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECL--TEYIATRWYRAPE 730
+++ + +HRDL N+L+ +KI D GLAR ++DS + + +W APE
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE 213
Query: 731 ILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+ + YT D+WS G +L E+ L S P +PG
Sbjct: 214 SIFNC-VYTFESDVWSYGILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG +G V+K K+ K VA+K E + + E LK + HPNI+ ++ +
Sbjct: 4 GKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKI-KFLSEARILKQYD-HPNIVKLIGV 60
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ +Y+V E + D +R K LK + G++Y+ + +HRD
Sbjct: 61 --CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILISNRRYTHHV 742
L N L+ ++ +KI D G++R D S L + I +W APE L + RY+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-IPIKW-TAPEAL-NYGRYSSES 175
Query: 743 DIWSLGCILAE 753
D+WS G +L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V KN Q A+K + +E R +T R R++L + IT
Sbjct: 10 GRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR----WITN 65
Query: 626 LDIYKAVNNKDLYVVFEY-MENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKV 681
L Y + +LY+V +Y + DL ++ D++ +D+ R+ + ++ + +H
Sbjct: 66 LH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVLAIDSVHQLGY 123
Query: 682 MHRDLKPSNILIDKSCSIKIGDLG-LARSLSDSKECLTEYIATRWYRAPEILISNR---- 736
+HRD+KP N+L+DK+ I++ D G R L+D + T Y +PEIL +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
RY D WSLG + EML + F S I+N
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 569 GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
G+ +G VYK + Q VAIK + + + + + ++ ++S +HPNI+
Sbjct: 14 GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD--KAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 624 TMLD----------IYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDV----HIRYIMF 667
+L I+ ++ DL ++V +D+ DK +K +I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIATR 724
Q+ G+ ++ + V+H+DL N+L+ ++KI DLGL R + + K + R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769
W +PE ++ +++ DIWS G +L E+ S L P S+Q
Sbjct: 192 WM-SPEAIMYG-KFSIDSDIWSYGVVLWEVF-SYGLQPYCGYSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-10
Identities = 75/362 (20%), Positives = 146/362 (40%), Gaps = 29/362 (8%)
Query: 223 LQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEET 282
+ E+E + + +L E L + ++ L KE L EL+ + + ++ R
Sbjct: 672 ILERRREIEELEEKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISAL 731
Query: 283 QKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKS----IDQLMK 338
+K + + EA VE ++E ++K ++L ++ L E + I++L
Sbjct: 732 RKD--LARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEA 789
Query: 339 DREDLQQQINLLKEG-----AELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAH 393
E L++++ L+E AEL E++ L+ ++E + + + + L +
Sbjct: 790 QIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEE 849
Query: 394 LKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQ 453
L E L+ E+ L E +E E L +R+ + + L+ +LE +
Sbjct: 850 LSEDIESLAAEIEELEELIEELESELEALLNERASLEEALALLRSELEELS-------EE 902
Query: 454 AHELKEELDERSRNILELEEERGDLTHRLQLAVARADS--EALAR--SIAEETVGELEKE 509
EL+ + E R + EL E+ L RL+ R D+ E L+ S+ E LE +
Sbjct: 903 LRELESKRSELRRELEELREKLAQLELRLEGLEVRIDNLQERLSEEYSLTLEEAEALENK 962
Query: 510 KTMKELELKDLMAKHRSDLSS-------KESLLSNGKEREVDYKKSIDQLMKDREDLQQQ 562
E E + + + + + KER + L + +E L++
Sbjct: 963 IEDDEEEARRRLKRLENKIKELGPVNLAAIEEYEELKERYDFLTAQKEDLTEAKETLEEA 1022
Query: 563 IN 564
I
Sbjct: 1023 IE 1024
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-09
Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 570 KGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITML 626
+GA+G VY KNN + A+K + +A +N + R+ L L + P I+ +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL---SKSPFIVHLY 70
Query: 627 DIYKAVNNKDLYVVFEYM-ENDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
++ NN +Y+V EY+ D+ + I +++ ++YI ++ L Y+H ++H
Sbjct: 71 YSLQSANN--VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHGIIH 127
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723
RDLKP N+LI IK+ D GL++ + + + + + T
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 63/250 (25%), Positives = 121/250 (48%), Gaps = 52/250 (20%)
Query: 560 QQQINLLKE-GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREIL-- 611
+++I LL+E G+G++G+VY+ ++ + VA+K + N++ + R E L
Sbjct: 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-----NESASLRERIEFLNE 59
Query: 612 --FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-------------K 655
+K F H +++ +L + + VV E M + DL +R
Sbjct: 60 ASVMKGFTCH-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 656 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715
L++ + + ++ +G++Y++A K +HRDL N ++ ++KIGD G+ R + +
Sbjct: 117 TLQE--MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--- 171
Query: 716 CLTEY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAS 765
T+Y + RW APE L + +T D+WS G +L E+ L +P + G S
Sbjct: 172 --TDYYRKGGKGLLPVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLS 226
Query: 766 TSHQLQLIVN 775
L+ +++
Sbjct: 227 NEQVLKFVMD 236
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V K+ ++ A+K + +E R +T R R +L Q IT
Sbjct: 10 GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ----WITT 65
Query: 626 LDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
L Y + LY+V +Y + DL ++ D++ +D+ R+ + ++ + IH
Sbjct: 66 LH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIAEMVLAIHSIHQLHY 123
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEILISNR---- 736
+HRD+KP N+L+D + I++ D G ++ + + T Y +PEIL +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+Y D WSLG + EML + F S I+N
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 6/210 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V A K + + A+K + + D + T E L + HP + +
Sbjct: 4 GKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYC 63
Query: 628 IYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + L+ V E++ DL + + + + R+ ++ + L ++H +++RD
Sbjct: 64 CFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+L+D K+ D G+ + + + + + T Y APEIL Y VD W
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL-QEMLYGPSVDWW 180
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
++G +L EML F + + I+N
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-09
Identities = 66/364 (18%), Positives = 144/364 (39%), Gaps = 21/364 (5%)
Query: 218 EKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVR 277
E E +L+ LER + +L + L + E L EL+ +
Sbjct: 176 EAERKLERTEENLERLEDLLEELEKQLEKLERQAEKAE-RYQELKAELRELELALLLAKL 234
Query: 278 AHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLM 337
+ + + E ++EL++ + + ++ +S L +E + ++ + +L
Sbjct: 235 KELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELK 294
Query: 338 KDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAR 397
++ E+L+ +I+LL+E L + + + L+ ++E+ + K +L+ +L + + L+
Sbjct: 295 EEIEELEGEISLLRE--RLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQL 352
Query: 398 EEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHEL 457
+L L E + EE + + L+++L + + + EL
Sbjct: 353 LAELEEAKEELEEKLSALLEE----------LEELFEALREELAELEAELAEIRNELEEL 402
Query: 458 KEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELEL 517
K E++ + L E DL L+ A + E + ELE++ L
Sbjct: 403 KREIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRL 462
Query: 518 KDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE----GKGAY 573
K+L +L+ + L ++ + +D+L ++ Q +L+ G Y
Sbjct: 463 KEL----ERELAELQEELQRLEKELSSLEARLDRLEAEQRASQGVRAVLEALESGLPGVY 518
Query: 574 GIVY 577
G V
Sbjct: 519 GPVA 522
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-09
Identities = 63/287 (21%), Positives = 120/287 (41%), Gaps = 21/287 (7%)
Query: 54 SARETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEA 113
A LR+ + L++ L+ L+ +L+ + R D S+ A + I E+L+ E
Sbjct: 673 PAELQRLRERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEE 732
Query: 114 ETATRLRKQSAE----LTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQER 169
E ++ E L + + EL+ + LE + L++ + L+A++S R
Sbjct: 733 EKLKERLEELEEDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSR 792
Query: 170 SSKTQAV-----NLHKELEGRLQALNTELERNKHRELQLAED--------NRHLGEKVSS 216
+ QA +E RL+ + +L R E + E L E++ S
Sbjct: 793 IPEIQAELSKLEEEVSRIEARLREIEQKLNR-LTLEKEYLEKEIQELQEQRIDLKEQIKS 851
Query: 217 LEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEV 276
+EKE ++ LN + E + +L R L ++ L+KE L +L+ + + +E+
Sbjct: 852 IEKE--IENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLRELE-RKIEEL 908
Query: 277 RAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGK 323
A E ++ R+ + + +EL ++ D E LS
Sbjct: 909 EAQIEKKRKRLSELKAKLEALEEELSEIEDPKGEDEEIPEEELSLED 955
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 42/218 (19%)
Query: 569 GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQRHPNI 622
G+ A+G +YK + ++ Q VAIK + ++ + Q+ +++ L + HPNI
Sbjct: 14 GECAFGKIYKGHLYLPGMDHAQLVAIKTL----KDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 623 ITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-------------------- 661
+ +L + + + ++FEY+ + DL++ + I++ H
Sbjct: 70 VCLLGV--VTQEQPVCMLFEYLNQGDLHEFL---IMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 662 -IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE- 719
+I Q+ G+ Y+ + +H+DL NILI + +KI DLGL+R + + +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 720 --YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ RW PE ++ +++ DIWS G +L E+
Sbjct: 185 KSLLPIRWM-PPEAIMYG-KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-09
Identities = 85/375 (22%), Positives = 167/375 (44%), Gaps = 36/375 (9%)
Query: 31 RERREM-------SQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
ERR++ S+ +ER+ + + E L D + +LEK L L E
Sbjct: 155 EERRKLIEEAAGVSKYKERKEEAERKLERTEENLERLEDLLEELEKQLEKLERQ-AEKAE 213
Query: 84 RADNESETKKKAEVNLQV--ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQ 141
R ++ E+ L + + ++ ++L+ E +RL ++ EL E+ + EL+
Sbjct: 214 RYQELKAELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELK 273
Query: 142 NILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHREL 201
+ L L E + LQ+E+ L+ +I +ELEG + L LE ++
Sbjct: 274 SELEELREELEELQEELLELKEEI--------------EELEGEISLLRERLEELENELE 319
Query: 202 QLAEDNRHLGEKVSSLEKE-----CRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEK 256
+L E L EK+ +L++E L+ L L + + +L E L E++ L +
Sbjct: 320 ELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFE 379
Query: 257 ECASLSLELKAAQAQYQQEVRAHE------ETQKSRMVNKEEASVEIVKELKDLMAKHRS 310
EL+A A+ + E+ + E + R+ + E E +KEL+ + + ++
Sbjct: 380 ALREELAELEAELAEIRNELEELKREIESLEERLERLSERLEDLKEELKELEAELEELQT 439
Query: 311 DLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-NLLKEGAELRQELEKSKTLQSQ 369
+L L +E+ + + + +L ++ +LQ+++ L KE + L L++ + Q
Sbjct: 440 ELEELNEELEELEEQLEELRDRLKELERELAELQEELQRLEKELSSLEARLDRLEAEQRA 499
Query: 370 VEQEQAKKFSLQSDL 384
+ +A +L+S L
Sbjct: 500 SQGVRAVLEALESGL 514
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-09
Identities = 67/379 (17%), Positives = 155/379 (40%), Gaps = 45/379 (11%)
Query: 89 SETKKKAEVNLQVISDMHEKLKTEAETATR-----LRKQSAELTVAKSAGEQMVVELQNI 143
E ++ ++ + E+L+ E E A R K+ E E + + + I
Sbjct: 183 EENIERLDLIIDEKRQQLERLRREREKAERYQALLKEKREYEGYELLKEKEALERQKEAI 242
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQL 203
+ +L++E+ L +IS+ + L +EL +++ L E +L++
Sbjct: 243 ER----QLASLEEELEKLTEEISELEKRLEEIEQLLEELNKKIKDLGEE------EQLRV 292
Query: 204 AEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSL 263
E L +++SLE+ + ELE + R +L + L ++ LE+E
Sbjct: 293 KEKIGELEAEIASLERS--IAEKERELEDAEERLAKLEAEIDKLLAEIEELEREIEEERK 350
Query: 264 ELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGK 323
E ELK+ + R++L + + +
Sbjct: 351 RRDKLT--------------------------EEYAELKEELEDLRAELEEVDKEFAETR 384
Query: 324 EREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSD 383
+ DY++ +++L ++ +L+++++ L+E EL++ E+ L + + +AK L+ +
Sbjct: 385 DELKDYREKLEKLKREINELKRELDRLQE--ELQRLSEELADLNAAIAGIEAKINELEEE 442
Query: 384 LSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETE 443
+ E + + EQL+ +++ + +++EEY +++ + S ++ E + Q
Sbjct: 443 KEDKALEIKKQEWKLEQLAADLSKYEQELYDLKEEYDRVEKELSKLQRELAEAEAQARAS 502
Query: 444 QYFSTLYKTQAHELKEELD 462
+ + LK +
Sbjct: 503 EERVRGGRAVEEVLKASIQ 521
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECL--TEYIATR 724
Q+ G+SY+H V+H+D+ N +ID+ +KI D L+R L CL E +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEM 754
W A E L+ N+ Y+ D+WS G +L E+
Sbjct: 185 WM-ALESLV-NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 50/244 (20%), Positives = 100/244 (40%), Gaps = 28/244 (11%)
Query: 569 GKGAYGIVYKA---YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G +G V + D ++ VA+K + ++ + E +K F HPN++ +
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKL 66
Query: 626 LDIYKAVNNKDL------YVVFEYMEN-DLNKVIRDKILKDVHIRY-------IMFQLCN 671
+ + L V+ +M++ DL+ + L + + M +
Sbjct: 67 IGV--CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---TRWYRA 728
G+ Y+ +HRDL N ++ + ++ + D GL++ + IA +W A
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-A 183
Query: 729 PEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPN-PPHA-D 785
E L ++R YT D+W+ G + E+ + + +PG + + R P D
Sbjct: 184 IESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD 242
Query: 786 KFYA 789
+ Y
Sbjct: 243 ELYD 246
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 569 GKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G+G +G V +A K K AIK + E F ++ D + E+ L HPNII +L
Sbjct: 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 627 DIYKAVNNKDLYVVFEYME--NDLNKVIRDKILK----------------DVHIRYIMFQ 668
+ N LY+ EY N L+ + + ++L+ +
Sbjct: 70 GACE--NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+ G+ Y+ + +HRDL N+L+ ++ + KI D GL+R + + RW
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAI 187
Query: 729 PEILISNRRYTHHVDIWSLGCILAEML 755
+ S YT D+WS G +L E++
Sbjct: 188 ESLNYS--VYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-09
Identities = 72/314 (22%), Positives = 127/314 (40%), Gaps = 36/314 (11%)
Query: 17 NGGQANGELKDL-LERERREMSQ-LEERQRQLSEQYEAVSARETALRDEMGQLEKNLTIL 74
GG A L RE E+ + +EE + +++E +A+ LR E+ +LE+ L L
Sbjct: 662 TGGSAKTNSSILERRREIEELEEKIEELEEKIAELEKAL----AELRKELEELEEELEQL 717
Query: 75 RHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGE 134
R +L+E R+ + + E +++ E +L K+ EL E
Sbjct: 718 RKELEELSRQISALRKDLARLE----------AEVEQLEERIAQLSKELTELEAEIEELE 767
Query: 135 QMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELE 194
+ + E + LA E E + L+ ++ L+ ++ R + EL L LN E
Sbjct: 768 ERLEEAEEELAEAEAEIEELEAQIEQLKEELKALREA-------LDELRAELTLLNEEAA 820
Query: 195 RNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSL 254
+ R L E RL+ L ++E LA + L E + L
Sbjct: 821 NLRERLESLERRIA---------ATERRLEDLEEQIEELSEDIESLAAEIEELEELIEEL 871
Query: 255 EKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEI---VKELKDLMAKHRSD 311
E E +L L +A+ + +R+ E + E E+ ++EL++ +A+
Sbjct: 872 ESELEAL-LNERASLEEALALLRSELEELSEELRELESKRSELRRELEELREKLAQLELR 930
Query: 312 LSSKESLLSNGKER 325
L E + N +ER
Sbjct: 931 LEGLEVRIDNLQER 944
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 44/250 (17%)
Query: 563 INLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 616
I LL+ G GA+G VY+ + VA+K + E+ + ++ E L + F
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKF 66
Query: 617 QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH--------IRYIMF 667
H NI+ ++ + + +++ E M DL +R+ + + +
Sbjct: 67 -NHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEY-- 720
+ G Y+ +HRD+ N L+ +C KI D G+AR + + Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLL--TCKGPGRVAKIADFGMARDIYRA-----SYYR 176
Query: 721 ------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQL 772
+ +W PE + +T D+WS G +L E+ L P +PG + ++
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVMEF 233
Query: 773 IVNLVRPNPP 782
+ R +PP
Sbjct: 234 VTGGGRLDPP 243
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 14/195 (7%)
Query: 569 GKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +G V K Y KQ K+ + K+ RE + +P I+ M+
Sbjct: 4 GSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIG 62
Query: 628 IYKAVNNKDLYVVFEYME-NDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ +A L +V E LNK + +D+I ++ +M Q+ G+ Y+ +H
Sbjct: 63 VCEAEA---LMLVMEMASGGPLNKFLSGKKDEITVS-NVVELMHQVSMGMKYLEGKNFVH 118
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRYTH 740
RDL N+L+ KI D GL+++L A +W + APE I+ R+++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC-INFRKFSS 177
Query: 741 HVDIWSLGCILAEML 755
D+WS G + E
Sbjct: 178 RSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-08
Identities = 75/345 (21%), Positives = 152/345 (44%), Gaps = 22/345 (6%)
Query: 20 QANGELKDLLERERR---EMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRH 76
+ EL +L + + E+ L+ R L + E + + L ++ +L++ L L
Sbjct: 671 ELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEE 730
Query: 77 DLKESQRRADNESETKKKAEVNL----QVISDMHEKLKTEAETATRLRKQSAELTVAKSA 132
+L++ Q R + E ++ E L + + ++ E+L++ E +L+++ EL + A
Sbjct: 731 ELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQA 790
Query: 133 GEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTE 192
++ + EL+ L E D L++E+ +L+ + + + +ELE +L L E
Sbjct: 791 LQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEE 850
Query: 193 LERNKHRELQLAEDNRHLGEKVSSLEKEC-----RLQALNTELERNKHRELQLAEDNRHL 247
LE + +L E+ L + LE E + L EL + +L E+ L
Sbjct: 851 LEELEKELEELKEELEELEAEKEELEDELKELEEEKEELEEELRELESELAELKEEIEKL 910
Query: 248 GEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAK 307
E++ LE + L +EL + + ++E ET+ R + + E +E + + +L A
Sbjct: 911 RERLEELEAKLERLEVELPELEEELEEEYEDTLETELEREIERLEEEIEALGPV-NLRAI 969
Query: 308 HRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 352
+ +ER + K + L + +E L + I L +
Sbjct: 970 EEYE---------EVEERYEELKSQREDLEEAKEKLLEVIEELDK 1005
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-08
Identities = 50/268 (18%), Positives = 122/268 (45%), Gaps = 8/268 (2%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARET-ALRDEMGQLEKNLTILRHDLKESQ 82
+L + + + + ++E+ +L+++ + + E +++++G+LE + L + E +
Sbjct: 255 KLTEEISELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIAEKE 314
Query: 83 RRADNESETKKKAEVNLQVISDMHEKLKTEAET-ATRLRKQSAELTVAKSAGEQMVVELQ 141
R ++ E K E + + E+L+ E E R K + E K E + EL+
Sbjct: 315 RELEDAEERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELE 374
Query: 142 NI---LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKH 198
+ A E ++++ L+ +I++ + + + L L LN + +
Sbjct: 375 EVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEA 434
Query: 199 RELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 258
+ +L E+ ++ ++E +L+ L +L + + L E+ + +++S L++E
Sbjct: 435 KINELEEEKEDKALEIK--KQEWKLEQLAADLSKYEQELYDLKEEYDRVEKELSKLQREL 492
Query: 259 ASLSLELKAAQAQYQQEVRAHEETQKSR 286
A + +A++ + + RA EE K+
Sbjct: 493 AEAEAQARASE-ERVRGGRAVEEVLKAS 519
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 569 GKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G+G +G V KA K + + AIK++ E + +K D + E+ L HPNII +L
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 627 DIYKAVNNKDLYVVFEYME--NDLNKVIRDKILK----------------DVHIRYIMFQ 668
+ + LY+ EY N L+ + + ++L+ + +
Sbjct: 63 GACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+ G+ Y+ + +HRDL NIL+ ++ KI D GL+R + + RW
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 180
Query: 729 PEILISNRRYTHHVDIWSLGCILAEML 755
+ S YT + D+WS G +L E++
Sbjct: 181 ESLNYS--VYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 547 KSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQR 605
KS+ +L++ ++ + L K G +G V K K +V +KI +A +
Sbjct: 4 KSLSELVQFLKNCEIVKKL-KLIDGKFGKVSVLKHKPTQKLFV--QKIIKA--------K 52
Query: 606 TYREILFL--KSFQRHPNIITMLDIYKAVNN-KDLYVVFEYM-ENDLNKVIR-DKILKDV 660
+ I + + + +PN I + Y +V K ++ +Y+ + DL +++ + L +
Sbjct: 53 NFNAIEPMVHQLMKDNPNFIKL---YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA 109
Query: 661 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTE 719
++ I+ QL L+ +H ++H D+K N+L D++ I + D GL + + C
Sbjct: 110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSC--- 165
Query: 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
Y T Y +PE I Y D W++G + E+L
Sbjct: 166 YDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELL 200
|
Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/242 (23%), Positives = 119/242 (49%), Gaps = 38/242 (15%)
Query: 560 QQQINLLKE-GKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREIL-- 611
+++I + +E G+G++G+VY+ K + VAIK + N+ + R E L
Sbjct: 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-----NEAASMRERIEFLNE 59
Query: 612 --FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDV 660
+K F H +++ +L + + V+ E M DL +R + +
Sbjct: 60 ASVMKEFNCH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 661 HIRYIM---FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---K 714
++ ++ ++ +G++Y++A K +HRDL N ++ + ++KIGD G+ R + ++ +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQL 772
+ + RW +PE L + +T + D+WS G +L E+ L +P + G S L+
Sbjct: 177 KGGKGLLPVRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRF 233
Query: 773 IV 774
++
Sbjct: 234 VM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-08
Identities = 99/574 (17%), Positives = 211/574 (36%), Gaps = 37/574 (6%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLK 79
+ L + + R ++ L ER L Q E + A+ L ++ +L + L L L+
Sbjct: 288 KELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLE 347
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATR--------LRKQSAELTVAKS 131
E + ++ ++ E L+ + E+L+ + ET + + E+ ++
Sbjct: 348 ELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEA 407
Query: 132 AGEQMVVELQNILATLEMERDTLQ-QEVATLQAKISQERSSKTQAVNLHKELEGRLQALN 190
E++ + + +E L+ E+ LQA++ + + + LE L+ L
Sbjct: 408 RLERLEDRRERLQQEIEELLKKLEEAELKELQAELEELEEELEELQEELERLEEALEELR 467
Query: 191 TELERNKHRELQLAEDNRHLGEKVSSLEK-ECRLQALNTELERNKHRELQLAEDNRHLGE 249
ELE + + L ++ SLE+ + L+ + ++ + L+ L E
Sbjct: 468 EELEEAEQALDAAERELAQLQARLDSLERLQENLEGFSEGVKALLKNQSGLSGILGVLSE 527
Query: 250 KVSSLEKECASLSLELKAAQAQY----QQEVRAHEETQKSRMVNKEEASVEIVKELKDLM 305
+S E A++ L + K + + + ++
Sbjct: 528 LISVDEGYEAAIEAALGGRLQAVVVENLNAAKKAIAFLKQNELGRVTFLPLDSIKGTEIQ 587
Query: 306 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDR-------EDLQQQINLLKE-GAELR 357
R L + E L K+ V + + + + +DL + L K+ R
Sbjct: 588 GNDREILKNIEGFLGVAKDL-VKFDPKLRKALSYLLGGVLVVDDLDNALELAKKLRPGYR 646
Query: 358 ------QELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREA 411
+ + + + + ++ + L+ + +L +A LR+
Sbjct: 647 IVTLDGDLVRPGGVITGGSAKTNSSILERRREIEELEEKIEELEEKIAELEKALAELRKE 706
Query: 412 KRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILEL 471
+EEE +L+ + Q+ L+ L + + + +L +EL E I EL
Sbjct: 707 LEELEEELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEEL 766
Query: 472 EEERGDLTHRLQLAVARADSEALARSI--AEETVGELEKEKTMKELELKDLMAKHRSDLS 529
EE + +LA A A+ E L I +E + L + EL L + +
Sbjct: 767 EERLEEA--EEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLL----NEEAA 820
Query: 530 SKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI 563
+ L + + R ++ ++ L + E+L + I
Sbjct: 821 NLRERLESLERRIAATERRLEDLEEQIEELSEDI 854
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 48/280 (17%)
Query: 571 GAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQRHPNIITMLDI 628
GA G + D ++V IK QR T E L++ HP+II +
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA----------GQRGGTATEAHILRAIN-HPSIIQLKGT 151
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687
+ NK ++ + DL + K + I I + + Y+H +++HRD+K
Sbjct: 152 F--TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK 209
Query: 688 PSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIATRWY--------RAPEILISNRRY 738
NI I+ + +GD G A C + A ++Y APE+L + Y
Sbjct: 210 AENIFINHPGDVCLGDFGAA--------CFPVDINANKYYGWAGTIATNAPELLARD-PY 260
Query: 739 THHVDIWSLGCILAEM-------LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791
VDIWS G +L EM + L + Q++LI +R + H ++F
Sbjct: 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI---IRRSGTHPNEFPIDA 317
Query: 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQME 831
++ + + +K ++ S+ + N +L + +E
Sbjct: 318 QANLDE----IYIGLAKKSSRKPGSRPLWTNLYELPIDLE 353
|
Length = 391 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-08
Identities = 117/484 (24%), Positives = 204/484 (42%), Gaps = 65/484 (13%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
EL++ LE ER ++ E+ + LS + E +S R L+E+
Sbjct: 50 ELEEELEAERAARAKAEKARADLSRELEELSER---------------------LEEAGG 88
Query: 84 RADNESETKKKAEVNLQVI-SDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQN 142
+ E KK E L + D+ E E LRK+ + EQ + +LQ
Sbjct: 89 ATAAQIELNKKREAELAKLRKDLEEANLQHEEALATLRKKHQD--AINELSEQ-IEQLQK 145
Query: 143 ILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQ 202
A E E+ LQ EV L A++ Q +K A K+LE +L L +L+
Sbjct: 146 QKAKAEKEKSQLQAEVDDLLAQLDQIAKAKLNAEKKAKQLESQLSELQVKLD-------- 197
Query: 203 LAEDNRHLGEKVSSLEKECRLQALNTELERNKH-RELQLAEDNRHLGEKVSSLE------ 255
E R L + S RLQ+ N++L R E Q++ ++ + S LE
Sbjct: 198 --ELQRQLNDLTSQKS---RLQSENSDLTRQLEEAEAQVSNLSKLKSQLESQLEEAKRSL 252
Query: 256 ----KECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSD 311
+E A+L +L+ + EE +++ E + E++ +K S+
Sbjct: 253 EEESRERANLQAQLRQLEHDLDSLREQLEEESEAK-AELERQLSKANAEIQQWRSKFESE 311
Query: 312 LSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL-KEGAELRQELEKSKTLQSQV 370
+ + L K++ + I +L + E + + L K + L+ ELE LQ ++
Sbjct: 312 GALRAEELEELKKK---LNQKISELEEAAEAANAKCDSLEKTKSRLQSELE---DLQIEL 365
Query: 371 EQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVED 430
E+ A L+ A K + ++L E+ + RN+ E +LK
Sbjct: 366 ERANAAASELEKKQKNFDKILAEWKRKVDELQAELDTAQREARNLSTELFRLKN------ 419
Query: 431 LQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTH-RLQLAVARA 489
+++EL+DQ+E + + + + H+L ++L E RN+ ELE+ R L + +L A
Sbjct: 420 -ELEELKDQVEALRRENKNLQDEIHDLTDQLGEGGRNVHELEKARRRLEAEKDELQAALE 478
Query: 490 DSEA 493
++EA
Sbjct: 479 EAEA 482
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 556 REDLQQQINLLKEGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREIL 611
R +LQ+ L G+G +G V+ A K + + + K + +++ RE+
Sbjct: 4 RSNLQEITTL---GRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKD-LYVVFEYME-NDLNKVIRDKILKD---------- 659
+ H N++ +L + + Y++ EY + DL + +R KD
Sbjct: 61 MFRKLS-HKNVVRLLGL---CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 660 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-- 717
+ Q+ G+ ++ + +HRDL N L+ +K+ L L++ + +S+
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGAS 765
I RW APE + + ++ D+WS G ++ E+ L F G S
Sbjct: 177 NALIPLRWL-APEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-08
Identities = 77/385 (20%), Positives = 163/385 (42%), Gaps = 52/385 (13%)
Query: 99 LQVISDMHEKLKTEAETA----TRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTL 154
LQ + + E LK E + R+ + EL+ S + + E++ + LE E + L
Sbjct: 676 LQRLRERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKL 735
Query: 155 QQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLG-EK 213
++ + L+ +S + KELE R++ L +L + E L + L +
Sbjct: 736 KERLEELEEDLSSLEQEIENVKSELKELEARIEELEEDLHK---LEEALNDLEARLSHSR 792
Query: 214 VSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQ 273
+ ++ E L L E+ R + R + +E++ L+LE + + + Q
Sbjct: 793 IPEIQAE--LSKLEEEVSRIEAR--------------LREIEQKLNRLTLEKEYLEKEIQ 836
Query: 274 QEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSI 333
+ + ++ I KE+++L K E L + D + +
Sbjct: 837 ELQEQRIDLKEQI--------KSIEKEIENLNGK----KEELEEELEELEAALRDLESRL 884
Query: 334 DQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAH 393
L K+R++L+ A+LR+ K + L++Q+E+++ + L++ L E +
Sbjct: 885 GDLKKERDELE---------AQLRELERKIEELEAQIEKKRKRLSELKAKLEALEEELSE 935
Query: 394 L---KAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLY 450
+ K +E++ E L + + ++ + R++E + M +Q+ E + L
Sbjct: 936 IEDPKGEDEEIPEEELSLEDVQAELQR---VEEEIRALEPVNMLAIQEYEEVLKRLDELK 992
Query: 451 KTQAHELKEELDERSRNILELEEER 475
+ +A +L+EE I E E+++
Sbjct: 993 EKRA-KLEEERKAILERIEEYEKKK 1016
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 8/102 (7%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL---TEYIAT 723
FQ+ G+ ++ + K +HRDL NIL+ ++ +KI D GLAR + + + + +
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+W APE I ++ YT D+WS G +L E+ L + P +PG
Sbjct: 241 KWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-08
Identities = 64/354 (18%), Positives = 158/354 (44%), Gaps = 35/354 (9%)
Query: 231 ERNKHRELQLAEDNRHL---GEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRM 287
ER K E +L +L + ++ LE++ SL + + A+ +Y++ E + + +
Sbjct: 172 ERRKETERKLERTRENLDRLEDILNELERQLKSLERQAEKAE-RYKELKAELRELELALL 230
Query: 288 VNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI 347
V + E E ++EL++ + + +L + L E +++ + +++ + Q+
Sbjct: 231 VLRLEELREELEELQEELKEAEEELEELTAEL-QELEEKLEELRLEVSELEEEIEELQKE 289
Query: 348 NLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAM 407
L E+ + L+ Q + + + +L+ L ++ L+++ ++L+ E+A
Sbjct: 290 LY-----ALANEISR---LEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAE 341
Query: 408 LREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN 467
L E ++EE ++ L+ +LE + +++ EL+E+L+
Sbjct: 342 LEEKLEELKEE--------------LESLEAELEELEAELEELESRLEELEEQLETLRSK 387
Query: 468 ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL--------ELKD 519
+ +LE + L + ++ AR + R ++ + EL K+ EL EL++
Sbjct: 388 VAQLELQIASLNNEIERLEARLERLEDRRERLQQEIEELLKKLEEAELKELQAELEELEE 447
Query: 520 LMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAY 573
+ + + +L E L +E + ++++D ++ LQ +++ L+ +
Sbjct: 448 ELEELQEELERLEEALEELREELEEAEQALDAAERELAQLQARLDSLERLQENL 501
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 51/227 (22%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 569 GKGAYGIVY---KAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSFQRHPN 621
G GAYG V+ K ++ + A+K + +A T+ RT R++L + ++ P
Sbjct: 9 GTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL--EHIRQSPF 66
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
++T+ Y + L+++ +Y+ + + + K+ ++ ++ L ++H
Sbjct: 67 LVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRR- 737
+++RD+K NIL+D + + + D GL++ D E + T Y AP+I+
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 738 YTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH 783
+ VD WS+G ++ E+L + P + Q ++ +++ PP+
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-08
Identities = 33/105 (31%), Positives = 59/105 (56%), Gaps = 7/105 (6%)
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIA 722
+ Q+ + ++H+ ++HRD+K +NIL+ + +K+GD G ++ + S + +
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 723 TRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGAS 765
T +Y APEI RR Y+ D++SLG +L E+L K F G +
Sbjct: 208 TPYYVAPEIW---RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 31/166 (18%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 723
+Q+ NG+ ++ + +HRDL N+LI + +KI D GLAR + +++ ++
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
+W APE I N YT D+WS G +L E +F T + P P
Sbjct: 306 KWM-APES-IFNNLYTTLSDVWSFGILLWE------IFTLGGTPY----------PELPM 347
Query: 784 ADKFYAGFKS-------KHEREKFNQVVVKCQKELQELQ---SQVV 819
++FY K H ++ +++ KC +E E++ SQ+V
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-08
Identities = 96/528 (18%), Positives = 193/528 (36%), Gaps = 32/528 (6%)
Query: 73 ILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSA 132
+ + E E + KA++ E + + +
Sbjct: 163 LFGLEKYEKLSELLKEVIKEAKAKIEELEGQLSELLEDIEDLLEALEEELKELKKLEEIQ 222
Query: 133 GEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTE 192
EQ EL+ + LE L++E L+ ++ ++ + K E L+ L
Sbjct: 223 EEQEEEELEQEIEALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERL 282
Query: 193 LERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVS 252
LE + + +L E R + E LE L EL + E EK+
Sbjct: 283 LEELEEKIERLEELEREIEELEEELEGLRALLEELEELLEKLKSLEERLEKLEEKLEKLE 342
Query: 253 SLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVK---ELKDLMAKHR 309
S +E A EL + +E+ E + + E ++ + ELK+ +A+
Sbjct: 343 SELEELAEEKNELAKLLEERLKELEERLEELEKELEKALERLKQLEEAIQELKEELAELS 402
Query: 310 SDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQ 369
+ L + L ++ + ++ +++L ++ + L++QIN L+ + EL +
Sbjct: 403 AALEEIQEELEELEKELEELERELEELEEEIKKLEEQINQLESKELMIAELAGAGEKCPV 462
Query: 370 VEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVE 429
QE + +L E E A LRE +E+E +L+ +
Sbjct: 463 CGQEL--PEEHEKELLELYELELEELEEELSREKEEAELREEIEELEKELRELEEELIEL 520
Query: 430 DLQMKELQDQLET---------EQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTH 480
+ L+++LE E+ K Q +LKEEL + + EL+E +L
Sbjct: 521 LELEEALKEELEEKLEKLENLLEELEELKEKLQLQQLKEELRQLEDRLQELKELLEELRL 580
Query: 481 -----------RLQLAVARADSEALARSIAEE-------TVGELEKEKTMKELELKDLMA 522
R +L + + L +++ + E E E E EL+ +
Sbjct: 581 LRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEAENELEEAEEELESELE 640
Query: 523 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGK 570
K +E L + +E E ++ ++ ++ + ++ + L ++ +
Sbjct: 641 KLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLEEKLE 688
|
Length = 908 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---IAT 723
+Q+ G+ Y+ K++HRDL N+L+ + +KI D GL+R + + + I
Sbjct: 134 WQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV 193
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+W A E L + YT D+WS G +L E+ L P +PG
Sbjct: 194 KWM-AIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 8/102 (7%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 723
FQ+ G+ ++ + K +HRDL NIL+ ++ +KI D GLAR + + + + +
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+W APE I +R YT D+WS G +L E+ L + P +PG
Sbjct: 246 KWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-07
Identities = 57/290 (19%), Positives = 105/290 (36%), Gaps = 33/290 (11%)
Query: 38 QLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEV 97
+L ER +Q E ++ A++ Q E+ L +L+E +R K+A +
Sbjct: 604 ELRERLQQAEEALQSAVAKQK-------QAEEQLVQANAELEEQKRAEAEARTALKQARL 656
Query: 98 NLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQE 157
+LQ + + + LK + E A RKQ AE + + + + Q ++ D +
Sbjct: 657 DLQRLQNEQQSLKDKLELAIAERKQQAETQLRQLDAQLKQLLEQQQAFLEALKDDFRELR 716
Query: 158 VATLQAKISQERSSKTQAVNLHKELEGRLQALNTEL---ERNKHRELQLAEDNRHLGEKV 214
L E Q L +E L ++ REL V
Sbjct: 717 TERLAKWQVVEGELDNQLAQLSAAIEAARTQAKARLKELKKQYDRELA---SLDVDPNTV 773
Query: 215 SSLEKECRLQALNTELERNKHRE-----------------LQLAEDNRHLGEKVSSLEKE 257
L+++ ++ L T +ER R L E+ +L ++ LE
Sbjct: 774 KELKRQ--IEELETTIERIAVRRPEVREYRAFMQETWLHRDSLREERPNLAIQLRELESS 831
Query: 258 CASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAK 307
L EL + R E ++ + + + E+++ L+D M +
Sbjct: 832 AEELQQELTRLIKDTKLR-RKKLEQERKALEKQLDQLDELLRGLRDEMRQ 880
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 12/192 (6%)
Query: 569 GKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G G +G V K K K + VA+K + + RE ++ +P I+ M+
Sbjct: 4 GSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMI 62
Query: 627 DIYKAVNNKDLYVVFEYME-NDLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
I +A + +V E E LNK + ++K + + +I ++ Q+ G+ Y+ +HR
Sbjct: 63 GICEAES---WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRYTHH 741
DL N+L+ KI D GL+++L + +W + APE + + +++
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSK 178
Query: 742 VDIWSLGCILAE 753
D+WS G ++ E
Sbjct: 179 SDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-07
Identities = 57/335 (17%), Positives = 136/335 (40%), Gaps = 22/335 (6%)
Query: 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQG 844
D G K N +++ ++E++EL+ ++ E +L+ L E+E+L+
Sbjct: 653 DLVRPGGVITGGSAKTNSSILERRREIEELEEKIEELEEKIAELEKALAELRKELEELEE 712
Query: 845 KLAALGSETASLSSADVENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIF 904
+L L E LS + + + Q K + + +++
Sbjct: 713 ELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEE 772
Query: 905 YNSENDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQ 964
E + + E EL+ + + + +L + L + + L + E L++
Sbjct: 773 AEEELAEAEAEIE-ELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLER 831
Query: 965 QINLLKEELRKSSNS----SEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKD-----INT 1015
+I + L SE++E L ++++ + L + ++L ++N + +
Sbjct: 832 RIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALAL 891
Query: 1016 TCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQVVVKCQK---ELQELQSQVVEE-- 1070
+ S ++R+ E + +L++EL + REK Q+ ++ + + LQ ++ EE
Sbjct: 892 LRSELEEL-SEELRELESKRSELRRELEELREKLAQLELRLEGLEVRIDNLQERLSEEYS 950
Query: 1071 ------NTSKLKLQMELDSKDSEIEQLQGKLAALG 1099
+ K++ + + +++L+ K+ LG
Sbjct: 951 LTLEEAEALENKIEDDEEEARRRLKRLENKIKELG 985
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-07
Identities = 67/309 (21%), Positives = 137/309 (44%), Gaps = 29/309 (9%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEA----VSARETALRDEMGQLEKNLTILRHDLK 79
E + LER RRE + E Q L E+ E + + AL + +E+ L L +L+
Sbjct: 195 EKRQQLERLRREREKAERYQALLKEKREYEGYELLKEKEALERQKEAIERQLASLEEELE 254
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAE-TATRLRKQSAELTV-------AKS 131
+ E +K+ E Q++ ++++K+K E R++++ EL + +
Sbjct: 255 KLTEEIS---ELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIA 311
Query: 132 AGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNT 191
E+ + + + LA LE E D L E+ L+ +I +ER + + + EL+ L+ L
Sbjct: 312 EKERELEDAEERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRA 371
Query: 192 ELERNKHRELQLAEDNRHLGEKVSSLEKEC-----RLQALNTELERNKHRELQLAEDNRH 246
ELE ++ ++ +++ ++ + L EL+R + +L+E+
Sbjct: 372 ELE-------EVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELAD 424
Query: 247 LGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMA 306
L ++ +E + L E + + +++ E+ ++K E + +KE D +
Sbjct: 425 LNAAIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAA--DLSKYEQELYDLKEEYDRVE 482
Query: 307 KHRSDLSSK 315
K S L +
Sbjct: 483 KELSKLQRE 491
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/218 (22%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G +G V + N VA+K + A +++ + E + +K F HPN++ +
Sbjct: 8 GEGEFGSVMEG-QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRL 65
Query: 626 LDIYKAVNNKDLY----VVFEYMEN-DLNKVIRDKILKDVHIRY-------IMFQLCNGL 673
+ + + Y V+ +M++ DL+ + L D M + +G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---TRWYRAPE 730
Y+ + +HRDL N +++++ ++ + D GL++ + + IA +W A E
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI-AIE 184
Query: 731 ILISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTS 767
L ++R YT D+WS G + E+ + + +PG S
Sbjct: 185 SL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-07
Identities = 66/347 (19%), Positives = 141/347 (40%), Gaps = 13/347 (3%)
Query: 102 ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATL 161
I ++ EK++ E L K AEL E+ + +L+ L L + L++++A L
Sbjct: 679 IEELEEKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISALRKDLARL 738
Query: 162 QAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 221
+A++ Q Q ELE ++ L LE + + + L ++ L++E
Sbjct: 739 EAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEEL 798
Query: 222 -----RLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEV 276
L L EL L E L ++++ E+ L +++ +
Sbjct: 799 KALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLA 858
Query: 277 RAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQL 336
EE ++ + E+ +E + + + + + L S+ LS + + +
Sbjct: 859 AEIEELEELI--EELESELEALLNERASLEEALALLRSELEELSEELRELESKRSELRRE 916
Query: 337 MKDREDLQQQINLLKEGAELR-QELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLK 395
+++ + Q+ L EG E+R L++ + + + E+A+ + + + +
Sbjct: 917 LEELREKLAQLELRLEGLEVRIDNLQERLSEEYSLTLEEAEALENKIE-----DDEEEAR 971
Query: 396 AREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLET 442
R ++L +++ L EEY +LK + Q ++L + ET
Sbjct: 972 RRLKRLENKIKELGPVNLAAIEEYEELKERYDFLTAQKEDLTEAKET 1018
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 569 GKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G+G +G V KA K + + AIK++ E + +K D + E+ L HPNII +L
Sbjct: 16 GEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 627 DIYKAVNNKDLYVVFEY---------------MENDLNKVIRDKI---LKDVHIRYIMFQ 668
+ + LY+ EY +E D I + L + +
Sbjct: 75 GACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+ G+ Y+ + +HRDL NIL+ ++ KI D GL+R + + RW
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192
Query: 729 PEILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRP---NP 781
+ S YT + D+WS G +L E+ L P A +L L +P +
Sbjct: 193 ESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 250
Query: 782 PHADKFYAGFKSK-HEREKFNQVVVKCQKELQELQSQV 818
D ++ K +ER F Q++V + L+E ++ V
Sbjct: 251 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIAT--R 724
Q+ G+ Y+ +++HR+L NIL+ ++I D G+A L D K+ T +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEML 755
W IL RYTH D+WS G + EM+
Sbjct: 177 WMALESILF--GRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 8e-07
Identities = 106/470 (22%), Positives = 186/470 (39%), Gaps = 64/470 (13%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKN-------LTILRH 76
EL++ E + LE+ + +L + E + +LEK L +
Sbjct: 332 ELEEAAEAANAKCDSLEKTKSRLQSELEDLQIELERANAAASELEKKQKNFDKILAEWKR 391
Query: 77 DLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSA----ELTVAKSA 132
+ E Q D + L + + E+LK + E R K +LT
Sbjct: 392 KVDELQAELDTAQREARNLSTELFRLKNELEELKDQVEALRRENKNLQDEIHDLTDQLGE 451
Query: 133 GEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVN----LHKELEGRLQA 188
G + V EL+ LE E+D LQ + +A + E S +A + E+E RL
Sbjct: 452 GGRNVHELEKARRRLEAEKDELQAALEEAEAALELEESKVLRAQVELSQIRSEIERRLAE 511
Query: 189 LNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHR-ELQLAE---DN 244
E E N + Q R + ++LE E + +A E R K + E + E
Sbjct: 512 KEEEFE-NTRKNHQ-----RAIESLQATLEAEAKGKA---EASRLKKKLEGDINELEIAL 562
Query: 245 RHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDL 304
H + + +K ++K Q Q ++E RA E+ ++ V + A+ + EL++L
Sbjct: 563 DHANKANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVAERRATA-LEAELEEL 621
Query: 305 MAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSK 364
RS L E +K + + + +++N L ++
Sbjct: 622 ----RSALEQAERA-----------RKQAET---ELAEASERVNELTA---------QNS 654
Query: 365 TLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKT 424
+L +Q + + + +LQSDL +E + R ++ + A L E R +E L+
Sbjct: 655 SLIAQKRKLEGELAALQSDLDEAVNELKAAEERAKKAQADAARLAEELRQEQEHSQHLER 714
Query: 425 KRSVEDLQMKELQDQLETEQYFST------LYKTQA--HELKEELDERSR 466
R + Q+KELQ +L+ + + + K +A EL+ ELD R
Sbjct: 715 LRKQLESQVKELQVRLDEAEAAALKGGKKMIQKLEARVRELEAELDGEQR 764
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 8/102 (7%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---T 723
FQ+ G+ ++ + K +HRDL NIL+ ++ +KI D GLAR + + + + A
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+W APE I ++ YT D+WS G +L E+ L + P +PG
Sbjct: 240 KWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-07
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 22/148 (14%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 723
+Q+ G+ ++ + +HRDL N+L+ + +KI D GLAR + +++ ++
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 782
+W APE + N YT D+WS G +L E+ +PG +IV+ N
Sbjct: 304 KWM-APESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPG--------MIVDSTFYN-- 351
Query: 783 HADKFYAGF---KSKHEREKFNQVVVKC 807
K +G+ K H ++ ++VKC
Sbjct: 352 ---KIKSGYRMAKPDHATQEVYDIMVKC 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|149849 pfam08912, Rho_Binding, Rho Binding | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-06
Identities = 28/68 (41%), Positives = 41/68 (60%), Gaps = 4/68 (5%)
Query: 949 KKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKL----HKQLKQEQLLKAQAVNKL 1004
K + L ++E+L ++ +EEL+K + + + KQL+ E+ LK QAVNKL
Sbjct: 1 TKDVANLANEKEELNNKLKKAQEELQKLKEEEQSINNIKAAFEKQLQTERTLKTQAVNKL 60
Query: 1005 AEIMNRKD 1012
AEIMNRKD
Sbjct: 61 AEIMNRKD 68
|
Rho Binding Domain is responsible for the recognition and binding of Rho binding domain-containing proteins (such as ROCK) to Rho, resulting in activation of the GTPase which in turn modulates the phosphorylation of various signalling proteins. This domain is within an amphipathic alpha-helical coiled-coil and interacts with Rho through predominantly hydrophobic interactions. Length = 68 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 60/260 (23%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQ-RTYREILFLKSFQRHPNIITM 625
GKGA+G V K+ + A+K + E F+ A + R++L + P ++++
Sbjct: 10 GKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL---AESDSPWVVSL 66
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + + LY++ E++ DL +I+ + R+ M + + +H +H
Sbjct: 67 Y--YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 684 RDLKPSNILIDKSCSIKIGDLGL---------------------ARSLSDSKECLT---- 718
RD+KP NILID+ IK+ D GL ++ D++ +
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 719 -------EYIATRW----------------YRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ IAT W Y APEI + + Y D WSLG I+ E L
Sbjct: 185 NLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECL 242
Query: 756 QSKPLFPGASTSHQLQLIVN 775
P F ++ + I+N
Sbjct: 243 IGWPPFCSENSHETYRKIIN 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 53/248 (21%), Positives = 103/248 (41%), Gaps = 48/248 (19%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V K+ A+K + +A + + R R+IL + + +
Sbjct: 10 GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV------EADSLWV 63
Query: 626 LDIYKAVNNK-DLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ ++ + +K +LY++ E++ + +++ L + ++ + + + IH +
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLA------------RSLSDS----------------- 713
HRD+KP N+L+D +K+ D GL R+L+ S
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 714 ------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767
++ + T Y APE+ + Y D WSLG I+ EML P F +
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 768 HQLQLIVN 775
+ ++N
Sbjct: 243 ETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-06
Identities = 88/502 (17%), Positives = 179/502 (35%), Gaps = 70/502 (13%)
Query: 25 LKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTI----LRHDLKE 80
+DL + R + EE+ RQ + E + A E+ LR ++ + L L
Sbjct: 394 ERDLEKNNERLAAIREEKDRQKAAIEEDLQALESQLRQQLEAGKLEFNEEEYELELRLGR 453
Query: 81 SQRRADN---ESETKKKAEVNLQVISDMHEKL-----KTEAETA--TRLRKQSAELTVAK 130
++R D+ E ++ E+N + + E+ E + +LRK+ E A
Sbjct: 454 LKQRLDSATATPEELEQLEINDEALEKAQEEQEQAEANVEQLQSELRQLRKRRDEALEAL 513
Query: 131 SAGEQMVVELQNILATLEM----ERDTLQQEVATLQAK--------ISQERSSKT--QAV 176
E+ +++L+ L LE+ + +L + IS E +T
Sbjct: 514 QRAERRLLQLRQALDELELQLSPQAGSLLHFLRNEAPGWEESIGKVISPELLERTDLDPQ 573
Query: 177 NLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHR 236
+ L ++ +L+R + E L E++ E+ AL + + + K
Sbjct: 574 LVEGSDSDTLYGVSLDLQRLDVPDYAANETE--LRERLQQAEE-----ALQSAVAKQKQA 626
Query: 237 ELQLAEDNRHLGEKVSSLEKECASLS---LELKAAQAQYQQEVRAHEETQKSRMVNKEEA 293
E QL + N L E+ + + +L L+L+ Q + Q E R E
Sbjct: 627 EEQLVQANAELEEQKRAEAEARTALKQARLDLQRLQNEQQSLKDKLELAIAERKQQAETQ 686
Query: 294 SVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEG 353
++ +LK L+ + ++ L + + E + + +L Q+ L
Sbjct: 687 LRQLDAQLKQLLEQQQAFLEALKDDFR---ELRTERLA---KWQVVEGELDNQLAQLSAA 740
Query: 354 AELRQELEKSKTLQSQVEQEQAKKF-----SLQSDLSVQTSEAAHLKAREEQLSHEVA-- 406
E + K++ + + + ++ + +L Q E R EV
Sbjct: 741 IEAARTQAKARLKELKKQYDRELASLDVDPNTVKELKRQIEELETTIERIAVRRPEVREY 800
Query: 407 --------------MLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKT 452
I+ + + S E+LQ +EL ++ + +
Sbjct: 801 RAFMQETWLHRDSLREERPNLAIQLR----ELESSAEELQ-QELTRLIKDTKLRRKKLEQ 855
Query: 453 QAHELKEELDERSRNILELEEE 474
+ L+++LD+ + L +E
Sbjct: 856 ERKALEKQLDQLDELLRGLRDE 877
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECL--TEYIAT 723
+Q+ G+S++ + +HRDL NIL+ KI D GLAR + +DS + +
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 763
+W APE I N YT D+WS G +L E+ L S P +PG
Sbjct: 281 KWM-APES-IFNCVYTFESDVWSYGILLWEIFSLGSSP-YPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-06
Identities = 108/547 (19%), Positives = 219/547 (40%), Gaps = 39/547 (7%)
Query: 31 RERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESE 90
E+ E ++ ++ + + A E DE + + +LK++ E
Sbjct: 1363 EEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAAKKKADE 1422
Query: 91 TKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEME 150
KKKAE + +D +K EA+ A +K++ E E+ + + E +
Sbjct: 1423 AKKKAEEKKK--ADEAKKKAEEAKKADEAKKKAEE----AKKAEEAKKKAEEAKKADEAK 1476
Query: 151 RDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHL 210
+ + + A K ++E K E + + E K E + AE+ +
Sbjct: 1477 KKAEEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKA 1536
Query: 211 -----GEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC------A 259
E+ ++ + + L E+ K E + AE+++++ + + K+
Sbjct: 1537 DEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIEE 1596
Query: 260 SLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLL 319
+ L + + + ++ +A E K+ + K E E K+++ L K + E L
Sbjct: 1597 VMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAE---EEKKKVEQLKKKEAEEKKKAEEL- 1652
Query: 320 SNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKF- 378
K E + K+ ++ K ED ++ K +E EK + E E+AKK
Sbjct: 1653 --KKAEEENKIKAAEEAKKAEEDKKKAEEAKKA-----EEDEKKAAEALKKEAEEAKKAE 1705
Query: 379 SLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQD 438
L+ + + +A LK EE+ + EAK+ EE+ K + + E+ + K
Sbjct: 1706 ELKKKEAEEKKKAEELKKAEEENKIKA---EEAKKEAEEDKKKAEEAKKDEEEKKKIAHL 1762
Query: 439 QLETEQYFSTLYKTQAHELKEELDER-SRNILELEEERGDLTHRLQLAVARADSEALARS 497
+ E E+ + K + ++EELDE + +E++++ D+ + L +
Sbjct: 1763 KKEEEKKAEEIRKEKEAVIEEELDEEDEKRRMEVDKKIKDIFDNFANIIEGGKEGNLVIN 1822
Query: 498 IAEETVGELEKE---KTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMK 554
++E KE +LE D KH+ + +++ N +E D+ K D
Sbjct: 1823 DSKEMEDSAIKEVADSKNMQLEEADAFEKHKFNKNNENGEDGN---KEADFNKEKDLKED 1879
Query: 555 DREDLQQ 561
D E++++
Sbjct: 1880 DEEEIEE 1886
|
Length = 2084 |
| >gnl|CDD|205692 pfam13514, AAA_27, AAA domain | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-06
Identities = 113/554 (20%), Positives = 187/554 (33%), Gaps = 79/554 (14%)
Query: 41 ERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRAD--NESETKKKAEVN 98
E+ + ++ E + + RD + +LE++L L L+ E E
Sbjct: 452 EQVQAFLKEAEEIMQAKRQKRDRLLELEEDLETLELQLRHLDAAGAVPTEEEVAAARARR 511
Query: 99 LQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEV 158
+ D +R+ A L SA E+ V E + LA Q V
Sbjct: 512 DALWQD--------------IRRGYALLEPTASAYEEAV-ESADQLAD---RLLREAQLV 553
Query: 159 ATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLA-------------E 205
LQ+ QE +++ + L KELE AL L + A
Sbjct: 554 GELQSLRQQEEAARRRLEQLEKELEVLELAL-AALREAWQAQWAAAGLPLTPAEMEDWLA 612
Query: 206 DNRHLGEKVSSLEKECR----------------LQALNTELERNKHRELQ-LAEDNRHLG 248
+ E+V + K AL EL L E R L
Sbjct: 613 ERATAREQVRAYFKARAELDALLDRRARLRAALRAALKAVAIVLPGEELAELLELARQLL 672
Query: 249 EKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKH 308
E+ ASL L+ A+ ++ H+E Q + +E+ + + E
Sbjct: 673 EEAEKQAARKASLDERLRDAERALEEAEERHDEAQSALEAWQEQWY-DALLEAGLGGRAS 731
Query: 309 RSDLSSKESLLSNGKER---EVDYKKSIDQLMKDREDLQQQINLLKEGAELR-------Q 358
+ LL N KE+ D ++ I + +D ++++ L E +
Sbjct: 732 PAGALDALELLQNIKEKLQAADDLRQRIAAMERDLARFEEEVEALAEAVAPEMLGTPADE 791
Query: 359 ELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEV-AMLREAKRNIEE 417
K + A L ++ E + A ++ + A+LR A+ E
Sbjct: 792 TARALKQRLKRARDTAAAAEKLAEEIEEAEKEVSEAAAALDEAEARLTALLRAARCTTIE 851
Query: 418 EYHKLKTKR---SVEDLQMKELQDQLETEQYFSTL-------YKTQAHELKEELDERSRN 467
E + ++ L+ L +L EL L+E +R+
Sbjct: 852 ELLAAVERSDTYRELRKRIAALERTLVRAGGGLSLEALVAEAAALDPDELPARLEELARD 911
Query: 468 ILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSD 527
I ELEEE +L ++ A+ LAR T ELE E+ +L+DL A+ +
Sbjct: 912 IEELEEELNELAQ--EVGAAKQ---ELARMDGGSTAAELEAERESLLAQLRDL-AERYLE 965
Query: 528 LSSKESLLSNGKER 541
L+ LL ER
Sbjct: 966 LALASRLLRKAIER 979
|
This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118 |
| >gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-06
Identities = 108/560 (19%), Positives = 219/560 (39%), Gaps = 84/560 (15%)
Query: 33 RREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESETK 92
R +S QL Q E ++ L + L L +L E + E +
Sbjct: 179 ERVLSDQRGSLDQLKAQIEEKEEKD---------LHERLNGLESELAELDEEIERYEEQR 229
Query: 93 KKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERD 152
++A E E ++ EL ++ E +L+ +A E ER+
Sbjct: 230 EQAR----------ETRDEADEVLEEHEERREELETLEAEIE----DLRETIAETERERE 275
Query: 153 TLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGE 212
L +EV L+ ++ ELE L E + + L +
Sbjct: 276 ELAEEVRDLRERLE--------------ELEEERDDLLAEAGLDDADAEAVEARREELED 321
Query: 213 KVSSLEK---ECRL--QALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKA 267
+ L ECR+ QA N E E + L E L E+ + LE E ++
Sbjct: 322 RDEELRDRLEECRVAAQAHNEEAESLREDADDLEERAEELREEAAELESELEEAREAVED 381
Query: 268 AQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREV 327
+ + +E+ E + R + + ++ + + + R +L +E E E
Sbjct: 382 RREE-IEELEEEIEELRERFGDAPVD-LGNAEDFLEELREERDELRERE------AELEA 433
Query: 328 DYKKSIDQLMKDREDLQQQINLLKEGA--ELRQELEKSKTLQSQVEQEQAKKFSLQSDLS 385
+ + +++ + LL+ G E Q +E S +++ +E+++ + L+++L
Sbjct: 434 TLRTARERVEEAEA-------LLEAGKCPECGQPVEGSPHVET-IEEDRERVEELEAELE 485
Query: 386 VQTSEAAHLKAREEQLSH------EVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQ 439
E ++ R E+ + L E + ++EE + + + + +EL+++
Sbjct: 486 DLEEEVEEVEERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKRERAEELRER 545
Query: 440 LETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIA 499
+ + + A E +EE +E + EL + +L R++ ++ R + A + A
Sbjct: 546 AAELEAEAEEKREAAAEAEEEAEEAREEVAELNSKLAELKERIE-SLERIRTLLAAIADA 604
Query: 500 EETVGEL-EKEKTMKELE------LKDLMAKHRSDLSSKE-----SLLSNGKEREVDY-- 545
E+ + L EK + + EL L + + R +L ++ KER +Y
Sbjct: 605 EDEIERLREKREALAELNDERRERLAEKRERKR-ELEAEFDEARIEEAREDKERAEEYLE 663
Query: 546 --KKSIDQLMKDREDLQQQI 563
++ +D+L ++R+DLQ +I
Sbjct: 664 QVEEKLDELREERDDLQAEI 683
|
Length = 880 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-06
Identities = 55/287 (19%), Positives = 128/287 (44%), Gaps = 16/287 (5%)
Query: 821 ENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASLSSADVENDESYVQDSRLEGWVSIP 880
S L + EL + E+ +L+ +L L E L S E L +
Sbjct: 658 NKRSSLAQKRELKELEEELAELEAQLEKLEEE---LKSLKNELRSLEDLLEELRRQLEEL 714
Query: 881 NKQN--IKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELELKDLMAKHRSDLSSKESLL 938
+Q +KR + + + + E ++ + EL++ + + +L S E L
Sbjct: 715 ERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEAL 774
Query: 939 SNGKEREVDYKKSIDQLMKDREDLQQQINLLKEEL----RKSSNSSEEMEKLHKQLKQEQ 994
+ KE + ++ L ++ E+L++++ + L R+ + + E+L +++++ +
Sbjct: 775 AKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELE 834
Query: 995 LLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQVVV 1054
+ KL E+ + + + + ++ + E E +L+ EL + E+ ++
Sbjct: 835 EEIEELEEKLDELEEELE---ELEKELEELKEELEELEAEKEELEDELKELEEEKEEL-- 889
Query: 1055 KCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSE 1101
++EL+EL+S++ E KL+ L+ ++++E+L+ +L L E
Sbjct: 890 --EEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEE 934
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-06
Identities = 50/232 (21%), Positives = 103/232 (44%), Gaps = 12/232 (5%)
Query: 352 EGAELRQELEKSK----TLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAM 407
E LR+ LE K +LQS++ + + + L +LS + + ++ EQL E
Sbjct: 675 ELQRLRERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEK 734
Query: 408 LREAKRNIEEEYHKLKTKRSVEDLQMKEL-----QDQLETEQYFSTLYKTQAHELKEELD 462
L+E +EE+ L+ + ++KEL + + + + L +A +
Sbjct: 735 LKERLEELEEDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSRIP 794
Query: 463 ERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMA 522
E + +LEEE + RL+ + + L + E+ + EL++++ + ++K +
Sbjct: 795 EIQAELSKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDLKEQIKSIEK 854
Query: 523 KHRSDLSSKESLLSNGKEREV---DYKKSIDQLMKDREDLQQQINLLKEGKG 571
+ + KE L +E E D + + L K+R++L+ Q+ L+
Sbjct: 855 EIENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLRELERKIE 906
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECL--TEYIAT 723
Q+ G+ ++ + +HRD+ N+L+ KI D GLAR ++DS + +
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPG 763
+W APE I + YT D+WS G +L E+ K +PG
Sbjct: 279 KWM-APES-IFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218661 pfam05622, HOOK, HOOK protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-06
Identities = 103/450 (22%), Positives = 176/450 (39%), Gaps = 73/450 (16%)
Query: 114 ETATRLRKQSAELTVAKSAGE---QMVVELQNILATLEMERDTLQQEVATLQAKISQERS 170
+L+K +L A+ + Q EL + L+ E+++LQQE LQ +++Q
Sbjct: 169 NLDQQLKKALEDLKEAQEEKDELAQRCHELDKQVLLLQEEKNSLQQENEKLQERLAQLEG 228
Query: 171 SKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC-RLQALNTE 229
S L + + L ++LE+ + +L K LEKE LQ N E
Sbjct: 229 SSLGPNQLGSK---KYNLLQSQLEQLQEENFRLEAARDDYRIKCEELEKELAELQHRNDE 285
Query: 230 LERNKHRELQLAEDN---RHLGEKVSSLEKECAS----------LSLELKAAQ---AQYQ 273
L L ++ R +K LE + + L ++K + A Y
Sbjct: 286 LTSLAAESQALKDEIDVLRESSDKAKKLEAQVETYKKKLEDLNDLRRQVKLLEERNAMYM 345
Query: 274 QEVRAHEETQKSRMVNKEEASVEIVK-ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKS 332
Q EE + + N +E K ++++L AK + + L K E
Sbjct: 346 QNTVQLEE--ELKKANAARGQLETYKRQVQELHAKLSEESKKADKLEFEYKRLEEKL--- 400
Query: 333 IDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEA- 391
+ L K++E LL E LR+ E+ + Q +Q+Q + + S A
Sbjct: 401 -EALQKEKE------RLLAERDSLRETNEELRC--GQAQQDQLTQADAGTSPSGDNLAAE 451
Query: 392 ---AHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFST 448
+ + + +L HE MLR + E ++ T ELQ LE
Sbjct: 452 LLPSEYREKLIRLQHENKMLRLGQ---EGSENERIT----------ELQQLLE------- 491
Query: 449 LYKTQAHELKEELDERSR----NILELEEERGDLTHRLQLAVARADSEALARSIAE---E 501
A+ EL+ + R ILEL+++ DL LQ ++++ +L +S E E
Sbjct: 492 ----DANRRNNELETQLRLANQRILELQQQVEDLQKALQEQGSKSEDSSLLKSKLEEHLE 547
Query: 502 TVGELEKEKTMKELELKDLMAKHRSDLSSK 531
+ E +E K ++++L +LS K
Sbjct: 548 QLHEANEELQKKREQIEELEPDQDQNLSRK 577
|
This family consists of several HOOK1, 2 and 3 proteins from different eukaryotic organisms. The different members of the human gene family are HOOK1, HOOK2 and HOOK3. Different domains have been identified in the three human HOOK proteins, and it was demonstrated that the highly conserved NH2-domain mediates attachment to microtubules, whereas the central coiled-coil motif mediates homodimerisation and the more divergent C-terminal domains are involved in binding to specific organelles (organelle-binding domains). It has been demonstrated that endogenous HOOK3 binds to Golgi membranes, whereas both HOOK1 and HOOK2 are localised to discrete but unidentified cellular structures. In mice the Hook1 gene is predominantly expressed in the testis. Hook1 function is necessary for the correct positioning of microtubular structures within the haploid germ cell. Disruption of Hook1 function in mice causes abnormal sperm head shape and fragile attachment of the flagellum to the sperm head. Length = 713 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 52/247 (21%), Positives = 97/247 (39%), Gaps = 46/247 (18%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+G V K+ A+K + +A + + R R+IL ++ M
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD---GAWVVKM 66
Query: 626 LDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
Y + ++LY++ E++ + +++ L + ++ + + + IH +H
Sbjct: 67 F--YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSL--------------------------------- 710
RD+KP N+L+D +K+ D GL L
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 711 --SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH 768
+ ++ + T Y APE+ + Y D WSLG I+ EML P F +
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 769 QLQLIVN 775
+ ++N
Sbjct: 244 TYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|218636 pfam05557, MAD, Mitotic checkpoint protein | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-06
Identities = 93/490 (18%), Positives = 195/490 (39%), Gaps = 33/490 (6%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLK 79
Q EL +R +LE + L+E YE R L + LE+ ++
Sbjct: 72 QLENELMQKELEHKRAQIELERKASTLAENYERELDRNLELEVRLKALEELEKKAENEAA 131
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVE 139
E++ A + K +L++ ++ ++LK E+ +R++ +E+ + +
Sbjct: 132 EAEEEA--KLLKDKLDAESLKLQNEKEDQLKEAKESISRIKNDLSEMQCRAQNADTELKL 189
Query: 140 LQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVN---LHKELEGRLQALNTELERN 196
L++ L L + + Q+E+A + K+ S + + + K LE L+ + E
Sbjct: 190 LESELEELREQLEECQKELAEAEKKLQSLTSEQASSADNSVKIKHLEEELKRYEQDAEVV 249
Query: 197 KHRELQLAEDNRHLGEKVSSLEKEC-RLQALNTELERNKHRELQLAEDNRHLGEKVSSLE 255
K + QL ++ LE+E L+ N +L K L E+ L ++ E
Sbjct: 250 KSMKEQLL--------QIPELERELAALREENRKLRSMKEDNELLKEELEDLQSRLERFE 301
Query: 256 KECASL-SLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSS 314
K L LEL+ + + + + + + + L++ + + S
Sbjct: 302 KMREKLADLELEKEKLENELKSWKSLLQDIGLNLRTPDDLSRRIVVLQNEELQLKEKNGS 361
Query: 315 KESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAE----LRQELEKSKTLQSQ- 369
S + ++ QL +R+ +I LK+ E L + L++ TL ++
Sbjct: 362 ISSSAKQ-------LETTLQQLQLERQKAVSEILELKKKLEALKALVRRLQRRLTLVTKE 414
Query: 370 VEQEQAKKFSLQSDLSVQTSEAAHLKAREE-----QLSHEVAMLREAK-RNIEEEYHKLK 423
+ +A S +L+ + +K EE Q E + +EE+ + K
Sbjct: 415 RDGLRAILNSYDKELTETSVSGQLMKRLEEAEDLVQKVQSHLAKMENQLSELEEDVGQQK 474
Query: 424 TKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQ 483
+ + + ++K L++QL + + + K + L+ +++ R L +E+ L +L+
Sbjct: 475 DRNNTLETEIKLLKEQLVSNERLLSFVKEATNALRLKIETLERERDRLRQEKSLLEMKLE 534
Query: 484 LAVARADSEA 493
+ D A
Sbjct: 535 HLCLQGDYNA 544
|
This family consists of several eukaryotic mitotic checkpoint (Mitotic arrest deficient or MAD) proteins. The mitotic spindle checkpoint monitors proper attachment of the bipolar spindle to the kinetochores of aligned sister chromatids and causes a cell cycle arrest in prometaphase when failures occur. Multiple components of the mitotic spindle checkpoint have been identified in yeast and higher eukaryotes. In S.cerevisiae, the existence of a Mad1-dependent complex containing Mad2, Mad3, Bub3 and Cdc20 has been demonstrated. Length = 722 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-05
Identities = 39/211 (18%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 911 KQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLK 970
K+ + EL + + L +S +E + +K + L + L+QQ +L+
Sbjct: 249 KEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALANEISRLEQQKQILR 308
Query: 971 EELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRK 1030
E L EE+E ++L+ + A+ + +L E ++++
Sbjct: 309 ERLANLERQLEELEAQLEELESKLDELAEELAELEEK-----------------LEELKE 351
Query: 1031 KEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 1090
+ + +EL E E+ + + +++L+ L+S+V + L E++ ++ +E+
Sbjct: 352 ELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLER 411
Query: 1091 LQGKLAALGSETASLSSADVENDESYVQDEV 1121
L+ + L E L E + +Q E+
Sbjct: 412 LEDRRERLQQEIEELLKKLEEAELKELQAEL 442
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 46/179 (25%)
Query: 567 KEGKGAYGIVYKAY---DKNNKQ--YVAIKKI-----FEAFRNKTDAQRTYREIL--FLK 614
K G+GA+G+VYKA ++ K+ YV +KK E + N+ +R F+
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEYGAVEIWMNER-VRRACPNSCADFVY 196
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK---------ILKDVH--- 661
F L+ + + ++V+ Y L +++ K +L V
Sbjct: 197 GF---------LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 662 ---------IRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSL 710
I+ IM Q+ L +H+ ++HRD+KP NI+ S S KI DLG A L
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
|
Length = 566 |
| >gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-05
Identities = 106/491 (21%), Positives = 188/491 (38%), Gaps = 68/491 (13%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
EL + + R + +LEE + L + A A+ +LE LR L+E +
Sbjct: 276 ELAEEVRDLRERLEELEEERDDLLAEAGLDDADAEAVEARREELEDRDEELRDRLEECRV 335
Query: 84 RADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRK--QSAELTVAKSAGEQMVVE-- 139
A ++AE + D+ E+ + E A L + A V E +E
Sbjct: 336 AA---QAHNEEAESLREDADDLEERAEELREEAAELESELEEAREAVEDRREEIEELEEE 392
Query: 140 -----------------LQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKE- 181
++ L L ERD L++ A L+A + R +A L +
Sbjct: 393 IEELRERFGDAPVDLGNAEDFLEELREERDELREREAELEATLRTARERVEEAEALLEAG 452
Query: 182 --------LEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC-RLQALNTELER 232
+EG E +R + E L + L E+V +E+ R + L E E
Sbjct: 453 KCPECGQPVEGSPHVETIEEDRERVEE--LEAELEDLEEEVEEVEERLERAEDL-VEAED 509
Query: 233 NKHRELQLAED-NRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKE 291
R + ED + E+ ++E++ EL+ A+ + E E E
Sbjct: 510 RIERLEERREDLEELIAERRETIEEKRERAE-ELRERAAELEAEAEEKREAAAEAEEEAE 568
Query: 292 EASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINL-- 349
EA E V EL +A+ + + S E + + D + I++L + RE L + +
Sbjct: 569 EAREE-VAELNSKLAELKERIESLERIRTLLAAIA-DAEDEIERLREKREALAELNDERR 626
Query: 350 --LKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAM 407
L E E ++ELE ++ ++++E+ + K + L + L+ + L E+
Sbjct: 627 ERLAEKRERKRELE-AEFDEARIEEAREDKERAEEYLEQVEEKLDELREERDDLQAEIGA 685
Query: 408 LREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLE-TEQYFSTLYKTQAHELKE-----EL 461
+ +EE ++E ++ LE + LY +A EL+
Sbjct: 686 VENELEELEE---------------LRERREALENRVEALEALYD-EAEELESMYGDLRA 729
Query: 462 DERSRNILELE 472
+ R RN+ LE
Sbjct: 730 ELRQRNVETLE 740
|
Length = 880 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 49/255 (19%)
Query: 569 GKGAYGIVY--KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPN 621
G G +G V +A+ +K V +K++ + ++LFL+ Q HPN
Sbjct: 4 GNGWFGKVLLGEAHRGMSKARVVVKEL-------RASATPDEQLLFLQEVQPYRELNHPN 56
Query: 622 IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKIL-------KDVHIRYIMFQLCNGL 673
++ L + + + +V E+ DL +R KDV R + ++ +GL
Sbjct: 57 VLQCLG--QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR-MACEVASGL 113
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-----LSDSKECLTEYIATRWYRA 728
++H +H DL N + S+KIGD GLA +K+C + RW A
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH--AVPLRWL-A 170
Query: 729 PEIL------ISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIV-----N 775
PE++ + + T +IWSLG + E+ +P +P S L+ +V
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVREQDIK 229
Query: 776 LVRPN--PPHADKFY 788
L +P ++D++Y
Sbjct: 230 LPKPQLDLKYSDRWY 244
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-05
Identities = 39/201 (19%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 919 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSN 978
EL+ + K +L S ++ L + ++ + ++ +++L + E+L++++ L+EEL + +
Sbjct: 678 ELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQS 737
Query: 979 SSEEMEKLHKQLKQEQLLKAQAVNKLAEIMN-----------RKDINTTCKGKSKASSAD 1027
EE+E+ ++L++E + + +L E + + + + +
Sbjct: 738 RLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEE 797
Query: 1028 VRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 1087
+ ++ +E + L +E E Q + ++E++EL+ ++ E +L+ EL+ + E
Sbjct: 798 LEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKE 857
Query: 1088 IEQLQGKLAALGSETASLSSA 1108
+E+L+ +L L +E L
Sbjct: 858 LEELKEELEELEAEKEELEDE 878
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-05
Identities = 49/227 (21%), Positives = 107/227 (47%), Gaps = 6/227 (2%)
Query: 904 FYNSENDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQ 963
+ + + ELE + K +L++ E L + R + ++ +++L ++ E+LQ
Sbjct: 700 LEDLLEELRRQLEELERQLEELK--RELAALEEELEQLQSRLEELEEELEELEEELEELQ 757
Query: 964 QQINLLKEELR----KSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKG 1019
+++ L+EEL + EE+E+L ++ + Q + +L E R D
Sbjct: 758 ERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELE 817
Query: 1020 KSKASSADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQM 1079
+ + ++ +E + +EL ++ ++ + + + +KEL+EL+ ++ E K +L+
Sbjct: 818 SLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELED 877
Query: 1080 ELDSKDSEIEQLQGKLAALGSETASLSSADVENDESYVQDEVRSRSV 1126
EL + E E+L+ +L L SE A L + E + E + +
Sbjct: 878 ELKELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERL 924
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-05
Identities = 54/246 (21%), Positives = 107/246 (43%), Gaps = 31/246 (12%)
Query: 333 IDQLMKDREDLQQQINLLKEGAELRQELEKSK--TLQSQVEQEQAKKFSLQSDLSVQTSE 390
ID+ + E L+++ + L +E + + L + E + +K +++ L+ E
Sbjct: 193 IDEKRQQLERLRREREKAERYQALLKEKREYEGYELLKEKEALERQKEAIERQLASLEEE 252
Query: 391 AAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLY 450
L +L + E ++ +EE K+K E L++KE
Sbjct: 253 LEKLTEEISELEKRLE---EIEQLLEELNKKIKDLGEEEQLRVKE--------------- 294
Query: 451 KTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADS-----EALARSIAEETVGE 505
+ EL+ E+ R+I E E E D RL A D E L R I EE
Sbjct: 295 --KIGELEAEIASLERSIAEKERELEDAEERLAKLEAEIDKLLAEIEELEREIEEERK-- 350
Query: 506 LEKEKTMKEL-ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 564
++K +E ELK+ + R++L + + ++ DY++ +++L ++ +L+++++
Sbjct: 351 -RRDKLTEEYAELKEELEDLRAELEEVDKEFAETRDELKDYREKLEKLKREINELKRELD 409
Query: 565 LLKEGK 570
L+E
Sbjct: 410 RLQEEL 415
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-05
Identities = 56/272 (20%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 808 QKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASLSSADVENDESY 867
++EL+ELQ ++ E +L EL + ++E+L+ +++ L E L E
Sbjct: 238 REELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQK---ELYALA 294
Query: 868 VQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELELKDLMAKH 927
+ SRLE Q + + + +++ E + + + EL +L K
Sbjct: 295 NEISRLE--------QQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKL 346
Query: 928 ----------RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSS 977
++L E+ L + R + ++ ++ L L+ QI L E+ +
Sbjct: 347 EELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLE 406
Query: 978 NSSEEMEKLHKQLKQEQ--LLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKEC 1035
E +E ++L+QE LLK +L E+ + ++ + + R +E
Sbjct: 407 ARLERLEDRRERLQQEIEELLKKLEEAELKEL--QAELEELEEELEELQEELERLEEAL- 463
Query: 1036 RKLQQELTQEREKFNQVVVKCQKELQELQSQV 1067
+EL +E E+ Q + ++EL +LQ+++
Sbjct: 464 ----EELREELEEAEQALDAAERELAQLQARL 491
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|234501 TIGR04211, SH3_and_anchor, SH3 domain protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRE--- 200
L L+ E LQ+E+A LQ ++++ + + LE L+ L EL R K
Sbjct: 68 LPELQQELAELQEELAELQEQLAELQQENQELKQELSTLEAELERLQKELARIKQLSANA 127
Query: 201 LQLAEDNRHLGEKVSSLEKECR-LQALNTELERNKHRE 237
++L E+NR L E+++ L++E L+A N L+ N+ R
Sbjct: 128 IELDEENRELREELAELKQENEALEAENERLQENEQRR 165
|
Members of this protein family have a signal peptide, a strongly conserved SH3 domain, a variable region, and then a C-terminal hydrophobic transmembrane alpha helix region. Length = 198 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-05
Identities = 46/258 (17%), Positives = 101/258 (39%), Gaps = 11/258 (4%)
Query: 35 EMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKK 94
++ + + R L + + A E L R + + ++ + K
Sbjct: 75 QLDDIRPQLRALRTELGTAQGEKRAAETEREAARSELQKARQEREAVRQELAAARQNLAK 134
Query: 95 AEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTL 154
A+ L ++ + L+T +T L +Q +L + + +LQ L+ + L
Sbjct: 135 AQQELARLTKQAQDLQTRLKT---LAEQRRQLEAQAQSLQASQKQLQASATQLKSQVLDL 191
Query: 155 --QQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGE 212
+ +A+ R++ QA +EL R A + + R+ Q+++ + +
Sbjct: 192 KLRSAQIEQEAQNLATRANAAQA--RTEELARRAAAAQQTAQAIQQRDAQISQKAQQIAA 249
Query: 213 KVSSL-EKECRLQALNTELERNKHRELQL---AEDNRHLGEKVSSLEKECASLSLELKAA 268
+ + E+E +LQ L T R + QL + L ++ ++ ++ + A
Sbjct: 250 RAEQIRERERQLQRLETAQARLEQEVAQLEAYYQAYVRLRQQAAATQRGQVLAGAAQRVA 309
Query: 269 QAQYQQEVRAHEETQKSR 286
QAQ Q + +A + +R
Sbjct: 310 QAQAQAQAQAQLLSSANR 327
|
Length = 499 |
| >gnl|CDD|129694 TIGR00606, rad50, rad50 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-05
Identities = 81/500 (16%), Positives = 194/500 (38%), Gaps = 74/500 (14%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQ------LEKNLTILRHD 77
+ +D L + +E++ LE+ + ++ + E+ + ++ D++ E +L L+ +
Sbjct: 588 QTRDRLAKLNKELASLEQNKNHINNELESKEEQLSSYEDKLFDVCGSQDEESDLERLKEE 647
Query: 78 LKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMV 137
+++S + + V Q I+ + ++ ++ R+ + AEL S + +
Sbjct: 648 IEKSSK---QRAMLAGATAVYSQFITQLTDENQSCCPVCQRVFQTEAELQEFISDLQSKL 704
Query: 138 VELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNK 197
+ L + E E ++ + +S EL +LQ +N +++R K
Sbjct: 705 RLAPDKLKSTESELKKKEKRRDEMLGLAPGRQSIIDLKEKEIPELRNKLQKVNRDIQRLK 764
Query: 198 HR-------------------------------ELQLAEDNRHLGEKVSSL--------- 217
+ +++L + R + ++ + L
Sbjct: 765 NDIEEQETLLGTIMPEEESAKVCLTDVTIMERFQMELKDVERKIAQQAAKLQGSDLDRTV 824
Query: 218 --------EKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQ 269
EK+ L + +++E N+ E +HL K + L+ E + L+ Q
Sbjct: 825 QQVNQEKQEKQHELDTVVSKIELNRKLIQDQQEQIQHLKSKTNELKSEKLQIGTNLQRRQ 884
Query: 270 AQYQQEVRAHEETQK--SRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREV 327
+Q V E Q + + +E + L+ + +SSKE+ +++
Sbjct: 885 QFEEQLVELSTEVQSLIREIKDAKEQDSPLETFLEKDQQEKEELISSKETSNKKAQDKVN 944
Query: 328 DYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQ 387
D K+ + + +D++ +I K+ ++E E + T+ +Q+E+ + + + D+ +
Sbjct: 945 DIKEKVKNIHGYMKDIENKIQDGKDDYLKQKETELN-TVNAQLEECEKHQEKINEDMRLM 1003
Query: 388 TSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFS 447
+ K +E L + + R E E +++ + +M ++Q
Sbjct: 1004 RQDIDTQKIQERWLQDNLTL-----RKRENELKEVEEELKQHLKEMGQMQ---------V 1049
Query: 448 TLYKTQAHELKEELDERSRN 467
K + +L+E +D RN
Sbjct: 1050 LQMKQEHQKLEENIDLIKRN 1069
|
All proteins in this family for which functions are known are involvedin recombination, recombinational repair, and/or non-homologous end joining.They are components of an exonuclease complex with MRE11 homologs. This family is distantly related to the SbcC family of bacterial proteins.This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). Length = 1311 |
| >gnl|CDD|235316 PRK04863, mukB, cell division protein MukB; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-05
Identities = 87/426 (20%), Positives = 164/426 (38%), Gaps = 60/426 (14%)
Query: 26 KDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRA 85
+ L RE+++L E + L + Y+A S ++ + Q EK + + DL+E + R
Sbjct: 306 QYRLVEMARELAELNEAESDLEQDYQAASDHLNLVQTALRQQEK-IERYQADLEELEERL 364
Query: 86 DNESETKKKAEVNLQVISDMHEKLKTEAET-ATRLRKQSAELTVAKSAGEQMVVELQNIL 144
+ ++E ++A + +E AE L+ Q A+ A + ++ Q +
Sbjct: 365 EEQNEVVEEA----DEQQEENEARAEAAEEEVDELKSQLADYQQALDVQQTRAIQYQQAV 420
Query: 145 ATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLA 204
LE + + L A A + +E + + Q EL + + L +A
Sbjct: 421 QALERAKQLCG--LPDLTAD---------NAEDWLEEFQAKEQEATEELLSLEQK-LSVA 468
Query: 205 EDNRHLGEKVSSLEKECRLQALNTELERN----KHRELQL-AEDNRHLGEKVSSLEKECA 259
+ E+ L ++ + E+ R+ REL + RHL E++ L +
Sbjct: 469 QAAHSQFEQAYQL-----VRKIAGEVSRSEAWDVARELLRRLREQRHLAEQLQQLRMRLS 523
Query: 260 SLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLL 319
LE + Q Q + + A + + ++ E+ EL+ L + + L S +
Sbjct: 524 --ELEQRLRQQQRAERLLAEFCKRLGKNLDDED-------ELEQLQEELEARLESLSESV 574
Query: 320 SNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFS 379
S +ER R L+QQ L++ Q L Q+ +
Sbjct: 575 SEARER--------------RMALRQQ---LEQLQARIQRLAARAP-AWLAAQDALARLR 616
Query: 380 LQSDLSVQTSEA-----AHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMK 434
QS + S+ L RE +L+ E L K+ ++EE +L ED ++
Sbjct: 617 EQSGEEFEDSQDVTEYMQQLLERERELTVERDELAARKQALDEEIERLSQPGGSEDPRLN 676
Query: 435 ELQDQL 440
L ++
Sbjct: 677 ALAERF 682
|
Length = 1486 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-05
Identities = 99/434 (22%), Positives = 175/434 (40%), Gaps = 54/434 (12%)
Query: 19 GQANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDL 78
G+ + +L + RR ++ +E Q L E A+ E ++ + + L+ +R ++
Sbjct: 450 GEGGRNVHELEKARRRLEAEKDELQAALEEAEAALELEE----SKVLRAQVELSQIRSEI 505
Query: 79 KESQRRADNESETKKKAEV----NLQVISDMHEKLKTEA-ETATRLRKQSAELTVAKSAG 133
+ + E E +K +LQ + K K EA +L EL +A
Sbjct: 506 ERRLAEKEEEFENTRKNHQRAIESLQATLEAEAKGKAEASRLKKKLEGDINELEIALDHA 565
Query: 134 EQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTEL 193
+ E Q + QQ+V LQ ++ +E+ ++ A E R AL EL
Sbjct: 566 NKANAEAQKNV-------KKYQQQVKELQTQVEEEQRAREDAREQLAVAERRATALEAEL 618
Query: 194 ER-----------NKHRELQLAEDNRHLGE---KVSSLEK-----ECRLQALNTELERNK 234
E K E +LAE + + E + SSL E L AL ++L+
Sbjct: 619 EELRSALEQAERARKQAETELAEASERVNELTAQNSSLIAQKRKLEGELAALQSDLD-EA 677
Query: 235 HRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVR---AHEETQKSRMVNKE 291
EL+ AE E+ + + A L+ EL+ Q Q R E K V +
Sbjct: 678 VNELKAAE------ERAKKAQADAARLAEELRQEQEHSQHLERLRKQLESQVKELQVRLD 731
Query: 292 EASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLK 351
EA +K K ++ K + + E+ L + R + +K++ ++ + ++LQ Q+
Sbjct: 732 EAEAAALKGGKKMIQKLEARVRELEAELDGEQRRHAETQKNLRKMERRVKELQFQV---- 787
Query: 352 EGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREA 411
E ++ LE+ LQ V++ QAK + + L A ++ + E+ E
Sbjct: 788 --EEDKKNLER---LQDLVDKLQAKIKTYKRQLEEAEEVAQINLSKYRKAQRELEDAEER 842
Query: 412 KRNIEEEYHKLKTK 425
E +KL+ K
Sbjct: 843 ADTAERSLNKLRAK 856
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 10/105 (9%)
Query: 673 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI- 731
L +H ++ RDL P+NIL+D I++ + DS C E + Y APE+
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAV-ENMYCAPEVG 154
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLF----PGASTSHQLQL 772
IS T D WSLG IL E+L K L G +T L +
Sbjct: 155 GISEE--TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI 197
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-05
Identities = 59/298 (19%), Positives = 121/298 (40%), Gaps = 46/298 (15%)
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQL 203
A + + +Q+E+A L+ KI +++ + + LE +L++L TE+ + + ++
Sbjct: 33 AAADDKQLKQIQKEIAALEKKIREQQDQRAK-------LEKQLKSLETEIASLEAQLIET 85
Query: 204 AEDNRHLGEKVSSLEKECRLQALNTELERNKHR-ELQLAEDNRHLGEKVSSLEKECASLS 262
A+D + L ++++ L RL AL + + R QLA R G +
Sbjct: 86 ADDLKKLRKQIADLNA--RLNALEVQEREQRRRLAEQLAALQR-SGRNPPPALLVSPEDA 142
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
Y A E + + LK L A R++++++++ L+
Sbjct: 143 QRSVRLAIYYGALNPARAERIDA-----------LKATLKQL-AAVRAEIAAEQAELTTL 190
Query: 323 KEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQS 382
+ + + QL+++R+ Q+N E + +++LE+ + +S+++ E A
Sbjct: 191 LSEQRAQQAKLAQLLEERKKTLAQLN--SELSADQKKLEELRANESRLKNEIAS------ 242
Query: 383 DLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQL 440
+EAA KARE A + KR+ E + + L
Sbjct: 243 ------AEAAAAKAREA---------AAAAEAAAARARAAEAKRTGETYKPTAPEKML 285
|
Length = 420 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-04
Identities = 89/484 (18%), Positives = 176/484 (36%), Gaps = 45/484 (9%)
Query: 109 LKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQE 168
++ A +L++ +L S ++ ++A E Q+E + ++ Q+
Sbjct: 241 IQKVAPEIEKLQEDFEQL---LSLELRLQHLHGELVADEERLA-EEQEERQEAKNRLRQQ 296
Query: 169 RSSKTQAVN-LHKELEGRLQALNTELERNKHRELQLAEDNR--HLGEKVSSLEKECRLQA 225
+ + EL L A N +L EL+L ED + + L+ +
Sbjct: 297 LRTLEDQLKEARDELNQELSAANAKLA-ADRSELELLEDQKGAFEDADIEQLQAD----L 351
Query: 226 LNTELERNKHRELQLAEDNRHLGEKVSSLEKEC----ASLSLELKAAQAQYQQEVRAHEE 281
R++ E++ L K ++++ + +L+ + + + A E
Sbjct: 352 DQLPSIRSELEEVE--ARLDALTGKHQDVQRKYERLKQKIKEQLERDLEKNNERLAAIRE 409
Query: 282 TQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDRE 341
+ + EE + +L+ + + + + +E L R K+ +D E
Sbjct: 410 EKDRQKAAIEEDLQALESQLRQQLEAGKLEFNEEEYELELRLGRL---KQRLDSATATPE 466
Query: 342 DLQQQINLLKEGAELRQELEKS--KTLQSQVEQEQAKKFSLQSDLSVQTSEAA------H 393
+L+Q + + ++E E++ Q Q E Q +K ++ ++Q +E
Sbjct: 467 ELEQLEINDEALEKAQEEQEQAEANVEQLQSELRQLRKRRDEALEALQRAERRLLQLRQA 526
Query: 394 LKAREEQLSHEVAMLREAKRNIEEEYHKLKTKR-SVEDLQMKELQDQLETEQYFSTLYKT 452
L E QLS + L RN + + K S E L+ +L QL TLY
Sbjct: 527 LDELELQLSPQAGSLLHFLRNEAPGWEESIGKVISPELLERTDLDPQLVEGSDSDTLYGV 586
Query: 453 QAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTM 512
+ ++ + + N EL E LQ AVA+ + AEE + + E
Sbjct: 587 SLDLQRLDVPDYAANETELRERLQQAEEALQSAVAK-------QKQAEEQLVQANAELEE 639
Query: 513 KELELKD-LMAKHRSDLSSKESLLSNGKEREVD-----YKKSIDQLMKDREDLQQQINLL 566
++ + A ++ L L N ++ D + Q L Q+ L
Sbjct: 640 QKRAEAEARTALKQARL--DLQRLQNEQQSLKDKLELAIAERKQQAETQLRQLDAQLKQL 697
Query: 567 KEGK 570
E +
Sbjct: 698 LEQQ 701
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-04
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIM 666
+ L F RHPNI+T ++ L+V+ +M N L K + + + I I+
Sbjct: 50 VVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNIL 107
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEY----- 720
F GL+Y+H +HR++K S+ILI + + L SL + ++ Y
Sbjct: 108 FGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 721 -IATRWYRAPEILISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 778
+ + +PE+L + Y DI+S+G E+ + F + Q+++ ++
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF---QDMLRTQMLLQKLK 224
Query: 779 PNPPHADKFYAGFKSKHEREKFNQ 802
PP++ F + R K +Q
Sbjct: 225 -GPPYSPLDITTFPCEESRMKNSQ 247
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|220365 pfam09726, Macoilin, Transmembrane protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-04
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 6 LHGFQVDNAIPNGG----QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALR 61
V+N IP A L+ +++ + E+ Q + + +L Q +++ E +L+
Sbjct: 388 SANGTVENCIPENKISTPSAIERLEQDIKKLQAELQQARQNESELRNQISLLTSLERSLK 447
Query: 62 DEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETAT---- 117
++GQL+K +L Q + ++ K+K + Q + M ++LK+EA++
Sbjct: 448 SDLGQLKKENDML-------QTKLNSMVSAKQKDK---QSMQSMEKRLKSEADSRVNAEK 497
Query: 118 -----RLRKQSAELTVAKSAG------EQMVVELQNILATLEMERDTLQQEVATLQAKIS 166
+ RK+ E T A++A E+ L+ LEME L+ + L+ K
Sbjct: 498 QLAEEKKRKKEEEETAARAAAQAAASREECAESLKQAKQDLEMEIKKLEHD---LKLKEE 554
Query: 167 QERSSKTQAVNLH------KELEGRLQALNTELERNKHRELQLAEDNR 208
+ R + +A L KE E + AL ++N E L+ + R
Sbjct: 555 ECRMLEKEAQELRKYQESEKETEVLMSALQAMQDKNLMLENSLSAETR 602
|
This entry is a highly conserved protein present in eukaryotes. Length = 680 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-04
Identities = 39/205 (19%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 919 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEEL----- 973
LK ++ +S+L E+ L + D + I ++ K+ E L+Q+ LKE L
Sbjct: 685 GLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELEE 744
Query: 974 ------RKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEI--MNRKDINTTCKGKSKASS 1025
++ N E+++L ++++ + + L ++ + +
Sbjct: 745 DLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKLE 804
Query: 1026 ADVRKKEKECRKLQQEL---TQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELD 1082
+V + E R+++Q+L T E+E + + + Q++ +L+ Q+ L + +
Sbjct: 805 EEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDLKEQIKSIEKEIENLNGKKE 864
Query: 1083 SKDSEIEQLQGKLAALGSETASLSS 1107
+ E+E+L+ L L S L
Sbjct: 865 ELEEELEELEAALRDLESRLGDLKK 889
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|218636 pfam05557, MAD, Mitotic checkpoint protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 70/360 (19%), Positives = 136/360 (37%), Gaps = 16/360 (4%)
Query: 232 RNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQ---YQQEVRAHEETQKSRMV 288
+K +++L L E L + LKA + + E EE K
Sbjct: 83 EHKRAQIELERKASTLAENYERELDRNLELEVRLKALEELEKKAENEAAEAEEEAKLLKD 142
Query: 289 NKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQIN 348
+ S+++ E +D + + + +S ++ LS + R + + L + E+L++Q+
Sbjct: 143 KLDAESLKLQNEKEDQLKEAKESISRIKNDLSEMQCRAQNADTELKLLESELEELREQLE 202
Query: 349 -LLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAM 407
KE AE ++L+ + Q+ K L+ +L +A +K+ +EQL +
Sbjct: 203 ECQKELAEAEKKLQSLTSEQASSADNSVKIKHLEEELKRYEQDAEVVKSMKEQLLQIPEL 262
Query: 408 LREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRN 467
RE EE K E L+ + Q E++ K EL++E E
Sbjct: 263 ERELAALREENRKLRSMKEDNELLKEELEDLQSRLERFEKMREKLADLELEKEKLENELK 322
Query: 468 ILELEEERGDLTHRLQLAVARADSEALARSI-AEETVGELEKEKTMKELELKDLMAKHRS 526
+ + L R ++R + +E G + E L+ L + +
Sbjct: 323 SWKSLLQDIGLNLRTPDDLSRRIVVLQNEELQLKEKNGSISSSAKQLETTLQQLQLERQK 382
Query: 527 DLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQ 586
+S L KK ++ L LQ+++ L+ + + + +YDK +
Sbjct: 383 AVSEILEL-----------KKKLEALKALVRRLQRRLTLVTKERDGLRAILNSYDKELTE 431
|
This family consists of several eukaryotic mitotic checkpoint (Mitotic arrest deficient or MAD) proteins. The mitotic spindle checkpoint monitors proper attachment of the bipolar spindle to the kinetochores of aligned sister chromatids and causes a cell cycle arrest in prometaphase when failures occur. Multiple components of the mitotic spindle checkpoint have been identified in yeast and higher eukaryotes. In S.cerevisiae, the existence of a Mad1-dependent complex containing Mad2, Mad3, Bub3 and Cdc20 has been demonstrated. Length = 722 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-04
Identities = 71/329 (21%), Positives = 141/329 (42%), Gaps = 30/329 (9%)
Query: 212 EKVSSLEKECRLQALNTELERNK---HRELQLAEDNRHLGEKVSSLEKECASLSLELKAA 268
E++ + E R Q ER K ++ L + E + E L + +A
Sbjct: 187 ERLDLIIDEKRQQLERLRREREKAERYQALLKEKREYEGYELLKEKEA----LERQKEAI 242
Query: 269 QAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVD 328
+ Q + E + E+ EI + L++L K + DL +E L K E++
Sbjct: 243 ERQLA-SLEEELEKLTEEISELEKRLEEIEQLLEELNKKIK-DLGEEEQLRVKEKIGELE 300
Query: 329 -----YKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSD 383
++SI + ++ ED ++++ L+ E+ + L + + L+ ++E+E+ ++ L +
Sbjct: 301 AEIASLERSIAEKERELEDAEERLAKLEA--EIDKLLAEIEELEREIEEERKRRDKLTEE 358
Query: 384 LSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETE 443
+ E L+A E++ E A R+ ++ E+ KLK + +L+ + + Q E +
Sbjct: 359 YAELKEELEDLRAELEEVDKEFAETRDELKDYREKLEKLKREI--NELKRELDRLQEELQ 416
Query: 444 QYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRL-----QLAVARADSEALARSI 498
+ L +L + I ELEEE+ D + +L AD + +
Sbjct: 417 RLSEEL-----ADLNAAIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAADLSKYEQEL 471
Query: 499 A--EETVGELEKEKTMKELELKDLMAKHR 525
+E +EKE + + EL + A+ R
Sbjct: 472 YDLKEEYDRVEKELSKLQRELAEAEAQAR 500
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-04
Identities = 99/557 (17%), Positives = 194/557 (34%), Gaps = 55/557 (9%)
Query: 23 GELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQ 82
GEL ER E + +E + +L +Q + E L++ +L + L+ L +
Sbjct: 270 GELVADEERLAEEQEERQEAKNRLRQQ---LRTLEDQLKEARDELNQELSAANAKLAADR 326
Query: 83 RRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQN 142
+ + K E E+L+ + + +R + E+ A ++Q
Sbjct: 327 SELELLEDQKGAFE------DADIEQLQADLDQLPSIRSELEEVEARLDALTGKHQDVQR 380
Query: 143 ILATLEMERDT-LQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHREL 201
L+ + L++++ + + + + +E LQAL ++L + E
Sbjct: 381 KYERLKQKIKEQLERDLEKNNE---RLAAIREEKDRQKAAIEEDLQALESQL--RQQLEA 435
Query: 202 QLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASL 261
E N E L + + T + E E+ E L
Sbjct: 436 GKLEFNEEEYELELRLGRLKQRLDSATATPEELEQLEINDEALEKAQEEQEQAEANVEQL 495
Query: 262 SLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSN 321
EL+ + + + + A + E + +++ L SLL
Sbjct: 496 QSELRQLRKRRDEALEAL---------QRAERRLLQLRQ--ALDELELQLSPQAGSLLHF 544
Query: 322 GKEREVDYKKSIDQLMK----DREDLQQQINLLKEGAELRQELEKSKTLQS-QVEQEQAK 376
+ +++SI +++ +R DL Q L EG++ S LQ V A
Sbjct: 545 LRNEAPGWEESIGKVISPELLERTDLDPQ---LVEGSDSDTLYGVSLDLQRLDVPDYAAN 601
Query: 377 KFSLQSDLSVQT----SEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQ 432
+ L+ L S A K EEQL A L E KR E LK R L
Sbjct: 602 ETELRERLQQAEEALQSAVAKQKQAEEQLVQANAELEEQKRAEAEARTALKQAR----LD 657
Query: 433 MKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSE 492
++ LQ++ ++ + A + E + + +L+ + L + Q + +
Sbjct: 658 LQRLQNEQQSLK----DKLELA--IAERKQQAETQLRQLDAQLKQLLEQQQAFLEALKDD 711
Query: 493 ALARSIA-----EETVGELEKEKTMKELELKDLMAKHRSDLSS-KESLLSNGKEREVDYK 546
+ GEL+ + ++ + ++ L K+ +VD
Sbjct: 712 FRELRTERLAKWQVVEGELDNQLAQLSAAIEAARTQAKARLKELKKQYDRELASLDVD-P 770
Query: 547 KSIDQLMKDREDLQQQI 563
++ +L + E+L+ I
Sbjct: 771 NTVKELKRQIEELETTI 787
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 77/500 (15%), Positives = 194/500 (38%), Gaps = 14/500 (2%)
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVE 139
E+ ++A+ + ++A+ + ++ + EA A R+Q+A ++ + +
Sbjct: 1227 EAVKKAEEAKKDAEEAKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEARKADE-LKK 1285
Query: 140 LQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHR 199
+ E ++ +++ + K ++E +A +E + + A + E K
Sbjct: 1286 AEEKKKADEAKKAEEKKKADEAKKK-AEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKA 1344
Query: 200 ELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECA 259
+ ++ + E++ E + K + + + ++ +E
Sbjct: 1345 AEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDK 1404
Query: 260 SLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLL 319
+ ELK A A ++ A ++ ++ + ++ + E K+ + K ++E+
Sbjct: 1405 KKADELKKAAAAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKK 1464
Query: 320 SNGKEREVD-------YKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQ 372
+ ++ D K D+ K E+ +++ + K+ AE +++ +++K + +
Sbjct: 1465 KAEEAKKADEAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKA 1524
Query: 373 EQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIE---EEYHKLKTKRSVE 429
++AKK KA E + + E+ E K+ E E K R E
Sbjct: 1525 DEAKKAEEAKKADEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAE 1584
Query: 430 DLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARA 489
+ + E E + + K +A E K+ + + + EL++ + QL A
Sbjct: 1585 EAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIK-AEELKKAEEEKKKVEQLKKKEA 1643
Query: 490 DSEALARSI-AEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKS 548
+ + A + E +++ + K+ E A+ E + ++E + K
Sbjct: 1644 EEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEAKKAEEDEKKAAEALKKEAEEAKK 1703
Query: 549 IDQLMKDREDLQQQINLLKE 568
++L K + +++ LK+
Sbjct: 1704 AEELKKKEAEEKKKAEELKK 1723
|
Length = 2084 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-04
Identities = 43/222 (19%), Positives = 85/222 (38%), Gaps = 6/222 (2%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
E +D + +++ LE L Q + LR ++ L L L +E +R
Sbjct: 56 EQQDQRAKLEKQLKSLETEIASLEAQLIETADDLKKLRKQIADLNARLNALEVQEREQRR 115
Query: 84 RADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNI 143
R + +++ N + + +A+ + RL L A+ + + L+
Sbjct: 116 RLAEQLAALQRSGRNPPPALLVSPE---DAQRSVRLAIYYGALNPAR---AERIDALKAT 169
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQL 203
L L R + E A L +S++R+ + + L +E + L LN+EL ++ + +L
Sbjct: 170 LKQLAAVRAEIAAEQAELTTLLSEQRAQQAKLAQLLEERKKTLAQLNSELSADQKKLEEL 229
Query: 204 AEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNR 245
+ L +++S E + AE R
Sbjct: 230 RANESRLKNEIASAEAAAAKAREAAAAAEAAAARARAAEAKR 271
|
Length = 420 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-04
Identities = 53/306 (17%), Positives = 128/306 (41%), Gaps = 36/306 (11%)
Query: 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALG 850
+ + E E+ + + + ++EL+ELQ ++ E +L+ EL+ E+E+LQ +L L
Sbjct: 235 KELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELK 294
Query: 851 SETASLSSADVENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSEND 910
E ++E + S +++ E + ++ ++ + +KI E +
Sbjct: 295 EE-----IEELEGEISLLRERLEEL------ENELEE---LEERLEELKEKIEALKEELE 340
Query: 911 KQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVD----YKKSIDQLMKDREDLQQQI 966
++ T EL+ L+A+ E LS E + ++ + +L + +++ ++
Sbjct: 341 ERETL-LEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNEL 399
Query: 967 NLLKEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSA 1026
LK E+ E + + + LK+E + +L +
Sbjct: 400 EELKREIESLEERLERLSERLEDLKEELKELEAELEEL-----------------QTELE 442
Query: 1027 DVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 1086
++ ++ +E + +EL ++ + + + Q+ELQ L+ ++ +L+ E +
Sbjct: 443 ELNEELEELEEQLEELRDRLKELERELAELQEELQRLEKELSSLEARLDRLEAEQRASQG 502
Query: 1087 EIEQLQ 1092
L+
Sbjct: 503 VRAVLE 508
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-04
Identities = 42/194 (21%), Positives = 86/194 (44%), Gaps = 10/194 (5%)
Query: 385 SVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQ 444
S + K ++L E+A L +EEE LK + + ++EL+ QLE +
Sbjct: 656 SRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELE 715
Query: 445 YFSTLYKTQAHELKEELDERSRNILELEEERGDLT----------HRLQLAVARADSEAL 494
K + L+EEL++ + ELEEE +L L+ + +
Sbjct: 716 RQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALA 775
Query: 495 ARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMK 554
E + E + + EL++ + + L + E L + ++R ++ I++L +
Sbjct: 776 KLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEE 835
Query: 555 DREDLQQQINLLKE 568
+ E+L+++++ L+E
Sbjct: 836 EIEELEEKLDELEE 849
|
Length = 1163 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-04
Identities = 42/206 (20%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 363 SKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKL 422
S++ +++++ + + L+ +LS SE ++ R ++LS E++ IE+E +L
Sbjct: 669 SRSEPAELQRLRERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQL 728
Query: 423 KTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLT--- 479
+ + +++EL++ L + + K++ EL+ ++E ++ +LEE DL
Sbjct: 729 EQEEEKLKERLEELEEDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARL 788
Query: 480 --HRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSN 537
R+ A S E + E+E++ LE + L ++ + +
Sbjct: 789 SHSRIPEIQAELSKLEEEVSRIEARLREIEQKLNRLTLEKEYL----EKEIQELQEQRID 844
Query: 538 GKEREVDYKKSIDQLMKDREDLQQQI 563
KE+ +K I+ L +E+L++++
Sbjct: 845 LKEQIKSIEKEIENLNGKKEELEEEL 870
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-04
Identities = 81/454 (17%), Positives = 175/454 (38%), Gaps = 23/454 (5%)
Query: 12 DNAIPNGGQANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNL 71
D A+ + + + +E+ + E+ QL +R+ + E + R LR + +LE L
Sbjct: 475 DEALEKAQEEQEQAEANVEQLQSELRQLRKRRDEALEALQRAERRLLQLRQALDELELQL 534
Query: 72 TILRHDLKE--SQRRADNESETKKKAEVNLQVISDMHEKLKTEAETAT----RLRKQSAE 125
+ L E K L +D+ +L +++ T L Q +
Sbjct: 535 SPQAGSLLHFLRNEAPGWEESIGKVISPELLERTDLDPQLVEGSDSDTLYGVSLDLQRLD 594
Query: 126 LTVAKSAGEQMVVELQNILATLEMERDTLQQ---EVATLQAKISQERSSKTQAVNLHKEL 182
+ + ++ LQ L+ +Q ++ A++ +++ ++ +A K+
Sbjct: 595 VPDYAANETELRERLQQAEEALQSAVAKQKQAEEQLVQANAELEEQKRAEAEARTALKQA 654
Query: 183 EGRLQALNTELERNKHR-ELQLAEDNRHLGEKVSSLEKECRL----QALNTELERNKHRE 237
LQ L E + K + EL +AE + ++ L+ + + Q E ++ RE
Sbjct: 655 RLDLQRLQNEQQSLKDKLELAIAERKQQAETQLRQLDAQLKQLLEQQQAFLEALKDDFRE 714
Query: 238 LQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEI 297
L+ E L+ + A LS ++AA+ Q + ++ ++ + + +
Sbjct: 715 LRT-ERLAKWQVVEGELDNQLAQLSAAIEAARTQAKARLKELKKQYDRELASL-DVDPNT 772
Query: 298 VKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKS---IDQLMKDREDLQQQI-NLLKEG 353
VKELK + + + + +E +++ D L ++R +L Q+ L
Sbjct: 773 VKELKRQIEELETTIERIAVRRPEVREYRAFMQETWLHRDSLREERPNLAIQLRELESSA 832
Query: 354 AELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKR 413
EL+QEL L + + K + L Q + L ++A L+E
Sbjct: 833 EELQQEL---TRLIKDTKLRRKKLEQERKALEKQLDQLDELLRGLRDEMRQLAELKEPAN 889
Query: 414 NIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFS 447
+ E + +E+ + K + + +++
Sbjct: 890 ANQAEGSISERLDQLEEFKRKRKRLSGDLKKFLE 923
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-04
Identities = 30/149 (20%), Positives = 64/149 (42%)
Query: 30 ERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNES 89
+ + + L E++RQL Q +++ A + L+ QL+ + L+ + ++ A N +
Sbjct: 147 QDLQTRLKTLAEQRRQLEAQAQSLQASQKQLQASATQLKSQVLDLKLRSAQIEQEAQNLA 206
Query: 90 ETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEM 149
A+ + ++ + A+ + Q ++ +A + + E + L LE
Sbjct: 207 TRANAAQARTEELARRAAAAQQTAQAIQQRDAQISQKAQQIAARAEQIRERERQLQRLET 266
Query: 150 ERDTLQQEVATLQAKISQERSSKTQAVNL 178
+ L+QEVA L+A + QA
Sbjct: 267 AQARLEQEVAQLEAYYQAYVRLRQQAAAT 295
|
Length = 499 |
| >gnl|CDD|225638 COG3096, MukB, Uncharacterized protein involved in chromosome partitioning [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-04
Identities = 90/442 (20%), Positives = 160/442 (36%), Gaps = 57/442 (12%)
Query: 35 EMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKK 94
E + + R+L+E A E + L T LR K + +AD E E +
Sbjct: 305 EQYRHVDMSRELAELNGAEGDLEADYQAASDHLNLVQTALRQQEKIERYQADLE-ELTIR 363
Query: 95 AEVNLQVISDMHEKLKTEAETAT-------RLRKQSAELTVAKSAGEQMVVELQNILATL 147
E +V+ + +E+ + A L+ Q A+ A + ++ Q +A L
Sbjct: 364 LEEQNEVVEEANERQEENEARAEAAELEVDELKSQLADYQQALDVQQTRAIQYQQAIAAL 423
Query: 148 EMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDN 207
E ++ + L A ++E + + + + +L + + + +A+
Sbjct: 424 ERAKELCH--LPDLTADSAEE---------WLETFQAKEEEATEKLLSLEQK-MSMAQAA 471
Query: 208 RHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKA 267
E+ L + +E L+ D RHL E+V L LS EL+
Sbjct: 472 HSQFEQAYQLVVAIAGELARSEAWDVARELLREGPDQRHLAEQVQPLR---MRLS-ELEQ 527
Query: 268 AQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREV 327
Q Q R + K + N + EL+ L + + + S +SN +E+ +
Sbjct: 528 RLRQQQSAERLLADFCKRQGKNLDAE------ELEALHQELEALIESLSDSVSNAREQRM 581
Query: 328 DYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQ 387
L +++E LQ +I L Q Q+ +EQ + +D
Sbjct: 582 -------ALRQEQEQLQSRI------QSLMQRAPVWLAAQNALEQLSEQSGEEFTDSQDV 628
Query: 388 TSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQ-------- 439
T L RE + + E L K ++EE +L ED ++ L ++
Sbjct: 629 TEYMQQLLEREREATVERDELGARKNALDEEIERLSQPGGSEDQRLNALAERFGGVLLSE 688
Query: 440 ------LETEQYFSTLYKTQAH 455
+E YFS LY H
Sbjct: 689 IYDDVTIEDAPYFSALYGPSRH 710
|
Length = 1480 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 26/194 (13%)
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCN--- 671
+HPNI+ L + V +VFEY E DL + ++ + + C
Sbjct: 53 QHPNILQCLG--QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRA 728
G++++H +H DL N + ++K+GD G+ S TE + RW A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169
Query: 729 PEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI-----VNL 776
PE++ T ++W+LG L E+ + + + S L + V L
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 777 VRPN--PPHADKFY 788
+P P+++++Y
Sbjct: 230 FKPQLELPYSERWY 243
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-04
Identities = 66/372 (17%), Positives = 123/372 (33%), Gaps = 10/372 (2%)
Query: 107 EKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKIS 166
E+LK E L + +L K ++ + + L +++ +E L
Sbjct: 174 ERLKKLIEETENLAELIIDLEELKLQELKLKEQAKKALEYYQLKEKLELEEENLLYLDYL 233
Query: 167 QERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQAL 226
+ + + E + + + L EK L++E L
Sbjct: 234 KLNEERIDLLQELLRDEQEEIESSKQELEKEEEILAQVLKENKEEEKEKKLQEEELKL-L 292
Query: 227 NTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSR 286
E E K L+L EK+ EKE L ELK ++E E +
Sbjct: 293 AKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKK-----EKEEIEELEKELKE 347
Query: 287 MVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQ 346
+ K EA E ++L+ L K + ER K ++ ++ + + +++
Sbjct: 348 LEIKREAEEEEEEQLEKLQEKLEQLEEELLAKKKLESERLSSAAKLKEEELELKNEEEKE 407
Query: 347 INLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVA 406
LL E +E ++L K + + E+ ++ + + E+Q +
Sbjct: 408 AKLLLELSEQEEDLLKEEKKEELKIVEELEESLETKQGKLTEEKE----ELEKQALKLLK 463
Query: 407 MLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSR 466
E K++ + K + + Q E Q S + A L D
Sbjct: 464 DKLELKKSEDLLKETKLVKLLEQLELLLLRQKLEEASQKESKAREGLAVLLALIKDGVGL 523
Query: 467 NILELEEERGDL 478
I+ GDL
Sbjct: 524 RIISAAGRGGDL 535
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-04
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 38/202 (18%)
Query: 304 LMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKS 363
L+ +S S++S L E + I QL + LQ Q+ L++ E+ E ++
Sbjct: 127 LIKGQQSLFESRKSTLRAQLELIL---AQIKQLEAELAGLQAQLQALRQQLEVISEELEA 183
Query: 364 KTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLR-EAKRNIEEEYHKL 422
+ +++++ S L+ E+ + + R EA+ L
Sbjct: 184 ---RRKLKEKGL------------VSRLELLELERERAEAQGELGRLEAELE------VL 222
Query: 423 KTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRL 482
K + L+ ++++ E+ EEL E + EL E RL
Sbjct: 223 KRQIDELQLERQQIEQTF-------------REEVLEELTEAQARLAELRERLNKARDRL 269
Query: 483 QLAVARADSEALARSIAEETVG 504
Q + R+ + +S+ TVG
Sbjct: 270 QRLIIRSPVDGTVQSLKVHTVG 291
|
Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-04
Identities = 40/203 (19%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 919 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSN 978
EL++ + + ++ +S L +E + ++ + +L ++ E+L+ +I+LL+E L + N
Sbjct: 257 ELQEELEEAEKEIEELKSELEELREELEELQEELLELKEEIEELEGEISLLRERLEELEN 316
Query: 979 SSEEMEKLHKQLK-----QEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEK 1033
EE+E+ ++LK ++ L+ + ++ + + SA + + E+
Sbjct: 317 ELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEE 376
Query: 1034 ECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQG 1093
L++EL + + ++ + EL+EL+ ++ +L L+ E+++L+
Sbjct: 377 LFEALREELAELEAELAEI----RNELEELKREIESLEERLERLSERLEDLKEELKELEA 432
Query: 1094 KLAALGSETASLSSADVENDESY 1116
+L L +E L+ E +E
Sbjct: 433 ELEELQTELEELNEELEELEEQL 455
|
Length = 1163 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-04
Identities = 109/497 (21%), Positives = 216/497 (43%), Gaps = 47/497 (9%)
Query: 105 MHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAK 164
E+ K E E L ++ +EL+ S E + Q ++A L+ + L+ + L+ +
Sbjct: 1 ELERQKRELENQ--LYRKESELSQLSSKLE----DEQALVAQLQKKIKELEARIRELEEE 54
Query: 165 ISQERSSKTQAVNLHKELEGRLQALNTELER-----------NKHRELQLAEDNRHLGEK 213
+ ER+++ +A +L L+ L+ LE NK RE +LA+ + L E
Sbjct: 55 LEAERAARAKAEKARADLSRELEELSERLEEAGGATAAQIELNKKREAELAKLRKDLEEA 114
Query: 214 VSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQ 273
E +AL T ++++ +L+E L ++ + EKE + L E+ AQ
Sbjct: 115 NLQHE-----EALATLRKKHQDAINELSEQIEQLQKQKAKAEKEKSQLQAEVDDLLAQLD 169
Query: 274 QEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREV----DY 329
Q +A +K + E+ + ++ D + + +DL+S++S L + +
Sbjct: 170 QIAKAKLNAEK--KAKQLESQLSELQVKLDELQRQLNDLTSQKSRLQSENSDLTRQLEEA 227
Query: 330 KKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTS 389
+ + L K + L+ Q+ K E +E + LQ+Q+ Q + SL+ L ++
Sbjct: 228 EAQVSNLSKLKSQLESQLEEAKRSLE--EESRERANLQAQLRQLEHDLDSLREQLEEESE 285
Query: 390 EAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTL 449
A L E QLS A +++ + E E +E+L+ K Q E E+
Sbjct: 286 AKAEL---ERQLSKANAEIQQWRSKFESE--GALRAEELEELKKKLNQKISELEE----- 335
Query: 450 YKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKE 509
+A K + E++++ L+ E E LQ+ + RA++ A ++ ++ E
Sbjct: 336 -AAEAANAKCDSLEKTKSRLQSELE------DLQIELERANAAASELEKKQKNFDKILAE 388
Query: 510 KTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEG 569
K EL+ + + + + + L K + K ++ L ++ ++LQ +I+ L +
Sbjct: 389 WKRKVDELQAELDTAQREARNLSTELFRLKNELEELKDQVEALRRENKNLQDEIHDLTDQ 448
Query: 570 KGAYGIVYKAYDKNNKQ 586
G G +K ++
Sbjct: 449 LGEGGRNVHELEKARRR 465
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-04
Identities = 43/257 (16%), Positives = 97/257 (37%), Gaps = 24/257 (9%)
Query: 38 QLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNE-SETKKKAE 96
+++ +Q+ ++ A+ + +D+ +LEK L L+ + + ET +
Sbjct: 35 ADDKQLKQIQKEIAALEKKIREQQDQRAKLEKQLK----SLETEIASLEAQLIETADDLK 90
Query: 97 VNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQ 156
+ I+D++ +L + R+Q L +A ++ +N L + + Q+
Sbjct: 91 KLRKQIADLNARLNALE---VQEREQRRRLAEQLAALQRSG---RNPPPALLVSPEDAQR 144
Query: 157 EV--ATLQAKISQERSSKTQAVNLHKELEGRLQALNT-----ELERNKHRELQLAEDNRH 209
V A ++ R+ + L+ L+ L E+ + L + +
Sbjct: 145 SVRLAIYYGALNPARAERI------DALKATLKQLAAVRAEIAAEQAELTTLLSEQRAQQ 198
Query: 210 LGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQ 269
E++ L LN+EL ++ + +L + L +++S E A AA+
Sbjct: 199 AKLAQLLEERKKTLAQLNSELSADQKKLEELRANESRLKNEIASAEAAAAKAREAAAAAE 258
Query: 270 AQYQQEVRAHEETQKSR 286
A + A +
Sbjct: 259 AAAARARAAEAKRTGET 275
|
Length = 420 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 24/235 (10%)
Query: 9 FQVDNAIPNGGQANGELKDLLERERREMSQLEERQRQLS---EQYEAVSARETALRDEMG 65
FQ+D+ P EL +R ++ E + +L ++ EAV A R +
Sbjct: 74 FQLDDIRPQLRALRTELGTAQGEKRAAETEREAARSELQKARQEREAVRQELAAARQNLA 133
Query: 66 QLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAE 125
+ ++ L L ++ Q R +E +++ E Q + ++L+ +AT+L+ Q +
Sbjct: 134 KAQQELARLTKQAQDLQTRLKTLAEQRRQLEAQAQSLQASQKQLQA---SATQLKSQVLD 190
Query: 126 LTVAKSAGEQMVVELQNI----------LATLEMERDTLQQEVATLQAKISQERSSKTQA 175
L + + EQ L LA Q + A+ISQ+
Sbjct: 191 LKLRSAQIEQEAQNLATRANAAQARTEELARRAAAAQQTAQAIQQRDAQISQKAQQIAAR 250
Query: 176 VNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTEL 230
+E E +LQ L T R + QL E R QA T+
Sbjct: 251 AEQIRERERQLQRLETAQARLEQEVAQL--------EAYYQAYVRLRQQAAATQR 297
|
Length = 499 |
| >gnl|CDD|129694 TIGR00606, rad50, rad50 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 0.001
Identities = 96/576 (16%), Positives = 216/576 (37%), Gaps = 79/576 (13%)
Query: 37 SQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQ-------------- 82
S+ +Q Q E + + + LEK L+ +KE Q
Sbjct: 419 SKERLKQEQADEIRDEKKGLGRTIELKKEILEKKQEELKFVIKELQQLEGSSDRILELDQ 478
Query: 83 --RRADNE---------SETKKKAEVNLQVI-SDMHEKLKTEAETATRLRKQSAELTVAK 130
R+A+ E +ET KK +LQ +D+ KL+ + +L + T +
Sbjct: 479 ELRKAERELSKAEKNSLTETLKKEVKSLQNEKADLDRKLRKLDQEMEQLNHHTTTRTQME 538
Query: 131 SAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALN 190
+ + + + I D L + K E +++ + RL LN
Sbjct: 539 MLTKDKMDKDEQIRKIKSRHSDELTSLLGYFPNKKQLEDWLHSKS-KEINQTRDRLAKLN 597
Query: 191 TELERNKHRELQLAEDNRHLGEKVSSLEKE----CRLQALNTELERNKHRELQLAEDNRH 246
EL + + + + E++SS E + C Q ++LER K + ++
Sbjct: 598 KELASLEQNKNHINNELESKEEQLSSYEDKLFDVCGSQDEESDLERLKEEIEKSSKQRAM 657
Query: 247 LGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMA 306
L + + L+ E ++ Q+ + E Q E + +L+ +
Sbjct: 658 LAGATAVYSQFITQLTDENQSCCPVCQRVFQTEAELQ------------EFISDLQSKLR 705
Query: 307 KHRSDLSSKESLLSNGKEREVD--------YKKSIDQLMKDREDLQQQI-NLLKEGAELR 357
L S ES L KE+ D + ID K+ +L+ ++ + ++ L+
Sbjct: 706 LAPDKLKSTESELKK-KEKRRDEMLGLAPGRQSIIDLKEKEIPELRNKLQKVNRDIQRLK 764
Query: 358 QELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEE 417
++E+ +TL + E+ +D+++ LK E +++ + A
Sbjct: 765 NDIEEQETLLGTIMPEEESAKVCLTDVTIMERFQMELKDVERKIAQQAA----------- 813
Query: 418 EYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGD 477
K + S D ++++ + + +Q+ ++ ++ + ++ I L+ + +
Sbjct: 814 -----KLQGSDLDRTVQQVNQEKQEKQHELDTVVSKIELNRKLIQDQQEQIQHLKSKTNE 868
Query: 478 L-THRLQLAVARADSEALARSIAEET---------VGELEKEKTMKELELKDLMAKHRSD 527
L + +LQ+ + + E + + + +++ + E L+ +
Sbjct: 869 LKSEKLQIGTNLQRRQQFEEQLVELSTEVQSLIREIKDAKEQDSPLETFLEKDQQEKEEL 928
Query: 528 LSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI 563
+SSKE+ +++ D K+ + + +D++ +I
Sbjct: 929 ISSKETSNKKAQDKVNDIKEKVKNIHGYMKDIENKI 964
|
All proteins in this family for which functions are known are involvedin recombination, recombinational repair, and/or non-homologous end joining.They are components of an exonuclease complex with MRE11 homologs. This family is distantly related to the SbcC family of bacterial proteins.This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). Length = 1311 |
| >gnl|CDD|227061 COG4717, COG4717, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 0.001
Identities = 103/555 (18%), Positives = 191/555 (34%), Gaps = 59/555 (10%)
Query: 27 DLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILR-HDLKESQRRA 85
L R +++S+++ +L+E + A LRD+ R HDL+ +
Sbjct: 316 QALVRLHQQLSEIKASAFELTETLAGIEAD---LRDKEEAAGNGFEAERVHDLRSLECML 372
Query: 86 DNESETKKKAEVNLQVISDMHEKL----KTEAETATRLRKQSAELTVAKSAGEQMVVELQ 141
+S ++ + + EK + E E RL E+ A E+ +
Sbjct: 373 RYQSSQRELKQTEAAYCKRLDEKRLFEDEAEEEARQRLADDEEEVRAGDEAREEKIAANS 432
Query: 142 NIL---ATLEM--ERDTLQQEVATLQAKISQERSSKT-QAVNLHKELEGRLQALNTELER 195
++ + RDT Q+ L+ K + KT + L G L + L
Sbjct: 433 QVIDKEEVCNLYDRRDTAWQKQRFLREKQTAFERQKTEHTKIIALRLAGMLLVALSRLLT 492
Query: 196 NKHRELQLAEDNRH--LGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSS 253
+ ++ A E SS +A T++ R L E
Sbjct: 493 SLIFQIIFAVAQIVFLSAEIKSSSRAVREEKAAVTDIPEELARLLITDE----------- 541
Query: 254 LEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLS 313
L A Q +R H + + + E A + A S
Sbjct: 542 ---------LPELAVDLLVQSRIRQHWQQLRKALDQLEAAYEALEGRFAAAEAAMAEWQS 592
Query: 314 S-KESLLSNGKEREVDYKKSID--QLMKDREDLQQQI-NLLKEGAELRQELEKSKTLQSQ 369
+E+L G RE+ ++ +D MKD + L Q+ L + A LR+E + +
Sbjct: 593 EWEEALDELGLSRELSPEQQLDILSTMKDLKKLMQKKAELTHQVARLREEQA---AFEER 649
Query: 370 VEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVE 429
VE A + DLS A E Q + + E + +TK +
Sbjct: 650 VEGLLAVLEAQFIDLSTLFCVQRLRVAAELQKE---------EARLALEGNIERTKELND 700
Query: 430 DLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARA 489
+L+ + + E F +E + + + E L QL A
Sbjct: 701 ELRAELELHRKEILDLFDCGTADTEDAFREA-AREEQQLTQRESRLESLEA--QLEGVAA 757
Query: 490 DSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSI 549
++ L+ S+ + + E E E D + + +L ++ + LS +++ ++
Sbjct: 758 EAYELSASLDQRELKEEELA---LLEEAIDALDEEVEELHAQVAALSRQIA-QLEGGGTV 813
Query: 550 DQLMKDREDLQQQIN 564
+L + RE L++ +
Sbjct: 814 AELRQRRESLKEDLE 828
|
Length = 984 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 18/46 (39%), Positives = 28/46 (60%)
Query: 662 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707
I+ +M Q+ GL +H ++HRD+KP N+L+ +KI D G A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|225747 COG3206, GumC, Uncharacterized protein involved in exopolysaccharide biosynthesis [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 16/178 (8%)
Query: 38 QLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESET----KK 93
QL Q+ + + SAR + E +L L +L + + R ES T ++
Sbjct: 234 QLLSEQQLSALNTQLQSARARLAQAE-ARLASLLQLLPLGREAAALREVLESPTIQDLRQ 292
Query: 94 KAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDT 153
+ Q I+D+ +L + L Q AEL +Q+ EL+ ILA+L E
Sbjct: 293 QYAQVRQQIADLSTELGAKHPQLVALEAQLAELR------QQIAAELRQILASLPNELAL 346
Query: 154 LQQEVATLQAKISQERSSKTQAVNLHK---ELEGRLQALNTELER--NKHRELQLAED 206
L+Q+ A L+ +++Q + ++ L ELE +A + E +++EL + E
Sbjct: 347 LEQQEAALEKELAQLKGRLSKLPKLQVQLRELEREAEAARSLYETLLQRYQELSIQEA 404
|
Length = 458 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 582 KNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--VNNKDLY 638
K +YV +++I EA N + + L + HPNI+ Y+A + + +L+
Sbjct: 22 KPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVP----YRATFIADNELW 75
Query: 639 VVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694
VV +M DL + ++ I YI+ + L YIH +HR +K S+ILI
Sbjct: 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 695 KSCSIKIGDLGLARSLSDSKECLT------EY-IATRWYRAPEILISNRR-YTHHVDIWS 746
+ + L S+ + + L +Y + + +PE+L N + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 747 LGCILAEM 754
+G E+
Sbjct: 196 VGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|222878 PHA02562, 46, endonuclease subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 31/180 (17%), Positives = 69/180 (38%), Gaps = 9/180 (5%)
Query: 935 ESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQEQ 994
E E + D+L+++ + ++ +I L +EL E+ +L
Sbjct: 205 EEQRKKNGENIARKQNKYDELVEEAKTIKAEIEELTDELLNLVMDIEDPSAALNKLNTAA 264
Query: 995 LL---KAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQ 1051
K + K+ ++ + + TC + + K + + ++LQ L + ++
Sbjct: 265 AKIKSKIEQFQKVIKMYEKGGVCPTCTQQISEGPDRITKIKDKLKELQHSLEKLDTAIDE 324
Query: 1052 VVVK------CQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASL 1105
+ K+L EL++++ S + L + + IE+LQ + E A L
Sbjct: 325 LEEIMDEFNEQSKKLLELKNKISTNKQSLITLVDKAKKVKAAIEELQAEFVDNAEELAKL 384
|
Length = 562 |
| >gnl|CDD|225288 COG2433, COG2433, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 22/97 (22%), Positives = 51/97 (52%)
Query: 30 ERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNES 89
E ERRE++ E+R ++L E E + + L+ E+ +L++ + L +L+ +R ++
Sbjct: 411 EEERREITVYEKRIKKLEETVERLEEENSELKRELEELKREIEKLESELERFRREVRDKV 470
Query: 90 ETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAEL 126
++ + I + ++L+ + + L ++ AEL
Sbjct: 471 RKDREIRARDRRIERLEKELEEKKKRVEELERKLAEL 507
|
Length = 652 |
| >gnl|CDD|116500 pfam07888, CALCOCO1, Calcium binding and coiled-coil domain (CALCOCO1) like | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 63/325 (19%), Positives = 128/325 (39%), Gaps = 29/325 (8%)
Query: 25 LKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRR 84
L++ LE +RE + L ++ L + +R + QLE L +E + +
Sbjct: 141 LQNQLEGCQRERNDLMKKFLALEGDV-------SDMRSRIEQLETALRHSTEKTEELEEQ 193
Query: 85 ADNESETKKKAEVNLQVISDMHEKLKTEAETATR---LRKQSAELTVAKSAGEQMVVELQ 141
+ + ++ + L AE R L + LT K ++++ Q
Sbjct: 194 HKEAQSSSESM------SAERNALLAQRAENQQRILELEQDIQTLTQKKQENDRVLEGTQ 247
Query: 142 NILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHREL 201
+I A LE + L+Q + + + E + + +++L L+ L LE ++ +
Sbjct: 248 DIEAELERMKGELKQRLKKMTIQRRDEETERIDLQLENEQLHEDLRTLQERLESSQQKAG 307
Query: 202 QLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASL 261
L E+ LG ++ + L+ + LQL++ N L E S +E +L
Sbjct: 308 LLGEELASLGSL-----RDHTIAELHQSRLESAQMSLQLSQLNLALKEGQSQWAQERETL 362
Query: 262 SLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSN 321
++A+A + + E K EE E + + L + + LS
Sbjct: 363 ---RQSAEADKDRIQKLSAELLK-----LEEWLQEERSQREKLEVELGIEKDCNRVQLSE 414
Query: 322 GKEREVDYKKSIDQLMKDREDLQQQ 346
+ + + ++ L K++E LQ++
Sbjct: 415 NRRELSELRSALRVLQKEKEQLQEE 439
|
Proteins found in this family are similar to the coiled-coil transcriptional coactivator protein coexpressed by Mus musculus (CoCoA/CALCOCO1). This protein binds to a highly conserved N-terminal domain of p160 coactivators, such as GRIP1, and thus enhances transcriptional activation by a number of nuclear receptors. CALCOCO1 has a central coiled-coil region with three leucine zipper motifs, which is required for its interaction with GRIP1 and may regulate the autonomous transcriptional activation activity of the C-terminal region. Length = 546 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.002
Identities = 34/145 (23%), Positives = 71/145 (48%), Gaps = 4/145 (2%)
Query: 25 LKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRR 84
L++L + EE + +LS E + ALR+E+ +LE L +R++L+E +R
Sbjct: 346 LEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKRE 405
Query: 85 ADNESETKKKA----EVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVEL 140
++ E ++ E + + ++ +L+ L ++ EL + EL
Sbjct: 406 IESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKEL 465
Query: 141 QNILATLEMERDTLQQEVATLQAKI 165
+ LA L+ E L++E+++L+A++
Sbjct: 466 ERELAELQEELQRLEKELSSLEARL 490
|
Length = 1163 |
| >gnl|CDD|205692 pfam13514, AAA_27, AAA domain | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 74/423 (17%), Positives = 145/423 (34%), Gaps = 26/423 (6%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEK---NLTILRH 76
A ELK+L E E RE+ + L + + LR E+ QLEK L LR
Sbjct: 154 VALKELKEL-EAEIREVQLKTRTWKDLVKALDEAEEELANLRKELRQLEKEKQRLERLRR 212
Query: 77 DLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETAT-RLRKQSAELTVAKSAGEQ 135
L R E + EV + + AE R + + E
Sbjct: 213 LLPLLAERKALEQQLAALGEVIDLPPDAVERYEEARAELRAARRNLELLTERLEALQAEL 272
Query: 136 MVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELER 195
+ L L + L Q+ + + + N + L + + +
Sbjct: 273 DEISLDEELLAQAAAIEALHQQRGEYRNAEQDLPDREGEIANAREAAAALLAQIGPDADE 332
Query: 196 NKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLE 255
L+ + + E V+ LEK R +AL+ L+ + + + + + ++++L
Sbjct: 333 EAVESLRPSLAAK---ETVTELEK--RKEALDQALKSARDALEERERELKQVRAQLAALP 387
Query: 256 KECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKEL----KDLMAKHRSD 311
L A A ++ A + + + + + L DL
Sbjct: 388 TVTVPEPLRAALADALRAGDIDAALAALEQEVAVAKRELAQALSRLGLWRGDLEELVALP 447
Query: 312 LSSKESLLSNGKERE------VDYKKSIDQLMKDREDLQQQINLLKEGAEL--RQELEKS 363
+ S E + + KE E + + +L +D E L+ Q+ L + +E+ +
Sbjct: 448 VPSAEQVQAFLKEAEEIMQAKRQKRDRLLELEEDLETLELQLRHLDAAGAVPTEEEVAAA 507
Query: 364 KTLQSQVEQEQAKKFSLQSDLSVQTSEAA--HLKAREEQLSH--EVAMLREAKRNIEEEY 419
+ + + Q+ + ++L + EA + + L V L+ ++ E
Sbjct: 508 RARRDALWQDIRRGYALLEPTASAYEEAVESADQLADRLLREAQLVGELQSLRQQEEAAR 567
Query: 420 HKL 422
+L
Sbjct: 568 RRL 570
|
This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.002
Identities = 85/564 (15%), Positives = 186/564 (32%), Gaps = 27/564 (4%)
Query: 24 ELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQR 83
ELK L + ++E ++EE +++L E A E EK + L + +
Sbjct: 323 ELKKLEKELKKEKEEIEELEKELKELEIKREAEEEEEEQLEKLQEKLEQLEEELLAKKKL 382
Query: 84 RADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNI 143
++ S K E L++ + + + EA+ L +Q +L + E +VE
Sbjct: 383 ESERLSSAAKLKEEELELKN----EEEKEAKLLLELSEQEEDLLKEEKKEELKIVEELEE 438
Query: 144 LATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQL 203
+ + T ++E QA + + K+ E L+ + L L
Sbjct: 439 SLETKQGKLTEEKEELEKQALKLLKDKLEL------KKSEDLLKETKLVKLLEQLELLLL 492
Query: 204 AEDNRHLGEKVSSLEKEC-RLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLS 262
+ +K S + L AL + + + + + A +
Sbjct: 493 RQKLEEASQKESKAREGLAVLLALIKDGVGLRIISAAGRGGDLGVAVANYKVAISVAVIV 552
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
A +++ T+ ++K +A D + + L+
Sbjct: 553 EVSAVADEVDERQKLVRALTELPLPARTFVLLDPLLKLPLKSIAVLEIDPALNLAQLNKA 612
Query: 323 KEREVDYKKSIDQLMKDRED------------LQQQINLLKEGAELRQELEKSKTLQSQV 370
+ K + +D + + E E + K S++
Sbjct: 613 TLEADEDDKRAKVVEGILKDTELTKLLESAKAKESGLRKGVSLEEGLAEKSELKASLSEL 672
Query: 371 EQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVED 430
+E + LQ + ++ L+ +EE E + E K+ E+ L K
Sbjct: 673 TKELLAEQELQEKAESELAKNEILRRQEEIKKKEQRIKEELKKLKLEKEELLADKVQEAQ 732
Query: 431 ----LQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAV 486
++K L+ +++ ++ + + E +EE E S EL EE
Sbjct: 733 DKINEELKLLEQKIKEKEEEEEKSRLKKEEEEEEKSELSLKEKELAEEEEKTEKLKVEEE 792
Query: 487 ARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYK 546
+A + E+ + ++E +L + + +E L +E++++
Sbjct: 793 KEEKLKAQEEELRALEEELKEEAELLEEEQLLIEQEEKIKEEELEELALELKEEQKLEKL 852
Query: 547 KSIDQLMKDREDLQQQINLLKEGK 570
+ + E ++++ K
Sbjct: 853 AEEELERLEEEITKEELLQELLLK 876
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|241276 cd01243, PH_MRCK, MRCK (myotonic dystrophy-related Cdc42-binding kinase) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 16/43 (37%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 874 EGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDP 916
EG+V +P +K+ GW++Q+ VV K+ Y+ DK N P
Sbjct: 15 EGYVKVPKPGGVKK-GWQRQFAVVCDFKLFLYDISEDK-NPQP 55
|
MRCK is thought to be coincidence detector of signaling by Cdc42 and phosphoinositides. It has been shown to promote cytoskeletal reorganization, which affects many biological processes. There are 2 members of this family: MRCKalpha and MRCKbeta. MRCK consists of a serine/threonine kinase domain, a cysteine rich (C1) region, a PH domain and a p21 binding motif. The MRCK PH domain is responsible for its targeting to cell to cell junctions. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 136 |
| >gnl|CDD|129705 TIGR00618, sbcc, exonuclease SbcC | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.002
Identities = 53/351 (15%), Positives = 121/351 (34%), Gaps = 31/351 (8%)
Query: 132 AGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNT 191
GEQ +L+ + + + +++ A+L+ ++ + + S L +
Sbjct: 532 RGEQTYAQLETSEEDVYHQLTSERKQRASLKEQMQEIQQS-----------FSILTQCDN 580
Query: 192 ELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKV 251
+ + + + L EK+S E L R E L + HL +
Sbjct: 581 RSKEDIPNLQNITVRLQDLTEKLSEAEDMLAC--EQHALLRKLQPEQDLQDVRLHLQQCS 638
Query: 252 SSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSD 311
L + +L + +E ++ + +++ ++ K+ + +
Sbjct: 639 QELALKLTALHALQLTLTQERVREHALSIRVLPKELLASRQLALQKMQSEKEQLTYWKEM 698
Query: 312 LSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVE 371
L+ ++LL + +Y DRE + + G++L + ++
Sbjct: 699 LAQCQTLLRELETHIEEY---------DREFNEIENASSSLGSDLAAREDALNQSLKELM 749
Query: 372 QEQAKKFSLQSDLSVQTSEAA-HLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSV-- 428
+ +++ +E +LSH A ++ R EE+ H LKT +
Sbjct: 750 HQARTVLKARTEAHFNNNEEVTAALQTGAELSHLAAEIQFFNRLREEDTHLLKTLEAEIG 809
Query: 429 ----EDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEER 475
D + LQ + ++ ++ E L E + +L+ EE
Sbjct: 810 QEIPSDEDILNLQCETLVQEEEQF--LSRLEEKSATLGEITHQLLKYEECS 858
|
All proteins in this family for which functions are known are part of an exonuclease complex with sbcD homologs. This complex is involved in the initiation of recombination to regulate the levels of palindromic sequences in DNA. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 1042 |
| >gnl|CDD|222878 PHA02562, 46, endonuclease subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 42/250 (16%), Positives = 90/250 (36%), Gaps = 50/250 (20%)
Query: 316 ESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEG-AELRQELEKSKTLQSQVEQEQ 374
E E + D+L+++ + ++ +I L + L ++E
Sbjct: 205 EEQRKKNGENIARKQNKYDELVEEAKTIKAEIEELTDELLNLVMDIE------------- 251
Query: 375 AKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLRE------AKRNIEEE---YHKLKTK 425
+ L+ + AA +K++ EQ + M + + I E K+K K
Sbjct: 252 ----DPSAALNKLNTAAAKIKSKIEQFQKVIKMYEKGGVCPTCTQQISEGPDRITKIKDK 307
Query: 426 RSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLA 485
+++L ++ + E+ +E +E+S+ +LEL+ + L
Sbjct: 308 LKELQHSLEKLDTAIDELE-----------EIMDEFNEQSKKLLELKNKISTNKQSLITL 356
Query: 486 VARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDY 545
V +A + + EL+ E EL L + + +S +E +
Sbjct: 357 VDKAKK-------VKAAIEELQAEFVDNAEELAKLQDELD-KIVKTKS----ELVKEKYH 404
Query: 546 KKSIDQLMKD 555
+ + L+KD
Sbjct: 405 RGIVTDLLKD 414
|
Length = 562 |
| >gnl|CDD|235600 PRK05771, PRK05771, V-type ATP synthase subunit I; Validated | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.003
Identities = 50/274 (18%), Positives = 97/274 (35%), Gaps = 47/274 (17%)
Query: 296 EIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE--- 352
E+++ L +L H DL + S K L L + ++ L+
Sbjct: 20 EVLEALHELGVVHIEDLKEELSNERLRK------------LRSLLTKLSEALDKLRSYLP 67
Query: 353 ----GAELRQELEKSKTLQSQVEQEQAKKFS-LQSDLSVQTSEAAHLKAREEQLSHEVAM 407
E ++++ ++ ++ ++ ++ ++ E + L+ ++L E
Sbjct: 68 KLNPLREEKKKVSVKSL--EELIKDVEEELEKIEKEIKELEEEISELENEIKELEQE--- 122
Query: 408 LREAK--RNIEEEYHKLKTKRSVE------DLQMKELQDQLETEQYFSTLYKTQAHE--- 456
+ + N + + L + V E + + + +
Sbjct: 123 IERLEPWGNFDLDLSLLLGFKYVSVFVGTVPEDKLEELKLESDVENVEYISTDKGYVYVV 182
Query: 457 ---LKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMK 513
LKE DE + +L ER L+L SE + R I EE + E+EKE+
Sbjct: 183 VVVLKELSDEVEEELKKLGFER------LELEEEGTPSELI-REIKEE-LEEIEKERESL 234
Query: 514 ELELKDLMAKHRSDLSSKESLLSNGKEREVDYKK 547
ELK+L K+ +L + L ER K
Sbjct: 235 LEELKELAKKYLEELLALYEYLEIELERAEALSK 268
|
Length = 646 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.004
Identities = 62/296 (20%), Positives = 135/296 (45%), Gaps = 25/296 (8%)
Query: 808 QKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASLSSA--DVENDE 865
+ EL L +++ E +L+ EL + E+E+LQ +L E L S ++ +
Sbjct: 224 ELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREEL 283
Query: 866 SYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELELKDLMA 925
+Q+ LE K+ I+ + + +++ N + + ELK+ +
Sbjct: 284 EELQEELLE------LKEEIEELEGEISLLRERLEELE--NELEELEERLE--ELKEKIE 333
Query: 926 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEK 985
+ +L +E+LL ++ + +++ ++L + L +++ L E LR EE+ +
Sbjct: 334 ALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALR------EELAE 387
Query: 986 LHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKECRKLQQELTQE 1045
L +L + + N+L E+ + + D++++ KE +EL E
Sbjct: 388 LEAELAEIR-------NELEELKREIESLEERLERLSERLEDLKEELKELEAELEELQTE 440
Query: 1046 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSE 1101
E+ N+ + + +++L+EL+ ++ E +LQ EL + E+ L+ +L L +E
Sbjct: 441 LEELNEELEELEEQLEELRDRLKELERELAELQEELQRLEKELSSLEARLDRLEAE 496
|
Length = 1163 |
| >gnl|CDD|218636 pfam05557, MAD, Mitotic checkpoint protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.004
Identities = 93/478 (19%), Positives = 184/478 (38%), Gaps = 40/478 (8%)
Query: 122 QSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKE 181
Q AEL +KS Q+ EL + + L+++ +TL +E + K
Sbjct: 59 QRAELIRSKSKLIQLENELMQKELEHKRAQIELERKASTLAENYERELDRNLELEVRLKA 118
Query: 182 LEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLA 241
LE + E + E +L +D EKE +L+ + R K+ ++
Sbjct: 119 LEELEKKAENEAAEAEE-EAKLLKDKLDAESLKLQNEKEDQLKEAKESISRIKNDLSEMQ 177
Query: 242 EDNRHLGEKVSSLEKECASLSLELKAAQAQYQQ--------EVRAHEETQKSRMVNKEEA 293
++ ++ LE E L +L+ Q + + S + E
Sbjct: 178 CRAQNADTELKLLESELEELREQLEECQKELAEAEKKLQSLTSEQASSADNSVKIKHLEE 237
Query: 294 SVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEG 353
++ ++ +++ + L L + + + + +D E L++++ L+
Sbjct: 238 ELKRYEQDAEVVKSMKEQLLQIPELERE-LAALREENRKLRSMKEDNELLKEELEDLQSR 296
Query: 354 AELRQELEKSKTLQSQVEQEQAKK-----FSLQSDLSVQTSEAAHLKAREEQLSHEVAML 408
E R E + K ++E+E+ + SL D+ + L R L +E L
Sbjct: 297 LE-RFEKMREKLADLELEKEKLENELKSWKSLLQDIGLNLRTPDDLSRRIVVLQNEELQL 355
Query: 409 REAK-------RNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEEL 461
+E + +E +L+ +R ++ EL+ +LE + + + + +E
Sbjct: 356 KEKNGSISSSAKQLETTLQQLQLERQKAVSEILELKKKLEALKALVRRLQRRLTLVTKER 415
Query: 462 DERSRNILELEEERGDLTHRLQLAVARADSEALAR-------------SIAEETVGELEK 508
D + ++E + + QL ++E L + S EE VG+ +
Sbjct: 416 DGLRAILNSYDKELTETSVSGQLMKRLEEAEDLVQKVQSHLAKMENQLSELEEDVGQQKD 475
Query: 509 EKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL 566
E E+K L + L S E LLS KE + I+ L ++R+ L+Q+ +LL
Sbjct: 476 RNNTLETEIKLL----KEQLVSNERLLSFVKEATNALRLKIETLERERDRLRQEKSLL 529
|
This family consists of several eukaryotic mitotic checkpoint (Mitotic arrest deficient or MAD) proteins. The mitotic spindle checkpoint monitors proper attachment of the bipolar spindle to the kinetochores of aligned sister chromatids and causes a cell cycle arrest in prometaphase when failures occur. Multiple components of the mitotic spindle checkpoint have been identified in yeast and higher eukaryotes. In S.cerevisiae, the existence of a Mad1-dependent complex containing Mad2, Mad3, Bub3 and Cdc20 has been demonstrated. Length = 722 |
| >gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.004
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 134 EQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTEL 193
E L+ L + + L+ E+A LQA++ ++ + Q + +ELE R + L
Sbjct: 136 ESRKSTLRAQLELILAQIKQLEAELAGLQAQL---QALRQQLEVISEELEARRKLKEKGL 192
Query: 194 -ERNKHREL--QLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEK 250
R + EL + AE LG + LE + Q +LER + + E + E+
Sbjct: 193 VSRLELLELERERAEAQGELGRLEAELEV-LKRQIDELQLERQQIEQTFREE----VLEE 247
Query: 251 VSSLEKECASLSLELKAAQAQYQQEV 276
++ + A L L A+ + Q+ +
Sbjct: 248 LTEAQARLAELRERLNKARDRLQRLI 273
|
Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423 |
| >gnl|CDD|197519 smart00109, C1, Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Score = 36.3 bits (84), Expect = 0.004
Identities = 11/33 (33%), Positives = 15/33 (45%), Gaps = 2/33 (6%)
Query: 1182 HEFLNISYHMPTTCEVCPKPIWHIIRPPPALEC 1214
H+ + ++ PT C VC K IW L C
Sbjct: 1 HKHVFRTFTKPTFCCVCRKSIWGS--FKQGLRC 31
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. Length = 50 |
| >gnl|CDD|234141 TIGR03185, DNA_S_dndD, DNA sulfur modification protein DndD | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.004
Identities = 71/387 (18%), Positives = 156/387 (40%), Gaps = 60/387 (15%)
Query: 152 DTLQQEVATLQAKISQERSSKTQAVNLHK--ELEGRLQALNTELE----RNKHRELQLAE 205
D + + L + + + S+ + L + LE L+ + + E H +L E
Sbjct: 182 DLIDRLAGDLTNVLRRRKKSELPSSILSEIEALEAELKEQSEKYEDLAQEIAHLRNELEE 241
Query: 206 DNRHLGEKVSSLEKECRLQ--ALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSL 263
R + SLEK+ R + L E E+ + + ++ + ++ L + L L
Sbjct: 242 AQR----SLESLEKKFRSEGGDLFEEREQLERQLKEIEAARKANRAQLRELAADPLPLLL 297
Query: 264 ELKAAQAQYQQEVRAHEETQKSRMVNK--EEASVEIVKELKDLM--AKHRSDLSSK--ES 317
+ + +++ E++Q++++ + EE E+++ L L A+H +++++ E
Sbjct: 298 -IPNLLDSTKAQLQKEEQSQQNQLTQEELEERDKELLESLPKLALPAEHVKEIAAELAEI 356
Query: 318 LLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKK 377
+ E+ ++ S +L Q+ +L + + + KS+ L+ E E+
Sbjct: 357 DKPATTDSEIPHRLSGSEL--------TQLEVLIQQVKRELQDAKSQLLKELRELEEELA 408
Query: 378 FSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQ 437
+ D + T + EEQ++ L E + E + + + Q++ L+
Sbjct: 409 ---EVDKKISTIPS------EEQIAQ----LLEELGEAQNELFRSEAEIEELLRQLETLK 455
Query: 438 DQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARS 497
+ +E L++ LDE+++ + E +T A+ +
Sbjct: 456 EAIE--------------ALRKTLDEKTKQKINAFELERAITI---ADKAKKTLKEFREK 498
Query: 498 IAEETVGELEKEKTMKELELKDLMAKH 524
+ E + +LE+E T K LM KH
Sbjct: 499 LLERKLQQLEEEITK---SFKKLMRKH 522
|
This model describes the DndB protein encoded by an operon associated with a sulfur-containing modification to DNA. The operon is sporadically distributed in bacteria, much like some restriction enzyme operons. DndD is described as a putative ATPase. The small number of examples known so far include species from among the Firmicutes, Actinomycetes, Proteobacteria, and Cyanobacteria [DNA metabolism, Restriction/modification]. Length = 650 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 24/137 (17%)
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRA 728
GL ++H +H DL N L+ ++KIGD GL+ + +T ++ RW A
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-A 170
Query: 729 PE--------ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIV---N 775
PE +L+ ++ T ++WSLG + E+ + S+P + S L V
Sbjct: 171 PELVDEVHGNLLVVDQ--TKESNVWSLGVTIWELFELGSQP-YRHLSDEQVLTYTVREQQ 227
Query: 776 LVRPNP----PHADKFY 788
L P P P +D++Y
Sbjct: 228 LKLPKPRLKLPLSDRWY 244
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1219 | |||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616|consensus | 355 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0574|consensus | 502 | 100.0 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| KOG4250|consensus | 732 | 99.98 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| KOG1151|consensus | 775 | 99.98 | ||
| KOG0603|consensus | 612 | 99.97 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG1187|consensus | 361 | 99.97 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0193|consensus | 678 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| KOG0584|consensus | 632 | 99.97 | ||
| KOG0194|consensus | 474 | 99.97 | ||
| KOG1035|consensus | 1351 | 99.97 | ||
| KOG0695|consensus | 593 | 99.97 | ||
| KOG2345|consensus | 302 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4721|consensus | 904 | 99.97 | ||
| KOG1026|consensus | 774 | 99.97 | ||
| KOG4257|consensus | 974 | 99.97 | ||
| KOG1095|consensus | 1025 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG4278|consensus | 1157 | 99.95 | ||
| KOG0199|consensus | 1039 | 99.95 | ||
| KOG1027|consensus | 903 | 99.95 | ||
| KOG0196|consensus | 996 | 99.95 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG1152|consensus | 772 | 99.95 | ||
| KOG1094|consensus | 807 | 99.94 | ||
| KOG0200|consensus | 609 | 99.94 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576|consensus | 829 | 99.93 | ||
| KOG3653|consensus | 534 | 99.93 | ||
| KOG2052|consensus | 513 | 99.93 | ||
| KOG1345|consensus | 378 | 99.92 | ||
| KOG1025|consensus | 1177 | 99.92 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1164|consensus | 322 | 99.88 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| KOG1163|consensus | 341 | 99.86 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1024|consensus | 563 | 99.85 | ||
| KOG0590|consensus | 601 | 99.85 | ||
| KOG0612|consensus | 1317 | 99.85 | ||
| KOG1165|consensus | 449 | 99.85 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0603|consensus | 612 | 99.81 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0606|consensus | 1205 | 99.79 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1240|consensus | 1431 | 99.73 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG4158|consensus | 598 | 99.72 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1166|consensus | 974 | 99.7 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0195|consensus | 448 | 99.59 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| KOG1033|consensus | 516 | 99.53 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| PF08912 | 69 | Rho_Binding: Rho Binding; InterPro: IPR015008 Rho | 99.5 | |
| KOG0590|consensus | 601 | 99.49 | ||
| KOG1023|consensus | 484 | 99.36 | ||
| KOG0606|consensus | 1205 | 99.27 | ||
| KOG0601|consensus | 524 | 99.26 | ||
| cd01242 | 112 | PH_ROK Rok (Rho- associated kinase) pleckstrin hom | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG1243|consensus | 690 | 99.14 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG0601|consensus | 524 | 98.89 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| KOG3087|consensus | 229 | 98.79 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| cd01243 | 122 | PH_MRCK MRCK (myotonic dystrophy-related Cdc42-bin | 98.65 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG1266|consensus | 458 | 98.52 | ||
| KOG3741|consensus | 655 | 98.48 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| KOG0161|consensus | 1930 | 98.13 | ||
| KOG2137|consensus | 700 | 98.12 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| PRK02224 | 880 | chromosome segregation protein; Provisional | 97.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| KOG1235|consensus | 538 | 97.83 | ||
| PRK02224 | 880 | chromosome segregation protein; Provisional | 97.79 | |
| TIGR02168 | 1179 | SMC_prok_B chromosome segregation protein SMC, com | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| KOG0161|consensus | 1930 | 97.68 | ||
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.5 | |
| PRK03918 | 880 | chromosome segregation protein; Provisional | 97.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.38 | |
| KOG0576|consensus | 829 | 97.36 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.24 | |
| KOG0976|consensus | 1265 | 97.23 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.22 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.15 | |
| TIGR02168 | 1179 | SMC_prok_B chromosome segregation protein SMC, com | 97.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| PRK03918 | 880 | chromosome segregation protein; Provisional | 97.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.98 | |
| COG1196 | 1163 | Smc Chromosome segregation ATPases [Cell division | 96.95 | |
| TIGR00606 | 1311 | rad50 rad50. This family is based on the phylogeno | 96.95 | |
| TIGR00606 | 1311 | rad50 rad50. This family is based on the phylogeno | 96.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.84 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.83 | |
| KOG1826|consensus | 2724 | 96.79 | ||
| KOG1035|consensus | 1351 | 96.72 | ||
| KOG2268|consensus | 465 | 96.69 | ||
| KOG4643|consensus | 1195 | 96.69 | ||
| TIGR02169 | 1164 | SMC_prok_A chromosome segregation protein SMC, pri | 96.49 | |
| TIGR02169 | 1164 | SMC_prok_A chromosome segregation protein SMC, pri | 96.48 |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-69 Score=647.96 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=215.9
Q ss_pred hHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEe
Q psy14431 548 SIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITML 626 (1219)
Q Consensus 548 sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~ 626 (1219)
.+..+..-+-..++|.|++.||.|+||.|.+++++.|++.||+|++.+-.. ...+...|..|-.+|... +.++|+.++
T Consensus 63 ~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~Lh 141 (1317)
T KOG0612|consen 63 IVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLH 141 (1317)
T ss_pred HHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHH
Confidence 344444456677899999999999999999999999999999999865321 123334455555566555 589999998
Q ss_pred eeeeccCCceEEEEEecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 627 DIYKAVNNKDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 627 gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
..|. +..++|+||+|++ |||..++... ++++.-+++|+..|+.||+-||+.|+|||||||+|||+|..|+++|+||
T Consensus 142 yAFQ--D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 142 YAFQ--DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred HHhc--CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccc
Confidence 7776 7889999999998 5888888753 5999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCc-ccccccccccccccCchhhhc---c-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--
Q psy14431 705 GLARSLSDS-KECLTEYIATRWYRAPEILIS---N-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-- 777 (1219)
Q Consensus 705 GLAr~l~~~-~~~~ts~vGT~~Y~APEvLl~---~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-- 777 (1219)
|.|-.+... .-.....+|||.|++||++.. + +.|++.+|+||+||++|||+.|..||...+-...+.+|++..
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 999888743 333456799999999999842 2 578999999999999999999999999999999999998873
Q ss_pred CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC-C---HHHHHcchhhh
Q psy14431 778 RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD-S---EIEQLQGKLAA 848 (1219)
Q Consensus 778 ~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK-R---aiEALqHpwfa 848 (1219)
.-+|+. ..+|+++.|||.++|.--+.+ . ..+.-.||||.
T Consensus 300 l~FP~~--------------------------------~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 300 LSFPDE--------------------------------TDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred cCCCcc--------------------------------cccCHHHHHHHHHHhcChhhhcccccHHHHHhCcccc
Confidence 111111 236889999999988544433 1 66778899983
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=461.43 Aligned_cols=301 Identities=39% Similarity=0.679 Sum_probs=270.5
Q ss_pred ccccCe-eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec---c
Q psy14431 557 EDLQQQ-INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA---V 632 (1219)
Q Consensus 557 ~dIqqY-~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~---~ 632 (1219)
+.+..+ ..++.||.|+||.|+.|.++.+|..||||++...+.+.....+.+||+.+|+.+. |+||+.+++++.. .
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD 96 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence 334333 3469999999999999999999999999999988999999999999999999997 9999999999975 2
Q ss_pred CCceEEEEEecchhhHHHHHhhcc-CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 633 NNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lrs~~-LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
....+|+|+|+|+.+|..+++.+. +++.+++.+++||+.||.|+|+.||+||||||+|+|++.++.+||||||+|+...
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 356799999999999999999877 9999999999999999999999999999999999999999999999999999886
Q ss_pred C--cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchhhh
Q psy14431 712 D--SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFY 788 (1219)
Q Consensus 712 ~--~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~l~ 788 (1219)
. .....+.++.|.||+|||+++....|+.++||||+||||+||++|+|.|+|.+..+++..|+...+.+ +..+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~--- 253 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ--- 253 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH---
Confidence 4 23446789999999999999999999999999999999999999999999999999999999988443 33333
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCCCcCCCCCCCC
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSETASLSSADVE 862 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s~~PS~d~s 862 (1219)
...+...+.++..+|...+.+|..+||+.+|.++|||.+||.+||.+ ++.+||.|||++....+...|.+...
T Consensus 254 -~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 254 -KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred -HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence 34578888899999999999999999999999999999999999998 59999999999998887777655433
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=420.84 Aligned_cols=280 Identities=36% Similarity=0.605 Sum_probs=248.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|..+++||+|.||+||+|++..||+.||||++.............+|||..|+.+. ||||+.++++|. ..+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~--~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFP--HKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhhcc--CCCceEE
Confidence 4688889999999999999999999999999999765444455667899999999996 999999999996 5677999
Q ss_pred EEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|+||++.+|..++++. .++..+++.|+.+++.||.|||+++|+||||||.|+||+.+|.+||+|||+|+.++++....
T Consensus 79 VfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 79 VFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred EEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9999999999999954 59999999999999999999999999999999999999999999999999999999887777
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~ 796 (1219)
+..+.|.||+|||.+++...|+..+||||+|||++||+.|.|.|+|.++.+++..|+..+ .|.+..|+.+.. -..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~----lpd 234 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS----LPD 234 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc----ccc
Confidence 777999999999999999999999999999999999999999999999999999999998 788888987652 112
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
...+..+ ...+...+|+..+.+++||+.+||.|||.+ ++.++|+|+||.-
T Consensus 235 Y~~~~~~---P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 235 YVKIQQF---PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHhcC---CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 2222223 334455589999999999999999999988 5899999999964
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=429.76 Aligned_cols=287 Identities=30% Similarity=0.514 Sum_probs=255.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..|+.|..+.+|++|+||.||+|+|+.|++.||+|.++........+...+|||.+|..+. |||||.+..+..+.+-+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccce
Confidence 4577899999999999999999999999999999999866555566677899999999996 999999999998888888
Q ss_pred EEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|||||||+.||..++.+ .+|....++.++.|++.|+.|||.++|+||||||+|+|++..|.+||+|||+|+.++.+.
T Consensus 152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999999999999984 579999999999999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s 793 (1219)
...+..+.|.||+|||.+++...|++++|+||+|||+.||++++|.|+|.+..+++.+|+..+ .|....|+++. .
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~----~ 307 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS----E 307 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc----c
Confidence 888999999999999999999999999999999999999999999999999999999999998 67777787664 2
Q ss_pred hhHHhhhHHhhhhchhhHHHHhccc--ChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQV--VEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~l--speaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
...... ..++......+...|+.. +....|||..+|.|||.+ ++.++|+|.||.-
T Consensus 308 lp~~k~-~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 308 LPAVKK-MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cchhhc-cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 222211 234455566677777765 489999999999999998 5999999999965
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=427.93 Aligned_cols=283 Identities=30% Similarity=0.551 Sum_probs=246.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|..+.++|+|+||+||+|++++||+.||||++.....++....-.+|||.+|+++. |||+|.++.+|. ....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFr--rkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFR--RKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHH--hcceeEE
Confidence 4588889999999999999999999999999999766555566677889999999996 999999999997 5678999
Q ss_pred EEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||||+.++..-+.. ..++...++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..++..+
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999999876666653 458899999999999999999999999999999999999999999999999999998888889
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
+.++.|.||+|||.+.+...|+.++||||+||++.||++|.|.|||.++.+++..|...+++.+|.-..++. .++.+.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~--~N~~F~ 236 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS--SNPFFH 236 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc--cCCcee
Confidence 999999999999999998999999999999999999999999999999999999999999877765544431 111111
Q ss_pred hhhHHhhhh-chhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 798 EKFNQVVVK-CQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~k-crk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.. .+|.. .+.+++..+|.++..++||+.+||.+||.+| -.+.|.|+||..
T Consensus 237 Gv--~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 237 GV--RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ee--ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11 23332 5778999999999999999999999999996 556699999844
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=443.54 Aligned_cols=283 Identities=34% Similarity=0.524 Sum_probs=248.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
..+.|..+.+||+|+||.||+|++..+|+.||+|++..............|||.||+++. ||||++|.++......+.+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence 456788899999999999999999999999999999766666677788899999999995 9999999999987667899
Q ss_pred EEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 638 YVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
|||||||+.||.-++... .|++.+++.|+.||+.||.|||++||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999999999999999865 69999999999999999999999999999999999999999999999999999776544
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s 793 (1219)
..++..+.|.||+|||++++...|++++|+||+||||.||+.|+|+|+|.+..+++..|...+ .|....|+... .
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k----L 349 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK----L 349 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc----C
Confidence 347888999999999999999999999999999999999999999999999999999999999 67777776221 1
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
|.+.. + +-....+..+.+.+..+++.+++|+..||.+||.+ ++..||.++||
T Consensus 350 P~~~~-~-kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 350 PHATI-F-KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred Ccccc-c-CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 11110 1 11112345677889999999999999999999998 59999999999
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=441.21 Aligned_cols=287 Identities=34% Similarity=0.590 Sum_probs=252.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.++++||.|+||.||+|....+|..||||.+++.+....+ -.-+||+..|+.+..|||||++.+++.+.+. .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 45789999999999999999999999999999999877655433 3467999999999779999999999986443 899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+|||||+.+|+++++. ..|++..++.|++||+.||+|+|.+|++|||+||+|||+.....+||+|||+|+.+... ..
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-pP 165 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-PP 165 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-CC
Confidence 9999999999999984 56999999999999999999999999999999999999998889999999999988754 45
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
++.++.|+||+|||+++..+.|+.++||||+|||++|+++-+|.|+|.+..+++.+|..++ .|....|+.-+ ..
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~-----~L 240 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY-----NL 240 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH-----HH
Confidence 7899999999999999999999999999999999999999999999999999999999999 56666665422 12
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
....-..+|...+.++..+++..++++.+||.+||.|||.+| |.++|+||||......
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 223333567778899999999999999999999999999995 7788999999774443
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=424.59 Aligned_cols=329 Identities=24% Similarity=0.358 Sum_probs=265.5
Q ss_pred HHHHHHHHHHhHHHHHhhhHHHHHhhh---hhHHHhHHhhHHHHHhcccCCcccccccccCCcccccchhhhHHHHhhcc
Q psy14431 480 HRLQLAVARADSEALARSIAEETVGEL---EKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDR 556 (1219)
Q Consensus 480 ~~~~~~e~r~d~~~~ar~~~E~~vsEl---E~Ek~mr~seledLm~s~rss~Sss~Sl~Sn~k~rev~~~~sl~eLL~dr 556 (1219)
......-.++++++.++.+++++|.+. ..++.++...++..++....+.+...-..+....++..+. .+...+
T Consensus 62 ~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~l----R~~R~r 137 (550)
T KOG0605|consen 62 YEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYL----RLRRTR 137 (550)
T ss_pred cccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHH----Hhcccc
Confidence 344566778999999999999999996 6777777777777776654444444434444444444442 233346
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|+.++||..||+|++.+... ..........|-.+|... ++|+||+||..|. +..
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQ--D~~ 214 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQ--DKE 214 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEec--CCC
Confidence 789999999999999999999999999999999999976542 334456677888888885 5999999998887 678
Q ss_pred eEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC-
Q psy14431 636 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD- 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~- 712 (1219)
++||||||++ ||+..++. .+.+++..+++|+.+++.|+..||+.|+|||||||+|+|||..|++||+|||+|..+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999 47888776 57899999999999999999999999999999999999999999999999999853211
Q ss_pred ---------------------c-cc------------------------ccccccccccccCchhhhccccccccccchh
Q psy14431 713 ---------------------S-KE------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWS 746 (1219)
Q Consensus 713 ---------------------~-~~------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWS 746 (1219)
. .. ...+.+|||.|+|||++++. +|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHH
Confidence 0 00 01246899999999999755 5999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHH
Q psy14431 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLV--RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTS 824 (1219)
Q Consensus 747 LG~ILyELLTGkpPF~g~s~~e~L~kIve~l--~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiD 824 (1219)
||||+||||.|.|||.+.++...+.+|+++. ...|... ..++++.|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------------------------~~s~eA~D 421 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------------------------DLSDEAKD 421 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------------------------cccHHHHH
Confidence 9999999999999999999999999998876 2222211 23688999
Q ss_pred HHHhccccCCCCC-----HHHHHcchhhhc
Q psy14431 825 KLKLQMELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 825 LLsKMLq~DPeKR-----aiEALqHpwfaL 849 (1219)
||.++|. ||..| +.+.-.||||..
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999 99885 678899999954
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=419.94 Aligned_cols=297 Identities=29% Similarity=0.540 Sum_probs=246.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc---eE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK---DL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~---~L 637 (1219)
.|...+.+|.|+||.||.|....++..||||++... .....+|+.+|+.+. |||||++..+|....+. +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHH
Confidence 578899999999999999999999999999988532 223458999999885 99999999998754444 45
Q ss_pred EEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-CcceecccccccccC
Q psy14431 638 YVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l~ 711 (1219)
.+|||||+.+|.++++ +..++...++-|++||++||.|||+.||+||||||.|||+|.+ |.+||||||+|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 6899999999999998 4568999999999999999999999999999999999999976 899999999999887
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAG 790 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~ 790 (1219)
.+... .++.+|+.|+|||.+++...|+.++||||.||+++||+.|+|.|+|.+..+++..|++.+ .|+...+..+...
T Consensus 178 ~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 178 KGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred cCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 65544 678999999999999999999999999999999999999999999999999999999999 4555555554432
Q ss_pred cCChhHHhhhHHhhhhchhhHHH-HhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCCCcCCCCCCCCCCccc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQE-LQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSETASLSSADVENDESY 867 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~e-l~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s~~PS~d~s~dE~~ 867 (1219)
+. -..+|.....+|.. +++..++++.||+.++|+|+|.+ ++.++|.||||+....+.
T Consensus 257 y~-------~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~------------- 316 (364)
T KOG0658|consen 257 YT-------EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN------------- 316 (364)
T ss_pred cc-------cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC-------------
Confidence 22 12344555566656 55778999999999999999988 599999999997744431
Q ss_pred ccccccCCCccCCCchhhhhh
Q psy14431 868 VQDSRLEGWVSIPNKQNIKRH 888 (1219)
Q Consensus 868 ~~dS~lEg~~~IPnk~nlk~~ 888 (1219)
...+.+..+|+-.+++..
T Consensus 317 ---~~l~~g~~lp~lf~f~~~ 334 (364)
T KOG0658|consen 317 ---TKLPNGRPLPPLFNFKRA 334 (364)
T ss_pred ---ccCcCCCcCCCccCchHH
Confidence 233344566666666554
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=403.76 Aligned_cols=287 Identities=35% Similarity=0.555 Sum_probs=247.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC-ccEEeeeeeccC----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVN---- 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN-IVkL~gvfe~~d---- 633 (1219)
...|..+++||+|+||+||+|+++.+|..||+|++.-.......+....+|+.+++.+. |+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence 44577788899999999999999999999999999755443445567889999999996 999 999999987422
Q ss_pred CceEEEEEecchhhHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
.+.+++||||+..+|..++... .++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|+
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 2379999999999999999842 47778899999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKF 787 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l 787 (1219)
.+.-+...++..++|.||+|||++++...|++.+||||+|||++||+++++.|+|.++.+++..|.... .|....|+..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 887666677888999999999999999899999999999999999999999999999999999999988 7888888875
Q ss_pred hhccCChhHHhhhHHhhhhc-hhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 788 YAGFKSKHEREKFNQVVVKC-QKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kc-rk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
.. .+.+.. .++... +..+....+..++.+.|++.+||+++|.+ ++..||.||||.....
T Consensus 249 ~~---~~~~k~---~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SS---LPDYKA---PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cc---cccccc---cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 42 111111 333333 67788888888999999999999999988 5899999999966433
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=417.39 Aligned_cols=269 Identities=26% Similarity=0.467 Sum_probs=232.7
Q ss_pred HHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeee
Q psy14431 550 DQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDI 628 (1219)
Q Consensus 550 ~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gv 628 (1219)
+..+.+... ..|...+.||+|||+.||.+++..+|..||+|++.+.. ..........+||.|.+.+. |||||+++++
T Consensus 9 p~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~ 86 (592)
T KOG0575|consen 9 PEVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHF 86 (592)
T ss_pred CCeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeE
Confidence 334444444 67999999999999999999999999999999997543 35566678999999999996 9999999999
Q ss_pred eeccCCceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 629 YKAVNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 629 fe~~d~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
|+ +..++|||+|+|. ++|..+++ .+++++.++++|+.||+.||.|||+.||||||||.+|||++.+.+|||+|||+
T Consensus 87 FE--Ds~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 87 FE--DSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred ee--cCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccce
Confidence 98 6788999999999 68888887 46799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
|..+..+.....+.||||.|+|||++. ..++++.+||||+|||||-||+|+|||...+-.+.+..|.......|.
T Consensus 165 At~le~~~Erk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~---- 239 (592)
T KOG0575|consen 165 ATQLEYDGERKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS---- 239 (592)
T ss_pred eeeecCcccccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----
Confidence 999887766667899999999999985 566899999999999999999999999998888888888665533333
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCC
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLS 857 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~P 857 (1219)
+++.++.|||.+||..||.+| +.++|.|+||.-+..+...|
T Consensus 240 ------------------------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 240 ------------------------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred ------------------------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 348889999999999999985 78889999994444444333
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=401.27 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=226.0
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.++++||.|+||.||.++.++|++.||+|++.+... ..........|..+|..+. ||+||+++..|. +.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQ--t~ 97 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQ--TE 97 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecc--cC
Confidence 4457889999999999999999999999999999999976543 3346778899999999985 999999998887 68
Q ss_pred ceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|||++|+.| .|...+. .+.|++..++.|+..|+.||.|||+.|||||||||+|||+|.+|+++|+|||+|+....
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 899999999995 7888887 67899999999999999999999999999999999999999999999999999997666
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
......++|||+.|||||++.+. +|+.++|+|||||++|+|++|.|||.+.+......+|.....+.++.
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~--------- 247 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG--------- 247 (357)
T ss_pred CCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---------
Confidence 65666778999999999998654 79999999999999999999999999999999999998877444332
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC------HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS------EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR------aiEALqHpwfaL 849 (1219)
.+++.+.|+|.++|..||++| +.+.-.||||..
T Consensus 248 ------------------------~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 248 ------------------------YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ------------------------cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 137889999999999999987 345567998843
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=408.01 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=215.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-----hhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-----~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.+.|.+.+.||.|+||.|-+|..+.||+.||||++.+..... .......+|+.+|+.+. |||||+++++|. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~--~ 247 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE--V 247 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee--c
Confidence 456888999999999999999999999999999997543221 12334579999999996 999999999998 4
Q ss_pred CceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---Ccceeccccccc
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLAR 708 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr 708 (1219)
....||||||++| +|.+.+- ++.+.+...+.+++|++.|+.|||+.||+||||||+|||++.+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 5567999999994 7776654 6779999999999999999999999999999999999999866 789999999999
Q ss_pred ccCCcccccccccccccccCchhhhccc--cccccccchhHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhhcCCCC-CCc
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNP-PHA 784 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~--~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e-~L~kIve~l~P~P-~~~ 784 (1219)
..+. .....+.||||.|.|||++.+.+ .++.++||||+||++|-+++|.|||.+..... ....|..+..+.- +.|
T Consensus 328 ~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 8874 44567899999999999985432 33458899999999999999999998766544 6777877774443 333
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
. .++.++.|||..||..||+.| +.+||+||||.....
T Consensus 407 ~-------------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 407 D-------------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred h-------------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 2 237889999999999999984 889999999976443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=375.69 Aligned_cols=281 Identities=31% Similarity=0.561 Sum_probs=228.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.++++||.|+||.||+|.+..++..||+|++..... ......+.+|+.++..+. ||||+++++++. ..+.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~ 78 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLK-HANIVTLHDIIH--TERCL 78 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCC-CCCEeeEEEEEc--CCCeE
Confidence 46789999999999999999999999999999999854321 222345778999999995 999999999987 46689
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|..++.. ..++...+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99999999999988863 3478889999999999999999999999999999999999999999999999986554433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+..... |.+..|+.... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS---NE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc---ch
Confidence 344567899999999987666789999999999999999999999999988888888877774 44444443221 11
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
.+... .++..+..++....+.+++++.|||.+||++||.+ ++.++|.||||
T Consensus 236 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 236 EFRSY--LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhcc--ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 11111 12223344455566778999999999999999998 58899999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=374.26 Aligned_cols=288 Identities=38% Similarity=0.613 Sum_probs=233.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---CceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~L 637 (1219)
+|.+.++||.|+||.||+|.+..+|..||||++............+.+|+.+++.+. ||||+++++++...+ ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceE
Confidence 588999999999999999999999999999998654444445567889999999995 999999999886432 2358
Q ss_pred EEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 638 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
|+||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999999999988874 468999999999999999999999999999999999999999999999999997653221
Q ss_pred -cccccccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+....+..+.....++++..... ..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---i~ 236 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR---VR 236 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH---hh
Confidence 11234679999999999743 25689999999999999999999999999888877777777665444332211 11
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.......+..+....+..+...++..++.+.+++.+||..||.+| +.++|.||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 223334444555555666777888889999999999999999985 778899999965333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=387.34 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=216.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+...+..||+|+.|+||+|.++.|++.+|+|++.. .........+.+|+.+++.+ +|||||.+||+|..... .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEe
Confidence 356678899999999999999999999999999943 33456667899999999999 59999999999984332 6999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||+ |+|..++.. +.+++..+-.++.+++.||.|||. .+||||||||+|||++..|.|||||||.+..+.+. .
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~ 233 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I 233 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence 999999 689998874 679999999999999999999995 99999999999999999999999999999988766 4
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-----STSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-----s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
..+++||..|||||.+ .+..|+.++||||||++++|+++|+.||+.. ++.+++..|+...+|..|.-
T Consensus 234 a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~------- 305 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG------- 305 (364)
T ss_pred cccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-------
Confidence 5678999999999998 5567999999999999999999999999874 55666666665544433311
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+++++.+|+..||+.||.+| +.+.|.|||+.-
T Consensus 306 -------------------------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 306 -------------------------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -------------------------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 138899999999999999985 777799999965
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=400.19 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=225.2
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+.+.||+|+|++||+|++..+++.||||++.+.+. .........+|-.+|..|.+||.|++|+..|. +.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cc
Confidence 4457889999999999999999999999999999999965543 33344567788899999988999999998887 67
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
..+|+|++|++ |+|.++|+. +.|++..+++|+.+|+.||+|||++|||||||||+|||+|.+|+++|+|||.|..+++
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 88999999999 789999984 7799999999999999999999999999999999999999999999999999987764
Q ss_pred cccc-------------cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 713 SKEC-------------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 713 ~~~~-------------~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P 779 (1219)
.... ..+++||..|.+||++ .....++.+|||+||||+|.|+.|.|||.+.+....+++|+....+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 2211 1458999999999997 5667899999999999999999999999999999999999998876
Q ss_pred CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 780 ~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.|+.+ ++.+.||+.++|+.||.+| ..+.-+||||+.
T Consensus 306 fp~~f----------------------------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 306 FPEGF----------------------------------PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCC----------------------------------CHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 66533 5779999999999999985 666688999954
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.98 Aligned_cols=278 Identities=33% Similarity=0.565 Sum_probs=224.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-CCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeec---cC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKA---VN 633 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~---~d 633 (1219)
++|.+++.||.|+||.||+|.+.. +|..||+|++..............+|+.++..+. .||||++++++|.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 5789999998654433334455677888887764 59999999998852 23
Q ss_pred CceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
...+++||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 456899999999999888863 34888999999999999999999999999999999999999999999999999866
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhh
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 789 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~ 789 (1219)
... .......||+.|+|||++. ...++.++|||||||++|+|++|.+||.+.++.+.+..|+.... |.+..|+....
T Consensus 161 ~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 161 SFQ-MALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred cCC-cccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 543 2234567899999999974 45689999999999999999999999999999888888887763 44444433210
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+. . ..+....+..+..+.+.+++.+.+|+.+||++||.+| +.++|.||||
T Consensus 239 -~~----~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 -LP----R---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred -cc----c---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 00 0 1122334556777778889999999999999999995 8889999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=375.07 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=223.8
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+.+++|.+++.||.|+||.|.+++++.+|..||+|++.+.. ..........+|..+|+.+. ||+++++++.|. +.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~--d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFK--DNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeec--cCC
Confidence 66888999999999999999999999999999999996432 23445567789999999997 999999998887 688
Q ss_pred eEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+||||||++| .|..+++. ++|++..+++|+.+|+.||+|||+++|++|||||+|||+|.+|++||+|||+|..+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999995 68888884 67999999999999999999999999999999999999999999999999999988754
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
+.+.||||.|+|||++ ...+|+.++|+|||||++|||+.|.|||.+.++...+.+|+.+....|..
T Consensus 198 ---T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~---------- 263 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY---------- 263 (355)
T ss_pred ---EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc----------
Confidence 4678999999999997 56679999999999999999999999999999999999999887544442
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+++++.|||.++|+.|-.+| ..+...||||+-
T Consensus 264 ------------------------fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 264 ------------------------FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred ------------------------cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 37889999999999998776 556678999963
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.85 Aligned_cols=279 Identities=31% Similarity=0.544 Sum_probs=220.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..++..||+|++............+.+|+.++..+. ||||++++++|. .++.+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEe--cCCEEEEE
Confidence 689999999999999999999999999999998654444444567789999999995 999999999987 56789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-ccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-ECL 717 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-~~~ 717 (1219)
|||+++++...+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9999986655554 3468999999999999999999999999999999999999999999999999998765432 122
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....||+.|+|||++. +..++.++|||||||++|+|++|++||++.+....+..+.....|.|......+. ..+...
T Consensus 159 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (287)
T cd07848 159 TEYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY--SNPRFH 235 (287)
T ss_pred cccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh--ccchhc
Confidence 3457899999999985 4568999999999999999999999999988888777777777666543322211 000000
Q ss_pred hhhHHhhhh-chh-hHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVK-CQK-ELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~k-crk-~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.. ..+.. .+. ........+++.+.|||.+||.+||.+| +.++|.||||
T Consensus 236 ~~--~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GL--RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cc--ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 00100 011 1122334578899999999999999995 8888999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.53 Aligned_cols=282 Identities=30% Similarity=0.494 Sum_probs=218.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.++++||.|+||.||+|.+..+|..||||++..... ........+|+.+++.+. ||||+++++++. +...+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCC-CCCcCeEEEEEe--cCCeEE
Confidence 4679999999999999999999999999999999864322 222345678999999995 999999999987 466899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9999999999888764 45889999999999999999999999999999999999999999999999999765443333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhhc-CCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQLIVNLV-RPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-~e~L~kIve~l-~P~P~~~d~l~~~~~s~ 794 (1219)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ ...+..+.... .|....|+..... +
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 236 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL---P 236 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc---c
Confidence 44567899999999986666789999999999999999999999988654 34555555444 3333333332110 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhcc--cChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQ--VVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~--lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
... ...+....+..+...++. .++.+.||+.+||++||.+| +.++|.||||.-
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 237 HFK--PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccc--cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 000 001111123333333332 45789999999999999984 888999999965
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.32 Aligned_cols=287 Identities=37% Similarity=0.666 Sum_probs=235.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
.++|.+++.||.|+||.||+|.+..++..||||++............+.+|+.+++.+. ||||++++++|.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccccc
Confidence 35688999999999999999999999999999998654433344566779999999996 999999999885321 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||++++++|..++....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 4579999999999999988888999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|.+||++.+....+..+......+++.. .......
T Consensus 172 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 246 (343)
T cd07878 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV---LKKISSE 246 (343)
T ss_pred --cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH---HHhcchh
Confidence 34567999999999986656789999999999999999999999999888888888777664333221 1112233
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.....+..++......+...+...++.+.+|+.+||.+||.+| +.++|.||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 3344444455555566677777888999999999999999885 788999999976433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=380.07 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=213.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.+.+.||.|+||+||+|+++.++..||||.+.+..........+..|+.+|+.+. |||||.+++++. .++++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~--~~~~i 84 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIE--DDDFI 84 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEe--cCCeE
Confidence 467899999999999999999999999999999999766556667788899999999996 999999999998 56799
Q ss_pred EEEEecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC------Ccceecccccccc
Q psy14431 638 YVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS------CSIKIGDLGLARS 709 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d------G~VKLiDFGLAr~ 709 (1219)
|||||||. |||..+++.. .+++..++.++.||+.||++||+++||||||||.|||++.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999 7999999964 89999999999999999999999999999999999999764 4589999999999
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--CCCCCCchhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV--RPNPPHADKF 787 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l--~P~P~~~d~l 787 (1219)
+.++. ...+.||+|.|||||++ ....|+.++|+||+|+|+|+|++|++||...+..+.+..|.... .|.++.
T Consensus 165 L~~~~-~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~---- 238 (429)
T KOG0595|consen 165 LQPGS-MAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA---- 238 (429)
T ss_pred CCchh-HHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh----
Confidence 88543 45678999999999997 46679999999999999999999999999999888877665544 222111
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..++...+|+-.+|+.||..| ..+.+.|++.+
T Consensus 239 -----------------------------~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 239 -----------------------------ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLA 272 (429)
T ss_pred -----------------------------hccCchhhhhhHHHhcCccccCchHHhhhhhhcc
Confidence 124556677778888887663 44555666543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=399.75 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=228.8
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
....+++|.++++||.|+||.|+++..+.+++.||||++++.. ....+......|..|+....+||+++.++.+|. .
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--T 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--c
Confidence 3567899999999999999999999999999999999997653 355667788899999999888999999999997 5
Q ss_pred CceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
..++|+||||+.| ++..+.+.+.|++..+++|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++..-.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 7899999999985 654445568899999999999999999999999999999999999999999999999999997665
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.+..++++||||.|+|||++ ....|+.++|+|||||+||+||.|.+||+|.+..++...|+......|-.
T Consensus 521 ~g~~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--------- 590 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--------- 590 (694)
T ss_pred CCCccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc---------
Confidence 55567889999999999997 56679999999999999999999999999999999999998766444332
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
++.++++++.++|..||++| +.+..+||||+.
T Consensus 591 -------------------------ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 591 -------------------------LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -------------------------ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 37789999999999999985 777899999954
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=361.09 Aligned_cols=283 Identities=31% Similarity=0.555 Sum_probs=228.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+..|.++++||.|+||.||+|.+..++..||+|.+..... ......+.+|+.++..+. ||||+++++++. .++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 79 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIVH--TDKSL 79 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCC-CCCcceEEEEEe--eCCeE
Confidence 35679999999999999999999999999999999864322 222345678999999995 999999999987 46689
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|..++.. ..++...++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99999999999888763 3478889999999999999999999999999999999999999999999999976554433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~d~l~~~~~s~ 794 (1219)
......+|+.|+|||++.+...++.++|||||||++|+|++|.+||++.+..+.+..+.....+ .+..|+... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 235 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS----SN 235 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc----ch
Confidence 3345578999999999866667899999999999999999999999999888888888877743 333343321 11
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.... ....+...+..+....+.+++.+.|||.+||.+||.+| +.++|.||||..
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 236 DEFK-NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhh-hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 1000 11223333444555667789999999999999999984 888899999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=395.20 Aligned_cols=301 Identities=30% Similarity=0.472 Sum_probs=234.9
Q ss_pred CcccccchhhhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc
Q psy14431 538 GKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 617 (1219)
Q Consensus 538 ~k~rev~~~~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~ 617 (1219)
+...+.+|.....+.+. .+|.|++.||.|+||.|.+|.+..|++.||||+++. ..........|+.+|..+.
T Consensus 169 ~~~~~~dY~~v~~d~i~-----~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln 240 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIA-----YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLN 240 (586)
T ss_pred CCCCCCceeEEecceeE-----EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHh
Confidence 33444555544444433 278999999999999999999999999999999963 3344566778999999997
Q ss_pred CC-----CCccEEeeeeeccCCceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCC
Q psy14431 618 RH-----PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689 (1219)
Q Consensus 618 ~H-----PNIVkL~gvfe~~d~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPs 689 (1219)
.| -|||+++++|. ..+|+|||+|.+..+|+++++.. .++...++.++.||+.||.+||..||||+||||+
T Consensus 241 ~~d~~~~~n~Vrm~d~F~--fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 241 KHDPDDKYNIVRMLDYFY--FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPE 318 (586)
T ss_pred ccCCCCCeeEEEeeeccc--cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence 34 48999999998 57899999999999999999854 4888999999999999999999999999999999
Q ss_pred CeeeccC--CcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH
Q psy14431 690 NILIDKS--CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767 (1219)
Q Consensus 690 NILLd~d--G~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~ 767 (1219)
|||+..- ..|||+|||+|+...... ..++.+..|+|||++++ .+|+.++||||||||++||++|.|.|+|.+..
T Consensus 319 NILL~~~~r~~vKVIDFGSSc~~~q~v---ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 319 NILLKDPKRSRIKVIDFGSSCFESQRV---YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred heeeccCCcCceeEEecccccccCCcc---eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 9999754 369999999999876543 37899999999999975 46999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCchh-------hhhc--c--------------CChhHHhhhHHhhhh-----chhhHHHHhc-cc
Q psy14431 768 HQLQLIVNLVRPNPPHADK-------FYAG--F--------------KSKHEREKFNQVVVK-----CQKELQELQS-QV 818 (1219)
Q Consensus 768 e~L~kIve~l~P~P~~~d~-------l~~~--~--------------~s~~~relI~klp~k-----crk~L~el~p-~l 818 (1219)
+++..|+..++.+|+..-. ++.. . .++..+..+...... ....+...++ .-
T Consensus 395 DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~ 474 (586)
T KOG0667|consen 395 DQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKAD 474 (586)
T ss_pred HHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccccc
Confidence 9999999999766654211 1110 0 001111211111111 1222333333 23
Q ss_pred ChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 819 VEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 819 speaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
...++|||.+||.|||.+ ++.+||.|||+.....
T Consensus 475 ~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 475 DKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 346799999999999988 5999999999975443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.60 Aligned_cols=284 Identities=34% Similarity=0.584 Sum_probs=224.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~ 634 (1219)
+++|.+++.||.|+||.||+|.+..++..||||++............+.+|+.+++.+. ||||++++++|... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccccccc
Confidence 56899999999999999999999999999999999765545555677889999999995 99999999988632 22
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||++++|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 46899999999998887754 48888999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....++|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..++....++.+.+.... .+
T Consensus 181 -~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 254 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL----QP 254 (364)
T ss_pred -cccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh----hH
Confidence 234567899999999984 556899999999999999999999999999988888888777644433221111 11
Q ss_pred hHHhhhHHhhhhchhhHHHHhc------------ccChhHHHHHHhccccCCCC--CHHHHHcchhhhcC
Q psy14431 795 HEREKFNQVVVKCQKELQELQS------------QVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALG 850 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p------------~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~ 850 (1219)
.....+...+......+...++ ..+..+.|||.+||.+||.+ ++.++|+||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 2222222222222222222222 13457899999999999998 58889999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=378.68 Aligned_cols=257 Identities=28% Similarity=0.387 Sum_probs=220.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+..|.+.+.||.|+||.|+.|.+..+|..||+|++.+.... ......+.+|+.+++.+..||||+++++++.. .
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~ 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--P 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--C
Confidence 467899999999999999999999999999999977653111 12345566899999999779999999999984 4
Q ss_pred ceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-CcceecccccccccC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l~ 711 (1219)
..+|+||||+.| +|.+++.. +++.+..++.++.||+.|++|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 559999999995 89999886 789999999999999999999999999999999999999999 999999999999874
Q ss_pred CcccccccccccccccCchhhhccccc-cccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRY-THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~y-T~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.......+.+||+.|+|||++.+...| +.++||||+||+||-|++|..||...+....+..|..+....|...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~------ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL------ 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc------
Confidence 344456788999999999998655525 5899999999999999999999999888877777766654443321
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. ++++.+|+.+||..||.+| ..+.+.||||..
T Consensus 247 -------------------------~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 -------------------------L--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------C--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1 7889999999999999884 777899999976
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=367.58 Aligned_cols=283 Identities=31% Similarity=0.555 Sum_probs=222.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
+++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|.... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcccc
Confidence 57899999999999999999999999999999999655444555677889999999995 999999999986422 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||++++|...+.. .++...+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 35899999999988887753 48888999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+++..+.... ..
T Consensus 178 -~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 251 (359)
T cd07876 178 -MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL----QP 251 (359)
T ss_pred -cCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH----HH
Confidence 234567899999999984 556899999999999999999999999998887777777766644333221110 01
Q ss_pred hHHhhhHHhhhhchhhHHHHhc------------ccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQS------------QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p------------~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....++...+......+.+.++ ..++.+.+||.+||.+||.+| +.++|.|||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1112222222222222333222 235678999999999999984 888899999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.39 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=215.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.|+++||.|+||.||++.+..+|..||.|.+.-...+.........|+.+|+++. |||||++++.-...+..-+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence 356789999999999999999999999999999999744455666788999999999995 9999999984333345558
Q ss_pred EEEEecch-hhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHh--cc--cccCCCCCCCeeeccCCcceecccccc
Q psy14431 638 YVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA--CK--VMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS--~G--IVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
+||||||+ |+|.++++ ...+++..++.++.|++.||.++|+ .. |+||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999 79999887 3469999999999999999999998 44 899999999999999999999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
+.+........+++|||+||+||++ ...+|++++||||+||++|||+.-++||.|.+-.....+|.++..|+. ++.+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--p~~~ 252 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--PDEH 252 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC--cHHH
Confidence 9999888788899999999999998 456799999999999999999999999999988888889988864432 2222
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+ |.++..++..|+..||+.|+.
T Consensus 253 Y------------------------------S~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 253 Y------------------------------STDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred h------------------------------hhHHHHHHHHHccCCcccCCC
Confidence 2 677888899999999988654
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=391.61 Aligned_cols=252 Identities=33% Similarity=0.522 Sum_probs=226.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+.+.||+|+||.||+|+.+.+...||+|.+.+......+...+.+|+.|++.+. |||||.++++|+ ...++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfE--t~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFE--TSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhc--ccceEEE
Confidence 4688889999999999999999999999999999888888888999999999999996 999999999998 5789999
Q ss_pred EEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 640 VFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 640 VMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|.||+.|+|..++. .+.++++.++.++++++.||.|||+++|+|||+||.|||++..|++|+||||+|+.........+
T Consensus 79 Vte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 79 VTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred EehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 99999999999998 57799999999999999999999999999999999999999999999999999999888777778
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
..-|||.|||||++ .+.+|+..+|+||||||+|||++|+|||...+.......|..-..+.|.
T Consensus 159 sikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~---------------- 221 (808)
T KOG0597|consen 159 SIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS---------------- 221 (808)
T ss_pred eccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----------------
Confidence 88999999999997 5778999999999999999999999999888777666666543322222
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
..++.+..||..+|..||.+ ++.+.+.|||...
T Consensus 222 ------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 ------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 23777899999999999988 5999999997643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.69 Aligned_cols=277 Identities=32% Similarity=0.539 Sum_probs=221.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeecc---CCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAV---NNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~---d~~ 635 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|.+..............+|+.++..+. +||||++++++|... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999999999999999998654333333345667787777664 599999999988632 235
Q ss_pred eEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+++||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 6899999999999888864 3489999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~ 791 (1219)
.. ......+|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+..... |....|+....
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (288)
T cd07863 161 QM-ALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT-- 236 (288)
T ss_pred cc-cCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc--
Confidence 32 223457899999999985 45689999999999999999999999999888888888777653 33333322110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.+ -..+....+..+....+.++..+.||+.+||.+||.+| +.+++.||||
T Consensus 237 -~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 -LP-----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -cc-----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 00122234455667778888999999999999999985 8889999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.80 Aligned_cols=288 Identities=32% Similarity=0.554 Sum_probs=241.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCC----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TG----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.++..|.++..||.|+||.||+|..++++ ..+|||.+......+.......+|+.+++.+. ||||+.+..+|..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~- 98 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLS- 98 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhc-
Confidence 45677999999999999999999766554 37999998655444445567899999999996 9999999999974
Q ss_pred CCceEEEEEecchhhHHHHHh------hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC----Ccceec
Q psy14431 633 NNKDLYVVFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIG 702 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lr------s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d----G~VKLi 702 (1219)
.+..++|+++|.+.+|..+|+ ...++...++.|++||+.|+.|||++.|+||||||.||||..+ |.|||+
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 377899999999999999997 2358999999999999999999999999999999999999877 899999
Q ss_pred ccccccccCCcccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC---------cHHHH
Q psy14431 703 DLGLARSLSDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---------TSHQL 770 (1219)
Q Consensus 703 DFGLAr~l~~~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s---------~~e~L 770 (1219)
|||+++.+.++-.. ....+.|.||+|||.+++...||+++||||+|||+.||++-.|.|.+.. ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999988775433 2357889999999999999999999999999999999999999997642 35788
Q ss_pred HHHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhh--HHHHhc---ccChhHHHHHHhccccCCCC--CHHHHH
Q psy14431 771 QLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKE--LQELQS---QVVEENTSKLKLQMELDSKD--SEIEQL 842 (1219)
Q Consensus 771 ~kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~--L~el~p---~lspeaiDLLsKMLq~DPeK--RaiEAL 842 (1219)
..|+.++ .|....|+.+. ..|.....+..+......+ +..++. .-++.+.+||.+||.+||.+ ++..||
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lk---k~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLK---KMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHcCCCccccchhhh---hCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 9999988 67778887664 2455556666666543333 555553 35677999999999999998 588999
Q ss_pred cchhhhc
Q psy14431 843 QGKLAAL 849 (1219)
Q Consensus 843 qHpwfaL 849 (1219)
+|+||..
T Consensus 336 eh~yF~~ 342 (438)
T KOG0666|consen 336 EHPYFTE 342 (438)
T ss_pred ccccccc
Confidence 9999955
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=347.58 Aligned_cols=279 Identities=29% Similarity=0.557 Sum_probs=247.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|...++||+|.||+||+|++..+++.||+|.++-.......+...++||.+++.+. |.|||+++++.. .+..+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlh--sdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhc--cCceeEEe
Confidence 466778999999999999999999999999999866666677788999999999996 999999999986 56789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
+|||..+|..++. ++.++...++.++.|++.||.|+|++++.|||+||.|+||+.+|.+||+|||+++.++-+..+++
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 9999999999987 56799999999999999999999999999999999999999999999999999999998888888
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~ 796 (1219)
..+.|.||+||.++++..-|++.+|+||.|||+.|+.. |+|.|+|.+-.+++..|...+ .|....|+.+.. .+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~---lp-- 234 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK---LP-- 234 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc---CC--
Confidence 88999999999999999999999999999999999987 899999999999999999988 677777876541 00
Q ss_pred HhhhHHhhhh-chhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 797 REKFNQVVVK-CQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~k-crk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
.....|.. ...+|..+.|.++....|||.++|..+|.+ ++.+||+||||.-
T Consensus 235 --dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 235 --DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred --CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 01112222 346788999999999999999999999998 5899999999954
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=381.87 Aligned_cols=276 Identities=30% Similarity=0.528 Sum_probs=218.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc------
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV------ 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~------ 632 (1219)
..+|.+++.||.|+||.||+|.+..++..||||++... .....+|+.+++.+. ||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcC-CCCCcceeeeEeecccccCC
Confidence 45799999999999999999999999999999988532 123457999999995 99999999887431
Q ss_pred CCceEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceeccccc
Q psy14431 633 NNKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGL 706 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGL 706 (1219)
....+++||||++++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 123578999999998877765 34688999999999999999999999999999999999999665 699999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC-CCch
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHAD 785 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P-~~~d 785 (1219)
|..+..... ...++||++|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..|+.....++ ..+.
T Consensus 218 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 218 AKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred chhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 987654332 34567899999999987666799999999999999999999999999998888888887764332 2221
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhc-ccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQS-QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p-~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
... +.... ..++...+..+...+| ..++++.+||.+||++||.+| +.++|.||||..
T Consensus 297 ~~~-----~~~~~--~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 297 EMN-----PNYAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred Hhc-----hhhhc--ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 111 00000 0122223344555555 367889999999999999985 888999999965
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.44 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=209.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.++..+. ||||+++++++. ++..+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEH--DQRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhc--cCCeEE
Confidence 368899999999999999999999999999999864321 2233456788999999995 999999999886 567899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++ |+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999998 589888864 56899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......|.....+.|
T Consensus 155 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (291)
T cd05612 155 TWTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP--------------- 218 (291)
T ss_pred cccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC---------------
Confidence 2345799999999997 455689999999999999999999999998887766666654432111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+..++.+.+|+.+||.+||.+| +.+++.||||..
T Consensus 219 -------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 219 -------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -------------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 1236678999999999999986 568899999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=362.15 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=213.1
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
....+.+|.+.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++..+. ||||++++++|. +
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~ 89 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQ--D 89 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--c
Confidence 34457889999999999999999999999999999999864321 2234456789999999995 999999999987 5
Q ss_pred CceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
++.+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 678999999997 588888864 568899999999999999999999999999999999999999999999999998765
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... ...+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 170 ~~~---~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--------- 236 (329)
T PTZ00263 170 DRT---FTLCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--------- 236 (329)
T ss_pred CCc---ceecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC---------
Confidence 432 3457999999999974 556899999999999999999999999888777666666544322111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++.+.+|+.+||..||.+| +.+++.||||.-
T Consensus 237 -------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 237 -------------------------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -------------------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 135678899999999999998 478899999954
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=361.89 Aligned_cols=284 Identities=35% Similarity=0.601 Sum_probs=222.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
+++|.+++.||.|+||.||+|.+..++..||||++............+.+|+.+++.+. ||||++++++|.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccccc
Confidence 56899999999999999999999999999999998765555555677889999999995 999999999986322 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||+++++...+.. .++...+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++......
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 45899999999988887754 48888999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s 793 (1219)
......||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+....+..++.... |.+..+... .
T Consensus 174 -~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 246 (355)
T cd07874 174 -MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-----Q 246 (355)
T ss_pred -ccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-----c
Confidence 234567899999999974 55689999999999999999999999999888877777766653 333222211 1
Q ss_pred hhHHhhhHHhhhhchhhHHHHh------------cccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQ------------SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGS 851 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~------------p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~ 851 (1219)
+....++...+......++..+ +..+..+.+||.+||.+||.+ ++.++|+|||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 1122222222211111111111 123457899999999999998 488889999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=351.37 Aligned_cols=286 Identities=31% Similarity=0.554 Sum_probs=228.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+++|.++++||.|+||.||+|.+..++..||+|.+..... ......+.+|+.++..+. ||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~--~~~~~ 79 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSL 79 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcC-CCCcceEEEEEe--cCCeE
Confidence 46789999999999999999999999999999998853322 223345778999999995 999999999987 46689
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|..++.. ..++...+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99999999999888864 4588899999999999999999999999999999999999999999999999986554333
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+..... |....|+.... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS---NE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc---cc
Confidence 334456789999999986666788999999999999999999999999888888777777663 44444433221 00
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+ .....+......+....+.+++.+.+||.+||.+||.+| +.++|+||||....+
T Consensus 237 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 237 EF--KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cc--cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00 001112222223344556778899999999999999985 788899999966444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=353.11 Aligned_cols=278 Identities=30% Similarity=0.562 Sum_probs=205.9
Q ss_pred EeeeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 565 LLKEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
..+||.|+||.||+|.+. .++..||+|.+... .......+|+.++..+. ||||++++++|....+..+|+||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 46789999988532 22345678999999995 999999999987666778999999
Q ss_pred cchhhHHHHHhh----------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee----ccCCcceeccccccc
Q psy14431 643 YMENDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLAR 708 (1219)
Q Consensus 643 ymeGSL~d~Lrs----------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL----d~dG~VKLiDFGLAr 708 (1219)
|++++|..++.. ..++...++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 999998887752 248888999999999999999999999999999999999 456789999999998
Q ss_pred ccCCcc---cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhh
Q psy14431 709 SLSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVNL 776 (1219)
Q Consensus 709 ~l~~~~---~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~---------~e~L~kIve~ 776 (1219)
.+.... ......+||++|+|||++.+...++.++||||+||++|+|++|.+||.+... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 765432 1233567899999999987666789999999999999999999999975432 3456666666
Q ss_pred cC-CCCCCchhhhhccCChhHHhhhHH-hhhhch--hhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 777 VR-PNPPHADKFYAGFKSKHEREKFNQ-VVVKCQ--KELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 777 l~-P~P~~~d~l~~~~~s~~~relI~k-lp~kcr--k~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
.. |....|.....-.........+.. ....+. ..+.......++.+.|||.+||++||.+ ++.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 53 333333332110000000000000 000010 0111112234667999999999999988 58889999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.18 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=207.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+|.+++.||.|+||.||+|.+..+|+.||||++.... ........+.+|+.++..+. ||||++++++|. ++..+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQ--DENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCeEE
Confidence 36899999999999999999999999999999996432 12233456778999999995 999999999987 577899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+||||++ |+|.+++.. +.+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999997 589888764 5689999999999999999999999999999999999999999999999999875432110
Q ss_pred -------------------------------------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC
Q psy14431 716 -------------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758 (1219)
Q Consensus 716 -------------------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk 758 (1219)
.....+||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCC
Confidence 011246999999999974 556899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-
Q psy14431 759 PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS- 837 (1219)
Q Consensus 759 pPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR- 837 (1219)
+||.+.+....+..+.......+. +. ...+++.+.+||.+||. +|.+|
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~--~~----------------------------~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQF--PD----------------------------EVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCC--CC----------------------------CCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999988877766666543311100 00 01247789999999997 77763
Q ss_pred ----HHHHHcchhhhc
Q psy14431 838 ----EIEQLQGKLAAL 849 (1219)
Q Consensus 838 ----aiEALqHpwfaL 849 (1219)
+.+++.||||..
T Consensus 286 ~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 286 GNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHhcCCCcCC
Confidence 678899999954
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.76 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=203.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||++++++|. .++.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQ--THDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEE--cCCEEEEEEeCC
Confidence 368999999999999999999999999965432 2334456788999999995 999999999987 567899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ ++|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 8 47877776 456899999999999999999999999999999999999999999999999999764433333445689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......|
T Consensus 158 t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p--------------------- 215 (323)
T cd05571 158 TPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--------------------- 215 (323)
T ss_pred CccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC---------------------
Confidence 9999999997 455689999999999999999999999988776555554433221111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.+++.||||..
T Consensus 216 -------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 216 -------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred -------------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 2347788999999999999988 577899999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=342.89 Aligned_cols=278 Identities=33% Similarity=0.534 Sum_probs=221.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||+++++++. ++..+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLM--QESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEe--eCCeEEEE
Confidence 488999999999999999999999999999998644333334456788999999996 999999999987 46789999
Q ss_pred EecchhhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEymeGSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.+|.++|+|||++.........
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 78 FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred EecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 99999988888753 45899999999999999999999999999999999999999999999999999866544333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~~ 795 (1219)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+..... +....|+... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 231 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT------S 231 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch------h
Confidence 34456789999999986666688999999999999999999999998887766666655553 3333332211 0
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+...++......+....+.+++++.+++.+||.+||.+| +.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011111122222223344456688999999999999999985 7888999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.15 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=205.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.++++||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||++++++|. ++..+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~--~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQ--DKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEE--eCCEEEE
Confidence 58899999999999999999999999999999864321 2233456778999999995 999999999987 5678999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc----
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---- 713 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~---- 713 (1219)
|||||+ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999998 588888764 56899999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------------ccccccccccccccCchhhhccccccccccchhHHHH
Q psy14431 714 -------------------------------------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750 (1219)
Q Consensus 714 -------------------------------------------~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~I 750 (1219)
.......+||+.|+|||++. +..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHH
Confidence 00012357999999999974 5568999999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhc
Q psy14431 751 LAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQ 829 (1219)
Q Consensus 751 LyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKM 829 (1219)
+|+|++|.+||.+.++......+....... .+. ...+++.+.++|.+|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------------~~~~s~~~~~li~~l 286 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP-------------------------------QAKLSPEASDLIIKL 286 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-------------------------------cccCCHHHHHHHHHH
Confidence 999999999999888776666665433111 010 123478899999998
Q ss_pred cccCCCCC-----HHHHHcchhhhc
Q psy14431 830 MELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 830 Lq~DPeKR-----aiEALqHpwfaL 849 (1219)
+ .||.+| +.+++.||||..
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 7 499886 778899999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.82 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=209.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+++.||.|+||.||+|.+..++..||||++..... .......+..|+.++..+..|++|+.++++|. ..+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence 48899999999999999999999999999999865432 23345667889999998875667889998887 4668999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++ |+|..++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..........
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999998 588888764 568999999999999999999999999999999999999999999999999987543333333
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+....+..|.....+.|
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~---------------- 221 (324)
T cd05587 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP---------------- 221 (324)
T ss_pred eeecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------------
Confidence 4567999999999974 55689999999999999999999999998887776666654332211
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
..+++.+.+++.+||..||.+|. .+.+.||||..
T Consensus 222 ------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 222 ------------------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 12367789999999999999985 68899999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.66 Aligned_cols=282 Identities=33% Similarity=0.568 Sum_probs=223.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---CceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~L 637 (1219)
+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||+++++++...+ ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence 477889999999999999999999999999998654444445567889999999995 999999999987432 1268
Q ss_pred EEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-c
Q psy14431 638 YVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-E 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-~ 715 (1219)
|+||||+.++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999999888876 4568999999999999999999999999999999999999999999999999998654322 1
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-CchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~d~l~~~~~s~ 794 (1219)
.....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..|......++. .+... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-----~~ 234 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA-----CE 234 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh-----hH
Confidence 2234578999999999876667899999999999999999999999999999888888887743322 11111 01
Q ss_pred hHHhhhHHhhhhchhhHHH---HhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQE---LQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~e---l~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....+...+.. +..+.. +.+..++.+.+||.+||.+||.+| +.++|.||||..
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 235 GARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 111222111111 111222 224567899999999999999985 788999999965
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.10 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=203.8
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||.||+|.+..++..||+|++.... ........+.+|+.++..+. ||||++++++|. ..+.+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQ--SPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEe--cCCeEEEEEcCCCC
Confidence 699999999999999999999999986432 22334566788999999995 999999999887 4678999999998
Q ss_pred hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccc
Q psy14431 646 NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724 (1219)
Q Consensus 646 GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~ 724 (1219)
|+|..++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+||+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 58888876 45689999999999999999999999999999999999999999999999999986544333344567999
Q ss_pred cccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhh
Q psy14431 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVV 804 (1219)
Q Consensus 725 ~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp 804 (1219)
.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.......|
T Consensus 158 ~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----------------------- 213 (312)
T cd05585 158 EYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----------------------- 213 (312)
T ss_pred ccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC-----------------------
Confidence 999999984 55689999999999999999999999988776665555543221111
Q ss_pred hhchhhHHHHhcccChhHHHHHHhccccCCCCC-----HHHHHcchhhhc
Q psy14431 805 VKCQKELQELQSQVVEENTSKLKLQMELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 805 ~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-----aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||.+||.+| +.+.|.||||.-
T Consensus 214 -----------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 214 -----------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred -----------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 2346788999999999999998 578899999965
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.58 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=207.3
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccCCceEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. +||||++++++|. .+..+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence 6789999999999999999999999999999964431 2233455667766654332 5999999999987 567899
Q ss_pred EEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 639 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
+||||++| +|...+....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..........
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 99999984 78888887889999999999999999999999999999999999999999999999999987654333334
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.......|
T Consensus 159 ~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p---------------- 221 (324)
T cd05589 159 STFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP---------------- 221 (324)
T ss_pred cccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 4568999999999974 55689999999999999999999999998887766666654332211
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.++|.+||..||.+| +.+.+.||||..
T Consensus 222 ------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 222 ------------------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ------------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 1236778899999999999987 567799999854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.77 Aligned_cols=320 Identities=38% Similarity=0.615 Sum_probs=246.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---Cce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~ 636 (1219)
++|.+.+.||.|+||.||+|.+..+|..||+|.+... ........+.+|+.++..+. ||||+++++++...+ ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccce
Confidence 5799999999999999999999999999999988532 22334566788999999996 999999999875322 246
Q ss_pred EEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 637 LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+|+|++|++++|..++....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 8999999999999999888899999999999999999999999999999999999999999999999999976543221
Q ss_pred --ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccC
Q psy14431 716 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFK 792 (1219)
Q Consensus 716 --~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~ 792 (1219)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+..... |.+..+... .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 238 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI----I 238 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh----h
Confidence 123457899999999976666789999999999999999999999998887777777777664 333333222 1
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCCCCCCCCCcccccc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLSSADVENDESYVQD 870 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~PS~d~s~dE~~~~d 870 (1219)
.......+...+.....++....+..++.+.+++.+||..||.+| +.+++.||||......+..|... . ...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~-----~-~~~ 312 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAE-----E-PFP 312 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCC-----C-CCC
Confidence 233333444445455566777778889999999999999999985 78889999997654432221110 0 111
Q ss_pred cccCCCccCCCchhhhhhcccc
Q psy14431 871 SRLEGWVSIPNKQNIKRHGWKK 892 (1219)
Q Consensus 871 S~lEg~~~IPnk~nlk~~~wke 892 (1219)
-.+++++.+| +..+++.++.+
T Consensus 313 ~~~~~~~~~~-~~~~~~~~~~~ 333 (336)
T cd07849 313 FDFELFDDLP-KEKLKELIFEE 333 (336)
T ss_pred hhhccccccC-HHHHHHHHHHH
Confidence 2345556666 66666555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.86 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=209.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+++.||.|+||.||+|.+..++..||+|++.+... ..........|..++..+..||+|+.++++|. ..+.+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence 48899999999999999999999999999999875432 22334456778888888877999999999987 4678999
Q ss_pred EEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++ |+|...+. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 999998 58888776 4568999999999999999999999999999999999999999999999999997654333334
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--------------- 222 (323)
T cd05616 159 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--------------- 222 (323)
T ss_pred ccCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---------------
Confidence 4567999999999974 566899999999999999999999999988877777666553322111
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
..++.+.+++.+||..||.+|. .+.+.||||..
T Consensus 223 -------------------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 223 -------------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred -------------------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 2367789999999999999874 57789999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.49 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=204.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.+++.||.|+||.||+|.+..+|..||+|.+...... ......+.+|+.++..+. ||||++++++|. .++.+|+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~--~~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYE--TKDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEc--cCCeEEE
Confidence 378899999999999999999999999999998643222 222345678999999995 999999999887 4668999
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||++ |+|...+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999998 578776642 358899999999999999999999999999999999999999999999999998764332
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+.......+.......+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE------------- 222 (285)
T ss_pred eecCCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc-------------
Confidence 224557899999999984 557899999999999999999999999876553333222222111110
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.....+++.+.+|+.+||..||.+| +.+.++||||..
T Consensus 223 -----------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 223 -----------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred -----------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0112357889999999999999998 578899999955
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.16 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=205.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||||++.+... .......+..|+.++..+.+||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 368999999999999999999999999865422 23345567788899988877999999999987 567899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 8 58888776 456899999999999999999999999999999999999999999999999998764433333445679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 159 t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------- 217 (320)
T cd05590 159 TPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT-------------------- 217 (320)
T ss_pred CccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--------------------
Confidence 9999999997 4556899999999999999999999999988877766666543322111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
.+++.+.+|+.+||..||.+|+ .+++.||||..
T Consensus 218 --------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 218 --------------WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred --------------CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 2367789999999999999974 66899999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.53 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=205.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||||++..... .......+..|+.++..+.+||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence 368999999999999999999999999865422 23344567788888887778999999999997 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ ++|...+. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 8 57877776 456899999999999999999999999999999999999999999999999999765443333455679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++ .+..++.++|||||||++|+|++|++||.+.+....+..|.......|.
T Consensus 159 t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~-------------------- 217 (321)
T cd05591 159 TPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV-------------------- 217 (321)
T ss_pred CccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--------------------
Confidence 9999999997 4556899999999999999999999999998887777766553322111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH---------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE---------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa---------iEALqHpwfaL 849 (1219)
.+++.+.++|.+||..||.+|+ .+++.||||..
T Consensus 218 --------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 218 --------------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred --------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 1367789999999999999875 67899999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=359.10 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=210.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCC-eEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNK-QYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TG-k~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+.+|.+++.||.|+||.||+|.+..++ ..||+|++..... .......+.+|+.++..+. ||||++++++|. +++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~ 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFK--DES 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEE--eCC
Confidence 4667999999999999999999876654 7899999864322 2334556788999999995 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 8999999997 589888864 56899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.++......|.......|
T Consensus 185 ---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------ 248 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP------------ 248 (340)
T ss_pred ---cceecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 23567999999999984 45689999999999999999999999998877766666654432221
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+++.+||..||.+| +.+++.||||..
T Consensus 249 ----------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 249 ----------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred ----------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1236678899999999999987 678899999964
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=369.49 Aligned_cols=287 Identities=22% Similarity=0.322 Sum_probs=217.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc-----CCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~-----~HPNIVkL~gvfe~~d 633 (1219)
..+|.++++||.|+||.||+|.+..++..||||++.... ........|+.++..+. +|++|+.++++|.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-C
Confidence 367999999999999999999999999999999985321 12233456777776664 24568899988864 4
Q ss_pred CceEEEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCC--------------
Q psy14431 634 NKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSC-------------- 697 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG-------------- 697 (1219)
..++|+||++++++|.+++. .+.+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 56899999999998888776 4579999999999999999999998 6999999999999998765
Q ss_pred --cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Q psy14431 698 --SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775 (1219)
Q Consensus 698 --~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve 775 (1219)
.+||+|||.+...... ....+||++|+|||++. +..|+.++|||||||++|+|++|++||.+.+..+.+..|..
T Consensus 284 ~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CceEEECCCCccccCccc---cccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4999999988654322 34568999999999985 45699999999999999999999999999998888888888
Q ss_pred hcCCCCCCchhhhhccCChhHHhhhHHhhh----hchhhHHHHhc-------ccChhHHHHHHhccccCCCCC--HHHHH
Q psy14431 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVV----KCQKELQELQS-------QVVEENTSKLKLQMELDSKDS--EIEQL 842 (1219)
Q Consensus 776 ~l~P~P~~~d~l~~~~~s~~~relI~klp~----kcrk~L~el~p-------~lspeaiDLLsKMLq~DPeKR--aiEAL 842 (1219)
..++.|..|.... .......++..... ..+..+..+.. ..++.+.|||.+||++||.+| +.++|
T Consensus 360 ~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 360 TLGRLPSEWAGRC---GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HcCCCCHHHHhhc---cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 8776666554321 11111112211110 01111111110 124668899999999999985 88999
Q ss_pred cchhhhcCCCCcCC
Q psy14431 843 QGKLAALGSETASL 856 (1219)
Q Consensus 843 qHpwfaL~~e~s~~ 856 (1219)
.||||......+..
T Consensus 437 ~Hp~~~~~~~~~~~ 450 (467)
T PTZ00284 437 THPYVLKYYPECRQ 450 (467)
T ss_pred cCccccccCCcccc
Confidence 99999775554443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=345.29 Aligned_cols=290 Identities=31% Similarity=0.527 Sum_probs=229.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.+.+.||.|+||.||+|.+..+|..||+|++..............+|+.++..+. ||||+++++++.....+.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence 467899999999999999999999999999999998644333333345668999999996 9999999999876555678
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|..++.. ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999999988888774 5689999999999999999999999999999999999999999999999999987765433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC-CCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P-~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+......++ ..|+.+.. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 239 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD----L 239 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc----c
Confidence 334445688999999986666789999999999999999999999999999888888888774333 32322210 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
.....+ .++......+...++..++.+.|||.+||.+||.+| +.+++.||||.-....
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 240 PLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000000 011111123344455678899999999999999985 8889999999654333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=378.90 Aligned_cols=269 Identities=28% Similarity=0.478 Sum_probs=236.1
Q ss_pred hhhhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccE
Q psy14431 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624 (1219)
Q Consensus 545 ~~~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVk 624 (1219)
+...+..+.....-...|....+||+|+.|.||.|....++..||||.+... .......+++|+.+|+... |||||.
T Consensus 258 ~~~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~-H~NiVn 334 (550)
T KOG0578|consen 258 ILAKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLH-HPNIVN 334 (550)
T ss_pred HHHHhheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhcc-chHHHH
Confidence 3334444555566677888999999999999999999999999999999543 3445567899999999996 999999
Q ss_pred EeeeeeccCCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 625 L~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
+++.|. .++.+|+|||||+ |+|.+++....+++.++..|++.++.||.|||..||+|||||.+|||++.+|.+||+|
T Consensus 335 fl~Syl--v~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 335 FLDSYL--VGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred HHHHhc--ccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEee
Confidence 999987 3578999999999 5899999988999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 704 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 704 FGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
||+|..+........+.+|||+|||||++ ....|++++||||||+|++||+-|.|||-..++...+..|.....|....
T Consensus 413 FGFcaqi~~~~~KR~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 413 FGFCAQISEEQSKRSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN 491 (550)
T ss_pred eeeeeccccccCccccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC
Confidence 99999988877777889999999999997 56679999999999999999999999999888888888887766665443
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+ +.+++.+.|||.+||++||.+| +.+.|+|||+...
T Consensus 492 ~-------------------------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 492 P-------------------------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred c-------------------------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 3 3458999999999999999995 7788999999663
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.85 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||||++..... ..........|..++....+||||++++++|. .+..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 368999999999999999999999999965432 22334456677778877767999999999987 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 7 58888776 456899999999999999999999999999999999999999999999999999865443333445679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.|
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 216 (316)
T cd05592 159 TPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--------------------- 216 (316)
T ss_pred CccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------------
Confidence 99999999974 45689999999999999999999999998887666655543221111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH---HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE---IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa---iEALqHpwfaL 849 (1219)
..+++.+.+||.+||..||.+|+ .+.+.||||..
T Consensus 217 -------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 217 -------------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred -------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 12366788999999999999985 36679999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=340.32 Aligned_cols=277 Identities=30% Similarity=0.539 Sum_probs=219.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|.+............+.+|+.+++.+. ||||+++++++. +...+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLH--SDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhc--cCCceEEE
Confidence 488999999999999999999999999999998644333333355778999999995 999999999987 56789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
+||++++|..++. .+.+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+........
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 9999999888876 35689999999999999999999999999999999999999999999999999987655443344
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCC-CCCCCcHHHHHHHHhhcCCCC-CCchhhhhccCChhH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKSKHE 796 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP-F~g~s~~e~L~kIve~l~P~P-~~~d~l~~~~~s~~~ 796 (1219)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |++.+....+..+.....+.+ ..|+.... . +.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~- 233 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK-L--PD- 233 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh-c--cc-
Confidence 557789999999986666689999999999999999998755 667776777777766664332 22222110 0 00
Q ss_pred HhhhHHhhhh-chhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVK-CQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~k-crk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+..++.. ....+....+.+++.+.+|+.+||.+||.+| +.+++.||||
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 ---YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ---ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0001111 1223455667789999999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=356.38 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=206.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||++++++|. +...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~--~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQ--DKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCCeEE
Confidence 368999999999999999999999999999999964322 2233456778999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+||||++ |+|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999998 58888886 46799999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCC
Q psy14431 716 ----------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761 (1219)
Q Consensus 716 ----------------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF 761 (1219)
.....+||+.|+|||++. +..++.++|||||||++|+|++|.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012457999999999984 456899999999999999999999999
Q ss_pred CCCCcHHHHHHHHhhcCC--CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC---
Q psy14431 762 PGASTSHQLQLIVNLVRP--NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--- 836 (1219)
Q Consensus 762 ~g~s~~e~L~kIve~l~P--~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--- 836 (1219)
.+.+....+..|...... .|+. ..+++.+.+|+.+|+. +|..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~--------------------------------~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPE--------------------------------VPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCc--------------------------------CCCCHHHHHHHHHHcC-ChhhcCC
Confidence 988887777777653311 1110 1246788999999875 5544
Q ss_pred --CHHHHHcchhhhc
Q psy14431 837 --SEIEQLQGKLAAL 849 (1219)
Q Consensus 837 --RaiEALqHpwfaL 849 (1219)
++.+.++||||..
T Consensus 284 r~~~~ei~~hp~f~~ 298 (363)
T cd05628 284 APGVEEIKTNPFFEG 298 (363)
T ss_pred CCCHHHHhCCCCCCC
Confidence 3688999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.33 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=202.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++..+. ||||++++++|. .++.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQ--TKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCEEEEEEeCC
Confidence 368999999999999999999999999965432 2334567788999999995 999999999887 567899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 8 47877776 456899999999999999999999999999999999999999999999999998764333333345679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+.|
T Consensus 158 t~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p--------------------- 215 (328)
T cd05593 158 TPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP--------------------- 215 (328)
T ss_pred CcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC---------------------
Confidence 99999999974 55689999999999999999999999988776655544432221111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.+++.||||..
T Consensus 216 -------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 216 -------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred -------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 2346788999999999999987 578899999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.05 Aligned_cols=278 Identities=33% Similarity=0.547 Sum_probs=225.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||||.+............+.+|+.++..+. ||||+++++++. ++..+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcc--cCCcEEEE
Confidence 488999999999999999999999999999988644333333456889999999995 999999999986 56789999
Q ss_pred EecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 641 FEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 641 MEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||+.++|..++.. ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 78 FEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred eeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 99999888888763 458899999999999999999999999999999999999999999999999998765443333
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC-chhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~-~d~l~~~~~s~~~ 796 (1219)
....++++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.....+++.. |+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT------SL 231 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh------HH
Confidence 445678899999997655567889999999999999999999999988877777777666443332 22211 01
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
......++......+....+.+++.+.++|.+||.+||.+| +.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11122233344555666677788999999999999999995 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=352.22 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=203.0
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++..+. ||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCEEEEEEeCC
Confidence 368999999999999999999999999965432 2234456778999999995 999999999987 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 8 57877776 456899999999999999999999999999999999999999999999999998764333333345679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.......|
T Consensus 158 t~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p--------------------- 215 (323)
T cd05595 158 TPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--------------------- 215 (323)
T ss_pred CcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---------------------
Confidence 99999999974 55689999999999999999999999988776655555433221111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
..+++.+.+||.+||..||.+| +.+++.||||..
T Consensus 216 -------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 216 -------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred -------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 1247788999999999999887 678899999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=356.44 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=206.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|..||+|++..... .......+..|+.++..+. ||||++++++|. +++++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~--~~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQ--DKRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCEEE
Confidence 368899999999999999999999999999999864321 2334456778999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
+||||++ |+|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999998 58888886 4568999999999999999999999999999999999999999999999999987543210
Q ss_pred ---------------------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCC
Q psy14431 715 ---------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 761 (1219)
Q Consensus 715 ---------------------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF 761 (1219)
......+||+.|+|||++. +..++.++|||||||++|+|++|.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999974 556899999999999999999999999
Q ss_pred CCCCcHHHHHHHHhhcCC--CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--
Q psy14431 762 PGASTSHQLQLIVNLVRP--NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-- 837 (1219)
Q Consensus 762 ~g~s~~e~L~kIve~l~P--~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-- 837 (1219)
.+.+....+..|...... .|+ ...+++.+.+||.+|+. ||..|
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~--------------------------------~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPP--------------------------------EVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCC--------------------------------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 988877766666543211 111 01247789999999874 88875
Q ss_pred ---HHHHHcchhhhc
Q psy14431 838 ---EIEQLQGKLAAL 849 (1219)
Q Consensus 838 ---aiEALqHpwfaL 849 (1219)
+.+++.||||..
T Consensus 284 ~~~~~ei~~hp~f~~ 298 (360)
T cd05627 284 SNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCHHHHhcCCCCCC
Confidence 578999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=369.96 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=221.3
Q ss_pred hhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc------------CchhHHHHHHHHHHHHhccCCC
Q psy14431 553 MKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------------NKTDAQRTYREILFLKSFQRHP 620 (1219)
Q Consensus 553 L~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~------------s~~~~e~~lREI~ILr~L~~HP 620 (1219)
..++-.+.+|++++.||.|.||.|-+|++..+++.||||++.+... .-.......+||.+|+.+. ||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~ 168 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HP 168 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-Cc
Confidence 4466778999999999999999999999999999999999954311 1122357889999999996 99
Q ss_pred CccEEeeeeeccCCceEEEEEecchh-hHHHHHhhcc-CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc
Q psy14431 621 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS 698 (1219)
Q Consensus 621 NIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~-LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~ 698 (1219)
|||+|+.+..++..+.+|||+|||.. .+...=...+ +++.+++.|+.+++.||.|||.+|||||||||+|+|++.+|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999999999999999999999984 4333323455 899999999999999999999999999999999999999999
Q ss_pred ceecccccccccCC-----cccccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHH
Q psy14431 699 IKIGDLGLARSLSD-----SKECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770 (1219)
Q Consensus 699 VKLiDFGLAr~l~~-----~~~~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L 770 (1219)
|||+|||.+..+.. ........+|||.|+|||.+.++ ...+.+.||||+||+||.|+.|+.||-+......+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999987732 22334557999999999998662 34478999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+|++...-.|. .+.+.+.+.|||.+||..||.+| ..+.-.|||..
T Consensus 329 ~KIvn~pL~fP~--------------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 329 DKIVNDPLEFPE--------------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHhcCcccCCC--------------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 999876533222 12346789999999999999985 66778899985
Q ss_pred c
Q psy14431 849 L 849 (1219)
Q Consensus 849 L 849 (1219)
.
T Consensus 377 ~ 377 (576)
T KOG0585|consen 377 R 377 (576)
T ss_pred c
Confidence 5
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.85 Aligned_cols=275 Identities=21% Similarity=0.240 Sum_probs=212.6
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
....|.+++.||.|+||.||+|.+..+++.||+|... ...+.+|+.++..+. ||||++++++|. .+...
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAIN-HPSIIQLKGTFT--YNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCC-CCCCCCEeEEEE--ECCee
Confidence 3467999999999999999999999999999999653 234678999999995 999999999987 46689
Q ss_pred EEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-cc
Q psy14431 638 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-KE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~-~~ 715 (1219)
|+||+++.++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++...... ..
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999999999888764 56889999999999999999999999999999999999999999999999999754322 12
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-------STSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-------s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+. +....+..|+....+.|..++...
T Consensus 239 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 234568999999999974 556899999999999999999999776543 234566667766655554332111
Q ss_pred hccCChhHHhhhHHhhh---h---chhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVV---K---CQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~---k---crk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.......+..... . .+..+. ....++.++.+||.+||.+||.+| +.++|.||||..
T Consensus 318 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 318 ----QANLDEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred ----hHHHHHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0001111101100 0 011122 223456789999999999999984 888999999954
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=358.68 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|+.||||++..... .......+.+|+.++..+. ||||++++++|. +++.+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCEEE
Confidence 369999999999999999999999999999999854321 2223456778999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc---
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--- 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~--- 713 (1219)
+||||++ |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999997 589988874 56888999999999999999999999999999999999999999999999997532100
Q ss_pred ----------------------------------------ccccccccccccccCchhhhccccccccccchhHHHHHHH
Q psy14431 714 ----------------------------------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAE 753 (1219)
Q Consensus 714 ----------------------------------------~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyE 753 (1219)
.......+||+.|+|||++ .+..++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeee
Confidence 0001235799999999997 45568999999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccC
Q psy14431 754 MLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELD 833 (1219)
Q Consensus 754 LLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~D 833 (1219)
|++|.+||.+.+.......+.......+. + ....+++.+.++|.+|+ .+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------~---------~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHI---------------------P---------SQAKLSREASDLILRLC-CG 285 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccC---------------------C---------CCCCCCHHHHHHHHHHh-cC
Confidence 99999999988876655555432211000 0 01234778899999977 48
Q ss_pred CCCC-----HHHHHcchhhhc
Q psy14431 834 SKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 834 PeKR-----aiEALqHpwfaL 849 (1219)
|.+| +.+++.||||..
T Consensus 286 p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCC
Confidence 8876 488899999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.68 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=205.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.++++||.|+||.||+|.+..+|+.||||++..... .......+.+|+.++..+. ||||++++++|. ++.++|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQ--DAQYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCeeEE
Confidence 68999999999999999999999999999999864321 2233456778999999985 999999999997 5678999
Q ss_pred EEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--
Q psy14431 640 VFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-- 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-- 715 (1219)
||||++ |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999997 58888876 45689999999999999999999999999999999999999999999999999863321000
Q ss_pred ---------------------------------------------ccccccccccccCchhhhccccccccccchhHHHH
Q psy14431 716 ---------------------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750 (1219)
Q Consensus 716 ---------------------------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~I 750 (1219)
.....+||+.|+|||++. +..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchh
Confidence 001247999999999974 5568999999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhcc
Q psy14431 751 LAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQM 830 (1219)
Q Consensus 751 LyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKML 830 (1219)
+|+|++|.+||.+.+....+..|........ ++. ...+++.+.+||.+||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~----------------------------~~~~s~~~~dli~~lL 287 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLY--FPD----------------------------DIHLSVEAEDLIRRLI 287 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccC--CCC----------------------------CCCCCHHHHHHHHHHh
Confidence 9999999999988887776666654321100 000 0134778999999999
Q ss_pred ccCCCC-----CHHHHHcchhhhc
Q psy14431 831 ELDSKD-----SEIEQLQGKLAAL 849 (1219)
Q Consensus 831 q~DPeK-----RaiEALqHpwfaL 849 (1219)
. +|.+ ++.+++.||||..
T Consensus 288 ~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 288 T-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred c-CHhhcCCCCCHHHHhcCCCcCC
Confidence 8 6654 5788999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.49 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=211.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++..... .......+..|+.++..+. ||||++++++|. ++..+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQ--DDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEE--cCCEEE
Confidence 368999999999999999999999999999999965432 2233456788999999996 999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 9999997 589998874 5689999999999999999999999999999999999999999999999999986654 2
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~l~~~~~s~~ 795 (1219)
....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+....... .+.+.
T Consensus 155 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---------- 223 (333)
T cd05600 155 ANSVVGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD---------- 223 (333)
T ss_pred cCCcccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC----------
Confidence 34567999999999985 4478999999999999999999999999888777666665432110 01000
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
.....+++.+.+||.+||..+|.+ ++.+++.||||.-
T Consensus 224 -----------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 224 -----------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred -----------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 001345788999999999988877 5888899999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.22 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=202.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++..... .......+..|+.++..+. ||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~--~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--THDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--cCCEEEEEEeCC
Confidence 368999999999999999999999999975432 2234456778999999885 999999999887 567899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
+ |+|..++. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.++|+|||++.............+
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 8 47877776 4568999999999999999999997 7999999999999999999999999999876443333344567
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.......|
T Consensus 158 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p-------------------- 216 (325)
T cd05594 158 GTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-------------------- 216 (325)
T ss_pred CCcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC--------------------
Confidence 999999999974 55689999999999999999999999988776655554433221111
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
..+++.+.+||.+||.+||.+| +.++++||||..
T Consensus 217 --------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 217 --------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred --------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 1246788999999999999988 578899999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=355.81 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=205.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.+++.||.|+||.||+|.+..++..||||++.... ........+.+|+.++..+. ||||++++++|. +...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~--~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEe--cCCEEEE
Confidence 5889999999999999999999999999999996432 22334567888999999995 999999999997 5678999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc---
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--- 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--- 714 (1219)
||||++ |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999997 588888864 568999999999999999999999999999999999999999999999999975431100
Q ss_pred --------------------------------------------cccccccccccccCchhhhccccccccccchhHHHH
Q psy14431 715 --------------------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750 (1219)
Q Consensus 715 --------------------------------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~I 750 (1219)
......+||+.|+|||++. +..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhH
Confidence 0012357999999999974 4568999999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhc
Q psy14431 751 LAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQ 829 (1219)
Q Consensus 751 LyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKM 829 (1219)
+|+|++|.+||.+.++......+...... ..+. ...+++++.+||.+|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------------~~~~s~~~~dli~~l 286 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP-------------------------------QVKLSPEAVDLITKL 286 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC-------------------------------CCCCCHHHHHHHHHH
Confidence 99999999999887776655555432211 1000 113478899999998
Q ss_pred cccCCCC----CHHHHHcchhhhc
Q psy14431 830 MELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 830 Lq~DPeK----RaiEALqHpwfaL 849 (1219)
+..+|.. ++.+++.||||..
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCC
Confidence 7765543 5889999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.37 Aligned_cols=294 Identities=38% Similarity=0.677 Sum_probs=234.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---Cce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~ 636 (1219)
.+|.+++.||.|+||+||+|.+..+|..||||.+............+.+|+.++..+. ||||+++++++.... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccccCc
Confidence 4689999999999999999999999999999998654434444566788999999995 999999999886432 245
Q ss_pred EEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 637 LYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+|+||||++++|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 899999999999888864 5689999999999999999999999999999999999999999999999999987655433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
......++..|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+.....++++..... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 240 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF---IRNEK 240 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh---cCchh
Confidence 334567889999999986555689999999999999999999999999887777777777664443322111 11223
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLS 857 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~P 857 (1219)
....+..++......+....+.+++.+.+++.+||.+||.+| +.++++||||.........|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~ 304 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP 304 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence 333333344333445566677889999999999999999985 78889999997654444333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.50 Aligned_cols=282 Identities=35% Similarity=0.549 Sum_probs=223.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC---ce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---KD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---~~ 636 (1219)
++|.+.+.||.|+||.||+|.+..+|..||||++............+.+|+.++..+.+||||+++++++...+. ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368899999999999999999999999999998864433333445678899999999878999999998864221 23
Q ss_pred EEEEEecchhhHHHHHhh------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccc
Q psy14431 637 LYVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARS 709 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~ 709 (1219)
+|+||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999998888753 24789999999999999999999999999999999999998 88999999999986
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFY 788 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~ 788 (1219)
+...........++++|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+.... .|....|+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 65443333445678899999998666678999999999999999999999999988887777776655 33333332211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
. .......+...+..+....+.+++.+.+||.+||.+||.+| +.+++.||||.
T Consensus 241 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 K-------LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred h-------ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00111223334444556667889999999999999999985 67889999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=350.12 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=210.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++..... .......+..|+.++..+. ||||++++++|. ++.++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQ--DEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhee--cCCeEE
Confidence 368999999999999999999999999999999965432 2234556788999999995 999999999887 567899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999997 589888875 479999999999999999999999999999999999999999999999999998665433
Q ss_pred ---------------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH
Q psy14431 715 ---------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767 (1219)
Q Consensus 715 ---------------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~ 767 (1219)
.......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1223457899999999984 457899999999999999999999999988876
Q ss_pred HHHHHHHhhcC--CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC---HHHHH
Q psy14431 768 HQLQLIVNLVR--PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS---EIEQL 842 (1219)
Q Consensus 768 e~L~kIve~l~--P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR---aiEAL 842 (1219)
.....|..... ..|. .+.+++.+.+||.+||. ||.+| +.+++
T Consensus 237 ~~~~~i~~~~~~~~~p~--------------------------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 237 ETYNKIINWKESLRFPP--------------------------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred HHHHHHhccCCcccCCC--------------------------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 66666655221 1111 01147889999999997 99884 77899
Q ss_pred cchhhhc
Q psy14431 843 QGKLAAL 849 (1219)
Q Consensus 843 qHpwfaL 849 (1219)
.||||..
T Consensus 284 ~hp~~~~ 290 (350)
T cd05573 284 SHPFFKG 290 (350)
T ss_pred cCCCcCC
Confidence 9999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=349.79 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=202.2
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.+++.||.|+||.||+|.+. .+|..||+|++.+... .......+..|+.++..+.+||||+.++++|. ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 4889999999999999999864 5789999999864321 22334567789999999988999999999887 567
Q ss_pred eEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||+. |+|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 8999999998 48888876 456899999999999999999999999999999999999999999999999999865432
Q ss_pred c-cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhhcCCCCCCchhhh
Q psy14431 714 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 714 ~-~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e----~L~kIve~l~P~P~~~d~l~ 788 (1219)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||....... ....+.....+.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 230 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF-------- 230 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--------
Confidence 2 223356799999999998655568899999999999999999999997543211 111111111111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+.+++.+.+++.+||..||.+|+ .+++.||||..
T Consensus 231 --------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 231 --------------------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred --------------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 123467889999999999999874 57899999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.74 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=208.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|++..... .......+..|+.++..+.+||+|++++++|. ..+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEE
Confidence 36788999999999999999999999999999865422 23344567788899988877788999999887 4568999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++ |+|..++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..........
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999998 588888764 568999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.......|
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p---------------- 221 (323)
T cd05615 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP---------------- 221 (323)
T ss_pred cCccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 4567999999999974 55689999999999999999999999998887766666654332111
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
..+++.+.+++.+||..||.+|. .+.+.||||..
T Consensus 222 ------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 222 ------------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred ------------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 12366789999999999999874 57799999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.76 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=214.0
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+++.||.|+||.||+|.+..+|..||+|++.... ........+..|+.++..+. ||||++++++|. ++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~--~~ 115 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQ--DD 115 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEe--cC
Confidence 345678999999999999999999999999999999986432 12233445678999999985 999999999887 56
Q ss_pred ceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
..+|+||||++ |+|..++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 78999999997 58999988878999999999999999999999999999999999999999999999999999876543
Q ss_pred cc-ccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KE-CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~-~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..|....... .++.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~--- 270 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL--TFPD--- 270 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--CCCC---
Confidence 21 22346799999999998542 247899999999999999999999999888776666665432110 0000
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
.+..+..+.+||.+||..+|.+ ++.+++.||||..
T Consensus 271 -------------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 271 -------------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred -------------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 1234788999999999998875 5889999999954
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=375.87 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=227.1
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecc-ccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks-~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...++-|.+.+.||.|+.|.|-+|++..||+.+|||++.+. .........+.+||.||+.+. ||||+.+|+++. +.
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe--~~ 84 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWE--NK 84 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeec--cC
Confidence 44578899999999999999999999999999999999755 334455677889999999996 999999999998 67
Q ss_pred ceEEEEEecchh-hHHHHH-hhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~L-rs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.++|+|.||++| .|.+++ ..+++++..+..+++||+.|+.|||..+|+|||+||+|+|++..+.+||+|||+|..-.+
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 899999999994 666665 478899999999999999999999999999999999999999999999999999986554
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
+....+.||+|.|.|||++.+.+..+.++||||+|||||.||+|+.||.+.+...++.++..+....|.
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs---------- 233 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS---------- 233 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----------
Confidence 345677899999999999987777789999999999999999999999999888888888887754443
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+++++.|||++||..||.+| ..+.++|||.-....
T Consensus 234 ------------------------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 234 ------------------------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ------------------------cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 348899999999999999985 677899999855433
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.87 Aligned_cols=277 Identities=30% Similarity=0.554 Sum_probs=203.7
Q ss_pred EeeeeccCceEEEEEEEcC--CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 565 LLKEGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~--TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
..+||.|+||.||+|.+.. ++..||+|.+... .....+.+|+.++..+. ||||++++++|....+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999999754 5688999988532 22345778999999995 999999999987656778999999
Q ss_pred cchhhHHHHHhh----------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee----ccCCcceeccccccc
Q psy14431 643 YMENDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLAR 708 (1219)
Q Consensus 643 ymeGSL~d~Lrs----------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL----d~dG~VKLiDFGLAr 708 (1219)
|++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||+++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 999998887741 247888899999999999999999999999999999999 466789999999998
Q ss_pred ccCCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhh
Q psy14431 709 SLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVNL 776 (1219)
Q Consensus 709 ~l~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~---------~e~L~kIve~ 776 (1219)
.+..... .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 7654321 223457899999999986666789999999999999999999999975432 2344555555
Q ss_pred cC-CCCCCchhhhhccCChhHHhhhHHhhhhchhhH----HHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 777 VR-PNPPHADKFYAGFKSKHEREKFNQVVVKCQKEL----QELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 777 l~-P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L----~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.. |....|.........+.....+.... .....+ .......+..+.+|+.+||++||.+| +.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTT-YANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccc-cCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 43 33344433221000000011100000 000111 11112346678999999999999994 8888999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.23 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=220.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+...||.|.|+.||++.+..||+.+|+|++..........+.+.+|+.|.+.+. |||||++.+.+. ..+..||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~--~~~~~yl 87 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHYL 87 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhc--ccceeEE
Confidence 3567778899999999999999999999999998655445557788999999999997 999999999886 5778999
Q ss_pred EEecchh-hH-HHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---CcceecccccccccCCcc
Q psy14431 640 VFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEymeG-SL-~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr~l~~~~ 714 (1219)
|||+|.| +| .+++..-.+++..+-.++.||+.||.|+|.+||||||+||.|+|+-.. .-+||+|||+|..++ ++
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 9999996 44 455556678999999999999999999999999999999999999543 359999999999888 44
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~d~l~~~~~s 793 (1219)
......+|||+|+|||++ ...+|+.++|||+.|||||-|+.|.+||.+.+...++..|..+..- +++.|
T Consensus 167 ~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w--------- 236 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW--------- 236 (355)
T ss_pred cccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc---------
Confidence 556778999999999997 5667999999999999999999999999999999999999888733 22334
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
+++++++.+|+++||..||.+ ++.+||.|||..-
T Consensus 237 ----------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 ----------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 456899999999999999998 5999999999854
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.88 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=201.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++..... ..........|+.++....+||||++++++|. +.+++|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence 468999999999999999999999999965432 12334556778888887767999999999987 567899999999
Q ss_pred h-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
. |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 8 488887764 56899999999999999999999999999999999999999999999999998754333333455689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.... |..+
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~-------------------- 216 (316)
T cd05620 159 TPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYP-------------------- 216 (316)
T ss_pred CcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC--------------------
Confidence 99999999974 5568999999999999999999999998877665555443222 1111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH---HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE---IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa---iEALqHpwfaL 849 (1219)
...++.+.+|+.+||..||.+|+ .+.+.||||..
T Consensus 217 -------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 217 -------------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 11367789999999999999984 35677999955
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.38 Aligned_cols=292 Identities=50% Similarity=0.839 Sum_probs=237.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+.+.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+.+||||++++++|...++..+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45688889999999999999999999999999988654444455566788999999995699999999998765566799
Q ss_pred EEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc----
Q psy14431 639 VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK---- 714 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~---- 714 (1219)
+||||++++|..++..+.+++..+..++.+|+.||.|||+.||+|+||+|+||+++.+|.++|+|||++.......
T Consensus 86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 9999999999999987788999999999999999999999999999999999999999999999999998664432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-CchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~d~l~~~~~ 792 (1219)
.....+.||++|+|||++.+...++.++|||||||++|+|++|++||++.+.......+.......+. .+... .
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 241 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI----K 241 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH----H
Confidence 22334678999999999866667889999999999999999999999998888888887776643322 22211 1
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETA 854 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s 854 (1219)
.+.....+..+......++....+..+..+.+++.+||.+||.+| +.+++.|||+.....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~ 305 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS 305 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence 222233333344444555667777789999999999999999985 67889999997754433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.08 Aligned_cols=278 Identities=30% Similarity=0.511 Sum_probs=223.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.++++||.|+||.||+|.+..++..||+|++....... ......+|+.++..+.+||||+++++++.....+.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678899999999999999999999999999986543322 2334568999999997899999999999855447899999
Q ss_pred ecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 642 EYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 642 EymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
||+++++.+.+.. ..+++..+..++.||+.||.|||+.|++||||+|+||+++. +.++|+|||++........ ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~ 157 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTE 157 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCC
Confidence 9999998888874 45899999999999999999999999999999999999999 9999999999987654332 234
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
..+++.|+|||++..+..++.++|||||||++|+|++|.+||++.+..+.+..+.......++.+..... ... ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~ 232 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR---KSR--HM 232 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc---ccc--cc
Confidence 5688999999987666668899999999999999999999999998888888887766555443322110 000 00
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
-..++......+..+.+..+..+.+++.+||.+||.+| +.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 01223333444556667789999999999999999985 7888999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=352.44 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=211.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
....+|.+++.||.|+||.||+|.+..++..||+|++.+... .......+.+|+.++..+. ||||++++++|. ++.
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--~~~ 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQ--DDK 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCC
Confidence 345789999999999999999999999999999999864321 2233445678888888885 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.+|+||||++ |+|.+++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 8999999997 589999988789999999999999999999999999999999999999999999999999998765332
Q ss_pred c-ccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 715 E-CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..|........ ++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~p~---- 270 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--FPE---- 270 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--CCC----
Confidence 2 22356799999999998543 2378899999999999999999999998887766666654331100 000
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
...+++.+.+++..||..+|.+ ++.++++||||..
T Consensus 271 ------------------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 271 ------------------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ------------------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 0124677899999999865543 5899999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.76 Aligned_cols=289 Identities=40% Similarity=0.692 Sum_probs=236.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCceE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDL 637 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~L 637 (1219)
++|.+.+.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|... ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceE
Confidence 5788999999999999999999999999999998755444445567788999999996 99999999988632 34578
Q ss_pred EEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 638 YVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
|+||||++++|..++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999999999999886 45589999999999999999999999999999999999999999999999999976543221
Q ss_pred ---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-Cchhhhhcc
Q psy14431 716 ---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADKFYAGF 791 (1219)
Q Consensus 716 ---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~d~l~~~~ 791 (1219)
.....+++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+++ .+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~---- 239 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI---- 239 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh----
Confidence 1234578999999999865566899999999999999999999999998888888777776643333 22222
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
........+..++.....++....+..++.+.+++.+||.+||.+| +.+++.||||......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 1233344444555556667778888899999999999999999985 7778999999654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=347.79 Aligned_cols=283 Identities=34% Similarity=0.585 Sum_probs=223.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcccc
Confidence 46799999999999999999999999999999998654444455567788999999995 999999999886322 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.++|+||||++++|...+... ++...+..++.||+.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 468999999999998888755 8899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||++. +..++.++|||||||++|+|++|+.||.+.+....+..++....++++.+.... ..
T Consensus 173 -~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 246 (353)
T cd07850 173 -MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL----QP 246 (353)
T ss_pred -CCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh----hh
Confidence 223456889999999984 556899999999999999999999999998888888888777755544332221 11
Q ss_pred hHHhhhHHhhhhchhhHHHHhc-------------ccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQS-------------QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p-------------~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....+...+.....++...++ ..++.+.++|.+||.+||.+| +.++|.|||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 1111122222222222333322 234568999999999999984 888999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.93 Aligned_cols=282 Identities=32% Similarity=0.587 Sum_probs=219.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++..||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|. .+..+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFR--RKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEe--eCCEEEE
Confidence 3688999999999999999999999999999998644333333455778999999996 999999999987 4668999
Q ss_pred EEecchhh-HHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMEND-LNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGS-L~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++++ |..++. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99999975 444443 3468999999999999999999999999999999999999999999999999998776544333
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+........+.....+. .....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS---TNQFF 234 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc---ccccc
Confidence 455688999999998665678899999999999999999999999888777776666554332221111110 00000
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+.........++...++.++..+.+|+.+||.+||.+| +.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000112233455667789999999999999999995 6788999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.73 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=198.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||+|++..... .......+..|+.++..+.+||||++++++|. ....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence 368999999999999999999999999975432 22334567789999999978999999999987 567899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 8 47877775 457999999999999999999999999999999999999999999999999998754333333445689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|++||....... .|.... ...+..
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---------~~~~~~-------------~~~~~~ 215 (329)
T cd05588 159 TPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD---------NPDQNT-------------EDYLFQ 215 (329)
T ss_pred CccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccc---------cccccc-------------hHHHHH
Confidence 99999999974 5568999999999999999999999996422100 000000 000000
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
........ +-+.+++.+.++|.+||.+||.+|+ .+++.||||..
T Consensus 216 ~~~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHcCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 00000000 0123577899999999999999984 58899999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.72 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=202.4
Q ss_pred EeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 565 LLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++.||.|+||.||+|.+. .++..||+|++..... .......+..|+.++..+. ||||++++++|. .++.+|+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~l 77 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQ--TGGKLYL 77 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEe--cCCeEEE
Confidence 367999999999999864 5789999999864321 2233455678999999995 999999999987 4678999
Q ss_pred EEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||+++ +|..++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999984 8888886 4567888999999999999999999999999999999999999999999999987544333333
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.|
T Consensus 158 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~---------------- 220 (323)
T cd05584 158 HTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP---------------- 220 (323)
T ss_pred cccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------------
Confidence 4567999999999974 45688999999999999999999999998877666666554332211
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.+.+.||||..
T Consensus 221 ------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 221 ------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred ------------------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 1236778999999999999987 577799999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.63 Aligned_cols=280 Identities=34% Similarity=0.573 Sum_probs=226.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.+. ||||+++++++. .+..+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP--HGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCeeEEE
Confidence 488999999999999999999999999999998755433444567889999999996 999999999987 46789999
Q ss_pred EecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-cc
Q psy14431 641 FEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CL 717 (1219)
Q Consensus 641 MEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-~~ 717 (1219)
|||++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99998899998863 5689999999999999999999999999999999999999999999999999987654321 23
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~ 796 (1219)
....++.+|+|||.+.+...++.++|||||||++|+|++|.+||.+.++...+..+.... .|.+..|+.+.. ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 233 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS----LPD 233 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC----cch
Confidence 345789999999998666667999999999999999999999999988888777777765 343433433210 000
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
... -.++......+...++..+..+.+|+.+||.+||.+| +.+++.||||.
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 0112223344566777888999999999999999985 78889999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.82 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=200.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHH-HhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFL-KSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~IL-r~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
+.||.|+||.||+|.+..+|..||||++..... .......+..|..++ ..+ +||||++++++|. +...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~--~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQ--TADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEE--eCCEEEEEEcC
Confidence 368999999999999999999999999864322 222334556666654 555 5999999999887 46789999999
Q ss_pred chh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 meG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
+.| +|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 984 7887776 45689999999999999999999999999999999999999999999999999876543333344567
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 158 gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (323)
T cd05575 158 GTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL--------------------- 215 (323)
T ss_pred CChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 999999999974 5568999999999999999999999998877766655554322111
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
.+..++.+.++|.+||..||.+|+ .+++.||||..
T Consensus 216 -------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 216 -------------KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 123477889999999999999974 58899999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.60 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=201.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||||++..... ..........|..++....+||||++++++|. +.+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence 368999999999999999999999999965432 22334556778888887667999999999987 466899999999
Q ss_pred h-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 7 589888874 46899999999999999999999999999999999999999999999999998754333333445679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.... |..+
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~-------------------- 216 (316)
T cd05619 159 TPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYP-------------------- 216 (316)
T ss_pred CccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC--------------------
Confidence 99999999974 5568999999999999999999999998877665555543221 1111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH---HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE---IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa---iEALqHpwfaL 849 (1219)
+.++..+.+++.+||..||.+|+ .+.+.||||..
T Consensus 217 -------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 217 -------------RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred -------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 12366789999999999999973 36789999955
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=349.91 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=200.9
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
||.|+||.||+|.+..+|..||||++..... ..........|..++.... +||||+.++++|. ....+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 6999999999999999999999999854321 2223345566777776654 7999999999987 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
. |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 8 57887776 456899999999999999999999999999999999999999999999999999765443333445689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..|.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------- 218 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-------------------- 218 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC--------------------
Confidence 999999999866566899999999999999999999999887766655555433211111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCC------HHHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS------EIEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR------aiEALqHpwfaL 849 (1219)
..+++.+.+|+.+||..||.+| +.+.+.||||..
T Consensus 219 -------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 219 -------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 1246778999999999999988 578899999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.29 Aligned_cols=284 Identities=31% Similarity=0.539 Sum_probs=225.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
++.+|.+.+.||.|+||.||+|.+..++..||+|.+............+.+|+.++..+. ||||+++++++...+...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcE
Confidence 356799999999999999999999999999999998644333333345678999999996 9999999999875545789
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.+|.++|+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999999999888864 3489999999999999999999999999999999999999999999999999987765433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+..... |.+..|+.+.. + +
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~ 238 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE-L--P 238 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc-c--c
Confidence 344556789999999986656678999999999999999999999999988888888877663 33333433210 0 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhccc--ChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQV--VEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~l--speaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.... ..........+...++.. ++.+.+++.+||..||++| +.++|.||||
T Consensus 239 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcc--cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000 011111223334445554 7889999999999999995 7788999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=346.27 Aligned_cols=289 Identities=34% Similarity=0.622 Sum_probs=235.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---- 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---- 634 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccccc
Confidence 34699999999999999999999999999999998644333334556789999999995 9999999999864221
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||+|++++|..++....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE- 171 (343)
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence 2468999999889999988888999999999999999999999999999999999999999999999999999866433
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+..+.....+.+..+.. .....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 246 (343)
T cd07880 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ---KLQSE 246 (343)
T ss_pred --ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH---hhcch
Confidence 2345678999999998654568899999999999999999999999888777777777766544433222 22233
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETA 854 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s 854 (1219)
.....+..++...+..+..+.+.+++.+.++|.+||..||.+| +.+++.||||.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 3344445555555566777778889999999999999999985 88889999997755443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=332.91 Aligned_cols=281 Identities=31% Similarity=0.526 Sum_probs=217.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.+++.||.|+||.||+|.+..+|..||||.+...... .....+.+|+.+++.+. ||||+++++++. ++.++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 78 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLK-HANIVTLHDIIH--TKKTL 78 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCC-CcceeeEEEEEe--cCCeE
Confidence 367899999999999999999999999999999998643221 22334678999999995 999999999987 56789
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++........
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99999999999988864 4578999999999999999999999999999999999999999999999999876543322
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhhc-CCCCCCchhhhhccCC
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLV-RPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s-~~e~L~kIve~l-~P~P~~~d~l~~~~~s 793 (1219)
......++..|+|||++.+...++.++||||+||++|+|++|.+||.+.. ..+.+..+.... .|.+..|+......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP-- 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc--
Confidence 22334578899999998666668999999999999999999999998766 455556665555 33333333322100
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccC--hhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVV--EENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~ls--peaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.... .......+..+....+.++ +.+.+++.+||.+||..| +.+++.||||
T Consensus 237 -~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 -EFKP--YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred -cccc--ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 0011112233444445555 789999999999999985 7888999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=330.53 Aligned_cols=277 Identities=31% Similarity=0.561 Sum_probs=224.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.++++||.|+||.||+|.+..+|..||||++..... ......+.+|+.+++.+. ||||+++++++. +.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELK-HENIVRLHDVIH--TENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhc-CCCEeeeeeeEe--eCCcEEEE
Confidence 48899999999999999999999999999999864322 223456778999999995 999999999987 45688999
Q ss_pred EecchhhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEymeGSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 77 FEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred EecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 99999999888764 34899999999999999999999999999999999999999999999999999866543333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|....|..+.. .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 231 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ---L-- 231 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc---C--
Confidence 3445678999999998666668899999999999999999999999988888888777665 444443433220 0
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+...++...........+..++.+.+++.+||..||.+| ..+++.||||
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 -PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred -chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11112233333445556667788999999999999999996 6688999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.06 Aligned_cols=282 Identities=34% Similarity=0.582 Sum_probs=224.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|.+.+.||.|+||.||+|.+..+|..||||.+...... ......+..|+.++..+. ||||+++++++. +...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFG--HKSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheee--cCCEE
Confidence 478889999999999999999999999999998644322 223345678999999996 999999999997 46789
Q ss_pred EEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||+.++|..++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.+|.++|+|||++........
T Consensus 78 ~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 78 NLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999999988999998754 589999999999999999999999999999999999999999999999999987765443
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.++...+..+..... |.+..|+.... . +
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~ 234 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS-L--P 234 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc-c--c
Confidence 344456788999999986666789999999999999999999999999888877777766553 33332222110 0 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
...........+....++..+..+.+++.+||.+||.+| +.+++.|+||.....
T Consensus 235 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 235 ----DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ----ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 001111112233445566778899999999999999985 788899999976443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=347.26 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=197.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||+|++.+... .......+..|+.++..+.+||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence 368999999999999999999999999975432 23344567788998888878999999999987 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 8 57877765 456999999999999999999999999999999999999999999999999999764433333445689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||....... .+..... ..+..
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---------~~~~~~~-------------~~~~~ 215 (329)
T cd05618 159 TPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---------NPDQNTE-------------DYLFQ 215 (329)
T ss_pred CccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcC---------CcccccH-------------HHHHH
Confidence 99999999974 5568999999999999999999999995321100 0000000 00000
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
........ +-...++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 216 ~i~~~~~~---~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCCC---CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 00000000 1123577889999999999999985 58899999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.83 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=197.8
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||+||+|.+..+|..||+|.+...... ......+..|+.++..+. ||||++++++|. .+..+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQ--TKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEc--CCCeEEEEEeCCCC
Confidence 69999999999999999999999998643221 223345678999999995 999999999887 4667999999998
Q ss_pred hhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 646 NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 646 GSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
|+|...+. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+..........
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 57877663 2458999999999999999999999999999999999999999999999999998765544444456
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
.||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.......+.......+..
T Consensus 158 ~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (280)
T cd05608 158 AGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT----------------- 219 (280)
T ss_pred CCCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC-----------------
Confidence 7899999999984 5568999999999999999999999997654332222221111111100
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
..+.+++.+.+++.+||..||.+|+ .+++.||||..
T Consensus 220 -------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 220 -------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred -------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 0123577899999999999999886 67899999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=343.31 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=203.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||||++.+... .......+.+|+.++..+.+||||++++++|. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 368999999999999999999999999975432 23344567788899988877999999999987 466899999999
Q ss_pred h-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 8 578877764 47999999999999999999999999999999999999999999999999998754333333345679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.......|
T Consensus 159 ~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~--------------------- 216 (318)
T cd05570 159 TPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP--------------------- 216 (318)
T ss_pred CccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------------------
Confidence 99999999984 55689999999999999999999999988876665555543221111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--H-----HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--E-----IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--a-----iEALqHpwfaL 849 (1219)
..+++.+.+|+.+||..||.+| + .+++.||||..
T Consensus 217 -------------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 217 -------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -------------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1236778999999999999997 3 77899999955
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=350.82 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=211.5
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
-.....+|.+++.||.|+||.||+|.+..++..||+|++.... ........+.+|+.++..+. ||||++++++|. +
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--~ 114 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ--D 114 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--c
Confidence 4455689999999999999999999999999999999986432 12233445678888888885 999999999987 5
Q ss_pred CceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+..+|+||||++ |+|..++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 678999999997 5899999887899999999999999999999999999999999999999999999999999987654
Q ss_pred ccc-ccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKE-CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~-~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..|.......+ ++.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~-- 270 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--FPD-- 270 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--CCC--
Confidence 321 22356799999999998532 2378999999999999999999999998887766666654331110 000
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
.+.+++.+.+|+..||.-+|.+ ++.+++.|+||.-
T Consensus 271 --------------------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 271 --------------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred --------------------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1245788999999999833332 4678899999844
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=357.07 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=220.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-..|.+.+.||.|.||.||.|.++.||..||+|++.+.... ........+|+.+|+.+.+|||||.++++|. +...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e--~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE--DPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE--cCCeE
Confidence 45688889999999999999999999999999999755432 2345678899999999988999999999998 45689
Q ss_pred EEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC----CcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d----G~VKLiDFGLAr~l~~ 712 (1219)
++|||+|. |.|.+.+....+++..+..++.||+.|+.|||+.||+||||||+|||+... +.++++|||++.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999 578777765459999999999999999999999999999999999999643 5799999999998887
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~l~~~~ 791 (1219)
.......+||+.|+|||++ ...+|+..+||||+||++|.|++|.+||.+.+.......|..+.... .+.
T Consensus 192 -~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~-------- 261 (382)
T KOG0032|consen 192 -GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP-------- 261 (382)
T ss_pred -CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC--------
Confidence 5556788999999999997 45679999999999999999999999999999888777777766322 222
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
++.++..+.||+.+||.+||.. ++.++|+|||...
T Consensus 262 -----------------------w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 262 -----------------------WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred -----------------------ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 2445888999999999999988 4888999999755
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.25 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=203.9
Q ss_pred eeeeccCceEEEEEEE---cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 566 LKEGKGAYGIVYKAYD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~d---k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
+.||.|+||.||++.+ ..+|..||+|++...............|+.++..+. ||||++++++|. .++.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQ--TEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEE--cCCEEEEEEc
Confidence 5789999999999976 467899999999754333334456778999999995 999999999987 4678999999
Q ss_pred cch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 643 YME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 643 yme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
|+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 997 588888864 468999999999999999999999999999999999999999999999999998765443334456
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+....+..|.......|
T Consensus 159 ~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p------------------- 218 (318)
T cd05582 159 CGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP------------------- 218 (318)
T ss_pred cCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC-------------------
Confidence 8999999999974 45689999999999999999999999998877666666544322111
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .+.+.||||..
T Consensus 219 ---------------~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 219 ---------------QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ---------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 12367788999999999999974 56799999854
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.69 Aligned_cols=287 Identities=31% Similarity=0.516 Sum_probs=218.2
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC--
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-- 633 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d-- 633 (1219)
..++++|.++++||.|+||.||+|.+..+|..||||.+..............+|+.+++.+. ||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence 34577899999999999999999999999999999988644333333445678999999995 999999999876422
Q ss_pred ----CceEEEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 634 ----NKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 634 ----~~~LyLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
...+|+||||++++|..++... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 2457999999999988888754 6899999999999999999999999999999999999999999999999999
Q ss_pred cccCCccc----ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 708 RSLSDSKE----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 708 r~l~~~~~----~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
..+..... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.....+.++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86643221 12234678899999998665567899999999999999999999999888877777776666444333
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhc--ccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQS--QVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p--~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+.+... .......+ .++............ ..++.+.||+.+||..||.+| +.++|.||||
T Consensus 247 ~~~~~~---~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVD---KLELFKKM-ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hccccc---chhhhhhc-cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 211110 00000000 011111111111111 235678999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.07 Aligned_cols=256 Identities=33% Similarity=0.560 Sum_probs=208.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|++++.||.|+||+||+|.+..++..||+|++..............+|+.++..+ +||||+++++++. ....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~--~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQ--DDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEE--ESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccc--ccccccccc
Confidence 7899999999999999999999999999999975543333334456799999999 5999999999997 477899999
Q ss_pred ecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 642 EYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 642 EymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
+|+++ +|..++. .+.++...+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99997 8999997 778999999999999999999999999999999999999999999999999999764333344556
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
..+++.|+|||++..+..++.++|||||||++|+|++|..||...........+.....+.....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS--------------- 222 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------------
Confidence 78899999999975366789999999999999999999999987744443333332221100000
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.. .....++.+.+++.+||..||.+| +.+.++||||
T Consensus 223 ---~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 ---SQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---TT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---cc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 000112789999999999999985 7888999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=344.53 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=199.4
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++..... .......+..|..++....+||||++++++|. .++.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence 368999999999999999999999999864422 22333455666665444336999999999887 467899999999
Q ss_pred hh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 eG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
.| +|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 85 7777765 456899999999999999999999999999999999999999999999999998764433333455679
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~---------------------- 215 (325)
T cd05604 159 TPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL---------------------- 215 (325)
T ss_pred ChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----------------------
Confidence 99999999974 5568999999999999999999999998887666555554322111
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
.+..+..+.++|.+||..||.+|+ .+++.||||..
T Consensus 216 ------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 216 ------------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred ------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 123467788999999999999874 57899999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=342.56 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=208.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+.+.||.|+||.||+|.+..+|..||+|++..... .......+..|+.++..+ +||||++++++|. +...+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~--~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQ--DKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEe--cCCeEE
Confidence 368999999999999999999999999999999975432 223345567888888887 5999999999887 467899
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||++ |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999997 589998875 4689999999999999999999999999999999999999999999999999987654332
Q ss_pred c-cccccccccccCchhhhc-----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 716 C-LTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~-----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
. .....||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..|........ +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~----- 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--F----- 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC--C-----
Confidence 2 223478999999999752 45678999999999999999999999988877766666654321100 0
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+ ..+.+++.+.+||.+||. ||.+| +.+++.||||..
T Consensus 231 --------------~---------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 231 --------------P---------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred --------------C---------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 0 012357789999999998 99885 778899999954
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.59 Aligned_cols=282 Identities=34% Similarity=0.577 Sum_probs=222.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+...||.|+||.||+|.+..+|+.||+|.+............+.+|+.+++.+. ||||+++++++. ++..+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 77 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH--SEKRLY 77 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEe--cCCeEE
Confidence 35799999999999999999999999999999988644333333456788999999995 999999999987 567899
Q ss_pred EEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccccCCcc
Q psy14431 639 VVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++++|..++... .++...+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++.......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 99999999888887632 2577888899999999999999999999999999999985 4579999999998665443
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s 793 (1219)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|....|.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 233 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS---- 233 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc----
Confidence 333445678999999998665668899999999999999999999999888777777776655 343333332210
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
........+...........+..++.+.+++.+||..||.+| +.+++.||||..
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 234 --LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred --chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 111112222223344445567788999999999999999996 678899999965
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.10 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=207.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|...+.||.|+||+||++.+..+|..+|||.+... +......+.+|+.+|..+. |||||+++|......+..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence 45678889999999999999999999999999988533 2222667899999999997 99999999975432223689
Q ss_pred EEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccccCC--
Q psy14431 639 VVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSD-- 712 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~-- 712 (1219)
+.|||++ |+|.+++... .+++..++.++.||+.||.|||++|||||||||+|||++. +|.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999 5899999853 5999999999999999999999999999999999999999 79999999999987663
Q ss_pred -cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 -SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 -~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.........||+.|||||++..+....+++|||||||++.||+||.+||... .....+..|.... ..|.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip----- 245 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIP----- 245 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCC-----
Confidence 1122345789999999999854333345999999999999999999999873 3333333332222 111221
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
..+++.+.|||.+||.+||.+| +.+.|.|||......
T Consensus 246 -------------------------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 246 -------------------------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -------------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 2358899999999999999885 777799999866433
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.10 Aligned_cols=289 Identities=43% Similarity=0.702 Sum_probs=237.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---CceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~L 637 (1219)
+|.+.+.||.|+||.||+|.+..+|..||||++............+.+|+.+++.+. ||||+++++++...+ ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccce
Confidence 488999999999999999999999999999998755443455667889999999996 999999999987432 2478
Q ss_pred EEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 638 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
|+||+|++++|..++.. ..+++..+..++.+|+.||.|||+.||+||||||.|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999999999888875 478999999999999999999999999999999999999999999999999998776543
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......++++|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+..+.....++++..... +..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~ 236 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF---ITS 236 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh---ccc
Confidence 2234557899999999986554789999999999999999999999999998888888877764443322111 123
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
......+.........++....+.+++.+.+++.+||.+||.+| +.+++.||||.-....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 33344444455555667777888899999999999999999985 7788999999664443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.23 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=197.8
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHH-HHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILF-LKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~I-Lr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
+.||.|+||.||+|.+..+|..||+|++..... .......+..|+.. ++.+ +||||++++++|. +.+.+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~--~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQ--TAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEE--cCCEEEEEEcC
Confidence 368999999999999999999999999864322 22233455666654 5556 5999999999887 56789999999
Q ss_pred chh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 meG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
++| +|...+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 985 7877665 45688999999999999999999999999999999999999999999999999876433333344567
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.....+.|
T Consensus 158 gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------- 216 (321)
T cd05603 158 GTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP-------------------- 216 (321)
T ss_pred CCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC--------------------
Confidence 99999999997 455689999999999999999999999988776665555543221111
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
+..+..+.+++.+||..||.+|. .+.+.|+||..
T Consensus 217 --------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 217 --------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred --------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 22366789999999999999874 47899999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=343.89 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=198.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+.+||||+.++++|. ....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence 368999999999999999999999999975432 23345567789999999878999999999987 467899999999
Q ss_pred h-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 7 58887776 457999999999999999999999999999999999999999999999999999764333333445689
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST------SHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~------~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
|+.|+|||++. +..++.++|||||||++|+|++|.+||..... ...+..++...
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------- 218 (327)
T cd05617 159 TPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------------------- 218 (327)
T ss_pred CcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------------------
Confidence 99999999974 55789999999999999999999999964321 11111111100
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
+.. +-..+++.+.+++.+||..||.+|. .+++.||||..
T Consensus 219 -----------~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 219 -----------PIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred -----------CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 000 0112467789999999999999984 48899999955
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.06 Aligned_cols=301 Identities=35% Similarity=0.578 Sum_probs=235.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCC--CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~T--Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~ 636 (1219)
+|.+.+.||.|+||.||+|.+..+ +..||+|++............+.+|+.++..+.+||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999888 899999998644433344566788999999997799999999875422 2346
Q ss_pred EEEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 637 LYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+|++++|++++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 89999999999998886 45689999999999999999999999999999999999999999999999999986553221
Q ss_pred ----ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 ----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ----~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++.....++.... ..+
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 237 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL---SRI 237 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH---Hhh
Confidence 1234578999999999766567899999999999999999999999998888888888887754443221 111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCCCCCCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLSSADVEND 864 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~PS~d~s~d 864 (1219)
..+.....+..+.......+....+..++.+.+++.+||.+||.+| +.+++.|||+.........|.+..+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~ 312 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD 312 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence 1222222233333333445666667788899999999999999985 778899999976554444444433333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=342.36 Aligned_cols=246 Identities=25% Similarity=0.425 Sum_probs=198.5
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHH-HHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILF-LKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~I-Lr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
+.||.|+||.||+|.+..++..||+|++..... .......+..|... +..+ +||||++++++|. ..+.+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~--~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQ--TADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEE--cCCeEEEEEeC
Confidence 368999999999999999999999999864321 12223345555554 4555 5999999999987 46789999999
Q ss_pred chh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 MEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 meG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
+.| +|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.............+
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 985 78888764 5688899999999999999999999999999999999999999999999999976543333345568
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+
T Consensus 158 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (325)
T cd05602 158 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ---------------------- 214 (325)
T ss_pred CCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----------------------
Confidence 999999999974 556899999999999999999999999888776665555432111
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
..+.+++.+.++|.+||+.||.+|+ .+++.|+||..
T Consensus 215 ------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 215 ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 1134577899999999999999874 37889999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.26 Aligned_cols=283 Identities=33% Similarity=0.564 Sum_probs=223.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC-----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----- 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----- 633 (1219)
+++|.++++||.|+||.||+|.+..++..||+|++..............+|+.++..+. ||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccccc
Confidence 67899999999999999999999999999999998644333333345678999999995 999999999875422
Q ss_pred -CceEEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 -NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 -~~~LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
...+|+||+|+++++...+.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 336899999999988877763 46999999999999999999999999999999999999999999999999999765
Q ss_pred CCccc-----------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-
Q psy14431 711 SDSKE-----------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR- 778 (1219)
Q Consensus 711 ~~~~~-----------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~- 778 (1219)
..... ..+...+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 43221 112346788999999986666689999999999999999999999999998888888777663
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
|.+..++.... ... ... ......++..+...++..++.+.+++.+||..||.+| +.+++.||||
T Consensus 246 ~~~~~~~~~~~-~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRS-LPG--CEG--VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhh-ccc--ccc--cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 33333332110 000 000 0112223444555667778899999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.08 Aligned_cols=277 Identities=35% Similarity=0.592 Sum_probs=222.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.+. ||||+++++++. ++..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~--~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVH--SENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheec--cCCeEEEEE
Confidence 56788999999999999999999999999998644333333456788999999996 999999999987 567899999
Q ss_pred ecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 642 EYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 642 EymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
||++++|..++... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 78 EFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred eccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 99998999988753 489999999999999999999999999999999999999999999999999986654333333
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~~~r 797 (1219)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+..... |....|+... ...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 231 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT------SLP 231 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh------hch
Confidence 446788999999876655678999999999999999999999998888777777766653 3322222211 011
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.+...++...........+.+++.+.+++.+||..||.+| ..+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1222233333444555667788999999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.55 Aligned_cols=316 Identities=35% Similarity=0.606 Sum_probs=251.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
-++|.++..||.|+||.||+|.+..++..||+|++............+.+|+.+++.+. ||||+++++++...+ .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccccccc
Confidence 45799999999999999999999999999999998654333444566788999999995 999999999876322 1
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+|++|++++|.+++....+++..+..++.+|+.||.|||+.||+||||+|+||+++.+|.++|+|||++......
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 3589999999999999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||++.+....+..+.....++++.+ ..++...
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~ 246 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL---LQKISSE 246 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH---Hhhccch
Confidence 23457889999999986555688999999999999999999999999888888888887765444322 2233344
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCCCCCCCCCcccccccc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLSSADVENDESYVQDSR 872 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~PS~d~s~dE~~~~dS~ 872 (1219)
....++...+......+...++..++.+.|++.+||..||.+| +.+++.||||.-.......+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-------------- 312 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-------------- 312 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc--------------
Confidence 4445555555556667777788889999999999999999985 778899999976433322211
Q ss_pred cCCCccCCCchhhhhhcccccee
Q psy14431 873 LEGWVSIPNKQNIKRHGWKKQYV 895 (1219)
Q Consensus 873 lEg~~~IPnk~nlk~~~wke~l~ 895 (1219)
.+-+..-++...+....|+...+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~ 335 (343)
T cd07851 313 APPYDQSFESRDLTVDEWKELVY 335 (343)
T ss_pred ccccCcchhhhhcCHHHHHHHhH
Confidence 12233344566677777766544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.68 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=206.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..++..||+|++.+.. ........+..|+.++..+ +||||+.++++|. +++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQ--DENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEe--cCCeEE
Confidence 36899999999999999999999999999999986422 1223345567888888888 5999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+. |+|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999997 589988864 4689999999999999999999999999999999999999999999999999876554322
Q ss_pred c-cccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC--CCCCCchhhh
Q psy14431 716 C-LTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR--PNPPHADKFY 788 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~--P~P~~~d~l~ 788 (1219)
. ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+..|..... +.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP------ 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC------
Confidence 1 223468999999999853 24578899999999999999999999988877666666654321 1111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
..+.+++.+.+|+.+||..++.. .+.+++.||||..
T Consensus 232 -------------------------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 232 -------------------------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred -------------------------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 01235788999999999875544 4788999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=339.12 Aligned_cols=284 Identities=37% Similarity=0.641 Sum_probs=228.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~~ 635 (1219)
++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|... ...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccccccc
Confidence 6799999999999999999999999999999998654333334566788999999995 99999999988532 124
Q ss_pred eEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 636 DLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+|+|+++++++|..++....+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-- 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 173 (345)
T ss_pred cEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--
Confidence 589999999999999888778999999999999999999999999999999999999999999999999998865432
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....++++|+|||++.+...++.++|||||||++|+|++|.+||++.+....+..+.......++.+... +....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 249 (345)
T cd07877 174 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK---ISSES 249 (345)
T ss_pred -ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh---cccHh
Confidence 23457899999999986556688999999999999999999999998888777777777664443332211 11222
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
....+..++......+.......++.+.++|.+||.+||.+| +.+++.||||.-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 333333333333444555555678899999999999999885 8888999999653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=350.78 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=221.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+...|.+...||.|..++||+|+...++..||||++.-...+ .+...+.+|+..+..+. ||||++++.+|. .+..+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~-HPNIv~~~~sFv--v~~~L 99 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLID-HPNIVTYHCSFV--VDSEL 99 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcC-CCCcceEEEEEE--eccee
Confidence 467899999999999999999999999999999999654433 33778899999999995 999999999997 57789
Q ss_pred EEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 638 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
|+||+||. |++.+++.. ..+++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|+|+|||.+..+...
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999998 688888873 45999999999999999999999999999999999999999999999999998765443
Q ss_pred ccc----cccccccccccCchhh-hccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 714 KEC----LTEYIATRWYRAPEIL-ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 714 ~~~----~ts~vGT~~Y~APEvL-l~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
+.. ...++||++|||||++ ....+|++++||||||++..||++|..||....+..++-.-++..+|.+... ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~-~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS-GLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc-cCC
Confidence 321 1456999999999994 4556899999999999999999999999999999887776666666655411 110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.. -....+..+..++..||+.||.+| +...|+|+||.....
T Consensus 259 ----~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 259 ----KD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ----hH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 00 011224478899999999999995 666799999966443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=337.74 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=207.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.++++||.|+||.||++.+..++..||+|++.+... .......+..|+.++..+ +||||++++++|. +...+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQ--DENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEe--cCCEEE
Confidence 368999999999999999999999999999999854221 222334466788888887 5999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999997 689999874 5689999999999999999999999999999999999999999999999999876543222
Q ss_pred -ccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 716 -CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.....+||+.|+|||++.. ...++.++|||||||++|+|++|++||.+.+....+..|.......+ +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~------ 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--F------ 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc--C------
Confidence 2233579999999999852 34688999999999999999999999998887777666654321100 0
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
+.....+++.+.+|+.+||..+|.. ++.++++||||..
T Consensus 230 ---------------------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 230 ---------------------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred ---------------------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 0011345788999999999876654 3788999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.08 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=203.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.++++||.|+||.||++.+..++..||+|++...... ......+.+|+.+++.+. ||||++++++|. .+..+|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeec--CCCeEEE
Confidence 488999999999999999999999999999998643222 222345678999999995 999999999987 4568999
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||+. |+|..++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999998 578777652 3589999999999999999999999999999999999999999999999999987643322
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
....+|++.|+|||++. +..++.++||||+||++|+|++|.+||.+.+.......+.......+...
T Consensus 158 -~~~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 224 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY----------- 224 (285)
T ss_pred -cccccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc-----------
Confidence 23457899999999984 45689999999999999999999999987665443333322221111100
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+.+++.+.+|+.+||..||.+|+ .+.+.||||+.
T Consensus 225 -------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 225 -------------------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred -------------------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 123477789999999999999876 47799999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=337.40 Aligned_cols=316 Identities=34% Similarity=0.575 Sum_probs=249.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|.. .+..+|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~~~ 86 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFIS-PLEDIY 86 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEec-CCCcEE
Confidence 35799999999999999999999999999999988654444444567789999999996 9999999998863 345789
Q ss_pred EEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 639 VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
+||||++++|..++....++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 87 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~ 163 (328)
T cd07856 87 FVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MT 163 (328)
T ss_pred EEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---cC
Confidence 999999999999988878899999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||++.+.......+.+.....++.+... ........
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT---ICSENTLR 240 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh---ccchhhHH
Confidence 456788999999976556789999999999999999999999999887777777777665544433221 11111222
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCCCCCCCCCcccccccccCCC
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLSSADVENDESYVQDSRLEGW 876 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~PS~d~s~dE~~~~dS~lEg~ 876 (1219)
++...+...+.+.....+..++.+.+++.+||..||.+| +.+++.|||+........ +.. -.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~----~~~---------~~~~~ 307 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD----EPV---------AEEKF 307 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc----ccC---------chhhc
Confidence 333333334455667777888999999999999999985 778899999965322211 111 11256
Q ss_pred ccCCCchhhhhhcccccee
Q psy14431 877 VSIPNKQNIKRHGWKKQYV 895 (1219)
Q Consensus 877 ~~IPnk~nlk~~~wke~l~ 895 (1219)
+.-.|..+++...|+-.++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~ 326 (328)
T cd07856 308 DWSFNDADLPVDTWKVMMY 326 (328)
T ss_pred CCchhcccCCHHHHHHHhc
Confidence 7777888899999998776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.49 Aligned_cols=280 Identities=33% Similarity=0.615 Sum_probs=218.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.++++||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|. ++..+|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcc--cCCeEEEE
Confidence 688999999999999999999999999999988654333334456778999999995 999999999986 56789999
Q ss_pred Eecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||+++ +|..+.. ...+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 999996 4555544 33589999999999999999999999999999999999999999999999999987655444445
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
...++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.......++...... .......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF---QKNPLFA 235 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh---ccchHhh
Confidence 5678999999999866566789999999999999999999999988877777777665533222111111 0000000
Q ss_pred hhHHhh-hhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 799 KFNQVV-VKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 799 lI~klp-~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.. ..+ .....+.....+.++..+.+|+.+||..||.+| +.+.++||||
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GM-RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cc-ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 001 112233444566788999999999999999996 6677999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=338.87 Aligned_cols=285 Identities=35% Similarity=0.629 Sum_probs=228.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----Cc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~~ 635 (1219)
.+|.+...||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|.... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCCCCc
Confidence 4788999999999999999999999999999998654433344456789999999995 999999999986322 23
Q ss_pred eEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 636 DLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+|+||+|+.++|..+. ...+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eEEEEecccccCHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 57999999998877765 346899999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+++++.+.... ....
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 246 (342)
T cd07879 171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL---EDKA 246 (342)
T ss_pred -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh---cccc
Confidence 234577899999999865556889999999999999999999999998877777777777654443332211 1222
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
....+...+...+..+...++..++.+.+|+.+||..||.+| +.+++.||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 222333334444566777788889999999999999999985 778899999976443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=351.88 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=218.2
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
....+++|.+++.||.|.-|+||+|....++..+|+|++.+.... .....+...|-.||..+. ||+++.||..|. .
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fe--t 148 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFE--T 148 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheee--c
Confidence 345678899999999999999999999999999999999765432 445567788999999995 999999999998 5
Q ss_pred CceEEEEEecchh-hHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+...|+|||||+| +|+.+.+ .+.|++..+++|+..++.||+|||-.|||+|||||+||||.++|++.|+||.++..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 7789999999994 7888777 35699999999999999999999999999999999999999999999999998743
Q ss_pred cCC---------------------------------c-c----------------------cccccccccccccCchhhh
Q psy14431 710 LSD---------------------------------S-K----------------------ECLTEYIATRWYRAPEILI 733 (1219)
Q Consensus 710 l~~---------------------------------~-~----------------------~~~ts~vGT~~Y~APEvLl 733 (1219)
... . . .....++||-.|.|||++
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI- 307 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI- 307 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee-
Confidence 210 0 0 001246889999999998
Q ss_pred ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHH
Q psy14431 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQE 813 (1219)
Q Consensus 734 ~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~e 813 (1219)
.+.+.+.++|||+|||++|||+.|..||.|.+....+.+|+....-.|.
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~------------------------------- 356 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE------------------------------- 356 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-------------------------------
Confidence 4556899999999999999999999999999999999888764422222
Q ss_pred HhcccChhHHHHHHhccccCCCCC------HHHHHcchhhhc
Q psy14431 814 LQSQVVEENTSKLKLQMELDSKDS------EIEQLQGKLAAL 849 (1219)
Q Consensus 814 l~p~lspeaiDLLsKMLq~DPeKR------aiEALqHpwfaL 849 (1219)
.+.++..+.|||+++|..||.+| +.+.-+||||..
T Consensus 357 -~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 357 -EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred -CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 12346789999999999999986 888899999943
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=338.61 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=206.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+++.||+|++.... ........+..|+.++..+. ||||+.++++|. +.+.+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~--~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQ--DENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCEEE
Confidence 46999999999999999999999999999999986422 12223344667888888774 999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+. |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999997 589998874 5689999999999999999999999999999999999999999999999999976654322
Q ss_pred c-cccccccccccCchhhhcc----ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 716 C-LTEYIATRWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~----~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
. ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..|.......+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 228 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ--------- 228 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---------
Confidence 1 1235799999999997431 4578899999999999999999999988877666666654321100
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
++.....+++.+.+++.+||..+|.+ .+.+.+.|+||..
T Consensus 229 --------------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 229 --------------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred --------------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 00112345788999999999877654 3678899999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.81 Aligned_cols=283 Identities=31% Similarity=0.525 Sum_probs=212.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcC--CCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKN--NKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~--TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.|.++++||.|+||.||+|.+.. ++..||+|.+.... ..........+|+.++..+. ||||++++++|....+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 47889999999999999999988 89999999986532 11233456778999999995 9999999999986555789
Q ss_pred EEEEecchhhHHHHHhh------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc----CCcceecccccc
Q psy14431 638 YVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK----SCSIKIGDLGLA 707 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~----dG~VKLiDFGLA 707 (1219)
|+||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++. +|.++|+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999999888776642 25788999999999999999999999999999999999999 899999999999
Q ss_pred cccCCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHh
Q psy14431 708 RSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---------HQLQLIVN 775 (1219)
Q Consensus 708 r~l~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---------e~L~kIve 775 (1219)
........ .....+++++|+|||++.+...++.++|||||||++|+|++|.+||.+.... ..+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87654322 1224567899999999866667899999999999999999999999865432 24445555
Q ss_pred hcC-CCCCCchhhhhccCChhHHhhhHH--hhhhchhhHHHHh---cccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 776 LVR-PNPPHADKFYAGFKSKHEREKFNQ--VVVKCQKELQELQ---SQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 776 ~l~-P~P~~~d~l~~~~~s~~~relI~k--lp~kcrk~L~el~---p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
... |.+..|..... .+........ ........+...+ ...++.+.+++.+||.+||.+| +.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKK---MPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhh---cccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 553 33322222110 0011110000 0000111222222 2567889999999999999985 7888999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.01 Aligned_cols=282 Identities=21% Similarity=0.320 Sum_probs=209.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||++++++|. .++.++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECCEEE
Confidence 467999999999999999999999999999999986432 2234467889999999995 999999999987 467899
Q ss_pred EEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++ +|.+++.. ..+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999984 89988874 5688999999999999999999985 69999999999999999999999999998664332
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch-hhh------
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-KFY------ 788 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d-~l~------ 788 (1219)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.......+............ ...
T Consensus 159 -~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -cccCCCCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 23457999999999974 556899999999999999999999999876654433222111100000000 000
Q ss_pred ------hccC---ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 ------AGFK---SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ------~~~~---s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.. .......+..+....+..+. ....++++.+|+.+||.+||++| +.+++.|||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0000 00001111111100000000 11357789999999999999996 668899999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=363.19 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=209.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.++++||.|+||.||+|.+..++..||+|++............+..|+.++..+. |||||+++++|.......+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEE
Confidence 467899999999999999999999999999999998655444555677889999999996 9999999999876566789
Q ss_pred EEEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhc-------ccccCCCCCCCeeecc---------
Q psy14431 638 YVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-------KVMHRDLKPSNILIDK--------- 695 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~-------GIVHRDLKPsNILLd~--------- 695 (1219)
||||||++ ++|..++.. ..+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999998 589888863 4689999999999999999999985 4999999999999964
Q ss_pred --------CCcceecccccccccCCcccccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCc
Q psy14431 696 --------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766 (1219)
Q Consensus 696 --------dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~ 766 (1219)
.+.++|+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|++|.+||...+.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2348999999998765432 23456799999999998543 4588999999999999999999999987665
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
...+..++... |..+ .+..++.+.+||..||.++|.+| +.++|.|
T Consensus 249 ~~qli~~lk~~-p~lp--------------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 FSQLISELKRG-PDLP--------------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHHhcC-CCCC--------------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 54433332221 1111 12236778999999999999985 7888999
Q ss_pred hhhhc
Q psy14431 845 KLAAL 849 (1219)
Q Consensus 845 pwfaL 849 (1219)
+|+..
T Consensus 296 ~~ik~ 300 (1021)
T PTZ00266 296 QIIKN 300 (1021)
T ss_pred HHHhh
Confidence 99964
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.72 Aligned_cols=280 Identities=33% Similarity=0.566 Sum_probs=222.6
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||+++++++.....+.+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEe
Confidence 67889999999999999999999999999999755433344566789999999996 99999999998743347899999
Q ss_pred ecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-ccc
Q psy14431 642 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CLT 718 (1219)
Q Consensus 642 EymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-~~t 718 (1219)
+|++++|..++... .+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 99999999888754 689999999999999999999999999999999999999999999999999987655431 123
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~r 797 (1219)
...++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|.+..|+.... . .. .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~-~ 235 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK-L--PW-F 235 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc-c--hh-h
Confidence 34678899999987665668999999999999999999999999988888778777765 343443432211 0 00 0
Q ss_pred hhhHHhhhhchhhHHHHhccc-ChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQV-VEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~l-speaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+ .........+...+... ++.+.+++.+||.+||.+| +.+++.||||
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENL-KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhc-cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000 00111223344555554 8899999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.77 Aligned_cols=280 Identities=33% Similarity=0.510 Sum_probs=210.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...|.+++.||.|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.+. ||||+++++++. .+..+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEe--cCCeEE
Confidence 4679999999999999999999999999999999854322 222345678999999995 999999999987 466899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||+++++..++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9999999888777653 45788889999999999999999999999999999999999999999999999765443322
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhhcC-CCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQLIVNLVR-PNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-~e~L~kIve~l~-P~P~~~d~l~~~~~s~ 794 (1219)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++ ...+..+..... |.+..++.... . ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK-L-PN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh-c-cc
Confidence 33456789999999976555688899999999999999999999986554 344444544443 22222221110 0 00
Q ss_pred hHHhhhHHhhhhchhhHHHHhcc--cChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQ--VVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~--lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
..... .+...+..+...... .++.+.+++.+||.+||.+ ++.+++.||||
T Consensus 238 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEW---FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchh---ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 000111122222222 2568899999999999998 48888999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.53 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=220.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc--C----chhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--N----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~--s----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
...|.-.+.||.|..++|-.|.++.+|..+|+|++..... . ..-......|+.||+++.+||+|+.+.++|.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-- 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-- 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--
Confidence 4567778889999999999999999999999999853221 1 1223456689999999999999999999998
Q ss_pred CCceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
.+..+++|++.|+ |.|.+++.. -.+++...+.|+.|++.|+.|||.++||||||||+|||++++..++|+|||+|+.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 5678999999999 789999985 46999999999999999999999999999999999999999999999999999998
Q ss_pred CCcccccccccccccccCchhhh-----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILI-----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHA 784 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl-----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~ 784 (1219)
.++. .....||||+|.|||.+- +.++|+..+|+||+|||+|.|+.|.|||......-++..|+.+... ..+.|
T Consensus 174 ~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 8654 467899999999999974 3467899999999999999999999999887777788888887632 22223
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
. +.+....||++++|+.||.+ ++.++|.||||..
T Consensus 253 a-------------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 A-------------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred h-------------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 2 23778999999999999998 5899999999944
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.19 Aligned_cols=278 Identities=39% Similarity=0.665 Sum_probs=226.9
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|++|.||+|.+..+|..|++|.+............+.+|+.+++.+. ||||+++++++. .+..+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFR--HKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhc--cCCCEEEEE
Confidence 56788999999999999999999999999998655444445567889999999996 999999999987 457899999
Q ss_pred ecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 642 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 642 EymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
||+++++..++... .+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||.+............
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 99999998888753 7899999999999999999999999999999999999999999999999999877654433344
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhHHh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~re 798 (1219)
..++..|+|||.+.+...++.++|+|||||++|+|++|++||++.+..+.+..+.... .|.+..|..... ....
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 232 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-----LARN 232 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh-----hhhh
Confidence 5688899999998655478999999999999999999999999998888877776665 344433333221 0111
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
....++...........+.++..+.+++.+||..||.+| +.+.+.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112233344445566677789999999999999999985 7788999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.02 Aligned_cols=281 Identities=34% Similarity=0.580 Sum_probs=219.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|++............+.+|+.+++.+. ||||++++++|. .++.+|+|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFR--RKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEE--ECCEEEEE
Confidence 689999999999999999999999999999988654444444567889999999996 999999999997 46789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-cc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CL 717 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-~~ 717 (1219)
|||+++++...+. ...++...+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 9999976555443 34588999999999999999999999999999999999999999999999999987665432 33
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.....+.++....... .....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 235 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS---SNPRF 235 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc---cCccc
Confidence 456789999999998655478999999999999999999999999888777777666655433332211110 00000
Q ss_pred hhhHHhhhhchhhHHHHhccc-ChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQV-VEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~l-speaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.............+...++.. ++.+.+|+.+||..||.+| +.+.+.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000111223344444544 7889999999999999996 6678999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.57 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=199.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+.+|.++++||.|+||.||+|.+..+|+.||||++.... .......+.+|+.++..+. ||||++++++|. .++.+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 147 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVN-HPNVVKCHDMFD--HNGEI 147 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCC-CCCcceeeeEec--cCCeE
Confidence 4566788899999999999999999999999999985332 2233456889999999995 999999999986 56789
Q ss_pred EEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 638 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|+||||+.+ +|... ...++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 148 ~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 148 QVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999999985 55432 23567778889999999999999999999999999999999999999999999876544333
Q ss_pred cccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 717 LTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
....+||..|+|||++.. +..++.++|||||||++|+|++|+.||...........+.......+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 294 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP---------- 294 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC----------
Confidence 345689999999998732 233457899999999999999999999743322211111111100000
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
......+..+.+||.+||..||.+| +.++++|||+...
T Consensus 295 --------------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 295 --------------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0012346789999999999999985 7888999999763
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.20 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=207.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|.+++.||.|+||.||++.+..++..||+|.+............+.+|+.+++.+. |||++++++.+.. .+..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEG-EDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecC-CCCEEEEE
Confidence 488999999999999999999999999999998654434445566788999999995 9999999988753 34568999
Q ss_pred Eecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ ++|.+++.. ..+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99998 588888864 34899999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....+++.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....|..+
T Consensus 159 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (257)
T cd08223 159 ASTLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP-------------- 223 (257)
T ss_pred cccccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc--------------
Confidence 44567899999999974 556889999999999999999999999877665555555443322111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+..++.+.+++.+||..||..| +.+.+.||||
T Consensus 224 -------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 224 -------------------KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------------cccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1236778999999999999985 7788999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.75 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=208.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..+|..|++|.+............+.+|+.+++.+. ||||+++++++. ..+.+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFL--DKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeec--cCCEEEEE
Confidence 478889999999999999999999999999998654444556677889999999995 999999999987 46789999
Q ss_pred Eecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ ++|.+++.. ..+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99997 589888864 35888899999999999999999999999999999999999999999999999877654433
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....++++|+|||++. +..++.++|+|||||++|+|++|.+||...+.......+.....+..+
T Consensus 158 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (256)
T cd08529 158 ANTIVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------------- 222 (256)
T ss_pred hhccccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--------------
Confidence 34557889999999974 456889999999999999999999999887766655555543322211
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
...++.+.+++.+|+..+|.+| +.+.+.|||
T Consensus 223 -------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 223 -------------------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred -------------------cccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 1236678999999999999996 677788887
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=345.10 Aligned_cols=275 Identities=23% Similarity=0.283 Sum_probs=210.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+.++..+. ||||++++++|. ....+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~ 161 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTIS-HRAIINLIHAYR--WKSTV 161 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcC-CCCccceeeeEe--eCCEE
Confidence 36999999999999999999764 45688999987532 23458999999995 999999999987 46689
Q ss_pred EEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 638 YVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
|+||+++.++|..++. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 162 CMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999999999988886 45689999999999999999999999999999999999999999999999999976654322
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s---~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.....+||+.|+|||++ ....|+.++|||||||++|+|++|.+||.+.. ....+..|+....+.+..++...
T Consensus 242 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~--- 317 (392)
T PHA03207 242 PQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG--- 317 (392)
T ss_pred ccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc---
Confidence 12346799999999997 45568999999999999999999999997654 34556666666544443322110
Q ss_pred CChhHHhhhHHhhhh--chhhHHHHh--cccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVK--CQKELQELQ--SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~k--crk~L~el~--p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
.......+..+... .+..++..+ ...+.++.++|.+||.+||.+ ++.++|.||||.-
T Consensus 318 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 318 -STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred -chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 01111111111111 111122222 234678899999999999988 4888899999955
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.89 Aligned_cols=284 Identities=33% Similarity=0.568 Sum_probs=220.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC-----
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----- 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~----- 634 (1219)
.+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcC-CCcchhhHhhhcccccccccc
Confidence 57999999999999999999999999999999885332 234566788999999995 9999999987753221
Q ss_pred -------ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceeccccc
Q psy14431 635 -------KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGL 706 (1219)
Q Consensus 635 -------~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGL 706 (1219)
..+|+||||++++|..++..+.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 3579999999999999888778999999999999999999999999999999999999974 55789999999
Q ss_pred ccccCCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-
Q psy14431 707 ARSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP- 782 (1219)
Q Consensus 707 Ar~l~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~- 782 (1219)
+........ .....+++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++......+....+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 976543211 1123467889999998766667889999999999999999999999988887776666654422221
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
...... ... ...+.........++....+.++..+.+|+.+||.+||.+| +.+++.||||....
T Consensus 242 ~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 242 DRNELL----NVI-PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred Hhhhhh----hhh-hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 111111 000 01111111123344556677889999999999999999985 77889999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=323.03 Aligned_cols=262 Identities=27% Similarity=0.460 Sum_probs=214.6
Q ss_pred hccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 554 KDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 554 ~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.-.....+|.+++.||.|+||.||+|.+..+|..||+|.+... .......+.+|+.+++.+. ||||++++++|. .
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~ 87 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELK-NPNIVNFLDSFL--V 87 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcC-CCceeeeeeeEe--c
Confidence 3344556799999999999999999999999999999988533 2233456788999999995 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+..+|+||||+. ++|..++....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 678999999998 5888888887899999999999999999999999999999999999999999999999999887654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.........+++.|+|||.+. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 237 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN--------- 237 (296)
T ss_pred ccccCCCcCCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCC---------
Confidence 433334457889999999974 5568899999999999999999999998877655544443222111110
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
...+++.+.+++.+||..||.+| +.+.+.||||.....
T Consensus 238 ----------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 238 ----------------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred ----------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 01246778899999999999985 778899999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=323.91 Aligned_cols=263 Identities=26% Similarity=0.451 Sum_probs=212.5
Q ss_pred hhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 553 MKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 553 L~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
..-.....+|.+++.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.++..+. ||||++++++|.
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~-- 87 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENK-NPNIVNYLDSYL-- 87 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCC-CCCEeeEEEEEE--
Confidence 334445678999999999999999999999999999999886432 233466788999999985 999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+..+|+||||++ ++|.+++....+++..+..++.+++.||.|||+.||+||||+|+|||++.++.++|+|||++....
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred eCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 4668999999998 589999887788999999999999999999999999999999999999999999999999988655
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
..........+++.|+|||.+. +..++.++|||||||++|+|++|.+||.+.++...+..+.....|....
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 238 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------- 238 (296)
T ss_pred ccccccCcccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCC--------
Confidence 4333334457889999999974 5568899999999999999999999998776544333332211111110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+.+++.+.+++.+||..||..| +.+.+.|||+....+
T Consensus 239 -----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 239 -----------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred -----------------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 01245678899999999999985 777899999976444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.12 Aligned_cols=277 Identities=37% Similarity=0.614 Sum_probs=225.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+.+.||.|+||.||+|.+..++..||+|++............+..|+.+++.+. ||||+++++++. +...+++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIH--TERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhh--cCCceEEEe
Confidence 56778899999999999999999999999999755433444566788999999996 999999999987 457899999
Q ss_pred ecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 642 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 642 EymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
||++++|.+++... .+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++............
T Consensus 78 e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 78 EYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 99999999999864 7999999999999999999999999999999999999999999999999999877654433444
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCChhHHh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~~~re 798 (1219)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+..... |.+..|..... . . .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~---~ 231 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK-L--P---D 231 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc-c--c---c
Confidence 56688899999986555789999999999999999999999999888888888877664 33333332211 0 0 0
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.-..++..........++..+..+.+++.+||..||.+| +.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 011122233344456677778899999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.12 Aligned_cols=269 Identities=26% Similarity=0.445 Sum_probs=215.0
Q ss_pred HHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeee
Q psy14431 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628 (1219)
Q Consensus 549 l~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gv 628 (1219)
+..++.......+|.+++.||.|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.+. ||||++++++
T Consensus 8 ~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~-h~~i~~~~~~ 84 (297)
T cd06656 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENK-NPNIVNYLDS 84 (297)
T ss_pred HHhhcccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 3344444555688999999999999999999999999999999885332 233456788999999885 9999999999
Q ss_pred eeccCCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 629 YKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 629 fe~~d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
|. .+..+|+||||++ ++|..++....+++..+..++.+++.||.|||+.||+||||+|+|||++.++.++|+|||++
T Consensus 85 ~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 85 YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred Ee--cCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 87 4678999999998 58999888778899999999999999999999999999999999999999999999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..............+++.|+|||.+. +..++.++|+|||||++|+|++|.+||.+.+....+..+.....|....
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 237 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN---- 237 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCC----
Confidence 87654433334557899999999974 5668899999999999999999999997765533322221111111000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETA 854 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s 854 (1219)
...+++.+.+|+.+||..||.+| +.+.+.||||....+..
T Consensus 238 ---------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 238 ---------------------------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred ---------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 01236678899999999999884 78889999997644433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.84 Aligned_cols=283 Identities=32% Similarity=0.513 Sum_probs=220.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC-----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----- 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----- 633 (1219)
+++|.+.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.+. ||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhhc
Confidence 56789999999999999999999999999999998654333334456778999999995 999999999886432
Q ss_pred ---CceEEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 634 ---NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 634 ---~~~LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
.+.+|+||||+++++..++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 347999999999988887774 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCccc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchh
Q psy14431 709 SLSDSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADK 786 (1219)
Q Consensus 709 ~l~~~~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~ 786 (1219)
....... ......++..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+.... .|.+..|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 7654331 12233567889999998655567899999999999999999999999888887777777765 444444433
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.... +.. ...... ......+...+..+++.+.+++.+||..||.+| +.+++.||||
T Consensus 245 ~~~~---~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKL---PYF-NTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccc---ccc-cccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 2110 000 000000 001123334445678899999999999999985 7888999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.08 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=197.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeE-EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~-VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
...+...||.|+||+||.|.+. |.. ||+|++............+.+|+.+|..+. |||||+++|++..+.. .++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC-ceEE
Confidence 3445556899999999999776 555 999999755444444678999999999996 9999999999974322 6899
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcc-cccCCCCCCCeeeccCC-cceecccccccccCCc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~G-IVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~ 713 (1219)
||||++ |+|..++.. ..++...+..++.+|+.|+.|||+.+ ||||||||.|||++.++ ++||||||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999 689999965 57999999999999999999999999 99999999999999998 9999999999876654
Q ss_pred ccccccccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hhcCCCCCCchhhhhcc
Q psy14431 714 KECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV-NLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIv-e~l~P~P~~~d~l~~~~ 791 (1219)
....+...||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.++......++ ...+|..+..
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~------- 270 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE------- 270 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc-------
Confidence 333445789999999999853 4679999999999999999999999999988866666554 4445543321
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.++.+..|+..|+.-||..|+
T Consensus 271 --------------------------~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 271 --------------------------CPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred --------------------------CCHHHHHHHHHhCCCCCCcCC
Confidence 256677778888888888763
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.35 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|+..+.||.|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++..+. ||||+.++++|. .++.+|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYE--TKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEe--cCCEEEE
Confidence 377889999999999999999999999999998543222 222345678999999995 999999998886 4678999
Q ss_pred EEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||+.+ +|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999985 78777652 358999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
......|+..|+|||++. +..++.++|+|||||++|+|++|.+||.+.........+..........
T Consensus 157 ~~~~~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~------------ 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV------------ 223 (285)
T ss_pred cccCCCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc------------
Confidence 223457899999999984 4568999999999999999999999998776544444433222111110
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH-------HHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI-------EQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai-------EALqHpwfaL 849 (1219)
..+.+++.+.+|+.+||..||.+|+. +.+.|+||..
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 224 ------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred ------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 01234677899999999999998765 8899999966
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.52 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
|.+.+.||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.++..+. ||||+.+++++. .+..+|+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEe--cCCEEEEE
Confidence 678889999999999999999999999999886432222 22345678999999995 999999999887 45689999
Q ss_pred Eecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99997 578887753 358889999999999999999999999999999999999999999999999997654332 2
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
....+|++.|+|||++. +..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 158 ~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------------- 219 (285)
T cd05630 158 IKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------------- 219 (285)
T ss_pred ccCCCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------------
Confidence 23457899999999974 456899999999999999999999999764321111111000000
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.. .......++.+.+|+.+||.+||.+|+ .+++.||||..
T Consensus 220 ------~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 220 ------VQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ------hh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 00 011234577899999999999999975 58999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.92 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=189.5
Q ss_pred cCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
++|.++++||.|+||.||+|.+ ..++..||+|++.... .......+.+|+.++..+.+||||++++++|.. .+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence 4689999999999999999975 2446789999986332 233456788999999999779999999998863 34
Q ss_pred ceEEEEEecch-hhHHHHHhhc----------------------------------------------------------
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK---------------------------------------------------------- 655 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~---------------------------------------------------------- 655 (1219)
+.+|+||||++ |+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999998 5888887631
Q ss_pred -----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--ccccccccccccC
Q psy14431 656 -----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRA 728 (1219)
Q Consensus 656 -----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~A 728 (1219)
++++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++....... ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 366778889999999999999999999999999999999999999999999986543221 1123345678999
Q ss_pred chhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH-HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhh
Q psy14431 729 PEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL-IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVK 806 (1219)
Q Consensus 729 PEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k-Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~k 806 (1219)
||++. +..++.++|||||||++|+|++ |.+||++......+.. +.....+.++
T Consensus 245 PE~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------ 299 (338)
T cd05102 245 PESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP------------------------ 299 (338)
T ss_pred cHHhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCC------------------------
Confidence 99974 4568999999999999999997 9999987654332222 2221111100
Q ss_pred chhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 807 CQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 807 crk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++.+.+++.+||..||.+|+.
T Consensus 300 ---------~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 300 ---------ENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred ---------CCCCHHHHHHHHHHccCChhhCcC
Confidence 123667899999999999999744
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=319.37 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=207.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||+++++++. ++..+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQ--DDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEE--cCCeEE
Confidence 368999999999999999999999999999999864322 2234566889999999996 999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|.|||++.+|.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999995 789888864 56899999999999999999999999999999999999999999999999999876544
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....+++.|+|||.+. +..++.++|||||||++|+|++|.+||...+.......+.....+.|.
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 219 (290)
T cd05580 155 TYTLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS-------------- 219 (290)
T ss_pred CCCCCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--------------
Confidence 23457899999999974 446889999999999999999999999887765555555433222211
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
..++.+.++|.+||..||.+|+ .+.+.||||..
T Consensus 220 --------------------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 220 --------------------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred --------------------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 2256788999999999998874 67799999844
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.17 Aligned_cols=273 Identities=23% Similarity=0.284 Sum_probs=202.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|.+++.||.|+||.||+|.+..++..||+|+.... ....|+.++..+. ||||++++++|. .+...|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVN-HPSVIRMKDTLV--SGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCC-CCCCcChhheEE--eCCeeEE
Confidence 4699999999999999999999999999999975321 2346899999995 999999999987 4667899
Q ss_pred EEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||+|+.++|..++.. ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 213 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AF 213 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-cc
Confidence 999999999988863 468999999999999999999999999999999999999999999999999997543222 23
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHhhcCCCCCCchhh
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGAST---------SHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~---------~e~L~kIve~l~P~P~~~d~l 787 (1219)
....||+.|+|||++. +..++.++|||||||++|+|+++. ++|.+... ...+..++......|..++..
T Consensus 214 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 3567999999999974 456899999999999999999854 55544221 123333444333333333210
Q ss_pred hhccCChhHHhhhHHhh-hhchhh-HHH-HhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 788 YAGFKSKHEREKFNQVV-VKCQKE-LQE-LQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp-~kcrk~-L~e-l~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
. .......++.... ...+.. +.. ....++..+.+||.+||.+||.+| +.++|.||||.
T Consensus 293 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 293 P---GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred C---ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0 0111111111000 000000 000 112457788999999999999995 88899999995
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=328.11 Aligned_cols=280 Identities=33% Similarity=0.544 Sum_probs=219.5
Q ss_pred cCeeE-EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch------------hHHHHHHHHHHHHhccCCCCccEEe
Q psy14431 560 QQQIN-LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT------------DAQRTYREILFLKSFQRHPNIITML 626 (1219)
Q Consensus 560 qqY~I-LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~------------~~e~~lREI~ILr~L~~HPNIVkL~ 626 (1219)
++|.. .+.||.|+||.||+|.+..+|..||||++........ ....+.+|+.++..+. ||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceeeee
Confidence 34554 4669999999999999999999999999864322110 0124678999999995 99999999
Q ss_pred eeeeccCCceEEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 627 DIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 627 gvfe~~d~~~LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
++|. .+..+|+||||+.|+|.+++.. ..++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 87 DVYV--EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEe--cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9987 4678999999999999998874 468999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--------------cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14431 706 LARSLSD--------------SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 771 (1219)
Q Consensus 706 LAr~l~~--------------~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~ 771 (1219)
++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9976651 11122234568899999998665567999999999999999999999999999888888
Q ss_pred HHHhhcC-CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 772 LIVNLVR-PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 772 kIve~l~-P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+..... |.+..|+.... .+ ....+....+..+...++..+..+.+++.+||.+||.+| +.++|.||||.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKK---LP----LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHhCCCchhhCcchhh---cc----cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 8877663 43333432210 00 000111112334455567778899999999999999985 77889999996
Q ss_pred c
Q psy14431 849 L 849 (1219)
Q Consensus 849 L 849 (1219)
.
T Consensus 318 ~ 318 (335)
T PTZ00024 318 S 318 (335)
T ss_pred C
Confidence 4
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.66 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----Cce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~~~ 636 (1219)
.|.+.+.||.|+||.||+|.+..++..||+|++.... .....+..|+.++..+.+||||++++++|.... ...
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4777888999999999999999999999999985332 234567889999999877999999999986432 246
Q ss_pred EEEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 637 LYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 899999998 488888774 3588899999999999999999999999999999999999999999999999986654
Q ss_pred cccccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.........|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...++......+.... .+..
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~----- 236 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRL----- 236 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCCC-----
Confidence 3333345678999999999752 3357889999999999999999999997655443332221110 0000
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.....+..+.+|+.+||..||.+| +.+++.||||
T Consensus 237 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 -------------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 011235678999999999999986 6688999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=350.77 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=211.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC---
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN--- 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~--- 634 (1219)
...+|.+.+.||.|+||+||+|.+..+|..||||++............+.+|+.++..+. |+||+++++.|...+.
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccCc
Confidence 346899999999999999999999999999999998755445555667889999999985 9999999887753221
Q ss_pred ---ceEEEEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 635 ---KDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 635 ---~~LyLVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
..+++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 14789999998 589888863 358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCc--ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 706 LARSLSDS--KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 706 LAr~l~~~--~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
+++.+... .......+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....++.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 265 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL-- 265 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--
Confidence 99865432 12223567999999999974 55689999999999999999999999988877666665544332110
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+++.+||..||.+| +.+++.|||+..
T Consensus 266 -------------------------------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 266 -------------------------------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -------------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 12346789999999999999986 677899999865
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=316.67 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=205.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|+||.||+|.+..++..+++|.+... .......+.+|+.++..+. ||||++++++|. .+..+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~--~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCD-HPNIVKLLDAFY--YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEe--eCCEEEEEE
Confidence 56788999999999999999999999999988432 2344567788999999995 999999999987 456899999
Q ss_pred ecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 642 EYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 642 EymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
||+++ +|..++. ..++++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++...........
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99985 6766665 35689999999999999999999999999999999999999999999999999976654333334
Q ss_pred cccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 719 EYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
...+++.|+|||++. .+..++.++|||||||++|+|++|.+||.+.++......+.....+.....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP---------- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCc----------
Confidence 557899999999974 234578899999999999999999999988776665555544332211100
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++..+.+++.+||..||.+| +.+.++|||+..
T Consensus 232 ---------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 232 ---------------------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred ---------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 1235678999999999999885 778899999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.75 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=209.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..++..||+|++... .......+..|+.++..+. ||||+++++++. .+..+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECK-HPNIVGLYEAYF--YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEe--cCCeEE
Confidence 34688999999999999999999989999999998532 3344567889999999996 999999999987 466899
Q ss_pred EEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++ +|..++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999985 78888764 4689999999999999999999999999999999999999999999999999876654433
Q ss_pred ccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
......+++.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..+.....|.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP------- 231 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCc-------
Confidence 3345678999999999742 34577899999999999999999999988776655555543322211100
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
...+..+.+++.+||..||.+| +.++++|||+...
T Consensus 232 ------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 232 ------------------------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 1235678899999999999985 7788999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.02 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=193.2
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccCc-hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||.||++.+..+|..||+|.+....... ........|+.++..+. ||||++++++|. .+.++|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~--~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFE--SKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEe--cCCeEEEEEecCCC
Confidence 699999999999999999999999985432221 22334567999999994 999999999987 5678999999997
Q ss_pred hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 646 NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 646 GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ......|
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence 578777653 348888899999999999999999999999999999999999999999999998765432 2234578
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhHHhhhH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
++.|+|||++. +..++.++|||||||++|+|++|.+||.+.........+.... .....
T Consensus 157 ~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------- 216 (277)
T cd05607 157 TNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK------------------- 216 (277)
T ss_pred CCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-------------------
Confidence 99999999985 4459999999999999999999999997643321111111111 00000
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
.....+++.+.+|+.+||..||.+|+ .+.+.|+||..
T Consensus 217 -----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 217 -----------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred -----------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 00123577899999999999999975 45789999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.42 Aligned_cols=277 Identities=34% Similarity=0.599 Sum_probs=220.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+.+.||.|+||.||+|.+..++..||||.+...... .......+|+..+..+.+||||+++++++. .++.+|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEE
Confidence 67889999999999999999999999999998644332 223345678999999977999999999987 467899999
Q ss_pred ecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 642 EYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 642 EymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
||++++|.+.+... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT 156 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence 99998998888743 689999999999999999999999999999999999999999999999999987654322 24
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC-CCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P-~~~d~l~~~~~s~~~r 797 (1219)
...++..|+|||++.....++.++|+|||||++++|++|++||++.+....+..+.....+++ ..|..... ...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 231 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-----LAS 231 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh-----hhc
Confidence 467889999999986666789999999999999999999999999988888888877764333 22221110 000
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..-..++......+...++..++.+.+++.+||..||.+| +.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0001122223333455566667889999999999999985 7788999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.72 Aligned_cols=280 Identities=22% Similarity=0.331 Sum_probs=206.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++++||.|+||.||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||++++++|. .++.+|+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l 80 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEISI 80 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCC-CCcccceeEEEE--ECCEEEE
Confidence 57899999999999999999999999999999885432 2334466889999999995 999999999997 4678999
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
||||+. ++|.+++.. +.+++..+..++.+|+.||.|||+. +|+|+||||+|||++.+|.++|+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999997 589998874 5688889999999999999999975 79999999999999999999999999997654322
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc---CCCCCCchhhhhccC-
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---RPNPPHADKFYAGFK- 792 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l---~P~P~~~d~l~~~~~- 792 (1219)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..... .+.... .+.............
T Consensus 159 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccc
Confidence 23457899999999974 556899999999999999999999999876554332 222211 011000000000000
Q ss_pred -----ChhH------HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 -----SKHE------REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 -----s~~~------relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.. ......+....+..+. ....++++.+|+.+||.+||.+| +.+++.|||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0000 0000000000000000 01246788999999999999995 788899999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.87 Aligned_cols=250 Identities=28% Similarity=0.492 Sum_probs=208.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||.+.+..+|..||+|.+............+.+|+.+++.+. ||||++++++|. ..+++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFE--ENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeec--CCCeEEEE
Confidence 488999999999999999999999999999998644334445567889999999995 999999999987 56789999
Q ss_pred Eecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99997 588888763 24788899999999999999999999999999999999999999999999999876554333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....|++.|+|||++. +..++.++|+|||||++|+|++|.+||...+.......+.....|..+
T Consensus 158 ~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (256)
T cd08218 158 ARTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS-------------- 222 (256)
T ss_pred hhhccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc--------------
Confidence 33456888999999974 456889999999999999999999999877766666555443322111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+..+.+++.+||..+|.+| +.+++.||||
T Consensus 223 -------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 223 -------------------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------------------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1236678999999999999985 8888999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.27 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=205.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-+.|+++++||.|+||.||+|.+..++..|++|.+... .......+.+|+.+++.+. ||||++++++|. .++.+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCN-HPYIVKLLGAFY--WDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEE--eCCeEE
Confidence 35689999999999999999999999999999998532 3344567788999999996 999999999987 456899
Q ss_pred EEEecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++ +|..++. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++........
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999985 6666664 34689999999999999999999999999999999999999999999999999876544333
Q ss_pred ccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+.....|....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC--------
Confidence 3345578899999999742 3457889999999999999999999998776554444443322211110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++..+.+++.+||..||.+| +.+.+.|||+..
T Consensus 238 -----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 238 -----------------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -----------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01235678899999999999985 778899999855
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.09 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=205.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
.++|.+.+.||.|+||.||+|.+..++..|++|++.... .....+.+|+.++..+.+||||++++++|.... +
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 467999999999999999999999999999999885332 234567899999999977999999999986432 4
Q ss_pred ceEEEEEecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
..+|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999995 77777652 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
.............++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.....+. +
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 238 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT---L 238 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC---C
Confidence 76554433445678999999999743 2356789999999999999999999998766554444443322111 0
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.. ....+..+.+|+.+||..||.+| +.+.+.|||.
T Consensus 239 ~~----------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KS----------------------------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred Cc----------------------------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00 01236678899999999999985 7778999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.44 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=208.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+++.+. ||||+++++.+. .+..+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCN-HPNVVKYYTSFV--VGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcC-CCCEEEEEEEEe--eCCEEEE
Confidence 36899999999999999999999899999999986433222 5667889999999985 999999999886 4678999
Q ss_pred EEecch-hhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 640 VFEYME-NDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999998 478888864 358899999999999999999999999999999999999999999999999997665533
Q ss_pred cc----cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 715 EC----LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 715 ~~----~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.. ....+|+..|+|||++.....++.++|+|||||++|+|++|.+||...+....+..+.....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA----- 231 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc-----
Confidence 22 134568899999999865547899999999999999999999999877665544444433211111000
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
....+++...+++.+||..||.+| +.+.+.||||
T Consensus 232 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 -----------------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 023457788999999999999985 7788999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.86 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=203.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
....+|.+.+.||.|+||.||+|.+..++..||+|++.... ......+.+|+.++..+. ||||+++++++. .++.
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~--~~~~ 80 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYL--RRDK 80 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--eCCE
Confidence 34457888899999999999999999999999999985332 233445778999999995 999999999987 4678
Q ss_pred EEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+||||++ ++|.+++. .+.+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998 48888876 4568999999999999999999999999999999999999999999999999987665433
Q ss_pred cccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 ECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......|++.|+|||++. ....++.++|+|||||++|+|++|.+||....+...+..+.... ..++.+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~------ 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-FQPPKLKD------ 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-CCCCcccc------
Confidence 3334567899999999973 24458899999999999999999999997665544333322211 11111100
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
...++..+.+++.+||..||.+| +.+.+.|||
T Consensus 234 ----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 ----------------------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----------------------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 01235678899999999999986 667789987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.43 Aligned_cols=252 Identities=31% Similarity=0.465 Sum_probs=208.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|.+............+..|+.+++.+. ||||+++++++....+..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEE
Confidence 488899999999999999999999999999998655444555667889999999996 9999999998876566789999
Q ss_pred Eecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHH-----hcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 641 FEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLH-----S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
|||++ ++|.+++.. ..+++..++.++.+|+.||.||| +.||+|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99998 588888763 46888999999999999999999 99999999999999999999999999999988
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
............+++.|+|||++. ...++.++|+|||||++|+|++|.+||.+.+.......+.....+. +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~----- 230 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---I----- 230 (265)
T ss_pred ccCCcccccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---C-----
Confidence 765443234567899999999974 4558899999999999999999999998877555444443322111 0
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
-+..++.+.+++.+||..+|.+| +.+.++|||.
T Consensus 231 -------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 -------------------------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01236678999999999999885 7788999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.13 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=209.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|++.... .......+.+|+.+++.+. ||||++++++|. ++..+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFL--KGSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEE--ECCeEEEE
Confidence 5788899999999999999999999999999986432 2334456789999999996 999999999887 45789999
Q ss_pred Eecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 641 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
+||+++ +|.+++....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999984 8999998778999999999999999999999999999999999999999999999999999877654333445
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
..+++.|+|||++. +..++.++|||||||++|+|++|.+||.+.++......+.....|..+.
T Consensus 158 ~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (274)
T cd06609 158 FVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG---------------- 220 (274)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc----------------
Confidence 67889999999985 4458999999999999999999999998766554444443332221110
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++.+.+++.+||..||.+| +.+.+.|||+.-
T Consensus 221 ----------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 221 ----------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ----------------cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 0136678899999999999986 668899999955
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.39 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=202.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~ 634 (1219)
...|.+.+.||.|+||.||+|.+..++..||+|++... ......+..|+.++..+.+||||++++++|... .+
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 35788899999999999999999999999999988532 223456778999999997899999999998532 34
Q ss_pred ceEEEEEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
..+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 678999999985 88888763 34788888999999999999999999999999999999999999999999998865
Q ss_pred CCcccccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 711 SDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
...........|++.|+|||++.. ...++.++|||||||++|+|++|.+||....+...+..+... .+..+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~- 247 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPPKLK- 247 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CCCCCc-
Confidence 433333345678999999999742 345788999999999999999999999766544333222111 111000
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
....++.+.+|+.+||..||.+| +.+.|.||||
T Consensus 248 ----------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 248 ----------------------------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------------------------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11346789999999999999985 7888999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.44 Aligned_cols=276 Identities=34% Similarity=0.580 Sum_probs=215.3
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccCC---ce
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNN---KD 636 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d~---~~ 636 (1219)
|.+++.||.|+||.||+|.+..+|..||+|.+............+.+|+.++..+. .||||+++++++...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999989999999998644333333445667888877764 59999999999874322 24
Q ss_pred EEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+++||||++++|.+++.. ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 899999999988887764 24899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~ 792 (1219)
.. .....++..|+|||++. +..++.++|||||||++|+|++|.+||.+.+..+.+..+..... +....|+...
T Consensus 161 ~~-~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 234 (287)
T cd07838 161 MA-LTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV---- 234 (287)
T ss_pred cc-cccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc----
Confidence 22 23445788999999984 45689999999999999999999999999888888877766542 2221111100
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
......++......+....+.+++.+.+++.+||..||.+| ..+++.||||
T Consensus 235 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 ----SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ----ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00001112222334455566778899999999999999985 7788999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.41 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=220.7
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+.+.||.|-||.||+|+.+.++-.||+|++.+... .......+.+|+.|-..+. ||||+++|++|. +.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh--d~ 94 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH--DS 94 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee--cc
Confidence 4457889999999999999999999999999999999976542 2333456779999999996 999999999998 57
Q ss_pred ceEEEEEecch-hhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
..+||++||.+ |.+...+. ...+++.....|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 78999999998 68888887 345999999999999999999999999999999999999999999999999999876
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
+.+ .....|||..|.|||.. .+..++..+|+|++|+++||++.|.|||...+..+.+..|.......|+
T Consensus 175 p~~--kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~-------- 243 (281)
T KOG0580|consen 175 PSN--KRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS-------- 243 (281)
T ss_pred CCC--CceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--------
Confidence 533 34678999999999997 5667999999999999999999999999999888888888776644433
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.++..+.|||.+||..+|.+| -.+++.|||..
T Consensus 244 --------------------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 244 --------------------------TISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred --------------------------ccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 347789999999999999884 77889999973
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.77 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=220.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+.+.||.|.||.|-+|.....|+.||||.+++.. .+..+...+.+||.|+..+ +||||+.+|.+|. +.+.++|
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFE--NkdKIvi 130 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFE--NKDKIVI 130 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhc--CCceEEE
Confidence 5788899999999999999999999999999997553 4566778899999999999 5999999999998 6778999
Q ss_pred EEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||.. |.|++++. .+.+++..++.++.||+.|+.|+|.++++|||||.+|||+|.++.+||+|||++..+... ...
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfL 209 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFL 209 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHH
Confidence 999998 68999998 567999999999999999999999999999999999999999999999999999988754 456
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
.++||+|.|.+||++.+.+.-++.+|.|||||+||-|+.|..||.|.+...++..|-.+..-.|+
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~--------------- 274 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE--------------- 274 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---------------
Confidence 78999999999999866666689999999999999999999999999998888888776632222
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HHHHcchhhhcCC
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IEQLQGKLAALGS 851 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iEALqHpwfaL~~ 851 (1219)
.+.++.-||+.||..||.+|+ .+.-.|=|.+|+-
T Consensus 275 --------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 275 --------------------TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred --------------------CCchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 244577789999999999864 4557788888743
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.07 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=200.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.+..+|..||+|++.... ......+.+|+.++..+. ||||+++++++. ....+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~--~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECK-HCNIVAYFGSYL--SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcC-CCCeeeeeEEEE--eCCEEE
Confidence 457999999999999999999999999999999985332 223445778999999995 999999999987 467899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++ ++|.+++. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999998 47888776 456899999999999999999999999999999999999999999999999999876543332
Q ss_pred cccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+++.|+|||.+. ....++.++|||||||++|+|++|.+||...++......+..... .++.+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-------- 233 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKD-------- 233 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCCcc--------
Confidence 34457889999999974 234578899999999999999999999966554332222211111 1111100
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
...++..+.+|+.+||..||.+| +.+++.|+|
T Consensus 234 --------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 234 --------------------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12346788999999999999985 666678876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=342.87 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=204.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCC-CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~T-Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.+.+.||.|+||.||.|.+..+ +..||+|.+... .......+.+|+.++..+. |||||+++++|. .++.+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~--~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACD-HFGIVKHFDDFK--SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE--ECCEEEE
Confidence 499999999999999999998877 788999976422 2334456678999999995 999999999987 4678999
Q ss_pred EEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 640 VFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
||||++ |+|.+++.. .++++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999997 588877652 35888999999999999999999999999999999999999999999999999876543
Q ss_pred cc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 KE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. .....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 292 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP--------- 292 (478)
T ss_pred cccccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---------
Confidence 21 23356799999999997 4567899999999999999999999999888777666666544322111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..+++.+.++|.+||..||..| +.+++.|+|+.
T Consensus 293 ------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 293 ------------------------CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred ------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 1236678999999999999986 66778898874
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.76 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=202.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+|.+.+.||.|+||.||.|.+..+|..||+|.+...... ......+.+|+.+++.+. ||||+++++++. ....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLR--DDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEc--cCCe
Confidence 3688899999999999999999999999999988643221 123356788999999995 999999999997 4568
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+||||++ ++|.+++.. +.++...+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999998 478888763 568889999999999999999999999999999999999999999999999997654322
Q ss_pred ccc---ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 ECL---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 ~~~---ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... ....++..|+|||++. +..++.++|||||||++|+|++|++||...+.......+.... .....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~------- 228 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQL------- 228 (263)
T ss_pred cccccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCC-------
Confidence 111 2346788999999985 4558999999999999999999999997765544433332211 11100
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
....+..+.+++.+||..||.+| +.+++.|+||
T Consensus 229 -----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 229 -----------------------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -----------------------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 12346778999999999999885 7888999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.24 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=200.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||.|+||.||+|.+..+|..||+|.+...... .....+..|+.++.+..+||||+++++++. .++.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEE
Confidence 3689999999999999999999999999999998654322 233456677777656667999999999987 4667999
Q ss_pred EEecchhhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 640 VFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
||||++|+|.+++.. ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.++|+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999988887753 3588999999999999999999997 9999999999999999999999999999876533
Q ss_pred ccccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~-s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.. .....++..|+|||++.+. ..++.++|+|||||++|+|++|.+||... .....+..+.....+..+
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 229 (283)
T cd06617 158 VA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP------- 229 (283)
T ss_pred cc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC-------
Confidence 21 2234688899999987432 34688999999999999999999999643 233333333322111100
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++..+.+++.+||..||.+| +.+.+.||||..
T Consensus 230 -------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 230 -------------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred -------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 01236778999999999999985 778899999966
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=356.54 Aligned_cols=254 Identities=25% Similarity=0.423 Sum_probs=217.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-+.|.|+..||.|+||.||+|..+.++-..|.|+|- .........++-||.||..+. ||+||+|++.|+ ..+.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy--~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECD-HPVIVKLLSAYY--FENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHh--ccCceE
Confidence 445788899999999999999999999999999883 345567788999999999996 999999999887 466899
Q ss_pred EEEecchhhHHHH-Hh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMENDLNKV-IR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeGSL~d~-Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|..|||+|+--+. +- ..++++.++..+++++|.||.|||+++|||||||..|||++-+|.++|+|||.+........
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999999754443 33 67899999999999999999999999999999999999999999999999999977665555
Q ss_pred ccccccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 CLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
...+++|||+|||||++. ...+|++++||||||++|.+|..|.||....+++.++-+|....+|..-..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP------- 258 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP------- 258 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-------
Confidence 566889999999999985 356899999999999999999999999999999988888877665543211
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+++..+.|||.+||..||+-| +.+.|+|||+.
T Consensus 259 ------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 259 ------------------------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred ------------------------chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 1225678899999999999886 55559999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.26 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=204.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---Cc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~ 635 (1219)
.++|.+...||.|+||.||+|.+..+|..||+|++... ......+.+|+.++..+.+||||++++++|...+ ++
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 67799999999999999999999999999999988532 1223456789999999977999999999986432 35
Q ss_pred eEEEEEecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+|+||||+++ +|.+++. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 68999999974 8887764 34689999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccc----cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~----~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
............++..|+|||++.... .++.++|||||||++|+|++|++||...++...+..+.....+....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 255 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH-- 255 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc--
Confidence 654332233456889999999974322 36889999999999999999999998776655444443222111000
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
....+..+.+|+.+||..||.+| +.++++||||.
T Consensus 256 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 -----------------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -----------------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 01234568999999999999985 78889999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.84 Aligned_cols=285 Identities=30% Similarity=0.513 Sum_probs=230.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec------c
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------V 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~------~ 632 (1219)
+..|..+.+||.|.||.||+|+.+.+|+.||+|++.............++|+.+|..+. |+|++.++.++.. .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence 55677788999999999999999999999999987654444455677889999999996 9999999988752 2
Q ss_pred CCceEEEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
+...+|+||.+|+.+|.-++.+. .++..+++.++..++.||.|+|++.|+|||+||.|+||+.+|.++|+|||+++.+
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 33569999999999999999854 6999999999999999999999999999999999999999999999999999766
Q ss_pred CCc----ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCch
Q psy14431 711 SDS----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHAD 785 (1219)
Q Consensus 711 ~~~----~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d 785 (1219)
..+ ...++..+.|.||++||.+++...|++++|||..|||+.+|++|.|.|.+.+...++..|...++ ..++.|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 542 23356678899999999999999999999999999999999999999999999999999988884 4555565
Q ss_pred hhhhccCChhHHhhhH--HhhhhchhhHHHHhc--ccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 786 KFYAGFKSKHEREKFN--QVVVKCQKELQELQS--QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~--klp~kcrk~L~el~p--~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
... .-..+.-+. -++......+..... --++++.||+.+||.+||.+| +.+||.|.||-
T Consensus 255 ~~d----~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 255 NVD----NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred Ccc----cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 432 111111110 012222222222222 126689999999999999996 88899999993
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=339.61 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=212.9
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.++.+||+|+||.||+|.++.+|..||||.+. -..+.+.+++|+.+++++. .|++|++||.|. ....+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~-S~yVVKYYGSYF--K~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCK-SKYVVKYYGSYF--KHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcC-Cchhhhhhhhhc--cCCceEeeh
Confidence 557889999999999999999999999999884 4567889999999999996 999999999886 567899999
Q ss_pred ecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 642 EYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 642 Eyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||+ |+..++++ +.++++..+..++...+.||.|||...-||||||..|||++.+|++||+|||.|..+.+.-....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999 79999987 56799999999999999999999999999999999999999999999999999998887666667
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
+.+|||.|||||++ ..-+|++.+||||||++..+|..|+|||.+-.+...+..| ...+||.+.. |
T Consensus 188 TVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF~K-------P---- 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTFKK-------P---- 252 (502)
T ss_pred ccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCCCC-------h----
Confidence 88999999999997 4556999999999999999999999999887775543333 3222332211 0
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+.++.||++.||...|++| +...|+|||...
T Consensus 253 -----------------E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 253 -----------------EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred -----------------HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 0125678999999999999985 667799999743
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=303.57 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=209.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||.+.+..++..|++|.+............+.+|+.+++.+. ||||++++++|. +...+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFM--DDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEe--cCCeEEEE
Confidence 588999999999999999999999999999998655444555667889999999995 999999999997 46789999
Q ss_pred Eecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ ++|.+++... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99998 5899888743 5889999999999999999999999999999999999999999999999999876554433
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....+++.|+|||.+. +..++.++|||||||++|+|++|..||.+.+.......+.....+..+
T Consensus 158 ~~~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (256)
T cd08221 158 AETVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-------------- 222 (256)
T ss_pred ccccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--------------
Confidence 34567899999999974 445889999999999999999999999887776666666543221111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+..+..+.+++.+||..||..| +.++|.|+|+
T Consensus 223 -------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 223 -------------------SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------------cccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 2236678999999999999885 7788888874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.66 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=204.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.++..+. ||||++++++|. ..+.+|+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAV-SPYIVDFYGAFF--IEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcC-CCcHHhhhhhee--cCCeEEEE
Confidence 5888999999999999999999999999999885432 2334467889999999995 999999999887 46789999
Q ss_pred Eecchh-hHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 641 FEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||+++ +|..++... .+++..+..++.+|+.||.|||+ .||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999985 788887754 68999999999999999999996 599999999999999999999999999997664332
Q ss_pred cccccccccccccCchhhhccc-----cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 715 ECLTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~-----~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+.......++..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 230 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL----- 230 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC-----
Confidence 23346888999999974322 358899999999999999999999976554443333322221111111
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
.+.+++.+.+++.+||..||.+| +.+.+.||||....
T Consensus 231 -------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 -------------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred -------------------------CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 12347778999999999999985 77889999996643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.07 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=206.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... ......+..|+.++..+. ||||+++++++. ++..+|+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQ--TETYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeee--cCCEEEE
Confidence 688999999999999999999999999999998654322 234567889999999996 999999999987 5678999
Q ss_pred EEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||+.| +|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999975 89888864 4589999999999999999999999999999999999999999999999999875532211
Q ss_pred -----------------------------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc
Q psy14431 716 -----------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766 (1219)
Q Consensus 716 -----------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~ 766 (1219)
.....+||..|+|||++. +..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 011346788999999974 45689999999999999999999999988877
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC------HHH
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS------EIE 840 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR------aiE 840 (1219)
...+..+.....+.+.. ...++.+.+++.+||..||..| +.+
T Consensus 238 ~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 238 DETFSNILKKEVTFPGS--------------------------------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred HHHHHHHhcCCccCCCc--------------------------------cccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 66555544222111110 1147789999999999999986 568
Q ss_pred HHcchhhhc
Q psy14431 841 QLQGKLAAL 849 (1219)
Q Consensus 841 ALqHpwfaL 849 (1219)
+|.||||..
T Consensus 286 ll~~~~~~~ 294 (316)
T cd05574 286 IKQHPFFRG 294 (316)
T ss_pred HHcCchhhc
Confidence 899999954
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.87 Aligned_cols=283 Identities=19% Similarity=0.235 Sum_probs=202.5
Q ss_pred EEeeeecc--CceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 564 NLLKEGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 564 ILKkIGeG--gFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
++.+||.| +||+||++.+..+|..||+|++............+.+|+.+++.+. ||||++++++|. .++.+|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~--~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFI--ADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--ECCEEEEEE
Confidence 45678999 7899999999999999999998654333344456778999999885 999999999987 466899999
Q ss_pred ecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--
Q psy14431 642 EYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-- 715 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-- 715 (1219)
||++ |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++++|||.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9998 588888863 3588999999999999999999999999999999999999999999999987654322111
Q ss_pred -----ccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 716 -----CLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 716 -----~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
......++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.............|..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 11123567789999998543 468999999999999999999999998766554444443332221111000000
Q ss_pred ----------ccCChhHHhhh--HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 ----------GFKSKHEREKF--NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ----------~~~s~~~relI--~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.......... ...+..............++.+.+|+.+||++||.+| +.++++||||.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000000000 0000001111111223457789999999999999985 888899999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=303.06 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=204.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||.|+||.||+|.+..++..|++|++.... ......+.+|+.++..+. ||||+++++++. ++..+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECR-HPNIVAYFGSYL--RRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCC-CCChhceEEEEE--eCCEEEE
Confidence 46899999999999999999999999999999986432 224567889999999995 999999999886 5678999
Q ss_pred EEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
||||+++ +|..++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999995 78887764 57899999999999999999999999999999999999999999999999999876554333
Q ss_pred cccccccccccCchhhhcc--ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~--~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+.......+.....+.+. ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~--------- 227 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-LK--------- 227 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-cc---------
Confidence 3455788999999997433 26889999999999999999999999887765544443322111111 00
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
..+..+..+.+++.+||..||..| +.+.+.|+|
T Consensus 228 -------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 228 -------------------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------------------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 001224568899999999999885 777788887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.89 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=206.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccCCceEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.|.+++.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.+. .||||++++++|. .+..+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEE
Confidence 4777889999999999999999999999999885432 2234456778999999886 5999999999886 567899
Q ss_pred EEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 639 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
+||||+++ +|.+++..+.+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 99999974 89999888889999999999999999999999999999999999999999999999999998776544334
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....|+..|+|||.+.++..++.++|+|||||++|+|++|.+||.+.+.......+... .++.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~----------- 224 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KPPRLED----------- 224 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CCCCCCc-----------
Confidence 45578999999999865566789999999999999999999999876544332222111 1111100
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++.+.+++.+||..||.+| +.+.+.|+|+.-
T Consensus 225 ------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 225 ------------------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred ------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 0136678999999999999985 777899999955
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.61 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=197.6
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.||.|+||.||+|.+..+|..||+|++...... .........|..++....+||||++++++|. .+..+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence 5689999999999999999999999998543211 1222334556666555557999999999987 467899999999
Q ss_pred h-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 e-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
+ ++|..++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----KKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc----ccCCC
Confidence 8 588888874 56899999999999999999999999999999999999999999999999998765432 23468
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+.......+..
T Consensus 156 ~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------- 215 (260)
T cd05611 156 TPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE------------------- 215 (260)
T ss_pred CcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCc-------------------
Confidence 8899999997544 48999999999999999999999998877666555544332111110
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-----HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-----IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-----iEALqHpwfaL 849 (1219)
..+..++.+.+++.+||.+||..|+ .+.|.||||.-
T Consensus 216 -----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 216 -----------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred -----------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 0123578899999999999999976 68899999943
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=344.23 Aligned_cols=273 Identities=20% Similarity=0.238 Sum_probs=204.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...|.+.+.||.|+||.||+|.+..++..||||... ...+.+|+.+++.+. |||||++++++. .++..|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~-HpnIv~l~~~~~--~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLS-HPAVLALLDVRV--VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCC-CCCCCcEEEEEE--ECCEEE
Confidence 346999999999999999999999999999999642 123568999999995 999999999886 467899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+||+++.++|..++.. ..+++..+..|+.||+.||.|||+.|||||||||+|||++.++.++|+|||+++.+.....
T Consensus 237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9999999999888864 3589999999999999999999999999999999999999999999999999986543221
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCC-CCCCC------cHHHHHHHHhhcCCCCCCchhh
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGAS------TSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP-F~g~s------~~e~L~kIve~l~P~P~~~d~l 787 (1219)
.....+||+.|+|||++. +..++.++|||||||++|+|++|..| |.... ....+..++.........++..
T Consensus 317 ~~~~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 122457999999999984 45689999999999999999998754 43321 1233444444332211111111
Q ss_pred hhccCChhHHhhhHH------hhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhh
Q psy14431 788 YAGFKSKHEREKFNQ------VVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAA 848 (1219)
Q Consensus 788 ~~~~~s~~~relI~k------lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfa 848 (1219)
. .......+.. .+......|.. +..+++.+.+||.+||.+||.+ ++.++|.||||.
T Consensus 396 ~----~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 396 A----GSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred c----chHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 0 0000011100 11111122322 2356778999999999999998 488899999995
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.11 Aligned_cols=255 Identities=25% Similarity=0.469 Sum_probs=207.2
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
.....||.|+||.||++.+..++..||||.+... .......+.+|+.++..+. ||||++++++|. .++.+|+|||
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~--~~~~~~lv~e 99 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYH-HENVVDMYNSYL--VGDELWVVME 99 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCC-CCcHHHHHHhee--cCCeEEEEEe
Confidence 3346789999999999999999999999988532 2334556889999999995 999999999987 4678999999
Q ss_pred cchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 643 YMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 643 ymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
|+++ +|..++..+.+++..+..++.+|+.||.|||+.||+||||+|+||+++.++.++|+|||++..............
T Consensus 100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 9985 788888777799999999999999999999999999999999999999999999999999976554333334567
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
+++.|+|||.+ .+..++.++|||||||++|+|++|..||.+.+....+..+.....+..+.
T Consensus 180 ~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 240 (292)
T cd06658 180 GTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD------------------ 240 (292)
T ss_pred cCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccc------------------
Confidence 89999999997 45568999999999999999999999998777655544443322211110
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETA 854 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s 854 (1219)
....+..+.+++.+||..||.+| +.++++||||.....+.
T Consensus 241 -------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 241 -------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 11246678899999999999985 77889999998754443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=305.57 Aligned_cols=250 Identities=28% Similarity=0.491 Sum_probs=201.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch-------hHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-------DAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~-------~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
+|.+...||.|+||.||+|.+..++..||+|.+........ ....+.+|+.++..+. ||||+++++++. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~ 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL--D 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--e
Confidence 37788899999999999999999999999998854332211 2245778999999995 999999999987 4
Q ss_pred CceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...+++||||+++ +|..++.. +.++...+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 6688999999975 88888874 568889999999999999999999999999999999999999999999999998665
Q ss_pred Ccc------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 712 DSK------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 712 ~~~------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
... .......|+..|+|||.+. +..++.++|+|||||++|+|++|.+||.+.+....+..+.....|..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 233 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP--- 233 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC---
Confidence 321 1112345788999999974 456889999999999999999999999876654444333332211111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+..+.+++.+||..||.+| +.+++.||||
T Consensus 234 ------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 ------------------------------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------------------cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 2246778999999999999885 7888999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.88 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=205.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+++.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.++..+. ||||++++++|. .++++|+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFE--TKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEe--cCCEEEE
Confidence 68899999999999999999999999999998864322 1233456778999999985 999999999987 4668999
Q ss_pred EEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc---
Q psy14431 640 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--- 714 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--- 714 (1219)
||||++| +|..++.. +.+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999985 89888864 568899999999999999999999999999999999999999999999999986321100
Q ss_pred ------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC
Q psy14431 715 ------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782 (1219)
Q Consensus 715 ------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~ 782 (1219)
.......++..|+|||.+. ...++.++|+|||||++|+|++|..||.+.+....+..+.....+.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0011245788899999975 456899999999999999999999999887776666665544322222
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-----HHHHHcchhhhc
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-----aiEALqHpwfaL 849 (1219)
.. +..++.+.+++.+||..||.+| +.+.|.||||..
T Consensus 238 ~~-------------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 238 GD-------------------------------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cc-------------------------------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 10 1246778999999999999997 477799999844
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=309.20 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=201.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec---cCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA---VNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~---~d~~ 635 (1219)
..+|.+++.||.|+||.||+|.+..+|..||+|++... ......+.+|+.++..+.+||||+++++++.. .++.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 56799999999999999999999999999999987432 12234567899999999779999999998742 2456
Q ss_pred eEEEEEecch-hhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+|+||||++ ++|.+++. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 7999999998 57887764 24578888999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
............|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.....+... .
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~- 251 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH-Q- 251 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc-C-
Confidence 6543333344578999999999742 245788999999999999999999999876654433322211111000 0
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
-...+..+.+++.+||..||.+| +.+++.|+|+
T Consensus 252 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 252 -----------------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 01125578899999999999985 7888999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.14 Aligned_cols=298 Identities=24% Similarity=0.396 Sum_probs=229.2
Q ss_pred cccccchhhhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccC
Q psy14431 539 KEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 618 (1219)
Q Consensus 539 k~rev~~~~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~ 618 (1219)
.+..+.+-+..++.+. .+|.++.++|+|.||.|..+.+..++..||||+++.. ........-|+.+|..+..
T Consensus 73 dD~dGH~v~~~gD~l~-----~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~ 144 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILT-----NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINE 144 (415)
T ss_pred CCCCceEEEEeccccc-----cceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHh
Confidence 3444445555555553 4688999999999999999999999999999998532 2334456678999999853
Q ss_pred C-C----CccEEeeeeeccCCceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCC
Q psy14431 619 H-P----NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN 690 (1219)
Q Consensus 619 H-P----NIVkL~gvfe~~d~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsN 690 (1219)
+ | -+|.+.++|. ..+++|||+|.++.++.+++..+ +++...++.+++||+.++.|||+++++|.||||+|
T Consensus 145 ~DP~g~~rcv~m~~wFd--yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 145 SDPNGKFRCVQMRDWFD--YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred cCCCCceEEEeeehhhh--ccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 3 2 4688888887 57899999999999999999853 58999999999999999999999999999999999
Q ss_pred eeecc--------------------CCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHH
Q psy14431 691 ILIDK--------------------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750 (1219)
Q Consensus 691 ILLd~--------------------dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~I 750 (1219)
||+-+ +..|+|+|||.|....... +..+.|..|+|||++++- +++.++||||+|||
T Consensus 223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCI 298 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCI 298 (415)
T ss_pred EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheecc-CcCCccCceeeeeE
Confidence 99832 2358999999998755433 567899999999999754 59999999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh--hccCC------hh--HHhhhHHhhhhchhhHHHHhcccCh
Q psy14431 751 LAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY--AGFKS------KH--EREKFNQVVVKCQKELQELQSQVVE 820 (1219)
Q Consensus 751 LyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~--~~~~s------~~--~relI~klp~kcrk~L~el~p~lsp 820 (1219)
|+||.+|...|.+.++.+.+..+..+++|.|...-.-. .++.. +. ..... +.....+.++...+...+.
T Consensus 299 L~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~-k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 299 LVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKS-KYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccc-hhhhcCCccHHHHhccCcH
Confidence 99999999999999999988888888888877542211 00000 00 00000 1111123445555544444
Q ss_pred ---hHHHHHHhccccCCCC--CHHHHHcchhhhcCC
Q psy14431 821 ---ENTSKLKLQMELDSKD--SEIEQLQGKLAALGS 851 (1219)
Q Consensus 821 ---eaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~ 851 (1219)
.+.|||.+||.|||.+ ++.+||.||||+...
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 5799999999999998 599999999998744
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.67 Aligned_cols=249 Identities=31% Similarity=0.492 Sum_probs=203.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+.+.||.|+||.||+|.+..++..|++|.+... .....+.+|+.+++.+ +||||+++++++. .+..+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~--~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQC-DSPYIVKYYGSYF--KNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhC-CCCcEeeeeeeee--cCCcEEE
Confidence 4688899999999999999999998999999988533 2256788999999999 5999999999987 4578999
Q ss_pred EEecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|+||+++ +|.+++. ...+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999995 8888886 346899999999999999999999999999999999999999999999999999877654433
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....++..|+|||++ .+..++.++|||||||++|+|++|++||...+.......+.....+. +.
T Consensus 156 ~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~----------- 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT---LS----------- 220 (256)
T ss_pred cccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC---CC-----------
Confidence 3445688899999997 45568999999999999999999999998765544332221111100 00
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.-+..+..+.+++.+||..||.+| +.++|.||||
T Consensus 221 -----------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 221 -----------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 001235678999999999999884 8888999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.97 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=202.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|++....... .....+.+|+.+++.+. ||||++++++|. ++..+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQ--DEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhc--CCCeEEE
Confidence 4889999999999999999999999999999996543222 34567889999999995 999999999886 5678999
Q ss_pred EEecchh-hHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||+.| +|..++... .+++..+..++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 9999984 888888755 79999999999999999999999999999999999999999999999999998765442 22
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~--e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
....++..|+|||++. ...++.++|+|||||++|+|++|..||...+.. ..+...... +.+. .
T Consensus 157 ~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~-~----------- 221 (258)
T cd05578 157 TSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVL-Y----------- 221 (258)
T ss_pred cccCCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--cccc-C-----------
Confidence 3456888999999974 455899999999999999999999999876642 222111111 1100 0
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--H--HHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--E--IEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--a--iEALqHpwf 847 (1219)
.+..++.+.++|.+||..||.+| . .+.+.||||
T Consensus 222 -------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 222 -------------------PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------------------cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 01235778999999999999985 4 667899997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.00 Aligned_cols=263 Identities=28% Similarity=0.467 Sum_probs=212.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
..++|.+++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.++..+. ||||++++++|. ....+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~ 91 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENK-HPNIVNYLDSYL--VGDEL 91 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcC-CCCeeehhheee--eCCcE
Confidence 356899999999999999999999989999999988532 2233466789999999995 999999999987 45679
Q ss_pred EEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 638 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|+|+||++ ++|.+++....++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998 58999998878899999999999999999999999999999999999999999999999998766554433
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|.+||...+....+..+.....|....
T Consensus 172 ~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN------------- 237 (293)
T ss_pred cccccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCC-------------
Confidence 44557889999999974 4568999999999999999999999998766543332221111111000
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCC
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLS 857 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~P 857 (1219)
...+++...+++.+||..+|.+| +.+.+.|+||.....-...+
T Consensus 238 ------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~ 282 (293)
T cd06647 238 ------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT 282 (293)
T ss_pred ------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence 01235678899999999999985 78889999998766555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=342.46 Aligned_cols=253 Identities=29% Similarity=0.483 Sum_probs=223.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|..++.||.|+||.+++++++..+..|++|.+.-.............|+.++..+. |||||.+++.|.. ++..+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~-~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEE-DGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhc-CCceEE
Confidence 46799999999999999999999999999999999766666666678899999999986 9999999999983 344499
Q ss_pred EEEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||+||+| ++.+.+.. ..|++..+..|+.||+.|+.|||+++|+|||||+.|||++.++.|+|+|||+|+...+..
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999995 88888873 359999999999999999999999999999999999999999999999999999998876
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s 793 (1219)
....+++||+.|++||++ .+.+|+.++|||||||++|||++-+++|.+.+....+.+|.... .|.|..+
T Consensus 161 ~~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y--------- 230 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY--------- 230 (426)
T ss_pred hhhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc---------
Confidence 667789999999999997 67789999999999999999999999999999999999998887 4444322
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
+.++..++..||+.+|..| +.+.|.+|...
T Consensus 231 -------------------------s~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 231 -------------------------SSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred -------------------------cHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 6678888999999999884 77778887654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.84 Aligned_cols=254 Identities=27% Similarity=0.468 Sum_probs=206.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|...+.||.|+||.||+|.+..++..|++|++... .......+.+|+.++..+. ||||++++++|. .+..+|+|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~--~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYL--VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcC-CCChheEEEEEE--cCCeEEEEE
Confidence 44457899999999999999999999999988532 2233456789999999995 999999999887 467899999
Q ss_pred ecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 642 EYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
+|+. ++|.+++....++...+..++.+|+.||.|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9997 589998888789999999999999999999999999999999999999999999999999887655433333445
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
.|++.|+|||.+. +..++.++|||||||++|+|++|.+||.+.++...+..+.....+....
T Consensus 176 ~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------- 237 (285)
T cd06648 176 VGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN----------------- 237 (285)
T ss_pred cCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcc-----------------
Confidence 7899999999974 4568999999999999999999999998777655555444332111110
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+..++.+.+++.+||.+||.+| +.+.+.|+|+.....
T Consensus 238 --------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 238 --------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred --------------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 01246778999999999999885 788899999976443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=348.48 Aligned_cols=227 Identities=29% Similarity=0.494 Sum_probs=194.9
Q ss_pred HHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEee
Q psy14431 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLD 627 (1219)
Q Consensus 549 l~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~g 627 (1219)
+..++....-=.-|.-++.||.|+||.||-|++..+...||||++.-.. ........++.|+.+|..+. |||+|.+.|
T Consensus 15 iA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkg 93 (948)
T KOG0577|consen 15 IADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKG 93 (948)
T ss_pred HHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccc
Confidence 3444433333334666788999999999999999999999999985332 34455678999999999996 999999999
Q ss_pred eeeccCCceEEEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 628 IYKAVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 628 vfe~~d~~~LyLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
||. .....|||||||-|+-.+++. ..++.+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||
T Consensus 94 CyL--re~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 94 CYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred eee--ccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecccc
Confidence 997 466789999999997777665 5679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC
Q psy14431 706 LARSLSDSKECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782 (1219)
Q Consensus 706 LAr~l~~~~~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~ 782 (1219)
.|....+. .+++|||+|||||+++ ..+.|+-++||||||+++.+|.-.+||+...+....+..|.....|...
T Consensus 172 SAsi~~PA----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq 246 (948)
T KOG0577|consen 172 SASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ 246 (948)
T ss_pred chhhcCch----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC
Confidence 99887654 5679999999999985 4567999999999999999999999999999999999999887766544
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.99 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=190.7
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchh-HHHHHHHHHHHHhc--cCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREILFLKSF--QRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~-~e~~lREI~ILr~L--~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
.||.|+||.||+|.+..+|..||+|.+......... .....++..++..+ .+||||+.++++|. .++.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence 379999999999999999999999988654322222 22334444444333 25999999999887 45689999999
Q ss_pred ch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 ME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 me-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
++ ++|..++. .+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcC
Confidence 98 57888776 4568999999999999999999999999999999999999999999999999997654332 22347
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
|++.|+|||.+.++..++.++|||||||++|+|++|..||.+....... .+.......+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~------------------- 216 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNV------------------- 216 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCc-------------------
Confidence 8999999999755566899999999999999999999999764322111 11111100000
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+.+..++.+.++|.+||..||.+| +.+.++||||..
T Consensus 217 -----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 217 -----------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -----------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 0112347789999999999999987 678899999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.85 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=200.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|.+...... ......+.+|+.++..+. ||||+++++++....+..+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence 588899999999999999999999999999988543221 223456788999999995 9999999999875456788
Q ss_pred EEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 638 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
++||||++ ++|.+++.. ..++...+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999998 489888874 468889999999999999999999999999999999999999999999999987653311
Q ss_pred --cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 --ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 --~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......++..|+|||++. +..++.++|||||||++|+|++|.+||...+....+..+.. .+..+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~------- 231 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLP------- 231 (266)
T ss_pred cCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCCCCc-------
Confidence 1122345788999999974 45688999999999999999999999987654433332211 11111110
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++.+.+++ .|+..+|.+| +.+.+.||||.+
T Consensus 232 -----------------------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~ 266 (266)
T cd06651 232 -----------------------SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL 266 (266)
T ss_pred -----------------------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence 12356678888 5666899985 778899999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.93 Aligned_cols=314 Identities=31% Similarity=0.543 Sum_probs=258.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----Cc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~~ 635 (1219)
.+|.-+..+|.|+- .|..|.|.-++.+||+|++..++.+.....+..+|..++..+. |+||++++.+|.... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHHHH
Confidence 45778889999998 8999999999999999999877888888899999999999995 999999999997432 24
Q ss_pred eEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 636 DLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+|+|||+|..+|..++. -.++-..+..+++|++.|+.|||+.||+||||||+||+++.++.+||+|||+|+..... -
T Consensus 95 e~y~v~e~m~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~ 172 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-F 172 (369)
T ss_pred hHHHHHHhhhhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-c
Confidence 589999999999999888 34777889999999999999999999999999999999999999999999999876654 3
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~ 794 (1219)
..+.++.|..|+|||++++.+ |...+||||+|||+.+|++|.-.|+|.+..++..+|+..+ .|.+.....+ .+
T Consensus 173 ~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL-----~~ 246 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL-----QP 246 (369)
T ss_pred ccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh-----hH
Confidence 467899999999999997665 9999999999999999999999999999999999999888 5555555544 36
Q ss_pred hHHhhhHHhhhhchhhHHHHhccc------------ChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCCCcCCCCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQV------------VEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSETASLSSAD 860 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~l------------speaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s~~PS~d 860 (1219)
..+.++...+..-..++.++||+. ...+.|||.+||..||++ ++.++|.|||+.++-.....+.+.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~ 326 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPP 326 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCC
Confidence 667777777777667888888752 236899999999999998 489999999998643333222221
Q ss_pred CCCCcccccccccCCCccCCCchhhhhhcccccee
Q psy14431 861 VENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYV 895 (1219)
Q Consensus 861 ~s~dE~~~~dS~lEg~~~IPnk~nlk~~~wke~l~ 895 (1219)
+. ..+..-+.+..+..+|++.++
T Consensus 327 pe------------~~d~~~d~~~~t~~e~ke~If 349 (369)
T KOG0665|consen 327 PE------------IYDKQLDEREHTIEEWKELIF 349 (369)
T ss_pred Cc------------hhhhhcccccCCHHHHHHHHH
Confidence 11 112222344455778888777
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.83 Aligned_cols=241 Identities=29% Similarity=0.480 Sum_probs=198.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.+. ||||++++++|. +++.+|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFE--ADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEEEEE
Confidence 4889999999999999999999999999999885332 2334566778999999995 999999999987 56789999
Q ss_pred Eecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ ++|..++.. ..++...+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99998 578887753 35788999999999999999999999999999999999999999999999999876554433
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....+++.|+|||++ .+..++.++|+|||||++|+|++|.+||...+.......+.....++.+
T Consensus 157 ~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP-------------- 221 (255)
T ss_pred cccccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC--------------
Confidence 4456789999999997 4556899999999999999999999999887766555555433322111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+..+.+++.+||..||.+|+.
T Consensus 222 -------------------~~~~~~~~~li~~~l~~~P~~Rp~ 245 (255)
T cd08219 222 -------------------SHYSYELRSLIKQMFKRNPRSRPS 245 (255)
T ss_pred -------------------cccCHHHHHHHHHHHhCCcccCCC
Confidence 123556889999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.10 Aligned_cols=279 Identities=23% Similarity=0.327 Sum_probs=206.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.++..+. ||||++++++|. .++.+|+|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv 77 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECN-SPYIVGFYGAFY--SDGEISIC 77 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCCEEEEE
Confidence 6899999999999999999999999999999885332 2233456889999999995 999999999987 56789999
Q ss_pred Eecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 641 FEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||++ ++|.+++.. +.+++..+..++.||+.||.|||+ .|++|+||+|+|||++.++.++|+|||++....... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--c
Confidence 99998 589988864 568899999999999999999997 699999999999999999999999999987654332 2
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc---hhhhhc-cCC
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA---DKFYAG-FKS 793 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~---d~l~~~-~~s 793 (1219)
...++++.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+..... .+........... ...... ...
T Consensus 156 ~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 156 NSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCc
Confidence 345789999999997 4556889999999999999999999999876644332 2222111000000 000000 000
Q ss_pred h---hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 K---HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~---~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+ ........+....+..+ ....+++.+.+|+.+||.+||.+| +.+++.||||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0 00011111110000000 001256789999999999999985 778899999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=346.56 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=214.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|..+..||.|+||.||+|.+..+++.||+|++.-.. .......+..|+.+|..+. +|||..+|+.|. .+..++++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~-~~~it~yygsyl--~g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCD-SPNITEYYGSYL--KGTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcC-cchHHhhhhhee--ecccHHHH
Confidence 4677789999999999999999999999999996433 3445677889999999996 999999999997 57789999
Q ss_pred Eecch-hhHHHHHhhccC-ChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYME-NDLNKVIRDKIL-KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~~L-seeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
||||+ |++.+.+..+.+ .+..+..++.+++.||.|||..+.+|||||+.|||+..+|.|+|+|||.+...........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999 588888886654 8889999999999999999999999999999999999999999999999998877666667
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
+++|||.|||||++. ...|+.++||||||++.+||++|.|||...+++.++..|.+..+ |..+.
T Consensus 170 tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P---P~L~~------------ 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP---PRLDG------------ 233 (467)
T ss_pred cccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC---Ccccc------------
Confidence 899999999999985 66799999999999999999999999998888655544433222 21211
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
++++.+.+|+..||..||+. +|.+.|+|+|..-
T Consensus 234 ------------------~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 234 ------------------DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------------ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 34788999999999999988 4788899998744
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.26 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=206.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|..+++||.|+||.||.|.+..++..||+|++.... .......+.+|+.++..+. ||||+++++++. ++..+|+|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KGTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCEEEEE
Confidence 4667889999999999999999999999999885332 2334567888999999995 999999999987 46789999
Q ss_pred Eecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 641 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
|||++| +|.+++..+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 999985 8999988888999999999999999999999999999999999999999999999999999876554333344
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
..++..|+|||++. +..++.++|+|||||++|+|++|.+||.+.++......+.....| ..
T Consensus 161 ~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~--------------- 221 (277)
T cd06640 161 FVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TL--------------- 221 (277)
T ss_pred ccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CC---------------
Confidence 56888999999974 456899999999999999999999999877655444333211111 00
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+..+.+++.+||..||.+| +.+.+.|+|+..
T Consensus 222 ---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 222 ---------------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred ---------------chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 01235668899999999999985 778899999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.04 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=193.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC----------------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCcc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN----------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~----------------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIV 623 (1219)
++|.+.++||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..+. ||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLK-DPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcC-CCCee
Confidence 468899999999999999997532 34579999886432 2333456889999999995 99999
Q ss_pred EEeeeeeccCCceEEEEEecch-hhHHHHHhhc--------------------cCChHHHHHHHHHHHHHHHHHHhcccc
Q psy14431 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK--------------------ILKDVHIRYIMFQLCNGLSYIHACKVM 682 (1219)
Q Consensus 624 kL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~--------------------~LseeeVr~Ia~QILsALaYLHS~GIV 682 (1219)
++++++. +.+.+|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+
T Consensus 83 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEe--cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999987 4567999999997 5888887532 256678889999999999999999999
Q ss_pred cCCCCCCCeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh--CC
Q psy14431 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SK 758 (1219)
Q Consensus 683 HRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT--Gk 758 (1219)
||||||+|||++.++.++|+|||++..+..... ......++..|+|||++. ...++.++|||||||++|+|++ |.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999986543321 112334578899999975 4568999999999999999987 56
Q ss_pred CCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 759 PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 759 pPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.||.+.+....+..+............ ....+..++.+.+|+.+|+..||.+|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVY--------------------------LFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhcccccc--------------------------ccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 788777666555444332211100000 000123467789999999999999986
Q ss_pred HHHHcch
Q psy14431 839 IEQLQGK 845 (1219)
Q Consensus 839 iEALqHp 845 (1219)
...--+.
T Consensus 294 s~~~i~~ 300 (304)
T cd05096 294 SFSDIHA 300 (304)
T ss_pred CHHHHHH
Confidence 6553333
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.70 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=201.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.....||.|+||.||++.+..+|..||+|.+...... .....+.+|+.++..+.+||||+++++++. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEE
Confidence 3456678899999999999999999999999988643322 345567899999999977999999999886 4567899
Q ss_pred EEecchhhHHHHHh------hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 640 VFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 640 VMEymeGSL~d~Lr------s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
||+|+++++.++.. ...+++..+..++.+++.||.|||+ .||+||||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99999876554432 3568999999999999999999997 4999999999999999999999999999976554
Q ss_pred cccccccccccccccCchhhhcc--ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 SKECLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~--~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
... .....|++.|+|||++.+. ..++.++|||||||++|+|++|.+||...+. ....+.......++.....
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~--- 234 (288)
T cd06616 161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNS--- 234 (288)
T ss_pred CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCc---
Confidence 322 1334688899999998544 3689999999999999999999999976542 2222222221111111000
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+++.+.+|+.+||..||.+| +.+.+.||||..
T Consensus 235 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 235 -----------------------EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -----------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 002347789999999999999985 778899999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=309.51 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=196.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..++..||+|++.... .......+.+|+.++..+. ||||++++++|. ....+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCD-SPYIIGFYGAFF--VENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--ECCEEEEE
Confidence 5778899999999999999999999999999985432 2233456889999999995 999999999987 45678999
Q ss_pred Eecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 641 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
|||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... ...
T Consensus 78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (279)
T cd06619 78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT 152 (279)
T ss_pred EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccC
Confidence 999996 44333 347888899999999999999999999999999999999999999999999998665432 234
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ---LQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~---L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
.++|..|+|||++. +..++.++|+|||||++|+|++|.+||........ ...+.... .+.++..
T Consensus 153 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 220 (279)
T cd06619 153 YVGTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL----------- 220 (279)
T ss_pred CCCChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-----------
Confidence 57899999999974 45689999999999999999999999965321110 00000000 0000000
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....++.+.+++.+||..||.+| +.+++.|||+..
T Consensus 221 ------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 221 ------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred ------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 012346788999999999999986 667899999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.58 Aligned_cols=286 Identities=28% Similarity=0.505 Sum_probs=232.6
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
-..+++|.+++++|.|-|+.||.|....++..|+||+++ +.....+.+|+.||..+.+||||++++++..++...
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 346789999999999999999999999999999999985 345667899999999999999999999999988888
Q ss_pred eEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-CcceecccccccccCCc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l~~~ 713 (1219)
.+.|||||+.+ ++..+. ..++...++.++++++.||.||||.||+|||+||.|++||.. ..++|+|+|+|..+.++
T Consensus 109 tpaLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred CchhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999999996 444433 247888999999999999999999999999999999999965 46999999999988865
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. ..-.+.+..|--||.+.....|+..-|+|||||+|+.|+..+ |.|.|.++.+++.+|...++.. ....+..++.
T Consensus 187 ~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~--el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 KE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD--ELYAYLNKYQ 263 (338)
T ss_pred ce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH--HHHHHHHHHc
Confidence 43 345678899999999988889999999999999999999977 6678999999999999887542 1222222222
Q ss_pred ChhHHhhhHH-hhhhchhhHHHHhc-----ccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 793 SKHEREKFNQ-VVVKCQKELQELQS-----QVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 793 s~~~relI~k-lp~kcrk~L~el~p-----~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
-.. ...+.. +....+.+|..+.+ -++|+++|||.++|+||..+ ++.+|+.||||....+
T Consensus 264 i~L-dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 264 IDL-DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred cCC-ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 111 111222 22234555665554 35799999999999999987 6999999999977444
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.53 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=203.4
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.++..+. ||||++++++|. .+..+|+||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~ 81 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYITRYYGSYL--KGTKLWIIM 81 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCC-CCccHhhhcccc--cCCceEEEE
Confidence 556678999999999999999999999999885332 2234457889999999995 999999999987 466899999
Q ss_pred ecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 642 EYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
||++ ++|.+++..+.+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 9998 588888888889999999999999999999999999999999999999999999999999998765443333345
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
.++..|+|||++. +..++.++|+|||||++|+|++|.+||...........+.....| .+
T Consensus 162 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~---------------- 221 (277)
T cd06642 162 VGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TL---------------- 221 (277)
T ss_pred cCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CC----------------
Confidence 6889999999974 556899999999999999999999999765544333322111111 00
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+..+.+++.+||..+|.+| +.+.+.|||+..
T Consensus 222 --------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 222 --------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred --------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 11235678899999999999996 668899999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.74 Aligned_cols=250 Identities=30% Similarity=0.512 Sum_probs=209.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|++............+.+|+.+++.+. |||++++++++. .+..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~--~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFE--EKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEe--cCCEEEEE
Confidence 488999999999999999999999999999998655444456677889999999996 999999999987 45789999
Q ss_pred Eecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 641 FEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||+++ +|..++.. ..++...+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999985 88888864 568999999999999999999999999999999999999999999999999998776554
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.......|++.|+|||.+. ...++.++|+||+|+++++|++|.+||...+.......+.....+..+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 224 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP------------ 224 (258)
T ss_pred ceecceeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC------------
Confidence 3334567899999999974 456889999999999999999999999877765555544333211111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
...+..+.+++..||..+|.+ ++.++|.||||
T Consensus 225 ---------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 225 ---------------------SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 123567899999999999988 48888999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.51 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=221.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
-|.+.+.||.|-|++|-+|++..||..||||++.+..........++.|+..|+.+. |||||++|.+.. ....+|||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViD--TQTKlyLi 95 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVID--TQTKLYLI 95 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhc--ccceEEEE
Confidence 466678899999999999999999999999999877777777788999999999996 999999999986 46789999
Q ss_pred Eecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+|+-+ |+|+++|. ...+.+..++.|+.||+.|+.|+|+..+|||||||+||.+. .-|-|||+|||++..+.++. .
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-K 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-h
Confidence 99998 59999987 45699999999999999999999999999999999998775 56899999999999887654 4
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
..+.||+..|.|||++++...-.+++||||||||||-|+||++||...++.+.+..|+......|.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs-------------- 240 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS-------------- 240 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch--------------
Confidence 577899999999999998876678999999999999999999999999999999888765533222
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+++.+..|||..||+.||.+| ..+...++|.....+
T Consensus 241 --------------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 241 --------------------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred --------------------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 347789999999999999996 455678999866444
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=344.42 Aligned_cols=283 Identities=23% Similarity=0.262 Sum_probs=201.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCC-CeEEEEEE--------------eecc-ccCchhHHHHHHHHHHHHhccCCCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNN-KQYVAIKK--------------IFEA-FRNKTDAQRTYREILFLKSFQRHPN 621 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~T-Gk~VAIKv--------------I~ks-~~s~~~~e~~lREI~ILr~L~~HPN 621 (1219)
.+.+|.++++||.|+||.||+|..+.. +..+++|. +.+. .........+.+|+.++..+. |||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCC
Confidence 357899999999999999999876432 22222221 1111 112223456779999999995 999
Q ss_pred ccEEeeeeeccCCceEEEEEecchhhHHHHHhhcc------CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 622 IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 622 IVkL~gvfe~~d~~~LyLVMEymeGSL~d~Lrs~~------LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
||++++++. ..+..|+|++++.++|..++.... .....++.|+.||+.||.|||+.|||||||||+|||++.
T Consensus 225 Iv~l~~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 225 ILKIEEILR--SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cCcEeEEEE--ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999997 456789999999998888776432 234567889999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCC-CCCCC--CcHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP-LFPGA--STSHQLQ 771 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkp-PF~g~--s~~e~L~ 771 (1219)
+|.++|+|||++..+..... .....+||+.|+|||++. +..++.++|||||||++|+|++|.. ||.+. +....+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999987654332 223467999999999974 4568999999999999999999874 55432 3345555
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHh-hhhchhhHHHHhc--ccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQV-VVKCQKELQELQS--QVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~kl-p~kcrk~L~el~p--~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
.++.........++... .....++... ....+..+..++. .++..+.++|.+||.+||.+| +.++|.|||
T Consensus 382 ~~~~~~~~~~~~~p~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPP-----CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccChhhcCCcH-----HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 55554433222222111 0011111111 0111222333332 356788999999999999984 888899999
Q ss_pred hhc
Q psy14431 847 AAL 849 (1219)
Q Consensus 847 faL 849 (1219)
|..
T Consensus 457 f~~ 459 (501)
T PHA03210 457 FSA 459 (501)
T ss_pred hhc
Confidence 955
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.19 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=205.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++..+.+||||++++++|. +++.+|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEEE
Confidence 68999999999999999999999999999999865322 22334567789999999966999999999886 5678999
Q ss_pred EEecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc---
Q psy14431 640 VFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--- 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--- 714 (1219)
||||+. ++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999995 7899988754 79999999999999999999999999999999999999999999999999998665432
Q ss_pred -----------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc
Q psy14431 715 -----------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 715 -----------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l 777 (1219)
.......++..|+|||++. ...++.++|+|||||+++++++|.+||...+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 1122346788999999974 4568899999999999999999999998877554444443322
Q ss_pred CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--H----HHHHcchhh
Q psy14431 778 RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--E----IEQLQGKLA 847 (1219)
Q Consensus 778 ~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--a----iEALqHpwf 847 (1219)
.+.| +.+++.+.+++.+||..||.+| + .+++.||||
T Consensus 239 ~~~~----------------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFP----------------------------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----------------------------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2211 1226778999999999999985 5 778999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.52 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=205.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||.|+||.||+|.+..++..||+|.+............+.+|+.+++.+. ||||+++++++. .++.+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFL--EDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEe--cCCEEEEE
Confidence 488999999999999999999999999999998655444455677889999999995 999999999886 46789999
Q ss_pred Eecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCccc
Q psy14431 641 FEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~~~ 715 (1219)
|||+++ +|.+++.. ..+++..+..++.+++.||.|||++||+|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999985 89988874 2488899999999999999999999999999999999998654 589999999987654332
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+++.|+|||.+. +..++.++|||||||++|+|++|..||.+.+.......+.....+..+
T Consensus 158 -~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 222 (256)
T cd08220 158 -AYTVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS------------- 222 (256)
T ss_pred -ccccccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC-------------
Confidence 23457889999999974 456889999999999999999999999887766555554432211111
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...++.+.+++..||..||.+| +.++++|||+
T Consensus 223 --------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 223 --------------------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------------CCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1236678899999999999985 7788999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=329.39 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=218.9
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.....+|..+++||.|.||.|.+|+.+.+|+.||+|++++.. .........+.|-.+|+... ||++..+...|. ..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQ--t~ 240 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQ--TQ 240 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhc--cC
Confidence 345677889999999999999999999999999999997654 33445667788999999996 999999987776 57
Q ss_pred ceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||..| .|.-.+. ...|++...++|...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.--.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 789999999985 5555444 56799999999999999999999999999999999999999999999999999986555
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.+.....+||||.|.|||++ ....|+.++|+|.+||++|+|+||+.||...+....+..|+......|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----------- 388 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----------- 388 (516)
T ss_pred ccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-----------
Confidence 55556789999999999997 667899999999999999999999999999888877777654332221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
..+++++..||..+|..||.+| +.+...|+||+.
T Consensus 389 -----------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 389 -----------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred -----------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 2358899999999999999986 778899999854
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=314.62 Aligned_cols=251 Identities=23% Similarity=0.434 Sum_probs=204.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.....||.|+||.||+|.+..++..||+|.+... .......+.+|+.++..+. ||||++++++|. .+..+|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYL--VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCC-CCchhhhhhhee--eCCeEEEEE
Confidence 34455789999999999999999999999998533 2233456789999999995 999999999987 467899999
Q ss_pred ecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 642 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
||+++ +|..++....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..........
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 99984 78888877789999999999999999999999999999999999999999999999999997665443333456
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
.++..|+|||++. +..++.++|||||||++|+|++|.+||...+....+..+.....+...
T Consensus 178 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 238 (297)
T cd06659 178 VGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK------------------ 238 (297)
T ss_pred ecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCcc------------------
Confidence 7899999999974 456899999999999999999999999877665554443221111100
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+..++.+.+++.+||..+|.+| +.+.++||||..
T Consensus 239 -------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 239 -------------NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred -------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 012346678899999999999985 778899999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.20 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=200.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+|.+.+.||.|+||.||+|.+ .+|..||+|.+...... ......+.+|+.++..+. ||||+++++++. +...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCL--DDNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEee--cCCe
Confidence 478889999999999999986 47889999988533211 222356778999999995 999999999987 4578
Q ss_pred EEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-
Q psy14431 637 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS- 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~- 713 (1219)
+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999974 89988874 56889999999999999999999999999999999999999999999999998765321
Q ss_pred -----ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 714 -----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 714 -----~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
........++..|+|||++ .+..++.++|||||||++|+|++|.+||...+.......+.....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 230 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL----- 230 (265)
T ss_pred ccccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC-----
Confidence 1112345688999999997 45568899999999999999999999998766544443333322221110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
-+..+..+.+++.+||..||.+| +.+.+.||||
T Consensus 231 --------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 --------------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 12246778999999999999985 7788999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.58 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=200.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+|.+.+.||.|+||.||.|.+..+|..||||.+...... ......+.+|+.++..+. ||||+++++++.......
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 3688999999999999999999999999999988532211 223457788999999995 999999999987555567
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+||||++ ++|.+++.. ..+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 899999998 589888864 467888899999999999999999999999999999999999999999999997654311
Q ss_pred ---cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 ---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 ---~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.......++..|+|||++. +..++.++|||||||++|+|++|++||.+.+....+..+.. .+..+..+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~------ 231 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPVLP------ 231 (265)
T ss_pred ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--CCCCCCCc------
Confidence 1123346888999999974 45689999999999999999999999976654443333221 11111110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAA 848 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfa 848 (1219)
+..+..+.++|.+|+ .+|.. ++.+.++|||+.
T Consensus 232 ------------------------~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 ------------------------PHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------------hhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 123567889999998 48877 477789999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.66 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=194.5
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||+||+|.+..+|+.||+|++...... ......+..|+.+++.+. ||||++++++|. ..+.+|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFE--TKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEe--cCCeEEEEEecCCC
Confidence 69999999999999999999999998643222 223445678999999996 999999999987 4668999999998
Q ss_pred hhHHHHHhh-c--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 646 NDLNKVIRD-K--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 646 GSL~d~Lrs-~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
++|..++.. . .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence 588888764 3 5899999999999999999999999999999999999999999999999999766532 22234567
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.......+.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------- 215 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------------------- 215 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--------------------
Confidence 889999999754 45899999999999999999999999765542222222211111000
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhh
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAA 848 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfa 848 (1219)
...+..++.+.++|.+||..||.+|+ .+.+.||||.
T Consensus 216 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 216 ----------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred ----------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 01123477899999999999999854 5678999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.11 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=196.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCC-----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TG-----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.+.+|.+++.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..+. ||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~-- 78 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT-- 78 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcC-CcccceEEEEEc--
Confidence 3567899999999999999999876554 779999885332 2233456789999999995 999999999986
Q ss_pred CCceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
+....|+||||++ ++|.+++.. ..++...+..++.||+.||.|||+.|++|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 4567899999998 589888863 3477788999999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||++....... .......+++.|+|||.+. +..++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999997654322 1123345678899999974 4568999999999999999998 999998887766655
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
.|.....+..+ +..++.+.+|+.+|+..||.+|+..
T Consensus 238 ~i~~~~~~~~~---------------------------------~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 238 MIRSRQLLPCP---------------------------------EDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred HHHcCCcCCCc---------------------------------ccCCHHHHHHHHHHccCChhhCcCH
Confidence 55443321110 2346789999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.30 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=208.3
Q ss_pred HhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 552 LMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 552 LL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
++....-...|.+.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.++..+. ||||++++++|.
T Consensus 7 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~ 85 (307)
T cd06607 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYL 85 (307)
T ss_pred hhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEE
Confidence 34444445668889999999999999999999999999998853322 2233456889999999995 999999999987
Q ss_pred ccCCceEEEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 631 AVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 631 ~~d~~~LyLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
++...|+||||+.|++.+++. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 86 --~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 86 --REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred --eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 466789999999998887775 3568999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
..... ....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+.....|... .
T Consensus 164 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 236 (307)
T cd06607 164 LVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---S 236 (307)
T ss_pred ecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---c
Confidence 65433 23568889999998742 356889999999999999999999999877765544444322111110 0
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+..+.+++.+||..||.+| +.+.+.|||+..
T Consensus 237 -----------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 237 -----------------------------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -----------------------------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0125678999999999999986 668899999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.23 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=205.3
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+++.||.|+||.||+|.+..++..||||++.... .......+.+|+.++..+. ||||++++++|. .+..+|+||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~ 81 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KDTKLWIIM 81 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEE--eCCeEEEEE
Confidence 667889999999999999999999999999875332 2233456778999999995 999999999987 467899999
Q ss_pred ecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccc
Q psy14431 642 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~ 720 (1219)
||+++ +|..++....+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 99985 78888887889999999999999999999999999999999999999999999999999987665433333345
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
.++.+|+|||.+. +..++.++|+|||||++|+|++|.+||...+.......+.....|. .
T Consensus 162 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~---------------- 221 (277)
T cd06641 162 VGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---L---------------- 221 (277)
T ss_pred cCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---C----------------
Confidence 6889999999974 4567889999999999999999999998766544444332221111 0
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
....+..+.+++.+||..||.+| +.+.+.||||...
T Consensus 222 --------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 222 --------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------------CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 12246778999999999999885 6788999999663
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.12 Aligned_cols=250 Identities=30% Similarity=0.499 Sum_probs=203.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|.+............+.+|+.+++.+. ||||+++++++. .+..+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQ--ENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheec--cCCeEEEE
Confidence 488999999999999999999999999999998654333344556779999999995 999999999886 56789999
Q ss_pred Eecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc-ceecccccccccCCccc
Q psy14431 641 FEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~-VKLiDFGLAr~l~~~~~ 715 (1219)
+||++ ++|.+++... .+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++. ++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99997 5888887632 4788999999999999999999999999999999999998864 69999999987765443
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
......|++.|+|||++. +..++.++|+|||||++|+|++|.+||.+.+.......+.....+.
T Consensus 158 ~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--------------- 221 (257)
T ss_pred cccccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---------------
Confidence 334456889999999974 4568899999999999999999999998766555444333221110
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+..+..+.+++.+||..+|.+| +.+++.||||
T Consensus 222 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 222 ------------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 012346679999999999999885 7788999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.04 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=199.5
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||+++++++. ++..+|+||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFK--DKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEE--cCCccEEEEecCCC
Confidence 6999999999999999999999999865432 2234467889999999995 999999999887 5678999999997
Q ss_pred hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccc
Q psy14431 646 NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724 (1219)
Q Consensus 646 GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~ 724 (1219)
++|.+++.. ..++...+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 589998875 458899999999999999999999999999999999999999999999999998776543 223457889
Q ss_pred cccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS--TSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 725 ~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s--~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
.|+|||.+. ...++.++|+|||||++|+|++|.+||.... ....+..+.... .....+
T Consensus 157 ~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~----------------- 216 (262)
T cd05572 157 EYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN--GKLEFP----------------- 216 (262)
T ss_pred CccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC--CCCCCC-----------------
Confidence 999999974 5568999999999999999999999998766 444444443211 000000
Q ss_pred hhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
...++.+.+++.+||..||.+|+ .+.++||||..
T Consensus 217 -------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 217 -------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred -------------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 11266789999999999999974 58899999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.44 Aligned_cols=247 Identities=29% Similarity=0.474 Sum_probs=195.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+.+|.+.+.||.|+||.||+|.+..+|..||||.+.... ........+.+|+.+++.+. ||||+++++++. ..+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 77 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFI--EDNEL 77 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEE--ECCeE
Confidence 357999999999999999999999999999999875422 22333456788999999995 999999999987 45688
Q ss_pred EEEEecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 638 YVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
++||||+++ +|..++. ...++...+..++.+|+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999994 7887774 2347888999999999999999999999999999999999999999999999998776
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhhcCCCCCCchhhhh
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~--~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..........+++.|+|||.+. +..++.++|+|||||++|+|++|..||..... ......+.....|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP------- 229 (267)
T ss_pred chhHHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC-------
Confidence 5443334457889999999974 45688999999999999999999999865432 2222222221111100
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
....+..+.+++.+|+..+|.+|+...
T Consensus 230 -------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~ 256 (267)
T cd08228 230 -------------------------TEHYSEKLRELVSMCIYPDPDQRPDIG 256 (267)
T ss_pred -------------------------hhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence 012356789999999999999975443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.63 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=190.9
Q ss_pred ccCeeEEeee--eccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 559 LQQQINLLKE--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 559 IqqY~ILKkI--GeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+..|.+.+.+ |.|+||.||++.+..+|..+|+|++....... .|+.....+.+||||++++++|.. ++.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCe
Confidence 3455666665 99999999999999999999999985432111 123233333469999999999973 568
Q ss_pred EEEEEecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||++......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999997 5899998754 789999999999999999999999999999999999999998 9999999999876533
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~-L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
....++..|+|||++. +..++.++|||||||++|+|++|.+||........ ...+.......+
T Consensus 164 ----~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 227 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL----------- 227 (267)
T ss_pred ----ccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC-----------
Confidence 2346889999999974 45689999999999999999999999975543221 111111110000
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH---HHHHcchhhh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE---IEQLQGKLAA 848 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa---iEALqHpwfa 848 (1219)
...+..++.+.+||.+||..||.+|+ .++|+||||.
T Consensus 228 --------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 228 --------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred --------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 01124688899999999999999974 6789999984
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.92 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=200.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|++...... ......+.+|+.+++.+. ||||+++++++. ++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATC--EDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceec--cCCe
Confidence 477888999999999999999999999999998643321 123467889999999995 999999999987 5678
Q ss_pred EEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~ 713 (1219)
+++||+|+.| +|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999985 78888864 5688999999999999999999999999999999999998776 5999999999876543
Q ss_pred cc----ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhh
Q psy14431 714 KE----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 788 (1219)
Q Consensus 714 ~~----~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~ 788 (1219)
.. ......++..|+|||++. +..++.++|||||||++|+|++|.+||...+.......+..... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS----- 231 (268)
T ss_pred cccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC-----
Confidence 21 112346788999999974 45689999999999999999999999975543332222222110 00000
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..+..++.+.+++.+||..||.+| +.+.+.||||.
T Consensus 232 -------------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 232 -------------------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------------------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 012346788999999999999985 78889999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.38 Aligned_cols=243 Identities=17% Similarity=0.252 Sum_probs=193.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++..+. ||||+++++++. .+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~ 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFD-HSNIVRLEGVIT--RGN 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEe--cCC
Confidence 356899999999999999999765 456789999886432 2233456889999999985 999999999987 467
Q ss_pred eEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||+++ +|.+++.. ..+++..+..++.+|+.||.|||+.|++||||||+|||++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 89999999985 78888864 4689999999999999999999999999999999999999999999999998765432
Q ss_pred cccc-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 SKEC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.... .....++..|+|||++. +..++.++|||||||++|++++ |.+||.+.+....+..+.....++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 230 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP-------- 230 (266)
T ss_pred cchhcccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC--------
Confidence 2111 11233467899999974 5678999999999999999775 99999888877766666544322111
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+..+.+++..|+..+|.+|+.
T Consensus 231 -------------------------~~~~~~~~~li~~c~~~~p~~RP~ 254 (266)
T cd05064 231 -------------------------RNCPNLLHQLMLDCWQKERGERPR 254 (266)
T ss_pred -------------------------CCCCHHHHHHHHHHcCCCchhCCC
Confidence 123566888999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=296.81 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=207.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|++...... .....+.+|+.++..+. ||||+++++++. ....+++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCE-SPYVVKCYGAFY--KEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc--cCCeEEEE
Confidence 588999999999999999999999999999998644322 44567889999999996 999999999987 45789999
Q ss_pred Eecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 641 FEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||++ ++|.+++.. ..+++..+..++.+|+.||.|||+ .|++|+||+|+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999 689999874 678999999999999999999999 999999999999999999999999999998776544433
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s---~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....++..|+|||.+. ...++.++|+|||||++|+|++|.+||...+ .......+..... +.+
T Consensus 158 ~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---------- 223 (264)
T cd06623 158 NTFVGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSL---------- 223 (264)
T ss_pred cceeecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCC----------
Confidence 3567889999999974 5578999999999999999999999997764 2222222221111 101
Q ss_pred hHHhhhHHhhhhchhhHHHHhcc-cChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQ-VVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~-lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
... .+..+.+++..||..+|..| +.+.+.|||+.-
T Consensus 224 --------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 224 --------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred --------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 011 46789999999999999885 788899999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=295.75 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=201.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc---CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~---s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|...+.||.|+||.||+|.+..++..|++|.+..... .......+.+|+.++..+. ||||+++++++. ++..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTER--EEDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEe--cCCeE
Confidence 36677889999999999999998999999998854321 1234567889999999995 999999999886 56789
Q ss_pred EEEEecchh-hHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||+++ +|.+++... .+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999985 898888754 48899999999999999999999999999999999999999999999999988765433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||...........+.... +. +.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-~~------------ 222 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-EL-PP------------ 222 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cC-CC------------
Confidence 23445688999999997543348899999999999999999999997765443333322111 00 00
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+.+.+++.+.+++.+||..||.+| +.+.+.|||+
T Consensus 223 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 223 ------------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 012346778999999999999885 7777999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=295.47 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=203.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|++............+..|+.++..+. ||||+++++++. +...+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEV--HREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEe--cCCEEEEE
Confidence 488899999999999999999999999999998755444446678889999999995 999999999876 56789999
Q ss_pred Eecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc-
Q psy14431 641 FEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL- 717 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~- 717 (1219)
+||++ ++|.+++..+ .+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99998 5898888754 58888999999999999999999999999999999999999999999999998765433221
Q ss_pred ---ccccccccccCchhhhccc--cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH-HHHhhcCCCCCCchhhhhcc
Q psy14431 718 ---TEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 718 ---ts~vGT~~Y~APEvLl~~~--~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~-kIve~l~P~P~~~d~l~~~~ 791 (1219)
....+++.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+...... .+.....|..+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD-------- 229 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc--------
Confidence 1356788999999975332 37899999999999999999999997654332222 222211111110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+++.+.+++.+||+.||.+| ..+.+.|||.
T Consensus 230 -----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 -----------------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11236778899999999999885 7778999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.00 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=200.2
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.+.+.||.|+||.||.|.+. .+|..||+|++..... .......+.+|+.++..+.+||||+.++++|. .+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence 4788999999999999999874 4789999999864321 22234567789999999988999999999887 456
Q ss_pred eEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ ++|.+++. ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 8899999999 48888876 456889999999999999999999999999999999999999999999999999866442
Q ss_pred c-cccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 K-ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~-~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
. .......|+..|+|||.+.+. ..++.++|||||||++|+|++|.+||...+.......+........+.+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY------- 231 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC-------
Confidence 2 112345688999999997542 3467899999999999999999999965433222222221110000000
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
-+..++.+.+++.+||..||.+| +.+++.||||..
T Consensus 232 -----------------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 232 -----------------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred -----------------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 01246778999999999999887 488899999965
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.93 Aligned_cols=240 Identities=23% Similarity=0.414 Sum_probs=195.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|.+.+.||.|+||.||+|.+..++..||+|++... ......+.+|+.+++.+. ||||+++++++. .+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCC-CCChhheEEEEc--CCCCcEE
Confidence 4588999999999999999999999999999988532 233556889999999995 999999999886 4667899
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999997 589888863 3488889999999999999999999999999999999999999999999999987654321
Q ss_pred cc-ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 CL-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~~-ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.. ....++..|+|||.+ .+..++.++|||||||++|+|++ |.+||++.+.......+.....+..+
T Consensus 160 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 227 (263)
T cd05052 160 TAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP----------- 227 (263)
T ss_pred eccCCCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC-----------
Confidence 11 122345679999987 45568999999999999999998 99999887766555555433211110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++.+.+++.+||..||.+|+.
T Consensus 228 ----------------------~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 228 ----------------------EGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred ----------------------CCCCHHHHHHHHHHccCCcccCCC
Confidence 224678999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.00 Aligned_cols=237 Identities=23% Similarity=0.372 Sum_probs=191.1
Q ss_pred eeeccCceEEEEEEE--cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~d--k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|.+ ..++..||+|++............+..|+.++..+. ||||+++++++. +..+++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE---AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc---CCCcEEEEecC
Confidence 589999999999965 467889999998644434444567889999999995 999999999874 45679999999
Q ss_pred h-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc---ccc
Q psy14431 645 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---LTE 719 (1219)
Q Consensus 645 e-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~---~ts 719 (1219)
+ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||.||+++.++.++|+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9 579888864 56899999999999999999999999999999999999999999999999999876543221 122
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
..+++.|+|||.+ ....++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 158 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------- 220 (257)
T cd05116 158 GKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP---------------- 220 (257)
T ss_pred CCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC----------------
Confidence 2345789999997 45568899999999999999998 99999887776666666544322211
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
+..++.+.+++.+|+.+||..|+..+
T Consensus 221 -----------------~~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 221 -----------------QRCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred -----------------CCCCHHHHHHHHHHhccCchhCcCHH
Confidence 12467889999999999999985544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=293.45 Aligned_cols=236 Identities=29% Similarity=0.457 Sum_probs=194.6
Q ss_pred eeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 566 LKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
+.||.|+||.||+|.+... +..|++|++....... ....+.+|+.++..+. ||||+++++++. .+..+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLG-HPNVVRLLGVCT--EEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcC-CCChheeeeeec--CCCceEEEEE
Confidence 3689999999999999866 8899999986543322 4567889999999997 999999999987 4678999999
Q ss_pred cch-hhHHHHHhh----------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 643 YME-NDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 643 yme-GSL~d~Lrs----------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
|++ ++|.+++.. ..+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 995 789999875 568999999999999999999999999999999999999999999999999998776
Q ss_pred Ccc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
... .......+++.|+|||.+. ...++.++|||||||++|+|++ |.+||.+.+.......+.....+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK------- 228 (262)
T ss_pred cccccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 532 2223456788999999974 4468999999999999999999 6999998877666665554221110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+.+++.+.+++.+||..||.+|+.
T Consensus 229 --------------------------~~~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 229 --------------------------PEYCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred --------------------------CccCChHHHHHHHHHccCCcccCcC
Confidence 1223678999999999999998743
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=307.39 Aligned_cols=237 Identities=21% Similarity=0.204 Sum_probs=191.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchh-HHHHHHHHHHHHhccCCCCccEEeeeeec--cCCceEEEEEe
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREILFLKSFQRHPNIITMLDIYKA--VNNKDLYVVFE 642 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~-~e~~lREI~ILr~L~~HPNIVkL~gvfe~--~d~~~LyLVME 642 (1219)
..||+|++|.||+|.. +|..||||++......... ...+.+|+.++..+. ||||++++++|.. .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 4689999999999976 6899999998654332222 356779999999996 9999999999875 33457899999
Q ss_pred cch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 643 YME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 643 yme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
|+. |+|.+++.. ..+++.....++.+++.||.|||+ .|++||||||+|||++.+|.++|+|||++....... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 999 579999874 468888999999999999999998 599999999999999999999999999998655432 34
Q ss_pred ccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 720 YIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
.++++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.....+.+. +
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~------------- 244 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--P------------- 244 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--C-------------
Confidence 568899999999753 256899999999999999999999999988776666665443311110 0
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
...++.+.+++.+||..||..|+..
T Consensus 245 -----------------~~~~~~l~~li~~cl~~dp~~Rps~ 269 (283)
T PHA02988 245 -----------------LDCPLEIKCIVEACTSHDSIKRPNI 269 (283)
T ss_pred -----------------CcCcHHHHHHHHHHhcCCcccCcCH
Confidence 1236678899999999999997543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.58 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=207.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..|++|.+............+.+|+.++..+. |||++++++++. +...+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIE--TSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEE--eCCEEEEE
Confidence 478899999999999999999999999999999755444455677889999999995 999999999987 45789999
Q ss_pred Eecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|+|+++ +|.+++.. ..+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++...........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999985 88888764 5689999999999999999999999999999999999999999999999999987766544334
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
...++..|+|||.+. +..++.++||||||+++|+|++|.+||...+.......+.....+..
T Consensus 158 ~~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 219 (254)
T cd06627 158 SVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----------------- 219 (254)
T ss_pred ccccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC-----------------
Confidence 567899999999974 44588999999999999999999999987665444433322111110
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.+.+++.+.+++.+||..+|.+| +.+.+.||||
T Consensus 220 ----------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 220 ----------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 12336778899999999999985 6777999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.25 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=204.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..+|..|++|++..... .....+.+|+.++..+. ||||++++++|. .+...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCK-HPNIVKYYGSYL--KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCC-CCCEeEEEEEEe--cCCeEEEE
Confidence 47888999999999999999998999999999864322 35567889999999996 999999999987 45779999
Q ss_pred Eecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 641 FEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
++|++ ++|.+++... .+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 99999 6899988754 789999999999999999999999999999999999999999999999999987765432 3
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....++..|+|||.+. ...++.++|+|||||++|+|++|.+||...+....+..+.....+..+ ..
T Consensus 155 ~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~----------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NP----------- 220 (253)
T ss_pred cceecCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC--cc-----------
Confidence 4457889999999974 445889999999999999999999999877654444433321111100 00
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
...+..+.+++.+||..||.+| +.+++.|||
T Consensus 221 ------------------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 221 ------------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------------cccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0126678999999999999885 778899998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.64 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=202.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+. ||||+++++++. ....+|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCN-SPYIVGFYGAFY--NNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCC-CCchhhhheeee--cCCEEEEE
Confidence 57788899999999999999999999999999865432 244566889999999996 999999999987 45789999
Q ss_pred Eecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ ++|.+++.. ..+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999 689998874 568899999999999999999999 99999999999999999999999999998766433221
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-----TSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s-----~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
...++..|+|||.+. +..++.++|||||||++|+|++|.+||...+ ....+..+.....|..+ .
T Consensus 158 --~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----- 226 (265)
T cd06605 158 --TFVGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---S----- 226 (265)
T ss_pred --cccCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC---h-----
Confidence 267888999999974 4578999999999999999999999997542 11222222221111100 0
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++.+.+++.+||..||.+| +.+.+.||||..
T Consensus 227 ------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 227 ------------------------GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ------------------------hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0147789999999999999996 668899999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.08 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=194.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+.+.||.|+||.||+|.+.. ++..||+|++..... ......+.+|+.++..+. ||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQ-HENIVKFYGVCT--E 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcC-CCCchheeeEEe--c
Confidence 4568888999999999999998753 367899999864322 223467889999999995 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhh---------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD---------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs---------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG 697 (1219)
+..+|+||||++ ++|.+++.. ..+++..+..++.+|+.||.|||+.|++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 578999999998 588888863 2367888999999999999999999999999999999999999
Q ss_pred cceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q psy14431 698 SIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIV 774 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIv 774 (1219)
.++|+|||++........ ......+++.|+|||++. +..+++++|||||||++|+|++ |..||.+.+.......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999976533221 112334578899999974 5568999999999999999998 999998877776666665
Q ss_pred hhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 775 NLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 775 e~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..+.++ ...+..+.+++.+||..||.+|+.
T Consensus 239 ~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 270 (280)
T cd05049 239 QGRLLQRP---------------------------------RTCPSEVYDIMLGCWKRDPQQRIN 270 (280)
T ss_pred cCCcCCCC---------------------------------CCCCHHHHHHHHHHcCCCcccCCC
Confidence 43322211 123567899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.82 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=188.7
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchh-HHHHHHHHHHHHhc--cCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREILFLKSF--QRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~-~e~~lREI~ILr~L--~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
.||.|+||.||+|.+..+|+.||+|.+......... ......+..++..+ .+||||+.++++|. ....+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence 379999999999999999999999998654322111 12233343333322 35999999999887 45689999999
Q ss_pred ch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 ME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 me-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
+. ++|..++. .+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.... ....+
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcC
Confidence 98 47877775 4568999999999999999999999999999999999999999999999999987654332 23457
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
|+..|+|||++.++..++.++||||+||++|+|++|.+||.+.................+. +
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~----------------- 218 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-L----------------- 218 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC-C-----------------
Confidence 8999999999865556899999999999999999999999765322111100000000000 0
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
-+..++.+.+++.+||..||.+| +.+.++||||..
T Consensus 219 -------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 219 -------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred -------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 12247789999999999999876 457799999966
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.03 Aligned_cols=242 Identities=19% Similarity=0.328 Sum_probs=191.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
|.+.+.||.|+||.||.|.+..+ +..||+|.+............+.+|+.+++.+. ||||+++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccC
Confidence 46788999999999999987653 478999998654444455567889999999995 999999999875322 1
Q ss_pred ceEEEEEecch-hhHHHHHhh-------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
..+++||||+. ++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 34799999998 588877742 2478889999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccc--ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 707 ARSLSDSKECL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 707 Ar~l~~~~~~~--ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
++......... ....++..|+|||.+ ....++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 237 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP- 237 (273)
T ss_pred eeeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 98665432111 112346679999997 45678999999999999999999 89999887776665555443221111
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+++.+||..||.+|+
T Consensus 238 --------------------------------~~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 238 --------------------------------EDCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred --------------------------------cCCCHHHHHHHHHHcCCChhhCc
Confidence 12366789999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.67 Aligned_cols=242 Identities=20% Similarity=0.351 Sum_probs=190.2
Q ss_pred eEEeeeeccCceEEEEEEEcCCCe--EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CCce
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNKD 636 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk--~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~~~ 636 (1219)
.+.+.||.|+||.||+|.+..++. .||+|.+............+.+|+.++..+. ||||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCC
Confidence 466889999999999999887765 6999988655444555677889999999995 99999999976421 1235
Q ss_pred EEEEEecch-hhHHHHHhh-------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
+++||+|+. |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 789999998 588877631 247888999999999999999999999999999999999999999999999998
Q ss_pred ccCCccccc--ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 709 SLSDSKECL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 709 ~l~~~~~~~--ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
.+....... ....+++.|+|||++ ....++.++|||||||++|+|++ |.+||.+.+.......+.....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 235 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---- 235 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 765432111 122456789999997 45568999999999999999999 8999988776665555543322110
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..+..+.+++.+||..||.+|+.
T Consensus 236 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 236 -----------------------------PPDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred -----------------------------CCCCCHHHHHHHHHHcCCCcccCcC
Confidence 0123566889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.65 Aligned_cols=247 Identities=28% Similarity=0.471 Sum_probs=196.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+.+|.+.+.||.|+||.||+|.+..+|..||||.+.... ........+.+|+.++..+. ||||++++++|. .++.+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~ 77 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI--EDNEL 77 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeE--eCCeE
Confidence 356888999999999999999999999999999875432 22233457789999999995 999999999987 46689
Q ss_pred EEEEecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 638 YVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
++||||+++ +|.+++. ...+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999985 7888775 2357889999999999999999999999999999999999999999999999998765
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhhcCCCCCCchhhhh
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~--e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..........++..|+|||.+ .+..++.++|+|||||++|+|++|.+||.+.... .....+.....|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP------- 229 (267)
T ss_pred cCCcccccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC-------
Confidence 544333455789999999997 4556889999999999999999999999764432 222222211111100
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
....++.+.+++.+||..||.+|+...
T Consensus 230 -------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 230 -------------------------SDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred -------------------------cccccHHHHHHHHHhcCCCcccCCCHH
Confidence 012466799999999999999975543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.96 Aligned_cols=244 Identities=30% Similarity=0.491 Sum_probs=194.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.+. ||||++++++|. .++.++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~--~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFI--ENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeee--cCCeEE
Confidence 579999999999999999999999999999998864322 2233567889999999995 999999999987 456889
Q ss_pred EEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 639 VVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+||||++ ++|..++.. ..++...+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999998 488888752 3478899999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~--~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.........+++.|+|||.+. +..++.++|||||||++|+|++|.+||.+... ......+.....++.+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP-------- 229 (267)
T ss_pred CCcccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC--------
Confidence 433334457889999999974 55689999999999999999999999965432 1222222221111100
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..+..+.+++.+||..+|..|+.
T Consensus 230 ------------------------~~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 230 ------------------------ADHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred ------------------------hhhcCHHHHHHHHHHcCCCcccCCC
Confidence 0133567889999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.06 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=200.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|...++||.|+||.||+|.+..++..||+|.+.... .......+.+|+.++..+. ||||++++++|.......+|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEE
Confidence 5889999999999999999999999999999886432 2244567889999999995 9999999999876566689999
Q ss_pred Eecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 641 FEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 641 MEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||+++ +|.+++. ...++...+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999984 7877654 2457888999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHhhcCCCCCCchhhhh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-----SHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-----~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.....++..|+|||.+ .+..++.++|||||||++|+|++|..||..... .+....+.....|..+....
T Consensus 160 --~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 233 (287)
T cd06621 160 --AGTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG--- 233 (287)
T ss_pred --cccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC---
Confidence 1234678899999997 455689999999999999999999999976522 22222222111111000000
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.....++.+.+++.+||.+||.+| +.+++.|||+
T Consensus 234 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 234 ------------------------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ------------------------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 000124568899999999999985 7788999999
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.82 Aligned_cols=245 Identities=30% Similarity=0.449 Sum_probs=200.5
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||.||+|.+..+|..|++|++..... .......+.+|+.++..+. ||||+++++++. .+..+|+||+|+.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQ--GKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhee--cCcEEEEEEecCCC
Confidence 6899999999999999999999999854322 2234567888999999996 999999999886 5678999999997
Q ss_pred hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--------c
Q psy14431 646 NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--------C 716 (1219)
Q Consensus 646 GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--------~ 716 (1219)
++|..++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 489888874 5689999999999999999999999999999999999999999999999999876543311 2
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
.....++..|+|||.+.. ..++.++|||||||++|+|++|.+||...+.......+.....+.+..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (265)
T cd05579 158 DKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED------------- 223 (265)
T ss_pred ccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc-------------
Confidence 234567889999999754 458899999999999999999999998877666555554422221110
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--H---HHHHcchhhh
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--E---IEQLQGKLAA 848 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--a---iEALqHpwfa 848 (1219)
...++.+.+++.+||..+|.+| + .++|.||||.
T Consensus 224 -------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 224 -------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred -------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 0136778999999999999986 4 8889999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.53 Aligned_cols=250 Identities=29% Similarity=0.467 Sum_probs=194.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
+.....||+|+||.||+|.+..++..||+|.+... .......+.+|+.++..+. ||||+++++++. .++.+++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDS--ENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeec--cCCEEEEEE
Confidence 33446799999999999999999999999987533 2334567889999999995 999999999987 467899999
Q ss_pred ecch-hhHHHHHhh--ccC--ChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccccCCccc
Q psy14431 642 EYME-NDLNKVIRD--KIL--KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs--~~L--seeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||++ ++|..++.. ..+ +...+..++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9998 589988874 345 77888899999999999999999999999999999976 67899999999987654333
Q ss_pred ccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||...................+.
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 232 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE------------ 232 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC------------
Confidence 33445688999999997443 34788999999999999999999999754332111100000000000
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+-..+++.+.+++.+||..+|.+| +.+.+.||||
T Consensus 233 -------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 233 -------------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -------------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 012346778999999999999985 6788999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=300.86 Aligned_cols=241 Identities=22% Similarity=0.384 Sum_probs=190.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
++|.+.+.||.|+||.||.|.+. .++..||+|++.... .......+.+|+.++..+. ||||+++++++. .+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~--~~ 81 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--QG 81 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc--CC
Confidence 46899999999999999999864 245779999885321 2234456789999999985 999999999986 56
Q ss_pred ceEEEEEecch-hhHHHHHhhc-----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceec
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG 702 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~-----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLi 702 (1219)
..+++||||++ ++|.+++... .++...+..++.+++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 78999999998 5898888632 24667788999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 703 DLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 703 DFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P 779 (1219)
|||++......... .....+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+.....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765432211 11234577899999974 4568999999999999999998 78999887776666555443322
Q ss_pred CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 780 ~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+ ...++.+.+++.+||..||.+|+
T Consensus 241 ~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 241 DKP---------------------------------DNCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred CCC---------------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 111 12356789999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.51 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=191.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCe--EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk--~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
++|.+.+.||.|+||.||+|.+..+|. .+++|.+.. .........+.+|+.++..+.+||||+++++++. ..+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcc
Confidence 468899999999999999999887764 468887752 2233345678899999999977999999999986 45679
Q ss_pred EEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~V 699 (1219)
|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999998 5899888632 37788899999999999999999999999999999999999999
Q ss_pred eecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 700 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 700 KLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|+|||++........ ......+..|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999875332111 11122355799999974 5568999999999999999997 9999988777665555543322
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
+..+ ..+++.+.+|+.+||..||.+|+..
T Consensus 237 ~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 265 (297)
T cd05089 237 MEKP---------------------------------RNCDDEVYELMRQCWRDRPYERPPF 265 (297)
T ss_pred CCCC---------------------------------CCCCHHHHHHHHHHcCCChhhCcCH
Confidence 1111 1246778999999999999997443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.43 Aligned_cols=249 Identities=26% Similarity=0.461 Sum_probs=203.3
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
.+||.|+||.||++.+..+|..||||++... .......+.+|+.++..+. ||||++++++|. .+.++|+||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcC-CcchhheeeEEE--eCCEEEEEEecCC
Confidence 5789999999999999999999999987422 2334556888999999995 999999999987 4678999999998
Q ss_pred h-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccc
Q psy14431 646 N-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724 (1219)
Q Consensus 646 G-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~ 724 (1219)
+ +|.+++....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 5 788888777789999999999999999999999999999999999999999999999999876654333334457889
Q ss_pred cccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhh
Q psy14431 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVV 804 (1219)
Q Consensus 725 ~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp 804 (1219)
.|+|||.+ .+..++.++|+|||||++|+|++|.+||.+.+....+..+.....+....
T Consensus 181 ~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------- 238 (292)
T cd06657 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN--------------------- 238 (292)
T ss_pred cccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCC---------------------
Confidence 99999987 45568899999999999999999999998776655444433222111110
Q ss_pred hhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 805 VKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 805 ~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
....++.+.+++.+||..||.+| +.+++.||||....
T Consensus 239 ----------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 239 ----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ----------cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 12346778899999999999985 77889999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.76 Aligned_cols=247 Identities=32% Similarity=0.484 Sum_probs=205.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.++||.|+||.||++.+..+|..||+|.+............+.+|+.+++.+. ||||+++++++. .+..+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL--DGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhc--cCCEEEEE
Confidence 488999999999999999999999999999998755444455667789999999996 999999999987 45789999
Q ss_pred Eecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 641 FEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||+++ +|..++.. ..+++..+..++.+++.||.|||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999974 88888765 45888899999999999999999999999999999999999999999999999877654
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+++.|+|||.+ .+..++.++|+||||+++|+|++|++||...+.......+.....|..+
T Consensus 157 -~~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 222 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP------------ 222 (256)
T ss_pred -CcccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc------------
Confidence 22335688999999997 4566889999999999999999999999887765544444332222111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
...+..+.+++.+||..+|.+| +.+.++||+
T Consensus 223 ---------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 223 ---------------------PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred ---------------------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 1235678999999999999996 668899985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.45 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=196.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.++++||.|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.+. ||||+++++++. ....+|+|
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv 80 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLR-HKHLISLFAVCS--VGEPVYII 80 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCC-CcchhheeeeEe--cCCCeEEE
Confidence 58889999999999999999988 8889999985432 223456888999999995 999999999887 46679999
Q ss_pred Eecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||+++ +|.+++.. ..++...+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999984 89999874 45889999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....++..|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 226 (261)
T cd05148 161 SSDKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP------------- 226 (261)
T ss_pred ccCCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC-------------
Confidence 33445667899999974 5568999999999999999998 89999888776666666543322111
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
...++.+.+++.+||..||.+|+..
T Consensus 227 --------------------~~~~~~~~~~i~~~l~~~p~~Rpt~ 251 (261)
T cd05148 227 --------------------AKCPQEIYKIMLECWAAEPEDRPSF 251 (261)
T ss_pred --------------------CCCCHHHHHHHHHHcCCCchhCcCH
Confidence 1235678899999999999987543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=301.45 Aligned_cols=243 Identities=22% Similarity=0.366 Sum_probs=191.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+.+|.+++.||.|+||.||+|... .++..||+|.+.... .......+.+|+.+++.+. ||||+++++++. .+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELH-HPNIVCLLGVVT--QE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe--cC
Confidence 567899999999999999999853 456789999886322 2333456788999999995 999999999987 46
Q ss_pred ceEEEEEecch-hhHHHHHhh------------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs------------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
..+|+||||++ ++|.+++.. ..+++..+..++.+|+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 67999999998 589888752 23677888999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||++....... .......++..|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999998654322 1122334567899999974 4568999999999999999998 9999988776555554
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+.....++.+ ...++.+.+++..||..||.+|+.
T Consensus 239 ~~~~~~~~~~---------------------------------~~~~~~~~~li~~cl~~~p~~Rp~ 272 (283)
T cd05090 239 VRKRQLLPCS---------------------------------EDCPPRMYSLMTECWQEGPSRRPR 272 (283)
T ss_pred HHcCCcCCCC---------------------------------CCCCHHHHHHHHHHcccCcccCcC
Confidence 4332211100 123567889999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.57 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=200.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC--------chhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--------KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s--------~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|.+...... ......+..|+.++..+. ||||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFET-- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEec--
Confidence 588899999999999999999999999999987532111 111345678999999995 999999999887
Q ss_pred CCceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
....+++||||++ ++|.+++.. +.++...+..++.+|+.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 79 TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 4568999999997 588888874 56888999999999999999999999999999999999999999999999999765
Q ss_pred CCcc--cccccccccccccCchhhhccc-cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchh
Q psy14431 711 SDSK--ECLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADK 786 (1219)
Q Consensus 711 ~~~~--~~~ts~vGT~~Y~APEvLl~~~-~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~ 786 (1219)
.... .......++..|+|||++.... .++.++|+|||||++|+|++|.+||...+....+..+.... .+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 234 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP---- 234 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC----
Confidence 4321 1123346788999999975433 47899999999999999999999997655443333222111 11000
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
....+.++..+.+++.+||..||..| +.+.++|||+
T Consensus 235 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 235 -------------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 01123457889999999999999985 7788999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.71 Aligned_cols=241 Identities=21% Similarity=0.340 Sum_probs=194.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.... +..||+|.+... ......+.+|+.+++.+. ||||++++++|. ....+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 75 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG---AMSEEDFIEEAKVMMKLS-HPKLVQLYGVCT--QQKPLY 75 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC---CccHHHHHHHHHHHHHCC-CCCceeEEEEEc--cCCCEE
Confidence 4568899999999999999998764 457999987532 223456788999999995 999999999987 456799
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||++ |+|.+++.. +.+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||.+........
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999998 689888863 4588899999999999999999999999999999999999999999999999986543322
Q ss_pred c-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....++..|+|||++. +..++.++|||||||++|+|++ |++||.+.+....+..+.....+..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------- 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK---------- 224 (256)
T ss_pred eccCCCCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC----------
Confidence 1 12234556799999974 5568999999999999999999 999998888777777765543322110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
..++.+.+++.+|+..||.+|+..
T Consensus 225 -----------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 225 -----------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred -----------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 124568999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=322.58 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=191.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
+..++|.+++.||.|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.+.+|||||+++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~- 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT- 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec-
Confidence 3455799999999999999999986443 4579999986432 22334567899999999966999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhh--------------------------------------------------------
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRD-------------------------------------------------------- 654 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs-------------------------------------------------------- 654 (1219)
..+.+|+||||+. |+|.+++..
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 4568999999998 588887752
Q ss_pred ---------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc--c
Q psy14431 655 ---------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC--L 717 (1219)
Q Consensus 655 ---------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~--~ 717 (1219)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......... .
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677788999999999999999999999999999999999999999999999865433211 1
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
....+++.|+|||++. ...++.++|||||||++|+|++ |.+||++......+..+.... .+..+
T Consensus 272 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~------------- 337 (374)
T cd05106 272 GNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP------------- 337 (374)
T ss_pred cCCCCccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC-------------
Confidence 1223456799999974 5568999999999999999997 999998765443333332211 11100
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
...++++.+++.+||..||.+|+..
T Consensus 338 --------------------~~~~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 338 --------------------DFAPPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred --------------------CCCCHHHHHHHHHHcCCChhhCcCH
Confidence 1236788999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.98 Aligned_cols=302 Identities=30% Similarity=0.467 Sum_probs=238.0
Q ss_pred ccccCCcccccchhhhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHH
Q psy14431 533 SLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612 (1219)
Q Consensus 533 Sl~Sn~k~rev~~~~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~I 612 (1219)
.+..|..+.+++|...+++++..+|.+..|. |.|-||+|..|.+...|..||||+|.. +..-...-++|+.|
T Consensus 410 ~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~-----GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~Elei 481 (752)
T KOG0670|consen 410 GLQDNWDDAEGYYRVRIGELLDSRYEVQGYT-----GKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEI 481 (752)
T ss_pred ccccCcccccceEEEehhhhhcceeEEEecc-----ccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHH
Confidence 4456677788899999999999876666665 999999999999999999999999963 33334556799999
Q ss_pred HHhccC-----CCCccEEeeeeeccCCceEEEEEecchhhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhccccc
Q psy14431 613 LKSFQR-----HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMH 683 (1219)
Q Consensus 613 Lr~L~~-----HPNIVkL~gvfe~~d~~~LyLVMEymeGSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVH 683 (1219)
|..|.. --|+++|+..|. ..+|+|||||.+.-+|..++.. -.+....++.|+.|++.||..|..+||+|
T Consensus 482 LkKL~~AD~Edk~Hclrl~r~F~--hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlH 559 (752)
T KOG0670|consen 482 LKKLNDADPEDKFHCLRLFRHFK--HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLH 559 (752)
T ss_pred HHHhhccCchhhhHHHHHHHHhh--hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeee
Confidence 999973 248899988887 5789999999999999999973 35888999999999999999999999999
Q ss_pred CCCCCCCeeeccCC-cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCC
Q psy14431 684 RDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP 762 (1219)
Q Consensus 684 RDLKPsNILLd~dG-~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~ 762 (1219)
.||||+||||+... .+||||||.|..+.... .+.|..+..|+|||++++ .+|++++|+||+||+||||.||+-.|+
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccCccceEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecC
Confidence 99999999999765 58999999998876543 567888999999999865 569999999999999999999999999
Q ss_pred CCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH----------------hhhHHhhhhch-hhHHHHh----------
Q psy14431 763 GASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER----------------EKFNQVVVKCQ-KELQELQ---------- 815 (1219)
Q Consensus 763 g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r----------------elI~klp~kcr-k~L~el~---------- 815 (1219)
|..+.+++...+...++.|.-+-.- ..|....+. ..+.-++...| ..+...+
T Consensus 637 G~TNN~MLrl~me~KGk~p~KmlRK-gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 637 GRTNNQMLRLFMELKGKFPNKMLRK-GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCcHHHHHHHHHhcCCCcHHHhhh-cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 9999999999988887777543110 011111110 00001111111 2222221
Q ss_pred cccChhHHHHHHhccccCCCC--CHHHHHcchhhh
Q psy14431 816 SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAA 848 (1219)
Q Consensus 816 p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfa 848 (1219)
+.....+.|||.+||.+||.+ +..+||.||||.
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 223457899999999999998 589999999984
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=286.71 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=204.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||.||+|.+..++..|++|++............+.+|+.+++.+. ||||+++++++.......+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence 477889999999999999999999999999998655443455678889999999996 9999999999874323789999
Q ss_pred Eecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--c
Q psy14431 641 FEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--C 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--~ 716 (1219)
+||++ ++|.+++... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99995 6899888754 789999999999999999999999999999999999999999999999999987765432 1
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~~ 795 (1219)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||...+... ..+..... ...+.
T Consensus 160 ~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~------------ 224 (260)
T cd06606 160 TGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSSGEPPE------------ 224 (260)
T ss_pred ccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccccCCCcC------------
Confidence 23456888999999974 4458999999999999999999999998766221 11111110 00000
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+....+..+.+++.+||..||.+| ..+.+.||||
T Consensus 225 ------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 225 ------------------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------------------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 011236778999999999999885 7788999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.51 Aligned_cols=241 Identities=25% Similarity=0.384 Sum_probs=194.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+|.+.+.||.|+||.||++.+. .++..||+|.+... .......+.+|+.++..+. ||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cC
Confidence 46889999999999999999853 34677999988532 2334556889999999995 999999999987 46
Q ss_pred ceEEEEEecch-hhHHHHHhhc--------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK--------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~--------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~V 699 (1219)
..+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 78999999998 5888888632 38899999999999999999999999999999999999999999
Q ss_pred eecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhh
Q psy14431 700 KIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNL 776 (1219)
Q Consensus 700 KLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~ 776 (1219)
+|+|||++........ ......+++.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+....+..+...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986543221 11223457789999997 45668999999999999999998 99999888776666666544
Q ss_pred cCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 777 VRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 777 l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
..+..+ ...++.+.+|+.+||..||.+|+.
T Consensus 239 ~~~~~~---------------------------------~~~~~~l~~li~~~l~~~p~~Rpt 268 (288)
T cd05093 239 RVLQRP---------------------------------RTCPKEVYDLMLGCWQREPHMRLN 268 (288)
T ss_pred CcCCCC---------------------------------CCCCHHHHHHHHHHccCChhhCCC
Confidence 322111 123567899999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.08 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=193.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+.+.||.|+||.||+|.+... ...||+|.+.... .......+.+|+.++..+.+||||+++++++. .
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--Q 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--C
Confidence 45688999999999999999987643 3789999886432 23344568899999999966999999999986 4
Q ss_pred CceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
++.+|+||||++ |+|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 667999999998 588888752 34788889999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||++..+...... .....++..|+|||++ .+..++.++|||||||++|+|++ |.+||++.+.......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999876543211 1222345679999997 45568999999999999999997 9999988776665554
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.....+..+ ...+..+.+|+.+||..||.+|+
T Consensus 247 ~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 247 LKEGYRMEKP---------------------------------QNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred HHcCCcCCCC---------------------------------CCCCHHHHHHHHHHcccCcccCc
Confidence 4332211110 12356789999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=320.48 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=190.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
...+|.+.++||.|+||.||+|.+ ..++..||||++.... .......+.+|+.++..+.+||||++++++|.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~-- 109 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT-- 109 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--
Confidence 345789999999999999999974 4567789999985332 23344678899999999967999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhhc--------------------------------------------------------
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK-------------------------------------------------------- 655 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~-------------------------------------------------------- 655 (1219)
.++..|+||||++ |+|.+++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 4667999999998 5888777531
Q ss_pred --------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 656 --------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 656 --------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 367778889999999999999999999999999999999999999999999986654321
Q ss_pred c--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh-hcCCCCCCchhhhhcc
Q psy14431 716 C--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve-~l~P~P~~~d~l~~~~ 791 (1219)
. .....++..|+|||++. +..++.++|||||||++|+|++ |.+||.+......+..++. ...+..+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--------- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC---------
Confidence 1 11233456799999974 5568999999999999999998 8999987654333322222 1111100
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+..+.+|+.+||..||.+|+.
T Consensus 340 ------------------------~~~~~~l~~li~~cl~~dP~~RPs 363 (375)
T cd05104 340 ------------------------ECAPSEMYDIMKSCWDADPLKRPT 363 (375)
T ss_pred ------------------------CCCCHHHHHHHHHHccCChhHCcC
Confidence 112567889999999999999743
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.43 Aligned_cols=243 Identities=22% Similarity=0.395 Sum_probs=193.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+.+.||.|+||.||+|.+... +..||+|.+.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--T 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc--C
Confidence 35789999999999999999988654 4889999875332 2233456788999999985 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCccee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKL 701 (1219)
+..+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 578999999997 6898888632 2567788999999999999999999999999999999999999999
Q ss_pred cccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 702 GDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|||+++.+..... ......++..|+|||.+. ...++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999976543321 122345678899999974 4568999999999999999998 9999988777666555542221
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+ ...+..+.+++.+||..+|.+|+.
T Consensus 240 ~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rpt 267 (277)
T cd05032 240 LDLP---------------------------------ENCPDKLLELMRMCWQYNPKMRPT 267 (277)
T ss_pred CCCC---------------------------------CCCCHHHHHHHHHHcCCChhhCCC
Confidence 1111 112567889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.38 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=194.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.++++||.|+||.||+|.+. ++..||+|.+... ......+.+|+.++..+. ||||+++++++. ....+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVT--KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCC-CCCeeeEEEEEc--CCCCcE
Confidence 457999999999999999999865 4567999987532 233567889999999995 999999999886 466789
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++.. ..++...+..++.+|+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999997 589988863 457888899999999999999999999999999999999999999999999998765432
Q ss_pred cc-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 EC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....++..|+|||++. ...++.++|||||||++|+|++ |.+||++.........+.....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 225 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR----------- 225 (261)
T ss_pred eeccCCCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 11 12334567899999974 4568899999999999999998 9999988777666555544321110
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
....+..+.+++.+||..||.+|+...
T Consensus 226 ----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 226 ----------------------MENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred ----------------------CCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 112356788999999999999985443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.57 Aligned_cols=278 Identities=35% Similarity=0.630 Sum_probs=224.9
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC---ceEEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---KDLYV 639 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---~~LyL 639 (1219)
.--+.||.|+||.||.+.|..+|+.||+|++...+.+-....++++|+.+|..+. |.|++..+++...+.- ..+|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHH
Confidence 4457899999999999999999999999999877777788899999999999996 9999999998865433 34789
Q ss_pred EEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-cccc
Q psy14431 640 VFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-KECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~-~~~~ 717 (1219)
|+|.|..+|+.++-+ ..++...++.+++||++||.|||+.||+||||||.|+|++.++.+||||||+++..... ....
T Consensus 135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 999999999998874 56999999999999999999999999999999999999999999999999999865442 2334
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~ 796 (1219)
+.-+.|.+|+|||++++...|+.++||||+|||+.||+..+-.|...++..+++.|...+ .|..+...-- ....
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A-----CEGA 289 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA-----CEGA 289 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH-----hhhh
Confidence 556789999999999999999999999999999999999999999999999999999988 4443332211 1222
Q ss_pred HhhhHHhhhhchhhHHHHhc-----ccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 797 REKFNQVVVKCQKELQELQS-----QVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p-----~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+.-+.+-+. ...+++.++. +-.....+++..||.+||++| ..+|+.|++.
T Consensus 290 k~H~LR~~~-k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 290 KNHVLRAGL-RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhccCC-CCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 222222221 1222333332 223478999999999999996 4555666665
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.10 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=189.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeE--EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~--VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+++|.+.+.||.|+||.||+|.+..+|.. +|+|.+... ........+.+|+.++..+.+||||+++++++. .++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~ 81 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRG 81 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCC
Confidence 356799999999999999999998877754 577766422 223344567889999999967999999999986 466
Q ss_pred eEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG 697 (1219)
.+|+||||++ ++|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 7999999997 5898888632 468889999999999999999999999999999999999999
Q ss_pred cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhh
Q psy14431 698 SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNL 776 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~ 776 (1219)
.++|+|||++....... ......++..|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred cEEeCccccCcccchhh-hcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999986432211 11112345679999987 45568999999999999999998 99999877665544433221
Q ss_pred cCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 777 VRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 777 l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+.. ....++.+.+|+.+||..||.+|+
T Consensus 240 ~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rp 268 (303)
T cd05088 240 YRLEK---------------------------------PLNCDDEVYDLMRQCWREKPYERP 268 (303)
T ss_pred CcCCC---------------------------------CCCCCHHHHHHHHHHcCCChhhCc
Confidence 11100 012366789999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.25 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=199.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc---cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~---~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.+. ||||+++++++.......+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEE
Confidence 6889999999999999999999999999999874321 12234457788999999995 9999999999875556678
Q ss_pred EEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc--
Q psy14431 638 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-- 713 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~-- 713 (1219)
++||||++ ++|.+++.. +.+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999998 478888774 56889999999999999999999999999999999999999999999999999865431
Q ss_pred -ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 -KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 -~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........++..|+|||++. +..++.++|+|||||++|+|++|++||........+..+.. .|.++..+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p------- 231 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLP------- 231 (264)
T ss_pred cCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCC-------
Confidence 11123456889999999974 45688999999999999999999999987655443333221 22222111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKL 846 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpw 846 (1219)
+.+++.+.+++.+||.. |.. ++.+.+.|||
T Consensus 232 -----------------------~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~~~ 263 (264)
T cd06653 232 -----------------------DGVSDACRDFLKQIFVE-EKRRPTAEFLLRHPF 263 (264)
T ss_pred -----------------------cccCHHHHHHHHHHhcC-cccCccHHHHhcCCC
Confidence 23467799999999985 444 4667788887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.77 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=203.6
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
|...++||.|+||.||+|.+..+|..|++|++..... .......+.+|+.+++.+. |||++++++++. ++...|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYL--KEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEE--eCCEEEEE
Confidence 6667889999999999999999999999999854322 2233456788999999995 999999999987 46679999
Q ss_pred EecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||+.|++..++.. ..+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++..... ..
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 99999988887753 4588999999999999999999999999999999999999999999999999865432 23
Q ss_pred cccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 719 EYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
...|+..|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..+.....|...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 241 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ-------------- 241 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------------
Confidence 4578899999999742 356888999999999999999999999887766655555433222111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+..+..+.+|+.+||.++|.+| +.+++.||||..
T Consensus 242 ------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 242 ------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 01235568899999999999985 778899999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=325.93 Aligned_cols=289 Identities=28% Similarity=0.424 Sum_probs=222.8
Q ss_pred hhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-------CCccEE
Q psy14431 553 MKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-------PNIITM 625 (1219)
Q Consensus 553 L~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-------PNIVkL 625 (1219)
+.+.+.-.+|.++++||+|-|++||+|.|..+.++||+|+.+.. ....+..+.||.+|+.+..+ .+||+|
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 45566667899999999999999999999999999999998633 34456778999999998844 389999
Q ss_pred eeeee--ccCCceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccC---
Q psy14431 626 LDIYK--AVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKS--- 696 (1219)
Q Consensus 626 ~gvfe--~~d~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~d--- 696 (1219)
++.|. ++++.|+|||||+++.+|..+|.. +.++...|+.|++||+.||.|||. +||||.||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEID 227 (590)
T ss_pred eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccc
Confidence 99996 577899999999999999998873 459999999999999999999995 799999999999997200
Q ss_pred --------------------------------------------------------------------------------
Q psy14431 697 -------------------------------------------------------------------------------- 696 (1219)
Q Consensus 697 -------------------------------------------------------------------------------- 696 (1219)
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q psy14431 697 -------------------------------------------------------------------------------- 696 (1219)
Q Consensus 697 -------------------------------------------------------------------------------- 696 (1219)
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence
Q ss_pred ---CcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC------CcH
Q psy14431 697 ---CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA------STS 767 (1219)
Q Consensus 697 ---G~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~------s~~ 767 (1219)
-.|||+|||.|+++... ++.-+.|..|+|||++++. +|++.+||||++||+|||+||..+|... -+.
T Consensus 388 ~~di~vKIaDlGNACW~~kh---FT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWVHKH---FTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred ccceeEEEeeccchhhhhhh---hchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 01234444444443321 2344568899999999765 5999999999999999999999888543 267
Q ss_pred HHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhh------chhhHHHHhc-------ccChhHHHHHHhccccCC
Q psy14431 768 HQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVK------CQKELQELQS-------QVVEENTSKLKLQMELDS 834 (1219)
Q Consensus 768 e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~k------crk~L~el~p-------~lspeaiDLLsKMLq~DP 834 (1219)
+.+..|+..++..|..+- ....+.+++|.+.... .+-++.+++- .-..++.|||.-||+++|
T Consensus 464 DHiA~i~ELLG~iPr~ia-----~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIA-----LGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred HHHHHHHHHHhhccHHHH-----hcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 889999999976665431 2244556666654433 2333443332 123478999999999999
Q ss_pred CCC--HHHHHcchhhhcCCCC
Q psy14431 835 KDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 835 eKR--aiEALqHpwfaL~~e~ 853 (1219)
++| |..+|+|||.+...-+
T Consensus 539 eKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cccccHHHHhcCccccCCCCC
Confidence 996 6677999999875554
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.58 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=200.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||+||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||+++++++. ....+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECR-SPYIVSFYGAFL--NENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcC-CCCcceEeeeEe--cCCEEE
Confidence 356888999999999999999999999999999886432 2334567889999999995 999999999987 457899
Q ss_pred EEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++ +|..++.. +.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999985 78887764 568999999999999999999997 699999999999999999999999999987653322
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHH--------HHHHHhhcCCCCCCchhh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--------LQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~--------L~kIve~l~P~P~~~d~l 787 (1219)
....+|+..|+|||++. +..++.++|||||||++|+|++|.+||...+.... ...+.......++.++
T Consensus 159 -~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-- 234 (284)
T ss_pred -cCccccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--
Confidence 22457899999999975 44688999999999999999999999986543210 1111111100000000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+..+.+|+.+||..||.+| +.+++.|+||.-
T Consensus 235 ---------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 235 ---------------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ---------------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01135678999999999999985 788899998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.66 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=194.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCe----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..+|.++++||.|+||+||+|.+..+|. .||+|++.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~---~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVG-SPYVCRLLGICL---T 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEc---C
Confidence 4578999999999999999999877765 48999885332 2333456788999999885 999999999886 3
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...+++|+|++ |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 45789999998 688888874 458999999999999999999999999999999999999999999999999998765
Q ss_pred Ccccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
..... .....+++.|+|||.+. +..++.++|||||||++|+|++ |.+||.+.........+.....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 233 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP------ 233 (279)
T ss_pred cccceeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC------
Confidence 33221 11223467899999974 4568999999999999999998 99999776655544444332222111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH-Hcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ-LQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA-LqHpwfaL 849 (1219)
+..++.+.+++.+||..||..|+... +-+.+..+
T Consensus 234 ---------------------------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 234 ---------------------------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 12356688999999999999874333 23444433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.32 Aligned_cols=280 Identities=23% Similarity=0.327 Sum_probs=215.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
+.||+|+||.|--|....+|..||||++.+. ......+.++|+.++..+.+|+||+.++++|. ++..+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceEEEEEeccc
Confidence 4679999999999999999999999999654 34556789999999999999999999999998 6788999999998
Q ss_pred h-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceecccccccccCC-------c
Q psy14431 646 N-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSD-------S 713 (1219)
Q Consensus 646 G-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLAr~l~~-------~ 713 (1219)
| +|...|. ...|++..+..++.+|+.||.|||..||.||||||+|||.....+ ||||||.+...+.- .
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 5 6666655 667999999999999999999999999999999999999976543 89999998864322 1
Q ss_pred ccccccccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.+...+.+|+..|||||+.- ....|+.++|.||||||+|-||+|.+||.|.-..+. +.....
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe------ 305 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGE------ 305 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCC------
Confidence 22344678899999999962 235689999999999999999999999977532110 000000
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCCcCCCCCCCCCC
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSETASLSSADVEND 864 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~s~~PS~d~s~d 864 (1219)
.-......+|..+......-...-+.+++.++.||++.+|..||..| +...+.|||++.-......|++.+...
T Consensus 306 -~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r 381 (463)
T KOG0607|consen 306 -VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQR 381 (463)
T ss_pred -ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccccc
Confidence 00111122233332222222223345678999999999999999885 677799999988777777777765543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.86 Aligned_cols=235 Identities=24% Similarity=0.386 Sum_probs=185.4
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.+. ||||+++++++. ....+|+||||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYS-HPNIVRLIGVCT--QKQPIYIVMELVQG 77 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc--CCCCeEEEEeeccC
Confidence 6899999999999999999999999875332 2333456889999999995 999999999987 4567999999997
Q ss_pred hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc--ccc
Q psy14431 646 NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT--EYI 721 (1219)
Q Consensus 646 GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t--s~v 721 (1219)
++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++........... ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 588888864 3588999999999999999999999999999999999999999999999999876543211111 112
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhh
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
++..|+|||.+. ++.++.++|||||||++|+|++ |.+||...+.......+.....+..+
T Consensus 158 ~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 218 (252)
T cd05084 158 IPVKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP------------------ 218 (252)
T ss_pred CceeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc------------------
Confidence 245699999974 4568999999999999999997 88999776655444444332211100
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+..+.+++.+||..||.+|+.
T Consensus 219 ---------------~~~~~~~~~li~~~l~~~p~~Rps 242 (252)
T cd05084 219 ---------------ELCPDAVYRLMERCWEYDPGQRPS 242 (252)
T ss_pred ---------------ccCCHHHHHHHHHHcCCChhhCcC
Confidence 123567899999999999999744
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.65 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=192.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
+.+|.+++.||.|+||.||+|.+..+ +..||+|++.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~ 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVT--K 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--C
Confidence 45678889999999999999987543 5789999986332 2233456778999999885 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
...++++++|+. ++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 567899999998 578888742 23777888999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||+++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |.+||.+.+....+..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999886543221 122334577899999975 4458999999999999999998 8899988877766666
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
+.....++.+ ...+..+.+|+..||..||.+|+..
T Consensus 239 i~~~~~~~~~---------------------------------~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 239 IRNRQVLPCP---------------------------------DDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HHcCCcCCCC---------------------------------CCCCHHHHHHHHHHhCCCcccCCCH
Confidence 6544321110 1235668899999999999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.71 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=204.5
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..+++|.+.+.||.|+||.||+|.+..+|..||||.+..... ......+..|+.++....+||||+++++++. .+..
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~ 88 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSD 88 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCe
Confidence 356789999999999999999999999999999999864322 2334556778887777777999999999987 4668
Q ss_pred EEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+++++..++.. ..+++..+..++.+|+.||.|||+ .||+||||+|+||+++.++.++|+|||++..+...
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999999877777653 468888999999999999999997 69999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
... ....++..|+|||.+.+. +.++.++|||||||++|+|++|++||..... ...+..+.....+..+..
T Consensus 169 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 242 (296)
T cd06618 169 KAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN----- 242 (296)
T ss_pred Ccc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC-----
Confidence 222 234578899999997433 3478899999999999999999999975432 233333333221111100
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
...+..+.+|+.+||..||.+| +.+++.|+|+....
T Consensus 243 --------------------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 243 --------------------------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred --------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 0235678999999999999986 67889999997633
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.64 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=204.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|...+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.+. |||++++++++. ++...|+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~l 102 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYL--REHTAWL 102 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--eCCeEEE
Confidence 37788899999999999999999999999999864322 2233456888999999995 999999999987 4567899
Q ss_pred EEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++|+|.+++. ...+++..+..++.+|+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 99999998887775 356889999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 718 TEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..+.....+...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 245 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ------------- 245 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC-------------
Confidence 23468889999999742 346889999999999999999999999877666555555443322111
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....++.+.+++.+||..+|..| +.+.+.|+|+..
T Consensus 246 -------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 246 -------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01235668899999999999985 777799999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.96 Aligned_cols=254 Identities=32% Similarity=0.494 Sum_probs=207.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
....|.+...||.|+||.||.|.+..++..|++|++..... ....+.+|+.++..+. ||||++++++|. ....+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCK-HPNIVDYYDSYL--VGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCC-CCCeeEEEEEEE--ECCEE
Confidence 45568888999999999999999998899999999864322 4566789999999995 999999999987 45789
Q ss_pred EEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+|+||++ ++|.+++... .++...+..++.+|+.||.|||+.||+|+||+|+||+++.+|.++|+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999 6999999865 79999999999999999999999999999999999999999999999999987665433
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.......+++.|+|||++. +..++.++|+|||||++|+|++|.+||...++......+.....+....
T Consensus 171 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 238 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN----------- 238 (286)
T ss_pred hhhccccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcc-----------
Confidence 3333446788999999974 5568999999999999999999999998776655444443322111110
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.++..+.+++.+||..+|..| +.+.+.|+|+..
T Consensus 239 --------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 239 --------------------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred --------------------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 01235678899999999999885 777899999966
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.20 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=188.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeE----EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~----VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..+|.+++.||+|+||.||+|.+..+|.. ||+|++... ........+..|+.++..+. ||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~--- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC---
Confidence 45699999999999999999998766654 899988532 22344567888999999995 9999999998863
Q ss_pred ceEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...++|++|+. |+|.+++... .++...+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 35789999998 6898888753 47888899999999999999999999999999999999999999999999998765
Q ss_pred Cccccc--ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSKECL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~~~~--ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
...... ....++..|+|||++. ...++.++|||||||++|+|++ |.+||.+.+.......+.....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP------ 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC------
Confidence 433221 1223466799999974 5568999999999999999997 99999876655433322222211111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..+..+.+++.+|+..||..|+
T Consensus 234 ---------------------------~~~~~~~~~li~~cl~~~p~~Rp 256 (316)
T cd05108 234 ---------------------------PICTIDVYMIMVKCWMIDADSRP 256 (316)
T ss_pred ---------------------------CCCCHHHHHHHHHHccCChhhCc
Confidence 11245678889999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.86 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=194.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.++|.+.+.||.|+||.||+|.+..+ ...||+|++.... .......+.+|+.++..+. ||||+++++++. .++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVT--KSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEe--cCC
Confidence 35688999999999999999988654 4579999885432 2333456788999999995 999999999886 466
Q ss_pred eEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||+++ +|.+++.. +.+++..+..++.+++.||.|||++||+|+||+|+|||++.++.++|+|||++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 79999999984 89988864 4689999999999999999999999999999999999999999999999999987753
Q ss_pred cccccc--cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 713 SKECLT--EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 713 ~~~~~t--s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
...... ...+++.|+|||.+ .+..++.++|||||||++|+|++ |.+||...........+.....++++
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 230 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP------- 230 (266)
T ss_pred cccceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 222111 23346789999997 45568999999999999999998 99999877766666655443322111
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...++.+.+++.+||..||.+|+.
T Consensus 231 --------------------------~~~~~~l~~li~~cl~~~p~~Rp~ 254 (266)
T cd05033 231 --------------------------MDCPSALYQLMLDCWQKDRNERPT 254 (266)
T ss_pred --------------------------CCCCHHHHHHHHHHcCCCcccCcC
Confidence 123566889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=293.81 Aligned_cols=239 Identities=24% Similarity=0.417 Sum_probs=192.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++++||.|+||.||+|... ++..||+|.+.... .....+.+|+.+++.+. ||||+++++++. ...+|+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~~ 77 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT---QEPIYI 77 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc---cCCcEE
Confidence 46889999999999999999865 46779999886332 23456889999999995 999999999874 456899
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
||||+. ++|.+++.. ..++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999997 588888763 357888999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......++..|+|||++ ....++.++|||||||++|+|++ |++||.+.+.......+.....+..+
T Consensus 158 ~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 225 (260)
T cd05067 158 TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP----------- 225 (260)
T ss_pred ccccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC-----------
Confidence 112233456789999997 45568999999999999999998 99999988776665555433221100
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
...+..+.+++.+||..||.+|+..
T Consensus 226 ----------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 226 ----------------------DNCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred ----------------------CCCCHHHHHHHHHHccCChhhCCCH
Confidence 1235678999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.54 Aligned_cols=242 Identities=27% Similarity=0.426 Sum_probs=199.2
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
||.|+||.||.|.+..++..||+|++...... ......+..|+.+++.+. ||||+++++++. .+..+|+||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 69999999999999989999999998644322 234557888999999996 999999999886 5778999999995
Q ss_pred hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccc
Q psy14431 646 NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724 (1219)
Q Consensus 646 GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~ 724 (1219)
++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 7899988754 689999999999999999999999999999999999999999999999999987655433334567888
Q ss_pred cccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhh
Q psy14431 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVV 804 (1219)
Q Consensus 725 ~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp 804 (1219)
.|+|||.+. +..++.++|+|||||++|+|++|..||...+.......+.....+.+.
T Consensus 158 ~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 214 (250)
T cd05123 158 EYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE---------------------- 214 (250)
T ss_pred cccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----------------------
Confidence 999999974 445788999999999999999999999877665444444431111111
Q ss_pred hhchhhHHHHhcccChhHHHHHHhccccCCCCCH-----HHHHcchhh
Q psy14431 805 VKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-----IEQLQGKLA 847 (1219)
Q Consensus 805 ~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-----iEALqHpwf 847 (1219)
..+....+++.+||..||..|+ .+.+.||||
T Consensus 215 ------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 215 ------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1256788999999999999874 678999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.55 Aligned_cols=241 Identities=22% Similarity=0.409 Sum_probs=188.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.+++.||.|+||.||+|.+.+ .+..||+|.+.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFT-CHHVVRLLGVVS--K 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc--C
Confidence 4578999999999999999997653 35689999875332 2233446778999999995 999999999986 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCccee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKL 701 (1219)
...+|+||||++ |+|.+++... .++...+..++.+|+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 567899999998 6899888631 2355678889999999999999999999999999999999999999
Q ss_pred cccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 702 GDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|||+++........ .....++..|+|||.+. +..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865432211 11224567899999974 4568999999999999999998 7899988777665555543321
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
+..+ ...++.+.+++.+||..||.+|
T Consensus 240 ~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 240 LDQP---------------------------------DNCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred CCCC---------------------------------CCCCHHHHHHHHHHcCCChhHC
Confidence 1110 1225679999999999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.83 Aligned_cols=240 Identities=22% Similarity=0.361 Sum_probs=191.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+.++||.|+||.||+|.+..++ .||+|++.... .....+.+|+.++..+. ||||+++++++. ...+|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~l 77 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT---MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIYI 77 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCc---cCHHHHHHHHHHHHhCC-CCCcceEEEEEC---CCCcEE
Confidence 46999999999999999999887664 59999886422 22356788999999995 999999998874 356899
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||++ ++|.+++.. ..+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999998 589998874 3478889999999999999999999999999999999999999999999999986654322
Q ss_pred c-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....++..|+|||++ .+..++.++|||||||++|+|++ |.+||.+......+..+.....++ .
T Consensus 158 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~----------- 224 (262)
T cd05071 158 TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-C----------- 224 (262)
T ss_pred ccccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-C-----------
Confidence 1 1233456789999987 45568999999999999999999 889998877666555543322110 0
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
.+..+..+.+++.+|+..||.+|+..+
T Consensus 225 ---------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 225 ---------------------PPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred ---------------------ccccCHHHHHHHHHHccCCcccCCCHH
Confidence 012356788999999999999985443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.22 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=195.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC----------------eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK----------------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG----------------k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNI 622 (1219)
.++|.+++.||.|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++..+. ||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLS-DPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcC-CCCE
Confidence 457899999999999999999876544 568999886432 2234567889999999995 9999
Q ss_pred cEEeeeeeccCCceEEEEEecch-hhHHHHHhhc------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCC
Q psy14431 623 ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689 (1219)
Q Consensus 623 VkL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPs 689 (1219)
++++++|. .++.+++||||+. ++|..++... .+++..+..++.+++.||.|||+.||+|+||||+
T Consensus 82 ~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred eEEEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999987 4578999999998 5888888643 4888999999999999999999999999999999
Q ss_pred CeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh--CCCCCCCCC
Q psy14431 690 NILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGAS 765 (1219)
Q Consensus 690 NILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT--GkpPF~g~s 765 (1219)
||+++.++.++|+|||++........ ......+++.|+|||++. ...++.++|||||||++|+|++ |.+||...+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999976543321 122345677899999974 4568999999999999999998 678888777
Q ss_pred cHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 766 TSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 766 ~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
....+..+............ . ...+..+..+.+++.+||..||.+|+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~--~------------------------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIY--L------------------------PRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred hHHHHHHHHhcccccccccc--C------------------------CCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 66666555443211100000 0 00123457899999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.37 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=205.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-..|..-++||.||||.||-|.-+.||+.||+|.+.+.... ...-...++|-.||..+. .|+||.+-..|. ..+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfe--Tkd~L 260 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFE--TKDAL 260 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeec--CCCce
Confidence 34566778899999999999999999999999988544322 222345678999999995 899999988887 56689
Q ss_pred EEEEecchh-hHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 638 YVVFEYMEN-DLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
|+||..|.| +|.-.|. +..|++..+++|+.+|+.||.+||+.+||+||+||.|||+|+.|+|+|+|+|+|..++.+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999985 7766555 236999999999999999999999999999999999999999999999999999998876
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
... ...+||.+|||||++. +..|++..|+|||||++|+|+.|+.||.......--..|-......+.
T Consensus 341 ~~~-~~rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~----------- 407 (591)
T KOG0986|consen 341 KPI-RGRVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE----------- 407 (591)
T ss_pred Ccc-ccccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-----------
Confidence 543 4559999999999985 455999999999999999999999999764433222222221111111
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.-..+++++.++++.+|..||.+| +.++-+||||.-
T Consensus 408 -------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 408 -------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred -------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 1113458999999999999999984 888999999843
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.12 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=192.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++++||.|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.+. ||||+++++++. ...+|+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLR-HDKLVQLYAVVS---EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcC-CCceEEEEeEEC---CCCcEE
Confidence 46888999999999999999876 456699998864322 2356889999999995 999999999874 346899
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||++ ++|.+++.. ..+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999998 589988864 3488899999999999999999999999999999999999999999999999987654321
Q ss_pred c-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....++..|+|||++. +..++.++|||||||++|+|++ |.+||.+.+..+....+.....++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 225 (260)
T cd05070 158 TARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP----------- 225 (260)
T ss_pred ccccCCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 1 12234566899999974 5568999999999999999999 89999887776666665443221110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
...+..+.+++.+||..||.+|+..+
T Consensus 226 ----------------------~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 226 ----------------------QDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred ----------------------CcCCHHHHHHHHHHcccCcccCcCHH
Confidence 12356789999999999999986555
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.89 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=190.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.++..+.+||||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 569999999999999999998643 23569999886432 23445678889999999977999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
.++.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4567999999998 5899988742 377888999999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||++......... .....+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999766432211 11223456899999974 4568999999999999999998 889998766554444
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+.....+.. ....+..+.+++.+||..+|..|+
T Consensus 254 ~~~~~~~~~~---------------------------------~~~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 254 LLKEGHRMDK---------------------------------PSNCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred HHHcCCCCCC---------------------------------CCcCCHHHHHHHHHHcccChhhCc
Confidence 4332221110 012367788999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.52 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=202.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
|..++.||.|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.+. |||++++++++. ....+|+|
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv 93 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--REHTAWLV 93 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEE--cCCeeEEE
Confidence 666788999999999999999999999999885332 22333456778999999995 999999999987 45678999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||+.|++..++. ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~ 169 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 169 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----c
Confidence 9999998887765 345888999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 719 EYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
...+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+.....|...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 235 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------------- 235 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC--------------
Confidence 3468889999999742 345788999999999999999999999776655444444333222111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
....+..+.+++.+||.++|.+| +.+.+.|+|+...
T Consensus 236 ------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 236 ------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ------------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 01235668899999999999985 7788999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.29 Aligned_cols=283 Identities=20% Similarity=0.264 Sum_probs=197.6
Q ss_pred eeecc--CceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeG--gFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.| +||+||+|.+..+|+.||+|++............+.+|+.++..+. ||||++++++|. .++.+|+||||+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~--~~~~~~~v~e~~ 81 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFT--TGSWLWVISPFM 81 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEe--cCCceEEEEecc
Confidence 45555 9999999999999999999998644333444567778888888885 999999999997 466799999999
Q ss_pred h-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc---
Q psy14431 645 E-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--- 717 (1219)
Q Consensus 645 e-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~--- 717 (1219)
. +++.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++|||.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 8 488887764 348889999999999999999999999999999999999999999999998654332211100
Q ss_pred ----ccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh---h
Q psy14431 718 ----TEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY---A 789 (1219)
Q Consensus 718 ----ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~---~ 789 (1219)
....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..+.......|....... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 112345679999998543 35789999999999999999999999887665544444433221111110000 0
Q ss_pred ccCChh--HHh-hhHHhhhh-c--hh---hH-HHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 790 GFKSKH--ERE-KFNQVVVK-C--QK---EL-QELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 790 ~~~s~~--~re-lI~klp~k-c--rk---~L-~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
.+.... ... ........ . .. .+ .......++.+.+|+.+||.+||.+ ++.++|+||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 000 00000000 0 00 00 0001234678999999999999998 4888899999966333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.91 Aligned_cols=236 Identities=22% Similarity=0.388 Sum_probs=189.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.+.||.|+||.||+|... |..||+|.+.. ......+.+|+.+++.+. |||++++++++.. .+..+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC----CchHHHHHHHHHHHHhCC-CCCeeeEEEEEEc-CCCceE
Confidence 457899999999999999999654 77899998752 233456889999999995 9999999997653 456789
Q ss_pred EEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++... .+++..+..++.+|+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999998 5899988743 37888999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....++..|+|||++ ....++.++|||||||++|+|++ |++||...+.......+.....+..
T Consensus 157 ---~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------------ 220 (256)
T ss_pred ---CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 233456789999997 45568999999999999999997 9999987665554444433221110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..++.+.+++.+|+..||.+|+.
T Consensus 221 ---------------------~~~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 221 ---------------------PDGCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred ---------------------CCCCCHHHHHHHHHHhcCChhhCcC
Confidence 1234677899999999999998743
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=328.27 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=202.7
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..-+-.-|..++.||-|+||.|+++...+|...||+|.+.+.. ...........|-.||.... .++||+||..|. +
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQ--D 700 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQ--D 700 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEec--c
Confidence 3444567899999999999999999999999999999886543 22333455667888888885 899999998886 6
Q ss_pred CceEEEEEecchh-hHHHHH-hhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~L-rs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+.+|+||+|++| ++..++ +-+.|.+..+++|+..+.+|+++.|..|+|||||||+|||||.+|++||+|||+|..+.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 7889999999995 766655 56889999999999999999999999999999999999999999999999999996331
Q ss_pred ---------Cccc---------------------------------ccccccccccccCchhhhccccccccccchhHHH
Q psy14431 712 ---------DSKE---------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGC 749 (1219)
Q Consensus 712 ---------~~~~---------------------------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ 749 (1219)
.+.. .....+||+.|+|||++. ..+|+..+|+||.||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGV 859 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhH
Confidence 1000 012468999999999985 456999999999999
Q ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhc
Q psy14431 750 ILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQ 829 (1219)
Q Consensus 750 ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKM 829 (1219)
|||+|+.|++||....+.....+|+++. .+. .++ .-..+++++.|+|.++
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~--------~~l-------------~~~---------~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWR--------NFL-------------HIP---------YQGNLSKEALDLIQKL 909 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehh--------hcc-------------ccc---------cccccCHHHHHHHHHH
Confidence 9999999999998877665444443322 110 011 0134688888888765
Q ss_pred cccCCCCC-----HHHHHcchhhhc
Q psy14431 830 MELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 830 Lq~DPeKR-----aiEALqHpwfaL 849 (1219)
- .++..| +.++-.||||..
T Consensus 910 c-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 910 C-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred h-cChhhhhcccchhhhhcCccccc
Confidence 4 455553 556788999854
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.44 Aligned_cols=237 Identities=20% Similarity=0.329 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEEcCCC---eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 566 LKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TG---k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
++||.|+||.||+|.+..++ ..||+|.+...... .....+.+|+.++..+. ||||+++++++. +..+++||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLD-HPCIVRLIGVCK---GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc---CCceEEEEE
Confidence 46899999999999876554 78999988644332 34567889999999995 999999999875 456899999
Q ss_pred cch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc-
Q psy14431 643 YME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE- 719 (1219)
Q Consensus 643 yme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts- 719 (1219)
|+. ++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 997 5899988754 4899999999999999999999999999999999999999999999999999876543322111
Q ss_pred --ccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 720 --YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 720 --~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
..++..|+|||.+ .+..++.++|||||||++|+|++ |.+||...+.......+.....+..+
T Consensus 156 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 220 (257)
T cd05060 156 TAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP-------------- 220 (257)
T ss_pred cCccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC--------------
Confidence 1224579999997 45568999999999999999998 99999877766555554433211100
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
+..++.+.+++.+||..||.+|+...
T Consensus 221 -------------------~~~~~~l~~li~~cl~~~p~~Rp~~~ 246 (257)
T cd05060 221 -------------------EECPQEIYSIMLSCWKYRPEDRPTFS 246 (257)
T ss_pred -------------------CCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 12356788999999999999975443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=292.05 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=191.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+.+.||.|+||.||+|.+.. +..||+|.+.... .....+.+|+.++..+. ||||+++++++. ..+.+|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l 78 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---MDPKDFLAEAQIMKKLR-HPKLIQLYAVCT--LEEPIYI 78 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---ccHHHHHHHHHHHHHCC-CCCccceeEEEe--cCCCeee
Confidence 468899999999999999998754 5679999885432 23456788999999996 999999999886 4667899
Q ss_pred EEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||++ ++|.+++... .+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999995 7899998743 588999999999999999999999999999999999999999999999999987653221
Q ss_pred c-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. ......+..|+|||++ .+..++.++|||||||++|+|++ |++||.+.+....+..+.....++.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 226 (261)
T cd05068 159 EAREGAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP----------- 226 (261)
T ss_pred cccCCCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 1 1112234579999997 45568999999999999999999 99999887776666555443221110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+..+.+++.+||..||.+|+.
T Consensus 227 ----------------------~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 227 ----------------------PGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred ----------------------CcCCHHHHHHHHHHhhcCcccCCC
Confidence 123567899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=329.62 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=202.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|.++++||.||.+.||++...+.+ .||+|++.....+......+..|+..|..+.+|.+||.+|+|-. .++.+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--~d~~lYm 437 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--TDGYLYM 437 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--cCceEEE
Confidence 35899999999999999999876554 46666554455566778889999999999999999999999865 5789999
Q ss_pred EEecchhhHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc-
Q psy14431 640 VFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC- 716 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs~~--LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~- 716 (1219)
||||-+.+|..+++.+. ++...+++|+.|++.|+.++|..||||.||||.|+|+ -.|.+||+|||+|..+......
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence 99999999999998543 4545899999999999999999999999999999998 5689999999999987664332
Q ss_pred -cccccccccccCchhhhccc----------cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 717 -LTEYIATRWYRAPEILISNR----------RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 717 -~ts~vGT~~Y~APEvLl~~~----------~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
...-+||+.||+||.+.... ..+.++||||||||||+|+.|++||...- ..+.++..+..|..+.-
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Ie- 593 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIE- 593 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcccc-
Confidence 23568999999999984221 25689999999999999999999995422 23344444443322100
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhccc--ChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQV--VEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~l--speaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
||.. ..++++++..||.+||.+| ..+.|+|||..+
T Consensus 594 -----------------------------fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 -----------------------------FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred -----------------------------ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1111 1138999999999999995 778899999866
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.58 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=192.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+|.+.+.||.|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~ 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFN-HQNIVRLIGVSF--ER 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cC
Confidence 468899999999999999999987 78899999875322 2233456888999999995 999999999886 35
Q ss_pred ceEEEEEecch-hhHHHHHhhc--------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cceec
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIG 702 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~--------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKLi 702 (1219)
...|+||||+. ++|.+++... .+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 56899999997 5899888642 478889999999999999999999999999999999998765 58999
Q ss_pred ccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 703 DLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 703 DFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P 779 (1219)
|||++......... ......+..|+|||++. +..++.++|||||||++|+|++ |..||.+.+.......+.....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999876432211 11223356799999984 4568999999999999999997 99999887766655444332211
Q ss_pred CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc
Q psy14431 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ 843 (1219)
Q Consensus 780 ~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq 843 (1219)
..+ +..++.+.+++.+||..||..| +.++++
T Consensus 241 ~~~---------------------------------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 241 DPP---------------------------------KGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred CCC---------------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 110 2236678999999999999997 444444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.72 Aligned_cols=273 Identities=21% Similarity=0.266 Sum_probs=194.6
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-hhHH
Q psy14431 571 GAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLN 649 (1219)
Q Consensus 571 GgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-GSL~ 649 (1219)
|++|.||.+.+..+|..||||++............+.+|+.++..+. ||||++++++|. ....+|++|||++ ++|.
T Consensus 11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFI--VDSELYVVSPLMAYGSCE 87 (314)
T ss_pred cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhheee--cCCeEEEEEeccCCCCHH
Confidence 35566777777789999999998754344556678899999999996 999999999987 4677999999998 5788
Q ss_pred HHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-------cccc
Q psy14431 650 KVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLTE 719 (1219)
Q Consensus 650 d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-------~~ts 719 (1219)
+++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||.+..+..... ....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 88764 3588899999999999999999999999999999999999999999999998875533211 1223
Q ss_pred ccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC---chhhhhccCChh
Q psy14431 720 YIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---ADKFYAGFKSKH 795 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~---~d~l~~~~~s~~ 795 (1219)
..++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+....+........+..-. ++..........
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 4567889999998543 358899999999999999999999998766544332222222111100 000000000000
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.... .+.............+++.+.+|+.+||.+||.+| +.++|.||||..
T Consensus 248 -~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 248 -SSNE--HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred -cccc--ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0000 00000000001112245678999999999999985 888899999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.55 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=206.8
Q ss_pred ccccccCeeEE-eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc-
Q psy14431 555 DREDLQQQINL-LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV- 632 (1219)
Q Consensus 555 dr~dIqqY~IL-KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~- 632 (1219)
.....++|.+- .+||-|-.|.|..|.++.||..+|+|++. +.....+|+...-...+|||||.++++|...
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 33445556553 46899999999999999999999999984 3345678999988888999999999999742
Q ss_pred -CCceEEEEEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceeccc
Q psy14431 633 -NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDL 704 (1219)
Q Consensus 633 -d~~~LyLVMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDF 704 (1219)
+...+.+|||+|+| .|...+.. ..|++..+-.|+.||+.|+.|||+.+|.||||||+|+|+.. +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 34567899999995 78887773 35999999999999999999999999999999999999974 456999999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhhcCCC
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPN 780 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~----~e~L~kIve~l~P~ 780 (1219)
|+|+...... ...+.+.||+|.|||++ +...|+..+|+||+|||+|-|+||.|||..... ...-.+|..+...+
T Consensus 209 GFAK~t~~~~-~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 209 GFAKETQEPG-DLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccCCCc-cccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9998766433 35567899999999997 777899999999999999999999999976543 22334555544222
Q ss_pred C-CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 781 P-PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 781 P-~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
| +.| ..+|..+.|+|+++|+.+|.+ +..+.+.|||.+-
T Consensus 287 P~pEW-------------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 287 PEPEW-------------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CChhH-------------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 2 222 234788999999999999998 5778899999855
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=293.12 Aligned_cols=240 Identities=21% Similarity=0.377 Sum_probs=192.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||.|.+.. +..||+|.+.... .....+.+|+.++..+. ||||+++++++. ....+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 75 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLS-HEKLVQLYGVCT--KQRPIY 75 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCC-CCCeeeEEEEEc--cCCCcE
Confidence 4568999999999999999997754 4459999875332 22356789999999996 999999999986 455789
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+. ++|.+++.. ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999997 578888864 3589999999999999999999999999999999999999999999999999886644321
Q ss_pred c-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 ~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....++..|+|||++. +..++.++|||||||++|+|++ |..||...+.......+.....+..+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 224 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH---------- 224 (256)
T ss_pred eecCCCccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC----------
Confidence 1 11233567799999974 4568999999999999999998 999998877766666665544322110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
..+..+.+++.+||..||.+|+.
T Consensus 225 -----------------------~~~~~~~~li~~cl~~~p~~Rp~ 247 (256)
T cd05113 225 -----------------------LASEKVYAIMYSCWHEKAEERPT 247 (256)
T ss_pred -----------------------CCCHHHHHHHHHHcCCCcccCCC
Confidence 12567899999999999998744
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=327.87 Aligned_cols=239 Identities=26% Similarity=0.420 Sum_probs=199.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
+..++.||+|-||.||.|....+ ..||+|.+... ......+.+|+.+|..+. |+|||++++++. .++.+||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~--~~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG---SMSPEAFLREAQIMKKLR-HEKLVKLYGVCT--KQEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCC-CcccceEEecc---ccChhHHHHHHHHHHhCc-ccCeEEEEEEEe--cCCceEEEE
Confidence 34567899999999999987653 35999998643 234456789999999996 999999999997 345799999
Q ss_pred ecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc-
Q psy14431 642 EYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC- 716 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~- 716 (1219)
|||. |+|.++++. ..+.......++.|||.|++||+++++|||||-..||||+.++.+||+|||+|+.+.+....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999 899999995 46889999999999999999999999999999999999999999999999999965543321
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
....--+.-|.|||.+ ....++.++|||||||+||||+| |+.||++.+..+.+..|.++.+.+.|.
T Consensus 361 ~~~~kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~------------ 427 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE------------ 427 (468)
T ss_pred cCCCCCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC------------
Confidence 1122235569999998 45679999999999999999999 999999999999999999988544331
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
.+++.+-+++..|...+|++|+.-.
T Consensus 428 ---------------------~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 428 ---------------------GCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred ---------------------CCCHHHHHHHHHHhhCCcccCCCHH
Confidence 2366778889999999999875444
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=340.75 Aligned_cols=241 Identities=23% Similarity=0.379 Sum_probs=195.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeee-eecc--CC--c
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI-YKAV--NN--K 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gv-fe~~--d~--~ 635 (1219)
+++|.+.|.+|||+.||+|.+...|..||+|++... +......+.+||.+|+.|.+|||||.++|. .... ++ -
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 568889999999999999999998899999998643 566677889999999999999999999993 3211 12 3
Q ss_pred eEEEEEecch-hhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCcceecccccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.++|.||||. |+|-+++. ...|++.+|..|+++++.|+.+||..+ |||||||-+||||+.+|+.||||||.|..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 4789999999 69999988 345999999999999999999999887 99999999999999999999999999975
Q ss_pred cCCccccc---------ccccccccccCchhh--hccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC
Q psy14431 710 LSDSKECL---------TEYIATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 710 l~~~~~~~---------ts~vGT~~Y~APEvL--l~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~ 778 (1219)
........ .....|+.|+|||++ ..+.+.+.++|||+|||+||-|+....||.+.... .|+++..
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y 271 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNY 271 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccc
Confidence 43222110 123469999999997 34567899999999999999999999999776432 3444443
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
-.|+. |..+..+.+||+.||+.||.+|+.
T Consensus 272 ~~P~~--------------------------------p~ys~~l~~LI~~mL~~nP~~RPn 300 (738)
T KOG1989|consen 272 SFPPF--------------------------------PNYSDRLKDLIRTMLQPNPDERPN 300 (738)
T ss_pred cCCCC--------------------------------ccHHHHHHHHHHHHhccCcccCCC
Confidence 33331 223667899999999999999843
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=295.78 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=190.2
Q ss_pred eeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 562 QINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
|.+++.||.|+||+||++. ...++..||+|++.... .......+.+|+.+++.+. ||||+++++++.......+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCceE
Confidence 3888999999999998865 34568899999885432 2234456789999999995 9999999998875556678
Q ss_pred EEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 638 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|+||||+. ++|.+++....+++..+..++.+++.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999998 58999988878999999999999999999999999999999999999999999999999999876543211
Q ss_pred ---cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 717 ---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 717 ---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||...... +..+.. +....+..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~---~~~~~~~~------- 230 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIG---PKQGQMTV------- 230 (283)
T ss_pred hccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhc---ccccccch-------
Confidence 11234566799999974 456899999999999999999999998654321 111111 11100000
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
......+.... ..+ .-...+..+.+++..||..||..|+.
T Consensus 231 ~~~~~~~~~~~---~~~---~~~~~~~~~~~li~~cl~~~p~~Rps 270 (283)
T cd05080 231 VRLIELLERGM---RLP---CPKNCPQEVYILMKNCWETEAKFRPT 270 (283)
T ss_pred hhhhhhhhcCC---CCC---CCCCCCHHHHHHHHHHhccChhhCCC
Confidence 00000000000 000 11235678999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=301.15 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=191.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk-------~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.+|.+.++||.|+||.||+|.+. ..+..||+|.+.... .......+..|+.++..+.+||||+++++++.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 46889999999999999999763 235679999886432 23345567889999999977999999999986
Q ss_pred CCceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
..+.+|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 4567999999998 589888863 2377888999999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||+++........ .....++..|+|||++. +..++.++|||||||++|+|++ |..||.+.+....+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999866532211 11223446799999974 4568999999999999999999 899998877666555
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+.....+.. ....+..+.+++.+||..||.+|+
T Consensus 248 ~~~~~~~~~~---------------------------------~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 248 LLREGHRMDK---------------------------------PSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred HHHcCCCCCC---------------------------------CCCCCHHHHHHHHHHcCCCcccCc
Confidence 5543221110 012356788999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=292.75 Aligned_cols=234 Identities=23% Similarity=0.342 Sum_probs=186.1
Q ss_pred eeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+. ||||+++++++. ...+++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~---~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE---AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc---CCCeEEEEEeC
Confidence 3799999999999765 456679999886432 2333456889999999995 999999999875 44689999999
Q ss_pred h-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc---c
Q psy14431 645 E-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL---T 718 (1219)
Q Consensus 645 e-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~---t 718 (1219)
+ ++|.+++. ...+++..+..++.+|+.||.|||+.|++||||||+|||++.++.++|+|||++..+....... .
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 8 58988886 3468999999999999999999999999999999999999999999999999998654332211 1
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+++.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+.......+..+..+..+
T Consensus 157 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05115 157 AGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP--------------- 220 (257)
T ss_pred CCCCCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------------
Confidence 122356899999974 4568999999999999999996 99999887776665555444322111
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++++.+++.+|+.+||.+|+.
T Consensus 221 ------------------~~~~~~l~~li~~c~~~~~~~Rp~ 244 (257)
T cd05115 221 ------------------AECPPEMYALMKDCWIYKWEDRPN 244 (257)
T ss_pred ------------------CCCCHHHHHHHHHHcCCChhhCcC
Confidence 123678889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=288.80 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=194.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+.+.||.|+||.||+|.+. ++..||||.+.... .....+.+|+.+++.+. ||||+++++++. ....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLR-HDKLVQLYAVCS--EEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCC-CCCEeeeeeeee--cCCceE
Confidence 457999999999999999999875 45779999886332 33456889999999996 999999999886 456789
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++.. ..++...+..++.+|+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999998 589998874 358899999999999999999999999999999999999999999999999998765321
Q ss_pred cc-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 EC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....++..|+|||.+. +..++.++|||||||++|+|++ |++||.+.+....+..+.....++.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 226 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP---------- 226 (261)
T ss_pred hhhhhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 11 11223456799999974 5568999999999999999998 99999888777766666544321111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
...+..+.+++.+||..||.+|+..
T Consensus 227 -----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~ 251 (261)
T cd05034 227 -----------------------PNCPEELYDLMLQCWDKDPEERPTF 251 (261)
T ss_pred -----------------------CCCCHHHHHHHHHHcccCcccCCCH
Confidence 1124568899999999999988544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=343.21 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=194.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+++|.++++||.|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+. ||||+++++++. +++.+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~--d~~~l 77 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICS--DGDPV 77 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEe--eCCEE
Confidence 46899999999999999999999999999999998644322 233457889999999996 999999999987 46789
Q ss_pred EEEEecchh-hHHHHHhh------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 638 YVVFEYMEN-DLNKVIRD------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
|+||||++| +|.+++.. ..++...+..++.||+.||.|||+.||+||||||+|||++.+|.++|+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 999999984 88887752 12445677889999999999999999999999999999999999999999
Q ss_pred ccccccCCcc------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc
Q psy14431 705 GLARSLSDSK------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766 (1219)
Q Consensus 705 GLAr~l~~~~------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~ 766 (1219)
|++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9998652110 0112357999999999974 55689999999999999999999999977544
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
...... .....|.... ....+++.+.+++.+||..||.+| ..+++.+
T Consensus 237 ~ki~~~---~~i~~P~~~~----------------------------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 237 RKISYR---DVILSPIEVA----------------------------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhh---hhccChhhcc----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332211 0111111000 012456778899999999999987 4444444
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=296.13 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=188.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeE----EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~----VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|.. |++|.+... ........+..|+.++..+. ||||+++++++. +
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~---~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP---G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC---C
Confidence 45788999999999999999998877764 666665321 11223355677888888885 999999999874 4
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
..+++|++|++ |+|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 45788999998 689999863 468999999999999999999999999999999999999999999999999998664
Q ss_pred Cccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.... ......++..|+|||++. +..++.++|||||||++|+|++ |.+||.+.........+.....+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 234 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ----- 234 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC-----
Confidence 3221 122345677899999974 4568999999999999999998 999998876655444443332222110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
..+....+++.+|+..||..|+..
T Consensus 235 ----------------------------~~~~~~~~li~~c~~~~p~~Rps~ 258 (279)
T cd05111 235 ----------------------------ICTIDVYMVMVKCWMIDENVRPTF 258 (279)
T ss_pred ----------------------------CCCHHHHHHHHHHcCCCcccCcCH
Confidence 124457788999999999987433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.76 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=193.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC---eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG---k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+|.+.+.||.|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++..+. ||||+++++++. .++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCC
Confidence 457889999999999999999886444 479999885432 2334567889999999995 999999999986 466
Q ss_pred eEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||++ ++|.+++.. ..++...+..++.+++.||.|||+.|++||||||+|||++.++.++|+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 8999999998 589988874 3588899999999999999999999999999999999999999999999999987654
Q ss_pred ccccc---ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKECL---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~~---ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
..... ....++..|+|||.+. +..++.++|+|||||++|++++ |..||.+.+.......+.....++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 231 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP------ 231 (267)
T ss_pred ccceeeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC------
Confidence 32211 1122356799999974 4568999999999999999886 99999887766666655543321110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...++.+.+++.+|+..+|..|+.
T Consensus 232 ---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 255 (267)
T cd05066 232 ---------------------------MDCPAALHQLMLDCWQKDRNERPK 255 (267)
T ss_pred ---------------------------CCCCHHHHHHHHHHcccCchhCCC
Confidence 123567889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=296.43 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=198.0
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.+.+.||.|+||.||+|.+. .++..||||++..... .......+.+|+.++..+.+||||++++++|. .+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 4788999999999999999864 4678999999864321 12334567889999999988999999999886 466
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ ++|..++.. ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 8999999998 488888764 56889999999999999999999999999999999999999999999999998865543
Q ss_pred ccc-cccccccccccCchhhhccc-cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHH----HhhcCCCCCCchhh
Q psy14431 714 KEC-LTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKF 787 (1219)
Q Consensus 714 ~~~-~ts~vGT~~Y~APEvLl~~~-~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kI----ve~l~P~P~~~d~l 787 (1219)
... .....|+..|+|||.+.+.. .++.++|||||||++|+|++|.+||...+.......+ .....+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF------- 231 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC-------
Confidence 221 22346889999999974332 3688999999999999999999999643322111111 1111111
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-----HHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-----IEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-----iEALqHpwfaL 849 (1219)
.+.+++.+.+++.+||..||..|+ .+.|.||||..
T Consensus 232 ---------------------------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 232 ---------------------------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred ---------------------------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 122467789999999999999974 56799999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.96 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=188.0
Q ss_pred CeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.+++.||.|+||.||+|.+. .+++.||+|++.... .......+.+|+.++..+.+||||+++++++.. .+.
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK-PGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CCC
Confidence 6889999999999999999753 345789999885332 223345678899999999779999999998763 456
Q ss_pred eEEEEEecch-hhHHHHHhh------------------------------------------------------------
Q psy14431 636 DLYVVFEYME-NDLNKVIRD------------------------------------------------------------ 654 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs------------------------------------------------------------ 654 (1219)
.+++||+|++ ++|.+++..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7899999998 478777642
Q ss_pred --ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc--cccccccccccCch
Q psy14431 655 --KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPE 730 (1219)
Q Consensus 655 --~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APE 730 (1219)
..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++..+...... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 25788889999999999999999999999999999999999999999999999876432211 12344567899999
Q ss_pred hhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh-hcCCCCCCchhhhhccCChhHHhhhHHhhhhch
Q psy14431 731 ILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQ 808 (1219)
Q Consensus 731 vLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve-~l~P~P~~~d~l~~~~~s~~~relI~klp~kcr 808 (1219)
++. +..++.++|||||||++|+|++ |.+||.+......+...+. ...+..
T Consensus 246 ~~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 297 (337)
T cd05054 246 SIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--------------------------- 297 (337)
T ss_pred Hhc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---------------------------
Confidence 974 4569999999999999999998 9999987544332222211 111110
Q ss_pred hhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 809 KELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 809 k~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
-...++.+.+++.+||..+|.+|+
T Consensus 298 ------~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 298 ------PEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred ------CccCCHHHHHHHHHHccCChhhCc
Confidence 012356789999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=294.25 Aligned_cols=241 Identities=28% Similarity=0.450 Sum_probs=191.1
Q ss_pred eEEeeeeccCceEEEEEEEc----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDK----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+.+.||.|+||.||+|... ..+..|+||++.. .........+.+|+..+..+ +||||++++|++. ..+.++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~--~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI--ENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE--SSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccc-ccccccccccccc--cccccc
Confidence 46788999999999999987 4568899999843 23334467899999999999 6999999999998 456699
Q ss_pred EEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ |+|.+++... .+++..+..|+.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998 6899999865 69999999999999999999999999999999999999999999999999998763211
Q ss_pred --cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 --ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 --~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.......+...|+|||.+. ...++.++||||||+++|+|++ |..||...+.......+.....+..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------- 227 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP--------- 227 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---------
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccceec---------
Confidence 1122345677899999974 4558999999999999999999 78999888877777777555533222
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
+..+..+.+++..|+..||.+|+...
T Consensus 228 ------------------------~~~~~~~~~li~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 228 ------------------------DNCPKDIYSLIQQCWSHDPEKRPSFQ 253 (259)
T ss_dssp ------------------------TTSBHHHHHHHHHHT-SSGGGS--HH
T ss_pred ------------------------cchhHHHHHHHHHHcCCChhhCcCHH
Confidence 12356688899999999999986543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.37 Aligned_cols=239 Identities=22% Similarity=0.346 Sum_probs=189.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+.+.||.|+||.||+|.+. ++..+|+|++.... .....+.+|+.++..+. ||||+++++++. ..+.+|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLS-HPNLVQLYGVCT--KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCC-CCCEEEEEEEEc--CCCceEE
Confidence 45888999999999999999876 46679999885332 22345778999999995 999999999886 4567999
Q ss_pred EEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999997 589988863 35889999999999999999999999999999999999999999999999999866533211
Q ss_pred c-ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 L-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~-ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
. ....++..|+|||.+. +..++.++|||||||++|+|++ |.+||.+.++......+.....+..+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP------------ 223 (256)
T ss_pred ccCCCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC------------
Confidence 1 1122345799999974 4568999999999999999998 89999877766555554433221111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++.+.+++.+||..+|.+|+.
T Consensus 224 ---------------------~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 224 ---------------------KLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred ---------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 123667899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=291.30 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=193.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCe---EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk---~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+..|.+.+.||.|+||.||+|.+..+|. .||||++.... .......+..|+.++..+. ||||+++++++. ++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCC-CcCcceEEEEEC--CCC
Confidence 4568899999999999999999887664 69999885432 3344567889999999995 999999999986 566
Q ss_pred eEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+++||||+++ +|..++.. +.++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 78999999985 78888864 4588999999999999999999999999999999999999999999999999876543
Q ss_pred ccccc--cc-c--cccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 713 SKECL--TE-Y--IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 713 ~~~~~--ts-~--vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
..... .. . ..+..|+|||.+ ....++.++|||||||++|+|++ |.+||.+.+.......+.....++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---- 233 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---- 233 (269)
T ss_pred CccccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc----
Confidence 22111 11 1 124579999997 45568999999999999999886 99999887776665555432211110
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
+..++.+.+++.+||..+|.+|+..
T Consensus 234 -----------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (269)
T cd05065 234 -----------------------------MDCPTALHQLMLDCWQKDRNARPKF 258 (269)
T ss_pred -----------------------------ccCCHHHHHHHHHHcCCChhhCcCH
Confidence 1235567889999999999986443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=295.43 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=192.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.+.++||.|+||.||+|... .++..||+|.+... .......+.+|+.++..+. ||||+++++++. +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQ-HQHIVRFYGVCT--E 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEe--c
Confidence 356788999999999999999753 34678999987532 2344567889999999995 999999999886 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS 696 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d 696 (1219)
...+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 567899999998 5888888642 37888999999999999999999999999999999999999
Q ss_pred CcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14431 697 CSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI 773 (1219)
Q Consensus 697 G~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kI 773 (1219)
+.++|+|||++........ ......+++.|+|||++. +..++.++|||||||++|+|++ |.+||........+..+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999975543221 112234567899999974 4568999999999999999998 99999877766655555
Q ss_pred HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 774 VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 774 ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
.....+..+ ...++.+.+++.+||..||.+|+..
T Consensus 238 ~~~~~~~~~---------------------------------~~~~~~~~~li~~cl~~~P~~Rp~~ 271 (280)
T cd05092 238 TQGRELERP---------------------------------RTCPPEVYAIMQGCWQREPQQRMVI 271 (280)
T ss_pred HcCccCCCC---------------------------------CCCCHHHHHHHHHHccCChhhCCCH
Confidence 443322111 1236778899999999999987443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.53 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=197.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc---cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~---~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|.+.+.||.|+||.||+|.+..++..+++|++.... ........+..|+.++..+. ||||+++++++. +...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFL--ERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHh--cCCce
Confidence 4888999999999999999998887777777764322 12233455678899999995 999999999886 45679
Q ss_pred EEEEecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 638 YVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
|+||||+++ +|..++. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++. +.++|+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999984 7777764 245899999999999999999999999999999999999975 579999999998765
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
..........+++.|+|||.+ .+..++.++|+||||+++|+|++|..||.+.+.......+.....|..+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 226 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP--------- 226 (260)
T ss_pred CCcccccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc---------
Confidence 544333445688899999997 4556888999999999999999999999876655544444332211110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+..+.+++.+||..||..| +.++++|||+
T Consensus 227 ------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 227 ------------------------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------------------------chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1225678899999999999985 8888999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.17 Aligned_cols=237 Identities=24% Similarity=0.379 Sum_probs=192.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.+.||.|+||.||+|.+. |..||+|.+..... ....+.+|+.++..+. ||||+++++++. +...+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLR-HPNLVQLLGVVL--QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcC-CcceeeeEEEEc--CCCCeE
Confidence 456888999999999999999764 78899999864322 4567889999999996 999999999987 367799
Q ss_pred EEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999998 5899998743 58999999999999999999999999999999999999999999999999998764332
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....++..|+|||.+. ...++.++|||||||++|+|++ |.+||...+.......+.....+..
T Consensus 157 ---~~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd05039 157 ---DSGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA------------ 220 (256)
T ss_pred ---ccCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 2334566799999974 4568899999999999999997 9999987765554443332211100
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
....++.+.+++.+||..+|.+|+..
T Consensus 221 ---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 221 ---------------------PEGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred ---------------------ccCCCHHHHHHHHHHhccChhhCcCH
Confidence 01236778999999999999987443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.27 Aligned_cols=239 Identities=28% Similarity=0.441 Sum_probs=194.3
Q ss_pred eEEeeeeccCceEEEEEEEcCCC----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TG----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+.+.||.|+||.||+|.+..++ ..||+|++.... .......+..|+.++..+ +||||+++++++. ..+.+|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~--~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKL-DHPNIVKLLGVCT--EEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhc-CCCchheEEEEEc--CCCeeE
Confidence 46788999999999999998766 899999985332 222456788999999999 6999999999987 456899
Q ss_pred EEEecch-hhHHHHHhhcc---CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~---LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||+|++ ++|.+++.... +++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999998 58988887432 8999999999999999999999999999999999999999999999999998765432
Q ss_pred cccc-cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 ECLT-EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~~t-s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.... ...+++.|+|||.+ ....++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 226 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---------- 226 (258)
T ss_pred ccccccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC----------
Confidence 1111 12367889999997 56678999999999999999998 88999887776666665544322111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+..+.+++.+||..||.+|+.
T Consensus 227 -----------------------~~~~~~~~~~i~~~l~~~p~~Rpt 250 (258)
T smart00219 227 -----------------------ENCPPEIYKLMLQCWAEDPEDRPT 250 (258)
T ss_pred -----------------------CcCCHHHHHHHHHHCcCChhhCcC
Confidence 113667899999999999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=297.99 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=191.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-------~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
..+|.+.+.||.|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++..+.+||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 456889999999999999999752 235679999885332 23345678899999999967999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
....+|+||||++ ++|.+++... .++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 92 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred -cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4567899999998 5898888642 36777889999999999999999999999999999999
Q ss_pred ccCCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14431 694 DKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL 770 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L 770 (1219)
+.++.++|+|||++......... .....+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999876543221 12234567899999974 4568999999999999999998 88999887766655
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+.....+..+ ...+..+.+++.+||..+|.+|+
T Consensus 250 ~~~~~~~~~~~~---------------------------------~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 250 KLLKEGHRMDKP---------------------------------ANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred HHHHcCCcCCCC---------------------------------CCCCHHHHHHHHHHcccChhhCC
Confidence 554332211100 12366788999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=295.94 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=191.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.+...||.|+||.||+|.+. .++..|++|.+... .......+.+|+.++..+. ||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQ-HEHIVKFYGVCG--D 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEc--c
Confidence 356889999999999999999854 34567999987432 2233456789999999995 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
+..+++||||++ ++|.+++... .+++..+..++.+|+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 667999999997 6899988632 2788899999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||++........ ......++..|+|||++. +..++.++|||||||++|+|++ |.+||...+....+..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999976543221 122345678899999974 4568999999999999999998 9999988776665555
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.....+..+ ...+..+.+++.+||..||.+|+
T Consensus 238 ~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~~P~~Rp 270 (291)
T cd05094 238 ITQGRVLERP---------------------------------RVCPKEVYDIMLGCWQREPQQRL 270 (291)
T ss_pred HhCCCCCCCC---------------------------------ccCCHHHHHHHHHHcccChhhCc
Confidence 4333222111 11356788999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=292.87 Aligned_cols=235 Identities=25% Similarity=0.342 Sum_probs=183.2
Q ss_pred eeeccCceEEEEEEEcCCCe--EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk--~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|.+..+|. .+++|.+... ........+.+|+.++..+.+||||++++++|. ..+.+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeC
Confidence 58999999999999988775 4688877522 223344577899999999977999999999987 456789999999
Q ss_pred h-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 645 E-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 645 e-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
+ ++|.+++... .+++..+..++.+++.||.|||+.|++|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 8 6899888632 367889999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
+........ ......+..|+|||++ ....++.++|||||||++|+|++ |.+||.+.+.......+.....+..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 232 (270)
T cd05047 159 SRGQEVYVK-KTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK---- 232 (270)
T ss_pred ccccchhhh-ccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC----
Confidence 864332111 1112335679999997 45668999999999999999997 9999987766555444432211100
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
....+..+.+++.+|+..||.+|+.
T Consensus 233 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rps 257 (270)
T cd05047 233 -----------------------------PLNCDDEVYDLMRQCWREKPYERPS 257 (270)
T ss_pred -----------------------------CCcCCHHHHHHHHHHcccChhhCCC
Confidence 0123567889999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.20 Aligned_cols=240 Identities=24% Similarity=0.386 Sum_probs=190.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+...||.|+||.||+|.+..++ .||+|.+.... .....+.+|+.++..+. ||||+++++++. ....|+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT---MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS---EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC---ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc---CCCcEE
Confidence 45889999999999999999876654 58999875322 23456788999999995 999999998874 346899
Q ss_pred EEecchh-hHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 640 VFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||+.+ +|.+++... .+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999984 899988642 378888999999999999999999999999999999999999999999999976643321
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
......++..|+|||.+ .+..++.++|||||||++|+|++ |.+||.+..+......+.....+..+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 225 (260)
T cd05069 158 TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP----------- 225 (260)
T ss_pred cccCCCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 11233456789999987 45568999999999999999999 99999887776655555433211100
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
+..+..+.+++.+||..||.+|+...
T Consensus 226 ----------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 226 ----------------------QGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred ----------------------cccCHHHHHHHHHHccCCcccCcCHH
Confidence 12356789999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=295.35 Aligned_cols=243 Identities=23% Similarity=0.384 Sum_probs=189.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.+.+.||.|+||.||+|.+.. ....|++|.+.... .......+.+|+.++..+. ||||+++++++. .++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVN-HPHVIKLYGACS--QDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEe--cCC
Confidence 47788999999999999998753 33678898875332 2234567889999999995 999999999887 456
Q ss_pred eEEEEEecch-hhHHHHHhh-------------------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-------------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-------------------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPs 689 (1219)
.+|+||||+. ++|.+++.. ..+++..+..++.+++.||.|||+.||+||||+|+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 7899999998 588887753 23678888999999999999999999999999999
Q ss_pred CeeeccCCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCc
Q psy14431 690 NILIDKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAST 766 (1219)
Q Consensus 690 NILLd~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~ 766 (1219)
|||++.++.++|+|||++......... .....++..|+|||.+. +..++.++|||||||++|+|++ |.+||++..+
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999865432211 12234567899999974 5568999999999999999998 9999988776
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
......+.....+..+ ...+..+.+++..||..||.+|+..+
T Consensus 236 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 236 ERLFNLLKTGYRMERP---------------------------------ENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred HHHHHHHhCCCCCCCC---------------------------------CCCCHHHHHHHHHHccCCcccCCCHH
Confidence 6554443332211111 12356788999999999999875433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.26 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=193.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
+.-++|.+.+.||.|+||.||+|.+ ..++..||+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACT- 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-
Confidence 3445789999999999999999975 3456689999885432 22334568899999999966999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
..+.+|+||||+. |+|..++... .+++..+..++.+|+.||.|||+.||+|+||||+|||++.++.++|+|||++
T Consensus 110 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 110 -IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred -cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 4567999999998 6899988742 3789999999999999999999999999999999999999999999999999
Q ss_pred cccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 708 RSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 708 r~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
..+..... ......+++.|+|||.+. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 265 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ-- 265 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC--
Confidence 86654321 112234567899999974 4568999999999999999998 99999876654433332221100000
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
....++.+.+++.+||.++|.+|+..
T Consensus 266 ------------------------------~~~~~~~~~~li~~cl~~~p~~Rpt~ 291 (302)
T cd05055 266 ------------------------------PEHAPAEIYDIMKTCWDADPLKRPTF 291 (302)
T ss_pred ------------------------------CCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 01236678999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.50 Aligned_cols=241 Identities=24% Similarity=0.372 Sum_probs=192.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCe---EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk---~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
++|...+.||.|+||.||+|.+..++. .||+|.+.... .......+..|+.++..+. ||||+++++++. ..+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVT--KFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEc--cCCC
Confidence 467888999999999999999876654 79999885432 2334566889999999995 999999999987 4567
Q ss_pred EEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+++ +|..++.. +.+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 8999999984 88888864 46889999999999999999999999999999999999999999999999999866433
Q ss_pred ccccc---cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KECLT---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~~~t---s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..... ....++.|+|||++. ...++.++|||||||++|+|++ |..||...+.......|.....++.+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~------- 232 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP------- 232 (268)
T ss_pred cccceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC-------
Confidence 22111 112345799999974 4568999999999999999997 99999887776666666543211110
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...+..+.+++.+|+..||..|+
T Consensus 233 --------------------------~~~~~~~~~li~~c~~~~p~~Rp 255 (268)
T cd05063 233 --------------------------MDCPSAVYQLMLQCWQQDRARRP 255 (268)
T ss_pred --------------------------CCCCHHHHHHHHHHcCCCcccCc
Confidence 12356788999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.66 Aligned_cols=242 Identities=22% Similarity=0.357 Sum_probs=192.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+|.+.+.||.|+||.||+|.+..+ ...||||.+.... .......+.+|+.++..+. ||||+++++++. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~---~~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFD-HPHIVKLIGVIT---ENP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCC-CCchhceeEEEc---CCC
Confidence 4588899999999999999987654 3568999875332 2334567889999999995 999999999886 345
Q ss_pred EEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.|+||||++ ++|.+++... .+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999998 6899998743 4889999999999999999999999999999999999999999999999999866543
Q ss_pred ccc-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 KEC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... .....++..|+|||.+ ....++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 230 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP--------- 230 (270)
T ss_pred cceecCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---------
Confidence 211 1122345679999997 45568999999999999999986 99999888776665555443322111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
+..++.+.+++.+|+.++|.+|+..
T Consensus 231 ------------------------~~~~~~~~~li~~~l~~~P~~Rpt~ 255 (270)
T cd05056 231 ------------------------PNCPPTLYSLMTKCWAYDPSKRPRF 255 (270)
T ss_pred ------------------------CCCCHHHHHHHHHHcCCChhhCcCH
Confidence 2236678999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.50 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=192.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCe----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++..+. ||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVD-HPHVVRLLGICLS--- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec---
Confidence 3568899999999999999999877664 58999875332 2334567889999999995 9999999998863
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
..+++||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 67899999997 689988874 358899999999999999999999999999999999999999999999999998765
Q ss_pred Ccccccc--cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSKECLT--EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~~~~t--s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
....... ...++..|+|||.+ ....++.++|+|||||++|++++ |.+||.+.+..+....+.....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 233 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP------ 233 (279)
T ss_pred CcccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC------
Confidence 4322211 12235679999997 45568999999999999999998 99999887766655555443321111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+..+.+++.+|+..||..|+.
T Consensus 234 ---------------------------~~~~~~~~~~~~~~l~~~p~~Rp~ 257 (279)
T cd05057 234 ---------------------------PICTIDVYMVLVKCWMIDAESRPT 257 (279)
T ss_pred ---------------------------CCCCHHHHHHHHHHcCCChhhCCC
Confidence 112456788999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.29 Aligned_cols=234 Identities=25% Similarity=0.405 Sum_probs=189.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+.+.||.|+||.||.+. .++..||+|.+... .....+.+|+.++..+. ||||+++++++.. ..+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~ 74 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLH-HKNLVRLLGVILH---NGLY 74 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---CCcE
Confidence 4679999999999999999985 56888999988532 23456789999999995 9999999998862 3479
Q ss_pred EEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||+. ++|.+++... .++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999998 5899988742 47888899999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.....+..|+|||.+ .+..++.++|+|||||++|+|++ |.+||.+.+.......+.....+.++
T Consensus 155 ---~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 219 (254)
T cd05083 155 ---DNSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP----------- 219 (254)
T ss_pred ---CCCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC-----------
Confidence 223446779999997 45568999999999999999997 99999887766555554433222111
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++.+.+++.+||..+|..|+.
T Consensus 220 ----------------------~~~~~~~~~li~~~l~~~p~~Rp~ 243 (254)
T cd05083 220 ----------------------EGCPADVYVLMTSCWETEPKKRPS 243 (254)
T ss_pred ----------------------CcCCHHHHHHHHHHcCCChhhCcC
Confidence 123567889999999999988754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.57 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=215.8
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
-++.+..++.-||.|+.|.||++..+.+|...|||.+.+.. +.....+++..+.++....++|+||+.+|+|. .+..
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi--~n~d 165 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI--TNTD 165 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe--eCch
Confidence 34556667788999999999999999999999999997654 45667889999998888777999999999998 4567
Q ss_pred EEEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+++.||.|...+..++. .+++++..+-.+...++.||.||.. +||||||+||+|||+|..|.+||||||++..+.+.
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 88999999987777776 4668888888999999999999985 69999999999999999999999999999887765
Q ss_pred ccccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 714 KECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
... +...|-+.|||||.+- ....|+.++||||||+++++|+||+.||++. .+.+.+.+|.+-.+|..+.-
T Consensus 246 kAh-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~------ 318 (391)
T KOG0983|consen 246 KAH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH------ 318 (391)
T ss_pred ccc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc------
Confidence 433 4557889999999983 2457899999999999999999999999984 56788888887444332211
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++.+.+|+..||+.||.+| ....|+|||..-
T Consensus 319 -------------------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 319 -------------------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred -------------------------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 1248899999999999999986 678899998754
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=323.32 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=208.4
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
-+.||.|-||+||-|+++.+|+.||||++.+.......-..+.+|+.||+.+. ||.||.+-..|+ ..+.+++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~E--T~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFE--TPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeec--CCceEEEEehhh
Confidence 46889999999999999999999999999776655555677889999999996 999999998887 456799999999
Q ss_pred hhhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---CcceecccccccccCCcccccc
Q psy14431 645 ENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 645 eGSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr~l~~~~~~~t 718 (1219)
.|++...+- .+.+++...++++.||+.||.|||-.||+|+||||+|||+... ..+||||||+|+.++.. ....
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRr 724 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRR 724 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhh
Confidence 999777765 4679999999999999999999999999999999999999654 46999999999998854 3456
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
+.+|||.|.|||++ .+.+|...-|+||+|||+|--++|..||... .++-..|.+.....|+..
T Consensus 725 sVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~P-------------- 787 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNP-------------- 787 (888)
T ss_pred hhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCc--------------
Confidence 78999999999998 5667999999999999999999999999644 344566666654444321
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhh
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAA 848 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfa 848 (1219)
| ..+++.++|||..+|+..=++ +....|.|||..
T Consensus 788 ------------W----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 788 ------------W----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred ------------h----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 1 234888999999999988776 477889999973
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=285.45 Aligned_cols=237 Identities=23% Similarity=0.325 Sum_probs=189.0
Q ss_pred eeeeccCceEEEEEEEcC-CC--eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 566 LKEGKGAYGIVYKAYDKN-NK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~-TG--k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
+.||.|+||.||+|.+.. ++ ..||||.+...... .....+.+|+.++..+. ||||+++++++.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEEE
Confidence 368999999999998865 33 36999998654332 45567889999999996 9999999999873 78999999
Q ss_pred cch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc--
Q psy14431 643 YME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-- 716 (1219)
Q Consensus 643 yme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~-- 716 (1219)
|++ ++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 997 6899988753 4889999999999999999999999999999999999999999999999999876543211
Q ss_pred -cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 -LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 -~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....++..|+|||.+ .+..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... +.++ .
T Consensus 156 ~~~~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~-~---------- 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERLE-R---------- 222 (257)
T ss_pred cccCCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcCC-C----------
Confidence 1124567889999997 45568999999999999999998 999998877766555554311 1000 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
-...+..+.+++.+||..+|.+|+..
T Consensus 223 --------------------~~~~~~~~~~li~~~l~~~p~~Rps~ 248 (257)
T cd05040 223 --------------------PEACPQDIYNVMLQCWAHNPADRPTF 248 (257)
T ss_pred --------------------CccCCHHHHHHHHHHCCCCcccCCCH
Confidence 01235678899999999999997543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=330.88 Aligned_cols=148 Identities=26% Similarity=0.431 Sum_probs=129.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+.+|.++++||.|+||.||+|.+..++..||||++.... ........+..|+.++..+. ||||+++++++. ...+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~ 78 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQ--SANN 78 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEE--ECCE
Confidence 3678999999999999999999999999999999986432 22333466788999998885 999999998886 4678
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
+||||||+. ++|..++.. +.+++..++.|+.||+.||.|||+.|||||||||+||||+.+|.++|+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999996 589888863 568889999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.19 Aligned_cols=244 Identities=20% Similarity=0.323 Sum_probs=192.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
-++|.+.+.||+|+||.||.|.+.. ++..|++|++... ........+.+|+.++..+ +||||+++++++.. .+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIE-DG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec-CC
Confidence 4578899999999999999999876 3688999987532 2344456788999999999 59999999998753 35
Q ss_pred ceEEEEEecch-hhHHHHHhh---------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs---------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
..++++++|++ ++|..++.. ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 67899999998 688888763 35889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCC
Q psy14431 705 GLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP 781 (1219)
Q Consensus 705 GLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P 781 (1219)
|+++.+...... .....++..|+|||++. +..++.++|||||||++|++++ |.+||.+.+.......+.....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 999865433211 11234567799999974 4568999999999999999998 9999988766554444333221110
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+ ...++.+.+++.+|+.+||..|+.
T Consensus 241 ~---------------------------------~~~~~~~~~li~~~l~~~p~~Rps 265 (280)
T cd05043 241 P---------------------------------INCPDELFAVMACCWALDPEERPS 265 (280)
T ss_pred C---------------------------------CcCCHHHHHHHHHHcCCChhhCCC
Confidence 0 112566889999999999998744
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=327.47 Aligned_cols=255 Identities=20% Similarity=0.356 Sum_probs=218.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+.++.++-.||-||||.|=++........+|+|++++.. ........+..|-.||..+. .|+||++|..|. +..+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfr--d~ky 494 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFR--DSKY 494 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhc--cchh
Confidence 3566778889999999999999877666679999997654 34555677889999999996 999999999997 6788
Q ss_pred EEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+.||-|- |.++.+++ .+.|.+..+++|+.+++.|++|||+.|||+|||||+|++++.+|.+||.|||+|+.+..+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999986 68999998 4679999999999999999999999999999999999999999999999999999988654
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
. +-++||||.|.|||+++. .+.+.++|.||||+++|||++|.|||.+.++...+..|+++.-.. .|
T Consensus 575 K-TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~---------- 640 (732)
T KOG0614|consen 575 K-TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EF---------- 640 (732)
T ss_pred c-eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hc----------
Confidence 3 457899999999999864 458999999999999999999999999999999999998876110 00
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
| ..++..+.+|+.++-+.+|.+| ..+.-.|.||..
T Consensus 641 ---------P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 641 ---------P-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ---------c-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 0 1235678899999999999886 567788999854
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.99 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=191.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.++..||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~--~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-HPNIVKLLGVCA--V 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcC-CCchheEEEEEc--C
Confidence 4568899999999999999998753 67889999885332 2233456788999999995 999999999887 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-----------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-----------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-----------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPs 689 (1219)
+..+|+||||++ ++|.+++... .+++..+..++.+|+.||.|||+.|++||||+|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 567899999998 5898888632 3677788999999999999999999999999999
Q ss_pred CeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCc
Q psy14431 690 NILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAST 766 (1219)
Q Consensus 690 NILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~ 766 (1219)
|||++.++.++|+|||++..+..... ......++..|+|||++. +..++.++|||||||++|+|++ |..||.+.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999876543211 112234466799999974 4568999999999999999997 8889987776
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+.+..+.....+..+ +..++.+.+|+.+||..||.+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 239 EEVIYYVRDGNVLSCP---------------------------------DNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred HHHHHHHhcCCCCCCC---------------------------------CCCCHHHHHHHHHHcccCcccCCC
Confidence 6655544432211100 123567899999999999999744
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.38 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=191.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC--------------CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN--------------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T--------------Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVk 624 (1219)
..+|.+.+.||.|+||.||+|.+..+ ...||+|.+.... .......+.+|+.++..+. ||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 35789999999999999999987543 2359999886432 2333456889999999995 999999
Q ss_pred EeeeeeccCCceEEEEEecch-hhHHHHHhhc-------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCC
Q psy14431 625 MLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN 690 (1219)
Q Consensus 625 L~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~-------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsN 690 (1219)
+++++. ....+|+||||+. ++|.+++... .+++..+..++.+|+.||.|||+.|++|+||||+|
T Consensus 82 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred EEEEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999987 4668999999998 5888887532 25778889999999999999999999999999999
Q ss_pred eeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh--CCCCCCCCCc
Q psy14431 691 ILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGAST 766 (1219)
Q Consensus 691 ILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT--GkpPF~g~s~ 766 (1219)
|+++.++.++|+|||++........ ......++..|+|||++. ...++.++|||||||++|+|++ |.+||...+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999976543221 112234567899999974 4568999999999999999988 6688887776
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
...+..+......... ..+ ....+..++.+.+|+.+|+.+||.+|+...
T Consensus 239 ~~~~~~~~~~~~~~~~---~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 239 EQVIENTGEFFRNQGR---QIY-----------------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred HHHHHHHHHhhhhccc---ccc-----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 6555544332211000 000 000112367899999999999999976544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=289.55 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=190.3
Q ss_pred cCeeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+|.+++.||.|+||.||.|. +..++..||+|.+... .......+.+|+.++..+. ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCC
Confidence 468899999999999999997 3457889999988532 2334557789999999995 99999999987655566
Q ss_pred eEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||++ ++|.+++.. ..+++..+..++.+|+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 7999999997 689998864 3588999999999999999999999999999999999999999999999999987654
Q ss_pred cccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 713 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 713 ~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.... .....++..|+|||++. +..++.++|||||||++|+|++|..|+..... .....+ ....+.+.....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~-- 235 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM-GNDKQGQMIVYHL-- 235 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc-ccccccccchHHH--
Confidence 3221 11123345699999974 55689999999999999999999877644321 111111 1111111100000
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
... +..... ....+..+..+.+|+.+|+..+|.+|+..
T Consensus 236 -------~~~---~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 273 (284)
T cd05081 236 -------IEL---LKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSF 273 (284)
T ss_pred -------HHH---HhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 000 000000 00123456789999999999999997443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=314.02 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=189.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.+.|.+++.||.|+||.||+|.+.. ++..||||++.... .......+.+|+.++..+..||||+++++++. .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT--K 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--c
Confidence 5578899999999999999998743 24579999985432 23345678899999999977999999999986 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc---------------------------------------------------------
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK--------------------------------------------------------- 655 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~--------------------------------------------------------- 655 (1219)
.+.+|||||||+ |+|.+++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 678999999998 5787776421
Q ss_pred ----------------------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 656 ----------------------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 656 ----------------------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
.+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 3666778899999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||++..+..... ......+++.|+|||++. +..++.++|||||||++|+|++ |..||++......+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999986543221 122345677899999974 4568999999999999999997 9999987543332222
Q ss_pred -HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 773 -IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 773 -Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+.....+.. -+..++.+.+++.+||..||.+|+.
T Consensus 352 ~~~~~~~~~~---------------------------------~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 352 KIKSGYRMAK---------------------------------PDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred HHhcCCCCCC---------------------------------CccCCHHHHHHHHHHCccCHhHCcC
Confidence 221111100 0124667899999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=325.64 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=223.9
Q ss_pred hccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 554 KDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 554 ~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.+...+..|.+.++||.|.|+.|.+|++..+|..||||++.+...+......+.+|+.++..+. |||||+++.+.. .
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~--t 126 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIE--T 126 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeeee--e
Confidence 4556788899999999999999999999999999999999988888777788999999999995 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...+|+||||+. |.+.+++. .+.+.+..++.++.|+++|++|||+.+|||||||+.|||++.+..+||+|||++..+.
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 667999999998 57888876 5667789999999999999999999999999999999999999999999999999887
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
. .....+++|++.|.|||++.+....++.+|+||+|+++|-|++|..||.|.+-...-...+.+..-.|
T Consensus 207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp---------- 275 (596)
T KOG0586|consen 207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP---------- 275 (596)
T ss_pred c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc----------
Confidence 4 44567889999999999998777778999999999999999999999998765443322222221110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
--++.+..++|+++|..+|.+| -.....|+|.+.+.+.
T Consensus 276 ------------------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 276 ------------------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ------------------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1236778999999999999995 4555889999886665
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=283.34 Aligned_cols=241 Identities=22% Similarity=0.398 Sum_probs=191.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+..+|.+.+.||.|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.+. ||||+++++++. ....+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA---MSEEDFIEEAQVMMKLS-HPKLVQLYGVCT--ERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC---CCHHHHHHHHHHHHhCC-CCCeeeEEEEEc--cCCce
Confidence 35678999999999999999998754 6689999885332 22345788999999995 999999999986 45678
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||+. ++|.+++.. +.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999998 478888863 458889999999999999999999999999999999999999999999999987654332
Q ss_pred cc-cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 EC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~-~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....++..|+|||.+. +..++.++|||||||++|+|++ |.+||...+....+..+.....+..+
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 223 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---------- 223 (256)
T ss_pred ccccCCCccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC----------
Confidence 11 11233567899999974 4568899999999999999998 99999877766555555433222111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+..+.+|+.+||..+|..|+.
T Consensus 224 -----------------------~~~~~~~~~l~~~~l~~~p~~Rp~ 247 (256)
T cd05112 224 -----------------------RLASQSVYELMQHCWKERPEDRPS 247 (256)
T ss_pred -----------------------CCCCHHHHHHHHHHcccChhhCCC
Confidence 012567899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=282.42 Aligned_cols=234 Identities=24% Similarity=0.398 Sum_probs=184.3
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
.||.|+||.||+|... ++..||+|++.... .......+.+|+.++..+. ||||+++++++. ....+++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~ 76 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYD-HPNIVKLIGVCT--QRQPIYIVMELVPG 76 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEe--cCCccEEEEECCCC
Confidence 6899999999999865 57889999886432 2233446788999999995 999999999987 4567899999998
Q ss_pred hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc-ccccc
Q psy14431 646 NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIA 722 (1219)
Q Consensus 646 GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~-ts~vG 722 (1219)
++|..++.. ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......... ....+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 588888763 357889999999999999999999999999999999999999999999999997654322111 11234
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
+..|+|||++ ....++.++|||||||++|++++ |.+||.+.........+.....+..
T Consensus 157 ~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 215 (250)
T cd05085 157 PIKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-------------------- 215 (250)
T ss_pred cccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence 5679999997 45568999999999999999998 9999988766554444433221110
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..++.+.+++.+|+..+|.+|+.
T Consensus 216 -------------~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 216 -------------PQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred -------------CCCCCHHHHHHHHHHcccCcccCCC
Confidence 0123677899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=327.10 Aligned_cols=248 Identities=29% Similarity=0.500 Sum_probs=203.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
-+||.|.||+||-|+|..|...+|||-+.. ......+.+..||...+.++ |.|||+++|++. .++++-|.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~s--enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLR-HKNIVRYLGSVS--ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHh-hHhHHHHhhccC--CCCeEEEEeecCC
Confidence 368999999999999999999999998853 34455677889999999996 999999999976 5778899999998
Q ss_pred -hhHHHHHhh--ccC--ChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceecccccccccCCccccccc
Q psy14431 646 -NDLNKVIRD--KIL--KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 646 -GSL~d~Lrs--~~L--seeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
|+|..+++. +++ .+.++-+|..||+.||.|||.+.|||||||-+||||+ -.|.+||+|||.++.+..-++++.+
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 589999984 566 7788999999999999999999999999999999997 5799999999999988777777788
Q ss_pred ccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 720 YIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
+.||..|||||++-. ..+|+.++|||||||++.||.||+|||...........-+.+....|+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP-------------- 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP-------------- 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc--------------
Confidence 899999999999843 35799999999999999999999999976544433222223332222211
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++..+..||.+|+..||..| +.+.|.+||...
T Consensus 802 -----------------eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 802 -----------------EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred -----------------HHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 1125678888999999999885 666788888644
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.95 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=219.4
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+-.+.+|..+.+||.|+||.|.+|..+.+.+.||||++++... ...+..-.+.|-.+|......|++++++.+|. .-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ--Tm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ--TM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh--hh
Confidence 4557789999999999999999999999999999999976542 34455566778888887777899999999997 45
Q ss_pred ceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||+.| +|.-.++ -+.+.+..+.+|+..|+-||-|||+.|||+||||.+|||++.+|++||+|||++..---
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 679999999984 7766665 47799999999999999999999999999999999999999999999999999986544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
....+.+++|||.|+|||++ ...+|+.++|+||+||+||||+.|+|||.|.+..++++.|.......|.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK---------- 571 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK---------- 571 (683)
T ss_pred CCcceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----------
Confidence 44456678999999999997 5778999999999999999999999999999999999999876533333
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+++.++.++...+|...|.+| ..+.-.||||..
T Consensus 572 ------------------------slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 572 ------------------------SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ------------------------cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 347789999999999999885 445677998854
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=283.31 Aligned_cols=235 Identities=26% Similarity=0.399 Sum_probs=186.2
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
++||.|+||.||+|.+.. +..||+|.+...... .....+..|+.+++.+. ||||+++++++. +...+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYD-HPNIVKLIGVCV--QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCeEEEEEEEe--cCCCeEEEEEcCC
Confidence 368999999999999888 999999988644322 34567889999999995 999999999887 5668999999997
Q ss_pred -hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc--cc
Q psy14431 646 -NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT--EY 720 (1219)
Q Consensus 646 -GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t--s~ 720 (1219)
++|.+++.. ..++...+..++.+++.||.|||++|++||||+|+|||++.++.++|+|||++........... ..
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 578888864 4578888999999999999999999999999999999999999999999999986543221111 12
Q ss_pred cccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 721 vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
.++..|+|||.+. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 156 ~~~~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 217 (251)
T cd05041 156 QIPIKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP----------------- 217 (251)
T ss_pred cceeccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC-----------------
Confidence 2356799999974 4568999999999999999998 88999887765544444322211110
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+..+.+++.+||..+|.+|+.
T Consensus 218 ----------------~~~~~~~~~li~~~l~~~p~~Rp~ 241 (251)
T cd05041 218 ----------------QLCPEEIYRLMLQCWAYDPENRPS 241 (251)
T ss_pred ----------------ccCCHHHHHHHHHHhccChhhCcC
Confidence 123567899999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=283.92 Aligned_cols=239 Identities=22% Similarity=0.332 Sum_probs=190.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...|.+.++||.|+||.||+|.+.. +..||+|.+... ......+.+|+.+++.+. ||||+++++++.. ..+|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC---CCeE
Confidence 3578999999999999999998654 556999987532 223456888999999995 9999999998863 5789
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++.. ..++...+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999997 589998874 347788899999999999999999999999999999999999999999999997664332
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......++..|+|||++. ...++.++|+|||||++|++++ |.+||.+.+.......+.....+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 224 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR----------- 224 (260)
T ss_pred cccccCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC-----------
Confidence 1 112234567799999974 5568999999999999999998 9999998777666555543321110
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..+..+.+++.+|+..||.+|+.
T Consensus 225 ----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 225 ----------------------PENCPEELYNIMMRCWKNRPEERPT 249 (260)
T ss_pred ----------------------cccCCHHHHHHHHHHcccCcccCcC
Confidence 0223667899999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=287.04 Aligned_cols=243 Identities=28% Similarity=0.473 Sum_probs=194.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcC-CCeEEEEEEeeccc--------cCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAF--------RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~-TGk~VAIKvI~ks~--------~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.|.+.+.||.|+||.||+|.+.. ++..||+|.+.... ........+..|+.++....+||||++++++|.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 37788899999999999999987 78899999875321 122334567788888887557999999999987
Q ss_pred cCCceEEEEEecchh-hHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceeccc
Q psy14431 632 VNNKDLYVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 632 ~d~~~LyLVMEymeG-SL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
.++.+|+||||+++ +|.+++. ...+++..++.++.+++.||.|||+ .|++|+||+|.||+++.++.++|+||
T Consensus 80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 56789999999985 7777663 2358888999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
|.+....... ......++..|+|||.+. +..++.++|||||||++|+|++|.+||...+.......+.....++.+.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 235 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE- 235 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc-
Confidence 9998765443 334567889999999985 4568999999999999999999999998776655555554433221110
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...++.+.+++.+||..||..|+.
T Consensus 236 -------------------------------~~~~~~l~~li~~cl~~~p~~Rp~ 259 (269)
T cd08528 236 -------------------------------GMYSEDVTDVITSCLTPDAEARPD 259 (269)
T ss_pred -------------------------------ccCCHHHHHHHHHHCCCCCccCCC
Confidence 123567889999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=290.76 Aligned_cols=257 Identities=20% Similarity=0.333 Sum_probs=190.8
Q ss_pred CeeEEeeeeccCceEEEEEEE----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~d----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.|.+++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++...++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCc
Confidence 478899999999999999974 4578899999985332 2334567889999999995 999999999987654567
Q ss_pred EEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+++||||++ ++|.+++.. ..+++..+..++.+|+.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999997 589988864 34789999999999999999999999999999999999999999999999999876543
Q ss_pred cc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 714 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 714 ~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.. ......++..|+|||++. +..++.++|||||||++|+|++|..|+.... . .......|........
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~~~~~~~~--- 233 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPTHGQMTVT--- 233 (284)
T ss_pred ccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhcccccccccHH---
Confidence 22 112345677899999974 4568999999999999999999887653321 1 1111222222111100
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+..+..... .......++.+.+|+.+||..||.+|+
T Consensus 234 -------~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 234 -------RLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred -------HHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCc
Confidence 00000000000 011234578899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=284.34 Aligned_cols=235 Identities=25% Similarity=0.399 Sum_probs=180.7
Q ss_pred eeeccCceEEEEEEEcC---CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 567 KEGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~---TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
.||.|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.+. ||||+++++++.. .++..|+||+|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~~lv~e~ 78 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLP-SEGSPLVVLPY 78 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeec-CCCCcEEEEec
Confidence 58999999999998653 3467999987422 22334567788999999985 9999999997653 34568899999
Q ss_pred ch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc----cc
Q psy14431 644 ME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK----EC 716 (1219)
Q Consensus 644 me-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~----~~ 716 (1219)
+. ++|.+++... .++...+..++.+|+.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 98 6899988743 35677788899999999999999999999999999999999999999999997654321 11
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....++..|+|||.+. ...++.++|||||||++|+|++ |.+||...+.......+.....+..+
T Consensus 159 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd05058 159 HTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP------------- 224 (262)
T ss_pred cccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC-------------
Confidence 12334567899999974 4568999999999999999999 57888877665555444333222111
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++.+||..+|.+|+
T Consensus 225 --------------------~~~~~~~~~li~~cl~~~p~~Rp 247 (262)
T cd05058 225 --------------------EYCPDPLYEVMLSCWHPKPEMRP 247 (262)
T ss_pred --------------------CcCCHHHHHHHHHHcCCChhhCC
Confidence 11245688999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=286.02 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=188.5
Q ss_pred eeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC----
Q psy14431 562 QINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---- 634 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---- 634 (1219)
|.+.+.||.|+||.||+|.+. .++..||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence 567789999999999999864 35789999998755545555667889999999995 9999999998764322
Q ss_pred ceEEEEEecch-hhHHHHHhh-------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
..++++++|+. |+|..++.. ..++...+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 23578999998 678777642 1368888999999999999999999999999999999999999999999999
Q ss_pred ccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 707 ARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 707 Ar~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
+........ ......+++.|++||.+ ....++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 237 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP- 237 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC-
Confidence 986643221 11223456779999997 45568899999999999999999 89999877665544444432211100
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+++.+||..+|..|+
T Consensus 238 --------------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 238 --------------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred --------------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 12356789999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.32 Aligned_cols=241 Identities=26% Similarity=0.409 Sum_probs=189.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.+|.+++.||.|+||.||+|.+.. .+..||+|.+... ........+.+|+.++..+.+||||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 358899999999999999998643 2346999987532 223345678899999999967999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
.++.+|+||||++ |+|.+++... .++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4567999999998 5898888632 366778889999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||+++........ .....++..|+|||++. +..++.++|||||||++|+|++ |.+||.+.+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999866543211 12223456799999974 4568999999999999999998 889998877666555
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
.+.....+..+ ...+..+.+++.+||..+|.+|
T Consensus 248 ~~~~~~~~~~~---------------------------------~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 248 LLKEGHRMDKP---------------------------------ANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred HHHcCCCCCCC---------------------------------CCCCHHHHHHHHHHcccChhhC
Confidence 55432221110 1235678899999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=291.56 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=187.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC----------------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCcc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN----------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~----------------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIV 623 (1219)
.+|.+.++||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..+. ||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLK-DPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcc
Confidence 468999999999999999986432 34579999885332 2333457889999999995 99999
Q ss_pred EEeeeeeccCCceEEEEEecch-hhHHHHHhhc------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCC
Q psy14431 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN 690 (1219)
Q Consensus 624 kL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsN 690 (1219)
++++++. .+..+|+||||+. ++|..++... .+++..+..++.+|+.||.|||+.||+|+||||+|
T Consensus 83 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999987 4567899999997 5898888642 25667899999999999999999999999999999
Q ss_pred eeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh--CCCCCCCCCc
Q psy14431 691 ILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGAST 766 (1219)
Q Consensus 691 ILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT--GkpPF~g~s~ 766 (1219)
||++.++.++|+|||++..+..... ......+++.|+|||+..+ ..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999986543221 1122334678999998754 468999999999999999998 7788877665
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+............ .. .++ ..+..++.+.+|+..||..||.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~---~~--------------~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~ 286 (296)
T cd05095 240 EQVIENTGEFFRDQGR---QV--------------YLP---------KPALCPDSLYKLMLSCWRRNAKERPS 286 (296)
T ss_pred HHHHHHHHHHHhhccc---cc--------------cCC---------CCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 5444332211100000 00 000 01223567889999999999999754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=286.67 Aligned_cols=202 Identities=23% Similarity=0.418 Sum_probs=168.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..|.+++.||.|+||.||+|.... ++..||+|++...... .....+.+|+.++..+. ||||+++++++...++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCC
Confidence 467788999999999999998653 4889999998644332 34567889999999995 99999999998765567
Q ss_pred eEEEEEecch-hhHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~--LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+++||||++ ++|.+++.... ++...+..++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999997 58999987544 89999999999999999999999999999999999999999999999999987763
Q ss_pred ccccc---ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC
Q psy14431 713 SKECL---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 764 (1219)
Q Consensus 713 ~~~~~---ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~ 764 (1219)
..... ....++..|+|||.+. ...++.++|||||||++|+|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 32211 1223456799999974 456899999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=285.59 Aligned_cols=207 Identities=22% Similarity=0.368 Sum_probs=162.6
Q ss_pred eeeccCceEEEEEEEcC--CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~--TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.+. ||||+++++++. ....+|+||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~--~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCI--ESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCC-CCCcceEEEEEC--CCCceEEEEEeC
Confidence 58999999999996533 45678888764322 2233456788999999885 999999999887 456799999999
Q ss_pred h-hhHHHHHhhc------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--
Q psy14431 645 E-NDLNKVIRDK------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-- 715 (1219)
Q Consensus 645 e-GSL~d~Lrs~------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-- 715 (1219)
+ |+|.+++... ..++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 8 5899988642 235677889999999999999999999999999999999999999999999875433211
Q ss_pred ccccccccccccCchhhhc------cccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc
Q psy14431 716 CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~------~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l 777 (1219)
......+++.|+|||++.. ...++.++|||||||++|+|++ |.+||....+.+.+..++...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 1122345677999999732 2356889999999999999999 789998877766666554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=300.78 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=186.7
Q ss_pred cCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
++|.+++.||.|+||.||+|.+ ..+++.||||++.... .......+.+|+.++..+.+||||+++++++.. .+
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec-CC
Confidence 4789999999999999999984 3567899999986432 223345688999999999879999999998753 34
Q ss_pred ceEEEEEecch-hhHHHHHhhc----------------------------------------------------------
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK---------------------------------------------------------- 655 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~---------------------------------------------------------- 655 (1219)
..+++||||++ |+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 57899999998 5888877531
Q ss_pred ----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--cccccccc
Q psy14431 656 ----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIAT 723 (1219)
Q Consensus 656 ----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT 723 (1219)
.++...+..++.||+.||.|||+.||+||||||.|||++.++.++|+|||++..+..... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 256777888999999999999999999999999999999999999999999986543221 11123456
Q ss_pred ccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH-HHHhhcCCCCCCchhhhhccCChhHHhhhH
Q psy14431 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGFKSKHEREKFN 801 (1219)
Q Consensus 724 ~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~-kIve~l~P~P~~~d~l~~~~~s~~~relI~ 801 (1219)
+.|+|||.+. +..++.++|||||||++|+|++ |.+||++......+. .+.....+..+
T Consensus 245 ~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------- 304 (343)
T cd05103 245 LKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP------------------- 304 (343)
T ss_pred cceECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC-------------------
Confidence 7799999974 4568999999999999999997 999998754332222 22111111111
Q ss_pred HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 802 QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 802 klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++..|+..||.+|+
T Consensus 305 --------------~~~~~~~~~~~~~cl~~~p~~Rp 327 (343)
T cd05103 305 --------------DYTTPEMYQTMLDCWHGEPSQRP 327 (343)
T ss_pred --------------CCCCHHHHHHHHHHccCChhhCc
Confidence 11256788999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=285.00 Aligned_cols=242 Identities=20% Similarity=0.357 Sum_probs=190.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+|.++..||.|+||.||+|.... +...|++|.+... ........+.+|+.++..+. ||||+++++++. +.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLS-HKNVVRLLGLCR--EA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcC-CcceeeeEEEEC--CC
Confidence 468899999999999999999754 3467999987432 12224567889999999995 999999999886 45
Q ss_pred ceEEEEEecch-hhHHHHHhhc----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
...|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 67899999998 6899988732 489999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc-cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCC
Q psy14431 704 LGLARSLSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP 781 (1219)
Q Consensus 704 FGLAr~l~~~~-~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P 781 (1219)
||++....... .......++..|+|||.+. +..++.++|||||||++|+|++ |.+||.+..+...+..+.....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99987543221 1122345677899999974 4457899999999999999998 8899987666554444432221110
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
. ....+..+.+++.+||..||.+|+
T Consensus 240 ~--------------------------------~~~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 240 V--------------------------------PEGCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred C--------------------------------CCCCCHHHHHHHHHHcCCCcccCC
Confidence 0 012356788999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=293.43 Aligned_cols=252 Identities=15% Similarity=0.114 Sum_probs=178.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCch-h--------HHHHHHHHHHHHhccCCCCccEEee
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKT-D--------AQRTYREILFLKSFQRHPNIITMLD 627 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~-~--------~e~~lREI~ILr~L~~HPNIVkL~g 627 (1219)
..|.+.+.||.|+||.||+|.+..+ +..+|+|+......... . ......+...+..+ .|+||+++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEE
Confidence 4799999999999999999998877 66778876432111000 0 01112223334445 4999999998
Q ss_pred eeeccCC--ceEEEEEecchhhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 628 IYKAVNN--KDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 628 vfe~~d~--~~LyLVMEymeGSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
++..... ...+++++++..++...+... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 7653222 245788998887777666543 4678889999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc-------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc
Q psy14431 705 GLARSLSDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 705 GLAr~l~~~~-------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l 777 (1219)
|+|+.+.... .......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+......
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~- 248 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC- 248 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-
Confidence 9998664221 111234699999999997 4567899999999999999999999999876432222111110
Q ss_pred CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 778 RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 778 ~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+++..+... ....+..++.+.+++..|+..+|.+|+.
T Consensus 249 --------------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 249 --------------------DFIKRLHEG-----KIKIKNANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred --------------------HHHHHhhhh-----hhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence 000000000 0012345678999999999999998754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=283.66 Aligned_cols=235 Identities=26% Similarity=0.436 Sum_probs=184.1
Q ss_pred eeeccCceEEEEEEEcCCC------eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 567 KEGKGAYGIVYKAYDKNNK------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TG------k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.+. ||||+++++++. ....+|+|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCL--LNEPQYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcC-CCCeeeEeeeec--CCCCeEEE
Confidence 5899999999999876544 789999875332 1234567889999999995 999999999986 45679999
Q ss_pred Eecch-hhHHHHHhh--------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-----cceeccccc
Q psy14431 641 FEYME-NDLNKVIRD--------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-----SIKIGDLGL 706 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs--------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-----~VKLiDFGL 706 (1219)
|||++ ++|.+++.. ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99998 588888863 2367788999999999999999999999999999999999877 899999999
Q ss_pred ccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 707 ARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 707 Ar~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
+........ ......++..|+|||++. +..++.++|||||||++|+|++ |.+||+..+.......+.....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-- 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK-- 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC--
Confidence 976543221 111234567899999974 5568999999999999999998 9999987776665554432221110
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+..++.+.+++.+||..+|.+|+.
T Consensus 235 -------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~ 259 (269)
T cd05044 235 -------------------------------PENCPDKIYQLMTNCWAQDPSERPT 259 (269)
T ss_pred -------------------------------cccchHHHHHHHHHHcCCCcccCCC
Confidence 0123567889999999999999753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=349.46 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=211.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.-..+||.|.||.||.|.+.++|...|+|-+.-..........+.+|..++..+. |||+|++||+-. .+..++|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEv--HRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEV--HREKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceee--cHHHHHH
Confidence 3466677899999999999999999999999987544334455567789999999995 999999999865 5677999
Q ss_pred EEecch-hhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc---
Q psy14431 640 VFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--- 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--- 714 (1219)
.||||. |+|.+++..+ ..++...+.|..|++.|+.|||+.|||||||||.|||++.+|.+|++|||.|..+.+..
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999998 6899999865 46667778899999999999999999999999999999999999999999998876543
Q ss_pred -cccccccccccccCchhhhcc--ccccccccchhHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhhcCCCCCCchhhhhc
Q psy14431 715 -ECLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~--~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~-L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.....++||+.|||||++.+. .+..-+.|||||||++.||+||+.||...+...+ +..+-.+..|..|.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~------- 1464 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE------- 1464 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch-------
Confidence 234568999999999999653 3456789999999999999999999987665544 44444444444331
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH--HHcchhhhcCCCC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE--QLQGKLAALGSET 853 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE--ALqHpwfaL~~e~ 853 (1219)
.++++..|||..||..||+.|++. .|.|.|.....+.
T Consensus 1465 --------------------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1465 --------------------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred --------------------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 148889999999999999998665 5788887665444
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=291.93 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=187.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCe----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++..+. ||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMD-HPHLVRLLGVCLS--- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC---
Confidence 4568889999999999999999887775 46888775332 2233346788999999995 9999999998863
Q ss_pred ceEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...++|++|++ |+|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 34679999998 6888888743 57888999999999999999999999999999999999999999999999998765
Q ss_pred Ccccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 712 DSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 712 ~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
..... .....++..|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+.....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP------ 233 (303)
T ss_pred CcccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC------
Confidence 43221 1223456789999997 45568999999999999999997 89999876654443333222211111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..+..+.+++.+|+..||.+|+
T Consensus 234 ---------------------------~~~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 234 ---------------------------PICTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred ---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 11245678899999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=287.18 Aligned_cols=229 Identities=15% Similarity=0.273 Sum_probs=177.0
Q ss_pred eeeccCceEEEEEEEcCCCeE-------EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQY-------VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~-------VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.||.|+||.||+|.+..++.. ||+|.+... .......+..|+.++..+. ||||+++++++. .+...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLS-HKHLVLNYGVCV--CGDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCC-CCChhheeeEEE--eCCCcEE
Confidence 689999999999988665543 888876432 1233456778888998885 999999999987 4567899
Q ss_pred EEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc--------ceeccccccc
Q psy14431 640 VFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--------IKIGDLGLAR 708 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~--------VKLiDFGLAr 708 (1219)
||||++ |+|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999998 5898888743 4788899999999999999999999999999999999987765 6999999987
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..... ....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+....... .....+.|
T Consensus 157 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~------ 225 (258)
T cd05078 157 TVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLP------ 225 (258)
T ss_pred ccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCC------
Confidence 65432 23467889999999865566899999999999999999984 77765544332211 11100000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..++.+.+++.+||..||.+|+.
T Consensus 226 ----------------------------~~~~~~~~~li~~~l~~~p~~Rps 249 (258)
T cd05078 226 ----------------------------APKWTELANLINQCMDYEPDFRPS 249 (258)
T ss_pred ----------------------------CCCcHHHHHHHHHHhccChhhCCC
Confidence 122456889999999999998743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=328.92 Aligned_cols=200 Identities=31% Similarity=0.472 Sum_probs=175.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----Cce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~~~ 636 (1219)
.|..-+.||.||||.||+|+++.+|+.||||.+.... .........+|+.+++.+. |||||+++++-.... ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccccc
Confidence 4566778999999999999999999999999987543 4556788899999999996 999999999866444 556
Q ss_pred EEEEEecch-hhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec--cCC--cceecccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSC--SIKIGDLGLA 707 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd--~dG--~VKLiDFGLA 707 (1219)
.++|||||. |+|..+++. ..+++..+..++.+++.||.|||.+|||||||||.||++- .+| ..||||||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 899999998 589999983 4699999999999999999999999999999999999984 334 3799999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
+.+.+.. ...+.+||+.|.+||++-....|+..+|.|||||++|+++||..||-.
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9988765 567899999999999985557899999999999999999999999954
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=280.41 Aligned_cols=227 Identities=18% Similarity=0.262 Sum_probs=176.8
Q ss_pred eeeeccCceEEEEEEEcCCC----------eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNK----------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TG----------k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+.||.|+||.||+|.+..++ ..|++|++.... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLS-HKHLVKLYGVCVR---D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCC-CcchhheeeEEec---C
Confidence 36899999999999998777 357888764321 11567889999999995 9999999998864 5
Q ss_pred eEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-------cceecccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-------SIKIGDLG 705 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-------~VKLiDFG 705 (1219)
..|+||||++ |+|..++... .++...+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 5799999998 5888888743 588889999999999999999999999999999999999887 79999999
Q ss_pred cccccCCcccccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 706 LARSLSDSKECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 706 LAr~l~~~~~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++ |.+||...+.......... ..+.+
T Consensus 154 ~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~-- 226 (259)
T cd05037 154 IPITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP-- 226 (259)
T ss_pred cccccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC--
Confidence 99876542 234567789999998544 368999999999999999999 5788866543322221110 00000
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
......+.+++.+||..||.+|+
T Consensus 227 --------------------------------~~~~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 227 --------------------------------MPDCAELANLINQCWTYDPTKRP 249 (259)
T ss_pred --------------------------------CCCchHHHHHHHHHhccChhhCC
Confidence 00025688999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=282.62 Aligned_cols=203 Identities=21% Similarity=0.312 Sum_probs=161.0
Q ss_pred eeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|... .++..+|+|.+..... ......+.+|+.++..+. ||||+++++++. +...+|+||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCT--EVTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--CCCCcEEEEECC
Confidence 5899999999999764 3557799998854322 233346788999999995 999999999886 456789999999
Q ss_pred h-hhHHHHHhhc------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc-
Q psy14431 645 E-NDLNKVIRDK------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC- 716 (1219)
Q Consensus 645 e-GSL~d~Lrs~------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~- 716 (1219)
+ |+|.+++... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 8 6898888632 3456677889999999999999999999999999999999999999999999754432211
Q ss_pred -cccccccccccCchhhhcc------ccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14431 717 -LTEYIATRWYRAPEILISN------RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI 773 (1219)
Q Consensus 717 -~ts~vGT~~Y~APEvLl~~------~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kI 773 (1219)
.....++..|+|||++.+. ..++.++|||||||++|+|++ |.+||+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 222 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 1234567889999997422 135789999999999999996 99999877665544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.80 Aligned_cols=229 Identities=17% Similarity=0.243 Sum_probs=174.3
Q ss_pred eeeccCceEEEEEEEcC------------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 567 KEGKGAYGIVYKAYDKN------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~------------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.||.|+||.||+|.... ....|++|++... .......+..|+.++..+. ||||+++++++. ..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~--~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVS-HKHIVLLYGVCV--RD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cC
Confidence 58999999999997532 2335888887532 2233456778888898885 999999999986 45
Q ss_pred ceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc-------ceeccc
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-------IKIGDL 704 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~-------VKLiDF 704 (1219)
...++||||+++ +|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 678999999995 67776653 45899999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELL-TGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
|++...... ....++..|+|||++..+..++.++|||||||++|+|+ +|.+||.+....... .+.....+.
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~--- 228 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCML--- 228 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccC---
Confidence 998765432 23467888999999755667899999999999999998 588888765433221 111110000
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
....++.+.+|+.+||.+||.+|+.
T Consensus 229 -------------------------------~~~~~~~~~~li~~cl~~dp~~Rp~ 253 (262)
T cd05077 229 -------------------------------VTPSCKELADLMTHCMNYDPNQRPF 253 (262)
T ss_pred -------------------------------CCCChHHHHHHHHHHcCCChhhCcC
Confidence 0112356789999999999998743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=299.21 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=199.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecc--cc---CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA--FR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks--~~---s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+|.++..||.|||+.||+|.|....++||+|+-... .. .........+|..|.+.+. ||.||++|++|.- +.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfsl-Dtd 541 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSL-DTD 541 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeee-ccc
Confidence 577788999999999999999999999999986321 11 1233456789999999995 9999999999974 667
Q ss_pred eEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhc--ccccCCCCCCCeeec---cCCcceeccccccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHAC--KVMHRDLKPSNILID---KSCSIKIGDLGLAR 708 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~--GIVHRDLKPsNILLd---~dG~VKLiDFGLAr 708 (1219)
.+|-|+|||+| +|.-++. +..+++..++.|+-||+.||.||... .|||-||||.|||+- ..|.+||+|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 79999999997 5666666 45699999999999999999999964 799999999999994 45789999999999
Q ss_pred ccCCcc-------cccccccccccccCchhhhcc---ccccccccchhHHHHHHHHHhCCCCCCCCCc-HHHHH--HHHh
Q psy14431 709 SLSDSK-------ECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQ--LIVN 775 (1219)
Q Consensus 709 ~l~~~~-------~~~ts~vGT~~Y~APEvLl~~---~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-~e~L~--kIve 775 (1219)
.+.+.. ..+....||.||.|||.|.-+ +..+.++||||+|||||.++.|+.||...-. .+++. .|++
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 876532 223457899999999998643 4568899999999999999999999954322 22221 1222
Q ss_pred hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HHHHcchhhhc
Q psy14431 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IEQLQGKLAAL 849 (1219)
Q Consensus 776 ~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iEALqHpwfaL 849 (1219)
... - .||. -|.+++++.+||++||.|.-+.|+ .+.-.||||.+
T Consensus 702 AtE---V-------------------qFP~---------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 702 ATE---V-------------------QFPP---------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cee---c-------------------cCCC---------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 110 0 0110 145689999999999999988863 34466888866
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=318.32 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=201.0
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+.+..+.|.+...+|.|+||.|-.|.+..++..+++|++.+. .....+|+.++....+||||+++.++|. ++
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~ 388 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYE--DG 388 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceec--CC
Confidence 456688899999999999999999999999999999999644 1223467778888888999999999997 67
Q ss_pred ceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee-ccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-DKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL-d~dG~VKLiDFGLAr~l~~ 712 (1219)
.+.|+|||.+.| -+.+-+...+.....+..|+.+|+.|+.|||+.|||||||||+|||+ +..|+++|||||.++....
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 889999999996 34444443333337778899999999999999999999999999999 6999999999999998765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
. ....+-|..|.|||++ ....|++++||||||++||+||+|+.||...... +++..| ..|...
T Consensus 469 ~---~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s--------- 532 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFS--------- 532 (612)
T ss_pred h---hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccc---------
Confidence 4 3344678999999997 4778999999999999999999999999876655 222222 111100
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+|..++|||..||++||.+| +.+++.|||+
T Consensus 533 ------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3458899999999999999985 7888999999
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.58 Aligned_cols=228 Identities=17% Similarity=0.242 Sum_probs=173.8
Q ss_pred eeeccCceEEEEEEEcCC------------------------CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCc
Q psy14431 567 KEGKGAYGIVYKAYDKNN------------------------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 622 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~T------------------------Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNI 622 (1219)
.||.|+||.||+|....+ ...||+|++... .......+..|+.++..+. ||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~-h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVS-HIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCC-CCCe
Confidence 589999999999975321 245889987532 1223456778888888885 9999
Q ss_pred cEEeeeeeccCCceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC--
Q psy14431 623 ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-- 697 (1219)
Q Consensus 623 VkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-- 697 (1219)
+++++++. .+...|+||||+++ +|..++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCV--RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEE--eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 99999987 45678999999994 78777753 5688899999999999999999999999999999999997644
Q ss_pred -----cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHH-hCCCCCCCCCcHHHHH
Q psy14431 698 -----SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQ 771 (1219)
Q Consensus 698 -----~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELL-TGkpPF~g~s~~e~L~ 771 (1219)
.++++|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|.+||.+.++.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999988654322 22357788999999865567899999999999999985 6999998765543222
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+ ....+.| ....+.+.+++.+||..+|.+|+
T Consensus 233 ~~-~~~~~~~----------------------------------~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 233 FY-EKKHRLP----------------------------------EPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred HH-HhccCCC----------------------------------CCCChHHHHHHHHHcccChhhCc
Confidence 11 1110000 01235688999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.85 Aligned_cols=225 Identities=21% Similarity=0.287 Sum_probs=177.9
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-hhHH
Q psy14431 571 GAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLN 649 (1219)
Q Consensus 571 GgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-GSL~ 649 (1219)
|.||.||+|.+..+|..||+|.+.... ...++...+... .||||+++++++. +...+|+||||++ |+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPH-CVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhc-CCCceeehhhhee--cCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986432 122344444444 4999999999987 4678999999998 5888
Q ss_pred HHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccccccC
Q psy14431 650 KVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728 (1219)
Q Consensus 650 d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~A 728 (1219)
+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+....... ....++..|+|
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~a 150 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCA 150 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccC
Confidence 87763 468999999999999999999999999999999999999999999999999887655432 23456778999
Q ss_pred chhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhch
Q psy14431 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQ 808 (1219)
Q Consensus 729 PEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcr 808 (1219)
||.+ ....++.++|+||+||++|+|++|.+||...... +.... . +
T Consensus 151 PE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------~~~~~----~---------~----- 195 (237)
T cd05576 151 PEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------INTHT----T---------L----- 195 (237)
T ss_pred Cccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------ccccc----c---------c-----
Confidence 9997 4556889999999999999999999887432110 00000 0 0
Q ss_pred hhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhh
Q psy14431 809 KELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLA 847 (1219)
Q Consensus 809 k~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwf 847 (1219)
.+-+.+++.+.++|.+||..||.+|+ .+.+.||||
T Consensus 196 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 ----NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ----CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00123477899999999999999985 678999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=303.21 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=189.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
++|.+.++||.|+||.||+|.+. .++..||+|++.... .......+.+|+.++..+.+|||||++++++. ..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--~~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT--KG 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--cC
Confidence 45778899999999999999864 356789999996432 22334568899999999977999999999987 45
Q ss_pred ceEEEEEecch-hhHHHHHhhc----------------------------------------------------------
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK---------------------------------------------------------- 655 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~---------------------------------------------------------- 655 (1219)
+.+|+||||+. |+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 67999999998 5888887531
Q ss_pred -----------------------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 656 -----------------------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 656 -----------------------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
.+++..+..|+.+|+.||.|||+.||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 245567788999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||++..+..... ......+++.|+|||.+. ...++.++|||||||++|+|++ |.+||..........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999986543221 112345678899999974 4568999999999999999998 889998765544433
Q ss_pred HHHh-hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 772 LIVN-LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 772 kIve-~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
..+. ...+..+ +..+..+.+++.+|+..+|..|+.
T Consensus 353 ~~~~~~~~~~~p---------------------------------~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 353 NAIKRGYRMAKP---------------------------------AHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HHHHcCCCCCCC---------------------------------CCCCHHHHHHHHHHcCCChhHCcC
Confidence 3322 1111100 123677899999999999988643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=303.49 Aligned_cols=208 Identities=27% Similarity=0.435 Sum_probs=170.9
Q ss_pred hhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEe
Q psy14431 547 KSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626 (1219)
Q Consensus 547 ~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~ 626 (1219)
++..++.... ++|.--..||.|+||.||+|...++ ..||||.+....... ...+.+|+.++..+. |||+|+|+
T Consensus 65 fs~~el~~AT---~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~-H~Nlv~Ll 137 (361)
T KOG1187|consen 65 FSYDELRKAT---NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLR-HPNLVKLL 137 (361)
T ss_pred eeHHHHHHHH---hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCC-CcCcccEE
Confidence 3455665554 4455567889999999999987664 889999775332221 345999999999997 99999999
Q ss_pred eeeeccCCc-eEEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhc---ccccCCCCCCCeeeccCCc
Q psy14431 627 DIYKAVNNK-DLYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHAC---KVMHRDLKPSNILIDKSCS 698 (1219)
Q Consensus 627 gvfe~~d~~-~LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~---GIVHRDLKPsNILLd~dG~ 698 (1219)
|||.. ++ +.+||+|||+ |+|.+.+... +++|.....|+.+++.||.|||.. .||||||||+|||+|.++.
T Consensus 138 GyC~e--~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 138 GYCLE--GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEec--CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 99984 44 6999999999 7999999843 789999999999999999999974 3999999999999999999
Q ss_pred ceecccccccccCCcccccccc-cccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC
Q psy14431 699 IKIGDLGLARSLSDSKECLTEY-IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 764 (1219)
Q Consensus 699 VKLiDFGLAr~l~~~~~~~ts~-vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~ 764 (1219)
+||+|||+|+..+......... .||.+|+|||++. .+..+.++|||||||+++||++|++|....
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999997665411112222 7999999999974 467899999999999999999999888643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=277.46 Aligned_cols=205 Identities=20% Similarity=0.348 Sum_probs=159.9
Q ss_pred eeeccCceEEEEEEEcCC--CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~T--Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.||.|+||.||+|....+ ...+++|.+... ........+.+|+.++..+. ||||++++++|. ....+|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCV--EAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccC-CcchhheEEEec--CCCccEEEEecC
Confidence 589999999999975433 345667765432 12234567889999999885 999999999987 456789999999
Q ss_pred h-hhHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--cc
Q psy14431 645 E-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--EC 716 (1219)
Q Consensus 645 e-GSL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--~~ 716 (1219)
+ |+|.+++... .++...+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 8 5899888742 35566778899999999999999999999999999999999999999999986432211 11
Q ss_pred cccccccccccCchhhhc------cccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q psy14431 717 LTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN 775 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~------~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve 775 (1219)
....+++..|+|||++.. ...++.++|||||||++|+|++ |.+||...++...+..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 223 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 234567889999999732 1235789999999999999997 5789987777666665543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=314.99 Aligned_cols=274 Identities=23% Similarity=0.251 Sum_probs=181.6
Q ss_pred HhhccccccCeeEEeeeeccCceEEEEEEEcCC----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEee
Q psy14431 552 LMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627 (1219)
Q Consensus 552 LL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~T----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~g 627 (1219)
.+......++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... .......+ .+.... +.+++.++.
T Consensus 124 ~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~-~~~~~~~~~ 196 (566)
T PLN03225 124 LFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRAC-PNSCADFVY 196 (566)
T ss_pred ccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhc-hhhHHHHHH
Confidence 345566788999999999999999999999988 9999999875321 11111111 111111 223333322
Q ss_pred eee----ccCCceEEEEEecch-hhHHHHHhhccC---------------------ChHHHHHHHHHHHHHHHHHHhccc
Q psy14431 628 IYK----AVNNKDLYVVFEYME-NDLNKVIRDKIL---------------------KDVHIRYIMFQLCNGLSYIHACKV 681 (1219)
Q Consensus 628 vfe----~~d~~~LyLVMEyme-GSL~d~Lrs~~L---------------------seeeVr~Ia~QILsALaYLHS~GI 681 (1219)
.|. ...+..+++||+|++ ++|.+++....+ ....+..++.||+.||.|||+.||
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 221 134567999999998 478888764321 123466799999999999999999
Q ss_pred ccCCCCCCCeeecc-CCcceecccccccccCCcc-cccccccccccccCchhhhccc---------------------cc
Q psy14431 682 MHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSK-ECLTEYIATRWYRAPEILISNR---------------------RY 738 (1219)
Q Consensus 682 VHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~-~~~ts~vGT~~Y~APEvLl~~~---------------------~y 738 (1219)
+||||||+|||++. ++.+||+|||+|..+.... .....+++|+.|+|||.+.... .+
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999999999986 5799999999998654322 2234568899999999763221 13
Q ss_pred cccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHH---HHh
Q psy14431 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQ---ELQ 815 (1219)
Q Consensus 739 T~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~---el~ 815 (1219)
+.++|||||||+||+|+++..| ..+....+..++.........|.... .......+. .++
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~ 419 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLV---------------EPRASPDLRRGFEVL 419 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhh---------------ccccchhhhhhhhhc
Confidence 3456999999999999986544 34443334443332222211121111 000111111 122
Q ss_pred cccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 816 SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 816 p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
...+....|||.+||.+||.+ ++.++|+||||..
T Consensus 420 d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 420 DLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred cccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCC
Confidence 223446779999999999998 4889999999955
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=315.59 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=193.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
....+...||.|+||+||+|.+. ..||||++..........+.|.+|+.+++.-+ |-||+-+.|++. ...+.|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~---~p~~AI 464 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACM---NPPLAI 464 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhc---CCceee
Confidence 34567889999999999999875 34999999888778888899999999999996 999999999997 233499
Q ss_pred EEecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC--cc
Q psy14431 640 VFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SK 714 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~--~~ 714 (1219)
|+-||+| +|+.+++ ...|.....+.|+.||+.|+.|||..+|||||||..|||+..+++|+|+|||++..-.- +.
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999997 7999887 44688889999999999999999999999999999999999999999999999964221 12
Q ss_pred cccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhcc
Q psy14431 715 ECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGF 791 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~ 791 (1219)
.......|...|||||++.. ..+|++.+|||||||++|||++|..||...+...++..+-.+. .|.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd----------- 613 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD----------- 613 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-----------
Confidence 22233456778999999852 3479999999999999999999999998554443333332222 111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
...+..+.+.++.+|+..|+.++|++|
T Consensus 614 -------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eR 640 (678)
T KOG0193|consen 614 -------------------LSKIRSNCPKAMKRLLSDCWKFDREER 640 (678)
T ss_pred -------------------chhhhccCHHHHHHHHHHHHhcCcccC
Confidence 112234446688999999999999887
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=304.98 Aligned_cols=281 Identities=25% Similarity=0.373 Sum_probs=213.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC---CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~---TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..|.++.+||.|+|++||++.+.. .+..||+|.+.. ...+.++..|+.+|..+.++.||+++.+++. .++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nnd~ 109 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCFR--NNDQ 109 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhhc--cCCe
Confidence 458899999999999999999887 789999998853 3456779999999999999999999999997 6788
Q ss_pred EEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccccCC--
Q psy14431 637 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSD-- 712 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~-- 712 (1219)
+++||||++. ...+++.. ++...++.|++.++.||.++|.+|||||||||+|+|++. .+.-.|+|||+|.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred eEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999996 56666554 667889999999999999999999999999999999985 46789999999962110
Q ss_pred --------------c------------------c----------cccccccccccccCchhhhccccccccccchhHHHH
Q psy14431 713 --------------S------------------K----------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750 (1219)
Q Consensus 713 --------------~------------------~----------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~I 750 (1219)
+ + .......||++|+|||+++..+..++++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 001135689999999999999999999999999999
Q ss_pred HHHHHhCCCCC-CCCCcHHHHHHHHhhcCCCC--------C---CchhhhhccCChhHHhhhHHh-hhhchh-----hHH
Q psy14431 751 LAEMLQSKPLF-PGASTSHQLQLIVNLVRPNP--------P---HADKFYAGFKSKHEREKFNQV-VVKCQK-----ELQ 812 (1219)
Q Consensus 751 LyELLTGkpPF-~g~s~~e~L~kIve~l~P~P--------~---~~d~l~~~~~s~~~relI~kl-p~kcrk-----~L~ 812 (1219)
+..++++..|| ...++...+..|+.++++.. . .|... .-...+.....|..+ ...|.. ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ks-n~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKS-NIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccc-cccccHHHHhchhccChhhcccccccceee
Confidence 99999998665 45666777777776663311 1 11110 011122222233333 122222 122
Q ss_pred HHh-cccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 813 ELQ-SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 813 el~-p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
... ...+..+.|||.+||..||.+ ++.+||+||||..
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 222 234558999999999999988 5999999999964
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=312.77 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=209.4
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEee--ccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~--ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
-..||.|+|-+||+|.|..+|..||.=-+. .-........++..|+.+|+.|. |||||++|+++.+.....+.+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeeee
Confidence 356899999999999999999988865442 23345566789999999999996 999999999998877788999999
Q ss_pred cch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhc--ccccCCCCCCCeeecc-CCcceecccccccccCCccccc
Q psy14431 643 YME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHAC--KVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 643 yme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~--GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
.+. |+|..+.. .+.++...++.|++||+.||.|||++ .|||||||-+||||+. .|.|||+|+|+|....... .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--A 201 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--c
Confidence 998 79999987 46789999999999999999999987 5999999999999975 5899999999999876544 3
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCC-CCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP-GASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~-g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
...+|||.|||||++ ...|+..+||||||++++||+|+..||. ..++..++.++..+..|. .+.
T Consensus 202 ksvIGTPEFMAPEmY--EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~--sl~----------- 266 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMY--EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA--ALS----------- 266 (632)
T ss_pred ceeccCccccChHHH--hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH--Hhh-----------
Confidence 458999999999998 3579999999999999999999999996 467777778887776442 111
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC-CHHHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD-SEIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK-RaiEALqHpwfaL 849 (1219)
.--+|++.+||.+||..-..+ ++.+.|.||||+.
T Consensus 267 -------------------kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 267 -------------------KVKDPEVREFIEKCLATKSERLSAKELLKDPFFDE 301 (632)
T ss_pred -------------------ccCCHHHHHHHHHHhcCchhccCHHHHhhChhhcc
Confidence 112788999999999994444 7999999999976
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=308.34 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=200.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCe---E-EEEEEeec-cccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQ---Y-VAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk---~-VAIKvI~k-s~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+..+.++||+|+||.||+|.....+. . ||+|.... ..........+++|..+++.+. |||||++||+.. ...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~--~~~ 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAV--LEE 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc--CCC
Confidence 34556899999999999998765422 3 89998864 2245566789999999999985 999999999886 577
Q ss_pred eEEEEEecch-hhHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~--LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.++||||+|. |+|.++++... ++..+...++.+.+.||+|||+.++|||||-.+|+|++.++.+||+|||+++.-..
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 8999999999 59999999643 99999999999999999999999999999999999999999999999999876541
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh-hcCCCCCCchhhhhc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve-~l~P~P~~~d~l~~~ 790 (1219)
-.......-.+..|+|||.+. .+.|++++|||||||++||+++ |..||++....+....|+. ..+.+++.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~------- 386 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS------- 386 (474)
T ss_pred eeeccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC-------
Confidence 111111123457799999984 5589999999999999999999 8899999999998888844 44333331
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLA 847 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwf 847 (1219)
..+..+..++..|...||..|+....-..++
T Consensus 387 --------------------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 387 --------------------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred --------------------------CCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 1244566678889999999876655444444
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=325.17 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=194.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeee--------
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK-------- 630 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe-------- 630 (1219)
+.+|..+..||+||||.||+|+++-+|+.||||+|.-.. .......+.+|+.++.++. |||||++|..+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcccc
Confidence 456888999999999999999999999999999997655 5566778999999999995 999999984320
Q ss_pred ------------------------------------------------c--c------------------C---------
Q psy14431 631 ------------------------------------------------A--V------------------N--------- 633 (1219)
Q Consensus 631 ------------------------------------------------~--~------------------d--------- 633 (1219)
. + +
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0 0
Q ss_pred ------------------------C--------ceEEEEEecchhh-HHHHHhhccCC--hHHHHHHHHHHHHHHHHHHh
Q psy14431 634 ------------------------N--------KDLYVVFEYMEND-LNKVIRDKILK--DVHIRYIMFQLCNGLSYIHA 678 (1219)
Q Consensus 634 ------------------------~--------~~LyLVMEymeGS-L~d~Lrs~~Ls--eeeVr~Ia~QILsALaYLHS 678 (1219)
. ..+||-||||+.+ +.+++..+.+. ....+.++.+|+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2378999999965 55566655553 67889999999999999999
Q ss_pred cccccCCCCCCCeeeccCCcceecccccccccC------------------CcccccccccccccccCchhhhccc--cc
Q psy14431 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS------------------DSKECLTEYIATRWYRAPEILISNR--RY 738 (1219)
Q Consensus 679 ~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~------------------~~~~~~ts~vGT~~Y~APEvLl~~~--~y 738 (1219)
.|||||||||.|||++.++.|||+|||+|.... .+....+..+||..|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999997621 1112346789999999999986555 69
Q ss_pred cccccchhHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcc
Q psy14431 739 THHVDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQ 817 (1219)
Q Consensus 739 T~kSDIWSLG~ILyELLTGkpPF~g-~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~ 817 (1219)
+.++|+||||||||||+. ||.. ......+..+-.+..|.++. ++ ..
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~---f~---------------------------~~ 842 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPAD---FF---------------------------DP 842 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcc---cc---------------------------cc
Confidence 999999999999999984 4643 22223333333333333311 11 11
Q ss_pred cChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 818 VVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 818 lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
--+....+|..||..||.+| |.+.|.+.|+.
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 13456778999999999985 67778888886
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=288.16 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=182.0
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.++++||.|+|+.|.+++.+.|.+.||+|++++... ...+..-...|-.+.....+||++|-+..+|. ..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--te 323 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TE 323 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--cc
Confidence 4567899999999999999999999999999999999976643 44555666778888888889999999999997 57
Q ss_pred ceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
..+++|.||++| +|.-.++ .+.++++.+++|...|+.||.|||++|||+||||.+|+|++..|++||+|+|+++.--.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 789999999995 6554444 56799999999999999999999999999999999999999999999999999987666
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP 762 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~ 762 (1219)
++..++++||||.|+|||++ .+..|++.+|+|+|||++++|+.|+.||.
T Consensus 404 ~gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 66777889999999999997 56679999999999999999999999995
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=283.01 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=169.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec--c-CCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--V-NNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~--~-d~~ 635 (1219)
-.+|+|.+.||+|||+-||++....++..||+|++.-. +..+....++|+...+.+. |||+++++++... . ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCce
Confidence 35799999999999999999999999999999998533 3567788999999999996 9999999987642 1 234
Q ss_pred eEEEEEecch-hhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCcceecccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
..||+++|.. |+|.+.+. +..+++..+..|+.+|++||.+||+.. +.||||||.|||+..++.++|+|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 5899999998 78998886 336999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCcccc---------cccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCC
Q psy14431 708 RSLSDSKEC---------LTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFP 762 (1219)
Q Consensus 708 r~l~~~~~~---------~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~ 762 (1219)
+..+-.... ...-..|..|+|||.+.- +...+.++|||||||+||.|+.|..||.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 865432111 112346889999999842 2346789999999999999999999994
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=310.88 Aligned_cols=218 Identities=28% Similarity=0.476 Sum_probs=189.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec---cCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA---VNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~---~d~~ 635 (1219)
-+.|.|...||.|.+|.||++++..+|+.+|+|+.... ......+..|..+++....|||++.+|++|.. ..++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45689999999999999999999999999999988533 23345677899999999999999999999863 3467
Q ss_pred eEEEEEecch-hhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 636 DLYVVFEYME-NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+|||||||+ |+..++++ +..+.+..+.+|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||.+..+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 8999999999 56777666 5679999999999999999999999999999999999999999999999999999988
Q ss_pred CcccccccccccccccCchhhhcc----ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 712 DSKECLTEYIATRWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~----~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P 779 (1219)
.......+.+|||.|||||++.+. ..|+..+|+||||++..||.-|.|||.+..+...+..|....+|
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 877777889999999999998543 35778999999999999999999999999988777666443333
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=289.89 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=205.8
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
-+..||.|+||+|++..++.+|+..|||.++... ......+++.|........+.||||++||... ..+..||.||+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~EGdcWiCMEL 144 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SEGDCWICMEL 144 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cCCceeeeHHH
Confidence 3567899999999999999999999999996432 34567788899998888888999999999876 56789999999
Q ss_pred chhhHHHHHh------hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 644 MENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 644 meGSL~d~Lr------s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|..+|..+.. ...+++..+-.|...++.||.||.. ..||||||||+|||++..|.|||||||++..+.++..
T Consensus 145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 9988766554 4568888888899999999999985 6899999999999999999999999999988765543
Q ss_pred cccccccccccCchhhhccc-cccccccchhHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~-~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.+.-+|-..|+|||.+-... +|+.++||||||++|||+.||..||.+.+. .+++..++.+.+|.......
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~-------- 295 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE-------- 295 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc--------
Confidence 24457888999999985433 599999999999999999999999987654 34555555554443221100
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
--+.+..+..++.-||..|-..| ....+.+||......
T Consensus 296 --------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 296 --------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred --------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 01347778999999999998775 667788888766443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=255.15 Aligned_cols=239 Identities=36% Similarity=0.622 Sum_probs=191.9
Q ss_pred CceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecchh-hHHH
Q psy14431 572 AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK 650 (1219)
Q Consensus 572 gFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d 650 (1219)
+||.||+|.+..+|..||+|++........ ...+.+|+..+..+ +||||+++++++. .....++||||+++ +|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKL-KHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhC-CCCcHHHHHhhee--eCCEEEEEEeCCCCCCHHH
Confidence 689999999999999999999864332221 56788999999999 5999999999987 45789999999997 8999
Q ss_pred HHhhcc-CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccccccCc
Q psy14431 651 VIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729 (1219)
Q Consensus 651 ~Lrs~~-LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~AP 729 (1219)
++.... ++...+..++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 887544 8899999999999999999999999999999999999999999999999998776542 23455788899999
Q ss_pred hhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhch
Q psy14431 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQ 808 (1219)
Q Consensus 730 EvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcr 808 (1219)
|.+. ...++.++||||||+++++|++|.+||...... ..+..+.....+....+
T Consensus 156 E~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------ 210 (244)
T smart00220 156 EVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE------------------------ 210 (244)
T ss_pred HHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc------------------------
Confidence 9974 556788999999999999999999999774333 33222222111111100
Q ss_pred hhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 809 KELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 809 k~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..++..+.+++.+||..||.+| +.+.++||||
T Consensus 211 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 211 -------WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -------ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0135678899999999999985 6777999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=301.96 Aligned_cols=188 Identities=30% Similarity=0.504 Sum_probs=165.0
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
-+..||.|+.|.||+|+.. ++.||||+++ .....+|.-|+.|. ||||+.|.|+|. ....+||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~---------elkETdIKHLRkLk-H~NII~FkGVCt--qsPcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR---------ELKETDIKHLRKLK-HPNIITFKGVCT--QSPCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHh---------hhhhhhHHHHHhcc-CcceeeEeeeec--CCceeEEeeec
Confidence 3567899999999999654 7889999874 22335678889996 999999999997 56789999999
Q ss_pred ch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 644 ME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 644 me-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
|. |.|..+++. ..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... .....++
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFa 272 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFA 272 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhh
Confidence 99 789999994 56889999999999999999999999999999999999999999999999999877654 2345689
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~ 767 (1219)
||..|||||++ .+.+++.++|||||||+|||||||.-||.+.+..
T Consensus 273 GTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 273 GTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 99999999997 6778999999999999999999999999876644
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=311.22 Aligned_cols=241 Identities=27% Similarity=0.423 Sum_probs=199.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+....+.||+|+||.||+|.... ....||||.++... .......|.+|+.++..+. |||||+|+|++. .
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~--~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQ-HPNIVRLLGVCR--E 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEc--c
Confidence 4456678899999999999997543 34679999986442 3345678999999999996 999999999998 6
Q ss_pred CceEEEEEecch-hhHHHHHhh-----------cc----CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-----------KI----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-----------~~----LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG 697 (1219)
++.+|||||||. |||.+|++. .. ++..+...|+.||+.|+.||-++.+|||||-.+|+||++..
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 788999999999 899999972 12 67788999999999999999999999999999999999999
Q ss_pred cceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q psy14431 698 SIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIV 774 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIv 774 (1219)
.|||+|||+++.+-..... .....-...|||||.++ .+.||+.+|||||||+|||+++ |..||.|.++.+++..|.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999865443211 11234467899999985 5579999999999999999998 999999999999999998
Q ss_pred hhcC-CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 775 NLVR-PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 775 e~l~-P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+.. +-|. ..+..+.+|+..|..-+|.+|+
T Consensus 720 ~g~lL~~Pe----------------------------------~CP~~vY~LM~~CW~~~P~~RP 750 (774)
T KOG1026|consen 720 AGQLLSCPE----------------------------------NCPTEVYSLMLECWNENPKRRP 750 (774)
T ss_pred cCCcccCCC----------------------------------CCCHHHHHHHHHHhhcCcccCC
Confidence 7762 2222 2366788889999999998863
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=301.15 Aligned_cols=234 Identities=24% Similarity=0.419 Sum_probs=195.0
Q ss_pred EEeeeeccCceEEEEEEEcCC----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNN----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~T----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..++||.|-||.||.|..... .-.||||..+.. ....+...|+.|..+++.+. |||||+++|++. ....||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfd-HphIikLIGv~~---e~P~Wi 467 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCV---EQPMWI 467 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCC-Ccchhheeeeee---ccceeE
Confidence 456789999999999986543 345999988643 34455788999999999996 999999999996 567999
Q ss_pred EEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||.++ |.|..++.. ..++......|++||+.||.|||+.++|||||-..|||+.....|||+|||+++++.+....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999 899999984 45888888999999999999999999999999999999999999999999999998765432
Q ss_pred cc-cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCC-CCCCchhhhhccCC
Q psy14431 717 LT-EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKS 793 (1219)
Q Consensus 717 ~t-s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P-~P~~~d~l~~~~~s 793 (1219)
.. ...-+.-|||||.+ ....++.++|||-|||.+||++. |..||.|..+.+++..|-++.++ .|+.
T Consensus 548 kaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n---------- 616 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN---------- 616 (974)
T ss_pred hccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC----------
Confidence 22 22235569999997 56679999999999999999987 99999999998888888888744 3332
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
++|.+..|..+|+.|+|.+|
T Consensus 617 ------------------------CPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 617 ------------------------CPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred ------------------------CChHHHHHHHHHhccCcccC
Confidence 35666777888888988885
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=310.73 Aligned_cols=213 Identities=27% Similarity=0.458 Sum_probs=178.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCC-----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TG-----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.......||.|.||.||.|...... ..||||.+.+. .+......|++|..+|..+. |||||+++|++. +.+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l--~~~ 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCL--DSG 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeec--CCC
Confidence 4567788999999999999875432 23999988643 34566788999999999995 999999999987 477
Q ss_pred eEEEEEecch-hhHHHHHhhc--------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~--------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
.++|++|||. |+|..|++.. .++..+...++.+|+.|+.||+++++|||||..+|+|++....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 8999999998 6999999854 378889999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccc--cccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 707 ARSLSDSKECLTEY--IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~--vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
|+.+.......... .-...|||||.+. .+.++.++|||||||++||+++ |..||++.++.+++...+.+-+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 99544332211111 2345799999985 4679999999999999999999 8999999999998886666553
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=267.64 Aligned_cols=215 Identities=26% Similarity=0.433 Sum_probs=182.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
...+..||.|+||.|-+.++..+|...|+|.+..... .....+.++|+.+..+...+|++|.+||.+. ..+.+++.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwIcM 124 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWICM 124 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEEeH
Confidence 3445678999999999999999999999999975544 4566788999999988888999999999876 567899999
Q ss_pred ecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 642 EYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 642 EymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|.|..+|..+.+ ++.+++..+-.|+..++.||.|||+. .|||||+||+|||+|.+|+||+||||.+..+.++..
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 999999888765 45689999999999999999999975 899999999999999999999999999998876543
Q ss_pred ccccccccccccCchhhh---ccccccccccchhHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhhcCCC
Q psy14431 716 CLTEYIATRWYRAPEILI---SNRRYTHHVDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLIVNLVRPN 780 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl---~~~~yT~kSDIWSLG~ILyELLTGkpPF~g-~s~~e~L~kIve~l~P~ 780 (1219)
. +-..|...|+|||.+. ....|+.++||||||++++||.+++.||+. .++.+++..++.-..|.
T Consensus 205 k-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 205 K-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred H-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 2 2245677899999973 234799999999999999999999999974 56778888887655443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=284.67 Aligned_cols=274 Identities=18% Similarity=0.223 Sum_probs=182.3
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEc----------------CCCeEEEEEEeeccccC------------chhHHHH
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDK----------------NNKQYVAIKKIFEAFRN------------KTDAQRT 606 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk----------------~TGk~VAIKvI~ks~~s------------~~~~e~~ 606 (1219)
.+...++|.+.++||+|+||+||+|.+. ..++.||||.+...... .......
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4556779999999999999999999752 23567999998532110 0011223
Q ss_pred HHHHHHHHhccCCC----CccEEeeeeecc------CCceEEEEEecch-hhHHHHHhhc--------------------
Q psy14431 607 YREILFLKSFQRHP----NIITMLDIYKAV------NNKDLYVVFEYME-NDLNKVIRDK-------------------- 655 (1219)
Q Consensus 607 lREI~ILr~L~~HP----NIVkL~gvfe~~------d~~~LyLVMEyme-GSL~d~Lrs~-------------------- 655 (1219)
..|+.++..+.++| +++.++++|... ..+..||||||++ ++|.+++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 45667777775322 346777776421 2356899999998 4787776521
Q ss_pred -----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc-cccccccccccCc
Q psy14431 656 -----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAP 729 (1219)
Q Consensus 656 -----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~-~ts~vGT~~Y~AP 729 (1219)
.+++..++.++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++......... .....+|+.|+||
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1345668889999999999999999999999999999999999999999999765432211 1123447899999
Q ss_pred hhhhcccc-------------------c--cccccchhHHHHHHHHHhCCC-CCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 730 EILISNRR-------------------Y--THHVDIWSLGCILAEMLQSKP-LFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 730 EvLl~~~~-------------------y--T~kSDIWSLG~ILyELLTGkp-PF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
|.+..... | ....||||+|||+|+|++|.. ||.+....... ..........|.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~~~~~~r-- 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDNDLNRWR-- 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---HhhccchHHHHH--
Confidence 99743210 1 124799999999999999874 77543211100 000000000000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCC---CC--CHHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDS---KD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DP---eK--RaiEALqHpwfaL 849 (1219)
... .....+. .+...++.+.||+.+||..+| .+ ++.++|.||||..
T Consensus 455 --------------~~~-~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 455 --------------MYK-GQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --------------hhc-ccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 0001111 244568899999999999876 33 6999999999954
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=241.88 Aligned_cols=215 Identities=35% Similarity=0.545 Sum_probs=178.4
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+...||.|++|.||+|.+..++..||+|.+...... .....+.+|+..+..+. |+|++++++++. .....++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~--~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLK-HPNIVKLYGVFE--DPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCC-CCChhhheeeee--cCCceEEEE
Confidence 56778999999999999999988999999998643222 24567888999999995 999999999886 456789999
Q ss_pred ecchh-hHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-ccc
Q psy14431 642 EYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-ECL 717 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~--LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-~~~ 717 (1219)
||+++ +|.+++.... ++...+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99997 8999887543 8899999999999999999999999999999999999999999999999998776542 122
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC-CCcH-HHHHHHHhhcCCC
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG-ASTS-HQLQLIVNLVRPN 780 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g-~s~~-e~L~kIve~l~P~ 780 (1219)
....++..|++||.+.....++.++|+||||+++++|++|++||.+ .++. .+...|..+.+++
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 3456788999999964455678899999999999999999999987 4444 5555565555333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=278.43 Aligned_cols=242 Identities=23% Similarity=0.389 Sum_probs=202.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
.+...+||.|-||.||.|.++...-.||||.++. +......|+.|..+|+.+. |||+|+|+|+|. ....+|||+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT--~EpPFYIiT 342 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--HEPPFYIIT 342 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhc-CccHHHHhhhhc--cCCCeEEEE
Confidence 4577899999999999999999999999998863 3456788999999999996 999999999997 466799999
Q ss_pred ecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 642 EYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||. |+|.++++.. -++...+.+++.||..|+.||...++|||||-..|+||..+..||++|||+++.+.... +
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--Y 420 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--Y 420 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--e
Confidence 9998 8999999843 36666778899999999999999999999999999999999999999999999876543 2
Q ss_pred cccc---ccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 718 TEYI---ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 718 ts~v---GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
+... ..+-|.|||.+ ....++.++|||+|||+|||+.| |-.||+|.+-..++..+-++.+...+
T Consensus 421 TAHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P----------- 488 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP----------- 488 (1157)
T ss_pred ecccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC-----------
Confidence 2223 35669999997 45568999999999999999998 88999999988888877776644332
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcch
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGK 845 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHp 845 (1219)
. .+++.+..|+..|++|+|..|+.-+-.|.
T Consensus 489 -----------e-----------GCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 489 -----------E-----------GCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -----------C-----------CCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 1 22566777888888888888766665555
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=283.25 Aligned_cols=210 Identities=24% Similarity=0.376 Sum_probs=178.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCC-C--eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNN-K--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~T-G--k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
....++||+|+||+||.|.+... | ..||||.+....... ....|++|+.+|..+. |||+|+|||+.. +..+.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~-H~hliRLyGvVl---~qp~m 186 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQ-HPHLIRLYGVVL---DQPAM 186 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhcc-CcceeEEeeeec---cchhh
Confidence 44567899999999999988753 3 459999986544332 6678999999999996 999999999987 35688
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||+++ |+|.+.++. ..|....+..|+.||+.|+.||.+.++|||||-..|||+-....|||||||+.+.++...
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999 789888874 457788889999999999999999999999999999999998899999999999887655
Q ss_pred cccc---cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc
Q psy14431 715 ECLT---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 715 ~~~t---s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l 777 (1219)
..+. .......|+|||.+ ....++.++|||+|||++|||++ |..||.|.+...++.+|-.+-
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE 332 (1039)
T ss_pred cceEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence 4332 12235679999997 56679999999999999999998 789999999999999887554
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=291.74 Aligned_cols=239 Identities=28% Similarity=0.381 Sum_probs=186.2
Q ss_pred eeeeccCceE-EEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGI-VYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGt-VYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+.+|.|+.|+ ||+|. ..|+.||||.+.. .......+|+..|+....|||||++|+.- .+..+.||+.|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHh
Confidence 4458999875 79995 4588999998842 34456789999999999999999998654 4788999999999
Q ss_pred hhhHHHHHhhcc-----CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CC--cceecccccccccCCcc
Q psy14431 645 ENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SC--SIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 645 eGSL~d~Lrs~~-----LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG--~VKLiDFGLAr~l~~~~ 714 (1219)
..+|.+++.... ......+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.+..+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999999998631 122456789999999999999999999999999999975 34 58999999999887654
Q ss_pred cc---cccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 715 EC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 715 ~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.. ..+..||.+|+|||++.. ...+.++||||+||++|+.++| .+||...-. .-.+|+.+..-.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L---------- 732 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTL---------- 732 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccce----------
Confidence 33 345789999999999854 4467799999999999999986 899954322 223444332100
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLA 847 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwf 847 (1219)
..+.+.....+.|||.+||.+||.. ++.++|.||+|
T Consensus 733 ---------------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 733 ---------------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred ---------------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 0011111227999999999999988 58899999998
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=287.11 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=206.1
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCC---eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TG---k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.-+.....|.++||.|.||.||.|+.+..| ..||||.++..+ .......|+.|..||-++. ||||++|-|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVT-- 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVT-- 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEe--
Confidence 345666788899999999999999988766 569999996443 3455678999999999996 999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
....+.||.|||+ |+|..|++ .+.|+..++.-+++.|+.|+.||-+.|+|||||-..|||||.+..+|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 5667889999999 79999998 46799999999999999999999999999999999999999999999999999998
Q ss_pred cCCcccc-cccccc--cccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC-CCCCCc
Q psy14431 710 LSDSKEC-LTEYIA--TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHA 784 (1219)
Q Consensus 710 l~~~~~~-~ts~vG--T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~-P~P~~~ 784 (1219)
+.+.... +++..| ...|.|||.+ ....++.++||||||++|||.++ |..||-..++.+++..|..+.+ |+|.+.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence 7554422 222222 4679999997 56779999999999999999776 9999999999999999999884 444433
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCC
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSK 835 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPe 835 (1219)
+. ... ++...|+..-...+|.+ .++...|.+|+ .+|.
T Consensus 860 P~--------aL~----qLMldCWqkdR~~RP~F-~qiV~~lDklI-rnP~ 896 (996)
T KOG0196|consen 860 PA--------ALY----QLMLDCWQKDRNRRPKF-AQIVSTLDKLI-RNPN 896 (996)
T ss_pred cH--------HHH----HHHHHHHHHHhhcCCCH-HHHHHHHHHHh-cCch
Confidence 22 112 23333433333333443 23566677766 3453
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=294.99 Aligned_cols=186 Identities=27% Similarity=0.414 Sum_probs=154.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|.....||.|+||.||+|.+..+|..||+|.+..... ....|+.++..+. |||||+++++|. +...+|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~-HpnIv~~~~~~~--~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQ-HPNIVKLIGLCR--SEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCC-CCCcceEEEEEE--cCCCCEEE
Confidence 35566789999999999999999999999998853211 1124578888885 999999999997 45678999
Q ss_pred Eecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHH---hcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 641 FEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH---ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLH---S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||++ |+|.++++. +++..+..++.+|+.||.||| +.+|+||||||+||+++.++.++++ ||.+......
T Consensus 762 ~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred EeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99998 689998863 788899999999999999999 6799999999999999998887765 6655443222
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
....+|+.|+|||++ .+..++.++|||||||++|||++|++||..
T Consensus 836 -~~~~~t~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 -TKCFISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -CCccccccccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 233688999999997 456799999999999999999999999853
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=281.95 Aligned_cols=204 Identities=26% Similarity=0.430 Sum_probs=177.7
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc------cCchhHHHHHHHHHHHHhcc--CCCCccEEe
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF------RNKTDAQRTYREILFLKSFQ--RHPNIITML 626 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~------~s~~~~e~~lREI~ILr~L~--~HPNIVkL~ 626 (1219)
..-.+.+|..+..+|.|+||.||+|.++.....|+||.+++.. ..+......-.||.||..+. .|+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 3445788999999999999999999999999999999987543 22333344557999999885 489999999
Q ss_pred eeeeccCCceEEEEEecch-h-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 627 DIYKAVNNKDLYVVFEYME-N-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 627 gvfe~~d~~~LyLVMEyme-G-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
++|+ +++++||+||--+ | +|.+++. ...+++..++.|+.|++.|+++||+.||||||||-+|++++.+|.+||+|
T Consensus 636 dfFE--ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 636 DFFE--DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred heee--cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 9998 6789999999887 3 8999998 45699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCC
Q psy14431 704 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP 762 (1219)
Q Consensus 704 FGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~ 762 (1219)
||.|....+++ ...++||..|.|||++-+....+..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998876653 5568999999999998666666889999999999999999888874
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=273.04 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=198.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-+...++++||+|-||.|.+|.- ..+..||+|.++.... ......+.+|+.+|.+++ |||||.++|+|. .++.+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~--~DePic 611 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLK-HPNIVELLGVCV--QDDPLC 611 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccC-CCCeeEEEeeee--cCCchH
Confidence 34567899999999999999974 4478999999875433 333578999999999995 999999999997 567899
Q ss_pred EEEecch-hhHHHHHhhcc---CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~---LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+|||+ |+|.+|+.... ........|+.||+.|++||.+.++|||||.|.|+|++.++++||+|||+++.+-.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999 79999998552 2344566799999999999999999999999999999999999999999999554432
Q ss_pred c--ccccccccccccCchhhhccccccccccchhHHHHHHHHH--hCCCCCCCCCcHHHHHHHHhhcCCCC-CCchhhhh
Q psy14431 715 E--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML--QSKPLFPGASTSHQLQLIVNLVRPNP-PHADKFYA 789 (1219)
Q Consensus 715 ~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELL--TGkpPF~g~s~~e~L~kIve~l~P~P-~~~d~l~~ 789 (1219)
. .....+-+..|||||.++.+ .++.++|+|+||+++||++ |...||...++.+...+....+...+ ....
T Consensus 692 yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l---- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL---- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec----
Confidence 1 22345667899999998654 5999999999999999976 47899998888877777665552221 1111
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhh
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLA 847 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwf 847 (1219)
..|.. ++..+..|+-+|..+|..+|+.-.--|.++
T Consensus 767 ------------~~P~~-----------cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 767 ------------SRPPA-----------CPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred ------------cCCCc-----------CcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 11212 245567778889988888765544444433
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=278.22 Aligned_cols=239 Identities=30% Similarity=0.452 Sum_probs=193.0
Q ss_pred eEEeeeeccCceEEEEEEEc----C---CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 563 INLLKEGKGAYGIVYKAYDK----N---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk----~---TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+.+.||+|.||.||+|... . ....||||.+...... .....+..|+.++..+..||||+.++|++.. .+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~ 375 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DG 375 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--CC
Confidence 34558999999999999743 1 2467999988655444 6778899999999999999999999999874 77
Q ss_pred eEEEEEecch-hhHHHHHhhcc-----------------CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKI-----------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~-----------------LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG 697 (1219)
.+++|+||+. |+|..+++... ++..+...+++||+.|++||++.++|||||-.+|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 8999999999 79999998666 88889999999999999999999999999999999999999
Q ss_pred cceecccccccccCCccccc-ccccc--cccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCC-cHHHHHH
Q psy14431 698 SIKIGDLGLARSLSDSKECL-TEYIA--TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAS-TSHQLQL 772 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~~~~~~-ts~vG--T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s-~~e~L~k 772 (1219)
.+||+|||+|+...+..... ....+ ...|||||.+. ...|+.++|||||||+|||+++ |.+||++.. ..+.+..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999999665433222 22222 34599999985 4789999999999999999998 889999865 5555666
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..+.++..|. ..++++.+++..|...+|.+|+
T Consensus 535 l~~G~r~~~P~---------------------------------~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 535 LKEGNRMEQPE---------------------------------HCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred HhcCCCCCCCC---------------------------------CCCHHHHHHHHHHhCCCcccCC
Confidence 66666544331 1255666777778888887763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=221.16 Aligned_cols=183 Identities=38% Similarity=0.691 Sum_probs=156.8
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-h
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-N 646 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-G 646 (1219)
||.|++|.||++.+..+|..+++|++....... ....+.+|+..+..+. |++|+++++++. .....++||||++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN-HPNIVKLYGVFE--DENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcC-CCCeeeEeeeee--cCCeEEEEEecCCCC
Confidence 689999999999998889999999986432211 3467889999999996 899999999987 3478999999999 6
Q ss_pred hHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceecccccccccCCccccccccccc
Q psy14431 647 DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIAT 723 (1219)
Q Consensus 647 SL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~~~~ts~vGT 723 (1219)
+|..++... .++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+.
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 899998865 6899999999999999999999999999999999999999 8999999999998766543223445678
Q ss_pred ccccCchhhhccccccccccchhHHHHHHHH
Q psy14431 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEM 754 (1219)
Q Consensus 724 ~~Y~APEvLl~~~~yT~kSDIWSLG~ILyEL 754 (1219)
..|++||.+.....++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 8999999974433788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=274.52 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=208.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.--++|..+..+|.|+||.||+|+++.++...|+|+++-. ...+..-+..|+.+++.++ |||||.+++.|. ....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~-h~nivay~gsyl--r~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYL--RRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCC-CcChHHHHhhhh--hhcC
Confidence 3356788999999999999999999999999999999643 2344556778999999996 999999999987 4567
Q ss_pred EEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
++++||||+| +|.+... .+++++.++.++.+..+.||.|||+.|-+|||||-.|||+++.|.|++.|||.+..+....
T Consensus 87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999995 7887776 6789999999999999999999999999999999999999999999999999999888766
Q ss_pred cccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 ECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
....+++||++|||||+-. ..+.|...+|||++|++..++.--+||.....+...+..+.+....+|..-++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~----- 241 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT----- 241 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc-----
Confidence 6677899999999999952 345799999999999999999998988877777776666554442222211111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..++.+-+|++..|..+|++| +...|+|||..
T Consensus 242 ------------------------kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 242 ------------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred ------------------------cchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 113345566777777777775 44457777653
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=258.59 Aligned_cols=196 Identities=25% Similarity=0.348 Sum_probs=160.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc-CCCCccEEeeeeeccC--Cc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVN--NK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~-~HPNIVkL~gvfe~~d--~~ 635 (1219)
+.....+..||+|.||.||+|.. +++.||||++. ..+...+..|-.|+.... .|+||+++++.-...+ .-
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 33455667889999999999954 46999999984 345566777877776543 5999999998754222 34
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc---------ccccCCCCCCCeeeccCCcceecccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC---------KVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~---------GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
.++||++|.+ |+|.+++....+++.....++..+++||+|||+- +|+|||||..||||..|++..|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 6899999999 8999999999999999999999999999999962 69999999999999999999999999
Q ss_pred cccccCCcc--cccccccccccccCchhhhcccccc-----ccccchhHHHHHHHHHhCCCCC
Q psy14431 706 LARSLSDSK--ECLTEYIATRWYRAPEILISNRRYT-----HHVDIWSLGCILAEMLQSKPLF 761 (1219)
Q Consensus 706 LAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT-----~kSDIWSLG~ILyELLTGkpPF 761 (1219)
+|..+.++. .....-+||..|||||++-+.-.+. .++||||+|.++|||++....+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 998876532 2233478999999999985433332 4689999999999999976544
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=253.56 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=157.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc-CCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~-~HPNIVkL~gvfe~~d~ 634 (1219)
+---.+..+++.||+|.||.||+|.++ |..||||+|. ..+-...++|..|++... +|+||+.+++.-....+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~-----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS-----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEec-----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 333456889999999999999999665 8899999995 234456788888886543 79999999876432222
Q ss_pred --ceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc--------ccccCCCCCCCeeeccCCcceecc
Q psy14431 635 --KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 635 --~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~--------GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
..+|||++|-+ |+|++++....++......++..++.||+|||-. .|.|||||..||||..+|..-|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 45899999999 8999999999999999999999999999999942 599999999999999999999999
Q ss_pred cccccccCCcc----cccccccccccccCchhhhccc---cc--cccccchhHHHHHHHHHh
Q psy14431 704 LGLARSLSDSK----ECLTEYIATRWYRAPEILISNR---RY--THHVDIWSLGCILAEMLQ 756 (1219)
Q Consensus 704 FGLAr~l~~~~----~~~ts~vGT~~Y~APEvLl~~~---~y--T~kSDIWSLG~ILyELLT 756 (1219)
+|+|-...... ......+||..|||||++-..- .+ -..+||||||.++||++.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99997665432 1234568999999999983221 11 136899999999999975
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=245.98 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=191.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+.|.|.+.+|+|.||.+.+|.++.+...+++|.+..+ ......+.+|...-..+..|.||+.-|++-.. ..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEE
Confidence 45688889999999999999999999999999988654 34567788998887888889999998876432 455788
Q ss_pred EEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc--CCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+++||++ |+|..-+....+.+...+.++.|+++|+.|+|+.++||||||.+||||-. ...|||||||..+..+....
T Consensus 99 F~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred EeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9999999 89999988888999999999999999999999999999999999999943 34799999999987664432
Q ss_pred ccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 716 CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
..-.+..|.|||++.. .-...+.+|+|.||+++|.+++|.+||...... .++.|
T Consensus 179 ---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~------------d~~Y~------- 236 (378)
T KOG1345|consen 179 ---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM------------DKPYW------- 236 (378)
T ss_pred ---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc------------CchHH-------
Confidence 2234567999998632 223578899999999999999999999643211 11111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
.+..........++..|..+++.+..+.++-|..+|.+|
T Consensus 237 -------~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 237 -------EWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred -------HHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 011222223334556666778888888888888888775
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=262.38 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=173.7
Q ss_pred eEEeeeeccCceEEEEEEEcCCC----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TG----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...++||.|+||+||+|.+-..| .+||||++.. .........++.|+.+|.++. |||++++++++.. ..+-
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~---s~~q 773 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLD-HPNLLRLLGVCML---STLQ 773 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCC-CchHHHHhhhccc---chHH
Confidence 34678999999999999986555 4688888753 334455678999999999995 9999999999863 3488
Q ss_pred EEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||++|++ |+|.++++ ...+.......|.+||+.|+.|||..++|||||-.+||||..-.+|||.|||+++...+...
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999 78999998 45688889999999999999999999999999999999999999999999999998876543
Q ss_pred cccc--ccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc
Q psy14431 716 CLTE--YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 716 ~~ts--~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l 777 (1219)
.+.. ....+-|+|-|.+ ....|+.++|||||||++||++| |..||.+.+..++-..+-.+.
T Consensus 854 ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence 3332 2235568888887 56679999999999999999998 999999988777665555544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-23 Score=209.24 Aligned_cols=257 Identities=32% Similarity=0.535 Sum_probs=195.3
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch-hHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~-~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
|.+...||.|+||.||.+.+. ..+++|.+........ ....+.+|+.++..+..|++|+++++++. .....++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEE
Confidence 778899999999999999887 7799999876655443 56788899999999974448999999995 45558999
Q ss_pred Eecchh-hHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCcc
Q psy14431 641 FEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~~ 714 (1219)
++++.+ ++..++... .++...+..++.+++.++.|+|+.|++|||+||.||+++..+ .++++|||.+..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999995 677666644 689999999999999999999999999999999999999988 79999999998655433
Q ss_pred c------ccccccccccccCchhhhcc--ccccccccchhHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhhcCC-CC
Q psy14431 715 E------CLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRP-NP 781 (1219)
Q Consensus 715 ~------~~ts~vGT~~Y~APEvLl~~--~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~----~e~L~kIve~l~P-~P 781 (1219)
. .....+||.+|+|||.+.+. ..++..+|+||+|++++++++|..||..... ......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 1 24567899999999998553 5788999999999999999999999887664 2333333222222 11
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....... . ........+++.+++..+|..| ......++|...
T Consensus 237 ~~~~~~~-----~---------------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SPLSPSN-----P---------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccCccc-----c---------------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111000 0 2223467888999999999875 444444544433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=266.03 Aligned_cols=194 Identities=14% Similarity=0.188 Sum_probs=141.0
Q ss_pred CCccEEeeeeec-----cCCceEEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCee
Q psy14431 620 PNIITMLDIYKA-----VNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL 692 (1219)
Q Consensus 620 PNIVkL~gvfe~-----~d~~~LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNIL 692 (1219)
+||+.++++|.. .....++++|||++++|.+++.. ..++...+..|+.||+.||.|||++||+||||||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 577888887731 12345788999999999999974 45899999999999999999999999999999999999
Q ss_pred ecc-------------------CCcceecccccccccCCcc----------------cccccccccccccCchhhhcccc
Q psy14431 693 IDK-------------------SCSIKIGDLGLARSLSDSK----------------ECLTEYIATRWYRAPEILISNRR 737 (1219)
Q Consensus 693 Ld~-------------------dG~VKLiDFGLAr~l~~~~----------------~~~ts~vGT~~Y~APEvLl~~~~ 737 (1219)
|+. ++.++|+|||+++...... ......+||++|+|||++. +..
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~ 191 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN-GSS 191 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc-cCC
Confidence 954 4456777777775422100 0011246899999999975 456
Q ss_pred ccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcc
Q psy14431 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQ 817 (1219)
Q Consensus 738 yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~ 817 (1219)
|+.++|||||||+||||++|.+||.... ..+..+.....| +. ...
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~--~~-------------------------------~~~ 236 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP--PQ-------------------------------ILL 236 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC--hh-------------------------------hhh
Confidence 8999999999999999999998875321 112222111111 00 001
Q ss_pred cChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 818 VVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 818 lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+...+++.+||..||.+| +.++|+|||+..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 13446688899999999885 788899999954
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=220.29 Aligned_cols=203 Identities=22% Similarity=0.257 Sum_probs=164.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCC-eEEEEEEeeccccCchhHHHHHHHHHHHHhcc---CCCCccEEeeeeeccCCce
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNK-QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---RHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TG-k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~---~HPNIVkL~gvfe~~d~~~ 636 (1219)
+|.+.++||.|+||.||.|.+..++ ..+|+|+......... ..+..|..++..+. +.++++.+++.+. ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999988775 6789998754322211 15667888888886 3468999998874 35667
Q ss_pred EEEEEecchhhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-----Ccceeccccccc
Q psy14431 637 LYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-----CSIKIGDLGLAR 708 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-----G~VKLiDFGLAr 708 (1219)
-|+||+.++.+|.++.. .+.++..++..++.|++.+|.+||+.|++||||||.|++++.. ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 89999999999999875 2569999999999999999999999999999999999999865 359999999998
Q ss_pred --ccCCcc--------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH
Q psy14431 709 --SLSDSK--------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767 (1219)
Q Consensus 709 --~l~~~~--------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~ 767 (1219)
.+.... .....+.||..|+++... .+...+.+.|+||++.++.+++.|..||.+....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 322111 101245699999999986 4567899999999999999999999999776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=195.99 Aligned_cols=163 Identities=20% Similarity=0.245 Sum_probs=123.3
Q ss_pred hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccccc
Q psy14431 646 NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723 (1219)
Q Consensus 646 GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT 723 (1219)
|+|.+++.. ..+++..++.|+.||+.||.|||+.| ||+|||++.++.+++ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 578888873 45999999999999999999999998 999999999999999 9999876542 22689
Q ss_pred ccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH
Q psy14431 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ 802 (1219)
Q Consensus 724 ~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k 802 (1219)
+.|+|||++. +..++.++|||||||++|+|++|.+||...... ..+..+.....+..+.....
T Consensus 68 ~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 131 (176)
T smart00750 68 PYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSN--------------- 131 (176)
T ss_pred ccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccccc---------------
Confidence 9999999984 556899999999999999999999999765432 22333333222111100000
Q ss_pred hhhhchhhHHHHhcccC--hhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 803 VVVKCQKELQELQSQVV--EENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 803 lp~kcrk~L~el~p~ls--peaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. ...+ +.+.+++.+||..||.+| +.+.+.|+|+..
T Consensus 132 --------~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 --------L----ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred --------H----HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 0011 368999999999999985 677799998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=209.16 Aligned_cols=207 Identities=18% Similarity=0.225 Sum_probs=171.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+..|.++++||.|+||.+|+|....+|..||||+-..... ...+..|..++..+.+.+.|+.+..++. +..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcc--ccccc
Confidence 36789999999999999999999999999999998643322 2346788899999988888888877665 56677
Q ss_pred EEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---CcceecccccccccCC
Q psy14431 638 YVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr~l~~ 712 (1219)
++||+.++.+|.+++. ...|+..++..++-|++.-++|+|..++|||||||+|+|+.-+ ..+.|+|||+|..+.+
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 9999999999999887 5679999999999999999999999999999999999999644 3589999999987755
Q ss_pred cc-------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14431 713 SK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 771 (1219)
Q Consensus 713 ~~-------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~ 771 (1219)
.. ..-....||..|.+-.... +...+.+.|+-|+|.++..+..|..||.|.......+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 32 1223578999998876653 3346788999999999999999999999866554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=222.01 Aligned_cols=175 Identities=18% Similarity=0.188 Sum_probs=130.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-CCeEEEEEEeecccc---CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-TGk~VAIKvI~ks~~---s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...|.+.+.||+|+||.||+|.+.. ++..||||++..... .......+.+|+.+|..+. |+||++.+..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT----- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc-----
Confidence 4579999999999999999998876 788889998753211 2223456889999999996 99988533221
Q ss_pred ceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCC-CCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL-KPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDL-KPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+..||||||++| +|. .+. ... ...++.+++.||.|||+.||+|||| ||+|||++.++.++|+|||+|+.+..
T Consensus 91 ~~~~LVmE~~~G~~L~-~~~--~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 GKDGLVRGWTEGVPLH-LAR--PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CCcEEEEEccCCCCHH-HhC--ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 347999999986 564 221 111 2467899999999999999999999 99999999999999999999987654
Q ss_pred ccc--------ccccccccccccCchhhhc-----cccccccccch
Q psy14431 713 SKE--------CLTEYIATRWYRAPEILIS-----NRRYTHHVDIW 745 (1219)
Q Consensus 713 ~~~--------~~ts~vGT~~Y~APEvLl~-----~~~yT~kSDIW 745 (1219)
... ......+++.|+|||.+.. ....+...|-|
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 321 1234567888999999732 12233456666
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=215.95 Aligned_cols=214 Identities=19% Similarity=0.320 Sum_probs=173.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCe-----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQ-----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk-----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
++..-.+-+|.||.||.|++.+... .|.+|.+. ...+......++.|-..+..+. |||+.++.++... +...
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie-~~~~ 362 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE-DYAT 362 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEee-ccCc
Confidence 5566677899999999998765433 35556553 2234555677888999999996 9999999998865 5677
Q ss_pred EEEEEecch-hhHHHHHhh---------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRD---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs---------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
+++++++++ |+|..|+.- ..++..++..++.|++.|++|||+.||||.||-..|.+|++.-.|||+|-.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 899999999 899999871 2366667888999999999999999999999999999999999999999999
Q ss_pred ccccCCcccc-ccc-ccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 707 ARSLSDSKEC-LTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 707 Ar~l~~~~~~-~ts-~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P 779 (1219)
++.+.+.... ..+ -..+..||+||.+ .+..|+.++|+|||||++|||+| |+.||..-++.++...+..+.+-
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 9976654321 111 1235569999998 45679999999999999999998 99999999999988888877743
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=240.75 Aligned_cols=258 Identities=24% Similarity=0.266 Sum_probs=189.6
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeec----cccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFE----AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~k----s~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
....+|.|+||.|+.+........++.|.+.. ..........+..|..+-..+. |||++..+..+.. ....+-
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~--~~~~~~ 398 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE--IDGILQ 398 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh--cccchh
Confidence 34567999999999988877777677775541 1111111222555666666775 9999888777653 222333
Q ss_pred EEecchhhHHHHHhhc-cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc---
Q psy14431 640 VFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--- 715 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs~-~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--- 715 (1219)
+||||+++|..++... .++...+..++.|++.|+.|||+.||.|||+||+|+++..+|.+||+|||.+..+..+..
T Consensus 399 ~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 4999999999988865 799999999999999999999999999999999999999999999999999986654332
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+|+..|+|||++.+...-...+||||.|++++.|++|+.||......+.... .... ..+.
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--~~~~---~~~~--------- 544 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--TNNY---SDQR--------- 544 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--hhcc---cccc---------
Confidence 345688999999999986554445679999999999999999999965443322110 0000 0000
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.-......+...++.....+|.+||++||.+| ..++++.+|++-
T Consensus 545 -----------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 545 -----------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred -----------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 00112233445567788999999999999995 677799999965
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-19 Score=219.50 Aligned_cols=539 Identities=40% Similarity=0.536 Sum_probs=393.0
Q ss_pred HhhHHHhhhhhhhhHHhhhhhhhhh--hhccchhhhhHHHHHHHHHHHHhHhhhhhccccccchhHHHHHHHHH------
Q psy14431 232 RNKHRELQLAEDNRHLGEKVSSLEK--ECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKD------ 303 (1219)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 303 (1219)
.-...++++.+.+|...|+++..|+ ..+-++++++..|.++||++..|..+ ||..+|.+--++...|.+
T Consensus 641 ~~~~~l~k~~el~r~~~e~~~~~ek~~~e~~~e~~lk~~q~~~eq~~~E~~~~---~L~~~e~~~~e~~~~lseek~ar~ 717 (1317)
T KOG0612|consen 641 AGKKELLKVEELKRENQERISDSEKEALEIKLERKLKMLQNELEQENAEHHRL---RLQDKEAQMKEIESKLSEEKSARE 717 (1317)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HHhhHHHHHHHHHHHhcccccHHH
Confidence 3345567788899999999999999 88899999999999999999999999 888874433333333221
Q ss_pred HHHhhccCCcchhhhhcCCcccccchHHhHHHHhhchHHHHHHHHhhhhhHHHHHHHhhhhhhhHHHHHHHhhhcccccc
Q psy14431 304 LMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSD 383 (1219)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (1219)
-+..++..+..-.++|+| ||+-+- +.+|-++--. ++.......|+++|++|..+|-.++..
T Consensus 718 k~e~~~~~i~~e~e~L~~------d~~~~~-----------~~~~~l~r~~--~~~~~~vl~Lq~~LEqe~~~r~~~~~e 778 (1317)
T KOG0612|consen 718 KAENLLLEIEAELEYLSN------DYKQSQ-----------EKLNELRRSK--DQLITEVLKLQSMLEQEISKRLSLQRE 778 (1317)
T ss_pred HHHHHHHHHHHHHHHHhh------hhhhhc-----------cchhhhhhhH--HHHHHHHHHHHHHHHHHHHHhhhhHHH
Confidence 112222222222222322 333322 2222222111 122223346899999999999999999
Q ss_pred ccchhhhhhhhHhhHHHHHHHHHHHHHHHHhhHHHhhhhccccchhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy14431 384 LSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDE 463 (1219)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 463 (1219)
|+.+.+++.| +.+|+|+.+.++.|++.|++||++...|.+...-..-|||++|+||++|+|||++||||+.|.+++..+
T Consensus 779 Lssq~~~~~t-~~~Ekq~~~~~~~l~~~K~~~e~~~~q~~~~~~~~~~~~k~lq~~leae~~~~~~~ktq~~e~~e~~~e 857 (1317)
T KOG0612|consen 779 LKSQEQEVNT-KMLEKQLKKLLDELAELKKQLEEENAQLRGLNRSAWGQMKELQDQLEAEQCFSSLMKTQIIEDREEIAE 857 (1317)
T ss_pred hhhHHHhhcc-HHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccccchhhhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 9999999999 999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred HhhhhhhhHHhhhhhhHHHHHHHHHHhHHHHHhhhHHHHHhhhhhHHHhHHhhHHHHHhcccCCcccccccccCCccccc
Q psy14431 464 RSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREV 543 (1219)
Q Consensus 464 ~~~~~~~l~~~r~~e~~~~~~~e~r~d~~~~ar~~~E~~vsElE~Ek~mr~seledLm~s~rss~Sss~Sl~Sn~k~rev 543 (1219)
+. +.++.||.-..++........+...+++.. ++.+.+++.+..... .++++..++..
T Consensus 858 k~---~~~~~er~~~~~Q~~~~~~~~~~~~la~~~-ee~~~el~~e~~~~~--t~~~~g~hRqe---------------- 915 (1317)
T KOG0612|consen 858 KN---QSLQAERMLLPKQVEQAVTKADSEQLARSL-EERIEELEQEKISKK--TKDVLGLHRQE---------------- 915 (1317)
T ss_pred cc---cchhhhhhhcchhcchhhchhhhHHHhhhh-hhHHHHHHHHHhhhh--HHHHHHHHHHH----------------
Confidence 77 889999999999999889989999999999 999999977766443 22222111100
Q ss_pred chhhhHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCcc
Q psy14431 544 DYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623 (1219)
Q Consensus 544 ~~~~sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIV 623 (1219)
+.. +.+.++ .. ..+...+ ++.+
T Consensus 916 ---------~~~------------------------------k~~t~a--------------c~--~e~~~~l---~q~~ 937 (1317)
T KOG0612|consen 916 ---------LTC------------------------------KDCTLA--------------CL--EETNRTL---TQKC 937 (1317)
T ss_pred ---------HHH------------------------------HHHhHH--------------HH--HHHHHHh---hhhc
Confidence 000 000000 00 0000000 0000
Q ss_pred EEeeeeeccCCceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 624 TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 624 kL~gvfe~~d~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
++
T Consensus 938 ~i------------------------------------------------------------------------------ 939 (1317)
T KOG0612|consen 938 KL------------------------------------------------------------------------------ 939 (1317)
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred cccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 704 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 704 FGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
+++.- ..+ +|. .-+.|+.+.
T Consensus 940 ------------------------~~~E~--e~~---------~~~------~~k~~~~~~------------------- 959 (1317)
T KOG0612|consen 940 ------------------------LSEEK--ERL---------LGK------HKKVQEEGV------------------- 959 (1317)
T ss_pred ------------------------chhhh--hhh---------hhh------hhhccchhh-------------------
Confidence 00000 000 000 000000000
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhhhcCCCCcCCCCCCCCC
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETASLSSADVEN 863 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwfaL~~e~s~~PS~d~s~ 863 (1219)
++.
T Consensus 960 -----------------------------------------~~~------------------------------------ 962 (1317)
T KOG0612|consen 960 -----------------------------------------VLK------------------------------------ 962 (1317)
T ss_pred -----------------------------------------hhh------------------------------------
Confidence 000
Q ss_pred CcccccccccCCCccCCCchhhhhhccccceeeecceeeeeccCccccccCCcchhhhHHHhhccCCcchhhhhhcCccc
Q psy14431 864 DESYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKE 943 (1219)
Q Consensus 864 dE~~~~dS~lEg~~~IPnk~nlk~~~wke~l~~~s~~ki~fyN~~~~~~n~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 943 (1219)
+. +|
T Consensus 963 ------------------~~-----------------------------------~i----------------------- 966 (1317)
T KOG0612|consen 963 ------------------DE-----------------------------------EI----------------------- 966 (1317)
T ss_pred ------------------hh-----------------------------------hH-----------------------
Confidence 00 00
Q ss_pred hhhhhHHhhhHHhhhHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccccccCCCCC
Q psy14431 944 REVDYKKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKA 1023 (1219)
Q Consensus 944 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~lk~~~vnkl~~~m~rk~~~~~~~~~~k~ 1023 (1219)
.. ...+|.+++..|.++|++|||||++||||+++-++ |++..
T Consensus 967 ---------------------------------~~---~d~efs~~~~~e~~v~~aa~~kl~eif~r~~~~i~--~~~~~ 1008 (1317)
T KOG0612|consen 967 ---------------------------------VL---RDAEFSKKLVTERDVKHAAVNKLAEIFNRKTSLIP--GKKST 1008 (1317)
T ss_pred ---------------------------------hh---ccHHHHhhhhhHHHHHHHHHHHHHHHHHHHhhccC--Ccccc
Confidence 00 22346667777999999999999999999998776 44446
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhhhhhhhhhcccchhHHHHHHhHhhhcccccc
Q psy14431 1024 SSADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSETA 1103 (1219)
Q Consensus 1024 ~~~d~rk~ek~~~~l~~~l~~e~~k~~~~v~k~~~e~~~~~~~~~~e~~~~~e~~m~~~s~~~~~e~~r~~~~~l~~~~~ 1103 (1219)
|+.+|||+|+|.|| +++|.++|.+|++++.++|+++ |||++ ++++..+..++|.++++.++|+++|++|+.+...+.
T Consensus 1009 ~t~~l~kkE~EkrK-v~~L~qlr~~l~k~~l~~q~~~-d~~~~-t~~~i~~~~~~~~id~~~~~I~~l~~~L~~~~~~~~ 1085 (1317)
T KOG0612|consen 1009 NTLDLRKKEKEKRK-VMELSQLRTKLNKLRLKNQKEL-DLQAQ-TEESIRKILLQMIIDSKASEIEELRSKLYEINDSSS 1085 (1317)
T ss_pred cHHHHHHHHHHHHH-HHHHHHHHHHHHHHhhhhHHHH-HHHHh-hhHHHHHHHHHHHHhhhHHHHHHHHhhhHHHhhhhh
Confidence 89999999999999 9999999999999999999999 99999 999999999999999999999999999999872111
Q ss_pred cccc-------------c-------ccCC----Cccc----e-----------------------ee---eeeeeecccc
Q psy14431 1104 SLSS-------------A-------DVEN----DESY----V-----------------------QD---EVRSRSVTQG 1129 (1219)
Q Consensus 1104 s~~~-------------~-------~~~~----d~~~----~-----------------------~~---~~~~~~~~~~ 1129 (1219)
..+. + +.++ |+-| | .| +||||+|||+
T Consensus 1086 v~~~~~~e~e~~l~~l~~~~~eg~lsl~~~~~~~~~~~~~~V~~s~~~~l~~~~~~~k~~~~~~il~i~k~~~v~~vt~~ 1165 (1317)
T KOG0612|consen 1086 VGSQPEDEAEQILPLLQGSRLEGWLSLPPRQNLDRDWKRIYVIVSSKKILFYVSEQDKEQSGPLILDIKKLFHVRQVTQT 1165 (1317)
T ss_pred cccCCcchhhcchhhhhhhhhhcccccCcccccccchheeEEeecccceEeeeccccccccchhhhhhhhceeEEeeccc
Confidence 1110 0 0011 1101 1 11 5799999999
Q ss_pred cccccccCchhhHHHHHhcCCCCCCCCCCCCCCccccccCCCCCCcccccccccccccccccCCCCCCCCCCccccccCC
Q psy14431 1130 DVIRADAKDIPRIFQLLYAGEGEARRPEDGGAELPAVLRGGDEKPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPP 1209 (1219)
Q Consensus 1130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1209 (1219)
|+|||+++|||+||||||+++|.|..+ .+|+..+.+ +|.++||||+|++++|||||.|++|.+||||||+
T Consensus 1166 d~~~~~~~eip~~fq~l~~~~~~~~~~----~~f~~l~l~----~~~~v~~~~~~~~~l~~~~~~~~~~~k~l~~~~~-- 1235 (1317)
T KOG0612|consen 1166 DVRRADAKEIPRIFQILYANEGESGHP----SEFSYLSLG----PNSLVHKGHEFIPFLYHFPTNCEACIKPLWHMFK-- 1235 (1317)
T ss_pred ccccchhhhcchhHHHHHhhcccccCc----cccchhhcc----chhhcCCCCcchHHHhhcchhHHHHhhhcccchh--
Confidence 999999999999999999999998888 667777765 9999999999999999999999999999999999
Q ss_pred Ccccccc
Q psy14431 1210 PALECGT 1216 (1219)
Q Consensus 1210 ~~~~~~~ 1216 (1219)
|++|.+
T Consensus 1236 -~ye~~~ 1241 (1317)
T KOG0612|consen 1236 -AYECRR 1241 (1317)
T ss_pred -HHHHHH
Confidence 999975
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=213.19 Aligned_cols=207 Identities=21% Similarity=0.289 Sum_probs=172.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.++||+|+||.++.|.+.-++.+||||.-.. ...+-.+..|...++.|.+.++|+.+|.+ ++.+-+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeee--ccccchhhhh
Confidence 68999999999999999999999999999996532 23344577889999999999999998743 4467777899
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-----cceecccccccccCCc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-----SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-----~VKLiDFGLAr~l~~~ 713 (1219)
+++++.+|.+++. .+.|+..++..++.|++.-+.|+|+..+|.|||||+|+||...+ .+.|+|||+|+.+-++
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 9999999999887 56799999999999999999999999999999999999997544 4899999999987664
Q ss_pred cc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC---cHHHHHHHH
Q psy14431 714 KE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIV 774 (1219)
Q Consensus 714 ~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s---~~e~L~kIv 774 (1219)
.. ...+..||..||+-...++ ...+.+.|+-|||-+|++.|.|..||.|.- ...-+.+|-
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 32 2345789999999877654 457889999999999999999999998743 344445553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=208.74 Aligned_cols=236 Identities=19% Similarity=0.312 Sum_probs=149.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-hhHHHHHHHHHHHHhccC---------CCCccEEeeeee
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQR---------HPNIITMLDIYK 630 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-~~~e~~lREI~ILr~L~~---------HPNIVkL~gvfe 630 (1219)
.+.....||.|+||.||.+.|..||+.+|+|++....... .....+.+|......+.+ |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4667889999999999999999999999999986443222 233444455444433221 212222222221
Q ss_pred ---------c-cCCc-----eEEEEEecchhhHHHHHh---hc-----cCChHHHHHHHHHHHHHHHHHHhcccccCCCC
Q psy14431 631 ---------A-VNNK-----DLYVVFEYMENDLNKVIR---DK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687 (1219)
Q Consensus 631 ---------~-~d~~-----~LyLVMEymeGSL~d~Lr---s~-----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLK 687 (1219)
. .+.. ..+++|+-+.++|..++. .. .+.......+..|++..+++||+.||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1 1111 246789999888887765 11 12222334566899999999999999999999
Q ss_pred CCCeeeccCCcceecccccccccCCcccccccccccccccCchhhhcc-------ccccccccchhHHHHHHHHHhCCCC
Q psy14431 688 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-------RRYTHHVDIWSLGCILAEMLQSKPL 760 (1219)
Q Consensus 688 PsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~-------~~yT~kSDIWSLG~ILyELLTGkpP 760 (1219)
|+|++++.+|.+.|+||+.....+..... ...+..|.|||..... ..++.+.|.|+||+++|.|+||..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999988776653321 3455789999986432 2578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 761 FPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 761 F~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
|....+... +. + ....| . +++..+.+||..||++||.+|
T Consensus 250 f~~~~~~~~---------~~---~------------------~f~~C-------~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEAD---------PE---W------------------DFSRC-------R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGST---------SG---G------------------GGTTS-------S----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCcccc---------cc---c------------------cchhc-------C-CcCHHHHHHHHHHccCCcccC
Confidence 975433210 00 0 00112 2 457778999999999999765
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.3e-21 Score=224.19 Aligned_cols=203 Identities=24% Similarity=0.410 Sum_probs=167.7
Q ss_pred eeccCceEEEEEE---EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 568 EGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 568 IGeGgFGtVYlA~---dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
+|.|+||.|+++. ..+.|..||+|+.++.............|..++..+.+||++|.+...|. ..+.++++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhhc
Confidence 6999999999875 34567889999987654433333366678888988988999999998887 567799999999
Q ss_pred hh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc
Q psy14431 645 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722 (1219)
Q Consensus 645 eG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG 722 (1219)
.| +|...+. ...+.+..+..+...++.|++++|+.||+|||+|++||+++.+|++++.|||+++..-.... .||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----ccc
Confidence 85 6655554 45688889999999999999999999999999999999999999999999999987655432 289
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
|.-|||||++. +...++|+||||+++|+|++|..||.+ +.+..|.....+.|..
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~ 209 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE 209 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh
Confidence 99999999974 478899999999999999999999987 5666776655555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=197.08 Aligned_cols=172 Identities=15% Similarity=0.164 Sum_probs=130.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhH-HH------HHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QR------TYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~-e~------~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
-.+|.+++.+|.|+||.||++.+ ++..||||++.+........ .. +.+|+..+..+. ||+|+.+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeeee
Confidence 34799999999999999999754 46679999997554433222 22 468888999995 9999999988763
Q ss_pred cC------CceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 632 VN------NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 632 ~d------~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
.. .+..+|||||++| +|.++.. ++. ....+++.+|..||+.|++|||++|+||+++++| ++|+||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 32 2458999999997 6766632 222 3466999999999999999999999999999999 999999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHH
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 754 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyEL 754 (1219)
|.+....... |-..+.....|+.++|+||||+++.-+
T Consensus 179 g~~~~~~e~~-------------a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 179 SGKRCTAQRK-------------AKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCcccccchh-------------hHHHHHHHhHhcccccccceeEeehHH
Confidence 9887653221 111122334577899999999988754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=189.86 Aligned_cols=141 Identities=21% Similarity=0.221 Sum_probs=107.8
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchh------------------------HHHHHHHHHHHHhccCCC
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------------------------AQRTYREILFLKSFQRHP 620 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~------------------------~e~~lREI~ILr~L~~HP 620 (1219)
...||.|+||.||+|.+. +|+.||||++......... ......|+.++..+. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 357899999999999987 8999999999754221111 112235999999996 77
Q ss_pred CccEEeeeeeccCCceEEEEEecchhh-HHHH-HhhccCChHHHHHHHHHHHHHHHHH-HhcccccCCCCCCCeeeccCC
Q psy14431 621 NIITMLDIYKAVNNKDLYVVFEYMEND-LNKV-IRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 621 NIVkL~gvfe~~d~~~LyLVMEymeGS-L~d~-Lrs~~LseeeVr~Ia~QILsALaYL-HS~GIVHRDLKPsNILLd~dG 697 (1219)
++.....+.. . ..+|||||++|+ +... +....++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 7643332221 1 238999999974 3333 4456789999999999999999999 799999999999999998 57
Q ss_pred cceecccccccccCC
Q psy14431 698 SIKIGDLGLARSLSD 712 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~ 712 (1219)
.++|+|||+|.....
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=183.68 Aligned_cols=141 Identities=19% Similarity=0.153 Sum_probs=110.7
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchh------------------------HHHHHHHHHHHHhccCCC
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------------------------AQRTYREILFLKSFQRHP 620 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~------------------------~e~~lREI~ILr~L~~HP 620 (1219)
...||.|+||.||+|.+. +|..||||++......... .....+|...+..+. |+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 468999999999999987 8999999998754221100 122357888999886 88
Q ss_pred CccEEeeeeeccCCceEEEEEecchhh-H-HHHHhhccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCC
Q psy14431 621 NIITMLDIYKAVNNKDLYVVFEYMEND-L-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 621 NIVkL~gvfe~~d~~~LyLVMEymeGS-L-~d~Lrs~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG 697 (1219)
+|.....+.. . ..||||||++|. + ...+....++...+..++.+++.++.++|+ .||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILL--K--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEe--c--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 8754443332 1 248999999974 3 334555678888999999999999999999 9999999999999999 88
Q ss_pred cceecccccccccCC
Q psy14431 698 SIKIGDLGLARSLSD 712 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~ 712 (1219)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=220.89 Aligned_cols=217 Identities=25% Similarity=0.362 Sum_probs=160.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|..++.|..|+||-||+++++.+...+|+| +.+. . .+++- ++... +.|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq-----~--lilRn--ilt~a-~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-----N--LILRN--ILTFA-GNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-cccc-----c--hhhhc--ccccc-CCccee----------------
Confidence 46788999999999999999999999999995 3211 1 11111 11111 233333
Q ss_pred EEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc----
Q psy14431 640 VFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK---- 714 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~---- 714 (1219)
||-...+.. +.++.. ++.++.|||+-||+|||+||+|++|+.-|++|++|||++....-..
T Consensus 136 ------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 322233332 223322 2789999999999999999999999999999999999986432110
Q ss_pred ----------c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 715 ----------E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 715 ----------~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
. .-...+||+.|+|||+++. .+|+..+|||++|+|+|+.+.|..||.|..+.+++..++......|+.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 0 0123689999999999864 469999999999999999999999999999998888877655333332
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-----HHHHHcchhhhc
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-----aiEALqHpwfaL 849 (1219)
-..+.+++.|++..+|+.+|..| +.++.+|+||..
T Consensus 281 -------------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 281 -------------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred -------------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 12347889999999999999875 777788998855
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=182.92 Aligned_cols=189 Identities=14% Similarity=0.048 Sum_probs=138.0
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC--chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s--~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.+...||.|+||+||.+.. .+..|+.+.+...... ......+.+|+.+|..+.+|++|+.++++. ..|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 3567899999999998854 5677877766432221 111225679999999998789999998852 36999
Q ss_pred Eecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCC-CCCCeeeccCCcceecccccccccCCcccc--
Q psy14431 641 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL-KPSNILIDKSCSIKIGDLGLARSLSDSKEC-- 716 (1219)
Q Consensus 641 MEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDL-KPsNILLd~dG~VKLiDFGLAr~l~~~~~~-- 716 (1219)
|+|+.| +|...... ....++.+++.+|.++|+.||+|||| ||.|||++.+|.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 77 RSYLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred EeeecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999987 45543221 12357889999999999999999999 799999999999999999999865543210
Q ss_pred -----------cccccccccccCchhhhcccccc-ccccchhHHHHHHHHHhCCCCCCCCC
Q psy14431 717 -----------LTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGAS 765 (1219)
Q Consensus 717 -----------~ts~vGT~~Y~APEvLl~~~~yT-~kSDIWSLG~ILyELLTGkpPF~g~s 765 (1219)
......++.|++|+.-.--...+ ...++++.|+.+|.++||..|+-+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00112477788887742222233 56788999999999999997775543
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-18 Score=208.22 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=174.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc--cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~--~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.|...+.||.+.|=.|.+|.+.. |. |+||++.+.. ..-......+.++. ..+..+||++++.-+.. .+...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~--t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLV--TDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHH--hhHHHH
Confidence 67888999999999999997654 43 9999986443 22233344555666 23336999999876643 455678
Q ss_pred EEEecchhhHHHHHhhcc-CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc--CCcc-
Q psy14431 639 VVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSK- 714 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~~-LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l--~~~~- 714 (1219)
||-+|+..+|++.+..++ +...+.+.|+.||+.||.-+|..||+|||||.+||||+.=..+.|+||...+.. +..+
T Consensus 98 lvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 999999999999998665 677788999999999999999999999999999999999999999999876422 1111
Q ss_pred cccccccc----cccccCchhhhccc----------cccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 715 ECLTEYIA----TRWYRAPEILISNR----------RYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 715 ~~~ts~vG----T~~Y~APEvLl~~~----------~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P 779 (1219)
..++-+.. -..|+|||.|.... ..+++.||||+||+++||++ |+|||. +..+......
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhHhcc
Confidence 11111122 23499999986422 15788999999999999988 899994 2222222211
Q ss_pred CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 780 ~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
... . ....+..+ .+.....|+..|++.||.+| +.+.|+.
T Consensus 251 ~~~-~-----------~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NAD-D-----------PEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Ccc-C-----------HHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 100 0 00111111 14578889999999999885 6666664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=174.93 Aligned_cols=136 Identities=17% Similarity=0.188 Sum_probs=106.6
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc----CCCCccEEeeeeeccCC-ceEE-
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----RHPNIITMLDIYKAVNN-KDLY- 638 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~----~HPNIVkL~gvfe~~d~-~~Ly- 638 (1219)
...||+|+||.||. ++.++.. +||++.... ......+.+|+.++..+. .||||+++++++....+ +.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46789999999995 7777665 699885432 223456899999999994 38999999999985432 3434
Q ss_pred EEEecch---hhHHHHHhhccCChHHHHHHHHHHHHHH-HHHHhcccccCCCCCCCeeeccC----Ccceecccccc
Q psy14431 639 VVFEYME---NDLNKVIRDKILKDVHIRYIMFQLCNGL-SYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLA 707 (1219)
Q Consensus 639 LVMEyme---GSL~d~Lrs~~LseeeVr~Ia~QILsAL-aYLHS~GIVHRDLKPsNILLd~d----G~VKLiDFGLA 707 (1219)
+||||++ ++|.+++..+.+++. ..++.+++.++ .|||++||+||||||+|||++.. +.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899955 699999987666665 46688888888 99999999999999999999743 37999995444
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=187.84 Aligned_cols=255 Identities=21% Similarity=0.246 Sum_probs=174.0
Q ss_pred HHHhhccccccCeeEEeeeeccCceEEEEEEEcCCC-----------------------------------eEEEEEEee
Q psy14431 550 DQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNK-----------------------------------QYVAIKKIF 594 (1219)
Q Consensus 550 ~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TG-----------------------------------k~VAIKvI~ 594 (1219)
+..+...+.|++|.|...||+|..+.||.|.....| -+.|||.++
T Consensus 147 ~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMf 226 (598)
T KOG4158|consen 147 PNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMF 226 (598)
T ss_pred cchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhc
Confidence 445566788999999999999999999998754321 135566554
Q ss_pred ccccCchhHHHHH----HHHH------HH--------H-------hccCCCCccEEeeeeecc-----------------
Q psy14431 595 EAFRNKTDAQRTY----REIL------FL--------K-------SFQRHPNIITMLDIYKAV----------------- 632 (1219)
Q Consensus 595 ks~~s~~~~e~~l----REI~------IL--------r-------~L~~HPNIVkL~gvfe~~----------------- 632 (1219)
.-... .....++ +|.. .+ + .+..|||||++.++|.+.
T Consensus 227 N~~~~-s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~ 305 (598)
T KOG4158|consen 227 NFEHD-SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPA 305 (598)
T ss_pred ccccC-CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccc
Confidence 21111 1111122 2211 11 1 223699999999988421
Q ss_pred --------CCceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec--cCC--cce
Q psy14431 633 --------NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSC--SIK 700 (1219)
Q Consensus 633 --------d~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd--~dG--~VK 700 (1219)
.+..+|+||-....+|..++-....+....+.++.|++.|+.|||.+||.|||+|.+|||+. +|+ .+.
T Consensus 306 R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 306 RWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred eecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence 12458999999999999999988899999999999999999999999999999999999984 444 478
Q ss_pred ecccccccccCCcc------cccccccccccccCchhhhccccc-----cccccchhHHHHHHHHHhCCCCCCCCCcHHH
Q psy14431 701 IGDLGLARSLSDSK------ECLTEYIATRWYRAPEILISNRRY-----THHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769 (1219)
Q Consensus 701 LiDFGLAr~l~~~~------~~~ts~vGT~~Y~APEvLl~~~~y-----T~kSDIWSLG~ILyELLTGkpPF~g~s~~e~ 769 (1219)
|+|||.+---...+ ....+..|....||||+....++. -.++|.|+.|.+.||+++...||.+......
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L 465 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL 465 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence 99999875322211 011233456668999997432221 1478999999999999999999977432211
Q ss_pred HHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 770 LQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 770 L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
-..- +... + ++-+-..+++.+.+|+.-+|+.||.+|
T Consensus 466 ~~r~---------------------Yqe~---q--------LPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 466 DTRT---------------------YQES---Q--------LPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred chhh---------------------hhhh---h--------CCCCcccCChHHHHHHHHHhcCCcccc
Confidence 0000 0000 0 011112457889999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=165.07 Aligned_cols=136 Identities=19% Similarity=0.226 Sum_probs=107.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch------hHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT------DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~------~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+.||.|++|.||+|.+ .|..|++|+......... ....+.+|+.++..+. |++|+....++. +....++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFV--DPENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEE--eCCCCEE
Confidence 5789999999999976 677899998653322111 1245778999999986 888876665554 3456789
Q ss_pred EEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 640 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
||||++| +|.+++..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+...
T Consensus 77 v~e~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999986 78887764322 7788999999999999999999999999999999 788999999998763
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.7e-17 Score=202.23 Aligned_cols=193 Identities=21% Similarity=0.264 Sum_probs=150.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHH-HHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~-~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-..|.|-+.||.|+||.||.|.+.+ |+.||||+-.++..+.-.+-. +...+. +.. -|.|..+..++.. .+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~--~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVF--QNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHcc--CCcc
Confidence 4568889999999999999999887 999999988665544433221 111122 111 2445555555543 3346
Q ss_pred EEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-------CCcceeccccccc
Q psy14431 638 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------SCSIKIGDLGLAR 708 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-------dG~VKLiDFGLAr 708 (1219)
+||++|.+ |+|.+++.. +.+++..+..++.|++..+.+||..|||||||||+|+||.. ...++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 89999999 899999984 56899999999999999999999999999999999999952 2358999999986
Q ss_pred ccC--CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCC
Q psy14431 709 SLS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 759 (1219)
Q Consensus 709 ~l~--~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkp 759 (1219)
.+. ..+......++|-.|-.+|.. .+.++++.+|.|.|+.+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 332 233345677899999999996 67789999999999999999999973
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-16 Score=173.05 Aligned_cols=145 Identities=14% Similarity=0.060 Sum_probs=110.1
Q ss_pred CeeEEeeeeccCceEEEEEE-EcCCCeEEEEEEeeccccCch----------------------hHHHHHHHHHHHHhcc
Q psy14431 561 QQINLLKEGKGAYGIVYKAY-DKNNKQYVAIKKIFEAFRNKT----------------------DAQRTYREILFLKSFQ 617 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~-dk~TGk~VAIKvI~ks~~s~~----------------------~~e~~lREI~ILr~L~ 617 (1219)
-|.+.+.||.|+||.||+|. +..+|..||||++........ ....+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788899999999999998 677899999999864321100 1123568999999996
Q ss_pred C-CCCccEEeeeeeccCCceEEEEEecchh-hHHHHH-hhccCChHHHHHHHHHHHHHHHHHHhcc-cccCCCCCCCeee
Q psy14431 618 R-HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSNILI 693 (1219)
Q Consensus 618 ~-HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~L-rs~~LseeeVr~Ia~QILsALaYLHS~G-IVHRDLKPsNILL 693 (1219)
. +..++.++++ ...|+||||++| +|.... ....+....+..++.+|+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 2 1334444432 124899999998 454433 3445666677899999999999999999 9999999999999
Q ss_pred ccCCcceecccccccccCC
Q psy14431 694 DKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~ 712 (1219)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=158.09 Aligned_cols=138 Identities=22% Similarity=0.159 Sum_probs=104.9
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc--------------------hhHHHHHHHHHHHHhccCCC-
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK--------------------TDAQRTYREILFLKSFQRHP- 620 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~--------------------~~~e~~lREI~ILr~L~~HP- 620 (1219)
|.+.+.||.|+||.||+|... +|..||||++....... .......+|+.++..+. |+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence 777889999999999999875 79999999875432110 01123567888888885 55
Q ss_pred -CccEEeeeeeccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc
Q psy14431 621 -NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS 698 (1219)
Q Consensus 621 -NIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~ 698 (1219)
+++.+++. ...++||||++| +|..+.. ......++.+|+.++.++|+.||+||||+|+||+++.++.
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~-----~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRV-----LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhccc-----cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 34444432 345899999997 5544322 1345678899999999999999999999999999999999
Q ss_pred ceecccccccccCC
Q psy14431 699 IKIGDLGLARSLSD 712 (1219)
Q Consensus 699 VKLiDFGLAr~l~~ 712 (1219)
++|+|||.+.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=155.51 Aligned_cols=132 Identities=22% Similarity=0.261 Sum_probs=100.1
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeecccc-Cc-----hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NK-----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~-----~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
||.|+||.||+|. .+|..|++|+...... .. .....+.+|+.++..+. |+++.....++. .....++||
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~~~~~~lv~ 76 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDV--DPDNKTIVM 76 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEE--ECCCCEEEE
Confidence 7999999999997 4578899998643221 11 12355678999999986 665443333332 234568999
Q ss_pred ecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 642 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
||++| +|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++....
T Consensus 77 e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred EEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99985 77777654211 7899999999999999999999999999999 8899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=153.00 Aligned_cols=139 Identities=22% Similarity=0.211 Sum_probs=97.7
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHH----------------------HHHHHHHHHhccCC-CC
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR----------------------TYREILFLKSFQRH-PN 621 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~----------------------~lREI~ILr~L~~H-PN 621 (1219)
.+.||.|+||.||.|.+. +|..||||++............ ...|...+..+..+ ..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467899999999999876 7899999998643221111111 13455566665422 22
Q ss_pred ccEEeeeeeccCCceEEEEEecchhh-HH-HHHhhccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCc
Q psy14431 622 IITMLDIYKAVNNKDLYVVFEYMEND-LN-KVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS 698 (1219)
Q Consensus 622 IVkL~gvfe~~d~~~LyLVMEymeGS-L~-d~Lrs~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~ 698 (1219)
+++++++. ..++||||++|+ +. ..+...... ..+..++.+++.++.++|. .||+|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 44444332 358999999972 11 111111111 5678899999999999999 9999999999999999 889
Q ss_pred ceecccccccccCC
Q psy14431 699 IKIGDLGLARSLSD 712 (1219)
Q Consensus 699 VKLiDFGLAr~l~~ 712 (1219)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-15 Score=164.63 Aligned_cols=298 Identities=17% Similarity=0.240 Sum_probs=203.8
Q ss_pred HHHHhhhHHHHHhh--hhhHHHhHHhhHHHHHhcccCCccc---ccccccCCcccccchhhhHHHHhhccccccCeeEEe
Q psy14431 492 EALARSIAEETVGE--LEKEKTMKELELKDLMAKHRSDLSS---KESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL 566 (1219)
Q Consensus 492 ~~~ar~~~E~~vsE--lE~Ek~mr~seledLm~s~rss~Ss---s~Sl~Sn~k~rev~~~~sl~eLL~dr~dIqqY~ILK 566 (1219)
+.+|...+-++++. +.+.+.+-...+.++..+...+... +.......+.+..+.. +. .-...++.+..++.
T Consensus 121 ~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdat--ls--r~~gid~~~lnl~t 196 (448)
T KOG0195|consen 121 SCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDAT--LS--RYTGIDVSSLNLIT 196 (448)
T ss_pred hccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccc--cc--cccCcchhhhhhhh
Confidence 45566666666666 4777777777777776655444321 1111111111111100 00 01234556666778
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME- 645 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme- 645 (1219)
+|.+.-.|..|+|++. |..++.|++............|..|.-.|+-+. ||||+++++.+.. ..++.++..||+
T Consensus 197 kl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacns--ppnlv~isq~mp~ 271 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACNS--PPNLVIISQYMPF 271 (448)
T ss_pred hhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhccC--CCCceEeeeeccc
Confidence 8999999999999776 555778877544333333455667777888885 9999999999874 467899999999
Q ss_pred hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCccee--cccccccccCCcccccc
Q psy14431 646 NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKI--GDLGLARSLSDSKECLT 718 (1219)
Q Consensus 646 GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKL--iDFGLAr~l~~~~~~~t 718 (1219)
|+|+.++... ..+..++..++.+|++|++|||+.. |.---|....++||.+.+++| +|--++....
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~------- 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV------- 344 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc-------
Confidence 8999999854 3677788999999999999999864 444568889999999887665 3444433211
Q ss_pred cccccccccCchhhhccccc--cccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHH-HhhcCCCCCCchhhhhccCChh
Q psy14431 719 EYIATRWYRAPEILISNRRY--THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI-VNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~y--T~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kI-ve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....|.|++||.+...+.. -.++|+|||++++|||.|...||...++.+.-.+| +.++++..|
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip------------- 411 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP------------- 411 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC-------------
Confidence 22457889999998543321 25799999999999999999999999988876665 444443322
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
|..++.+-.|+.-|+.-||.+|+
T Consensus 412 --------------------pgis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 412 --------------------PGISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred --------------------CCccHHHHHHHHHHhcCCCCcCC
Confidence 33456677778888888887753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-14 Score=137.83 Aligned_cols=134 Identities=23% Similarity=0.247 Sum_probs=107.7
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEeeeeeccCCceEEEEEe
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~gvfe~~d~~~LyLVME 642 (1219)
+++.||.|+++.||++.... ..+++|.+..... ...+..|+.++..+..+ ++++++++++. ..+..+++|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEE
Confidence 45789999999999998754 6799998753322 45678899999999744 68899888776 3467899999
Q ss_pred cchhh-HHHHHhhccCChHHHHHHHHHHHHHHHHHHhc---ccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 643 YMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC---KVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 643 ymeGS-L~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~---GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
|++|. +..+ +......++.+++.+|.+||.. |++|+|++|.||+++..+.++++|||.+....
T Consensus 74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 99863 3322 4456677899999999999984 79999999999999998999999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.1e-14 Score=171.00 Aligned_cols=141 Identities=21% Similarity=0.273 Sum_probs=107.7
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecc-ccC-----chhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRN-----KTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks-~~s-----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
.....|...+.||.|+||.||+|.+... .+++|+.... ... ......+.+|+.++..+. |++|+..+.++.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~ 406 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDV 406 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEE
Confidence 3344556778999999999999976543 3455543221 111 122356789999999996 999887765554
Q ss_pred ccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 631 AVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 631 ~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.....++||||++| +|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 407 --~~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 407 --DPEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --eCCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 34457899999985 7887765 356789999999999999999999999999999 678899999999976
Q ss_pred c
Q psy14431 710 L 710 (1219)
Q Consensus 710 l 710 (1219)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-15 Score=173.08 Aligned_cols=188 Identities=28% Similarity=0.406 Sum_probs=132.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEee-------eee-
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD-------IYK- 630 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~g-------vfe- 630 (1219)
+.+.+..|.+++|.++......+ ...++-+... ..+........+++..+.....|+..+. .+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhccc
Confidence 33445556666666555433322 2223322221 1111345566777777777765554432 22 111
Q ss_pred c--cCCceEEEEEecch-hhHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 631 A--VNNKDLYVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 631 ~--~d~~~LyLVMEyme-GSL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
. ....++||.|.+|. .+|.+++..+ ..+......++.|+..|+.| .|.+|+|+||.||++..++.++|+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhh
Confidence 0 01235889999998 6899999743 35667788999999999999 9999999999999999999999999
Q ss_pred cccccccCCcc------cccccccccccccCchhhhccccccccccchhHHHHHHHHHh
Q psy14431 704 LGLARSLSDSK------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ 756 (1219)
Q Consensus 704 FGLAr~l~~~~------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT 756 (1219)
||+........ ...+..+||.+||+||.+. +..|+.++||||||+||+||+.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHH
Confidence 99998665433 2345678999999999984 5679999999999999999997
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-13 Score=149.45 Aligned_cols=137 Identities=15% Similarity=0.174 Sum_probs=103.3
Q ss_pred eee-ccCceEEEEEEEcCCCeEEEEEEeeccc------c-----CchhHHHHHHHHHHHHhccCCCCc--cEEeeeeecc
Q psy14431 567 KEG-KGAYGIVYKAYDKNNKQYVAIKKIFEAF------R-----NKTDAQRTYREILFLKSFQRHPNI--ITMLDIYKAV 632 (1219)
Q Consensus 567 kIG-eGgFGtVYlA~dk~TGk~VAIKvI~ks~------~-----s~~~~e~~lREI~ILr~L~~HPNI--VkL~gvfe~~ 632 (1219)
.|| .||.|+||.+... +..++||.+.... . .......+.+|+.++..+. |++| +..+++....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVR 114 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeee
Confidence 467 7888888888653 6779999885321 0 1123356788999999996 7664 6676654322
Q ss_pred CCc--eEEEEEecchh--hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 633 NNK--DLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 633 d~~--~LyLVMEymeG--SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
.+. ..++||||++| +|.+++....++.. .+.+|+.+|.+||+.||+|+||||.|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 221 24699999996 78888876656554 35789999999999999999999999999999999999999887
Q ss_pred cc
Q psy14431 709 SL 710 (1219)
Q Consensus 709 ~l 710 (1219)
..
T Consensus 191 ~~ 192 (239)
T PRK01723 191 LR 192 (239)
T ss_pred cC
Confidence 64
|
|
| >PF08912 Rho_Binding: Rho Binding; InterPro: IPR015008 Rho is responsible for the recognition and binding of Rho binding domain-containing proteins (such as ROCK) to Rho, resulting in activation of the GTPase which in turn modulates the phosphorylation of various signalling proteins | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-14 Score=128.16 Aligned_cols=64 Identities=47% Similarity=0.679 Sum_probs=55.4
Q ss_pred HHhhhHHhhhHHHHHHHHHHHHHHHHhcCCChHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q psy14431 949 KKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEM----EKLHKQLKQEQLLKAQAVNKLAEIMNRKD 1012 (1219)
Q Consensus 949 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~e~~lk~~~vnkl~~~m~rk~ 1012 (1219)
.+.++.|+++.+||.+++...++++.+....+.+| ..++|+|.+|+|||+||||||||||||||
T Consensus 2 ~kdv~~l~~EkeeL~~klk~~qeel~~~k~~~~~~~~ik~~~eK~L~~E~~LK~QAVNKLAEIMNRKD 69 (69)
T PF08912_consen 2 TKDVANLAKEKEELNNKLKKQQEELQKLKEEEQEIEEIKAQYEKQLNTERTLKQQAVNKLAEIMNRKD 69 (69)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCHHHHHHHCHHHHHHHHHHHHHHHHHHHCTT-
T ss_pred chHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCC
Confidence 35678999999999999999999998776655444 56689999999999999999999999997
|
This domain is within an amphipathic alpha-helical coiled-coil and interacts with Rho through predominantly hydrophobic interactions []. ; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0000910 cytokinesis, 0006468 protein phosphorylation; PDB: 1UIX_A 1S1C_X. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-15 Score=182.24 Aligned_cols=260 Identities=23% Similarity=0.265 Sum_probs=190.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...|.+.+.||.|+|+.|-.+... .+...+|.|.+............+-.|..+-..+.+|+|++.+++... +....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCccc
Confidence 345777888999999999988764 345567777765443333444555567777777767999999998876 56678
Q ss_pred EEEEecchh-hHHHHH-hh-c-cCChHHHHHHHHHHHHHHHHHH-hcccccCCCCCCCeeeccCC-cceecccccccccC
Q psy14431 638 YVVFEYMEN-DLNKVI-RD-K-ILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEymeG-SL~d~L-rs-~-~LseeeVr~Ia~QILsALaYLH-S~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~ 711 (1219)
+++++|..| ++...+ .. . ..+......++.|+..++.|+| ..|+.|+||+|+|.+++..+ .+++.|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 899999774 566666 42 2 5777888999999999999999 99999999999999999999 99999999998776
Q ss_pred C-cc--cccccccc-cccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 712 D-SK--ECLTEYIA-TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 712 ~-~~--~~~ts~vG-T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
. .+ ......+| ++.|.|||.+.+.....+..|+||.|+++.-+++|..|+.......... ..|
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------~~~--- 243 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------SSW--- 243 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------eee---
Confidence 5 22 22345678 9999999998665567889999999999999999999986544322000 000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+...-...+..++....+++.++|..+|..| ..+.-.+||...
T Consensus 244 ----------------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 244 ----------------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ----------------cccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000000111234557789999999999999874 334455777755
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.7e-12 Score=151.50 Aligned_cols=197 Identities=21% Similarity=0.331 Sum_probs=142.5
Q ss_pred HhccCCCCccEEeeeeeccCCceEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhccc-ccCCCCCC
Q psy14431 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKV-MHRDLKPS 689 (1219)
Q Consensus 614 r~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GI-VHRDLKPs 689 (1219)
+.+. |.|+.+++|.+. ++...++|.+||. |+|.+++... .+++.....++++|+.||.|||...| +|+.+++.
T Consensus 2 ~~l~-h~n~~~f~g~~~--~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASV--DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cccc-hhhhhhheeeEe--cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 3454 999999999987 4578999999999 7999999864 36666677899999999999998766 99999999
Q ss_pred CeeeccCCcceecccccccccCCc--ccccccccccccccCchhhhcc--c----cccccccchhHHHHHHHHHhCCCCC
Q psy14431 690 NILIDKSCSIKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISN--R----RYTHHVDIWSLGCILAEMLQSKPLF 761 (1219)
Q Consensus 690 NILLd~dG~VKLiDFGLAr~l~~~--~~~~ts~vGT~~Y~APEvLl~~--~----~yT~kSDIWSLG~ILyELLTGkpPF 761 (1219)
|.+++....+||+|||+....... ........-...|.|||.+... . ..+.+.||||||++++++++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876421 0111112234568999998442 1 1467899999999999999999999
Q ss_pred CCCC----cHHHHHHHHh-hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC
Q psy14431 762 PGAS----TSHQLQLIVN-LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD 836 (1219)
Q Consensus 762 ~g~s----~~e~L~kIve-~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK 836 (1219)
+... +.+.+..+.. +..|..|.+... ....+....++..|..-+|..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~----------------------------~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELL----------------------------NELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhh----------------------------hhcchHHHHHHHHhcccChhh
Confidence 7532 2233333333 112222211110 023446888899999999987
Q ss_pred CHHHH
Q psy14431 837 SEIEQ 841 (1219)
Q Consensus 837 RaiEA 841 (1219)
|+...
T Consensus 211 rPs~~ 215 (484)
T KOG1023|consen 211 RPSIE 215 (484)
T ss_pred CccHH
Confidence 64443
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-12 Score=160.78 Aligned_cols=259 Identities=20% Similarity=0.201 Sum_probs=186.0
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.+..++.+.+++.+-.|+||.++.+.-..+|...++|+...... ..........+-.++-.. .+|.++.....| +.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CC
Confidence 45567888999999999999999998778887777776532211 111112222222222211 135454443322 34
Q ss_pred CceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
....+||++|++ ++|...++. ++.+....+.++..+..+++|||+..++|+|++|.|+|+..+|+..++|||.....+
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 667899999997 477777775 447777888899999999999999999999999999999999999999998443211
Q ss_pred Cc----------c---------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCC
Q psy14431 712 DS----------K---------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL 760 (1219)
Q Consensus 712 ~~----------~---------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP 760 (1219)
-. . ......++|+.|.+||.+++ ...+.++|+|++|+++++.++|.+|
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 0 00123568999999999864 4578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH-
Q psy14431 761 FPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI- 839 (1219)
Q Consensus 761 F~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai- 839 (1219)
|....+...+..|.++..|-|.-. ...++.+.+++.++|..+|.+|..
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~-------------------------------~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGP-------------------------------EEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCc-------------------------------cccChhhhhhhhhhhccCchhccCc
Confidence 999999888888877765443311 123677899999999999988632
Q ss_pred ----HHHcchhhh
Q psy14431 840 ----EQLQGKLAA 848 (1219)
Q Consensus 840 ----EALqHpwfa 848 (1219)
+.-.|+||.
T Consensus 1084 ~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQ 1096 (1205)
T ss_pred ccccccccCCccC
Confidence 445677773
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-12 Score=152.09 Aligned_cols=199 Identities=26% Similarity=0.321 Sum_probs=165.2
Q ss_pred CeeEEeeeec--cCceEEEEEEE--cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 561 QQINLLKEGK--GAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 561 qY~ILKkIGe--GgFGtVYlA~d--k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+.+...+|. |.+|.||.+.. ..++..+|+|.-...........+-.++......+..|+|.++.+..+. .++.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cCCc
Confidence 3556778899 99999999988 8889999999865555555556667788888888888999999777776 5778
Q ss_pred EEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHH----HHHHHHhcccccCCCCCCCeeeccC-Ccceecccccccc
Q psy14431 637 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCN----GLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARS 709 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILs----ALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~ 709 (1219)
.++-+|+|+.+|..+... ..++...++.++.+... ||.++|+.+++|-|++|.||+...+ +..+++|||+...
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 999999999988888773 34788889999999999 9999999999999999999999999 8899999999998
Q ss_pred cCCcccccc-----cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 710 LSDSKECLT-----EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 710 l~~~~~~~t-----s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
++++.-... ...|...|++||.+ .+-+++..|+||+|.++.+..+|..++..
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccC
Confidence 876542211 22567789999996 45689999999999999999998866644
|
|
| >cd01242 PH_ROK Rok (Rho- associated kinase) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-12 Score=126.88 Aligned_cols=48 Identities=63% Similarity=1.170 Sum_probs=44.8
Q ss_pred cCCCccCCCchhhhh-hccccceeeecceeeeeccCccccccCCcchhh
Q psy14431 873 LEGWVSIPNKQNIKR-HGWKKQYVVVSSKKIIFYNSENDKQNTDPELEL 920 (1219)
Q Consensus 873 lEg~~~IPnk~nlk~-~~wke~l~~~s~~ki~fyN~~~~~~n~~~~~~l 920 (1219)
.+||..+|+..+.++ ..|+.+++++++.+|.|||.++++.+.+|.++|
T Consensus 2 lEGwlsvP~~~~~~~k~gW~r~yvVv~~~Kl~lYd~e~~~~~~~p~~vl 50 (112)
T cd01242 2 MEGWLSLPNRTNKSRKPGWKKQYVVVSSRKILFYNDEQDKENSTPSMIL 50 (112)
T ss_pred cceeEEccCCCCccccCCceEEEEEEeCCEEEEEecCccccCCCcEEEE
Confidence 589999999999877 799999999999999999999999999999888
|
Rok (Rho- associated kinase) pleckstrin homology (PH) domain. Rok is a serine/threonine kinase that binds GTP-rho. It consists of a kinase domain, a coiled coil region and a PH domain. The Rok PH domain is interrupted by a C1 domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-11 Score=142.70 Aligned_cols=144 Identities=17% Similarity=0.192 Sum_probs=94.8
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch------------------------hH--------------HHH
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT------------------------DA--------------QRT 606 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~------------------------~~--------------e~~ 606 (1219)
.+.||.|++|.||+|+.. +|+.||||+.++...... .. ..+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 467999999999999875 689999999854321000 00 013
Q ss_pred HHHHHHHHhcc----CCCCccEEeeeeeccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHH-HHHHHHhcc
Q psy14431 607 YREILFLKSFQ----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCN-GLSYIHACK 680 (1219)
Q Consensus 607 lREI~ILr~L~----~HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILs-ALaYLHS~G 680 (1219)
.+|...+..+. ++|+| .+-.+|.. ..+..+|||||++| +|.++........ ....++..++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~-~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWD-RTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehh-hcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCC
Confidence 33444444443 23433 33333322 12346999999986 5666544221111 23345555555 467899999
Q ss_pred cccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 681 IVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
++|+|++|.||+++.+|.++|+|||++..+++
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.5e-11 Score=119.69 Aligned_cols=128 Identities=15% Similarity=0.062 Sum_probs=93.4
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecc
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
++.|+.|.++.||.+... |..|++|+...... ......+|+.++..+.....+++++.+.. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 467899999999999754 77899998753321 12235688889988864333455554432 2347999999
Q ss_pred hh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhccc-----ccCCCCCCCeeeccCCcceecccccccc
Q psy14431 645 EN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV-----MHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 645 eG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GI-----VHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+| ++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 97 33321 01123467899999999999885 9999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=124.55 Aligned_cols=140 Identities=16% Similarity=0.220 Sum_probs=101.8
Q ss_pred eeeeccCceEEEEEEEcC------CCeEEEEEEeecccc--------------------CchhHHHHH----HHHHHHHh
Q psy14431 566 LKEGKGAYGIVYKAYDKN------NKQYVAIKKIFEAFR--------------------NKTDAQRTY----REILFLKS 615 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~------TGk~VAIKvI~ks~~--------------------s~~~~e~~l----REI~ILr~ 615 (1219)
..||.|--+.||.|.... .+..+|||+++.... .......+. +|...|..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 357899999752110 011122222 79999988
Q ss_pred ccCC-CCccEEeeeeeccCCceEEEEEecchhh-H-HHHHhhccCChHHHHHHHHHHHHHHHHH-HhcccccCCCCCCCe
Q psy14431 616 FQRH-PNIITMLDIYKAVNNKDLYVVFEYMEND-L-NKVIRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSNI 691 (1219)
Q Consensus 616 L~~H-PNIVkL~gvfe~~d~~~LyLVMEymeGS-L-~d~Lrs~~LseeeVr~Ia~QILsALaYL-HS~GIVHRDLKPsNI 691 (1219)
+... -+++.++++. .-+|||||++++ + ...+....++...+..++.+++.+|..| |..|||||||+|.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8743 5677777652 358999999863 2 1223334455566778889999999999 899999999999999
Q ss_pred eeccCCcceecccccccccCC
Q psy14431 692 LIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 692 LLd~dG~VKLiDFGLAr~l~~ 712 (1219)
|++ +|.+.|+|||.+.....
T Consensus 157 L~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEE-CCcEEEEECCCceeCCC
Confidence 997 57899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.5e-11 Score=145.62 Aligned_cols=145 Identities=17% Similarity=0.197 Sum_probs=93.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc--------------------------------hhHHH-
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK--------------------------------TDAQR- 605 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~--------------------------------~~~e~- 605 (1219)
+..|.. +.||.|++|.||.|+.+++|+.||||+.++..... .....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 344555 78999999999999999889999999996432100 00111
Q ss_pred -----HHHHHHHHHhcc---CCCCccEEeeeeeccCCceEEEEEecchh-hHHHH--Hhhc-----cCChHHHHHHHHHH
Q psy14431 606 -----TYREILFLKSFQ---RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV--IRDK-----ILKDVHIRYIMFQL 669 (1219)
Q Consensus 606 -----~lREI~ILr~L~---~HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~--Lrs~-----~LseeeVr~Ia~QI 669 (1219)
+.+|...+..+. .+.+.+.+-.+|.+ -.+..+|||||+.| ++.++ +... .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 223333333332 12222333333322 12356899999997 56553 2222 23334444555555
Q ss_pred HHHHHHHHhcccccCCCCCCCeeeccCC----cceecccccccccCC
Q psy14431 670 CNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLARSLSD 712 (1219)
Q Consensus 670 LsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr~l~~ 712 (1219)
+ ..|++|+|++|.||+++.+| .++++|||++..++.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 58999999999999999888 999999999987754
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=139.06 Aligned_cols=179 Identities=21% Similarity=0.378 Sum_probs=132.6
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecchhh
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND 647 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEymeGS 647 (1219)
.+-++.+.+-.|..+.++.+|.|.++..... .......+-+..|+.++ ||||+++++.+. ..+.+|||+|.+..
T Consensus 20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e--~~~~~ylvTErV~P- 93 (690)
T KOG1243|consen 20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLR-HPNILSYLDTTE--EEGTLYLVTERVRP- 93 (690)
T ss_pred ccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhcc-Cchhhhhhhhhc--ccCceEEEeecccc-
Confidence 3444444322566778889999998853322 33455677788888886 999999999987 46689999999864
Q ss_pred HHHHHhhccCChHHHHHHHHHHHHHHHHHH-hcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccccc
Q psy14431 648 LNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726 (1219)
Q Consensus 648 L~d~Lrs~~LseeeVr~Ia~QILsALaYLH-S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y 726 (1219)
|..++.. ++...+...++||+.||.||| ..+++|++|..+.|+|+..|..+|++|.++..............--..|
T Consensus 94 l~~~lk~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~ 171 (690)
T KOG1243|consen 94 LETVLKE--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESF 171 (690)
T ss_pred HHHHHHH--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcc
Confidence 3333332 336677888999999999998 6899999999999999999999999999987665433222223333457
Q ss_pred cCchhhhccccccccccchhHHHHHHHHHhC
Q psy14431 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQS 757 (1219)
Q Consensus 727 ~APEvLl~~~~yT~kSDIWSLG~ILyELLTG 757 (1219)
..|+.+- +-+...|.|-|||++++++.|
T Consensus 172 ~~P~~~~---~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEID---PSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcC---ccccchhhhhHHHHHHHHhCc
Confidence 7777642 122567999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.9e-09 Score=110.89 Aligned_cols=144 Identities=15% Similarity=0.163 Sum_probs=98.1
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEeeeeeccC-CceEEEEEec
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVN-NKDLYVVFEY 643 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~gvfe~~d-~~~LyLVMEy 643 (1219)
+.||.|.++.||++...+ |..|++|+....... .....+.+|..++..+..+ .++++++.+..... .+..++||+|
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998754 678999987533221 1344678899999998642 34666776654211 1357899999
Q ss_pred chh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q psy14431 644 MEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-------------------------------------------- 678 (1219)
Q Consensus 644 meG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS-------------------------------------------- 678 (1219)
++| ++...+....++......++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 997 33332221234445555556666666666652
Q ss_pred ------------cccccCCCCCCCeeecc--CCcceecccccccccC
Q psy14431 679 ------------CKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLS 711 (1219)
Q Consensus 679 ------------~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~ 711 (1219)
..++|+|+.|.||+++. ++.+.|+||+.+....
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 34699999999999998 6678999999887543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-09 Score=129.69 Aligned_cols=198 Identities=22% Similarity=0.283 Sum_probs=153.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEc-CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDK-NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk-~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
-..+|..+..||.|.|+.|+.+... .++..|++|-..............+.|+.+...+.-|.|++.++..+. ....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--cccc
Confidence 3567889999999999999998755 678889999886665555555667788888888888999999877765 3445
Q ss_pred EEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-CcceecccccccccCCc
Q psy14431 637 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l~~~ 713 (1219)
.|+-.|||.+ ++...+. ...+.+...+.+..+++.++.++|+..++|+|++|+||++..+ +..+++|||.+..+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 6789999975 3332222 3457888899999999999999999999999999999999876 77899999988643211
Q ss_pred cccccccccccccc-CchhhhccccccccccchhHHHHHHHHHhCCCC
Q psy14431 714 KECLTEYIATRWYR-APEILISNRRYTHHVDIWSLGCILAEMLQSKPL 760 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~-APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP 760 (1219)
. ....+.-++. .+|++.....+..+.|++|||..+.+.++|.+.
T Consensus 421 ~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 S---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred c---ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 1 1223344445 366666777788999999999999999999743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.9e-08 Score=106.50 Aligned_cols=129 Identities=23% Similarity=0.247 Sum_probs=83.9
Q ss_pred EEEEEEEcCCCeEEEEEEeeccc--------------c----------CchhHHHHHHHHHHHHhccCC-CCccEEeeee
Q psy14431 575 IVYKAYDKNNKQYVAIKKIFEAF--------------R----------NKTDAQRTYREILFLKSFQRH-PNIITMLDIY 629 (1219)
Q Consensus 575 tVYlA~dk~TGk~VAIKvI~ks~--------------~----------s~~~~e~~lREI~ILr~L~~H-PNIVkL~gvf 629 (1219)
.||.|... .|..+|||+.+... . .........+|...|..+... -+++.++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38889764 47789999874211 0 011124556899999999743 3577777553
Q ss_pred eccCCceEEEEEecch--hhHHHHHhhccCChHHHHHHHHHHHHHHHH-HHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 630 KAVNNKDLYVVFEYME--NDLNKVIRDKILKDVHIRYIMFQLCNGLSY-IHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 630 e~~d~~~LyLVMEyme--GSL~d~Lrs~~LseeeVr~Ia~QILsALaY-LHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
. -+|||||++ |.....+....++......++.+++..+.. +|..||+|||+.+.|||++.+ .+.|+|||.
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred C------CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 379999999 633333333334455677788888885555 579999999999999999887 899999998
Q ss_pred ccccC
Q psy14431 707 ARSLS 711 (1219)
Q Consensus 707 Ar~l~ 711 (1219)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.5e-08 Score=104.87 Aligned_cols=130 Identities=22% Similarity=0.289 Sum_probs=91.9
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEe-eccccCc-----hhHHHHHHHHHHHHhccCC-CCccEEeeeeeccCCceEEE
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNK-----TDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI-~ks~~s~-----~~~e~~lREI~ILr~L~~H-PNIVkL~gvfe~~d~~~LyL 639 (1219)
.|+.|+-+.+|.+.+ -|.++++|.= .+.+..+ -...+..+|..++..+..- -+.+.++++ +.....|
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----D~~~~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----DPDNGLI 76 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCEE
Confidence 568899999999955 3555777743 2333322 2235666888888877621 233344433 3345679
Q ss_pred EEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 640 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
||||++| .|.+++... ...++..+-.-+.-||.+||||+||.++||+++.++ +.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998 466677654 134667777788889999999999999999997765 99999999874
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.7e-08 Score=103.90 Aligned_cols=141 Identities=21% Similarity=0.245 Sum_probs=100.7
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEee-ccccC-----chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRN-----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~-ks~~s-----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+..|-+|+-+.|+.+. ..|+.+.||.=+ +.+.. .-...+..+|+..|..+. --.|.-..-+|.+ ...-
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D--~~~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFID--TYGG 85 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEe--cCCC
Confidence 56678899999999995 558888888543 22222 223456778888888775 2233322223432 2334
Q ss_pred EEEEecchh--hHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceecccccccc
Q psy14431 638 YVVFEYMEN--DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARS 709 (1219)
Q Consensus 638 yLVMEymeG--SL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLAr~ 709 (1219)
+|+|||++| ++.+++... .....-...++..|-..+.-||.++|||+||..+||++.++|. +.++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 788999998 788887732 2333334678999999999999999999999999999987763 58999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.8e-08 Score=112.43 Aligned_cols=191 Identities=9% Similarity=0.076 Sum_probs=134.4
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEee----eeeccCCce-EE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD----IYKAVNNKD-LY 638 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~g----vfe~~d~~~-Ly 638 (1219)
..+.||.|+-+.+|-.-. -...+.|++..+... ....-+..|...-.||-+..-+. ...+.+++. +.
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa-----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPA-----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCch-----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 356789999999997622 223567887643221 12223444555545664433111 112233333 78
Q ss_pred EEEecchh--hHHHHHhh-------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 639 VVFEYMEN--DLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 639 LVMEymeG--SL~d~Lrs-------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+.|+.+.| ....+++. ....+..+.++++.|+.+.+-||..|.+-+|+.++|||+++++.|.|+|-.....
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 99999986 56666541 1367788899999999999999999999999999999999999999998765544
Q ss_pred cCCcccccccccccccccCchhhh----ccccccccccchhHHHHHHHHHhC-CCCCCC
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQS-KPLFPG 763 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g 763 (1219)
.. .+......+|...|.+||.-. .+..-+...|.|.||+++|+|+.| ++||.|
T Consensus 167 ~~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NA-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cc-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 33 333445678999999999852 122346789999999999999986 899976
|
|
| >cd01243 PH_MRCK MRCK (myotonic dystrophy-related Cdc42-binding kinase) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-09 Score=104.75 Aligned_cols=48 Identities=31% Similarity=0.599 Sum_probs=41.3
Q ss_pred ccCCCccCCCchhhhhhccccceeeecceeeeeccCcccccc---CCcchhh
Q psy14431 872 RLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQN---TDPELEL 920 (1219)
Q Consensus 872 ~lEg~~~IPnk~nlk~~~wke~l~~~s~~ki~fyN~~~~~~n---~~~~~~l 920 (1219)
..+||..+|.....+. .|..++++++..||.|||..+++.+ .++++.|
T Consensus 3 ~~EGwvkvP~~~~~kr-GW~r~~vVv~~~Kl~lYd~e~~k~~~p~~~~~~vL 53 (122)
T cd01243 3 AYEGHVKIPKPGGVKK-GWQRALVVVCDFKLFLYDIAEDRASQPSVVISQVL 53 (122)
T ss_pred cceeeEeccCCCCccc-CceEEEEEEeCCEEEEEeCCccccCCccCceeEEE
Confidence 4689999999999987 9999999999999999999998877 3455555
|
MRCK (myotonic dystrophy-related Cdc42-binding kinase) pleckstrin homology (PH) domain. MRCK consists of a serine/threonine kinase domain, a cysteine rich (C1) region, a PH domain and a p21 binding motif. It has been shown to promote cytoskeletal reorganization, which affects many biological processes. The MRCK PH domain is responsible for its targeting to cell to cell junctions. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.3e-07 Score=101.00 Aligned_cols=133 Identities=13% Similarity=0.068 Sum_probs=90.3
Q ss_pred eEEEEEEEcCCCeEEEEEEeeccccCc---------hhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccC---CceEEE
Q psy14431 574 GIVYKAYDKNNKQYVAIKKIFEAFRNK---------TDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVN---NKDLYV 639 (1219)
Q Consensus 574 GtVYlA~dk~TGk~VAIKvI~ks~~s~---------~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d---~~~LyL 639 (1219)
..|+.+. -.|+.|.||......... .....+.+|...+..+. +.| .+.++.++.... ...-+|
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIp-tP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVD-TMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCC-CCCeeEEEEecCCCccceeEE
Confidence 3355553 347789999663221100 11113667888777774 222 233343443211 235789
Q ss_pred EEecchh--hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-------CCcceecccccc
Q psy14431 640 VFEYMEN--DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------SCSIKIGDLGLA 707 (1219)
Q Consensus 640 VMEymeG--SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-------dG~VKLiDFGLA 707 (1219)
|||++++ +|.+++.. ...+......++.+++..+.-||..||+|+|++|+|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999997 68888752 34556677789999999999999999999999999999975 457999999987
Q ss_pred cc
Q psy14431 708 RS 709 (1219)
Q Consensus 708 r~ 709 (1219)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.5e-07 Score=94.53 Aligned_cols=127 Identities=20% Similarity=0.243 Sum_probs=88.6
Q ss_pred CCeEEEEEEeecccc-----CchhHHHHHHHHHHHHhccC-CCCccEEeeeeeccCC--ceEEEEEecchh--hHHHHHh
Q psy14431 584 NKQYVAIKKIFEAFR-----NKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVNN--KDLYVVFEYMEN--DLNKVIR 653 (1219)
Q Consensus 584 TGk~VAIKvI~ks~~-----s~~~~e~~lREI~ILr~L~~-HPNIVkL~gvfe~~d~--~~LyLVMEymeG--SL~d~Lr 653 (1219)
.++.|-+|....... .........+|...+..+.. .-.++..+++.....+ ...+||++++++ +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 355566665432211 11233456677776666641 1224455554442222 345899999997 6888887
Q ss_pred h-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cceeccccccccc
Q psy14431 654 D-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDLGLARSL 710 (1219)
Q Consensus 654 s-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKLiDFGLAr~l 710 (1219)
. ...+......++.+++..+.-||.+||+|+|++|.|||++.++ .+.|+||+.+...
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5 2356667788999999999999999999999999999999887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-07 Score=106.60 Aligned_cols=139 Identities=22% Similarity=0.352 Sum_probs=103.6
Q ss_pred CCCccEEeeeeecc---CCceEEEEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhc--ccccCCCC
Q psy14431 619 HPNIITMLDIYKAV---NNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC--KVMHRDLK 687 (1219)
Q Consensus 619 HPNIVkL~gvfe~~---d~~~LyLVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~--GIVHRDLK 687 (1219)
|.|||+++.|+.+. +.....++.+||. |++..+++. ..+.....+.|+.||+.||.|||+. -|+|+++.
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlT 205 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLT 205 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcc
Confidence 88999999888642 2345789999998 789888872 3477888999999999999999987 59999999
Q ss_pred CCCeeeccCCcceecccccccccCCcc----cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC
Q psy14431 688 PSNILIDKSCSIKIGDLGLARSLSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758 (1219)
Q Consensus 688 PsNILLd~dG~VKLiDFGLAr~l~~~~----~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk 758 (1219)
.+-|++..+|-++++--........-. .......+-++|.+|+.= .....+.++|||+||+...+|..|.
T Consensus 206 c~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 206 CDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred hhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHhe
Confidence 999999999888864322111111100 001122456889999983 2334577899999999999998876
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=100.94 Aligned_cols=165 Identities=18% Similarity=0.290 Sum_probs=125.1
Q ss_pred ceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCceEEEEEecchh--hH
Q psy14431 573 YGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN--DL 648 (1219)
Q Consensus 573 FGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~LyLVMEymeG--SL 648 (1219)
..+.|+|....+|..|++|.+..... ........=+.+|+.+. |+|||++.++|... ++..+++|++|.++ +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45789999999999999999832211 11122334467888896 99999999998632 34568999999995 67
Q ss_pred HHHHh----------------hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 649 NKVIR----------------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 649 ~d~Lr----------------s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+..- +...++..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+..++|+..|+...+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 66543 12367789999999999999999999999999999999999888899988887765543
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk 758 (1219)
.. .+| + .. -.+-|.-.||.+++.|.||.
T Consensus 446 d~------------~~~--l-e~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DP------------TEP--L-ES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC------------Ccc--h-hH---HhhhhHHHHHHHHHHHhhcc
Confidence 32 011 1 11 13468889999999999996
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-06 Score=97.50 Aligned_cols=137 Identities=22% Similarity=0.171 Sum_probs=99.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecc------------c------cC--chhHHHHHHHHHHHHhccCC-C
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA------------F------RN--KTDAQRTYREILFLKSFQRH-P 620 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks------------~------~s--~~~~e~~lREI~ILr~L~~H-P 620 (1219)
+.+..+||-|--|.||.|.+. .|..+|||.=+.. . .+ ........+|..+|..+..+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346688999999999999876 5788999963210 0 00 12234566899999999633 2
Q ss_pred CccEEeeeeeccCCceEEEEEecchhh-HHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcc
Q psy14431 621 NIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699 (1219)
Q Consensus 621 NIVkL~gvfe~~d~~~LyLVMEymeGS-L~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~V 699 (1219)
.++..+++ +..++||||+.|- |... ++....+..++..|+.-+..+-..||||+|+++-||+++.+|.+
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 46666543 3468999999983 2221 12345556677777777777779999999999999999999999
Q ss_pred eecccccccc
Q psy14431 700 KIGDLGLARS 709 (1219)
Q Consensus 700 KLiDFGLAr~ 709 (1219)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999965543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.7e-06 Score=89.86 Aligned_cols=137 Identities=12% Similarity=0.109 Sum_probs=99.0
Q ss_pred eccCceEEEEEEEcCCCeEEEEEEee----ccccCchhHHHHHHHHHHHHhccC--CCCccEEeeeee---ccCCceEEE
Q psy14431 569 GKGAYGIVYKAYDKNNKQYVAIKKIF----EAFRNKTDAQRTYREILFLKSFQR--HPNIITMLDIYK---AVNNKDLYV 639 (1219)
Q Consensus 569 GeGgFGtVYlA~dk~TGk~VAIKvI~----ks~~s~~~~e~~lREI~ILr~L~~--HPNIVkL~gvfe---~~d~~~LyL 639 (1219)
|.||.|.|+..... |..|-+|.-. .....+.....+.+|...+..+.. -| +++++ ++. .+....-+|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence 67999999997543 4468888653 111112334568889988888762 23 44444 222 112234679
Q ss_pred EEecchh--hHHHHHhhcc---CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc--ceecccccccc
Q psy14431 640 VFEYMEN--DLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLARS 709 (1219)
Q Consensus 640 VMEymeG--SL~d~Lrs~~---LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~--VKLiDFGLAr~ 709 (1219)
|++-++| +|.+++.... .+......++.+|+..+.-||+.|+.|+|+.|.|||++.+|. |.++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999985 8988887644 355666789999999999999999999999999999987777 99999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.8e-06 Score=91.08 Aligned_cols=150 Identities=17% Similarity=0.162 Sum_probs=102.1
Q ss_pred hccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-----------------hhH-----HHHHHHHH
Q psy14431 554 KDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----------------TDA-----QRTYREIL 611 (1219)
Q Consensus 554 ~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-----------------~~~-----e~~lREI~ 611 (1219)
..+..+..|. ..|+.|--+.||+|.. .++..||+|++......- ... .-..+|..
T Consensus 44 ~~rg~i~~~~--g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~ 120 (268)
T COG1718 44 LSRGVITELV--GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR 120 (268)
T ss_pred hcCCceeeeE--eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence 3455555543 3778888899999964 458899999985321100 011 11225666
Q ss_pred HHHhccC-CCCccEEeeeeeccCCceEEEEEecchhh--HHHHHhhccCChHHHHHHHHHHHHHHHHHHh-cccccCCCC
Q psy14431 612 FLKSFQR-HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLK 687 (1219)
Q Consensus 612 ILr~L~~-HPNIVkL~gvfe~~d~~~LyLVMEymeGS--L~d~Lrs~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLK 687 (1219)
.|.++.. +-.+++.++++. -+|||||++.. -.-.+..-++....+..+..+++..+.-|-. .|+||+||+
T Consensus 121 NL~R~~eAGVrvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLS 194 (268)
T COG1718 121 NLKRAYEAGVRVPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLS 194 (268)
T ss_pred HHHHHHHcCCCCCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccch
Confidence 6666652 244566665543 37999999853 1222233334444677888899999998876 999999999
Q ss_pred CCCeeeccCCcceecccccccccCCc
Q psy14431 688 PSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 688 PsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.-|||+. +|.+.|+|||-|.....+
T Consensus 195 EyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 195 EYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hhheEEE-CCeEEEEECccccccCCC
Confidence 9999999 889999999988765543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=80.47 Aligned_cols=139 Identities=23% Similarity=0.265 Sum_probs=79.7
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEeeeeec-cCCceEEEEEe
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKA-VNNKDLYVVFE 642 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~gvfe~-~d~~~LyLVME 642 (1219)
++.|+.|..+.||.+.... + .+++|+.... .....+.+|..++..+..+ ..++.++.+... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5688999999999998765 4 7899987422 3455677888888888644 235666654322 22345799999
Q ss_pred cchhh-HHH----------------HHh---hc-----cCChHH------HHH---H------------HHHHHH-HHHH
Q psy14431 643 YMEND-LNK----------------VIR---DK-----ILKDVH------IRY---I------------MFQLCN-GLSY 675 (1219)
Q Consensus 643 ymeGS-L~d----------------~Lr---s~-----~Lseee------Vr~---I------------a~QILs-ALaY 675 (1219)
+++|. +.. ++. .. .+.... ... . ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 99872 322 111 10 000000 000 0 111222 3333
Q ss_pred HH-------hcccccCCCCCCCeeec-cCCcceecccccccc
Q psy14431 676 IH-------ACKVMHRDLKPSNILID-KSCSIKIGDLGLARS 709 (1219)
Q Consensus 676 LH-------S~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr~ 709 (1219)
++ ..+++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33 24699999999999999 556667999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0161|consensus | Back alignment and domain information |
|---|
Probab=98.13 E-value=0.012 Score=79.88 Aligned_cols=365 Identities=27% Similarity=0.361 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHhHhhhhhhHhhhhhhhhhhhhhHhhhhhhHH-hhhhcchhhhhhhchhhhhhhhhhHHhhh----hhH
Q psy14431 39 LEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKES-QRRADNESETKKKAEVNLQVISDMHEKLK----TEA 113 (1219)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 113 (1219)
+|++.+++...+.+-...-..|.+--..||.-+..+.-.|..- ..|.+.| ..++|.+-.+. ++.+.+. .-.
T Consensus 990 lEe~~~~l~~~l~~~eek~~~l~k~~~kle~~l~~le~~le~e~~~r~e~E-k~~rkle~el~---~~~e~~~~~~~~~~ 1065 (1930)
T KOG0161|consen 990 LEERIRELQDDLQAEEEKAKSLNKAKAKLEQQLDDLEVTLEREKRIRMELE-KAKRKLEGELK---DLQESIEELKKQKE 1065 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHH---HhhhHHHHHHHHHH
Confidence 6667777776666655555556666666666666665555433 3333333 22333333332 2222221 112
Q ss_pred HHHHHHhhhccceehhccccchhHHHHHHHHHHHhhchhhHHHHHHHHHHHhhhhhccccchhhhhhhhhhHHHHhhhHH
Q psy14431 114 ETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTEL 193 (1219)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (1219)
+....|++...++.-..+- +-+++..++++.-....|+..++.|+..+..+|.+..-+-.-..+|..-+.+|+.+|
T Consensus 1066 el~~~l~kke~El~~l~~k----~e~e~~~~~~l~k~i~eL~~~i~el~e~le~er~~r~K~ek~r~dL~~ele~l~~~L 1141 (1930)
T KOG0161|consen 1066 ELDNQLKKKESELSQLQSK----LEDEQAEVAQLQKQIKELEARIKELEEELEAERASRAKAERQRRDLSEELEELKEEL 1141 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHH----hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3333444444444332221 234455555555555556666666666666666655555555555555566665555
Q ss_pred hhcccccchhhhhhcchhhhhhhhhHHHhhhHhhH----HHHHhhHHHhhhhh---hhhHHhhhhhhhhhhhccchhhhh
Q psy14431 194 ERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNT----ELERNKHRELQLAE---DNRHLGEKVSSLEKECASLSLELK 266 (1219)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 266 (1219)
+---+......+.|.-.-..|..|.+--+-..+.- +.-|..|..- .++ -.-.+-..=..|+|+..+|..|..
T Consensus 1142 ee~~~~t~~q~e~~~k~e~e~~~l~~~leee~~~~e~~~~~lr~~~~~~-~~el~~qle~l~~~k~~lekek~~lq~e~~ 1220 (1930)
T KOG0161|consen 1142 EEQGGTTAAQLELNKKREAEVQKLRRDLEEETLDHEAQIEELRKKHADS-LAELQEQLEQLQKDKAKLEKEKSDLQREIA 1220 (1930)
T ss_pred HHHhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 54433333333322222222221111111000000 0001111000 000 000000001122333333333332
Q ss_pred HHHHHHHHHHHHhHhhhhhccccccchhHHHHHHHHHHHHhhccCCcchhhhhcC----CcccccchHHhHHHHhhchHH
Q psy14431 267 AAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSN----GKEREVDYKKSIDQLMKDRED 342 (1219)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 342 (1219)
--..+-.+...+-..+++-+ .+-|+.+.=+..--+-+..+++|++.+.+-+.+ +.-+.-+-..-+.++.++...
T Consensus 1221 ~l~~ev~~~~~~k~~~e~~~--k~~E~~l~elq~k~~~~~~~~~~l~~q~~~l~~E~~~l~~~lee~e~~~~~~~r~~~~ 1298 (1930)
T KOG0161|consen 1221 DLAAELEQLSSEKKDLEKKD--KKLEAQLSELQLKLDEQERLRNDLTAKRSRLQNENEELSRQLEEAEAKLSALSRDKQA 1298 (1930)
T ss_pred HHHHHHHHHhhhhccHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHHHHhhHhHHHHHHHHHHHHHHHH
Confidence 22222223333333333222 233344433333334455566666655554432 222223334467788888888
Q ss_pred HHHHHHhhhhhH--HHHHH----------HhhhhhhhHHHHHHHhhhccccccccchhhhhhhhHhhHHHHHHH-HHHHH
Q psy14431 343 LQQQINLLKEGA--ELRQE----------LEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHE-VAMLR 409 (1219)
Q Consensus 343 ~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 409 (1219)
+..||..++.-. +.+++ =..-+.|+.+++-++..+.-|+.-++....+++..+..=+-...+ ...+-
T Consensus 1299 ~~~qle~~k~qle~e~r~k~~l~~~l~~l~~e~~~l~e~leee~e~~~~l~r~lsk~~~e~~~~~~k~e~~~~~~~eele 1378 (1930)
T KOG0161|consen 1299 LESQLEELKRQLEEETREKSALENALRQLEHELDLLREQLEEEQEAKNELERKLSKANAELAQWKKKFEEEVLQRLEELE 1378 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 888888886532 22221 122345667777777777777777777777766554432222222 34444
Q ss_pred HHHHh
Q psy14431 410 EAKRN 414 (1219)
Q Consensus 410 ~~~~~ 414 (1219)
++|+.
T Consensus 1379 e~kk~ 1383 (1930)
T KOG0161|consen 1379 ELKKK 1383 (1930)
T ss_pred HHHHH
Confidence 44443
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=8.9e-07 Score=107.66 Aligned_cols=98 Identities=20% Similarity=0.421 Sum_probs=77.0
Q ss_pred HHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCccccc---------ccccccccccCchhhhcccc
Q psy14431 668 QLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL---------TEYIATRWYRAPEILISNRR 737 (1219)
Q Consensus 668 QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~---------ts~vGT~~Y~APEvLl~~~~ 737 (1219)
+++.|+.|+|. .++||++|.|.+|.++..|..||+.|+++....++.... ........|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 34489999994 699999999999999999999999999987655422110 11233567999999854 66
Q ss_pred ccccccchhHHHHHHHHH-hCCCCCCCCCc
Q psy14431 738 YTHHVDIWSLGCILAEML-QSKPLFPGAST 766 (1219)
Q Consensus 738 yT~kSDIWSLG~ILyELL-TGkpPF~g~s~ 766 (1219)
.++++|+||+||++|.+. .|++.|.+.+.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~ 215 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGG 215 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCC
Confidence 889999999999999998 67787766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-05 Score=97.59 Aligned_cols=142 Identities=18% Similarity=0.273 Sum_probs=87.7
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc------------------------hhH--------H------HHH
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK------------------------TDA--------Q------RTY 607 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~------------------------~~~--------e------~~l 607 (1219)
..|+.++-|.||.|..+. |+.||||+.++..... -.. . .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999766 9999999975332100 000 1 112
Q ss_pred HHHHHHHhcc----CCCCccEEeeeeeccCCceEEEEEecchh-hHHHH--HhhccCChHHHHHHHHHHHHH-HHHHHhc
Q psy14431 608 REILFLKSFQ----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV--IRDKILKDVHIRYIMFQLCNG-LSYIHAC 679 (1219)
Q Consensus 608 REI~ILr~L~----~HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d~--Lrs~~LseeeVr~Ia~QILsA-LaYLHS~ 679 (1219)
+|...+..+. +.|+|. +-.+|.. -.+.-+|+|||++| .+.++ +....++... ++..++.+ +.-+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 3333333332 234331 2222321 12346899999998 44444 3333444322 23332222 2223347
Q ss_pred ccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 680 GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
|++|+|..|.||+++.+|.+.+.|||+...+++.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.3e-05 Score=82.85 Aligned_cols=133 Identities=16% Similarity=0.172 Sum_probs=79.9
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEeeeeeccCCceEEEEEecc
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
..||.|..+.||+. .|..+++|...... ......+|..++..+.... .+++.+++.. +++..++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeec
Confidence 46799999999984 24457889775322 3345688999998886332 2466666554 345578899999
Q ss_pred hhh--HHHHH---------------------hhc---cCChHH-HHHHHHH----------HHH-HHHHHH----hcccc
Q psy14431 645 END--LNKVI---------------------RDK---ILKDVH-IRYIMFQ----------LCN-GLSYIH----ACKVM 682 (1219)
Q Consensus 645 eGS--L~d~L---------------------rs~---~Lseee-Vr~Ia~Q----------ILs-ALaYLH----S~GIV 682 (1219)
+|. +...+ +.- ..+... ...+..+ +.. ...+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 983 11111 110 001000 0001000 011 122222 12478
Q ss_pred cCCCCCCCeeeccCCcceecccccccc
Q psy14431 683 HRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 683 HRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
|+|+.|.||+++.++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK02224 chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.091 Score=67.38 Aligned_cols=24 Identities=17% Similarity=0.484 Sum_probs=13.1
Q ss_pred chHHhHHHHhhchHHHHHHHHhhh
Q psy14431 328 DYKKSIDQLMKDREDLQQQINLLK 351 (1219)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~ 351 (1219)
+|...++.+-...++|..++.-++
T Consensus 472 ~~~~~~~~~~~~~~~le~~l~~~~ 495 (880)
T PRK02224 472 EDRERVEELEAELEDLEEEVEEVE 495 (880)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 455556665555555555554443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.5e-05 Score=82.85 Aligned_cols=138 Identities=14% Similarity=0.132 Sum_probs=83.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----------chhHHHHHHHHHHHHhccCCCCccEEeeee
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----------KTDAQRTYREILFLKSFQRHPNIITMLDIY 629 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----------~~~~e~~lREI~ILr~L~~HPNIVkL~gvf 629 (1219)
.+|.+++.+-......|.+.. -.|..+++|........ .......+..+..+... +...+..++.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~-g~~~~~~~yl~~ 107 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNE-GFTEPADPYLAA 107 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHc-Cccccccceeee
Confidence 467888888777777777763 44677999987543211 11112222222222222 122333322222
Q ss_pred ecc---CCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 630 KAV---NNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 630 e~~---d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
.-. -....+|||||++| .|.++.. +++ .+...|..++.-||..|++|+|+.|+|++++.++ ++++||+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 111 12345689999998 3443321 222 2445677889999999999999999999998655 9999998
Q ss_pred ccc
Q psy14431 706 LAR 708 (1219)
Q Consensus 706 LAr 708 (1219)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=78.67 Aligned_cols=71 Identities=13% Similarity=0.101 Sum_probs=48.2
Q ss_pred eeeccCc-eEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 567 KEGKGAY-GIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 567 kIGeGgF-GtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
.|-.|.+ +.||++... +..+++|+..... .....+|+.++..+..+--+++++++.. .++..++||++++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEEEeeC
Confidence 3444555 789999543 4578888764221 2346689999888876655667776654 3356789999998
Q ss_pred h
Q psy14431 646 N 646 (1219)
Q Consensus 646 G 646 (1219)
|
T Consensus 76 G 76 (244)
T cd05150 76 G 76 (244)
T ss_pred C
Confidence 7
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.83 E-value=4.3e-05 Score=92.48 Aligned_cols=141 Identities=20% Similarity=0.193 Sum_probs=88.0
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-----------------------------chhHHHH------HHH
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-----------------------------KTDAQRT------YRE 609 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-----------------------------~~~~e~~------lRE 609 (1219)
-+.||.-+.|.||+|+.++ |..||||+-++.... +.-...+ .+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4678999999999999877 999999985432110 0001112 222
Q ss_pred HHHHHhcc---CCCC------ccEEeeeeeccCCceEEEEEecchh----hHHHHHhhccCChHHHHHHHHHHHHHHHHH
Q psy14431 610 ILFLKSFQ---RHPN------IITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676 (1219)
Q Consensus 610 I~ILr~L~---~HPN------IVkL~gvfe~~d~~~LyLVMEymeG----SL~d~Lrs~~LseeeVr~Ia~QILsALaYL 676 (1219)
......+. .|-+ |+++|-.+ .+.-+|+||||+| ++ +.+....++...+...+.++..-. |
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~gi~~~~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRGISPHDILNKLVEAYLEQ--I 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcCCCHHHHHHHHHHHHHHH--H
Confidence 22222221 1333 44443332 2357899999997 44 555555566664443333322222 2
Q ss_pred HhcccccCCCCCCCeeecc----CCcceecccccccccCCc
Q psy14431 677 HACKVMHRDLKPSNILIDK----SCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 677 HS~GIVHRDLKPsNILLd~----dG~VKLiDFGLAr~l~~~ 713 (1219)
-..|++|+|-.|.||+++. ++.+.+-|||+...+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2468999999999999984 567999999999877654
|
|
| >PRK02224 chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.13 Score=65.97 Aligned_cols=17 Identities=41% Similarity=0.501 Sum_probs=8.9
Q ss_pred HHHHHHHHHhhhhhhhH
Q psy14431 456 ELKEELDERSRNILELE 472 (1219)
Q Consensus 456 ~~~~~~~e~~~~~~~l~ 472 (1219)
++++++.+.+.++.+|+
T Consensus 624 ~~~~~l~~~r~~i~~l~ 640 (880)
T PRK02224 624 ERRERLAEKRERKRELE 640 (880)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 45555555555555554
|
|
| >TIGR02168 SMC_prok_B chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.18 Score=65.46 Aligned_cols=20 Identities=25% Similarity=0.220 Sum_probs=7.8
Q ss_pred HHHHHHHHHhhhhhhhHHhh
Q psy14431 456 ELKEELDERSRNILELEEER 475 (1219)
Q Consensus 456 ~~~~~~~e~~~~~~~l~~~r 475 (1219)
.+++++....+++..++.+.
T Consensus 814 ~~~~~l~~~~~~~~~l~~~~ 833 (1179)
T TIGR02168 814 LLNEEAANLRERLESLERRI 833 (1179)
T ss_pred HHHHHHHHHHHHHHHHHHHH
Confidence 33333333333444444333
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00018 Score=91.18 Aligned_cols=83 Identities=14% Similarity=0.178 Sum_probs=56.4
Q ss_pred EEeeeeccCceEEEEEEEcCCC--eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCc--cEEeeeeecc-CCceEE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI--ITMLDIYKAV-NNKDLY 638 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TG--k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNI--VkL~gvfe~~-d~~~Ly 638 (1219)
.+..|+.|.++.+|+......+ ..+++|+..... .......+.+|..++..+..|++| ++++.++.+. ..+.+|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4678899999999998765433 457777653221 112334677999999999656654 7777666532 124689
Q ss_pred EEEecchhh
Q psy14431 639 VVFEYMEND 647 (1219)
Q Consensus 639 LVMEymeGS 647 (1219)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999873
|
|
| >KOG0161|consensus | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.21 Score=68.67 Aligned_cols=232 Identities=28% Similarity=0.353 Sum_probs=131.2
Q ss_pred HHHHHhHhhhhhhHhhhhhhhhhhhhhHhhh--------------hhhHHhhhhcchhhhhhhchhhhhhhhhhHHhhhh
Q psy14431 46 LSEQYEAVSARETALRDEMGQLEKNLTILRH--------------DLKESQRRADNESETKKKAEVNLQVISDMHEKLKT 111 (1219)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (1219)
+-.-+.+...+-..|.++|.+++.++.-|-. |+-.....+..-...+.+-+ +-+.||-..|..
T Consensus 955 ~~~Ek~~~e~~~~~l~~e~~~~~e~~~kL~kekk~lEe~~~~l~~~l~~~eek~~~l~k~~~kle---~~l~~le~~le~ 1031 (1930)
T KOG0161|consen 955 LELEKNAAENKLKNLEEEINSLDENISKLSKEKKELEERIRELQDDLQAEEEKAKSLNKAKAKLE---QQLDDLEVTLER 1031 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHH
Confidence 3444556666666777777777665544322 22222222222222222222 334555555544
Q ss_pred hHH----HHHHHhhhccceehhcccc---chhHHHHHHHHHHHhhchhhHHHHHHHHHHHhhhhhccccchhhhhhhhhh
Q psy14431 112 EAE----TATRLRKQSAELTVAKSAG---EQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEG 184 (1219)
Q Consensus 112 ~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (1219)
+-. .-+..||--.+|..+...- ...+-+|+|.|+..+-|.-.++.++..+++-+++ +--.-++|+.
T Consensus 1032 e~~~r~e~Ek~~rkle~el~~~~e~~~~~~~~~~el~~~l~kke~El~~l~~k~e~e~~~~~~-------l~k~i~eL~~ 1104 (1930)
T KOG0161|consen 1032 EKRIRMELEKAKRKLEGELKDLQESIEELKKQKEELDNQLKKKESELSQLQSKLEDEQAEVAQ-------LQKQIKELEA 1104 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHH-------HHHHHHHHHH
Confidence 432 2234455555553332221 1234577788887777777777776666665543 4455677888
Q ss_pred HHHHhhhHHhhcccccchhhhhhcchhhhhhhhhHHHhhh--HhhHHHHHhhHHHhhhhhhhhHHhhhhhhhhhhhccch
Q psy14431 185 RLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQ--ALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLS 262 (1219)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (1219)
++..|-.+|+--+...-.+-.-.+.|...+..|..+|--+ +...-.+-|+.++...++-++.|-+..+..|...+.|.
T Consensus 1105 ~i~el~e~le~er~~r~K~ek~r~dL~~ele~l~~~Lee~~~~t~~q~e~~~k~e~e~~~l~~~leee~~~~e~~~~~lr 1184 (1930)
T KOG0161|consen 1105 RIKELEEELEAERASRAKAERQRRDLSEELEELKEELEEQGGTTAAQLELNKKREAEVQKLRRDLEEETLDHEAQIEELR 1184 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 8877777765443333333344567888888898888766 45555566677777777777777777776666555543
Q ss_pred ----hhhhHHHHHHHHHHHHhH--hhhhhcc
Q psy14431 263 ----LELKAAQAQYQQEVRAHE--ETQKSRM 287 (1219)
Q Consensus 263 ----~~~~~~~~~~~~~~~~~~--~~~~~~~ 287 (1219)
..+..-.+++.+.-+.|+ +.+|+.+
T Consensus 1185 ~~~~~~~~el~~qle~l~~~k~~lekek~~l 1215 (1930)
T KOG0161|consen 1185 KKHADSLAELQEQLEQLQKDKAKLEKEKSDL 1215 (1930)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 234444555655554444 4444443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.001 Score=78.59 Aligned_cols=79 Identities=16% Similarity=0.184 Sum_probs=55.5
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-----CchhHHHHHHHHHHHHhccCC--CCccEEeeeeeccCCce
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-----NKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-----s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~d~~~ 636 (1219)
..+.||.|.++.||++.+..+++.|+||...+... ..-...+...|...|..+..+ .++++++.+ +...
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----D~~~ 105 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----DEEL 105 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE----CCCC
Confidence 35678999999999999876556899997542211 123456777888888876533 457777755 2345
Q ss_pred EEEEEecchh
Q psy14431 637 LYVVFEYMEN 646 (1219)
Q Consensus 637 LyLVMEymeG 646 (1219)
.++||||+++
T Consensus 106 ~~lVME~L~~ 115 (401)
T PRK09550 106 AVTVMEDLSD 115 (401)
T ss_pred CEEEEecCCC
Confidence 7899999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.001 Score=70.87 Aligned_cols=73 Identities=15% Similarity=0.193 Sum_probs=47.2
Q ss_pred EeeeeccCceEEEEEEEcC-CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 565 LLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~-TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
++.|+.|-...||++.... .+..|++|+...... ......+|+.++..+..+.-.+++++.+. + .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4677888899999996543 356788997643211 11223478888888864444556654432 2 379999
Q ss_pred chh
Q psy14431 644 MEN 646 (1219)
Q Consensus 644 meG 646 (1219)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 986
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00041 Score=74.59 Aligned_cols=73 Identities=11% Similarity=0.124 Sum_probs=43.9
Q ss_pred EeeeeccCce-EEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC--CCccEEeeeeeccCC-ceEEEE
Q psy14431 565 LLKEGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNN-KDLYVV 640 (1219)
Q Consensus 565 LKkIGeGgFG-tVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~d~-~~LyLV 640 (1219)
+..|+.|+.. .||.. +..+++|+... ......+.+|..++..+..+ -.++.+++.....+. +..|+|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 3567777776 59986 23477886532 12234688899999888643 134444443322111 245889
Q ss_pred Eecchh
Q psy14431 641 FEYMEN 646 (1219)
Q Consensus 641 MEymeG 646 (1219)
|++++|
T Consensus 73 ~~~i~G 78 (235)
T cd05155 73 YRWLEG 78 (235)
T ss_pred EEeecC
Confidence 999887
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK03918 chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.68 Score=59.46 Aligned_cols=23 Identities=26% Similarity=0.494 Sum_probs=10.9
Q ss_pred HHHHhhchhhHHHHHHHHHHHhh
Q psy14431 144 LATLEMERDTLQQEVATLQAKIS 166 (1219)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~ 166 (1219)
+..++.+...+++++..++..+.
T Consensus 261 i~~l~~el~~l~~~l~~l~~~~~ 283 (880)
T PRK03918 261 IRELEERIEELKKEIEELEEKVK 283 (880)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH
Confidence 34444444455555554444443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00036 Score=74.60 Aligned_cols=131 Identities=15% Similarity=0.115 Sum_probs=88.4
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
...+.||.|.+|.||+|.+. |..+|+|+-+. +.....+..|..+|..+.+----+.+|.+-. -++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhh
Confidence 34567899999999999654 66899998753 3345567889999988874444455554322 345699
Q ss_pred cchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCC-CCCeeeccCCcceecccccccccC
Q psy14431 643 YMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK-PSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 643 ymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLK-PsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
|+.| .|....... + +.-+..++.+---|-..||-|+.|. |..+++-.++.+.|+||..|+.-.
T Consensus 93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 9998 666554422 1 2233445555455667899999995 444444445599999999997433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0014 Score=71.28 Aligned_cols=130 Identities=18% Similarity=0.153 Sum_probs=90.8
Q ss_pred cCeeEEeeeeccCc-eEEEEEEEcCCCeEEEEEEeec---c--------cc-Cc-------hhHHHHHHHHHHHHhcc--
Q psy14431 560 QQQINLLKEGKGAY-GIVYKAYDKNNKQYVAIKKIFE---A--------FR-NK-------TDAQRTYREILFLKSFQ-- 617 (1219)
Q Consensus 560 qqY~ILKkIGeGgF-GtVYlA~dk~TGk~VAIKvI~k---s--------~~-s~-------~~~e~~lREI~ILr~L~-- 617 (1219)
.++..++.||.|+- |.||++.- .|..||||++.. . .. .. .....+..|.....++.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 99999954 578999999321 0 00 00 12235667777766665
Q ss_pred CCCCc--cEEeeeeecc----------------CCceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc
Q psy14431 618 RHPNI--ITMLDIYKAV----------------NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679 (1219)
Q Consensus 618 ~HPNI--VkL~gvfe~~----------------d~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~ 679 (1219)
++.++ |+.+|++.-. ......||.+|++..- .++. .-+.+|++-+..+|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~~~----~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PLQI----RDIPQMLRDLKILHKL 183 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------ccch----hHHHHHHHHHHHHHHC
Confidence 34455 8999987421 1122468999887532 1222 2356778888899999
Q ss_pred ccccCCCCCCCeeeccCCcceecccccc
Q psy14431 680 KVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 680 GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
||+-+|+++.|.. .-+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc-----CCEEEecccC
Confidence 9999999999986 3589999865
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.36 E-value=6.7e-05 Score=91.26 Aligned_cols=179 Identities=20% Similarity=0.197 Sum_probs=126.4
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC-ccEEeeeeeccCCceEEEEEecch
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN-IVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
-+++|+++.+|+.+...+...+ .+++.. . ....-++.+|..+. ||| .+..++-+. ...+.+++++++.
T Consensus 249 ~fvK~altknpKkRptaeklL~-h~fvs~-----~--l~~rl~~eLLdK~n-~P~~~v~~~~d~~--~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ-HPFVSQ-----T--LSRRLAIELLDKVN-NPNPVVRYLEDYD--GEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee-ceeecc-----c--hhhHHHHHHHHHcc-CCCCcccccccCC--cccccchhhhhhc
Confidence 3488999999999776655544 555531 1 33445778888885 999 444444333 4567889999998
Q ss_pred hh--HHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccccc
Q psy14431 646 ND--LNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721 (1219)
Q Consensus 646 GS--L~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~v 721 (1219)
+. ...... .-.+.......+...-+.+++++|+.--+|+| ||+... +.++..||+....+.... ......
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCC
Confidence 53 111111 11234444556677778899999998778998 776644 689999999988776543 345678
Q ss_pred ccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 722 GT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
+|+.++|||+. ....+....|.||+|+--.++.-|-+|-..
T Consensus 392 ~~~~~~~pev~-~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 392 GTPEPLAPEVI-QENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCchhh-cccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 99999999987 455688899999999988888888887644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0017 Score=72.68 Aligned_cols=155 Identities=14% Similarity=0.132 Sum_probs=89.3
Q ss_pred hHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEe
Q psy14431 548 SIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITML 626 (1219)
Q Consensus 548 sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~ 626 (1219)
.+..++. .+++.....+..++.|....||.+.. .+| .+++|+.... .....+..++.++..+..+ -.+++++
T Consensus 11 ~l~~~l~-~y~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 11 EMSSFLD-GYDLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred HHHHHHH-hcCCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3444554 46777677788888888889999863 344 5778876431 1123345666777666422 1244444
Q ss_pred eeee----ccCCceEEEEEecchhh------HH------HHH---hh--ccCCh-------HHHH---------------
Q psy14431 627 DIYK----AVNNKDLYVVFEYMEND------LN------KVI---RD--KILKD-------VHIR--------------- 663 (1219)
Q Consensus 627 gvfe----~~d~~~LyLVMEymeGS------L~------d~L---rs--~~Lse-------eeVr--------------- 663 (1219)
.... ...++..++||+|++|. .. ..+ +. ..++. ...+
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 3211 11245678999998861 11 111 10 01100 0000
Q ss_pred -HHHHHHHHHHHHHH-------hcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 664 -YIMFQLCNGLSYIH-------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 664 -~Ia~QILsALaYLH-------S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.....+...+.++. ..++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 00111233455553 25899999999999999888778999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0018 Score=75.71 Aligned_cols=76 Identities=17% Similarity=0.275 Sum_probs=51.7
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeeccc-----cCchhHHHHHHHHHHHHhccCC-C-CccEEeeeeeccCCceEEE
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-----RNKTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-----~s~~~~e~~lREI~ILr~L~~H-P-NIVkL~gvfe~~d~~~LyL 639 (1219)
.||.|....||++.+..+++.|+||.-.+.. ..+-...+...|...|...... | +++++|.+ +.....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----cccccee
Confidence 4799999999999986555789999754221 2244556677788888776543 4 45555533 3555679
Q ss_pred EEecchh
Q psy14431 640 VFEYMEN 646 (1219)
Q Consensus 640 VMEymeG 646 (1219)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999863
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0976|consensus | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.19 Score=62.97 Aligned_cols=339 Identities=23% Similarity=0.311 Sum_probs=180.8
Q ss_pred hchhhhhhhhhhHHhhhhhHHHHHHHhhhccceehhccccchhHHHHHHHHHHHhhchhhHHHHHHHHHHHhhhhhcccc
Q psy14431 94 KAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKT 173 (1219)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (1219)
||-.|..||-.--.+.-|+. .+++|.-+.++.--+---+.-+-+|||-+.++||+..+||.-++.+|. +-+-.+|
T Consensus 67 kaglneSviie~sk~vstqe--triyRrdv~llEddlk~~~sQiriLQn~c~~lE~ekq~lQ~ti~~~q~---d~ke~et 141 (1265)
T KOG0976|consen 67 KAGLNESVIIEQSKKVSTQE--TRIYRRDVNLLEDDLKHHESQIRILQNKCLRLEMEKQKLQDTIQGAQD---DKKENEI 141 (1265)
T ss_pred HhhccchhhhhhcchhhHHH--HHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHH
Confidence 45666667655445555543 467888887777666666667789999999999999999876666654 4444555
Q ss_pred chhhhhhhhhhHHHHhhhHHhhcccccchhhhhhcchhhhhhhhhHHHhhhHhhHHHHHhhHHHhhhhhhhhHHhhhhhh
Q psy14431 174 QAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSS 253 (1219)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (1219)
.--|+..+ |..+-.+|--..|.-.-..+|-+.-.+++.+++.+ ++.++.| +++.|++|-+++..
T Consensus 142 elE~~~sr----lh~le~eLsAk~~eIf~~~~~L~nk~~~lt~~~~q--~~tkl~e----------~~~en~~le~k~~k 205 (1265)
T KOG0976|consen 142 EIENLNSR----LHKLEDELSAKAHDIFMIGEDLHDKNEELNEFNME--FQTKLAE----------ANREKKALEEKLEK 205 (1265)
T ss_pred HHHhhHHH----HHHHHHHHhhhhHHHHHHHHHHhhhhhHHhHHHHH--HHHHHHH----------HHHHHHHHHHHHHH
Confidence 54444433 33344444433333333444444444455444432 2222222 23445555555443
Q ss_pred hhhhhccchhhhhHHHHHHHHHHHHhHhhhhhccccccchhHHHHHHHHHHHHhhccCCcchhhhhcCCcccccchHHhH
Q psy14431 254 LEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSI 333 (1219)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (1219)
+.. ++++ ..+--+|+ |+...-.+-|.+++-.+-- -++.|.--|.+.| --+|+..|..-|-
T Consensus 206 ~~e-------~~~~-nD~~sle~--~~~q~~tq~vl~ev~QLss---~~q~ltp~rk~~s-------~i~E~d~~lq~sa 265 (1265)
T KOG0976|consen 206 FKE-------DLIE-KDQKSLEL--HKDQENTQKVLKEVMQLSS---QKQTLTPLRKTCS-------MIEEQDMDLQASA 265 (1265)
T ss_pred HHH-------Hhhc-chHHHHHH--HHHHHHHHHHHHHHHHHHH---hHhhhhhHhhhhH-------HHHHHHHHHHHHH
Confidence 321 1111 11222222 2222222222222211110 1222333333322 2234444444444
Q ss_pred HHHhhchHHHHHHHHhhhhhHHHHHHHhhhhhhhHHHHHHHhhhccccccccchhh--hhhhhHhhHHHHHHHHHHHHHH
Q psy14431 334 DQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTS--EAAHLKAREEQLSHEVAMLREA 411 (1219)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 411 (1219)
+.+...-.+|.-.-. --|.||-++-++-+.+|..|..+.|-++.--||.+..|+ +++.||-+-+-+--+ -+|+++
T Consensus 266 k~ieE~m~qlk~kns--~L~~ElSqkeelVk~~qeeLd~lkqt~t~a~gdseqatkylh~enmkltrqkadir-c~LlEa 342 (1265)
T KOG0976|consen 266 KEIEEKMRQLKAKNS--VLGDELSQKEELVKELQEELDTLKQTRTRADGDSEQATKYLHLENMKLTRQKADIR-CALLEA 342 (1265)
T ss_pred HHHHHHHHHHHHHHH--HHhhhhhHHHHHHHHHHHHHHHHHHHHHHhhccHHHHHHHHHHHHHHHHHHHHHHH-HHHHHH
Confidence 444333333322211 237899999999999999999999999999999887665 566666554433322 246778
Q ss_pred HHhhHHHhhh----hccccchhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhHHhhhh
Q psy14431 412 KRNIEEEYHK----LKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGD 477 (1219)
Q Consensus 412 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~l~~~r~~ 477 (1219)
+++.| |+++ |-.+++|--....-+|.-++++.---.-.+.-..++.++.||+.-.|--+++=+.|
T Consensus 343 rrk~e-gfddk~~eLEKkrd~al~dvr~i~e~k~nve~elqsL~~l~aerqeQidelKn~if~~e~~~~d 411 (1265)
T KOG0976|consen 343 RRKAE-GFDDKLNELEKKRDMALMDVRSIQEKKENVEEELQSLLELQAERQEQIDELKNHIFRLEQGKKD 411 (1265)
T ss_pred HHhhc-chhHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccch
Confidence 87765 4443 33456665555666777777665433333333344555555555555555554443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0033 Score=67.86 Aligned_cols=129 Identities=19% Similarity=0.277 Sum_probs=89.0
Q ss_pred eeeeccCceEEEEEEEcCCCeEEEEEEeeccc--------------cCchhHHHHHHHHHHHHhcc-----CCCCccEEe
Q psy14431 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--------------RNKTDAQRTYREILFLKSFQ-----RHPNIITML 626 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~--------------~s~~~~e~~lREI~ILr~L~-----~HPNIVkL~ 626 (1219)
..||.|+.=.||.- +. .....||++.... ..........+|+.-+..+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999964 33 3446799886443 11122345566666655553 368899999
Q ss_pred eeeeccCCceEEEEEecch---h----hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC--
Q psy14431 627 DIYKAVNNKDLYVVFEYME---N----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-- 697 (1219)
Q Consensus 627 gvfe~~d~~~LyLVMEyme---G----SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-- 697 (1219)
|+... +-.+.+|+|.+. | +|.+++..+.++. . +...+-.-..||-+.+|+.+|++|.||++...+
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99873 445788888874 2 6888988777766 3 333344556688899999999999999996432
Q ss_pred --cceecc
Q psy14431 698 --SIKIGD 703 (1219)
Q Consensus 698 --~VKLiD 703 (1219)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0034 Score=70.85 Aligned_cols=78 Identities=10% Similarity=0.065 Sum_probs=54.6
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC--CCccEEeeeeecc-CCceEEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAV-NNKDLYV 639 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~-d~~~LyL 639 (1219)
.-+..||.|..+.||.....+ + .+++|... . ......+..|...++.+..+ ..++++++++... ..+..+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-S---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-c---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 345678999999999985433 3 46677642 2 11235688999999988754 4688888776532 2456899
Q ss_pred EEecchh
Q psy14431 640 VFEYMEN 646 (1219)
Q Consensus 640 VMEymeG 646 (1219)
|||+++|
T Consensus 91 VmE~i~G 97 (297)
T PRK10593 91 LLERLRG 97 (297)
T ss_pred EEeccCC
Confidence 9999885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0011 Score=73.07 Aligned_cols=147 Identities=14% Similarity=0.100 Sum_probs=85.1
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEeeeee----
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYK---- 630 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~gvfe---- 630 (1219)
.+++....-++.|+.|....+|++.. .+..+++|++.. .....+..|+.++..+..+- .+++++....
T Consensus 10 ~y~~~~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~ 82 (296)
T cd05153 10 DYDLGELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYL 82 (296)
T ss_pred HcCCCchhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEe
Confidence 44454555577888888899999854 234688898742 22345667777777775321 2455543211
Q ss_pred ccCCceEEEEEecchhh-H--------H---HHH---hh--ccCCh----------HHH--H--------HHHHHHHHHH
Q psy14431 631 AVNNKDLYVVFEYMEND-L--------N---KVI---RD--KILKD----------VHI--R--------YIMFQLCNGL 673 (1219)
Q Consensus 631 ~~d~~~LyLVMEymeGS-L--------~---d~L---rs--~~Lse----------eeV--r--------~Ia~QILsAL 673 (1219)
...++..++|++|++|. + . ..+ +. ..+.. ... . .....+..++
T Consensus 83 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 162 (296)
T cd05153 83 SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL 162 (296)
T ss_pred eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence 01234568999999862 1 0 111 00 00100 000 0 0111122334
Q ss_pred HHHHh-------cccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 674 SYIHA-------CKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 674 aYLHS-------~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.++.. .++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 44442 4799999999999999887778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0013 Score=71.53 Aligned_cols=132 Identities=11% Similarity=0.119 Sum_probs=75.0
Q ss_pred eeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecchhh
Q psy14431 568 EGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND 647 (1219)
Q Consensus 568 IGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEymeGS 647 (1219)
+..|-.+.+|+.. .+|..+++|+....... ......+|..++..+..+.-.++++.+.. -++||+|++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 4668888999886 44667888875422111 00134678888888864433344444332 26899999872
Q ss_pred -HH--------------HHHh---hcc-----CChH-HHHHHHHHH---------HHHHHHHHh--------cccccCCC
Q psy14431 648 -LN--------------KVIR---DKI-----LKDV-HIRYIMFQL---------CNGLSYIHA--------CKVMHRDL 686 (1219)
Q Consensus 648 -L~--------------d~Lr---s~~-----Lsee-eVr~Ia~QI---------LsALaYLHS--------~GIVHRDL 686 (1219)
+. ..+. ..+ ++.. .+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 11 1111 111 1111 112222122 111222211 25899999
Q ss_pred CCCCeeeccCCcceeccccccccc
Q psy14431 687 KPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 687 KPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
.|.||+++.++ +.|+||+.|..-
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcC
Confidence 99999999877 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02168 SMC_prok_B chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Probab=97.05 E-value=2.1 Score=55.98 Aligned_cols=6 Identities=17% Similarity=0.169 Sum_probs=2.7
Q ss_pred hCCCCC
Q psy14431 756 QSKPLF 761 (1219)
Q Consensus 756 TGkpPF 761 (1219)
.+.|||
T Consensus 1109 ~~~~~~ 1114 (1179)
T TIGR02168 1109 VKPAPF 1114 (1179)
T ss_pred cCCCCe
Confidence 344444
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0088 Score=66.99 Aligned_cols=152 Identities=11% Similarity=0.079 Sum_probs=79.9
Q ss_pred HHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEeee
Q psy14431 550 DQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDI 628 (1219)
Q Consensus 550 ~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~gv 628 (1219)
..++ ..+++....-++.|+.|....+|.+... +| .+++|++. . . .......++.++..+..+ -.+++++..
T Consensus 13 ~~~l-~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~-~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 13 AAFL-APYDLGELLSLKGIAEGIENSNFFLTTT-QG-EYVLTLFE-R-L---TAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHH-HhcCCchhhccchhccccccceEEEEeC-CC-cEEEEEec-c-C---ChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 3444 3455544445567788888899998643 34 58899874 1 1 122333455555555311 114444421
Q ss_pred ee----ccCCceEEEEEecchhh---------H---HHHHh-----hccC--------C--h-HHH-H-----------H
Q psy14431 629 YK----AVNNKDLYVVFEYMEND---------L---NKVIR-----DKIL--------K--D-VHI-R-----------Y 664 (1219)
Q Consensus 629 fe----~~d~~~LyLVMEymeGS---------L---~d~Lr-----s~~L--------s--e-eeV-r-----------~ 664 (1219)
-. ....+..+++++|++|. . -..+. ...+ . + ... . .
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 10 11245678999999873 1 11110 0001 0 0 000 0 0
Q ss_pred HHHH-HHHHHHHHH-------hcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 665 IMFQ-LCNGLSYIH-------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 665 Ia~Q-ILsALaYLH-------S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+.. +...+..+. ..|+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 111122222 23899999999999998665568999998754
|
|
| >PRK03918 chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=1.8 Score=55.79 Aligned_cols=26 Identities=19% Similarity=0.369 Sum_probs=13.6
Q ss_pred HHHHHHHhhchhhHHHHHHHHHHHhh
Q psy14431 141 QNILATLEMERDTLQQEVATLQAKIS 166 (1219)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (1219)
.+.+..++.+++.+++++..++..+.
T Consensus 306 ~~~~~~l~~~~~~l~~~~~~l~~~l~ 331 (880)
T PRK03918 306 LDELREIEKRLSRLEEEINGIEERIK 331 (880)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 33444555555556655555554443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0013 Score=69.99 Aligned_cols=99 Identities=19% Similarity=0.121 Sum_probs=79.1
Q ss_pred HHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecchh-hHHH----HHhhccCChHHHHHHHHHHHHHHHHHHh---
Q psy14431 607 YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK----VIRDKILKDVHIRYIMFQLCNGLSYIHA--- 678 (1219)
Q Consensus 607 lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEymeG-SL~d----~Lrs~~LseeeVr~Ia~QILsALaYLHS--- 678 (1219)
..|..+++.+.+.+++++++|++. -++|.||++. ++.. +..-...++.....|+.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888887689999999984 2678899984 4431 1112236788899999999999999997
Q ss_pred cccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 679 ~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
..+.-.|++|+|+-|+.+|.++++|.+.+....
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 457789999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1196 Smc Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.95 E-value=2.9 Score=56.06 Aligned_cols=39 Identities=26% Similarity=0.234 Sum_probs=18.6
Q ss_pred HHHhhhccccccccchhhhhhhhHhhHHHHHHHHHHHHH
Q psy14431 372 QEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLRE 410 (1219)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (1219)
+...+.-+++++++..-.+++.+......++.++..+.+
T Consensus 727 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 765 (1163)
T COG1196 727 ALEEELEQLQSRLEELEEELEELEEELEELQERLEELEE 765 (1163)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 333444455555555555555544444444444443333
|
|
| >TIGR00606 rad50 rad50 | Back alignment and domain information |
|---|
Probab=96.95 E-value=3.2 Score=56.41 Aligned_cols=150 Identities=18% Similarity=0.192 Sum_probs=72.7
Q ss_pred HHHHHHHHHHHHhHhhhhhhHhhhhhhhhhhhhhHhhhhhhHHhhhhcchhhhhhhchhhhhhhhhhHHhhhhhHHHHHH
Q psy14431 39 LEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATR 118 (1219)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (1219)
++.-+..+........+.-..+++.+...+..+.....++....++.......-...++...-+.+..+.+ ..+..+
T Consensus 410 ~~~~~~e~~~~~~~~q~~L~ei~~~l~~~eq~~~~~~e~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~---~~~~~~ 486 (1311)
T TIGR00606 410 AAQLCADLQSKERLKQEQADEIRDEKKGLGRTIELKKEILEKKQEELKFVIKELQQLEGSSDRILELDQEL---RKAERE 486 (1311)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccChHHHHHHHHHH---HHHHHH
Confidence 34444555555555555666666666666666666655555444443322222222222222222222222 122223
Q ss_pred HhhhccceehhccccchhHHHHHHHHHHHhhchhhHHHHHHHHHHHhhhhhccccchhhhhhhhhhHHHHhhhHHhhcc
Q psy14431 119 LRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNK 197 (1219)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (1219)
|....+...++ .=.+-+.+.+.-+..|+.+.+.|++++.++...-. ..++---+-+++..+.+.|++-+.+..
T Consensus 487 ~~~~~~~~~~~--~~~~~i~~~~~~~~~le~~~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~k~~~~~~~~~~~~ 559 (1311)
T TIGR00606 487 LSKAEKNSLTE--TLKKEVKSLQNEKADLDRKLRKLDQEMEQLNHHTT----TRTQMEMLTKDKMDKDEQIRKIKSRHS 559 (1311)
T ss_pred HHHHHhhhhhh--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 33322222221 12233455666778888888888888776643321 122233345667777666666555543
|
This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). |
| >TIGR00606 rad50 rad50 | Back alignment and domain information |
|---|
Probab=96.92 E-value=3.3 Score=56.22 Aligned_cols=71 Identities=13% Similarity=0.150 Sum_probs=49.5
Q ss_pred HHHHHHhhhhhhhHHHHHHHhhhccccccccchhhhhhhhHhhHHHHHHHHHHHHHHHHhhHHHhhhhccc
Q psy14431 355 ELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTK 425 (1219)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (1219)
+|+.++........++...-+.+.+|+..|..-..++..+....+.+..++..|..........|..++..
T Consensus 861 ~Lq~ki~el~~~klkl~~~l~~r~~le~~L~el~~el~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1311)
T TIGR00606 861 HLKSKTNELKSEKLQIGTNLQRRQQFEEQLVELSTEVQSLIREIKDAKEQDSPLETFLEKDQQEKEELISS 931 (1311)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHHHHHHH
Confidence 34444444455555555555677888888888888888888888888888877777777777777665543
|
This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0057 Score=67.95 Aligned_cols=73 Identities=15% Similarity=0.147 Sum_probs=46.7
Q ss_pred EeeeeccCceEEEEEEEcC------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 565 LLKEGKGAYGIVYKAYDKN------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++.|..|-...||++.... ++..|++|+..... .......+|..++..+..+.-.+++++++. + .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---~---~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP---N---G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC---C---C
Confidence 4566777778999987543 25789999864322 222345678888888764443456665553 2 3
Q ss_pred EEEecchh
Q psy14431 639 VVFEYMEN 646 (1219)
Q Consensus 639 LVMEymeG 646 (1219)
+|++|++|
T Consensus 74 ~v~e~i~G 81 (302)
T cd05156 74 RIEEFIPS 81 (302)
T ss_pred chhheeCC
Confidence 57888876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0062 Score=72.14 Aligned_cols=79 Identities=16% Similarity=0.175 Sum_probs=54.8
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecc----ccCchhHHHHHHHHHHHHhccC-CC-CccEEeeeeeccCCceE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA----FRNKTDAQRTYREILFLKSFQR-HP-NIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks----~~s~~~~e~~lREI~ILr~L~~-HP-NIVkL~gvfe~~d~~~L 637 (1219)
.++.||.|....||++.+..++..|+||.-.+. ...+-...+...|..+|+.... .| +++++|.+ +....
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~e~~ 108 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DSVMN 108 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----CcHHh
Confidence 477889999999999988544667999965322 1234556777888888887653 24 45556543 34556
Q ss_pred EEEEecchh
Q psy14431 638 YVVFEYMEN 646 (1219)
Q Consensus 638 yLVMEymeG 646 (1219)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 789999863
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.00029 Score=91.83 Aligned_cols=153 Identities=16% Similarity=0.077 Sum_probs=113.2
Q ss_pred HHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch-hhHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhc--
Q psy14431 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHAC-- 679 (1219)
Q Consensus 608 REI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~-- 679 (1219)
.|...++... |+++...+.-..+......|.++.|+. |.+..++-.+ .+....+-....+.+.+..-+|+.
T Consensus 1278 ~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3433444444 888887776665556667889999998 6787777643 233333333334447777777743
Q ss_pred ---ccccCCCCCCCeeeccCCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh
Q psy14431 680 ---KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ 756 (1219)
Q Consensus 680 ---GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT 756 (1219)
-.+|+++++-|.+|..+..++++++|+.+...+.....+..++++.|+.|++. ..-.++.++|+|+.||-+|.+..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHHhc
Confidence 26899999999999999999999999999555555555667889999999986 44567888999999999999999
Q ss_pred CCCCCC
Q psy14431 757 SKPLFP 762 (1219)
Q Consensus 757 GkpPF~ 762 (1219)
|.++|.
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 999884
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.01 Score=76.91 Aligned_cols=157 Identities=21% Similarity=0.275 Sum_probs=104.2
Q ss_pred hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC-c-eEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHH
Q psy14431 601 TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-K-DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYI 676 (1219)
Q Consensus 601 ~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~-~-~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYL 676 (1219)
.......-|+..+.... |+|++.++.|-...-. + .+.+..++|.+ ++...+.+ +.++...++.+..+++.||.|+
T Consensus 224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence 33445556777777775 9999999876542111 1 11223345553 45555553 5688889999999999999999
Q ss_pred HhcccccCCCCCC---CeeeccCCcceec--ccccccccCCcccccccccccccccCchhhhcccccc--ccccchhHHH
Q psy14431 677 HACKVMHRDLKPS---NILIDKSCSIKIG--DLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT--HHVDIWSLGC 749 (1219)
Q Consensus 677 HS~GIVHRDLKPs---NILLd~dG~VKLi--DFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT--~kSDIWSLG~ 749 (1219)
|+....|.-+..+ +.-++..+.+.++ ||+.+..+++..... ....+..+.+|+... ...+. ...|+|.+|.
T Consensus 303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~-~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLK-ENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccc-cccchhhhhhHHHHHHH
Confidence 9986666665555 4444556666666 999888776654332 234456677888752 33333 3479999999
Q ss_pred HHHHHHhCCCC
Q psy14431 750 ILAEMLQSKPL 760 (1219)
Q Consensus 750 ILyELLTGkpP 760 (1219)
.+..+..|..+
T Consensus 381 l~~~~~~~~~i 391 (1351)
T KOG1035|consen 381 LLLQLSQGEDI 391 (1351)
T ss_pred HHhhhhhcCcc
Confidence 99999888654
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0011 Score=76.50 Aligned_cols=136 Identities=17% Similarity=0.150 Sum_probs=93.6
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecc---c---------------cC--chhHHHHHHHHHHHHhccCCCC
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEA---F---------------RN--KTDAQRTYREILFLKSFQRHPN 621 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks---~---------------~s--~~~~e~~lREI~ILr~L~~HPN 621 (1219)
|.+...||-|--+.||.+-+.. |.+.++|.-+-. + .+ .-......+|...|..+..|.+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 5678899999999999997643 778888853200 0 00 1112345678888888875433
Q ss_pred -ccEEeeeeeccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcc
Q psy14431 622 -IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699 (1219)
Q Consensus 622 -IVkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~V 699 (1219)
+++.+++ ...|+||+++.| +|..+-. ...+..+...+..-+.-|-.+|+||+|+.-=||++.+++.+
T Consensus 173 pVPkpiD~------~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 173 PVPKPIDH------NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCcccc------cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 3444433 347899999987 4443321 11233455566666778889999999999999999999999
Q ss_pred eecccccccc
Q psy14431 700 KIGDLGLARS 709 (1219)
Q Consensus 700 KLiDFGLAr~ 709 (1219)
+++||--+..
T Consensus 242 ~vIDFPQmvS 251 (465)
T KOG2268|consen 242 VVIDFPQMVS 251 (465)
T ss_pred EEeechHhhc
Confidence 9999965543
|
|
| >KOG4643|consensus | Back alignment and domain information |
|---|
Probab=96.69 E-value=3.7 Score=53.43 Aligned_cols=245 Identities=26% Similarity=0.299 Sum_probs=134.2
Q ss_pred cCCCCCcCcchhhHHHHHHHHHhh----HHHHHHHHHHHHHhHhhhhhhHhhhhhhhhhhhhhHhhhhhhHH---hhhhc
Q psy14431 14 AIPNGGQANGELKDLLERERREMS----QLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKES---QRRAD 86 (1219)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 86 (1219)
+-|.||.+.|.-+++--+.+-.|+ -+++..|-|..+.|.-+-----+|.|+.+|++-+.-||...-+- ++||+
T Consensus 153 ~s~s~~~~~~sp~~~~~~~~~hL~velAdle~kir~LrqElEEK~enll~lr~eLddleae~~klrqe~~e~l~ea~ra~ 232 (1195)
T KOG4643|consen 153 ESRSGKELYKSPYDIVVKKNLHLEVELADLEKKIRTLRQELEEKFENLLRLRNELDDLEAEISKLRQEIEEFLDEAHRAD 232 (1195)
T ss_pred ccccCCCCCCCcchhhcchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 346666677766666666555443 46666666666666555555567777888877777776543322 22322
Q ss_pred c--------------hhhhhhhchhhhhhhhhhHHhhhhh-----------HHHHHHHhhhccceehhccccchhHHHHH
Q psy14431 87 N--------------ESETKKKAEVNLQVISDMHEKLKTE-----------AETATRLRKQSAELTVAKSAGEQMVVELQ 141 (1219)
Q Consensus 87 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (1219)
- -+.+-|.+-..+-...|--+.|+.. -+-..++|+|+.-.|. +.-++-++
T Consensus 233 ~yrdeldalre~aer~d~~ykerlmDs~fykdRveelkedN~vLleekeMLeeQLq~lrarse~~tl-----eseiiqlk 307 (1195)
T KOG4643|consen 233 RYRDELDALREQAERPDTTYKERLMDSDFYKDRVEELKEDNRVLLEEKEMLEEQLQKLRARSEGATL-----ESEIIQLK 307 (1195)
T ss_pred hhhhHHHHHHHhhhcCCCccchhhhhhHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHhccccCCh-----HHHHHHHH
Confidence 2 2222233333333344444444433 1334577888744333 33467788
Q ss_pred HHHHHHhhchhhHHHHHHHHHHHhhhhhccccchhhhhhhhhhHHHHhhhHHhhcccccchhhhhhcchhhhhhhhhHHH
Q psy14431 142 NILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 221 (1219)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (1219)
.-++++.|+|||.|-..+.|+..+|+--.-+. +.+.--+|.+-. .-|.|++ |-.++--+..|.. -
T Consensus 308 qkl~dm~~erdtdr~kteeL~eEnstLq~q~e-qL~~~~ellq~~-se~~E~e------------n~Sl~~e~eqLts-~ 372 (1195)
T KOG4643|consen 308 QKLDDMRSERDTDRHKTEELHEENSTLQVQKE-QLDGQMELLQIF-SENEELE------------NESLQVENEQLTS-D 372 (1195)
T ss_pred HHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHH-HhhhhhhHhhhh-hcchhhh------------hhhHHHHHHHhhh-H
Confidence 88999999999999999999998887554331 122222222221 0001110 1111111111211 1
Q ss_pred hhhHhhHHHHHhhH--HHhhhhhhhhHHhhhhhhhhhhhccchhhhhHHHHHHHHHHHHh
Q psy14431 222 RLQALNTELERNKH--RELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAH 279 (1219)
Q Consensus 222 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (1219)
|+-.++-|-.|-.. .|+|.. +--.+.-++.+|+|+|..|+.+.+--+.+|+|..+.-
T Consensus 373 ralkllLEnrrlt~tleelqss-s~Ee~~SK~leleke~KnLs~k~e~Leeri~ql~qq~ 431 (1195)
T KOG4643|consen 373 RALKLLLENRRLTGTLEELQSS-SYEELISKHLELEKEHKNLSKKHEILEERINQLLQQL 431 (1195)
T ss_pred HHHHHHHHhHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhHhHhHHHHHHHHHHHHHHHHH
Confidence 11111111111110 122222 4556778889999999999999999999999876543
|
|
| >TIGR02169 SMC_prok_A chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Probab=96.49 E-value=5.1 Score=52.69 Aligned_cols=20 Identities=20% Similarity=0.401 Sum_probs=10.3
Q ss_pred HhHHHHhhchHHHHHHHHhh
Q psy14431 331 KSIDQLMKDREDLQQQINLL 350 (1219)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~ 350 (1219)
+.|..+..+.+.++.++.-+
T Consensus 674 ~~l~~l~~~l~~l~~~l~~l 693 (1164)
T TIGR02169 674 AELQRLRERLEGLKRELSSL 693 (1164)
T ss_pred HHHHHHHHHHHHHHHHHHHH
Confidence 34555555555555555443
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent. |
| >TIGR02169 SMC_prok_A chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.7 Score=60.48 Aligned_cols=22 Identities=32% Similarity=0.451 Sum_probs=13.9
Q ss_pred cccccCchhhHHHHHhcCCCCC
Q psy14431 1132 IRADAKDIPRIFQLLYAGEGEA 1153 (1219)
Q Consensus 1132 ~~~~~~~~~~~~~~~~~~~~~~ 1153 (1219)
|-+=....-.||+.|.|+.|.-
T Consensus 1024 f~~~~~~f~~~~~~l~~~~~~l 1045 (1164)
T TIGR02169 1024 FEAINENFNEIFAELSGGTGEL 1045 (1164)
T ss_pred HHHHHHHHHHHHHHHhCCeEEE
Confidence 3334566677888888665543
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1219 | ||||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-66 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-54 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-54 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-54 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-54 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-54 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-53 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-53 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-53 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-53 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-53 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-52 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-52 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-52 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-52 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-52 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-52 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-52 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-52 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-52 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-52 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-52 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-52 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-52 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-52 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-52 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-51 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-51 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-51 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-51 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-51 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-51 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-51 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-51 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-51 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-51 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-51 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-51 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-51 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-51 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-51 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-51 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-51 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-51 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-51 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-51 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-51 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-51 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-51 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-51 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-51 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-51 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-51 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-51 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-51 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-51 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-51 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-51 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-51 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-51 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-51 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-51 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-50 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-50 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-50 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-50 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-50 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-50 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-50 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-50 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-50 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-50 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-50 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-50 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-50 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-50 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-50 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-50 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-50 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-50 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-50 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-50 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-50 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-49 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-49 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-49 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-49 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-49 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-49 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-49 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-48 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-48 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-47 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-46 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-46 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-43 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-42 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-42 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-42 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-42 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-42 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-42 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-42 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-41 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-41 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-41 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-41 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-41 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-41 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-41 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-41 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-41 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-41 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-41 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-41 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-41 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-41 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-41 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-41 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-41 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-41 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-41 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-41 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-41 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-41 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-41 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-41 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-41 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-41 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-41 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-41 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-41 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-41 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-41 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-41 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-41 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-41 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-41 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-41 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-41 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-41 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-41 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-41 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-41 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-41 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-41 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-41 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-41 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-40 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-40 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-40 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-40 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-40 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-40 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-40 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-40 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-40 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-40 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-40 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-39 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-39 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-39 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-39 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-39 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-38 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-38 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-38 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-37 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-37 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-37 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-36 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-35 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-35 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-34 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-34 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-34 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-34 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-34 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-33 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-32 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-32 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-32 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-32 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-32 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-32 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-30 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-30 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-30 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-30 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-30 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-30 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-30 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-30 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-29 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-29 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-29 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-29 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-29 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-29 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-29 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-28 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-28 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-28 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-28 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-28 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-28 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-28 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-28 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-27 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-26 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-22 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-22 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-22 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-22 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-22 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-22 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-22 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-22 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-22 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-22 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-22 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-21 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-21 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-21 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-21 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-21 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-20 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-16 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 2rov_A | 117 | The Split Ph Domain Of Rock Ii Length = 117 | 4e-12 | ||
| 2rov_A | 117 | The Split Ph Domain Of Rock Ii Length = 117 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-12 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2row_A | 84 | The C1 Domain Of Rock Ii Length = 84 | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-08 |
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ROV|A Chain A, The Split Ph Domain Of Rock Ii Length = 117 | Back alignment and structure |
|
| >pdb|2ROV|A Chain A, The Split Ph Domain Of Rock Ii Length = 117 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ROW|A Chain A, The C1 Domain Of Rock Ii Length = 84 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-108
Identities = 110/238 (46%), Positives = 164/238 (68%), Gaps = 22/238 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKGAYGIV+K+ D+ + VA+KKIF+AF+N TDAQRT+REI+ L H NI+ +L++
Sbjct: 18 GKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKP 688
+A N++D+Y+VF+YME DL+ VIR IL+ VH +Y+++QL + Y+H+ ++HRD+KP
Sbjct: 78 LRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137
Query: 689 SNILIDKSCSIKIGDLGLARSLSDSKEC---------------------LTEYIATRWYR 727
SNIL++ C +K+ D GL+RS + + LT+Y+ATRWYR
Sbjct: 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
APEIL+ + +YT +D+WSLGCIL E+L KP+FPG+ST +QL+ I+ ++ P + D
Sbjct: 198 APEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI-DFPSNED 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-103
Identities = 95/227 (41%), Positives = 142/227 (62%), Gaps = 16/227 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V A K + VAIKKI E F A RT REI LK F +H NIIT+ +I
Sbjct: 20 GEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHF-KHENIITIFNI 77
Query: 629 YKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ N ++Y++ E M+ DL++VI ++L D HI+Y ++Q + +H V+HRD
Sbjct: 78 QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKEC----------LTEYIATRWYRAPEILISN 735
LKPSN+LI+ +C +K+ D GLAR + +S + E++ATRWYRAPE+++++
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 781
+Y+ +D+WS GCILAE+ +P+FPG HQL LI ++ P+
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-102
Identities = 88/233 (37%), Positives = 125/233 (53%), Gaps = 20/233 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G G+V+ A D + + VAIKKI + + REI ++ H NI+ + +I
Sbjct: 20 GCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRL-DHDNIVKVFEI 76
Query: 629 YKAVNN------------KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676
+ +Y+V EYME DL V+ L + H R M+QL GL YI
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 677 HACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEIL 732
H+ V+HRDLKP+N+ I+ + +KIGD GLAR + K L+E + T+WYR+P +L
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
+S YT +D+W+ GCI AEML K LF GA Q+QLI+ + P D
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI-PVVHEED 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-100
Identities = 92/226 (40%), Positives = 137/226 (60%), Gaps = 9/226 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
+L G GAYG V A D VAIKK++ F+++ A+R YRE+ LK RH N+I
Sbjct: 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVI 87
Query: 624 TMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
+LD++ D Y+V +M DL K+++ + L + I+++++Q+ GL YIHA
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRDLKP N+ +++ C +KI D GLAR +T Y+ TRWYRAPE++++ RYT
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYT 204
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
VDIWS+GCI+AEM+ K LF G+ QL+ I+ + PP
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT-GTPPAEF 249
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-100
Identities = 110/223 (49%), Positives = 149/223 (66%), Gaps = 9/223 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V AYD NK VAIKKI F ++T QRT REI L F RH NII + DI
Sbjct: 36 GEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 93
Query: 629 YKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+A KD+Y+V + ME DL K+++ + L + HI Y ++Q+ GL YIH+ V+HRD
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISNRRYTHHV 742
LKPSN+L++ +C +KI D GLAR D LTEY+ATRWYRAPEI+++++ YT +
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
DIWS+GCILAEML ++P+FPG QL I+ ++ +P D
Sbjct: 214 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-GSPSQED 255
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = 2e-99
Identities = 92/213 (43%), Positives = 132/213 (61%), Gaps = 9/213 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG V A DK + + VAIKK+ F+++ A+R YRE+L LK +H N+I +LD+
Sbjct: 33 GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDV 91
Query: 629 YKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ N D Y+V +M+ DL K++ K + I+Y+++Q+ GL YIH+ V+HR
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-FSEEKIQYLVYQMLKGLKYIHSAGVVHR 150
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKP N+ +++ C +KI D GLAR +T Y+ TRWYRAPE+++S Y VDI
Sbjct: 151 DLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDI 207
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
WS+GCI+AEML K LF G QL I+ +
Sbjct: 208 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = 8e-98
Identities = 93/213 (43%), Positives = 139/213 (65%), Gaps = 8/213 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GAYG V A+D VA+KK+ F++ A+RTYRE+ LK +H N+I +LD+
Sbjct: 38 GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDV 96
Query: 629 YKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + D+Y+V M DLN +++ + L D H++++++Q+ GL YIH+ ++HR
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR 156
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSN+ +++ C +KI D GLAR +D +T Y+ATRWYRAPEI+++ Y VDI
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
WS+GCI+AE+L + LFPG QL+LI+ LV
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 1e-97
Identities = 83/231 (35%), Positives = 116/231 (50%), Gaps = 18/231 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---------FRNKTDAQRTYREILFLKSFQRH 619
G+YG V D VAIK++F + +R REI L F H
Sbjct: 31 SSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HH 88
Query: 620 PNIITMLDIYKAVNN---KDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLS 674
PNI+ + DI+ LY+V E M DL +VI ++ HI+Y M+ + GL
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
+H V+HRDL P NIL+ + I I D LAR + T Y+ RWYRAPE+++
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQ 207
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
+ +T VD+WS GC++AEM K LF G++ +QL IV +V P D
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV-GTPKIED 257
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = 3e-95
Identities = 85/218 (38%), Positives = 138/218 (63%), Gaps = 8/218 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
NL G GA GIV AYD ++ VAIKK+ F+N+T A+R YRE++ +K H NII
Sbjct: 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNII 87
Query: 624 TMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
+L+++ + +D+Y+V E M+ +L +VI+ + L + Y+++Q+ G+ ++H+
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSA 146
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRDLKPSNI++ C++KI D GLAR+ + +T Y+ TR+YRAPE+++ Y
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG-MGYK 204
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777
+VDIWS+GCI+ EM++ LFPG Q ++ +
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 4e-95
Identities = 93/271 (34%), Positives = 139/271 (51%), Gaps = 56/271 (20%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G+YG VY AYDKN ++ VAIKK+ F + D +R REI L + II + D+
Sbjct: 35 GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDL 93
Query: 629 YKAVNN---KDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ +LY+V E ++DL K+ + I L + HI+ I++ L G ++IH ++HR
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----------------------LTEYIA 722
DLKP+N L+++ CS+K+ D GLAR+++ K+ LT ++
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-----------KPLFPGASTS---- 767
TRWYRAPE+++ YT +DIWS GCI AE+L PLFPG+S
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 768 -------------HQLQLIVNLVRPNPPHAD 785
QL +I N++ P D
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNII-GTPTEDD 303
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 5e-94
Identities = 91/279 (32%), Positives = 138/279 (49%), Gaps = 64/279 (22%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G+YG V +AYDK K+ VAIKKI F + D +R REI L H +++ +LDI
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDI 120
Query: 629 YK---AVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+LYVV E ++D K+ R + L ++HI+ +++ L G+ Y+H+ ++HR
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---------------------------L 717
DLKP+N L+++ CS+K+ D GLAR++ + L
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-----------KPLFPGAST 766
T ++ TRWYRAPE+++ YT +D+WS+GCI AE+L PLFPG+S
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 767 --------------------SHQLQLIVNLVRPNPPHAD 785
QL +I N++ P D
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL-GTPSEED 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = 7e-94
Identities = 85/221 (38%), Positives = 136/221 (61%), Gaps = 9/221 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA GIV AYD + VAIKK+ F+N+T A+R YRE++ +K H NII++L++
Sbjct: 71 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNV 129
Query: 629 YKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ +D+Y+V E M+ +L +VI+ L + Y+++Q+ G+ ++H+ ++HR
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHR 188
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSNI++ C++KI D GLAR+ + +T Y+ TR+YRAPE+++ Y +VDI
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG-MGYKENVDI 246
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
WS+GCI+ EM++ K LFPG Q ++ + P
Sbjct: 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL-GTPCPEF 286
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 6e-88
Identities = 73/221 (33%), Positives = 119/221 (53%), Gaps = 18/221 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G V +K+ VAIKK+ + + R + + L HPNI+ +
Sbjct: 32 GQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAVL-HHPNIVQLQSY 87
Query: 629 YKAVNNKD-----LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA 678
+ + +D L VV EY+ + L++ R + I+ +FQL + +H
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 679 C--KVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
V HRD+KP N+L++++ ++K+ D G A+ LS E YI +R+YRAPE++ N
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGN 206
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+ YT VDIWS+GCI AEM+ +P+F G +++ QL IV +
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 8e-87
Identities = 72/218 (33%), Positives = 121/218 (55%), Gaps = 18/218 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++G+VY+A ++ + VAIKK+ + D + RE+ ++ H NI+ +
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKL-DHCNIVRLRYF 115
Query: 629 YKAVNNK----DLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC 679
+ + K L +V +Y+ + +V R + L ++++ M+QL L+YIH+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 680 KVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+ HRD+KP N+L+D +K+ D G A+ L E YI +R+YRAPE++ Y
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPELIFGATDY 234
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
T +D+WS GC+LAE+L +P+FPG S QL I+ +
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-85
Identities = 69/214 (32%), Positives = 118/214 (55%), Gaps = 11/214 (5%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G Y V++A + N + V +K + ++ REI L++ + PNIIT+
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 627 DIYKAVNNKDLYVVFEY-MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
DI K ++ +VFE+ D ++ + L D IR+ M+++ L Y H+ +MHRD
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRD 155
Query: 686 LKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
+KP N++ID + +++ D GLA +E +A+R+++ PE+L+ + Y + +D+
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDM 214
Query: 745 WSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLV 777
WSLGC+LA M+ K P F G QL I ++
Sbjct: 215 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 4e-85
Identities = 75/212 (35%), Positives = 127/212 (59%), Gaps = 5/212 (2%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G+G+YG+V+K +++ Q VAIKK E+ + + REI LK +HPN++ +L
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLL 68
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++++ + L++VFEY ++ + + + + + ++ I +Q +++ H +HR
Sbjct: 69 EVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+KP NILI K IK+ D G AR L+ + + +ATRWYR+PE+L+ + +Y VD+
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
W++GC+ AE+L PL+PG S QL LI
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 1e-84
Identities = 70/250 (28%), Positives = 122/250 (48%), Gaps = 50/250 (20%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++GIV + +D + + A+KK+ + D + RE+ +K H NII ++D
Sbjct: 16 GTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVL-DHVNIIKLVDY 68
Query: 629 Y------------------------------------KAVNNKDLYVVFEYMENDLNKVI 652
+ NK L V+ EY+ + L+KV+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 653 R-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGL 706
+ + + I ++QL + +IH+ + HRD+KP N+L++ K ++K+ D G
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766
A+ L E YI +R+YRAPE+++ YT +D+WS+GC+ E++ KPLF G ++
Sbjct: 189 AKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 767 SHQLQLIVNL 776
QL I+ +
Sbjct: 248 IDQLVRIIQI 257
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 3e-82
Identities = 72/218 (33%), Positives = 124/218 (56%), Gaps = 19/218 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++G+V++A + + VAIKK+ + D + RE+ ++ +HPN++ +
Sbjct: 49 GNGSFGVVFQAKLVESDE-VAIKKVLQ------DKRFKNRELQIMRIV-KHPNVVDLKAF 100
Query: 629 YKAVNNK----DLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC 679
+ + +K L +V EY+ + + R + + + I+ M+QL L+YIH+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 680 KVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+ HRD+KP N+L+D +K+ D G A+ L + E YI +R+YRAPE++ Y
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYYRAPELIFGATNY 219
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
T ++DIWS GC++AE++Q +PLFPG S QL I+ +
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 2e-81
Identities = 78/210 (37%), Positives = 128/210 (60%), Gaps = 5/210 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G+YG+V K +K+ + VAIKK E+ +K + REI LK RH N++ +L++
Sbjct: 34 GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEV 92
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
K K Y+VFE++++ + + L ++ +FQ+ NG+ + H+ ++HRD+
Sbjct: 93 CK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP NIL+ +S +K+ D G AR+L+ E + +ATRWYRAPE+L+ + +Y VD+W+
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+GC++ EM +PLFPG S QL I+
Sbjct: 211 IGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 6e-76
Identities = 88/221 (39%), Positives = 121/221 (54%), Gaps = 20/221 (9%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---------REILFLKSFQ 617
G+G + VYKA DKN Q VAIKKI K + REI L+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKI------KLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSY 675
HPNII +LD + + ++ +VF++ME DL +I+D +L HI+ M GL Y
Sbjct: 70 SHPNIIGLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
+H ++HRDLKP+N+L+D++ +K+ D GLA+S T + TRWYRAPE+L
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
R Y VD+W++GCILAE+L P PG S QL I
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 9e-76
Identities = 75/217 (34%), Positives = 119/217 (54%), Gaps = 18/217 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHPNI 622
G+G YG V+KA ++ + VA+K++ + D REI LK +H NI
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKEL-KHKNI 63
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACK 680
+ + D+ ++K L +VFE+ + DL K L ++ +FQL GL + H+
Sbjct: 64 VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
V+HRDLKP N+LI+++ +K+ + GLAR+ C + + T WYR P++L + Y+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 741 HVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNL 776
+D+WS GCI AE+ + +PLFPG QL+ I L
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-75
Identities = 87/218 (39%), Positives = 134/218 (61%), Gaps = 18/218 (8%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHP 620
K G+G YG+VYKA D + VA+K+I + DA+ REI LK HP
Sbjct: 28 KVGEGTYGVVYKAKDSQG-RIVALKRI------RLDAEDEGIPSTAIREISLLKEL-HHP 79
Query: 621 NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHA 678
NI++++D+ + + L +VFE+ME DL KV+ + L+D I+ ++QL G+++ H
Sbjct: 80 NIVSLIDVI--HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 738
+++HRDLKP N+LI+ ++K+ D GLAR+ T + T WYRAP++L+ +++Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+ VDIWS+GCI AEM+ KPLFPG + QL I ++
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-75
Identities = 84/216 (38%), Positives = 126/216 (58%), Gaps = 18/216 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHPNI 622
G+G YG+VYKA + + A+KKI + + + T REI LK +H NI
Sbjct: 11 GEGTYGVVYKAQNNYG-ETFALKKI------RLEKEDEGIPSTTIREISILKEL-KHSNI 62
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACK 680
+ + D+ K L +VFE+++ DL K++ L+ V + + QL NG++Y H +
Sbjct: 63 VKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 740
V+HRDLKP N+LI++ +KI D GLAR+ T I T WYRAP++L+ +++Y+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+DIWS+GCI AEM+ PLFPG S + QL I +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 6e-75
Identities = 85/222 (38%), Positives = 128/222 (57%), Gaps = 21/222 (9%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TYREILFLKSFQRHPN 621
K G G Y VYK +K YVA+K++ K D++ REI +K +H N
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKEL-KHEN 64
Query: 622 IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV-------HIRYIMFQLCNGLS 674
I+ + D+ L +VFE+M+NDL K + + + + ++Y +QL GL+
Sbjct: 65 IVRLYDVI--HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
+ H K++HRDLKP N+LI+K +K+GD GLAR+ + + T WYRAP++L+
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+R Y+ +DIWS GCILAEM+ KPLFPG + QL+LI ++
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 1e-74
Identities = 88/222 (39%), Positives = 123/222 (55%), Gaps = 21/222 (9%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQRHP 620
K G+G YG VYKA D + VAIK+I + + + RE+ LK +H
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKEL-QHR 93
Query: 621 NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHAC 679
NII + + +N L+++FEY ENDL K + + I+ ++QL NG+++ H+
Sbjct: 94 NIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 680 KVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
+ +HRDLKP N+L+ S + +KIGD GLAR+ T I T WYR PEIL+
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
+R Y+ VDIWS+ CI AEML PLFPG S QL I +
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 5e-74
Identities = 81/219 (36%), Positives = 122/219 (55%), Gaps = 16/219 (7%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-----RTYREILFLKSFQRH 619
L K G+G Y VYK K VA+K+I + + + RE+ LK +H
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDL-KH 59
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIH 677
NI+T+ DI K L +VFEY++ DL + + D I+ +++ +FQL GL+Y H
Sbjct: 60 ANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
KV+HRDLKP N+LI++ +K+ D GLAR+ S + + T WYR P+IL+ +
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
Y+ +D+W +GCI EM +PLFPG++ QL I +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 7e-72
Identities = 81/225 (36%), Positives = 118/225 (52%), Gaps = 25/225 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---------TYREILFLK--SFQ 617
G GAYG VYKA D ++ +VA+K + + T RE+ L+
Sbjct: 18 GVGAYGTVYKARDPHSGHFVALKSV------RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 618 RHPNIITMLDIYKAVNNKD---LYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCN 671
HPN++ ++D+ + +VFE+++ DL + L I+ +M Q
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 731
GL ++HA ++HRDLKP NIL+ ++K+ D GLAR S LT + T WYRAPE+
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEV 190
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
L+ Y VD+WS+GCI AEM + KPLF G S + QL I +L
Sbjct: 191 LLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-70
Identities = 75/230 (32%), Positives = 119/230 (51%), Gaps = 25/230 (10%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQR 618
L K G+G +G V+KA + Q VA+KK+ + ++ REI L+ +
Sbjct: 22 LAKIGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKILQLL-K 74
Query: 619 HPNIITMLDI------YKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLC 670
H N++ +++I +Y+VF++ E+DL ++ + I+ +M L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS----LSDSKECLTEYIATRWY 726
NGL YIH K++HRD+K +N+LI + +K+ D GLAR+ + T + T WY
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 776
R PE+L+ R Y +D+W GCI+AEM P+ G + HQL LI L
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 8e-70
Identities = 86/229 (37%), Positives = 128/229 (55%), Gaps = 24/229 (10%)
Query: 569 GKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKSFQ--RH 619
G+GAYG V+KA D KN ++VA+K++ + T RE+ L+ + H
Sbjct: 20 GEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 620 PNIITMLDI---YKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGL 673
PN++ + D+ + L +VFE+++ DL + + I+ +MFQL GL
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 733
++H+ +V+HRDLKP NIL+ S IK+ D GLAR S LT + T WYRAPE+L+
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLL 192
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 781
Y VD+WS+GCI AEM + KPLF G+S QL I++++ P
Sbjct: 193 Q-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 5e-69
Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 34/261 (13%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKT 601
D+K + + EDL + K G+G YG VYKA K+ K + A+K+I + +
Sbjct: 6 DFKVKLSSERERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS 64
Query: 602 DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--------- 652
REI L+ +HPN+I++ ++ + ++ ++++F+Y E+DL +I
Sbjct: 65 ----ACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 653 -RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS----IKIGDLGLA 707
+ L ++ +++Q+ +G+ Y+HA V+HRDLKP+NIL+ +KI D+G A
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 708 RSLSDSKECLTEYIA---TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 764
R + + L + T WYRAPE+L+ R YT +DIW++GCI AE+L S+P+F
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239
Query: 765 S---------TSHQLQLIVNL 776
QL I N+
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNV 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-56
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 16/231 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G+YG K K++ + + K++ + + Q E+ L+ +HPNI+ D
Sbjct: 15 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDR 73
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQLCNGLSYIHACK-- 680
N LY+V EY E DL VI + + + +M QL L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 681 ---VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
V+HRDLKP+N+ +D ++K+GD GLAR L+ ++ T +Y +PE + +
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-NRMS 192
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788
Y DIWSLGC+L E+ P F S Q +L + Y
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIPYRY 240
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G + VY+A + VA+KK+ + +EI LK HPN+I
Sbjct: 41 GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYA 99
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQLCNGLSYIHACKV 681
+ + + +L +V E + DL+++I+ + + QLC+ L ++H+ +V
Sbjct: 100 SF--IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
MHRD+KP+N+ I + +K+GDLGL R S + T +Y +PE I Y
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHENGYNFK 216
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
DIWSLGC+L EM + F G + L + + + P
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYP 256
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 7/204 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G+YG V+K K + + A+K+ FR D R E+ + +HP + +
Sbjct: 66 GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
++ LY+ E L + L + + + L+++H+ ++H D+
Sbjct: 126 WE--EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP+NI + K+GD GL L + + Y APE+L Y D++S
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMAPELL--QGSYGTAADVFS 240
Query: 747 LGCILAEMLQSKPLFPGASTSHQL 770
LG + E+ + L G QL
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQL 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-54
Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 8/211 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G + + IK+I + + + + + RE+ L + +HPNI+ +
Sbjct: 33 GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRES 91
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ N LY+V +Y E DL K I + + ++ I Q+C L ++H K++HR
Sbjct: 92 F--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
D+K NI + K ++++GD G+AR L+ + E I T +Y +PEI N+ Y + DI
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKPYNNKSDI 208
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
W+LGC+L E+ K F S + + I++
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G V+KA + + + IK++ K + ++ RE+ L H NI+
Sbjct: 20 GSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKL-DHVNIVHYNGC 72
Query: 629 Y--------------KAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLC 670
+ K L++ E+ + L + I R + L V + Q+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
G+ YIH+ K+++RDLKPSNI + + +KIGD GL SL + + T T Y +PE
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPE 191
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
IS++ Y VD+++LG ILAE+L TS + + + +
Sbjct: 192 Q-ISSQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDGIISD 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 73/248 (29%), Positives = 110/248 (44%), Gaps = 34/248 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GA+G V KA + + +Y AIKKI + E++ L S H ++
Sbjct: 15 GQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASL-NHQYVVRYYAA 70
Query: 629 YKAVNNKD-----------LYVVFEYMEN-DLNKVIRDKILKD--VHIRYIMFQLCNGLS 674
+ N L++ EY EN L +I + L + Q+ LS
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC--------------LTEY 720
YIH+ ++HRDLKP NI ID+S ++KIGD GLA+++ S + LT
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
I T Y A E+L Y +D++SLG I EM+ P G + L+ + ++
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEF 248
Query: 781 PPHADKFY 788
PP D
Sbjct: 249 PPDFDDNK 256
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-52
Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G+V++A +K + AIK+I + ++ RE+ L HP I+ +
Sbjct: 14 GRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKL-EHPGIVRYFNA 71
Query: 629 YKAVNNKD----------LYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGL 673
+ N + LY+ + +L + + + +I Q+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC------------LTEYI 721
++H+ +MHRDLKPSNI +K+GD GL ++ +E T +
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781
T+ Y +PE + Y+H VDI+SLG IL E+L P L + NL P
Sbjct: 192 GTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFPPL 248
Query: 782 P 782
Sbjct: 249 F 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-50
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 22/229 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN--IITML 626
G G V++ ++ Q AIK + + EI +L + + II +
Sbjct: 37 GSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 94
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D ++ +Y+V E DLN ++ K + + + + IH ++H D
Sbjct: 95 DYEI--TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 152
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISN-------- 735
LKP+N LI +K+ D G+A + + + T Y PE +
Sbjct: 153 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 736 --RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+ + D+WSLGCIL M K F +Q+ + ++ PN
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHE 258
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-49
Identities = 53/244 (21%), Positives = 97/244 (39%), Gaps = 22/244 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD- 627
G+G + V ++ + A+K+I + D + RE + F HPNI+ ++
Sbjct: 38 GEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLF-NHPNILRLVAY 94
Query: 628 -IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQLCNGLSYIHACK 680
+ + + +++ + + L I K I +++ +C GL IHA
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---------TRWYRAPEI 731
HRDLKP+NIL+ + DLG E + + T YRAPE+
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 732 --LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789
+ S+ D+WSLGC+L M+ + + + + + P + + +
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS 274
Query: 790 GFKS 793
Sbjct: 275 ALWQ 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-49
Identities = 49/235 (20%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
++ + G G +G V+K + + AIK+ + D Q RE+ +H
Sbjct: 14 HELEKI--GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 621 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLS 674
+++ + + + + EY L I + K+ ++ ++ Q+ GL
Sbjct: 72 HVVRYFSAW--AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 675 YIHACKVMHRDLKPSNILIDKSCSI-------------------KIGDLGLARSLSDSKE 715
YIH+ ++H D+KPSNI I ++ KIGDLG +S +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770
+ A E+L N + DI++L + ++PL H++
Sbjct: 190 E----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-49
Identities = 57/301 (18%), Positives = 105/301 (34%), Gaps = 25/301 (8%)
Query: 553 MKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 611
M + L G+GA V++ K AIK +F RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFE 59
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIM 666
LK H NI+ + I + + ++ E+ L V+ + L + ++
Sbjct: 60 VLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIA 722
+ G++++ ++HR++KP NI+ D K+ D G AR L D ++ ++ Y
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-G 177
Query: 723 TRWYRAPEIL-------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
T Y P++ ++Y VD+WS+G F + + ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSK 835
+ P + + V C L + T L +E D +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCS-----LSRGLQVLLTPVLANILEADQE 292
Query: 836 D 836
Sbjct: 293 K 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 22/229 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN--IITML 626
G G V++ ++ Q AIK + + EI +L + + II +
Sbjct: 18 GSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 75
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D ++ +Y+V E DLN ++ K + + + + IH ++H D
Sbjct: 76 DYEI--TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILI---------- 733
LKP+N LI +K+ D G+A + + T Y PE +
Sbjct: 134 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
S + + D+WSLGCIL M K F +Q+ + ++ PN
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHE 239
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 70/251 (27%), Positives = 107/251 (42%), Gaps = 33/251 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD- 627
+G + VY+A D + + A+K++ + + +E+ F+K HPNI+
Sbjct: 37 AEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 628 --IYKAVNNKDLYVVFEYME-------NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 678
I K ++ E L K+ L + I +Q C + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 679 CK--VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--------KECLTEYIATR---- 724
K ++HRDLK N+L+ +IK+ D G A ++S + L E TR
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 725 WYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
YR PEI L SN DIW+LGCIL + + F + +L+ IVN PP
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA---KLR-IVNGKYSIPP 270
Query: 783 HADKFYAGFKS 793
H D Y F S
Sbjct: 271 H-DTQYTVFHS 280
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-46
Identities = 57/301 (18%), Positives = 101/301 (33%), Gaps = 25/301 (8%)
Query: 553 MKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 611
M + L G+GA V++ K AIK +F RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFE 59
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIM 666
LK H NI+ + I + + ++ E+ L V+ + L + ++
Sbjct: 60 VLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIA 722
+ G++++ ++HR++KP NI+ D K+ D G AR L D E
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177
Query: 723 TRWYRAPEIL-------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
T Y P++ ++Y VD+WS+G F + + ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSK 835
+ P + + V C L + T L +E D +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCS-----LSRGLQVLLTPVLANILEADQE 292
Query: 836 D 836
Sbjct: 293 K 293
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-46
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 22/229 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN--IITML 626
G G V++ ++ Q AIK + + EI +L + + II +
Sbjct: 65 GSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 122
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
D ++ +Y+V E DLN ++ K + + + + IH ++H D
Sbjct: 123 DYEI--TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILI---------- 733
LKP+N LI +K+ D G+A + + + Y PE +
Sbjct: 181 LKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
S + + D+WSLGCIL M K F +Q+ + ++ PN
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHE 286
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-45
Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 28/263 (10%)
Query: 531 KESLLSNGKEREVDYKKSIDQLMKDR---------EDLQQQINLLKE-GKGAYGIVYKAY 580
K L+N E + ++ + D + L+ + + K G GA G V A+
Sbjct: 96 KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155
Query: 581 DKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634
++ + VAI+ I + R A EI LK HP II + + + +
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF---DA 211
Query: 635 KDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL 692
+D Y+V E ME +L +KV+ +K LK+ + +Q+ + Y+H ++HRDLKP N+L
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271
Query: 693 I---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL--ISNRRYTHHVDIWSL 747
+ ++ C IKI D G ++ L ++ + T Y APE+L + Y VD WSL
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 748 GCILAEMLQSKPLFPGASTSHQL 770
G IL L P F T L
Sbjct: 331 GVILFICLSGYPPFSEHRTQVSL 353
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 60/260 (23%), Positives = 107/260 (41%), Gaps = 25/260 (9%)
Query: 539 KEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR 598
++ + D + S+ + K + + G GA G + + + VA+K+I
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVL-----GHGAEGTIVYR-GMFDNRDVAVKRI----- 56
Query: 599 NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKI 656
RE+ L+ HPN+I K + + Y+ E L + + +D
Sbjct: 57 LPECFSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAIELCAATLQEYVEQKDFA 114
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-----DKSCSIKIGDLGLARSLS 711
+ ++ Q +GL+++H+ ++HRDLKP NILI I D GL + L+
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 712 D---SKECLTEYIATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766
S + T + APE+L T+ VDI+S GC+ ++ G S
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 767 SHQLQLIVNLVRPNPPHADK 786
Q +++ + H +K
Sbjct: 235 QRQANILLGACSLDCLHPEK 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 7/218 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG + ++ D + K+ A K + ++ EI +S H +++
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHG 82
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ +N ++VV E L ++ R K L + RY + Q+ G Y+H +V+HRD
Sbjct: 83 FFE--DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+ +++ +KIGD GLA + E T Y APE+ +S + ++ VD+W
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV-LSKKGHSFEVDVW 199
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
S+GCI+ +L KP F + I P H
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-44
Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 30/282 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHP-----NI 622
GKG++G V KAYD Q+VA+K + RN+ R EI L+ ++ N+
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 623 ITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIH 677
I ML+ ++ + + FE + +L ++I+ + +R + L +H
Sbjct: 162 IHMLENFTFR----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 678 ACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
+++H DLKP NIL+ IK+ D G + + + YI +R+YRAPE+++
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVIL-G 273
Query: 736 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795
RY +D+WSLGCILAE+L PL PG QL ++ L+ SK
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-----ASKR 328
Query: 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837
+ + + L V N + + +S
Sbjct: 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-44
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++ VYK D VA ++ + K++ QR E LK Q HPNI+ D
Sbjct: 35 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDS 93
Query: 629 YKAVNNKD--LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VM 682
+++ + +V E M + L ++ K++K +R Q+ GL ++H ++
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 683 HRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
HRDLK NI I + S+KIGDLGLA S I T + APE+ +Y
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMY--EEKYDES 209
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784
VD+++ G + EM S+ + + Q+ V P +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPAS 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 554 KDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQR 605
+ + G+G +V + K + A+K I F A + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 606 TYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-- 662
T +E+ L+ HPNII + D Y+ N ++VF+ M+ +L D + + V +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 123
Query: 663 ---RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719
R IM L + +H ++HRDLKP NIL+D +IK+ D G + L E L E
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRE 182
Query: 720 YIATRWYRAPEIL-----ISNRRYTHHVDIWSLGCIL 751
T Y APEI+ ++ Y VD+WS G I+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-44
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 7/218 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG + ++ D + K+ A K + ++ EI +S H +++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHG 108
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ +N ++VV E L ++ R K L + RY + Q+ G Y+H +V+HRD
Sbjct: 109 FFE--DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK N+ +++ +KIGD GLA + E T Y APE+ +S + ++ VD+W
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV-LSKKGHSFEVDVW 225
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
S+GCI+ +L KP F + I P H
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-43
Identities = 30/252 (11%), Positives = 70/252 (27%), Gaps = 36/252 (14%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSF----------- 616
G +V+ D + A+K A ++++ +R +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 617 ------------QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR--------DKI 656
Q P + + ++ DL +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716
+ + + QL + + + ++H P N+ I + +GD+ +
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA 250
Query: 717 LTEYIATRWYRAPEILISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+ Y E L ++ +TH ++ W LG + + F + +
Sbjct: 251 SS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 776 LVRPNPPHADKF 787
+R + F
Sbjct: 308 SLRVPGTDSLAF 319
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 29/279 (10%)
Query: 523 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDK 582
+ + E +L K + VDY+ ++ + G+G++G V++ DK
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRV--GRGSFGEVHRMKDK 80
Query: 583 NNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641
A+KK+ E FR E++ P I+ + + + +
Sbjct: 81 QTGFQCAVKKVRLEVFRV--------EELVACAGL-SSPRIVPLYGAVR--EGPWVNIFM 129
Query: 642 EYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CS 698
E +E L ++I+ L + Y + Q GL Y+H +++H D+K N+L+
Sbjct: 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSR 189
Query: 699 IKIGDLGLARSLSDSKECLTEYIA-----TRWYRAPEILISNRRYTHHVDIWSLGCILAE 753
+ D G A L + T + APE+ + + VDIWS C++
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLH 248
Query: 754 MLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792
ML + I + P
Sbjct: 249 MLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
K G+GA G VY A D Q VAI+++ + + + EIL ++ ++PNI+
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMREN-KNPNIV 80
Query: 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
LD Y + +L+VV EY+ L V+ + + + I + + L ++H+ +V+
Sbjct: 81 NYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K NIL+ S+K+ D G ++ + + + T ++ APE+ ++ + Y V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKV 197
Query: 743 DIWSLGCILAEMLQSKP 759
DIWSLG + EM++ +P
Sbjct: 198 DIWSLGIMAIEMIEGEP 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-43
Identities = 78/257 (30%), Positives = 126/257 (49%), Gaps = 32/257 (12%)
Query: 542 EVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT 601
DY + DR ++ I GKG++G V KAYD+ +++VAIK I +NK
Sbjct: 41 NYDYIVKNGEKWMDRYEIDSLI-----GKGSFGQVVKAYDRVEQEWVAIKII----KNKK 91
Query: 602 DAQRT-YREILFLKSFQRHP-----NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIR 653
E+ L+ +H I+ + +++ L +VFE + +L ++R
Sbjct: 92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR----NHLCLVFEMLSYNLYDLLR 147
Query: 654 D---KILKDVHIRYIMFQLCNGLSYIHA--CKVMHRDLKPSNILI--DKSCSIKIGDLGL 706
+ + + R Q+C L ++ ++H DLKP NIL+ K +IKI D G
Sbjct: 148 NTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG- 206
Query: 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766
S + + +YI +R+YR+PE+ + Y +D+WSLGCIL EM +PLF GA+
Sbjct: 207 --SSCQLGQRIYQYIQSRFYRSPEV-LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 767 SHQLQLIVNLVRPNPPH 783
Q+ IV ++ P H
Sbjct: 264 VDQMNKIVEVLGIPPAH 280
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 74/228 (32%), Positives = 111/228 (48%), Gaps = 19/228 (8%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYRE 609
+ L+ + + K G GA G V A+++ + VAIK I + R A E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMF 667
I LK HP II + + + A +D Y+V E ME +L +KV+ +K LK+ + +
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATR 724
Q+ + Y+H ++HRDLKP N+L+ ++ C IKI D G ++ L ++ + T
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTP 180
Query: 725 WYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770
Y APE+L + Y VD WSLG IL L P F T L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 56/197 (28%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
+ +K G+G+ GIV A +K++ + VA+K + R + + + E++ ++ +Q H N++
Sbjct: 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQ-HFNVV 105
Query: 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
M Y + ++L+V+ E+++ L ++ L + I + + L+Y+HA V+
Sbjct: 106 EMYKSY--LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
HRD+K +IL+ +K+ D G +S + T ++ APE+ IS Y V
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-ISRSLYATEV 222
Query: 743 DIWSLGCILAEMLQSKP 759
DIWSLG ++ EM+ +P
Sbjct: 223 DIWSLGIMVIEMVDGEP 239
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 22/249 (8%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
+DL+ + E G+GAYG+V K + Q +A+K+I A N + +R ++
Sbjct: 7 DDLE----PIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMR 61
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLC 670
P +T D+++ E M+ L+K + + + + + I +
Sbjct: 62 TVDCPFTVTFYGAL--FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 671 NGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729
L ++H+ V+HRD+KPSN+LI+ +K+ D G++ L D + Y AP
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAP 178
Query: 730 EILISNRR---YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HA 784
E + Y+ DIWSLG + E+ + FP S Q + +V P A
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 785 DKFYAGFKS 793
DKF A F
Sbjct: 237 DKFSAEFVD 245
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG YGIVY D +N+ +AIK+I R+ +Q + EI K +H NI+ L
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHL-KHKNIVQYLGS 87
Query: 629 YKAVNNKDLYVVFEYMEND-LNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ N + + E + L+ ++R K + I + Q+ GL Y+H +++H
Sbjct: 88 FS--ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 684 RDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE-ILISNRRYTHH 741
RD+K N+LI+ S +KI D G ++ L+ C + T Y APE I R Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 742 VDIWSLGCILAEMLQSKP 759
DIWSLGC + EM KP
Sbjct: 206 ADIWSLGCTIIEMATGKP 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++ VY+A + VAIK I +A QR E+ +HP+I+ + +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYN 78
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ ++ +Y+V E N ++N+ + R K + R+ M Q+ G+ Y+H+ ++HR
Sbjct: 79 YFE--DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DL SN+L+ ++ +IKI D GLA L E T Y +PEI + + D+
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-ATRSAHGLESDV 195
Query: 745 WSLGCILAEMLQSKPLF 761
WSLGC+ +L +P F
Sbjct: 196 WSLGCMFYTLLIGRPPF 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G YG VYK Q AIK + + + ++ EI LK + H NI T
Sbjct: 33 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYGA 89
Query: 629 Y----KAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ + L++V E+ DL K + LK+ I YI ++ GLS++H K
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--- 737
V+HRD+K N+L+ ++ +K+ D G++ L + +I T ++ APE++ +
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209
Query: 738 -YTHHVDIWSLGCILAEMLQSKP 759
Y D+WSLG EM + P
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-42
Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 25/241 (10%)
Query: 529 SSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQY 587
+ + + + + ++ Q+ + G+G +V + +
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 588 VAIKKI------FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641
A+K + + + + T RE L+ HP+IIT++D Y+ ++ +++VF
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--SSSFMFLVF 179
Query: 642 EYMEN-DLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695
+ M +L D + + V + R IM L +S++HA ++HRDLKP NIL+D
Sbjct: 180 DLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 696 SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL-----ISNRRYTHHVDIWSLGCI 750
+ I++ D G + L E L E T Y APEIL ++ Y VD+W+ G I
Sbjct: 236 NMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 751 L 751
L
Sbjct: 295 L 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 13/242 (5%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
+ L E G G G V+K + +A+K++ NK + +R ++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDC 83
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
P I+ + + N D+++ E M + K + + + + + L Y+
Sbjct: 84 PYIVQCFGTF--ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 678 AC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---- 732
V+HRD+KPSNIL+D+ IK+ D G++ L D K Y APE +
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPPD 200
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAGF 791
+ Y D+WSLG L E+ + + T L ++ P P F F
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 792 KS 793
+S
Sbjct: 261 QS 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-41
Identities = 55/239 (23%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 548 SIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 607
+ +Q +K+ ++ + G G+ G V + VA+K++
Sbjct: 8 NFEQSLKNLVVSEKIL-----GYGSSGTVVFQGSFQGRP-VAVKRM-----LIDFCDIAL 56
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--------ILKD 659
EI L HPN+I ++ LY+ E +L ++ K + K+
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSET--TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 660 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-------------KSCSIKIGDLGL 706
+ ++ Q+ +G++++H+ K++HRDLKP NIL+ ++ I I D GL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 707 ARSLSDSKECLTEYIATR----WYRAPEIL------ISNRRYTHHVDIWSLGCILAEML 755
+ L + + +RAPE+L + RR T +DI+S+GC+ +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 72/226 (31%), Positives = 106/226 (46%), Gaps = 24/226 (10%)
Query: 541 REVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 599
+ V + QL ++ + ++ G G+Y + + K A+K I ++
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KS 58
Query: 600 KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILK 658
K D EI L + +HPNIIT+ D+Y + K +YVV E M+ +L DKIL+
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL----LDKILR 109
Query: 659 DVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARS 709
++F + + Y+HA V+HRDLKPSNIL SI+I D G A+
Sbjct: 110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
L L T + APE+L + Y DIWSLG +L ML
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTML 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 65/320 (20%), Positives = 127/320 (39%), Gaps = 40/320 (12%)
Query: 521 MAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQ--QQINLLKEGKGAYGIVYK 578
M H + + + D + DL ++I G G++G V++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKI-----GAGSFGTVHR 55
Query: 579 AYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK-DL 637
A + + VA+K + E + RE+ +K RHPNI+ AV +L
Sbjct: 56 A--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLF---MGAVTQPPNL 109
Query: 638 YVVFEYMEN-DLNKVIRDKILKDV----HIRYIMFQLCNGLSYIHACK--VMHRDLKPSN 690
+V EY+ L +++ ++ + + + G++Y+H ++HR+LK N
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 691 ILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 750
+L+DK ++K+ D GL+R + + T + APE+ + + D++S G I
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRDEPSNEKSDVYSFGVI 228
Query: 751 LAEMLQSKPLFPGASTSHQLQLIVNLV----RPN-PPHADKFYAGF------KSKHEREK 799
L E+ + + + Q++ + R P + + A +R
Sbjct: 229 LWELATLQQPWGNL---NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPS 285
Query: 800 FNQVVVKCQKELQELQSQVV 819
F ++ L+ L V
Sbjct: 286 FATIM----DLLRPLIKSAV 301
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-41
Identities = 49/240 (20%), Positives = 91/240 (37%), Gaps = 18/240 (7%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
+ + ++ +G V A K +YV +++I + E+ K
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLC 670
F HPNI+ + + + +L+VV +M DL + ++ I YI+ +
Sbjct: 82 LF-NHPNIVPYRATF--IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-------KECLTEYIAT 723
L YIH +HR +K S+ILI + + L S+ + +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 724 RWYRAPEILISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+ +PE+L N + Y DI+S+G E+ F Q+++ + P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLNGTVP 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 19/223 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
GKG +G VY A +K +K +A+K +F + + + Q RE+ RHPNI+ +
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHL-RHPNILRLY 75
Query: 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + +Y++ EY + + ++ + + +L N LSY H+ +V+HR
Sbjct: 76 GYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPEILISNRRYTH 740
D+KP N+L+ + +KI D G + S+ C T +Y+ PE+ I R +
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEM-IEGRMHDE 186
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
VD+WSLG + E L KP F + + I + P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++ I K K + Q A+K I +K T +EI LK + HPNI+ + ++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHACKVM 682
+ + ++V E + +L ++I K H YIM +L + +S++H V+
Sbjct: 75 FH--DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 683 HRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
HRDLKP N+L + + IKI D G AR + L T Y APE+L + Y
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYD 187
Query: 740 HHVDIWSLGCILAEML 755
D+WSLG IL ML
Sbjct: 188 ESCDLWSLGVILYTML 203
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++ +E GKGA+ +V + K A K I + D Q+ RE +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 669
Q HPNI+ + D + Y+VF+ + +L + I+ + + Q+
Sbjct: 62 LQ-HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQI 114
Query: 670 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
++Y H+ ++HR+LKP N+L+ K ++K+ D GLA ++DS E + T Y
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGY 173
Query: 727 RAPEILISNRRYTHHVDIWSLGCIL 751
+PE+L Y+ VDIW+ G IL
Sbjct: 174 LSPEVL-KKDPYSKPVDIWACGVIL 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 24/254 (9%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
EDL+ + G+GAYG V K K + Q +A+K+I + ++ + ++ ++ +
Sbjct: 20 TAEDLKDLGEI---GRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVM 75
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD------KILKDVHIRYIMFQ 668
P I+ D ++ E M +K + ++ + + I
Sbjct: 76 RSSDCPYIVQFYGAL--FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 669 LCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
L+++ K++HRD+KPSNIL+D+S +IK+ D G++ L DS T R Y
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYM 192
Query: 728 APEILISNRR---YTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNP-- 781
APE + + Y D+WSLG L E+ + +P ++ QL +V P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQL 250
Query: 782 --PHADKFYAGFKS 793
+F F +
Sbjct: 251 SNSEEREFSPSFIN 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 7/220 (3%)
Query: 542 EVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK 600
+ + + + D ++ L++ GKG++G V+K D ++ VAIK I + +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAE 61
Query: 601 TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKD 659
+ + +EI L P + Y + + L+++ EY+ ++ L +
Sbjct: 62 DEIEDIQQEITVLSQC-DSPYVTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDE 118
Query: 660 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719
I I+ ++ GL Y+H+ K +HRD+K +N+L+ + +K+ D G+A L+D++
Sbjct: 119 TQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 759
++ T ++ APE+ I Y DIWSLG E+ + +P
Sbjct: 179 FVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-40
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 60/302 (19%)
Query: 521 MAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAY 580
M H S +E+L G + V + L+ + + +++ G G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKM-----GDGTFGRVLLCQ 55
Query: 581 DKNNKQYVAIKKIFEAFRNKTDAQRTYR-----EILFLKSFQRHP----NIITMLD--IY 629
+NK+Y A+K + RN + Y E LK Q NI+ +Y
Sbjct: 56 HIDNKKYYAVKVV----RNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107
Query: 630 KAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ ++FE + L ++I I+ ++ L+Y+ + H DL
Sbjct: 108 Y----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163
Query: 687 KPSNILI-------------------------DKSCSIKIGDLGLARSLSDSKECLTEYI 721
KP NIL+ KS IK+ D G + + I
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKSDYHGSII 220
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781
TR YRAPE+++ N + D+WS GC+LAE+ LF L ++ ++++P P
Sbjct: 221 NTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIP 279
Query: 782 PH 783
+
Sbjct: 280 KN 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 20/227 (8%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++ N++ GKG++G V K D+ +Q A+K I +A D RE+ LK
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQL 669
HPNI+ + +I + ++ Y+V E +L D+I+K I+ Q+
Sbjct: 78 LD-HPNIMKLFEILE--DSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQV 130
Query: 670 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
+G++Y+H ++HRDLKP NIL+ +K C IKI D GL+ + + + I T +Y
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYY 189
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
APE+L Y D+WS G IL +L P F G + L+ +
Sbjct: 190 IAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 37/244 (15%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLK-------SFQRHP 620
G G + V+ A D N +VA+K + R EI L+ + +
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 621 ---NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNG 672
+I+ +LD +K N + +VFE + +L +I+ + + ++++ I QL G
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 673 LSYIHA-CKVMHRDLKPSNILIDKSCS------IKIGDLGLARSLSDSKECLTEYIATRW 725
L Y+H C ++H D+KP N+L++ S IKI DLG A E T I TR
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTRE 200
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------HQLQLIVNLVRP 779
YR+PE+L+ + DIWS C++ E++ LF + I+ L+
Sbjct: 201 YRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259
Query: 780 NPPH 783
P +
Sbjct: 260 LPSY 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
+ ++ G GA+G V+ ++++ IK I + R++ ++ EI LKS
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKS 76
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQL 669
HPNII + ++++ + ++Y+V E E +L + I + + +M Q+
Sbjct: 77 LD-HPNIIKIFEVFE--DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 670 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
N L+Y H+ V+H+DLKP NIL IKI D GLA + T T Y
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTALY 192
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
APE+ R T DIWS G ++ +L F G S Q
Sbjct: 193 MAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-40
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 56/292 (19%)
Query: 537 NGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIF- 594
+ ++++ +LQ++ +L G+G+YG+V A + + AIK +
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 595 --EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME------- 645
N D +R E+ +K HPNI + ++Y+ + + + +V E
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYE--DEQYICLVMELCHGGHLLDK 118
Query: 646 -----------------------------------NDLNKVIRDKILKDVHIRYIMFQLC 670
+ D + ++ I IM Q+
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 671 NGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATR---- 724
+ L Y+H + HRD+KP N L +KS IK+ D GL++ + T+
Sbjct: 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 725 WYRAPEIL-ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
++ APE+L +N Y D WS G +L +L FPG + + + ++N
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-40
Identities = 71/321 (22%), Positives = 128/321 (39%), Gaps = 32/321 (9%)
Query: 510 KTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEG 569
K ++ELEL + + + L K E+ +D ++ L G
Sbjct: 2 KKLEELELDE-----QQRKRLEAFLTQKQKVGELKD-----------DDFEKISEL---G 42
Query: 570 KGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY 629
G G+V+K K + +A K I + RE+ L P I+ +
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAF 100
Query: 630 KAVNNKDLYVVFEYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDL 686
++ ++ + E+M+ L++V++ + + + + + GL+Y+ K+MHRD+
Sbjct: 101 --YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KPSNIL++ IK+ D G++ L DS + ++ TR Y +PE + Y+ DIWS
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS-FVGTRSYMSPER-LQGTHYSVQSDIWS 215
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVK 806
+G L EM + P + V + + + +
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD---SR 272
Query: 807 CQKELQELQSQVVEENTSKLK 827
+ EL +V E KL
Sbjct: 273 PPMAIFELLDYIVNEPPPKLP 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 546 KKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
K + ++ D + ++ E G GA+G VYKA +K A K I +++ + +
Sbjct: 4 KSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE 61
Query: 605 RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDV 660
EI L + HP I+ +L Y ++ L+++ E+ + + D+ L +
Sbjct: 62 DYIVEIEILATCD-HPYIVKLLGAY--YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEP 117
Query: 661 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720
I+ + Q+ L+++H+ +++HRDLK N+L+ I++ D G++ + + +
Sbjct: 118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177
Query: 721 IATRWYRAPEILISNRR----YTHHVDIWSLGCILAEMLQSKP 759
I T ++ APE+++ Y + DIWSLG L EM Q +P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 54/284 (19%), Positives = 96/284 (33%), Gaps = 73/284 (25%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK------------------------------KIFEAFR 598
G+G +G+V++A +K + AIK + F A+
Sbjct: 15 GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74
Query: 599 NKTDAQRTYREILFLKSFQRHPNII-----------------------TMLDIYKAVNNK 635
+ + + T+ + +
Sbjct: 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134
Query: 636 DLYVVFEYMEN-DLNKVIRDKILKDV----HIRYIMFQLCNGLSYIHACKVMHRDLKPSN 690
LY+ + +L + + + +I Q+ + ++H+ +MHRDLKPSN
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194
Query: 691 ILIDKSCSIKIGDLGLARSLSDSKEC------------LTEYIATRWYRAPEILISNRRY 738
I +K+GD GL ++ +E T + T+ Y +PE + Y
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI-HGNNY 253
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+H VDI+SLG IL E+L + + NL P
Sbjct: 254 SHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLF 295
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-40
Identities = 96/542 (17%), Positives = 188/542 (34%), Gaps = 44/542 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G V + ++ + VAIK + + +R EI +K HPN+++ ++
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREV 80
Query: 629 Y----KAVNNKDLYVVFEYMEN-DLNKVI----RDKILKDVHIRYIMFQLCNGLSYIHAC 679
K N + EY E DL K + LK+ IR ++ + + L Y+H
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 680 KVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 736
+++HRDLKP NI++ KI DLG A+ L E TE++ T Y APE+ + +
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPEL-LEQK 198
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG-FKSKH 795
+YT VD WS G + E + F Q V G K
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSS 258
Query: 796 EREKFNQVVVKCQKELQELQSQVVEENTSK--LKLQMELDSKDSEIEQLQGK--LAALGS 851
N + +L+ ++ + + Q ++ + L+ +
Sbjct: 259 VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNM 318
Query: 852 ETASLSSADVENDESYVQDSRL-----------------EGWVSIPNKQNIKRHGWKKQY 894
+ + + V +E+ G + +
Sbjct: 319 VSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVI 378
Query: 895 VVVSSKKIIFYNSENDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 954
+ + + +N K +P++ L L + L+ R V + +
Sbjct: 379 DGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSIVLQDPKRPLTYTHLRRV-WGQIWQT 437
Query: 955 LMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDIN 1014
+ +ED + + + + + E+ K + E ++ +
Sbjct: 438 IRALKEDCARLLQGQRTSMVNLLRYNTELSKKKNSMTSECEQLKAKLDFFRSSIQIDLEK 497
Query: 1015 TTCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSK 1074
+ + + +S + +E + + +ERE V ++ LQ+ V+ +
Sbjct: 498 YSEQMEFGITSEKLLSAWREMEQAVELCGRERE-----VQALVDKMMALQTDSVDLQRNP 552
Query: 1075 LK 1076
L
Sbjct: 553 LG 554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 32/232 (13%)
Query: 555 DREDLQQQIN---LLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----------------- 593
Q+N L E GKG+YG+V AY++N+ Y A+K +
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 594 -------FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN 646
+ + ++ Y+EI LK HPN++ ++++ N LY+VFE +
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 647 -DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705
+ +V K L + R+ L G+ Y+H K++HRD+KPSN+L+ + IKI D G
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 706 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTH--HVDIWSLGCILAEML 755
++ S L+ + T + APE L R+ +D+W++G L +
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 554 KDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
+ D+ Q L G+G++G V A K + A KKI D R +EI
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEI 59
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIM 666
+KS HPNII + + ++ +N D+Y+V E +L ++++ IM
Sbjct: 60 MKSLD-HPNIIRLYETFE--DNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIM 112
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIAT 723
+ + ++Y H V HRDLKP N L +K+ D GLA K + + T
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKVGT 171
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCIL 751
+Y +P++L Y D WS G ++
Sbjct: 172 PYYVSPQVL--EGLYGPECDEWSAGVMM 197
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 58/288 (20%)
Query: 569 GKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYR-----EILFLKSFQRH--- 619
G+GA+G V + D K ++VA+K + +N Y EI L+
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIV----KNV----DRYCEAARSEIQVLEHLNTTDPN 74
Query: 620 --PNIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNG 672
+ ML+ + + +VFE + I++ + HIR + +Q+C
Sbjct: 75 STFRCVQMLEWFEHH----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 673 LSYIHACKVMHRDLKPSNILID-------------------KSCSIKIGDLGLARSLSDS 713
++++H+ K+ H DLKP NIL + IK+ D G S +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYD 187
Query: 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
E + ++TR YRAPE+ I ++ D+WS+GCIL E +FP + L ++
Sbjct: 188 DEHHSTLVSTRHYRAPEV-ILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246
Query: 774 VNLVRPNPPH-------ADKFYAGFKSKHEREKFNQVVVKCQKELQEL 814
++ P P H F+ E + V + K L+E
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-39
Identities = 70/235 (29%), Positives = 113/235 (48%), Gaps = 21/235 (8%)
Query: 552 LMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYRE 609
+ + + GKG++G V DK Q A+K I + KTD + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-----IR 663
+ LK HPNI+ + + ++ + Y+V E +L D+I+
Sbjct: 77 VQLLKQLD-HPNIMKLYEFFE--DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA 129
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 720
I+ Q+ +G++Y+H K++HRDLKP N+L+ K +I+I D GL+ SK+ + +
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDK 188
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
I T +Y APE+L + Y D+WS G IL +L P F GA+ L+ +
Sbjct: 189 IGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
L K G+G+YG VYKA K Q VAIK++ ++D Q +EI ++ P+++
Sbjct: 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQC-DSPHVV 87
Query: 624 TMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
Y N DL++V EY +D+ ++ R+K L + I I+ GL Y+H
Sbjct: 88 KYYGSY--FKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
+ +HRD+K NIL++ K+ D G+A L+D+ I T ++ APE+ I Y
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYN 203
Query: 740 HHVDIWSLGCILAEMLQSKP 759
DIWSLG EM + KP
Sbjct: 204 CVADIWSLGITAIEMAEGKP 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 20/234 (8%)
Query: 552 LMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI 610
+ + L + +K+ G GAYG V DK AIK I + + + + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-----IRY 664
LK HPNI+ + D ++ + ++ Y+V E + +L D+I+ +
Sbjct: 88 AVLKLLD-HPNIMKLYDFFE--DKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAV 140
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYI 721
I+ Q+ +G++Y+H ++HRDLKP N+L+ +K IKI D GL+ + K+ + E +
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERL 199
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
T +Y APE+L ++Y D+WS+G IL +L P F G + L+ +
Sbjct: 200 GTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 29/244 (11%)
Query: 550 DQLMKDREDLQQQINLLKE--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 607
+ + L K+ G G G V + + + Q A+K + D+ +
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKAR 69
Query: 608 REILFLKSFQRHPNIITMLDIY--KAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY 664
+E+ P+I+ +LD+Y + L ++ E ME +L +I + +
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAF 125
Query: 665 -------IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSK 714
IM + + ++H+ + HRD+KP N+L +K +K+ D G A+ + +
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
L T +Y APE+L +Y D+WSLG I+ +L P F + +
Sbjct: 186 --LQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 775 NLVR 778
+R
Sbjct: 243 RRIR 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-39
Identities = 72/240 (30%), Positives = 117/240 (48%), Gaps = 20/240 (8%)
Query: 546 KKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
S + + + ++ N++ GKG++G V K D+ +Q A+K I +A D
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 605 RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-- 661
RE+ LK HPNI+ + +I + ++ Y+V E +L D+I+K
Sbjct: 67 TILREVELLKKLD-HPNIMKLFEILE--DSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 662 ---IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKE 715
I+ Q+ +G++Y+H ++HRDLKP NIL+ +K C IKI D GL+ +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T 178
Query: 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+ + I T +Y APE+L Y D+WS G IL +L P F G + L+ +
Sbjct: 179 KMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 43/271 (15%)
Query: 532 ESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIK 591
S + + +++ + ++QI GKG +G+V+K +K VAIK
Sbjct: 5 GSEFPKSRLPTLAD----NEI-----EYEKQI-----GKGGFGLVHKGRLVKDKSVVAIK 50
Query: 592 KIF-EAFRNKTDAQRTY----REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN 646
+ +T+ + RE+ + + HPNI+ + + + +V E++
Sbjct: 51 SLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLY----GLMHNPPRMVMEFVPC 105
Query: 647 -DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKS----- 696
DL + DK +K +M + G+ Y+ ++HRDL+ NI +
Sbjct: 106 GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165
Query: 697 CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI-SNRRYTHHVDIWSLGCILAEML 755
K+ D GL++ S ++ + + APE + YT D +S IL +L
Sbjct: 166 VCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 756 QSKPLFPGASTSHQLQLIVNLV----RPNPP 782
+ F S +++ I + RP P
Sbjct: 223 TGEGPFDEYSYG-KIKFINMIREEGLRPTIP 252
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 19/223 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
GKG +G VY A +K NK +A+K +F + + + Q REI RHPNI+ M
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHL-RHPNILRMY 80
Query: 627 DIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ + + K +Y++ E+ +L ++ + + M +L + L Y H KV+HR
Sbjct: 81 NYFH--DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHR 138
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPEILISNRRYTH 740
D+KP N+L+ +KI D G + + C T +Y+ PE+ I + +
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEM-IEGKTHDE 191
Query: 741 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
VD+W G + E L P F S + + IVN+ PP
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 234
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-39
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIITM 625
GKG + +V + ++ Q A+K + A + RE + HP+I+ +
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVEL 91
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI---------RYIMFQLCNGLSY 675
L+ Y ++ LY+VFE+M+ DL +I+K + M Q+ L Y
Sbjct: 92 LETYS--SDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 676 IHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 732
H ++HRD+KP +L+ + S +K+G G+A L +S + T + APE++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 733 ISNRRYTHHVDIWSLGCIL 751
Y VD+W G IL
Sbjct: 206 -KREPYGKPVDVWGCGVIL 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 66/211 (31%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFL 613
++D ++ + L+E G G++G VY A D N + VAIKK+ + ++ Q +E+ FL
Sbjct: 49 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME---NDLNKVIRDKILKDVHIRYIMFQLC 670
+ RHPN I Y + ++V EY +DL +V K L++V I +
Sbjct: 109 QKL-RHPNTIQYRGCY--LREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGAL 164
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
GL+Y+H+ ++HRD+K NIL+ + +K+GD G A ++ + ++ T ++ APE
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPE 220
Query: 731 ILISNRR--YTHHVDIWSLGCILAEMLQSKP 759
++++ Y VD+WSLG E+ + KP
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G GA +V AY K+ VAIK+I E + +T +EI + HPNI++
Sbjct: 24 GSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQC-HHPNIVSYYT 80
Query: 628 IYKAVNNKDLYVVFEYME----NDLNKVI------RDKILKDVHIRYIMFQLCNGLSYIH 677
+ V +L++V + + D+ K I + +L + I I+ ++ GL Y+H
Sbjct: 81 SF--VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-----YIATRWYRAPEIL 732
+HRD+K NIL+ + S++I D G++ L+ + ++ T + APE++
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKP 759
R Y DIWS G E+
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-38
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 546 KKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
+ + +M ++ +E GKGA+ +V + K A K I + D Q
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 605 RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI- 662
+ RE + Q HPNI+ + D + Y+VF+ + +L + I+
Sbjct: 74 KLEREARICRKLQ-HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL----FEDIVAREFYS 126
Query: 663 ----RYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKE 715
+ + Q+ ++Y H+ ++HR+LKP N+L+ K ++K+ D GLA ++DS E
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E 185
Query: 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCIL 751
+ T Y +PE+L Y+ VDIW+ G IL
Sbjct: 186 AWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVIL 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 58/288 (20%)
Query: 569 GKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYR-----EILFLKSFQRH--- 619
G+G +G V + D K VA+K I RN YR EI LK +
Sbjct: 28 GEGTFGKVVECLDHARGKSQVALKII----RNV----GKYREAARLEINVLKKIKEKDKE 79
Query: 620 --PNIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNG 672
+ M D + + + FE + + + +++ + H+R++ +QLC+
Sbjct: 80 NKFLCVLMSDWFNFH----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 673 LSYIHACKVMHRDLKPSNILI-------------------DKSCSIKIGDLGLARSLSDS 713
L ++H ++ H DLKP NIL K+ SI++ D G S +
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFD 192
Query: 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
E T +ATR YR PE+ I + D+WS+GCIL E + LF L ++
Sbjct: 193 HEHHTTIVATRHYRPPEV-ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251
Query: 774 VNLVRPNPPH-------ADKFYAGFKSKHEREKFNQVVVKCQKELQEL 814
++ P P H FY G E + V + K L+
Sbjct: 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GA+ V + Q A+K I + R +RE+ L Q H N++ +++
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHACKVM 682
++ Y+VFE M + I K H ++ + + L ++H +
Sbjct: 80 FE--EEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 683 HRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKEC-------LTEYIATRWYRAPEIL 732
HRDLKP NIL ++ +KI D L + + +C L + Y APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 733 ----ISNRRYTHHVDIWSLGCIL 751
Y D+WSLG IL
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVIL 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 554 KDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYR 608
KDRE + + L GKG +G V+ + ++ VAIK I + +D+
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 609 EILFLK---SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIRDKILKDVHI 662
E+ L + HP +I +LD ++ + +V E DL + + L +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYI 721
R Q+ + + H+ V+HRD+K NILID + K+ D G L D T++
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFD 199
Query: 722 ATRWYRAPEILISNRRYT-HHVDIWSLGCILAEML 755
TR Y PE IS +Y +WSLG +L +M+
Sbjct: 200 GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMV 233
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 16/243 (6%)
Query: 524 HRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDK 582
H SS + D + K++E L+ Q + G G +G VY
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65
Query: 583 NNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVNNKDL 637
++ VAIK + + + R E++ LK +I +LD ++
Sbjct: 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RPDSF 123
Query: 638 YVVFEYMEN--DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694
++ E E DL + + L++ R +Q+ + + H C V+HRD+K NILID
Sbjct: 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183
Query: 695 -KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILA 752
+K+ D G L D+ T++ TR Y PE I RY +WSLG +L
Sbjct: 184 LNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEW-IRYHRYHGRSAAVWSLGILLY 240
Query: 753 EML 755
+M+
Sbjct: 241 DMV 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-38
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++ L +E GKGA+ +V + Q A I + D Q+ RE +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 669
+ HPNI+ + D Y++F+ + +L + I+ + + + Q+
Sbjct: 67 LK-HPNIVRLHDSIS--EEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQI 119
Query: 670 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
+ + H V+HR+LKP N+L+ K ++K+ D GLA + ++ + T Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 727 RAPEILISNRRYTHHVDIWSLGCIL 751
+PE+L Y VD+W+ G IL
Sbjct: 180 LSPEVL-RKDPYGKPVDLWACGVIL 203
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 43/307 (14%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
++I + + G+GA+G+V KA K + VAIK+I ++++ + E+ L H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRV-NH 60
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLS 674
PNI+ + + +V EY E L V+ H Q G++
Sbjct: 61 PNIVKLY----GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 675 YIHACK---VMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
Y+H+ + ++HRDLKP N+L+ +KI D G A + +T + + APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPE 173
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLIVNLVRPN-PPHADKF 787
+ Y+ D++S G IL E++ + F + + N RP + K
Sbjct: 174 V-FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 788 YAGF------KSKHEREKFNQVVVKCQKELQELQSQVVEENT-----SKLKLQMELDSKD 836
K +R ++V K + L + + L D +
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288
Query: 837 SEIEQLQ 843
Sbjct: 289 EPYVDFA 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 558 DLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILF 612
++ + +E G G + IV K K + A K I + R + RE+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLC 670
L+ + HPNIIT+ DI++ N D+ ++ E + +L + + + L + + Q+
Sbjct: 62 LREIR-HPNIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 671 NGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
+G+ Y+H+ ++ H DLKP NI++ + IK+ D G+A + E T +
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEF 177
Query: 727 RAPEILISNRRYTHHVDIWSLGCIL 751
APEI+ + D+WS+G I
Sbjct: 178 VAPEIV-NYEPLGLEADMWSIGVIT 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 37/293 (12%)
Query: 546 KKSIDQLMKDREDLQ--QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 603
+ + D + Q+I G G++G VYK + VA+K +
Sbjct: 13 RDAADDWEIPDGQITVGQRI-----GSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL 64
Query: 604 QRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDV 660
Q E+ L+ RH NI+ L +V ++ E L + +
Sbjct: 65 QAFKNEVGVLRKT-RHVNILLF---MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 661 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720
+ I Q G+ Y+HA ++HRDLK +NI + + ++KIGD GLA S
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 721 IATRWYR--APEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL--QLIV 774
+ APE++ + Y+ D+++ G +L E++ + + + Q+ +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
Query: 775 NLVRPN----PPHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQSQ 817
+ P+ + K K + ER F +++ E++EL +
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL----AEIEELARE 289
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-38
Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 28/245 (11%)
Query: 522 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE--GKGAYGIVYKA 579
L + ++ L + + + + G G G V +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 580 YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY--KAVNNKDL 637
++K ++ A+K + D + RE+ + P+I+ ++D+Y K L
Sbjct: 82 FNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 638 YVVFEYMEN-DLNKVIRDKILKDVHIRY-------IMFQLCNGLSYIHACKVMHRDLKPS 689
+V E ++ +L +I + IM + + Y+H+ + HRD+KP
Sbjct: 135 LIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 690 NILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
N+L + +K+ D G A+ + LT T +Y APE+L +Y D+WS
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 248
Query: 747 LGCIL 751
LG I+
Sbjct: 249 LGVIM 253
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREIL 611
+ ++ ++ +E G G + IV K +K+ A K I A R + RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQL 669
L+ H N+IT+ D+Y+ N D+ ++ E + +L + + + + L + + Q+
Sbjct: 68 ILRQVL-HHNVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 670 CNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 725
+G++Y+H K+ H DLKP NI++ IK+ D GLA + D E T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPE 183
Query: 726 YRAPEILISNRRYTHHVDIWSLGCIL 751
+ APEI+ + D+WS+G I
Sbjct: 184 FVAPEIV-NYEPLGLEADMWSIGVIT 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 9e-38
Identities = 42/298 (14%), Positives = 94/298 (31%), Gaps = 41/298 (13%)
Query: 525 RSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNN 584
S+ +SL+S ++ + +R + +L G+ +A D+
Sbjct: 46 EYMQSAADSLVSTSLWNT-GQPFRVESELGERPRTLVRGTVL--GQEDPYAYLEATDQET 102
Query: 585 KQYVAIKKIFEAFRNKTDA-QRTYREILFLKSF---------QRHPNIITMLDIYKAVNN 634
+ + + R ++A ++ E+L L+ + H I D+ K
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 635 KDL---------------YVVFEYMENDLNKVIR--------DKILKDVHIRYIMFQLCN 671
K + + ++ M+++L K L + Q+
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIATRWYRAPE 730
L+ +H ++H L+P +I++D+ + + S A A
Sbjct: 223 LLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAER 282
Query: 731 ILISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784
+L + T D W+LG + + + + + I + P
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPV 340
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-37
Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 23/241 (9%)
Query: 552 LMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI-----------FEAFRN 599
+ K + + +++ G GAYG V +KN AIK I +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 600 KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDKIL 657
+ + Y EI LKS HPNII + D+++ + K Y+V E+ E ++I
Sbjct: 87 EKFHEEIYNEISLLKSLD-HPNIIKLFDVFE--DKKYFYLVTEFYEGGELFEQIINRHKF 143
Query: 658 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSK 714
+ IM Q+ +G+ Y+H ++HRD+KP NIL+ + +IKI D GL+ S
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
+ L + + T +Y APE+L ++Y D+WS G I+ +L P F G + ++ +
Sbjct: 204 K-LRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 775 N 775
Sbjct: 261 K 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 550 DQLMKDREDLQQQINLLKE--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 607
+ + E+ L + G+G + +V + K+ Q A K + + R +
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY-- 664
EI L+ + P +I + ++Y+ N ++ ++ EY ++ L ++
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYE--NTSEIILILEYAAGGEI----FSLCLPELAEMVSE 130
Query: 665 -----IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKEC 716
++ Q+ G+ Y+H ++H DLKP NIL+ IKI D G++R + + E
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCIL 751
L E + T Y APEIL + T D+W++G I
Sbjct: 190 LREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIA 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++++ ++ G GA+ V+ + + A+K I EI LK
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKK 62
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 669
+ H NI+T+ DIY+ + Y+V + + +L D+IL+ ++ Q+
Sbjct: 63 IK-HENIVTLEDIYE--STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQV 115
Query: 670 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
+ + Y+H ++HRDLKP N+L +++ I I D GL++ + ++ T Y
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGY 173
Query: 727 RAPEILISNRRYTHHVDIWSLGCIL 751
APE+L + + Y+ VD WS+G I
Sbjct: 174 VAPEVL-AQKPYSKAVDCWSIGVIT 197
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 45/274 (16%), Positives = 101/274 (36%), Gaps = 29/274 (10%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
+Q+N L + + G ++K + + +K + + ++ E L+ F H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SH 66
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSY 675
PN++ +L ++ ++ +M L V+ + ++ + G+++
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 676 IHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 733
+H + + L +++ID+ + +I + S W APE L
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV-APEALQ 181
Query: 734 SNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPN-PPHADKFYA 789
D+WS +L E++ + F S + +RP PP +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 790 GF------KSKHEREKFNQVVVKCQKELQELQSQ 817
+ +R KF+ +V L+++Q +
Sbjct: 242 KLMKICMNEDPAKRPKFDMIV----PILEKMQDK 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 30/259 (11%), Positives = 75/259 (28%), Gaps = 47/259 (18%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK-----------------------KIFEAFRNKTDAQR 605
G+ +A D+ + + ++ +N+ A+
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 606 TYREILFLKSFQR--HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--------RDK 655
R I + +I + + + + ++ M+++L K
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 656 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715
L + Q+ L+ +H ++H L+P +I++D+ + +
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV 261
Query: 716 CLTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEMLQSKPLFPGAS 765
+R + PE+ T D W+LG ++ + + +
Sbjct: 262 SSV----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 766 TSHQLQLIVNLVRPNPPHA 784
+ I + P
Sbjct: 318 ALGGSEWIFRSCKNIPQPV 336
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREI 610
+E++ + +E G G + +V K +K+ A K I ++ R + RE+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQ 668
LK Q HPN+IT+ ++Y+ N D+ ++ E + +L + + + L + + Q
Sbjct: 66 SILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 669 LCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATR 724
+ NG+ Y+H+ ++ H DLKP NI++ IKI D GLA + E T
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTP 181
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCIL 751
+ APEI+ + D+WS+G I
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVIT 207
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTY-REILF 612
D +L + + G G +G VY+A VA+K + + + +E
Sbjct: 5 DFAELTLEEII---GIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 613 LKSFQRHPNIITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLC 670
+HPNII + + L +V E+ LN+V+ K + + Q+
Sbjct: 60 FAML-KHPNIIAL---RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIA 115
Query: 671 NGLSYIHACK---VMHRDLKPSNILIDKSCS--------IKIGDLGLARSLSDSKECLTE 719
G++Y+H ++HRDLK SNILI + +KI D GLAR +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMS 173
Query: 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763
+ APE+ I ++ D+WS G +L E+L + F G
Sbjct: 174 AAGAYAWMAPEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 54/251 (21%), Positives = 102/251 (40%), Gaps = 36/251 (14%)
Query: 555 DREDLQQQINLLKE--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REIL 611
DL E GKG +G K + + + +K++ R + QRT+ +E+
Sbjct: 8 RPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELI---RFDEETQRTFLKEVK 59
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQ 668
++ HPN++ + + +K L + EY++ L +I+
Sbjct: 60 VMRCL-EHPNVLKFIGV--LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
+ +G++Y+H+ ++HRDL N L+ ++ ++ + D GLAR + D K +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 724 ----------RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQ 771
W APE+ I+ R Y VD++S G +L E++ P
Sbjct: 177 KKRYTVVGNPYWM-APEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
Query: 772 LIVNLVRPNPP 782
+ + P
Sbjct: 235 NVRGFLDRYCP 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 8/218 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG + V A + VAIK I + N T Q+ +RE+ +K HPNI+ + ++
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEV 82
Query: 629 YKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ K LY++ EY ++ + ++ +K+ R Q+ + + Y H +++HRDL
Sbjct: 83 IE--TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDIW 745
K N+L+D +IKI D G + + L + Y APE L ++Y VD+W
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVW 198
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
SLG IL ++ F G + + ++ P +
Sbjct: 199 SLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREIL 611
+ ++ ++ +E G G + IV K +K+ A K I A R + RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQL 669
L+ HPNIIT+ D+Y+ N D+ ++ E + +L + + + + L + + Q+
Sbjct: 68 ILRQVL-HPNIITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 670 CNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 725
+G++Y+H K+ H DLKP NI++ IK+ D GLA + D E T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPE 183
Query: 726 YRAPEILISNRRYTHHVDIWSLGCIL 751
+ APEI+ + D+WS+G I
Sbjct: 184 FVAPEIV-NYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 23/239 (9%)
Query: 523 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYD 581
S S+ ++ +R+ L + E G+GA IVY+
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 582 KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641
K ++ A+K + + D + EI L HPNII + +I++ ++ +V
Sbjct: 75 KGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFE--TPTEISLVL 127
Query: 642 EYME-NDLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILI-- 693
E + +L D+I++ + + Q+ ++Y+H ++HRDLKP N+L
Sbjct: 128 ELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183
Query: 694 -DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCIL 751
+KI D GL++ + + T Y APEIL Y VD+WS+G I
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIIT 240
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRHPNIITML 626
G+G+YG V + D A+K + + R +EI L+ RH N+I ++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLV 72
Query: 627 DIYKAVNNKDLYVVFEYMEND----LNKVIRDKILKDVHIRYIMF-QLCNGLSYIHACKV 681
D+ + +Y+V EY L+ V + Y F QL +GL Y+H+ +
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY--FCQLIDGLEYLHSQGI 130
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILISNRR 737
+H+D+KP N+L+ ++KI LG+A +L + T ++ PEI
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPAFQPPEIANGLDT 188
Query: 738 YT-HHVDIWSLGCILAEML 755
++ VDIWS G L +
Sbjct: 189 FSGFKVDIWSAGVTLYNIT 207
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-36
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF---------------EAFRNKTDAQRTYREILFL 613
+G + + + + ++ A+KK + K+ E+ +
Sbjct: 40 NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-----------DLNKVIRDKILKDVHI 662
++ +T I N ++Y+++EYMEN L+K I V
Sbjct: 98 TDI-KNEYCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 663 RYIMFQLCNGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 721
I + N SYIH K + HRD+KPSNIL+DK+ +K+ D G + + D K +
Sbjct: 155 CII-KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKGSR 211
Query: 722 ATRWYRAPEILISNRRY-THHVDIWSLGCILAEML 755
T + PE + Y VDIWSLG L M
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 32/250 (12%)
Query: 555 DREDLQ--QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
E L+ + I GKG +G VY VAI+ I N+ + RE++
Sbjct: 31 PFEQLEIGELI-----GKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 613 LKSFQRHPNIITMLDIYKAVNNK-DLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQ 668
+ RH N++ A + L ++ + L V+RD +L R I +
Sbjct: 83 YRQT-RHENVVLF---MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-----SLSDSKECLTEYIAT 723
+ G+ Y+HA ++H+DLK N+ D + I D GL ++ L
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 724 RWYRAPEIL--------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+ APEI+ ++ H D+++LG I E+ + F + +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 776 LVRPNPPHAD 785
++PN
Sbjct: 258 GMKPNLSQIG 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +G V + VA+K + + R+ + REI LK F RHP+II +
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQ 78
Query: 628 IYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ D ++V EY+ +L + + + ++++ R + Q+ + + Y H V+HRD
Sbjct: 79 VIS--TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD 136
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDI 744
LKP N+L+D + KI D GL+ ++ E L + Y APE+ IS R Y VDI
Sbjct: 137 LKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEV-ISGRLYAGPEVDI 194
Query: 745 WSLGCILAEML 755
WS G IL +L
Sbjct: 195 WSCGVILYALL 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-35
Identities = 49/249 (19%), Positives = 111/249 (44%), Gaps = 13/249 (5%)
Query: 509 EKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
++ + S + ++ + + + + ++ +E
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 569 -GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G GA+G+V++ ++ A K + +++D + +EI + + HP ++ + D
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLR-HPTLVNLHD 221
Query: 628 IYKAVNNKDLYVVFEYMEN-DL-NKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ ++ ++ +++E+M +L KV + + + M Q+C GL ++H +H
Sbjct: 222 AFE--DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 685 DLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 742
DLKP NI+ +S +K+ D GL L D K+ + T + APE+ + ++
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVA-EGKPVGYYT 337
Query: 743 DIWSLGCIL 751
D+WS+G +
Sbjct: 338 DMWSVGVLS 346
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 48/244 (19%), Positives = 89/244 (36%), Gaps = 49/244 (20%)
Query: 550 DQLMKDREDLQQQINLLKE--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 607
L + + + + G G G V + ++K ++ A+K + D +
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKAR 58
Query: 608 REILFLKSFQRHPNIITMLDIY--KAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY 664
RE+ + P+I+ ++D+Y K L +V E ++ +L +I +
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAF 114
Query: 665 -------IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSK 714
IM + + Y+H+ + HRD+KP N+L + +K+ D G
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 774
A E +Y D+WSLG I+ +L P F +
Sbjct: 167 -------------AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
Query: 775 NLVR 778
+R
Sbjct: 212 TRIR 215
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
+ I LL+ GKG YG V++ + VA+K R++ R E+ RH
Sbjct: 8 RDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFRE-TELYNTVML-RH 61
Query: 620 PNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676
NI+ + D+ ++ L+++ Y E L ++ L V I+ + +GL+++
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 677 HA--------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATR 724
H + HRDLK NIL+ K+ I DLGLA S S L + T+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 725 WYRAPEIL-----ISNRRYTHHVDIWSLGCILAEML 755
Y APE+L + VDIW+ G +L E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSFQRHPNI 622
G GA+G V+ A DK + V +K I + + + EI L H NI
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANI 91
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
I +LDI++ N +V E + DL + R L + YI QL + + Y+
Sbjct: 92 IKVLDIFE--NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
++HRD+K NI+I + +IK+ D G A + + + + T Y APE+ + Y
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGTIEYCAPEV-LMGNPYR 207
Query: 740 -HHVDIWSLGCIL 751
+++WSLG L
Sbjct: 208 GPELEMWSLGVTL 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG V A ++ ++ VA+K I + R + +EI K H N++
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML-NHENVVKFYGH 73
Query: 629 YKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ Y+ EY +L +++ D + + + QL G+ Y+H + HRD+
Sbjct: 74 RR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISNRRYT-HHVD 743
KP N+L+D+ ++KI D GLA + L + T Y APE+ + R + VD
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRREFHAEPVD 190
Query: 744 IWSLGCILAEML 755
+WS G +L ML
Sbjct: 191 VWSCGIVLTAML 202
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 21/226 (9%)
Query: 536 SNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIF 594
+ ++ K + + + ++L+E G GA+G+V++ +K + K I
Sbjct: 26 YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI- 84
Query: 595 EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR 653
D EI + HP +I + D ++ + ++ ++ E++ +L
Sbjct: 85 -NTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEMVLILEFLSGGEL----F 136
Query: 654 DKILKDVH------IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLG 705
D+I + + + M Q C GL ++H ++H D+KP NI+ K+ S+KI D G
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 706 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCIL 751
LA L+ + + AT + APEI+ + D+W++G +
Sbjct: 197 LATKLNPDEI-VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLG 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++L ++ + ++ G+G +GIV++ + ++K+ K + TD +EI L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKIL-KDVH-----IRYIMFQ 668
+ H NI+ + + ++ + ++L ++FE++ D+ ++I I + Q
Sbjct: 58 AR-HRNILHLHESFE--SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQ 110
Query: 669 LCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 726
+C L ++H+ + H D++P NI+ +S +IKI + G AR L + Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEY 169
Query: 727 RAPEILISNRRYTHHVDIWSLGCIL 751
APE+ + + D+WSLG ++
Sbjct: 170 YAPEVH-QHDVVSTATDMWSLGTLV 193
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 41/246 (16%), Positives = 92/246 (37%), Gaps = 34/246 (13%)
Query: 544 DYKKSIDQL--MKDREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFE 595
+++ + + + + + + + G+GA+ VY+A D NKQ +K
Sbjct: 46 EWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP 105
Query: 596 AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------DL 648
A N + + + LK + + + +V E +L
Sbjct: 106 A--NPWEFYIGTQLMERLKP-SMQHMFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINL 160
Query: 649 NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-----------DKSC 697
K +K++ + ++ + +H C+++H D+KP N ++ D S
Sbjct: 161 YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 698 SIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ + DLG + + T T ++ E+L SN+ + + +D + + + ML
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCML 279
Query: 756 QSKPLF 761
+
Sbjct: 280 FGTYMK 285
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 63/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G++G V A +Q VA+K I + + R REI +LK RHP+II + D
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYD 76
Query: 628 IYKAVNNKDLYVVFEYMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ D+ +V EY +L + ++ K + + R Q+ + Y H K++HRDL
Sbjct: 77 VIT--TPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDIW 745
KP N+L+D + ++KI D GL+ ++D L + Y APE+ I+ + Y VD+W
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV-INGKLYAGPEVDVW 192
Query: 746 SLGCILAEML 755
S G +L ML
Sbjct: 193 SCGIVLYVML 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 13/192 (6%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G+ DK K+ VA+K E R + REI+ +S RHPNI+ ++
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVK-YIE--RGAAIDENVQREIINHRSL-RHPNIVRFKEV 84
Query: 629 YKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
L ++ EY +L ++ + R+ QL +G+SY H+ ++ HRDL
Sbjct: 85 IL--TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 687 KPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVD 743
K N L+D S + +KI D G + S + T Y APE+ + + Y D
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV-LLRQEYDGKIAD 200
Query: 744 IWSLGCILAEML 755
+WS G L ML
Sbjct: 201 VWSCGVTLYVML 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG V A ++ ++ VA+K I + R + +EI K H N++
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML-NHENVVKFYGH 73
Query: 629 YKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ Y+ EY +L +++ D + + + QL G+ Y+H + HRD+
Sbjct: 74 RR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISNRRYT-HHVD 743
KP N+L+D+ ++KI D GLA + L + T Y APE+ + R + VD
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRREFHAEPVD 190
Query: 744 IWSLGCILAEML 755
+WS G +L ML
Sbjct: 191 VWSCGIVLTAML 202
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
+QI ++K+ GKG YG V+ K + VA+K F + R EI RH
Sbjct: 37 KQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT--TEEASWFRE-TEIYQTVLM-RH 90
Query: 620 PNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676
NI+ + DI + LY++ +Y EN L ++ L + + + +GL ++
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 677 HA--------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----IATR 724
H + HRDLK NIL+ K+ + I DLGLA + + T+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 725 WYRAPEIL-----ISNRRYTHHVDIWSLGCILAEML 755
Y PE+L ++ + D++S G IL E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 20/192 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G +G V+K + +A K I R D + EI + H N+I + D
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLD-HANLIQLYDA 154
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH------IRYIMFQLCNGLSYIHACKV 681
++ + D+ +V EY++ +L D+I+ + + M Q+C G+ ++H +
Sbjct: 155 FE--SKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208
Query: 682 MHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
+H DLKP NIL + IKI D GLAR +E L T + APE++ + +
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVV-NYDFVS 266
Query: 740 HHVDIWSLGCIL 751
D+WS+G I
Sbjct: 267 FPTDMWSVGVIA 278
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 27/220 (12%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
+ + I L + GKG +G V++ K + VA+K R + R EI
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFRE-AEIYQTVM 92
Query: 616 FQRHPNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNG 672
RH NI+ + D L++V +Y E+ L + + + + +G
Sbjct: 93 L-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 151
Query: 673 LSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-- 722
L+++H + HRDLK NIL+ K+ + I DLGLA + + +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 723 --TRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEML 755
T+ Y APE+L + + DI+++G + E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR---------H 619
G+G G VY+A D ++ VA+K + E + D F QR
Sbjct: 43 GRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPV-------FRTRMQREARTAGRLQE 93
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIH 677
P+++ + D + LYV + DL ++R + L I+ Q+ + L H
Sbjct: 94 PHVVPIHDF--GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILIS 734
A HRD+KP NIL+ + D G+A + +D K LT+ + T +Y APE S
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPE-RFS 208
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767
T+ DI++L C+L E L P + G S
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--Y 607
+ L+ L++ GKG +G V N + VA+KK+ ++ T+
Sbjct: 8 EERHLK----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFE 59
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRY 664
REI LKS +H NI+ + + ++L ++ EY+ L ++ + + + +
Sbjct: 60 REIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT- 723
Q+C G+ Y+ + +HRDL NIL++ +KIGD GL + L KE +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---FKVKE 175
Query: 724 ------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
WY APE ++ +++ D+WS G +L E+
Sbjct: 176 PGESPIFWY-APES-LTESKFSVASDVWSFGVVLYELF 211
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +G V + VA+K + + R+ + REI LK F RHP+II +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQ 83
Query: 628 IYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ D+++V EY+ +L + + ++ L + R + Q+ +G+ Y H V+HRD
Sbjct: 84 VIS--TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDI 744
LKP N+L+D + KI D GL+ ++ E L + Y APE+ IS R Y VDI
Sbjct: 142 LKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEV-ISGRLYAGPEVDI 199
Query: 745 WSLGCILAEML 755
WS G IL +L
Sbjct: 200 WSSGVILYALL 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNK 600
++ D + + L++ +L G+G +G V + + VA+K + +
Sbjct: 19 FQGPGDPTVFHKRYLKKIRDL---GEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DA 72
Query: 601 TDAQRT--YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKIL 657
R+ +EI L++ H +II + L +V EY+ L + +
Sbjct: 73 GPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI 131
Query: 658 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717
+ Q+C G++Y+HA +HRDL N+L+D +KIGD GLA+++ + E
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-- 189
Query: 718 TEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
Y WY APE + ++ + D+WS G L E+L
Sbjct: 190 -YYRVREDGDSPVFWY-APEC-LKEYKFYYASDVWSFGVTLYELL 231
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTY-RE 609
+ L+ L GKG +G V N VA+K++ + D QR + RE
Sbjct: 21 EERHLKYISQL---GKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQRE 74
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIM 666
I LK+ I+ + + L +V EY+ + L ++ L +
Sbjct: 75 IQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--- 723
Q+C G+ Y+ + + +HRDL NIL++ +KI D GLA+ L K+ Y+
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPG 190
Query: 724 ----RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
WY APE +S+ ++ D+WS G +L E+
Sbjct: 191 QSPIFWY-APES-LSDNIFSRQSDVWSFGVVLYELF 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--Y 607
+ L+ L++ GKG +G V N + VA+KK+ ++ T+
Sbjct: 39 EERHLK----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFE 90
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRY 664
REI LKS +H NI+ + + ++L ++ EY+ L ++ + + + +
Sbjct: 91 REIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT- 723
Q+C G+ Y+ + +HRDL NIL++ +KIGD GL + L KE Y
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---YYKVKE 206
Query: 724 ------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
WY APE ++ +++ D+WS G +L E+
Sbjct: 207 PGESPIFWY-APES-LTESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 30/231 (12%)
Query: 542 EVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEA 596
E +D ++ L+ +++ G+G +G V N + VA+K +
Sbjct: 6 EKKPATEVDPTHFEKRFLK----RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP- 60
Query: 597 FRNKTDAQRT--YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR 653
+EI L++ H NI+ I + ++ E++ + L + +
Sbjct: 61 --ESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 654 D--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711
+ Q+C G+ Y+ + + +HRDL N+L++ +KIGD GL +++
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 712 DSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
KE Y WY APE + ++ D+WS G L E+L
Sbjct: 178 TDKE---YYTVKDDRDSPVFWY-APEC-LMQSKFYIASDVWSFGVTLHELL 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 33/232 (14%)
Query: 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 608
I +++ +R + ++ G G VY A D VAIK IF R +
Sbjct: 5 IGKIINERYKIVDKL-----GGGGMSTVYLAEDTILNIKVAIKAIFIPPRE--KEE---- 53
Query: 609 EILFLKSFQR---------HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-IL 657
LK F+R H NI++M+D+ + Y+V EY+E L++ I L
Sbjct: 54 ---TLKRFEREVHNSSQLSHQNIVSMIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 658 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717
Q+ +G+ + H +++HRD+KP NILID + ++KI D G+A++LS++ L
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--L 166
Query: 718 TE---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766
T+ + T Y +PE DI+S+G +L EML +P F G +
Sbjct: 167 TQTNHVLGTVQYFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 31/234 (13%)
Query: 548 SIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 607
+ + DR +L + + G G V+ A D + + VA+K + D
Sbjct: 5 TTPSHLSDRYELGEIL-----GFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPS--- 54
Query: 608 REILFLKSFQR---------HPNIITMLDIYKAVNNKDL--YVVFEYME-NDLNKVIRDK 655
F F+R HP I+ + D +A Y+V EY++ L ++ +
Sbjct: 55 ----FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE 110
Query: 656 -ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714
+ ++ C L++ H ++HRD+KP+NI+I + ++K+ D G+AR+++DS
Sbjct: 111 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 715 ECLTE---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 765
+T+ I T Y +PE D++SLGC+L E+L +P F G S
Sbjct: 171 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK-----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
G+G++ V A + + AIK I + NK R+++ S HP +
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVM---SRLDHPFFV 93
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
+ ++ +++ LY Y +N +L K I + + R+ ++ + L Y+H +
Sbjct: 94 KLYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLT-EYIATRWYRAPEILI 733
+HRDLKP NIL+++ I+I D G A+ LS + T +Y+ +PE+L
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV------SPELL- 204
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
+ + D+W+LGCI+ +++ P F + Q I+ L P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 257
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 36/248 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--Y 607
+ + +K G GA+G VYK + K VAIK++ E +
Sbjct: 13 KETEFK----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEIL 65
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRY 664
E + S +P++ +L I + ++ + M L +R + ++
Sbjct: 66 DEAYVMASV-DNPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT- 723
Q+ G++Y+ +++HRDL N+L+ +KI D GLA+ L ++ EY A
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEG 178
Query: 724 -----RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNL 776
+W A E I +R YTH D+WS G + E++ SKP + G S ++
Sbjct: 179 GKVPIKWM-ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKG 235
Query: 777 VR-PNPPH 783
R P PP
Sbjct: 236 ERLPQPPI 243
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 32/253 (12%)
Query: 557 EDLQQQINLLKE----GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
E+L Q L+ +G +G V+KA N +YVA+K + + E+
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPI---QDKQSWQNEYEVYS 71
Query: 613 LKSFQRHPNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY-IMFQ 668
L +H NI+ + + + DL+++ + E L+ ++ ++ + I
Sbjct: 72 LPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV-SWNELCHIAET 129
Query: 669 LCNGLSYIHAC----------KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL- 717
+ GL+Y+H + HRD+K N+L+ + + I D GLA K
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 718 -TEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 772
+ TR Y APE+L R +D++++G +L E+ G + L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 773 IVNLVRPNPPHAD 785
+ +P D
Sbjct: 250 -EEEIGQHPSLED 261
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YREIL 611
+ ED + L ++ G+G +G V+ + + VA+K E + +E
Sbjct: 112 NHED----LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEAR 164
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQ 668
LK + HPNI+ ++ + + +Y+V E ++ D +R + L+ + ++
Sbjct: 165 ILKQY-SHPNIVRLIGV--CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
G+ Y+ + +HRDL N L+ + +KI D G++R +D Y A+
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQ 276
Query: 724 ---RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W APE ++ RY+ D+WS G +L E
Sbjct: 277 VPVKWT-APEA-LNYGRYSSESDVWSFGILLWETF 309
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/246 (23%), Positives = 110/246 (44%), Gaps = 37/246 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
+R D+ + + G G YG VY+ K VA+K + E + + + +E +
Sbjct: 11 ERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVM 63
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMF 667
K +HPN++ +L V Y++ E+M +L +R+ + + V + Y+
Sbjct: 64 KEI-KHPNLVQLL----GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT---- 723
Q+ + + Y+ +HRDL N L+ ++ +K+ D GL+R ++ Y A
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAK 173
Query: 724 ---RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR 778
+W APE ++ +++ D+W+ G +L E+ P +PG S +L+ R
Sbjct: 174 FPIKWT-APES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYR 230
Query: 779 -PNPPH 783
P
Sbjct: 231 MERPEG 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-29
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 20/226 (8%)
Query: 569 GKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +Y A D+N N + V +K + + + E FL HP+I+ + +
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVV-HPSIVQIFN 146
Query: 628 I---YKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ Y+V EY+ L + K+ I + ++ LSY+H+ +++
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-YLLEILPALSYLHSIGLVY 205
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
DLKP NI++ + +K+ DLG ++ T ++APEI+ T D
Sbjct: 206 NDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIV--RTGPTVATD 258
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789
I+++G LA + P G + P D +
Sbjct: 259 IYTVGRTLAALTLDLPTRNGRYVDG-----LPEDDPVLKTYDSYGR 299
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILF 612
DR+ L + L G G +G V K Y + K VA+K + + E
Sbjct: 14 DRKLLTLEDKEL--GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLC 670
++ +P I+ M+ I + +V E E LNK ++ + +KD +I ++ Q+
Sbjct: 72 MQQL-DNPYIVRMIGI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------- 723
G+ Y+ +HRDL N+L+ KI D GL+++L + Y A
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPV 184
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+WY APE I+ +++ D+WS G ++ E
Sbjct: 185 KWY-APEC-INYYKFSSKSDVWSFGVLMWEAF 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 34/217 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YR 608
RED+ L + G+G +G VY+ K K VA+K + + T +
Sbjct: 10 AREDVV----LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK---DCTLDNKEKFMS 62
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYI 665
E + +K+ HP+I+ ++ I + + +++ E +L + LK + +
Sbjct: 63 EAVIMKNL-DHPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-- 723
Q+C ++Y+ + +HRD+ NIL+ +K+GD GL+R + D +Y
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASV 173
Query: 724 -----RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W +PE I+ RR+T D+W + E+L
Sbjct: 174 TRLPIKWM-SPES-INFRRFTTASDVWMFAVCMWEIL 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE++ LLKE G G +G+V K VA+K I E ++E +
Sbjct: 6 KREEIT----LLKELGSGQFGVVKLGKWKGQYD-VAVKMIKE---GSMSEDEFFQEAQTM 57
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQ 668
HP ++ V +Y+V EY+ N L +R K L+ + + +
Sbjct: 58 MKL-SHPKLVKFY----GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
+C G++++ + + +HRDL N L+D+ +K+ D G+ R + D +Y+++
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKF 167
Query: 724 --RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W APE+ +Y+ D+W+ G ++ E+
Sbjct: 168 PVKWS-APEV-FHYFKYSSKSDVWAFGILMWEVF 199
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/265 (19%), Positives = 104/265 (39%), Gaps = 37/265 (13%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRN 599
+ K+ ++ ++ + Q L + GKG +G V +A + + VA+K +
Sbjct: 10 ELKEKLEDVLIPEQ----QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65
Query: 600 KTDAQRTYREILFLKSFQRHPNIITML----DIYKAVNNKDLYVVFEYMEN-DLNKVIR- 653
+D + RE +K F HP++ ++ V+ +M++ DL+ +
Sbjct: 66 SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 654 ------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707
L + M + G+ Y+ + +HRDL N ++ + ++ + D GL+
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 708 RSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSK 758
R + Y +W A E L ++ YT H D+W+ G + E+
Sbjct: 185 RKIYSGD----YYRQGCASKLPVKWL-ALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 759 PLFPGASTSHQLQLIVNLVRPNPPH 783
P + G + ++ R P
Sbjct: 239 P-YAGIENAEIYNYLIGGNRLKQPP 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
D +DL LKE G G +G+V + VAIK I E E +
Sbjct: 22 DPKDLT----FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKE---GSMSEDEFIEEAKVM 73
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQ 668
+ H ++ + V + ++++ EYM N L +R + + +
Sbjct: 74 MNL-SHEKLVQLY----GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
+C + Y+ + + +HRDL N L++ +K+ D GL+R + D EY ++
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----DEYTSSVGSKF 183
Query: 724 --RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
RW PE+ + +++ DIW+ G ++ E+
Sbjct: 184 PVRWS-PPEV-LMYSKFSSKSDIWAFGVLMWEIY 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTY-RE 609
+DL+ LL++ G G++G+V + VA+K + ++ +A + RE
Sbjct: 16 GEKDLR----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIM 666
+ + S H N+I + + V + +V E L +R +
Sbjct: 72 VNAMHSL-DHRNLIRLYGV---VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--- 723
Q+ G+ Y+ + + +HRDL N+L+ +KIGD GL R+L + + Y+
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD---HYVMQEHR 184
Query: 724 ----RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
W APE + R ++H D W G L EM
Sbjct: 185 KVPFAWC-APES-LKTRTFSHASDTWMFGVTLWEMF 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YR 608
RE ++ L + G+G +G V++ +N VAIK +D+ R +
Sbjct: 13 QRERIE----LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQ 65
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYI 665
E L ++ F HP+I+ ++ + + ++++ E +L ++ L +
Sbjct: 66 EALTMRQF-DHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-- 723
+QL L+Y+ + + +HRD+ N+L+ + +K+GD GL+R + DS Y
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASK 176
Query: 724 -----RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNL 776
+W APE I+ RR+T D+W G + E+L KP F G + + I N
Sbjct: 177 GKLPIKWM-APES-INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENG 233
Query: 777 VR-PNPPHA-DKFYAG-----FKSKHEREKFNQVVVKCQKELQELQSQ 817
R P PP+ Y+ R +F ++ + L+E ++Q
Sbjct: 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 59/263 (22%), Positives = 113/263 (42%), Gaps = 40/263 (15%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRN 599
+ +++ ++ L ++ + G+G +G VY + K + A+K +
Sbjct: 10 ELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---I 64
Query: 600 KTDAQRT--YREILFLKSFQRHPNIITMLDIYKAVNNKD--LYVVFEYMEN-DLNKVIR- 653
+ + E + +K F HPN++++L I + VV YM++ DL IR
Sbjct: 65 TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGI---CLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 654 -DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712
+ Q+ G+ Y+ + K +HRDL N ++D+ ++K+ D GLAR + D
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
Query: 713 SKECLTEYIAT----------RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL 760
EY + +W A E + +++T D+WS G +L E++ + P
Sbjct: 181 -----KEYYSVHNKTGAKLPVKWM-ALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPP- 232
Query: 761 FPGASTSHQLQLIVNLVRPNPPH 783
+P +T ++ R P
Sbjct: 233 YPDVNTFDITVYLLQGRRLLQPE 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 38/300 (12%)
Query: 562 QINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLK 614
+ +K G GA+G VYK + K VAIK++ E + E +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMA 72
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCN 671
S +P++ +L I + ++ + M L +R + ++ Q+
Sbjct: 73 SV-DNPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RW 725
G++Y+ +++HRDL N+L+ +KI D GLA+ L ++ EY A +W
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKW 185
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 782
A E I +R YTH D+WS G + E++ SKP + G S ++ R P PP
Sbjct: 186 M-ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPP 242
Query: 783 HA-DKFYAG-----FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD 836
Y R KF +++++ K ++ Q +V + ++ L DS
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YR 608
+ + + K G G G V VAIK + T+ QR
Sbjct: 47 EASRIH----IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA---GYTERQRRDFLS 99
Query: 609 EILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIR 663
E + F HPNII + V + +V EYMEN L+ +R D + +
Sbjct: 100 EASIMGQF-DHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723
++ + G+ Y+ +HRDL N+L+D + K+ D GL+R L D + T
Sbjct: 155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD---AAYTT 211
Query: 724 -------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
RW APE I+ R ++ D+WS G ++ E+L
Sbjct: 212 TGGKIPIRWT-APEA-IAFRTFSSASDVWSFGVVMWEVL 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--Y 607
+ K G G +G VYK + VAIK + T+ QR
Sbjct: 42 HPSCVT----RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFL 94
Query: 608 REILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHI 662
E + F H NII + V K + ++ EYMEN L+K +R D + +
Sbjct: 95 GEAGIMGQF-SHHNIIRLE----GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722
++ + G+ Y+ +HRDL NIL++ + K+ D GL+R L D E Y
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTT 207
Query: 723 T------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ RW APE IS R++T D+WS G ++ E++
Sbjct: 208 SGGKIPIRWT-APEA-ISYRKFTSASDVWSFGIVMWEVM 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
D +L ++E G G +G+V+ Y NK VAIK I E + E +
Sbjct: 6 DPSELT----FVQEIGSGQFGLVHLGY-WLNKDKVAIKTIRE---GAMSEEDFIEEAEVM 57
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQ 668
HP ++ + V + +V E+ME+ L+ +R + + +
Sbjct: 58 MKL-SHPKLVQLY----GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
+C G++Y+ V+HRDL N L+ ++ IK+ D G+ R + D +Y ++
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKF 167
Query: 724 --RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W +PE+ S RY+ D+WS G ++ E+
Sbjct: 168 PVKWA-SPEV-FSFSRYSSKSDVWSFGVLMWEVF 199
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 72/303 (23%), Positives = 117/303 (38%), Gaps = 76/303 (25%)
Query: 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL--FLKSFQRHPN- 621
+ K G G + V+ ++D K++VA+ K+ ++ + T+ +L S PN
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 622 --IITMLDI--YKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLS 674
++ +LD VN + +VFE + + L K I + L ++ I+ Q+ GL
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 675 YIHA-CKVMHRDLKPSNILI---------------------------------------- 693
Y+H C+++H D+KP NIL+
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 694 ---------DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
+ +KI DLG A + + TE I TR YR+ E+LI Y DI
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLI-GSGYNTPADI 276
Query: 745 WSLGCILAEMLQSKPLFPGASTS------HQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798
WS C+ E+ LF S + LI+ L+ P K+ +E
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK---LIV--AGKYSKE 331
Query: 799 KFN 801
F
Sbjct: 332 FFT 334
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-27
Identities = 71/324 (21%), Positives = 133/324 (41%), Gaps = 28/324 (8%)
Query: 453 QAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTM 512
E EE+ + LE EEER + + + A + ++ + ++
Sbjct: 81 PLVEFYEEIKKY--EKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVK 138
Query: 513 KEL------ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLL 566
K++ + + ++ ++ + S+ R +K + D ++
Sbjct: 139 KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV-HRII 197
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNII 623
G+G +G VY + + A+K + + + R +L L S P I+
Sbjct: 198 --GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
M Y L + + M DL+ + + + + +R+ ++ GL ++H V
Sbjct: 256 CM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPEILISNRR 737
++RDLKP+NIL+D+ ++I DLGLA S K T Y+ APE+L
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM------APEVLQKGVA 367
Query: 738 YTHHVDIWSLGCILAEMLQSKPLF 761
Y D +SLGC+L ++L+ F
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/226 (23%), Positives = 85/226 (37%), Gaps = 42/226 (18%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIF----EAFRNKTDAQRTYREILFLKSF 616
+ LL+ G+G YG VYK +++ VA+K + F N+ + R
Sbjct: 14 NLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINEKNIYRVPL-------- 63
Query: 617 QRHPNIITML--DIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNG 672
H NI + D + + +V EY N L K + V + + G
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRG 123
Query: 673 LSYIHA---------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA- 722
L+Y+H + HRDL N+L+ + I D GL+ L+ ++
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 723 -------TRWYRAPEIL------ISNRRYTHHVDIWSLGCILAEML 755
T Y APE+L VD+++LG I E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 63/255 (24%), Positives = 93/255 (36%), Gaps = 57/255 (22%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT-- 606
R L K G GA+G V +A + VA+K + + +R
Sbjct: 21 PRNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREAL 73
Query: 607 YREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK-------- 655
E+ L H NI+ +L V+ EY DL +R K
Sbjct: 74 MSELKVLSYLGNHMNIVNLL----GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 656 -----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704
L + +Q+ G++++ + +HRDL NIL+ KI D
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 705 GLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--L 755
GLAR + + Y+ +W APE I N YT D+WS G L E+ L
Sbjct: 190 GLARDIKNDS----NYVVKGNARLPVKWM-APE-SIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 756 QSKPLFPGASTSHQL 770
S P +PG +
Sbjct: 244 GSSP-YPGMPVDSKF 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 31/284 (10%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE L+ L + G+G +G V+ + VAIK + + +E +
Sbjct: 182 PRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVM 233
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQL 669
K RH ++ + Y V+ + +Y+V EYM L ++ K L+ + + Q+
Sbjct: 234 KKL-RHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWYR 727
+G++Y+ +HRDL+ +NIL+ ++ K+ D GLAR + D++ + +W
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 784
APE R+T D+WS G +L E+ P +PG L + R P PP
Sbjct: 349 APEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMPCPPEC 406
Query: 785 -DKFYAGFKS--KHEREK---FNQVVVKCQKELQELQSQVVEEN 822
+ + + E E+ F + + + Q
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 31/284 (10%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE L+ L + G+G +G V+ + VAIK + + +E +
Sbjct: 265 PRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQL 669
K RH ++ + Y V+ + +Y+V EYM L ++ K L+ + + Q+
Sbjct: 317 KKL-RHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWYR 727
+G++Y+ +HRDL+ +NIL+ ++ K+ D GLAR + D++ + +W
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 431
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 784
APE R+T D+WS G +L E+ P +PG L + R P PP
Sbjct: 432 APEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMPCPPEC 489
Query: 785 -DKFYAGFKS--KHEREK---FNQVVVKCQKELQELQSQVVEEN 822
+ + + E E+ F + + + Q
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 550 DQLMKDREDLQQQINLLKEGKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRT- 606
+L R++L I ++ G G +G V + + + VAIK + + A
Sbjct: 2 KKLFLKRDNLL--IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEE 56
Query: 607 -YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHI 662
RE + +P I+ ++ + + L +V E L+K + + + ++
Sbjct: 57 MMREAQIMHQL-DNPYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722
++ Q+ G+ Y+ +HRDL N+L+ KI D GL+++L Y A
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTA 169
Query: 723 T-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+WY APE I+ R+++ D+WS G + E L
Sbjct: 170 RSAGKWPLKWY-APEC-INFRKFSSRSDVWSYGVTMWEAL 207
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 58/250 (23%), Positives = 113/250 (45%), Gaps = 34/250 (13%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
+R D+ + + G G YG VY+ K VA+K + E + + + +E +
Sbjct: 218 ERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVM 270
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQL 669
K +HPN++ +L + Y++ E+M +L +R+ + + V + Y+ Q+
Sbjct: 271 KEI-KHPNLVQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 723
+ + Y+ +HR+L N L+ ++ +K+ D GL+R ++ Y A
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFP 382
Query: 724 -RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-P 779
+W APE ++ +++ D+W+ G +L E+ P +PG S +L+ R
Sbjct: 383 IKWT-APES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRME 439
Query: 780 NPPHA-DKFY 788
P +K Y
Sbjct: 440 RPEGCPEKVY 449
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YR 608
D ++ + K G G +G V + VAIK + T+ QR
Sbjct: 43 DATNIS----IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV---GYTEKQRRDFLG 95
Query: 609 EILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIR 663
E + F HPNII + V +K + +V EYMEN L+ +R D + +
Sbjct: 96 EASIMGQF-DHPNIIRLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723
++ + +G+ Y+ +HRDL NILI+ + K+ D GL R L D E Y
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTR 208
Query: 724 ------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
RW +PE I+ R++T D+WS G +L E++
Sbjct: 209 GGKIPIRWT-SPEA-IAYRKFTSASDVWSYGIVLWEVM 244
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 47/234 (20%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRN 599
+ + ++ ++ DR + L K G+G +G V + + VA+K + +
Sbjct: 21 ELQNKLEDVVIDRN----LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS 76
Query: 600 KTDAQRTYREILFLKSFQRHPNIITMLDI---YKAVNNKDLYVVFEYMEN-DLNKVIR-- 653
+ + + E +K F HPN+I +L + + V+ +M+ DL+ +
Sbjct: 77 QREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 654 -----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708
K + + M + G+ Y+ +HRDL N ++ ++ + D GL++
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 709 SLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ Y +W A E L ++R YT D+W+ G + E+
Sbjct: 196 KIYSG----DYYRQGRIAKMPVKWI-AIESL-ADRVYTSKSDVWAFGVTMWEIA 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE L+ L++ G G +G V+ Y + + VA+K + + E +
Sbjct: 11 PRETLK----LVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ---GSMSPDAFLAEANLM 62
Query: 614 KSFQRHPNIITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQ 668
K +H ++ + AV ++ +Y++ EYMEN L ++ L + + Q
Sbjct: 63 KQL-QHQRLVRLY----AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 723
+ G+++I +HRDL+ +NIL+ + S KI D GLAR + D EY A
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-----NEYTAREGAKF 172
Query: 724 --RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W APE I+ +T D+WS G +L E++
Sbjct: 173 PIKWT-APEA-INYGTFTIKSDVWSFGILLTEIV 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 69/366 (18%), Positives = 135/366 (36%), Gaps = 35/366 (9%)
Query: 410 EAKRNIEEEYHKLKTKRSVEDLQMKE-LQDQLETEQYFSTLYKTQAHELKEELDERSRNI 468
+ +++ + + ++ + ++ L+ + + ++ ++
Sbjct: 49 ALRESLDLGFEGMCLEQPIGKRLFQQFLRTHEQHGPALQLWKDIEDYDTADD-------- 100
Query: 469 LELEEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKEL-ELKDLMAKHRSD 527
R L+ A ++ + ETV L + H
Sbjct: 101 ----ALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQ 156
Query: 528 LSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQ 586
+E L S R + +K Q M + + G+G +G V+ K +
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMG-EDWF----LDFRVLGRGGFGEVFACQMKATGK 211
Query: 587 YVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643
A KK+ + R ++IL + I+++ Y DL +V
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKIL---AKVHSRFIVSL--AYAFETKTDLCLVMTI 266
Query: 644 MEN-DL-----NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697
M D+ N + ++ + Q+ +GL ++H +++RDLKP N+L+D
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG 326
Query: 698 SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS 757
+++I DLGLA L + Y T + APE+L Y VD ++LG L EM+ +
Sbjct: 327 NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAA 385
Query: 758 KPLFPG 763
+ F
Sbjct: 386 RGPFRA 391
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 67/291 (23%), Positives = 128/291 (43%), Gaps = 42/291 (14%)
Query: 516 ELKDLMAKHRSDLS------SKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE- 568
++ +L+ +S+++ ++L+ + + K+ID + +D +I L+
Sbjct: 8 KMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMK 67
Query: 569 ----------GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 615
G+GA+G V K+ ++ A+K + + R+ + R+I+ +
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM---A 124
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLS 674
F P ++ + Y +++ LY+V EYM DL ++ + + + R+ ++ L
Sbjct: 125 FANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------EYIATRWYR 727
IH+ +HRD+KP N+L+DKS +K+ D G ++ +YI
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236
Query: 728 APEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+PE+L S + Y D WS+G L EML F S I+N
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 52/231 (22%)
Query: 561 QQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILF 612
+ I L +E G+GA+G V+ A +K VA+K + + T A R RE
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 613 LKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR---------------- 653
L + Q H +I+ V + L +VFEYM++ DLNK +R
Sbjct: 71 LTNLQ-HEHIVKFY----GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 654 -DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712
L + +I Q+ +G+ Y+ + +HRDL N L+ + +KIGD G++R +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 713 SKECLTEYIAT--------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
T+Y RW PE I R++T D+WS G IL E+
Sbjct: 186 -----TDYYRVGGHTMLPIRWM-PPES-IMYRKFTTESDVWSFGVILWEIF 229
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 45/247 (18%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
+ ++L+ LL+ GKG +G V + NK VA+K I +N AQ E +
Sbjct: 19 NMKELK----LLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVM 68
Query: 614 KSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIM 666
RH N++ +L V LY+V EYM L +R +L +
Sbjct: 69 TQL-RHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--- 723
+C + Y+ +HRDL N+L+ + K+ D GL +
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---------ASSTQDTG 174
Query: 724 ----RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLV 777
+W APE + ++++ D+WS G +L E+ P +P + +
Sbjct: 175 KLPVKWT-APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGY 231
Query: 778 R-PNPPH 783
+ P
Sbjct: 232 KMDAPDG 238
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 56/264 (21%), Positives = 113/264 (42%), Gaps = 42/264 (15%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRN 599
+ +++ ++ L ++ + G+G +G VY + K + A+K +
Sbjct: 74 ELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---I 128
Query: 600 KTDAQRT--YREILFLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIR 653
+ + E + +K F HPN++++L + + VV YM++ DL IR
Sbjct: 129 TDIGEVSQFLTEGIIMKDF-SHPNVLSLL----GICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 654 --DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711
+ Q+ G+ ++ + K +HRDL N ++D+ ++K+ D GLAR +
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 712 DSKECLTEYIAT----------RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKP 759
D E+ + +W A E + +++T D+WS G +L E++ + P
Sbjct: 244 D-----KEFDSVHNKTGAKLPVKWM-ALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
Query: 760 LFPGASTSHQLQLIVNLVRPNPPH 783
+P +T ++ R P
Sbjct: 297 -YPDVNTFDITVYLLQGRRLLQPE 319
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE L+ L K+ G G +G V+ A + + VA+K + + E +
Sbjct: 186 PRESLK----LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKP---GSMSVEAFLAEANVM 237
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQL 669
K+ +H ++ + + V + +Y++ E+M L ++ + Q+
Sbjct: 238 KTL-QHDKLVKL---HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 723
G+++I +HRDL+ +NIL+ S KI D GLAR + D+ EY A
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-----EYTAREGAKFP 348
Query: 724 -RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W APE I+ +T D+WS G +L E++
Sbjct: 349 IKWT-APEA-INFGSFTIKSDVWSFGILLMEIV 379
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 522 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYD 581
AK S+ S + L+ KE + ++ Q + + L G G++G V
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTL---GTGSFGRVMLVKH 62
Query: 582 KNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639
K + + A+K + + K + T E L++ P ++ + +K +N +LY+
Sbjct: 63 KESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAV-NFPFLVKLEFSFK--DNSNLYM 118
Query: 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697
V EY+ ++ +R + H R+ Q+ Y+H+ +++RDLKP N+LID+
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 698 SIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
I++ D G A+ + C T E + APEI I ++ Y VD W+LG ++ EM
Sbjct: 179 YIQVTDFGFAKRVKGRTWTLCGTPEAL------APEI-ILSKGYNKAVDWWALGVLIYEM 231
Query: 755 LQSKPLFPGASTSHQLQLIVN 775
P F + IV+
Sbjct: 232 AAGYPPFFADQPIQIYEKIVS 252
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 36/248 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YREIL 611
+ ++L+ LL+ GKG +G V + NK VA+K I K DA E
Sbjct: 191 NMKELK----LLQTIGKGEFGDVMLGDYRGNK--VAVKCI------KNDATAQAFLAEAS 238
Query: 612 FLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRY 664
+ RH N++ +L V LY+V EYM L +R +L +
Sbjct: 239 VMTQL-RHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724
+C + Y+ +HRDL N+L+ + K+ D GL + S +++ T + +
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVK 351
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNP 781
W APE + ++++ D+WS G +L E+ P +P + + + P
Sbjct: 352 WT-APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAP 408
Query: 782 PHA-DKFY 788
Y
Sbjct: 409 DGCPPAVY 416
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 56/254 (22%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT-- 606
R+ L+ L K G+GA+G V +A + VA+K + E T ++
Sbjct: 25 PRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRAL 77
Query: 607 YREILFLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD-------- 654
E+ L H N++ +L L V+ E+ + +L+ +R
Sbjct: 78 MSELKILIHIGHHLNVVNLL----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 655 ---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705
L H+ FQ+ G+ ++ + K +HRDL NIL+ + +KI D G
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 706 LARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQ 756
LAR + +Y+ +W APE + +R YT D+WS G +L E+ L
Sbjct: 194 LARDIYKDP----DYVRKGDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 757 SKPLFPGASTSHQL 770
+ P +PG +
Sbjct: 248 ASP-YPGVKIDEEF 260
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 62/308 (20%)
Query: 522 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY 580
+ H S++ +L+ E E+ + R+ L L K G+GA+G V A
Sbjct: 3 SSHHHHHHSQDPMLAGVSEYELPED---PKWEFPRDKLT----LGKPLGEGAFGQVVMAE 55
Query: 581 -------DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHPNIITMLDIYKA 631
VA+K + + + T+ + E+ +K +H NII +L
Sbjct: 56 AVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGKHKNIINLL----G 108
Query: 632 V--NNKDLYVVFEYMEN-DLNKVIR-----------------DKILKDVHIRYIMFQLCN 671
+ LYV+ EY +L + +R ++ + + +QL
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------R 724
G+ Y+ + K +HRDL N+L+ ++ +KI D GLAR +++ Y T +
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVK 224
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR-PNP 781
W APE L +R YTH D+WS G ++ E+ L P +PG +L+ R P
Sbjct: 225 WM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKP 281
Query: 782 PHA-DKFY 788
+ ++ Y
Sbjct: 282 ANCTNELY 289
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 53/249 (21%), Positives = 96/249 (38%), Gaps = 38/249 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--Y 607
+L+ LK G G +G V+K ++ K V IK I +
Sbjct: 11 KETELR----KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED---KSGRQSFQAVT 63
Query: 608 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRY 664
+L + S H +I+ +L + L +V +Y+ L +R L +
Sbjct: 64 DHMLAIGSL-DHAHIVRLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 665 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT- 723
Q+ G+ Y+ ++HR+L N+L+ +++ D G+A L + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQLLYS 175
Query: 724 ------RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVN 775
+W A E I +YTH D+WS G + E++ ++P + G + L+
Sbjct: 176 EAKTPIKWM-ALES-IHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLLEK 232
Query: 776 LVR-PNPPH 783
R P
Sbjct: 233 GERLAQPQI 241
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 42/254 (16%), Positives = 95/254 (37%), Gaps = 42/254 (16%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKA-------YDKNNKQYVAIKKIFEAFRNKTDAQRT 606
EDL + G+G + ++K Y + ++ V +K + +A RN +++
Sbjct: 6 RNEDLI----FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--F 59
Query: 607 YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIR 663
+ + H +++ + V + +V E+++ L+ ++ + +
Sbjct: 60 FEAASMMSKL-SHKHLVLNYGV--CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--------IKIGDLGLARSLSDSKE 715
+ QL + ++ ++H ++ NIL+ + IK+ D G++ ++
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 716 CLTEY--IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQ 771
+ W PE + + + D WS G L E+ KP + +LQ
Sbjct: 175 ---DILQERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQ 229
Query: 772 LIVN---LVRPNPP 782
+ L P
Sbjct: 230 FYEDRHQLPAPKAA 243
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 611
+R + GKG +G+VY N+ AIK + + RE L
Sbjct: 19 ERVVTHSDRVI---GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGL 74
Query: 612 FLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYI 665
++ HPN++ ++ + +V+ YM + DL + IR + +
Sbjct: 75 LMRGL-NHPNVLALI----GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-- 723
Q+ G+ Y+ K +HRDL N ++D+S ++K+ D GLAR + D EY +
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----REYYSVQQ 184
Query: 724 --------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+W A E L R+T D+WS G +L E+L
Sbjct: 185 HRHARLPVKWT-ALESL-QTYRFTTKSDVWSFGVLLWELL 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
R++L L G G +G V + + + VAIK + + D + RE
Sbjct: 333 KRDNLLIADIEL--GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQI 389
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQL 669
+ +P I+ ++ + + L +V E L+K + + + ++ ++ Q+
Sbjct: 390 MHQL-DNPYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 445
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 723
G+ Y+ +HR+L N+L+ KI D GL+++L Y A
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWP 502
Query: 724 -RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+WY APE I+ R+++ D+WS G + E L
Sbjct: 503 LKWY-APEC-INFRKFSSRSDVWSYGVTMWEAL 533
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 65/284 (22%), Positives = 105/284 (36%), Gaps = 71/284 (25%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT-- 606
RE+L+ K G GA+G V A VA+K + E ++R
Sbjct: 43 PRENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREAL 95
Query: 607 YREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK-------- 655
E+ + H NI+ +L + +Y++FEY DL +R K
Sbjct: 96 MSELKMMTQLGSHENIVNLL----GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 656 ----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699
+L + +Q+ G+ ++ +HRDL N+L+ +
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 211
Query: 700 KIGDLGLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILA 752
KI D GLAR + Y+ +W APE + YT D+WS G +L
Sbjct: 212 KICDFGLARDIMSDS----NYVVRGNARLPVKWM-APE-SLFEGIYTIKSDVWSYGILLW 265
Query: 753 EM--LQSKPLFPGASTSHQLQLIVNLVR-----PNPPHA-DKFY 788
E+ L P +PG L++ P +A ++ Y
Sbjct: 266 EIFSLGVNP-YPGIPVDANF---YKLIQNGFKMDQPFYATEEIY 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-25
Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 27/242 (11%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YR 608
RE ++ L + G+G +G V++ +N VAIK +D+ R +
Sbjct: 388 QRERIE----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQ 440
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYI 665
E L ++ F HP+I+ ++ + + ++++ E +L ++ L +
Sbjct: 441 EALTMRQF-DHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IAT 723
+QL L+Y+ + + +HRD+ N+L+ + +K+GD GL+R + DS +
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNP 781
+W APE I+ RR+T D+W G + E+L KP F G + + I N R
Sbjct: 557 KWM-APES-INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPM 613
Query: 782 PH 783
P
Sbjct: 614 PP 615
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 51/229 (22%)
Query: 562 QINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFL 613
I L E G+GA+G V+ A + +K VA+K + EA +++ R RE L
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELL 97
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR----------------D 654
+H +I+ V + L +VFEYM + DLN+ +R
Sbjct: 98 TML-QHQHIVRFF----GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 655 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714
L + + Q+ G+ Y+ +HRDL N L+ + +KIGD G++R +
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-- 210
Query: 715 ECLTEY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
T+Y + RW PE I R++T D+WS G +L E+
Sbjct: 211 ---TDYYRVGGRTMLPIRWM-PPES-ILYRKFTTESDVWSFGVVLWEIF 254
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 75/336 (22%), Positives = 131/336 (38%), Gaps = 25/336 (7%)
Query: 461 LDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGELE---KEKTMKEL-- 515
LD + + +++R L L + + V ++ K+L
Sbjct: 84 LDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQ 143
Query: 516 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYG 574
EL L ++ S + L S R + +K Q + + + GKG +G
Sbjct: 144 ELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT-----KNTFRQYRVLGKGGFG 198
Query: 575 IVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631
V + + A KK+ + R ++IL ++++ Y
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL---EKVNSRFVVSL--AYAY 253
Query: 632 VNNKDLYVVFEYMEN-DLN---KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687
L +V M DL + + + ++C GL +H ++++RDLK
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 688 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 747
P NIL+D I+I DLGLA + + + + T Y APE++ N RYT D W+L
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV-KNERYTFSPDWWAL 371
Query: 748 GCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
GC+L EM+ + F + + + LV+ P
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 33/224 (14%), Positives = 53/224 (23%), Gaps = 34/224 (15%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G ++A D + VA+ + + Q T L L P + +LD
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLD 98
Query: 628 IYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ VV E++ L +V V M L H V
Sbjct: 99 V--VHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
PS + + + + DI
Sbjct: 156 HPSRVRVSIDGDVVLAYPA--------------------TMPDA--------NPQDDIRG 187
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790
+G L +L ++ P A L P
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 561 QQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILF 612
+ ++E G+ +G VYK + Q VAIK + + R E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD---KAEGPLREEFRHEAML 65
Query: 613 LKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR---------------- 653
+HPN++ +L V ++ L ++F Y + DL++ +
Sbjct: 66 RARL-QHPNVVCLL----GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 654 -DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712
L+ +++ Q+ G+ Y+ + V+H+DL N+L+ ++KI DLGL R +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 713 SKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ Y RW APE I +++ DIWS G +L E+
Sbjct: 181 A----DYYKLLGNSLLPIRWM-APEA-IMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-25
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 54/237 (22%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-------DKNNKQYVAIKKIFEAFRNKTDAQRT 606
R+ L L K G+GA+G V A N VA+K + + T+ +
Sbjct: 67 PRDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLS 119
Query: 607 --YREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-------- 653
E+ +K +H NII +L + LYV+ EY +L + ++
Sbjct: 120 DLISEMEMMKMIGKHKNIINLL----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 654 ---------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704
++ L + +Q+ G+ Y+ + K +HRDL N+L+ + +KI D
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 235
Query: 705 GLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
GLAR + Y T +W APE L +R YTH D+WS G +L E+
Sbjct: 236 GLARDIHHID----YYKKTTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEI 286
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 52/228 (22%), Positives = 88/228 (38%), Gaps = 34/228 (14%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+GA+ V K Q A+K + + R + R R++L I +
Sbjct: 70 GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL---VNGDRRWITQL 126
Query: 626 LDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 680
+ + LY+V EY L+K + + R+ + ++ + +H
Sbjct: 127 H--FAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------EYIATRWYRAPEILI 733
+HRD+KP NIL+D+ I++ D G L + +Y+ +PEIL
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL------SPEILQ 236
Query: 734 S------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+ Y D W+LG EM + F ST+ IV+
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 59/259 (22%), Positives = 112/259 (43%), Gaps = 56/259 (21%)
Query: 561 QQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILF 612
++I + +E G+G++G+VY+ + VAIK + E + +R E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASV 81
Query: 613 LKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-----------DKILK 658
+K F +++ +L V + V+ E M DL +R
Sbjct: 82 MKEF-NCHHVVRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 659 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718
+ + ++ +G++Y++A K +HRDL N ++ + ++KIGD G+ R + + T
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----T 191
Query: 719 EYIATRWYR------------APEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGA 764
+Y YR +PE L + +T + D+WS G +L E+ L +P + G
Sbjct: 192 DY-----YRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGL 244
Query: 765 STSHQLQLIVNLVRPNPPH 783
S L+ ++ + P
Sbjct: 245 SNEQVLRFVMEGGLLDKPD 263
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 55/268 (20%)
Query: 562 QINLLKE-GKGAYGIVYKAY-------DKNNKQYVAIKKIFEAFRNKTDAQRT--YREIL 611
++ L K G+G +G V A VA+K + + + T+ + E+
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEME 138
Query: 612 FLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--------------- 653
+K +H NII +L + LYV+ EY +L + +R
Sbjct: 139 MMKMIGKHKNIINLL----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 654 --DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711
++ + + +QL G+ Y+ + K +HRDL N+L+ ++ +KI D GLAR ++
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 712 DSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFP 762
+ Y T +W APE L +R YTH D+WS G ++ E+ L P +P
Sbjct: 255 NID----YYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YP 307
Query: 763 GASTSHQLQLIVNLVR-PNPPHA-DKFY 788
G +L+ R P + ++ Y
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELY 335
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 58/251 (23%), Positives = 99/251 (39%), Gaps = 53/251 (21%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT-- 606
R +LQ K G GA+G V +A ++ VA+K + ++
Sbjct: 44 PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS---TAHADEKEAL 96
Query: 607 YREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK-------- 655
E+ + +H NI+ +L + + V+ EY DL +R K
Sbjct: 97 MSELKIMSHLGQHENIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 656 -------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708
+ + Q+ G++++ + +HRD+ N+L+ KIGD GLAR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 709 SLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKP 759
+ + YI +W APE + + YT D+WS G +L E+ L P
Sbjct: 213 DIMNDS----NYIVKGNARLPVKWM-APESIF-DCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 760 LFPGASTSHQL 770
+PG + +
Sbjct: 267 -YPGILVNSKF 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/232 (24%), Positives = 87/232 (37%), Gaps = 52/232 (22%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRT--YRE 609
D D++ G+G +G V KA + AIK++ E + E
Sbjct: 23 DWNDIK----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGE 75
Query: 610 ILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR------------- 653
+ L HPNII +L + LY+ EY + +L +R
Sbjct: 76 LEVLCKLGHHPNIINLL----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 654 ----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709
L + + + G+ Y+ + +HRDL NIL+ ++ KI D GL+R
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191
Query: 710 LSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM 754
Y+ RW A E L YT + D+WS G +L E+
Sbjct: 192 QE-------VYVKKTMGRLPVRWM-AIESLN-YSVYTTNSDVWSYGVLLWEI 234
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 530 SKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYV 588
+E + E + + Q+ RED + +LK G+GA+G V KN +
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFE----ILKVIGRGAFGEVAVVKLKNADKVF 102
Query: 589 AIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645
A+K + + R +T R R++L I T+ Y ++ +LY+V +Y
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVL---VNGDSKWITTLH--YAFQDDNNLYLVMDYYV 157
Query: 646 -----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIK 700
L+K + L + R+ + ++ + +H +HRD+KP NIL+D + I+
Sbjct: 158 GGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
Query: 701 IGDLGLARSLSDSKECLT-------EYIATRWYRAPEILISN----RRYTHHVDIWSLGC 749
+ D G L + + +YI +PEIL + RY D WSLG
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYI------SPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 750 ILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPHADKF 787
+ EML + F S I+N P
Sbjct: 270 CMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRH 619
+ LK GKG +G V +K +Y A+K K +++ T +L RH
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL---QNTRH 64
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
P + + Y + L V EY +L + R+++ + R+ ++ + L Y+H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEI 731
+ V++RD+K N+++DK IKI D GL KE +++ + Y APE+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPEV 176
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
L + Y VD W LG ++ EM+ + F +LI+
Sbjct: 177 L-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 18/214 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
G G++G V+ ++N +Y A+K K R K + T E L L HP II M
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIV-THPFIIRMW 72
Query: 627 DIYKAVNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
++ + + ++++ +Y+E +L ++R + + ++ ++C L Y+H+ +++R
Sbjct: 73 GTFQ--DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR 130
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAPEILISNRRYTHH 741
DLKP NIL+DK+ IKI D G A+ + D C T +YI APE+ +S + Y
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEV-VSTKPYNKS 183
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+D WS G ++ EML F ++T + I+N
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIK-----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 623
GKG++G V + K+ A+K K E RN+ +I+ HP ++
Sbjct: 24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--RNEVRNVFKELQIM---QGLEHPFLV 78
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
+ Y + +D+++V + + DL + ++ K+ ++ + +L L Y+ ++
Sbjct: 79 NL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-----EYIATRWYRAPEILISNR 736
+HRD+KP NIL+D+ + I D +A L + T Y+ APE+ S +
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM------APEMFSSRK 190
Query: 737 R--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
Y+ VD WSLG E+L+ + + S++ +++
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRH 619
++ GKG++G V A K A+K + + + + T + IL L H
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NH 83
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
P + + L+ V E++ DL + + + + R+ ++ + L ++H
Sbjct: 84 PFLTQLF--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEI 731
+++RDLK N+L+D K+ D G+ KE + + T Y APEI
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGM------CKEGICNGVTTATFCGTPDYIAPEI 195
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
L Y VD W++G +L EML F + + I+N
Sbjct: 196 L-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 68/224 (30%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRH 619
L K GKG++G V+ A K Q+ AIK K + D + T E L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIH 677
P + M ++L+ V EY+ DL I + ++ GL ++H
Sbjct: 78 PFLTHMF--CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEI 731
+ +++RDLK NIL+DK IKI D G+ KE + T Y APEI
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGM------CKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
L ++Y H VD WS G +L EML + F G I
Sbjct: 190 L-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRH 619
N L GKG++G V + K + A+K + + + + + +L L +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KP 80
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIH 677
P + + LY V EY+ DL + + K+ H + ++ GL ++
Sbjct: 81 PFLTQLH--SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEI 731
+ +++RDLK N+++D IKI D G+ KE + + + T+ Y APEI
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 732 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+ + + Y VD W+ G +L EML + F G Q I+
Sbjct: 193 I-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 4e-23
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM 625
GKG++G V + K + A+K + + + + + +L L + P + +
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFLTQL 407
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 683
LY V EY+ DL + + K+ H + ++ GL ++ + +++
Sbjct: 408 H--SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISNRR 737
RDLK N+++D IKI D G+ KE + + + T+ Y APEI+ + +
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAPEII-AYQP 518
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
Y VD W+ G +L EML + F G Q I+
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/254 (22%), Positives = 97/254 (38%), Gaps = 48/254 (18%)
Query: 562 QINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFL 613
I L++ G GA+G VY+ + + VA+K + E ++ E L +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALII 87
Query: 614 KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--------DKILKDVHI 662
F H NI+ + V + +++ E M DL +R L + +
Sbjct: 88 SKF-NHQNIVRCI----GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLTE 719
++ + G Y+ +HRD+ N L+ KIGD G+AR +
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----AS 197
Query: 720 YIAT--------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQ 769
Y +W PE + +T D WS G +L E+ L P +P S
Sbjct: 198 YYRKGGCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEV 254
Query: 770 LQLIVNLVRPNPPH 783
L+ + + R +PP
Sbjct: 255 LEFVTSGGRMDPPK 268
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 55/282 (19%), Positives = 114/282 (40%), Gaps = 29/282 (10%)
Query: 523 KHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-----NLLKE-GKGAYGIV 576
+ S + + G E + + +++ LLK G GAYG V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 577 Y---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631
+ K + + A+K + +A + + T E L+ ++ P ++T+ Y
Sbjct: 71 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYAF 128
Query: 632 VNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 689
L+++ +Y+ +L + + + + ++ + ++ L ++H +++RD+K
Sbjct: 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 690 NILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-------YRAPEILISNRR-YTHH 741
NIL+D + + + D GL SKE + + + Y AP+I+ +
Sbjct: 189 NILLDSNGHVVLTDFGL------SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
VD WSLG ++ E+L F + I + + P
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 61/243 (25%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT-- 606
R++L L K G+G +G V KA + VA+K + E N + ++
Sbjct: 21 PRKNLV----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDL 73
Query: 607 YREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR---------- 653
E LK HP++I + + L ++ EY + L +R
Sbjct: 74 LSEFNVLKQVN-HPHVIKLY----GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 654 ---------------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS 698
++ L + +Q+ G+ Y+ K++HRDL NIL+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 699 IKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCIL 751
+KI D GL+R + + Y+ +W A E L + YT D+WS G +L
Sbjct: 189 MKISDFGLSRDVYEED----SYVKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLL 242
Query: 752 AEM 754
E+
Sbjct: 243 WEI 245
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 1e-22
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 28/228 (12%)
Query: 564 NLLK-EGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTY--REILFLKS 615
LL+ GKG YG V+ K N + A+K + +A RN D T R IL
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL---E 76
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGL 673
+HP I+ + IY LY++ EY+ +L ++ R+ I + + + ++ L
Sbjct: 77 EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 674 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECLT-----EYIATRWYR 727
++H +++RDLKP NI+++ +K+ D GL + S+ D T EY+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM------ 188
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
APEIL + VD WSLG ++ +ML P F G + + I+
Sbjct: 189 APEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRH 619
+ LK GKG++G V A K + + A+K K + + + R +L +H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV--KH 98
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIRDKILKDVHIRYIMFQLCNGLSYI 676
P ++ + + LY V +Y+ N +L + R++ + R+ ++ + L Y+
Sbjct: 99 PFLVGL--HFSFQTADKLYFVLDYI-NGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPE 730
H+ +++RDLKP NIL+D I + D GL KE + T Y APE
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGL------CKENIEHNSTTSTFCGTPEYLAPE 209
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
+L + Y VD W LG +L EML P F +T+ I+N
Sbjct: 210 VL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 57/238 (23%)
Query: 561 QQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILF 612
I +++ G+GA+G V++A VA+K + E + + RE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAAL 103
Query: 613 LKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR---------------- 653
+ F +PNI+ +L V K + ++FEYM DLN+ +R
Sbjct: 104 MAEF-DNPNIVKLL----GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 654 ---------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704
L I Q+ G++Y+ K +HRDL N L+ ++ +KI D
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 705 GLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
GL+R++ + Y A RW PE + RYT D+W+ G +L E+
Sbjct: 219 GLSRNIYSAD----YYKADGNDAIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIF 270
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 24/268 (8%)
Query: 515 LELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI-----NLLK-E 568
+ H D+ + E+L G ++ ++ + +LL+
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G+Y V K + A++ + E + D E + HP ++ +
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 628 IYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
L+ V EY+ DL + R + L + H R+ ++ L+Y+H +++RD
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISNRRYT 739
LK N+L+D IK+ D G+ KE L T Y APEIL Y
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEIL-RGEDYG 231
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTS 767
VD W+LG ++ EM+ + F +S
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSS 259
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-22
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 564 NLLK-EGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPN 621
+LL+ G+G+Y V K + A+K + E + D E + HP
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
++ + L+ V EY+ DL + R + L + H R+ ++ L+Y+H
Sbjct: 72 LVGLH--SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILI 733
+++RDLK N+L+D IK+ D G+ KE L T Y APEIL
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEIL- 182
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 767
Y VD W+LG ++ EM+ + F +S
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 48/255 (18%)
Query: 561 QQINLLKE-GKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILF 612
+ I L++ G GA+G VY+ + + VA+K + E ++ E L
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALI 127
Query: 613 LKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--------DKILKDVH 661
+ F H NI+ + V + +++ E M DL +R L +
Sbjct: 128 ISKF-NHQNIVRCI----GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 662 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLT 718
+ ++ + G Y+ +HRD+ N L+ KIGD G+AR +
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----A 237
Query: 719 EY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSH 768
Y + +W PE + +T D WS G +L E+ L P +P S
Sbjct: 238 GYYRKGGCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQE 294
Query: 769 QLQLIVNLVRPNPPH 783
L+ + + R +PP
Sbjct: 295 VLEFVTSGGRMDPPK 309
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 564 NLLK-EGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQ 617
LLK G+G++G V+ K + +Q A+K + +A D RT R+IL
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL---VEV 83
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSY 675
HP I+ + Y LY++ +++ DL ++ ++ + + +++ + +L L +
Sbjct: 84 NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAP 729
+H+ +++RDLKP NIL+D+ IK+ D GL SKE + Y AP
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGL------SKESIDHEKKAYSFCGTVEYMAP 195
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
E++ + R +T D WS G ++ EML F G + +I+
Sbjct: 196 EVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-21
Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 507 EKEKTMKELE-----LKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQ 561
E+E+ ++ LK A S S S +E EV K ++ +
Sbjct: 95 EREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN------ 148
Query: 562 QINLLK-EGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQ 617
+ LK GKG +G V +K +Y A+K + + +++ T +L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL---QNS 205
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQLCNGLSY 675
RHP + + Y + L V EY +L + R+++ + R+ ++ + L Y
Sbjct: 206 RHPFLTALK--YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 676 IHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRA 728
+H+ K V++RDLK N+++DK IKI D GL KE + + + Y A
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLA 317
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 775
PE+L + Y VD W LG ++ EM+ + F +LI+
Sbjct: 318 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-19
Identities = 56/357 (15%), Positives = 129/357 (36%), Gaps = 20/357 (5%)
Query: 108 KLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQ 167
L ++ + EL K ++ EL+ LE + L +E LQ K+
Sbjct: 848 PLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKE----LEQKHTQLCEEKNLLQEKLQA 903
Query: 168 ERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALN 227
E +A + L + Q L L + R + E ++ L + ++++ L
Sbjct: 904 ETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQM--LDLE 961
Query: 228 TELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRM 287
+LE + +L + K+ +E + + + + + + +
Sbjct: 962 EQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNL- 1020
Query: 288 VNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQI 347
E K L L KH S +S E L ++ + +K +L + DL +QI
Sbjct: 1021 ----AEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQI 1076
Query: 348 NLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAM 407
L+ ++ + + + +++ A+ S + + L++ L ++
Sbjct: 1077 AELQA--QIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHISDLQEDLES 1134
Query: 408 LREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDER 464
+ A+ E++ L +++ L+ +LE + + ++ D++
Sbjct: 1135 EKAARNKAEKQKRDLSE-------ELEALKTELEDTLDTTATQQELRGSDYKDDDDK 1184
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-19
Identities = 61/365 (16%), Positives = 151/365 (41%), Gaps = 32/365 (8%)
Query: 20 QANGELKDLLERERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLK 79
++ ++ + E+ + +ERQ++ + + + + T L +E L++ L
Sbjct: 850 LKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYA 909
Query: 80 ESQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVE 139
E++ + K++ E +++ +M +++ E E + +L+ + ++ +Q +++
Sbjct: 910 EAEEMRVRLAAKKQELE---EILHEMEARIEEEEERSQQLQAEKKKM-------QQQMLD 959
Query: 140 LQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHR 199
L+ L E R LQ E T KI + + + +L + L +
Sbjct: 960 LEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVS----- 1014
Query: 200 ELQLAEDNRHLGEKVSSLEKE-CRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 258
L + EK +L K + +++ +ELE +E + ++ + K LE E
Sbjct: 1015 --DLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK---LEGES 1069
Query: 259 ASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESL 318
+ L ++ QAQ + + Q ++ + +A++ +++ + ES
Sbjct: 1070 SDLHEQIAELQAQIAE-----LKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESH 1124
Query: 319 LSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKF 378
+S+ +E K + ++ K + DL +++ L+ ELE + + ++ + +
Sbjct: 1125 ISDLQEDLESEKAARNKAEKQKRDLSEELE------ALKTELEDTLDTTATQQELRGSDY 1178
Query: 379 SLQSD 383
D
Sbjct: 1179 KDDDD 1183
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-16
Identities = 79/440 (17%), Positives = 182/440 (41%), Gaps = 33/440 (7%)
Query: 133 GEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEG--RLQA-L 189
G+ + +LA LE ERD +V + ++ ++LE +Q +
Sbjct: 769 GQSKIFFRTGVLAHLEEERDLKITDVIIAFQAQCRGYLARKAFAKRQQQLESIFCIQYNV 828
Query: 190 NTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGE 249
+ + + L + + +E +QA + EL+R K R+ + + + L +
Sbjct: 829 RSFMNVXHWPWMXLF---FXIXPLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQ 885
Query: 250 KVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHR 309
K + L +E L +L+A + E+ A E + R+ K++ EI+ E+
Sbjct: 886 KHTQLCEEKNLLQEKLQA-----ETELYAEAEEMRVRLAAKKQELEEILHEM-------- 932
Query: 310 SDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSK-TLQS 368
E+ + +ER + ++ + DL++Q+ + RQ+L+ K T
Sbjct: 933 ------EARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEA---ARQKLQLEKVTADG 983
Query: 369 QVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSV 428
++++ + ++ + T E L+ R L+ +A E +N+ + +K ++ S
Sbjct: 984 KIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISE 1043
Query: 429 EDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVAR 488
++++K+ + + + + ++ +L E++ E I EL+ + LQ A+AR
Sbjct: 1044 LEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALAR 1103
Query: 489 ADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKS 548
+ E ++ A + + ELE + +L++ + ++ + E + E K
Sbjct: 1104 LEDETSQKNNALKKIRELESHIS----DLQEDLESEKAARNKAEKQKRDLSEELEALKTE 1159
Query: 549 IDQLMKDREDLQQQINLLKE 568
++ + Q+ +
Sbjct: 1160 LEDTLDTTATQQELRGSDYK 1179
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 6e-10
Identities = 34/206 (16%), Positives = 83/206 (40%), Gaps = 18/206 (8%)
Query: 919 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSN 978
E + K + + + + + ++ + + ++L K+R+ L+++++ L L +
Sbjct: 966 EEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEE 1025
Query: 979 SSEEMEKLHKQLKQ------EQLLKAQAVNKLAEIMNRK---------DINTTCKGKSKA 1023
++ + KL + + +L K + + E + RK + + +
Sbjct: 1026 KAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAE 1085
Query: 1024 SSADVRKKEKECRKLQQELTQEREKFNQVVVK---CQKELQELQSQVVEENTSKLKLQME 1080
A + KKE+E + L E + N + K + + +LQ + E ++ K + +
Sbjct: 1086 LKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHISDLQEDLESEKAARNKAEKQ 1145
Query: 1081 LDSKDSEIEQLQGKLAALGSETASLS 1106
E+E L+ +L TA+
Sbjct: 1146 KRDLSEELEALKTELEDTLDTTATQQ 1171
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-09
Identities = 30/189 (15%), Positives = 81/189 (42%), Gaps = 10/189 (5%)
Query: 919 ELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSN 978
E ++ + +++ + + + +E+ + + + +L ++ +I +++++
Sbjct: 938 EEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDI---LI 994
Query: 979 SSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKECRKL 1038
++ KL K+ K + + LAE + T K K ++ +++ + K+ K
Sbjct: 995 MEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKS 1054
Query: 1039 QQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAAL 1098
+QEL + + K + E +L Q+ E +L+ +L K+ E++ +L
Sbjct: 1055 RQELEKIKRKL-------EGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDE 1107
Query: 1099 GSETASLSS 1107
S+ +
Sbjct: 1108 TSQKNNALK 1116
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 61/306 (19%), Positives = 113/306 (36%), Gaps = 43/306 (14%)
Query: 792 KSKHEREKFNQVVVKCQ---KELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAA 848
E ++ K Q + L E+++++ EE +LQ E ++ L+ +L
Sbjct: 907 LYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEE 966
Query: 849 LGSETASLSSADVENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSE 908
+ L V D + ++E + I QN K +K S E
Sbjct: 967 EEAARQKLQLEKVTADG---KIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEE 1023
Query: 909 NDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINL 968
+K L L KH S +S E L ++ + +K +L + DL +QI
Sbjct: 1024 EEKAK-----NLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAE 1078
Query: 969 LKEEL----RKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKAS 1024
L+ ++ + + EE++ +L+ E K A+ K+ E+
Sbjct: 1079 LQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIREL----------------- 1121
Query: 1025 SADVRKKEKECRKLQQELTQEREKFNQV---VVKCQKELQELQSQVVEENTSKLKLQMEL 1081
E LQ++L E+ N+ +EL+ L+++ +E+ Q EL
Sbjct: 1122 -------ESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTE-LEDTLDTTATQQEL 1173
Query: 1082 DSKDSE 1087
D +
Sbjct: 1174 RGSDYK 1179
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 27/154 (17%), Positives = 73/154 (47%), Gaps = 3/154 (1%)
Query: 954 QLMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDI 1013
+ ++ + +++ KE +K+ +E+E+ H QL +E+ L + + E+ +
Sbjct: 854 RQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAE- 912
Query: 1014 NTTCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTS 1073
+ + A ++ + E +E + ++ K Q+++ +L+ Q+ EE +
Sbjct: 913 --EMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAA 970
Query: 1074 KLKLQMELDSKDSEIEQLQGKLAALGSETASLSS 1107
+ KLQ+E + D +I++++ + + + L+
Sbjct: 971 RQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTK 1004
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 35/202 (17%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 925 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEELRK-SSNSSEEM 983
+ ++ +K+ L KER+ + + +L + L ++ NLL+E+L+ + +E
Sbjct: 853 TRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAE 912
Query: 984 EKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKEKECRKLQ---Q 1040
E + ++Q L+ A I ++ + + A+ +K +++ L+ +
Sbjct: 913 EMRVRLAAKKQELEEILHEMEARIEEEEERS-------QQLQAEKKKMQQQMLDLEEQLE 965
Query: 1041 ELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGS 1100
E R+K V ++++++ ++ KL E + + L LA
Sbjct: 966 EEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEE 1025
Query: 1101 ETASLSSADVENDESYVQDEVR 1122
+ +L+ +++ + EVR
Sbjct: 1026 KAKNLTKLKNKHESMISELEVR 1047
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 38/220 (17%), Positives = 80/220 (36%), Gaps = 19/220 (8%)
Query: 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAALGSET 853
+ R+K V ++++++ ++ KL E + + L LA +
Sbjct: 968 EAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKA 1027
Query: 854 ASLSSA----DVENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYV--VVSSKKIIFYNS 907
+L+ + E V+ + E K K G + + I +
Sbjct: 1028 KNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQI---A 1084
Query: 908 ENDKQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDY----------KKSIDQLMK 957
E Q E EL+ +A+ + S K + L +E E K + ++ K
Sbjct: 1085 ELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHISDLQEDLESEKAARNKAEK 1144
Query: 958 DREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQEQLLK 997
+ DL +++ LK EL + +++ ++L ++ K
Sbjct: 1145 QKRDLSEELEALKTELEDTLDTTATQQELRGSDYKDDDDK 1184
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 4e-04
Identities = 37/189 (19%), Positives = 67/189 (35%), Gaps = 14/189 (7%)
Query: 917 ELELKDLMAKHRSDLSSKESL-------LSNGKEREVDYKKSIDQLMKDREDLQQQINLL 969
E ELK+L KH K L E E + + + E L + +
Sbjct: 877 EAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARI 936
Query: 970 KEELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVR 1029
+EE +S E +K+ +Q+ L+ Q + A + T GK K D+
Sbjct: 937 EEEEERSQQLQAEKKKMQQQMLD---LEEQLEEEEAARQKLQLEKVTADGKIKKMEDDIL 993
Query: 1030 KKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 1089
E + KL +E E+ + + L E + + K K + + + ++
Sbjct: 994 IMEDQNNKLTKERKLLEERVSDL----TTNLAEEEEKAKNLTKLKNKHESMISELEVRLK 1049
Query: 1090 QLQGKLAAL 1098
+ + L
Sbjct: 1050 KEEKSRQEL 1058
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 9e-18
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFLKSFQRHPNI 622
N+L G+G +G VYK + VA+K++ E + Q +T E+ + S H N+
Sbjct: 36 NIL--GRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQT--EVEMI-SMAVHRNL 89
Query: 623 ITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRY-IMFQLCNGLSYI 676
+ + + L V+ YM N L + + D R I GL+Y+
Sbjct: 90 LRLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 677 H-AC--KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-TRWYRAPEIL 732
H C K++HRD+K +NIL+D+ +GD GLA+ + +T + T + APE L
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207
Query: 733 ISNRRYTHHVDIWSLGCILAEML 755
+ + + D++ G +L E++
Sbjct: 208 STGKS-SEKTDVFGYGVMLLELI 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 1e-17
Identities = 91/646 (14%), Positives = 209/646 (32%), Gaps = 159/646 (24%)
Query: 428 VEDLQMKELQDQLETEQYFSTLYKTQAHELKEELD--ERSRNILE-LEEERGDLTHRLQL 484
V++ K++QD + S L K + + D + + L ++ ++ +
Sbjct: 30 VDNFDCKDVQDMPK-----SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 485 AVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVD 544
V R + + L I E ++ +M + + R L + + + + V
Sbjct: 85 EVLRINYKFLMSPIKTEQ-----RQPSMMT----RMYIEQRDRLYNDNQVFA---KYNVS 132
Query: 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
+ +L + +L+ N+L +G G K +VA+ + +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSG----------KTWVAL----DVCLSYKVQC 178
Query: 605 RTYREI--LFLKSFQRHPNIITMLD--IYKAVNN--------KDLYVVFEYMENDLNKVI 652
+ +I L LK+ ++ ML +Y+ N ++ + ++ +L +++
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 653 RDK-------ILKDV----HIRYIMFQLCNGLSYIHACKVM--HRDLKPSNILI-DKSCS 698
+ K +L +V CK++ R + ++ L +
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLS----------CKILLTTRFKQVTDFLSAATTTH 288
Query: 699 IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758
I + + + + K L +Y+ R P E+L +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR----------------------EVLTTN 326
Query: 759 PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH-EREKFNQVVVKCQKELQ--ELQ 815
P +L +I +R D + KH +K ++ L+ E +
Sbjct: 327 PR--------RLSIIAESIRDGLATWDNW------KHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 816 SQ-----VVEEN---TSKLKLQMEL--DSKDSEIEQLQGKLAALGSETASLSSADVENDE 865
V + + L L + + D S++ + KL SL +
Sbjct: 373 KMFDRLSVFPPSAHIPTIL-LSL-IWFDVIKSDVMVVVNKL-----HKYSLVEKQPKEST 425
Query: 866 SYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKII-FYNSENDKQNTDPELELKD-- 922
+ LE V + N+ + H + I+ YN + D D
Sbjct: 426 ISIPSIYLELKVKLENEYAL--H-----------RSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 923 --------LMAKHRSDLSSK-ESLLSNGK--EREVDYKKSIDQLMKDREDLQQQINLLKE 971
L + + + + + E+++ + + + QQ+ K
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 972 ELRKSSNSSEEMEK-LHKQLKQ--EQLLKAQAVN--KLAEIMNRKD 1012
+ + E + + L + E L+ ++ + ++A +M +
Sbjct: 533 YICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIA-LMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 85.7 bits (211), Expect = 6e-17
Identities = 82/664 (12%), Positives = 194/664 (29%), Gaps = 182/664 (27%)
Query: 509 EKTMKELELKDLMAKHRSDLSSKE-SLLSNGKEREVDYKKSIDQLMKDREDLQQQI--NL 565
+ + + KD+ +S LS +E + K+ + L+ +E++ Q+ +
Sbjct: 27 DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 566 LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK--TDAQR-----TYREILF------ 612
L+ Y + +Q + +++ R++ D Q R +
Sbjct: 87 LRIN---YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA 143
Query: 613 LKSFQRHPNIIT--MLDIYKAVNNKDLYVVFEYMENDL-NKVIRDKILKDV---HIRYIM 666
L + N++ +L K + V ++ I ++
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTW---------------VALDVCLSYKVQCKMDFKIFWLN 188
Query: 667 FQLCN--GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 724
+ CN K++++ D S +IK+ + + L + ++
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL-------RIHSIQAELRRLLKSK 241
Query: 725 WYRAPEILISNRRYTHHV--DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
Y L+ V ++ + A L K L T+ Q+ L
Sbjct: 242 PY--ENCLL--------VLLNVQNAKAWNAFNLSCKILL----TTRFKQVTDFLSAATTT 287
Query: 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQL 842
H H E++ L + ++ L ++ L
Sbjct: 288 H-------ISLDHHSMTLT------PDEVKSLLLKYLDCRPQDLPREV-----------L 323
Query: 843 QGKLAALGSETASLSSADVENDESYVQDSRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKI 902
L S+ + + + + + W K I
Sbjct: 324 TTNPRRL-----SIIAESIRDGL-----ATWDNW---------------KHVNCDKLTTI 358
Query: 903 IFYNSENDKQNTDPELELKDL---MAKHRSDLSSKESLLS----NGKEREVD------YK 949
I E+ +P E + + ++ LLS + + +V +K
Sbjct: 359 I----ESSLNVLEPA-EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 950 KSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQE---------------- 993
S+ + K ++ I + EL+ E LH+ +
Sbjct: 414 YSL--VEKQPKESTISIPSIYLELKV---KLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 994 -----------QLLKAQAVNKLAEI---------MNRKDINTTCKGKSKASSADVRKKEK 1033
L + ++ + +K + + + S + +
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL---Q 525
Query: 1034 ECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI----- 1088
+ + + + K+ ++V L +++ ++ + L L++ L ++D I
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL-LRIALMAEDEAIFEEAH 584
Query: 1089 EQLQ 1092
+Q+Q
Sbjct: 585 KQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 2e-16
Identities = 108/692 (15%), Positives = 205/692 (29%), Gaps = 182/692 (26%)
Query: 63 EMGQLE-KNLTILRH---DLKESQRRADNESETK---KKAEVNLQVISDMHEKLKTEAET 115
E G+ + + IL ++ D + K K E++ +I K
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID-HII-----MSKDAVSG 63
Query: 116 ATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQA 175
RL S E+MV + +E + L+ L + I E+ +
Sbjct: 64 TLRL------FWTLLSKQEEMVQKF--------VE-EVLRINYKFLMSPIKTEQRQPSMM 108
Query: 176 VNLHKELEGRLQALNTEL-ERNKHRELQLAEDNRHLGEKVSSLEKECRL----------Q 224
++ E RL N + N R + L + + L +
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK----LRQALLELRPAKNVLIDGVLGSGKT 164
Query: 225 ALNTELERNKHRELQLAEDNR----HLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHE 280
+ ++ + ++Q D + +L C S L+ Q Q + +
Sbjct: 165 WVALDVCLSY--KVQCKMDFKIFWLNLKN--------CNSPETVLEMLQKLLYQ-IDPNW 213
Query: 281 ETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDR 340
++ N + I EL+ L+ + LL V K+ +
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPY----ENCLLV---LLNVQNAKAWNAF---- 262
Query: 341 EDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQSDLSVQT-SEAAHLKAREE 399
+L +I LL + K + + SL T E L +
Sbjct: 263 -NLSCKI-LL---------TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK-- 309
Query: 400 QLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQM--KELQDQLETEQYFSTLYKTQAHEL 457
L L + + L + + ++D L T +K +
Sbjct: 310 YLDCRPQDLPREVLTT----NPRR-------LSIIAESIRDGLATWDN----WKHVNCDK 354
Query: 458 KEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEETVGEL-------EKEK 510
+ E S N+LE E R +L+V + I + + +
Sbjct: 355 LTTIIESSLNVLEPAEYR---KMFDRLSVFPPSAH-----IPTILLSLIWFDVIKSDVMV 406
Query: 511 TMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGK 570
+ +L L+ K + + S+ S ++ K ++ + L + I
Sbjct: 407 VVNKLHKYSLVEKQPKESTI--SIPS----IYLELKVKLE----NEYALHRSI------V 450
Query: 571 GAYGIVYKAYDKNNK----------QYVA--IKKI-----FEAFRNKTDAQRTYREILFL 613
Y I K +D ++ ++ +K I FR + + FL
Sbjct: 451 DHYNI-PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR------MVFLDFRFL 503
Query: 614 KSFQRHP-----------NIITMLDIYKA--VNNKDLYVVFEYMENDL--------NKVI 652
+ RH N + L YK +N Y E + N + +I
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY---ERLVNAILDFLPKIEENLI 560
Query: 653 RDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
K + I +M + + + A K + R
Sbjct: 561 CSKYTDLLRIA-LMAE--DEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-11
Identities = 92/628 (14%), Positives = 186/628 (29%), Gaps = 171/628 (27%)
Query: 642 EYMENDLNKVIRDKILKDVHIRYIMFQLCNGLS---YIHACKVMHRDLKPSNILIDKSCS 698
+Y D+ V D + + + + + LS H + L S
Sbjct: 15 QYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG-TLRLFWTLLS 73
Query: 699 IKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRYTHHVDIWSLGCILAEML 755
+ + + + + +++ + R P + R Y D +
Sbjct: 74 --KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS--MMTRMYIEQRD---------RLY 120
Query: 756 QSKPLFPGASTS-----HQLQLIVNLVRPNPP---HADKFYAGF-KSKHEREKFNQVVVK 806
+F + S +L+ + +RP G K+ V
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV---LGSGKT---------WVA- 167
Query: 807 CQKELQELQSQVVEENTSK----LKLQMELDSKDSEIEQLQGKLAALGSETASLSSADVE 862
L S V+ L L+ +S ++ +E LQ L + S S
Sbjct: 168 ----LDVCLSYKVQCKMDFKIFWLNLK-NCNSPETVLEMLQKLLYQIDPNWTSRS----- 217
Query: 863 NDESYVQDSRLEGWVSIPNKQNIKRHGWKKQY----VV---VSSKKII--FYNS------ 907
D S R+ + ++R K Y +V V + K F S
Sbjct: 218 -DHSSNIKLRIHSI-----QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 908 ENDKQNTDPELELKDLMAKHRSDLSSKESL--LSNGKEREVDYKKSIDQLMKD--REDLQ 963
KQ TD L A + +S L+ + + + K +D +D RE L
Sbjct: 272 TRFKQVTD------FLSAATTTHISLDHHSMTLTPDEVKSL-LLKYLDCRPQDLPREVLT 324
Query: 964 ---QQINLLKEELRKSSNSSEEMEKLHKQLKQEQLLKA--QAVNKLAEIMNR-------- 1010
++++++ E +R + + K + ++L ++N L R
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNW----KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 1011 --KDINTTCKGKS----KASSADVRKKEKECRKLQQELTQEREKFN-------QVVVKCQ 1057
+ S +DV + K L +++ K + + +K +
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK--YSLVEKQPKESTISIPSIYLELKVK 438
Query: 1058 -KELQELQSQVVE----------ENTSKLKL-------------QMELDSKDSEIEQ--- 1090
+ L +V+ ++ L +E + +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 1091 ----LQGKLAALGSETASLSS-----ADVENDESYV--QDEVRSRSVT---------QGD 1130
L+ K+ + + S ++ + Y+ D R V + +
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558
Query: 1131 VIRADAKDIPRIFQLLYAGEG---EARR 1155
+I + D+ RI L+ E EA +
Sbjct: 559 LICSKYTDLLRI-ALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-07
Identities = 73/545 (13%), Positives = 158/545 (28%), Gaps = 157/545 (28%)
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797
+ HH+D E + + +Q + I+ D F F K +
Sbjct: 3 HHHHMDF--------ETGEHQ---------YQYKDIL------SVFEDAFVDNFDCKDVQ 39
Query: 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ-----LQGKLAALGSE 852
+ ++ K +E+ + + + L ++ +++ L+ L S
Sbjct: 40 DMPKSILSK--EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 853 TASLSSADVENDESYV-QDSRLEGWVSIPNKQNIKR----------------------HG 889
+ Y+ Q RL + K N+ R G
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 890 WK---KQYV---VVSSKKI-------IFYNSENDKQNTDPELE-LKDLMAKHRSDLSSKE 935
K +V V S K+ IF+ + + + + LE L+ L+ + + +S+
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 936 SLLSNGKEREVDYKKSIDQLMKDRE--------------------DLQQQI--------- 966
SN K R + + +L+K + +L +I
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 967 -NLLKEELRKSSNSSEEMEKLHKQLKQEQLLKA--QAVNKLAEIMNRKDINTTCKGKSKA 1023
+ L + L + LLK L + +
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--------LTTNPRR 329
Query: 1024 SS--ADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMEL 1081
S A+ ++ +K ++ L+ + + K+ ++ +
Sbjct: 330 LSIIAE-SIRDGLAT-WDNWKHVNCDKLTTIIESSLNVLEPAEYR-------KMFDRLSV 380
Query: 1082 DSKDSEI-EQLQGKLAALGSETASLSSADVENDESYVQDEVRSRSVTQGDVIRADAKD-- 1138
+ I L L+ + + +++D V +++ S+ + K+
Sbjct: 381 FPPSAHIPTIL---LSLIWFD-------VIKSDVMVVVNKLHKYSL-----VEKQPKEST 425
Query: 1139 --IPRIFQLLYAGEGEARRPEDGGAEL----------PAVLRGGDEKPGIIALKGHEFLN 1186
IP I+ L + + L P D P L + + +
Sbjct: 426 ISIPSIYLEL-------KVKLENEYALHRSIVDHYNIPKTFDSDDLIP--PYLDQYFYSH 476
Query: 1187 ISYHM 1191
I +H+
Sbjct: 477 IGHHL 481
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-05
Identities = 60/458 (13%), Positives = 123/458 (26%), Gaps = 148/458 (32%)
Query: 6 LHG----------------FQVDNAIPNG------GQANGELKDLLERERREMSQLEERQ 43
+ G ++V + N + +LE ++ + Q++
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-SPETVLEMLQKLLYQIDPNW 213
Query: 44 RQLSEQYEAVSARETALRDEMGQL------EKNLTILRH----------DLK-------E 80
S+ + R +++ E+ +L E L +L + +L
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 81 SQRRADNESETKKKAEVNLQVISDMHEKLKTEAETATRLRK----QSAELTVAKSAGEQM 136
++ D S + D H T E + L K + +L
Sbjct: 274 FKQVTDFLSAATTT-----HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 137 VVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERN 196
+ +I+A ++ +AT + L +E L L R
Sbjct: 329 RL---SIIAES------IRDGLATW------DNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 197 KHRELQLAEDNRHLGEKV-----------------------SSLEKE-----CRLQALNT 228
L + + H+ + S +EK+ + ++
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 229 EL------ERNKHREL----------------QLAEDN-------RHL-----GEKVSSL 254
EL E HR + D HL E+++
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF 493
Query: 255 EKECASLS-LELKAAQAQYQQEVRAHE-------ETQKSRMVNKEEASVEIVKELKDLMA 306
LE K + K + + + +V + D +
Sbjct: 494 RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 307 KHRSDL-SSKES-----LLSNGKEREVDYKKSIDQLMK 338
K +L SK + L E E ++++ Q+ +
Sbjct: 554 KIEENLICSKYTDLLRIALMA--EDEAIFEEAHKQVQR 589
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (201), Expect = 1e-16
Identities = 41/245 (16%), Positives = 77/245 (31%), Gaps = 62/245 (25%)
Query: 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSFQ 617
K G+G +G V++ + VAIK I ++ + EI+ K
Sbjct: 24 RCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELS 81
Query: 618 --------RHPNIITMLDIY----------------------------KAVNNKDLYVVF 641
R I + ++ + L++V
Sbjct: 82 LLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVL 141
Query: 642 EYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCS 698
E+ DL + +R K+ + I+ QL L+ + + HRDL N+L+ K+
Sbjct: 142 EFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL 200
Query: 699 IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758
K+ +S I + + I + R + ++ +
Sbjct: 201 KKLHYTLNGKSS---------TIPSCGLQVSIIDYTLSRLE-----RDGIVVFCDVSMDE 246
Query: 759 PLFPG 763
LF G
Sbjct: 247 DLFTG 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-----RTYREILFLKSFQRHPNII 623
G G +G VYK ++ + VA+K+ R +Q T EI L SF RHP+++
Sbjct: 48 GHGVFGKVYKGVLRDGAK-VALKR-----RTPESSQGIEEFET--EIETL-SFCRHPHLV 98
Query: 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH----IRY-IMFQLCNGLSYIH 677
+++ N L +++YMEN +L + + L + R I GL Y+H
Sbjct: 99 SLIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 732
++HRD+K NIL+D++ KI D G+++ ++ + +++T Y PE
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEYF 213
Query: 733 ISNRRYTHHVDIWSLGCILAEMLQSKP 759
I R T D++S G +L E+L ++
Sbjct: 214 IKG-RLTEKSDVYSFGVVLFEVLCARS 239
|
| >2rov_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} Length = 117 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 5e-16
Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 2/82 (2%)
Query: 871 SRLEGWVSIPNKQNIKRHGWKKQYVVVSSKKIIFYNSENDKQNTDPELELKDLMAKHRSD 930
SRLEGW+S+P + N K+ GW K+YV+VSSKKI+FY+SE DK+ ++P + L D+
Sbjct: 1 SRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVL-DIDKLFHVR 59
Query: 931 LSSKESLLSNGKEREVDYKKSI 952
++ + +E+ I
Sbjct: 60 -PVTQTDVYRADAKEIPRIFQI 80
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 7e-16
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ--RTYR-EIL 611
D + N + G+G +G+VYK Y N VA+KK+ A + T + + + EI
Sbjct: 28 DERPISVGGNKM--GEGGFGVVYKGYVNN--TTVAVKKL-AAMVDITTEELKQQFDQEIK 82
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRY-I 665
+ Q H N++ +L ++ L V+ YM N L+ + L H+R I
Sbjct: 83 VMAKCQ-HENLVELLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPL-SWHMRCKI 138
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW 725
NG++++H +HRD+K +NIL+D++ + KI D GLAR+ + + +R
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ---TVMTSRI 195
Query: 726 -----YRAPEILISNRRY-----THHVDIWSLGCILAEML 755
Y APE T DI+S G +L E++
Sbjct: 196 VGTTAYMAPE-------ALRGEITPKSDIYSFGVVLLEII 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 37/210 (17%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G G++G +Y D + VAIK E KT + + E K Q I T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LE--CVKTKHPQLHIESKIYKMMQGGVGIPTI- 70
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVM 682
+ +V E + L + LK V + + Q+ + + YIH+ +
Sbjct: 71 -RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHSKNFI 127
Query: 683 HRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNR 736
HRD+KP N L+ K + I D GLA+ D++ T YR + L
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR--------THQHIPYRENKNLTGTA 179
Query: 737 RY----TH-------HVDIWSLGCILAEML 755
RY TH D+ SLG +L
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} Length = 84 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-13
Identities = 26/44 (59%), Positives = 30/44 (68%)
Query: 1171 DEKPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALEC 1214
EK I KGHEF+ YH PT CE C KP+WH+ +PPPALEC
Sbjct: 14 GEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALEC 57
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
+ G+G++G++++ + N Q VAIK FE ++DA + E K I +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FE--PRRSDAPQLRDEYRTYKLLAGCTGIPNV- 71
Query: 627 DIYKAVNNKDLYVVFEYM----ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
Y +V + + E+ L+ R +K V + Q+ + IH ++
Sbjct: 72 -YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKSLV 128
Query: 683 HRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
+RD+KP N LI + S I + D G+ + D ++I YR + L R
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIP---YREKKNLSGTAR 183
Query: 738 Y----TH-------HVDIWSLGCILAEML 755
Y TH D+ +LG + L
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFL 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 33/209 (15%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G G +G + + +YVAIK E K+ A + + E F K I +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK--LE--PMKSRAPQLHLEYRFYKQLGSGDGIPQV- 70
Query: 627 DIYKAVNNKDLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVM 682
Y K +V E + L + LK V + I QL + + Y+H+ ++
Sbjct: 71 -YYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYVHSKNLI 127
Query: 683 HRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
+RD+KP N LI + + I I D LA+ D + ++I YR + L R
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--KHIP---YREHKSLTGTAR 182
Query: 738 Y----TH-------HVDIWSLGCILAEML 755
Y TH D+ +LG + L
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-12
Identities = 52/268 (19%), Positives = 87/268 (32%), Gaps = 42/268 (15%)
Query: 31 RERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESE 90
R+ + + L R M + K++ I +H R
Sbjct: 830 VVRKRYQCMRDATIALQALLRGYLVRNKY--QMMLREHKSIIIQKHVRGWLARV---HYH 884
Query: 91 TKKKAEVNLQVISDMH------EKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNIL 144
KA V LQ +KLK EA + R +K L E +++LQ +
Sbjct: 885 RTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGL-------ENKIMQLQRKI 937
Query: 145 ATLEMERDTLQQEVATLQAKISQERSS--------------KTQAVNLHKELEGRLQALN 190
E +L +++ L+ S E A N L+ + L
Sbjct: 938 DEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLR 997
Query: 191 TELER----NKHRELQLAEDNRHLGEKVSSLEKEC-RLQALNTELERNKHRELQLAEDNR 245
EL + K E + + VS L+++ L+ EL R H + + +
Sbjct: 998 KELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETM 1057
Query: 246 HLGEKVSSLEKECASLSLELKAAQAQYQ 273
L +E L L+L + +YQ
Sbjct: 1058 E-----KKLVEETKQLELDLNDERLRYQ 1080
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-11
Identities = 44/265 (16%), Positives = 96/265 (36%), Gaps = 24/265 (9%)
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
++ A Q +R + K +M+ +E S+ I K ++ +A+ + K +
Sbjct: 836 QCMRDATIALQALLRGYLVRNKYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYL-- 893
Query: 323 KEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKT-LQSQVEQEQAKKFSLQ 381
Q R ++++ LK A + +K L++++ Q Q K
Sbjct: 894 ------------QCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQN 941
Query: 382 SDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLE 441
+ + +L+ + ++ E R EEE + + LQ+++
Sbjct: 942 KEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNR-------VLSLQEEIA 994
Query: 442 TEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADS--EALARSIA 499
+ +T+ ++E D+ +L E + L+ + A+ I
Sbjct: 995 KLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEIT 1054
Query: 500 EETVGELEKEKTMKELELKDLMAKH 524
E +L +E EL+L D ++
Sbjct: 1055 ETMEKKLVEETKQLELDLNDERLRY 1079
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-10
Identities = 43/307 (14%), Positives = 112/307 (36%), Gaps = 23/307 (7%)
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
+ ++ A Q+ VR H+ + + + A++ I K + + + R ++
Sbjct: 788 MRMRRAAITIQRYVRGHQARCYATFLRRTRAAIIIQKFQRMYVVRKRYQCMRDATIALQA 847
Query: 323 KEREVDYKKSIDQLMKDRED--LQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSL 380
R + ++++ + +Q+ + + L+ LQ + AK+
Sbjct: 848 LLRGYLVRNKYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKR--E 905
Query: 381 QSDLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQ----MKEL 436
L ++ K L +++ L+ +EY L K + ++ ++L
Sbjct: 906 LKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKL 965
Query: 437 Q---DQLETEQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEA 493
+ ++L + + + L+EE+ + + + + + E+ ++ + E
Sbjct: 966 RSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEK----KTIEEWADKYKHE- 1020
Query: 494 LARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLM 553
E+ V EL+++ T+ + E ++L + + E K+ L
Sbjct: 1021 -----TEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEET--KQLELDLN 1073
Query: 554 KDREDLQ 560
+R Q
Sbjct: 1074 DERLRYQ 1080
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-10
Identities = 39/272 (14%), Positives = 84/272 (30%), Gaps = 22/272 (8%)
Query: 56 RETALRDEMGQLEKNLTILRHDLKESQRRADNESETKKKAEVNLQVISDMHEKLKTEAET 115
R +R + L+ L+ R + ++ + +Q + ++
Sbjct: 827 RMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSIIIQ------KHVRGWLAR 880
Query: 116 ATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQA 175
R A + + M L + ++ L+ KI
Sbjct: 881 VHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKI---------- 930
Query: 176 VNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKH 235
+L+ ++ N E + + L EK+ S + L+ E + +
Sbjct: 931 ----MQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVER--LRMSEEEAKNATN 984
Query: 236 RELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASV 295
R L L E+ L +++ + E ++ + + +Q V +E KEE +
Sbjct: 985 RVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNR 1044
Query: 296 EIVKELKDLMAKHRSDLSSKESLLSNGKEREV 327
I + K++ L + L E
Sbjct: 1045 RIHDQAKEITETMEKKLVEETKQLELDLNDER 1076
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 48/323 (14%), Positives = 114/323 (35%), Gaps = 22/323 (6%)
Query: 143 ILATLEMERDTLQQEVAT-LQAKI------SQERSSKTQAVNLHKELEGRLQALNTELER 195
+A LE R + +Q I + + A+ + + + G R
Sbjct: 755 QVAYLEKIRADKLRAACIRIQKTIRGWLMRKKYMRMRRAAITIQRYVRGHQARCYATFLR 814
Query: 196 NKH---------RELQLAEDNRHLGEKVSSLEKECR--LQALNTELERNKHRELQLAEDN 244
R + + + + + +L+ R L ++ +H+ + + +
Sbjct: 815 RTRAAIIIQKFQRMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSIIIQKHV 874
Query: 245 RHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDL 304
R +V A + L+ + ++E++ + + + ++ + + ++ L
Sbjct: 875 RGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKK-LKIEARSVERYKKLHIGLENKIMQL 933
Query: 305 MAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKS- 363
K +SLL E+ Y ++L D E L+ K L++
Sbjct: 934 QRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEI 993
Query: 364 KTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAR-EEQLSHEVAMLREAKRNIEEEYHKL 422
L+ ++ Q Q +K +++ E L + +EQ + E R I ++ ++
Sbjct: 994 AKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEI 1053
Query: 423 -KTKRSVEDLQMKELQDQLETEQ 444
+T + K+L+ L E+
Sbjct: 1054 TETMEKKLVEETKQLELDLNDER 1076
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 7e-09
Identities = 41/251 (16%), Positives = 87/251 (34%), Gaps = 17/251 (6%)
Query: 106 HEKLKTEAETA-TRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAK 164
++ ++ LR E + +Q + + A + +
Sbjct: 835 YQCMRDATIALQALLRGYLVRNKYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQ 894
Query: 165 IS-QERSSKTQAVNLHKELE--GRLQALNTELERNKHRELQ-----LAEDNRHLGEKVSS 216
+ +K + L E R + L+ LE NK +LQ ++ + L EK+++
Sbjct: 895 CCYRRMMAKRELKKLKIEARSVERYKKLHIGLE-NKIMQLQRKIDEQNKEYKSLLEKMNN 953
Query: 217 LEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQY---Q 273
LE +L + R E+ ++ +V SL++E A L EL Q + +
Sbjct: 954 LEIT--YSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIE 1011
Query: 274 QEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSI 333
+ ++ + + +E + + E ++L + + E K+
Sbjct: 1012 EWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEET--KQLE 1069
Query: 334 DQLMKDREDLQ 344
L +R Q
Sbjct: 1070 LDLNDERLRYQ 1080
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 29/184 (15%), Positives = 74/184 (40%), Gaps = 10/184 (5%)
Query: 917 ELELKDLMAKHRSDLSSKESLLSNGKEREVDYKK----SIDQLMKDREDLQQQINLLKEE 972
L ++ + + +RE+ K S+++ K L+ +I L+ +
Sbjct: 877 WLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRK 936
Query: 973 LRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRKKE 1032
+ + + +E + L +++ ++ + KL + R ++ + ++K ++ V +
Sbjct: 937 IDEQN---KEYKSLLEKMNNLEITYSTETEKLRSDVERLRMS---EEEAKNATNRVLSLQ 990
Query: 1033 KECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQ 1092
+E KL++EL Q + + + K E + V E L+ E + + I
Sbjct: 991 EEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQA 1050
Query: 1093 GKLA 1096
++
Sbjct: 1051 KEIT 1054
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-07
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 17/170 (10%)
Query: 911 KQNTDPELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLK 970
K + E ++ L K +SLL E+ Y ++L D E L+ K
Sbjct: 921 KLHIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAK 980
Query: 971 EELRKSSNSSEEMEKLHKQLKQEQLLKAQAVNKLAEIMNRKDINTTCKGKSKASSADVRK 1030
+ + EE+ KL K+L Q Q + E ++ + +
Sbjct: 981 NATNRVLSLQEEIAKLRKELHQTQ----TEKKTIEEWADKYK-------------HETEQ 1023
Query: 1031 KEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQME 1080
E ++ L E+E+ N+ + KE+ E + + E T +L+L +
Sbjct: 1024 LVSELKEQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEETKQLELDLN 1073
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 31/288 (10%)
Query: 492 EALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQ 551
EA A I + K +KE L S+ +L + + ++
Sbjct: 40 EADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILI-----HIGHHLNVVN 90
Query: 552 LMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 611
L+ + ++ E +G + ++V K FR D Y +
Sbjct: 91 LLGACTKPGGPLMVIVEF-CKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD----YVGAI 145
Query: 612 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCN 671
+ +R + IT + + + + E + + + L H+ FQ+
Sbjct: 146 PVDLKRRL-DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------R 724
G+ ++ + K +HRDL NIL+ + +KI D GLAR + +Y+ +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLK 260
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQL 770
W APE + +R YT D+WS G +L E+ L + P +PG +
Sbjct: 261 WM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 305
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 42/186 (22%), Positives = 70/186 (37%), Gaps = 14/186 (7%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYRE 609
R+ L+ L K G+GA+G V +A DK K+ + ++ + E
Sbjct: 20 PRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 75
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQ 668
+ L H N++ +L L V+ E+ + +L+ +R K + V + +
Sbjct: 76 LKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
G Y+ A DLK I S S +SLSD +E + +
Sbjct: 135 FRQGKDYVGAI---PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 729 PEILIS 734
E LI
Sbjct: 192 LEHLIC 197
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 626
K G G++G +Y + + VAIK E KT + E + Q I +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LE--NVKTKHPQLLYESKIYRILQGGTGIPNV- 68
Query: 627 DIYKAVNNKDLYVVFEYM----ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ V +V + + E+ N R LK V + + Q+ N + ++H+ +
Sbjct: 69 -RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFVHSKSFL 125
Query: 683 HRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY- 738
HRD+KP N L+ ++ + I D GLA+ D+ ++I YR + L RY
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIP---YRENKNLTGTARYA 180
Query: 739 ---TH-------HVDIWSLGCILAEML 755
TH D+ SLG +L L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 29/168 (17%), Positives = 60/168 (35%), Gaps = 28/168 (16%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G +G++Y A+ N + A + E + + E+ F + + I ++
Sbjct: 46 GSGGFGLIYLAFPTNKPEKDARHVVKVE----YQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 628 IYK---------------AVNNKDLYV-VFEYMENDLNKVIRDK---ILKDVHIRYIMFQ 668
+ + V E + DL K+ V + +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ--LGIR 159
Query: 669 LCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSK 714
+ + L YIH + +H D+K +N+L+ + + D GL+ +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 25/177 (14%), Positives = 59/177 (33%), Gaps = 41/177 (23%)
Query: 569 GKGAYGIVYKAYDKN--------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
+ GI+Y+A + KQ ++K +A R + E F + +
Sbjct: 51 TRDNQGILYEAAPTSTLTCDSGPQKQKFSLK--LDA-----KDGRLFNEQNFFQRAAKPL 103
Query: 621 NIITMLDIYKAVNNKDL-----------------YVVFEYMENDLNKVIRDKILKDVHIR 663
++ +K + + L ++V + L + + R
Sbjct: 104 ----QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSER 159
Query: 664 ---YIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKE 715
+ +L + L ++H + +H ++ NI + + + + G A S +
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 32/168 (19%), Positives = 60/168 (35%), Gaps = 25/168 (14%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G +Y A +++ V +D + E+ F + + I +
Sbjct: 44 GQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 629 YK---------------AVNNKDLYV-VFEYMENDLNKVIRDKI----LKDVHIRYIMFQ 668
K N K + + +DL K+ K V + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ--LSLR 160
Query: 669 LCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSK 714
+ + L YIH + +H D+K SN+L++ + + D GLA
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-08
Identities = 35/261 (13%), Positives = 82/261 (31%), Gaps = 1/261 (0%)
Query: 143 ILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQ 202
LA +E R+ T + + + LE R + E ++ +
Sbjct: 750 QLARIEEAREQRLGSEQTKSDYLKRANELVQWINDKQASLESRDFGDSIESVQSFMNAHK 809
Query: 203 LAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLS 262
+ + E E +L T+L K RE +A E S+ +
Sbjct: 810 EYKKTEKPPKGQEVSELEAIYNSLQTKLRLIK-REPFVAPAGLTPNEIDSTWSALEKAEQ 868
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
+A + + +++ + QK + K+ + K + + +++ ++ L N
Sbjct: 869 EHAEALRIELKRQKKIAVLLQKYNRILKKLENWATTKSVYLGSNETGDSITAVQAKLKNL 928
Query: 323 KEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQS 382
+ + + + Q D + Q+ L K Q ++ + ++
Sbjct: 929 EAFDGECQSLEGQSNSDLLSILAQLTELNYNGVPELTERKDTFFAQQWTGVKSSAETYKN 988
Query: 383 DLSVQTSEAAHLKAREEQLSH 403
L + ++ H
Sbjct: 989 TLLAELERLQKIEDLHHHHHH 1009
|
| >1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-05
Identities = 33/264 (12%), Positives = 73/264 (27%), Gaps = 37/264 (14%)
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
+ K A + + + E Q + KE K + S+ + N
Sbjct: 782 INDKQASLESRDFGDSIESVQSF---------MNAHKEYKKTEKPPKGQEVSELEAIYNS 832
Query: 323 KEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQS 382
+ ++ K + + + + QE ++ ++ + +++ A
Sbjct: 833 LQTKLRLIKREPFVAPAGLTPNEIDSTWSALEKAEQEHAEALRIELKRQKKIA------- 885
Query: 383 DLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLET 442
+ +Q K + V + + D + + L+ Q +
Sbjct: 886 -VLLQKYNRILKKLENWATTKSVYLGSNETGDSITAVQAKLKNLEAFDGECQSLEGQSNS 944
Query: 443 EQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQLAVARADSEALARSIAEET 502
+ L + + + EL E + A +S AE
Sbjct: 945 DL---------LSILAQLTELNYNGVPELTERKDTF---------FAQQWTGVKSSAETY 986
Query: 503 VGEL--EKEKTMKELELKDLMAKH 524
L E E+ K +L H
Sbjct: 987 KNTLLAELERLQKIEDLHHHHHHH 1010
|
| >1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 27/229 (11%), Positives = 71/229 (31%), Gaps = 17/229 (7%)
Query: 31 RERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESE 90
R +E Q ++ E + E+ +LE L+ L+ +R
Sbjct: 790 ESRDFGDSIESVQSFMNAHKEYKKTEKPPKGQEVSELEAIYNSLQTKLRLIKREPFVAPA 849
Query: 91 TKKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQN--ILATLE 148
E++ S + + + AE K+ ++ V +++ +L+N ++
Sbjct: 850 GLTPNEID-STWSALEKAEQEHAEALRIELKRQKKIAVLLQKYNRILKKLENWATTKSVY 908
Query: 149 MERDTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNR 208
+ + + +QAK+ + + +L + L ++ +L + + + +
Sbjct: 909 LGSNETGDSITAVQAKLKNLEAFDGECQSLEGQSNSDLLSILAQLTELNYNGVPELTERK 968
Query: 209 HLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKE 257
+ K E++ +E
Sbjct: 969 D--------------TFFAQQWTGVKSSAETYKNTLLAELERLQKIEDL 1003
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 8e-08
Identities = 66/543 (12%), Positives = 175/543 (32%), Gaps = 55/543 (10%)
Query: 32 ERREMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHDLKESQRRADNESET 91
R + ++ Q++L + + + E QLE N L+ L+ S R A SE
Sbjct: 275 NRAPENTMQAMQQKLEDFRDYRRLHKPPKVQEKCQLEINFNTLQTKLRLSNRPAFMPSEG 334
Query: 92 KKKAEVNLQVISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMER 151
K +++N + + E L + L E+ + + + +
Sbjct: 335 KMVSDIN----NAWGGLEQAEKGYEEWLLNEIRRLERLDHLAEKFRQKASIHESWTDGKE 390
Query: 152 DTLQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLG 211
LQQ+ + K H+ E L A +E+ +L E + +
Sbjct: 391 AMLQQKDYETATLSEIKALLKK-----HEAFESDLAAHQDRVEQIAAIAQELNELDYYDS 445
Query: 212 EKVSSLEKE--CRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECASLSLELKAAQ 269
V++ ++ + L ++ + + + + + K A + ++ A
Sbjct: 446 PSVNARCQKICDQWDNLGALTQKRREALERTEKLLETIDQLYLEYAKRAAPFNNWMEGAM 505
Query: 270 AQYQQEVRAHE--------------ETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSK 315
Q H + + +A + I E+ ++ + +++
Sbjct: 506 EDLQDTFIVHTIEEIQGLTTAHEQFKATLPDADKERQAILGIHNEVSKIVQTYHVNMAGT 565
Query: 316 ESLLSNGKEREVDYKKSIDQLMKDR-EDLQQQINLLKEGAELRQEL------------EK 362
+ + + + QL+ R + L ++ ++ LR++ K
Sbjct: 566 NPYTTITPQEINGKWEHVRQLVPRRDQALMEEHARQQQNERLRKQFGAQANVIGPWIQTK 625
Query: 363 SKTLQSQVEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREAK----RNIEEE 418
+ + + + L + K + +QL + ++EA ++
Sbjct: 626 MEEIGRISIEMHGTLEDQLNHLRQYEKSIVNYKPKIDQLEGDHQQIQEALIFDNKHTNYT 685
Query: 419 YHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKE------ELDERSRNILELE 472
++ + +++E + ++ E D + +++ E
Sbjct: 686 MEHIRVGWEQLLTTIARTINEVENQILTRDAKGISQEQMNEFRASFNHFDRKKTGMMDCE 745
Query: 473 EERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSKE 532
+ R L + + A+ + + +G + + + D M++ +D + +
Sbjct: 746 DFRACLI-SMGYNMGEAEFARIMSIVDPNRMGVVTFQAFI------DFMSRETADTDTAD 798
Query: 533 SLL 535
++
Sbjct: 799 QVM 801
|
| >3o0z_A RHO-associated protein kinase 1; coiled-coil, transferase; HET: MSE; 2.33A {Homo sapiens} Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-07
Identities = 34/145 (23%), Positives = 69/145 (47%)
Query: 102 ISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATL 161
+ + ++ L+TE++TA RLRK E++ + S E + ELQ LE + ++ L
Sbjct: 15 LEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQL 74
Query: 162 QAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKEC 221
QA + ER + + +L+ R+ +L E++ KH ++ + + + ++ EKE
Sbjct: 75 QAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEK 134
Query: 222 RLQALNTELERNKHRELQLAEDNRH 246
++ + ++ E N H
Sbjct: 135 NNLEIDLNYKLKSLQQRLEQEVNEH 159
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* 3vkh_C* Length = 3245 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 24/155 (15%), Positives = 65/155 (41%), Gaps = 5/155 (3%)
Query: 955 LMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQL--KQEQLLKAQ--AVNKLAEIMNR 1010
+ + R+ L+++ L L+K ++ +++ L L K +L A KL +++
Sbjct: 1908 INEKRDQLEEEQLHLNIGLKKLRDTEAQVKDLQVSLAQKNRELDVKNEQANQKLKQMVQD 1967
Query: 1011 KDINTTCKGKSKASSADVRKKEKECRKLQQELTQEREKFNQVVVKCQKELQELQSQVVEE 1070
+ + ++ + + KE + + + EK ++E+++L++ E
Sbjct: 1968 QQAAEIKQKDARELQVQLDVRNKEIAVQKVKAYADLEKAEPTGPL-REEVEQLENAANEL 2026
Query: 1071 NTSKLKLQMELDSKDSEIEQLQGKLAALGSETASL 1105
+ ++ + + + I + + A L ET +
Sbjct: 2027 KLKQDEIVATITALEKSIATYKEEYATLIRETEQI 2061
|
| >1uix_A RHO-associated kinase; coiled-coil, transferase; HET: MSE; 1.80A {Bos taurus} SCOP: h.1.27.1 Length = 71 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 9e-06
Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 950 KSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKL----HKQLKQEQLLKAQAVNKLA 1005
+ L ++E+L ++ +E+L + + + KQL E+ LK QAVNKLA
Sbjct: 4 SDVANLANEKEELNNKLKEAQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLA 63
Query: 1006 EIMNRKD 1012
EIMNRK+
Sbjct: 64 EIMNRKE 70
|
| >2ycu_A Non muscle myosin 2C, alpha-actinin; motor protein; HET: AOV; 2.25A {Homo sapiens} PDB: 1br1_A* 1br4_A* 1br2_A* Length = 995 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 24/189 (12%), Positives = 65/189 (34%), Gaps = 14/189 (7%)
Query: 117 TRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAV 176
+L + K E V ++ L++ + E + +
Sbjct: 820 AIYNSLQTKLRLIKR--EPFVAPAGLTPNEIDSTWSALEKAEQEHAEALRIELKRQKKIA 877
Query: 177 NLHKELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECR-LQALNTELERNKH 235
L ++ L+ L N + + G+ +++++ + + L+A + E +
Sbjct: 878 VLLQKYNRILKKL-----ENWATTKSVYLGSNETGDSITAVQAKLKNLEAFDGECQS--- 929
Query: 236 RELQLAEDNRHLGEKVSSLEKECASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASV 295
+ N L ++ L + + EL + + + ++ N A +
Sbjct: 930 ---LEGQSNSDLLSILAQLTELNYNGVPELTERKDTFFAQQWTGVKSSAETYKNTLLAEL 986
Query: 296 EIVKELKDL 304
E +++++DL
Sbjct: 987 ERLQKIEDL 995
|
| >2ycu_A Non muscle myosin 2C, alpha-actinin; motor protein; HET: AOV; 2.25A {Homo sapiens} PDB: 1br1_A* 1br4_A* 1br2_A* Length = 995 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-05
Identities = 30/247 (12%), Positives = 75/247 (30%), Gaps = 8/247 (3%)
Query: 143 ILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLH-KELEGRLQAL----NTELERNK 197
+LA LE ER + Q + L+ + + +L ++ ++++ N E K
Sbjct: 746 VLAQLEEERASEQTKSDYLKRANELVQWINDKQASLESRDFGDSIESVQSFMNAHKEYKK 805
Query: 198 HRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKE 257
+ ++ L +SL+ + RL + ++ L + +
Sbjct: 806 TEKPPKGQEVSELEAIYNSLQTKLRLIKREPFVAPAGLTPNEIDSTWSALEKAEQEHAEA 865
Query: 258 CASLSLELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKES 317
K Q+ R ++ + E D + ++ L + E+
Sbjct: 866 LRIELKRQKKIAVLLQKYNRILKKLENWATTKSVYLG---SNETGDSITAVQAKLKNLEA 922
Query: 318 LLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKK 377
+ E + ++ +L + ++ ++S E +
Sbjct: 923 FDGECQSLEGQSNSDLLSILAQLTELNYNGVPELTERKDTFFAQQWTGVKSSAETYKNTL 982
Query: 378 FSLQSDL 384
+ L
Sbjct: 983 LAELERL 989
|
| >2ycu_A Non muscle myosin 2C, alpha-actinin; motor protein; HET: AOV; 2.25A {Homo sapiens} PDB: 1br1_A* 1br4_A* 1br2_A* Length = 995 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 25/221 (11%), Positives = 63/221 (28%), Gaps = 14/221 (6%)
Query: 263 LELKAAQAQYQQEVRAHEETQKSRMVNKEEASVEIVKELKDLMAKHRSDLSSKESLLSNG 322
+ + Q + AH+E +K+ K + E+ L K R L
Sbjct: 784 RDFGDSIESVQSFMNAHKEYKKTEKPPKGQEVSELEAIYNSLQTKLR---------LIKR 834
Query: 323 KEREVDYKKSIDQLMKDREDLQQQINLLKEGAELRQELEKSKTLQSQVEQEQAKKFSLQS 382
+ + +++ L++ E + + +K + + Q+ +
Sbjct: 835 EPFVAPAGLTPNEIDSTWSALEKAEQEHAEALRIELKRQKKIAV---LLQKYNRILKKLE 891
Query: 383 DLSVQTSEAAHLKAREEQLSHEVAMLREAKRNIEEEYHKLKTKRSVEDLQMKELQDQLET 442
+ + S + ++ A L+ + E S + +L +
Sbjct: 892 NWATTKSVYLGSNETGDSITAVQAKLKNLEAFDGECQSLEGQSNSDLLSILAQLTELNYN 951
Query: 443 EQYFSTLYKTQAHELKEELDERSRNILELEEERGDLTHRLQ 483
L + + ++ + + RLQ
Sbjct: 952 GV--PELTERKDTFFAQQWTGVKSSAETYKNTLLAELERLQ 990
|
| >1s1c_X RHO-associated, coiled-coil containing protein kinase 1; GTPase, RHO kinase, ROCK, signaling protein; HET: GNP; 2.60A {Homo sapiens} SCOP: h.1.27.1 Length = 71 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-05
Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 2/67 (2%)
Query: 949 KKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKLH--KQLKQEQLLKAQAVNKLAE 1006
K I+ L ++ E+L +++ +EE + K K + E+ LK QAVNKLAE
Sbjct: 5 TKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAE 64
Query: 1007 IMNRKDI 1013
IMNRKD
Sbjct: 65 IMNRKDF 71
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A Length = 52 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 1e-04
Identities = 6/26 (23%), Positives = 12/26 (46%)
Query: 1179 LKGHEFLNISYHMPTTCEVCPKPIWH 1204
L H F ++ C++C K + +
Sbjct: 1 LTTHNFARKTFLKLAFCDICQKFLLN 26
|
| >1w1w_A Structural maintenance of chromosome 1; cohesin, chromosome segregation, cell adhesion, kleisin, MIT cell cycle; HET: ATG; 2.90A {Saccharomyces cerevisiae} SCOP: c.37.1.12 Length = 430 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 28/217 (12%), Positives = 71/217 (32%), Gaps = 14/217 (6%)
Query: 361 EKSKTLQSQ---------VEQEQAKKFSLQSDLSVQTSEAAHLKAREEQLSHEVAMLREA 411
+S L+S V ++ + ++A++KA ++ + V ++R
Sbjct: 52 VRSNHLRSNILKDLIYRGVLNDENSDDYDNEGAASSNPQSAYVKAFYQKGNKLVELMRII 111
Query: 412 KRNIEEEYHKLKTKRSVEDLQMKELQDQLETEQYFSTLYKTQAHELKEELDERSRNILEL 471
RN + Y S +D + + + + +++ ++ + +
Sbjct: 112 SRNGDTSYKIDGKTVSYKDYSIFLENENILIKAKNFLVFQGDVEQIAAQSPVELSRM--F 169
Query: 472 EEERGDLTHRLQLAVARADSEALARSIAEETVGELEKEKTMKELELKDLMAKHRSDLSSK 531
EE G + ++ + + E L++S E +K + L
Sbjct: 170 EEVSGSIQYKKEYEELKEKIEKLSKSATESIKNRRRIHGELKTYKSPGLEVL--FQGPRG 227
Query: 532 ESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE 568
+ R +QL + + + Q +K+
Sbjct: 228 SR-YDEAEGRFEVINNETEQLKAEEKKILNQFLKIKK 263
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 29/216 (13%), Positives = 70/216 (32%), Gaps = 27/216 (12%)
Query: 509 EKTMKELELKDLMAKHRSDLSSKESLLSNGKEREVDYKKSIDQL-------MKDREDLQQ 561
+ + + A++ S ++ N ++ + L + +
Sbjct: 34 QLISSHARIGEEKARNILKYLSDLRVVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDA 93
Query: 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQR 618
L+ EGK + V+ Y + + V K + K +R Y ++ F R
Sbjct: 94 IGKLMGEGKES--AVFNCYSEKFGECV--VKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 149
Query: 619 -----HPNIITMLDIY--KAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCN 671
+ + + K + V+ E ++ +R + +V +
Sbjct: 150 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD-----MILE 204
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707
++ + ++H DL N+L+ + I D +
Sbjct: 205 EVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1219 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3o0z_A | 168 | RHO-associated protein kinase 1; coiled-coil, tran | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1uix_A | 71 | RHO-associated kinase; coiled-coil, transferase; H | 99.53 | |
| 1s1c_X | 71 | RHO-associated, coiled-coil containing protein kin | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2row_A | 84 | RHO-associated protein kinase 2; ATP-binding, coil | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 2rov_A | 117 | RHO-associated protein kinase 2; ATP-binding, coil | 97.79 | |
| 2yuu_A | 83 | NPKC-delta, protein kinase C delta type; metal bin | 97.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 2enn_A | 77 | NPKC-theta, protein kinase C theta type; zinc bind | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2enz_A | 65 | NPKC-theta, protein kinase C theta type; zinc bind | 97.35 | |
| 1y8f_A | 66 | UNC-13 homolog A, MUNC13-1; cysteine-rich domain, | 97.32 | |
| 2db6_A | 74 | SH3 and cysteine rich domain 3; STAC3, C1 domain, | 97.2 | |
| 2eli_A | 85 | Protein kinase C alpha type; PKC-alpha, PKC-A, str | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 1ptq_A | 50 | Protein kinase C delta type; phosphotransferase; 1 | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.72 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 3uej_A | 65 | NPKC-delta, protein kinase C delta type; proteine | 96.41 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 96.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.31 | |
| 1faq_A | 52 | RAF-1; transferase, serine/threonine-protein kinas | 96.25 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 96.18 | |
| 1c1g_A | 284 | Tropomyosin; contractIle protein; 7.00A {Sus scrof | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.55 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.4 | |
| 3o0z_A | 168 | RHO-associated protein kinase 1; coiled-coil, tran | 90.83 | |
| 3ky9_A | 587 | Proto-oncogene VAV; calponin homology domain, DBL | 90.67 | |
| 4b6d_A | 61 | RAC GTPase-activating protein 1; signaling protein | 89.15 | |
| 2v71_A | 189 | Nuclear distribution protein NUDE-like 1; developm | 88.34 | |
| 1rfh_A | 59 | RAS association (ralgds/AF-6) domain family 5; zin | 87.63 | |
| 3na7_A | 256 | HP0958; flagellar biogenesis, flagellum export, C4 | 87.28 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 86.06 | |
| 2vrw_B | 406 | P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP | 85.65 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 85.49 | |
| 2fnf_X | 72 | Putative RAS effector NORE1; zinc, signal transduc | 84.82 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 84.31 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 81.45 | |
| 3ol1_A | 119 | Vimentin; structural genomics, PSI-2, protein stru | 80.74 | |
| 3s4r_A | 93 | Vimentin; alpha-helix, cytoskeleton, intermediate | 80.46 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-54 Score=486.72 Aligned_cols=290 Identities=38% Similarity=0.655 Sum_probs=248.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~~ 635 (1219)
++|.+++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.+. |||||+++++|... +.+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccccCC
Confidence 4699999999999999999999999999999999766555566778899999999995 99999999998632 346
Q ss_pred eEEEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-
Q psy14431 636 DLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS- 713 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~- 713 (1219)
++|||||||+|+|.+++. .+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 899999999999999987 467999999999999999999999999999999999999999999999999999876442
Q ss_pred ---ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-Cchhhhh
Q psy14431 714 ---KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADKFYA 789 (1219)
Q Consensus 714 ---~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~d~l~~ 789 (1219)
.......+||++|+|||++.+...|+.++||||+|||+|+|++|++||.+.+..+++..|......++. .+..
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~--- 289 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA--- 289 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh---
Confidence 223456799999999999877777899999999999999999999999999999999999988854443 3322
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCCCc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSETA 854 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s 854 (1219)
.........+..++...+.++..+++.+++++.|||.+||.+||.+ ++.++|+||||.-...+.
T Consensus 290 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 290 -VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred -hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 2234455666677777888899999999999999999999999998 589999999997654433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=463.89 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=225.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...|.++++||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+|+.+. |||||+++++|. +.+.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~--~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEE
Confidence 3569999999999999999999999999999999964432 23355789999999995 999999999998 567899
Q ss_pred EEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 639 VVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||||+ |+|.+++..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.......
T Consensus 148 ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp EEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999998 589999998899999999999999999999999999999999999999999999999999999887665556
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||++|+|||++ .+..|+.++||||||||+|+|++|.+||.+.+....+..|.....|..+.+
T Consensus 228 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~------------- 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL------------- 293 (346)
T ss_dssp CCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCG-------------
T ss_pred cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc-------------
Confidence 778999999999997 556799999999999999999999999999998888888877655444332
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+.+++++.|||.+||..||.+| +.++|+||||.-.
T Consensus 294 ------------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 294 ------------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 2357889999999999999984 8889999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=446.07 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=204.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+++.+. |||||+++++|. +.
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~ 85 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIK--SK 85 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--EC
Confidence 4457889999999999999999999999999999999975433 2334567889999999995 999999999997 56
Q ss_pred ceEEEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 635 KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+.+|||||||+|+|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 7899999999999998886 467999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. ...+.+||+.|+|||++.+...+++++|||||||++|+|++|++||.+.+....+..|.....+.|.
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----------- 233 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----------- 233 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 3 3356789999999999865554578999999999999999999999998888777777665433222
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+| +.++|+||||..
T Consensus 234 -----------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 234 -----------------------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------------------CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 247789999999999999985 789999999965
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=462.58 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=219.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.+. |||||+++++|. +++.+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~--~~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFE--ENGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEE--ECCEEE
Confidence 57899999999999999999999999999999999766556666778999999999995 999999999997 567899
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||||+ |+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999998 599999963 347889999999999999999999999999999999999999999999999999877654
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+||++|+|||++. +..|+.++||||||||+|+|++|++||.+.+....+..|.....|+.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~------------ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS------------ 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC------------
T ss_pred ccccccCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC------------
Confidence 4456678999999999974 567999999999999999999999999999998888888876643221
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++++.+||.+||..||.+| +.++|+||||.-
T Consensus 247 ---------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 247 ---------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1247789999999999999985 888899999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=453.53 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=219.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..++|.+++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. |||||+++++|. +.+.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCE
Confidence 4567999999999999999999999999999999996542 22334567899999999995 999999999998 5778
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS- 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~- 713 (1219)
+|||||||. |+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999998 599999874 67999999999999999999999999999999999999999999999999999877533
Q ss_pred -ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 -KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 -~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.....+.+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~---------- 255 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE---------- 255 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------
T ss_pred CcccccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----------
Confidence 22345679999999999984 567999999999999999999999999999988888888776533222
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH--------HHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI--------EQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai--------EALqHpwfaL 849 (1219)
.+++++.|||.+||..||.+|+. ..++||||..
T Consensus 256 ------------------------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 256 ------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp ------------------------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ------------------------ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 23778999999999999999753 2488999954
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=464.58 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=225.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
...|.++++||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.+. |||||+++++|. +++.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~--~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--ECCEEE
Confidence 356999999999999999999999999999999996432 233456889999999995 999999999998 467899
Q ss_pred EEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 639 VVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||||+ |+|.+++..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|..+.......
T Consensus 225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999998 589999998899999999999999999999999999999999999999999999999999999877665556
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...+||++|||||++ .+..|+.++||||||||+|+|++|.+||.+.+....+..|.....|..+.+
T Consensus 305 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~------------- 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL------------- 370 (423)
T ss_dssp CCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT-------------
T ss_pred cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccc-------------
Confidence 778999999999997 556799999999999999999999999999999888888877654443322
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+.+++.+.|||.+||..||.+| +.++|+||||.-.
T Consensus 371 ------------------~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 371 ------------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ------------------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 2357889999999999999984 8889999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=454.34 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=212.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+.++|.+++.||+|+||.||+|++. .+++.||||++.+..........+.+|+.++..+. |||||+++++|. +.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~ 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQ--TE 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEE--ET
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--EC
Confidence 3467999999999999999999874 57899999999755433334456788999999995 999999999998 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|||||||+ |+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 78999999998 589999874 6799999999999999999999999999999999999999999999999999987665
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++ .+..|+.++|||||||++|+|++|++||.+.+....+..|.+...+.|.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~---------- 247 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ---------- 247 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred CCccccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----------
Confidence 55555678999999999997 4567999999999999999999999999999998888888775533322
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+++++.+||.+||..||.+|+ .++++||||..
T Consensus 248 ------------------------~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 248 ------------------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------------------cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 2478899999999999999985 47899999954
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=431.64 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=209.6
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCceEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYV 639 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~LyL 639 (1219)
|.+.++||+|+||+||+|.+..+|..||+|++............+.+|+.+++.+. |||||+++++|... ....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEE
Confidence 36677899999999999999999999999999766556666778999999999995 99999999998642 2456899
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeecc-CCcceecccccccccCCcc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~-dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||||+ |+|.+++.. +.+++..++.|+.||+.||.|||++| ||||||||+|||++. +|.+||+|||+|+.....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999998 599999874 57999999999999999999999998 999999999999974 799999999999865433
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+||+.|+|||++. + .|+.++|||||||++|+|+||++||.+.+....+...+.... .|+.++
T Consensus 186 -~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~-~~~~~~--------- 252 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFD--------- 252 (290)
T ss_dssp -SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGG---------
T ss_pred -ccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC-CCCCCC---------
Confidence 245678999999999873 3 599999999999999999999999987766554443332221 111111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
+..++++.+||.+||..||.+| +.++|+||||.
T Consensus 253 ---------------------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 253 ---------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp ---------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 2347789999999999999985 88889999995
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=442.06 Aligned_cols=282 Identities=22% Similarity=0.319 Sum_probs=214.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+.|.++++||+|+||+||+|.++ .+++.||||++... .....+.+|+.++..+.+|||||+++++|. +.++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~--~~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR--KNDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE--ETTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE--ECCE
Confidence 45999999999999999999875 46789999988532 344568899999999988999999999997 5678
Q ss_pred EEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-CcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l~~~~ 714 (1219)
+|||||||+ |+|.+++. .+++..++.|+.||+.||.|||++|||||||||+|||++.+ |.+||+|||+|+...+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999998 58998884 58999999999999999999999999999999999999876 799999999997654321
Q ss_pred ----------------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCC-CCCC
Q psy14431 715 ----------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF-PGAS 765 (1219)
Q Consensus 715 ----------------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF-~g~s 765 (1219)
...+..+||++|+|||++.+...|+.++||||+|||+|+|++|++|| ++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 11234689999999999877777999999999999999999999887 5667
Q ss_pred cHHHHHHHHhhcCCCCCC-chhhh-------hccCChhHHhhhHHhhhh------------chhhHHHHhcccChhHHHH
Q psy14431 766 TSHQLQLIVNLVRPNPPH-ADKFY-------AGFKSKHEREKFNQVVVK------------CQKELQELQSQVVEENTSK 825 (1219)
Q Consensus 766 ~~e~L~kIve~l~P~P~~-~d~l~-------~~~~s~~~relI~klp~k------------crk~L~el~p~lspeaiDL 825 (1219)
..+++..|....++++.. +.... ..+...........+... ........++.+++++.||
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 778888887765421110 00000 000001111111111000 0011123345678999999
Q ss_pred HHhccccCCCC--CHHHHHcchhhhc
Q psy14431 826 LKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 826 LsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
|.+||++||.+ ++.++|+||||.-
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999998 5899999999953
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=433.28 Aligned_cols=297 Identities=39% Similarity=0.739 Sum_probs=234.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+.+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+.+||||++++++|...+...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 56899999999999999999999999999999999766666777788999999999998899999999999866667899
Q ss_pred EEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-----
Q psy14431 639 VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS----- 713 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~----- 713 (1219)
+|||||+++|..++..+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|+.+...
T Consensus 88 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp EEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC
T ss_pred EEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999865321
Q ss_pred ----------------ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc
Q psy14431 714 ----------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 714 ----------------~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l 777 (1219)
....+.++||++|+|||++.+...|+.++|||||||++|+|++|.+||++.+...++..|+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 247 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 1223457899999999998766789999999999999999999999999999999999998777
Q ss_pred CCCC-CCchhhhhccCChhHHhhhHHhhhhc---hhhHHHHh-------------cccChhHHHHHHhccccCCCCC--H
Q psy14431 778 RPNP-PHADKFYAGFKSKHEREKFNQVVVKC---QKELQELQ-------------SQVVEENTSKLKLQMELDSKDS--E 838 (1219)
Q Consensus 778 ~P~P-~~~d~l~~~~~s~~~relI~klp~kc---rk~L~el~-------------p~lspeaiDLLsKMLq~DPeKR--a 838 (1219)
..++ ..+.. ..++.....+..++... ...+...+ +..++.+.|||.+||.+||.+| +
T Consensus 248 ~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 248 DFPSNEDVES----IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp CCCCHHHHHT----SCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCHHHHHh----ccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 4333 22222 22333444444333221 11111111 1568899999999999999985 8
Q ss_pred HHHHcchhhhcCCCCcCCCCC
Q psy14431 839 IEQLQGKLAALGSETASLSSA 859 (1219)
Q Consensus 839 iEALqHpwfaL~~e~s~~PS~ 859 (1219)
.++|+||||.......+.|.+
T Consensus 324 ~e~l~Hp~~~~~~~~~~~~~~ 344 (388)
T 3oz6_A 324 NDALKHPFVSIFHNPNEEPNC 344 (388)
T ss_dssp HHHTTSTTTTTTCCGGGCCCC
T ss_pred HHHhCCHHHHHhcCCccCCCC
Confidence 899999999876655554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=440.98 Aligned_cols=240 Identities=20% Similarity=0.309 Sum_probs=201.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..+..|.+.++||+|+||.||+|+++.+|+.||||++..... ..+|+.++..+. |||||+++++|. +++.
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~-HpnIV~l~~~~~--~~~~ 124 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLS-SPRIVPLYGAVR--EGPW 124 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCC-CTTBCCEEEEEE--ETTE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence 356779999999999999999999999999999999964321 247999999995 999999999997 5678
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~ 713 (1219)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+...
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 599999974 6799999999999999999999999999999999999999988 6999999999876543
Q ss_pred cc-----ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 714 KE-----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 714 ~~-----~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.. .....+||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.+....+..|.....|.+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~------- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR------- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-------
T ss_pred CcccceecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-------
Confidence 21 122358999999999985 56799999999999999999999999998877766666665432211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+.+.+++.+.+||.+||..||.+|+
T Consensus 277 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~ 302 (336)
T 4g3f_A 277 ------------------------EIPPSCAPLTAQAIQEGLRKEPVHRA 302 (336)
T ss_dssp ------------------------GSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------hcCccCCHHHHHHHHHHccCCHhHCc
Confidence 11245688999999999999999963
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=424.68 Aligned_cols=290 Identities=33% Similarity=0.586 Sum_probs=227.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc---CCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---NNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~---d~~ 635 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. |||||+++++|... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcccCc
Confidence 36799999999999999999999999999999999766666667788999999999995 99999999998532 236
Q ss_pred eEEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 636 DLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.+|+||||++++|..++.. ..+++..++.|+.||+.||.|||+.|||||||||+||||+.+|.+||+|||+|+......
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 7999999999999999885 459999999999999999999999999999999999999999999999999998764321
Q ss_pred ---------------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-----------
Q psy14431 715 ---------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ----------- 756 (1219)
Q Consensus 715 ---------------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT----------- 756 (1219)
...+..+||++|+|||++.....|+.++||||||||+|+|++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 123557889999999987677789999999999999999998
Q ss_pred CCCCCCCCCc--------------------HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhc
Q psy14431 757 SKPLFPGAST--------------------SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQS 816 (1219)
Q Consensus 757 GkpPF~g~s~--------------------~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p 816 (1219)
|.+||+|.+. .+++..|....+.++... ...........++..++......+...++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED---IEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHH---HHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHH---HhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7889988652 466777777775443322 12233455555666666666677778888
Q ss_pred ccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 817 QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 817 ~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
..++.+.|||.+||.+||.+| +.++|+||||.....
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 999999999999999999995 889999999976443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=418.78 Aligned_cols=293 Identities=32% Similarity=0.580 Sum_probs=245.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC---
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN--- 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~--- 634 (1219)
-.++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcC
Confidence 356899999999999999999999999999999999766666667788999999999996 9999999999874322
Q ss_pred ceEEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 635 KDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 67999999999999999985 45999999999999999999999999999999999999999999999999999876543
Q ss_pred c----------------------cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-----------CCCC
Q psy14431 714 K----------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-----------SKPL 760 (1219)
Q Consensus 714 ~----------------------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-----------GkpP 760 (1219)
. ...+..+||++|+|||++.....|+.++||||||||+|+|++ |.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 2 123567899999999997677789999999999999999997 6677
Q ss_pred CCCCC-----------------cHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHH
Q psy14431 761 FPGAS-----------------TSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENT 823 (1219)
Q Consensus 761 F~g~s-----------------~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeai 823 (1219)
|++.+ ..+++..|+...+.++... ............+..++...+.++...++.+++.+.
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD---LKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHH---HHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHH---HHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 77765 3567788888775444322 223345666777777777788889999999999999
Q ss_pred HHHHhccccCCCC--CHHHHHcchhhhcCCCCc
Q psy14431 824 SKLKLQMELDSKD--SEIEQLQGKLAALGSETA 854 (1219)
Q Consensus 824 DLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s 854 (1219)
+||.+||.+||.+ ++.++|+||||.......
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999998 488999999997654433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=410.84 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=191.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC-----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----- 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----- 633 (1219)
+.+|.+++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.++..+. |||||+++++|...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence 456999999999999999999999999999999986432 3344567889999999995 999999999986433
Q ss_pred -----CceEEEEEecch-hhHHHHHhhcc----CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 634 -----NKDLYVVFEYME-NDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 634 -----~~~LyLVMEyme-GSL~d~Lrs~~----LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
..++|||||||. |+|.+++.... .+...++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 235899999998 58999997432 34456889999999999999999999999999999999999999999
Q ss_pred cccccccCCccc------------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14431 704 LGLARSLSDSKE------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 771 (1219)
Q Consensus 704 FGLAr~l~~~~~------------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~ 771 (1219)
||+|+.+..... ..+..+||+.|+|||++. +..|+.++|||||||++|+|++ ||.+.. +...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 999987654221 123468999999999974 5679999999999999999996 775432 2222
Q ss_pred HHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 772 LIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 772 kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+.... .+.|+ .++..++...+||.+||..||.+| +.++|+||||.
T Consensus 236 ~~~~~~~~~~p~-------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~ 284 (299)
T 4g31_A 236 TLTDVRNLKFPP-------------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284 (299)
T ss_dssp HHHHHHTTCCCH-------------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHhcCCCCC-------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 222222 11111 122336778899999999999985 78889999995
Q ss_pred c
Q psy14431 849 L 849 (1219)
Q Consensus 849 L 849 (1219)
.
T Consensus 285 ~ 285 (299)
T 4g31_A 285 D 285 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=412.56 Aligned_cols=288 Identities=34% Similarity=0.617 Sum_probs=243.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccC
Confidence 46799999999999999999999999999999999766555566678899999999996 999999999987432 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||++++|.+++....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 4579999999999999999888999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|+...+.++..+ ...+.+.
T Consensus 182 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~---~~~~~~~ 256 (367)
T 1cm8_A 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF---VQRLQSD 256 (367)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH---HHTCSCH
T ss_pred --cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH---HHHhhhH
Confidence 35578999999999987657799999999999999999999999999999999999998886555432 2234456
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
....++..++......+..+++..++.+.+||.+||.+||.+| +.++|.||||......
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 6677777777777778888888999999999999999999984 8899999999764443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=449.13 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=209.1
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHH---HHHHHhccCCCCccEEeeeee
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYRE---ILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lRE---I~ILr~L~~HPNIVkL~gvfe 630 (1219)
....+++|.+++.||.|+||.||+|+++.+|+.||||++.+.... ........+| +.++..+ +|||||+++++|.
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFH 262 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEE
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEE
Confidence 355688999999999999999999999999999999999654211 1122233344 4444555 5999999999998
Q ss_pred ccCCceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 631 AVNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 631 ~~d~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
+.+.+|||||||. |+|..++. .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|.
T Consensus 263 --~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 263 --TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred --ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 5778999999998 58999987 4679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhhcCCCCCCch
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---e~L~kIve~l~P~P~~~d 785 (1219)
.+.... ..+.+||+.|+|||++.++..|+.++||||||||+|+|++|.+||.+.+.. .....+.....+.|
T Consensus 341 ~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 341 DFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp ECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred ecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 776543 346799999999999866667999999999999999999999999865432 22222322221111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++++.|||.+||..||.+| +.+++.||||..
T Consensus 415 ------------------------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 415 ------------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp ------------------------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred ------------------------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 2347889999999999999997 478999999954
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=411.44 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=202.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+.+++.+.++||+|+||+||+|.+.. .||||++............+.+|+.++..+. |||||++++++. .+.+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~---~~~~ 106 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMT---KDNL 106 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE---CCeE
Confidence 35678899999999999999997542 5999998755555566678999999999995 999999999875 3468
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc-
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS- 713 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~- 713 (1219)
|||||||+ |+|.+++.. ..+++..+..|+.||+.||.|||+.|||||||||+|||++.++.+||+|||+|+.....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999998 699999963 56999999999999999999999999999999999999999999999999999876532
Q ss_pred -ccccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 714 -KECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 714 -~~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.......+||+.|+|||++.+ ...|+.++|||||||++|||+||++||.+.+....+..++......|. .+.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~---- 261 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LSK---- 261 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-STT----
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-ccc----
Confidence 223445789999999999853 346899999999999999999999999988877666655543322111 111
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLA 847 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwf 847 (1219)
..+.+++.+.+|+.+||..||.+|+ .+.|+|++.
T Consensus 262 -----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 262 -----------------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -----------------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -----------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0133577899999999999999973 234566654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=408.83 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=207.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
-.+|.+.++||+|+||.||+|.+. .+|..||||++... .......+.+|+.++..+. |||||+++++|. +
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~--~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--E 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEe--e
Confidence 357899999999999999999875 36889999999643 3345567899999999995 999999999997 4
Q ss_pred CceEEEEEecch-hhHHHHHhh--------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD--------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS 698 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs--------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~ 698 (1219)
++.+|||||||+ |+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 678999999998 699999974 25899999999999999999999999999999999999999999
Q ss_pred ceecccccccccCCcccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q psy14431 699 IKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN 775 (1219)
Q Consensus 699 VKLiDFGLAr~l~~~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve 775 (1219)
+||+|||+|+........ ....+||+.|+|||++. +..|+.++|||||||++|||+| |++||.+.+..+.+..|..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999866543321 23356899999999985 5579999999999999999998 9999999999888888887
Q ss_pred hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhh
Q psy14431 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLA 847 (1219)
Q Consensus 776 ~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwf 847 (1219)
+..+..+ +.+++.+.+|+.+||..||.+|+...--++|+
T Consensus 246 ~~~~~~p---------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 246 GRVLQRP---------------------------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp TCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCC---------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6644322 12367789999999999999986544335554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=435.27 Aligned_cols=255 Identities=20% Similarity=0.355 Sum_probs=221.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+++|.+++.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+|..+. |||||+++++|. +...+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--~~~~~ 229 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDNEM 229 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--CSSEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCEE
Confidence 357899999999999999999999999999999998643 2344567889999999995 999999999998 57789
Q ss_pred EEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC--CcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d--G~VKLiDFGLAr~l~~ 712 (1219)
|||||||. |+|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+.+..
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999998 58999885 3579999999999999999999999999999999999999854 8999999999998765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||++|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.......+...
T Consensus 310 ~~-~~~~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 379 (573)
T 3uto_A 310 KQ-SVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-------- 379 (573)
T ss_dssp TS-EEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG--------
T ss_pred CC-ceeeeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc--------
Confidence 43 345678999999999984 56799999999999999999999999999999988888877654333211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
++.+++.+.|||.+||.+||.+| +.++|+||||..
T Consensus 380 ----------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 380 ----------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp ----------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 23458889999999999999985 889999999965
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=393.87 Aligned_cols=283 Identities=33% Similarity=0.600 Sum_probs=231.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-+++|.++++||.|+||+||+|.+. +|+.||+|++............+.+|+.++..+. ||||++++++|. +...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIH--SERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--CSSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEc--cCCEE
Confidence 3578999999999999999999985 4899999999655444445567889999999995 999999999987 56789
Q ss_pred EEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999999999988874 3489999999999999999999999999999999999999999999999999988765554
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~ 794 (1219)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|.+..|+.... .+
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~ 251 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE---LP 251 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT---SH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc---cc
Confidence 55567899999999998766778999999999999999999999999998888888888877 455555544321 11
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.. ..+......++..+.+.+++++.+||.+||.+||.+| +.++|+||||.-
T Consensus 252 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 252 LWKQ--RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHS--CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhh--cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 1110 0111223455777788899999999999999999985 888999999965
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=408.33 Aligned_cols=241 Identities=25% Similarity=0.414 Sum_probs=197.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.+.++||+|+||.||+|.+. .++..||||++... .......+.+|+.+|..+. |||||+++++|. +
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~--~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQ-HQHIVRFFGVCT--E 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--E
Confidence 457889999999999999999865 36899999999643 3445577899999999995 999999999997 5
Q ss_pred CceEEEEEecch-hhHHHHHhh----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS 696 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d 696 (1219)
.+.+|||||||+ |+|.+++.. +++++..+..|+.||+.||.|||+.|||||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 678999999999 699999863 358999999999999999999999999999999999999999
Q ss_pred CcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14431 697 CSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI 773 (1219)
Q Consensus 697 G~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kI 773 (1219)
+.+||+|||+|+.+..... .....+||+.|+|||++. +..|+.++|||||||++|||+| |++||.+.+..+.+..|
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987654321 223567999999999974 5679999999999999999998 89999999988888888
Q ss_pred HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 774 VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 774 ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+..+..+ +.+++.+.+|+.+||..||.+|+
T Consensus 274 ~~g~~~~~p---------------------------------~~~~~~~~~li~~cl~~dP~~RP 305 (329)
T 4aoj_A 274 TQGRELERP---------------------------------RACPPEVYAIMRGCWQREPQQRH 305 (329)
T ss_dssp HHTCCCCCC---------------------------------TTCCHHHHHHHHHHCCSSTTTSC
T ss_pred HcCCCCCCc---------------------------------ccccHHHHHHHHHHcCcChhHCc
Confidence 776644322 12367789999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=409.16 Aligned_cols=289 Identities=36% Similarity=0.639 Sum_probs=232.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~ 634 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccC
Confidence 36899999999999999999999999999999999765555566778899999999996 99999999998642 23
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||+|++++|.+++....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++.....
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 5689999999999999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|++||++.+...++..|....+.++.. ....+.+.
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~---~~~~~~~~ 260 (367)
T 2fst_X 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE---LLKKISSE 260 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH---HHTTCCCH
T ss_pred --CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH---HHHHhhhH
Confidence 3457899999999998765779999999999999999999999999999999999999887554332 22234456
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCCCc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSETA 854 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e~s 854 (1219)
....++..++......+...++..++.+.|||.+||.+||.+ ++.++|.||||.....+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 666777777777778889999999999999999999999998 488999999997654443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=421.28 Aligned_cols=285 Identities=34% Similarity=0.593 Sum_probs=233.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~ 634 (1219)
+.+|.+++.||.|+||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||++++++|... +.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccccC
Confidence 57899999999999999999999999999999999876666667788999999999995 99999999999643 23
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+||||||++++|...+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred CeEEEEEeCCCCCHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 57899999999998888765 48999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC-chhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~-~d~l~~~~~s 793 (1219)
.....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||++.+..+++..|+...+.+++. +... .
T Consensus 219 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~-----~ 291 (464)
T 3ttj_A 219 -MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-----Q 291 (464)
T ss_dssp -CC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS-----C
T ss_pred -ccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc-----c
Confidence 3456789999999999854 579999999999999999999999999999999999999988544332 2221 2
Q ss_pred hhHHhhhHHhhhhchhhHHHHhccc------------ChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQV------------VEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~l------------speaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+....++...+......++..++.. ++.+.|||.+||.+||.+| +.++|+||||.....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 3444455555544555566666543 5679999999999999984 889999999976443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=402.90 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=203.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.+.++.++++||+|+||.||+|... .+++.||||++.... .......+.+|+.++..+. |||||+++|++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~-- 99 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVT-- 99 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEE--
Confidence 3556889999999999999999853 467899999986432 3344567899999999995 999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
+++.+|||||||+ |+|.+++.. ..+++..+..|+.||+.||.|||+.|||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 4667999999998 699999853 2488999999999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.+||+|||+|+...... ...+..+||+.|+|||++. +..|+.++|||||||++|||+| |.+||.+.+..+.+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998765432 2234568999999999985 5579999999999999999998 899999999988888
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.|..+..++.+ +.+++.+.+|+.+|+..||.+|+
T Consensus 259 ~i~~~~~~~~p---------------------------------~~~~~~~~~li~~C~~~dP~~RP 292 (308)
T 4gt4_A 259 MIRNRQVLPCP---------------------------------DDCPAWVYALMIECWNEFPSRRP 292 (308)
T ss_dssp HHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHcCCCCCCc---------------------------------ccchHHHHHHHHHHcCCChhHCc
Confidence 88776543322 12366788999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=385.80 Aligned_cols=281 Identities=30% Similarity=0.550 Sum_probs=230.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||+||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|. +++.+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 77 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEE--eCCEEE
Confidence 46899999999999999999999999999999999765555555677889999999995 999999999997 567899
Q ss_pred EEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||+++++...+. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999999998887776 357999999999999999999999999999999999999999999999999999887655555
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~ 794 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|. |||.+.+....+..+.... .|.+..|+.......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-- 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD-- 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc--
Confidence 566789999999999876666899999999999999999876 5577888888888888777 444444443321000
Q ss_pred hHHhhhHHhhh-hchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVV-KCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~-kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+. .....+....+.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 236 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 -----YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp -----CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred -----ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 000000 01122334446678999999999999999984 888999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=386.56 Aligned_cols=280 Identities=34% Similarity=0.567 Sum_probs=224.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||.||+|.+ .+|..||+|++............+.+|+.++..+. ||||+++++++. ..+.+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 76 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLV 76 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEc--cCCeEE
Confidence 46799999999999999999998 67899999998644333333466789999999995 999999999997 467899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 9999999999998874 56899999999999999999999999999999999999999999999999999876654444
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|....|+..... +
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 232 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P- 232 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS---T-
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc---c-
Confidence 4556889999999998666678999999999999999999999999999888888887766 3444444432210 0
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+...+....+.++....+.+++.+.+||.+||.+||.+| +.++|+||||.
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 233 --KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp --TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred --ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0000111122334445556788999999999999999985 88899999995
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=392.40 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=225.0
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
....+++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.+++.+. ||||+++++++. ..
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~ 86 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIE--TE 86 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--EC
Confidence 455688999999999999999999999999999999999776666666778899999999996 999999999987 56
Q ss_pred ceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 78999999997 58988886 46799999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||++|+|||++.+...+++++|||||||++|+|++|.+||.+.+.......+.....+.|.
T Consensus 167 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~---------- 235 (328)
T 3fe3_A 167 GG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF---------- 235 (328)
T ss_dssp SC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred CC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----------
Confidence 43 3456789999999999866554568999999999999999999999999888777777665433222
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+++.+.+||.+||.+||.+| +.++++||||.....
T Consensus 236 ------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 236 ------------------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ------------------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ------------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 136778999999999999984 888999999976443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=392.05 Aligned_cols=288 Identities=39% Similarity=0.633 Sum_probs=243.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---Cce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~ 636 (1219)
.+|.+++.||.|+||.||+|.+..++..||||++... ........+.+|+.++..+. ||||+++++++.... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccccce
Confidence 4799999999999999999999999999999998632 23444577889999999995 999999999986432 256
Q ss_pred EEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 637 LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+|+||||++++|.+++....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 8999999999999999988899999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 --~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..|.....+++.... .....
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~ 261 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL---NCIIN 261 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH---HTCCC
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH---HHhhh
Confidence 1245689999999999877777999999999999999999999999999999999999887754433221 12223
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
.........++.....++...++.+++.+.+||.+||.+||.+ ++.++|+||||.-...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 3444555556666677788889999999999999999999998 4889999999976433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=391.47 Aligned_cols=284 Identities=30% Similarity=0.566 Sum_probs=225.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||.||+|.+..+|..||||++..... ......+.+|+.++..+. ||||++++++|. +.+.+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 76 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSLT 76 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCC-CTTBCCEEEEEE--CSSCEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcC-CCCCCeeeeEEe--eCCEEE
Confidence 4689999999999999999999999999999999853321 111123457999999995 999999999987 567899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||++|+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred EEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9999999999998874 45899999999999999999999999999999999999999999999999999876655444
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|.+..|+.... ...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS---NEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG---CHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc---chh
Confidence 5566889999999998766778999999999999999999999999999999999988877 455555554431 111
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGS 851 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~ 851 (1219)
... ...+......+....+.+++.+.+||.+||.+||.+ ++.++|+||||.-..
T Consensus 234 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 234 FKT--YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHH--TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcc--cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 110 112233344556667788999999999999999988 488899999996543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=388.36 Aligned_cols=282 Identities=33% Similarity=0.579 Sum_probs=214.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||++++++|. .++.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELK-HENIVRLYDVIH--TENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEEC--CTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcC-CCCcceEEEEEE--ECCeEE
Confidence 467999999999999999999999999999999986433 2233456789999999995 999999999987 567899
Q ss_pred EEEecchhhHHHHHhhc-------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 639 VVFEYMENDLNKVIRDK-------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs~-------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+||||++|+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 99999999999988742 48899999999999999999999999999999999999999999999999998776
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 790 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~ 790 (1219)
.........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..|..... |....|+....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 238 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK- 238 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG-
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh-
Confidence 5444445668999999999986656789999999999999999999999999999988888888764 44444433221
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHh-----cccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQ-----SQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~-----p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
. +.. ...+....+..+...+ ..+++.+.+||.+||.+||.+| +.++|+||||.-.
T Consensus 239 ~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 239 L--PKY---NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp C--TTC---CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred h--hhc---ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 0 000 0001111111122222 2467899999999999999985 8889999999763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=387.92 Aligned_cols=285 Identities=34% Similarity=0.537 Sum_probs=220.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
...+++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||+++++++. ++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~ 106 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIH--HNH 106 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEE--ETT
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEe--cCC
Confidence 34577899999999999999999999999999999999655444444566789999999995 999999999997 567
Q ss_pred eEEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-----cCCcceecccccccc
Q psy14431 636 DLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-----KSCSIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-----~dG~VKLiDFGLAr~ 709 (1219)
.+|+||||++|+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++ ..+.++|+|||++..
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 8999999999999999874 4699999999999999999999999999999999999995 445599999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFY 788 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~ 788 (1219)
+..........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.... .|....|+...
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 76554445566889999999998766678999999999999999999999999999988888888776 34444443322
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhc-ccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQS-QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p-~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. .+ .....++......+...++ .+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 267 ~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 267 A---LP---DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp G---ST---TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred h---hh---hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 1 00 0111222223333444444 378899999999999999985 888999999954
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.42 Aligned_cols=281 Identities=31% Similarity=0.508 Sum_probs=227.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc---CchhHHHHHHHHHHHHhcc--CCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~---s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~d 633 (1219)
.++|.+++.||.|+||+||+|.+..+|+.||||++..... .........+|+.++..+. .||||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 3579999999999999999999999999999999864321 1112345667888777765 4999999999987433
Q ss_pred Cc---eEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 634 NK---DLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 634 ~~---~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
.. .+++||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 22 58999999999999998853 3899999999999999999999999999999999999999999999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCchh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADK 786 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~d~ 786 (1219)
....... .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|...... +...|+.
T Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 168 RIYSYQM-ALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTSTTCC-CSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccCCCc-ccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 8765433 235678999999999985 456899999999999999999999999999999999998887743 3333432
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
... .+ ...++...+..+....+.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 246 ~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 246 DVS---LP-----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp SCS---SC-----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hhh---cc-----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 210 00 01233344566777888999999999999999999985 888999999954
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=377.90 Aligned_cols=264 Identities=26% Similarity=0.455 Sum_probs=224.8
Q ss_pred HhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 552 LMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 552 LL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.........+|.+++.||.|+||.||+|.+..+|..||||++..... .....+.+|+.++..+. ||||++++++|.
T Consensus 12 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~- 87 (297)
T 3fxz_A 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK-NPNIVNYLDSYL- 87 (297)
T ss_dssp HSBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred ccCcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCC-CCCCCeEeEEEE-
Confidence 33344456789999999999999999999999999999999864432 33466889999999995 999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
.++.+|+||||+. ++|.+++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++...
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 88 -VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp -ETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -ECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 4678999999996 69999999888999999999999999999999999999999999999999999999999999877
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
..........+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 239 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------ 239 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG------
T ss_pred CCcccccCCccCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc------
Confidence 66555556678999999999974 55689999999999999999999999998888777766655544332211
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+.+++.+.+||.+||.+||.+| +.++|+||||....+
T Consensus 240 -------------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 240 -------------------------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp -------------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -------------------------cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 2346778999999999999985 788999999977443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=394.61 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=214.2
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||.|+||.||+|.+..+|..||||++.+.. ........+.+|+.++..+.+||||++++++|. +.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~ 96 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TP 96 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eC
Confidence 345789999999999999999999999999999999996542 123345667899999999877999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||+. |+|..++.. +.+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|.....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 78999999998 489888874 6799999999999999999999999999999999999999999999999999987554
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.......|.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~---------- 245 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT---------- 245 (353)
T ss_dssp ---------CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred CCccccccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 444456678999999999974 556899999999999999999999999999988888888775533322
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 246 ------------------------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 246 ------------------------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ------------------------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 1367899999999999999974 56899999954
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=378.18 Aligned_cols=290 Identities=35% Similarity=0.606 Sum_probs=238.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc---CCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---NNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~---d~~ 635 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++... ........+.+|+.++..+. ||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccc
Confidence 45799999999999999999999999999999998532 23344567789999999995 99999999987632 236
Q ss_pred eEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 636 DLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+|+||||++++|.+++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 88 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred eEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 79999999999999999988899999999999999999999999999999999999999999999999999987653211
Q ss_pred ----------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 716 ----------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 716 ----------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
.....+||++|+|||++.++..++.++|||||||++|+|++|.+||.+.+....+..+......++....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1224578999999999876677999999999999999999999999999988888888777644332211
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
......+.....+..++......+...++.+++.+.+||.+||.+||.+| +.++|+||||.....
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 248 --LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp --TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred --ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 11122344445555555555666778888999999999999999999985 888899999976433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=375.79 Aligned_cols=283 Identities=30% Similarity=0.555 Sum_probs=223.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|. +.+.+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFR--RKRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheee--cCCeEE
Confidence 46899999999999999999999999999999998655444444567889999999996 999999999997 567899
Q ss_pred EEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||+++ +|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999996 5666665 456999999999999999999999999999999999999999999999999999887655544
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.......++.....+. ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 233 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS---TN-- 233 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH---TC--
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc---cc--
Confidence 5567899999999998766778999999999999999999999999999988888887776554443222110 00
Q ss_pred HhhhHH--hhh-hchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 797 REKFNQ--VVV-KCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 797 relI~k--lp~-kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
..+.. ++. .....+...++.+++.+.+|+.+||.+||.+| +.++|+||||.-.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 234 -QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp -GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred -cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00000 000 11233455567889999999999999999985 7889999999653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=397.85 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=203.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+++.||+|+||.||+|.+..+ ++.||||++.... .......+.+|+.+|..+..|||||+++++|.. .
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-P 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-T
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-c
Confidence 46799999999999999999987654 4789999986432 334456789999999999867999999998863 3
Q ss_pred CceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
++.+|||||||+ |+|.++++. ..+++..+..|+.||+.||.|||++|||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 457899999998 699999973 23788999999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH-H
Q psy14431 696 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL-Q 771 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L-~ 771 (1219)
++.+||+|||+|+.+..... .....+||+.|+|||++. +..|+.++|||||||++|||+| |.+||++.+....+ .
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987654322 234567999999999985 5679999999999999999998 99999987654444 4
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
.+..+.+|..+ +..++++.+|+.+||..||.+| +.+.++|
T Consensus 300 ~i~~g~~~~~p---------------------------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAP---------------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCC---------------------------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44444433322 1236778999999999999986 5555655
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=386.36 Aligned_cols=286 Identities=35% Similarity=0.620 Sum_probs=239.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---- 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---- 634 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccc
Confidence 36899999999999999999999999999999999765555555678889999999996 9999999999974322
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||++++|..++.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred eeEEEEEccccccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 13499999999999888754 4999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.....+++..+. ..+...
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~ 272 (371)
T 4exu_A 198 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV---QKLNDK 272 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH---TTCSCH
T ss_pred --cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH---HHhhhh
Confidence 345688999999999866577999999999999999999999999999999999999888765544332 223344
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.....+..++......+...++..++.+.+||.+||.+||.+| +.++|+||||.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 5555666666667777888889999999999999999999985 888999999976443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=388.32 Aligned_cols=284 Identities=35% Similarity=0.604 Sum_probs=220.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---- 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---- 633 (1219)
.+.+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccccc
Confidence 367899999999999999999999999999999999765555566678889999999995 999999999987432
Q ss_pred CceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
...+|+||||++++|.+++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ccceEEEEEcCCCCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 24789999999999998886 45899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC-chhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~-~d~l~~~~~ 792 (1219)
. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|+.....+++. +..+
T Consensus 181 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~----- 253 (371)
T 2xrw_A 181 F-MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL----- 253 (371)
T ss_dssp ----------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS-----
T ss_pred c-ccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh-----
Confidence 2 234568999999999985 4568999999999999999999999999999988888888877444332 2111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhccc------------ChhHHHHHHhccccCCCC--CHHHHHcchhhhcC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQV------------VEENTSKLKLQMELDSKD--SEIEQLQGKLAALG 850 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~l------------speaiDLLsKMLq~DPeK--RaiEALqHpwfaL~ 850 (1219)
.+.....+...+......+...++.. ++.+.+||.+||.+||.+ ++.++|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 22223333333333333344443322 567899999999999998 48889999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=382.48 Aligned_cols=286 Identities=29% Similarity=0.514 Sum_probs=227.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---- 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---- 633 (1219)
.+++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence 477899999999999999999999999999999998655444444567789999999996 999999999987432
Q ss_pred --CceEEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 634 --NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 634 --~~~LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
++.+|+||||++++|...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 457899999999998888874 4699999999999999999999999999999999999999999999999999986
Q ss_pred cCCc----ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-Cc
Q psy14431 710 LSDS----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HA 784 (1219)
Q Consensus 710 l~~~----~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~ 784 (1219)
+... .......+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..|.....+.++ .|
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 6422 222345678999999999876667899999999999999999999999999999988888887754443 33
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhc--ccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQS--QVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p--~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.... + .....+. ........+...+. ..++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 254 ~~~~~-~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 254 PNVDN-Y---ELYEKLE-LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTGGG-C---GGGTSSC-CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred ccccc-c---hhhcccc-cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 32210 0 0000000 00111111222221 247889999999999999984 889999999954
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=384.31 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=217.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+++|.+++.||.|+||.||+|.+..+|+.||||++.+... .......+.+|+.++..+. ||||++++++|. +.+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~--~~~~ 79 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSSE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEE--eCCE
Confidence 46789999999999999999999999999999999965421 2234567889999999995 999999999997 5678
Q ss_pred EEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+||||++| +|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999985 88888874 569999999999999999999999999999999999999999999999999998755444
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......|.......|
T Consensus 160 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 225 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------- 225 (337)
T ss_dssp CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred CcccccccChhhCChhhh-cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 445667899999999997 455789999999999999999999999998887777776665432211
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.++++||||..
T Consensus 226 ---------------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 226 ---------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ---------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ---------------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 1247789999999999999998 478899999954
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=382.77 Aligned_cols=282 Identities=33% Similarity=0.559 Sum_probs=227.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc---hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK---TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~---~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+|.+++.||.|+||.||+|.+..+|..||||++....... .....+.+|+.++..+. ||||++++++|. +.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~ 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG--HK 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC--CT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEe--eC
Confidence 4678999999999999999999999999999999986432211 11235779999999995 999999999987 46
Q ss_pred ceEEEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++++|..++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 679999999999999988753 589999999999999999999999999999999999999999999999999988765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~ 791 (1219)
........+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..|.... .|.+..|+.....
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 243 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL- 243 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS-
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC-
Confidence 55455667899999999998666678999999999999999999999999999999888888776 4555555443210
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
+. ...+......++..+++..++.+.+||.+||.+||.+ ++.++|+||||..
T Consensus 244 --~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 244 --PD----YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp --TT----CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred --cc----cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00 0001112234466677888999999999999999998 4888999999965
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=391.13 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=211.8
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||.|+||.||+|.+..+|..||+|++.... ........+.+|+.++..+. |||||+++++|. +.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~ 87 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQ--DE 87 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence 345788999999999999999999999999999999986432 22234567889999999995 999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||+. |+|..++.. ..+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+..
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 78999999997 589888875 4699999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhhcCCCCCCchhh
Q psy14431 713 SKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---e~L~kIve~l~P~P~~~d~l 787 (1219)
.. .....+||+.|+|||++.. +..|+.++|||||||++|+|++|.+||.+.+.. ..+..+.....+.|
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p------ 240 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP------ 240 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC------
T ss_pred CC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC------
Confidence 32 3456789999999999853 345899999999999999999999999764432 22222222222211
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC---HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS---EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR---aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.+.+.||||..
T Consensus 241 ----------------------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 241 ----------------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ----------------------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ----------------------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 1237789999999999999997 567899999954
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=371.90 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=212.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC------------------------chhHHHHHHHHHH
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------------------------KTDAQRTYREILF 612 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s------------------------~~~~e~~lREI~I 612 (1219)
..+++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3477899999999999999999999999999999998643211 1123467899999
Q ss_pred HHhccCCCCccEEeeeeeccCCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCe
Q psy14431 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI 691 (1219)
Q Consensus 613 Lr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNI 691 (1219)
+..+. ||||+++++++.......+|+||||++ ++|.+++....+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 99995 999999999998666788999999998 4777776677899999999999999999999999999999999999
Q ss_pred eeccCCcceecccccccccCCcccccccccccccccCchhhhcccc--ccccccchhHHHHHHHHHhCCCCCCCCCcHHH
Q psy14431 692 LIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769 (1219)
Q Consensus 692 LLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~--yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~ 769 (1219)
|++.+|.++|+|||++..+..........+||+.|+|||++.+... ++.++|||||||++|+|++|.+||.+.+....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9999999999999999877655444456789999999999854332 47889999999999999999999988776655
Q ss_pred HHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 770 LQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 770 L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
...+.....+.+. .+.+++.+.+||.+||..||.+| +.++|+||||
T Consensus 249 ~~~~~~~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 249 HSKIKSQALEFPD--------------------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp HHHHHHCCCCCCS--------------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred HHHHhcccCCCCC--------------------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 5555443322111 13457789999999999999985 8888999998
Q ss_pred h
Q psy14431 848 A 848 (1219)
Q Consensus 848 a 848 (1219)
.
T Consensus 297 ~ 297 (298)
T 2zv2_A 297 T 297 (298)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=386.91 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=219.3
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+++.||.|+||.||+|.+..+|+.||||++.+... .......+..|..++..+.+||||++++++|. +.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~ 93 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TM 93 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CS
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cC
Confidence 3457899999999999999999999999999999999965421 22345667889999988877999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 78999999997 589998874 6799999999999999999999999999999999999999999999999999987544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~---------- 242 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---------- 242 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred CCcccccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----------
Confidence 444455678999999999974 566899999999999999999999999998888888877764432221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 243 ------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 243 ------------------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ------------------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 2477899999999999999986 78899999953
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=378.62 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=212.0
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|.+..+|+.||||++.+... .......+.+|+.++..+.+||||++++++|. +..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCC
Confidence 457789999999999999999999999999999999975543 33445667899999998867999999999997 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 8999999997 589888874 57999999999999999999999999999999999999999999999999999865444
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHhhcCCCCCCc
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---------HQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---------e~L~kIve~l~P~P~~~ 784 (1219)
.......+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.... .....|.....+.|
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--- 239 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--- 239 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC---
T ss_pred CCcccccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC---
Confidence 44456678999999999984 556899999999999999999999999653211 11122221111100
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 240 -------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 240 -------------------------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp -------------------------------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred -------------------------------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 23578899999999999999985 57899999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=377.93 Aligned_cols=285 Identities=35% Similarity=0.619 Sum_probs=233.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---- 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---- 634 (1219)
..+|.+.+.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccccc
Confidence 36799999999999999999999999999999999765555555677889999999996 9999999999874322
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
..+|+||||++++|..++.. .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred eeEEEEeccccCCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 24699999999998887754 4999999999999999999999999999999999999999999999999999876533
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....++|++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.++..+. ..+...
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~ 254 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV---QKLNDK 254 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH---TTCSCH
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH---HHHhhH
Confidence 345688999999999866567899999999999999999999999999998888888887755444332 222333
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
.....+..++......+....+..++.+.+||.+||.+||.+| +.++|.||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 3444444455444555666667889999999999999999985 78889999997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=386.49 Aligned_cols=276 Identities=26% Similarity=0.501 Sum_probs=222.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc------
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV------ 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~------ 632 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++..... ...+|+.+++.+. ||||++++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCC-CTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcC-CCCccchhheeeecCccccc
Confidence 4579999999999999999999999999999999864322 1237999999995 99999999998532
Q ss_pred ------------------------------CCceEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHH
Q psy14431 633 ------------------------------NNKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIH 677 (1219)
Q Consensus 633 ------------------------------d~~~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLH 677 (1219)
+..++++||||++++|.+++. ...+++..++.++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334589999999998887775 356999999999999999999999
Q ss_pred hcccccCCCCCCCeeec-cCCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh
Q psy14431 678 ACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ 756 (1219)
Q Consensus 678 S~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT 756 (1219)
+.||+||||||+|||++ .++.++|+|||++..+.... .....+||++|+|||++.+...++.++|||||||++|+|++
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999999998 68899999999998765433 23456889999999998766679999999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHhhcCCCC-CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcc-cChhHHHHHHhccccCC
Q psy14431 757 SKPLFPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQ-VVEENTSKLKLQMELDS 834 (1219)
Q Consensus 757 GkpPF~g~s~~e~L~kIve~l~P~P-~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~-lspeaiDLLsKMLq~DP 834 (1219)
|.+||.+.+..+.+..|+.....++ ..+......+.. ..++......+...++. .++.+.+||.+||.+||
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE-------VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---------CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc-------ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999988774433 222222111100 01222334455666654 78889999999999999
Q ss_pred CCC--HHHHHcchhhhc
Q psy14431 835 KDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 835 eKR--aiEALqHpwfaL 849 (1219)
.+| +.++|+||||..
T Consensus 311 ~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDH 327 (383)
T ss_dssp GGSCCHHHHHTSGGGHH
T ss_pred hhCCCHHHHhcCHHHHH
Confidence 984 889999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.04 Aligned_cols=285 Identities=33% Similarity=0.568 Sum_probs=223.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec------
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------ 631 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~------ 631 (1219)
-.++|.+++.||.|+||.||+|.+..+|+.||||++... .......+.+|+.++..+. ||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccccc
Confidence 346899999999999999999999999999999988532 3445567889999999995 9999999998743
Q ss_pred ------cCCceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceeccc
Q psy14431 632 ------VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDL 704 (1219)
Q Consensus 632 ------~d~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDF 704 (1219)
.....+|+||||++|+|.+++..+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 234678999999999999999988899999999999999999999999999999999999997 5678999999
Q ss_pred ccccccCCcc---cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC
Q psy14431 705 GLARSLSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781 (1219)
Q Consensus 705 GLAr~l~~~~---~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P 781 (1219)
|++....... .......+|++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 1233456799999999987667799999999999999999999999999998888888877664332
Q ss_pred CCc-hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 782 PHA-DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 782 ~~~-d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
... .... ..... .+.........++....+.+++.+.+|+.+||..||.+| +.++|+||||...
T Consensus 246 ~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 246 EEDRQELL-SVIPV----YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHHH-TTSCH----HHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhhh-hcCcc----cccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 211 1111 00111 111111223445666778889999999999999999984 8888999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=384.14 Aligned_cols=257 Identities=27% Similarity=0.365 Sum_probs=217.1
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||.|+||.||+|.+..+|+.||||++.+... ..........|..++..+.+||||++++++|. +.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TK 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eC
Confidence 3457889999999999999999999999999999999965421 12344567889999988867999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 78999999997 589998874 6799999999999999999999999999999999999999999999999999986544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.......|.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~---------- 239 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR---------- 239 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred CCCcccCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence 444456678999999999984 456899999999999999999999999998888777777654322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH---HHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI---EQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai---EALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+. ++++||||..
T Consensus 240 ------------------------~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 240 ------------------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp ------------------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ------------------------ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 23678999999999999999753 6789999954
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.77 Aligned_cols=285 Identities=31% Similarity=0.569 Sum_probs=225.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|. +.+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 99 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCK--KKKRW 99 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEee--cCCEE
Confidence 477899999999999999999999999999999998755544455566789999999996 999999999987 56789
Q ss_pred EEEEecchhh-HHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYMEND-LNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeGS-L~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|+||||++++ |..+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999964 555544 45699999999999999999999999999999999999999999999999999987765544
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.....+.++.....+.. .+.
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 257 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK--NPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH--CGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh--ccc
Confidence 455678999999999986666789999999999999999999999999999888888887775554433222110 000
Q ss_pred HHhhhHHhh-hhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVV-VKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp-~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
... . .++ .....+.....+.+++.+.+|+.+||.+||.+| +.++|+||||..
T Consensus 258 ~~~-~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAG-V-RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTT-C-CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccc-c-cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000 0 000 012344556667889999999999999999985 778899999965
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=375.64 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=216.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++..+. ||||++++++|. +..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~ 79 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQ 79 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEE--eCC
Confidence 457889999999999999999999999999999999965421 1233456778999999985 999999999997 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 8999999998 589998874 56999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|+
T Consensus 160 ---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----------- 224 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----------- 224 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT-----------
T ss_pred ---cccccCCccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------
Confidence 24568999999999974 567999999999999999999999999998888877777765432221
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 225 -----------------------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 225 -----------------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp -----------------------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -----------------------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 2367899999999999999875 67899999953
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=377.74 Aligned_cols=281 Identities=26% Similarity=0.342 Sum_probs=220.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc----CCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----RHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~----~HPNIVkL~gvfe~~d~ 634 (1219)
-++|.++++||.|+||.||+|.+..+|..||||++.. ..........|+.++..+. +||||++++++|. ..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~--~~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM--YY 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE--ET
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee--EC
Confidence 3579999999999999999999999999999999852 2334456778999999886 5999999999997 46
Q ss_pred ceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc----------------
Q psy14431 635 KDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---------------- 695 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---------------- 695 (1219)
+.+|+||||++++|.+++... .++...++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 789999999988999999854 4899999999999999999999999999999999999975
Q ss_pred ---------CCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc
Q psy14431 696 ---------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766 (1219)
Q Consensus 696 ---------dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~ 766 (1219)
++.++|+|||++...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 788999999999875543 24568999999999985 45699999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHH---hhhHHhhhhc---------hhhHHHHhcccChhHHHHHHhccccCC
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHER---EKFNQVVVKC---------QKELQELQSQVVEENTSKLKLQMELDS 834 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r---elI~klp~kc---------rk~L~el~p~lspeaiDLLsKMLq~DP 834 (1219)
...+..+.....|.|..+............. .....++... ....+......++.+.+||.+||.+||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 9988888888877665432211000000000 0000000000 000111122345788899999999999
Q ss_pred CCC--HHHHHcchhhh
Q psy14431 835 KDS--EIEQLQGKLAA 848 (1219)
Q Consensus 835 eKR--aiEALqHpwfa 848 (1219)
.+| +.++|+||||.
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 985 88899999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=385.48 Aligned_cols=277 Identities=27% Similarity=0.496 Sum_probs=222.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
..+|.+++.||.|+||.||+|.+..++. ||+|++..... ...+|+.+++.+. ||||++++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCc
Confidence 4569999999999999999999988777 88887753321 1237999999995 999999999986422 2
Q ss_pred ceEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceeccccccc
Q psy14431 635 KDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLAR 708 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr 708 (1219)
..+|+||||+++++...+. ...+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3488999999987766554 45699999999999999999999999999999999999999 78999999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC-CCchhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHADKF 787 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P-~~~d~l 787 (1219)
.+..... ....+||++|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+.+..|+.....++ ..+...
T Consensus 191 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 7654332 34568899999999987666799999999999999999999999999999999999988774433 323222
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhc-ccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCC
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQS-QVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGS 851 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p-~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~ 851 (1219)
...+.. ..++...+.++...++ ..++.+.+||.+||.+||.+ ++.++|.||||.-..
T Consensus 270 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYME-------HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSS-------SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred Chhhhh-------hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 111110 1233344556666665 48899999999999999988 488999999996533
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.20 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=217.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|.+..+|..||||++.+... .......+.+|+.++..+. ||||++++++|. +..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--cCC
Confidence 457789999999999999999999999999999999964321 2234567889999999994 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 8999999997 589998874 67999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 195 ---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----------- 259 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----------- 259 (350)
T ss_dssp ---BCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-----------
T ss_pred ---cccccCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 24568999999999985 556899999999999999999999999998888887777765433222
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+| +.+++.||||..
T Consensus 260 -----------------------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 260 -----------------------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -----------------------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -----------------------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 236788999999999999998 578899999964
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=388.44 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=211.0
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+++.||.|+||.||+|.+..++..||+|++.+.... ......+..|..++..+.+||||++++++|. +.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~ 125 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TE 125 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--EC
Confidence 34578899999999999999999999999999999999755432 2233457789999998877999999999997 56
Q ss_pred ceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++| +|..++.. +.+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|.....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 789999999985 88888874 6799999999999999999999999999999999999999999999999999987544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHhhcCCCCCC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---------HQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---------e~L~kIve~l~P~P~~ 783 (1219)
........+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.... .....|.....+.|
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 282 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 282 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC--
T ss_pred CCCccccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC--
Confidence 444456789999999999984 567999999999999999999999999654321 11222222111111
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--------HHHHcchhhhc
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--------IEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 283 --------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 283 --------------------------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp --------------------------------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred --------------------------------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 23578899999999999999985 58899999954
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.45 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=161.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC--ceE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN--KDL 637 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~--~~L 637 (1219)
.+|.+.++||+|+||.||+|.+ +|+.||||++... .........|+..+..+. |||||++++++...+. ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 5899999998532 111222334555556674 9999999999875433 368
Q ss_pred EEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc--------ccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 638 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~--------GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
|||||||+ |+|.++++...+++..+..++.|++.||.|||+. |||||||||+|||++.+|.+||+|||+|+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999998 6999999988999999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCccc----ccccccccccccCchhhhcc-----ccccccccchhHHHHHHHHHhCCCCCCCC
Q psy14431 709 SLSDSKE----CLTEYIATRWYRAPEILISN-----RRYTHHVDIWSLGCILAEMLQSKPLFPGA 764 (1219)
Q Consensus 709 ~l~~~~~----~~ts~vGT~~Y~APEvLl~~-----~~yT~kSDIWSLG~ILyELLTGkpPF~g~ 764 (1219)
....... .....+||++|+|||++.+. ..|+.++|||||||++|||+||.+||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 7654322 12346899999999998542 24788999999999999999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=382.21 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=218.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+.|.+++.||.|+||.||+|.+..+|..||+|++....... .....+.+|+.++..+. ||||++++++|. +.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~--~~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE--NR 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE--eC
Confidence 456999999999999999999999999999999997543221 23567889999999996 999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC----cceeccccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLAR 708 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr 708 (1219)
..+|+||||++ |+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 78999999996 689999874 5699999999999999999999999999999999999998877 79999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.+.... .....+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..|.......++
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------ 239 (361)
T 2yab_A 168 EIEDGV-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE------ 239 (361)
T ss_dssp ECCTTC-CCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH------
T ss_pred EcCCCC-ccccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc------
Confidence 776533 23567899999999997 4557899999999999999999999999999888888777765433221
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++.+++.+.+||.+||..||.+| +.++|+||||..
T Consensus 240 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 240 ------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 1134568889999999999999984 889999999954
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=388.95 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=218.8
Q ss_pred hccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 554 KDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 554 ~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.-.....+|.+++.||.|+||.||+|.+..+|..||+|++.+... .......+.+|+.++..+. ||||++++++|.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--
Confidence 344567889999999999999999999999999999999864211 1112234678999999985 999999999997
Q ss_pred CCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+...+||||||++ |+|.+++....+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|....
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 5778999999996 699999988889999999999999999999999999999999999999999999999999998765
Q ss_pred Cccc-ccccccccccccCchhhhccc---cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--CCCCCCch
Q psy14431 712 DSKE-CLTEYIATRWYRAPEILISNR---RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV--RPNPPHAD 785 (1219)
Q Consensus 712 ~~~~-~~ts~vGT~~Y~APEvLl~~~---~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l--~P~P~~~d 785 (1219)
.... .....+||+.|+|||++.+.. .|+.++|||||||++|+|++|.+||.+.+....+..|.... .+.|.
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~--- 296 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD--- 296 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT---
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC---
Confidence 4332 234678999999999985432 28899999999999999999999999999888888887643 11111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..+|.+ ++.++++||||..
T Consensus 297 -----------------------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 297 -----------------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp -----------------------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred -----------------------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 1235788999999999988865 4889999999954
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=383.70 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=211.5
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. ||||++++++|. ..+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~~ 82 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVIT--TPT 82 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCC
Confidence 4578999999999999999999999999999999998643221 122356789999999996 999999999997 467
Q ss_pred eEEEEEecchhhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 636 DLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.+|+||||++|+|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 899999999999888876 5679999999999999999999999999999999999999999999999999998766543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+||+.|+|||++.+...+++++|||||||++|+|++|.+||.+.+.......+.....+
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 226 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--------------- 226 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC---------------
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---------------
Confidence 3355689999999999865544578999999999999999999999765432211111000000
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+ -+.+++.+.+||.+||.+||.+| +.++++||||....+
T Consensus 227 --------~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 227 --------M-----------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp --------C-----------CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred --------C-----------cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 0 02357889999999999999985 888899999976443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.03 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=204.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
...+|.+++.||.|+||.||+|.+. .+|..||+|++..... .......+.+|+.++..+. ||||++++++|.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-- 91 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQ-- 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEE--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEE--
Confidence 4568999999999999999999985 6899999999965422 2233456778999999995 999999999997
Q ss_pred CCceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
.++.+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 5678999999997 589888874 56899999999999999999999999999999999999999999999999999865
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
..........+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|.....+.|+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~-------- 242 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP-------- 242 (327)
T ss_dssp -------CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--------
T ss_pred ccCCccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--------
Confidence 54444445678999999999974 456899999999999999999999999998888777777665433222
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 243 --------------------------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 243 --------------------------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp --------------------------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred --------------------------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 2367889999999999999874 68899999953
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=381.05 Aligned_cols=281 Identities=29% Similarity=0.516 Sum_probs=206.1
Q ss_pred CeeE-EeeeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQIN-LLKEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~I-LKkIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.|.+ .++||.|+||.||+|.+. .++..||||++.... ....+.+|+.++..+. ||||++++++|....+..+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeE
Confidence 3555 457999999999999976 468899999985332 2345789999999996 9999999999976567889
Q ss_pred EEEEecchhhHHHHHhhc----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee----ccCCcceecc
Q psy14431 638 YVVFEYMENDLNKVIRDK----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGD 703 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs~----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL----d~dG~VKLiD 703 (1219)
|+||||++++|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.++|+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 999999999998887621 38999999999999999999999999999999999999 6778999999
Q ss_pred cccccccCCcc---cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc---------HHHHH
Q psy14431 704 LGLARSLSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQ 771 (1219)
Q Consensus 704 FGLAr~l~~~~---~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~---------~e~L~ 771 (1219)
||++..+.... ......+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+. ..++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765432 2234568999999999987666799999999999999999999999987654 46778
Q ss_pred HHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhh--chhhHHHH----hcccChhHHHHHHhccccCCCC--CHHHHH
Q psy14431 772 LIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVK--CQKELQEL----QSQVVEENTSKLKLQMELDSKD--SEIEQL 842 (1219)
Q Consensus 772 kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~k--crk~L~el----~p~lspeaiDLLsKMLq~DPeK--RaiEAL 842 (1219)
.|+... .|....|..+.. .+.....+..+... ....+... ....++.+.+||.+||.+||.+ ++.++|
T Consensus 256 ~i~~~~g~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKK---MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGG---STTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhCCCChhhcchhhc---CcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 888777 455555554321 11111111111111 11111111 1234778999999999999998 488999
Q ss_pred cchhhhc
Q psy14431 843 QGKLAAL 849 (1219)
Q Consensus 843 qHpwfaL 849 (1219)
+||||.-
T Consensus 333 ~hp~f~~ 339 (405)
T 3rgf_A 333 QDPYFLE 339 (405)
T ss_dssp TSGGGTS
T ss_pred cChhhcc
Confidence 9999965
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=386.64 Aligned_cols=277 Identities=26% Similarity=0.484 Sum_probs=221.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----C
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----N 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d 633 (1219)
....|.+++.||.|+||.||+|.+..+|..||||++..... ...+|+.+++.+. ||||++++++|... +
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcC-CCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999864321 2347999999995 99999999988532 2
Q ss_pred CceEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-Ccceecccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLA 707 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLA 707 (1219)
..++++||||+++++..++. ...+++..++.|+.||+.||.|||+.||+||||||+||||+.+ +.+||+|||++
T Consensus 125 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 23478999999998777665 3568999999999999999999999999999999999999965 56899999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADK 786 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~ 786 (1219)
+.+.... .....+||++|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+.+..|+.....+ ...+..
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8765433 23456899999999998766679999999999999999999999999999999999988877433 232322
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHh-cccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQ-SQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~-p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+... .++.....+|...+ +..++.+.+||.+||.+||.+| +.++|.||||..
T Consensus 284 ~~~~~~~~-------~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 284 MNPNYTEF-------KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HCSCCCCC-------CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hChhhhhh-------ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 21111100 12333344566555 4678899999999999999984 888999999965
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=390.56 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=219.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.+. ||||++++++|. +.+.+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~--~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSIS--EEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEE--CSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEE--ECCEEE
Confidence 34699999999999999999999999999999999755444455667889999999995 999999999997 577899
Q ss_pred EEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec---cCCcceecccccccccCCc
Q psy14431 639 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd---~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||+.| +|.+.+. .+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999985 8888776 45699999999999999999999999999999999999998 4578999999999887765
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......+||++|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.+...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 236 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE--------- 236 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred CceeecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc---------
Confidence 5555667899999999997 455799999999999999999999999999988888888877664332211
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
++.+++.+.+||.+||.+||.+| +.++|+|||+..
T Consensus 237 ---------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 ---------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 13447889999999999999984 888999999954
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.45 Aligned_cols=282 Identities=26% Similarity=0.454 Sum_probs=217.9
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.....++|.+++.||.|+||.||+|.+..+|..||||++.. .....+.+|+.++..+.+||||+++++++.....
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 34456789999999999999999999999999999999852 2346788999999999889999999999986667
Q ss_pred ceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~ 712 (1219)
..+++||||+. ++|..++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred CceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 88999999998 47777764 488999999999999999999999999999999999999777 899999999987654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCC-CCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP-GASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~-g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||. +.+....+..+.....+... .......
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~ 260 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL--YDYIDKY 260 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH--HHHHHHT
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh--hhHHHHh
Confidence 33 23456899999999998765779999999999999999999998884 45555666666554432110 0000000
Q ss_pred ---CChhHHhhhHHhhhhchhhHHHH-----hcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 792 ---KSKHEREKFNQVVVKCQKELQEL-----QSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ---~s~~~relI~klp~kcrk~L~el-----~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+.....+. ......+... .+.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 261 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 261 NIELDPRFNDILG---RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp TCCCCTHHHHHHC---CCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccchhhhhh---hccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0011111100 0011111111 12368899999999999999984 889999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=386.94 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=207.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+..+.+|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||++++++|. ..
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~--~~ 220 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--TH 220 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEE--ET
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEe--eC
Confidence 4456789999999999999999999999999999999965432 2334456778999999985 999999999997 46
Q ss_pred ceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+.+|+||||++| +|..++. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.++|+|||++....
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 789999999985 8888876 4568999999999999999999998 999999999999999999999999999998755
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.........+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+.......|.....+.|.
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--------- 370 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--------- 370 (446)
T ss_dssp C-----CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT---------
T ss_pred CCCcccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence 544445667899999999997 4567999999999999999999999999998887777777654432221
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++.+.+||.+||.+||.+| +.++++||||..
T Consensus 371 -------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 371 -------------------------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp -------------------------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -------------------------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 236789999999999999987 468899999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=376.11 Aligned_cols=290 Identities=19% Similarity=0.213 Sum_probs=214.2
Q ss_pred cccCeeEEeeeecc--CceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 558 DLQQQINLLKEGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeG--gFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..++|.+++.||.| +||.||+|.+..+|..||||++............+.+|+.+++.+. |||||+++++|. +++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFI--ADN 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETT
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE--ECC
Confidence 46789999999999 9999999999999999999999766555556677888999999996 999999999997 567
Q ss_pred eEEEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 8999999998 589988874 569999999999999999999999999999999999999999999999999986543
Q ss_pred Ccc-------cccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 712 DSK-------ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 712 ~~~-------~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+.....|....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 112234789999999998653 568999999999999999999999999887766665554433221111
Q ss_pred chhhhh---------ccCChhHHhhhH---HhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 784 ADKFYA---------GFKSKHEREKFN---QVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~---------~~~s~~~relI~---klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...... ..........+. ..+...........+.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000000 000000000000 000001111122345678899999999999999985 888999999965
Q ss_pred C
Q psy14431 850 G 850 (1219)
Q Consensus 850 ~ 850 (1219)
.
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=376.32 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=217.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||++++++|. +.+.+|+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCEEEE
Confidence 4699999999999999999999999999999999765555556677889999999995 999999999997 5678999
Q ss_pred EEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cceecccccccccCCcc
Q psy14431 640 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKLiDFGLAr~l~~~~ 714 (1219)
||||+.| +|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999985 8888876 45689999999999999999999999999999999999998654 59999999998776433
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.......+...
T Consensus 186 -~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------- 253 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE---------- 253 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG----------
T ss_pred -ccccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc----------
Confidence 234578999999999974 55699999999999999999999999999888887777776653322211
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
++.+++.+.+||.+||..||.+| +.++|.|||+..
T Consensus 254 --------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 --------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 13457889999999999999985 888999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=368.87 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=217.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||+|++... ......+.+|+.++..+. ||||++++++|. +.+.+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIAR-HRNILHLHESFE--SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCC-CCCCCeEeEEEe--cCCEEE
Confidence 46799999999999999999999999999999998532 334556789999999995 999999999997 467899
Q ss_pred EEEecchh-hHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc--CCcceecccccccccCCc
Q psy14431 639 VVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||++| +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++..+...
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999985 899998753 5899999999999999999999999999999999999987 789999999999877644
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.+.
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 224 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------- 224 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----------
T ss_pred C-ccccccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-----------
Confidence 3 234568999999999974 456899999999999999999999999998888877777765533221
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++.+++.+.+|+.+||..||.+| +.++|+||||.-
T Consensus 225 -------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 225 -------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 1134568899999999999999984 888999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.97 Aligned_cols=283 Identities=28% Similarity=0.464 Sum_probs=213.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---- 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---- 633 (1219)
.+++|.+++.||.|+||.||+|.+..+|..||||++..... .......++..+..+. ||||++++++|....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccc
Confidence 36789999999999999999999999999999998854322 2234567777778885 999999999986422
Q ss_pred -CceEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHH--hcccccCCCCCCCeeecc-CCcceeccc
Q psy14431 634 -NKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIH--ACKVMHRDLKPSNILIDK-SCSIKIGDL 704 (1219)
Q Consensus 634 -~~~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLH--S~GIVHRDLKPsNILLd~-dG~VKLiDF 704 (1219)
...+|+||||++++|...+. ...+++..++.++.||+.||.||| +.||+||||||+|||++. ++.++|+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 23488999999998766554 346888999999999999999999 999999999999999997 899999999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
|++..+..... ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++.....++..+
T Consensus 177 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 177 GSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 99987765432 34567899999999987666789999999999999999999999999999999999888775444322
Q ss_pred -hhhhhccCChhHHhhhHHhhhhchhhHHHHhcc----cChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 785 -DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQ----VVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 785 -d~l~~~~~s~~~relI~klp~kcrk~L~el~p~----lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
..+...... ..+......++...++. .++.+.+||.+||.+||.+| +.++|+||||.-...
T Consensus 256 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 256 LRKLNPSHTD-------VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHCTTCCC-------GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHhcccchhh-------ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 221110000 01112233445555554 46789999999999999985 888999999976433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=368.88 Aligned_cols=286 Identities=30% Similarity=0.498 Sum_probs=223.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC---------chhHHHHHHHHHHHHhccCCCCccEEeeee
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---------KTDAQRTYREILFLKSFQRHPNIITMLDIY 629 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s---------~~~~e~~lREI~ILr~L~~HPNIVkL~gvf 629 (1219)
.++|.+++.||.|+||.||+|.+.. |..||||++...... ......+.+|+.++..+. ||||++++++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIF 98 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeeeE
Confidence 4679999999999999999999865 899999998643221 222467889999999996 99999999998
Q ss_pred ec---cCCceEEEEEecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccc
Q psy14431 630 KA---VNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 630 e~---~d~~~LyLVMEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
.. .....+|+||||++|+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 54 234578999999999999988743 5899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 705 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 705 GLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
|++....... .....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++.....++...
T Consensus 179 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 179 NLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred Cccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 9998654432 234568999999999986657799999999999999999999999999999998888888775443221
Q ss_pred hhhhhccCChhHHhhhHHhh-hhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 785 DKFYAGFKSKHEREKFNQVV-VKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp-~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
.. .+..+.....+.... ......+....+..++.+.+||.+||.+||.+| +.++|+||||.-.
T Consensus 258 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 258 VV---MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HH---HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hh---hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 11 122333333332222 123445667778889999999999999999884 8899999999653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.26 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=219.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+. ||||+++++++. .++..|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE--cCCEEE
Confidence 45799999999999999999999999999999999766555566677889999999995 999999999987 567899
Q ss_pred EEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceecccccccccCCc
Q psy14431 639 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLAr~l~~~ 713 (1219)
+||||+.+ +|.+.+. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999985 7877766 456899999999999999999999999999999999999987665 999999999876644
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.......+...
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 230 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------- 230 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred c-cccCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh---------
Confidence 3 234568999999999974 55689999999999999999999999999888877777766553322211
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+.+++.+.+|+.+||.+||.+| +.++|.||||.....
T Consensus 231 ---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 231 ---------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ---------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ---------------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 12347789999999999999985 888999999976433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=367.97 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=216.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+.|.+.+.||.|+||.||+|.+..+|..||+|++....... .....+.+|+.++..+. ||||++++++|. +.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--NK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence 346999999999999999999999999999999996543221 23567889999999996 999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC----cceeccccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLAR 708 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr 708 (1219)
..+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 78999999997 599999874 5699999999999999999999999999999999999999887 79999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
...... .....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....+.+.
T Consensus 167 ~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 238 (326)
T 2y0a_A 167 KIDFGN-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 238 (326)
T ss_dssp ECCTTS-CCCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH------
T ss_pred ECCCCC-ccccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc------
Confidence 775432 23456899999999997 4567899999999999999999999999988887777766554422211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++..++.+.+||.+||..||.+| +.++|+||||..
T Consensus 239 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 239 ------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp ------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 1234568889999999999999985 788999999954
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=361.44 Aligned_cols=281 Identities=33% Similarity=0.550 Sum_probs=224.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeec---c
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKA---V 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~---~ 632 (1219)
.++|.+++.||.|+||.||+|.+. .+|..||+|++............+.+|+.+++.+. +||||++++++|.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 367999999999999999999995 77899999998654433333335667888877774 59999999999862 2
Q ss_pred CCceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
....+|+||||++|+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 3567899999999999999874 3489999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 788 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~ 788 (1219)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..++.... |.+..|+...
T Consensus 170 ~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 170 YSFQM-ALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCGGG-GGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccCCC-CccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 65432 334567899999999984 45689999999999999999999999999998888888887663 3333333211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. .+ .. .+......++....+.+++.+.+||.+||.+||.+| +.++|.||||.-
T Consensus 248 ~---~~--~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 248 A---LP--RQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp S---SC--GG---GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred c---cc--hh---hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 0 00 00 011112223444556788999999999999999985 888999999954
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.07 Aligned_cols=252 Identities=24% Similarity=0.426 Sum_probs=215.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|...++||.|+||.||+|.+..+|+.||||++.... ......+.+|+.++..+. ||||++++++|. .++.+|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYL--VGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEEEEE
Confidence 4778889999999999999999999999999986432 334567889999999995 999999999987 46689999
Q ss_pred Eecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccccc
Q psy14431 641 FEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 719 (1219)
Q Consensus 641 MEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts 719 (1219)
|||++ ++|.+++....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++............
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 99997 58999998888999999999999999999999999999999999999999999999999999877654444456
Q ss_pred ccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhh
Q psy14431 720 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREK 799 (1219)
Q Consensus 720 ~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~rel 799 (1219)
.+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....|....
T Consensus 201 ~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------- 263 (321)
T 2c30_A 201 LVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------------- 263 (321)
T ss_dssp CCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTT----------------
T ss_pred ccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCc----------------
Confidence 7899999999997 45578999999999999999999999999888777666665543332211
Q ss_pred hHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 800 FNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 800 I~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+++.+.+|+.+||..||.+| +.+++.||||.-
T Consensus 264 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 264 ---------------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ---------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ---------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 12347789999999999999985 788899999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=380.06 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=208.9
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+++.||.|+||.||+|.+..++..||||++.+.... ......+..|..++....+||||++++++|. +.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eC
Confidence 34567899999999999999999999999999999999755332 2334456677776544336999999999997 56
Q ss_pred ceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||+.| +|..++.. +.+++..++.++.+|+.||.|||+.||+||||||+|||++.+|+++|+|||++.....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 789999999985 89888874 5699999999999999999999999999999999999999999999999999987544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.......+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------- 259 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----------- 259 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC-----------
T ss_pred CCCccccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC-----------
Confidence 444456678999999999974 55699999999999999999999999999888887777766432211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH------HHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE------IEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 260 -----------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 260 -----------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp -----------------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred -----------------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 23477899999999999999974 57899999954
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=387.20 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=216.9
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+...++|.++++||.|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++..+. ||||++++++|. +.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~--~~ 146 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQ--DD 146 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEE--CS
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--eC
Confidence 3456789999999999999999999999999999999964211 1112233678999999884 999999999997 57
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+.+|||||||+ |+|..++.. +.+++..++.|+.||+.||.|||+.|||||||||+|||++.+|.+||+|||+|....
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 78999999996 699999975 679999999999999999999999999999999999999999999999999997665
Q ss_pred Cccc-ccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--CCCCCCc
Q psy14431 712 DSKE-CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV--RPNPPHA 784 (1219)
Q Consensus 712 ~~~~-~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l--~P~P~~~ 784 (1219)
.... .....+||++|+|||++.. ...|+.++|||||||++|+|++|.+||.+.+....+..|+... .+.|..
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~- 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ- 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS-
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc-
Confidence 4332 2334689999999999852 4568999999999999999999999999999888888887543 222221
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC----CHHHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD----SEIEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK----RaiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..+|.+ ++.++++||||..
T Consensus 306 ------------------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 306 ------------------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp ------------------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred ------------------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 1345888999999999998876 3688999999953
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=371.81 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=210.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc---cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~---~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+.|.+++.||.|+||.||+|.+..+|..||||++.... ........+.+|+.++..+. ||||++++++|. +.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~ 100 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS--SDGM 100 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eCCE
Confidence 46999999999999999999999999999999985332 11123567889999999995 999999999997 4678
Q ss_pred EEEEEecch-hhHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceecccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLA 707 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLA 707 (1219)
+|+|||||. ++|...+... .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999998 5887776532 4899999999999999999999999999999999999987654 999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
.............+||++|+|||++. +..++.++|||||||++|+|++|.+||.+.+ ...+..+.....+.++
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~----- 253 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP----- 253 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH-----
T ss_pred eEecCCCeeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc-----
Confidence 88766544445678999999999974 5568999999999999999999999998743 3444445443322111
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 254 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 254 -------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp -------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 1124568889999999999999985 888999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=353.70 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=193.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|+.||+|++...... ........+...+....+||||+++++++. +++.+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALF--REGDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCCEE
Confidence 56899999999999999999999999999999998644322 233344455555444446999999999997 567899
Q ss_pred EEEecchhhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 639 VVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+||||++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999999988777653 5699999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhh---hccccccccccchhHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKECLTEYIATRWYRAPEIL---ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvL---l~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
... .....||+.|+|||++ .....++.++|||||||++|+|++|.+||.+. .....+..+.....+..+
T Consensus 163 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 235 (290)
T 3fme_A 163 DVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP------ 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC------
T ss_pred ccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc------
Confidence 332 2345799999999997 35567899999999999999999999999863 333344444333222211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+++.+.+|+.+||..||.+| +.++++||||..
T Consensus 236 --------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 236 --------------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp --------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --------------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 01346789999999999999885 888899999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=366.07 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=207.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-+++|.+++.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.++..+. ||||+++++++. +++.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~ 80 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQ 80 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cCCeE
Confidence 46789999999999999999999999999999999853322 222356789999999995 999999999987 56789
Q ss_pred EEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc--
Q psy14431 638 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-- 713 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~-- 713 (1219)
|+||||++| +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999975 88888874 46999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+................+.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP---------- 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT----------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc----------
Confidence 2223456899999999998665555889999999999999999999998765432222111111111110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
...+++.+.+||.+||.+||.+| +.++++||||.-.
T Consensus 231 ---------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 231 ---------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ---------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 13457888999999999999985 8889999999653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=383.35 Aligned_cols=259 Identities=22% Similarity=0.255 Sum_probs=215.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
....++|.+++.||.|+||.||+|.+..+|+.||||++.+... .......+.+|+.++..+. ||||++++++|. +.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~--~~ 133 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQ--DE 133 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEE--CS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEe--eC
Confidence 4457789999999999999999999999999999999964321 1122334678999999885 999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+.+||||||++ |+|..++.. ..+++..++.|+.+|+.||.|||+.||+||||||+|||++.+|++||+|||++....
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 78999999996 699999875 369999999999999999999999999999999999999999999999999998765
Q ss_pred Cccc-ccccccccccccCchhhhc------cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc--CCCCC
Q psy14431 712 DSKE-CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV--RPNPP 782 (1219)
Q Consensus 712 ~~~~-~~ts~vGT~~Y~APEvLl~------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l--~P~P~ 782 (1219)
.... .....+||+.|+|||++.. ...|+.++|||||||++|+|++|.+||.+.+....+..|+... .+.|.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 4332 2234689999999999853 3568999999999999999999999999998888888877543 11111
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-----HHHHHcchhhhc
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-----EIEQLQGKLAAL 849 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-----aiEALqHpwfaL 849 (1219)
..+.+++.+.+||.+||. +|.+| +.+++.||||..
T Consensus 294 -------------------------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 294 -------------------------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp ----------------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred -------------------------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 113458899999999999 99886 778899999954
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=383.08 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=216.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||+||+|.+..+|..||||++............+.+|+.++..+. ||||++++++|. +...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILE--DSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEE--cCCEEE
Confidence 45699999999999999999999999999999999755444455677899999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec---cCCcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd---~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||+. ++|.+.+. .+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++..+...
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999998 48877775 56799999999999999999999999999999999999995 4567999999999876544
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....+||++|+|||++. +.|+.++|||||||++|+|++|.+||.+.+....+..+.....+.+...
T Consensus 178 ~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 245 (486)
T 3mwu_A 178 T-KMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ--------- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG---------
T ss_pred C-ccCCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc---------
Confidence 3 234568999999999974 3589999999999999999999999999998888888877653322110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||.+||.+| +.++|+|||+.-
T Consensus 246 ---------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 246 ---------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ---------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ---------------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 13457889999999999999985 888999999965
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=379.07 Aligned_cols=277 Identities=27% Similarity=0.397 Sum_probs=222.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc-----CCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~-----~HPNIVkL~gvfe~~d 633 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++... ......+.+|+.++..+. +||||+.++++|. .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~--~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT--F 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE--E
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc--c
Confidence 45799999999999999999999999999999998532 233456778888888874 5789999999987 4
Q ss_pred CceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc--ceeccccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLAR 708 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~--VKLiDFGLAr 708 (1219)
..++|+||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 6789999999999999998753 3899999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
..... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+..+.+..|+....+++..+....
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ecCCc---ccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 65433 34568999999999985 456899999999999999999999999999999999999888866554432211
Q ss_pred hccCChhHHhhhHH--hh---------------------------hhchhhHHHHhc-ccChhHHHHHHhccccCCCC--
Q psy14431 789 AGFKSKHEREKFNQ--VV---------------------------VKCQKELQELQS-QVVEENTSKLKLQMELDSKD-- 836 (1219)
Q Consensus 789 ~~~~s~~~relI~k--lp---------------------------~kcrk~L~el~p-~lspeaiDLLsKMLq~DPeK-- 836 (1219)
. ....++.. .+ ......+...++ ..++.+.|||.+||.+||.+
T Consensus 327 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 327 K-----RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp T-----THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred h-----hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0 00000000 00 001122333443 34778999999999999998
Q ss_pred CHHHHHcchhhhc
Q psy14431 837 SEIEQLQGKLAAL 849 (1219)
Q Consensus 837 RaiEALqHpwfaL 849 (1219)
++.++|+||||.-
T Consensus 402 ta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 402 TPGQALRHPWLRR 414 (429)
T ss_dssp CHHHHHTSTTTC-
T ss_pred CHHHHhCChhhcc
Confidence 5889999999965
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.37 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=210.4
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc---cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~---~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+|.+++.||.|+||.||+|.+..++..||+|++.... ........+.+|+.++..+. ||||++++++|. +.+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~ 102 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYE--DEQY 102 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhc--cCCe
Confidence 35999999999999999999999999999999986432 13345677889999999995 999999999997 5678
Q ss_pred EEEEEecch-hhHHHHHh-----------------------------------------hccCChHHHHHHHHHHHHHHH
Q psy14431 637 LYVVFEYME-NDLNKVIR-----------------------------------------DKILKDVHIRYIMFQLCNGLS 674 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr-----------------------------------------s~~LseeeVr~Ia~QILsALa 674 (1219)
+|+||||++ |+|.+++. ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999997 68988884 112467778899999999999
Q ss_pred HHHhcccccCCCCCCCeeeccCC--cceecccccccccCCccc----ccccccccccccCchhhhc-cccccccccchhH
Q psy14431 675 YIHACKVMHRDLKPSNILIDKSC--SIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILIS-NRRYTHHVDIWSL 747 (1219)
Q Consensus 675 YLHS~GIVHRDLKPsNILLd~dG--~VKLiDFGLAr~l~~~~~----~~ts~vGT~~Y~APEvLl~-~~~yT~kSDIWSL 747 (1219)
|||+.||+||||||+|||++.++ .++|+|||++..+..... ......||+.|+|||++.+ ...++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 899999999986543211 2345679999999999854 2578999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHH
Q psy14431 748 GCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLK 827 (1219)
Q Consensus 748 G~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLs 827 (1219)
||++|+|++|.+||.+.+....+..+.....+.+... .+.+++.+.+||.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~li~ 312 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN------------------------------YNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG------------------------------GGGSCHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc------------------------------cccCCHHHHHHHH
Confidence 9999999999999999888887777766543322211 1235788999999
Q ss_pred hccccCCCCC--HHHHHcchhhhcC
Q psy14431 828 LQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 828 KMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+||.+||.+| +.++|+||||...
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999985 8889999999763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=401.63 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=220.9
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+.+|.+++.||.|+||.||+|.+..+|+.||||++.+.. ........+..|..++..+.+||||+.++++|. +.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~ 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TM 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eC
Confidence 345788999999999999999999999999999999996532 122344667889999998878999999999987 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+||||||+. |+|..++.. +.+++..++.|+.||+.||.|||+.|||||||||+||||+.+|+++|+|||++.....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 78999999998 589988874 6799999999999999999999999999999999999999999999999999986544
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
........+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---------- 563 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---------- 563 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----------
T ss_pred CCcccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence 44445677899999999997 4567999999999999999999999999999988888888765433222
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|. .+++.||||..
T Consensus 564 ------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 564 ------------------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp ------------------------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred ------------------------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 2478899999999999999985 67899999954
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.14 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=212.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+++|.+++.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||++++++|. +.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEe--cCC
Confidence 457889999999999999999999999999999999864321 1122456788999999996 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 8999999998 588888874 56899999999999999999999999999999999999999999999999998765443
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.....+.|.
T Consensus 163 ~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 228 (279)
T 3fdn_A 163 R--RTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----------- 228 (279)
T ss_dssp -------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred c--ccccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC-----------
Confidence 2 3456899999999997 4566899999999999999999999999988877777666554433322
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
..++.+.+||.+||.+||.+| +.++++||||....+
T Consensus 229 -----------------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 229 -----------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp -----------------------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred -----------------------cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 136678899999999999984 888999999976443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=367.45 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=187.8
Q ss_pred CeeEE---eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINL---LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~IL---KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+|.+. +.||.|+||.||+|.+..+|..||||++... ......+|+.++..+.+||||++++++|. +...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~ 81 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHT 81 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEE
Confidence 45554 7899999999999999999999999998532 34567789999999988999999999997 56789
Q ss_pred EEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cceecccccccccCC
Q psy14431 638 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKLiDFGLAr~l~~ 712 (1219)
|+||||++| +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999999985 89998874 5699999999999999999999999999999999999998766 799999999987766
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhhcCCCCCCch
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-------SHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~-------~e~L~kIve~l~P~P~~~d 785 (1219)
........+||++|+|||++ .+..++.++|||||||++|+|++|.+||.+.+. ...+..|.....+.+.
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 237 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG--- 237 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS---
T ss_pred CCCcccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc---
Confidence 55555667889999999997 455699999999999999999999999987543 2233333322211111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
...+.+++.+.+||.+||.+||.+| +.+++.||||...
T Consensus 238 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 ---------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 1124568899999999999999985 6778999999653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=360.99 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=205.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++++||.|+||+||+|.+..+|+.||||++...............|+..+..+.+||||++++++|. +++.+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEEEE
Confidence 46999999999999999999999999999999987655555666677788888888867999999999997 5778999
Q ss_pred EEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 213 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AG 213 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CC
Confidence 999999999988874 459999999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+... ...+..... +
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~--~---------------- 270 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYL--P---------------- 270 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCC--C----------------
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCC--C----------------
Confidence 44579999999999743 689999999999999999999876654322 122211110 0
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
....+.+++.+.+|+.+||.+||.+| +.++|+||||.
T Consensus 271 --------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 271 --------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp --------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred --------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 01224568899999999999999984 88889999995
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=368.51 Aligned_cols=252 Identities=29% Similarity=0.387 Sum_probs=208.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++..... ...+|+.++..+.+||||++++++|. ++..+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEE
Confidence 4569999999999999999999999999999999964432 23468888988877999999999997 577899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC----CcceecccccccccCC
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLARSLSD 712 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d----G~VKLiDFGLAr~l~~ 712 (1219)
+||||+. |+|.+++. .+.+++..+..++.||+.||.|||+.||+||||||+|||+... +.++|+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999997 58888876 4569999999999999999999999999999999999998533 3599999999987765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA---STSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~---s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
........+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+. +....+..|.....+.+...
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~----- 246 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY----- 246 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT-----
T ss_pred CCCceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc-----
Confidence 544455678999999999974 456899999999999999999999999863 34445555555443322211
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..||.+| +.++++||||..
T Consensus 247 -------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 -------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp -------------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred -------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 13457889999999999999985 888899999954
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=356.56 Aligned_cols=272 Identities=22% Similarity=0.296 Sum_probs=202.0
Q ss_pred cCeeEE-eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINL-LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~IL-KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+.|.++ +.||.|+||.||+|.+..+|..||||++... .......+.+|+.++..+.+||||++++++|. +.+.+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~--~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFE--EEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe--eCCEEE
Confidence 457775 6799999999999999999999999998644 23345678899999999767999999999997 467899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLAr~l~~~ 713 (1219)
+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999998 689998874 56899999999999999999999999999999999999998776 999999999765422
Q ss_pred c-------cccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC
Q psy14431 714 K-------ECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782 (1219)
Q Consensus 714 ~-------~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~ 782 (1219)
. ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------------- 234 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC------------- 234 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS-------------
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc-------------
Confidence 1 11234569999999999853 24588999999999999999999999987643210
Q ss_pred CchhhhhccCChh-HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 783 HADKFYAGFKSKH-EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 783 ~~d~l~~~~~s~~-~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
.|... ...+. ....+..+............+.+++.+.+||.+||.+||.+| +.++|+||||....
T Consensus 235 ~~~~~---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 235 GWDRG---EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CC-------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccccc---ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 00000 00000 001111111111111112235578899999999999999985 88899999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=382.79 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=211.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|.++++||.|+||+||+|.+..++..||||++............+.+|+.++..+. ||||++++++|. +...+|+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE--DKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCEEEE
Confidence 4699999999999999999999999999999999765544445667889999999995 999999999997 5678999
Q ss_pred EEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---CcceecccccccccCCcc
Q psy14431 640 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr~l~~~~ 714 (1219)
|||||.| +|.+.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.. +.++|+|||++..+....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999984 8877776 4679999999999999999999999999999999999999764 459999999998776543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.....+||++|+|||++. ..|+.++|||||||++|+|++|.+||.+.+....+..+.....+.+...
T Consensus 194 -~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 260 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE---------- 260 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG----------
T ss_pred -cccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh----------
Confidence 335568999999999973 4699999999999999999999999999998888888877654332211
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
++.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 261 --------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 --------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 13457889999999999999984 889999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.21 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=206.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+.+||||++++++|. +.+.+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~--~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA--EDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE--ETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEE
Confidence 356999999999999999999999999999999997665556667788999999999967999999999987 467899
Q ss_pred EEEecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---------------
Q psy14431 639 VVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC--------------- 697 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG--------------- 697 (1219)
+||||+++ +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999975 99999874 4589999999999999999999999999999999999998544
Q ss_pred ----cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q psy14431 698 ----SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773 (1219)
Q Consensus 698 ----~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kI 773 (1219)
.++|+|||++....... ...||+.|+|||++.+...+++++|||||||++|+|++|.+||...+ ....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred CCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 79999999998766432 34689999999998666577889999999999999999998875442 23333
Q ss_pred HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 774 VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 774 ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....|..+ +.+++.+.+|+.+||..||.+| +.++++||||..
T Consensus 241 ~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 241 RQGRLPRIP---------------------------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HTTCCCCCS---------------------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HcCCCCCCC---------------------------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 333222111 2347789999999999999984 888899999964
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=370.31 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=196.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
...++|.+++.||.|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.+. ||||++++++|. +.+.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~ 90 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLR-HPNIVRFKEVIL--TPTH 90 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCC-CCCCCcEEEEEe--eCCE
Confidence 346789999999999999999999999999999999964322 2245779999999996 999999999997 5678
Q ss_pred EEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc--ceecccccccccCC
Q psy14431 637 LYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSD 712 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~--VKLiDFGLAr~l~~ 712 (1219)
+|+||||+. |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999997 58988886 467999999999999999999999999999999999999987765 99999999975433
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHH----HHHHhhcCCCCCCchhhh
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL----QLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L----~kIve~l~P~P~~~d~l~ 788 (1219)
.. .....+||++|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+ ..+.......|.
T Consensus 171 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 243 (361)
T 3uc3_A 171 HS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------ 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT------
T ss_pred cC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC------
Confidence 22 2345689999999999866554455699999999999999999999875543222 222222111111
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+++.+.+||.+||.+||.+| +.++++||||.-
T Consensus 244 --------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 244 --------------------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp --------------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred --------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 01347889999999999999985 888999999954
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.83 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=211.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
+++|.+++.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++..+. ||||+++++++...+...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCe
Confidence 5679999999999999999999999999999999964321 1234567889999999995 999999999986556678
Q ss_pred EEEEEecchhhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 99999999988877776 356899999999999999999999999999999999999999999999999999876432
Q ss_pred --ccccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 714 --KECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 714 --~~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+.......+.....+.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 233 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--------- 233 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC---------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC---------
Confidence 1223355789999999998542 2347899999999999999999999998877766666655432222
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+..++.+.+||.+||..||.+| +.++++||||.-...
T Consensus 234 -------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 -------------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -------------------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -------------------------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 1236778899999999999985 788899999976433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=380.54 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=216.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. ||||++++++|. +.+.+|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~ 102 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFE--DKGYFY 102 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eCCEEE
Confidence 4699999999999999999999999999999998654322 345677899999999995 999999999997 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||+. ++|.+.+. .+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999997 58888776 4679999999999999999999999999999999999999 46788999999999876644
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..|.....+.+...
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 250 (484)
T 3nyv_A 183 K-KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ--------- 250 (484)
T ss_dssp C-SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG---------
T ss_pred c-ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------
Confidence 3 2345689999999999743 589999999999999999999999999998888888877653322110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||.+||.+| +.++|.|||+..
T Consensus 251 ---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 251 ---------------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp ---------------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ---------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 13457889999999999999984 888999999965
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=367.89 Aligned_cols=277 Identities=29% Similarity=0.470 Sum_probs=219.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC-----ccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-----IITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN-----IVkL~gvfe~~d 633 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++... ......+.+|+.++..+..|++ |+.++++|. .
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--~ 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--F 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE--E
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec--c
Confidence 57899999999999999999999999999999998532 2334567788899888875664 899999887 4
Q ss_pred CceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHH--hcccccCCCCCCCeeec--cCCcceeccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIH--ACKVMHRDLKPSNILID--KSCSIKIGDLGL 706 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLH--S~GIVHRDLKPsNILLd--~dG~VKLiDFGL 706 (1219)
.+.+|+||||++++|.+++... .+++..++.++.||+.||.||| ..||+||||||+|||++ .++.++|+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 6789999999999999998753 4899999999999999999999 57999999999999995 477899999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
+...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..|+....+++..+..
T Consensus 208 a~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 208 SCQLGQR---IYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ceecccc---cccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876543 34568999999999985 4569999999999999999999999999999999999998887655543321
Q ss_pred hhhccCChhHHhhhHHhhhh-----------------chhhHHHHhcc------------------cChhHHHHHHhccc
Q psy14431 787 FYAGFKSKHEREKFNQVVVK-----------------CQKELQELQSQ------------------VVEENTSKLKLQME 831 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~k-----------------crk~L~el~p~------------------lspeaiDLLsKMLq 831 (1219)
. .+....++..++.. ....+...++. .++.+.+||.+||.
T Consensus 284 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 284 Q-----APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp T-----CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred h-----hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 1 11122222222211 01112222210 11368999999999
Q ss_pred cCCCC--CHHHHHcchhhhc
Q psy14431 832 LDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 832 ~DPeK--RaiEALqHpwfaL 849 (1219)
+||.+ ++.++|+||||.-
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC
T ss_pred CChhhCCCHHHHhcCccccc
Confidence 99998 5888999999954
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.72 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=214.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.++..+. ||||++++++|. ++..+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLD-HPNIIRLYETFE--DNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCeEEE
Confidence 469999999999999999999999999999999865433 33567889999999995 999999999997 5678999
Q ss_pred EEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCcc
Q psy14431 640 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||+++ +|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999974 8888776 4568999999999999999999999999999999999999 778899999999998765433
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.+.......+.....+.+..
T Consensus 164 -~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 229 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----------- 229 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----------
T ss_pred -chhccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----------
Confidence 234567999999999973 348999999999999999999999999988887777776654333221
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+.+++.+.+|+.+||.+||.+| +.++|+||||.-
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 230 -------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 123457889999999999999985 788999999965
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=359.24 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=207.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC--c
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN--K 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~--~ 635 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. ||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCCCc
Confidence 45799999999999999999999999999999999654332 233457789999999995 9999999999874332 3
Q ss_pred eEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|+||||++ ++|.+++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 5699999997 68999987 456999999999999999999999999999999999999999999999999999876543
Q ss_pred cc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 714 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 714 ~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+......++
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--------- 239 (311)
T ss_dssp ------------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---------
T ss_pred ccccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---------
Confidence 21 223457899999999984 55689999999999999999999999998887766555544321111
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
....+.+++.+.+++.+||..||.+| ..+++.|+|+...
T Consensus 240 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 ---------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11124568889999999999999997 6788999999763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.98 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=216.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+.|.+++.||.|+||.||+|.+..+|..||+|++....... .....+.+|+.++..+. ||||++++++|. +..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~ 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE--NRT 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCC
Confidence 46999999999999999999999999999999996543221 23567889999999996 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC----cceecccccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr~ 709 (1219)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 8999999996 599999874 5689999999999999999999999999999999999999887 799999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....+.++
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 239 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------- 239 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCccc-cccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------
Confidence 66533 23456799999999997 4556899999999999999999999999998887777776654432211
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+..++.+.+||.+||..||.+| +.+++.||||..
T Consensus 240 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 240 -----------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp -----------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 1234567889999999999999984 888999999954
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.27 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=216.5
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
....+++|.+++.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||+++++++. +
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~ 85 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFH--D 85 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--C
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEE--c
Confidence 45668899999999999999999999999999999999864321 1222456789999999995 999999999987 5
Q ss_pred CceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+.+|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 678999999997 589888874 568999999999999999999999999999999999999999999999999997655
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+.|
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 232 (284)
T 2vgo_A 166 SLR--RRTMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP---------- 232 (284)
T ss_dssp SSC--BCCCCSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------
T ss_pred ccc--cccccCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----------
Confidence 432 24567999999999974 55689999999999999999999999998887776666655432221
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
+.+++.+.++|.+||..||.+| +.+++.||||.....
T Consensus 233 ------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 233 ------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ------------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 1246778999999999999885 888999999976443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.59 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=216.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.+++|.+++.||.|+||.||+|.+..+|+.||+|++............+.+|+.++..+. ||||+++++++....+..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence 367899999999999999999999999999999999765545556678889999999995 9999999998865567789
Q ss_pred EEEEecchh-hHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhcc-----cccCCCCCCCeeeccCCcceeccccc
Q psy14431 638 YVVFEYMEN-DLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACK-----VMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~G-----IVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999985 899988743 3899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
+..............||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---- 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---- 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC----
T ss_pred heeeccccccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC----
Confidence 987665433334567899999999974 456899999999999999999999999988877766666655432211
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++.+.+++.+||..||.+| +.+++.|+|+.-
T Consensus 238 -----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 238 -----------------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -----------------------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1246788999999999999885 888899999855
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=352.29 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=211.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.++|.+++.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||+++++++. .++.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~--~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE--EDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE--CSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee--eCCeE
Confidence 4579999999999999999999999999999999864433 3344567889999999995 999999999987 56789
Q ss_pred EEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 638 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
|+||||++| +|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999975 89998874 569999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....|..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 232 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV------------- 232 (294)
T ss_dssp --------CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH-------------
T ss_pred cccCccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc-------------
Confidence 2233467999999999974 55689999999999999999999999998877655444433222111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
.....+.+++.+.+++.+||..||.+| ..+++.+.|..+..+.
T Consensus 233 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 ----------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 111234567889999999999999997 5778999998774443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=381.10 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=214.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-----------hhHHHHHHHHHHHHhccCCCCccEEe
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----------TDAQRTYREILFLKSFQRHPNIITML 626 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-----------~~~e~~lREI~ILr~L~~HPNIVkL~ 626 (1219)
-...|.++++||.|+||+||+|.+..++..||||++....... .....+.+|+.++..+. ||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEE
Confidence 3567999999999999999999999999999999996543221 33567889999999995 99999999
Q ss_pred eeeeccCCceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---ccee
Q psy14431 627 DIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKI 701 (1219)
Q Consensus 627 gvfe~~d~~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKL 701 (1219)
++|. +...+|+|||||+| +|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|
T Consensus 113 ~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 113 DVFE--DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEE--CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEE--cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9997 57789999999985 8888776 46799999999999999999999999999999999999998776 6999
Q ss_pred cccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC
Q psy14431 702 GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781 (1219)
Q Consensus 702 iDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P 781 (1219)
+|||++..+.... .....+||++|+|||++. ..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.+
T Consensus 191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EECCCCEEcCCCC-ccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999998776543 235568999999999974 4589999999999999999999999999998888887766543221
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. ..++.+++.+.+||.+||.+||.+| +.++|.|||+.-
T Consensus 268 ~------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 F------------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp H------------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred c------------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 1 0124568899999999999999984 888999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.82 Aligned_cols=282 Identities=27% Similarity=0.377 Sum_probs=213.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc-------CCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-------RHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~-------~HPNIVkL~gvfe~ 631 (1219)
.++|.++++||.|+||.||+|.+..+|..||||++... ......+.+|+.++..+. +||||++++++|..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 36799999999999999999999999999999998532 334567889999999986 27889999999863
Q ss_pred c--CCceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCC--------
Q psy14431 632 V--NNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSC-------- 697 (1219)
Q Consensus 632 ~--d~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG-------- 697 (1219)
. ++..+|+||||++++|.+.+.. ..+++..++.|+.||+.||.|||+. ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 4567999999999888877763 3599999999999999999999998 999999999999998775
Q ss_pred -----------------------------------------cceecccccccccCCcccccccccccccccCchhhhccc
Q psy14431 698 -----------------------------------------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 736 (1219)
Q Consensus 698 -----------------------------------------~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~ 736 (1219)
.++|+|||++...... ....+||+.|+|||++. +.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~-~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI-GS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH-TS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc-CC
Confidence 7999999999876543 34568999999999985 45
Q ss_pred cccccccchhHHHHHHHHHhCCCCCCCCC------cHHHHHHHHhhcCCCCCCchhhhhccCChhHH--hhhHHhhhhch
Q psy14431 737 RYTHHVDIWSLGCILAEMLQSKPLFPGAS------TSHQLQLIVNLVRPNPPHADKFYAGFKSKHER--EKFNQVVVKCQ 808 (1219)
Q Consensus 737 ~yT~kSDIWSLG~ILyELLTGkpPF~g~s------~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r--elI~klp~kcr 808 (1219)
.++.++|||||||++|+|++|.+||.+.+ ....+..+.....+.|..+.... .+....+. ..+..+....+
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG-KYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHC-TTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcc-cccccccCCccccccccccCC
Confidence 68999999999999999999999998755 44566677776655543221000 00000000 00000000000
Q ss_pred hhHHHHh-------cccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 809 KELQELQ-------SQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 809 k~L~el~-------p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..+...+ ...++.+.+||.+||.+||.+| +.++|+||||.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111111 1234578899999999999984 88999999995
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.74 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=213.6
Q ss_pred CeeEE-eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINL-LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~IL-KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.+. +.||.|+||.||+|.+..+|..||+|++............+.+|+.++..+.+||||++++++|. +...+|+
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~~~~~l 106 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NTSEIIL 106 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eCCeEEE
Confidence 36666 88999999999999999999999999997665555566788999999999988899999999997 5678999
Q ss_pred EEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccccccccCC
Q psy14431 640 VFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFGLAr~l~~ 712 (1219)
||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999985 88888753 56899999999999999999999999999999999999987 78999999999987754
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.....+.+...
T Consensus 187 ~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 256 (327)
T 3lm5_A 187 AC-ELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET-------- 256 (327)
T ss_dssp --------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT--------
T ss_pred cc-ccccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh--------
Confidence 33 23456899999999997 455789999999999999999999999999888877777766553332211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
++.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 257 ----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 257 ----------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp ----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred ----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 13447789999999999999985 888899999954
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=362.99 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=213.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. ||||++++++|. ..+.+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--REHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCeEE
Confidence 4599999999999999999999999999999998644322 233467889999999995 999999999987 467899
Q ss_pred EEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||||+.|+|.+++. ...+++..+..++.+|+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 999999999888875 456999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
...+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+.....|... .
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~--------- 275 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--S--------- 275 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--C---------
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--C---------
Confidence 34579999999999853 456899999999999999999999999988877777666654433211 0
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...++.+.+|+.+||..||.+| +.++++|||+..
T Consensus 276 ---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 276 ---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 1236678899999999999985 788899999954
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=370.91 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=216.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-.+.|.+++.||.|+||.||+|.+..+|..||+|++.... ......+.+|+.++..+. ||||++++++|. +...+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEE--eCCEE
Confidence 3567999999999999999999999999999999986432 234456889999999995 999999999997 56789
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc--CCcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~~ 712 (1219)
|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++. .+.++|+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999997 589998874 36899999999999999999999999999999999999974 46799999999987754
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.++..
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 273 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA-------- 273 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST--------
T ss_pred Cc-ceeeeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--------
Confidence 32 234557999999999974 55689999999999999999999999999888777777766543222211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALG 850 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~ 850 (1219)
++.+++.+.+||.+||..||.+ ++.++|+||||...
T Consensus 274 ----------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 274 ----------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 2345788999999999999998 48889999999653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.42 Aligned_cols=276 Identities=26% Similarity=0.452 Sum_probs=215.2
Q ss_pred cCeeEEeeeeccCceEEEEEEE-cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC------CccEEeeeeecc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP------NIITMLDIYKAV 632 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~d-k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP------NIVkL~gvfe~~ 632 (1219)
.+|.+++.||.|+||.||+|.+ ..+|..||||++... ......+.+|+.++..+. |+ +|++++++|.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~~~-- 87 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQMLEWFE-- 87 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEEEE--
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhh-hcCCCCceeeEeeecccc--
Confidence 5799999999999999999998 568999999998532 234566788999998885 44 5999999987
Q ss_pred CCceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc--------------
Q psy14431 633 NNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------------- 695 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-------------- 695 (1219)
..+.+|+||||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 46789999999999999998754 5889999999999999999999999999999999999987
Q ss_pred -----CCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHH
Q psy14431 696 -----SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 770 (1219)
Q Consensus 696 -----dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L 770 (1219)
++.++|+|||++...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999875543 24568999999999985 556899999999999999999999999999988888
Q ss_pred HHHHhhcCCCCCCchhhhhc----------cCC-hhHHhhhHHhhhhchhhHHHH---hcccChhHHHHHHhccccCCCC
Q psy14431 771 QLIVNLVRPNPPHADKFYAG----------FKS-KHEREKFNQVVVKCQKELQEL---QSQVVEENTSKLKLQMELDSKD 836 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~----------~~s-~~~relI~klp~kcrk~L~el---~p~lspeaiDLLsKMLq~DPeK 836 (1219)
..+.....+.|..+...... +.. ......+. ..+ ..+... .+..++.+.+||.+||.+||.+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVS---RAC-KPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHH---HHC-CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhh---hcC-cchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 88877777666543211100 000 00000000 000 000111 1123467899999999999998
Q ss_pred C--HHHHHcchhhhc
Q psy14431 837 S--EIEQLQGKLAAL 849 (1219)
Q Consensus 837 R--aiEALqHpwfaL 849 (1219)
| +.++|+||||..
T Consensus 320 Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 320 RITLREALKHPFFDL 334 (339)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred ccCHHHHhcCHHHHH
Confidence 5 888899999965
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=351.08 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=205.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---- 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---- 633 (1219)
..++|.+++.||.|+||.||+|.+..+|..||||++.... .....+.+|+.++..+.+||||++++++|....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 4568999999999999999999999999999999986432 234567899999999977999999999997532
Q ss_pred CceEEEEEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
...+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 5689999999985 89999874 4689999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhc----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
............||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..+.....|...
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 255 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK--- 255 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCC---
Confidence 6554333445679999999999852 456889999999999999999999999888776665555443322111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..||.+| +.+++.||||..
T Consensus 256 -----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 256 -----------------------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp -----------------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred -----------------------------ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 12346788999999999999885 788899999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=381.61 Aligned_cols=258 Identities=27% Similarity=0.366 Sum_probs=219.8
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
....+++|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||+++++++. .
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~--~ 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIS--T 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE--C
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--E
Confidence 34567899999999999999999999999999999999964321 1223457889999999995 999999999997 4
Q ss_pred CceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+.+|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 678999999996 689998874 569999999999999999999999999999999999999999999999999998765
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--------- 237 (476)
T 2y94_A 168 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--------- 237 (476)
T ss_dssp TTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT---------
T ss_pred ccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc---------
Confidence 432 3345689999999999865554578999999999999999999999998888777777665433222
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
.+++.+.+||.+||..||.+| +.+++.||||...
T Consensus 238 -------------------------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 238 -------------------------YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------------------cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 236778999999999999985 8888999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=358.24 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=202.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~gvfe~~d~~~L 637 (1219)
-..|.+++.||.|+||.||+|.+. ++..||||++............+.+|+.++..+..| |||+++++++. .+..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCEE
Confidence 346999999999999999999874 588999999976555555567788999999999733 99999999987 56789
Q ss_pred EEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 638 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 638 yLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
|+|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99999888999999885 5689999999999999999999999999999999999997 67899999999987654332
Q ss_pred -ccccccccccccCchhhhc----------cccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCC
Q psy14431 716 -CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~----------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~ 783 (1219)
.....+||++|+|||++.+ ...++.++|||||||++|+|++|.+||.+.... ..+..++... ....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 241 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--HEIE 241 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT--SCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC--cccC
Confidence 2235689999999999853 256899999999999999999999999765432 2222222211 1111
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
++ ...++.+.+|+.+||.+||.+| +.++|.||||....
T Consensus 242 ~~------------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 242 FP------------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CC------------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred Cc------------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 11 1125678899999999999985 88899999997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.36 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=209.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCceE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDL 637 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~L 637 (1219)
..|.+.+.||.|+||.||+|.+..++..||+|++............+.+|+.++..+. ||||++++++|... ++..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCceE
Confidence 3488899999999999999999999999999999766556666778899999999995 99999999998642 35678
Q ss_pred EEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeec-cCCcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILID-KSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd-~dG~VKLiDFGLAr~l~~ 712 (1219)
|+||||++ ++|.+++.. ..+++..++.++.+|+.||.|||+.| |+||||||+|||++ .++.++|+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999997 599999885 67899999999999999999999999 99999999999997 789999999999976554
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+..........+....+ +..+
T Consensus 185 ~~--~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~-------- 251 (290)
T 1t4h_A 185 SF--AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASF-------- 251 (290)
T ss_dssp TS--BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGG--------
T ss_pred cc--cccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-cccc--------
Confidence 32 34567999999999873 45899999999999999999999999886655443332221111 1101
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....++.+.+||.+||..||.+| +.++|.||||.-
T Consensus 252 ----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 252 ----------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 12336789999999999999984 888999999953
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.00 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=217.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.....+|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||+++++++. +.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~ 87 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--DN 87 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeec--cC
Confidence 3446789999999999999999999999999999999865433 2344567889999999995 999999999987 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 78999999998 588888774 5689999999999999999999999999999999999999999999999999987664
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.........||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.....+.|
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 235 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----------- 235 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred CccccccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc-----------
Confidence 44444556799999999997 455689999999999999999999999988877665555544322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
..+++.+.+++.+||..||.+| +.+++.||||.....+
T Consensus 236 -----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 236 -----------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred -----------------------cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1236678899999999999985 7888999999764443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.13 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=217.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-------chhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-------KTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-------~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
-.++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+.+||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 367899999999999999999999999999999998643211 1224567899999999977999999999987
Q ss_pred ccCCceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 631 AVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 631 ~~d~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
....+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.+|.++|+|||++.
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 --TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 5678999999998 589999875 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccccccccccccccCchhhhc-----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~-----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
...... ......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+.......+..
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 765433 2345679999999999752 4468899999999999999999999999888777777766654322210
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. .+..++.+.+|+.+||..||.+| +.++|+||||.-
T Consensus 252 ~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 252 E------------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp T------------------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred c------------------------------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 0 12347789999999999999985 888899999954
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.29 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=187.8
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+.+|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||+++++++. +.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 84 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFE--DSN 84 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEE--CSS
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEc--cCC
Confidence 356789999999999999999999999999999999864321 1223467889999999995 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 8999999997 589998875 4689999999999999999999999999999999999999999999999999987664
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.........||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.....+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 231 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM------------ 231 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC------------
T ss_pred CCCcceeccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC------------
Confidence 443344567999999999974 5568999999999999999999999998765443332221100000
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
-+.+++.+.+|+.+||..||.+| +.+++.||||.-
T Consensus 232 ----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 232 ----------------------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ----------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ----------------------ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 01246788999999999999985 788899999954
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=346.69 Aligned_cols=251 Identities=29% Similarity=0.391 Sum_probs=204.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+.|.+.+.||.|+||.||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||++++++|. +...+|+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFE--DYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCC-CchHHhHHHhee--cCCeEEE
Confidence 46899999999999999999999999999999986543 3344577889999999995 999999999997 5678999
Q ss_pred EEecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceeccccccccc
Q psy14431 640 VFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l 710 (1219)
||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999985 88887752 569999999999999999999999999999999999999 45678999999999876
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+.......+..
T Consensus 178 ~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 247 (285)
T 3is5_A 178 KSDE-HSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE------- 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--------
T ss_pred CCcc-cCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-------
Confidence 5432 234567999999999973 458999999999999999999999999887766555544333221110
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
....++.+.+|+.+||.+||.+| +.++|.||||.
T Consensus 248 ------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 248 ------------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp -------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred ------------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 12247789999999999999985 88889999995
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=350.65 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC-----
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----- 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----- 633 (1219)
+++|.+++.||.|+||.||+|.+..+|..||||++.... .......+.+|+.++..+. ||||++++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhh
Confidence 457999999999999999999999999999999986433 3345577899999999995 999999999885322
Q ss_pred --------------------------------------------------CceEEEEEecchh-hHHHHHhhc----cCC
Q psy14431 634 --------------------------------------------------NKDLYVVFEYMEN-DLNKVIRDK----ILK 658 (1219)
Q Consensus 634 --------------------------------------------------~~~LyLVMEymeG-SL~d~Lrs~----~Ls 658 (1219)
..++|+||||+.| +|.+++... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 1248999999985 899998753 345
Q ss_pred hHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc------------cccccccccccc
Q psy14431 659 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK------------ECLTEYIATRWY 726 (1219)
Q Consensus 659 eeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~------------~~~ts~vGT~~Y 726 (1219)
+..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ......+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 55689999999999999999999999999999999999999999999998766532 122345799999
Q ss_pred cCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhh
Q psy14431 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVK 806 (1219)
Q Consensus 727 ~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~k 806 (1219)
+|||++. +..++.++|||||||++|+|++|.+|+.. .......+... +.
T Consensus 243 ~aPE~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~-------------------------- 291 (332)
T 3qd2_B 243 MSPEQIH-GNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KF-------------------------- 291 (332)
T ss_dssp SCHHHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CC--------------------------
T ss_pred cChHHhc-CCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CC--------------------------
Confidence 9999974 55689999999999999999998776521 11111111111 11
Q ss_pred chhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 807 CQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 807 crk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
+...+..++.+.+|+.+||..||.+| +.++|+||||.
T Consensus 292 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 292 -----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp -----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred -----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhh
Confidence 11123346778999999999999985 88889999995
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=386.52 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=213.6
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
....++|.+++.||.|+||.||+|.+..+|+.||||++.+... .......+.+|+.++..+. ||||++++++|. +.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~~ 257 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFE--TK 257 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe--eC
Confidence 4456789999999999999999999999999999999964422 1233456889999999995 999999999987 56
Q ss_pred ceEEEEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
..+|+||||++ |+|..++.. ..+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 78999999998 589888864 259999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhhcCCCCCCc
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~----~e~L~kIve~l~P~P~~~ 784 (1219)
.+..........+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+. ......|.....+.|
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eccCCCcccccccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 8765544445568999999999985 45799999999999999999999999987542 333333433221111
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .+++.||||..
T Consensus 414 -------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 414 -------------------------------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp -------------------------------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred -------------------------------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 23478899999999999999985 68899999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=347.85 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=208.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
....|.+++.||.|+||.||+|.+..+|..||+|++... .......+.+|+.++..+. ||||++++++|. ..+.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCD-HPYIVKLLGAYY--HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeee--eCCeE
Confidence 356799999999999999999999999999999998543 2344567889999999995 999999999987 46689
Q ss_pred EEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||+++ +|..++.. ..+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999985 78887763 569999999999999999999999999999999999999999999999999986543332
Q ss_pred cccccccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 715 ECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+....+..+.....|.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 245 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP------ 245 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc------
Confidence 2334567999999999974 355688999999999999999999999998887776666655443321110
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.+++.+.+++.+||..||.+| +.++++||||..
T Consensus 246 -------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 246 -------------------------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp -------------------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred -------------------------cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 2236778999999999999985 788899999965
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=369.87 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=201.2
Q ss_pred cccccCeeEE-eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec--c
Q psy14431 556 REDLQQQINL-LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--V 632 (1219)
Q Consensus 556 r~dIqqY~IL-KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~--~ 632 (1219)
...+++|.++ +.||.|+||.||+|.+..+|..||||++.. .....+|+.++..+.+||||++++++|.. .
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3456788887 689999999999999999999999999852 23467889988777789999999999863 2
Q ss_pred CCceEEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLG 705 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFG 705 (1219)
+..++|||||||. |+|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 3567899999997 5899999743 4999999999999999999999999999999999999997 7889999999
Q ss_pred cccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhhcCCCC
Q psy14431 706 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNP 781 (1219)
Q Consensus 706 LAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e----~L~kIve~l~P~P 781 (1219)
++....... .....+||++|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+... ....|.......+
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp TCEECC------------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccCCCC-ccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 998765432 23466899999999997 55679999999999999999999999997755321 2233332221111
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.. .++.+++.+.+||.+||..||.+| +.++|.||||.-
T Consensus 288 ~~------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 288 NP------------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TT------------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred Cc------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 10 013457889999999999999984 888999999965
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.95 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=215.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
..|.+++.||.|+||.||+|.+..+|..||||++.... .......+.+|+.++..+. ||||++++++|. ....+|+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l 97 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KDTKLWI 97 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe--cCCeEEE
Confidence 45999999999999999999999999999999986443 2344677889999999995 999999999987 4678999
Q ss_pred EEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 640 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 640 VMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
||||+++ +|.+++..+.+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++...........
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 9999985 899999988899999999999999999999999999999999999999999999999999987765544445
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
...||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+..
T Consensus 178 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 239 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL----------------- 239 (303)
T ss_dssp CCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------------
T ss_pred ccCCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC-----------------
Confidence 668999999999974 55689999999999999999999999988877666555544332211
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....++.+.+|+.+||..||.+| +.++++||||.-
T Consensus 240 ----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 240 ----------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ----------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ----------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 12346778999999999999985 788899999954
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.21 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=206.0
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||+++++++. ..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~ 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIS--TP 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEe--cC
Confidence 3457889999999999999999999999999999999864321 1233457889999999995 999999999987 46
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 78999999997 589998874 5689999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.....+.|.
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 232 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE---------- 232 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----------
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----------
Confidence 32 2345578999999999865544578999999999999999999999887776666655543322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
..++.+.+++.+||..||.+ ++.+++.||||.-
T Consensus 233 ------------------------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 233 ------------------------YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ------------------------hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 23667889999999999988 4888899999965
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.92 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=211.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
++|.+++.||.|+||.||+|.+..+|..||+|++...... ......+.+|+.++..+. ||||+++++++. +..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE--NKT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec--CCC
Confidence 3599999999999999999999999999999998654322 123567889999999996 999999999987 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC----cceecccccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr~ 709 (1219)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 8999999997 689998874 5699999999999999999999999999999999999998877 799999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.......+.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 232 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------- 232 (283)
T ss_dssp CC---------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred ccCCC-cccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-------
Confidence 65433 23456799999999997 4556899999999999999999999999988877766666543322111
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+..++.+.+|+.+||..||.+| +.+++.||||..
T Consensus 233 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 -----------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -----------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -----------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1234567889999999999999985 778899999965
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.97 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=207.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-..|.+++.||.|+||.||+|.+..+|..||||++... .....+.+|+.++..+. ||||+++++++. ..+.+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 100 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCD-SPHVVKYYGSYF--KNTDLW 100 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCC-CCCCccEEEEEE--eCCEEE
Confidence 45799999999999999999999999999999998643 23456889999999995 999999999987 467899
Q ss_pred EEEecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++ +|.+++. ...+++..+..++.+|+.||.|||+.||+|+||+|+||+++.+|.++|+|||++........
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999985 8999886 45799999999999999999999999999999999999999999999999999987765444
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+....
T Consensus 181 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 247 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------------ 247 (314)
T ss_dssp CBCCCCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS------------
T ss_pred ccCccCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCC------------
Confidence 445668999999999974 5568999999999999999999999998877665554443332221110
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+++.+.+|+.+||..||.+| +.+++.||||..
T Consensus 248 -------------------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 248 -------------------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp -------------------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred -------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 01236778999999999999984 888899999965
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=359.91 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=194.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+.|.+.+.||.|+||.||+|.+..+++.||||++.... ....+.+|+.++..+. ||||++++++|. ....+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLS-HPNIIKLKEIFE--TPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCC-CCCCcceeeeEe--cCCeEE
Confidence 356999999999999999999999999999999986432 3355778999999996 999999999997 467899
Q ss_pred EEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++......
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999997 589888874 56899999999999999999999999999999999999975 889999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e-~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+..... .+..+.....+.+..+
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-------- 274 (349)
T 2w4o_A 205 V-LMKTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW-------- 274 (349)
T ss_dssp ---------CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT--------
T ss_pred c-ccccccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch--------
Confidence 2 234567999999999974 5568999999999999999999999998766554 4445554432222111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 275 ----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 275 ----------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp ----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ----------------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 13457889999999999999985 888999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.37 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=211.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.+..+|+.||+|++.... ......+.+|+.++..+. ||||++++++|. +.+.+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIK-HENIVTLEDIYE--STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCC-CCCeeehhhhcc--cCCEEE
Confidence 356999999999999999999999999999999986432 223356789999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||++ ++|.+++. .+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999997 58988876 4568999999999999999999999999999999999999 77889999999999765443
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....+.+...
T Consensus 163 --~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 230 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF--------- 230 (304)
T ss_dssp --TTHHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT---------
T ss_pred --ccccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc---------
Confidence 23445799999999997 455689999999999999999999999998888777777766553322211
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..||.+| +.++|.||||..
T Consensus 231 ---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 231 ---------------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ---------------------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 12457889999999999999985 888899999965
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.67 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=214.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC------chhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s------~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
..+|.+.+.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+.+||||++++++|.
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 170 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-- 170 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe--
Confidence 34699999999999999999999999999999998644321 1123567789999999967999999999987
Q ss_pred CCceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
..+.+|+||||++| +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.+|.++|+|||++..+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 46789999999985 89998874 46999999999999999999999999999999999999999999999999999877
Q ss_pred CCcccccccccccccccCchhhhc-----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 711 SDSKECLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~-----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
.... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+.....+.+.
T Consensus 251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 326 (365)
T 2y7j_A 251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS--- 326 (365)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH---
T ss_pred CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 6433 2345789999999999853 235889999999999999999999999888877766666554422111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
...+..++.+.+||.+||.+||.+| +.++|+||||.
T Consensus 327 ---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 ---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp ---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 0123457889999999999999985 88899999994
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.52 Aligned_cols=279 Identities=19% Similarity=0.276 Sum_probs=212.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-.+|.+++.||.|+||.||+|.+..+|..||||++..... ......+.+|+.++..+. ||||+++++++...+...+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEE
Confidence 3569999999999999999999999999999999864322 233566789999999996 99999999999866666899
Q ss_pred EEEecch-hhHHHHHhhcc----CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee----ccCCcceecccccccc
Q psy14431 639 VVFEYME-NDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARS 709 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~----LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL----d~dG~VKLiDFGLAr~ 709 (1219)
+||||++ ++|.+++.... +++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999997 68999987432 8999999999999999999999999999999999999 7778899999999987
Q ss_pred cCCcccccccccccccccCchhhhc-------cccccccccchhHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhhcC
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILIS-------NRRYTHHVDIWSLGCILAEMLQSKPLFPGAS----TSHQLQLIVNLVR 778 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~-------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s----~~e~L~kIve~l~ 778 (1219)
...... ....+||+.|+|||++.. +..++.++|||||||++|+|++|.+||.+.+ ....+..+....+
T Consensus 166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred cCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 765432 345679999999999753 4678999999999999999999999997543 2344444544332
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+ ..+........... .....++..+ .+...+++.+.+||.+||.+||.+| +.++|+||--..
T Consensus 245 ~--~~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 S--GAISGVQKAENGPI--DWSGDMPVSC-----SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp T--TCCEEEECSTTCCE--EEESSCCTTC-----SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred c--ccchhhhcccCCcc--ccCccCCccc-----ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2 11111110000000 0000001000 1112345678999999999999985 888899997654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.71 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||.||+|.+..+|..||||++.... .......+.+|+.++..+. ||||+++++++. +++.+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcC-CCCceeeeeEEE--cCCEEE
Confidence 567999999999999999999999999999999986433 2334567889999999995 999999999987 467899
Q ss_pred EEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 639 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999985 88888874 468999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e-~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+... .+..+..... ..+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~----------- 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLN----------- 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-TST-----------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-ccC-----------
Confidence 223456789999999998655545889999999999999999999998765432 2222221110 000
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+.+++.+.+||.+||..||.+| +.+++.||||.-
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 230 --------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp --------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 013457889999999999999985 888899999965
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.60 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=203.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccC-CCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~-HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..|.+++.||.|+||.||+|.+.. |..||||++............+.+|+.++..+.. ||||+++++++. ....+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~--~~~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe--cCCEEE
Confidence 459999999999999999998865 8999999997655455566788999999999974 699999999987 466799
Q ss_pred EEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--
Q psy14431 639 VVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-- 715 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-- 715 (1219)
||||+.+++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++..+.....
T Consensus 133 lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 9999888899999874 5688889999999999999999999999999999999995 68999999999987654322
Q ss_pred ccccccccccccCchhhhc----------cccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCCc
Q psy14431 716 CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~----------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~~ 784 (1219)
.....+||++|+|||++.+ ...++.++||||||||+|+|++|.+||.+.... ..+..++..... ..+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~--~~~ 289 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--IEF 289 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC--CCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc--CCC
Confidence 2345689999999999853 236899999999999999999999999875432 333333321110 000
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+ ...++.+.+||.+||..||.+| +.++|+||||...
T Consensus 290 ~------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 290 P------------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp C------------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred C------------------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 0 1125678999999999999985 8888999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.43 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=207.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|...+.||.|+||.||+|.+..+|..||+|++... .......+.+|+.++..+. ||||++++++|. ..+.+||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLD-HANLIQLYDAFE--SKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCEEEEEE
Confidence 34467899999999999999999999999998643 2244567889999999995 999999999997 467899999
Q ss_pred ecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee--ccCCcceecccccccccCCcccc
Q psy14431 642 EYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL--d~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+.... .
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K 244 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence 9997 588888763 468999999999999999999999999999999999999 566789999999998776443 2
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
....+||+.|+|||++ ....++.++|||||||++|+|++|.+||.+.+....+..|.....+.+..
T Consensus 245 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 310 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE------------- 310 (373)
T ss_dssp CCCCCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------------
T ss_pred cccccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------------
Confidence 3455799999999997 45678999999999999999999999999999888888887655332221
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.++.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 311 -----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 311 -----------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 123458889999999999999984 888999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.65 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=218.6
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
+.....+|.+++.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++..+. ||||++++++|. +
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~ 112 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--D 112 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--C
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--c
Confidence 34456789999999999999999999999999999999865432 3344567889999999995 999999999997 5
Q ss_pred CceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+.+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 678999999998 588888774 569999999999999999999999999999999999999999999999999998775
Q ss_pred CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 712 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 712 ~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
..........||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+.......+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 261 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP---------- 261 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----------
T ss_pred cCcccccccCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----------
Confidence 4444445568999999999974 55689999999999999999999999988776666555544332211
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSET 853 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e~ 853 (1219)
..+++.+.+||.+||..||.+| +.++|.|+||.....+
T Consensus 262 ------------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 262 ------------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ------------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 1236678899999999999985 7788999999764433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=363.51 Aligned_cols=257 Identities=20% Similarity=0.310 Sum_probs=205.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
..+.+|.+++.||.|+||.||+|.+. .+|..||||++..... .......+.+|+.++..+.+||||++++++|.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ- 129 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-
Confidence 44678999999999999999999984 5899999999864321 12233456689999999977999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
....+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 130 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 4678999999998 589998874 5699999999999999999999999999999999999999999999999999986
Q ss_pred cCCcc-cccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhhcCCCCCC
Q psy14431 710 LSDSK-ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS----HQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 710 l~~~~-~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~----e~L~kIve~l~P~P~~ 783 (1219)
+.... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||...+.. .....+.....+.+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 64322 223456899999999998642 45789999999999999999999999754322 22222222111111
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+|+ .++++||||.-
T Consensus 287 --------------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 287 --------------------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp --------------------------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred --------------------------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 23467789999999999999885 78899999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.42 Aligned_cols=263 Identities=12% Similarity=0.108 Sum_probs=188.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhcc-CCCCccEEe-------eee
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQ-RHPNIITML-------DIY 629 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~-~HPNIVkL~-------gvf 629 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999765432 233455667755555554 499988865 333
Q ss_pred eccCC---------------ceEEEEEecchhhHHHHHhh--ccCChHHH------HHHHHHHHHHHHHHHhcccccCCC
Q psy14431 630 KAVNN---------------KDLYVVFEYMENDLNKVIRD--KILKDVHI------RYIMFQLCNGLSYIHACKVMHRDL 686 (1219)
Q Consensus 630 e~~d~---------------~~LyLVMEymeGSL~d~Lrs--~~LseeeV------r~Ia~QILsALaYLHS~GIVHRDL 686 (1219)
..... ..+||||||++|+|.+++.. ..++.... ..++.||+.||.|||+.||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22111 45899999999999999984 34555555 577799999999999999999999
Q ss_pred CCCCeeeccCCcceecccccccccCCcccccccccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCCCCC
Q psy14431 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 765 (1219)
Q Consensus 687 KPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s 765 (1219)
||+|||++.+|.+||+|||++....... ....+|+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+..
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999998765432 24567799999999853 2578999999999999999999999998764
Q ss_pred cHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc
Q psy14431 766 TSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ 843 (1219)
Q Consensus 766 ~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq 843 (1219)
+.... ....+..... .. ....+ ...+.+++.+.+||.+||.+||.+| +.++|+
T Consensus 298 ~~~~~----~~~~~~~~~~--~~------------------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 298 PGIKG----SWKRPSLRVP--GT------------------DSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTCTT----CCCBCCTTSC--CC------------------CSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccc----chhhhhhhhc--cc------------------cccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 32100 0000000000 00 00000 0024568899999999999999985 888999
Q ss_pred chhhhc
Q psy14431 844 GKLAAL 849 (1219)
Q Consensus 844 HpwfaL 849 (1219)
||||.-
T Consensus 353 hp~f~~ 358 (371)
T 3q60_A 353 TPEFLQ 358 (371)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 999954
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.51 Aligned_cols=282 Identities=22% Similarity=0.318 Sum_probs=208.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||+|++.... .......+.+|+.++..+. ||||++++++|. .++.+|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE--ETTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE--ECCEEE
Confidence 467999999999999999999999999999999986442 3444567889999999995 999999999987 467899
Q ss_pred EEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||++| +|.+++.. +.+++..+..++.+|+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999975 99999875 4799999999999999999999985 9999999999999999999999999999765432
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchh------hh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADK------FY 788 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~------l~ 788 (1219)
.....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.... ...+...+. ..
T Consensus 186 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 234568999999999974 5568999999999999999999999998877655433221111 100000000 00
Q ss_pred hccC-----ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFK-----SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~-----s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+. .......+..+.......+ ....+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000 0000011111110000000 001357789999999999999985 888999999954
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.70 Aligned_cols=280 Identities=25% Similarity=0.394 Sum_probs=214.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC-eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC------ccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK-QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN------IITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG-k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN------IVkL~gvfe~ 631 (1219)
.++|.+++.||.|+||.||+|.+..++ ..||+|++... ......+.+|+.++..+. |++ ++.++++|.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIK-EKDKENKFLCVLMSDWFN- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeee-
Confidence 357999999999999999999998776 79999998532 234566778999999886 544 888888887
Q ss_pred cCCceEEEEEecchhhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---------------
Q psy14431 632 VNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--------------- 693 (1219)
Q Consensus 632 ~d~~~LyLVMEymeGSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL--------------- 693 (1219)
..+.+|+||||+++++.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 93 -~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 -FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp -ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred -eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 46789999999998888877643 58999999999999999999999999999999999999
Q ss_pred ----ccCCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHH
Q psy14431 694 ----DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769 (1219)
Q Consensus 694 ----d~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~ 769 (1219)
+.++.++|+|||++...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999875443 24568999999999985 55689999999999999999999999999988888
Q ss_pred HHHHHhhcCCCCCCchhhhhc--------cCChhHHhhhHHhhhhchhhHHHHh---cccChhHHHHHHhccccCCCCC-
Q psy14431 770 LQLIVNLVRPNPPHADKFYAG--------FKSKHEREKFNQVVVKCQKELQELQ---SQVVEENTSKLKLQMELDSKDS- 837 (1219)
Q Consensus 770 L~kIve~l~P~P~~~d~l~~~--------~~s~~~relI~klp~kcrk~L~el~---p~lspeaiDLLsKMLq~DPeKR- 837 (1219)
+..+.....+.|..+...... ..-+............|.. +.... ...++.+.+||.+||.+||.+|
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 888888777766543211100 0000000000000011100 00000 1124578899999999999985
Q ss_pred -HHHHHcchhhhc
Q psy14431 838 -EIEQLQGKLAAL 849 (1219)
Q Consensus 838 -aiEALqHpwfaL 849 (1219)
+.++|+||||.-
T Consensus 327 t~~e~l~hp~f~~ 339 (355)
T 2eu9_A 327 TLAEALLHPFFAG 339 (355)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhcC
Confidence 888999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=387.38 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=211.1
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
......+|.+++.||.|+||.||+|.+..+|..||||++.+... .......+.+|+.++..+. ||||++++++|. +
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~ 255 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--T 255 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe--e
Confidence 34556789999999999999999999999999999999964321 2233456789999999995 999999999987 5
Q ss_pred CceEEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+.+|+||||++ |+|..++... .+++..++.|+.||+.||.|||+.|||||||||+|||++.+|.++|+|||++..
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 678999999997 6899888742 389999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhhcCCCCCCch
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~----~e~L~kIve~l~P~P~~~d 785 (1219)
+.... .....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+. ......|...... +
T Consensus 336 ~~~~~-~~~~~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~- 408 (576)
T 2acx_A 336 VPEGQ-TIKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE----Y- 408 (576)
T ss_dssp CCTTC-CEECCCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC----C-
T ss_pred cccCc-cccccCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc----C-
Confidence 75443 234568999999999984 45699999999999999999999999987543 2222222221111 0
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-------HHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-------IEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-------iEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..||.+|+ .++++||||..
T Consensus 409 -----------------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 409 -----------------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp -----------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred -----------------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 023478899999999999999986 78899999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.83 Aligned_cols=249 Identities=11% Similarity=0.146 Sum_probs=194.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhcc--CCCCccEEe-------ee
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQ--RHPNIITML-------DI 628 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~--~HPNIVkL~-------gv 628 (1219)
..+|.+.+.||.|+||.||+|.+..+|..||||++.... ........+.+|+.++..+. +|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 367999999999999999999999999999999996442 23345567889996555554 599999998 55
Q ss_pred eeccCC----------c-----eEEEEEecchhhHHHHHhh-ccCCh-------HHHHHHHHHHHHHHHHHHhcccccCC
Q psy14431 629 YKAVNN----------K-----DLYVVFEYMENDLNKVIRD-KILKD-------VHIRYIMFQLCNGLSYIHACKVMHRD 685 (1219)
Q Consensus 629 fe~~d~----------~-----~LyLVMEymeGSL~d~Lrs-~~Lse-------eeVr~Ia~QILsALaYLHS~GIVHRD 685 (1219)
+...+. + ..||||||++|+|.+++.. +.+++ ..+..|+.||+.||.|||+.||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 442211 1 3889999999999999874 33444 77788999999999999999999999
Q ss_pred CCCCCeeeccCCcceecccccccccCCcccccccccccccccCchhhhcc----------ccccccccchhHHHHHHHHH
Q psy14431 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEML 755 (1219)
Q Consensus 686 LKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~----------~~yT~kSDIWSLG~ILyELL 755 (1219)
|||+|||++.+|.+||+|||++...... ....+| +.|+|||++.+. ..++.++|||||||++|+|+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999999865432 345577 999999998654 26899999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCC
Q psy14431 756 QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSK 835 (1219)
Q Consensus 756 TGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPe 835 (1219)
+|.+||.+.+...... ... . ..+.+++.+.+|+.+||.+||.
T Consensus 308 tg~~Pf~~~~~~~~~~--------------~~~----------------~--------~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 308 CADLPITKDAALGGSE--------------WIF----------------R--------SCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HSSCCC------CCSG--------------GGG----------------S--------SCCCCCHHHHHHHHHHTCSSGG
T ss_pred HCCCCCcccccccchh--------------hhh----------------h--------hccCCCHHHHHHHHHHcCCCch
Confidence 9999997654321100 000 0 0135678899999999999999
Q ss_pred CC--HHHHHcchhhhc
Q psy14431 836 DS--EIEQLQGKLAAL 849 (1219)
Q Consensus 836 KR--aiEALqHpwfaL 849 (1219)
+| +.++++||||..
T Consensus 350 ~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 350 DRLLPLQAMETPEYEQ 365 (377)
T ss_dssp GCCCHHHHHTSHHHHH
T ss_pred hCCCHHHHhhChHHHH
Confidence 85 888999999954
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.01 Aligned_cols=285 Identities=26% Similarity=0.355 Sum_probs=214.1
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc----------CCCCccE
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----------RHPNIIT 624 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~----------~HPNIVk 624 (1219)
+.....+|.+++.||.|+||.||+|.+..+|..||||++.. .......+.+|+.++..+. +||||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 34456789999999999999999999999999999999853 2234456778999988875 2799999
Q ss_pred Eeeeeecc--CCceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeecc---
Q psy14431 625 MLDIYKAV--NNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDK--- 695 (1219)
Q Consensus 625 L~gvfe~~--d~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~--- 695 (1219)
++++|... ++..+++||||++++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998743 2347899999998899998874 4589999999999999999999998 9999999999999953
Q ss_pred ---CCcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC------c
Q psy14431 696 ---SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS------T 766 (1219)
Q Consensus 696 ---dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s------~ 766 (1219)
.+.++|+|||++...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+ .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 347999999999876543 34558999999999985 4568999999999999999999999998654 4
Q ss_pred HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHH------hhhhchhhHHHHh-------cccChhHHHHHHhccccC
Q psy14431 767 SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQ------VVVKCQKELQELQ-------SQVVEENTSKLKLQMELD 833 (1219)
Q Consensus 767 ~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~k------lp~kcrk~L~el~-------p~lspeaiDLLsKMLq~D 833 (1219)
...+..+.....+.|..+.... .....++.. +......++.... +..++.+.+||.+||.+|
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNG-----KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHC-----TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred HHHHHHHHHhcCCCCHHHHhcc-----chhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 4566677776665554321110 000000000 0000000111111 234567899999999999
Q ss_pred CCCC--HHHHHcchhhhcCC
Q psy14431 834 SKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 834 PeKR--aiEALqHpwfaL~~ 851 (1219)
|.+| +.++|+||||.-..
T Consensus 322 P~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred ccccCCHHHHhhChhhhccc
Confidence 9985 88899999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.30 Aligned_cols=255 Identities=30% Similarity=0.427 Sum_probs=198.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC------chhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s------~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.++|.+.+.||.|+||.||+|.+..++..||||++...... ......+.+|+.++..+. ||||++++++|.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~-- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD-- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe--
Confidence 45799999999999999999999999999999998653211 112234779999999995 999999999985
Q ss_pred CCceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cceecccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDLGLA 707 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VKLiDFGLA 707 (1219)
...+|+||||++ |+|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 456899999997 48887776 45699999999999999999999999999999999999997554 5999999999
Q ss_pred cccCCcccccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhhcCCCCCCc
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHA 784 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~-L~kIve~l~P~P~~~ 784 (1219)
....... .....+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+...... ...+.....+.
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 8776432 2345789999999999743 45688999999999999999999999986543322 22232222111
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+...+.+++.+.+|+.+||.+||.+| +.++|+||||.
T Consensus 365 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 365 --------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp --------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 112235568899999999999999985 88899999994
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.79 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=215.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch---------------hHHHHHHHHHHHHhccCCCC
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT---------------DAQRTYREILFLKSFQRHPN 621 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~---------------~~e~~lREI~ILr~L~~HPN 621 (1219)
..+.+|.+++.||.|+||.||+|.+ +|..||||++........ ....+.+|+.++..+. |||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence 3467899999999999999999998 899999999864432211 1167889999999996 999
Q ss_pred ccEEeeeeeccCCceEEEEEecchh-hHHHH------Hh---hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCC
Q psy14431 622 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKV------IR---DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSN 690 (1219)
Q Consensus 622 IVkL~gvfe~~d~~~LyLVMEymeG-SL~d~------Lr---s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsN 690 (1219)
|+++++++. +.+.+|+||||+++ +|.++ +. ...+++..++.++.||+.||.|||+ .||+||||+|+|
T Consensus 105 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 105 CLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp BCCCSEEEE--SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred cceEEEEEe--eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 999999987 46789999999986 88887 54 3568999999999999999999999 999999999999
Q ss_pred eeeccCCcceecccccccccCCcccccccccccccccCchhhhccccccc-cccchhHHHHHHHHHhCCCCCCCCCc-HH
Q psy14431 691 ILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGAST-SH 768 (1219)
Q Consensus 691 ILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~-kSDIWSLG~ILyELLTGkpPF~g~s~-~e 768 (1219)
||++.++.++|+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. ..
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999999999999876543 2345689999999999865545666 99999999999999999999998777 66
Q ss_pred HHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchh
Q psy14431 769 QLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKL 846 (1219)
Q Consensus 769 ~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpw 846 (1219)
....+.....+.|......... ..........+.+++.+.+||.+||.+||.+| +.++++|||
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYP---------------LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTT---------------TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhccCcCCccchhhhhcc---------------ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 6666655543333322211100 01111223345678899999999999999985 888999999
Q ss_pred hhc
Q psy14431 847 AAL 849 (1219)
Q Consensus 847 faL 849 (1219)
|..
T Consensus 326 f~~ 328 (348)
T 2pml_X 326 LAD 328 (348)
T ss_dssp GTT
T ss_pred ccC
Confidence 954
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.81 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=190.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCe---EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk---~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.++|.+++.||.|+||.||+|.+..++. .||||++............+.+|+.++..+. ||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeeccccc
Confidence 4579999999999999999999887765 8999999765555566788999999999995 99999999998742221
Q ss_pred ----eEEEEEecchh-hHHHHHhhc-------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 636 ----DLYVVFEYMEN-DLNKVIRDK-------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 636 ----~LyLVMEymeG-SL~d~Lrs~-------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
.+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 24999999985 899888632 489999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCC
Q psy14431 704 LGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPN 780 (1219)
Q Consensus 704 FGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~ 780 (1219)
||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+.
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 999987654321 122345678899999974 5568999999999999999999 999999988877777666544322
Q ss_pred CCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC---------HHHHHcchhhhc
Q psy14431 781 PPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS---------EIEQLQGKLAAL 849 (1219)
Q Consensus 781 P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR---------aiEALqHpwfaL 849 (1219)
.+ +..++.+.+|+.+||..||.+| ..+.+.|+|+..
T Consensus 260 ~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 260 QP---------------------------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CC---------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CC---------------------------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 11 2346778999999999999997 345578998855
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.94 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=192.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...+|.+++.||.|+||.||+|.+..+|..||||++..... ......+.+|+.++..+. ||||+++++++. ..+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 88 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCH-HPNIVSYYTSFV--VKDEL 88 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCC-CTTBCCEEEEEE--SSSCE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcC-CCCEeeEEEEEe--ecCCc
Confidence 45789999999999999999999998999999998853321 233456788999999995 999999999987 45679
Q ss_pred EEEEecch-hhHHHHHhh---------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 638 YVVFEYME-NDLNKVIRD---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs---------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.++|+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999997 588888862 45899999999999999999999999999999999999999999999999999
Q ss_pred cccCCcc-----cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC
Q psy14431 708 RSLSDSK-----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782 (1219)
Q Consensus 708 r~l~~~~-----~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~ 782 (1219)
....... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+........+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7664322 11234578999999999865466899999999999999999999999987776655544443322221
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.... .....+..++.+.+++.+||..||.+| +.++++||||.-
T Consensus 249 ~~~~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 249 TGVQ------------------------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp C-----------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cccc------------------------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 1100 011224567889999999999999884 888899999954
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=347.36 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=193.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...+|.+++.||.|+||.||+|.+ +|..||||++............+.+|+.++..+. ||||++++++|. +.+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~ 109 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVT--QPPNL 109 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--STTCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCce
Confidence 356899999999999999999976 5889999999765555555678899999999996 999999999987 46678
Q ss_pred EEEEecchh-hHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 638 YVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
|+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999985 899998743 3899999999999999999999999 999999999999999999999999999866
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
...........||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+....... . +
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~-~------ 260 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-E-I------ 260 (309)
T ss_dssp ------------CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-C-C------
T ss_pred cccccccccCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-C-C------
Confidence 55443445678999999999974 5568999999999999999999999999888776665553322111 1 0
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
-+.+++.+.+|+.+||..||.+|+
T Consensus 261 ------------------------~~~~~~~l~~li~~~l~~dP~~Rp 284 (309)
T 3p86_A 261 ------------------------PRNLNPQVAAIIEGCWTNEPWKRP 284 (309)
T ss_dssp ------------------------CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------CccCCHHHHHHHHHHccCChhhCc
Confidence 023467889999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.78 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=214.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++............+.+|+.++..+. ||||+++++++. +.+.+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILE--DSSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEe--CCCeEE
Confidence 45799999999999999999999999999999999766555556778899999999995 999999999987 467899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---CcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr~l~~~ 713 (1219)
+||||+. ++|.+++. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.+ +.++|+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999997 58877775 4679999999999999999999999999999999999999764 46999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+.....+.+..
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 244 (287)
T 2wei_A 178 T-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------- 244 (287)
T ss_dssp S-SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG----------
T ss_pred C-ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch----------
Confidence 2 2334568999999999743 48999999999999999999999999988877777776654322110
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+.+++.+.++|.+||.+||.+| +.++|.||||.-
T Consensus 245 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 245 --------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp --------------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred --------------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 012357789999999999999985 788899999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=346.07 Aligned_cols=255 Identities=30% Similarity=0.429 Sum_probs=202.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc------CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~------s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++..... .......+.+|+.++..+. ||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEES--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEcC--
Confidence 469999999999999999999999999999999864321 1122345779999999995 9999999999863
Q ss_pred CceEEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceeccccccc
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLAR 708 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGLAr 708 (1219)
..+|+||||+++ +|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 87 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 348999999974 8988876 456999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCcccccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhhcCCCCCCch
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e-~L~kIve~l~P~P~~~d 785 (1219)
...... ......||+.|+|||++. +...++.++|||||||++|+|++|.+||.+..... ....+.....+.
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 239 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----- 239 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-----
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-----
Confidence 765432 234567999999999974 35568999999999999999999999997654432 222232222111
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+...+.+++.+.+|+.+||.+||.+| +.++|+||||..
T Consensus 240 -------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 -------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 112234568889999999999999985 788899999843
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=337.30 Aligned_cols=263 Identities=29% Similarity=0.468 Sum_probs=205.5
Q ss_pred hhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 553 MKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 553 L~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
....+.+..|.....||.|+||.||+|.+..++..||||++... .......+.+|+.++..+. ||||++++++|.
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-- 89 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFS-- 89 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCC-CTTBCCEEEEEE--
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEE--
Confidence 44456667777777999999999999999999999999998643 2334567889999999995 999999999997
Q ss_pred CCceEEEEEecch-hhHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-CCcceeccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGL 706 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-dG~VKLiDFGL 706 (1219)
..+.+++||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 4678999999996 6899988743 4568889999999999999999999999999999999987 89999999999
Q ss_pred ccccCCcccccccccccccccCchhhhcc-ccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~-~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
+..............||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+...............+. +
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~- 247 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-I- 247 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC-C-
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc-c-
Confidence 98776544334556799999999998543 24789999999999999999999999765433221111111111111 0
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
.+.+++.+.+|+.+||..||.+| +.++|.||||....
T Consensus 248 -----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 248 -----------------------------PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -----------------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -----------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 12347788999999999999985 77889999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.72 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=197.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc-------
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV------- 632 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~------- 632 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++... ......+.+|+.++..+. ||||++++++|...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhh
Confidence 4699999999999999999999999999999998532 234567889999999995 99999999987532
Q ss_pred ----CCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 633 ----NNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 633 ----d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
....+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 2467899999997 599999974 357788999999999999999999999999999999999999999999999
Q ss_pred cccccCCc--------------ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC-CCcHHHH
Q psy14431 706 LARSLSDS--------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG-ASTSHQL 770 (1219)
Q Consensus 706 LAr~l~~~--------------~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g-~s~~e~L 770 (1219)
++...... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 99866432 1223456789999999998655578999999999999999998 4433 3333333
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
..+.......|+.++ +..++.+.+++.+||..||.+| +.++++||||.
T Consensus 239 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFD------------------------------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHSTTCCCCTTCC------------------------------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred HhccccccccCcccc------------------------------ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 444333222222111 2235678899999999999985 88889999995
Q ss_pred c
Q psy14431 849 L 849 (1219)
Q Consensus 849 L 849 (1219)
.
T Consensus 289 ~ 289 (303)
T 1zy4_A 289 V 289 (303)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.65 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=190.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHH-HHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL-FLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~-ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+.+|.+++.||.|+||.||+|.+..+|..||||++...... ........++. ++..+ +||||+++++++. ..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~--~~~ 97 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFI--TNT 97 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEE--CSS
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEe--cCC
Confidence 3477899999999999999999999999999999999644322 23334445554 45555 6999999999987 467
Q ss_pred eEEEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||+++.+..+.. ...+++..+..++.+|+.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 899999999766666655 35799999999999999999999995 999999999999999999999999999977654
Q ss_pred cccccccccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhhcCCCCCCchhh
Q psy14431 713 SKECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~-s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
.. ......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+. +....+..+.....+..+..
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 253 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH--- 253 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS---
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc---
Confidence 32 233457999999999984 3456889999999999999999999999874 44455555554433322211
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++.+.+|+.+||..||.+| +.+++.||||.-
T Consensus 254 ----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 254 ----------------------------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ----------------------------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ----------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 1347789999999999999985 788899999954
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.20 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=204.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc------hhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK------TDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~------~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++....... .....+.+|+.++..+. ||||++++++|.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE-- 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--
Confidence 457999999999999999999999999999999996543211 12335668999999995 999999999997
Q ss_pred CCceEEEEEecch-h-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYME-N-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEyme-G-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+.+.+++||||+. | +|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 5678999999986 4 89888875 4699999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
..... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.... .....+.|
T Consensus 180 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~-------- 244 (335)
T 3dls_A 180 LERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEAAIHPP-------- 244 (335)
T ss_dssp CCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTTCCCCS--------
T ss_pred CCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------HhhccCCC--------
Confidence 76543 2345689999999999865554588999999999999999999999652210 00000000
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..+++.+.+||.+||..||.+| +.++++||||.-
T Consensus 245 --------------------------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 245 --------------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp --------------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred --------------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 1247789999999999999985 788899999954
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.51 Aligned_cols=242 Identities=22% Similarity=0.266 Sum_probs=196.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.+++.||.|+||.||+|.+..+|..||||++..... ...+.+|+.++..+.+||||+++++++. .+..+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGP--CGKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEE--ETTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEe--cCCccEE
Confidence 579999999999999999999999999999999864322 2347789999999967999999999987 4678999
Q ss_pred EEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc-----ceecccccccccCC
Q psy14431 640 VFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSD 712 (1219)
Q Consensus 640 VMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~-----VKLiDFGLAr~l~~ 712 (1219)
||||++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++..+..
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 83 VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999889999988 467999999999999999999999999999999999999998887 99999999987654
Q ss_pred ccc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH---HHHHHHhhcCCCCC
Q psy14431 713 SKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH---QLQLIVNLVRPNPP 782 (1219)
Q Consensus 713 ~~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e---~L~kIve~l~P~P~ 782 (1219)
... .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+... .+..|.....+.+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred CCCCccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 322 124568999999999974 5668999999999999999999999998754332 2233322221111
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.....+. .|.+.+++..||..||.+|+
T Consensus 241 ----------------------------~~~~~~~-~p~~~~li~~~l~~~p~~RP 267 (330)
T 2izr_A 241 ----------------------------IEVLCEN-FPEMATYLRYVRRLDFFEKP 267 (330)
T ss_dssp ----------------------------HHHHTTT-CHHHHHHHHHHHHCCTTCCC
T ss_pred ----------------------------HHHHhcc-ChHHHHHHHHHHhCCCCCCC
Confidence 1111122 34899999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=338.03 Aligned_cols=244 Identities=19% Similarity=0.200 Sum_probs=200.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-++|.+++.||.|+||.||+|.+..+|..||||++.... ....+.+|+.++..+.+||||+.+++++. .+..+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeE
Confidence 457999999999999999999999999999999985332 22347789999999978999999999886 567899
Q ss_pred EEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc-----ceecccccccccC
Q psy14431 639 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLS 711 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~-----VKLiDFGLAr~l~ 711 (1219)
+||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9999998899999984 45999999999999999999999999999999999999987776 9999999998765
Q ss_pred Cccc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhhcCCCC
Q psy14431 712 DSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---SHQLQLIVNLVRPNP 781 (1219)
Q Consensus 712 ~~~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~---~e~L~kIve~l~P~P 781 (1219)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+. ...+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 237 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 237 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred cccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence 4322 13456799999999997 455689999999999999999999999987542 22222222211
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...+.....+.+++.+.+++.+||..||.+|+
T Consensus 238 -------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP 269 (298)
T 1csn_A 238 -------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATP 269 (298)
T ss_dssp -------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred -------------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCC
Confidence 11223344456788999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.70 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=201.2
Q ss_pred cccCeeEEeeeeccCceEEEEEE-----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~-----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
..++|.+++.||.|+||.||+|. +..+++.||||++... ........+.+|+.++..+.+||||++++++|..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence 35689999999999999999998 4567799999999643 2334456789999999999779999999999874
Q ss_pred CCceEEEEEecch-hhHHHHHhhcc-------------------------------------------------------
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDKI------------------------------------------------------- 656 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~~------------------------------------------------------- 656 (1219)
.+..+|+||||+. |+|.+++....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 3456899999998 48999987432
Q ss_pred ------------CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--cccccccc
Q psy14431 657 ------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIA 722 (1219)
Q Consensus 657 ------------LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~--~~~ts~vG 722 (1219)
+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 8889999999999999999999999999999999999999999999999998664332 22345678
Q ss_pred cccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhh-cCCCCCCchhhhhccCChhHHhhh
Q psy14431 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKSKHEREKF 800 (1219)
Q Consensus 723 T~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~-l~P~P~~~d~l~~~~~s~~~relI 800 (1219)
|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+...+.. ..+..+
T Consensus 258 t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 318 (359)
T 3vhe_A 258 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP------------------ 318 (359)
T ss_dssp CGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC------------------
T ss_pred CceeEChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC------------------
Confidence 89999999975 5668999999999999999998 99999887755444433332 222111
Q ss_pred HHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 801 NQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 801 ~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
...++.+.+++.+||..||.+| +.+++.|
T Consensus 319 ---------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 319 ---------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1236778999999999999986 4444443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.10 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=201.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeee
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY 629 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk-------~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvf 629 (1219)
...++|.+++.||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+.+||||++++++|
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34678999999999999999999874 35678999998643 23345567899999999996699999999998
Q ss_pred eccCCceEEEEEecchh-hHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCe
Q psy14431 630 KAVNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI 691 (1219)
Q Consensus 630 e~~d~~~LyLVMEymeG-SL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNI 691 (1219)
. ..+.+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 157 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 157 T--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred c--cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 7 46679999999985 999998743 378889999999999999999999999999999999
Q ss_pred eeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHH
Q psy14431 692 LIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSH 768 (1219)
Q Consensus 692 LLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e 768 (1219)
|++.+|.+||+|||++..+..... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999986654321 223456788999999985 5569999999999999999999 999999888776
Q ss_pred HHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 769 QLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 769 ~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
.+..+.....+..+ ..+++.+.+++.+||..||.+|
T Consensus 314 ~~~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 314 LFKLLKEGHRMDKP---------------------------------ANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp HHHHHHTTCCCCCC---------------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhcCCCCCCC---------------------------------CCCCHHHHHHHHHHcCCChhhC
Confidence 66666554432211 1236778999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.55 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=203.4
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
.....+|.+++.||.|+||.||+|.+. .++..||||++.... .......+.+|+.++..+. ||||++++++|.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-NPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc
Confidence 455678999999999999999999987 456899999986432 3344567889999999995 999999999987
Q ss_pred ccCCceEEEEEecchh-hHHHHHhh-------------------------ccCChHHHHHHHHHHHHHHHHHHhcccccC
Q psy14431 631 AVNNKDLYVVFEYMEN-DLNKVIRD-------------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHR 684 (1219)
Q Consensus 631 ~~d~~~LyLVMEymeG-SL~d~Lrs-------------------------~~LseeeVr~Ia~QILsALaYLHS~GIVHR 684 (1219)
.++.+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||+.||+||
T Consensus 121 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred --cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 46779999999985 99999875 468899999999999999999999999999
Q ss_pred CCCCCCeeeccCCcceecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCC
Q psy14431 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLF 761 (1219)
Q Consensus 685 DLKPsNILLd~dG~VKLiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF 761 (1219)
||||+|||++.++.++|+|||++....... .......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999999998654332 1223456789999999975 4568999999999999999999 99999
Q ss_pred CCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 762 PGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 762 ~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.+.+.......+.....+..+ +.+++.+.+++.+||..||.+|+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILACP---------------------------------ENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCChHHHHHHHhCCCcCCCC---------------------------------CCCCHHHHHHHHHHcccCcccCCC
Confidence 988887777666654432211 123677899999999999998743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.66 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=202.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+.++|.+++.||.|+||.||+|.+.. +..||+|++..... ....+.+|+.++..+. ||||+++++++. +.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 80 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM---SEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPI 80 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSSE
T ss_pred ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc---CHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCce
Confidence 34679999999999999999999874 67799999964332 3456889999999996 999999999987 46679
Q ss_pred EEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999984 89999864 458999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......+|+.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 229 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------- 229 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred cccccCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC----------
Confidence 122345567889999997 45568999999999999999999 99999998888777777665433222
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ 843 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq 843 (1219)
...++.+.+++.+||..||.+| +.++++
T Consensus 230 -----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 230 -----------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1136678999999999999986 444443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=354.00 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=207.3
Q ss_pred cccCeeEEeeeeccCceEEEEEE-----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~-----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
...+|.+++.||.|+||.||+|. +..++..||||++... ........+.+|+.++..+. ||||++++++|.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~-- 144 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL-- 144 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe--
Confidence 34679999999999999999999 4567889999998532 23445567889999999995 999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhhc--------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC---cce
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIK 700 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~--------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG---~VK 700 (1219)
+....|+||||+. |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+| .++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 4667899999996 5999999753 388899999999999999999999999999999999999655 499
Q ss_pred ecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhc
Q psy14431 701 IGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV 777 (1219)
Q Consensus 701 LiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l 777 (1219)
|+|||++..+.... .......||+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997543221 1223456899999999985 4569999999999999999998 999999988888777776655
Q ss_pred CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 778 RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 778 ~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.++ ..+++.+.+|+.+||..||.+| +.+++++.++..
T Consensus 304 ~~~~~---------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPP---------------------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------------------------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 33322 1236678899999999999986 677788887644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.86 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=186.1
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
...++|.+++.||.|+||.||+|.+..+|..||||++.... .......+..|+..+....+||||+++++++. ..+.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~ 95 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGD 95 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCc
Confidence 34678999999999999999999999999999999996442 23344566777775555446999999999987 4678
Q ss_pred EEEEEecchhhHHHHHh------hccCChHHHHHHHHHHHHHHHHHHhc-ccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 637 LYVVFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lr------s~~LseeeVr~Ia~QILsALaYLHS~-GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+|+||||++++|.+++. ...+++..+..++.+++.||.|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99999999998888776 45689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhh---ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILI---SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl---~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
...... .....||+.|+|||++. .+..++.++|||||||++|+|++|.+||.+.+.. ...+.......++.++.
T Consensus 176 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 176 LVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCCC
T ss_pred cccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCCCCCC
Confidence 654322 23447999999999973 3456899999999999999999999999875432 11111111111111100
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. ..+..++.+.+|+.+||..||.+| +.++++||||..
T Consensus 253 ~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 253 S--------------------------EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp C--------------------------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred c--------------------------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0 013457889999999999999885 888899999954
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.47 Aligned_cols=241 Identities=17% Similarity=0.267 Sum_probs=200.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..+++|.+++.||.|+||.||+|.+. |..||||++............+.+|+.++..+. ||||+++++++.......
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence 45778999999999999999999875 889999999765555556678899999999995 999999999998655578
Q ss_pred EEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 637 LYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
+++||||++ |+|.+++... .+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999998 5999999854 4899999999999999999999999 999999999999999999999988887654
Q ss_pred CCcccccccccccccccCchhhhccc--cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhh
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKF 787 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~--~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l 787 (1219)
.. ....||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+.......+.... .|..+
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 233 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP----- 233 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC-----
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC-----
Confidence 32 2347899999999985432 23347999999999999999999999888777665554433 11111
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+++.+||..||.+|+
T Consensus 234 ----------------------------~~~~~~~~~li~~~l~~~p~~Rp 256 (271)
T 3kmu_A 234 ----------------------------PGISPHVSKLMKICMNEDPAKRP 256 (271)
T ss_dssp ----------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ----------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 23477899999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=337.83 Aligned_cols=262 Identities=25% Similarity=0.340 Sum_probs=199.7
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
...+++|.+++.||.|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. ||||+++++++. .+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~--~~ 106 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGE--ID 106 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ET
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEe--eC
Confidence 34578899999999999999999999999999999998654332 233467889999999995 999999999987 46
Q ss_pred ceEEEEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++| +|.+++.. +.+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 789999999985 89998874 5699999999999999999999999999999999999999999999999999987654
Q ss_pred cc-cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 713 SK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~-~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. .......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+... +...+....+.+..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~-------- 256 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPST-------- 256 (309)
T ss_dssp ----------CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGG--------
T ss_pred cccccccccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccc--------
Confidence 32 2233567899999999974 5578999999999999999999999998766543 22322222221111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HHHHcchhhhcCCC
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IEQLQGKLAALGSE 852 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iEALqHpwfaL~~e 852 (1219)
..+.+++.+.+++.+||..||.+|+ .+++.+.|......
T Consensus 257 ----------------------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 257 ----------------------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----------------------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----------------------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1234578899999999999999985 67777777655333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.62 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=201.8
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCC---eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TG---k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
......+|.+.+.||.|+||.||+|.+..+| ..||||++.... .......+.+|+.++..+. ||||++++++|.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~- 120 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFD-HPNIIRLEGVVT- 120 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE-
Confidence 3455678999999999999999999998554 459999986432 3344567889999999995 999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
+++.+|+||||++ ++|.+++.. +.+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 121 -RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp -GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred -eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 4667899999997 499999863 479999999999999999999999999999999999999999999999999998
Q ss_pred ccCCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 709 SLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 709 ~l~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
.+..... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP-- 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC--
T ss_pred ccccCccceeeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC--
Confidence 7654322 122345677899999984 5568999999999999999999 99999998888877777665432211
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+++.+.+|+.+||..||.+|+
T Consensus 277 -------------------------------~~~~~~l~~li~~~l~~dp~~Rp 299 (325)
T 3kul_A 277 -------------------------------MGCPHALHQLMLDCWHKDRAQRP 299 (325)
T ss_dssp -------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -------------------------------CCcCHHHHHHHHHHccCChhhCc
Confidence 12367789999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=334.72 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=200.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccC-CCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~-HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.+|.+++.||.|+||.||+|.+. +|..||||++............+.+|+.++..+.. ||||+++++++. ....+|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~~ 104 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY 104 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--CSSEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--cCCEEE
Confidence 46999999999999999999885 48899999997555455566788899999999974 699999999987 467899
Q ss_pred EEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc--
Q psy14431 639 VVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-- 715 (1219)
Q Consensus 639 LVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~-- 715 (1219)
+|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++........
T Consensus 105 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 105 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence 9999888999999874 5689999999999999999999999999999999999996 48999999999987654322
Q ss_pred ccccccccccccCchhhhc----------cccccccccchhHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhhcCCCCCCc
Q psy14431 716 CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~----------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~-e~L~kIve~l~P~P~~~ 784 (1219)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.... ..+..+...... ..+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 261 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--IEF 261 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--CCC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc--cCC
Confidence 1234578999999999853 146889999999999999999999999765432 222222211100 000
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
....++.+.+++.+||..||.+| +.++|+||||....
T Consensus 262 ------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 262 ------------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ------------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ------------------------------cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 01225678999999999999985 88889999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.05 Aligned_cols=244 Identities=23% Similarity=0.370 Sum_probs=200.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
....+|.+.+.||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~- 96 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACS- 96 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe-
Confidence 34568999999999999999999983 45689999998643 23445577889999999995 999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhhc-------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCC
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDK-------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~-------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRD 685 (1219)
..+.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+|||
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 4667999999998 6899998742 378899999999999999999999999999
Q ss_pred CCCCCeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCC
Q psy14431 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFP 762 (1219)
Q Consensus 686 LKPsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~ 762 (1219)
|||+|||++.++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986654322 123446788899999984 4568999999999999999999 999999
Q ss_pred CCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 763 GASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 763 g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+.......+.....+..+ +.+++.+.+++.+||..||.+|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERP---------------------------------DNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCHHHHHHHhhcCCcCCCC---------------------------------ccCCHHHHHHHHHHccCChhhCc
Confidence 88776666555444322111 23467899999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.26 Aligned_cols=245 Identities=20% Similarity=0.356 Sum_probs=197.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
...++|.+.+.||.|+||.||+|.+..+|..||+|++.. ........+.+|+.++..+. ||||+++++++. +++.
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~ 81 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLY--KDKR 81 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEe--cCCe
Confidence 346789999999999999999999999999999998843 23455677889999999996 999999999987 5678
Q ss_pred EEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999985 99999985 56999999999999999999999999999999999999999999999999999876543
Q ss_pred ccc--------------cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC
Q psy14431 714 KEC--------------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779 (1219)
Q Consensus 714 ~~~--------------~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P 779 (1219)
... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~----------- 229 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----------- 229 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC-----------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH-----------
Confidence 221 11467999999999974 5678999999999999999999999997543210
Q ss_pred CCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 780 ~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.... ......+.. ...+.+++.+.+++.+||..||.+|+
T Consensus 230 --~~~~--------~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rp 268 (310)
T 3s95_A 230 --MDFG--------LNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRP 268 (310)
T ss_dssp --TTSS--------BCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSC
T ss_pred --HHHh--------hhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCc
Confidence 0000 000000000 01145678899999999999999973
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.75 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=193.5
Q ss_pred cccCeeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
...+|.+++.||.|+||.||+|. +..+|..||||++... .......+.+|+.++..+. ||||+++++++...+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 45689999999999999999998 5678999999998532 3344567889999999996 999999999987655
Q ss_pred CceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
...+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 667899999997 599999874 34999999999999999999999999999999999999999999999999999876
Q ss_pred CCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 711 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 711 ~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..... ......+|+.|+|||++. +..++.++|||||||++|+|++|..||..... ... ......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~----~~~~~~~~~~~-- 236 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-EFM----RMIGNDKQGQM-- 236 (295)
T ss_dssp -----------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-HHH----HHHCTTCCTHH--
T ss_pred cCCcceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChH-HHH----hhhcCccccch--
Confidence 54321 122345778899999974 45689999999999999999999999864321 111 11111111000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
........+......+ ..+.+++.+.+++.+||..||.+|+
T Consensus 237 -------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp 277 (295)
T 3ugc_A 237 -------IVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRP 277 (295)
T ss_dssp -------HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred -------hHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCC
Confidence 0000111111000000 1134578899999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.49 Aligned_cols=246 Identities=20% Similarity=0.345 Sum_probs=202.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
..++|.+++.||.|+||.||+|.+. ++..||+|++..... ....+.+|+.++..+. ||||+++++++. +...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 78 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLS-HPKLVKFYGVCS--KEYPI 78 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCce
Confidence 3567999999999999999999776 567799999864322 3456889999999996 999999999986 56779
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999997 579998874 358999999999999999999999999999999999999999999999999998665432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+.++.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH--------- 228 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------
T ss_pred hhcccCCCcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC---------
Confidence 2 223345677899999974 5568999999999999999999 999999888877776666554333221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..++.+.+++.+||..||.+| +.+++++
T Consensus 229 ------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 229 ------------------------LASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 125678899999999999986 4444443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=330.59 Aligned_cols=241 Identities=23% Similarity=0.425 Sum_probs=202.6
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...+|.+.+.||.|+||.||+|.+..++..||+|++.. .......+.+|+.++..+. ||||+++++++. +.+.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCCE
Confidence 35679999999999999999999999999999999853 2345567889999999996 999999999986 56779
Q ss_pred EEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 638 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
|+||||++ ++|.+++.. ..+++..+..++.+|+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999998 689999874 44899999999999999999999999999999999999999999999999999876543
Q ss_pred c-cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~-~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
. .......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 234 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--------- 234 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------
T ss_pred ccccccCCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC---------
Confidence 3 2223456788999999974 4568999999999999999999 99999988776666655544322211
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+|+.+||..||.+|+
T Consensus 235 ------------------------~~~~~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 235 ------------------------EGCPEKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp ------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------CCCCHHHHHHHHHHhCCChhhCc
Confidence 12367789999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.75 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=199.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
...+|.+.+.||.|+||.||+|.+ ..++..||||++.... .......+.+|+.++..+.+||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--
Confidence 346899999999999999999985 4678899999986432 23445778899999999966999999999987
Q ss_pred CCceEEEEEecchh-hHHHHHhhc-------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCee
Q psy14431 633 NNKDLYVVFEYMEN-DLNKVIRDK-------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL 692 (1219)
Q Consensus 633 d~~~LyLVMEymeG-SL~d~Lrs~-------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNIL 692 (1219)
.++.+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 46678999999975 999998743 3899999999999999999999999999999999999
Q ss_pred eccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14431 693 IDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ 769 (1219)
Q Consensus 693 Ld~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~ 769 (1219)
++.++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999987655432 123456788999999975 4568999999999999999998 9999988765554
Q ss_pred HHHHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 770 LQLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 770 L~kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++... .+..+ +..++.+.+++.+||..||.+|+
T Consensus 257 ~~~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 257 FYKMIKEGFRMLSP---------------------------------EHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHHTCCCCCC---------------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHhccCCCCCCc---------------------------------ccCCHHHHHHHHHHcCCCchhCc
Confidence 44443322 11111 22467889999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.41 Aligned_cols=203 Identities=25% Similarity=0.390 Sum_probs=172.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC--Cc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--NK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d--~~ 635 (1219)
...+|.+++.||.|+||.||+|.+. +..||||++... ........+|+.++..+. ||||+++++++.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence 4678999999999999999999765 799999998532 233445567888899985 999999999987533 34
Q ss_pred eEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc----------ccccCCCCCCCeeeccCCcceeccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC----------KVMHRDLKPSNILIDKSCSIKIGDL 704 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~----------GIVHRDLKPsNILLd~dG~VKLiDF 704 (1219)
.+|+||||+++ +|.+++....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 58999999985 999999988899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCccc--ccccccccccccCchhhhcc----ccccccccchhHHHHHHHHHhCCCCCCCCCc
Q psy14431 705 GLARSLSDSKE--CLTEYIATRWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGAST 766 (1219)
Q Consensus 705 GLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~----~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~ 766 (1219)
|++..+..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+...
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99987654322 23346799999999998542 4577889999999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.19 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=183.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec------cC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------VN 633 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~------~d 633 (1219)
.+|.+.+.||.|+||.||+|.+..+|..||||++... .......+.+|+.++..+.+||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3799999999999999999999999999999988533 334556788999999999779999999999842 24
Q ss_pred CceEEEEEecchhhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCcceecccccc
Q psy14431 634 NKDLYVVFEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 634 ~~~LyLVMEymeGSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
...+|+||||++|+|.+++.. +.+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 556899999999999888863 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccc------------cccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q psy14431 708 RSLSDSKEC------------LTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773 (1219)
Q Consensus 708 r~l~~~~~~------------~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kI 773 (1219)
......... ....+||+.|+|||++. .+..++.++|||||||++|+|++|.+||.+......+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence 876543211 11456899999999973 3456889999999999999999999999765443221
Q ss_pred HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 774 VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 774 ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
......+. ....++.+.+|+.+||.+||.+| +.+++++-+.
T Consensus 263 -~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 263 -NGKYSIPP--------------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ----CCCCT--------------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred -cCcccCCc--------------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111110 01234567899999999999986 5666666543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.73 Aligned_cols=247 Identities=20% Similarity=0.347 Sum_probs=201.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...+|.+++.||.|+||.||+|.+. ++..||+|++..... ....+.+|+.++..+. ||||+++++++. +...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLS-HEKLVQLYGVCT--KQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCC-CCCEeeEEEEEe--cCCCe
Confidence 4568999999999999999999876 577899999964322 3456889999999996 999999999986 56789
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999997 589999874 569999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+.
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 244 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH--------- 244 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------
T ss_pred cccccCCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC---------
Confidence 1223345678899999985 4568999999999999999998 999999988887777776655333221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcch
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGK 845 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHp 845 (1219)
..++.+.+++.+||..||.+| +.+++.|-
T Consensus 245 ------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 245 ------------------------LASEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp ------------------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ------------------------cCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 125678899999999999986 44455443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.00 Aligned_cols=241 Identities=22% Similarity=0.344 Sum_probs=188.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+|.+.+.||.|+||.||+|.+..+ +..||+|++... ........+.+|+.++..+. ||||+++++++. ++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~ 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---EN 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc---cC
Confidence 46799999999999999999998653 567999988532 23344567889999999995 999999999984 45
Q ss_pred eEEEEEecchh-hHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 68999999985 899998743 589999999999999999999999999999999999999999999999999987654
Q ss_pred ccc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 SKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
... ......+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 239 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-------- 239 (281)
T ss_dssp ----------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC--------
T ss_pred ccccccccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC--------
Confidence 322 123345678999999974 5568999999999999999996 99999988877777666554422111
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+++.+||..||.+|+
T Consensus 240 -------------------------~~~~~~l~~li~~~l~~~p~~Rp 262 (281)
T 1mp8_A 240 -------------------------PNCPPTLYSLMTKCWAYDPSRRP 262 (281)
T ss_dssp -------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -------------------------CCCCHHHHHHHHHHccCChhhCc
Confidence 23477889999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.58 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=188.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC--chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s--~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
++.+|.+.+.||.|+||.||+|.+. |..||||++...... ......+.+|+.++..+. ||||+++++++. .++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~ 79 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCL--KEP 79 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--CC-
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe--cCC
Confidence 4678999999999999999999874 889999998643222 233467889999999996 999999999987 466
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcc---cccCCCCCCCeeecc--------CCcceecc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK---VMHRDLKPSNILIDK--------SCSIKIGD 703 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~G---IVHRDLKPsNILLd~--------dG~VKLiD 703 (1219)
.+|+||||++ ++|.+++....+++..+..++.||+.||.|||+.| |+||||||+|||++. ++.++|+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 7899999997 68999998888999999999999999999999999 899999999999986 67899999
Q ss_pred cccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 704 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 704 FGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
||++....... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.....+.+.
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 235 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI- 235 (271)
T ss_dssp CCC---------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC-
T ss_pred CCccccccccc--ccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC-
Confidence 99998765433 23457999999999974 556899999999999999999999999988776655554433321110
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
....++.+.+++.+||..||.+|+
T Consensus 236 -------------------------------~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 236 -------------------------------PSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp -------------------------------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -------------------------------CcccCHHHHHHHHHHhcCCcccCc
Confidence 012367789999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.39 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=206.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.++|.+++.||.|+||.||+|.+.. .+..||||++... ........+.+|+.++..+.+||||++++++|.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 4679999999999999999999753 3468999998643 334455778899999999967999999999987
Q ss_pred cCCceEEEEEecchh-hHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 632 VNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 632 ~d~~~LyLVMEymeG-SL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
..+.+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 146 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 46679999999985 999999753 38999999999999999999999999999999999999
Q ss_pred ccCCcceecccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14431 694 DKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL 770 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L 770 (1219)
+.++.++|+|||++....... .......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998765432 2233456788999999985 5668999999999999999999 99999998877776
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcch
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGK 845 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHp 845 (1219)
..+.....+..+ ..+++.+.+|+.+||..||.+| +.+++++-
T Consensus 304 ~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 304 KLLKEGHRMDKP---------------------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHHTTCCCCCC---------------------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCC---------------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 666655433221 1236778999999999999986 44455443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.28 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=176.5
Q ss_pred ccCeeEEe-eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCc
Q psy14431 559 LQQQINLL-KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNK 635 (1219)
Q Consensus 559 IqqY~ILK-kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~ 635 (1219)
.++|.+++ .||.|+||.||+|.+..+|+.||||++... ....+++..+....+||||++++++|... ++.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46788866 599999999999999999999999998532 22344555555555799999999998642 245
Q ss_pred eEEEEEecchh-hHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---Ccceeccccccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLAR 708 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKLiDFGLAr 708 (1219)
.+|+||||+.| +|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 68999999985 999999753 59999999999999999999999999999999999999864 459999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
...... ....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+...........
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 252 (336)
T 3fhr_A 180 ETTQNA--LQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF---- 252 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC----
T ss_pred eccccc--cccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc----
Confidence 765432 3456789999999997 456789999999999999999999999977654332211111110000000
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+ ......+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 253 ---------------~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 253 ---------------P-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---------------C-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---------------C-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 00013457889999999999999984 888999999965
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.48 Aligned_cols=237 Identities=14% Similarity=0.246 Sum_probs=192.6
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCC-------eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNK-------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TG-------k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
..++|.+.+.||.|+||.||+|.+..++ ..||+|++... .......+.+|+.++..+. ||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLS-HKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence 3568999999999999999999998877 57999998543 2344567889999999996 999999999987
Q ss_pred ccCCceEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc--------c
Q psy14431 631 AVNNKDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--------I 699 (1219)
Q Consensus 631 ~~d~~~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~--------V 699 (1219)
+++..|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++. +
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred --eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 4667899999998 5999999853 3899999999999999999999999999999999999998887 9
Q ss_pred eecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhhcC
Q psy14431 700 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 700 KLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+...... +.....
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~ 235 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH 235 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC
Confidence 99999999766543 2346889999999986657799999999999999999995 56665555443332 222211
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+ +..++.+.+|+.+||.+||.+|+
T Consensus 236 ~~~----------------------------------~~~~~~l~~li~~~l~~dp~~Rp 261 (289)
T 4fvq_A 236 QLP----------------------------------APKAAELANLINNCMDYEPDHRP 261 (289)
T ss_dssp CCC----------------------------------CCSSCTTHHHHHHHSCSSGGGSC
T ss_pred CCC----------------------------------CCCCHHHHHHHHHHcCCChhHCc
Confidence 111 11256688999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.14 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=189.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhc-cCCCCccEEeeeeecc--CCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF-QRHPNIITMLDIYKAV--NNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L-~~HPNIVkL~gvfe~~--d~~ 635 (1219)
.++|.+++.||.|+||.||+|.+ +|..||||++.. .....+.+|..++... .+||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45799999999999999999977 689999999853 2345566677777663 2599999999987532 245
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHH--------hcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH--------ACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLH--------S~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
.+|+||||++ |+|.+++....+++..+..++.||+.||.||| +.||+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 6899999998 49999999888999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCcccc----cccccccccccCchhhhccc-----cccccccchhHHHHHHHHHhC----------CCCCCCCC--
Q psy14431 707 ARSLSDSKEC----LTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQS----------KPLFPGAS-- 765 (1219)
Q Consensus 707 Ar~l~~~~~~----~ts~vGT~~Y~APEvLl~~~-----~yT~kSDIWSLG~ILyELLTG----------kpPF~g~s-- 765 (1219)
+......... ....+||+.|+|||++.+.. .++.++|||||||++|+|++| .+||.+..
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 9765443221 22347999999999985432 456899999999999999999 88885432
Q ss_pred --cHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 766 --TSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 766 --~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
....+..+.......+....... ....++.+.+|+.+||..||.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWF--------------------------SDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGG--------------------------GSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred CcchhhhhHHHhccCCCCCCChhhc--------------------------cCccHHHHHHHHHHHhhcChhhCCC
Confidence 22233333222211111111000 0113467899999999999998743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.63 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=192.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||.|+||.||+|.+..+|..||||++...... ..+.+|+.++..+. |++++..+.++.. .+..+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQ-GGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHT-TSTTCCCEEEEEE-ETTEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhc-CCCCCCeeeeecC-CCCceEE
Confidence 5799999999999999999999999999999987533222 24778999999997 6665555555532 5678899
Q ss_pred EEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCcc
Q psy14431 640 VFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999889999987 4679999999999999999999999999999999999999 788999999999998765432
Q ss_pred c-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHH---HHHHHHhhcCCCCCCc
Q psy14431 715 E-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH---QLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 715 ~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e---~L~kIve~l~P~P~~~ 784 (1219)
. ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+... .+..+....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 234 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 234 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-------
T ss_pred cCccCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-------
Confidence 1 223567999999999974 5568999999999999999999999997654321 111111111
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
...+.....+.+++.+.+++.+||..||.+|+.
T Consensus 235 ----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 267 (296)
T 4hgt_A 235 ----------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp ----------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred ----------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC
Confidence 112233344567889999999999999999743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=349.27 Aligned_cols=243 Identities=21% Similarity=0.355 Sum_probs=200.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+..+|.+.+.||.|+||.||+|.+..+|..||||++... ........+.+|+.++..+. ||||+++++++. ..+.+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~ 187 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCT--QKQPI 187 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEEC--SSSSC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--cCCCc
Confidence 356799999999999999999999999999999998643 22333456789999999995 999999999986 45679
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||++ |+|.+++.. ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999997 689999874 358999999999999999999999999999999999999999999999999998654432
Q ss_pred ccc--ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 ECL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 ~~~--ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
... ....+++.|+|||++. ...++.++|||||||++|+|++ |.+||++.+.......+.....++.+
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 337 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP--------- 337 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC---------
T ss_pred eeecCCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence 111 1223577899999974 4568999999999999999998 99999998877766666554432211
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+|+.+||..||.+|+
T Consensus 338 ------------------------~~~~~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 338 ------------------------ELCPDAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp ------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------CCCCHHHHHHHHHHcCCCchhCc
Confidence 11356788999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.32 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=201.8
Q ss_pred ccccCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
....+|.+.+.||.|+||.||+|.+ ..++..||||++.... .......+.+|+.++..+.+||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT- 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 4467899999999999999999997 3467789999986432 23344678899999999966999999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHhhc------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCC
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDK------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDL 686 (1219)
..+.+|+||||++ |+|.+++... .+++..+..++.||+.||.|||+.||+||||
T Consensus 120 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 120 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred -eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4667999999997 5999998742 2788899999999999999999999999999
Q ss_pred CCCCeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCC
Q psy14431 687 KPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPG 763 (1219)
Q Consensus 687 KPsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g 763 (1219)
||+|||++.++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999986654322 223456788999999974 4568999999999999999998 9999988
Q ss_pred CCcHHHHHHHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHH
Q psy14431 764 ASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIE 840 (1219)
Q Consensus 764 ~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiE 840 (1219)
.+....+..++... .+..+ +..++.+.+|+.+||..||.+| +.+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQP---------------------------------FYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCcHHHHHHHHhcCCCCCCC---------------------------------CCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 77655444443322 21111 1236788999999999999986 555
Q ss_pred HHcchhh
Q psy14431 841 QLQGKLA 847 (1219)
Q Consensus 841 ALqHpwf 847 (1219)
++.+-..
T Consensus 325 l~~~l~~ 331 (344)
T 1rjb_A 325 LTSFLGC 331 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=333.67 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=192.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcC---CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~---TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+..+|.+.+.||.|+||.||+|.+.. ++..||+|++............+.+|+.++..+. ||||+++++++...+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence 35679999999999999999998765 5678999998755555556677899999999996 9999999999874332
Q ss_pred ---ceEEEEEecch-hhHHHHHh-------hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecc
Q psy14431 635 ---KDLYVVFEYME-NDLNKVIR-------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 703 (1219)
Q Consensus 635 ---~~LyLVMEyme-GSL~d~Lr-------s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiD 703 (1219)
..+|+||||+. ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 25699999998 48998884 24589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCC
Q psy14431 704 LGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPN 780 (1219)
Q Consensus 704 FGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~ 780 (1219)
||++..+..... ......+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+.
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 999987654321 123345788999999974 5678999999999999999999 899999888777666665544322
Q ss_pred CCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 781 PPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 781 P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+ +.+++.+.+++.+||..||.+|+
T Consensus 270 ~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rp 294 (313)
T 3brb_A 270 QP---------------------------------EDCLDELYEIMYSCWRTDPLDRP 294 (313)
T ss_dssp CB---------------------------------TTCCHHHHHHHHHTTCSSGGGSC
T ss_pred CC---------------------------------ccccHHHHHHHHHHcCCChhhCc
Confidence 11 23467789999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.05 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=199.2
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCeE----EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeee
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK 630 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~----VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe 630 (1219)
......+|.+++.||.|+||.||+|.+..+|.. ||+|++.... .......+.+|+.++..+. ||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc
Confidence 345567899999999999999999999888876 6666653221 1222345678999999995 999999999885
Q ss_pred ccCCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 631 AVNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 631 ~~d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
+..+++||+|+. |+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 86 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 ---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp ---BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred ---CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 456899999998 689998874 47999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 708 RSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 708 r~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
..+..... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 240 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ- 240 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT-
T ss_pred cccCcccccccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC-
Confidence 87754322 234456788999999984 4569999999999999999999 999999888777666665544222221
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..++.+.+++.+||.+||.+| +.+++.+
T Consensus 241 --------------------------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 --------------------------------ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------------------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------------------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 125667889999999999986 4444443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.06 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=204.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhcc-CCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ-RHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~-~HPNIVkL~gvfe~~ 632 (1219)
-..+|.+++.||.|+||.||+|.+..+|..||||++....... .....+.+|+.++..+. +||||++++++|.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~-- 118 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-- 118 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence 3567999999999999999999999999999999996543221 12234567999999997 3799999999997
Q ss_pred CCceEEEEEecch--hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceeccccccc
Q psy14431 633 NNKDLYVVFEYME--NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLAR 708 (1219)
Q Consensus 633 d~~~LyLVMEyme--GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDFGLAr 708 (1219)
..+.+++||+++. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 5678999999997 689998874 5789999999999999999999999999999999999999 78899999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
...... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ .+.......
T Consensus 199 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~-------- 262 (320)
T 3a99_A 199 LLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF-------- 262 (320)
T ss_dssp ECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--------
T ss_pred cccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc--------
Confidence 766432 3456799999999998665555889999999999999999999996532 111111110
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+|+.+||..||.+| +.++++||||..
T Consensus 263 --------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 263 --------------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp --------------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred --------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 12357789999999999999985 888899999965
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.40 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=199.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-------CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-------~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.++|.+++.||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+.+||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 468999999999999999999975 46788999998643 233455678899999999966999999999987
Q ss_pred cCCceEEEEEecchh-hHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 632 VNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 632 ~d~~~LyLVMEymeG-SL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
..+.+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 112 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 112 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp -SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred -cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 46679999999985 999998743 37889999999999999999999999999999999999
Q ss_pred ccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14431 694 DKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL 770 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L 770 (1219)
+.++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987654321 123446788999999974 4568999999999999999999 99999988877766
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
..+.....+..+ ...++.+.+++.+||..||.+|
T Consensus 270 ~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 270 KLLKEGHRMDKP---------------------------------ANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp HHHHHTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhcCCCCCCC---------------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 666554422211 1236778999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.54 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=194.1
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhH-----HHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-----QRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~-----e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
...++|.+.+.||.|+||.||+|.+..++..||+|++.......... ..+.+|+.++..+. ||||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecC
Confidence 33568999999999999999999999999999999986443222221 57889999999995 9999999999863
Q ss_pred cCCceEEEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeeccCCc-----cee
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCS-----IKI 701 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd~dG~-----VKL 701 (1219)
. .++||||+. ++|.+++. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++. ++|
T Consensus 95 --~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 95 --P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp --T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred --C--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 2 279999998 68988875 346899999999999999999999999 999999999999988776 999
Q ss_pred cccccccccCCcccccccccccccccCchhhh-ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhhcC
Q psy14431 702 GDLGLARSLSDSKECLTEYIATRWYRAPEILI-SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl-~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~--L~kIve~l~ 778 (1219)
+|||++...... .....||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+.... ...+....
T Consensus 171 ~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 246 (287)
T 4f0f_A 171 ADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG- 246 (287)
T ss_dssp CCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-
T ss_pred CCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-
Confidence 999999865443 34568999999999973 244578999999999999999999999987654433 22222211
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+. + .+.+++.+.+++.+||..||.+|+
T Consensus 247 ~~~~-~------------------------------~~~~~~~l~~li~~~l~~dp~~Rp 275 (287)
T 4f0f_A 247 LRPT-I------------------------------PEDCPPRLRNVIELCWSGDPKKRP 275 (287)
T ss_dssp CCCC-C------------------------------CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCC-C------------------------------CcccCHHHHHHHHHHhcCChhhCc
Confidence 1111 1 123477899999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=344.69 Aligned_cols=255 Identities=15% Similarity=0.141 Sum_probs=187.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-----CeEEEEEEeeccccCc---------hhHHHHHHHHHHHHhccCCCCccE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNK---------TDAQRTYREILFLKSFQRHPNIIT 624 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-----Gk~VAIKvI~ks~~s~---------~~~e~~lREI~ILr~L~~HPNIVk 624 (1219)
..+|.+++.||.|+||.||+|.+..+ ++.||||++....... ........++..+..+ .||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCe
Confidence 34799999999999999999998765 5889999985331100 0001122333444445 3999999
Q ss_pred EeeeeeccCC--ceEEEEEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec--cCCc
Q psy14431 625 MLDIYKAVNN--KDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCS 698 (1219)
Q Consensus 625 L~gvfe~~d~--~~LyLVMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd--~dG~ 698 (1219)
+++++..... .++||||||++++|.+++.. ..+++..+..|+.||+.||.|||+.||+||||||+|||++ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9999874322 56899999998899999875 5699999999999999999999999999999999999999 8899
Q ss_pred ceecccccccccCCcccc-------cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14431 699 IKIGDLGLARSLSDSKEC-------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 771 (1219)
Q Consensus 699 VKLiDFGLAr~l~~~~~~-------~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~ 771 (1219)
++|+|||++..+...... ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999876543211 13456999999999974 5568999999999999999999999998643322222
Q ss_pred HHHh-hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 772 LIVN-LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 772 kIve-~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.... ...+ .+..+...|. ..+..++.+.+++..|+..||.+|+.
T Consensus 272 ~~~~~~~~~-------------------~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 272 RDSKIRYRE-------------------NIASLMDKCF-----PAANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp HHHHHHHHH-------------------CHHHHHHHHS-----CTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred HHHHHHhhh-------------------hHHHHHHHhc-----ccccCHHHHHHHHHHHhcCCCCCCCC
Confidence 1111 1100 0001111110 01456889999999999999999744
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.57 Aligned_cols=244 Identities=20% Similarity=0.217 Sum_probs=194.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++..... ...+.+|+.++..+. |++++..+.++.. .+..+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQ-GGVGIPTIRWCGA-EGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHT-TSTTCCCEEEEEE-ETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhh-cCCCCCccccccC-CCCceE
Confidence 4679999999999999999999999999999999864322 234789999999997 6666555555532 567889
Q ss_pred EEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCc
Q psy14431 639 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999889999987 4569999999999999999999999999999999999999 48889999999999876543
Q ss_pred cc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhhcCCCCCC
Q psy14431 714 KE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 714 ~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~---e~L~kIve~l~P~P~~ 783 (1219)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.. ..+..+....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred ccccccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------
Confidence 22 124567999999999974 556899999999999999999999999864321 1222221111
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...+...+.+.+++.+.+++.+||..||.+|+
T Consensus 235 -----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 266 (296)
T 3uzp_A 235 -----------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 266 (296)
T ss_dssp -----------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC
T ss_pred -----------------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC
Confidence 01112233356788999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.42 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=199.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+..+|.+++.||.|+||.||+|.+. ++..||+|++..... ....+.+|+.++..+. ||||+++++++. +.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~ 78 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPI 78 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSSC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCCe
Confidence 3568999999999999999999986 577899999964332 2356889999999995 999999999987 45679
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999997 589999875 458999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------- 227 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------- 227 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred ccccccccccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC----------
Confidence 1223456778899999974 5568999999999999999999 89999988887777776655432221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+++.+||..||.+|+
T Consensus 228 -----------------------~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 228 -----------------------RLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------ccCcHHHHHHHHHHccCChhhCc
Confidence 11366788999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.30 Aligned_cols=248 Identities=21% Similarity=0.378 Sum_probs=202.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+.+.||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+. ||||+++++++. +
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~ 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--Q 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc--c
Confidence 457999999999999999999876 46788999998633 23344556889999999995 999999999986 4
Q ss_pred CceEEEEEecch-hhHHHHHhh-----------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCccee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD-----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs-----------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKL 701 (1219)
++.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 667899999998 589998874 34688899999999999999999999999999999999999999999
Q ss_pred cccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 702 GDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 99999986654321 123346788999999974 5568999999999999999999 8999998887777666655442
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
+..+ +.+++.+.+++.+||..||.+| +.+++.+
T Consensus 259 ~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKP---------------------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC---------------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2211 1346778999999999999986 4555544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.45 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=197.7
Q ss_pred cccCeeEEe-eeeccCceEEEEEEE--cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLL-KEGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILK-kIGeGgFGtVYlA~d--k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+..+|.+.. .||.|+||.||+|.+ ..++..||||++............+.+|+.++..+. ||||+++++++. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~ 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---A 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---S
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEC---C
Confidence 356788888 999999999999954 567899999999755444455677889999999995 999999999984 4
Q ss_pred ceEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 67899999998 589999875 4599999999999999999999999999999999999999999999999999987654
Q ss_pred cccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.... .....+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 242 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP------ 242 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC------
T ss_pred CCCcccccccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence 3221 12334678899999984 5568999999999999999999 99999988877766666554322211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+++.+||..||.+|+
T Consensus 243 ---------------------------~~~~~~l~~li~~~l~~dp~~Rp 265 (291)
T 1xbb_A 243 ---------------------------AGCPREMYDLMNLCWTYDVENRP 265 (291)
T ss_dssp ---------------------------TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred ---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 23467899999999999999973
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=348.79 Aligned_cols=267 Identities=20% Similarity=0.288 Sum_probs=202.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-.+|.+.+.||.|+||.||+|.+..+|..||||++..... ......+.+|+.++..+. ||||+++++++...+...+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeE
Confidence 3579999999999999999999999999999999864322 233566789999999996 99999999999866666899
Q ss_pred EEEecch-hhHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee----ccCCcceecccccccc
Q psy14431 639 VVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARS 709 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL----d~dG~VKLiDFGLAr~ 709 (1219)
+||||+. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999997 5899998743 28999999999999999999999999999999999999 7777899999999987
Q ss_pred cCCcccccccccccccccCchhhhc-------cccccccccchhHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhhcC
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILIS-------NRRYTHHVDIWSLGCILAEMLQSKPLFPGA----STSHQLQLIVNLVR 778 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~-------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~----s~~e~L~kIve~l~ 778 (1219)
..... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+. .....+..+....+
T Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 76543 2345679999999999854 256889999999999999999999999653 33445555544332
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
+..+........... .....++..+ .+...+++.+.++|.+||.+||.+|
T Consensus 245 --~~~~~~~~~~~~~~~--~~~~~~~~~~-----~l~~~~~~~l~~ll~~~L~~dP~~R 294 (396)
T 4eut_A 245 --SGAISGVQKAENGPI--DWSGDMPVSC-----SLSRGLQVLLTPVLANILEADQEKC 294 (396)
T ss_dssp --TTCCEEEECSTTCCE--EEESSCCTTC-----SSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred --cccchhheeccCCCc--ccCccCCccc-----ccchHHHhhchHHHHHhhccChhhh
Confidence 222211110000000 0000011111 0112335678899999999999996
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.12 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=201.1
Q ss_pred cccCeeEEeeeeccCceEEEEEEE-----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~d-----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
..++|.+++.||.|+||.||+|.+ ..++..||||++.... .......+.+|+.++..+.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence 356899999999999999999985 4577999999986432 334456788999999999779999999999864
Q ss_pred CCceEEEEEecch-hhHHHHHhhcc-----------------CChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRDKI-----------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID 694 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs~~-----------------LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd 694 (1219)
.+..+|+||||++ ++|.+++.... +++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 3456899999998 59999987432 78899999999999999999999999999999999999
Q ss_pred cCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14431 695 KSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ 771 (1219)
Q Consensus 695 ~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~ 771 (1219)
.++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999987654322 223456789999999984 5568999999999999999998 999998866443333
Q ss_pred -HHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 772 -LIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 772 -kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
.+.....+..+ ...++.+.+++.+||..||.+| +.+++.|
T Consensus 262 ~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMRAP---------------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCCCC---------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33332221111 1236778999999999999986 5555544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.71 Aligned_cols=260 Identities=20% Similarity=0.350 Sum_probs=196.5
Q ss_pred cccCeeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.-..|.+++.||.|+||.||+|. +..+|..||+|++.... .......+.+|+.++..+. ||||+++++++...+
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 34569999999999999999998 56789999999986443 2334567889999999996 999999999998655
Q ss_pred CceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 ~~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
...+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 5779999999975 99999853 46899999999999999999999999999999999999999999999999999876
Q ss_pred CCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 711 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 711 ~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..... ......+|+.|+|||++. +..++.++|||||||++|+|++|.+||... ...+.....|.......
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~- 249 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQMTV- 249 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGGHH-
T ss_pred cCCCcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccccCH-
Confidence 65432 233456888899999974 456889999999999999999999987432 12222222332221110
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
......+...... ...+.+++.+.+|+.+||.+||.+|+
T Consensus 250 ---------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rp 288 (302)
T 4e5w_A 250 ---------TRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRT 288 (302)
T ss_dssp ---------HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred ---------HHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCC
Confidence 0111111111000 01135678899999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.55 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=188.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-.+|.+.++||.|+||.||+|.+.. .||+|++............+.+|+.++..+. ||||+++++++. ...++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST---APQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeecc---CCccE
Confidence 4579999999999999999997543 4999999765555566678899999999996 999999999653 45689
Q ss_pred EEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc--
Q psy14431 639 VVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-- 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~-- 713 (1219)
+||||+. ++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999998 58988885 356899999999999999999999999999999999999999999999999999765431
Q ss_pred ccccccccccccccCchhhh--ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 KECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl--~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
........||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+....+..++......+. +..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~----- 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-LSK----- 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-TTS-----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-hhh-----
Confidence 22234567999999999974 2456888999999999999999999999887766655555443321111 100
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+.+++.+.+|+.+||..||.+|+
T Consensus 250 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 250 ----------------------VRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp ----------------------SCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ----------------------ccccCCHHHHHHHHHHccCChhhCC
Confidence 1123477899999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.13 Aligned_cols=253 Identities=21% Similarity=0.335 Sum_probs=202.0
Q ss_pred ccCeeEEeeeeccCceEEEEEE-----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~-----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
..+|.+++.||.|+||.||+|. +..++..||||++... ........+.+|+.++..+ +||||+++++++. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~--~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL--Q 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEc--C
Confidence 4679999999999999999998 5567889999998532 2344556788999999999 4999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc--------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC---Cccee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKI 701 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~--------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d---G~VKL 701 (1219)
...+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 567899999996 6999999743 38888999999999999999999999999999999999854 46999
Q ss_pred cccccccccCCcc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcC
Q psy14431 702 GDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|||++....... .......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9999997553322 1123456789999999974 4568999999999999999998 9999998887777766665543
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.++ +.+++.+.+++.+||..||.+| +.+++.+.|+..
T Consensus 264 ~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 MDPP---------------------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---------------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 3222 1236778999999999999885 777888888754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=328.37 Aligned_cols=246 Identities=28% Similarity=0.475 Sum_probs=186.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+.+|.+++.||.|+||.||+|.+..+|..||||++.... ........+.+|+.++..+. ||||++++++|. ..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~ 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI--EDN 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETT
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCC
Confidence 45678999999999999999999999999999999986432 23345567889999999995 999999999987 467
Q ss_pred eEEEEEecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+|+||||+.+ +|.+++.. ..+++..+..++.+|+.||.|||+.||+||||+|+|||++.+|.++|+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 89999999985 89888863 4589999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhhcCCCCCCchhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~--~e~L~kIve~l~P~P~~~d~l 787 (1219)
............||+.|+|||++. +..++.++|||||||++|+|++|.+||.+... ......+.....|..+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 259 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP----- 259 (310)
T ss_dssp -------------CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC-----
T ss_pred ecCCCccccccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc-----
Confidence 765444445567999999999974 55689999999999999999999999976432 2223333322221111
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...+++.+.+|+.+||..||.+|+
T Consensus 260 ---------------------------~~~~~~~l~~li~~~l~~dp~~Rp 283 (310)
T 2wqm_A 260 ---------------------------SDHYSEELRQLVNMCINPDPEKRP 283 (310)
T ss_dssp ---------------------------TTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ---------------------------ccccCHHHHHHHHHHcCCChhhCC
Confidence 023467899999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.59 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=200.6
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEE--EEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYV--AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~V--AIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.++.+|.+.+.||.|+||.||+|.+..+|..+ |+|.+... ........+.+|+.++..+.+||||+++++++. +.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HR 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ET
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee--eC
Confidence 45678999999999999999999999888865 99988632 233345568899999999966999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS 696 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d 696 (1219)
+.+|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 78999999997 5999998743 58999999999999999999999999999999999999999
Q ss_pred CcceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q psy14431 697 CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN 775 (1219)
Q Consensus 697 G~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve 775 (1219)
+.++|+|||++....... ......+++.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CeEEEcccCcCccccccc-cccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 999999999997543322 12334678899999997 45568999999999999999998 9999998887766655544
Q ss_pred hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcch
Q psy14431 776 LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGK 845 (1219)
Q Consensus 776 ~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHp 845 (1219)
...+..+ ..+++.+.+|+.+||..||.+| +.+++.+-
T Consensus 257 ~~~~~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 257 GYRLEKP---------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp TCCCCCC---------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCC---------------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3322111 1346788999999999999986 45555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.45 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=198.5
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCe-----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQ-----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk-----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
....+|.+.+.||.|+||.||+|.+..++. .||+|++.... .......+.+|+.++..+.+||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT- 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 446789999999999999999999977654 79999986432 33445678899999999966999999999987
Q ss_pred cCCceEEEEEecchh-hHHHHHhh---------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc
Q psy14431 632 VNNKDLYVVFEYMEN-DLNKVIRD---------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 695 (1219)
Q Consensus 632 ~d~~~LyLVMEymeG-SL~d~Lrs---------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~ 695 (1219)
.++.+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 121 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 121 -HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred -cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 46679999999985 89998863 24788999999999999999999999999999999999999
Q ss_pred CCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14431 696 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL 772 (1219)
Q Consensus 696 dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~k 772 (1219)
++.++|+|||++........ ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+......+..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 99999999999986644321 123455788999999975 4568999999999999999998 9999988776555554
Q ss_pred HHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 773 IVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 773 Ive~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
++....+.+. .+..++.+.+++.+||..||.+|
T Consensus 279 ~~~~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~~p~~R 311 (333)
T 2i1m_A 279 LVKDGYQMAQ--------------------------------PAFAPKNIYSIMQACWALEPTHR 311 (333)
T ss_dssp HHHHTCCCCC--------------------------------CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhcCCCCCC--------------------------------CCCCCHHHHHHHHHHhccChhhC
Confidence 4433211110 01125678899999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.35 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=200.5
Q ss_pred hccccccCeeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeee
Q psy14431 554 KDREDLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY 629 (1219)
Q Consensus 554 ~dr~dIqqY~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvf 629 (1219)
.+-....+|.+++.||.|+||.||+|. +..++..||||++... .......+.+|+.++..+. ||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALH-SDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcC-CCceeEEEEEE
Confidence 344556789999999999999999998 5678999999998643 3344567889999999995 99999999998
Q ss_pred eccCCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccc
Q psy14431 630 KAVNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 630 e~~d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
...+...+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 7667788999999996 689999874 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC
Q psy14431 707 ARSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783 (1219)
Q Consensus 707 Ar~l~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~ 783 (1219)
+........ ......+|+.|+|||++. +..++.++|||||||++|+|++|.+||.+...... ..... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~-~~~ 246 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGC-ERD 246 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC-----
T ss_pred ceecccCCccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccc-ccc
Confidence 987654322 223456788899999974 55689999999999999999999999965432211 00000 000
Q ss_pred chhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 784 ADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 784 ~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
. +........+...... ...+.+++.+.+|+.+||..||.+|
T Consensus 247 ~---------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~R 288 (327)
T 3lxl_A 247 V---------PALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDR 288 (327)
T ss_dssp C---------CHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred c---------ccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhC
Confidence 0 0000111111110000 0113467889999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.74 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=191.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEE----EEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYV----AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~V----AIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
...+|.+++.||.|+||.||+|.+..+|..| |+|.+... ........+.+|+.++..+. ||||++++++|..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec--
Confidence 3567999999999999999999998887765 66666422 22344567889999999995 9999999999873
Q ss_pred CceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
+..++|++|+. |+|.+++.. ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 34788899988 689988874 46899999999999999999999999999999999999999999999999999876
Q ss_pred CCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 711 SDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 711 ~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 241 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP----- 241 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-----
T ss_pred cCCcccccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC-----
Confidence 54322 123345688999999985 5568999999999999999999 99999988776655555444322211
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ 843 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq 843 (1219)
+..++.+.+++.+||..||.+| +.+.+.
T Consensus 242 ----------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 242 ----------------------------PICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----------------------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred ----------------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1236678899999999999986 444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.83 Aligned_cols=252 Identities=17% Similarity=0.183 Sum_probs=193.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc------CchhHHHHHHHHHHHHhcc--------CCCCcc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------NKTDAQRTYREILFLKSFQ--------RHPNII 623 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~------s~~~~e~~lREI~ILr~L~--------~HPNIV 623 (1219)
...+|.+++.||.|+||.||+|.+ +|..||||++..... .......+.+|+.+++.+. +||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 356788999999999999999987 689999999975432 2333467889999999886 477777
Q ss_pred EEeeeeecc----------------------------CCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHH
Q psy14431 624 TMLDIYKAV----------------------------NNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLS 674 (1219)
Q Consensus 624 kL~gvfe~~----------------------------d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALa 674 (1219)
++.+++... +.+.+||||||+. |++.+.+....+++..++.|+.||+.||.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 776654211 2678999999997 44555566677899999999999999999
Q ss_pred HHH-hcccccCCCCCCCeeeccCC--------------------cceecccccccccCCcccccccccccccccCchhhh
Q psy14431 675 YIH-ACKVMHRDLKPSNILIDKSC--------------------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 733 (1219)
Q Consensus 675 YLH-S~GIVHRDLKPsNILLd~dG--------------------~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl 733 (1219)
||| +.||+||||||+|||++.+| .+||+|||+|+..... ..+||+.|+|||++.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence 999 99999999999999999887 8999999999876543 348999999999985
Q ss_pred ccccccccccchhHHHH-HHHHHhCCCCCCCCCc-HHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhH
Q psy14431 734 SNRRYTHHVDIWSLGCI-LAEMLQSKPLFPGAST-SHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKEL 811 (1219)
Q Consensus 734 ~~~~yT~kSDIWSLG~I-LyELLTGkpPF~g~s~-~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L 811 (1219)
+. .+.++||||||++ .+++++|.+||.+... ......+...........
T Consensus 251 g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------- 301 (336)
T 2vuw_A 251 GD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN--------------------------- 301 (336)
T ss_dssp CC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCC---------------------------
T ss_pred CC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccc---------------------------
Confidence 43 3889999998777 7778889999954322 112223332221111100
Q ss_pred HHHhcccChhHHHHHHhccccCCCCCHHHHH-cchhhh
Q psy14431 812 QELQSQVVEENTSKLKLQMELDSKDSEIEQL-QGKLAA 848 (1219)
Q Consensus 812 ~el~p~lspeaiDLLsKMLq~DPeKRaiEAL-qHpwfa 848 (1219)
....+.+++.+.|||.+||.+| ++.++| +||||.
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS---SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS---SHHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC---CHHHHHhcCCCcC
Confidence 0112345788999999999998 899999 999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.13 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=195.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhcc---CCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ---RHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~---~HPNIVkL~gvfe~ 631 (1219)
.++|.+++.||.|+||.||+|.+..+|..||||++....... .....+.+|+.++..+. +||||++++++|.
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~- 108 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE- 108 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-
Confidence 456999999999999999999999999999999985432211 12234557899998884 5999999999987
Q ss_pred cCCceEEEEEec-ch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec-cCCcceecccccc
Q psy14431 632 VNNKDLYVVFEY-ME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLA 707 (1219)
Q Consensus 632 ~d~~~LyLVMEy-me-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd-~dG~VKLiDFGLA 707 (1219)
..+..++||+| +. ++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++
T Consensus 109 -~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 109 -TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred -cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 45678999998 54 689998874 5699999999999999999999999999999999999999 8899999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
....... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.. .+.......
T Consensus 188 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~------- 252 (312)
T 2iwi_A 188 ALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF------- 252 (312)
T ss_dssp EECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC-------
T ss_pred hhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC-------
Confidence 8776432 3456799999999998655555679999999999999999999996531 122111110
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCCC
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGSE 852 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~e 852 (1219)
.+.+++.+.+|+.+||..||.+| +.++++||||....+
T Consensus 253 ---------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 253 ---------------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ---------------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ---------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 02346788999999999999985 888999999966433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.07 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=195.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcC---CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~---TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
..++|.+.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..+. ||||+++++++. .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~ 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE---E 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCC-CCCcceEEEEEc---C
Confidence 35689999999999999999998654 34579999986432 3345677889999999995 999999999986 3
Q ss_pred ceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+..|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 45689999998 589999874 348999999999999999999999999999999999999999999999999998765
Q ss_pred Cccc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 712 DSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 712 ~~~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.... ......+|+.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+.....++.+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 236 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP------- 236 (281)
T ss_dssp --------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC-------
T ss_pred cccccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC-------
Confidence 4321 12334578899999997 45568999999999999999998 99999887776666665554322211
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+++.+||..||.+|+
T Consensus 237 --------------------------~~~~~~l~~li~~~l~~~p~~Rp 259 (281)
T 3cc6_A 237 --------------------------DLCPPVLYTLMTRCWDYDPSDRP 259 (281)
T ss_dssp --------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred --------------------------CCCCHHHHHHHHHHccCCchhCc
Confidence 12367789999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.84 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=203.7
Q ss_pred ccCeeEEe-eeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLL-KEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILK-kIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+|.++. .||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+. ||||+++++++. .+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---AE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEec---CC
Confidence 45677777 9999999999999864 56889999998643 23445677889999999995 999999999984 45
Q ss_pred eEEEEEecchh-hHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||+++ +|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 68999999985 8999886 34699999999999999999999999999999999999999999999999999987654
Q ss_pred cccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 713 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 713 ~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.... .....+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP------ 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC------
T ss_pred CcceeeccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC------
Confidence 3221 22345688999999974 4568999999999999999998 99999988877777666554422211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
+.+++.+.+++.+||..||.+| +.+++.+.+.
T Consensus 236 ---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 236 ---------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ---------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------------------------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2346789999999999999986 5555665543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=350.44 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=189.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
|.+.+.||.|+||+||.+ ...+|+.||||++... ....+.+|+.++..+.+||||+++++++. +++.+||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEE
Confidence 555688999999999875 4567999999998532 23457899999998867999999999986 567899999
Q ss_pred ecchhhHHHHHhhccC--------ChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-------------Ccce
Q psy14431 642 EYMENDLNKVIRDKIL--------KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-------------CSIK 700 (1219)
Q Consensus 642 EymeGSL~d~Lrs~~L--------seeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-------------G~VK 700 (1219)
|||+|+|.+++..... ++..+..++.||+.||.|||+.||+||||||+|||++.+ +.++
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9999999999985432 223456799999999999999999999999999999754 3799
Q ss_pred ecccccccccCCcccc----cccccccccccCchhhhc------cccccccccchhHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14431 701 IGDLGLARSLSDSKEC----LTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ 769 (1219)
Q Consensus 701 LiDFGLAr~l~~~~~~----~ts~vGT~~Y~APEvLl~------~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~ 769 (1219)
|+|||++......... ....+||++|+|||++.+ ...++.++|||||||++|+|++ |.+||.+.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999877653321 234679999999999854 2568999999999999999999 999997655433
Q ss_pred HHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 770 LQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 770 L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+.......+.. .... .+.+++.+.+|+.+||..||.+| +.++++||||
T Consensus 248 -~~i~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 248 -SNIIRGIFSLDEM-KCLH--------------------------DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp -HHHHHTCCCCCCC-TTCC--------------------------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred -HHHhcCCCCcccc-cccc--------------------------cccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 3344333221111 0000 01235678999999999999985 7888999999
Q ss_pred h
Q psy14431 848 A 848 (1219)
Q Consensus 848 a 848 (1219)
.
T Consensus 300 ~ 300 (434)
T 2rio_A 300 W 300 (434)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.46 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=195.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCe---EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk---~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.|.+.+.||.|+||.||+|.+..++. .||+|++.. .........+.+|+.++..+. ||||+++++++.. .+...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLP-PEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC-SSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEec-CCCCc
Confidence 57788999999999999999765544 799998853 233345577889999999995 9999999999874 33455
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
++||+|+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 89999996 689999874 568899999999999999999999999999999999999999999999999998664422
Q ss_pred ----cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 715 ----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 715 ----~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.......+|+.|+|||.+ .+..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~------- 250 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP------- 250 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC-------
T ss_pred ccccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC-------
Confidence 122345678999999997 45568999999999999999999 56777777776666666554432221
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++.+||..||.+|+
T Consensus 251 --------------------------~~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 251 --------------------------EYCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp --------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred --------------------------ccchHHHHHHHHHHccCChhhCc
Confidence 12356789999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=320.47 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=197.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+++.||.|+||.||+|.+. ++..||+|++.... .....+.+|+.++..+. ||||+++++++. .+.+|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT---QEPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCC-CcCcceEEEEEc---CCCcE
Confidence 367999999999999999999875 56789999986432 23567889999999995 999999999885 44689
Q ss_pred EEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999997 6999998743 69999999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 232 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---------- 232 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred cccccCCCCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc----------
Confidence 2 223345678899999974 5568999999999999999999 99999988877776666554322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++.+||..||.+|+
T Consensus 233 -----------------------~~~~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 233 -----------------------DNCPEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp -----------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------ccccHHHHHHHHHHhccChhhCC
Confidence 12367889999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.23 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=190.5
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEE----EEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYV----AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~V----AIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
....+|.+++.||.|+||.||+|.+..+|..| |+|.+... ........+.+|+.++..+. ||||++++++|..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT- 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec-
Confidence 44578999999999999999999998888765 55555322 23345677889999999995 9999999999873
Q ss_pred CCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+..++|++|+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 89 --~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp --SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred --CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 34788899888 589988874 4689999999999999999999999999999999999999999999999999987
Q ss_pred cCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 710 LSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 710 l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
...... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....++.+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 241 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---- 241 (327)
T ss_dssp -------------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC----
T ss_pred ccCccccccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence 654322 223345688899999985 5568999999999999999999 99999988777666655544422211
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
+..++.+.+++.+||..||.+|
T Consensus 242 -----------------------------~~~~~~l~~li~~~l~~dp~~R 263 (327)
T 3lzb_A 242 -----------------------------PICTIDVYMIMRKCWMIDADSR 263 (327)
T ss_dssp -----------------------------TTBCHHHHHHHHHHTCSSGGGS
T ss_pred -----------------------------ccCCHHHHHHHHHHcCCChhHC
Confidence 1236678899999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.79 Aligned_cols=237 Identities=22% Similarity=0.389 Sum_probs=188.3
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
....+|.+++.||.|+||.||+|.+. |..||||++... .....+.+|+.++..+. ||||+++++++.. ..+.
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~ 89 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGG 89 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--C
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc-CCCc
Confidence 34678999999999999999999764 889999998532 34567889999999995 9999999998753 3457
Q ss_pred EEEEEecchh-hHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 637 LYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+|+||||+++ +|.+++... .+++..+..++.+|+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 999998743 388999999999999999999999999999999999999999999999999986554
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. ....+++.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 170 ~~---~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 236 (278)
T 1byg_A 170 TQ---DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--------- 236 (278)
T ss_dssp ---------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC---------
T ss_pred cc---cCCCccccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc---------
Confidence 32 2346788999999974 5568999999999999999998 99999887766655555443222111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+++.+||..||.+|+
T Consensus 237 ------------------------~~~~~~l~~li~~~l~~~p~~Rp 259 (278)
T 1byg_A 237 ------------------------DGCPPAVYEVMKNCWHLDAAMRP 259 (278)
T ss_dssp ------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------ccCCHHHHHHHHHHhcCChhhCC
Confidence 23467889999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.81 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=196.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
....|.+.+.||.|+||.||+|.+..+ +..||+|.+.. .........+.+|+.+++.+. ||||+++++++.. .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~ 99 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SE 99 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEc-CC
Confidence 345699999999999999999987543 34689998853 223445567889999999995 9999999998653 45
Q ss_pred ceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
+.+|+||||+++ +|.+++.. ..++...+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 678999999986 99999974 458899999999999999999999999999999999999999999999999998765
Q ss_pred Ccc----cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 712 DSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 712 ~~~----~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
... .......+|+.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 254 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---- 254 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC----
T ss_pred ccchhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC----
Confidence 432 122345678899999997 45568999999999999999999 67899888777766666655433222
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++.+||..||.+|+
T Consensus 255 -----------------------------~~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 255 -----------------------------EYCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp -----------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------------ccCCHHHHHHHHHHcCCChhhCc
Confidence 11356788999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.11 Aligned_cols=253 Identities=15% Similarity=0.155 Sum_probs=189.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC---CCeEEEEEEeeccccCc---------hhHHHHHHHHHHHHhccCCCCccEEe
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNK---------TDAQRTYREILFLKSFQRHPNIITML 626 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~---TGk~VAIKvI~ks~~s~---------~~~e~~lREI~ILr~L~~HPNIVkL~ 626 (1219)
-.+|.+++.||.|+||.||+|.+.. ++..||||++....... .....+.+|+.++..+. ||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcceee
Confidence 3579999999999999999999987 78899999986432110 01123556777888885 99999999
Q ss_pred eeeec--cCCceEEEEEecchhhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC--ccee
Q psy14431 627 DIYKA--VNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC--SIKI 701 (1219)
Q Consensus 627 gvfe~--~d~~~LyLVMEymeGSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG--~VKL 701 (1219)
+++.. .+...+|+||||++++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 99874 23678999999998899999874 4799999999999999999999999999999999999999887 9999
Q ss_pred cccccccccCCccc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC-cHHHHHHH
Q psy14431 702 GDLGLARSLSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLI 773 (1219)
Q Consensus 702 iDFGLAr~l~~~~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s-~~e~L~kI 773 (1219)
+|||++..+..... ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.. ........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999987643221 124567999999999974 5568999999999999999999999996532 22222222
Q ss_pred HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhc--ccChhHHHHHHhccccCCCCCHH
Q psy14431 774 VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQS--QVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 774 ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p--~lspeaiDLLsKMLq~DPeKRai 839 (1219)
.....+ ..+..+....+ .+++.+.+++.+||.+||.+|+.
T Consensus 274 ~~~~~~--------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 274 KTNLLD--------------------------ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp HHHHHH--------------------------TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred HHhhcc--------------------------cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC
Confidence 111111 01111222223 57889999999999999999743
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.03 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=189.6
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEc---CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk---~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
..+..+|.+.+.||.|+||.||+|.+. .++..||||++.... .......+.+|+.++..+. ||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-- 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVT-- 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--
Confidence 345668999999999999999999876 467789999986432 3344567889999999995 999999999987
Q ss_pred CCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
....+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 4667999999996 699999974 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 710 LSDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 710 l~~~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
....... .....+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~--- 272 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP--- 272 (373)
T ss_dssp -----------------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---
T ss_pred cccCCccceeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 6543221 12234577899999974 5569999999999999999998 99999988887777666555422221
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
...++.+.+++.+||..||.+|
T Consensus 273 ------------------------------~~~~~~l~~li~~cl~~dp~~R 294 (373)
T 2qol_A 273 ------------------------------MDCPAALYQLMLDCWQKDRNNR 294 (373)
T ss_dssp ------------------------------TTCBHHHHHHHHHHTCSSGGGS
T ss_pred ------------------------------ccccHHHHHHHHHHhCcChhhC
Confidence 1235678899999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.23 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=187.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+.+.||.|+||+||. ....+|+.||||++..... ....+|+.++..+.+|||||++++++. +...+|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv 96 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEEE
Confidence 589999999999999764 3456789999999854322 124589999999967999999999987 56789999
Q ss_pred EecchhhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CC--cceecccccccccCCc
Q psy14431 641 FEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SC--SIKIGDLGLARSLSDS 713 (1219)
Q Consensus 641 MEymeGSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG--~VKLiDFGLAr~l~~~ 713 (1219)
||||+|+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++ .++|+|||++......
T Consensus 97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999999999999854 3555677899999999999999999999999999999953 33 4779999999876543
Q ss_pred c---cccccccccccccCchhhhc--cccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 714 K---ECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 714 ~---~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
. ......+||++|+|||++.+ ...++.++|||||||++|+|++ |.+||....... ...+...... .....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~~--~~~~~- 252 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGACSL--DCLHP- 252 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTTCCCC--TTSCT-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhccCCc--cccCc-
Confidence 2 22345679999999999853 3457889999999999999999 899996554432 2222111111 10000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
....++.+.+||.+||..||.+| +.++++||||.
T Consensus 253 ---------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 253 ---------------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp ---------------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred ---------------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 00113457899999999999985 88899999994
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.09 Aligned_cols=244 Identities=16% Similarity=0.194 Sum_probs=191.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCC--------CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccE-------
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNN--------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT------- 624 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~T--------Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVk------- 624 (1219)
++|.+++.||.|+||.||+|.+..+ +..||||++... ..+.+|+.++..+. ||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAA-KPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHC-CHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhc-ccchhhhhhhhcc
Confidence 6899999999999999999999874 889999998532 35779999999996 999987
Q ss_pred --------EeeeeeccCCceEEEEEecchhhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 625 --------MLDIYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 625 --------L~gvfe~~d~~~LyLVMEymeGSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
+++++.. .+..+|+||||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 4555442 3678999999998899999985 579999999999999999999999999999999999999
Q ss_pred ccCC--cceecccccccccCCccc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC
Q psy14431 694 DKSC--SIKIGDLGLARSLSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 764 (1219)
Q Consensus 694 d~dG--~VKLiDFGLAr~l~~~~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~ 764 (1219)
+.++ .++|+|||++..+..... ......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 899999999987654321 123457999999999974 556899999999999999999999999876
Q ss_pred C-cHHHHHHHHh-hcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 765 S-TSHQLQLIVN-LVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 765 s-~~e~L~kIve-~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
. ....+..... .....+....... ....+++.+.+|+.+||..||.+|+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCG-------------------------HWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTS-------------------------CEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred CcCHHHHHHHHHhccCChhhhhhhcc-------------------------ccCCCcHHHHHHHHHHHhCChhhCC
Confidence 4 3333332222 2211111111000 0134578899999999999999973
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.93 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=194.5
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCC----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TG----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
......|.+.+.||.|+||.||+|.+..++ ..||||++.... .......+.+|+.++..+. ||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~- 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS- 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe-
Confidence 445678999999999999999999887553 469999986432 3344567889999999995 999999999987
Q ss_pred cCCceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 632 VNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 632 ~d~~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
..+.+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 117 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 117 -KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp -SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred -cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 56789999999985 89999874 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 709 SLSDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 709 ~l~~~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
........ .....+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+.....++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP-- 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC--
T ss_pred hhccccccccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc--
Confidence 76543211 12334678899999974 5568999999999999999998 99999988887777766655432211
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+++.+||..||.+|+
T Consensus 273 -------------------------------~~~~~~l~~li~~~l~~~p~~Rp 295 (333)
T 1mqb_A 273 -------------------------------MDCPSAIYQLMMQCWQQERARRP 295 (333)
T ss_dssp -------------------------------TTCBHHHHHHHHHHTCSSTTTSC
T ss_pred -------------------------------ccCCHHHHHHHHHHcCCChhhCc
Confidence 12366788999999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.23 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=196.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec--------
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA-------- 631 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~-------- 631 (1219)
.+|.+++.||.|+||.||+|.+..+|..||+|++.... ..+.+|+.++..+. ||||++++++|..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccc
Confidence 46999999999999999999999999999999986331 24668999999995 9999999998853
Q ss_pred ------cCCceEEEEEecchh-hHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCccee
Q psy14431 632 ------VNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701 (1219)
Q Consensus 632 ------~d~~~LyLVMEymeG-SL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKL 701 (1219)
.....+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 124568999999995 99999863 46899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCC
Q psy14431 702 GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 781 (1219)
Q Consensus 702 iDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P 781 (1219)
+|||++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||.... .....+.... .
T Consensus 164 ~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~--~- 236 (284)
T 2a19_B 164 GDFGLVTSLKNDGK-RTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI--I- 236 (284)
T ss_dssp CCCTTCEESSCCSC-CCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTTC--C-
T ss_pred Ccchhheecccccc-ccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhccc--c-
Confidence 99999987665432 34567999999999974 5568999999999999999999998874211 1111111100 0
Q ss_pred CCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 782 PHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 782 ~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+.+++.+.+++.+||..||.+| +.+++.+.+.-
T Consensus 237 ---------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 237 ---------------------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 02246778999999999999985 77778888763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.08 Aligned_cols=201 Identities=28% Similarity=0.395 Sum_probs=162.2
Q ss_pred cccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHH--HhccCCCCccEEeeeee---
Q psy14431 556 REDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL--KSFQRHPNIITMLDIYK--- 630 (1219)
Q Consensus 556 r~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~IL--r~L~~HPNIVkL~gvfe--- 630 (1219)
..++++|.+++.||.|+||.||+|.+ +|..||||++... ....+..|..++ ..+ .||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLM-EHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhc-cCcchhhheecccccc
Confidence 45688999999999999999999965 6899999998532 223344444443 335 5999999998653
Q ss_pred ccCCceEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc---------ccccCCCCCCCeeeccCCcce
Q psy14431 631 AVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC---------KVMHRDLKPSNILIDKSCSIK 700 (1219)
Q Consensus 631 ~~d~~~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~---------GIVHRDLKPsNILLd~dG~VK 700 (1219)
..+...+|+||||++ |+|.+++.....++..+..++.||+.||.|||+. ||+||||||+|||++.+|.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 223456899999996 5999999988889999999999999999999999 999999999999999999999
Q ss_pred ecccccccccCCcc--------cccccccccccccCchhhhcc------ccccccccchhHHHHHHHHHhCCC-CCCCC
Q psy14431 701 IGDLGLARSLSDSK--------ECLTEYIATRWYRAPEILISN------RRYTHHVDIWSLGCILAEMLQSKP-LFPGA 764 (1219)
Q Consensus 701 LiDFGLAr~l~~~~--------~~~ts~vGT~~Y~APEvLl~~------~~yT~kSDIWSLG~ILyELLTGkp-PF~g~ 764 (1219)
|+|||++..+.... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.. ||++.
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999998765321 122345799999999998542 457789999999999999999964 45443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=329.78 Aligned_cols=200 Identities=25% Similarity=0.417 Sum_probs=171.7
Q ss_pred eeEEeeeeccCceEEEEEEE----cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 562 QINLLKEGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~d----k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
|.+++.||.|+||.||+|.. ..+|..||||++... ........+.+|+.++..+. ||||+++++++...+...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceE
Confidence 59999999999999988754 457899999999643 23344567889999999996 9999999999986666789
Q ss_pred EEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 638 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
|+||||++ ++|.+++....+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 99999998 5999999988899999999999999999999999999999999999999999999999999987765332
Q ss_pred --ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC
Q psy14431 716 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 764 (1219)
Q Consensus 716 --~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~ 764 (1219)
......+|+.|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 223456788899999984 556899999999999999999999999653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=345.29 Aligned_cols=237 Identities=22% Similarity=0.393 Sum_probs=196.8
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
....+|.+++.||.|+||.||+|.+. |..||||++... .....+.+|+.++..+. ||||+++++++.. ..+.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~ 261 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGG 261 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCC-CTTBCCEEEEEEC-TTSC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEc-CCCc
Confidence 45678999999999999999999875 789999998643 24567889999999995 9999999998763 3447
Q ss_pred EEEEEecch-hhHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 637 LYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+|+||||++ |+|.+++... .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999998 5999999843 378899999999999999999999999999999999999999999999999986543
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. ....+++.|+|||++. +..++.++|||||||++|+|++ |.+||++.+..+....+..+..+..+
T Consensus 342 ~~---~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p--------- 408 (450)
T 1k9a_A 342 TQ---DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--------- 408 (450)
T ss_dssp --------CCCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC---------
T ss_pred cc---cCCCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence 22 2336788999999984 5579999999999999999998 99999988877777666655433221
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+|+.+||..||.+|+
T Consensus 409 ------------------------~~~~~~l~~li~~cl~~dp~~Rp 431 (450)
T 1k9a_A 409 ------------------------DGCPPAVYDVMKNCWHLDAATRP 431 (450)
T ss_dssp ------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------CcCCHHHHHHHHHHcCCChhHCc
Confidence 12367889999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=345.05 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=200.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.+.||.|+||.||+|.+.. +..||||++.... .....+.+|+.++..+. ||||+++++++. ...+|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS---BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCE
T ss_pred hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC---ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe---CCccE
Confidence 4579999999999999999998864 6789999986432 34677899999999995 999999999985 45689
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||+. |+|.+++.. ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999997 599999974 368889999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....++.+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------- 407 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP---------- 407 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC----------
T ss_pred eeccCCCcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 1 122345678899999984 4569999999999999999999 99999998888877777665533221
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
..+++.+.+|+.+||..||.+|+.
T Consensus 408 -----------------------~~~~~~l~~li~~cl~~dp~~RPt 431 (454)
T 1qcf_A 408 -----------------------ENCPEELYNIMMRCWKNRPEERPT 431 (454)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----------------------CCCCHHHHHHHHHHccCChhHCcC
Confidence 123677899999999999999743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.00 Aligned_cols=242 Identities=22% Similarity=0.401 Sum_probs=202.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.+.||.|+||.||+|.+..++..||||++... ......+.+|+.++..+. ||||++++++|. ....+|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcC-CCCEeeEEEEEe--cCCcEE
Confidence 45799999999999999999999999999999998643 234567899999999995 999999999987 456799
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999998 699999974 458899999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......+++.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 441 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------- 441 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC----------
T ss_pred eeecCCCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 1 122345678899999974 5568999999999999999999 99999998877666655544322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIE 840 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiE 840 (1219)
..+++.+.+|+.+||..||.+|+..
T Consensus 442 -----------------------~~~~~~l~~li~~cl~~dP~~RPs~ 466 (495)
T 1opk_A 442 -----------------------EGCPEKVYELMRACWQWNPSDRPSF 466 (495)
T ss_dssp -----------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----------------------CCCCHHHHHHHHHHcCcChhHCcCH
Confidence 1236778999999999999997433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.35 Aligned_cols=238 Identities=21% Similarity=0.352 Sum_probs=186.2
Q ss_pred cccccCeeEE-eeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec--c
Q psy14431 556 REDLQQQINL-LKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--V 632 (1219)
Q Consensus 556 r~dIqqY~IL-KkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~--~ 632 (1219)
...+.+|.++ +.||.|+||.||+|.+..+|..||+|++.. .....+|+.++..+.+||||++++++|.. .
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3446778888 779999999999999999999999999852 23467899998777789999999999863 2
Q ss_pred CCceEEEEEecchh-hHHHHHhhc---cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccc
Q psy14431 633 NNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLG 705 (1219)
Q Consensus 633 d~~~LyLVMEymeG-SL~d~Lrs~---~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFG 705 (1219)
+...+|+||||++| +|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 35678999999985 999998753 5999999999999999999999999999999999999998 7889999999
Q ss_pred cccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCch
Q psy14431 706 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785 (1219)
Q Consensus 706 LAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d 785 (1219)
++.... +..++.++|||||||++|+|++|.+||.+.+.......+..........+
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 221 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF- 221 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS-
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC-
Confidence 886432 23478899999999999999999999977654322111100000000000
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....+.+++.+.+|+.+||.+||.+| +.++|+||||.-
T Consensus 222 -------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 222 -------------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp -------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -------------------------CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 001224568899999999999999985 788999999965
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.09 Aligned_cols=197 Identities=19% Similarity=0.277 Sum_probs=165.9
Q ss_pred ccCeeEEeeeeccCceEEEEE-----EEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccC--CCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKA-----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR--HPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA-----~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~--HPNIVkL~gvfe~ 631 (1219)
-.+|.+.+.||.|+||.||+| .+..+++.||||++... ....+.+|+.++..+.. ||||+.+++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 457999999999999999999 46778999999998532 34456777877777752 899999999987
Q ss_pred cCCceEEEEEecch-hhHHHHHh------hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---------
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--------- 695 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lr------s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~--------- 695 (1219)
..+..||||||++ |+|.+++. ...+++..++.|+.||+.||.|||+.|||||||||+|||++.
T Consensus 138 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 138 -FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp -CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred -cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 4667899999998 68999986 346999999999999999999999999999999999999998
Q ss_pred --CCcceecccccccccC--CcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 696 --SCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 696 --dG~VKLiDFGLAr~l~--~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
++.++|+|||+|..+. .........+||++|+|||++. +..|+.++|||||||++|+|++|++||..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999997543 2223345678999999999985 45699999999999999999999999854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.73 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=193.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCce
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKD 636 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~ 636 (1219)
..+|.+++.||.|+||.||+|.+..+|..||||++... .......+.+|+.++..+. ||||+++++++... ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCce
Confidence 45799999999999999999999999999999988542 3445667889999999995 99999999998632 3457
Q ss_pred EEEEEecchh-hHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999985 89888864 56899999999999999999999999999999999999999999999999998765
Q ss_pred CCccc---------ccccccccccccCchhhhccc--cccccccchhHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhhc
Q psy14431 711 SDSKE---------CLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLV 777 (1219)
Q Consensus 711 ~~~~~---------~~ts~vGT~~Y~APEvLl~~~--~yT~kSDIWSLG~ILyELLTGkpPF~g~s~--~e~L~kIve~l 777 (1219)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+... ......+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 43211 112346799999999975332 378899999999999999999999953110 00111111100
Q ss_pred CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 778 RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 778 ~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..+. .+..++.+.++|.+||..||.+| +.+++.+
T Consensus 265 -~~~~--------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 -SIPQ--------------------------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCC--------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCc--------------------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 13457789999999999999986 4444444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.01 Aligned_cols=192 Identities=28% Similarity=0.425 Sum_probs=157.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhc-cCCCCccEEeeeeeccCC--c
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF-QRHPNIITMLDIYKAVNN--K 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L-~~HPNIVkL~gvfe~~d~--~ 635 (1219)
.++|.+++.||.|+||.||+|.+. |..||||++... ......+|..++..+ .+||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 357999999999999999999875 899999998532 234455566666554 269999999999874322 6
Q ss_pred eEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhc--------ccccCCCCCCCeeeccCCcceeccccc
Q psy14431 636 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 636 ~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~--------GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
.+|+||||+.+ +|.+++....+++..+..++.+|+.||.|||+. ||+||||||+|||++.++.++|+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 79999999985 999999988899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcccc----cccccccccccCchhhhccccccc------cccchhHHHHHHHHHhCC
Q psy14431 707 ARSLSDSKEC----LTEYIATRWYRAPEILISNRRYTH------HVDIWSLGCILAEMLQSK 758 (1219)
Q Consensus 707 Ar~l~~~~~~----~ts~vGT~~Y~APEvLl~~~~yT~------kSDIWSLG~ILyELLTGk 758 (1219)
+..+...... ....+||+.|+|||++.+. .++. ++|||||||++|+|++|.
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhcc
Confidence 9766543221 1245799999999998543 3333 499999999999999993
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.66 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=189.5
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcC-CC--eEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKN-NK--QYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~-TG--k~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
...+|.+++.||.|+||.||+|.+.. ++ ..||||++..... .......+.+|+.++..+. ||||+++++++..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 92 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-- 92 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS--
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcc--
Confidence 45679999999999999999998643 33 3699999864432 3345677889999999995 9999999999873
Q ss_pred CceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
...++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 93 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 34899999998 589988874 46999999999999999999999999999999999999999999999999999876
Q ss_pred CCccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 711 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 711 ~~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
..... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+.....+.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 246 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---- 246 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC----
T ss_pred cccccchhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC----
Confidence 54322 122346788899999974 5568999999999999999999 99999998887776666544322111
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.+.+++.+.+++.+||..||.+|+
T Consensus 247 ----------------------------~~~~~~~l~~li~~~l~~~p~~Rp 270 (291)
T 1u46_A 247 ----------------------------PEDCPQDIYNVMVQCWAHKPEDRP 270 (291)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ----------------------------CcCcCHHHHHHHHHHccCCcccCc
Confidence 023467899999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.03 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=191.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc--cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~--~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.|...+.||.|+||.||+|.+ ++..||+|++.... ........+.+|+.++..+. ||||+++++++. +.+.+|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~ 106 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSS--DGDDLC 106 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEe--cCCceE
Confidence 345568999999999999975 68899999986432 22334567889999999995 999999999987 466799
Q ss_pred EEEecch-hhHHHHHhh----ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs----~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+||||++ ++|.+++.. ..+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 9999997 689888862 35899999999999999999999999999999999999999999999999999866542
Q ss_pred cc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 KE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. ......||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.+....+..+..........+..+..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID-- 262 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC--
T ss_pred cccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc--
Confidence 21 223457899999999974 348999999999999999999999998765443333332222111111111110
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
... ....+..+..+.+++.+||..||.+|+
T Consensus 263 ----------~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 263 ----------KKM-------NDADSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp ----------SSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred ----------ccc-------cccchHHHHHHHHHHHHHcCCCcccCc
Confidence 000 000112245688999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=327.87 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=194.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+.+.||.|+||.||+|.+ .+|..||||++...... .....+.+|+.++..+. ||||++++++|. ..+..|
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~ 103 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCM--TPTERL 103 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCC-CTTBCCCCEEEC--CSSCCE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhcc-CCCccceEEEEe--cCCceE
Confidence 45788999999999999999974 46889999998643221 12235789999999996 999999999987 466789
Q ss_pred EEEecchh-hHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhc---ccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 639 VVFEYMEN-DLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHAC---KVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~---GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+||||+.+ +|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999985 899998743 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCcc-cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhhcCCCCCCc
Q psy14431 710 LSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA----STSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 710 l~~~~-~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~----s~~e~L~kIve~l~P~P~~~ 784 (1219)
..... .......||+.|+|||++. +..++.++|||||||++|+|++|.+||... .....+...+........ .
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 261 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-L 261 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC-S
T ss_pred cCcccccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh-h
Confidence 65432 2234456999999999974 456899999999999999999999999521 111111111111111000 0
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
.... ... .. ....+..++.+.+++.+||..||.+| +.++++|-..
T Consensus 262 ~~~~----~~~-------~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 262 EALV----DVD-------LQ-------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSS----CTT-------CT-------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhc----Chh-------hc-------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 000 00 00011224678999999999999985 6666776654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.08 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=198.8
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
...+|.+.+.||.|+||.||+|.+. +|..||||++... .......+.+|+.++..+. ||||+++++++. ..+.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCR-HPHLVSLIGFCD--ERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECC--CTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--CCCeE
Confidence 4678999999999999999999864 6889999988543 2344567889999999995 999999999987 46689
Q ss_pred EEEEecch-hhHHHHHhhc-----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 638 YVVFEYME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~-----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
|+||||++ |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999998 5898888643 48899999999999999999999999999999999999999999999999998654
Q ss_pred Ccc--cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHH---Hhhc-CC-CCCCc
Q psy14431 712 DSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI---VNLV-RP-NPPHA 784 (1219)
Q Consensus 712 ~~~--~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kI---ve~l-~P-~P~~~ 784 (1219)
... .......||+.|+|||++. +..++.++|||||||++|+|++|++||.+..+......+ .... .. .....
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred cccccccccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 322 1223456899999999975 456899999999999999999999999765432211111 0000 00 00000
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
+. . ......+..+..+.+++.+||..||.+| +.+++.+....
T Consensus 270 ~~--------~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 270 DP--------N--------------LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SS--------S--------------CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ch--------h--------------hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 0 0000112235578899999999999986 55666665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.78 Aligned_cols=232 Identities=26% Similarity=0.390 Sum_probs=181.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+..+|.+.+.||.|+||.||+|.+. +..||||++.. ......+.+|+.++..+. ||||+++++++. +..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~ 74 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVN-HPNIVKLYGACL----NPV 74 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT----TTT
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----CCc
Confidence 4678999999999999999999874 78899999852 344567889999999995 999999999875 247
Q ss_pred EEEEecch-hhHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHh---cccccCCCCCCCeeeccCCc-ceeccccccc
Q psy14431 638 YVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHA---CKVMHRDLKPSNILIDKSCS-IKIGDLGLAR 708 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS---~GIVHRDLKPsNILLd~dG~-VKLiDFGLAr 708 (1219)
|+||||++ ++|.+++... .++...+..++.||+.||.|||+ .||+||||||+|||++.++. ++|+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 99999997 5999999743 36788899999999999999999 89999999999999998886 7999999998
Q ss_pred ccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhhcCCCCCCchh
Q psy14431 709 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 709 ~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~--e~L~kIve~l~P~P~~~d~ 786 (1219)
..... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||...... .....+.....|..
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 225 (307)
T 2eva_A 155 DIQTH---MTNNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----- 225 (307)
T ss_dssp -------------CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-----
T ss_pred ccccc---cccCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-----
Confidence 65533 23457999999999974 557899999999999999999999999764332 22222222111110
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
.+.+++.+.+++.+||..||.+|
T Consensus 226 ----------------------------~~~~~~~l~~li~~~l~~dp~~R 248 (307)
T 2eva_A 226 ----------------------------IKNLPKPIESLMTRCWSKDPSQR 248 (307)
T ss_dssp ----------------------------BTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ----------------------------ccccCHHHHHHHHHHhcCChhhC
Confidence 12346778999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=341.16 Aligned_cols=238 Identities=23% Similarity=0.383 Sum_probs=193.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.++||.|+||.||+|.+.. +..||||++.... .....+.+|+.++..+. ||||+++++++. .+.+|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---~~~~~ 254 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIY 254 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCC-CCCEeeEEEEEc---CCceE
Confidence 4579999999999999999999875 4669999986432 23467899999999995 999999999986 35689
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999998 599999973 358999999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....++.+
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------- 403 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------- 403 (452)
T ss_dssp --------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred eecccCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 1 122345678899999975 4568999999999999999999 99999998888877777665432211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+|+.+||..||.+|+
T Consensus 404 -----------------------~~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 404 -----------------------PECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------CCCCHHHHHHHHHHccCChhhCc
Confidence 12367788999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.74 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=194.2
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
...++|.+.+.||.|+||.||+|.+.. .||+|++............+.+|+.++..+. ||||+++++++. +.+.
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~ 103 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACM--SPPH 103 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEE--CSSC
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEe--cCCc
Confidence 346789999999999999999998754 3999998654433333455678999999995 999999999987 4567
Q ss_pred EEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999997 6899999853 589999999999999999999999999999999999998 689999999998754321
Q ss_pred -----ccccccccccccccCchhhhc--------cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC
Q psy14431 714 -----KECLTEYIATRWYRAPEILIS--------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780 (1219)
Q Consensus 714 -----~~~~ts~vGT~~Y~APEvLl~--------~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~ 780 (1219)
........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.....|.
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 112234568999999999853 2457899999999999999999999999888777666665554333
Q ss_pred CCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 781 PPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 781 P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
... ..+++.+.+++.+||..||.+|+
T Consensus 263 ~~~--------------------------------~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 263 LSQ--------------------------------IGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp CCC--------------------------------SSCCTTHHHHHHHHHCSSTTTSC
T ss_pred CCc--------------------------------CCCCHHHHHHHHHHhcCChhhCc
Confidence 221 12367789999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.80 Aligned_cols=248 Identities=13% Similarity=0.123 Sum_probs=188.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccE--------------
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIIT-------------- 624 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVk-------------- 624 (1219)
..|...+.||.|+||.||+|.+..+|+.||||++.... ........+.+|+.++..+..++|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45888999999999999999999999999999986222 222234667889999888852232211
Q ss_pred -------EeeeeeccC---CceEEEEEecchhhHHHHHh--------hccCChHHHHHHHHHHHHHHHHHHhcccccCCC
Q psy14431 625 -------MLDIYKAVN---NKDLYVVFEYMENDLNKVIR--------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686 (1219)
Q Consensus 625 -------L~gvfe~~d---~~~LyLVMEymeGSL~d~Lr--------s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDL 686 (1219)
++.++.... ...++++|+++.++|.+++. ...+++..+..++.||+.||.|||+.|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111111111 23478999999999998885 345778888999999999999999999999999
Q ss_pred CCCCeeeccCCcceecccccccccCCcccccccccccccccCchhhh---------ccccccccccchhHHHHHHHHHhC
Q psy14431 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI---------SNRRYTHHVDIWSLGCILAEMLQS 757 (1219)
Q Consensus 687 KPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl---------~~~~yT~kSDIWSLG~ILyELLTG 757 (1219)
||+|||++.+|.+||+|||++...... ....+| +.|+|||++. ....++.++|||||||++|+|++|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999876543 345577 9999999983 444588899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 758 KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 758 kpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
++||.+.+...... .. ... .+.+++.+.+|+.+||..||.+|
T Consensus 314 ~~Pf~~~~~~~~~~--------------~~----------------~~~--------~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 314 DLPNTDDAALGGSE--------------WI----------------FRS--------CKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp SCCCCTTGGGSCSG--------------GG----------------GSS--------CCCCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCcchhhhHH--------------HH----------------Hhh--------cccCCHHHHHHHHHHccCChhhC
Confidence 99997654321100 00 000 12457889999999999999985
Q ss_pred --HHHHHcchhhhc
Q psy14431 838 --EIEQLQGKLAAL 849 (1219)
Q Consensus 838 --aiEALqHpwfaL 849 (1219)
+.+++.||||..
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 788999999844
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=334.78 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=186.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
..|.+.+.||.|+||.||+|.+..+ +..||+|.+... ........+.+|+.++..+. ||||+++++++.. ..+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~-~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECC-CSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEc-CCCC
Confidence 3578899999999999999987543 356899988532 33455678899999999995 9999999998653 3457
Q ss_pred EEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 8999999985 99999974 45888999999999999999999999999999999999999999999999999866432
Q ss_pred cc----ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 714 KE----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 714 ~~----~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.. ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+.......+.....+..+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p------ 318 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------ 318 (373)
T ss_dssp ------------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC------
T ss_pred ccccccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence 21 123456788999999974 5578999999999999999999 78999887776666666554432221
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS 837 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR 837 (1219)
+.+++.+.+++.+||..||.+|
T Consensus 319 ---------------------------~~~~~~l~~li~~cl~~dp~~R 340 (373)
T 3c1x_A 319 ---------------------------EYCPDPLYEVMLKCWHPKAEMR 340 (373)
T ss_dssp ---------------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred ---------------------------CCCCHHHHHHHHHHcCCChhhC
Confidence 1235678899999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=349.74 Aligned_cols=251 Identities=20% Similarity=0.317 Sum_probs=201.0
Q ss_pred cCeeEEe-eeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLL-KEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILK-kIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.++.+.. .||.|+||.||+|.+. .++..||||++... ........+.+|+.++..+. |||||++++++.. +.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES---SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc---CC
Confidence 3455555 8999999999999876 45678999998644 23345678999999999995 9999999999862 46
Q ss_pred EEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999998 589998863 45899999999999999999999999999999999999999999999999999876543
Q ss_pred ccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
... .....+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+..+.+..|..+..+..+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p------- 561 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP------- 561 (613)
T ss_dssp ------------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC-------
T ss_pred CceeeeccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 221 12234568899999974 5579999999999999999998 99999999888887777665533221
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH-----HHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE-----IEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa-----iEALqHpwfaL 849 (1219)
+.+++.+.+|+..||..||.+|+ ...|.+.|+..
T Consensus 562 --------------------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 562 --------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --------------------------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------------------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 12467889999999999999973 23366667665
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=321.62 Aligned_cols=203 Identities=27% Similarity=0.478 Sum_probs=171.4
Q ss_pred ccccCeeEEeeeeccCceEEEEEE----EcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~----dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
....+|.+++.||.|+||.||+|. +..+|..||||++... .......+.+|+.++..+. ||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 345679999999999999999998 4568999999998642 3445567889999999995 99999999998755
Q ss_pred CCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+...+++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 5567899999997 499999975 3589999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccc---cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 710 LSDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 710 l~~~~~~---~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
....... .....++..|+|||++. +..++.++|||||||++|+|++|..||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 6543321 22345778899999974 45689999999999999999999999854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=353.84 Aligned_cols=236 Identities=23% Similarity=0.375 Sum_probs=194.7
Q ss_pred EeeeeccCceEEEEEEE--cCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEe
Q psy14431 565 LLKEGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~d--k~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVME 642 (1219)
.+.||.|+||.||+|.+ ..++..||||++............+.+|+.++..+. |||||++++++. ...+++|||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~---~~~~~lv~E 449 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AESWMLVME 449 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SSSEEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCCEEEEEE
Confidence 35799999999999965 456789999999766555556678999999999996 999999999985 345899999
Q ss_pred cch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc---cc
Q psy14431 643 YME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CL 717 (1219)
Q Consensus 643 yme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~---~~ 717 (1219)
|+. |+|.+++.. ..+++..+..|+.||+.||.|||+.|||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 998 589999874 4689999999999999999999999999999999999999999999999999987654321 12
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~ 796 (1219)
....+|+.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.+.......+..+..+..+
T Consensus 530 ~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-------------- 594 (635)
T 4fl3_A 530 THGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-------------- 594 (635)
T ss_dssp -----CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--------------
T ss_pred cCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--------------
Confidence 334567889999998 45569999999999999999998 99999999888877777665533221
Q ss_pred HhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 797 relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+++.+.+|+..||..||.+|+
T Consensus 595 -------------------~~~~~~l~~li~~cl~~dP~~RP 617 (635)
T 4fl3_A 595 -------------------AGCPREMYDLMNLCWTYDVENRP 617 (635)
T ss_dssp -------------------TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred -------------------CCCCHHHHHHHHHHcCCCHhHCc
Confidence 12367889999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=342.79 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=196.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.++++||.|+||.||+|.+..+|..||||++...... ..+.+|+.++..+..|++|+.+..++. .....|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGV--EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEE--ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEe--eCCEEE
Confidence 46799999999999999999999999999999987643222 237789999999985566666655544 567899
Q ss_pred EEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee---ccCCcceecccccccccCCc
Q psy14431 639 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL---d~dG~VKLiDFGLAr~l~~~ 713 (1219)
|||||++++|.+++. ...+++..++.|+.||+.||.|||+.|||||||||+|||| +.++.++|+|||++..+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999989999997 5679999999999999999999999999999999999999 68899999999999876543
Q ss_pred cc-------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchh
Q psy14431 714 KE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786 (1219)
Q Consensus 714 ~~-------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~ 786 (1219)
.. .....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.........+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~--------- 229 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS--------- 229 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH---------
T ss_pred ccccccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh---------
Confidence 22 122568999999999974 5568999999999999999999999998755432222211111
Q ss_pred hhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 787 FYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 787 l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
.......+..+...+++.+.+|+..||.+||.+|+
T Consensus 230 -----------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP 264 (483)
T 3sv0_A 230 -----------------EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP 264 (483)
T ss_dssp -----------------HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC
T ss_pred -----------------hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc
Confidence 00011222333456688999999999999999973
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.32 Aligned_cols=198 Identities=24% Similarity=0.371 Sum_probs=167.1
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhc-cCCCCccEEeeeeeccCC--ce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF-QRHPNIITMLDIYKAVNN--KD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L-~~HPNIVkL~gvfe~~d~--~~ 636 (1219)
.+|.+.+.||.|+||.||+|.+ +|..||||++.. .....+.+|+.++..+ .+||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 4689999999999999999987 589999999853 2345677888888874 269999999999874332 37
Q ss_pred EEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHH--------hcccccCCCCCCCeeeccCCcceecccccc
Q psy14431 637 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH--------ACKVMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLH--------S~GIVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
+|+||||+++ +|.+++....+++..+..++.||+.||.||| +.||+||||||+|||++.++.++|+|||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 9999999985 9999999888999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCccc----ccccccccccccCchhhhccc-----cccccccchhHHHHHHHHHhC----------CCCCCCC
Q psy14431 708 RSLSDSKE----CLTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQS----------KPLFPGA 764 (1219)
Q Consensus 708 r~l~~~~~----~~ts~vGT~~Y~APEvLl~~~-----~yT~kSDIWSLG~ILyELLTG----------kpPF~g~ 764 (1219)
........ ......||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 86654332 123457999999999985432 344789999999999999999 6777654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=341.63 Aligned_cols=238 Identities=23% Similarity=0.383 Sum_probs=198.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+|.+.++||.|+||.||+|.+.. +..||||++.... .....+.+|+.++..+. ||||+++++++. ...+|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~---~~~~~ 337 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIY 337 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCC-CCCEeeEEEEEe---eccce
Confidence 4578999999999999999999875 4669999986432 23467899999999996 999999999986 35689
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999998 599999973 358999999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......++..|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------- 486 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------- 486 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred eecccCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 1 122345678899999985 4569999999999999999999 99999998888777777655432211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+|+.+||..||.+|+
T Consensus 487 -----------------------~~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 487 -----------------------PECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp -----------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------CCCCHHHHHHHHHHcCCChhHCc
Confidence 12366788999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=345.99 Aligned_cols=241 Identities=22% Similarity=0.349 Sum_probs=197.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
..+|.+.+.||.|+||.||+|.+..+ +..||||++... ........+.+|+.++..+. ||||+++++++. ++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~ 463 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---EN 463 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe---cC
Confidence 46799999999999999999998643 567999988532 23344567889999999995 999999999985 45
Q ss_pred eEEEEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
.+|+||||++ |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999998 6899998743 588999999999999999999999999999999999999999999999999987654
Q ss_pred ccc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 713 SKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 713 ~~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
... ......+|+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+....+..+.....+..+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 614 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-------- 614 (656)
T ss_dssp ----------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC--------
T ss_pred CcceeccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 322 122345678999999984 5579999999999999999997 99999998888877777665433211
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+|+.+||..||.+|+
T Consensus 615 -------------------------~~~~~~l~~li~~~l~~dP~~RP 637 (656)
T 2j0j_A 615 -------------------------PNCPPTLYSLMTKCWAYDPSRRP 637 (656)
T ss_dssp -------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -------------------------ccccHHHHHHHHHHcCCChhHCc
Confidence 12367789999999999999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=347.99 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=192.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC---c
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---K 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~---~ 635 (1219)
++|.+++.||.|+||.||+|.+.. +|+.||||++... ........+.+|+.++..+. ||||++++++|...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCc
Confidence 689999999999999999999976 7999999988542 23344567889999999995 9999999999875332 1
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.+||||||++ ++|.+++.. .+++..+..|+.||+.||.|||+.|||||||||+|||++.+ .++|+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 2799999998 478777655 79999999999999999999999999999999999999875 8999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
...+||++|+|||++.+ .++.++|||||||++|+|++|.+||.+.... ..+...+
T Consensus 235 ---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~~~--------- 289 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPEDDP--------- 289 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTTCH---------
T ss_pred ---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccccc---------
Confidence 44579999999999743 3589999999999999999999998752110 0000000
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....++.+.++|.+||..||.+| ..+++.|+|+..
T Consensus 290 --------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 290 --------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01125678899999999999997 478899998854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.30 Aligned_cols=230 Identities=16% Similarity=0.097 Sum_probs=181.2
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
++|.+++.||.|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+. ||||+++++++. ..+.+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~--~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVH--TRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEE--ECCcEE
Confidence 5799999999999999999999999999999999755433 334567889999999995 999999999987 467899
Q ss_pred EEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 639 VVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
+||||++ ++|.+++..+. ....+..|+.||+.||.|||+.||+||||||+|||++.+|.++|+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999997 58999997654 556788899999999999999999999999999999999999998554
Q ss_pred ccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 718 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
|++ .++.++|||||||++|+|++|.+||.+.+....+.......
T Consensus 175 --------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------------- 218 (286)
T 3uqc_A 175 --------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-------------------- 218 (286)
T ss_dssp --------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT--------------------
T ss_pred --------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh--------------------
Confidence 223 36889999999999999999999998765432110000000
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhhh
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLAA 848 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwfa 848 (1219)
...........+.+++.+.+++.+||..||.+|....+...+..
T Consensus 219 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rs~~el~~~L~~ 262 (286)
T 3uqc_A 219 -------AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262 (286)
T ss_dssp -------TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCCCHHHHHHHHHH
T ss_pred -------ccCCCChhhcccCCCHHHHHHHHHHcccCCccCCHHHHHHHHHH
Confidence 00011123344667889999999999999999844444444443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=358.88 Aligned_cols=276 Identities=25% Similarity=0.351 Sum_probs=202.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec----cCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA----VNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~----~d~ 634 (1219)
+++|.+++.||.|+||.||+|.+..+|..||||++... ........+.+|+.++..+. ||||+++++++.. ..+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence 56899999999999999999999999999999998643 23445667889999999995 9999999998753 235
Q ss_pred ceEEEEEecch-hhHHHHHhhc----cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCc---ceeccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGL 706 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs~----~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~---VKLiDFGL 706 (1219)
+.+|+||||++ |+|.+++... .+++..++.++.+|+.||.|||+.||+||||||+|||++.++. ++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999996 5999998742 5899999999999999999999999999999999999997765 89999999
Q ss_pred ccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCch
Q psy14431 707 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHAD 785 (1219)
Q Consensus 707 Ar~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d 785 (1219)
+....... .....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+......+...+...... .....
T Consensus 171 a~~~~~~~-~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE-LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC-CCCCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc-ccccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98776543 23456899999999997 45679999999999999999999999997754332111100000000 00000
Q ss_pred hhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 786 KFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 786 ~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.....+. +...+ .....+.+.+++.+.+||.+||.+||.+| +.++|.||||..
T Consensus 249 ~l~g~~~-------~~~~l----p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 249 DLTGAVK-------FSSVL----PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSSSCC-------CCSSS----CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhccccc-------ccccc----CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000 00000 00011123356789999999999999996 556799999843
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=299.59 Aligned_cols=187 Identities=14% Similarity=0.087 Sum_probs=134.4
Q ss_pred eeeccCceEEEEEEEcCCCeEEEEEEeecccc--------CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 567 KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--------NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 567 kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~--------s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
..+.|++|.+..++....|..||+|++..... .......+.+|+.+|+.+..||||++++++|. +++.+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEEE
Confidence 45778888888888888899999999964421 12334568899999999988999999999997 678899
Q ss_pred EEEecchh-hHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||||++| +|.+++.. ++++. ..|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+........
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 99999996 89999985 44554 358999999999999999999999999999999999999999999987765555
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCC
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL 760 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP 760 (1219)
..+.+||++|+|||++.+ .+..++|+||+|++++.|.+|..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 667899999999999843 467889999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-24 Score=256.45 Aligned_cols=186 Identities=21% Similarity=0.222 Sum_probs=142.2
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch------hHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT------DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~------~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
...+.||+|+||.||+| ...+..+++|+......... ....+.+|+.++..+. ||||+.+..++. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--~~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDV--DLDN 413 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEE--ETTT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEE--eCCc
Confidence 44678999999999999 45678899998753322111 2345789999999995 999994443333 2445
Q ss_pred EEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 637 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.||||||++ ++|.+++.. +..++.||+.||.|||+.||+||||||+|||++. .++|+|||+++.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred cEEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 699999997 699998876 5689999999999999999999999999999998 999999999998765432
Q ss_pred c-------cccccccccccCchhhhc-cccccccccchhHHHHHHHHHhCCCCCC
Q psy14431 716 C-------LTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFP 762 (1219)
Q Consensus 716 ~-------~ts~vGT~~Y~APEvLl~-~~~yT~kSDIWSLG~ILyELLTGkpPF~ 762 (1219)
. ....+||++|+|||++.. ...|+..+|+||.++-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 235789999999999843 1458888999999999998888887773
|
| >3o0z_A RHO-associated protein kinase 1; coiled-coil, transferase; HET: MSE; 2.33A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=205.38 Aligned_cols=151 Identities=28% Similarity=0.398 Sum_probs=133.6
Q ss_pred hhhhhHHhhhhhHHHHHHHhhhccceehhccccchhHHHHHHHHHHHhhchhhHHHHHHHHHHHhhhhhccccchhhhhh
Q psy14431 101 VISDMHEKLKTEAETATRLRKQSAELTVAKSAGEQMVVELQNILATLEMERDTLQQEVATLQAKISQERSSKTQAVNLHK 180 (1219)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (1219)
-+.+|-++|++|.|++.|+||+-+|+..+.+.-++.+-|||..++.|+-.++.|+++++.||+.+.+||.+.+|+-.++.
T Consensus 14 QL~E~n~kLk~EsE~~~rlkK~~tEl~k~~~~~E~~~rELq~~~~~L~~~k~~Leke~~~LQa~L~qEr~~r~q~se~~~ 93 (168)
T 3o0z_A 14 QLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIG 93 (168)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhHHHHhhhHHhhcccccchhhhhhcchhhhhhhhhHHHhhhHhhHHHHHhhHHHhhhhhhhhHHhhhhhhhhhhhcc
Q psy14431 181 ELEGRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECRLQALNTELERNKHRELQLAEDNRHLGEKVSSLEKECAS 260 (1219)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (1219)
+|+||+++|.+|+ .|-+.++.++..|||.|-|+|+.|||+++|
T Consensus 94 elq~ri~~L~~El-------------------------------------~~~k~~~~k~~~e~r~L~Ekl~~lEKe~a~ 136 (168)
T 3o0z_A 94 DLQARITSLQEEV-------------------------------------KHLKHNLEKVEGERKEAQDMLNHSEKEKNN 136 (168)
T ss_dssp HHHHHHHHHHHHH-------------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH-------------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999666555554 555667778888999999999999999999
Q ss_pred ch----hhhhHHHHHHHHHHHHhHhhhhhcccc
Q psy14431 261 LS----LELKAAQAQYQQEVRAHEETQKSRMVN 289 (1219)
Q Consensus 261 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (1219)
+. |+||++|.+|+|||++|++| |+|+++
T Consensus 137 ~eid~~~eLKalQ~~~eqE~~~H~~T-karL~~ 168 (168)
T 3o0z_A 137 LEIDLNYKLKSLQQRLEQEVNEHKVT-KARLTD 168 (168)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHH-HHHhcC
Confidence 99 99999999999999999999 888864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6e-22 Score=214.38 Aligned_cols=145 Identities=17% Similarity=0.153 Sum_probs=114.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----------------hhHHHHHHHHHHHHhccCCCCcc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----------------TDAQRTYREILFLKSFQRHPNII 623 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----------------~~~e~~lREI~ILr~L~~HPNIV 623 (1219)
..|.+.+.||.|+||.||+|.+ .+|..||||++....... .....+.+|+.++..+. | +
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~ 164 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---L 164 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---S
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---C
Confidence 3477889999999999999999 889999999985322111 13456889999999996 4 4
Q ss_pred EEeeeeeccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceec
Q psy14431 624 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG 702 (1219)
Q Consensus 624 kL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLi 702 (1219)
++++++. .+.+|+||||++| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ +|.++|+
T Consensus 165 ~v~~~~~---~~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 165 AVPKVYA---WEGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SSCCEEE---EETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CcCeEEe---ccceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 4555443 2456999999975 7876 32 234567999999999999999999999999999999 9999999
Q ss_pred ccccccccCCcccccccccccccccCchhh
Q psy14431 703 DLGLARSLSDSKECLTEYIATRWYRAPEIL 732 (1219)
Q Consensus 703 DFGLAr~l~~~~~~~ts~vGT~~Y~APEvL 732 (1219)
|||+|.. +..|.|||++
T Consensus 235 DFG~a~~-------------~~~~~a~e~l 251 (282)
T 1zar_A 235 DFPQSVE-------------VGEEGWREIL 251 (282)
T ss_dssp CCTTCEE-------------TTSTTHHHHH
T ss_pred ECCCCeE-------------CCCCCHHHHH
Confidence 9999863 3346888887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.3e-19 Score=188.76 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=108.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeE--EEEEEeeccccCc----------------------hhHHHHHHHHHHHHhcc
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNK----------------------TDAQRTYREILFLKSFQ 617 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~--VAIKvI~ks~~s~----------------------~~~e~~lREI~ILr~L~ 617 (1219)
|.+...||.|+||.||+|.+..+|.. ||||++....... .....+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778999 9999875321110 11135778999999996
Q ss_pred CCCCc--cEEeeeeeccCCceEEEEEecchh------hHHHHHhhccCChHHHHHHHHHHHHHHHHHH-hcccccCCCCC
Q psy14431 618 RHPNI--ITMLDIYKAVNNKDLYVVFEYMEN------DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKP 688 (1219)
Q Consensus 618 ~HPNI--VkL~gvfe~~d~~~LyLVMEymeG------SL~d~Lrs~~LseeeVr~Ia~QILsALaYLH-S~GIVHRDLKP 688 (1219)
|++| +.++++ ...||||||+++ +|.++... .++..+..++.||+.||.||| +.||+||||||
T Consensus 129 -~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 -EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp -HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred -hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 6654 334332 246899999963 56665432 345578899999999999999 99999999999
Q ss_pred CCeeeccCCcceecccccccccC
Q psy14431 689 SNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 689 sNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.|||++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999988 89999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=176.08 Aligned_cols=137 Identities=13% Similarity=0.075 Sum_probs=96.3
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC------------chhHH--------HHHHHHHHHHhccCCCC
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------------KTDAQ--------RTYREILFLKSFQRHPN 621 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s------------~~~~e--------~~lREI~ILr~L~~HPN 621 (1219)
|.+..+||.|+||.||+|.+. +|+.||||+++..... ..... ...+|...|..+. +++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 899999999999999999875 5899999987532110 00011 1234566666663 333
Q ss_pred c--cEEeeeeeccCCceEEEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-
Q psy14431 622 I--ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC- 697 (1219)
Q Consensus 622 I--VkL~gvfe~~d~~~LyLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG- 697 (1219)
+ +..+++. ..+|||||++| +|..+. ....+..++.||+.+|.|||+.|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~------~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQS------RHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEEEE------TTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCeeeecc------CceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 2 2222211 23799999996 444322 2234567889999999999999999999999999998877
Q ss_pred ---------cceecccccccccC
Q psy14431 698 ---------SIKIGDLGLARSLS 711 (1219)
Q Consensus 698 ---------~VKLiDFGLAr~l~ 711 (1219)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999775433
|
| >1uix_A RHO-associated kinase; coiled-coil, transferase; HET: MSE; 1.80A {Bos taurus} SCOP: h.1.27.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=128.95 Aligned_cols=62 Identities=42% Similarity=0.644 Sum_probs=57.2
Q ss_pred HHhhhHHhhhHHHHHHHHHHHHHHHHhcCCChHHHH------HHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q psy14431 949 KKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEME------KLHKQLKQEQLLKAQAVNKLAEIMNRKD 1012 (1219)
Q Consensus 949 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~e~~lk~~~vnkl~~~m~rk~ 1012 (1219)
.+.++.|.++.++|.+++..+++++.+.. ++++. .|+|+|.+|+|||+||||||||||||||
T Consensus 3 ~k~v~~l~~E~eel~~klk~~~ee~~~~~--eee~~~~~~k~~lek~L~~E~~LK~QAVNKLAEIMNRKd 70 (71)
T 1uix_A 3 TSDVANLANEKEELNNKLKEAQEQLSRLK--DEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKE 70 (71)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 46789999999999999999999998866 77788 9999999999999999999999999998
|
| >1s1c_X RHO-associated, coiled-coil containing protein kinase 1; GTPase, RHO kinase, ROCK, signaling protein; HET: GNP; 2.60A {Homo sapiens} SCOP: h.1.27.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=128.14 Aligned_cols=64 Identities=42% Similarity=0.635 Sum_probs=58.2
Q ss_pred hHHhhhHHhhhHHHHHHHHHHHHHHHHhcCCChHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhhccc
Q psy14431 948 YKKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEME----KLHKQLKQEQLLKAQAVNKLAEIMNRKDI 1013 (1219)
Q Consensus 948 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~e~~lk~~~vnkl~~~m~rk~~ 1013 (1219)
..+.++.|.++.++|.+++..+++++.+.. ++++. .|+++|.+|+|||+||||||||||||||+
T Consensus 4 L~k~i~~l~~E~eel~~klk~~~ee~~~~~--eee~~~~~~~lek~L~~E~~LK~QAVNKLAEIMNRKd~ 71 (71)
T 1s1c_X 4 LTKDIEILRRENEELTEKMKKAEEEYKLEK--EEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDF 71 (71)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHHTC--
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCC
Confidence 467899999999999999999999998766 78888 99999999999999999999999999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-11 Score=127.86 Aligned_cols=141 Identities=13% Similarity=0.109 Sum_probs=109.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+..|.+...+|.|+++.||++.. .|..+++|+....... ....+.+|+.++..+..+..++++++++. +.+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEe--cCCceE
Confidence 45688889999999999999964 3678999988643211 12357889999999976778889998876 467899
Q ss_pred EEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy14431 639 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--------------------------------------- 678 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS--------------------------------------- 678 (1219)
+||+|++| +|...+. +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999997 5655421 223345688899999999998
Q ss_pred --------------------cccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 679 --------------------CKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 679 --------------------~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766667999997754
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-12 Score=117.40 Aligned_cols=59 Identities=49% Similarity=1.043 Sum_probs=51.5
Q ss_pred CCCCCCCCCCCccccccCCCCCCcccccccccccccccccCCCCCCCCCCccccccCCCcccccc
Q psy14431 1152 EARRPEDGGAELPAVLRGGDEKPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECGT 1216 (1219)
Q Consensus 1152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1216 (1219)
|||+++ |++..+. ++|++++.++||.|+.++||.||.|+.|++.||+++|+||++.|..
T Consensus 1 ~~~~~~----~~~~~~~--~~~~~~~~~~~H~F~~~~~~~PT~Cd~C~~~lWGl~kqp~G~~C~~ 59 (84)
T 2row_A 1 ESKKEP----EFPVEPV--GEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRR 59 (84)
T ss_dssp CCCCCC----SCCCCCC--CSCCCCEEETTEEEEEECCSSCEECSSSSSEECCSSSCCCEEEESS
T ss_pred CCcCch----hhccccc--ccccceEEcCCcceEeEcCCCCcchhhcCHhhhccccCCCCCEecC
Confidence 567774 3455554 4899999999999999999999999999999999999999999974
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.1e-10 Score=118.00 Aligned_cols=136 Identities=13% Similarity=0.073 Sum_probs=94.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC-ccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN-IVkL~gvfe~~d~~~L 637 (1219)
+..|.+....+.|+++.||++.. .+|..|++|+.... ....+.+|+.++..+..++- ++++++++. .++..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCC
Confidence 34455544444666799999954 45777999987532 12346789999998875522 566877765 34668
Q ss_pred EEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q psy14431 638 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK------------------------------------ 680 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~G------------------------------------ 680 (1219)
|+||+|++| ++. .. ..+ ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999997 442 11 111 2246667777777777643
Q ss_pred ----------------------cccCCCCCCCeeeccCCcceecccccccc
Q psy14431 681 ----------------------VMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 681 ----------------------IVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=8.8e-10 Score=118.91 Aligned_cols=183 Identities=17% Similarity=0.182 Sum_probs=116.5
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCC--ccEEeeeeeccC-CceEEEEE
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN--IITMLDIYKAVN-NKDLYVVF 641 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPN--IVkL~gvfe~~d-~~~LyLVM 641 (1219)
+..++.|.++.||.+. ..+++|+... ......+.+|..++..+..+.. ++.++.+....+ ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999873 4588997642 2345678899999988854433 344443332111 12458999
Q ss_pred ecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy14431 642 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA------------------------------------------ 678 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS------------------------------------------ 678 (1219)
+|++| ++..... ..++......++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp ECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99997 3432211 235666666677777777777774
Q ss_pred ----------------cccccCCCCCCCeeecc--CCcceecccccccccCCcccccccccccccc---cCchhh---hc
Q psy14431 679 ----------------CKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSDSKECLTEYIATRWY---RAPEIL---IS 734 (1219)
Q Consensus 679 ----------------~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y---~APEvL---l~ 734 (1219)
..++|+|++|.||+++. .+.+.|+||+.+....+.. .......+ ..|+.. +.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHHHHHHH
Confidence 24799999999999998 4568899999987643321 11111111 222221 00
Q ss_pred c----------ccccccccchhHHHHHHHHHhCCCCC
Q psy14431 735 N----------RRYTHHVDIWSLGCILAEMLQSKPLF 761 (1219)
Q Consensus 735 ~----------~~yT~kSDIWSLG~ILyELLTGkpPF 761 (1219)
. .....-.+.|++|+++|.+.+|.++|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 01122358899999999999999887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.5e-09 Score=117.77 Aligned_cols=159 Identities=11% Similarity=0.134 Sum_probs=108.3
Q ss_pred HHHHhhccc-cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEee--ccccCchhHHHHHHHHHHHHhccC-CCCccE
Q psy14431 549 IDQLMKDRE-DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQR-HPNIIT 624 (1219)
Q Consensus 549 l~eLL~dr~-dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~--ks~~s~~~~e~~lREI~ILr~L~~-HPNIVk 624 (1219)
+..++.... .......++.|+.|.++.||++... +..+++|+.. ... .......+.+|+.++..+.. +..+++
T Consensus 26 l~~~l~~~~~~~~~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~ 102 (359)
T 3dxp_A 26 LEAWMRQHVEGFAGPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAK 102 (359)
T ss_dssp HHHHHHHHSTTCCCCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCC
T ss_pred HHHHHHHhCCCCCCCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCc
Confidence 444444432 2344556788999999999999653 4568888764 221 11223457789999998864 345788
Q ss_pred EeeeeeccC-CceEEEEEecchhh-HHHHHhhccCChHHHHHHHHHHHHHHHHHHh------------------------
Q psy14431 625 MLDIYKAVN-NKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA------------------------ 678 (1219)
Q Consensus 625 L~gvfe~~d-~~~LyLVMEymeGS-L~d~Lrs~~LseeeVr~Ia~QILsALaYLHS------------------------ 678 (1219)
++.++.... .+..|+||||++|. +.+.. ...++......++.+++.+|..||+
T Consensus 103 ~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3dxp_A 103 MYALCEDESVIGRAFYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER 181 (359)
T ss_dssp EEEEECCTTTTSSCEEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred EEEECCCCCccCCeEEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence 887765321 14589999999973 32211 1235677778889999999999997
Q ss_pred ----------------------------------cccccCCCCCCCeeeccCCc--ceecccccccccC
Q psy14431 679 ----------------------------------CKVMHRDLKPSNILIDKSCS--IKIGDLGLARSLS 711 (1219)
Q Consensus 679 ----------------------------------~GIVHRDLKPsNILLd~dG~--VKLiDFGLAr~l~ 711 (1219)
.++||+|++|.|||++.++. +.|+||+.+....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 36899999999999997763 6899999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.9e-06 Score=93.97 Aligned_cols=137 Identities=18% Similarity=0.172 Sum_probs=86.5
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-C-CccEEeeeeeccCCceEEEEE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-P-NIVkL~gvfe~~d~~~LyLVM 641 (1219)
.+..++.|....||.. |..+++|+.. .......+.+|..+|..+..+ + .++.++.+.. ...+..|+||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~ 92 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGY 92 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEE
Confidence 3566789999999998 4568888752 223456788999999999754 2 3556665553 2456688999
Q ss_pred ecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHH-------------------------------------------
Q psy14431 642 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH------------------------------------------- 677 (1219)
Q Consensus 642 EymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLH------------------------------------------- 677 (1219)
+|++| ++....- ..++......++.++...|..||
T Consensus 93 e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 93 RKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99997 3332110 11122222222222222222222
Q ss_pred -----------------hcccccCCCCCCCeeecc---CCc-ceecccccccccC
Q psy14431 678 -----------------ACKVMHRDLKPSNILIDK---SCS-IKIGDLGLARSLS 711 (1219)
Q Consensus 678 -----------------S~GIVHRDLKPsNILLd~---dG~-VKLiDFGLAr~l~ 711 (1219)
...++|+|++|.|||++. ++. +.|+||+.+...+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 225699999999999987 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.4e-06 Score=89.59 Aligned_cols=133 Identities=19% Similarity=0.222 Sum_probs=89.8
Q ss_pred eeeccCce-EEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEecch
Q psy14431 567 KEGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME 645 (1219)
Q Consensus 567 kIGeGgFG-tVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEyme 645 (1219)
.+..|..| .||+......+..+++|+... .....+.+|..+|+.+..+-.++++++++. +.+..|+||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~--~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIR--TPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEE--ECCeEEEEEEeeC
Confidence 44555555 699988777788899998642 234567789999998876555777887765 4567899999998
Q ss_pred h-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q psy14431 646 N-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA---------------------------------------------- 678 (1219)
Q Consensus 646 G-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS---------------------------------------------- 678 (1219)
| ++.+..... ......+..++...|.-||+
T Consensus 104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7 343332211 11122233334444444442
Q ss_pred ------------cccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 679 ------------CKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 679 ------------~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877778999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.7e-06 Score=94.01 Aligned_cols=80 Identities=18% Similarity=0.249 Sum_probs=50.2
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc--C---chhHHHHHHHHHHHHhccCC-CC-ccEEeeeeeccCCc
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--N---KTDAQRTYREILFLKSFQRH-PN-IITMLDIYKAVNNK 635 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~--s---~~~~e~~lREI~ILr~L~~H-PN-IVkL~gvfe~~d~~ 635 (1219)
..++.||.|.++.||++....++..|+||....... . .....+...|..++..+..+ |. ++.++.+ . ..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d---~~ 108 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D---TE 108 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E---TT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c---CC
Confidence 356789999999999997666678899998643211 0 11234567788888877543 33 3455533 2 23
Q ss_pred eEEEEEecchh
Q psy14431 636 DLYVVFEYMEN 646 (1219)
Q Consensus 636 ~LyLVMEymeG 646 (1219)
..++||||++|
T Consensus 109 ~~~lvmE~l~g 119 (397)
T 2olc_A 109 MAVTVMEDLSH 119 (397)
T ss_dssp TTEEEECCCTT
T ss_pred ccEEEEEeCCC
Confidence 45899999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=2.3e-05 Score=84.10 Aligned_cols=152 Identities=14% Similarity=0.135 Sum_probs=83.4
Q ss_pred HHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEee
Q psy14431 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLD 627 (1219)
Q Consensus 549 l~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~g 627 (1219)
+...+...+.+. ..-+..|+.|..+.||++... +| .+++|++... ...+..|+.++..+..+ -.++.++.
T Consensus 22 l~~~l~~~~~~~-~~~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~ 92 (346)
T 2q83_A 22 LAENVLQGWDVQ-AEKIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILP 92 (346)
T ss_dssp HHHHHGGGSCCC-CCEEEECC----CEEEEEEET-TE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCC
T ss_pred HHHHHHHHcCCc-eEEeeeccccccCcEEEEEeC-CC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceee
Confidence 344454555553 334566777889999999653 33 4889988531 12333455555554321 13444443
Q ss_pred ee----eccCCceEEEEEecchhh-H---------------HHHHh-hccC--C-----------hHH------------
Q psy14431 628 IY----KAVNNKDLYVVFEYMEND-L---------------NKVIR-DKIL--K-----------DVH------------ 661 (1219)
Q Consensus 628 vf----e~~d~~~LyLVMEymeGS-L---------------~d~Lr-s~~L--s-----------eee------------ 661 (1219)
.. ....++..++||+|++|. + ..+-. ...+ + +..
T Consensus 93 ~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 172 (346)
T 2q83_A 93 NKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETW 172 (346)
T ss_dssp CTTSCSCEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHH
Confidence 11 011355789999999862 1 11111 0101 1 100
Q ss_pred -------------------HHHHHHHHHHHHHHHH-------------hcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 662 -------------------IRYIMFQLCNGLSYIH-------------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 662 -------------------Vr~Ia~QILsALaYLH-------------S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+..+...+..++.+|+ ..++||+|++|.|||++.++.+.|+||+.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 173 KLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111122334566665 25799999999999998888999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.6e-05 Score=90.23 Aligned_cols=79 Identities=11% Similarity=0.067 Sum_probs=47.1
Q ss_pred HhcccccCCCCCCCeeeccCCcceecccccccccCCcccccccccc--cccccCchhhhcc--ccccccccchhHHHHHH
Q psy14431 677 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA--TRWYRAPEILISN--RRYTHHVDIWSLGCILA 752 (1219)
Q Consensus 677 HS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vG--T~~Y~APEvLl~~--~~yT~kSDIWSLG~ILy 752 (1219)
+...++|+|++|.|||++.++ +.|+||+.+...++.... ..... ...|++|+..... .......++.+++..+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 356899999999999998877 999999998765432211 11111 1335555543110 01122334446677777
Q ss_pred HHHhC
Q psy14431 753 EMLQS 757 (1219)
Q Consensus 753 ELLTG 757 (1219)
..+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=1.3e-05 Score=87.80 Aligned_cols=84 Identities=8% Similarity=-0.030 Sum_probs=53.2
Q ss_pred eEEeee-eccCceEEEEEEEc---C---CCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCC--CCccEEeeeeecc
Q psy14431 563 INLLKE-GKGAYGIVYKAYDK---N---NKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAV 632 (1219)
Q Consensus 563 ~ILKkI-GeGgFGtVYlA~dk---~---TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~ 632 (1219)
..++.| +.|..+.+|.+... . ++..+++|+...... .......+.+|+.++..+..+ ..+++++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999998653 1 156788997643210 000113466788888887654 3467777765421
Q ss_pred C-CceEEEEEecchh
Q psy14431 633 N-NKDLYVVFEYMEN 646 (1219)
Q Consensus 633 d-~~~LyLVMEymeG 646 (1219)
. .+..|+||+|++|
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 1 1457899999986
|
| >2rov_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.79 E-value=3.7e-06 Score=81.43 Aligned_cols=32 Identities=69% Similarity=0.985 Sum_probs=30.5
Q ss_pred eeeeeecccccccccccCchhhHHHHHhcCCC
Q psy14431 1120 EVRSRSVTQGDVIRADAKDIPRIFQLLYAGEG 1151 (1219)
Q Consensus 1120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1151 (1219)
.|||++||++||++|..+++|+||||.|++.|
T Consensus 55 ~~~V~~V~~~d~i~~~~~~~p~iF~I~~~~~~ 86 (117)
T 2rov_A 55 LFHVRPVTQTDVYRADAKEIPRIFQILYANEG 86 (117)
T ss_dssp EEEEEECCTTTCSSSCTTTGGGEEEEEECSSS
T ss_pred cEEEEEcccccccccccccCCcEEEEEeCCCC
Confidence 48999999999999999999999999999887
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.2e-05 Score=73.54 Aligned_cols=40 Identities=30% Similarity=0.707 Sum_probs=36.4
Q ss_pred CcccccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1174 PGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
.++..++||.|...+|+.||.|+.|++.||++++ +++.|.
T Consensus 10 ~k~~~~~~H~F~~~~~~~pt~C~~C~~~lwGl~k--qg~~C~ 49 (83)
T 2yuu_A 10 AKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNK--QGYKCR 49 (83)
T ss_dssp CCEECGGGCCEEEECCSSCCCCSSSCCCCCSSSC--CEEEET
T ss_pred hhCcccCCCceEeEeCCCCcChhhcChhhccccc--cccccC
Confidence 5677889999999999999999999999999988 778775
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.58 E-value=3.1e-05 Score=70.10 Aligned_cols=41 Identities=27% Similarity=0.653 Sum_probs=36.9
Q ss_pred CCcccccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1173 KPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
...+..++||.|...+|+.||.|+.|++.||++++ +++.|.
T Consensus 15 ~~~~~~~~~H~F~~~~f~~pt~C~~C~~~lwGl~k--qG~~C~ 55 (77)
T 2enn_A 15 QAKVHHVKCHEFTATFFPQPTFCSVCHEFVWGLNK--QGYQCR 55 (77)
T ss_dssp CCCCEESSSCEEEEECCSSCEECSSSCCEECCTTC--CEEECS
T ss_pred ccccccCCCCccEEEcCCCCcCccccChhhccccc--cccCcC
Confidence 44778899999999999999999999999999987 788775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00034 Score=75.49 Aligned_cols=137 Identities=12% Similarity=0.040 Sum_probs=76.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
++.-++.|+.|....+|++ ..+++|+....... .....+|..++..+..+.-.+++++++. ..-++|
T Consensus 19 ~~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v 85 (301)
T 3dxq_A 19 GYTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDP----ATGVMV 85 (301)
T ss_dssp TCCSCEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEE
T ss_pred cccceeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEE
Confidence 3444788999999999999 34788877532111 1123467777777764433356665432 223689
Q ss_pred Eecc-hh-hH-----HH-------H---H---hhcc--CC-----hHHHHHHHHH--------------HHHHHHHHH--
Q psy14431 641 FEYM-EN-DL-----NK-------V---I---RDKI--LK-----DVHIRYIMFQ--------------LCNGLSYIH-- 677 (1219)
Q Consensus 641 MEym-eG-SL-----~d-------~---L---rs~~--Ls-----eeeVr~Ia~Q--------------ILsALaYLH-- 677 (1219)
++|+ +| ++ .+ + + +... ++ ...+..+... +...+..+.
T Consensus 86 ~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 165 (301)
T 3dxq_A 86 TRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA 165 (301)
T ss_dssp EECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred EeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence 9999 65 11 11 0 0 1100 11 0111111111 111111111
Q ss_pred ------hcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 678 ------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 678 ------S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
...++|+|+.|.||+ ..++.+.|+||..+...+
T Consensus 166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 124899999999999 566778999999887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00028 Score=76.05 Aligned_cols=154 Identities=10% Similarity=0.053 Sum_probs=84.0
Q ss_pred HHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEee
Q psy14431 549 IDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLD 627 (1219)
Q Consensus 549 l~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~g 627 (1219)
+..++.. +.+....-++.|+.|....||.+... +| .+++|+..... ....+..|+.++..+..+. .++.++.
T Consensus 12 l~~~l~~-~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 12 LRNFLTQ-YDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp HHHHHTT-BCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred HHHHHHh-CCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3444543 55655566778888999999999754 34 57899875321 1223456777777765331 1333332
Q ss_pred eee----ccCCceEEEEEecchhh-H-----------HHH---Hhh--ccC--------ChHHHHH--------------
Q psy14431 628 IYK----AVNNKDLYVVFEYMEND-L-----------NKV---IRD--KIL--------KDVHIRY-------------- 664 (1219)
Q Consensus 628 vfe----~~d~~~LyLVMEymeGS-L-----------~d~---Lrs--~~L--------seeeVr~-------------- 664 (1219)
... ....+..++||+|++|. + ... ++. ..+ .......
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 110 01135678999999862 1 011 110 001 0000000
Q ss_pred -HHHHHHHHHHHHHh-------cccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 665 -IMFQLCNGLSYIHA-------CKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 665 -Ia~QILsALaYLHS-------~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+...+...+.++.. .++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113334555542 4799999999999998876668999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0013 Score=73.05 Aligned_cols=75 Identities=15% Similarity=0.061 Sum_probs=56.3
Q ss_pred eEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC--CCccEEeeeeeccCCceEEEE
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~d~~~LyLV 640 (1219)
.-+..|+.|.+..+|++.. ++..+++|+.... ....+..|...|..+..+ ..+++++.+.. ..+..|+|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~--~~g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGN--SQGHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE--CSSEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee--cCCceEEE
Confidence 4567889999999999964 4667889987432 355678898888888643 56777877654 34679999
Q ss_pred Eecchh
Q psy14431 641 FEYMEN 646 (1219)
Q Consensus 641 MEymeG 646 (1219)
|+|++|
T Consensus 110 me~l~G 115 (312)
T 3jr1_A 110 LEALNK 115 (312)
T ss_dssp EECCCC
T ss_pred EEeccC
Confidence 999986
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0001 Score=64.52 Aligned_cols=35 Identities=34% Similarity=0.737 Sum_probs=32.3
Q ss_pred cccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1179 LKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
+.+|.|.+.+|+.||.|+.|++.||++++ +++.|.
T Consensus 10 ~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~--qg~~C~ 44 (65)
T 2enz_A 10 DMPHRFKVYNYKSPTFCEHCGTLLWGLAR--QGLKCD 44 (65)
T ss_dssp CCCCCEEECCCCSCCBCSSSCCBCCCSSS--CSEEES
T ss_pred CCCCccEeEcCCCCcCchhcChhheecCC--cccccC
Confidence 57999999999999999999999999988 788875
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.32 E-value=6.1e-05 Score=66.20 Aligned_cols=40 Identities=28% Similarity=0.473 Sum_probs=31.1
Q ss_pred CcccccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1174 PGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
++...+.+|.|...+|+.||.|+.|++.||++++ +++.|.
T Consensus 6 ~~~~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~--qg~~C~ 45 (66)
T 1y8f_A 6 SGGGGGIQHNFEVWTATTPTYCYECEGLLWGIAR--QGMRCT 45 (66)
T ss_dssp -------CCCEEEEECSSCCCCTTTCCCCCSSCC--EEEEET
T ss_pred cCCCCCCCcccEeeeCCCCcChhhcChhhcccCc--ceeEcC
Confidence 3455678999999999999999999999999998 788875
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=7.5e-05 Score=67.13 Aligned_cols=39 Identities=26% Similarity=0.505 Sum_probs=34.8
Q ss_pred cccccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1175 GIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
....++||.|...+|+.||.|+.|++.||++++ +++.|.
T Consensus 11 k~~~~~~H~F~~~~f~~pt~C~~C~~~lwGl~k--qG~~C~ 49 (74)
T 2db6_A 11 KLVNDKPHKFKDHFFKKPKFCDVCARMIVLNNK--FGLRCK 49 (74)
T ss_dssp CCSCSSBCCEEEEECSSCEECSSSCCEECHHHH--EEEEES
T ss_pred ccccCCCCceEEeeCCCCcCchhcChhhccccC--CccccC
Confidence 356778999999999999999999999999988 777775
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0002 Score=65.98 Aligned_cols=37 Identities=24% Similarity=0.573 Sum_probs=33.5
Q ss_pred cccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1177 IALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
-++++|.|.+.+|+.||.|+.|++.||++++ +++.|.
T Consensus 13 ~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~k--qG~~C~ 49 (85)
T 2eli_A 13 DPRSKHKFKIHTYGSPTFCDHCGSLLYGLIH--QGMKCD 49 (85)
T ss_dssp CTTTSCCCEEECCSSCCBCSSSCCBCCCSSS--CEEECS
T ss_pred CCCCCcccEeeeCCCCcCCcccCcccccccc--CCCcCC
Confidence 3567999999999999999999999999988 788875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0012 Score=72.04 Aligned_cols=33 Identities=21% Similarity=0.234 Sum_probs=28.2
Q ss_pred cccccCCCCCCCeeeccC----CcceecccccccccC
Q psy14431 679 CKVMHRDLKPSNILIDKS----CSIKIGDLGLARSLS 711 (1219)
Q Consensus 679 ~GIVHRDLKPsNILLd~d----G~VKLiDFGLAr~l~ 711 (1219)
.+++|||+.|.|||++.+ +.+.|+||+.+...+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 479999999999999874 678999999887544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.002 Score=74.19 Aligned_cols=73 Identities=10% Similarity=0.151 Sum_probs=51.1
Q ss_pred EEeeeeccCceEEEEEEEcC-------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 564 NLLKEGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~-------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+..|+.|....||++.... .+..|++|+.... . ....+.+|..++..+..+.-.+++++++. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~---~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS---G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET---T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--
Confidence 46778889999999998653 2567899987321 1 11345579999988875544577777653 2
Q ss_pred EEEEEecchh
Q psy14431 637 LYVVFEYMEN 646 (1219)
Q Consensus 637 LyLVMEymeG 646 (1219)
.+|++|++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 389999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0016 Score=74.24 Aligned_cols=136 Identities=10% Similarity=0.116 Sum_probs=83.0
Q ss_pred EeeeeccCceEEEEEEEcC-------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 565 LLKEGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~-------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
++.|..|-...+|++.... .+..|++++.-. .........+|..+++.+..+.-.+++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~---~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFP---E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET---T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC---C---
Confidence 4667778889999997642 346789997632 11234556689999988876655577777654 2
Q ss_pred EEEEecchhh------HH------HH---Hh---hc--c----C--ChHHHHHHHHHHHH-------------------H
Q psy14431 638 YVVFEYMEND------LN------KV---IR---DK--I----L--KDVHIRYIMFQLCN-------------------G 672 (1219)
Q Consensus 638 yLVMEymeGS------L~------d~---Lr---s~--~----L--seeeVr~Ia~QILs-------------------A 672 (1219)
.+||+|++|. +. .+ +. .. + . -+..+..++.++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999861 11 11 11 11 1 1 12345555544422 2
Q ss_pred HHHHH----h----cccccCCCCCCCeeeccC----Ccceecccccccc
Q psy14431 673 LSYIH----A----CKVMHRDLKPSNILIDKS----CSIKIGDLGLARS 709 (1219)
Q Consensus 673 LaYLH----S----~GIVHRDLKPsNILLd~d----G~VKLiDFGLAr~ 709 (1219)
+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33333 1 368999999999999876 7899999998864
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00028 Score=58.24 Aligned_cols=32 Identities=31% Similarity=0.860 Sum_probs=29.8
Q ss_pred ccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1182 HEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
|.|.+.+|+.||.|+.|++.||++++ +++.|.
T Consensus 1 H~F~~~~~~~pt~C~~C~~~l~g~~~--qg~~C~ 32 (50)
T 1ptq_A 1 HRFKVYNYMSPTFCDHCGSLLWGLVK--QGLKCE 32 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSS--CEEEET
T ss_pred CCCEeecCCCCCCcCCCCceeeccCC--ccCEeC
Confidence 89999999999999999999999988 778775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0023 Score=70.91 Aligned_cols=74 Identities=11% Similarity=0.080 Sum_probs=44.4
Q ss_pred EEeeeeccCceEEEEEEEcC--------CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 564 NLLKEGKGAYGIVYKAYDKN--------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~--------TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+..|+.|....||++.... .+..|++|+..... ........|..++..+..+..++++++.+. +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN---G- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET---T-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC---C-
Confidence 45678888889999997643 13678899774321 111123578888887765433556665542 2
Q ss_pred eEEEEEecchh
Q psy14431 636 DLYVVFEYMEN 646 (1219)
Q Consensus 636 ~LyLVMEymeG 646 (1219)
++||+|++|
T Consensus 110 --~~v~e~i~G 118 (369)
T 3c5i_A 110 --GRIEEWLYG 118 (369)
T ss_dssp --EEEEECCCS
T ss_pred --cEEEEEecC
Confidence 689999986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0055 Score=66.18 Aligned_cols=76 Identities=13% Similarity=0.120 Sum_probs=47.0
Q ss_pred EeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEeeeeec----cCCceEEE
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKA----VNNKDLYV 639 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~gvfe~----~d~~~LyL 639 (1219)
+..++ |....||.+.. .+|..+++|+...... ....+..|..++..+..+. .++.++.. .+ ..++..++
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEE
Confidence 45567 88889998853 3466789998853211 2345667888887776331 24444432 11 12456789
Q ss_pred EEecchh
Q psy14431 640 VFEYMEN 646 (1219)
Q Consensus 640 VMEymeG 646 (1219)
||+|++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.012 Score=63.09 Aligned_cols=77 Identities=12% Similarity=0.076 Sum_probs=51.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC--CCccEEeeeeeccCCceEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H--PNIVkL~gvfe~~d~~~Ly 638 (1219)
...-+..+|.|..+.||++... +|+.|++|+..... ......+..|...|+.+... -.+++++++. .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc------Cce
Confidence 3456788999999999999754 57889999764322 12223467899998888533 2345555432 137
Q ss_pred EEEecchh
Q psy14431 639 VVFEYMEN 646 (1219)
Q Consensus 639 LVMEymeG 646 (1219)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0069 Score=67.11 Aligned_cols=33 Identities=24% Similarity=0.264 Sum_probs=28.6
Q ss_pred cccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 679 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 679 ~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
.+++|+|+.|.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 468999999999999988889999998876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.019 Score=67.08 Aligned_cols=74 Identities=14% Similarity=0.053 Sum_probs=49.0
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
-+..|+.|-...+|++....++..|++|+....... .....+|..++..+..+.-.+++++++. + .+||+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 467888899999999987655578999987432111 1112578889988875544567777663 2 259999
Q ss_pred chh
Q psy14431 644 MEN 646 (1219)
Q Consensus 644 meG 646 (1219)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3uej_A NPKC-delta, protein kinase C delta type; proteine kinase cdelta, phosphotransferase, anesthetic bindi metal binding protein; 1.30A {Mus musculus} PDB: 3ugi_A 3ugl_A 3uey_A 3ugd_A 3uff_A 1ptq_A 1ptr_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.001 Score=58.14 Aligned_cols=37 Identities=27% Similarity=0.757 Sum_probs=32.1
Q ss_pred cccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1177 IALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
....+|.|.+.+|..||.|+.|++.||++++ +++.|.
T Consensus 5 ~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~--qg~~C~ 41 (65)
T 3uej_A 5 ASVGSHRFKVYNYMSPTFCDHCGSLLWGLVK--QGLKCE 41 (65)
T ss_dssp EEEEECCEEEECCSSCCBCTTTCCBCCSSSS--CEEEET
T ss_pred eEeCCceEEeEeCCCCCcccccChhhhccCc--eeeECC
Confidence 4456999999999999999999999999987 566664
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0021 Score=82.94 Aligned_cols=18 Identities=11% Similarity=0.222 Sum_probs=0.0
Q ss_pred hhhhhhhhhhhccchhhh
Q psy14431 248 GEKVSSLEKECASLSLEL 265 (1219)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~ 265 (1219)
.+.+..++.+...|.-++
T Consensus 947 ~~e~~~le~el~~L~~el 964 (1184)
T 1i84_S 947 QAEKKKMQQQMLDLEEQL 964 (1184)
T ss_dssp ------------------
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 334444444444433333
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0012 Score=54.84 Aligned_cols=30 Identities=20% Similarity=0.577 Sum_probs=27.7
Q ss_pred ccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1180 KGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
.+|.|...+|+.||.|+.|++.|| +++.|.
T Consensus 2 ~~H~F~~~~~~~pt~C~~C~~~l~------qG~~C~ 31 (52)
T 1faq_A 2 TTHNFARKTFLKLAFCDICQKFLL------NGFRCQ 31 (52)
T ss_dssp CCCCCEEECCSSCEECTTSSSEEC------SEEECT
T ss_pred CCceeEeEeCCCCcCCCCcccccc------cCCEeC
Confidence 589999999999999999999999 688775
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0049 Score=79.65 Aligned_cols=44 Identities=20% Similarity=0.272 Sum_probs=22.5
Q ss_pred HHhhHHHHHHHHHHHHHhHhhhhhhHhhhhhhhhhhhhhHhhhh
Q psy14431 34 REMSQLEERQRQLSEQYEAVSARETALRDEMGQLEKNLTILRHD 77 (1219)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (1219)
++|..+++....+.+....+...-..+..++..|+..+..++..
T Consensus 857 ~El~~L~~eL~el~~~L~~le~~l~ele~~l~~Le~e~~~l~~~ 900 (1184)
T 1i84_S 857 EEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEK 900 (1184)
T ss_dssp HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45555555555555555555544444555555554444444433
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A | Back alignment and structure |
|---|
Probab=95.93 E-value=0.54 Score=48.13 Aligned_cols=21 Identities=10% Similarity=0.256 Sum_probs=10.0
Q ss_pred HhhchhhHHHHHHHHHHHhhh
Q psy14431 147 LEMERDTLQQEVATLQAKISQ 167 (1219)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~ 167 (1219)
+.++.+.+...+..+..++..
T Consensus 11 l~~~~~~~~~~~~~l~~~l~~ 31 (284)
T 1c1g_A 11 LKLDKENALDRADEAEADKKA 31 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhHHHHHHHHHHHHHHHHH
Confidence 444444555555544444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.55 E-value=0.049 Score=63.16 Aligned_cols=75 Identities=7% Similarity=0.026 Sum_probs=49.9
Q ss_pred eEEeeeeccCceEEEEEEEcCC-------CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 563 INLLKEGKGAYGIVYKAYDKNN-------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 563 ~ILKkIGeGgFGtVYlA~dk~T-------Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.-++.|..|-...+|++..... +..|++++..... .......+|..++..+..+.-.+++++.+. +
T Consensus 73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---~- 145 (424)
T 3mes_A 73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP---E- 145 (424)
T ss_dssp EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET---T-
T ss_pred eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---C-
Confidence 3466778888999999986531 5678899864221 111224578888888875555567776442 2
Q ss_pred eEEEEEecchh
Q psy14431 636 DLYVVFEYMEN 646 (1219)
Q Consensus 636 ~LyLVMEymeG 646 (1219)
++||+|++|
T Consensus 146 --~~I~efI~G 154 (424)
T 3mes_A 146 --GRIEEFIDG 154 (424)
T ss_dssp --EEEEECCCS
T ss_pred --CEEEEEeCC
Confidence 689999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.55 E-value=0.19 Score=56.92 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=25.1
Q ss_pred ccccCCCCCCCeeec------cCCcceecccccccc
Q psy14431 680 KVMHRDLKPSNILID------KSCSIKIGDLGLARS 709 (1219)
Q Consensus 680 GIVHRDLKPsNILLd------~dG~VKLiDFGLAr~ 709 (1219)
.++|+|+.+.|||+. .++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 468999999999993 456799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.40 E-value=0.28 Score=53.05 Aligned_cols=97 Identities=15% Similarity=0.180 Sum_probs=64.7
Q ss_pred hHHHHHh--hccCChHHHHHHHHHHHHHHHHHH-hcccccCCCCCCCeeeccCCcceecccccccccCCccccccccccc
Q psy14431 647 DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 723 (1219)
Q Consensus 647 SL~d~Lr--s~~LseeeVr~Ia~QILsALaYLH-S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ts~vGT 723 (1219)
+|.+++. +.++++.++|.+++|.+.+|.-+- ...-..+=+.|..|++..+|.|.+.+ +.+. ...
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE 100 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence 6888887 678999999999999999987762 12222344567899999999888764 1111 122
Q ss_pred ccccCchhhhccccccccccchhHHHHHHHHHhCC
Q psy14431 724 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 758 (1219)
Q Consensus 724 ~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk 758 (1219)
..|.|||.+. ...+.+.=|||||+++|.-+--.
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence 3466888752 34567888999999999988633
|
| >3o0z_A RHO-associated protein kinase 1; coiled-coil, transferase; HET: MSE; 2.33A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.83 E-value=0.4 Score=49.67 Aligned_cols=78 Identities=27% Similarity=0.320 Sum_probs=44.9
Q ss_pred cceehhccccchhHHHHHHHHHHHhhchhh---HHHHHHHHHHHhhhhhccccchhhhhhhhhhHHHHhhhHHhhccccc
Q psy14431 124 AELTVAKSAGEQMVVELQNILATLEMERDT---LQQEVATLQAKISQERSSKTQAVNLHKELEGRLQALNTELERNKHRE 200 (1219)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (1219)
+-|.-++.+=++=+..|| +.|+-||.. ..+.++.|+.+|. .|+-||+ .+. .++
T Consensus 58 ~~L~~~k~~Leke~~~LQ---a~L~qEr~~r~q~se~~~elq~ri~----------~L~~El~----~~k-------~~~ 113 (168)
T 3o0z_A 58 RILENSKSQTDKDYYQLQ---AILEAERRDRGHDSEMIGDLQARIT----------SLQEEVK----HLK-------HNL 113 (168)
T ss_dssp HHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHH----HHH-------HHH
T ss_pred HHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHH----HHH-------HHH
Confidence 333444444444444444 444445533 3344556666654 2444443 332 234
Q ss_pred chhhhhhcchhhhhhhhhHHHhhhH
Q psy14431 201 LQLAEDNRHLGEKVSSLEKECRLQA 225 (1219)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (1219)
-++..||++|-++|+.|||||--..
T Consensus 114 ~k~~~e~r~L~Ekl~~lEKe~a~~e 138 (168)
T 3o0z_A 114 EKVEGERKEAQDMLNHSEKEKNNLE 138 (168)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 4567899999999999999986544
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A | Back alignment and structure |
|---|
Probab=90.67 E-value=0.096 Score=62.67 Aligned_cols=36 Identities=22% Similarity=0.548 Sum_probs=31.9
Q ss_pred ccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1178 ALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
..+||.|...+|+.||.|..|++.||++++ +.+-|.
T Consensus 515 ~~~~H~F~~~~~~~~t~C~~C~~~l~gl~~--qg~~C~ 550 (587)
T 3ky9_A 515 TANGHDFQMFSFEETTSCKACQMLLRGTFY--QGYRCH 550 (587)
T ss_dssp TGGGCCEEEECCSSCCBCTTTCSBCCSSSC--CEEEET
T ss_pred cccCCceeEEeCCCCccccccccccccccc--CCcCCC
Confidence 457999999999999999999999999987 566664
|
| >4b6d_A RAC GTPase-activating protein 1; signaling protein, cytokinesis, plasma membrane, phospholipi centralspindlin, spindle midzone, central spindle; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.15 E-value=0.099 Score=45.64 Aligned_cols=33 Identities=27% Similarity=0.552 Sum_probs=27.1
Q ss_pred ccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1180 KGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
.+|.|...+|.-|++|+.|++.+| +-+ +++.|+
T Consensus 7 ~~H~F~~kt~~~~~~C~~Cg~~i~-~gk--q~~kC~ 39 (61)
T 4b6d_A 7 RLHDFVSKTVIKPESCVPCGKRIK-FGK--LSLKCR 39 (61)
T ss_dssp CCCCEEEEECCSCEECTTTCCEEC-TTC--EEEEES
T ss_pred cceeEEeeeccCCcccccccCEEE-Eee--EeeECC
Confidence 489999999999999999998876 322 667665
|
| >2v71_A Nuclear distribution protein NUDE-like 1; developmental protein, nuclear protein, neurogenesis, cytosk LIS1 binding, differentiation; 2.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=88.34 E-value=5.3 Score=42.13 Aligned_cols=108 Identities=19% Similarity=0.204 Sum_probs=61.0
Q ss_pred chhhhhHHhhhHHhhhHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhhccccccccCCC
Q psy14431 943 EREVDYKKSIDQLMKDREDLQQQINLLKEELRKSSNSSEEMEKLHKQLKQ-EQLLKAQAVNKLAEIMNRKDINTTCKGKS 1021 (1219)
Q Consensus 943 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-e~~lk~~~vnkl~~~m~rk~~~~~~~~~~ 1021 (1219)
+--.+||....++.+..++++..++.|++.=+ +-=.+|+++|.+ |+
T Consensus 10 ee~~ywk~~~~~~~q~~~~le~El~EFqesSr------ELE~ELE~eL~~~Ek--------------------------- 56 (189)
T 2v71_A 10 EETAYWKELSMKYKQSFQEARDELVEFQEGSR------ELEAELEAQLVQAEQ--------------------------- 56 (189)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH------HHHHHHHHHHHHHHH---------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH------HHHHHHHHHHHHHHH---------------------------
Confidence 33467888899999999999999999986321 111223333331 00
Q ss_pred CCCchHHHHHHHHHHHHHHHHHHHHHHhhHH-------HHHHHHHHHHHHHHHHHHhhhhhhhhhhcccchhHH
Q psy14431 1022 KASSADVRKKEKECRKLQQELTQEREKFNQV-------VVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 1088 (1219)
Q Consensus 1022 k~~~~d~rk~ek~~~~l~~~l~~e~~k~~~~-------v~k~~~e~~~~~~~~~~e~~~~~e~~m~~~s~~~~~ 1088 (1219)
-.|.-..++..|..++..=|.||.+. +.+.|+||..++.....--...-++-..+|.+++..
T Consensus 57 -----~~~~L~~~~~~L~~E~e~~k~K~~~~~~e~~~~~~~Lq~el~~l~~~~~~l~~~ireLEq~NDdlEr~~ 125 (189)
T 2v71_A 57 -----RNRDLQADNQRLKYEVEALKEKLEHQYAQSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAK 125 (189)
T ss_dssp -----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHH
Confidence 12223344556667777777888777 444455555555444444444445555555444433
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=87.63 E-value=0.17 Score=43.63 Aligned_cols=32 Identities=28% Similarity=0.637 Sum_probs=26.8
Q ss_pred cccccccc-cccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1179 LKGHEFLN-ISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1179 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
..||.|.. .+|..||.|+.|++-|| -+++-|.
T Consensus 8 ~~~H~F~~~~~~~~pt~C~~C~~~i~-----kqg~kC~ 40 (59)
T 1rfh_A 8 GEGHRFVELALRGGPGWCDLCGREVL-----RQALRCA 40 (59)
T ss_dssp CSSCCCEECCCSSCCEECTTTCSEEC-----SCCEECT
T ss_pred CCCCcCeeeeccCCCeEchhcchhhh-----hCccEeC
Confidence 46999999 99999999999999983 3566664
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} | Back alignment and structure |
|---|
Probab=87.28 E-value=8.4 Score=41.65 Aligned_cols=12 Identities=25% Similarity=0.775 Sum_probs=9.2
Q ss_pred CCCCCCCCCccc
Q psy14431 1193 TTCEVCPKPIWH 1204 (1219)
Q Consensus 1193 ~~~~~~~~~~~~ 1204 (1219)
..|+.||+=||.
T Consensus 223 v~Cp~CgRIL~~ 234 (256)
T 3na7_A 223 ITCPYCGRILYA 234 (256)
T ss_dssp EECTTTCCEEEC
T ss_pred EECCCCCeeEEe
Confidence 569999987764
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=86.06 E-value=14 Score=47.89 Aligned_cols=20 Identities=30% Similarity=0.172 Sum_probs=0.0
Q ss_pred HHhHHHHhhchHHHHHHHHh
Q psy14431 330 KKSIDQLMKDREDLQQQINL 349 (1219)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~ 349 (1219)
++...+|.+..++||+++..
T Consensus 920 ~~~~~~LE~kl~eLq~rL~~ 939 (1080)
T 2dfs_A 920 KKLHIGLENKIMQLQRKIDE 939 (1080)
T ss_dssp --------------------
T ss_pred HHHHHHHHHHHHHHHHHHHH
Confidence 33445555566666665544
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A | Back alignment and structure |
|---|
Probab=85.65 E-value=0.32 Score=55.22 Aligned_cols=35 Identities=23% Similarity=0.533 Sum_probs=30.0
Q ss_pred cccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1179 LKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
.+||.|...+|.-||.|..|++.+|++++ +.+-|+
T Consensus 344 ~~~h~f~~~~~~~~t~C~~C~~~~~g~~~--qg~~C~ 378 (406)
T 2vrw_B 344 ANGHDFQMFSFEETTSCKACQMLLRGTFY--QGYRCY 378 (406)
T ss_dssp GGGCCEEEECCSSCCBCTTTCCBCCSSSS--CEEEET
T ss_pred CCCCCCccccCCCCCCCccccchhceeCC--CCCCCC
Confidence 56999999999999999999999999987 444443
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=85.49 E-value=3.1 Score=53.77 Aligned_cols=15 Identities=33% Similarity=0.341 Sum_probs=6.9
Q ss_pred hhhhhhhhHhhhhhh
Q psy14431 65 GQLEKNLTILRHDLK 79 (1219)
Q Consensus 65 ~~~~~~~~~~~~~~~ 79 (1219)
|=||||-..|..|+.
T Consensus 563 gfleKN~D~l~~~~~ 577 (1080)
T 2dfs_A 563 GFLEKNKDTVYEEQI 577 (1080)
T ss_dssp THHHHHBCCCCHHHH
T ss_pred hHHHhccccccHHHH
Confidence 345555444444433
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=84.82 E-value=0.47 Score=42.52 Aligned_cols=33 Identities=27% Similarity=0.612 Sum_probs=27.5
Q ss_pred ccccccccc-cccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1178 ALKGHEFLN-ISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1178 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
...||.|.. .+|..||.|+.|++-|| -+++-|.
T Consensus 20 ~~~~H~F~~~~~~~~pt~C~~C~~~l~-----~qG~kC~ 53 (72)
T 2fnf_X 20 RGEGHRFVELALRGGPGWCDLCGREVL-----RQALRCA 53 (72)
T ss_dssp GCSSCCCEECCCCSSCCBCTTTSSBCS-----SCCEECT
T ss_pred cCCCCccceeecCCCCcchhhhhHHHH-----hCcCccC
Confidence 557999999 99999999999999993 2566664
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=84.31 E-value=0.19 Score=60.92 Aligned_cols=41 Identities=24% Similarity=0.619 Sum_probs=0.0
Q ss_pred CCcccccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1173 KPGIIALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
+.++...+||.|...+|.-||.|+.|+.-||++++ +.+-|.
T Consensus 29 ~~~~~~~~~H~f~~~~~~~p~~C~~C~~~i~g~~~--qg~~C~ 69 (674)
T 3pfq_A 29 QKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGK--QGFQCQ 69 (674)
T ss_dssp -------------------------------------------
T ss_pred ccCCcccCCceEEeeeCCCCCccccccccccccCC--ceeECC
Confidence 33466778999999999999999999999999865 566664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=81.45 E-value=9.3 Score=45.08 Aligned_cols=71 Identities=18% Similarity=0.180 Sum_probs=50.1
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHhhHHH----HHHH---HHHHHHHHHHHHHhhhhhhhhhhcccchhHHHHHHhHh
Q psy14431 1025 SADVRKKEKECRKLQQELTQEREKFNQVV----VKCQ---KELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKL 1095 (1219)
Q Consensus 1025 ~~d~rk~ek~~~~l~~~l~~e~~k~~~~v----~k~~---~e~~~~~~~~~~e~~~~~e~~m~~~s~~~~~e~~r~~~ 1095 (1219)
+.++.+..++.+.....+..+-+.+.+.+ ..++ +|+.+|+.++.+.-+...+++-++.....+|.+|-.++
T Consensus 504 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~le~~~~~~~~~~~~l~~e~~~~~~~~~~l~~~~ 581 (597)
T 3oja_B 504 SDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKK 581 (597)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhhhhhhHHHHHHHHHhhhhhhcchhhHHhhhHHHHHHHhhhhhHHHHHHHHHHHHHHHHHHHHHHh
Confidence 57788888888777777777777666666 3333 56667777777777777777777777777777666554
|
| >3s4r_A Vimentin; alpha-helix, cytoskeleton, intermediate filament, structural; 2.45A {Homo sapiens} PDB: 3ssu_A | Back alignment and structure |
|---|
Probab=80.46 E-value=5.7 Score=37.37 Aligned_cols=69 Identities=28% Similarity=0.323 Sum_probs=57.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhH-HHHHHHHHHHHHHHHHHHHhhhhhhhhhhcccchhHHHHHHhHh
Q psy14431 1027 DVRKKEKECRKLQQELTQEREKFNQ-VVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKL 1095 (1219)
Q Consensus 1027 d~rk~ek~~~~l~~~l~~e~~k~~~-~v~k~~~e~~~~~~~~~~e~~~~~e~~m~~~s~~~~~e~~r~~~ 1095 (1219)
-+|--|.+|+.|+.++..=+.+-.. +--.|..+|.+|+.+|..=...+..+..+++....+++.++.+|
T Consensus 24 KVR~LEqqN~~Le~~i~~l~~~~~~~~~~~ye~~i~~Lr~~i~~~~~ek~~l~~e~dnl~~~~~~~k~KL 93 (93)
T 3s4r_A 24 KVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKL 93 (93)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHhhccCCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhC
Confidence 4788899999999888766554322 33458999999999999999999999999999999999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1219 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-48 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d1xa6a3 | 62 | g.49.1.1 (A:209-270) Beta-chimaerin, middle domain | 2e-05 | |
| d1ptqa_ | 50 | g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {M | 3e-05 | |
| d1faqa_ | 52 | g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: | 5e-05 | |
| d1tbna_ | 66 | g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus | 9e-05 | |
| d1r79a_ | 84 | g.49.1.1 (A:) Diacylglycerol kinase delta {Human ( | 0.003 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 68/226 (30%), Positives = 103/226 (45%), Gaps = 13/226 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G+YG K K++ + + K++ + + Q E+ L+ +HPNI+ D
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDR 71
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIH----- 677
N LY+V EY E DL VI + L + + +M QL L H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
V+HRDLKP+N+ +D ++K+GD GLAR L+ ++ T +Y +PE + +
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-NRMS 190
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
Y DIWSLGC+L E+ P F S I P+
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-55
Identities = 66/239 (27%), Positives = 122/239 (51%), Gaps = 8/239 (3%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
D +++ ++ G+GA G VY A D Q VAI+++ + + + EIL ++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 674
++PNI+ LD Y + +L+VV EY+ L V+ + + + I + + L
Sbjct: 74 N-KNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 675 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 734
++H+ +V+HRD+K NIL+ S+K+ D G ++ + + + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 189
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793
+ Y VDIWSLG + EM++ +P + + L LI P + +K A F+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-55
Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 14/246 (5%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 614
+ ED + I L G GA+G VYKA +K A K I +++ + + EI L
Sbjct: 9 NPEDFWEIIGEL--GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILA 64
Query: 615 SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCN 671
S HPNI+ +LD + +L+++ E+ + ++ L + I+ + Q +
Sbjct: 65 SC-DHPNIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 731
L+Y+H K++HRDLK NIL IK+ D G++ + + + +I T ++ APE+
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 732 LISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787
++ R Y + D+WSLG L EM + +P + L I P ++
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241
Query: 788 YAGFKS 793
+ FK
Sbjct: 242 SSNFKD 247
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 8/229 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG V A ++ ++ VA+K + + R + +EI K H N++
Sbjct: 14 GEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKML-NHENVVKFYGH 71
Query: 629 YKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ Y+ EY +++ D + + + QL G+ Y+H + HRD+
Sbjct: 72 RR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 129
Query: 687 KPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
KP N+L+D+ ++KI D GLA + + L + T Y APE+L + VD+
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793
WS G +L ML + + S S Q + K + +
Sbjct: 190 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 7/220 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
GKG +G VY A +K +K +A+K +F+A K + R + ++S RHPNI+ +
Sbjct: 15 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 74
Query: 629 YKAVNNKDLYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ + +Y++ EY ++ + + + +L N LSY H+ +V+HRD+
Sbjct: 75 F--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 132
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP N+L+ + +KI D G + S+ T Y PE+ I R + VD+WS
Sbjct: 133 KPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEM-IEGRMHDEKVDLWS 189
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
LG + E L KP F + + I + P +
Sbjct: 190 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 8e-54
Identities = 90/246 (36%), Positives = 130/246 (52%), Gaps = 10/246 (4%)
Query: 563 INLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQRH 619
++ L G+G + VYKA DKN Q VAIKKI R++ + REI L+ H
Sbjct: 3 LDFL--GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIH 677
PNII +LD + + ++ +VF++ME DL +I+D +L HI+ M GL Y+H
Sbjct: 60 PNIIGLLDAFG--HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 737
++HRDLKP+N+L+D++ +K+ D GLA+S T + TRWYRAPE+L R
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 738 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797
Y VD+W++GCILAE+L P PG S QL I +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 798 EKFNQV 803
+ F +
Sbjct: 238 KSFPGI 243
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-53
Identities = 84/274 (30%), Positives = 138/274 (50%), Gaps = 16/274 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G +G V+KA + Q VA+KK+ + REI L+ +H N++ +++I
Sbjct: 19 GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEI 77
Query: 629 YKA------VNNKDLYVVFEYMENDLNKVIRDKILKDVH--IRYIMFQLCNGLSYIHACK 680
+ +Y+VF++ E+DL ++ + ++K I+ +M L NGL YIH K
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 137
Query: 681 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILISNR 736
++HRD+K +N+LI + +K+ D GLAR+ S +K T + T WYR PE+L+ R
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHE 796
Y +D+W GCI+AEM P+ G + HQL LI L P + +
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE---VWPNVDNYEL 254
Query: 797 REKFNQVVVKCQKELQELQSQVVEENTSKLKLQM 830
EK V + +K L++ V + L ++
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-53
Identities = 98/266 (36%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G YG+VYKA +K + VA+KKI + REI LK HPNI+ +LD+
Sbjct: 11 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDV 69
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHACKVMHRD 685
LY+VFE++ DL K + L + I+ +FQL GL++ H+ +V+HRD
Sbjct: 70 IH--TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP N+LI+ +IK+ D GLAR+ T + T WYRAPEIL+ + Y+ VDIW
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS------KHEREK 799
SLGCI AEM+ + LFPG S QL I + K R+
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 800 FNQVVVKCQKELQELQSQVVEENTSK 825
F++VV ++ + L SQ++ + +K
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNK 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-52
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 15/236 (6%)
Query: 551 QLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI 610
+L D + ++ G G G+V+K K + +A K I + + RE+
Sbjct: 2 ELKDDDFEKISEL-----GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIREL 55
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQ 668
L P I+ + ++ ++ + E+M+ L++V+ + + + + +
Sbjct: 56 QVLHEC-NSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 112
Query: 669 LCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
+ GL+Y+ K+MHRD+KPSNIL++ IK+ D G++ L DS ++ TR Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYM 170
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
+PE L Y+ DIWS+G L EM + P + V +
Sbjct: 171 SPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 3e-52
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 13/236 (5%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFL 613
++D ++ + L+E G G++G VY A D N + VAIKK+ + ++ Q +E+ FL
Sbjct: 10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKV--IRDKILKDVHIRYIMFQLCN 671
+ RHPN I Y + ++V EY + + + K L++V I +
Sbjct: 70 QKL-RHPNTIQYRGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 731
GL+Y+H+ ++HRD+K NIL+ + +K+GD G A ++ + ++ T ++ APE+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEV 182
Query: 732 L--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
+ + +Y VD+WSLG E+ + KP + L I P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 181 bits (461), Expect = 7e-52
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 18/240 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQRTYREILFLKSFQRHPN 621
G+G +V + K + A+K I F A + + T +E+ L+ HPN
Sbjct: 12 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 71
Query: 622 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHAC 679
II + D Y+ N ++VF+ M+ +L + +K+ L + R IM L + +H
Sbjct: 72 IIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL-----IS 734
++HRDLKP NIL+D +IK+ D G + L D E L E T Y APEI+ +
Sbjct: 130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDN 188
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAGFKS 793
+ Y VD+WS G I+ +L P F L++I++ + P D + K
Sbjct: 189 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 248
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-51
Identities = 111/271 (40%), Positives = 159/271 (58%), Gaps = 16/271 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+GAYG+V AYD NK VAIKKI F ++T QRT REI L F RH NII + DI
Sbjct: 17 GEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 74
Query: 629 YKA---VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+A KD+Y+V M DL K+++ + L + HI Y ++Q+ GL YIH+ V+HRD
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 134
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHV 742
LKPSN+L++ +C +KI D GLAR + LTEY+ATRWYRAPEI+++++ YT +
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 743 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS--------K 794
DIWS+GCILAEML ++P+FPG QL I+ ++ K+
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 795 HEREKFNQVVVKCQKELQELQSQVVEENTSK 825
+ +N++ + +L +++ N K
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 13/222 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++ VYK D VA ++ + K++ QR E LK +HPNI+ D
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDS 76
Query: 629 YKAV--NNKDLYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQLCNGLSYIHACK--VM 682
+++ K + +V E M + + R K++K +R Q+ GL ++H ++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136
Query: 683 HRDLKPSNILI-DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 741
HRDLK NI I + S+KIGDLGLA S I T + APE+ +Y
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY--EEKYDES 192
Query: 742 VDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPP 782
VD+++ G + EM S+ + + Q+ + + + V+P
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 8/264 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G YG V+KA ++ + VA+K++ ++ REI LK +H NI+ + D+
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDV 69
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKP 688
+ L F + + L ++ +FQL GL + H+ V+HRDLKP
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 689 SNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLG 748
N+LI+++ +K+ + GLAR+ C + + T WYR P++L + Y+ +D+WS G
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 749 CILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPH------ADKFYAGFKSKHEREKFN 801
CI AE+ + PLFPG QL+ I L+ Y +
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 802 QVVVKCQKELQELQSQVVEENTSK 825
VV K ++L +++ N +
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 3e-50
Identities = 53/254 (20%), Positives = 113/254 (44%), Gaps = 22/254 (8%)
Query: 545 YKKSIDQLMKDREDLQQQI---------NLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIF 594
Y + + K +I ++ +E G GA+G+V++ ++ A K +
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 595 EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR 653
+++D + +EI + RHP ++ + D ++ ++ ++ +++E+M +L + +
Sbjct: 61 T--PHESDKETVRKEIQTMSVL-RHPTLVNLHDAFE--DDNEMVMIYEFMSGGELFEKVA 115
Query: 654 DK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARS 709
D+ + + M Q+C GL ++H +H DLKP NI+ +S +K+ D GL
Sbjct: 116 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 769
L + T + APE+ + ++ D+WS+G + +L F G +
Sbjct: 176 LDPKQSVKV-TTGTAEFAAPEV-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233
Query: 770 LQLIVNLVRPNPPH 783
L+ + +
Sbjct: 234 LRNVKSCDWNMDDS 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-49
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 9/220 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G+G++ V A + + AIK + + RE + HP + +
Sbjct: 17 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYF 75
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ +++ LY Y +N L + + + R+ ++ + L Y+H ++HRD
Sbjct: 76 TFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVD 743
LKP NIL+++ I+I D G A+ LS + ++ T Y +PE+ ++ + D
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKSACKSSD 192
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
+W+LGCI+ +++ P F + Q I+ L P
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-49
Identities = 93/257 (36%), Positives = 149/257 (57%), Gaps = 9/257 (3%)
Query: 551 QLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE 609
++ K +++ L+ G GAYG V A D VAIKK++ F+++ A+R YRE
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKILKDVHIRYI 665
+ LK RH N+I +LD++ D Y+V +M DL K+++ + L + I+++
Sbjct: 68 LRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW 725
++Q+ GL YIHA ++HRDLKP N+ +++ C +KI D GLAR +T Y+ TRW
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRW 183
Query: 726 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 785
YRAPE++++ RYT VDIWS+GCI+AEM+ K LF G+ QL+ I+ + P
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 786 KFYAGFKSKHEREKFNQ 802
+ ++K+ + +
Sbjct: 244 QRLQSDEAKNYMKGLPE 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-49
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 6/221 (2%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG++G V+ A K Q+ AIK + + D + T E L HP + M
Sbjct: 11 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 70
Query: 628 IYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ ++L+ V EY+ DL I+ + ++ GL ++H+ +++RD
Sbjct: 71 TF--QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 128
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LK NIL+DK IKI D G+ + + T Y APEI + ++Y H VD W
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI-LLGQKYNHSVDWW 187
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
S G +L EML + F G I P +K
Sbjct: 188 SFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 6e-49
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 13/247 (5%)
Query: 554 KDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 612
K ED++ + G GA+ V A DK ++ VAIK I + + EI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAV 60
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLC 670
L +HPNI+ + DIY+ + LY++ + + +L I +K + ++FQ+
Sbjct: 61 LHKI-KHPNIVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 671 NGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
+ + Y+H ++HRDLKP N+L D+ I I D GL++ + D L+ T Y
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 176
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADK 786
AP +++ + Y+ VD WS+G I +L P F + + + I+ + P+ D
Sbjct: 177 AP-EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 787 FYAGFKS 793
K
Sbjct: 236 ISDSAKD 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 173 bits (440), Expect = 2e-48
Identities = 71/260 (27%), Positives = 130/260 (50%), Gaps = 13/260 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G Y V++A + N + V +K + ++ REI L++ + PNIIT+ DI
Sbjct: 44 GRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687
K ++ +VFE++ N D ++ + L D IR+ M+++ L Y H+ +MHRD+K
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 688 PSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
P N++ID + +++ D GLA +E +A+R+++ PE+L+ + Y + +D+WS
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 747 LGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVV 805
LGC+LA M+ K P F G QL I ++ + + + + + +
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL--GTEDLYDYIDKYNIELDPRFNDILGR 273
Query: 806 KCQKELQELQSQVVEENTSK 825
+K + + S
Sbjct: 274 HSRKRWERFVHSENQHLVSP 293
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-48
Identities = 97/262 (37%), Positives = 156/262 (59%), Gaps = 10/262 (3%)
Query: 545 YKKSIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ 604
Y++ +++ + + + Q ++ + G GAYG V A+D VA+KK+ F++ A+
Sbjct: 5 YRQELNKTIWEVPERYQNLSPV--GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 605 RTYREILFLKSFQRHPNIITMLDIYKA----VNNKDLYVVFEYMENDLNKVIRDKILKDV 660
RTYRE+ LK +H N+I +LD++ D+Y+V M DLN +++ + L D
Sbjct: 63 RTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 661 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 720
H++++++Q+ GL YIH+ ++HRDLKPSN+ +++ C +KI D GLAR D T Y
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGY 178
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
+ATRWYRAPEI+++ Y VDIWS+GCI+AE+L + LFPG QL+LI+ LV
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 781 PPHADKFYAGFKSKHEREKFNQ 802
K + +++ + Q
Sbjct: 239 GAELLKKISSESARNYIQSLTQ 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-48
Identities = 74/261 (28%), Positives = 133/261 (50%), Gaps = 23/261 (8%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
++ G G++G+VY+A ++ + VAIKK+ D + RE+ ++ H
Sbjct: 23 TDTKVI--GNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKL-DHC 73
Query: 621 NIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCN 671
NI+ + + + K L +V +Y+ + +V R L ++++ M+QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 672 GLSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
L+YIH+ + HRD+KP N+L+D ++ K+ D G A+ L + ++ YI +R+YRAPE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPE 192
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790
++ YT +D+WS GC+LAE+L +P+FPG S QL I+ ++ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR---EQIRE 249
Query: 791 FKSKHEREKFNQVVVKCQKEL 811
+ KF Q+ ++
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKV 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-48
Identities = 87/270 (32%), Positives = 137/270 (50%), Gaps = 15/270 (5%)
Query: 569 GKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITM 625
G+GAYG V+KA D KN ++VA+K++ + T RE+ L+ + HPN++ +
Sbjct: 16 GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 626 LDIYKAVNNKD---LYVVFEYMEND---LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 679
D+ L +VFE+++ D + + + I+ +MFQL GL ++H+
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135
Query: 680 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 739
+V+HRDLKP NIL+ S IK+ D GLAR S T + T WYRAPE+ + Y
Sbjct: 136 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEV-LLQSSYA 193
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP----PHADKFYAGFKSKH 795
VD+WS+GCI AEM + KPLF G+S QL I++++ P
Sbjct: 194 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 253
Query: 796 EREKFNQVVVKCQKELQELQSQVVEENTSK 825
+ + V + ++L + + N +K
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 15/229 (6%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 620
QI + + G G++G VYK + VA+K + Q E+ L+ RH
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHV 64
Query: 621 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 677
NI+ + L +V ++ E L + + + + + I Q G+ Y+H
Sbjct: 65 NILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEIL--I 733
A ++HRDLK +NI + + ++KIGD GLA S + + + APE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
Y+ D+++ G +L E++ + + + Q+ +V +P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 167 bits (424), Expect = 7e-47
Identities = 91/265 (34%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G YG+VYKA + + A+KKI ++ T REI LK +H NI+ + D+
Sbjct: 11 GEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDV 68
Query: 629 YKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
K L +VFE+++ DL K++ + L+ V + + QL NG++Y H +V+HRDL
Sbjct: 69 IH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 687 KPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWS 746
KP N+LI++ +KI D GLAR+ T I T WYRAP++L+ +++Y+ +DIWS
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 747 LGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKF-----YAGFKSKHEREKF 800
+GCI AEM+ PLFPG S + QL I L PN + Y + +E +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 801 NQVVVKCQKELQELQSQVVEENTSK 825
+ + +L S++++ + ++
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQ 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-47
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 16/239 (6%)
Query: 556 REDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREI 610
+E++ + +E G G + +V K +K+ A K I ++ R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQ 668
LK +HPN+IT+ ++Y+ N D+ ++ E + + + + L + + Q
Sbjct: 65 SILKEI-QHPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 669 LCNGLSYIHACKVMHRDLKPSNILIDK----SCSIKIGDLGLARSLSDSKECLTEYIATR 724
+ NG+ Y+H+ ++ H DLKP NI++ IKI D GLA + E T
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTP 180
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
+ APEI ++ D+WS+G I +L F G + L + +
Sbjct: 181 EFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-46
Identities = 54/236 (22%), Positives = 110/236 (46%), Gaps = 14/236 (5%)
Query: 557 EDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 615
++L ++ + ++ G+G +GIV++ + ++K+ K + TD +EI L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 616 FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNG 672
RH NI+ + + ++ + ++L ++FE++ D+ + I L + I + Q+C
Sbjct: 58 A-RHRNILHLHESFE--SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 673 LSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 730
L ++H+ + H D++P NI+ +S +IKI + G AR L + A +Y
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 731 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
+ + D+WSLG ++ +L F + ++ I+N A K
Sbjct: 175 H--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (428), Expect = 1e-46
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA+G+V++ +K + K I + D EI + HP +I + D
Sbjct: 38 GSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDA 94
Query: 629 YKAVNNKDLYVVFEYMEN-DLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
++ + ++ ++ E++ +L I D + + + M Q C GL ++H ++H D
Sbjct: 95 FE--DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 686 LKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
+KP NI+ + K+ S+KI D GLA L+ E + AT + APEI + + D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEI-VDREPVGFYTD 210
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784
+W++G + +L F G LQ + A
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 165 bits (419), Expect = 7e-46
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
G G++G V+ ++N +Y A+K + E + T E L L HP II M
Sbjct: 13 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWG 71
Query: 628 IYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ + + ++++ +Y+E + + + + + ++ ++C L Y+H+ +++RD
Sbjct: 72 TF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
LKP NIL+DK+ IKI D G A+ + D T Y APE++ S + Y +D W
Sbjct: 130 LKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVV-STKPYNKSIDWW 185
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
S G ++ EML F ++T + I+N PP ++
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 3e-45
Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 15/236 (6%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFL 613
DR +L + + G G V+ A D + VA+K + + R+ + R RE
Sbjct: 7 DRYELGEIL-----GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 614 KSFQRHPNIITMLDIYKAVNNKD--LYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQL 669
+ HP I+ + D +A Y+V EY++ + V + + ++
Sbjct: 62 AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWY 726
C L++ H ++HRD+KP+NI+I + ++K+ D G+AR+++DS +T+ I T Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+PE D++SLGC+L E+L +P F G S V P
Sbjct: 181 LSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-45
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 27/284 (9%)
Query: 548 SIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT 606
+ D RE L+ L + G+G +G V+ + VAIK + +
Sbjct: 8 AKDAWEIPRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAF 59
Query: 607 YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHI 662
+E +K RH ++ + + + + +Y+V EYM D K K L+ +
Sbjct: 60 LQEAQVMKKL-RHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 115
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-YI 721
+ Q+ +G++Y+ +HRDL+ +NIL+ ++ K+ D GLAR + D++ +
Sbjct: 116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175
Query: 722 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR-P 779
+ APE R+T D+WS G +L E+ + +PG L + R P
Sbjct: 176 FPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234
Query: 780 NPPHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQSQ 817
PP + K ER F + + + Q
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 7e-45
Identities = 59/270 (21%), Positives = 109/270 (40%), Gaps = 29/270 (10%)
Query: 561 QQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 619
+++ LL+ GKG +G V + NK VA+K I +N AQ E + RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-RH 59
Query: 620 PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSY 675
N++ +L + LY+V EYM L +R + +L + +C + Y
Sbjct: 60 SNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 735
+ +HRDL N+L+ + K+ D GL + S ++ + APE L
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEAL-RE 174
Query: 736 RRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGF-- 791
++++ D+WS G +L E+ + +P + + + + P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 792 ----KSKHEREKFNQVVVKCQKELQELQSQ 817
R F Q+ ++L+ +++
Sbjct: 235 NCWHLDAAMRPSFLQLR----EQLEHIKTH 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-44
Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 23/243 (9%)
Query: 550 DQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE 609
+ ++ D + Q + G G G V + ++K ++ A+K + D + RE
Sbjct: 7 NAIIDDYKVTSQVL-----GLGINGKVLQIFNKRTQEKFALKML-------QDCPKARRE 54
Query: 610 ILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIR 663
+ + P+I+ ++D+Y+ + K L +V E ++ +L I+D+ +
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 664 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSKECLTEY 720
IM + + Y+H+ + HRD+KP N+L + +K+ D G A+ + T
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-P 173
Query: 721 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 780
T +Y APE+L +Y D+WSLG I+ +L P F + +R
Sbjct: 174 CYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 781 PPH 783
Sbjct: 233 QYE 235
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
RE L+ L++ G G +G V+ Y + + VA+K + + E +
Sbjct: 11 PRETLK----LVERLGAGQFGEVWMGYYNGHTK-VAVKSLK---QGSMSPDAFLAEANLM 62
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQL 669
K +H ++ + + + +Y++ EYMEN D K L + + Q+
Sbjct: 63 KQL-QHQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 729
G+++I +HRDL+ +NIL+ + S KI D GLAR + D++ E
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 730 EILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPP 782
I+ +T D+WS G +L E++ + +PG + +Q + R P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (412), Expect = 3e-44
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 9/230 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM 625
G+G +G VY + + A+K + + + R +L L S P I+ M
Sbjct: 13 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 72
Query: 626 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMH 683
+ L + + M DL+ + + + +R+ ++ GL ++H V++
Sbjct: 73 SYAF--HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 130
Query: 684 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 743
RDLKP+NIL+D+ ++I DLGLA S K + T Y APE+L Y D
Sbjct: 131 RDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSAD 188
Query: 744 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793
+SLGC+L ++L+ F T + ++ + D F +S
Sbjct: 189 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 14/225 (6%)
Query: 559 LQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFL 613
L+ Q + G G +G VY ++ VAIK + + + R E++ L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 614 KSFQ-RHPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDK-ILKDVHIRYIMFQL 669
K +I +LD ++ ++ E E DL I ++ L++ R +Q+
Sbjct: 62 KKVSSGFSGVIRLLDWFE--RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 670 CNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRA 728
+ + H C V+HRD+K NILID + +K+ D G L D+ T++ TR Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSP 177
Query: 729 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 773
PE + +R + +WSLG +L +M+ F + Q+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 15/236 (6%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILF 612
DR+ L + L G G +G V K Y + K + VA+K + + E
Sbjct: 4 DRKLLTLEDKEL--GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLC 670
++ +P I+ M+ I + + +V E E LNK + +++ +KD +I ++ Q+
Sbjct: 62 MQQL-DNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYR 727
G+ Y+ +HRDL N+L+ KI D GL+++L + T +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPP 782
APE + + +++ D+WS G ++ E + + G S ++ R P
Sbjct: 178 APECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-43
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 7/221 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 627
GKG +G V +K +Y A+K + E K + T E L++ RHP + +
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKY 72
Query: 628 IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 685
+ + L V EY + R+++ + R+ ++ + L Y+H+ V++RD
Sbjct: 73 AF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 686 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 745
+K N+++DK IKI D GL + + + T Y APE+L + Y VD W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYGRAVDWW 189
Query: 746 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 786
LG ++ EM+ + F +LI+ P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 18/235 (7%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
D +DL LKE G G +G+V + VAIK I E E +
Sbjct: 2 DPKDLT----FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKE---GSMSEDEFIEEAKVM 53
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLC 670
+ H ++ + + + ++++ EYM N + + + +C
Sbjct: 54 MNL-SHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CLTEYIATRWYRAP 729
+ Y+ + + +HRDL N L++ +K+ D GL+R + D + + P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 730 EILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPH 783
E+L +++ DIW+ G ++ E+ K + + S + I +R PH
Sbjct: 171 EVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 24/288 (8%)
Query: 551 QLMKDREDLQQQINLLKEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYR 608
+L R++L I ++ G G +G V + + + VAIK + + K D + R
Sbjct: 2 KLFLKRDNLL--IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMR 58
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYI 665
E + +P I+ ++ + +A L +V E L+K + K + ++ +
Sbjct: 59 EAQIMHQL-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 666 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA--- 722
+ Q+ G+ Y+ +HRDL N+L+ KI D GL+++L T A
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPN- 780
+ APE + + R+++ D+WS G + E L + + + I R
Sbjct: 175 PLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 781 PPHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQSQVVEEN 822
PP +R F V + + L S+V +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 18/234 (7%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 613
D +L ++E G G +G+V+ Y N + VAIK I E + E +
Sbjct: 3 DPSEL----TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIRE---GAMSEEDFIEEAEVM 54
Query: 614 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV--HIRYIMFQLC 670
HP ++ + + + + +VFE+ME+ L+ +R + + + +C
Sbjct: 55 MKL-SHPKLVQLYGVC--LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 671 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-TRWYRAP 729
G++Y+ V+HRDL N L+ ++ IK+ D G+ R + D + + + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 730 EILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPP 782
E+ S RY+ D+WS G ++ E+ + K + S S ++ I R P
Sbjct: 172 EVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (385), Expect = 2e-41
Identities = 39/228 (17%), Positives = 78/228 (34%), Gaps = 21/228 (9%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G+G++G++++ + N Q VAIK ++DA + E K I +
Sbjct: 14 GEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 629 YKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+ +V + + L ++ + + Q+ + IH +++RD+
Sbjct: 70 GQ--EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 687 KPSNILIDKSC-----SIKIGDLGLARSLSDSKE-------CLTEYIATRWYRAPEILIS 734
KP N LI + I + D G+ + D T Y +
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT-HL 186
Query: 735 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
R + D+ +LG + L+ + G + Q +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-41
Identities = 86/219 (39%), Positives = 137/219 (62%), Gaps = 8/219 (3%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G GA GIV AYD + VAIKK+ F+N+T A+R YRE++ +K H NII++L++
Sbjct: 26 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNV 84
Query: 629 YKAVN----NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 684
+ +D+Y+V E M+ +L +VI+ ++ + + Y+++Q+ G+ ++H+ ++HR
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-RMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 685 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 744
DLKPSNI++ C++KI D GLAR+ S +T Y+ TR+YRAPE+ I Y +VDI
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEV-ILGMGYKENVDI 201
Query: 745 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 783
WS+GCI+ EM++ K LFPG Q ++ + P
Sbjct: 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (386), Expect = 4e-41
Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 11/267 (4%)
Query: 522 AKHRSDLSSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAY 580
AK S+ S + L+ KE + ++ Q + +K G G++G V
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD----RIKTLGTGSFGRVMLVK 61
Query: 581 DKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639
K + + A+K + + + T E L++ P ++ + +K +N + +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVM 120
Query: 640 VFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI 699
+ + + R + H R+ Q+ Y+H+ +++RDLKP N+LID+ I
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 700 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 759
++ D G A+ + T APEI+ ++ Y VD W+LG ++ EM P
Sbjct: 181 QVTDFGFAKRVKGRT---WTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 760 LFPGASTSHQLQLIVNLVRPNPPHADK 786
F + IV+ P H
Sbjct: 237 PFFADQPIQIYEKIVSGKVRFPSHFSS 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 9e-41
Identities = 49/241 (20%), Positives = 100/241 (41%), Gaps = 16/241 (6%)
Query: 548 SIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT 606
+ D+ +R D+ + + G G YG VY+ K VA+K + E + + +
Sbjct: 8 NYDKWEMERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEF 60
Query: 607 YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHI 662
+E +K +HPN++ +L + Y++ E+M + + V +
Sbjct: 61 LKEAAVMKEI-KHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 663 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA 722
Y+ Q+ + + Y+ +HRDL N L+ ++ +K+ D GL+R ++
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 723 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP 781
++ +++ D+W+ G +L E+ +PG S +L+ R
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 782 P 782
P
Sbjct: 238 P 238
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 56/280 (20%), Positives = 99/280 (35%), Gaps = 31/280 (11%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDK---NNKQYVAIKKI-FEAFRNKTDAQRTYRE 609
+DL+ LL++ G G++G+V + VA+K + + RE
Sbjct: 6 GEKDLR----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 610 ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIM 666
+ + S H N+I + + + +V E +
Sbjct: 62 VNAMHSL-DHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 667 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATR 724
Q+ G+ Y+ + + +HRDL N+L+ +KIGD GL R+L + + + E+
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 725 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVN--LVRPNP 781
+ + R ++H D W G L EM + + G + S L I P P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 782 PHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQ 815
+ +R F + L E Q
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALR----DFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 68/318 (21%), Positives = 113/318 (35%), Gaps = 55/318 (17%)
Query: 529 SSKESLLSNGKEREVDYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQ- 586
S E + +E E D K RE+L+ K G GA+G V A +
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFP-----RENLE----FGKVLGSGAFGKVMNATAYGISKT 64
Query: 587 ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 642
VA+K + E + ++ + E+ + H NI+ +L + +Y++FE
Sbjct: 65 GVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC--TLSGPIYLIFE 121
Query: 643 YMEN-DLNKVIRDK------------------------ILKDVHIRYIMFQLCNGLSYIH 677
Y DL +R K +L + +Q+ G+ ++
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 678 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA--TRWYRAPEILISN 735
+HRDL N+L+ +KI D GLAR + + A + APE L
Sbjct: 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FE 240
Query: 736 RRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVN--LVRPNPPHADKFYAGF- 791
YT D+WS G +L E+ +PG ++ P +A +
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM 300
Query: 792 -----KSKHEREKFNQVV 804
+R F +
Sbjct: 301 QSCWAFDSRKRPSFPNLT 318
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 9e-40
Identities = 59/298 (19%), Positives = 123/298 (41%), Gaps = 29/298 (9%)
Query: 544 DYKKSIDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRN 599
+ +++ ++ L ++ + G+G +G VY +N K + A+K + +
Sbjct: 12 ELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITD 68
Query: 600 KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKI 656
+ + E + +K F HPN++++L I + VV YM++ +
Sbjct: 69 IGEVSQFLTEGIIMKDF-SHPNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715
+ Q+ G+ ++ + K +HRDL N ++D+ ++K+ D GLAR + D +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 716 ---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQ 771
T + A E L +++T D+WS G +L E++ + P +P +T
Sbjct: 187 SVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 772 LIVNLVRP-NPPHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQSQVVEEN 822
++ R P + R F+++V + + S + E+
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV----SRISAIFSTFIGEH 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 9e-40
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 569 GKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 625
G G +G V + K + +VAIK + + K + E + F HPN+I +
Sbjct: 35 GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQF-DHPNVIHL 92
Query: 626 LDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ + + ++ E+MEN D + + ++ + G+ Y+ +
Sbjct: 93 EGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 150
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-----YIATRWYRAPEILISNRR 737
HRDL NIL++ + K+ D GL+R L D T + APE I R+
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA-IQYRK 209
Query: 738 YTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPP 782
+T D+WS G ++ E++ + + + + I R PP
Sbjct: 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 2e-39
Identities = 46/226 (20%), Positives = 78/226 (34%), Gaps = 19/226 (8%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI 628
G G++G +Y D + VAIK KT + + E K Q I T+
Sbjct: 16 GSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 629 YKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL 686
+V E + L + + + + Q+ + + YIH+ +HRD+
Sbjct: 72 G--AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 129
Query: 687 KPSNILI---DKSCSIKIGDLGLARSLSDSKE-------CLTEYIATRWYRAPEILISNR 736
KP N L+ K + I D GLA+ D++ T Y +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT-HLGI 188
Query: 737 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
+ D+ SLG +L + G + + Q +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-39
Identities = 63/262 (24%), Positives = 107/262 (40%), Gaps = 23/262 (8%)
Query: 569 GKGAYGIVYKAYDKNN----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 624
G G +G VYK K + + VAIK + + K E + F H NII
Sbjct: 16 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQF-SHHNIIR 73
Query: 625 MLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKV 681
+ + K + ++ EYMEN +D + + ++ + G+ Y+
Sbjct: 74 LEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 131
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYRAPEILISNRRY 738
+HRDL NIL++ + K+ D GL+R L D E + + APE IS R++
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-ISYRKF 190
Query: 739 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPHADKFYAGF----- 791
T D+WS G ++ E++ ++H++ +N P P
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 792 -KSKHEREKFNQVVVKCQKELQ 812
+ + R KF +V K ++
Sbjct: 251 QQERARRPKFADIVSILDKLIR 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-39
Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 36/292 (12%)
Query: 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILF 612
D D++ +++ G+G +G V KA K + + AIK++ E + +K D + E+
Sbjct: 8 DWNDIKF-QDVI--GEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEV 63
Query: 613 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--------------- 656
L HPNII +L + + LY+ EY + +L +R
Sbjct: 64 LCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 657 --LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714
L + + + G+ Y+ + +HRDL NIL+ ++ KI D GL+R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVY 180
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLI 773
T + A E L + YT + D+WS G +L E++ + G + + + +
Sbjct: 181 VKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 774 VNLVRPN-PPHADKFYAGF------KSKHEREKFNQVVVKCQKELQELQSQV 818
R P + D + +ER F Q++V + L+E ++ V
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-38
Identities = 67/296 (22%), Positives = 106/296 (35%), Gaps = 45/296 (15%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYR 608
R L K G GA+G V +A + VA+K + + + T+ +
Sbjct: 21 PRNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMS 75
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK------------ 655
E+ L H NI+ +L V+ EY DL +R K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 656 -------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708
L + +Q+ G++++ + +HRDL NIL+ KI D GLAR
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 709 SLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGAS 765
+ + + APE I N YT D+WS G L E+ +PG
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 766 TSHQLQLIVN--LVRPNPPHADKFYAGF------KSKHEREKFNQVVVKCQKELQE 813
+ ++ +P HA +R F Q+V +K++ E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 24/278 (8%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRTYREI 610
RE ++ L + G+G +G V++ + + VAIK + ++ +E
Sbjct: 5 QRERIE----LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEA 59
Query: 611 LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMF 667
L ++ F HP+I+ ++ + ++++ E + R L + +
Sbjct: 60 LTMRQF-DHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 668 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 727
QL L+Y+ + + +HRD+ N+L+ + +K+GD GL+R + DS
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 728 APEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR-PNPPHAD 785
I+ RR+T D+W G + E+L F G + + I N R P PP+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 786 KFYAGF------KSKHEREKFNQVVVKCQKELQELQSQ 817
R +F ++ + L+E ++Q
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-37
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 21/289 (7%)
Query: 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQ 617
++I +L G GA+G VYK + V I K + + E + S
Sbjct: 12 KKIKVL--GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV- 68
Query: 618 RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD--VHIRYIMFQLCNGLSY 675
+P++ +L I + + + L +R+ ++ Q+ G++Y
Sbjct: 69 DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 676 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILI 733
+ +++HRDL N+L+ +KI D GLA+ L + + + A E I
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-I 185
Query: 734 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGF 791
+R YTH D+WS G + E++ + ++ I+ P PP
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 792 ------KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDS 834
R KF +++++ K ++ Q +V + ++ L DS
Sbjct: 246 MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 9e-37
Identities = 60/268 (22%), Positives = 104/268 (38%), Gaps = 38/268 (14%)
Query: 549 IDQLMKDREDLQQQINLLKE-GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTD 602
++ + E + I +++ G+GA+G V++A VA+K + E
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-M 59
Query: 603 AQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK------ 655
RE + F +PNI+ +L + K + ++FEYM DLN+ +R
Sbjct: 60 QADFQREAALMAEF-DNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 656 -------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS 696
L I Q+ G++Y+ K +HRDL N L+ ++
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176
Query: 697 CSIKIGDLGLARSL-SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 755
+KI D GL+R++ S A P I RYT D+W+ G +L E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 756 Q-SKPLFPGASTSHQLQLIVNLVRPNPP 782
+ G + + + + P
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILACP 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 66/257 (25%), Positives = 104/257 (40%), Gaps = 37/257 (14%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRT 606
R+ L L K G+GA+G V A N VA+K + K D
Sbjct: 11 PRDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDL 65
Query: 607 YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------------ 653
E+ +K +H NII +L + LYV+ EY +L + ++
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 654 -----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708
++ L + +Q+ G+ Y+ + K +HRDL N+L+ + +KI D GLAR
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 709 SLSDSKECLT--EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAS 765
+ + APE L +R YTH D+WS G +L E+ +PG
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 766 TSHQLQLIVNLVRPNPP 782
+L+ R + P
Sbjct: 243 VEELFKLLKEGHRMDKP 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-36
Identities = 40/223 (17%), Positives = 94/223 (42%), Gaps = 11/223 (4%)
Query: 569 GKGAYGIVYKAYDKNNK---QYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRHPNII 623
G GAYG V+ + + A+K + +A + + T E L+ ++ P ++
Sbjct: 33 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 92
Query: 624 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKV 681
T+ ++ L+++ +Y+ +L + + + ++ + ++ L ++H +
Sbjct: 93 TLHYAFQ--TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150
Query: 682 MHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISNRRYT 739
++RD+K NIL+D + + + D GL++ ++ + + + +
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 210
Query: 740 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 782
VD WSLG ++ E+L F + I + + P
Sbjct: 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 30/286 (10%)
Query: 562 QINLLKE-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-RH 619
I L + GKG +G V++ + + VA+K + + + +RE ++ RH
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIF-----SSREERSWFREAEIYQTVMLRH 56
Query: 620 PNIITMLDIYKAVNN--KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 676
NI+ + N L++V +Y E+ L + + + + +GL+++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 677 HAC--------KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATR 724
H + HRDLK NIL+ K+ + I DLGLA + + + T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 725 WYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 779
Y APE+L + DI+++G + E+ + + + P
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 780 NPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSK 825
+ K K + + + + ++ + N +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAA 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 55/249 (22%), Positives = 111/249 (44%), Gaps = 30/249 (12%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYR 608
RE + + +E G+G++G+VY+ K + VAIK + EA + +
Sbjct: 18 AREKIT----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLN 72
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-----------I 656
E +K F +++ +L + + V+ E M DL +R
Sbjct: 73 EASVMKEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 657 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSK 714
+ + ++ +G++Y++A K +HRDL N ++ + ++KIGD G+ R + +D
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI 773
+ + + +PE L + +T + D+WS G +L E+ ++ + G S L+ +
Sbjct: 190 RKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 774 VNLVRPNPP 782
+ + P
Sbjct: 249 MEGGLLDKP 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-33
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 33/255 (12%)
Query: 555 DREDLQQQINLLKE-GKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYR 608
R+ L+ L K G+GA+G V +A + VA+K + E + + +
Sbjct: 11 PRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMS 65
Query: 609 EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK------------- 655
E+ L H N++ +L + +V +L+ +R K
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 656 ----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711
L H+ FQ+ G+ ++ + K +HRDL NIL+ + +KI D GLAR +
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 712 DSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSH 768
+ + + APE I +R YT D+WS G +L E+ +PG
Sbjct: 186 KDPDYVRKGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 769 QL-QLIVNLVRPNPP 782
+ + + R P
Sbjct: 245 EFCRRLKEGTRMRAP 259
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 4e-31
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 35/243 (14%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----------R 618
G G + V+ A D N +VA+K + +K + EI L+
Sbjct: 22 GWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 619 HPNIITMLDIYKAVNNKDLYVVFEYMEN-----DLNKVIRDKILKDVHIRYIMFQLCNGL 673
+I+ +LD + ++VV + L K + + ++++ I QL GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 674 SYI-HACKVMHRDLKPSNILIDKS------CSIKIGDLGLARSLSDSKECLTEYIATRWY 726
Y+ C ++H D+KP N+L++ IKI DLG A + I TR Y
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---SIQTREY 195
Query: 727 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------HQLQLIVNLVRPN 780
R+PE+L + DIWS C++ E++ LF + I+ L+
Sbjct: 196 RSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 781 PPH 783
P +
Sbjct: 255 PSY 257
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.5 bits (242), Expect = 1e-23
Identities = 29/195 (14%), Positives = 64/195 (32%), Gaps = 22/195 (11%)
Query: 569 GKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSFQRHPNI 622
G+G V+ Y + + +K F+ + K D + +L ++S +
Sbjct: 9 GEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 623 ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 682
+ L ME L ++ + ++ + ++ + ++
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 683 HRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIA--TRWYRAPEILISNRRY 738
H DL N+L+ + I I D + + +E L + ++ R Y
Sbjct: 126 HGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTY 176
Query: 739 THHVDIWSLGCILAE 753
DI S + +
Sbjct: 177 RTEKDINSAIDRILQ 191
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (96), Expect = 2e-05
Identities = 9/28 (32%), Positives = 13/28 (46%)
Query: 1180 KGHEFLNISYHMPTTCEVCPKPIWHIIR 1207
K H F ++ P CE C +W +I
Sbjct: 3 KTHNFKVHTFRGPHWCEYCANFMWGLIA 30
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} Length = 50 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 40.4 bits (94), Expect = 3e-05
Identities = 10/33 (30%), Positives = 17/33 (51%), Gaps = 2/33 (6%)
Query: 1182 HEFLNISYHMPTTCEVCPKPIWHIIRPPPALEC 1214
H F +Y PT C+ C +W +++ L+C
Sbjct: 1 HRFKVYNYMSPTFCDHCGSLLWGLVK--QGLKC 31
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 52 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (93), Expect = 5e-05
Identities = 6/26 (23%), Positives = 12/26 (46%)
Query: 1179 LKGHEFLNISYHMPTTCEVCPKPIWH 1204
L H F ++ C++C K + +
Sbjct: 1 LTTHNFARKTFLKLAFCDICQKFLLN 26
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} Length = 66 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Score = 39.6 bits (92), Expect = 9e-05
Identities = 8/33 (24%), Positives = 14/33 (42%)
Query: 1177 IALKGHEFLNISYHMPTTCEVCPKPIWHIIRPP 1209
H+F SY PT C+ C ++ ++
Sbjct: 4 DPRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQG 36
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} Length = 84 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.8 bits (82), Expect = 0.003
Identities = 7/27 (25%), Positives = 13/27 (48%)
Query: 1182 HEFLNISYHMPTTCEVCPKPIWHIIRP 1208
H++L + + C VC K ++R
Sbjct: 28 HQWLEGNLPVSAKCTVCDKTCGSVLRL 54
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1219 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.56 | |
| d1xa6a3 | 62 | Beta-chimaerin, middle domain {Human (Homo sapiens | 97.16 | |
| d1tbna_ | 66 | Protein kinase c-gamma {Rat (Rattus rattus) [TaxId | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.13 | |
| d1ptqa_ | 50 | Protein kinase C-delta (PKCdelta) {Mouse (Mus musc | 95.95 | |
| d1r79a_ | 84 | Diacylglycerol kinase delta {Human (Homo sapiens) | 93.68 | |
| d1faqa_ | 52 | RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.46 | |
| d1kbea_ | 49 | Kinase suppressor of Ras, Ksr {Mouse (Mus musculus | 91.77 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=433.76 Aligned_cols=276 Identities=34% Similarity=0.561 Sum_probs=225.5
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCch---hHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT---DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~---~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.+++||.|+||+||+|.+..+|+.||||++........ ....+.+|+.+++.+. |||||+++++|. +++++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~--~~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG--HKSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC--CTTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeec--cCCceeeh
Confidence 46889999999999999999999999999864332211 1246789999999995 999999999997 56789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||+.|++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...........
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9999976555554 45699999999999999999999999999999999999999999999999999988776555556
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcC-CCCCCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~-P~P~~~d~l~~~~~s~~~r 797 (1219)
..+||++|+|||++.....|+.++|||||||++|+|++|.+||.+.++.+++..|..... |....|+......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~------ 232 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP------ 232 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST------
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc------
Confidence 678999999999987777789999999999999999999999999999999999988874 4444443322100
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
....+......++..+++..++.+.|||.+||++||.+| +.++|+||||.-
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 233 -DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp -TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred -hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000111223455677788899999999999999999995 889999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=436.34 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=223.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+++.+. |||||+++++|. +.+.+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENK-NPNIVNYLDSYL--VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCC-CCCEeeEeEEEE--ECCEEEE
Confidence 46999999999999999999999999999999986443 234567899999999995 999999999997 4678999
Q ss_pred EEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccccc
Q psy14431 640 VFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 718 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~t 718 (1219)
|||||+ |+|.+++..+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|..+........
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999998 5899988888899999999999999999999999999999999999999999999999999998766555556
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHHh
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHERE 798 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~re 798 (1219)
..+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..+.....|.++.+
T Consensus 175 ~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------------- 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------- 239 (293)
T ss_dssp CCCSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSG--------------
T ss_pred ccccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc--------------
Confidence 778999999999984 56789999999999999999999999999988888887776655443322
Q ss_pred hhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 799 KFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 799 lI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
+.+++.+.+||.+||..||.+| +.++|+||||...
T Consensus 240 -----------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 240 -----------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp -----------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2347889999999999999995 8889999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=426.58 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=218.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+.+++|.+++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.+. |||||+++++|. +.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~ 79 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DAT 79 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSS
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEE--ECC
Confidence 457889999999999999999999999999999999864432 2234567889999999995 999999999998 567
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
.+|||||||+ |+|.+++.. +.+++..++.|+.||+.||.|||+.|||||||||+|||++.+|.+||+|||+|......
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 8999999998 589988874 67999999999999999999999999999999999999999999999999999876644
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. ....+||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.+....+..|.....+.|+
T Consensus 160 ~--~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----------- 225 (263)
T d2j4za1 160 R--RTTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----------- 225 (263)
T ss_dssp C--CEETTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred c--ccccCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 3 34568999999999984 566899999999999999999999999998888877777665433222
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+++.+.+||.+||.+||.+| +.++|+||||.-
T Consensus 226 -----------------------~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 226 -----------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------------------cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 236789999999999999984 888899999953
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=426.42 Aligned_cols=282 Identities=34% Similarity=0.543 Sum_probs=234.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||.|+||+||+|.+..+|+.||||++............+.+|+.+++.+. |||||+++++|. +++.+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~--~~~~~~ 77 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKLY 77 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccc--ccccee
Confidence 46899999999999999999999999999999999654433344567889999999995 999999999997 567899
Q ss_pred EEEecchhhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||+++++..++. ...+++..++.++.||+.||.|||+.|||||||||+|||++.++.+||+|||+|........
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 999999987666654 35699999999999999999999999999999999999999999999999999988766555
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCC-CchhhhhccCCh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADKFYAGFKSK 794 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~-~~d~l~~~~~s~ 794 (1219)
.....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+.....++.. .++....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----- 232 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS----- 232 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-----
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc-----
Confidence 5667789999999999877777789999999999999999999999999999999888877744333 3332211
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
........+......+....+.+++.+.|||.+||++||.+ ++.++|+||||.-
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 233 -MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp -STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred -ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 11112223344556677788889999999999999999998 4888999999954
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=435.81 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=221.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+++|.+++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.+. |||||+++++|. +...
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~~~ 79 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSSE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeec--cccc
Confidence 46789999999999999999999999999999999975432 2334577889999999995 999999999998 5778
Q ss_pred EEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+|||||+ |+|..++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 588888874 679999999999999999999999999999999999999999999999999999776555
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+||+.|+|||++ .+..|+.++|||||||++|+|++|++||.+.+....+..|.....+.|.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~------------ 226 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR------------ 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT------------
T ss_pred cccccceeCHHHhhhhhc-cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc------------
Confidence 555678999999999997 4567999999999999999999999999999988877777665433222
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++++.|||.+||++||.+| +.++++||||..
T Consensus 227 ----------------------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 227 ----------------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ----------------------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ----------------------cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 247889999999999999998 467899999954
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=434.64 Aligned_cols=286 Identities=34% Similarity=0.613 Sum_probs=240.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC----C
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d----~ 634 (1219)
-++|.++++||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.+. |||||+++++|...+ .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccccc
Confidence 35799999999999999999999999999999999766556666778899999999995 999999999997432 2
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.++|+||||++++|..++..+.+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||+|......
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 3689999999989999998889999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
.+..+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+.....+++..+. ......
T Consensus 175 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 249 (346)
T d1cm8a_ 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV---QRLQSD 249 (346)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH---HTCSCH
T ss_pred --cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH---hhhcch
Confidence 356789999999999877777899999999999999999999999999999999888888766554332 223344
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcCC
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALGS 851 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~~ 851 (1219)
........++......+...++..++.+.|||.+||.+||.+| +.++|+||||.-..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 4455555566666777788888899999999999999999995 89999999996533
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=425.30 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=206.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+++.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.+. |||||+++++|.+..++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence 46799999999999999999999999999999999766555566678899999999995 99999999998765667899
Q ss_pred EEEecch-hhHHHHHhh-----ccCChHHHHHHHHHHHHHHHHHHhcc-----cccCCCCCCCeeeccCCcceecccccc
Q psy14431 639 VVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACK-----VMHRDLKPSNILIDKSCSIKIGDLGLA 707 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs-----~~LseeeVr~Ia~QILsALaYLHS~G-----IVHRDLKPsNILLd~dG~VKLiDFGLA 707 (1219)
||||||+ |+|.+++.. ..+++..++.++.||+.||.|||+.| ||||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999998 589988862 46999999999999999999999876 999999999999999999999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
..+..........+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+..+....|.....+..+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~----- 235 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP----- 235 (269)
T ss_dssp HHC-----------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC-----
T ss_pred eecccCCCccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 9876655555678899999999997 4567999999999999999999999999999888888877765533221
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhh
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLA 847 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwf 847 (1219)
..+++++.+||.+||..||.+| +.++|+|||.
T Consensus 236 ----------------------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 ----------------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 1236789999999999999984 8888999993
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=426.47 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=210.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+++.+. |||||+++++|. +++.+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~--~~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCC-CCCEeeEeeeec--cCceeE
Confidence 6789999999999999999999999999999999864322 223456889999999995 999999999997 567899
Q ss_pred EEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc--
Q psy14431 639 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~-- 714 (1219)
||||||+ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..+....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999998 58998887 4579999999999999999999999999999999999999999999999999998765332
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.....+.++.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----------- 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT-----------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-----------
Confidence 234567899999999998655555789999999999999999999998766543333332222221111
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||..||.+| +.++|+||||.-
T Consensus 229 --------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 229 --------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 13457889999999999999985 788899999953
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=433.77 Aligned_cols=280 Identities=21% Similarity=0.310 Sum_probs=208.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.++++||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+|+.+. |||||+++++|. +.+++||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~~~i 81 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEISI 81 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEEE
Confidence 47999999999999999999999999999999986543 3344567889999999995 999999999998 5678999
Q ss_pred EEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||||. |+|.+++. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|..+.+..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 999999 48999886 4579999999999999999999997 599999999999999999999999999998765432
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH-HHHhhcCCCCCCchhhhhccCC--
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGFKS-- 793 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~-kIve~l~P~P~~~d~l~~~~~s-- 793 (1219)
....+||++|+|||++. +..|++++|||||||++|+|++|++||.+.+...... .+..... .+...+........
T Consensus 160 ~~~~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG-DAAETPPRPRTPGRPL 237 (322)
T ss_dssp C---CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC-CcccCCcccccccccc
Confidence 34679999999999985 4579999999999999999999999998866543222 1111111 11100000000000
Q ss_pred ----------hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 ----------KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ----------~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
......+..+....+..++ ....++++.|||.+||.+||.+| +.++|+||||.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000111111110000000 01257889999999999999984 888999999954
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=427.29 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=218.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
+.|.+++.||+|+||.||+|.+..+|..||||++... .......+.+|+.+++.+. |||||+++++|. +.+.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCD-HPNIVKLLDAFY--YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCCeEEE
Confidence 3589999999999999999999999999999998643 3344567889999999995 999999999997 5678999
Q ss_pred EEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 640 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
|||||+ |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.........
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999998 588888753 56999999999999999999999999999999999999999999999999999876554444
Q ss_pred cccccccccccCchhhh----ccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 717 LTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl----~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
....+||+.|+|||++. ....|+.++|||||||++|+|++|.+||.+.+....+..|.....|.....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 238 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------- 238 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG--------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc--------
Confidence 45678999999999974 345689999999999999999999999999998888888877654433211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.+++++.+||.+||.+||.+| +.++|+||||..
T Consensus 239 -----------------------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 239 -----------------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -----------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -----------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 2347889999999999999985 788899999954
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=423.49 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=213.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
.++|.+++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. |||||+++++|. +.+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEE--CSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEE--ECCEE
Confidence 357999999999999999999999999999999996432 22334567889999999995 999999999997 56789
Q ss_pred EEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 638 YVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
|||||||+ |+|.+++. .+.+++..++.++.||+.||.|||+.|||||||||+|||++.+|.++|+|||+|+.+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999998 58988877 4679999999999999999999999999999999999999999999999999998775432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
......+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----------- 231 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----------- 231 (288)
T ss_dssp ------CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred ccccccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc-----------
Confidence 2234568999999999984 557999999999999999999999999999888888888765432221
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH--------HHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI--------EQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai--------EALqHpwfaL 849 (1219)
.+++.+.|||.+||..||.+|+. ..++||||..
T Consensus 232 -----------------------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 232 -----------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp -----------------------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -----------------------cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 24778999999999999999853 2578999854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-48 Score=416.55 Aligned_cols=280 Identities=34% Similarity=0.569 Sum_probs=227.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.++++||+|+||+||+|.++ +|+.||||++............+.+|+.+++.+. |||||+++++|. +.+..|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~ 76 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLV 76 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecc--cCCcee
Confidence 368999999999999999999986 7899999999655444444578899999999995 999999999998 567899
Q ss_pred EEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||+|+.+++...+. .+.+++..++.++.||+.||.|||+.|||||||||+|||++.+|.+||+|||+|.........
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999999986655554 456999999999999999999999999999999999999999999999999999887665544
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhhhhccCChh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~ 795 (1219)
....++++.|+|||.+.+...+++++|||||||++|+|++|++||.+.+..+++..+.... .|....|+.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----- 231 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL----- 231 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-----
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh-----
Confidence 5566899999999999777788999999999999999999999999999999888888777 4444444433210
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
...........+.++....+.+++.+.||+.+||++||.+| +.++|+||||.
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 232 -PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp -TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred -hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 01111222334455666677889999999999999999985 88999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-48 Score=423.91 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=217.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+++|.+++.||.|+||+||+|.++.+|+.||||++.+... .......+.+|+.+++.+. |||||+++++|. +.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~ 78 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQ 78 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEe--eCCe
Confidence 47789999999999999999999999999999999964432 2334567889999999995 999999999997 5778
Q ss_pred EEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+|||||.| +|..++. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999985 6777766 456888899999999999999999999999999999999999999999999999887654
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....+||+.|+|||++ .+..|+.++|||||||++|+|++|++||.+.+....+..|.....+.|+
T Consensus 158 --~~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~------------ 222 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP------------ 222 (316)
T ss_dssp --BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT------------
T ss_pred --cccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC------------
Confidence 3457899999999997 4567999999999999999999999999999988888888776533322
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++++.+++.+||..||.+| +.++|+||||.-
T Consensus 223 ----------------------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 223 ----------------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ----------------------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ----------------------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 237789999999999999987 577899999954
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-47 Score=425.35 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=218.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.+++|.+++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+++.+. |||||+++++|. +...
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~ 115 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNSN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccc--cccc
Confidence 3678999999999999999999999999999999986432 22344567889999999995 999999999997 5678
Q ss_pred EEEEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|+||+|+.| +|..++. .+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999984 7777776 467999999999999999999999999999999999999999999999999999987643
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCCh
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSK 794 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~ 794 (1219)
....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.|.
T Consensus 195 --~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~------------ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS------------ 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT------------
T ss_pred --cccccCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc------------
Confidence 24568999999999985 567999999999999999999999999999888888888766533322
Q ss_pred hHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+++++.+||.+||..||.+| +.++++||||..
T Consensus 260 ----------------------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 260 ----------------------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ----------------------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ----------------------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 237789999999999999987 578899999954
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=415.23 Aligned_cols=281 Identities=33% Similarity=0.541 Sum_probs=223.8
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCC-CeEEEEEEeeccccCchhHHHHHHHHHHHHhcc--CCCCccEEeeeeecc---
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAV--- 632 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~T-Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~--~HPNIVkL~gvfe~~--- 632 (1219)
.++|.++++||+|+||+||+|.+..+ ++.||||++............+.+|+.+++.+. +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999755 788999999755444434445678888887764 599999999998532
Q ss_pred CCceEEEEEecchhhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 633 NNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 633 d~~~LyLVMEymeGSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
....+|+||||+++++..+.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.++|+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 345789999999976554433 45689999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCC-CCCchhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFY 788 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~-P~~~d~l~ 788 (1219)
..... .....+||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.++.+.+..|.....++ +..|+...
T Consensus 166 ~~~~~-~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 166 YSFQM-ALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCGGG-GGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hcccc-cCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65433 345678999999999985 5679999999999999999999999999999999999998877443 33332211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
. .+ . ..+......++....+.+++.+.|||.+||++||.+| +.++|+||||.-
T Consensus 244 ~---~~--~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 244 A---LP--R---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp S---SC--G---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred c---ch--h---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0 00 0 0111122333445566789999999999999999984 889999999953
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-48 Score=423.58 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=200.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
.|.+++.||+|+||+||+|.++.+|+.||||++...... .....+.+|+.++..+. |||||+++++|. +++.+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~~~lv 85 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIK-HPNIVALDDIYE--SGGHLYLI 85 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEEE
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEEEE
Confidence 499999999999999999999999999999999654332 22355779999999995 999999999997 57789999
Q ss_pred Eecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec---cCCcceecccccccccCCccc
Q psy14431 641 FEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 641 MEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd---~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
||||+ |+|.+++. .+.+++..+..|+.||+.||.|||+.||+||||||+|||+. .+|.+||+|||+|.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99998 69999887 45799999999999999999999999999999999999995 57899999999998765433
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+||+.|+|||++. +..|++++|||||||++|+|++|.+||.+.+.......|.....+.+...
T Consensus 165 ~~~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------- 232 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY----------- 232 (307)
T ss_dssp --------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT-----------
T ss_pred eeeeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc-----------
Confidence 334678999999999984 55799999999999999999999999999988888888877654332211
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 233 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 233 -------------------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -------------------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 13457889999999999999984 888899999954
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=419.48 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=214.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.|.+++.||+|+||.||+|.+..+|..||||++...... ......+.+|+.++..+. |||||+++++|. +.+.+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--REHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEE--ECCEEEE
Confidence 499999999999999999999999999999998654332 234467889999999996 999999999997 4678999
Q ss_pred EEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccccc
Q psy14431 640 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 717 (1219)
Q Consensus 640 VMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~~ 717 (1219)
|||||.| +|..++. .+++++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|......
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999986 4544443 567999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 718 TEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 718 ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
...+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+.+....+..+.....|.+..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 236 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------------ 236 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC------------
Confidence 35689999999999853 3468999999999999999999999999998888888887765443321
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||.+||.+| +.++|+|||+.-
T Consensus 237 --------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 237 --------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1237789999999999999985 788899999954
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-47 Score=423.98 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=220.2
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-+++|.+++.||+|+||.||+|.+..+|..||||++... .......+.+|+.++..+. |||||+++++|. +.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--ETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEE
Confidence 356899999999999999999999999999999998643 2344567889999999996 999999999997 56789
Q ss_pred EEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc--CCcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~--dG~VKLiDFGLAr~l~~ 712 (1219)
|||||||+ |+|.+++. .+.+++..++.|+.||+.||.|||++|||||||||+|||++. +|.+||+|||+|..+..
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999998 58999885 356999999999999999999999999999999999999964 57899999999988765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||++|+|||++. +..|+.++|||||||++|+|++|++||.+.+..+.+..|.......+...
T Consensus 179 ~~-~~~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 248 (350)
T d1koaa2 179 KQ-SVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-------- 248 (350)
T ss_dssp TS-CEEEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG--------
T ss_pred cc-ccceecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--------
Confidence 43 334678999999999974 55689999999999999999999999999998888888877654332211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhcC
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAALG 850 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL~ 850 (1219)
.+.+++.+.+||.+||.+||.+| +.++|+||||...
T Consensus 249 ----------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 249 ----------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp ----------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 23457889999999999999884 7889999999653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=411.12 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=218.8
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----chhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
+.|.+++.||+|+||+||+|.++.+|+.||||++.+.... ......+.+|+.+++.+. |||||+++++|. +.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--NKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECC
Confidence 3599999999999999999999999999999999654321 223567889999999995 999999999997 577
Q ss_pred eEEEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC----cceecccccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG----~VKLiDFGLAr~ 709 (1219)
.+|||||||+ |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+| .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 8999999998 589999874 5799999999999999999999999999999999999998776 499999999988
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
...... ....+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.+.
T Consensus 167 ~~~~~~-~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------- 237 (293)
T d1jksa_ 167 IDFGNE-FKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 237 (293)
T ss_dssp CTTSCB-CSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCCCcc-ccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-------
Confidence 765432 34568999999999984 567999999999999999999999999999988888887765433221
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+.+++.+.+||.+||..||.+| +.++|+||||..
T Consensus 238 -----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 238 -----------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp -----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred -----------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 1234568899999999999999985 888899999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=417.22 Aligned_cols=286 Identities=36% Similarity=0.644 Sum_probs=239.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~~ 635 (1219)
++|.++++||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.+. |||||+++++|... +..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccccCc
Confidence 5799999999999999999999999999999999766666666778899999999995 99999999998632 234
Q ss_pred eEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 636 DLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
.+|+++++++|+|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++++|||++......
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-- 174 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--
Confidence 567777777789999999889999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|.......+..+.. ......
T Consensus 175 -~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~---~~~~~~ 250 (348)
T d2gfsa1 175 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK---KISSES 250 (348)
T ss_dssp -GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT---TCCCHH
T ss_pred -cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh---hccchh
Confidence 3456899999999998777778999999999999999999999999999999888888877554433222 223344
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
....+..++......+...++.+++.++|||.+||.+||.+ ++.++|+||||.-...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 44555555555667788888999999999999999999998 5899999999975443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=407.86 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=208.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc--CCceEEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYV 639 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~--d~~~LyL 639 (1219)
|.+.++||+|+||+||+|.+..++..||+|++............+.+|+.+++.+. |||||+++++|... +...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEE
Confidence 46677899999999999999999999999999766555566678899999999996 99999999998642 3457899
Q ss_pred EEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcc--cccCCCCCCCeeec-cCCcceecccccccccCCcc
Q psy14431 640 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~G--IVHRDLKPsNILLd-~dG~VKLiDFGLAr~l~~~~ 714 (1219)
|||||+ |+|.+++.. ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|.......
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 999998 589998874 57999999999999999999999998 99999999999996 57899999999998654432
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHH-HHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~-kIve~l~P~P~~~d~l~~~~~s 793 (1219)
....+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+..+...+. .+..... |+.+
T Consensus 170 --~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~--------- 234 (270)
T d1t4ha_ 170 --AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASF--------- 234 (270)
T ss_dssp --BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGG---------
T ss_pred --cCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--Cccc---------
Confidence 34678999999999973 359999999999999999999999998766555443 3332221 1111
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhh
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAA 848 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfa 848 (1219)
.+..++++.+||.+||.+||.+| +.++|+||||.
T Consensus 235 ---------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 ---------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 12347789999999999999985 88889999983
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-47 Score=424.23 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=220.3
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
-++.|.+++.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++..+. |||||+++++|. +++.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEE
Confidence 3567999999999999999999999999999999986432 234567789999999995 999999999997 57789
Q ss_pred EEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeec--cCCcceecccccccccCC
Q psy14431 638 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd--~dG~VKLiDFGLAr~l~~ 712 (1219)
|||||||+ |+|.+.+.. ..+++..++.|+.||+.||.|||++|||||||||+|||++ .+|.+||+|||+|..+..
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998 589887763 3699999999999999999999999999999999999998 578999999999998765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. .....+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..|.....+.+...
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 251 (352)
T d1koba_ 182 DE-IVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA-------- 251 (352)
T ss_dssp TS-CEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST--------
T ss_pred CC-ceeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--------
Confidence 43 33556899999999997 456799999999999999999999999999999988888887764443321
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
.+.+++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 252 ----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 252 ----------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 23458889999999999999985 778999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=419.52 Aligned_cols=254 Identities=27% Similarity=0.369 Sum_probs=217.9
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccc-cCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~-~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+++|.+++.||.|+||+||+|.+..+|+.||||++.+.. ........+.+|+.++....+|||||+++++|. +++.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCce
Confidence 578999999999999999999999999999999996432 223345667788888775446999999999998 57789
Q ss_pred EEEEecch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 638 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|||||||+ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999998 589999874 5699999999999999999999999999999999999999999999999999987766555
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChh
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKH 795 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~ 795 (1219)
.....+||+.|+|||++. +..|++++|||||||++|+|++|++||.+.+....+..|.....+.|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~------------- 224 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR------------- 224 (320)
T ss_dssp CBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-------------
T ss_pred cccccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------
Confidence 556678999999999985 567999999999999999999999999999988888777654322221
Q ss_pred HHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH---HHHcchhhhc
Q psy14431 796 EREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI---EQLQGKLAAL 849 (1219)
Q Consensus 796 ~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai---EALqHpwfaL 849 (1219)
.+++.+.+||.+||..||.+|+. +.++||||.-
T Consensus 225 ---------------------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 225 ---------------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ---------------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ---------------------cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 24788999999999999999843 5689999954
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-47 Score=425.43 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=207.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHH---HHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYRE---ILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lRE---I~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
+++|.+++.||+|+||.||+|.+..+|+.||||++.+.... ......+.+| +.++..+ +|||||+++++|. +.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~--~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFH--TP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEE--CS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEE--EC
Confidence 67899999999999999999999999999999998643211 1122233444 5555555 4999999999997 56
Q ss_pred ceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 635 KDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
+.+|||||||+ |+|..++. ...+++..++.|+.||+.||.|||+.|||||||||+|||++.+|.+||+|||+|..+..
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 78999999998 68999887 45689999999999999999999999999999999999999999999999999987765
Q ss_pred cccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 713 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 713 ~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.. ....+||+.|+|||++..+..|++++|||||||++|+|++|++||.+.+.......+.....+.+..+
T Consensus 160 ~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (364)
T d1omwa3 160 KK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP-------- 229 (364)
T ss_dssp SC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC--------
T ss_pred Cc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--------
Confidence 43 34568999999999986666799999999999999999999999987654433322222222211111
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
+.+++.+.+||.+||..||.+| +.++++||||..
T Consensus 230 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 230 -----------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp -----------------------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred -----------------------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 2357889999999999999998 468899999954
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=416.07 Aligned_cols=288 Identities=39% Similarity=0.629 Sum_probs=239.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC---Cce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d---~~~ 636 (1219)
.+|.++++||+|+||+||+|.+..+|+.||||++... ........+.+|+.+|+.+. ||||+++++++.... ...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccccce
Confidence 4599999999999999999999999999999998643 23445667889999999995 999999999986432 345
Q ss_pred EEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc-
Q psy14431 637 LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 715 (1219)
Q Consensus 637 LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~- 715 (1219)
+|+||++++|+|.+++..+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 7888888889999999988999999999999999999999999999999999999999999999999999986654322
Q ss_pred --ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 --~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.....+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+....+......+.... ......
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 242 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED---LNCIIN 242 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH---HHTCCC
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh---hhhhhh
Confidence 234567999999999986777789999999999999999999999999988888887777664433322 122334
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhcCCC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALGSE 852 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~~e 852 (1219)
......+..++.....++...++.+++.+.+||.+||.+||.+ ++.++|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 4445556666777788899999999999999999999999998 5889999999975433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=409.82 Aligned_cols=288 Identities=29% Similarity=0.496 Sum_probs=222.9
Q ss_pred ccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----
Q psy14431 557 EDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---- 632 (1219)
Q Consensus 557 ~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~---- 632 (1219)
.++++|.++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.+. ||||++++++|...
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccc
Confidence 4588999999999999999999999999999999998655444555677889999999995 99999999988532
Q ss_pred --CCceEEEEEecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 633 --NNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 633 --d~~~LyLVMEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
..+++|+||||+++++...+. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 245689999999977666554 3568999999999999999999999999999999999999999999999999997
Q ss_pred ccCCcc----cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 709 SLSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 709 ~l~~~~----~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
.+.... ......+||++|+|||++.+...|++++|||||||++|+|++|++||.+.++...+..|.......++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 665322 2233467999999999987777899999999999999999999999999999988888888774443332
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHh--cccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQ--SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~--p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
.... ........+... ......+...+ ...++.++|||.+||++||.+ ++.++|.||||..
T Consensus 246 ~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNV---DNYELYEKLELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTC---CCC-------CC-SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccc---chhhhhhhhccc-ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 2111 111111111111 11122222222 235788999999999999999 4899999999953
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-46 Score=405.19 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=221.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc-------hhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-------TDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~-------~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.++|.+++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.++..+..|||||+++++|.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 368999999999999999999999999999999996543221 123467899999999988999999999998
Q ss_pred cCCceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 709 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~ 709 (1219)
+++.+|||||||+ |+|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 -~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 81 -TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred -cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 5778999999998 59999996 56799999999999999999999999999999999999999999999999999998
Q ss_pred cCCcccccccccccccccCchhhhc-----cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCc
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 784 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~-----~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~ 784 (1219)
+.... .....+||+.|+|||++.+ ...++.++||||+||++|+|++|++||.+.+.......|.......+..
T Consensus 160 ~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 237 (277)
T d1phka_ 160 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP- 237 (277)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred ccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence 76543 3356789999999999853 3457889999999999999999999999999888888887765322111
Q ss_pred hhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 785 DKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 785 d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
..+++++++.+|+.+||..||.+ ++.++|+||||.-
T Consensus 238 -----------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 -----------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 12356889999999999999998 4889999999953
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=410.45 Aligned_cols=275 Identities=27% Similarity=0.495 Sum_probs=219.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec----cCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA----VNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~----~d~~ 635 (1219)
.+|..+++||+|+||+||+|++..+|+.||||++..... ...+|+.+++.+. ||||++++++|.. .+..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence 369999999999999999999999999999999964322 1347999999995 9999999999853 2345
Q ss_pred eEEEEEecchhhHHHHHh-----hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccc
Q psy14431 636 DLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARS 709 (1219)
Q Consensus 636 ~LyLVMEymeGSL~d~Lr-----s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~ 709 (1219)
++|||||||++++...+. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 689999999987655543 34699999999999999999999999999999999999999876 899999999987
Q ss_pred cCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCC-chhhh
Q psy14431 710 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFY 788 (1219)
Q Consensus 710 l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~-~d~l~ 788 (1219)
+.... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+.+..|+...+.++.. +....
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 75443 23457899999999998777789999999999999999999999999999999999998877544332 22211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHH-HhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQE-LQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~e-l~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
..+... .++.....++.. ..+..++.+.|||.+||.+||.+ ++.++|+||||..
T Consensus 252 ~~~~~~-------~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 252 PNYTEF-------KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp C---CC-------CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred cchhhc-------cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 111000 011111111221 23467889999999999999998 4889999999965
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=414.03 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=206.4
Q ss_pred cccCeeEEe-eeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec--cCC
Q psy14431 558 DLQQQINLL-KEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--VNN 634 (1219)
Q Consensus 558 dIqqY~ILK-kIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~--~d~ 634 (1219)
-+++|.++. .||+|+||+||+|.+..+|+.||||++.. ...+.+|+.++..+.+|||||+++++|.. ..+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 467899886 59999999999999999999999999852 23567899998777679999999999864 235
Q ss_pred ceEEEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccccc
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLA 707 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFGLA 707 (1219)
.++|||||||+ |+|.+++.. ..+++..++.|+.||+.||.|||+.||+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999998 599999974 35999999999999999999999999999999999999985 467999999999
Q ss_pred cccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 708 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 708 r~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
+...... .....+||+.|+|||++ .+..|+.++|||||||++|+|++|++||.+.+.......+..........++.
T Consensus 162 ~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~- 238 (335)
T d2ozaa1 162 KETTSHN-SLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN- 238 (335)
T ss_dssp EECCCCC-CCCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT-
T ss_pred eeccCCC-ccccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC-
Confidence 8776543 34567899999999997 55679999999999999999999999998877655544443322111110000
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+.+++++.+||.+||++||.+| +.++|.||||.-
T Consensus 239 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 239 -------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -------------------------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred -------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0123468899999999999999985 888999999953
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=394.50 Aligned_cols=281 Identities=27% Similarity=0.497 Sum_probs=227.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.++++||+|+||+||+|.+..+|+.||||++............+.+|+.+++.+. ||||++++++|. +....+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~--~~~~~~ 77 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccc--ccccee
Confidence 36899999999999999999999999999999999766555566788999999999995 999999999997 567899
Q ss_pred EEEecchh-hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcccc
Q psy14431 639 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 716 (1219)
Q Consensus 639 LVMEymeG-SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~~ 716 (1219)
+||+++.+ ++..++. .+.+++..++.++.|++.||.|||++|||||||||+|||++.++.++|+|||.|.........
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999996 5555554 457899999999999999999999999999999999999999999999999999987766555
Q ss_pred cccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCC-CCCCCcHHHHHHHHhhcCCCC-CCchhhhhccCCh
Q psy14431 717 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKSK 794 (1219)
Q Consensus 717 ~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpP-F~g~s~~e~L~kIve~l~P~P-~~~d~l~~~~~s~ 794 (1219)
.....+++.|+|||++.....++.++|||||||++|+|++|+.| |.+.+..+.+..+.....+++ ..++.... ....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK-LPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG-STTC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh-cccc
Confidence 56677889999999987666789999999999999999998865 667777777777777664433 33332211 0000
Q ss_pred hHHhhhHHhhh-hchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 795 HEREKFNQVVV-KCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 795 ~~relI~klp~-kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
...+. ..........+.+++.+.|||.+||++||.+| +.++|+||||.-
T Consensus 237 ------~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 237 ------KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp ------CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ------cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00000 01122334446678999999999999999995 788999999953
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=406.65 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=217.7
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+++|.+++.||+|+||+||+|.+..+|+.||||++... ......+.+|+.+|..+. |||||+++++|. +.+.+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIAR-HRNILHLHESFE--SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCEEE
Confidence 56899999999999999999999999999999999643 233456789999999996 999999999998 567899
Q ss_pred EEEecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC--CcceecccccccccCCc
Q psy14431 639 VVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d--G~VKLiDFGLAr~l~~~ 713 (1219)
||||||. |+|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++......
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999998 4899999743 68999999999999999999999999999999999999854 47999999999877543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
. .....++|+.|+|||.+ .+..|+.++|||||||++|+|++|.+||.+.+....+..|.......+.
T Consensus 158 ~-~~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 224 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------- 224 (321)
T ss_dssp C-EEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----------
T ss_pred C-cccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-----------
Confidence 3 23456899999999997 4567999999999999999999999999999988888888775533222
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
..++.+++.+.+||.+||..||.+| +.++|+||||.-
T Consensus 225 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 -------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1234568899999999999999985 789999999954
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=408.80 Aligned_cols=283 Identities=34% Similarity=0.598 Sum_probs=221.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeecc----CC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~----d~ 634 (1219)
+++|.++++||+|+||+||+|.+..+|..||||++............+.+|+.+++.+. |||||+++++|... ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccccC
Confidence 46899999999999999999999999999999999876666666778899999999995 99999999999643 34
Q ss_pred ceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 635 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 635 ~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
.++|+|||||.+++...+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++++|||+++......
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred ceeEEEEeccchHHHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 7899999999998877765 458999999999999999999999999999999999999999999999999998766543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCC-CCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P-~P~~~d~l~~~~~s 793 (1219)
.....++|+.|+|||++. +..+++++||||+||++|+|++|++||.+.+....+..++..... .+..|... .
T Consensus 174 -~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~ 246 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-----Q 246 (355)
T ss_dssp --------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS-----C
T ss_pred -ccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh-----h
Confidence 345678999999999985 457999999999999999999999999999999988888877744 33333222 2
Q ss_pred hhHHhhhHHhhhhchhhHHHHh------------cccChhHHHHHHhccccCCCC--CHHHHHcchhhhcC
Q psy14431 794 KHEREKFNQVVVKCQKELQELQ------------SQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAALG 850 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~------------p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL~ 850 (1219)
......+...+......++..+ ...++++.|||.+||.+||.+ ++.++|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 2333333333322223333322 234678999999999999998 58999999999763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=404.98 Aligned_cols=284 Identities=27% Similarity=0.407 Sum_probs=215.9
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
..++|.++++||.|+||+||+|++..+|+.||||++.. .....+.+|+.+|..+.+||||++++++|.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 45789999999999999999999999999999999853 2346688999999999789999999999987667789
Q ss_pred EEEEecchh-hHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC-cceecccccccccCCccc
Q psy14431 638 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 638 yLVMEymeG-SL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG-~VKLiDFGLAr~l~~~~~ 715 (1219)
|+|||||.+ +|..+. +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .++|+|||+|.......
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999995 665543 4699999999999999999999999999999999999998765 69999999998776543
Q ss_pred ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhhcCCCC-CCchhhhhccCC
Q psy14431 716 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLVRPNP-PHADKFYAGFKS 793 (1219)
Q Consensus 716 ~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s-~~e~L~kIve~l~P~P-~~~d~l~~~~~s 793 (1219)
.....++|+.|+|||.+.+...++.++||||+||++|+|++|.+||.... ...+...+.....++. ..+.........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 24567899999999998777778999999999999999999999997654 4445555555443211 111000000000
Q ss_pred hhHHhhhHHhhhhch--hhHHHHhcccChhHHHHHHhccccCCCC--CHHHHHcchhhhc
Q psy14431 794 KHEREKFNQVVVKCQ--KELQELQSQVVEENTSKLKLQMELDSKD--SEIEQLQGKLAAL 849 (1219)
Q Consensus 794 ~~~relI~klp~kcr--k~L~el~p~lspeaiDLLsKMLq~DPeK--RaiEALqHpwfaL 849 (1219)
+.........+.... .........+++++.|||.+||.+||.+ ++.++|+||||.-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 000000000000000 0011122456889999999999999988 5999999999953
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-45 Score=392.96 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=209.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC-chhHHHHHHHHHHHHhccCCCCccEEeeeeeccC--Cce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--NKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s-~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d--~~~ 636 (1219)
++|.+++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+. |||||++++++...+ ...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCCCce
Confidence 4599999999999999999999999999999999755433 344567889999999995 999999999987533 245
Q ss_pred EEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 637 LYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+|||||||+ ++|..++. .+.+++..++.|+.||+.||.|||++|||||||||+|||++.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 899999998 47887776 4579999999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 ---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 ---~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
......+||+.|+|||++ .+..|++++|||||||++|+|++|.+||.+.+....+..++.....++..
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 236 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-------- 236 (277)
T ss_dssp -------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG--------
T ss_pred ccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch--------
Confidence 233456899999999997 45579999999999999999999999999998888777776544322111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HHHHcchhhhc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IEQLQGKLAAL 849 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iEALqHpwfaL 849 (1219)
..+.+++.+.+||.+||..||.+|+ .+++.|+|..+
T Consensus 237 ----------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 237 ----------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1245688899999999999999985 67888998765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=392.22 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=203.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCc----hhHHHHHHHHHHHHhcc-CCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~----~~~e~~lREI~ILr~L~-~HPNIVkL~gvfe~~d~ 634 (1219)
++|.+.+.||+|+||+||+|.+..+|..||||++....... .....+.+|+.+++.+. +|||||+++++|. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence 47999999999999999999999999999999986543221 12234568999999986 4899999999997 56
Q ss_pred ceEEEEEecchh--hHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC-Ccceeccccccccc
Q psy14431 635 KDLYVVFEYMEN--DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSL 710 (1219)
Q Consensus 635 ~~LyLVMEymeG--SL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d-G~VKLiDFGLAr~l 710 (1219)
+.+|+||||+.+ ++..++. ...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 789999999974 6777776 5679999999999999999999999999999999999999854 78999999999876
Q ss_pred CCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhc
Q psy14431 711 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 790 (1219)
Q Consensus 711 ~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~ 790 (1219)
.... .+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ .+.......+
T Consensus 162 ~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~--------- 224 (273)
T d1xwsa_ 162 KDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--------- 224 (273)
T ss_dssp CSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS---------
T ss_pred cccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC---------
Confidence 5432 4567899999999998766666788999999999999999999997532 2322221111
Q ss_pred cCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcchhhhc
Q psy14431 791 FKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGKLAAL 849 (1219)
Q Consensus 791 ~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHpwfaL 849 (1219)
+.+++++.+||.+||.+||.+| +.++|+||||..
T Consensus 225 -------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 225 -------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp -------------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -------------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 2357889999999999999985 888999999954
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=387.05 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=209.8
Q ss_pred cCeeEEe-eeeccCceEEEEEEEcC--CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLL-KEGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILK-kIGeGgFGtVYlA~dk~--TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
++|.+.. +||+|+||.||+|.+.. ++..||||++... ........+.+|+.++..+. |||||++++++. .+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~---~~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---AEA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SSS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeec---cCe
Confidence 3567777 49999999999998754 4668999998643 33455678899999999995 999999999986 346
Q ss_pred EEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|||||||+ |+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 899999999 589998763 56999999999999999999999999999999999999999999999999999876543
Q ss_pred cc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 714 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 714 ~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.. ......||+.|+|||++. ...++.++|||||||++|||+| |.+||.+.+..+.+..|..+.+|..+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p------- 234 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP------- 234 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC-------
T ss_pred ccccccccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 22 223456899999999974 5579999999999999999998 99999998888888888776644322
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-----HHHHHcchhhhcCCC
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-----EIEQLQGKLAALGSE 852 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-----aiEALqHpwfaL~~e 852 (1219)
+.+++++.+|+.+||..||.+| ..+.|+|+|+.+...
T Consensus 235 --------------------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 235 --------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp --------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred --------------------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 1236778999999999999998 234488999877444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-44 Score=390.24 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=202.6
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+.+.||+|+||+||+|.+..+|..||||++... ......+.+|+.++..+. |||||+++++|. +++.+|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~~ 89 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFY 89 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCC-CCCEecCCccEe--eCCeeE
Confidence 45799999999999999999999999999999998643 234567899999999995 999999999987 567899
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
||||||+ |+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999998 588888863 468999999999999999999999999999999999999999999999999998775533
Q ss_pred c-ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 ~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ......||+.|+|||++. +..|+.++|||||||++|+|++|. |||.+.+.......+.....|..+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~---------- 238 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------- 238 (287)
T ss_dssp SEEETTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred ceeeccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC----------
Confidence 2 233456889999999975 556999999999999999999965 555555555544444443322211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHHHcchhh
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQLQGKLA 847 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEALqHpwf 847 (1219)
+.+++.+.+|+.+||..||.+|+...--+.++
T Consensus 239 -----------------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 239 -----------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp -----------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----------------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 12467899999999999999985544334443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=389.56 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=200.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.+.+.||+|+||.||+|... ..||||++............+.+|+.++..+. |||||++++++. .+.+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~---~~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST---APQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe---ccEEE
Confidence 467899999999999999999643 35999999766556666788999999999995 999999999874 45689
Q ss_pred EEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 639 VVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
||||||+ |+|.+++. ...+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999998 69999986 3569999999999999999999999999999999999999999999999999998765422
Q ss_pred -cccccccccccccCchhhhc--cccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 715 -ECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~--~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.......||+.|+|||++.+ ...|+.++|||||||++|+|++|++||.+.+....+..++......|. ...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~----- 233 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-LSK----- 233 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-GGG-----
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-chh-----
Confidence 23345689999999999853 235899999999999999999999999988877666655443322221 111
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HHHHcc
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IEQLQG 844 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iEALqH 844 (1219)
..+.+++.+.+|+.+||..||.+|+ .+.+.+
T Consensus 234 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 ----------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1134577899999999999999974 444544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=385.67 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=199.8
Q ss_pred eeeeccCceEEEEEEEc--CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEEec
Q psy14431 566 LKEGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY 643 (1219)
Q Consensus 566 KkIGeGgFGtVYlA~dk--~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVMEy 643 (1219)
++||+|+||.||+|.+. .+++.||||++............+.+|+.++..+. |||||++++++. .+.+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~---~~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---SSSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEec---cCCEEEEEEc
Confidence 47999999999999864 45688999999755545555678999999999995 999999999985 3457999999
Q ss_pred ch-hhHHHHHhh-ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc---ccc
Q psy14431 644 ME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT 718 (1219)
Q Consensus 644 me-GSL~d~Lrs-~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~---~~t 718 (1219)
|+ |+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.+|.++|+|||+|+.+..... ...
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 98 589998875 5699999999999999999999999999999999999999999999999999987654322 123
Q ss_pred cccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCChhHH
Q psy14431 719 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKSKHER 797 (1219)
Q Consensus 719 s~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~r 797 (1219)
...||+.|+|||++. +..++.++|||||||++|+|++ |.+||.+.+..+....|..+.+|..+
T Consensus 169 ~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p--------------- 232 (277)
T d1xbba_ 169 HGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP--------------- 232 (277)
T ss_dssp --CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------------
T ss_pred ccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------
Confidence 457899999999984 5569999999999999999998 89999998888777777665543322
Q ss_pred hhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH--HH---HHcchhhhc
Q psy14431 798 EKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE--IE---QLQGKLAAL 849 (1219)
Q Consensus 798 elI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa--iE---ALqHpwfaL 849 (1219)
+.+++.+.+|+.+||..||.+|+ .+ .|+|+|+..
T Consensus 233 ------------------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 233 ------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp ------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------------------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 12367789999999999999984 22 267777643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-44 Score=388.91 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=194.0
Q ss_pred ccccccCeeEEeeeeccCceEEEEEEEcCCCe---EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 555 DREDLQQQINLLKEGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 555 dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk---~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
...+.+.|.+.+.||+|+||+||+|.+..+|. .||||.+... ........+.+|+.+|..+. |||||++++++.
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~- 97 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVT- 97 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEe-
Confidence 34556789999999999999999999987664 6889987533 23345567899999999995 999999999986
Q ss_pred cCCceEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
.++.+|+|||||+ |+|.+++.. +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+
T Consensus 98 -~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 98 -KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred -eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 4677999999998 588887774 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcccc-----cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCC
Q psy14431 709 SLSDSKEC-----LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 782 (1219)
Q Consensus 709 ~l~~~~~~-----~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~ 782 (1219)
.+...... .....||+.|+|||++. +..|+.++|||||||++|||+| |.+||.+.+....+..|.....++++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 255 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255 (299)
T ss_dssp -------------------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 76543211 12346789999999974 5679999999999999999998 89999999988888888776544322
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+++.+.+|+.+||..||.+|+
T Consensus 256 ---------------------------------~~~~~~l~~li~~cl~~~P~~RP 278 (299)
T d1jpaa_ 256 ---------------------------------MDCPSALHQLMLDCWQKDRNHRP 278 (299)
T ss_dssp ---------------------------------TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred ---------------------------------ccchHHHHHHHHHHcCCCHhHCc
Confidence 12366788999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=381.27 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=204.7
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
++|.+++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++..+. |||||++++++. .+.+|+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~---~~~~~i 84 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT---QEPIYI 84 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCC-CCCEeEEEeeec---cCCeEE
Confidence 67999999999999999999975 57889999986432 33467899999999995 999999999875 346799
Q ss_pred EEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc-
Q psy14431 640 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK- 714 (1219)
Q Consensus 640 VMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~- 714 (1219)
||||++ |+|.+++.. ..+++..+..|+.||+.||.|||+.||+||||||+||||+.++.+||+|||+|+......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999998 588887763 358999999999999999999999999999999999999999999999999998776543
Q ss_pred cccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 715 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 715 ~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
.......||+.|+|||++. ...|+.++|||||||++|+|+| |.+||.+.+....+..|..+..|..+
T Consensus 165 ~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p----------- 232 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP----------- 232 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-----------
T ss_pred ccccccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc-----------
Confidence 2234567899999999974 5569999999999999999999 56778888877777777766544322
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc--chhhh
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ--GKLAA 848 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq--Hpwfa 848 (1219)
+.+++.+.+|+.+||..||.+| +.+.++ |+||.
T Consensus 233 ----------------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 ----------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1236778999999999999997 445544 67763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=394.19 Aligned_cols=259 Identities=20% Similarity=0.324 Sum_probs=211.4
Q ss_pred cccCeeEEeeeeccCceEEEEEEE---cCCCeEEEEEEeecccc--CchhHHHHHHHHHHHHhccCCCCccEEeeeeecc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYD---KNNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV 632 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~d---k~TGk~VAIKvI~ks~~--s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~ 632 (1219)
.+++|.+++.||+|+||+||+|.+ ..+|+.||||++.+... .......+.+|+.+++.+..||||++++++|.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~-- 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec--
Confidence 467899999999999999999987 45799999999864322 22334567899999999986699999999997
Q ss_pred CCceEEEEEecch-hhHHHHHh-hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceeccccccccc
Q psy14431 633 NNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 710 (1219)
Q Consensus 633 d~~~LyLVMEyme-GSL~d~Lr-s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l 710 (1219)
+...+|+||||+. |+|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+|..+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 4668999999998 58988887 456889999999999999999999999999999999999999999999999999876
Q ss_pred CCcc-cccccccccccccCchhhhccc-cccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhc-CCCCCCchhh
Q psy14431 711 SDSK-ECLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKF 787 (1219)
Q Consensus 711 ~~~~-~~~ts~vGT~~Y~APEvLl~~~-~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l-~P~P~~~d~l 787 (1219)
.... .......|++.|+|||.+.+.. .++.++|||||||+||+|++|.+||.+.+.......+.... .+.++ .
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-~--- 255 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-Y--- 255 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-C---
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-C---
Confidence 5432 2344568999999999986443 57889999999999999999999998876655555554433 11111 0
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC-------HHHHHcchhhhc
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS-------EIEQLQGKLAAL 849 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR-------aiEALqHpwfaL 849 (1219)
.+..++.+.+||.+||.+||.+| +.++|+||||..
T Consensus 256 ---------------------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 256 ---------------------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp ---------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ---------------------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 12358899999999999999998 468999999954
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=376.22 Aligned_cols=239 Identities=23% Similarity=0.389 Sum_probs=191.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
-++|.+++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++..+. |||||+++++|. ..+.+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~--~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcC-CCCcccccceec--cCCceE
Confidence 457999999999999999999986 46789999986432 33456899999999995 999999999987 456799
Q ss_pred EEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||++ |+|.+++.. ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999998 689998864 5588999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
......||+.|+|||++. +..|+.++|||||||++|+|+| |.+||.+.+....+..|.....+..+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------- 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---------- 225 (263)
T ss_dssp --------CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT----------
T ss_pred eeecceecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc----------
Confidence 223467899999999974 5569999999999999999999 678888888877777777765443221
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..++.+.+|+.+||..||.+|+
T Consensus 226 -----------------------~~~~~l~~li~~cl~~~p~~Rp 247 (263)
T d1sm2a_ 226 -----------------------LASTHVYQIMNHCWKERPEDRP 247 (263)
T ss_dssp -----------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------ccCHHHHHHHHHHccCCHhHCc
Confidence 1256789999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=388.46 Aligned_cols=243 Identities=24% Similarity=0.370 Sum_probs=198.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC-----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG-----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+++.||.|+||+||+|.+..++ ..||+|++.... .......+.+|+.++..+.+|||||+++++|. +
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT--L 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--e
Confidence 367999999999999999999987554 369999886432 23344578899999999977999999999997 5
Q ss_pred CceEEEEEecch-hhHHHHHhhc------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKP 688 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKP 688 (1219)
.+.+|||||||+ |+|.+++... .+++..+..|+.||+.||.|||++|||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 667999999998 5899998642 478889999999999999999999999999999
Q ss_pred CCeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCC
Q psy14431 689 SNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAS 765 (1219)
Q Consensus 689 sNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s 765 (1219)
+|||++.++.+||+|||+|+....... .....+||+.|+|||++. +..|++++|||||||++|+|++ |.+||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654332 223567899999999974 5579999999999999999997 899999887
Q ss_pred cHHHHHHHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 766 TSHQLQLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 766 ~~e~L~kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
....+..++... .|..+ +.+++.+.+|+.+||..||.+|+
T Consensus 272 ~~~~~~~~~~~~~~~~~p---------------------------------~~~~~~l~~li~~cl~~dP~~RP 312 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMDQP---------------------------------FYATEEIYIIMQSCWAFDSRKRP 312 (325)
T ss_dssp CSHHHHHHHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHhcCCCCCCC---------------------------------CcCCHHHHHHHHHHcCCChhHCc
Confidence 766666665443 22211 12367899999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=371.64 Aligned_cols=245 Identities=20% Similarity=0.339 Sum_probs=206.4
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|.++++||+|+||+||+|+++ ++..||||++..... ....+.+|+.++..+. ||||++++++|. +.+.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~--~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLS-HEKLVQLYGVCT--KQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCC-CTTBCCEEEEEC--CSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcC-CCceeeEEEEEe--eCCceE
Confidence 467899999999999999999985 788999999975432 3456899999999995 999999999987 456799
Q ss_pred EEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc
Q psy14431 639 VVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~ 715 (1219)
+||||++ |+|..++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999998 67888765 45688999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
......||+.|+|||++. +..|+.++|||||||++|+|+| |++||.+.+..+....|..+.++.++.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------- 224 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---------- 224 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT----------
T ss_pred eeecccCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 233467899999999974 5569999999999999999998 899999999888888887766544331
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..++.+.+|+.+||..||.+| +.+.+.|
T Consensus 225 -----------------------~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 225 -----------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 125678999999999999986 4444554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=373.33 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=190.3
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCC---CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~T---Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
++|.+++.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+++.+. |||||+++++|. .+.
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~~ 81 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---ENP 81 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---SSS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCe
Confidence 5799999999999999999998654 467899987532 23444567889999999995 999999999985 457
Q ss_pred EEEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 637 LYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 637 LyLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
+|+||||++ |+|..++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+|+.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 899999998 57877765 346899999999999999999999999999999999999999999999999999876543
Q ss_pred cc-ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhcc
Q psy14431 714 KE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 791 (1219)
Q Consensus 714 ~~-~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~ 791 (1219)
.. ......||+.|+|||++. +..|+.++|||||||++|+|++ |.+||.+.+..+.+..|..+..++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~--------- 231 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP--------- 231 (273)
T ss_dssp ---------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------
T ss_pred cceeccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence 22 234557899999999984 5679999999999999999998 89999999988888888776543221
Q ss_pred CChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 792 KSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 792 ~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+.+++.+.+||.+||.+||.+|+
T Consensus 232 ------------------------~~~~~~~~~li~~cl~~dp~~Rp 254 (273)
T d1mp8a_ 232 ------------------------PNCPPTLYSLMTKCWAYDPSRRP 254 (273)
T ss_dssp ------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------CCCCHHHHHHHHHHcCCCHhHCc
Confidence 23467899999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=369.94 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=190.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC----eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG----k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
.+.|.+.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.++..+. |||||++++++. ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~--~~ 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS--KY 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe--cC
Confidence 356889999999999999999987654 579999985432 3344557889999999995 999999999987 46
Q ss_pred ceEEEEEecchh-hHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEymeG-SL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
..+++||||+.+ ++..++.. ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 679999999985 56666653 569999999999999999999999999999999999999999999999999998765
Q ss_pred Cccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 712 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 712 ~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++| .+||.+.+....+..+..+..|+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~----- 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP----- 235 (283)
T ss_dssp ------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-----
T ss_pred CCCccceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc-----
Confidence 4321 12345689999999997 456799999999999999999985 5667777777777777665543322
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...++.+.+|+.+||..||.+|+
T Consensus 236 ----------------------------~~~~~~l~~li~~cl~~~p~~RP 258 (283)
T d1mqba_ 236 ----------------------------MDCPSAIYQLMMQCWQQERARRP 258 (283)
T ss_dssp ----------------------------TTCBHHHHHHHHHHTCSSTTTSC
T ss_pred ----------------------------hhhHHHHHHHHHHHCcCCHhHCc
Confidence 11256788999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=368.68 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=193.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
++|.++++||+|+||.||+|.+.. +++.||||++.... .......+.+|+.++..+.+||||+.+++++.. .+
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CC
Confidence 679999999999999999999754 45789999986432 334456788899999999889999999998763 45
Q ss_pred ceEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS 696 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~d 696 (1219)
..+++|||||+ |+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 67899999998 689998863 237889999999999999999999999999999999999999
Q ss_pred CcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHH
Q psy14431 697 CSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLI 773 (1219)
Q Consensus 697 G~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kI 773 (1219)
|.+||+|||+|+....... .....+||+.|+|||++. +..++.++|||||||++|+|++| .+||.+.+....+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986654322 234567999999999985 56799999999999999999986 5789887655544443
Q ss_pred -HhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 774 -VNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 774 -ve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..+..|..+ +.+++.+.+|+.+||..||.+| +.++++|
T Consensus 250 ~~~~~~~~~~---------------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAP---------------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCC---------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333333211 1236778999999999999986 5565655
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=373.20 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=195.5
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCe----EEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk----~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
.+|.+++.||+|+||+||+|.+..+|+ .||+|.+... ........+.+|+.++..+. |||||++++++.. +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~---~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT---S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---C
Confidence 469999999999999999999988876 4777777533 23344567899999999995 9999999999873 3
Q ss_pred eEEEEEecch-hhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~ 712 (1219)
..++||+|+. |+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 4667777776 678887763 4689999999999999999999999999999999999999999999999999987654
Q ss_pred cccc--cccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhh
Q psy14431 713 SKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 789 (1219)
Q Consensus 713 ~~~~--~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~ 789 (1219)
.... .....||+.|+|||++. +..|+.++|||||||++|+|+| |.+||.+.+.......+..+..|+.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p------- 235 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP------- 235 (317)
T ss_dssp TCC--------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC-------
T ss_pred ccccccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 3322 23456899999999985 4569999999999999999998 89999988877777766665543322
Q ss_pred ccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcch
Q psy14431 790 GFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQGK 845 (1219)
Q Consensus 790 ~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqHp 845 (1219)
+.+++.+.+|+.+||..||.+| +.+.+.|.
T Consensus 236 --------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 236 --------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp --------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1236778999999999999986 45556553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=369.15 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=197.5
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
.++|++.+.||+|+||.||+|.+..+ ..||||++.... .....+.+|+.++..+. |||||++++++. .+.+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~---~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcc-cCCEeEEEEEEe---cCCeE
Confidence 46899999999999999999998765 569999986432 33467899999999995 999999999885 34579
Q ss_pred EEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCcc
Q psy14431 639 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 714 (1219)
Q Consensus 639 LVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~ 714 (1219)
+||||+. |+|..++.. ..+++..+..|+.+|+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999 467777753 459999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 715 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 715 -~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
.......||+.|+|||++. ...++.++|||||||++|+|++| .+||.+.+....+..+.....++.+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~---------- 236 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------- 236 (285)
T ss_dssp --------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----------
T ss_pred ceeeccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC----------
Confidence 2233467899999999984 56789999999999999999995 6777777777777777765533211
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHc--chhhhc
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQ--GKLAAL 849 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALq--HpwfaL 849 (1219)
+.+++.+.+|+.+||..||.+| +.+.+. ++||..
T Consensus 237 -----------------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 -----------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1236778999999999999997 444333 667743
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-42 Score=368.06 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=201.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+++.||+|+||+||+|++. .++..||||++... ........+.+|+.++..+. ||||++++++|. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~--~ 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFD-NPNIVKLLGVCA--V 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcC-CCCcccceeeec--c
Confidence 457999999999999999999875 35688999998643 23344567899999999995 999999999987 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-------------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCC
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 687 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-------------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLK 687 (1219)
.+.+++||||++ |+|.+++... .+++..+..|+.||+.||.|||+.||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 678999999998 6898888531 37888999999999999999999999999999
Q ss_pred CCCeeeccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCC
Q psy14431 688 PSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGA 764 (1219)
Q Consensus 688 PsNILLd~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~ 764 (1219)
|+|||++.++.+||+|||+|+...+... ..+..+||+.|+|||++. +..|+.++|||||||++|+|++|. +||.+.
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999986644322 223567889999999985 567999999999999999999985 899999
Q ss_pred CcHHHHHHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 765 STSHQLQLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 765 s~~e~L~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
+..+.+..+.....|..+ +.+++++.+|+.+||..||.+|+.
T Consensus 247 ~~~e~~~~v~~~~~~~~p---------------------------------~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 247 AHEEVIYYVRDGNILACP---------------------------------ENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp CHHHHHHHHHTTCCCCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CHHHHHHHHHcCCCCCCC---------------------------------ccchHHHHHHHHHHcCCChhHCcC
Confidence 988888887766543221 123677899999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-41 Score=361.43 Aligned_cols=256 Identities=20% Similarity=0.191 Sum_probs=198.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEE
Q psy14431 561 QQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV 640 (1219)
Q Consensus 561 qY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLV 640 (1219)
+|.+++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+.+|++|+.+.+++. .++..++|
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~--~~~~~~iv 81 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA--EGDYNVMV 81 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEE--ETTEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEe--cCCEEEEE
Confidence 699999999999999999999999999999988643222 246789999999974555555555554 56789999
Q ss_pred EecchhhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc---CCcceecccccccccCCccc
Q psy14431 641 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSKE 715 (1219)
Q Consensus 641 MEymeGSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~---dG~VKLiDFGLAr~l~~~~~ 715 (1219)
|||+++++...+. ...+++..+..++.||+.||.|||++|||||||||+|||++. ++.++|+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9999998877765 456999999999999999999999999999999999999864 45799999999987654321
Q ss_pred -------ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHHHHHHhhcCCCCCCchhhh
Q psy14431 716 -------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 788 (1219)
Q Consensus 716 -------~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~ 788 (1219)
.....+||+.|+|||++. +..+++++|||||||++|+|++|.+||.+.+.......+....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----------- 229 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----------- 229 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-----------
T ss_pred ccceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-----------
Confidence 223568999999999974 5569999999999999999999999998766544333322211
Q ss_pred hccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH-----HHHcchhhhc
Q psy14431 789 AGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI-----EQLQGKLAAL 849 (1219)
Q Consensus 789 ~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai-----EALqHpwfaL 849 (1219)
......+.+...+.+++.+.+++.+|+..||.+|+. +.|+|+|...
T Consensus 230 ---------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 ---------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 001112234455677899999999999999999842 4477777644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=366.12 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=198.2
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCC-------eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeec
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNK-------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA 631 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TG-------k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~ 631 (1219)
.++|.+++.||+|+||.||+|++..++ ..||||++.... .......+.+|+..+..+.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence 468999999999999999999876554 579999986443 33455778899999999977999999999997
Q ss_pred cCCceEEEEEecch-hhHHHHHhhc-----------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 632 VNNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 632 ~d~~~LyLVMEyme-GSL~d~Lrs~-----------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
+++.+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+.|||||||||+|||+
T Consensus 90 -~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 90 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp -SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred -cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 4678999999998 5899988632 38999999999999999999999999999999999999
Q ss_pred ccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14431 694 DKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL 770 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L 770 (1219)
+.+|.+||+|||++........ .....+||+.|+|||++. ++.|+.++|||||||++|+|++ |.+||.+.+.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 233467899999999984 5679999999999999999998 79999988887777
Q ss_pred HHHHhhcCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 771 QLIVNLVRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 771 ~kIve~l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
..+..+..|..+ +.+++.+.+|+.+||.+||.+|+
T Consensus 248 ~~i~~~~~~~~p---------------------------------~~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 248 KLLKEGHRMDKP---------------------------------SNCTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp HHHHTTCCCCCC---------------------------------SSCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHcCCCCCCC---------------------------------ccchHHHHHHHHHHccCCHhHCc
Confidence 666665543322 12367789999999999999963
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=364.42 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=191.1
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-CCC--eEEEEEEeecccc-CchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-NNK--QYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN 634 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-~TG--k~VAIKvI~ks~~-s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~ 634 (1219)
-.+|.+++.||+|+||.||+|.+. .++ ..||||++.+... .......+.+|+.++..+. |||||+++++|..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT--- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee---
Confidence 467999999999999999999864 333 4789999865433 3344567899999999995 9999999999962
Q ss_pred ceEEEEEecch-hhHHHHHh--hccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccC
Q psy14431 635 KDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 711 (1219)
Q Consensus 635 ~~LyLVMEyme-GSL~d~Lr--s~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~ 711 (1219)
..+++||||+. |++.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 46789999998 57777665 4569999999999999999999999999999999999999999999999999999765
Q ss_pred Cccc---ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhh
Q psy14431 712 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF 787 (1219)
Q Consensus 712 ~~~~---~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l 787 (1219)
.... ......||++|+|||++. +..++.++|||||||++|+|++ |.+||.+.+..+.+..|......+ +..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~--- 237 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-PRP--- 237 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-CCC---
T ss_pred cCCCcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-CCc---
Confidence 4322 223456788999999985 5679999999999999999998 899999999988888776543111 100
Q ss_pred hhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHHHH
Q psy14431 788 YAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEIEQ 841 (1219)
Q Consensus 788 ~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRaiEA 841 (1219)
+.+++.+.+|+.+||..||.+|+...
T Consensus 238 ----------------------------~~~~~~l~~li~~cl~~dp~~RPt~~ 263 (273)
T d1u46a_ 238 ----------------------------EDCPQDIYNVMVQCWAHKPEDRPTFV 263 (273)
T ss_dssp ----------------------------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----------------------------ccccHHHHHHHHHHcCCChhHCcCHH
Confidence 23367789999999999999985433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=363.24 Aligned_cols=236 Identities=22% Similarity=0.388 Sum_probs=191.0
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceE
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL 637 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~L 637 (1219)
+.++|.++++||+|+||.||+|.+ +|..||||++.. ......+.+|+.++..+. ||||+++++++.. +.+.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~ 76 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGL 76 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--CC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEe-cCCcE
Confidence 456799999999999999999987 478899999853 234567889999999995 9999999998853 33568
Q ss_pred EEEEecch-hhHHHHHhh---ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCc
Q psy14431 638 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 713 (1219)
Q Consensus 638 yLVMEyme-GSL~d~Lrs---~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~ 713 (1219)
|+||||++ |+|.+++.. ..+++..+..|+.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999998 589999864 34899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhhcCCCCCCchhhhhccC
Q psy14431 714 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 792 (1219)
Q Consensus 714 ~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~ 792 (1219)
. ....+|+.|+|||++. +..+++++|||||||++|+|++ |.+||.+.+..+....|.+...|..+
T Consensus 157 ~---~~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~---------- 222 (262)
T d1byga_ 157 Q---DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------- 222 (262)
T ss_dssp --------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC----------
T ss_pred C---ccccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 2 3457889999999985 4579999999999999999998 79999988888877777665543322
Q ss_pred ChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 793 SKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 793 s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..++.+.+|+.+||..||.+|+
T Consensus 223 -----------------------~~~~~~~~~li~~cl~~dP~~Rp 245 (262)
T d1byga_ 223 -----------------------DGCPPAVYEVMKNCWHLDAAMRP 245 (262)
T ss_dssp -----------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------ccCCHHHHHHHHHHcccCHhHCc
Confidence 12367789999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=367.96 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=202.7
Q ss_pred cccCeeEEeeeeccCceEEEEEEEcCCCeE--EEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCc
Q psy14431 558 DLQQQINLLKEGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK 635 (1219)
Q Consensus 558 dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~--VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~ 635 (1219)
++++|.+.++||+|+||.||+|.+..+|.. ||||.+.... .......+.+|+.+|..+.+|||||+++++|. +.+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~ 84 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRG 84 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETT
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe--cCC
Confidence 467899999999999999999999988874 6777764322 23345578999999999967999999999997 567
Q ss_pred eEEEEEecch-hhHHHHHhh-----------------ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCC
Q psy14431 636 DLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC 697 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs-----------------~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG 697 (1219)
.+|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 8999999999 689998863 3589999999999999999999999999999999999999999
Q ss_pred cceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhh
Q psy14431 698 SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL 776 (1219)
Q Consensus 698 ~VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGk-pPF~g~s~~e~L~kIve~ 776 (1219)
.+||+|||+|+....... .....||+.|+|||.+. ...|+.++|||||||++|+|++|. +||.+.+....+..|..+
T Consensus 165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp CEEECCTTCEESSCEECC-C----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred ceEEcccccccccccccc-ccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 999999999986654332 23457899999999984 567999999999999999999965 789888888877777665
Q ss_pred cCCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 777 VRPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 777 l~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
..|..+ ..+++.+.+||.+||..||.+| +.+++++
T Consensus 243 ~~~~~~---------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKP---------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCC---------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCC---------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 543322 1236789999999999999996 5666665
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=361.11 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=202.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEc-----CCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk-----~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.+.++||.|+||.||+|.+. .+++.||||++.... .......+.+|+.++..+.+|||||++++++. +
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT--I 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--e
Confidence 468999999999999999999863 567899999986443 34556678899999999977999999999997 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-------------------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI 693 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-------------------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILL 693 (1219)
...+|||||||+ |+|..++... .+++..+..|+.||+.||.|||+.|||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 567999999998 5888887632 48889999999999999999999999999999999999
Q ss_pred ccCCcceecccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14431 694 DKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL 770 (1219)
Q Consensus 694 d~dG~VKLiDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLT-GkpPF~g~s~~e~L 770 (1219)
+.++.++|+|||+++....... .....+||+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+....+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987765332 223467899999999984 5679999999999999999998 77888887776666
Q ss_pred HHHHhhc-CCCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCHH
Q psy14431 771 QLIVNLV-RPNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSEI 839 (1219)
Q Consensus 771 ~kIve~l-~P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRai 839 (1219)
..++... .|..+ ...++.+.+||.+||.+||.+|+.
T Consensus 258 ~~~i~~~~~~~~~---------------------------------~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 258 YKMIKEGFRMLSP---------------------------------EHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp HHHHHHTCCCCCC---------------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHhcCCCCCCc---------------------------------ccccHHHHHHHHHHcCCChhHCcC
Confidence 6655433 22211 123677999999999999999743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-40 Score=355.91 Aligned_cols=243 Identities=18% Similarity=0.199 Sum_probs=197.9
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEE
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV 639 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyL 639 (1219)
.+|.++++||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+.+||||+.+++++. .+...|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEE
Confidence 479999999999999999999999999999998854322 2236678899999987799999999886 5778999
Q ss_pred EEecchhhHHHHHhh--ccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeecc-----CCcceecccccccccCC
Q psy14431 640 VFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-----SCSIKIGDLGLARSLSD 712 (1219)
Q Consensus 640 VMEymeGSL~d~Lrs--~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~-----dG~VKLiDFGLAr~l~~ 712 (1219)
||||++++|.+++.. ..++...+..++.|++.||.|||+.|||||||||+|||++. ++.++|+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 999999999988873 46999999999999999999999999999999999999974 57899999999987653
Q ss_pred cc-------cccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhhcCCCCC
Q psy14431 713 SK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP 782 (1219)
Q Consensus 713 ~~-------~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s~~e~L---~kIve~l~P~P~ 782 (1219)
.. ......+||+.|+|||++. +..+++++|||||||++|+|++|.+||.+.+..... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~----- 232 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK----- 232 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----
T ss_pred CccccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-----
Confidence 21 1234568999999999984 567999999999999999999999999875443222 2221111
Q ss_pred CchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 783 HADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 783 ~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
...+...+.+.+++++.+++..|+..+|.+|+
T Consensus 233 ------------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 233 ------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp ------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred ------------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 11223445566788999999999999998875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-40 Score=359.45 Aligned_cols=278 Identities=26% Similarity=0.373 Sum_probs=202.6
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhcc----------CCCCccEEeeee
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----------RHPNIITMLDIY 629 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~----------~HPNIVkL~gvf 629 (1219)
++|.++++||.|+||+||+|++..+|+.||||++... ......+.+|+.+++.+. +||||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999633 223456778888888774 368999999998
Q ss_pred eccCCceEEEEEecch--hhHHHHHh---hccCChHHHHHHHHHHHHHHHHHHh-cccccCCCCCCCeeeccCCc-----
Q psy14431 630 KAVNNKDLYVVFEYME--NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS----- 698 (1219)
Q Consensus 630 e~~d~~~LyLVMEyme--GSL~d~Lr---s~~LseeeVr~Ia~QILsALaYLHS-~GIVHRDLKPsNILLd~dG~----- 698 (1219)
........++||.++. ++...... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7655556666666664 33333222 4568999999999999999999997 89999999999999987653
Q ss_pred -ceecccccccccCCcccccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCCCCCC------cHHHHH
Q psy14431 699 -IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS------TSHQLQ 771 (1219)
Q Consensus 699 -VKLiDFGLAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF~g~s------~~e~L~ 771 (1219)
++|+|||.+...... ....+||+.|+|||++. ...|+.++||||+||++++|++|++||.+.+ ....+.
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc---cccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 899999999876543 24568999999999985 4568999999999999999999999997543 234455
Q ss_pred HHHhhcCCCCCCchhhhhccCChhHHhhhH------HhhhhchhhHHHHh-------cccChhHHHHHHhccccCCCCC-
Q psy14431 772 LIVNLVRPNPPHADKFYAGFKSKHEREKFN------QVVVKCQKELQELQ-------SQVVEENTSKLKLQMELDSKDS- 837 (1219)
Q Consensus 772 kIve~l~P~P~~~d~l~~~~~s~~~relI~------klp~kcrk~L~el~-------p~lspeaiDLLsKMLq~DPeKR- 837 (1219)
.++..+++.+..+.... ......+. .+......++.... +..++.+.|||.+||.+||.+|
T Consensus 246 ~~~~~lg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNG-----KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHCSCCHHHHHHC-----TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHhCCCCHHHhhcc-----cccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 55555555443322110 00000000 01111111111111 2346789999999999999985
Q ss_pred -HHHHHcchhhhc
Q psy14431 838 -EIEQLQGKLAAL 849 (1219)
Q Consensus 838 -aiEALqHpwfaL 849 (1219)
+.++|+||||..
T Consensus 321 ta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 321 DAGGLVNHPWLKD 333 (362)
T ss_dssp CHHHHHTCGGGTT
T ss_pred CHHHHhcCcccCC
Confidence 889999999973
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=356.99 Aligned_cols=242 Identities=21% Similarity=0.373 Sum_probs=202.0
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcC-----CCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccC
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 633 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~-----TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d 633 (1219)
.++|.++++||+|+||.||+|.+.. ++..||||++... ........+.+|+.++..+. |||||++++++. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--Q 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEe--c
Confidence 4689999999999999999998752 3578999998643 23445567889999999995 999999999986 4
Q ss_pred CceEEEEEecch-hhHHHHHhhc-----------cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCccee
Q psy14431 634 NKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI 701 (1219)
Q Consensus 634 ~~~LyLVMEyme-GSL~d~Lrs~-----------~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKL 701 (1219)
.+.+++||||+. |+|.+++... .++...+..++.+|+.||.|||+.+|+||||||+|||++.++.+||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 667899999998 6888887621 3578889999999999999999999999999999999999999999
Q ss_pred cccccccccCCccc--ccccccccccccCchhhhccccccccccchhHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhhcC
Q psy14431 702 GDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR 778 (1219)
Q Consensus 702 iDFGLAr~l~~~~~--~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTG-kpPF~g~s~~e~L~kIve~l~ 778 (1219)
+|||+|+....... .....+||+.|+|||.+. +..++.++|||||||++|+|++| .+||.+.+....+..|.+...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999987654322 223457899999999974 56689999999999999999998 599999998888888877664
Q ss_pred CCCCCchhhhhccCChhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCCH
Q psy14431 779 PNPPHADKFYAGFKSKHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDSE 838 (1219)
Q Consensus 779 P~P~~~d~l~~~~~s~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKRa 838 (1219)
+..+ +.+++.+.+++.+||..||.+|+
T Consensus 254 ~~~p---------------------------------~~~~~~l~~li~~cl~~~P~~RP 280 (308)
T d1p4oa_ 254 LDKP---------------------------------DNCPDMLFELMRMCWQYNPKMRP 280 (308)
T ss_dssp CCCC---------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCc---------------------------------ccchHHHHHHHHHHcCCChhHCc
Confidence 4322 12367799999999999999973
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=352.06 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=190.2
Q ss_pred EeeeeccCceEEEEEEEcCCC---eEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEEEEE
Q psy14431 565 LLKEGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF 641 (1219)
Q Consensus 565 LKkIGeGgFGtVYlA~dk~TG---k~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~LyLVM 641 (1219)
-++||+|+||+||+|.+..++ ..||||++.. .........+.+|+.++..+. |||||++++++.. ..+.+++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEE-TTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEe-cCCceEEEE
Confidence 578999999999999987643 4699999853 234556678999999999996 9999999998753 356799999
Q ss_pred ecch-hhHHHHHhhc--cCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccccccccCCccc---
Q psy14431 642 EYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--- 715 (1219)
Q Consensus 642 Eyme-GSL~d~Lrs~--~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFGLAr~l~~~~~--- 715 (1219)
|||+ |+|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999 5788887743 467788899999999999999999999999999999999999999999999987654321
Q ss_pred -ccccccccccccCchhhhccccccccccchhHHHHHHHHHhCCCCC-CCCCcHHHHHHHHhhcCCCCCCchhhhhccCC
Q psy14431 716 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF-PGASTSHQLQLIVNLVRPNPPHADKFYAGFKS 793 (1219)
Q Consensus 716 -~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~ILyELLTGkpPF-~g~s~~e~L~kIve~l~P~P~~~d~l~~~~~s 793 (1219)
......||+.|+|||++. ...++.++|||||||++|+|++|..|| .+.+..+....+..+..|..+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p----------- 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----------- 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC-----------
T ss_pred eecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 223457899999999974 556999999999999999999966554 445555556666665544322
Q ss_pred hhHHhhhHHhhhhchhhHHHHhcccChhHHHHHHhccccCCCCC--HHHHHcc
Q psy14431 794 KHEREKFNQVVVKCQKELQELQSQVVEENTSKLKLQMELDSKDS--EIEQLQG 844 (1219)
Q Consensus 794 ~~~relI~klp~kcrk~L~el~p~lspeaiDLLsKMLq~DPeKR--aiEALqH 844 (1219)
+.+++.+.+|+.+||..||.+| +.+.++|
T Consensus 257 ----------------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 257 ----------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1236678899999999999996 5555554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=349.78 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=161.0
Q ss_pred cCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHH--HHHHHhccCCCCccEEeeeeeccCC--c
Q psy14431 560 QQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE--ILFLKSFQRHPNIITMLDIYKAVNN--K 635 (1219)
Q Consensus 560 qqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lRE--I~ILr~L~~HPNIVkL~gvfe~~d~--~ 635 (1219)
.+|.+.+.||+|+||.||+|++ +|..||||++... ......+| +..+..+ +|||||++++++...+. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcce
Confidence 4688999999999999999975 5899999998532 22334444 4444556 49999999999875433 3
Q ss_pred eEEEEEecch-hhHHHHHhhccCChHHHHHHHHHHHHHHHHHHh--------cccccCCCCCCCeeeccCCcceeccccc
Q psy14431 636 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDLGL 706 (1219)
Q Consensus 636 ~LyLVMEyme-GSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS--------~GIVHRDLKPsNILLd~dG~VKLiDFGL 706 (1219)
.+|+|||||. |+|..+++...+++..+..++.+++.||.|||+ .|||||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 6899999998 599999998889999999999999999999996 5999999999999999999999999999
Q ss_pred ccccCCccc----ccccccccccccCchhhhcc-----ccccccccchhHHHHHHHHHhCCCCCCC
Q psy14431 707 ARSLSDSKE----CLTEYIATRWYRAPEILISN-----RRYTHHVDIWSLGCILAEMLQSKPLFPG 763 (1219)
Q Consensus 707 Ar~l~~~~~----~~ts~vGT~~Y~APEvLl~~-----~~yT~kSDIWSLG~ILyELLTGkpPF~g 763 (1219)
+........ .....+||+.|+|||++... ..++.++|||||||++|+|++|.+||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 987654322 22356899999999997432 1368899999999999999999988854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.9e-23 Score=205.98 Aligned_cols=172 Identities=14% Similarity=0.078 Sum_probs=121.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccC----------------chhHHHHHHHHHHHHhccCCCCccEE
Q psy14431 562 QINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----------------KTDAQRTYREILFLKSFQRHPNIITM 625 (1219)
Q Consensus 562 Y~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s----------------~~~~e~~lREI~ILr~L~~HPNIVkL 625 (1219)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ........+|...+..+. |++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 457899999999999999985 6899999987532110 011233456888888885 8999988
Q ss_pred eeeeeccCCceEEEEEecchhhHHHHHhhccCChHHHHHHHHHHHHHHHHHHhcccccCCCCCCCeeeccCCcceecccc
Q psy14431 626 LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 705 (1219)
Q Consensus 626 ~gvfe~~d~~~LyLVMEymeGSL~d~Lrs~~LseeeVr~Ia~QILsALaYLHS~GIVHRDLKPsNILLd~dG~VKLiDFG 705 (1219)
+++.. .++||+|+++... ..++...+..++.||+.||.|||+.||+||||||+|||+++++ ++|+|||
T Consensus 80 ~~~~~------~~lvme~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 80 YAWEG------NAVLMELIDAKEL-----YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp EEEET------TEEEEECCCCEEG-----GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred EEecC------CEEEEEeeccccc-----cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECC
Confidence 76542 2799999997421 2356666788999999999999999999999999999998655 8999999
Q ss_pred cccccCCcccccccccccccccCchhhhccccccccccchhHHHHH
Q psy14431 706 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCIL 751 (1219)
Q Consensus 706 LAr~l~~~~~~~ts~vGT~~Y~APEvLl~~~~yT~kSDIWSLG~IL 751 (1219)
.|.....+... .+...-...-.+.+ ...|+..+|+||+.--+
T Consensus 148 ~a~~~~~~~~~--~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR--EILERDVRNIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH--HHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH--HHHHHHHHHHHHHH--cCCCCCcccHHHHHHHH
Confidence 99766543211 00000000001222 34688999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.1e-06 Score=89.18 Aligned_cols=82 Identities=9% Similarity=0.068 Sum_probs=56.3
Q ss_pred ccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCceEE
Q psy14431 559 LQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY 638 (1219)
Q Consensus 559 IqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~Ly 638 (1219)
+..|.+++..+.|+.+.||++. .++..++||+....... ....+.+|..++..+..+--+++++.+.. +++..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceE
Confidence 3457777776666668999884 44566788877533221 23346788888888765545677777665 457889
Q ss_pred EEEecchh
Q psy14431 639 VVFEYMEN 646 (1219)
Q Consensus 639 LVMEymeG 646 (1219)
+||++++|
T Consensus 87 lv~~~l~G 94 (263)
T d1j7la_ 87 LLMSEADG 94 (263)
T ss_dssp EEEECCSS
T ss_pred EEEEeccc
Confidence 99999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=6.2e-06 Score=90.90 Aligned_cols=79 Identities=18% Similarity=0.206 Sum_probs=50.0
Q ss_pred EEeeeeccCceEEEEEEEcCCCeEEEEEEeecccc-----CchhHHHHHHHHHHHHhccCC-C-CccEEeeeeeccCCce
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-----NKTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNNKD 636 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~-----s~~~~e~~lREI~ILr~L~~H-P-NIVkL~gvfe~~d~~~ 636 (1219)
..+.||.|....||++.+..+|+.|+||...+... ......+...|..+|..+..+ | .+++++.+ . ...
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d---~~~ 105 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D---TEM 105 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E---TTT
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-c---CCC
Confidence 35678999999999999888888999997543211 122334566788888877544 2 34555543 2 334
Q ss_pred EEEEEecchh
Q psy14431 637 LYVVFEYMEN 646 (1219)
Q Consensus 637 LyLVMEymeG 646 (1219)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 5789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.56 E-value=0.00013 Score=73.27 Aligned_cols=72 Identities=10% Similarity=0.129 Sum_probs=45.9
Q ss_pred eeeccC-ceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEeeeeeccCCceEEEEEecc
Q psy14431 567 KEGKGA-YGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKAVNNKDLYVVFEYM 644 (1219)
Q Consensus 567 kIGeGg-FGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~gvfe~~d~~~LyLVMEym 644 (1219)
.+..|. .+.||+... .+|..+++|..... ....+..|...++.+..+. .+++++.+.. +++..++||+|+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEee
Confidence 444454 368898864 45666888976422 1223567777777665432 2566666654 456789999999
Q ss_pred hh
Q psy14431 645 EN 646 (1219)
Q Consensus 645 eG 646 (1219)
+|
T Consensus 89 ~G 90 (255)
T d1nd4a_ 89 PG 90 (255)
T ss_dssp SS
T ss_pred ec
Confidence 86
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.16 E-value=7.4e-05 Score=62.89 Aligned_cols=35 Identities=29% Similarity=0.721 Sum_probs=32.3
Q ss_pred ccccccccccccCCCCCCCCCCccccccCCCcccccc
Q psy14431 1180 KGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECGT 1216 (1219)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1216 (1219)
|+|.|...+|+.||.|++|++.||++++ +++.|..
T Consensus 3 k~H~F~~~~~~~pt~C~~C~~~i~g~~~--~g~~C~~ 37 (62)
T d1xa6a3 3 KTHNFKVHTFRGPHWCEYCANFMWGLIA--QGVRCSD 37 (62)
T ss_dssp CCCCCCEECCSSCCBCTTTCCBCCTTTT--CEECCSS
T ss_pred CCCEEEEeeCCCCCCCcccCcccccccc--CeEEcCC
Confidence 7999999999999999999999999998 6888863
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Probab=96.95 E-value=0.00015 Score=61.62 Aligned_cols=37 Identities=24% Similarity=0.588 Sum_probs=33.1
Q ss_pred cccccccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1177 IALKGHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
+|.++|.|...+|..|+.|++|++.||++++ .++.|.
T Consensus 4 ~p~~~H~F~~~~~~~~~~C~~C~~~i~g~~~--~g~~C~ 40 (66)
T d1tbna_ 4 DPRNKHKFRLHSYSSPTFCDHCGSLLYGLVH--QGMKCS 40 (66)
T ss_dssp CCCCSCCEEECCSSSCCBCSSSCCBCCTTSS--SCEEET
T ss_pred CCCCCCceEEEeCCCCcCCcCCCCcccCccc--CccccC
Confidence 4667999999999999999999999999886 688875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.83 E-value=0.0026 Score=69.09 Aligned_cols=73 Identities=10% Similarity=0.129 Sum_probs=52.2
Q ss_pred EEeeeeccCceEEEEEEEcCC-------CeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCCCccEEeeeeeccCCce
Q psy14431 564 NLLKEGKGAYGIVYKAYDKNN-------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 636 (1219)
Q Consensus 564 ILKkIGeGgFGtVYlA~dk~T-------Gk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HPNIVkL~gvfe~~d~~~ 636 (1219)
.++.|+.|-.-.+|++..... +..|.+++.-. ........+|..+++.+..+.-.++++++|. +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---~-- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFS---G-- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---T--
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---C--
Confidence 457888899999999987542 35577776631 2233456689999998886665678887764 2
Q ss_pred EEEEEecchh
Q psy14431 637 LYVVFEYMEN 646 (1219)
Q Consensus 637 LyLVMEymeG 646 (1219)
++|++|++|
T Consensus 117 -g~I~efi~g 125 (395)
T d1nw1a_ 117 -GRLEEYIPS 125 (395)
T ss_dssp -EEEECCCCE
T ss_pred -ceEEEEecc
Confidence 688999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.0065 Score=63.10 Aligned_cols=154 Identities=9% Similarity=0.018 Sum_probs=81.0
Q ss_pred hHHHHhhccccccCeeEEeeeeccCceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCC-CCccEEe
Q psy14431 548 SIDQLMKDREDLQQQINLLKEGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITML 626 (1219)
Q Consensus 548 sl~eLL~dr~dIqqY~ILKkIGeGgFGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~H-PNIVkL~ 626 (1219)
.+..++. .|++....-++.|..|.--+.|.+... .|+ +++|++.... . ...+..++.++..+..+ ..++..+
T Consensus 7 el~~~l~-~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 7 ELRNFLT-QYDVGSLTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp HHHHHHT-TBCCCCEEEEEEECC---EEEEEEEES-SCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred HHHHHHH-hCCCCCceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCCC-C---HHHHHHHHHHHHhhhhccccccccc
Confidence 3455664 488888888888888988999998754 354 7899874321 1 22334456666665522 1111111
Q ss_pred ee----eeccCCceEEEEEecchhh------------HHHHH---h----hc------c------------------CCh
Q psy14431 627 DI----YKAVNNKDLYVVFEYMEND------------LNKVI---R----DK------I------------------LKD 659 (1219)
Q Consensus 627 gv----fe~~d~~~LyLVMEymeGS------------L~d~L---r----s~------~------------------Lse 659 (1219)
.. +...-.+..+.++.++.|. +...+ . .. . ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 0011123456666666531 10010 0 00 0 000
Q ss_pred HHHHHHHHHHHHHHHHHH----hcccccCCCCCCCeeeccCCcceeccccccc
Q psy14431 660 VHIRYIMFQLCNGLSYIH----ACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 708 (1219)
Q Consensus 660 eeVr~Ia~QILsALaYLH----S~GIVHRDLKPsNILLd~dG~VKLiDFGLAr 708 (1219)
......+..+...+.-.+ ..|+||+|+.|+||+++.++..-|+|||.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222333333332 2489999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.13 E-value=0.0088 Score=63.21 Aligned_cols=70 Identities=13% Similarity=0.112 Sum_probs=41.9
Q ss_pred ceEEEEEEEcCCCeEEEEEEeeccccCchhHHHHHHHHHHHHhccCCC-CccEEeeee---eccCCceEEEEEecchh
Q psy14431 573 YGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIY---KAVNNKDLYVVFEYMEN 646 (1219)
Q Consensus 573 FGtVYlA~dk~TGk~VAIKvI~ks~~s~~~~e~~lREI~ILr~L~~HP-NIVkL~gvf---e~~d~~~LyLVMEymeG 646 (1219)
--.||.+.. .+|..|++|+.++... ....+..|+..+..+..+. -++..+..- ....++..+.|++|++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999965 4578899998864322 2345667888887776321 122121110 01124568889999876
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.95 E-value=0.0012 Score=53.05 Aligned_cols=32 Identities=31% Similarity=0.860 Sum_probs=29.6
Q ss_pred ccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1182 HEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
|.|.+.+|..||.|++|++.||++++ +++.|.
T Consensus 1 H~F~~~~~~~~~~C~~C~~~i~g~~~--qg~~C~ 32 (50)
T d1ptqa_ 1 HRFKVYNYMSPTFCDHCGSLLWGLVK--QGLKCE 32 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSS--CEEEET
T ss_pred CceEEecCCCCcCCcccCCcccCccc--CcEECC
Confidence 89999999999999999999999987 688775
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.68 E-value=0.029 Score=49.48 Aligned_cols=34 Identities=24% Similarity=0.499 Sum_probs=30.1
Q ss_pred cccccccccccCCCCCCCCCCccccccCCCccccc
Q psy14431 1181 GHEFLNISYHMPTTCEVCPKPIWHIIRPPPALECG 1215 (1219)
Q Consensus 1181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1215 (1219)
.|-|....|..|+.|++|++.||++++. +++.|.
T Consensus 27 ~H~w~~~n~~~~~~C~~C~~~i~~~~~~-qg~~C~ 60 (84)
T d1r79a_ 27 PHQWLEGNLPVSAKCTVCDKTCGSVLRL-QDWRCL 60 (84)
T ss_dssp CCCEEESCCCTTCBCSSSCCBCCCTTTC-CCEEES
T ss_pred CceEEeCCCCCCCCCcccCcccCCcccc-CcEecC
Confidence 5999999999999999999999999864 378775
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.46 E-value=0.0097 Score=48.11 Aligned_cols=27 Identities=19% Similarity=0.459 Sum_probs=24.6
Q ss_pred ccccccccccccCCCCCCCCCCccccc
Q psy14431 1180 KGHEFLNISYHMPTTCEVCPKPIWHII 1206 (1219)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1206 (1219)
.+|.|...+|..|+.|+.|++.||..+
T Consensus 2 ~~H~F~~~~f~~~~~C~~C~~~i~~g~ 28 (52)
T d1faqa_ 2 TTHNFARKTFLKLAFCDICQKFLLNGF 28 (52)
T ss_dssp CCCCCEEECCSSCEECTTSSSEECSEE
T ss_pred CceEEEEeeCCCCcCCccCCCccccCC
Confidence 589999999999999999999999543
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.77 E-value=0.031 Score=44.96 Aligned_cols=25 Identities=28% Similarity=0.488 Sum_probs=21.0
Q ss_pred ccccccccccccCCCCCCCCCCcccc
Q psy14431 1180 KGHEFLNISYHMPTTCEVCPKPIWHI 1205 (1219)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 1205 (1219)
+.|.|...+|..|| |+.|++.||..
T Consensus 3 i~H~F~~~~~~~~t-C~~C~~~l~qg 27 (49)
T d1kbea_ 3 VTHRFSTKSWLSQV-CNVCQKSMIFG 27 (49)
T ss_dssp CCCCEEEECCSSCC-CSSSCCSSCCE
T ss_pred CccEEeecCcCCCC-chhhchhhhCc
Confidence 37999998887665 99999999953
|